7:117120149:A:C,P13569,M1L,0.984,Loss of MoRF binding (P = 0.1564); Loss of glycosylation at P5 (P = 0.1716); Loss of phosphorylation at S4 (P = 0.3269); Loss of disorder (P = 0.3646); Loss of solvent accessibility (P = 0.5485)
7:117120149:A:G,P13569,M1V,0.977,Loss of glycosylation at P5 (P = 0.1081); Loss of MoRF binding (P = 0.2189); Gain of helix (P = 0.2684); Loss of phosphorylation at S4 (P = 0.2955); Loss of solvent accessibility (P = 0.3103)
7:117120149:A:T,P13569,M1L,0.984,Loss of MoRF binding (P = 0.1564); Loss of glycosylation at P5 (P = 0.1716); Loss of phosphorylation at S4 (P = 0.3269); Loss of disorder (P = 0.3646); Loss of solvent accessibility (P = 0.5485)
7:117120150:T:A,P13569,M1K,0.982,Loss of stability (P = 0.0263); Gain of MoRF binding (P = 0.0526); Gain of glycosylation at P5 (P = 0.2398); Gain of helix (P = 0.2684); Gain of disorder (P = 0.2783)
7:117120150:T:C,P13569,M1T,0.98,Gain of catalytic residue at M1 (P = 0.0203); Gain of glycosylation at M1 (P = 0.0221); Gain of phosphorylation at M1 (P = 0.026); Loss of stability (P = 0.0658); Loss of MoRF binding (P = 0.1783)
7:117120150:T:G,P13569,M1R,0.985,Gain of MoRF binding (P = 0.0225); Gain of solvent accessibility (P = 0.11); Loss of stability (P = 0.1554); Gain of phosphorylation at S4 (P = 0.2386); Gain of helix (P = 0.2684)
7:117120151:G:A,P13569,M1I,0.987,Gain of catalytic residue at M1 (P = 0.0426); Loss of glycosylation at P5 (P = 0.0961); Loss of phosphorylation at S4 (P = 0.1912); Loss of MoRF binding (P = 0.192); Loss of disorder (P = 0.2984)
7:117120151:G:C,P13569,M1I,0.987,Gain of catalytic residue at M1 (P = 0.0426); Loss of glycosylation at P5 (P = 0.0961); Loss of phosphorylation at S4 (P = 0.1912); Loss of MoRF binding (P = 0.192); Loss of disorder (P = 0.2984)
7:117120151:G:T,P13569,M1I,0.987,Gain of catalytic residue at M1 (P = 0.0426); Loss of glycosylation at P5 (P = 0.0961); Loss of phosphorylation at S4 (P = 0.1912); Loss of MoRF binding (P = 0.192); Loss of disorder (P = 0.2984)
7:117120152:C:A,P13569,Q2K,0.289,Gain of methylation at Q2 (P = 0.0084); Gain of MoRF binding (P = 0.0356); Gain of ubiquitination at Q2 (P = 0.0539); Gain of phosphorylation at S4 (P = 0.2553); Gain of helix (P = 0.2684)
7:117120152:C:G,P13569,Q2E,0.278,Loss of MoRF binding (P = 0.0808); Gain of phosphorylation at S4 (P = 0.2563); Gain of disorder (P = 0.2999); Gain of glycosylation at P5 (P = 0.3279); Loss of sheet (P = 0.6423)
7:117120153:A:C,P13569,Q2P,0.366,Gain of catalytic residue at Q2 (P = 0.0023); Gain of glycosylation at Q2 (P = 0.0137); Loss of MoRF binding (P = 0.1082); Gain of relative solvent accessibility (P = 0.1571); Gain of helix (P = 0.2684)
7:117120153:A:G,P13569,Q2R,0.26,Gain of MoRF binding (P = 0.0268); Gain of phosphorylation at S4 (P = 0.2134); Loss of glycosylation at P5 (P = 0.2228); Loss of relative solvent accessibility (P = 0.3219); Gain of disorder (P = 0.3246)
7:117120153:A:T,P13569,Q2L,0.277,Gain of stability (P = 0.0159); Gain of MoRF binding (P = 0.151); Gain of relative solvent accessibility (P = 0.1571); Loss of disorder (P = 0.2333); Loss of glycosylation at P5 (P = 0.2566)
7:117120154:G:C,P13569,Q2H,0.246,Loss of MoRF binding (P = 0.1985); Loss of glycosylation at P5 (P = 0.2016); Gain of disorder (P = 0.2672); Loss of phosphorylation at S4 (P = 0.3512); Loss of stability (P = 0.6353)
7:117120154:G:T,P13569,Q2H,0.246,Loss of MoRF binding (P = 0.1985); Loss of glycosylation at P5 (P = 0.2016); Gain of disorder (P = 0.2672); Loss of phosphorylation at S4 (P = 0.3512); Loss of stability (P = 0.6353)
7:117120155:A:G,P13569,R3G,0.464,Loss of solvent accessibility (P = 0.0159); Loss of MoRF binding (P = 0.0496); Loss of glycosylation at P5 (P = 0.0682); Loss of phosphorylation at S4 (P = 0.1109); Loss of ubiquitination at K8 (P = 0.1923)
7:117120155:A:T,P13569,R3W,0.783,Loss of solvent accessibility (P = 0.0217); Loss of disorder (P = 0.0508); Loss of phosphorylation at S4 (P = 0.0584); Loss of glycosylation at P5 (P = 0.0676); Loss of MoRF binding (P = 0.0845)
7:117120156:G:A,P13569,R3K,0.391,Gain of methylation at R3 (P = 0.0036); Gain of ubiquitination at R3 (P = 0.0177); Loss of MoRF binding (P = 0.0933); Gain of disorder (P = 0.2452); Gain of helix (P = 0.2684)
7:117120156:G:C,P13569,R3T,0.444,Gain of glycosylation at R3 (P = 0.0339); Loss of MoRF binding (P = 0.0479); Loss of phosphorylation at S4 (P = 0.0866); Loss of solvent accessibility (P = 0.089); Loss of ubiquitination at K8 (P = 0.1664)
7:117120156:G:T,P13569,R3M,0.451,Loss of solvent accessibility (P = 0.0146); Loss of MoRF binding (P = 0.0627); Loss of glycosylation at P5 (P = 0.0644); Gain of catalytic residue at R3 (P = 0.1132); Loss of phosphorylation at S4 (P = 0.1461)
7:117120157:G:C,P13569,R3S,0.443,Loss of MoRF binding (P = 0.0494); Gain of phosphorylation at R3 (P = 0.0542); Loss of solvent accessibility (P = 0.0606); Gain of disorder (P = 0.1723); Loss of glycosylation at P5 (P = 0.1743)
7:117120157:G:T,P13569,R3S,0.443,Loss of MoRF binding (P = 0.0494); Gain of phosphorylation at R3 (P = 0.0542); Loss of solvent accessibility (P = 0.0606); Gain of disorder (P = 0.1723); Loss of glycosylation at P5 (P = 0.1743)
7:117120158:T:A,P13569,S4T,0.29,Loss of helix (P = 0.0558); Loss of disorder (P = 0.0837); Loss of phosphorylation at S4 (P = 0.1069); Loss of ubiquitination at K8 (P = 0.1172); Loss of MoRF binding (P = 0.1446)
7:117120158:T:C,P13569,S4P,0.389,Gain of glycosylation at S4 (P = 0.0207); Loss of phosphorylation at S4 (P = 0.0237); Gain of catalytic residue at S4 (P = 0.0243); Loss of helix (P = 0.0376); Loss of MoRF binding (P = 0.0716)
7:117120158:T:G,P13569,S4A,0.334,Loss of phosphorylation at S4 (P = 0.0237); Loss of helix (P = 0.0558); Loss of methylation at K8 (P = 0.0567); Loss of disorder (P = 0.0702); Gain of MoRF binding (P = 0.1413)
7:117120159:C:G,P13569,S4W,0.386,Gain of MoRF binding (P = 0.012); Loss of disorder (P = 0.0135); Loss of phosphorylation at S4 (P = 0.0237); Loss of helix (P = 0.0376); Loss of methylation at K8 (P = 0.0599)
7:117120161:C:A,P13569,P5T,0.455,Loss of glycosylation at P5 (P = 0.0216); Gain of MoRF binding (P = 0.0309); Gain of phosphorylation at P5 (P = 0.0542); Loss of methylation at K8 (P = 0.1062); Gain of ubiquitination at K8 (P = 0.1472)
7:117120161:C:G,P13569,P5A,0.48,Loss of glycosylation at P5 (P = 0.0149); Gain of MoRF binding (P = 0.0204); Gain of helix (P = 0.062); Loss of loop (P = 0.0986); Gain of ubiquitination at K8 (P = 0.1063)
7:117120161:C:T,P13569,P5S,0.51,Gain of phosphorylation at P5 (P = 0.0143); Loss of glycosylation at P5 (P = 0.0191); Gain of MoRF binding (P = 0.0368); Gain of disorder (P = 0.0789); Gain of ubiquitination at K8 (P = 0.1295)
7:117120162:C:A,P13569,P5H,0.448,Loss of glycosylation at P5 (P = 0.0149); Gain of helix (P = 0.0199); Loss of loop (P = 0.0235); Loss of ubiquitination at K8 (P = 0.0468); Gain of MoRF binding (P = 0.0542)
7:117120162:C:G,P13569,P5R,0.487,Gain of MoRF binding (P = 2e-04); Loss of glycosylation at P5 (P = 0.0149); Loss of ubiquitination at K8 (P = 0.0211); Loss of methylation at K8 (P = 0.0821); Gain of solvent accessibility (P = 0.1422)
7:117120162:C:T,P13569,P5L,0.729,Loss of glycosylation at P5 (P = 0.0149); Gain of MoRF binding (P = 0.0274); Loss of disorder (P = 0.0722); Loss of phosphorylation at S4 (P = 0.1114); Loss of methylation at K8 (P = 0.1471)
7:117120164:C:A,P13569,L6M,0.448,Gain of MoRF binding (P = 0.0619); Gain of ubiquitination at K8 (P = 0.0853); Gain of disorder (P = 0.101); Gain of helix (P = 0.132); Gain of phosphorylation at S10 (P = 0.1955)
7:117120164:C:G,P13569,L6V,0.738,Loss of glycosylation at P5 (P = 0.0845); Gain of MoRF binding (P = 0.0858); Gain of ubiquitination at K8 (P = 0.1295); Gain of disorder (P = 0.2159); Gain of methylation at K8 (P = 0.2224)
7:117120165:T:A,P13569,L6Q,0.483,Gain of disorder (P = 0.0379); Gain of helix (P = 0.0696); Gain of MoRF binding (P = 0.0728); Gain of ubiquitination at K8 (P = 0.1165); Gain of methylation at K8 (P = 0.1576)
7:117120165:T:C,P13569,L6P,0.481,Gain of glycosylation at L6 (P = 0.0023); Gain of disorder (P = 0.0205); Loss of MoRF binding (P = 0.0713); Gain of ubiquitination at K8 (P = 0.1295); Gain of helix (P = 0.132)
7:117120165:T:G,P13569,L6R,0.473,Gain of MoRF binding (P = 4e-04); Gain of disorder (P = 0.0274); Loss of ubiquitination at K8 (P = 0.0286); Gain of solvent accessibility (P = 0.1071); Gain of phosphorylation at S10 (P = 0.126)
7:117120167:G:A,P13569,E7K,0.465,Gain of MoRF binding (P = 0); Gain of methylation at E7 (P = 0.0037); Loss of ubiquitination at K8 (P = 0.0211); Loss of stability (P = 0.1016); Gain of helix (P = 0.132)
7:117120167:G:C,P13569,E7Q,0.284,Gain of MoRF binding (P = 0.0113); Loss of ubiquitination at K8 (P = 0.0234); Loss of phosphorylation at S4 (P = 0.1283); Loss of disorder (P = 0.2182); Gain of glycosylation at P5 (P = 0.2365)
7:117120168:A:C,P13569,E7A,0.258,Loss of ubiquitination at K8 (P = 0.0304); Gain of MoRF binding (P = 0.0399); Loss of disorder (P = 0.085); Gain of helix (P = 0.132); Loss of phosphorylation at S10 (P = 0.1777)
7:117120168:A:G,P13569,E7G,0.287,Loss of stability (P = 0.026); Loss of ubiquitination at K8 (P = 0.0297); Gain of MoRF binding (P = 0.0388); Loss of glycosylation at P5 (P = 0.0977); Loss of disorder (P = 0.1444)
7:117120168:A:T,P13569,E7V,0.311,Loss of ubiquitination at K8 (P = 0.0272); Loss of disorder (P = 0.0318); Gain of MoRF binding (P = 0.0382); Gain of catalytic residue at E7 (P = 0.0476); Loss of glycosylation at P5 (P = 0.0593)
7:117120169:A:C,P13569,E7D,0.199,Loss of glycosylation at P5 (P = 0.0991); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.136); Loss of methylation at K8 (P = 0.1519); Loss of ubiquitination at K8 (P = 0.1664)
7:117120169:A:T,P13569,E7D,0.199,Loss of glycosylation at P5 (P = 0.0991); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.136); Loss of methylation at K8 (P = 0.1519); Loss of ubiquitination at K8 (P = 0.1664)
7:117120170:A:C,P13569,K8Q,0.384,Loss of methylation at K8 (P = 0.0084); Loss of ubiquitination at K8 (P = 0.0107); Loss of MoRF binding (P = 0.0563); Loss of helix (P = 0.1299); Loss of phosphorylation at S10 (P = 0.1343)
7:117120170:A:G,P13569,K8E,0.381,Loss of methylation at K8 (P = 0.0084); Loss of MoRF binding (P = 0.0094); Loss of ubiquitination at K8 (P = 0.0107); Loss of helix (P = 0.1299); Loss of glycosylation at P5 (P = 0.1871)
7:117120171:A:C,P13569,K8T,0.404,Loss of methylation at K8 (P = 0.0084); Loss of ubiquitination at K8 (P = 0.0107); Loss of MoRF binding (P = 0.0554); Loss of disorder (P = 0.0781); Gain of phosphorylation at K8 (P = 0.0958)
7:117120171:A:G,P13569,K8R,0.318,Loss of methylation at K8 (P = 0.0099); Loss of ubiquitination at K8 (P = 0.0107); Gain of MoRF binding (P = 0.0786); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1409)
7:117120171:A:T,P13569,K8M,0.435,Loss of methylation at K8 (P = 0.0084); Loss of ubiquitination at K8 (P = 0.0107); Gain of catalytic residue at K8 (P = 0.0289); Loss of disorder (P = 0.0477); Loss of MoRF binding (P = 0.09)
7:117120172:G:C,P13569,K8N,0.383,Loss of methylation at K8 (P = 0.0084); Loss of ubiquitination at K8 (P = 0.0107); Loss of MoRF binding (P = 0.0481); Loss of disorder (P = 0.1051); Loss of phosphorylation at S10 (P = 0.1061)
7:117120172:G:T,P13569,K8N,0.383,Loss of methylation at K8 (P = 0.0084); Loss of ubiquitination at K8 (P = 0.0107); Loss of MoRF binding (P = 0.0481); Loss of disorder (P = 0.1051); Loss of phosphorylation at S10 (P = 0.1061)
7:117120173:G:A,P13569,A9T,0.515,Loss of ubiquitination at K8 (P = 0.0503); Loss of helix (P = 0.0558); Gain of loop (P = 0.0851); Gain of phosphorylation at A9 (P = 0.1023); Loss of MoRF binding (P = 0.1082)
7:117120173:G:C,P13569,A9P,0.692,Gain of disorder (P = 0.0209); Loss of MoRF binding (P = 0.0495); Loss of helix (P = 0.0558); Loss of ubiquitination at K8 (P = 0.0642); Gain of loop (P = 0.0851)
7:117120173:G:T,P13569,A9S,0.597,Gain of disorder (P = 0.0093); Gain of phosphorylation at A9 (P = 0.0203); Gain of ubiquitination at K14 (P = 0.07); Loss of MoRF binding (P = 0.1065); Gain of glycosylation at A9 (P = 0.1615)
7:117120174:C:A,P13569,A9D,0.598,Loss of MoRF binding (P = 0.027); Gain of disorder (P = 0.0412); Gain of ubiquitination at K14 (P = 0.07); Gain of helix (P = 0.132); Gain of phosphorylation at S10 (P = 0.1633)
7:117120174:C:G,P13569,A9G,0.523,Gain of disorder (P = 0.0696); Loss of stability (P = 0.0885); Loss of MoRF binding (P = 0.1285); Gain of ubiquitination at K8 (P = 0.1621); Gain of phosphorylation at S10 (P = 0.2113)
7:117120174:C:T,P13569,A9V,0.548,Loss of ubiquitination at K8 (P = 0.0532); Gain of MoRF binding (P = 0.0975); Loss of disorder (P = 0.1253); Gain of methylation at K8 (P = 0.1396); Loss of glycosylation at P5 (P = 0.1675)
7:117120176:A:C,P13569,S10R,0.818,Gain of MoRF binding (P = 7e-04); Loss of ubiquitination at K8 (P = 0.0213); Loss of phosphorylation at S10 (P = 0.0398); Loss of disorder (P = 0.0939); Loss of loop (P = 0.0986)
7:117120176:A:G,P13569,S10G,0.545,Loss of stability (P = 0.0238); Loss of phosphorylation at S10 (P = 0.0398); Gain of catalytic residue at A9 (P = 0.054); Loss of disorder (P = 0.0849); Gain of ubiquitination at K14 (P = 0.1025)
7:117120176:A:T,P13569,S10C,0.625,Loss of disorder (P = 0.0048); Loss of phosphorylation at S10 (P = 0.0398); Loss of ubiquitination at K8 (P = 0.0468); Loss of MoRF binding (P = 0.0606); Gain of catalytic residue at V12 (P = 0.0989)
7:117120177:G:A,P13569,S10N,0.524,Loss of phosphorylation at S10 (P = 0.0398); Loss of ubiquitination at K8 (P = 0.0503); Loss of disorder (P = 0.0822); Gain of MoRF binding (P = 0.1114); Loss of helix (P = 0.1299)
7:117120177:G:C,P13569,S10T,0.551,Loss of ubiquitination at K8 (P = 0.0503); Loss of disorder (P = 0.0622); Loss of phosphorylation at S10 (P = 0.0962); Loss of MoRF binding (P = 0.1288); Loss of helix (P = 0.1299)
7:117120177:G:T,P13569,S10I,0.599,Loss of disorder (P = 0.0069); Loss of phosphorylation at S10 (P = 0.0398); Gain of catalytic residue at L15 (P = 0.0507); Loss of ubiquitination at K8 (P = 0.0532); Gain of helix (P = 0.062)
7:117120178:C:A,P13569,S10R,0.818,Gain of MoRF binding (P = 7e-04); Loss of ubiquitination at K8 (P = 0.0213); Loss of phosphorylation at S10 (P = 0.0398); Loss of disorder (P = 0.0939); Loss of loop (P = 0.0986)
7:117120178:C:G,P13569,S10R,0.818,Gain of MoRF binding (P = 7e-04); Loss of ubiquitination at K8 (P = 0.0213); Loss of phosphorylation at S10 (P = 0.0398); Loss of disorder (P = 0.0939); Loss of loop (P = 0.0986)
7:117120179:G:C,P13569,V11L,0.584,Loss of ubiquitination at K8 (P = 0.058); Gain of helix (P = 0.062); Loss of catalytic residue at V11 (P = 0.0749); Loss of loop (P = 0.0804); Loss of MoRF binding (P = 0.0936)
7:117120179:G:T,P13569,V11F,0.681,Loss of ubiquitination at K8 (P = 0.0468); Loss of MoRF binding (P = 0.0831); Loss of catalytic residue at V11 (P = 0.1059); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2257)
7:117120180:T:A,P13569,V11D,0.777,Gain of disorder (P = 0.0141); Loss of catalytic residue at V11 (P = 0.0352); Loss of MoRF binding (P = 0.0498); Loss of methylation at K8 (P = 0.0526); Loss of ubiquitination at K8 (P = 0.0532)
7:117120180:T:C,P13569,V11A,0.638,Gain of disorder (P = 0.0436); Loss of catalytic residue at V11 (P = 0.0656); Gain of ubiquitination at K14 (P = 0.07); Gain of glycosylation at S10 (P = 0.0862); Loss of methylation at K8 (P = 0.0966)
7:117120180:T:G,P13569,V11G,0.788,Gain of disorder (P = 0.0213); Gain of glycosylation at S10 (P = 0.0297); Loss of ubiquitination at K8 (P = 0.0642); Loss of stability (P = 0.0658); Loss of methylation at K8 (P = 0.1235)
7:117120182:G:A,P13569,V12I,0.547,Gain of helix (P = 0.0117); Loss of loop (P = 0.0235); Loss of ubiquitination at K8 (P = 0.1172); Loss of MoRF binding (P = 0.1267); Loss of disorder (P = 0.1578)
7:117120182:G:C,P13569,V12L,0.634,Gain of helix (P = 0.0425); Loss of loop (P = 0.0804); Loss of MoRF binding (P = 0.094); Gain of ubiquitination at K14 (P = 0.1215); Loss of methylation at K8 (P = 0.1282)
7:117120182:G:T,P13569,V12F,0.642,Gain of helix (P = 0.0425); Loss of ubiquitination at K8 (P = 0.0724); Loss of loop (P = 0.0804); Loss of MoRF binding (P = 0.0832); Loss of disorder (P = 0.234)
7:117120183:T:A,P13569,V12D,0.819,Gain of disorder (P = 0.0165); Loss of MoRF binding (P = 0.0309); Loss of helix (P = 0.0558); Loss of ubiquitination at K8 (P = 0.1172); Loss of methylation at K8 (P = 0.1419)
7:117120183:T:C,P13569,V12A,0.643,Gain of disorder (P = 0.0489); Gain of ubiquitination at K14 (P = 0.0597); Loss of methylation at K8 (P = 0.1066); Loss of MoRF binding (P = 0.1297); Gain of helix (P = 0.132)
7:117120183:T:G,P13569,V12G,0.727,Loss of stability (P = 0.019); Gain of helix (P = 0.0225); Gain of disorder (P = 0.0249); Loss of loop (P = 0.0374); Gain of ubiquitination at K14 (P = 0.07)
7:117120185:T:A,P13569,S13T,0.686,Gain of loop (P = 0.0435); Loss of helix (P = 0.0626); Loss of disorder (P = 0.0786); Gain of ubiquitination at K14 (P = 0.1025); Gain of catalytic residue at S13 (P = 0.1206)
7:117120185:T:C,P13569,S13P,0.724,Loss of helix (P = 0.0196); Gain of loop (P = 0.0435); Loss of MoRF binding (P = 0.0598); Gain of glycosylation at S10 (P = 0.1247); Loss of ubiquitination at K14 (P = 0.1473)
7:117120185:T:G,P13569,S13A,0.692,Loss of helix (P = 0.0626); Loss of disorder (P = 0.0654); Gain of ubiquitination at K14 (P = 0.1025); Gain of loop (P = 0.1069); Gain of MoRF binding (P = 0.1101)
7:117120186:C:A,P13569,S13Y,0.74,Loss of helix (P = 0.0196); Loss of disorder (P = 0.0324); Gain of loop (P = 0.0435); Loss of MoRF binding (P = 0.1109); Loss of phosphorylation at S10 (P = 0.1157)
7:117120186:C:G,P13569,S13C,0.758,Loss of disorder (P = 0.0162); Loss of MoRF binding (P = 0.0694); Loss of phosphorylation at S10 (P = 0.0735); Gain of loop (P = 0.1069); Loss of glycosylation at S13 (P = 0.1396)
7:117120186:C:T,P13569,S13F,0.849,Loss of disorder (P = 0.0229); Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Gain of ubiquitination at K14 (P = 0.07); Loss of MoRF binding (P = 0.1044)
7:117120188:A:C,P13569,K14Q,0.557,Loss of methylation at K14 (P = 0.0027); Loss of ubiquitination at K14 (P = 0.0255); Loss of MoRF binding (P = 0.0424); Loss of helix (P = 0.0558); Loss of phosphorylation at S10 (P = 0.1657)
7:117120188:A:G,P13569,K14E,0.565,Loss of MoRF binding (P = 0.0024); Loss of methylation at K14 (P = 0.0027); Loss of ubiquitination at K14 (P = 0.0255); Loss of helix (P = 0.0558); Gain of loop (P = 0.0851)
7:117120189:A:C,P13569,K14T,0.586,Loss of methylation at K14 (P = 0.0027); Loss of MoRF binding (P = 0.0202); Loss of ubiquitination at K14 (P = 0.0255); Gain of catalytic residue at S13 (P = 0.0394); Loss of phosphorylation at S10 (P = 0.1575)
7:117120189:A:G,P13569,K14R,0.434,Loss of methylation at K14 (P = 0.0083); Loss of ubiquitination at K14 (P = 0.0255); Loss of helix (P = 0.0558); Gain of MoRF binding (P = 0.0558); Gain of phosphorylation at S13 (P = 0.1126)
7:117120190:A:C,P13569,K14N,0.559,Loss of methylation at K14 (P = 0.0027); Loss of ubiquitination at K14 (P = 0.0255); Loss of MoRF binding (P = 0.0307); Loss of helix (P = 0.0558); Loss of phosphorylation at S10 (P = 0.1289)
7:117120190:A:T,P13569,K14N,0.559,Loss of methylation at K14 (P = 0.0027); Loss of ubiquitination at K14 (P = 0.0255); Loss of MoRF binding (P = 0.0307); Loss of helix (P = 0.0558); Loss of phosphorylation at S10 (P = 0.1289)
7:117120191:C:A,P13569,L15I,0.443,Gain of MoRF binding (P = 0.1115); Gain of ubiquitination at K14 (P = 0.1215); Gain of helix (P = 0.132); Loss of phosphorylation at S10 (P = 0.1682); Loss of disorder (P = 0.1891)
7:117120191:C:G,P13569,L15V,0.4,Gain of MoRF binding (P = 0.0868); Gain of ubiquitination at K14 (P = 0.1025); Loss of stability (P = 0.1274); Gain of helix (P = 0.132); Gain of glycosylation at S13 (P = 0.2219)
7:117120191:C:T,P13569,L15F,0.469,Gain of helix (P = 0.0325); Loss of loop (P = 0.0512); Loss of MoRF binding (P = 0.1035); Gain of ubiquitination at K14 (P = 0.1446); Loss of stability (P = 0.1798)
7:117120192:T:A,P13569,L15H,0.562,Loss of stability (P = 0.0098); Gain of disorder (P = 0.0339); Gain of MoRF binding (P = 0.1279); Loss of helix (P = 0.1299); Loss of ubiquitination at K14 (P = 0.1647)
7:117120192:T:C,P13569,L15P,0.863,Loss of stability (P = 0.0036); Gain of disorder (P = 0.0185); Loss of helix (P = 0.0558); Gain of glycosylation at S13 (P = 0.062); Gain of ubiquitination at K14 (P = 0.07)
7:117120192:T:G,P13569,L15R,0.841,Gain of MoRF binding (P = 0.013); Loss of stability (P = 0.0238); Gain of disorder (P = 0.0275); Loss of ubiquitination at K14 (P = 0.0384); Gain of methylation at L15 (P = 0.043)
7:117120194:T:A,P13569,F16I,0.528,Gain of MoRF binding (P = 0.083); Gain of helix (P = 0.132); Loss of ubiquitination at K14 (P = 0.1647); Gain of phosphorylation at S18 (P = 0.2829); Gain of catalytic residue at F16 (P = 0.3322)
7:117120194:T:C,P13569,F16L,0.525,Gain of MoRF binding (P = 0.0989); Gain of ubiquitination at K14 (P = 0.1215); Gain of helix (P = 0.132); Gain of disorder (P = 0.2369); Loss of phosphorylation at S18 (P = 0.2996)
7:117120194:T:G,P13569,F16V,0.561,Gain of MoRF binding (P = 0.0696); Gain of helix (P = 0.132); Gain of ubiquitination at K14 (P = 0.1446); Loss of stability (P = 0.2625); Gain of disorder (P = 0.2804)
7:117120195:T:A,P13569,F16Y,0.548,Gain of ubiquitination at K14 (P = 0.0856); Gain of MoRF binding (P = 0.0943); Loss of stability (P = 0.1777); Gain of helix (P = 0.2059); Gain of catalytic residue at F16 (P = 0.2295)
7:117120195:T:C,P13569,F16S,0.667,Gain of disorder (P = 0.0052); Gain of ubiquitination at K14 (P = 0.05); Loss of stability (P = 0.0621); Gain of phosphorylation at F16 (P = 0.0623); Gain of MoRF binding (P = 0.073)
7:117120195:T:G,P13569,F16C,0.606,Loss of MoRF binding (P = 0.0997); Gain of ubiquitination at K14 (P = 0.1446); Gain of catalytic residue at S18 (P = 0.1876); Loss of stability (P = 0.1899); Loss of helix (P = 0.2022)
7:117120196:T:A,P13569,F16L,0.525,Gain of MoRF binding (P = 0.0989); Gain of ubiquitination at K14 (P = 0.1215); Gain of helix (P = 0.132); Gain of disorder (P = 0.2369); Loss of phosphorylation at S18 (P = 0.2996)
7:117120196:T:G,P13569,F16L,0.525,Gain of MoRF binding (P = 0.0989); Gain of ubiquitination at K14 (P = 0.1215); Gain of helix (P = 0.132); Gain of disorder (P = 0.2369); Loss of phosphorylation at S18 (P = 0.2996)
7:117120197:T:A,P13569,F17I,0.737,Gain of MoRF binding (P = 0.0994); Loss of ubiquitination at K14 (P = 0.1647); Loss of helix (P = 0.2022); Loss of catalytic residue at F17 (P = 0.2261); Gain of phosphorylation at S18 (P = 0.2435)
7:117120197:T:C,P13569,F17L,0.723,Gain of ubiquitination at K14 (P = 0.1025); Gain of MoRF binding (P = 0.1117); Gain of catalytic residue at F17 (P = 0.1317); Gain of phosphorylation at S18 (P = 0.1605); Gain of helix (P = 0.2059)
7:117120197:T:G,P13569,F17V,0.744,Gain of MoRF binding (P = 0.0781); Gain of ubiquitination at K14 (P = 0.0856); Gain of helix (P = 0.132); Gain of phosphorylation at S18 (P = 0.1901); Gain of glycosylation at S13 (P = 0.2071)
7:117120198:T:A,P13569,F17Y,0.728,Gain of MoRF binding (P = 0.0894); Gain of phosphorylation at F17 (P = 0.0899); Gain of helix (P = 0.132); Gain of ubiquitination at K14 (P = 0.1446); Gain of glycosylation at P22 (P = 0.151)
7:117120198:T:C,P13569,F17S,0.828,Gain of disorder (P = 0.0068); Gain of ubiquitination at K14 (P = 0.0645); Gain of MoRF binding (P = 0.068); Gain of phosphorylation at S18 (P = 0.0839); Gain of glycosylation at S13 (P = 0.1588)
7:117120198:T:G,P13569,F17C,0.744,Gain of helix (P = 0.0425); Loss of MoRF binding (P = 0.1424); Gain of ubiquitination at K14 (P = 0.1446); Gain of glycosylation at P22 (P = 0.2066); Loss of phosphorylation at S18 (P = 0.2313)
7:117120199:C:A,P13569,F17L,0.723,Gain of ubiquitination at K14 (P = 0.1025); Gain of MoRF binding (P = 0.1117); Gain of catalytic residue at F17 (P = 0.1317); Gain of phosphorylation at S18 (P = 0.1605); Gain of helix (P = 0.2059)
7:117120199:C:G,P13569,F17L,0.723,Gain of ubiquitination at K14 (P = 0.1025); Gain of MoRF binding (P = 0.1117); Gain of catalytic residue at F17 (P = 0.1317); Gain of phosphorylation at S18 (P = 0.1605); Gain of helix (P = 0.2059)
7:117120200:A:C,P13569,S18R,0.794,Gain of methylation at S18 (P = 0.0436); Gain of MoRF binding (P = 0.0497); Loss of ubiquitination at K14 (P = 0.0598); Loss of phosphorylation at S18 (P = 0.0853); Gain of helix (P = 0.132)
7:117120200:A:G,P13569,S18G,0.838,Loss of stability (P = 0.0263); Loss of phosphorylation at S18 (P = 0.0853); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1424); Gain of ubiquitination at K14 (P = 0.1446)
7:117120200:A:T,P13569,S18C,0.66,Gain of catalytic residue at W19 (P = 0.0047); Loss of MoRF binding (P = 0.0659); Loss of phosphorylation at S18 (P = 0.0853); Gain of ubiquitination at K14 (P = 0.0856); Gain of helix (P = 0.2059)
7:117120201:G:A,P13569,S18N,0.64,Loss of phosphorylation at S18 (P = 0.0853); Gain of helix (P = 0.132); Loss of ubiquitination at K14 (P = 0.1647); Gain of MoRF binding (P = 0.195); Loss of stability (P = 0.213)
7:117120201:G:C,P13569,S18T,0.649,Loss of phosphorylation at S18 (P = 0.1148); Gain of ubiquitination at K14 (P = 0.1215); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1491); Loss of stability (P = 0.2156)
7:117120201:G:T,P13569,S18I,0.656,Gain of ubiquitination at K14 (P = 0.0645); Loss of phosphorylation at S18 (P = 0.0853); Loss of MoRF binding (P = 0.086); Gain of helix (P = 0.132); Gain of catalytic residue at R21 (P = 0.2491)
7:117144307:C:A,P13569,S18R,0.794,Gain of methylation at S18 (P = 0.0436); Gain of MoRF binding (P = 0.0497); Loss of ubiquitination at K14 (P = 0.0598); Loss of phosphorylation at S18 (P = 0.0853); Gain of helix (P = 0.132)
7:117144307:C:G,P13569,S18R,0.794,Gain of methylation at S18 (P = 0.0436); Gain of MoRF binding (P = 0.0497); Loss of ubiquitination at K14 (P = 0.0598); Loss of phosphorylation at S18 (P = 0.0853); Gain of helix (P = 0.132)
7:117144308:T:A,P13569,W19R,0.834,Gain of disorder (P = 0.0017); Gain of methylation at W19 (P = 0.0103); Loss of catalytic residue at P22 (P = 0.0441); Loss of ubiquitination at K14 (P = 0.0598); Gain of phosphorylation at S18 (P = 0.0618)
7:117144308:T:C,P13569,W19R,0.834,Gain of disorder (P = 0.0017); Gain of methylation at W19 (P = 0.0103); Loss of catalytic residue at P22 (P = 0.0441); Loss of ubiquitination at K14 (P = 0.0598); Gain of phosphorylation at S18 (P = 0.0618)
7:117144308:T:G,P13569,W19G,0.824,Gain of disorder (P = 0.023); Loss of catalytic residue at P22 (P = 0.0262); Gain of methylation at R21 (P = 0.0458); Gain of ubiquitination at K14 (P = 0.0645); Loss of MoRF binding (P = 0.0787)
7:117144309:G:C,P13569,W19S,0.77,Gain of disorder (P = 3e-04); Gain of catalytic residue at W19 (P = 0.0112); Gain of phosphorylation at W19 (P = 0.0555); Gain of methylation at R21 (P = 0.0638); Gain of ubiquitination at K14 (P = 0.0645)
7:117144309:G:T,P13569,W19L,0.779,Loss of catalytic residue at P22 (P = 0.0365); Gain of ubiquitination at K14 (P = 0.0561); Loss of MoRF binding (P = 0.066); Gain of disorder (P = 0.1038); Gain of phosphorylation at S18 (P = 0.153)
7:117144310:G:C,P13569,W19C,0.909,Loss of catalytic residue at P22 (P = 0.0262); Loss of MoRF binding (P = 0.0325); Gain of ubiquitination at K14 (P = 0.07); Gain of methylation at R21 (P = 0.1539); Loss of glycosylation at P22 (P = 0.2089)
7:117144310:G:T,P13569,W19C,0.909,Loss of catalytic residue at P22 (P = 0.0262); Loss of MoRF binding (P = 0.0325); Gain of ubiquitination at K14 (P = 0.07); Gain of methylation at R21 (P = 0.1539); Loss of glycosylation at P22 (P = 0.2089)
7:117144311:A:C,P13569,T20P,0.715,Gain of glycosylation at T20 (P = 0.0654); Gain of phosphorylation at S18 (P = 0.1242); Gain of disorder (P = 0.1245); Gain of methylation at R25 (P = 0.1414); Loss of MoRF binding (P = 0.1968)
7:117144311:A:G,P13569,T20A,0.446,Gain of methylation at R25 (P = 0.1112); Gain of helix (P = 0.2059); Gain of phosphorylation at S18 (P = 0.2176); Gain of MoRF binding (P = 0.2602); Gain of catalytic residue at T20 (P = 0.3281)
7:117144311:A:T,P13569,T20S,0.607,Gain of phosphorylation at T20 (P = 0.0682); Gain of disorder (P = 0.0704); Gain of methylation at R25 (P = 0.0959); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.2671)
7:117144312:C:A,P13569,T20N,0.518,Gain of catalytic residue at T20 (P = 0.0184); Gain of methylation at R25 (P = 0.1339); Gain of helix (P = 0.2294); Loss of phosphorylation at S18 (P = 0.2671); Gain of MoRF binding (P = 0.283)
7:117144312:C:G,P13569,T20S,0.607,Gain of phosphorylation at T20 (P = 0.0682); Gain of disorder (P = 0.0704); Gain of methylation at R25 (P = 0.0959); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.2671)
7:117144312:C:T,P13569,T20I,0.432,Loss of methylation at R25 (P = 0.0977); Loss of glycosylation at P22 (P = 0.2088); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2753); Gain of phosphorylation at S18 (P = 0.2772)
7:117144314:A:G,P13569,R21G,0.607,Loss of MoRF binding (P = 0.0506); Loss of stability (P = 0.0804); Gain of catalytic residue at I23 (P = 0.0847); Loss of methylation at K26 (P = 0.1124); Loss of glycosylation at P22 (P = 0.128)
7:117144315:G:A,P13569,R21K,0.663,Gain of methylation at R21 (P = 0.0157); Gain of catalytic residue at R21 (P = 0.0532); Loss of glycosylation at P22 (P = 0.1432); Loss of stability (P = 0.1789); Loss of phosphorylation at S18 (P = 0.2221)
7:117144315:G:C,P13569,R21T,0.596,Loss of MoRF binding (P = 0.0484); Gain of phosphorylation at R21 (P = 0.085); Gain of methylation at R25 (P = 0.1497); Loss of glycosylation at P22 (P = 0.1517); Loss of helix (P = 0.1706)
7:117144315:G:T,P13569,R21I,0.613,Loss of MoRF binding (P = 0.0315); Loss of methylation at R25 (P = 0.1086); Loss of glycosylation at P22 (P = 0.1217); Loss of phosphorylation at S18 (P = 0.1457); Loss of helix (P = 0.2271)
7:117144316:A:C,P13569,R21S,0.604,Loss of MoRF binding (P = 0.0624); Loss of helix (P = 0.0626); Loss of methylation at K26 (P = 0.0994); Loss of glycosylation at P22 (P = 0.153); Gain of catalytic residue at S18 (P = 0.1947)
7:117144316:A:T,P13569,R21S,0.604,Loss of MoRF binding (P = 0.0624); Loss of helix (P = 0.0626); Loss of methylation at K26 (P = 0.0994); Loss of glycosylation at P22 (P = 0.153); Gain of catalytic residue at S18 (P = 0.1947)
7:117144317:C:A,P13569,P22T,0.592,Loss of catalytic residue at P22 (P = 0.062); Gain of phosphorylation at P22 (P = 0.0652); Loss of glycosylation at P22 (P = 0.0815); Gain of methylation at R25 (P = 0.1386); Loss of helix (P = 0.2271)
7:117144317:C:G,P13569,P22A,0.606,Loss of glycosylation at P22 (P = 0.0764); Gain of methylation at R25 (P = 0.0845); Loss of catalytic residue at P22 (P = 0.0994); Gain of loop (P = 0.2045); Gain of helix (P = 0.2294)
7:117144317:C:T,P13569,P22S,0.58,Gain of phosphorylation at P22 (P = 0.0317); Loss of glycosylation at P22 (P = 0.086); Gain of methylation at R25 (P = 0.1025); Loss of catalytic residue at P22 (P = 0.1152); Loss of helix (P = 0.2022)
7:117144318:C:A,P13569,P22Q,0.601,Loss of catalytic residue at P22 (P = 0.02); Loss of methylation at R25 (P = 0.0727); Loss of glycosylation at P22 (P = 0.0764); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.2402)
7:117144318:C:G,P13569,P22R,0.633,Gain of solvent accessibility (P = 0.0584); Loss of glycosylation at P22 (P = 0.0764); Loss of methylation at K26 (P = 0.0874); Gain of relative solvent accessibility (P = 0.09); Gain of MoRF binding (P = 0.1519)
7:117144318:C:T,P13569,P22L,0.584,Loss of catalytic residue at P22 (P = 0.0266); Loss of glycosylation at P22 (P = 0.0764); Loss of methylation at K26 (P = 0.0875); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117144320:A:C,P13569,I23L,0.585,Gain of glycosylation at P22 (P = 0.0562); Loss of methylation at K26 (P = 0.0576); Gain of catalytic residue at I23 (P = 0.0937); Gain of phosphorylation at T20 (P = 0.1172); Gain of disorder (P = 0.1607)
7:117144320:A:G,P13569,I23V,0.555,Gain of methylation at R25 (P = 0.0707); Gain of phosphorylation at T20 (P = 0.1296); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2187)
7:117144320:A:T,P13569,I23F,0.607,Gain of methylation at R25 (P = 0.069); Gain of glycosylation at P22 (P = 0.0894); Gain of phosphorylation at T20 (P = 0.1184); Gain of catalytic residue at I23 (P = 0.1327); Loss of MoRF binding (P = 0.1915)
7:117144321:T:A,P13569,I23N,0.732,Gain of glycosylation at P22 (P = 0.0453); Gain of disorder (P = 0.0472); Loss of methylation at K26 (P = 0.0521); Gain of phosphorylation at T20 (P = 0.1353); Loss of helix (P = 0.2271)
7:117144321:T:C,P13569,I23T,0.739,Gain of disorder (P = 0.0413); Gain of glycosylation at P22 (P = 0.0448); Gain of phosphorylation at I23 (P = 0.049); Loss of methylation at K26 (P = 0.0589); Gain of helix (P = 0.132)
7:117144321:T:G,P13569,I23S,0.701,Gain of disorder (P = 0.0047); Gain of phosphorylation at I23 (P = 0.0104); Gain of glycosylation at P22 (P = 0.0376); Gain of methylation at R25 (P = 0.053); Loss of stability (P = 0.1704)
7:117144322:T:G,P13569,I23M,0.63,Gain of glycosylation at P22 (P = 0.0609); Gain of methylation at R25 (P = 0.0717); Gain of disorder (P = 0.0885); Gain of phosphorylation at S18 (P = 0.1584); Gain of MoRF binding (P = 0.1941)
7:117144323:T:A,P13569,L24M,0.611,Gain of methylation at K26 (P = 0.0694); Gain of MoRF binding (P = 0.1087); Loss of stability (P = 0.1968); Gain of helix (P = 0.2059); Gain of disorder (P = 0.2595)
7:117144323:T:G,P13569,L24V,0.705,Loss of stability (P = 0.0486); Gain of methylation at K26 (P = 0.0656); Gain of MoRF binding (P = 0.1364); Gain of catalytic residue at K26 (P = 0.1952); Gain of helix (P = 0.2059)
7:117144324:T:C,P13569,L24S,0.745,Loss of stability (P = 0.0141); Gain of phosphorylation at L24 (P = 0.016); Gain of disorder (P = 0.0174); Gain of methylation at R25 (P = 0.0711); Gain of glycosylation at P22 (P = 0.1071)
7:117144324:T:G,P13569,L24W,0.665,Loss of stability (P = 0.0223); Loss of methylation at R25 (P = 0.041); Gain of MoRF binding (P = 0.0718); Gain of catalytic residue at W19 (P = 0.1224); Gain of helix (P = 0.132)
7:117144325:G:C,P13569,L24F,0.854,Gain of methylation at K26 (P = 0.0843); Loss of stability (P = 0.1188); Loss of MoRF binding (P = 0.162); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117144325:G:T,P13569,L24F,0.854,Gain of methylation at K26 (P = 0.0843); Loss of stability (P = 0.1188); Loss of MoRF binding (P = 0.162); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117144326:A:G,P13569,R25G,0.541,Loss of methylation at R25 (P = 0.0165); Loss of MoRF binding (P = 0.0169); Loss of stability (P = 0.0861); Loss of glycosylation at P22 (P = 0.126); Gain of catalytic residue at I23 (P = 0.1613)
7:117144326:A:T,P13569,R25W,0.57,Loss of methylation at R25 (P = 0.0165); Loss of MoRF binding (P = 0.0726); Loss of disorder (P = 0.0957); Loss of glycosylation at P22 (P = 0.1356); Gain of helix (P = 0.2059)
7:117144327:G:A,P13569,R25K,0.514,Loss of methylation at R25 (P = 0.0436); Loss of MoRF binding (P = 0.0889); Loss of catalytic residue at R25 (P = 0.1781); Loss of stability (P = 0.2009); Gain of helix (P = 0.2059)
7:117144327:G:C,P13569,R25T,0.539,Loss of methylation at R25 (P = 0.0165); Loss of MoRF binding (P = 0.0205); Gain of phosphorylation at R25 (P = 0.0747); Loss of stability (P = 0.1434); Loss of glycosylation at P22 (P = 0.1524)
7:117144327:G:T,P13569,R25M,0.525,Loss of methylation at R25 (P = 0.0165); Loss of MoRF binding (P = 0.0386); Loss of glycosylation at P22 (P = 0.1263); Loss of catalytic residue at R25 (P = 0.1983); Gain of helix (P = 0.2059)
7:117144328:G:C,P13569,R25S,0.552,Loss of methylation at R25 (P = 0.0165); Loss of MoRF binding (P = 0.0285); Gain of helix (P = 0.132); Loss of glycosylation at P22 (P = 0.1623); Gain of disorder (P = 0.2224)
7:117144328:G:T,P13569,R25S,0.552,Loss of methylation at R25 (P = 0.0165); Loss of MoRF binding (P = 0.0285); Gain of helix (P = 0.132); Loss of glycosylation at P22 (P = 0.1623); Gain of disorder (P = 0.2224)
7:117144329:A:C,P13569,K26Q,0.447,Loss of methylation at K26 (P = 0.0248); Loss of MoRF binding (P = 0.0564); Loss of glycosylation at K26 (P = 0.1038); Loss of helix (P = 0.1299); Loss of ubiquitination at K26 (P = 0.338)
7:117144329:A:G,P13569,K26E,0.479,Loss of MoRF binding (P = 0.0069); Loss of methylation at K26 (P = 0.0248); Loss of glycosylation at K26 (P = 0.1038); Gain of helix (P = 0.1736); Gain of disorder (P = 0.2815)
7:117144330:A:C,P13569,K26T,0.453,Loss of methylation at K26 (P = 0.0248); Gain of phosphorylation at K26 (P = 0.0293); Loss of MoRF binding (P = 0.0522); Loss of glycosylation at K26 (P = 0.1152); Loss of helix (P = 0.1299)
7:117144330:A:G,P13569,K26R,0.381,Gain of methylation at K26 (P = 0.0917); Loss of glycosylation at K26 (P = 0.1038); Gain of MoRF binding (P = 0.1053); Loss of helix (P = 0.1299); Gain of catalytic residue at K26 (P = 0.1768)
7:117144330:A:T,P13569,K26I,0.478,Loss of methylation at K26 (P = 0.0248); Loss of MoRF binding (P = 0.0575); Loss of helix (P = 0.079); Gain of catalytic residue at K26 (P = 0.0966); Loss of glycosylation at K26 (P = 0.1038)
7:117144331:A:C,P13569,K26N,0.452,Loss of methylation at K26 (P = 0.0248); Loss of MoRF binding (P = 0.0532); Loss of glycosylation at K26 (P = 0.1038); Loss of helix (P = 0.1299); Loss of disorder (P = 0.3254)
7:117144331:A:T,P13569,K26N,0.452,Loss of methylation at K26 (P = 0.0248); Loss of MoRF binding (P = 0.0532); Loss of glycosylation at K26 (P = 0.1038); Loss of helix (P = 0.1299); Loss of disorder (P = 0.3254)
7:117144332:G:A,P13569,G27R,0.86,Gain of MoRF binding (P = 0.0472); Gain of disorder (P = 0.0831); Gain of catalytic residue at K26 (P = 0.0953); Gain of solvent accessibility (P = 0.1319); Gain of helix (P = 0.132)
7:117144332:G:C,P13569,G27R,0.86,Gain of MoRF binding (P = 0.0472); Gain of disorder (P = 0.0831); Gain of catalytic residue at K26 (P = 0.0953); Gain of solvent accessibility (P = 0.1319); Gain of helix (P = 0.132)
7:117144333:G:A,P13569,G27E,0.864,Loss of MoRF binding (P = 0.045); Loss of methylation at R25 (P = 0.0582); Gain of disorder (P = 0.0684); Loss of helix (P = 0.079); Gain of solvent accessibility (P = 0.1045)
7:117144333:G:C,P13569,G27A,0.678,Gain of MoRF binding (P = 0.1103); Loss of methylation at R25 (P = 0.1243); Gain of helix (P = 0.132); Loss of catalytic residue at L32 (P = 0.2786); Loss of glycosylation at K26 (P = 0.2951)
7:117144333:G:T,P13569,G27V,0.689,Gain of methylation at K26 (P = 0.0379); Gain of MoRF binding (P = 0.0899); Loss of disorder (P = 0.2092); Loss of helix (P = 0.2271); Loss of glycosylation at K26 (P = 0.2411)
7:117144335:T:A,P13569,Y28N,0.569,Gain of disorder (P = 0.0353); Gain of methylation at K26 (P = 0.0532); Gain of relative solvent accessibility (P = 0.1012); Gain of MoRF binding (P = 0.1128); Gain of loop (P = 0.2045)
7:117144335:T:C,P13569,Y28H,0.572,Gain of disorder (P = 0.0443); Gain of methylation at K26 (P = 0.0603); Gain of catalytic residue at K26 (P = 0.1202); Gain of helix (P = 0.132); Gain of glycosylation at K26 (P = 0.1373)
7:117144335:T:G,P13569,Y28D,0.663,Gain of disorder (P = 0.0151); Gain of relative solvent accessibility (P = 0.0507); Loss of MoRF binding (P = 0.0613); Loss of methylation at R25 (P = 0.0668); Loss of helix (P = 0.079)
7:117144336:A:C,P13569,Y28S,0.661,Gain of disorder (P = 0.0052); Gain of phosphorylation at Y28 (P = 0.0178); Gain of methylation at K26 (P = 0.0505); Gain of MoRF binding (P = 0.0981); Gain of loop (P = 0.2045)
7:117144336:A:G,P13569,Y28C,0.56,Gain of methylation at K26 (P = 0.0615); Loss of MoRF binding (P = 0.0904); Gain of helix (P = 0.132); Gain of catalytic residue at K26 (P = 0.1879); Loss of loop (P = 0.2237)
7:117144336:A:T,P13569,Y28F,0.478,Gain of methylation at K26 (P = 0.0628); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1446); Gain of loop (P = 0.2045); Loss of catalytic residue at Y28 (P = 0.2562)
7:117144338:A:G,P13569,R29G,0.517,Loss of MoRF binding (P = 0.0094); Loss of methylation at R25 (P = 0.0886); Loss of helix (P = 0.1299); Gain of catalytic residue at R31 (P = 0.1617); Loss of solvent accessibility (P = 0.1813)
7:117144339:G:A,P13569,R29K,0.448,Gain of methylation at R29 (P = 0.0214); Loss of MoRF binding (P = 0.0817); Loss of helix (P = 0.1299); Gain of relative solvent accessibility (P = 0.1894); Gain of disorder (P = 0.2599)
7:117144339:G:C,P13569,R29T,0.465,Loss of MoRF binding (P = 0.0141); Gain of phosphorylation at R29 (P = 0.0512); Loss of methylation at R25 (P = 0.0748); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2589)
7:117144339:G:T,P13569,R29I,0.545,Loss of MoRF binding (P = 0.0094); Gain of catalytic residue at L34 (P = 0.0343); Loss of methylation at R25 (P = 0.0534); Gain of loop (P = 0.069); Loss of disorder (P = 0.1175)
7:117144340:A:C,P13569,R29S,0.443,Loss of MoRF binding (P = 0.0185); Gain of phosphorylation at R29 (P = 0.0652); Loss of methylation at R25 (P = 0.0666); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1958)
7:117144340:A:T,P13569,R29S,0.443,Loss of MoRF binding (P = 0.0185); Gain of phosphorylation at R29 (P = 0.0652); Loss of methylation at R25 (P = 0.0666); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1958)
7:117144341:C:A,P13569,Q30K,0.359,Gain of methylation at Q30 (P = 0.0148); Gain of MoRF binding (P = 0.0526); Loss of helix (P = 0.0558); Gain of solvent accessibility (P = 0.0789); Gain of relative solvent accessibility (P = 0.09)
7:117144341:C:G,P13569,Q30E,0.395,Loss of MoRF binding (P = 0.0406); Gain of methylation at K26 (P = 0.1502); Gain of phosphorylation at S35 (P = 0.172); Gain of helix (P = 0.1736); Gain of disorder (P = 0.1845)
7:117144342:A:C,P13569,Q30P,0.493,Gain of glycosylation at Q30 (P = 0.0306); Loss of helix (P = 0.0558); Gain of methylation at R25 (P = 0.0562); Loss of MoRF binding (P = 0.0644); Loss of stability (P = 0.1006)
7:117144342:A:G,P13569,Q30R,0.312,Gain of MoRF binding (P = 0.05); Gain of methylation at K26 (P = 0.0608); Loss of helix (P = 0.1299); Gain of phosphorylation at S35 (P = 0.1623); Loss of stability (P = 0.2478)
7:117144342:A:T,P13569,Q30L,0.346,Loss of methylation at K26 (P = 0.0393); Gain of MoRF binding (P = 0.1291); Loss of disorder (P = 0.1879); Gain of helix (P = 0.2684); Loss of glycosylation at K26 (P = 0.3283)
7:117144343:G:C,P13569,Q30H,0.366,Gain of methylation at R25 (P = 0.0559); Loss of MoRF binding (P = 0.1118); Gain of catalytic residue at L32 (P = 0.1298); Loss of helix (P = 0.1299); Loss of stability (P = 0.1419)
7:117144343:G:T,P13569,Q30H,0.366,Gain of methylation at R25 (P = 0.0559); Loss of MoRF binding (P = 0.1118); Gain of catalytic residue at L32 (P = 0.1298); Loss of helix (P = 0.1299); Loss of stability (P = 0.1419)
7:117144344:C:A,P13569,R31S,0.497,Gain of phosphorylation at R31 (P = 0.0341); Gain of methylation at K26 (P = 0.0481); Loss of MoRF binding (P = 0.0575); Loss of solvent accessibility (P = 0.1322); Loss of helix (P = 0.1706)
7:117144344:C:G,P13569,R31G,0.541,Loss of solvent accessibility (P = 0.0509); Loss of MoRF binding (P = 0.053); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Gain of methylation at K26 (P = 0.1272)
7:117144345:G:C,P13569,R31P,0.567,Loss of MoRF binding (P = 0.0168); Gain of methylation at K26 (P = 0.0636); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Loss of solvent accessibility (P = 0.1473)
7:117144347:C:A,P13569,L32M,0.581,Gain of MoRF binding (P = 0.0678); Loss of helix (P = 0.1299); Gain of disorder (P = 0.2239); Loss of catalytic residue at L32 (P = 0.242); Loss of stability (P = 0.2463)
7:117144347:C:G,P13569,L32V,0.595,Gain of MoRF binding (P = 0.0831); Loss of stability (P = 0.2612); Loss of catalytic residue at L32 (P = 0.2906); Loss of disorder (P = 0.3296); Loss of phosphorylation at S35 (P = 0.3476)
7:117144348:T:A,P13569,L32Q,0.81,Loss of stability (P = 0.0295); Gain of disorder (P = 0.0299); Gain of MoRF binding (P = 0.0828); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117144348:T:C,P13569,L32P,0.882,Loss of stability (P = 0.0112); Gain of disorder (P = 0.0236); Gain of glycosylation at L32 (P = 0.0507); Loss of MoRF binding (P = 0.0759); Loss of helix (P = 0.1299)
7:117144348:T:G,P13569,L32R,0.807,Gain of MoRF binding (P = 0.0151); Loss of stability (P = 0.027); Gain of disorder (P = 0.0274); Gain of phosphorylation at S35 (P = 0.0608); Loss of helix (P = 0.1299)
7:117144350:G:A,P13569,E33K,0.468,Gain of MoRF binding (P = 0.0073); Gain of methylation at E33 (P = 0.0323); Loss of stability (P = 0.0568); Loss of helix (P = 0.2662); Gain of catalytic residue at R29 (P = 0.2914)
7:117144350:G:C,P13569,E33Q,0.375,Gain of MoRF binding (P = 0.0387); Gain of helix (P = 0.1736); Loss of stability (P = 0.1902); Gain of catalytic residue at R29 (P = 0.3024); Loss of phosphorylation at S35 (P = 0.3281)
7:117144351:A:C,P13569,E33A,0.443,Gain of MoRF binding (P = 0.0433); Loss of solvent accessibility (P = 0.1434); Loss of disorder (P = 0.1575); Loss of stability (P = 0.1681); Gain of helix (P = 0.2684)
7:117144351:A:G,P13569,E33G,0.427,Loss of stability (P = 0.0126); Gain of MoRF binding (P = 0.0499); Loss of solvent accessibility (P = 0.1115); Gain of catalytic residue at R29 (P = 0.2204); Loss of disorder (P = 0.2322)
7:117144351:A:T,P13569,E33V,0.541,Gain of MoRF binding (P = 0.0376); Loss of disorder (P = 0.0824); Loss of solvent accessibility (P = 0.239); Loss of phosphorylation at Y38 (P = 0.242); Loss of loop (P = 0.2897)
7:117144352:A:C,P13569,E33D,0.348,Gain of MoRF binding (P = 0.1275); Loss of stability (P = 0.1856); Gain of disorder (P = 0.3197); Loss of solvent accessibility (P = 0.322); Gain of phosphorylation at S35 (P = 0.3428)
7:117144352:A:T,P13569,E33D,0.348,Gain of MoRF binding (P = 0.1275); Loss of stability (P = 0.1856); Gain of disorder (P = 0.3197); Loss of solvent accessibility (P = 0.322); Gain of phosphorylation at S35 (P = 0.3428)
7:117144353:T:A,P13569,L34M,0.318,Gain of MoRF binding (P = 0.0755); Gain of disorder (P = 0.2032); Gain of helix (P = 0.2684); Gain of relative solvent accessibility (P = 0.2751); Gain of phosphorylation at S35 (P = 0.2936)
7:117144353:T:G,P13569,L34V,0.318,Gain of MoRF binding (P = 0.0853); Loss of stability (P = 0.251); Gain of relative solvent accessibility (P = 0.2751); Loss of disorder (P = 0.3221); Loss of loop (P = 0.3664)
7:117144354:T:C,P13569,L34S,0.518,Gain of disorder (P = 0.009); Gain of phosphorylation at L34 (P = 0.0385); Loss of stability (P = 0.072); Gain of MoRF binding (P = 0.1388); Gain of relative solvent accessibility (P = 0.1571)
7:117144354:T:G,P13569,L34W,0.418,Gain of MoRF binding (P = 0.0365); Gain of catalytic residue at L32 (P = 0.077); Loss of stability (P = 0.108); Loss of disorder (P = 0.1673); Gain of relative solvent accessibility (P = 0.2751)
7:117144355:G:C,P13569,L34F,0.267,Loss of MoRF binding (P = 0.1433); Loss of disorder (P = 0.2587); Loss of phosphorylation at S35 (P = 0.3134); Loss of stability (P = 0.3326); Loss of loop (P = 0.4412)
7:117144355:G:T,P13569,L34F,0.267,Loss of MoRF binding (P = 0.1433); Loss of disorder (P = 0.2587); Loss of phosphorylation at S35 (P = 0.3134); Loss of stability (P = 0.3326); Loss of loop (P = 0.4412)
7:117144356:T:A,P13569,S35T,0.351,Loss of stability (P = 0.069); Gain of catalytic residue at S35 (P = 0.1001); Loss of disorder (P = 0.1158); Loss of MoRF binding (P = 0.1236); Loss of phosphorylation at S35 (P = 0.1879)
7:117144356:T:C,P13569,S35P,0.427,Loss of MoRF binding (P = 0.0694); Loss of stability (P = 0.0828); Loss of phosphorylation at S35 (P = 0.1379); Gain of catalytic residue at L32 (P = 0.2306); Loss of disorder (P = 0.2511)
7:117144356:T:G,P13569,S35A,0.361,Loss of disorder (P = 0.1103); Loss of MoRF binding (P = 0.1306); Loss of phosphorylation at S35 (P = 0.1379); Loss of stability (P = 0.3249); Loss of loop (P = 0.3664)
7:117144357:C:T,P13569,S35L,0.424,Gain of catalytic residue at S35 (P = 0.0449); Loss of disorder (P = 0.0768); Loss of MoRF binding (P = 0.094); Loss of phosphorylation at S35 (P = 0.1379); Loss of loop (P = 0.3664)
7:117144359:G:A,P13569,D36N,0.86,Gain of MoRF binding (P = 0.05); Loss of phosphorylation at Y38 (P = 0.0815); Loss of disorder (P = 0.2208); Gain of relative solvent accessibility (P = 0.2363); Gain of helix (P = 0.2684)
7:117144359:G:C,P13569,D36H,0.731,Gain of MoRF binding (P = 0.0574); Loss of phosphorylation at Y38 (P = 0.1005); Gain of catalytic residue at E33 (P = 0.1815); Loss of disorder (P = 0.1926); Loss of stability (P = 0.2754)
7:117144359:G:T,P13569,D36Y,0.714,Gain of MoRF binding (P = 0.0604); Loss of phosphorylation at Y38 (P = 0.0652); Loss of disorder (P = 0.0839); Gain of catalytic residue at D36 (P = 0.2194); Gain of loop (P = 0.4248)
7:117144360:A:C,P13569,D36A,0.765,Gain of MoRF binding (P = 0.0492); Loss of phosphorylation at Y38 (P = 0.0851); Loss of disorder (P = 0.1627); Loss of loop (P = 0.3664); Loss of stability (P = 0.4315)
7:117144360:A:G,P13569,D36G,0.726,Gain of MoRF binding (P = 0.0526); Gain of relative solvent accessibility (P = 0.0999); Loss of phosphorylation at Y38 (P = 0.1016); Gain of glycosylation at S35 (P = 0.1488); Loss of stability (P = 0.1692)
7:117144360:A:T,P13569,D36V,0.719,Gain of MoRF binding (P = 0.0446); Loss of phosphorylation at Y38 (P = 0.0752); Loss of disorder (P = 0.0786); Gain of catalytic residue at E33 (P = 0.2856); Gain of loop (P = 0.4248)
7:117144361:C:A,P13569,D36E,0.663,Loss of phosphorylation at Y38 (P = 0.13); Gain of MoRF binding (P = 0.1443); Gain of disorder (P = 0.1852); Gain of solvent accessibility (P = 0.2192); Gain of relative solvent accessibility (P = 0.2363)
7:117144361:C:G,P13569,D36E,0.663,Loss of phosphorylation at Y38 (P = 0.13); Gain of MoRF binding (P = 0.1443); Gain of disorder (P = 0.1852); Gain of solvent accessibility (P = 0.2192); Gain of relative solvent accessibility (P = 0.2363)
7:117144362:A:C,P13569,I37L,0.546,Loss of catalytic residue at I37 (P = 0.0696); Gain of disorder (P = 0.1185); Loss of MoRF binding (P = 0.1556); Loss of stability (P = 0.2083); Gain of phosphorylation at S42 (P = 0.2178)
7:117144362:A:G,P13569,I37V,0.515,Loss of catalytic residue at I37 (P = 0.055); Loss of stability (P = 0.1223); Gain of MoRF binding (P = 0.1424); Gain of disorder (P = 0.174); Gain of phosphorylation at S42 (P = 0.2395)
7:117144362:A:T,P13569,I37L,0.546,Loss of catalytic residue at I37 (P = 0.0696); Gain of disorder (P = 0.1185); Loss of MoRF binding (P = 0.1556); Loss of stability (P = 0.2083); Gain of phosphorylation at S42 (P = 0.2178)
7:117144363:T:A,P13569,I37K,0.775,Loss of stability (P = 0.002); Gain of disorder (P = 0.0059); Gain of ubiquitination at I37 (P = 0.017); Gain of MoRF binding (P = 0.0504); Gain of solvent accessibility (P = 0.0837)
7:117144363:T:C,P13569,I37T,0.764,Loss of stability (P = 8e-04); Loss of catalytic residue at I37 (P = 0.0307); Gain of disorder (P = 0.0363); Loss of MoRF binding (P = 0.1705); Loss of phosphorylation at S42 (P = 0.2467)
7:117144363:T:G,P13569,I37R,0.793,Gain of disorder (P = 0.0085); Loss of stability (P = 0.0158); Gain of MoRF binding (P = 0.0325); Gain of phosphorylation at S35 (P = 0.0806); Loss of catalytic residue at I37 (P = 0.2261)
7:117144364:A:G,P13569,I37M,0.617,Gain of disorder (P = 0.0719); Loss of stability (P = 0.0819); Gain of MoRF binding (P = 0.1051); Gain of phosphorylation at S42 (P = 0.2045); Loss of catalytic residue at L32 (P = 0.4407)
7:117144365:T:A,P13569,Y38N,0.636,Gain of disorder (P = 0.0169); Loss of phosphorylation at Y38 (P = 0.0208); Gain of relative solvent accessibility (P = 0.0249); Loss of catalytic residue at I37 (P = 0.0671); Gain of solvent accessibility (P = 0.0674)
7:117144365:T:G,P13569,Y38D,0.685,Gain of disorder (P = 0.0057); Loss of phosphorylation at Y38 (P = 0.0208); Loss of catalytic residue at I37 (P = 0.0801); Gain of relative solvent accessibility (P = 0.1066); Loss of MoRF binding (P = 0.1444)
7:117144366:A:C,P13569,Y38S,0.641,Gain of disorder (P = 0.0022); Loss of catalytic residue at I37 (P = 0.0751); Loss of phosphorylation at Y38 (P = 0.1056); Gain of relative solvent accessibility (P = 0.1066); Loss of stability (P = 0.1124)
7:117144366:A:G,P13569,Y38C,0.651,Loss of phosphorylation at Y38 (P = 0.0208); Loss of catalytic residue at I37 (P = 0.0441); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.1883); Gain of disorder (P = 0.234)
7:117144366:A:T,P13569,Y38F,0.621,Loss of phosphorylation at Y38 (P = 0.0208); Loss of catalytic residue at I37 (P = 0.0413); Loss of disorder (P = 0.1725); Loss of MoRF binding (P = 0.2197); Gain of helix (P = 0.2684)
7:117144368:C:A,P13569,Q39K,0.467,Gain of methylation at Q39 (P = 0.0077); Gain of ubiquitination at Q39 (P = 0.023); Gain of relative solvent accessibility (P = 0.0522); Gain of solvent accessibility (P = 0.0584); Gain of MoRF binding (P = 0.0806)
7:117144368:C:G,P13569,Q39E,0.319,Gain of disorder (P = 0.0891); Gain of phosphorylation at S42 (P = 0.1063); Gain of catalytic residue at Q39 (P = 0.143); Loss of MoRF binding (P = 0.2319); Gain of helix (P = 0.5668)
7:117144369:A:C,P13569,Q39P,0.364,Gain of catalytic residue at Q39 (P = 0.0301); Loss of phosphorylation at Y38 (P = 0.0854); Gain of disorder (P = 0.1196); Loss of MoRF binding (P = 0.2432); Loss of solvent accessibility (P = 0.3854)
7:117144369:A:G,P13569,Q39R,0.321,Gain of MoRF binding (P = 0.0528); Gain of phosphorylation at S42 (P = 0.0786); Gain of catalytic residue at Q39 (P = 0.1349); Gain of disorder (P = 0.1683); Loss of loop (P = 0.4412)
7:117144369:A:T,P13569,Q39L,0.411,Gain of stability (P = 0.0144); Gain of catalytic residue at Q39 (P = 0.0291); Loss of disorder (P = 0.0772); Gain of phosphorylation at S42 (P = 0.1898); Loss of MoRF binding (P = 0.2662)
7:117144370:A:C,P13569,Q39H,0.327,Gain of phosphorylation at S42 (P = 0.2128); Loss of disorder (P = 0.2151); Gain of helix (P = 0.2684); Loss of MoRF binding (P = 0.275); Loss of solvent accessibility (P = 0.4011)
7:117144370:A:T,P13569,Q39H,0.327,Gain of phosphorylation at S42 (P = 0.2128); Loss of disorder (P = 0.2151); Gain of helix (P = 0.2684); Loss of MoRF binding (P = 0.275); Loss of solvent accessibility (P = 0.4011)
7:117144371:A:C,P13569,I40L,0.544,Gain of disorder (P = 0.1125); Gain of phosphorylation at S45 (P = 0.2076); Gain of relative solvent accessibility (P = 0.2816); Loss of MoRF binding (P = 0.3703); Loss of catalytic residue at S42 (P = 0.3846)
7:117144371:A:G,P13569,I40V,0.528,Gain of disorder (P = 0.1688); Loss of catalytic residue at I40 (P = 0.1998); Gain of phosphorylation at S45 (P = 0.2319); Gain of relative solvent accessibility (P = 0.2629); Gain of helix (P = 0.2684)
7:117144371:A:T,P13569,I40F,0.528,Gain of helix (P = 0.1736); Loss of stability (P = 0.1748); Loss of phosphorylation at S42 (P = 0.2313); Loss of disorder (P = 0.239); Gain of relative solvent accessibility (P = 0.2816)
7:117144372:T:A,P13569,I40N,0.735,Gain of disorder (P = 0.0121); Loss of stability (P = 0.0659); Loss of catalytic residue at I40 (P = 0.156); Loss of phosphorylation at S42 (P = 0.2033); Gain of relative solvent accessibility (P = 0.2629)
7:117144372:T:C,P13569,I40T,0.679,Gain of disorder (P = 0.0268); Gain of phosphorylation at I40 (P = 0.041); Loss of stability (P = 0.0472); Loss of catalytic residue at I40 (P = 0.1761); Gain of relative solvent accessibility (P = 0.2629)
7:117144372:T:G,P13569,I40S,0.716,Gain of disorder (P = 0.002); Gain of phosphorylation at I40 (P = 0.0357); Loss of stability (P = 0.0587); Loss of catalytic residue at I40 (P = 0.1027); Gain of relative solvent accessibility (P = 0.2629)
7:117144373:C:G,P13569,I40M,0.573,Gain of disorder (P = 0.0595); Gain of phosphorylation at S42 (P = 0.1792); Gain of relative solvent accessibility (P = 0.2629); Gain of helix (P = 0.2684); Gain of MoRF binding (P = 0.2886)
7:117144374:C:A,P13569,P41T,0.412,Gain of phosphorylation at P41 (P = 0.0714); Loss of stability (P = 0.0853); Loss of disorder (P = 0.1037); Loss of helix (P = 0.1706); Gain of catalytic residue at S42 (P = 0.3132)
7:117144374:C:G,P13569,P41A,0.441,Gain of catalytic residue at P41 (P = 0.0409); Loss of disorder (P = 0.0963); Loss of helix (P = 0.1706); Loss of phosphorylation at Y38 (P = 0.1749); Loss of stability (P = 0.2382)
7:117144374:C:T,P13569,P41S,0.339,Gain of phosphorylation at P41 (P = 0.055); Gain of disorder (P = 0.0848); Loss of stability (P = 0.1207); Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.3603)
7:117144375:C:A,P13569,P41H,0.38,Loss of disorder (P = 0.1214); Loss of phosphorylation at S45 (P = 0.1227); Loss of stability (P = 0.1656); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237)
7:117144375:C:G,P13569,P41R,0.415,Gain of MoRF binding (P = 0.0676); Loss of phosphorylation at Y38 (P = 0.105); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.1422); Gain of catalytic residue at P41 (P = 0.1626)
7:117144375:C:T,P13569,P41L,0.511,Gain of catalytic residue at P41 (P = 0.0249); Loss of disorder (P = 0.0457); Loss of phosphorylation at Y38 (P = 0.105); Loss of loop (P = 0.1242); Loss of helix (P = 0.1706)
7:117144377:T:A,P13569,S42T,0.419,Loss of disorder (P = 0.0547); Loss of phosphorylation at S45 (P = 0.1263); Loss of helix (P = 0.3949); Loss of loop (P = 0.4412); Gain of solvent accessibility (P = 0.4496)
7:117144377:T:C,P13569,S42P,0.419,Gain of catalytic residue at P41 (P = 0.0127); Loss of phosphorylation at S42 (P = 0.0409); Loss of loop (P = 0.1242); Loss of disorder (P = 0.185); Gain of helix (P = 0.2059)
7:117144377:T:G,P13569,S42A,0.436,Loss of phosphorylation at S42 (P = 0.0409); Loss of disorder (P = 0.052); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Gain of catalytic residue at S42 (P = 0.2709)
7:117144378:C:A,P13569,S42Y,0.56,Loss of disorder (P = 0.0153); Loss of loop (P = 0.0986); Loss of phosphorylation at S45 (P = 0.1082); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.1683)
7:117144378:C:G,P13569,S42C,0.586,Loss of disorder (P = 0.0081); Gain of catalytic residue at P41 (P = 0.0193); Loss of phosphorylation at S42 (P = 0.0409); Loss of helix (P = 0.3949); Loss of loop (P = 0.4412)
7:117144380:G:C,P13569,V43L,0.289,Gain of solvent accessibility (P = 0.0156); Gain of relative solvent accessibility (P = 0.0166); Gain of helix (P = 0.062); Gain of disorder (P = 0.0905); Gain of phosphorylation at S42 (P = 0.1915)
7:117144380:G:T,P13569,V43F,0.241,Gain of catalytic residue at P41 (P = 0.1669); Gain of helix (P = 0.1736); Gain of disorder (P = 0.2383); Loss of phosphorylation at S42 (P = 0.2447); Loss of stability (P = 0.2692)
7:117144381:T:A,P13569,V43D,0.432,Gain of disorder (P = 0.0057); Gain of relative solvent accessibility (P = 0.0166); Gain of solvent accessibility (P = 0.0171); Gain of phosphorylation at S45 (P = 0.1146); Gain of helix (P = 0.132)
7:117144381:T:C,P13569,V43A,0.362,Gain of relative solvent accessibility (P = 0.0166); Gain of disorder (P = 0.0308); Gain of solvent accessibility (P = 0.1116); Gain of phosphorylation at S45 (P = 0.1524); Loss of stability (P = 0.1585)
7:117144381:T:G,P13569,V43G,0.471,Loss of stability (P = 0.0104); Gain of catalytic residue at V43 (P = 0.0148); Gain of relative solvent accessibility (P = 0.0166); Gain of disorder (P = 0.0185); Gain of glycosylation at S42 (P = 0.1116)
7:117144383:G:A,P13569,D44N,0.492,Loss of catalytic residue at D44 (P = 0.0547); Loss of phosphorylation at S42 (P = 0.1139); Loss of disorder (P = 0.1721); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117144383:G:C,P13569,D44H,0.519,Loss of catalytic residue at D44 (P = 0.0616); Loss of disorder (P = 0.085); Loss of phosphorylation at S45 (P = 0.1255); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117144383:G:T,P13569,D44Y,0.477,Loss of disorder (P = 0.0211); Loss of phosphorylation at S45 (P = 0.1136); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of catalytic residue at D44 (P = 0.2635)
7:117144384:A:C,P13569,D44A,0.525,Loss of disorder (P = 0.0739); Loss of phosphorylation at S45 (P = 0.1817); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059); Loss of solvent accessibility (P = 0.2668)
7:117144384:A:G,P13569,D44G,0.785,Loss of disorder (P = 0.1119); Loss of stability (P = 0.1315); Loss of phosphorylation at S42 (P = 0.1837); Loss of solvent accessibility (P = 0.1868); Gain of loop (P = 0.2045)
7:117144384:A:T,P13569,D44V,0.292,Loss of disorder (P = 0.0199); Loss of phosphorylation at S45 (P = 0.1362); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059); Loss of solvent accessibility (P = 0.239)
7:117144385:T:A,P13569,D44E,0.486,Loss of catalytic residue at D44 (P = 0.0958); Gain of disorder (P = 0.161); Gain of phosphorylation at S42 (P = 0.1853); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117144385:T:G,P13569,D44E,0.486,Loss of catalytic residue at D44 (P = 0.0958); Gain of disorder (P = 0.161); Gain of phosphorylation at S42 (P = 0.1853); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117144386:T:A,P13569,S45T,0.282,Loss of disorder (P = 0.0511); Loss of phosphorylation at S50 (P = 0.1218); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of glycosylation at S50 (P = 0.3754)
7:117144386:T:C,P13569,S45P,0.338,Loss of phosphorylation at S45 (P = 0.039); Gain of helix (P = 0.132); Loss of disorder (P = 0.1843); Loss of stability (P = 0.1929); Gain of glycosylation at S50 (P = 0.1946)
7:117144386:T:G,P13569,S45A,0.292,Loss of phosphorylation at S45 (P = 0.039); Loss of disorder (P = 0.0495); Gain of helix (P = 0.132); Gain of catalytic residue at S45 (P = 0.1873); Loss of stability (P = 0.2144)
7:117144387:C:A,P13569,S45Y,0.325,Loss of disorder (P = 0.009); Gain of phosphorylation at S45 (P = 0.1096); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.2689); Loss of glycosylation at S50 (P = 0.2692)
7:117144387:C:G,P13569,S45C,0.378,Loss of disorder (P = 0.0039); Loss of phosphorylation at S45 (P = 0.039); Loss of helix (P = 0.0626); Loss of loop (P = 0.2237); Loss of glycosylation at S50 (P = 0.3186)
7:117144387:C:T,P13569,S45F,0.361,Loss of disorder (P = 0.0034); Loss of phosphorylation at S45 (P = 0.039); Gain of helix (P = 0.132); Loss of glycosylation at S50 (P = 0.2151); Loss of loop (P = 0.2237)
7:117144389:G:A,P13569,A46T,0.262,Gain of phosphorylation at A46 (P = 0.0336); Loss of stability (P = 0.111); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.1583); Gain of disorder (P = 0.1607)
7:117144389:G:C,P13569,A46P,0.411,Gain of disorder (P = 0.0378); Loss of stability (P = 0.0629); Gain of phosphorylation at S45 (P = 0.1204); Loss of catalytic residue at D44 (P = 0.2407); Loss of loop (P = 0.2897)
7:117144389:G:T,P13569,A46S,0.411,Gain of disorder (P = 0.0213); Gain of phosphorylation at A46 (P = 0.0343); Loss of helix (P = 0.1299); Loss of stability (P = 0.2277); Loss of glycosylation at S50 (P = 0.2886)
7:117144390:C:A,P13569,A46D,0.73,Gain of disorder (P = 0.0413); Gain of solvent accessibility (P = 0.0971); Gain of phosphorylation at S45 (P = 0.1275); Loss of helix (P = 0.1299); Gain of relative solvent accessibility (P = 0.1684)
7:117144390:C:G,P13569,A46G,0.293,Gain of glycosylation at S45 (P = 0.0572); Loss of stability (P = 0.0658); Gain of disorder (P = 0.1201); Gain of phosphorylation at S45 (P = 0.1853); Loss of loop (P = 0.2897)
7:117144392:G:A,P13569,D47N,0.354,Gain of helix (P = 0.0696); Loss of ubiquitination at K52 (P = 0.0777); Loss of stability (P = 0.0955); Loss of phosphorylation at S42 (P = 0.1139); Loss of disorder (P = 0.1909)
7:117144392:G:C,P13569,D47H,0.374,Gain of catalytic residue at N48 (P = 0.0806); Loss of ubiquitination at K52 (P = 0.0877); Loss of loop (P = 0.0986); Loss of stability (P = 0.107); Loss of disorder (P = 0.112)
7:117144392:G:T,P13569,D47Y,0.401,Loss of disorder (P = 0.024); Gain of phosphorylation at D47 (P = 0.0405); Loss of ubiquitination at K52 (P = 0.1322); Loss of helix (P = 0.1706); Loss of relative solvent accessibility (P = 0.1807)
7:117144393:A:C,P13569,D47A,0.36,Loss of disorder (P = 0.0871); Loss of ubiquitination at K52 (P = 0.0877); Loss of solvent accessibility (P = 0.1115); Loss of stability (P = 0.1167); Gain of helix (P = 0.132)
7:117144393:A:G,P13569,D47G,0.392,Loss of stability (P = 0.0216); Gain of catalytic residue at A46 (P = 0.0772); Loss of ubiquitination at K52 (P = 0.0992); Loss of solvent accessibility (P = 0.1202); Loss of disorder (P = 0.1267)
7:117144393:A:T,P13569,D47V,0.39,Loss of disorder (P = 0.0244); Gain of helix (P = 0.062); Loss of ubiquitination at K52 (P = 0.0709); Loss of solvent accessibility (P = 0.0907); Loss of loop (P = 0.0986)
7:117144394:C:A,P13569,D47E,0.26,Loss of ubiquitination at K52 (P = 0.0637); Gain of disorder (P = 0.1771); Gain of phosphorylation at S50 (P = 0.1964); Gain of loop (P = 0.2045); Gain of glycosylation at K52 (P = 0.2503)
7:117144394:C:G,P13569,D47E,0.26,Loss of ubiquitination at K52 (P = 0.0637); Gain of disorder (P = 0.1771); Gain of phosphorylation at S50 (P = 0.1964); Gain of loop (P = 0.2045); Gain of glycosylation at K52 (P = 0.2503)
7:117144395:A:C,P13569,N48H,0.312,Loss of ubiquitination at K52 (P = 0.0992); Loss of helix (P = 0.1299); Gain of glycosylation at K52 (P = 0.1536); Loss of stability (P = 0.1595); Gain of disorder (P = 0.1666)
7:117144395:A:G,P13569,N48D,0.313,Gain of disorder (P = 0.0898); Gain of phosphorylation at S50 (P = 0.1091); Loss of ubiquitination at K52 (P = 0.1322); Gain of glycosylation at K52 (P = 0.1983); Gain of helix (P = 0.2059)
7:117144395:A:T,P13569,N48Y,0.33,Gain of phosphorylation at N48 (P = 0.0333); Loss of disorder (P = 0.0617); Loss of ubiquitination at K52 (P = 0.0877); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.2601)
7:117144396:A:C,P13569,N48T,0.297,Gain of phosphorylation at N48 (P = 0.0405); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of ubiquitination at K52 (P = 0.1151); Loss of stability (P = 0.1565)
7:117144396:A:G,P13569,N48S,0.327,Gain of phosphorylation at N48 (P = 0.023); Gain of disorder (P = 0.0436); Gain of glycosylation at N48 (P = 0.0444); Loss of ubiquitination at K52 (P = 0.0587); Gain of helix (P = 0.2059)
7:117144396:A:T,P13569,N48I,0.348,Loss of disorder (P = 0.0475); Loss of ubiquitination at K52 (P = 0.0637); Gain of catalytic residue at L53 (P = 0.14); Gain of phosphorylation at S50 (P = 0.1915); Gain of helix (P = 0.2059)
7:117144397:T:G,P13569,N48K,0.423,Gain of ubiquitination at N48 (P = 0.0238); Loss of stability (P = 0.0949); Gain of disorder (P = 0.1022); Gain of phosphorylation at S50 (P = 0.1168); Gain of solvent accessibility (P = 0.1319)
7:117144398:C:A,P13569,L49I,0.259,Gain of glycosylation at S50 (P = 0.0925); Gain of ubiquitination at K52 (P = 0.115); Gain of helix (P = 0.132); Loss of phosphorylation at S50 (P = 0.1996); Loss of disorder (P = 0.2112)
7:117144398:C:G,P13569,L49V,0.293,Loss of ubiquitination at K52 (P = 0.0992); Gain of glycosylation at S50 (P = 0.1061); Loss of helix (P = 0.1299); Loss of phosphorylation at S50 (P = 0.2477); Loss of disorder (P = 0.2477)
7:117144399:T:A,P13569,L49Q,0.411,Loss of stability (P = 0.0451); Gain of disorder (P = 0.0501); Loss of ubiquitination at K52 (P = 0.1151); Gain of glycosylation at K52 (P = 0.1281); Loss of helix (P = 0.1299)
7:117144399:T:C,P13569,L49P,0.526,Loss of stability (P = 0.0164); Gain of disorder (P = 0.0398); Loss of helix (P = 0.0558); Gain of glycosylation at L49 (P = 0.0635); Loss of ubiquitination at K52 (P = 0.0992)
7:117144399:T:G,P13569,L49R,0.425,Loss of stability (P = 0.0427); Gain of disorder (P = 0.0474); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of ubiquitination at K52 (P = 0.0992)
7:117144401:T:A,P13569,S50T,0.518,Loss of disorder (P = 0.0672); Loss of ubiquitination at K52 (P = 0.0709); Loss of phosphorylation at S50 (P = 0.0714); Loss of glycosylation at S50 (P = 0.1176); Loss of helix (P = 0.1706)
7:117144401:T:C,P13569,S50P,0.777,Loss of phosphorylation at S50 (P = 0.0377); Gain of catalytic residue at N48 (P = 0.1043); Loss of ubiquitination at K52 (P = 0.1151); Gain of helix (P = 0.132); Gain of glycosylation at K52 (P = 0.1565)
7:117144401:T:G,P13569,S50A,0.499,Loss of phosphorylation at S50 (P = 0.0377); Loss of disorder (P = 0.0701); Loss of glycosylation at S50 (P = 0.0833); Gain of helix (P = 0.0854); Loss of ubiquitination at K52 (P = 0.1151)
7:117144402:C:A,P13569,S50Y,0.775,Loss of disorder (P = 0.0138); Loss of glycosylation at S50 (P = 0.0833); Loss of phosphorylation at S45 (P = 0.0972); Loss of ubiquitination at K52 (P = 0.1151); Gain of helix (P = 0.132)
7:117144402:C:G,P13569,S50C,0.605,Loss of disorder (P = 0.003); Loss of phosphorylation at S50 (P = 0.0377); Gain of helix (P = 0.0696); Loss of ubiquitination at K52 (P = 0.0709); Loss of glycosylation at S50 (P = 0.0833)
7:117144402:C:T,P13569,S50F,0.596,Loss of disorder (P = 0.0043); Loss of phosphorylation at S50 (P = 0.0377); Gain of helix (P = 0.0696); Loss of ubiquitination at K52 (P = 0.0777); Loss of glycosylation at S50 (P = 0.0833)
7:117144404:G:A,P13569,E51K,0.367,Gain of ubiquitination at E51 (P = 0.0276); Loss of stability (P = 0.101); Loss of phosphorylation at S50 (P = 0.1384); Gain of MoRF binding (P = 0.1531); Gain of glycosylation at E51 (P = 0.2394)
7:117144404:G:C,P13569,E51Q,0.279,Loss of ubiquitination at K52 (P = 0.0877); Loss of phosphorylation at S50 (P = 0.1113); Loss of glycosylation at S50 (P = 0.2136); Loss of disorder (P = 0.2155); Loss of loop (P = 0.2237)
7:117144405:A:C,P13569,E51A,0.316,Loss of disorder (P = 0.0797); Gain of ubiquitination at K52 (P = 0.0985); Loss of stability (P = 0.1028); Loss of phosphorylation at S50 (P = 0.1157); Loss of helix (P = 0.1706)
7:117144405:A:G,P13569,E51G,0.35,Gain of glycosylation at S50 (P = 0.0427); Loss of stability (P = 0.0619); Gain of ubiquitination at K52 (P = 0.115); Loss of phosphorylation at S50 (P = 0.1364); Loss of disorder (P = 0.1396)
7:117144405:A:T,P13569,E51V,0.345,Loss of disorder (P = 0.0103); Gain of ubiquitination at K52 (P = 0.0872); Loss of phosphorylation at S50 (P = 0.1018); Loss of glycosylation at K52 (P = 0.1204); Loss of helix (P = 0.1706)
7:117144406:A:C,P13569,E51D,0.314,Loss of ubiquitination at K52 (P = 0.1322); Loss of phosphorylation at S50 (P = 0.2237); Loss of glycosylation at K52 (P = 0.2524); Loss of stability (P = 0.2968); Gain of disorder (P = 0.3072)
7:117144406:A:T,P13569,E51D,0.314,Loss of ubiquitination at K52 (P = 0.1322); Loss of phosphorylation at S50 (P = 0.2237); Loss of glycosylation at K52 (P = 0.2524); Loss of stability (P = 0.2968); Gain of disorder (P = 0.3072)
7:117144407:A:C,P13569,K52Q,0.36,Loss of ubiquitination at K52 (P = 0.0183); Loss of glycosylation at K52 (P = 0.048); Gain of helix (P = 0.0854); Loss of phosphorylation at S50 (P = 0.1235); Gain of loop (P = 0.2045)
7:117144407:A:G,P13569,K52E,0.341,Loss of ubiquitination at K52 (P = 0.0183); Loss of glycosylation at K52 (P = 0.048); Loss of helix (P = 0.1299); Gain of phosphorylation at S50 (P = 0.1636); Gain of loop (P = 0.2754)
7:117144408:A:C,P13569,K52T,0.422,Loss of ubiquitination at K52 (P = 0.0183); Loss of glycosylation at K52 (P = 0.0598); Loss of solvent accessibility (P = 0.1144); Loss of helix (P = 0.1299); Loss of disorder (P = 0.147)
7:117144408:A:G,P13569,K52R,0.301,Loss of ubiquitination at K52 (P = 0.0183); Loss of glycosylation at K52 (P = 0.048); Loss of helix (P = 0.1299); Gain of phosphorylation at S50 (P = 0.1592); Gain of catalytic residue at K52 (P = 0.1937)
7:117144408:A:T,P13569,K52I,0.462,Loss of disorder (P = 0.009); Loss of ubiquitination at K52 (P = 0.0183); Loss of glycosylation at K52 (P = 0.048); Loss of solvent accessibility (P = 0.0703); Gain of catalytic residue at K52 (P = 0.1125)
7:117144409:A:C,P13569,K52N,0.358,Loss of ubiquitination at K52 (P = 0.0183); Loss of glycosylation at K52 (P = 0.048); Loss of phosphorylation at S50 (P = 0.1253); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.239)
7:117144409:A:T,P13569,K52N,0.358,Loss of ubiquitination at K52 (P = 0.0183); Loss of glycosylation at K52 (P = 0.048); Loss of phosphorylation at S50 (P = 0.1253); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.239)
7:117144410:T:A,P13569,L53M,0.406,Gain of loop (P = 0.069); Gain of ubiquitination at K52 (P = 0.0985); Loss of helix (P = 0.1299); Gain of glycosylation at S50 (P = 0.184); Gain of phosphorylation at S50 (P = 0.2079)
7:117144410:T:G,P13569,L53V,0.407,Gain of methylation at K52 (P = 0.047); Loss of ubiquitination at K52 (P = 0.1151); Gain of glycosylation at S50 (P = 0.1263); Loss of helix (P = 0.1299); Gain of phosphorylation at S50 (P = 0.2639)
7:117144411:T:C,P13569,L53S,0.564,Gain of phosphorylation at L53 (P = 0.0082); Loss of stability (P = 0.0489); Gain of ubiquitination at K52 (P = 0.078); Gain of disorder (P = 0.0855); Gain of glycosylation at S50 (P = 0.0941)
7:117144411:T:G,P13569,L53W,0.424,Loss of ubiquitination at K52 (P = 0.1151); Loss of helix (P = 0.1299); Loss of stability (P = 0.1379); Loss of disorder (P = 0.1401); Loss of phosphorylation at S50 (P = 0.1785)
7:117144412:G:C,P13569,L53F,0.391,Gain of methylation at K52 (P = 0.0349); Loss of ubiquitination at K52 (P = 0.0992); Loss of helix (P = 0.1299); Gain of glycosylation at S50 (P = 0.1344); Loss of phosphorylation at S50 (P = 0.1881)
7:117144412:G:T,P13569,L53F,0.391,Gain of methylation at K52 (P = 0.0349); Loss of ubiquitination at K52 (P = 0.0992); Loss of helix (P = 0.1299); Gain of glycosylation at S50 (P = 0.1344); Loss of phosphorylation at S50 (P = 0.1881)
7:117144413:G:A,P13569,E54K,0.541,Gain of ubiquitination at E54 (P = 0.0192); Gain of MoRF binding (P = 0.0344); Loss of helix (P = 0.1299); Loss of glycosylation at K52 (P = 0.1581); Gain of relative solvent accessibility (P = 0.1894)
7:117144413:G:C,P13569,E54Q,0.412,Loss of phosphorylation at S50 (P = 0.1287); Gain of helix (P = 0.132); Loss of ubiquitination at K52 (P = 0.1322); Loss of disorder (P = 0.144); Gain of MoRF binding (P = 0.1721)
7:117144414:A:C,P13569,E54A,0.408,Loss of disorder (P = 0.0557); Loss of ubiquitination at K52 (P = 0.1151); Loss of helix (P = 0.1299); Loss of phosphorylation at S50 (P = 0.1471); Gain of MoRF binding (P = 0.1513)
7:117144414:A:G,P13569,E54G,0.411,Gain of ubiquitination at K52 (P = 0.0985); Loss of disorder (P = 0.1016); Loss of stability (P = 0.13); Loss of phosphorylation at S50 (P = 0.1423); Gain of helix (P = 0.1736)
7:117144414:A:T,P13569,E54V,0.491,Loss of disorder (P = 0.0036); Gain of ubiquitination at K52 (P = 0.078); Gain of MoRF binding (P = 0.1106); Loss of phosphorylation at S50 (P = 0.1138); Gain of helix (P = 0.132)
7:117144415:A:C,P13569,E54D,0.404,Loss of ubiquitination at K52 (P = 0.1151); Gain of helix (P = 0.132); Loss of glycosylation at K52 (P = 0.2012); Loss of phosphorylation at S50 (P = 0.2125); Loss of loop (P = 0.2237)
7:117144415:A:T,P13569,E54D,0.404,Loss of ubiquitination at K52 (P = 0.1151); Gain of helix (P = 0.132); Loss of glycosylation at K52 (P = 0.2012); Loss of phosphorylation at S50 (P = 0.2125); Loss of loop (P = 0.2237)
7:117144416:A:G,P13569,R55G,0.473,Loss of solvent accessibility (P = 0.0509); Gain of ubiquitination at K52 (P = 0.0719); Loss of stability (P = 0.0969); Loss of glycosylation at K52 (P = 0.1217); Loss of phosphorylation at S50 (P = 0.1614)
7:117144417:G:A,P13569,R55K,0.775,Gain of ubiquitination at R55 (P = 0.023); Gain of methylation at R55 (P = 0.038); Loss of glycosylation at K52 (P = 0.1286); Gain of helix (P = 0.132); Loss of stability (P = 0.1899)
7:117144417:G:C,P13569,R55T,0.471,Gain of ubiquitination at K52 (P = 0.0671); Loss of glycosylation at K52 (P = 0.1055); Loss of helix (P = 0.1299); Loss of phosphorylation at S50 (P = 0.1372); Loss of solvent accessibility (P = 0.1651)
7:117144417:G:T,P13569,R55I,0.461,Loss of disorder (P = 0.0152); Loss of solvent accessibility (P = 0.0561); Gain of ubiquitination at K52 (P = 0.0671); Loss of glycosylation at K52 (P = 0.09); Loss of phosphorylation at S50 (P = 0.1132)
7:117149088:A:C,P13569,R55S,0.459,Gain of phosphorylation at R55 (P = 0.0305); Gain of ubiquitination at K52 (P = 0.078); Loss of glycosylation at K52 (P = 0.102); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1322)
7:117149088:A:T,P13569,R55S,0.459,Gain of phosphorylation at R55 (P = 0.0305); Gain of ubiquitination at K52 (P = 0.078); Loss of glycosylation at K52 (P = 0.102); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1322)
7:117149089:G:A,P13569,E56K,0.831,Gain of MoRF binding (P = 0.0113); Gain of ubiquitination at E56 (P = 0.0192); Gain of methylation at E56 (P = 0.0242); Gain of glycosylation at E56 (P = 0.045); Loss of stability (P = 0.0853)
7:117149089:G:C,P13569,E56Q,0.441,Gain of MoRF binding (P = 0.0647); Loss of disorder (P = 0.1053); Loss of helix (P = 0.1299); Loss of ubiquitination at K52 (P = 0.1322); Gain of loop (P = 0.2045)
7:117149090:A:C,P13569,E56A,0.45,Loss of disorder (P = 0.0412); Gain of MoRF binding (P = 0.0646); Loss of stability (P = 0.0946); Loss of ubiquitination at K52 (P = 0.1151); Gain of catalytic residue at E56 (P = 0.1276)
7:117149090:A:G,P13569,E56G,0.495,Loss of stability (P = 0.0467); Gain of MoRF binding (P = 0.069); Loss of disorder (P = 0.0854); Gain of ubiquitination at K52 (P = 0.0872); Gain of helix (P = 0.2059)
7:117149090:A:T,P13569,E56V,0.485,Loss of disorder (P = 9e-04); Gain of MoRF binding (P = 0.0533); Loss of ubiquitination at K52 (P = 0.1151); Loss of helix (P = 0.1299); Loss of glycosylation at K52 (P = 0.1571)
7:117149091:A:C,P13569,E56D,0.451,Gain of ubiquitination at K52 (P = 0.115); Gain of helix (P = 0.132); Loss of disorder (P = 0.2258); Loss of stability (P = 0.2711); Gain of loop (P = 0.2754)
7:117149091:A:T,P13569,E56D,0.451,Gain of ubiquitination at K52 (P = 0.115); Gain of helix (P = 0.132); Loss of disorder (P = 0.2258); Loss of stability (P = 0.2711); Gain of loop (P = 0.2754)
7:117149092:T:A,P13569,W57R,0.88,Gain of disorder (P = 0.0354); Gain of ubiquitination at K52 (P = 0.0624); Loss of stability (P = 0.1588); Loss of glycosylation at K52 (P = 0.1732); Loss of helix (P = 0.2022)
7:117149092:T:C,P13569,W57R,0.88,Gain of disorder (P = 0.0354); Gain of ubiquitination at K52 (P = 0.0624); Loss of stability (P = 0.1588); Loss of glycosylation at K52 (P = 0.1732); Loss of helix (P = 0.2022)
7:117149092:T:G,P13569,W57G,0.881,Loss of stability (P = 0.0125); Gain of disorder (P = 0.0429); Loss of ubiquitination at K52 (P = 0.0709); Gain of glycosylation at K52 (P = 0.1875); Loss of helix (P = 0.2022)
7:117149093:G:C,P13569,W57S,0.689,Gain of phosphorylation at W57 (P = 0.0011); Gain of disorder (P = 0.0241); Gain of ubiquitination at K52 (P = 0.0483); Loss of stability (P = 0.077); Gain of loop (P = 0.1069)
7:117149093:G:T,P13569,W57L,0.639,Loss of ubiquitination at K52 (P = 0.0587); Gain of disorder (P = 0.1176); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.2081); Gain of glycosylation at K52 (P = 0.2606)
7:117149094:G:C,P13569,W57C,0.577,Loss of ubiquitination at K52 (P = 0.1322); Loss of stability (P = 0.1446); Loss of MoRF binding (P = 0.1715); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2499)
7:117149094:G:T,P13569,W57C,0.577,Loss of ubiquitination at K52 (P = 0.1322); Loss of stability (P = 0.1446); Loss of MoRF binding (P = 0.1715); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2499)
7:117149095:G:A,P13569,D58N,0.81,Gain of MoRF binding (P = 0.0528); Loss of helix (P = 0.0626); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2903); Loss of glycosylation at S63 (P = 0.3136)
7:117149095:G:C,P13569,D58H,0.485,Gain of MoRF binding (P = 0.0606); Gain of helix (P = 0.1736); Gain of glycosylation at S63 (P = 0.1801); Loss of disorder (P = 0.2064); Loss of loop (P = 0.2237)
7:117149095:G:T,P13569,D58Y,0.456,Loss of disorder (P = 0.016); Gain of MoRF binding (P = 0.0539); Gain of phosphorylation at D58 (P = 0.1884); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117149096:A:C,P13569,D58A,0.504,Gain of MoRF binding (P = 0.0432); Loss of disorder (P = 0.1041); Gain of helix (P = 0.132); Gain of glycosylation at S63 (P = 0.19); Loss of loop (P = 0.2237)
7:117149096:A:G,P13569,D58G,0.812,Gain of MoRF binding (P = 0.0479); Gain of helix (P = 0.132); Loss of stability (P = 0.2044); Loss of loop (P = 0.2237); Loss of glycosylation at S63 (P = 0.245)
7:117149096:A:T,P13569,D58V,0.519,Loss of disorder (P = 0.0101); Gain of MoRF binding (P = 0.0307); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of glycosylation at S63 (P = 0.2972)
7:117149097:T:A,P13569,D58E,0.406,Gain of disorder (P = 0.1677); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2396); Gain of glycosylation at S63 (P = 0.2963)
7:117149097:T:G,P13569,D58E,0.406,Gain of disorder (P = 0.1677); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2396); Gain of glycosylation at S63 (P = 0.2963)
7:117149098:A:G,P13569,R59G,0.412,Loss of MoRF binding (P = 0.0705); Loss of methylation at K64 (P = 0.0913); Loss of ubiquitination at K64 (P = 0.1216); Loss of solvent accessibility (P = 0.1813); Gain of relative solvent accessibility (P = 0.1894)
7:117149099:G:A,P13569,R59K,0.447,Gain of ubiquitination at R59 (P = 0.0146); Gain of methylation at R59 (P = 0.0168); Gain of relative solvent accessibility (P = 0.09); Gain of glycosylation at R59 (P = 0.1213); Loss of helix (P = 0.1299)
7:117149099:G:C,P13569,R59T,0.421,Gain of glycosylation at R59 (P = 0.0647); Loss of MoRF binding (P = 0.07); Loss of methylation at K64 (P = 0.1287); Gain of helix (P = 0.132); Loss of ubiquitination at K64 (P = 0.1381)
7:117149099:G:T,P13569,R59I,0.41,Loss of disorder (P = 0.0107); Loss of MoRF binding (P = 0.0765); Gain of ubiquitination at K64 (P = 0.0898); Loss of methylation at K64 (P = 0.1108); Gain of helix (P = 0.132)
7:117149100:A:C,P13569,R59S,0.355,Gain of phosphorylation at R59 (P = 0.0235); Loss of MoRF binding (P = 0.0708); Gain of relative solvent accessibility (P = 0.09); Loss of ubiquitination at K64 (P = 0.1062); Gain of disorder (P = 0.1272)
7:117149100:A:T,P13569,R59S,0.355,Gain of phosphorylation at R59 (P = 0.0235); Loss of MoRF binding (P = 0.0708); Gain of relative solvent accessibility (P = 0.09); Loss of ubiquitination at K64 (P = 0.1062); Gain of disorder (P = 0.1272)
7:117149101:G:A,P13569,E60K,0.772,Gain of MoRF binding (P = 0.0044); Gain of methylation at E60 (P = 0.0124); Loss of ubiquitination at K64 (P = 0.0811); Loss of stability (P = 0.0979); Loss of glycosylation at S63 (P = 0.1556)
7:117149101:G:C,P13569,E60Q,0.396,Gain of MoRF binding (P = 0.0289); Loss of ubiquitination at K64 (P = 0.0499); Loss of disorder (P = 0.0915); Loss of helix (P = 0.1299); Gain of methylation at K64 (P = 0.1653)
7:117149102:A:C,P13569,E60A,0.452,Gain of MoRF binding (P = 0.0245); Loss of disorder (P = 0.0363); Loss of ubiquitination at K64 (P = 0.0421); Loss of solvent accessibility (P = 0.0721); Loss of methylation at K65 (P = 0.0754)
7:117149102:A:G,P13569,E60G,0.431,Loss of stability (P = 0.011); Gain of MoRF binding (P = 0.0255); Loss of ubiquitination at K64 (P = 0.0421); Loss of solvent accessibility (P = 0.0477); Loss of disorder (P = 0.0796)
7:117149102:A:T,P13569,E60V,0.504,Loss of disorder (P = 8e-04); Gain of MoRF binding (P = 0.0148); Loss of solvent accessibility (P = 0.0199); Loss of ubiquitination at K65 (P = 0.0386); Loss of relative solvent accessibility (P = 0.0981)
7:117149103:G:C,P13569,E60D,0.411,Loss of ubiquitination at K64 (P = 0.093); Gain of MoRF binding (P = 0.1233); Gain of helix (P = 0.132); Loss of methylation at K64 (P = 0.1614); Loss of disorder (P = 0.1925)
7:117149103:G:T,P13569,E60D,0.411,Loss of ubiquitination at K64 (P = 0.093); Gain of MoRF binding (P = 0.1233); Gain of helix (P = 0.132); Loss of methylation at K64 (P = 0.1614); Loss of disorder (P = 0.1925)
7:117149104:C:A,P13569,L61M,0.387,Gain of catalytic residue at L61 (P = 0.0108); Gain of methylation at K64 (P = 0.0759); Gain of MoRF binding (P = 0.0785); Gain of ubiquitination at K65 (P = 0.1047); Loss of helix (P = 0.1299)
7:117149104:C:G,P13569,L61V,0.266,Gain of methylation at K64 (P = 0.0862); Gain of MoRF binding (P = 0.0995); Loss of ubiquitination at K65 (P = 0.1062); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117149105:T:A,P13569,L61Q,0.457,Gain of disorder (P = 0.0489); Gain of MoRF binding (P = 0.0926); Gain of methylation at K64 (P = 0.1006); Gain of ubiquitination at K64 (P = 0.1047); Gain of relative solvent accessibility (P = 0.1066)
7:117149105:T:C,P13569,L61P,0.841,Gain of glycosylation at L61 (P = 0.0205); Gain of disorder (P = 0.0375); Gain of methylation at K64 (P = 0.055); Loss of MoRF binding (P = 0.0775); Loss of ubiquitination at K65 (P = 0.1062)
7:117149105:T:G,P13569,L61R,0.427,Gain of MoRF binding (P = 0.0137); Gain of disorder (P = 0.049); Gain of phosphorylation at S63 (P = 0.0587); Loss of ubiquitination at K64 (P = 0.093); Gain of helix (P = 0.132)
7:117149107:G:A,P13569,A62T,0.296,Gain of phosphorylation at A62 (P = 0.03); Gain of methylation at K64 (P = 0.0853); Loss of ubiquitination at K64 (P = 0.093); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1367)
7:117149107:G:C,P13569,A62P,0.428,Gain of glycosylation at A62 (P = 0.0103); Gain of methylation at K64 (P = 0.0463); Loss of MoRF binding (P = 0.0691); Gain of disorder (P = 0.0897); Loss of ubiquitination at K64 (P = 0.093)
7:117149107:G:T,P13569,A62S,0.334,Gain of phosphorylation at A62 (P = 0.0143); Gain of disorder (P = 0.0551); Gain of methylation at K64 (P = 0.0835); Loss of ubiquitination at K64 (P = 0.093); Gain of helix (P = 0.132)
7:117149108:C:A,P13569,A62D,0.4,Loss of MoRF binding (P = 0.0702); Gain of ubiquitination at K64 (P = 0.0719); Gain of disorder (P = 0.0806); Gain of methylation at K64 (P = 0.1257); Gain of helix (P = 0.132)
7:117149108:C:G,P13569,A62G,0.303,Loss of ubiquitination at K65 (P = 0.0736); Gain of methylation at K64 (P = 0.1051); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1385); Gain of disorder (P = 0.1471)
7:117149108:C:T,P13569,A62V,0.304,Loss of disorder (P = 0.0651); Loss of ubiquitination at K64 (P = 0.0736); Gain of MoRF binding (P = 0.1014); Gain of methylation at K64 (P = 0.1211); Loss of helix (P = 0.1299)
7:117149110:T:A,P13569,S63T,0.315,Loss of disorder (P = 0.07); Loss of ubiquitination at K64 (P = 0.0811); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1339); Loss of glycosylation at S63 (P = 0.1339)
7:117149110:T:C,P13569,S63P,0.401,Gain of glycosylation at S63 (P = 0.0582); Loss of MoRF binding (P = 0.0617); Gain of methylation at K64 (P = 0.0676); Loss of stability (P = 0.0925); Gain of ubiquitination at K65 (P = 0.1204)
7:117149110:T:G,P13569,S63A,0.339,Loss of glycosylation at S63 (P = 0.0554); Loss of disorder (P = 0.0573); Loss of methylation at K68 (P = 0.0831); Loss of ubiquitination at K64 (P = 0.093); Loss of MoRF binding (P = 0.1317)
7:117149111:C:T,P13569,S63L,0.379,Loss of disorder (P = 0.0088); Loss of methylation at K68 (P = 0.0499); Loss of ubiquitination at K64 (P = 0.0547); Loss of glycosylation at S63 (P = 0.0554); Loss of MoRF binding (P = 0.1427)
7:117149113:A:C,P13569,K64Q,0.455,Loss of solvent accessibility (P = 0.0117); Loss of ubiquitination at K64 (P = 0.021); Loss of methylation at K64 (P = 0.0329); Loss of MoRF binding (P = 0.0537); Loss of relative solvent accessibility (P = 0.0676)
7:117149113:A:G,P13569,K64E,0.77,Loss of MoRF binding (P = 0.0088); Loss of ubiquitination at K64 (P = 0.021); Loss of methylation at K64 (P = 0.0329); Loss of catalytic residue at K64 (P = 0.0817); Loss of glycosylation at P67 (P = 0.0947)
7:117149114:A:C,P13569,K64T,0.494,Loss of solvent accessibility (P = 0.0056); Loss of ubiquitination at K64 (P = 0.021); Loss of methylation at K64 (P = 0.0329); Loss of MoRF binding (P = 0.0488); Loss of disorder (P = 0.0571)
7:117149114:A:G,P13569,K64R,0.392,Loss of ubiquitination at K64 (P = 0.021); Loss of solvent accessibility (P = 0.0217); Loss of methylation at K64 (P = 0.0384); Gain of MoRF binding (P = 0.0671); Loss of relative solvent accessibility (P = 0.0676)
7:117149114:A:T,P13569,K64M,0.498,Loss of solvent accessibility (P = 0.0045); Loss of disorder (P = 0.0165); Loss of ubiquitination at K64 (P = 0.021); Loss of methylation at K65 (P = 0.0262); Loss of relative solvent accessibility (P = 0.0404)
7:117149115:G:C,P13569,K64N,0.479,Loss of solvent accessibility (P = 0.0079); Loss of ubiquitination at K64 (P = 0.021); Loss of methylation at K64 (P = 0.0329); Loss of MoRF binding (P = 0.0487); Loss of relative solvent accessibility (P = 0.0676)
7:117149115:G:T,P13569,K64N,0.479,Loss of solvent accessibility (P = 0.0079); Loss of ubiquitination at K64 (P = 0.021); Loss of methylation at K64 (P = 0.0329); Loss of MoRF binding (P = 0.0487); Loss of relative solvent accessibility (P = 0.0676)
7:117149116:A:C,P13569,K65Q,0.386,Loss of methylation at K65 (P = 0.0071); Loss of ubiquitination at K65 (P = 0.021); Loss of MoRF binding (P = 0.0613); Loss of glycosylation at P67 (P = 0.1117); Loss of disorder (P = 0.1161)
7:117149116:A:G,P13569,K65E,0.413,Loss of methylation at K65 (P = 0.0071); Loss of MoRF binding (P = 0.0099); Loss of ubiquitination at K65 (P = 0.021); Loss of glycosylation at P67 (P = 0.1022); Loss of catalytic residue at K64 (P = 0.1516)
7:117149117:A:C,P13569,K65T,0.378,Loss of methylation at K65 (P = 0.0071); Loss of ubiquitination at K65 (P = 0.021); Loss of disorder (P = 0.0575); Gain of phosphorylation at K65 (P = 0.0623); Loss of MoRF binding (P = 0.0688)
7:117149117:A:G,P13569,K65R,0.318,Loss of methylation at K65 (P = 0.0103); Loss of ubiquitination at K65 (P = 0.021); Gain of MoRF binding (P = 0.0883); Loss of disorder (P = 0.106); Loss of glycosylation at P67 (P = 0.1297)
7:117149117:A:T,P13569,K65I,0.453,Loss of disorder (P = 9e-04); Loss of methylation at K65 (P = 0.0071); Loss of ubiquitination at K65 (P = 0.021); Loss of solvent accessibility (P = 0.045); Loss of glycosylation at P67 (P = 0.0476)
7:117149118:A:C,P13569,K65N,0.382,Loss of methylation at K65 (P = 0.0071); Loss of ubiquitination at K65 (P = 0.021); Loss of MoRF binding (P = 0.0568); Loss of disorder (P = 0.1413); Loss of glycosylation at P67 (P = 0.144)
7:117149118:A:T,P13569,K65N,0.382,Loss of methylation at K65 (P = 0.0071); Loss of ubiquitination at K65 (P = 0.021); Loss of MoRF binding (P = 0.0568); Loss of disorder (P = 0.1413); Loss of glycosylation at P67 (P = 0.144)
7:117149119:A:C,P13569,N66H,0.434,Loss of ubiquitination at K64 (P = 0.0811); Gain of methylation at K64 (P = 0.1116); Loss of MoRF binding (P = 0.1197); Gain of helix (P = 0.132); Loss of stability (P = 0.1533)
7:117149119:A:G,P13569,N66D,0.465,Loss of MoRF binding (P = 0.0595); Gain of relative solvent accessibility (P = 0.09); Gain of ubiquitination at K68 (P = 0.1025); Loss of methylation at K64 (P = 0.1083); Gain of solvent accessibility (P = 0.1376)
7:117149119:A:T,P13569,N66Y,0.431,Loss of disorder (P = 0.0224); Gain of helix (P = 0.0696); Loss of methylation at K68 (P = 0.0738); Loss of ubiquitination at K65 (P = 0.0811); Loss of MoRF binding (P = 0.1412)
7:117149120:A:C,P13569,N66T,0.455,Gain of phosphorylation at N66 (P = 0.0283); Loss of ubiquitination at K65 (P = 0.0811); Gain of methylation at K64 (P = 0.1138); Gain of MoRF binding (P = 0.1214); Loss of disorder (P = 0.1371)
7:117149120:A:G,P13569,N66S,0.793,Gain of phosphorylation at N66 (P = 0.0635); Gain of disorder (P = 0.0757); Loss of ubiquitination at K64 (P = 0.093); Gain of MoRF binding (P = 0.125); Loss of methylation at K64 (P = 0.1395)
7:117149120:A:T,P13569,N66I,0.493,Loss of disorder (P = 0.0114); Loss of ubiquitination at K64 (P = 0.0518); Gain of methylation at K64 (P = 0.055); Loss of glycosylation at P67 (P = 0.0668); Gain of helix (P = 0.0696)
7:117149121:T:A,P13569,N66K,0.525,Gain of methylation at N66 (P = 0.0085); Gain of ubiquitination at N66 (P = 0.03); Gain of MoRF binding (P = 0.041); Gain of disorder (P = 0.0851); Gain of relative solvent accessibility (P = 0.1259)
7:117149121:T:G,P13569,N66K,0.525,Gain of methylation at N66 (P = 0.0085); Gain of ubiquitination at N66 (P = 0.03); Gain of MoRF binding (P = 0.041); Gain of disorder (P = 0.0851); Gain of relative solvent accessibility (P = 0.1259)
7:117149122:C:A,P13569,P67T,0.602,Loss of glycosylation at P67 (P = 0.02); Gain of MoRF binding (P = 0.0415); Loss of stability (P = 0.0797); Loss of ubiquitination at K64 (P = 0.0811); Loss of disorder (P = 0.1151)
7:117149122:C:G,P13569,P67A,0.578,Loss of glycosylation at P67 (P = 0.0103); Gain of MoRF binding (P = 0.0466); Loss of stability (P = 0.0539); Loss of ubiquitination at K65 (P = 0.0672); Loss of methylation at K64 (P = 0.0923)
7:117149122:C:T,P13569,P67S,0.825,Gain of MoRF binding (P = 0.0399); Loss of glycosylation at P67 (P = 0.0426); Loss of ubiquitination at K65 (P = 0.0811); Gain of disorder (P = 0.0885); Loss of methylation at K64 (P = 0.0936)
7:117149123:C:A,P13569,P67H,0.603,Loss of glycosylation at P67 (P = 0.0103); Gain of MoRF binding (P = 0.0492); Loss of ubiquitination at K64 (P = 0.0811); Loss of stability (P = 0.1377); Gain of methylation at K64 (P = 0.1737)
7:117149123:C:G,P13569,P67R,0.555,Gain of MoRF binding (P = 0.0021); Loss of glycosylation at P67 (P = 0.0103); Loss of ubiquitination at K64 (P = 0.0672); Gain of methylation at K64 (P = 0.121); Loss of stability (P = 0.1936)
7:117149125:A:C,P13569,K68Q,0.768,Loss of methylation at K68 (P = 0.0069); Loss of ubiquitination at K68 (P = 0.0255); Loss of glycosylation at P67 (P = 0.0422); Loss of MoRF binding (P = 0.0449); Loss of disorder (P = 0.1013)
7:117149126:A:C,P13569,K68T,0.692,Loss of methylation at K68 (P = 0.0069); Loss of ubiquitination at K68 (P = 0.0255); Loss of MoRF binding (P = 0.038); Loss of disorder (P = 0.0562); Gain of glycosylation at S63 (P = 0.1272)
7:117149126:A:G,P13569,K68R,0.533,Loss of methylation at K68 (P = 0.0115); Loss of ubiquitination at K68 (P = 0.0255); Gain of MoRF binding (P = 0.0638); Loss of glycosylation at P67 (P = 0.0928); Loss of disorder (P = 0.0969)
7:117149126:A:T,P13569,K68I,0.659,Loss of disorder (P = 0.0036); Loss of methylation at K68 (P = 0.0069); Loss of ubiquitination at K68 (P = 0.0255); Loss of MoRF binding (P = 0.0425); Gain of catalytic residue at L73 (P = 0.0626)
7:117149127:A:C,P13569,K68N,0.855,Loss of methylation at K68 (P = 0.0069); Loss of ubiquitination at K68 (P = 0.0255); Loss of MoRF binding (P = 0.0386); Loss of disorder (P = 0.125); Loss of helix (P = 0.2022)
7:117149127:A:T,P13569,K68N,0.855,Loss of methylation at K68 (P = 0.0069); Loss of ubiquitination at K68 (P = 0.0255); Loss of MoRF binding (P = 0.0386); Loss of disorder (P = 0.125); Loss of helix (P = 0.2022)
7:117149128:C:G,P13569,L69V,0.521,Gain of methylation at K64 (P = 0.0677); Gain of MoRF binding (P = 0.093); Gain of ubiquitination at K68 (P = 0.1025); Loss of glycosylation at P67 (P = 0.1235); Loss of stability (P = 0.1857)
7:117149128:C:T,P13569,L69F,0.475,Gain of methylation at K64 (P = 0.0739); Gain of ubiquitination at K68 (P = 0.1025); Gain of MoRF binding (P = 0.1157); Loss of disorder (P = 0.138); Gain of loop (P = 0.2045)
7:117149129:T:A,P13569,L69H,0.918,Gain of disorder (P = 0.0234); Loss of stability (P = 0.0255); Gain of methylation at K64 (P = 0.0411); Loss of ubiquitination at K64 (P = 0.0736); Loss of MoRF binding (P = 0.0927)
7:117149129:T:C,P13569,L69P,0.865,Gain of disorder (P = 0.011); Loss of stability (P = 0.0223); Gain of methylation at K64 (P = 0.0402); Loss of MoRF binding (P = 0.0424); Gain of glycosylation at L69 (P = 0.0483)
7:117149129:T:G,P13569,L69R,0.84,Gain of disorder (P = 0.0192); Gain of MoRF binding (P = 0.0247); Loss of ubiquitination at K64 (P = 0.0368); Loss of stability (P = 0.0448); Gain of methylation at K64 (P = 0.0465)
7:117149131:A:C,P13569,I70L,0.479,Loss of methylation at K68 (P = 0.07); Gain of disorder (P = 0.0908); Loss of MoRF binding (P = 0.0984); Loss of ubiquitination at K65 (P = 0.1216); Loss of helix (P = 0.2022)
7:117149131:A:G,P13569,I70V,0.33,Gain of ubiquitination at K65 (P = 0.1204); Gain of MoRF binding (P = 0.1391); Gain of disorder (P = 0.1623); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117149131:A:T,P13569,I70F,0.375,Loss of MoRF binding (P = 0.1163); Gain of ubiquitination at K65 (P = 0.1204); Loss of methylation at K68 (P = 0.1819); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117149132:T:A,P13569,I70N,0.71,Gain of disorder (P = 0.0079); Gain of ubiquitination at K68 (P = 0.0762); Loss of MoRF binding (P = 0.0982); Loss of methylation at K68 (P = 0.1031); Loss of stability (P = 0.1799)
7:117149132:T:C,P13569,I70T,0.692,Gain of disorder (P = 0.019); Loss of stability (P = 0.0457); Gain of phosphorylation at I70 (P = 0.0982); Loss of MoRF binding (P = 0.1035); Loss of ubiquitination at K65 (P = 0.1062)
7:117149132:T:G,P13569,I70S,0.697,Gain of disorder (P = 0.0026); Loss of methylation at K68 (P = 0.0693); Loss of ubiquitination at K65 (P = 0.0811); Gain of phosphorylation at I70 (P = 0.1001); Loss of stability (P = 0.1076)
7:117149133:T:G,P13569,I70M,0.431,Loss of ubiquitination at K65 (P = 0.0421); Gain of disorder (P = 0.0459); Gain of MoRF binding (P = 0.1038); Loss of methylation at K65 (P = 0.1968); Loss of helix (P = 0.2022)
7:117149134:A:C,P13569,N71H,0.502,Loss of MoRF binding (P = 0.1075); Gain of catalytic residue at L73 (P = 0.1365); Gain of ubiquitination at K68 (P = 0.1446); Gain of methylation at R74 (P = 0.1626); Gain of disorder (P = 0.1792)
7:117149134:A:G,P13569,N71D,0.585,Loss of MoRF binding (P = 0.0632); Gain of ubiquitination at K68 (P = 0.1025); Gain of relative solvent accessibility (P = 0.1259); Loss of methylation at K68 (P = 0.1265); Loss of helix (P = 0.2022)
7:117149134:A:T,P13569,N71Y,0.523,Loss of disorder (P = 0.0667); Loss of MoRF binding (P = 0.0947); Gain of ubiquitination at K68 (P = 0.1025); Gain of methylation at R74 (P = 0.2909); Gain of glycosylation at P67 (P = 0.3043)
7:117149135:A:C,P13569,N71T,0.471,Gain of phosphorylation at N71 (P = 0.057); Gain of ubiquitination at K68 (P = 0.0856); Loss of MoRF binding (P = 0.1173); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2034)
7:117149135:A:G,P13569,N71S,0.457,Gain of disorder (P = 0.0749); Gain of ubiquitination at K68 (P = 0.1025); Loss of MoRF binding (P = 0.132); Loss of helix (P = 0.2022); Loss of methylation at K68 (P = 0.2603)
7:117149135:A:T,P13569,N71I,0.522,Loss of disorder (P = 0.0476); Loss of MoRF binding (P = 0.0997); Loss of ubiquitination at K68 (P = 0.1647); Loss of helix (P = 0.2271); Gain of glycosylation at P67 (P = 0.2583)
7:117149136:T:A,P13569,N71K,0.61,Gain of methylation at N71 (P = 0.0042); Gain of ubiquitination at N71 (P = 0.0247); Gain of MoRF binding (P = 0.036); Gain of glycosylation at N71 (P = 0.074); Gain of disorder (P = 0.1102)
7:117149136:T:G,P13569,N71K,0.61,Gain of methylation at N71 (P = 0.0042); Gain of ubiquitination at N71 (P = 0.0247); Gain of MoRF binding (P = 0.036); Gain of glycosylation at N71 (P = 0.074); Gain of disorder (P = 0.1102)
7:117149137:G:A,P13569,A72T,0.794,Gain of MoRF binding (P = 0.1291); Loss of ubiquitination at K68 (P = 0.1647); Gain of phosphorylation at A72 (P = 0.1676); Gain of disorder (P = 0.2106); Gain of methylation at K68 (P = 0.2865)
7:117149137:G:C,P13569,A72P,0.727,Loss of MoRF binding (P = 0.0609); Gain of glycosylation at A72 (P = 0.0782); Gain of disorder (P = 0.0875); Gain of catalytic residue at A72 (P = 0.0892); Loss of ubiquitination at K68 (P = 0.1296)
7:117149137:G:T,P13569,A72S,0.512,Gain of disorder (P = 0.0405); Gain of phosphorylation at A72 (P = 0.0535); Gain of MoRF binding (P = 0.1142); Gain of relative solvent accessibility (P = 0.1259); Loss of ubiquitination at K68 (P = 0.1296)
7:117149138:C:A,P13569,A72D,0.859,Loss of MoRF binding (P = 0.0707); Gain of relative solvent accessibility (P = 0.09); Gain of disorder (P = 0.129); Gain of solvent accessibility (P = 0.1376); Loss of ubiquitination at K68 (P = 0.1473)
7:117149138:C:G,P13569,A72G,0.552,Loss of stability (P = 0.1033); Gain of relative solvent accessibility (P = 0.1259); Gain of MoRF binding (P = 0.1429); Loss of ubiquitination at K68 (P = 0.1473); Gain of disorder (P = 0.1563)
7:117149138:C:T,P13569,A72V,0.548,Loss of disorder (P = 0.0822); Gain of MoRF binding (P = 0.109); Gain of ubiquitination at K68 (P = 0.1446); Loss of helix (P = 0.2271); Gain of methylation at K68 (P = 0.3057)
7:117149140:C:A,P13569,L73I,0.411,Gain of MoRF binding (P = 0.116); Loss of ubiquitination at K68 (P = 0.1647); Loss of stability (P = 0.1716); Loss of disorder (P = 0.2075); Gain of helix (P = 0.2294)
7:117149140:C:G,P13569,L73V,0.4,Gain of MoRF binding (P = 0.1102); Loss of stability (P = 0.1276); Gain of ubiquitination at K68 (P = 0.1446); Loss of disorder (P = 0.2215); Gain of helix (P = 0.2294)
7:117149140:C:T,P13569,L73F,0.431,Loss of stability (P = 0.1196); Gain of ubiquitination at K68 (P = 0.1215); Gain of MoRF binding (P = 0.1343); Loss of disorder (P = 0.1895); Gain of methylation at R74 (P = 0.1979)
7:117149141:T:A,P13569,L73H,0.686,Loss of stability (P = 0.0072); Gain of disorder (P = 0.0278); Gain of ubiquitination at K68 (P = 0.0856); Loss of MoRF binding (P = 0.1081); Gain of helix (P = 0.2294)
7:117149141:T:C,P13569,L73P,0.778,Loss of stability (P = 0.0052); Gain of disorder (P = 0.0363); Loss of MoRF binding (P = 0.0521); Gain of glycosylation at L73 (P = 0.0879); Gain of ubiquitination at K68 (P = 0.1215)
7:117149141:T:G,P13569,L73R,0.825,Loss of stability (P = 0.0144); Gain of methylation at L73 (P = 0.0182); Gain of disorder (P = 0.0401); Gain of MoRF binding (P = 0.0547); Loss of ubiquitination at K68 (P = 0.1473)
7:117149143:C:G,P13569,R74G,0.728,Gain of methylation at R75 (P = 0.0473); Loss of MoRF binding (P = 0.0658); Loss of stability (P = 0.1769); Gain of catalytic residue at R75 (P = 0.2257); Loss of disorder (P = 0.4001)
7:117149144:G:C,P13569,R74P,0.74,Loss of MoRF binding (P = 0.0122); Loss of methylation at R74 (P = 0.1253); Loss of stability (P = 0.1433); Loss of catalytic residue at R74 (P = 0.2214); Loss of helix (P = 0.2271)
7:117149144:G:T,P13569,R74L,0.615,Loss of MoRF binding (P = 0.0707); Loss of methylation at R74 (P = 0.1253); Loss of catalytic residue at R74 (P = 0.1833); Loss of helix (P = 0.2271); Loss of disorder (P = 0.2732)
7:117149146:C:G,P13569,R75G,0.536,Loss of stability (P = 0.0209); Loss of MoRF binding (P = 0.0305); Gain of methylation at R74 (P = 0.0432); Loss of helix (P = 0.2271); Loss of solvent accessibility (P = 0.239)
7:117149147:G:C,P13569,R75P,0.601,Loss of MoRF binding (P = 0.0018); Gain of catalytic residue at R75 (P = 0.079); Loss of stability (P = 0.1328); Loss of helix (P = 0.2271); Gain of methylation at R74 (P = 0.3114)
7:117149147:G:T,P13569,R75L,0.831,Loss of MoRF binding (P = 0.0337); Gain of helix (P = 0.2294); Gain of catalytic residue at R75 (P = 0.2355); Gain of methylation at R80 (P = 0.2384); Loss of solvent accessibility (P = 0.3103)
7:117149149:T:A,P13569,C76S,0.488,Loss of stability (P = 0.0322); Gain of MoRF binding (P = 0.0919); Gain of phosphorylation at C76 (P = 0.2244); Loss of helix (P = 0.2271); Loss of catalytic residue at R74 (P = 0.2946)
7:117149149:T:C,P13569,C76R,0.511,Gain of MoRF binding (P = 0.0278); Loss of stability (P = 0.084); Gain of solvent accessibility (P = 0.2097); Gain of helix (P = 0.2294); Loss of catalytic residue at R74 (P = 0.2624)
7:117149149:T:G,P13569,C76G,0.515,Loss of stability (P = 0.0037); Gain of MoRF binding (P = 0.0974); Gain of methylation at R75 (P = 0.1772); Loss of catalytic residue at C76 (P = 0.1981); Gain of loop (P = 0.4661)
7:117149150:G:A,P13569,C76Y,0.498,Loss of stability (P = 0.1024); Gain of MoRF binding (P = 0.1159); Loss of catalytic residue at C76 (P = 0.1857); Gain of helix (P = 0.2294); Gain of solvent accessibility (P = 0.28)
7:117149150:G:C,P13569,C76S,0.488,Loss of stability (P = 0.0322); Gain of MoRF binding (P = 0.0919); Gain of phosphorylation at C76 (P = 0.2244); Loss of helix (P = 0.2271); Loss of catalytic residue at R74 (P = 0.2946)
7:117149150:G:T,P13569,C76F,0.532,Loss of catalytic residue at C76 (P = 0.0669); Gain of MoRF binding (P = 0.0824); Gain of helix (P = 0.2294); Loss of stability (P = 0.2594); Gain of methylation at R80 (P = 0.3006)
7:117149152:T:A,P13569,F77I,0.469,Gain of MoRF binding (P = 0.1122); Gain of helix (P = 0.2294); Loss of methylation at R74 (P = 0.3021); Loss of stability (P = 0.3865); Loss of catalytic residue at C76 (P = 0.6014)
7:117149152:T:C,P13569,F77L,0.456,Gain of catalytic residue at F77 (P = 0.0102); Loss of MoRF binding (P = 0.1446); Gain of helix (P = 0.2294); Loss of methylation at R74 (P = 0.3095); Loss of stability (P = 0.4427)
7:117149152:T:G,P13569,F77V,0.51,Loss of stability (P = 0.0775); Gain of MoRF binding (P = 0.1264); Loss of helix (P = 0.2271); Loss of methylation at R74 (P = 0.335); Loss of catalytic residue at C76 (P = 0.6388)
7:117149153:T:A,P13569,F77Y,0.538,Loss of MoRF binding (P = 0.1084); Loss of stability (P = 0.1729); Gain of helix (P = 0.2294); Gain of methylation at R74 (P = 0.3376); Gain of catalytic residue at R74 (P = 0.3867)
7:117149153:T:C,P13569,F77S,0.486,Gain of phosphorylation at F77 (P = 0.0519); Loss of stability (P = 0.081); Gain of MoRF binding (P = 0.1302); Loss of helix (P = 0.2271); Gain of catalytic residue at F77 (P = 0.2511)
7:117149153:T:G,P13569,F77C,0.612,Loss of MoRF binding (P = 0.089); Loss of stability (P = 0.117); Gain of helix (P = 0.2294); Gain of catalytic residue at R75 (P = 0.2422); Loss of methylation at R74 (P = 0.3364)
7:117149154:T:A,P13569,F77L,0.456,Gain of catalytic residue at F77 (P = 0.0102); Loss of MoRF binding (P = 0.1446); Gain of helix (P = 0.2294); Loss of methylation at R74 (P = 0.3095); Loss of stability (P = 0.4427)
7:117149154:T:G,P13569,F77L,0.456,Gain of catalytic residue at F77 (P = 0.0102); Loss of MoRF binding (P = 0.1446); Gain of helix (P = 0.2294); Loss of methylation at R74 (P = 0.3095); Loss of stability (P = 0.4427)
7:117149155:T:A,P13569,F78I,0.484,Gain of MoRF binding (P = 0.119); Loss of methylation at R80 (P = 0.3195); Loss of stability (P = 0.3632); Loss of catalytic residue at C76 (P = 0.6118); Loss of helix (P = 0.6555)
7:117149155:T:C,P13569,F78L,0.489,Gain of MoRF binding (P = 0.1374); Loss of helix (P = 0.2271); Loss of methylation at R74 (P = 0.3328); Loss of stability (P = 0.4762); Loss of catalytic residue at C76 (P = 0.6812)
7:117149155:T:G,P13569,F78V,0.46,Gain of catalytic residue at F78 (P = 0.0058); Gain of MoRF binding (P = 0.1198); Loss of stability (P = 0.1756); Loss of helix (P = 0.2271); Gain of methylation at R74 (P = 0.3376)
7:117149156:T:A,P13569,F78Y,0.479,Loss of MoRF binding (P = 0.1303); Gain of catalytic residue at L73 (P = 0.2154); Loss of helix (P = 0.2271); Loss of stability (P = 0.2699); Gain of methylation at R74 (P = 0.2714)
7:117149156:T:C,P13569,F78S,0.499,Gain of catalytic residue at F78 (P = 0.0035); Loss of stability (P = 0.073); Gain of MoRF binding (P = 0.0978); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.2271)
7:117149156:T:G,P13569,F78C,0.5,Gain of catalytic residue at W79 (P = 0.0026); Loss of MoRF binding (P = 0.1028); Loss of stability (P = 0.1606); Loss of helix (P = 0.2271); Gain of methylation at R80 (P = 0.2978)
7:117149157:C:A,P13569,F78L,0.489,Gain of MoRF binding (P = 0.1374); Loss of helix (P = 0.2271); Loss of methylation at R74 (P = 0.3328); Loss of stability (P = 0.4762); Loss of catalytic residue at C76 (P = 0.6812)
7:117149157:C:G,P13569,F78L,0.489,Gain of MoRF binding (P = 0.1374); Loss of helix (P = 0.2271); Loss of methylation at R74 (P = 0.3328); Loss of stability (P = 0.4762); Loss of catalytic residue at C76 (P = 0.6812)
7:117149158:T:A,P13569,W79R,0.874,Loss of catalytic residue at M82 (P = 0.0064); Gain of methylation at W79 (P = 0.0286); Gain of solvent accessibility (P = 0.0584); Gain of MoRF binding (P = 0.0753); Gain of relative solvent accessibility (P = 0.09)
7:117149158:T:C,P13569,W79R,0.874,Loss of catalytic residue at M82 (P = 0.0064); Gain of methylation at W79 (P = 0.0286); Gain of solvent accessibility (P = 0.0584); Gain of MoRF binding (P = 0.0753); Gain of relative solvent accessibility (P = 0.09)
7:117149158:T:G,P13569,W79G,0.661,Loss of catalytic residue at M82 (P = 0.0076); Gain of methylation at R80 (P = 0.023); Loss of MoRF binding (P = 0.0452); Loss of stability (P = 0.0461); Gain of relative solvent accessibility (P = 0.1259)
7:117149159:G:C,P13569,W79S,0.659,Loss of catalytic residue at M82 (P = 0.0076); Gain of methylation at R80 (P = 0.0439); Loss of MoRF binding (P = 0.0548); Gain of relative solvent accessibility (P = 0.1259); Loss of stability (P = 0.2206)
7:117149159:G:T,P13569,W79L,0.65,Loss of catalytic residue at M82 (P = 0.0075); Gain of methylation at R74 (P = 0.0421); Loss of MoRF binding (P = 0.0528); Loss of helix (P = 0.4763); Loss of phosphorylation at Y84 (P = 0.8398)
7:117149160:G:C,P13569,W79C,0.631,Loss of MoRF binding (P = 0.0294); Gain of methylation at R80 (P = 0.0392); Loss of catalytic residue at M82 (P = 0.0504); Gain of helix (P = 0.2294); Loss of stability (P = 0.3899)
7:117149160:G:T,P13569,W79C,0.631,Loss of MoRF binding (P = 0.0294); Gain of methylation at R80 (P = 0.0392); Loss of catalytic residue at M82 (P = 0.0504); Gain of helix (P = 0.2294); Loss of stability (P = 0.3899)
7:117149161:A:G,P13569,R80G,0.643,Loss of MoRF binding (P = 0.0268); Loss of stability (P = 0.1178); Loss of methylation at R80 (P = 0.1493); Gain of helix (P = 0.2294); Gain of catalytic residue at W79 (P = 0.245)
7:117149162:G:A,P13569,R80K,0.624,Gain of methylation at R80 (P = 0.0085); Gain of ubiquitination at R80 (P = 0.0311); Loss of MoRF binding (P = 0.1075); Gain of helix (P = 0.2294); Loss of stability (P = 0.2327)
7:117149162:G:C,P13569,R80T,0.616,Loss of MoRF binding (P = 0.0289); Gain of catalytic residue at F83 (P = 0.116); Loss of methylation at R80 (P = 0.1493); Gain of helix (P = 0.2294); Loss of stability (P = 0.3785)
7:117149162:G:T,P13569,R80I,0.585,Loss of MoRF binding (P = 0.042); Loss of catalytic residue at R80 (P = 0.0547); Loss of methylation at R80 (P = 0.1493); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786)
7:117149163:A:C,P13569,R80S,0.604,Loss of MoRF binding (P = 0.0322); Loss of methylation at R80 (P = 0.1493); Gain of helix (P = 0.2294); Loss of stability (P = 0.3728); Loss of loop (P = 0.4786)
7:117149163:A:T,P13569,R80S,0.604,Loss of MoRF binding (P = 0.0322); Loss of methylation at R80 (P = 0.1493); Gain of helix (P = 0.2294); Loss of stability (P = 0.3728); Loss of loop (P = 0.4786)
7:117149164:T:A,P13569,F81I,0.652,Gain of MoRF binding (P = 0.1072); Gain of helix (P = 0.2294); Loss of stability (P = 0.2803); Loss of methylation at R80 (P = 0.2851); Loss of catalytic residue at C76 (P = 0.287)
7:117149164:T:C,P13569,F81L,0.674,Gain of MoRF binding (P = 0.1395); Loss of catalytic residue at C76 (P = 0.3209); Loss of methylation at R80 (P = 0.3245); Loss of stability (P = 0.3823); Loss of helix (P = 0.4763)
7:117149164:T:G,P13569,F81V,0.68,Gain of MoRF binding (P = 0.1191); Loss of stability (P = 0.1551); Gain of helix (P = 0.2294); Loss of catalytic residue at C76 (P = 0.2938); Loss of methylation at R80 (P = 0.3512)
7:117149165:T:A,P13569,F81Y,0.747,Loss of MoRF binding (P = 0.0975); Loss of stability (P = 0.1143); Loss of helix (P = 0.2271); Loss of catalytic residue at C76 (P = 0.2648); Loss of methylation at R80 (P = 0.3313)
7:117149165:T:C,P13569,F81S,0.628,Gain of catalytic residue at F81 (P = 0.0044); Loss of stability (P = 0.0248); Gain of MoRF binding (P = 0.1341); Loss of helix (P = 0.2271); Loss of methylation at R80 (P = 0.3128)
7:117149165:T:G,P13569,F81C,0.744,Loss of stability (P = 0.0762); Loss of MoRF binding (P = 0.0877); Gain of catalytic residue at F81 (P = 0.1531); Loss of helix (P = 0.2271); Loss of methylation at R80 (P = 0.3264)
7:117149166:T:A,P13569,F81L,0.674,Gain of MoRF binding (P = 0.1395); Loss of catalytic residue at C76 (P = 0.3209); Loss of methylation at R80 (P = 0.3245); Loss of stability (P = 0.3823); Loss of helix (P = 0.4763)
7:117149166:T:G,P13569,F81L,0.674,Gain of MoRF binding (P = 0.1395); Loss of catalytic residue at C76 (P = 0.3209); Loss of methylation at R80 (P = 0.3245); Loss of stability (P = 0.3823); Loss of helix (P = 0.4763)
7:117149167:A:C,P13569,M82L,0.612,Loss of catalytic residue at M82 (P = 0.0251); Loss of MoRF binding (P = 0.1192); Loss of methylation at R80 (P = 0.3337); Loss of helix (P = 0.6555); Loss of stability (P = 0.6584)
7:117149167:A:G,P13569,M82V,0.647,Loss of catalytic residue at M82 (P = 0.0711); Loss of MoRF binding (P = 0.1384); Loss of stability (P = 0.2401); Loss of methylation at R80 (P = 0.3508); Loss of helix (P = 0.6555)
7:117149167:A:T,P13569,M82L,0.612,Loss of catalytic residue at M82 (P = 0.0251); Loss of MoRF binding (P = 0.1192); Loss of methylation at R80 (P = 0.3337); Loss of helix (P = 0.6555); Loss of stability (P = 0.6584)
7:117149168:T:A,P13569,M82K,0.874,Gain of methylation at M82 (P = 0.0062); Gain of ubiquitination at M82 (P = 0.0258); Gain of MoRF binding (P = 0.036); Loss of stability (P = 0.0519); Loss of helix (P = 0.2271)
7:117149168:T:C,P13569,M82T,0.697,Loss of stability (P = 0.0758); Loss of MoRF binding (P = 0.126); Loss of catalytic residue at M82 (P = 0.1974); Gain of methylation at R80 (P = 0.2246); Loss of helix (P = 0.2271)
7:117149168:T:G,P13569,M82R,0.928,Gain of methylation at M82 (P = 0.0076); Gain of MoRF binding (P = 0.0261); Loss of stability (P = 0.1009); Loss of helix (P = 0.2271); Loss of catalytic residue at F87 (P = 0.374)
7:117149169:G:A,P13569,M82I,0.629,Loss of catalytic residue at M82 (P = 0.0324); Gain of MoRF binding (P = 0.1446); Loss of helix (P = 0.2271); Loss of methylation at R80 (P = 0.3093); Loss of stability (P = 0.5285)
7:117149169:G:C,P13569,M82I,0.629,Loss of catalytic residue at M82 (P = 0.0324); Gain of MoRF binding (P = 0.1446); Loss of helix (P = 0.2271); Loss of methylation at R80 (P = 0.3093); Loss of stability (P = 0.5285)
7:117149169:G:T,P13569,M82I,0.629,Loss of catalytic residue at M82 (P = 0.0324); Gain of MoRF binding (P = 0.1446); Loss of helix (P = 0.2271); Loss of methylation at R80 (P = 0.3093); Loss of stability (P = 0.5285)
7:117149170:T:A,P13569,F83I,0.561,Gain of catalytic residue at F83 (P = 0.0119); Gain of MoRF binding (P = 0.111); Loss of stability (P = 0.2399); Loss of methylation at R80 (P = 0.3291); Loss of helix (P = 0.5596)
7:117149170:T:C,P13569,F83L,0.619,Gain of MoRF binding (P = 0.1443); Gain of catalytic residue at F83 (P = 0.2188); Loss of stability (P = 0.286); Loss of methylation at R80 (P = 0.339); Loss of helix (P = 0.5596)
7:117149170:T:G,P13569,F83V,0.619,Gain of catalytic residue at F83 (P = 0.0901); Gain of MoRF binding (P = 0.1213); Loss of stability (P = 0.1256); Gain of methylation at R80 (P = 0.3489); Loss of helix (P = 0.5596)
7:117149171:T:A,P13569,F83Y,0.766,Gain of catalytic residue at F83 (P = 0.0847); Loss of MoRF binding (P = 0.1004); Loss of stability (P = 0.109); Loss of methylation at R80 (P = 0.3402); Loss of helix (P = 0.5596)
7:117149171:T:C,P13569,F83S,0.672,Loss of stability (P = 0.0363); Gain of catalytic residue at F83 (P = 0.1082); Gain of MoRF binding (P = 0.1295); Gain of phosphorylation at F83 (P = 0.3188); Loss of methylation at R80 (P = 0.3242)
7:117149171:T:G,P13569,F83C,0.785,Loss of stability (P = 0.0717); Loss of MoRF binding (P = 0.0925); Gain of catalytic residue at F83 (P = 0.1006); Loss of methylation at R80 (P = 0.3375); Loss of helix (P = 0.5596)
7:117149172:C:A,P13569,F83L,0.619,Gain of MoRF binding (P = 0.1443); Gain of catalytic residue at F83 (P = 0.2188); Loss of stability (P = 0.286); Loss of methylation at R80 (P = 0.339); Loss of helix (P = 0.5596)
7:117149172:C:G,P13569,F83L,0.619,Gain of MoRF binding (P = 0.1443); Gain of catalytic residue at F83 (P = 0.2188); Loss of stability (P = 0.286); Loss of methylation at R80 (P = 0.339); Loss of helix (P = 0.5596)
7:117149173:T:A,P13569,Y84N,0.758,Gain of MoRF binding (P = 0.0695); Loss of stability (P = 0.268); Gain of methylation at R80 (P = 0.2954); Gain of helix (P = 0.5668); Loss of catalytic residue at Y84 (P = 0.6377)
7:117149173:T:C,P13569,Y84H,0.76,Gain of MoRF binding (P = 0.1058); Gain of catalytic residue at G85 (P = 0.1682); Loss of stability (P = 0.1871); Gain of methylation at R80 (P = 0.3128); Gain of helix (P = 0.5668)
7:117149173:T:G,P13569,Y84D,0.763,Loss of MoRF binding (P = 0.085); Loss of methylation at R80 (P = 0.3339); Loss of stability (P = 0.3351); Gain of phosphorylation at Y89 (P = 0.528); Loss of helix (P = 0.6555)
7:117149174:A:C,P13569,Y84S,0.638,Gain of glycosylation at Y84 (P = 0.0221); Gain of MoRF binding (P = 0.0817); Loss of stability (P = 0.2233); Gain of methylation at R80 (P = 0.3475); Gain of catalytic residue at G85 (P = 0.3555)
7:117149174:A:G,P13569,Y84C,0.74,Loss of MoRF binding (P = 0.1233); Loss of methylation at R80 (P = 0.3356); Gain of catalytic residue at G85 (P = 0.5319); Loss of stability (P = 0.5444); Loss of helix (P = 0.6555)
7:117149174:A:T,P13569,Y84F,0.732,Loss of catalytic residue at Y84 (P = 0.0423); Gain of MoRF binding (P = 0.1107); Loss of methylation at R80 (P = 0.3351); Loss of helix (P = 0.6555); Loss of phosphorylation at Y89 (P = 0.6735)
7:117149176:G:A,P13569,G85R,0.945,Gain of MoRF binding (P = 0.016); Gain of methylation at G85 (P = 0.0249); Loss of catalytic residue at F87 (P = 0.1872); Loss of phosphorylation at Y89 (P = 0.6757); Loss of helix (P = 0.7926)
7:117149176:G:C,P13569,G85R,0.945,Gain of MoRF binding (P = 0.016); Gain of methylation at G85 (P = 0.0249); Loss of catalytic residue at F87 (P = 0.1872); Loss of phosphorylation at Y89 (P = 0.6757); Loss of helix (P = 0.7926)
7:117149177:G:C,P13569,G85A,0.822,Loss of MoRF binding (P = 0.1405); Gain of catalytic residue at G85 (P = 0.1597); Gain of methylation at R80 (P = 0.3209); Loss of stability (P = 0.5193); Loss of phosphorylation at Y89 (P = 0.6757)
7:117149177:G:T,P13569,G85V,0.911,Gain of MoRF binding (P = 0.1096); Loss of catalytic residue at L90 (P = 0.3394); Loss of methylation at R80 (P = 0.3534); Loss of phosphorylation at Y89 (P = 0.6728); Loss of helix (P = 0.7926)
7:117149179:A:C,P13569,I86L,0.756,Loss of catalytic residue at I86 (P = 0.1044); Loss of MoRF binding (P = 0.1071); Loss of stability (P = 0.4433); Loss of phosphorylation at Y89 (P = 0.6667); Gain of helix (P = 0.6868)
7:117149179:A:G,P13569,I86V,0.695,Loss of MoRF binding (P = 0.1247); Loss of stability (P = 0.2099); Loss of phosphorylation at Y89 (P = 0.6682); Gain of catalytic residue at F87 (P = 0.7007); Loss of helix (P = 0.7926)
7:117149179:A:T,P13569,I86F,0.786,Loss of stability (P = 0.0697); Loss of catalytic residue at I86 (P = 0.0846); Loss of MoRF binding (P = 0.1167); Loss of phosphorylation at Y89 (P = 0.6684); Loss of helix (P = 0.7926)
7:117149180:T:A,P13569,I86N,0.797,Loss of stability (P = 0.0132); Loss of MoRF binding (P = 0.0989); Loss of catalytic residue at Y89 (P = 0.5586); Gain of phosphorylation at Y89 (P = 0.5941); Gain of helix (P = 0.6868)
7:117149180:T:C,P13569,I86T,0.787,Loss of stability (P = 0.0025); Loss of MoRF binding (P = 0.0944); Gain of phosphorylation at I86 (P = 0.2439); Gain of catalytic residue at G85 (P = 0.568); Gain of helix (P = 0.6868)
7:117149180:T:G,P13569,I86S,0.756,Loss of stability (P = 0.0143); Loss of MoRF binding (P = 0.0977); Gain of catalytic residue at G85 (P = 0.4227); Gain of phosphorylation at Y89 (P = 0.528); Gain of disorder (P = 0.7853)
7:117149181:C:G,P13569,I86M,0.717,Loss of catalytic residue at I86 (P = 0.0062); Loss of MoRF binding (P = 0.1143); Loss of stability (P = 0.1146); Gain of phosphorylation at Y89 (P = 0.5787); Loss of helix (P = 0.7926)
7:117149182:T:A,P13569,F87I,0.943,Gain of MoRF binding (P = 0.1347); Loss of catalytic residue at F87 (P = 0.3255); Loss of phosphorylation at Y89 (P = 0.6714); Loss of helix (P = 0.7926); Gain of stability (P = 0.8462)
7:117149182:T:C,P13569,F87L,0.932,Loss of MoRF binding (P = 0.1363); Loss of catalytic residue at F87 (P = 0.1851); Gain of phosphorylation at Y89 (P = 0.6384); Gain of helix (P = 0.6868); Gain of disorder (P = 0.8391)
7:117149182:T:G,P13569,F87V,0.843,Gain of MoRF binding (P = 0.1303); Gain of catalytic residue at F87 (P = 0.3962); Gain of phosphorylation at Y89 (P = 0.5717); Gain of helix (P = 0.6868); Gain of disorder (P = 0.8414)
7:117149183:T:A,P13569,F87Y,0.779,Loss of MoRF binding (P = 0.1269); Gain of catalytic residue at F87 (P = 0.5186); Gain of phosphorylation at Y89 (P = 0.6223); Loss of helix (P = 0.7926); Gain of disorder (P = 0.8303)
7:117149183:T:C,P13569,F87S,0.747,Gain of MoRF binding (P = 0.0999); Gain of catalytic residue at G85 (P = 0.3047); Gain of phosphorylation at Y89 (P = 0.4737); Loss of stability (P = 0.4797); Gain of helix (P = 0.6868)
7:117149183:T:G,P13569,F87C,0.781,Gain of catalytic residue at L88 (P = 0.0245); Loss of MoRF binding (P = 0.1136); Loss of phosphorylation at Y89 (P = 0.6675); Gain of helix (P = 0.6868); Loss of stability (P = 0.7458)
7:117149184:T:A,P13569,F87L,0.932,Loss of MoRF binding (P = 0.1363); Loss of catalytic residue at F87 (P = 0.1851); Gain of phosphorylation at Y89 (P = 0.6384); Gain of helix (P = 0.6868); Gain of disorder (P = 0.8391)
7:117149184:T:G,P13569,F87L,0.932,Loss of MoRF binding (P = 0.1363); Loss of catalytic residue at F87 (P = 0.1851); Gain of phosphorylation at Y89 (P = 0.6384); Gain of helix (P = 0.6868); Gain of disorder (P = 0.8391)
7:117149185:T:A,P13569,L88I,0.765,Gain of catalytic residue at L88 (P = 0.0633); Gain of MoRF binding (P = 0.1362); Loss of stability (P = 0.6412); Loss of phosphorylation at Y89 (P = 0.6755); Loss of helix (P = 0.7926)
7:117149185:T:G,P13569,L88V,0.776,Gain of MoRF binding (P = 0.1329); Gain of catalytic residue at L88 (P = 0.2983); Loss of stability (P = 0.3608); Gain of phosphorylation at Y89 (P = 0.4982); Loss of helix (P = 0.5596)
7:117149186:T:C,P13569,L88S,0.886,Loss of stability (P = 0.0325); Gain of catalytic residue at L88 (P = 0.0916); Gain of MoRF binding (P = 0.1005); Gain of phosphorylation at Y89 (P = 0.5335); Gain of disorder (P = 0.6773)
7:117149187:A:T,P13569,L88F,0.766,Gain of MoRF binding (P = 0.1463); Loss of stability (P = 0.1738); Gain of catalytic residue at L88 (P = 0.2692); Loss of phosphorylation at Y89 (P = 0.6717); Loss of helix (P = 0.7926)
7:117149188:T:A,P13569,Y89N,0.717,Loss of stability (P = 0.0922); Gain of MoRF binding (P = 0.1111); Gain of catalytic residue at G85 (P = 0.5055); Loss of phosphorylation at Y89 (P = 0.6405); Loss of helix (P = 0.6555)
7:117149188:T:C,P13569,Y89H,0.74,Loss of stability (P = 0.0521); Loss of catalytic residue at Y89 (P = 0.1565); Gain of MoRF binding (P = 0.1659); Gain of disorder (P = 0.5852); Loss of phosphorylation at Y89 (P = 0.6405)
7:117149188:T:G,P13569,Y89D,0.806,Loss of MoRF binding (P = 0.1088); Loss of stability (P = 0.1241); Gain of catalytic residue at G91 (P = 0.3373); Loss of phosphorylation at Y89 (P = 0.6405); Loss of helix (P = 0.6555)
7:117149189:A:C,P13569,Y89S,0.705,Loss of stability (P = 0.0652); Gain of MoRF binding (P = 0.1286); Loss of catalytic residue at Y89 (P = 0.2831); Gain of disorder (P = 0.5713); Loss of phosphorylation at Y89 (P = 0.6531)
7:117149189:A:T,P13569,Y89F,0.73,Gain of MoRF binding (P = 0.1273); Loss of stability (P = 0.3225); Loss of catalytic residue at Y89 (P = 0.3255); Loss of phosphorylation at Y89 (P = 0.6405); Loss of helix (P = 0.6555)
7:117149191:T:A,P13569,L90I,0.685,Gain of MoRF binding (P = 0.188); Gain of ubiquitination at K95 (P = 0.1884); Gain of catalytic residue at G91 (P = 0.4612); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117149191:T:G,P13569,L90V,0.688,Gain of MoRF binding (P = 0.2128); Loss of ubiquitination at K95 (P = 0.2335); Gain of catalytic residue at G91 (P = 0.384); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117149192:T:C,P13569,L90S,0.908,Gain of glycosylation at L90 (P = 0.0596); Loss of stability (P = 0.0826); Loss of ubiquitination at K95 (P = 0.1808); Gain of catalytic residue at G91 (P = 0.1862); Loss of MoRF binding (P = 0.2234)
7:117149193:A:C,P13569,L90F,0.747,Loss of catalytic residue at L90 (P = 0.1788); Gain of MoRF binding (P = 0.2095); Gain of ubiquitination at K95 (P = 0.2129); Gain of helix (P = 0.2294); Loss of stability (P = 0.3369)
7:117149193:A:T,P13569,L90F,0.747,Loss of catalytic residue at L90 (P = 0.1788); Gain of MoRF binding (P = 0.2095); Gain of ubiquitination at K95 (P = 0.2129); Gain of helix (P = 0.2294); Loss of stability (P = 0.3369)
7:117149194:G:A,P13569,G91R,0.946,Gain of MoRF binding (P = 0.0199); Loss of catalytic residue at F87 (P = 0.1326); Loss of ubiquitination at K95 (P = 0.2243); Loss of stability (P = 0.2879); Loss of glycosylation at K95 (P = 0.4076)
7:117149194:G:C,P13569,G91R,0.946,Gain of MoRF binding (P = 0.0199); Loss of catalytic residue at F87 (P = 0.1326); Loss of ubiquitination at K95 (P = 0.2243); Loss of stability (P = 0.2879); Loss of glycosylation at K95 (P = 0.4076)
7:117149194:G:T,P13569,G91W,0.822,Gain of MoRF binding (P = 0.0788); Loss of ubiquitination at K95 (P = 0.2094); Loss of catalytic residue at F87 (P = 0.2332); Loss of stability (P = 0.2621); Loss of helix (P = 0.4763)
7:117149195:G:A,P13569,G91E,0.806,Loss of catalytic residue at Y89 (P = 0.1639); Loss of MoRF binding (P = 0.2159); Gain of helix (P = 0.2294); Loss of ubiquitination at K95 (P = 0.2335); Loss of stability (P = 0.3411)
7:117149195:G:C,P13569,G91A,0.687,Gain of catalytic residue at G91 (P = 0.1176); Loss of stability (P = 0.1346); Gain of ubiquitination at K95 (P = 0.2129); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2754)
7:117149195:G:T,P13569,G91V,0.724,Gain of ubiquitination at K95 (P = 0.1884); Gain of MoRF binding (P = 0.2516); Loss of catalytic residue at F87 (P = 0.3704); Loss of glycosylation at K95 (P = 0.4444); Loss of helix (P = 0.4763)
7:117170953:G:A,P13569,E92K,0.948,Gain of MoRF binding (P = 0.0121); Gain of ubiquitination at E92 (P = 0.0276); Loss of catalytic residue at E92 (P = 0.1441); Loss of stability (P = 0.3462); Loss of glycosylation at K95 (P = 0.4552)
7:117170953:G:C,P13569,E92Q,0.854,Gain of MoRF binding (P = 0.0831); Loss of catalytic residue at E92 (P = 0.1191); Loss of ubiquitination at K95 (P = 0.1962); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661)
7:117170954:A:C,P13569,E92A,0.775,Gain of MoRF binding (P = 0.1626); Gain of ubiquitination at K95 (P = 0.1884); Loss of helix (P = 0.2271); Gain of catalytic residue at Y89 (P = 0.4609); Loss of stability (P = 0.4955)
7:117170954:A:G,P13569,E92G,0.743,Gain of catalytic residue at V93 (P = 0.0464); Loss of stability (P = 0.1255); Gain of ubiquitination at K95 (P = 0.1306); Gain of MoRF binding (P = 0.1654); Gain of glycosylation at K95 (P = 0.4504)
7:117170954:A:T,P13569,E92V,0.82,Gain of MoRF binding (P = 0.1268); Loss of ubiquitination at K95 (P = 0.1808); Loss of helix (P = 0.2271); Gain of catalytic residue at T94 (P = 0.4416); Loss of glycosylation at K95 (P = 0.4488)
7:117170955:A:C,P13569,E92D,0.923,Loss of catalytic residue at E92 (P = 0.082); Gain of ubiquitination at K95 (P = 0.2129); Gain of MoRF binding (P = 0.2623); Loss of helix (P = 0.4763); Loss of glycosylation at K95 (P = 0.5037)
7:117170955:A:T,P13569,E92D,0.923,Loss of catalytic residue at E92 (P = 0.082); Gain of ubiquitination at K95 (P = 0.2129); Gain of MoRF binding (P = 0.2623); Loss of helix (P = 0.4763); Loss of glycosylation at K95 (P = 0.5037)
7:117170956:G:A,P13569,V93I,0.624,Gain of catalytic residue at V93 (P = 0.157); Gain of ubiquitination at K95 (P = 0.2129); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.3673); Gain of glycosylation at K95 (P = 0.4296)
7:117170956:G:C,P13569,V93L,0.684,Loss of ubiquitination at K95 (P = 0.2094); Loss of helix (P = 0.2271); Loss of catalytic residue at K95 (P = 0.2364); Loss of MoRF binding (P = 0.4016); Gain of glycosylation at K95 (P = 0.4106)
7:117170956:G:T,P13569,V93F,0.707,Loss of helix (P = 0.2271); Loss of ubiquitination at K95 (P = 0.2335); Gain of MoRF binding (P = 0.3865); Gain of glycosylation at K95 (P = 0.454); Gain of loop (P = 0.4661)
7:117170957:T:A,P13569,V93D,0.927,Gain of ubiquitination at K95 (P = 0.1884); Gain of catalytic residue at V93 (P = 0.2034); Loss of helix (P = 0.2271); Loss of stability (P = 0.294); Loss of MoRF binding (P = 0.3528)
7:117170957:T:C,P13569,V93A,0.646,Loss of stability (P = 0.1549); Loss of ubiquitination at K95 (P = 0.2094); Loss of helix (P = 0.2271); Gain of catalytic residue at V93 (P = 0.2549); Gain of glycosylation at K95 (P = 0.3053)
7:117170957:T:G,P13569,V93G,0.751,Loss of stability (P = 0.0053); Gain of glycosylation at K95 (P = 0.1264); Gain of ubiquitination at K95 (P = 0.2129); Loss of helix (P = 0.2271); Gain of catalytic residue at V93 (P = 0.2537)
7:117170959:A:C,P13569,T94P,0.891,Gain of glycosylation at K95 (P = 0.1427); Loss of ubiquitination at K95 (P = 0.2094); Loss of helix (P = 0.2271); Loss of catalytic residue at T94 (P = 0.325); Loss of MoRF binding (P = 0.4362)
7:117170959:A:G,P13569,T94A,0.722,Loss of ubiquitination at K95 (P = 0.2335); Gain of glycosylation at K95 (P = 0.3743); Gain of catalytic residue at T94 (P = 0.4387); Loss of MoRF binding (P = 0.4622); Gain of loop (P = 0.4661)
7:117170959:A:T,P13569,T94S,0.744,Loss of ubiquitination at K95 (P = 0.1962); Loss of helix (P = 0.2271); Loss of catalytic residue at T94 (P = 0.2695); Gain of MoRF binding (P = 0.4478); Gain of glycosylation at T94 (P = 0.4524)
7:117170960:C:A,P13569,T94N,0.746,Loss of ubiquitination at K95 (P = 0.1808); Loss of catalytic residue at K95 (P = 0.2093); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.443); Loss of glycosylation at K95 (P = 0.4521)
7:117170960:C:G,P13569,T94S,0.744,Loss of ubiquitination at K95 (P = 0.1962); Loss of helix (P = 0.2271); Loss of catalytic residue at T94 (P = 0.2695); Gain of MoRF binding (P = 0.4478); Gain of glycosylation at T94 (P = 0.4524)
7:117170962:A:C,P13569,K95Q,0.52,Loss of ubiquitination at K95 (P = 0.0362); Loss of glycosylation at K95 (P = 0.1853); Loss of catalytic residue at K95 (P = 0.2434); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763)
7:117170962:A:G,P13569,K95E,0.546,Loss of ubiquitination at K95 (P = 0.0362); Loss of catalytic residue at K95 (P = 0.0585); Loss of glycosylation at K95 (P = 0.1853); Gain of helix (P = 0.2294); Gain of loop (P = 0.4661)
7:117170963:A:C,P13569,K95T,0.595,Loss of ubiquitination at K95 (P = 0.0362); Loss of solvent accessibility (P = 0.1551); Gain of catalytic residue at T94 (P = 0.1616); Loss of relative solvent accessibility (P = 0.3219); Loss of helix (P = 0.4763)
7:117170963:A:G,P13569,K95R,0.574,Loss of ubiquitination at K95 (P = 0.0362); Loss of catalytic residue at K95 (P = 0.1042); Gain of methylation at K95 (P = 0.1242); Loss of glycosylation at K95 (P = 0.1853); Gain of helix (P = 0.2294)
7:117170963:A:T,P13569,K95I,0.621,Loss of ubiquitination at K95 (P = 0.0362); Gain of stability (P = 0.1008); Loss of solvent accessibility (P = 0.1551); Loss of glycosylation at K95 (P = 0.1853); Gain of catalytic residue at V93 (P = 0.2193)
7:117170964:A:C,P13569,K95N,0.585,Loss of ubiquitination at K95 (P = 0.0362); Loss of catalytic residue at K95 (P = 0.0612); Loss of glycosylation at K95 (P = 0.1853); Loss of solvent accessibility (P = 0.4274); Loss of helix (P = 0.4763)
7:117170964:A:T,P13569,K95N,0.585,Loss of ubiquitination at K95 (P = 0.0362); Loss of catalytic residue at K95 (P = 0.0612); Loss of glycosylation at K95 (P = 0.1853); Loss of solvent accessibility (P = 0.4274); Loss of helix (P = 0.4763)
7:117170965:G:A,P13569,A96T,0.59,Gain of glycosylation at A96 (P = 0.1147); Loss of ubiquitination at K95 (P = 0.1808); Loss of catalytic residue at A96 (P = 0.1846); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.5756)
7:117170965:G:C,P13569,A96P,0.902,Loss of ubiquitination at K95 (P = 0.1668); Loss of catalytic residue at A96 (P = 0.174); Loss of helix (P = 0.2271); Loss of stability (P = 0.2813); Gain of glycosylation at K95 (P = 0.4255)
7:117170965:G:T,P13569,A96S,0.768,Loss of ubiquitination at K95 (P = 0.1808); Gain of helix (P = 0.2294); Gain of disorder (P = 0.4211); Loss of glycosylation at K95 (P = 0.4515); Loss of loop (P = 0.4786)
7:117170966:C:A,P13569,A96E,0.944,Gain of ubiquitination at K95 (P = 0.2129); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2969); Loss of catalytic residue at K95 (P = 0.301); Gain of loop (P = 0.4661)
7:117170966:C:G,P13569,A96G,0.745,Gain of catalytic residue at V97 (P = 0.1157); Loss of ubiquitination at K95 (P = 0.1668); Gain of glycosylation at K95 (P = 0.1698); Loss of stability (P = 0.3614); Loss of helix (P = 0.4763)
7:117170966:C:T,P13569,A96V,0.598,Loss of catalytic residue at A96 (P = 0.151); Loss of ubiquitination at K95 (P = 0.2243); Gain of helix (P = 0.2294); Loss of glycosylation at K95 (P = 0.4757); Loss of loop (P = 0.4786)
7:117170968:G:A,P13569,V97I,0.658,Gain of catalytic residue at L102 (P = 0.1156); Gain of ubiquitination at K95 (P = 0.2129); Gain of helix (P = 0.2294); Gain of glycosylation at K95 (P = 0.4047); Loss of loop (P = 0.4786)
7:117170968:G:C,P13569,V97L,0.7,Loss of ubiquitination at K95 (P = 0.2243); Gain of helix (P = 0.2294); Gain of glycosylation at K95 (P = 0.4114); Loss of catalytic residue at A96 (P = 0.574); Loss of MoRF binding (P = 0.6195)
7:117170968:G:T,P13569,V97L,0.7,Loss of ubiquitination at K95 (P = 0.2243); Gain of helix (P = 0.2294); Gain of glycosylation at K95 (P = 0.4114); Loss of catalytic residue at A96 (P = 0.574); Loss of MoRF binding (P = 0.6195)
7:117170969:T:A,P13569,V97E,0.895,Gain of disorder (P = 0.0432); Gain of ubiquitination at K95 (P = 0.1306); Loss of helix (P = 0.2022); Gain of glycosylation at K95 (P = 0.2849); Loss of catalytic residue at A96 (P = 0.3088)
7:117170969:T:C,P13569,V97A,0.778,Loss of ubiquitination at K95 (P = 0.2094); Loss of helix (P = 0.2271); Gain of glycosylation at K95 (P = 0.3476); Loss of stability (P = 0.3603); Gain of loop (P = 0.4661)
7:117170969:T:G,P13569,V97G,0.845,Loss of stability (P = 0.052); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2026); Loss of ubiquitination at K95 (P = 0.2335); Gain of catalytic residue at L102 (P = 0.2426)
7:117170971:C:A,P13569,Q98K,0.801,Gain of ubiquitination at Q98 (P = 0.0452); Gain of glycosylation at Q98 (P = 0.1979); Gain of methylation at Q98 (P = 0.2035); Gain of helix (P = 0.2294); Gain of catalytic residue at Q98 (P = 0.308)
7:117170971:C:G,P13569,Q98E,0.804,Gain of ubiquitination at K95 (P = 0.1575); Loss of catalytic residue at Q98 (P = 0.2261); Loss of helix (P = 0.2271); Gain of glycosylation at K95 (P = 0.4133); Gain of loop (P = 0.4661)
7:117170972:A:C,P13569,Q98P,0.917,Loss of ubiquitination at K95 (P = 0.1808); Gain of glycosylation at P99 (P = 0.2303); Gain of catalytic residue at Q98 (P = 0.3029); Loss of helix (P = 0.4763); Gain of phosphorylation at T94 (P = 0.5735)
7:117170972:A:G,P13569,Q98R,0.936,Loss of catalytic residue at Q98 (P = 0.144); Gain of ubiquitination at K95 (P = 0.2129); Gain of helix (P = 0.2294); Gain of glycosylation at K95 (P = 0.3195); Gain of MoRF binding (P = 0.3568)
7:117170972:A:T,P13569,Q98L,0.703,Gain of stability (P = 0.0591); Loss of catalytic residue at Q98 (P = 0.1303); Gain of ubiquitination at K95 (P = 0.1884); Gain of helix (P = 0.2294); Loss of glycosylation at K95 (P = 0.4705)
7:117170973:G:C,P13569,Q98H,0.776,Loss of catalytic residue at Q98 (P = 0.1068); Loss of ubiquitination at K95 (P = 0.2094); Gain of helix (P = 0.2294); Gain of glycosylation at K95 (P = 0.4241); Loss of loop (P = 0.4786)
7:117170973:G:T,P13569,Q98H,0.776,Loss of catalytic residue at Q98 (P = 0.1068); Loss of ubiquitination at K95 (P = 0.2094); Gain of helix (P = 0.2294); Gain of glycosylation at K95 (P = 0.4241); Loss of loop (P = 0.4786)
7:117170974:C:A,P13569,P99T,0.873,Loss of catalytic residue at P99 (P = 0.138); Loss of ubiquitination at K95 (P = 0.2094); Loss of methylation at R104 (P = 0.4518); Loss of helix (P = 0.4763); Loss of glycosylation at K95 (P = 0.5081)
7:117170974:C:G,P13569,P99A,0.896,Loss of ubiquitination at K95 (P = 0.2094); Loss of catalytic residue at P99 (P = 0.2199); Gain of helix (P = 0.2294); Gain of methylation at R104 (P = 0.4256); Gain of glycosylation at K95 (P = 0.5061)
7:117170974:C:T,P13569,P99S,0.871,Loss of catalytic residue at P99 (P = 0.1002); Loss of ubiquitination at K95 (P = 0.2243); Gain of methylation at R104 (P = 0.4435); Loss of helix (P = 0.4763); Loss of glycosylation at K95 (P = 0.4827)
7:117170975:C:A,P13569,P99H,0.889,Loss of catalytic residue at P99 (P = 0.0908); Gain of ubiquitination at K95 (P = 0.2129); Loss of methylation at R104 (P = 0.4508); Loss of helix (P = 0.4763); Gain of glycosylation at K95 (P = 0.4798)
7:117170975:C:G,P13569,P99R,0.924,Loss of catalytic residue at P99 (P = 0.0864); Gain of MoRF binding (P = 0.1238); Loss of ubiquitination at K95 (P = 0.1962); Loss of glycosylation at K95 (P = 0.4201); Loss of methylation at R104 (P = 0.4488)
7:117170975:C:T,P13569,P99L,0.905,Gain of stability (P = 0.0258); Loss of catalytic residue at P99 (P = 0.0316); Gain of ubiquitination at K95 (P = 0.0707); Loss of helix (P = 0.2271); Loss of methylation at R104 (P = 0.4479)
7:117170977:C:A,P13569,L100I,0.659,Loss of catalytic residue at L100 (P = 0.0235); Gain of ubiquitination at K95 (P = 0.1884); Loss of methylation at R104 (P = 0.4402); Loss of helix (P = 0.4763); Gain of glycosylation at K95 (P = 0.5136)
7:117170977:C:T,P13569,L100F,0.688,Gain of ubiquitination at K95 (P = 0.2129); Loss of helix (P = 0.2271); Loss of stability (P = 0.3074); Loss of catalytic residue at L100 (P = 0.3842); Loss of methylation at R104 (P = 0.4467)
7:117170978:T:A,P13569,L100H,0.679,Loss of catalytic residue at L100 (P = 0.0394); Loss of stability (P = 0.043); Loss of ubiquitination at K95 (P = 0.1808); Loss of helix (P = 0.2271); Gain of methylation at R104 (P = 0.3762)
7:117170978:T:C,P13569,L100P,0.789,Loss of stability (P = 0.0149); Loss of catalytic residue at L100 (P = 0.0562); Loss of ubiquitination at K95 (P = 0.1668); Loss of helix (P = 0.2271); Gain of methylation at R104 (P = 0.3496)
7:117170978:T:G,P13569,L100R,0.778,Loss of catalytic residue at L100 (P = 0.0292); Loss of stability (P = 0.0484); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Gain of methylation at L100 (P = 0.2183)
7:117170980:T:A,P13569,L101I,0.757,Gain of helix (P = 0.2294); Gain of catalytic residue at L102 (P = 0.3401); Loss of methylation at R104 (P = 0.4422); Loss of loop (P = 0.4786); Gain of MoRF binding (P = 0.7093)
7:117170980:T:G,P13569,L101V,0.762,Gain of catalytic residue at L101 (P = 0.1896); Gain of helix (P = 0.2294); Gain of methylation at R104 (P = 0.421); Loss of loop (P = 0.4786); Loss of stability (P = 0.5043)
7:117170981:T:C,P13569,L101S,0.895,Loss of stability (P = 0.0618); Loss of helix (P = 0.2271); Gain of methylation at R104 (P = 0.4011); Loss of catalytic residue at L101 (P = 0.4234); Gain of disorder (P = 0.444)
7:117170982:A:C,P13569,L101F,0.757,Gain of helix (P = 0.2294); Gain of catalytic residue at L101 (P = 0.2528); Loss of stability (P = 0.2736); Gain of methylation at R104 (P = 0.439); Loss of loop (P = 0.4786)
7:117170982:A:T,P13569,L101F,0.757,Gain of helix (P = 0.2294); Gain of catalytic residue at L101 (P = 0.2528); Loss of stability (P = 0.2736); Gain of methylation at R104 (P = 0.439); Loss of loop (P = 0.4786)
7:117170983:C:A,P13569,L102M,0.744,Gain of catalytic residue at L102 (P = 0.2245); Loss of helix (P = 0.2271); Gain of methylation at R104 (P = 0.3904); Gain of disorder (P = 0.6142); Loss of stability (P = 0.6206)
7:117170983:C:G,P13569,L102V,0.725,Loss of catalytic residue at L102 (P = 0.4129); Gain of methylation at R104 (P = 0.4223); Loss of helix (P = 0.6555); Loss of stability (P = 0.6962); Loss of disorder (P = 0.7136)
7:117170984:T:A,P13569,L102Q,0.799,Loss of stability (P = 0.2172); Loss of helix (P = 0.2271); Loss of catalytic residue at Q98 (P = 0.3493); Gain of methylation at R104 (P = 0.3801); Gain of disorder (P = 0.4719)
7:117170984:T:C,P13569,L102P,0.974,Loss of stability (P = 0.0884); Gain of catalytic residue at L101 (P = 0.1733); Gain of methylation at R104 (P = 0.2518); Gain of disorder (P = 0.3817); Loss of helix (P = 0.6555)
7:117170984:T:G,P13569,L102R,0.974,Gain of methylation at L102 (P = 0.026); Loss of stability (P = 0.2547); Loss of catalytic residue at Q98 (P = 0.2764); Gain of disorder (P = 0.4306); Gain of MoRF binding (P = 0.4606)
7:117170986:G:A,P13569,G103R,0.683,Loss of catalytic residue at P99 (P = 0.0688); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Loss of stability (P = 0.2844); Loss of methylation at R104 (P = 0.4091)
7:117170986:G:C,P13569,G103R,0.683,Loss of catalytic residue at P99 (P = 0.0688); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Loss of stability (P = 0.2844); Loss of methylation at R104 (P = 0.4091)
7:117170987:G:A,P13569,G103E,0.674,Loss of catalytic residue at P99 (P = 0.0688); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of disorder (P = 0.3674); Loss of stability (P = 0.3678)
7:117170987:G:C,P13569,G103A,0.688,Loss of catalytic residue at P99 (P = 0.0688); Gain of helix (P = 0.2294); Loss of stability (P = 0.2491); Gain of glycosylation at S108 (P = 0.3718); Loss of methylation at R104 (P = 0.4313)
7:117170987:G:T,P13569,G103V,0.724,Loss of catalytic residue at P99 (P = 0.0688); Loss of disorder (P = 0.3982); Loss of methylation at R104 (P = 0.422); Loss of stability (P = 0.4259); Loss of helix (P = 0.4763)
7:117170990:G:A,P13569,R104K,0.62,Gain of methylation at R104 (P = 0.0157); Gain of ubiquitination at R104 (P = 0.0211); Loss of stability (P = 0.0683); Gain of glycosylation at R104 (P = 0.1656); Gain of disorder (P = 0.2206)
7:117170990:G:C,P13569,R104T,0.729,Loss of stability (P = 0.1676); Loss of catalytic residue at R104 (P = 0.1856); Loss of solvent accessibility (P = 0.239); Loss of disorder (P = 0.2569); Gain of glycosylation at R104 (P = 0.3713)
7:117170990:G:T,P13569,R104I,0.697,Loss of catalytic residue at R104 (P = 0.0806); Loss of disorder (P = 0.1017); Loss of helix (P = 0.2271); Loss of solvent accessibility (P = 0.239); Gain of loop (P = 0.2754)
7:117170991:A:C,P13569,R104S,0.719,Gain of glycosylation at R104 (P = 0.0471); Gain of disorder (P = 0.0918); Loss of stability (P = 0.1347); Loss of solvent accessibility (P = 0.239); Loss of methylation at R104 (P = 0.3741)
7:117170991:A:T,P13569,R104S,0.719,Gain of glycosylation at R104 (P = 0.0471); Gain of disorder (P = 0.0918); Loss of stability (P = 0.1347); Loss of solvent accessibility (P = 0.239); Loss of methylation at R104 (P = 0.3741)
7:117170992:A:C,P13569,I105L,0.632,Gain of disorder (P = 0.193); Gain of helix (P = 0.2684); Gain of methylation at R104 (P = 0.2869); Loss of catalytic residue at L102 (P = 0.3842); Loss of loop (P = 0.4786)
7:117170992:A:G,P13569,I105V,0.689,Gain of catalytic residue at I105 (P = 0.0932); Gain of methylation at R104 (P = 0.174); Gain of helix (P = 0.2294); Gain of disorder (P = 0.2303); Gain of phosphorylation at Y109 (P = 0.4609)
7:117170992:A:T,P13569,I105F,0.677,Gain of methylation at R104 (P = 0.1935); Loss of stability (P = 0.2361); Loss of disorder (P = 0.2544); Gain of helix (P = 0.2684); Loss of catalytic residue at L102 (P = 0.3787)
7:117170993:T:A,P13569,I105N,0.941,Gain of disorder (P = 0.0283); Loss of stability (P = 0.0307); Gain of methylation at R104 (P = 0.1682); Gain of catalytic residue at I105 (P = 0.2012); Gain of helix (P = 0.2294)
7:117170993:T:C,P13569,I105T,0.816,Loss of stability (P = 0.01); Gain of disorder (P = 0.0409); Gain of methylation at R104 (P = 0.1684); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897)
7:117170993:T:G,P13569,I105S,0.812,Gain of disorder (P = 0.0083); Loss of stability (P = 0.0162); Gain of phosphorylation at I105 (P = 0.0524); Gain of catalytic residue at I105 (P = 0.1379); Gain of methylation at R104 (P = 0.177)
7:117170994:C:G,P13569,I105M,0.644,Gain of disorder (P = 0.0866); Gain of methylation at R104 (P = 0.1948); Gain of phosphorylation at Y109 (P = 0.3754); Loss of catalytic residue at L102 (P = 0.3816); Loss of stability (P = 0.3825)
7:117170995:A:C,P13569,I106L,0.505,Gain of glycosylation at P111 (P = 0.1864); Gain of disorder (P = 0.1885); Loss of catalytic residue at S108 (P = 0.2025); Loss of helix (P = 0.2271); Gain of methylation at R104 (P = 0.399)
7:117170995:A:G,P13569,I106V,0.542,Gain of catalytic residue at I106 (P = 0.1501); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2286); Gain of glycosylation at P111 (P = 0.2458); Gain of methylation at R104 (P = 0.3305)
7:117170995:A:T,P13569,I106L,0.505,Gain of glycosylation at P111 (P = 0.1864); Gain of disorder (P = 0.1885); Loss of catalytic residue at S108 (P = 0.2025); Loss of helix (P = 0.2271); Gain of methylation at R104 (P = 0.399)
7:117170996:T:A,P13569,I106K,0.872,Gain of disorder (P = 0.0064); Gain of ubiquitination at I106 (P = 0.0211); Loss of stability (P = 0.0846); Loss of helix (P = 0.1299); Loss of catalytic residue at S108 (P = 0.1487)
7:117170996:T:C,P13569,I106T,0.777,Gain of disorder (P = 0.033); Loss of stability (P = 0.0821); Gain of phosphorylation at I106 (P = 0.0876); Gain of glycosylation at P111 (P = 0.1816); Loss of catalytic residue at S108 (P = 0.2296)
7:117170996:T:G,P13569,I106R,0.913,Gain of disorder (P = 0.0179); Gain of methylation at I106 (P = 0.0193); Gain of catalytic residue at I106 (P = 0.0818); Gain of phosphorylation at S108 (P = 0.0894); Loss of glycosylation at P111 (P = 0.1581)
7:117170997:A:G,P13569,I106M,0.533,Gain of disorder (P = 0.0789); Gain of glycosylation at P111 (P = 0.166); Loss of catalytic residue at S108 (P = 0.1976); Loss of loop (P = 0.2897); Gain of methylation at R104 (P = 0.3192)
7:117170998:G:A,P13569,A107T,0.499,Gain of relative solvent accessibility (P = 0.0479); Gain of phosphorylation at A107 (P = 0.0754); Gain of solvent accessibility (P = 0.0917); Loss of catalytic residue at A107 (P = 0.1404); Gain of disorder (P = 0.1654)
7:117170998:G:C,P13569,A107P,0.7,Gain of disorder (P = 0.0452); Loss of stability (P = 0.1733); Gain of glycosylation at P111 (P = 0.251); Gain of loop (P = 0.2754); Gain of catalytic residue at A107 (P = 0.2852)
7:117170998:G:T,P13569,A107S,0.508,Gain of relative solvent accessibility (P = 0.0215); Gain of disorder (P = 0.0231); Gain of phosphorylation at A107 (P = 0.0423); Gain of solvent accessibility (P = 0.0611); Gain of glycosylation at P111 (P = 0.2637)
7:117170999:C:A,P13569,A107D,0.648,Gain of relative solvent accessibility (P = 0.0215); Gain of solvent accessibility (P = 0.0306); Gain of disorder (P = 0.0363); Loss of glycosylation at P111 (P = 0.1125); Loss of helix (P = 0.2271)
7:117170999:C:G,P13569,A107G,0.834,Gain of relative solvent accessibility (P = 0.0215); Gain of disorder (P = 0.0683); Gain of solvent accessibility (P = 0.1422); Loss of stability (P = 0.1678); Loss of glycosylation at P111 (P = 0.176)
7:117170999:C:T,P13569,A107V,0.851,Loss of disorder (P = 0.0893); Loss of glycosylation at P111 (P = 0.2295); Gain of catalytic residue at A107 (P = 0.3696); Loss of helix (P = 0.3949); Loss of methylation at R104 (P = 0.4444)
7:117171001:T:A,P13569,S108T,0.585,Gain of glycosylation at S108 (P = 0.0121); Loss of disorder (P = 0.0741); Gain of phosphorylation at S108 (P = 0.1382); Loss of catalytic residue at S108 (P = 0.1428); Gain of helix (P = 0.2684)
7:117171001:T:C,P13569,S108P,0.702,Loss of stability (P = 0.1096); Gain of glycosylation at P111 (P = 0.1463); Loss of disorder (P = 0.1955); Gain of catalytic residue at S108 (P = 0.255); Gain of helix (P = 0.2684)
7:117171001:T:G,P13569,S108A,0.716,Loss of disorder (P = 0.0642); Gain of helix (P = 0.2294); Gain of glycosylation at P111 (P = 0.2436); Loss of stability (P = 0.2674); Loss of loop (P = 0.2897)
7:117171002:C:A,P13569,S108Y,0.736,Loss of disorder (P = 0.0259); Gain of phosphorylation at S108 (P = 0.1166); Loss of catalytic residue at S108 (P = 0.2261); Gain of helix (P = 0.2294); Loss of stability (P = 0.2472)
7:117171002:C:G,P13569,S108C,0.752,Loss of disorder (P = 0.0043); Loss of catalytic residue at S108 (P = 0.2278); Gain of helix (P = 0.2294); Loss of glycosylation at P111 (P = 0.2469); Loss of loop (P = 0.2897)
7:117171002:C:T,P13569,S108F,0.859,Loss of disorder (P = 0.0082); Loss of glycosylation at P111 (P = 0.2128); Gain of helix (P = 0.2294); Loss of catalytic residue at S108 (P = 0.3285); Gain of methylation at R104 (P = 0.44)
7:117171004:T:A,P13569,Y109N,0.916,Gain of disorder (P = 0.0141); Gain of ubiquitination at K114 (P = 0.0445); Gain of glycosylation at S108 (P = 0.0837); Loss of stability (P = 0.0925); Gain of catalytic residue at Y109 (P = 0.1044)
7:117171004:T:C,P13569,Y109H,0.859,Gain of disorder (P = 0.0239); Gain of ubiquitination at K114 (P = 0.0467); Loss of stability (P = 0.0765); Gain of glycosylation at K114 (P = 0.14); Loss of methylation at K114 (P = 0.2164)
7:117171004:T:G,P13569,Y109D,0.846,Gain of disorder (P = 0.0064); Gain of ubiquitination at K114 (P = 0.0467); Loss of glycosylation at P111 (P = 0.1309); Loss of stability (P = 0.1555); Loss of methylation at K114 (P = 0.1754)
7:117171005:A:C,P13569,Y109S,0.808,Gain of disorder (P = 0.0042); Gain of ubiquitination at K114 (P = 0.0445); Gain of glycosylation at Y109 (P = 0.0557); Loss of stability (P = 0.0668); Loss of helix (P = 0.1299)
7:117171005:A:G,P13569,Y109C,0.856,Loss of methylation at K114 (P = 0.0721); Loss of disorder (P = 0.0955); Loss of ubiquitination at K114 (P = 0.1151); Loss of stability (P = 0.1424); Loss of helix (P = 0.2271)
7:117171005:A:T,P13569,Y109F,0.644,Loss of methylation at K114 (P = 0.0671); Loss of ubiquitination at K114 (P = 0.0877); Loss of glycosylation at P111 (P = 0.135); Loss of disorder (P = 0.149); Loss of helix (P = 0.3949)
7:117171007:G:A,P13569,D110N,0.822,Gain of ubiquitination at K114 (P = 0.0985); Loss of disorder (P = 0.1801); Gain of glycosylation at P111 (P = 0.221); Gain of methylation at K114 (P = 0.3035); Gain of catalytic residue at P111 (P = 0.3367)
7:117171007:G:C,P13569,D110H,0.888,Gain of ubiquitination at K114 (P = 0.0872); Loss of disorder (P = 0.1126); Loss of solvent accessibility (P = 0.1279); Loss of relative solvent accessibility (P = 0.1807); Loss of glycosylation at P111 (P = 0.1911)
7:117171008:A:C,P13569,D110A,0.665,Loss of disorder (P = 0.0685); Gain of catalytic residue at D110 (P = 0.0703); Gain of ubiquitination at K114 (P = 0.115); Loss of solvent accessibility (P = 0.1279); Loss of relative solvent accessibility (P = 0.1807)
7:117171008:A:G,P13569,D110G,0.746,Gain of ubiquitination at K114 (P = 0.0985); Loss of solvent accessibility (P = 0.1279); Gain of catalytic residue at Y109 (P = 0.1595); Gain of glycosylation at K114 (P = 0.1635); Loss of stability (P = 0.1668)
7:117171008:A:T,P13569,D110V,0.76,Loss of disorder (P = 0.0109); Loss of ubiquitination at K114 (P = 0.0877); Loss of glycosylation at P111 (P = 0.0962); Loss of solvent accessibility (P = 0.1279); Loss of relative solvent accessibility (P = 0.1807)
7:117171009:C:A,P13569,D110E,0.834,Gain of ubiquitination at K114 (P = 0.0467); Gain of disorder (P = 0.1428); Gain of catalytic residue at D110 (P = 0.1484); Gain of glycosylation at P111 (P = 0.2248); Gain of helix (P = 0.2684)
7:117171009:C:G,P13569,D110E,0.834,Gain of ubiquitination at K114 (P = 0.0467); Gain of disorder (P = 0.1428); Gain of catalytic residue at D110 (P = 0.1484); Gain of glycosylation at P111 (P = 0.2248); Gain of helix (P = 0.2684)
7:117171010:C:A,P13569,P111T,0.463,Loss of stability (P = 0.0314); Loss of glycosylation at P111 (P = 0.0384); Loss of disorder (P = 0.1252); Gain of phosphorylation at P111 (P = 0.1303); Loss of ubiquitination at K114 (P = 0.1322)
7:117171010:C:G,P13569,P111A,0.824,Loss of stability (P = 0.012); Loss of glycosylation at P111 (P = 0.0242); Loss of methylation at K114 (P = 0.0803); Loss of disorder (P = 0.099); Loss of ubiquitination at K114 (P = 0.0992)
7:117171010:C:T,P13569,P111S,0.398,Loss of glycosylation at P111 (P = 0.0361); Gain of ubiquitination at K114 (P = 0.0467); Loss of stability (P = 0.0565); Loss of methylation at K114 (P = 0.1049); Gain of disorder (P = 0.1105)
7:117171011:C:A,P13569,P111Q,0.444,Loss of glycosylation at P111 (P = 0.0242); Loss of stability (P = 0.0925); Gain of solvent accessibility (P = 0.1116); Loss of ubiquitination at K114 (P = 0.1151); Gain of relative solvent accessibility (P = 0.1894)
7:117171011:C:G,P13569,P111R,0.542,Loss of glycosylation at P111 (P = 0.0242); Loss of ubiquitination at K114 (P = 0.0637); Loss of stability (P = 0.1159); Gain of solvent accessibility (P = 0.1422); Loss of methylation at K114 (P = 0.1655)
7:117171013:G:A,P13569,D112N,0.351,Gain of ubiquitination at K114 (P = 0.115); Loss of disorder (P = 0.1913); Gain of glycosylation at P111 (P = 0.2101); Loss of helix (P = 0.2271); Gain of methylation at K114 (P = 0.2506)
7:117171013:G:C,P13569,D112H,0.398,Gain of ubiquitination at K114 (P = 0.078); Loss of helix (P = 0.1299); Loss of glycosylation at P111 (P = 0.1314); Gain of disorder (P = 0.1471); Loss of stability (P = 0.2195)
7:117171013:G:T,P13569,D112Y,0.54,Loss of disorder (P = 0.027); Gain of phosphorylation at D112 (P = 0.0641); Loss of ubiquitination at K114 (P = 0.0877); Loss of glycosylation at P111 (P = 0.107); Loss of helix (P = 0.1299)
7:117171014:A:C,P13569,D112A,0.394,Loss of ubiquitination at K114 (P = 0.0637); Loss of disorder (P = 0.0808); Loss of glycosylation at P111 (P = 0.1216); Loss of helix (P = 0.1299); Loss of stability (P = 0.1577)
7:117171014:A:G,P13569,D112G,0.404,Loss of stability (P = 0.0572); Gain of ubiquitination at K114 (P = 0.115); Loss of glycosylation at P111 (P = 0.1224); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1903)
7:117171014:A:T,P13569,D112V,0.596,Loss of disorder (P = 0.0106); Loss of glycosylation at P111 (P = 0.0502); Loss of ubiquitination at K114 (P = 0.0709); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117171015:T:A,P13569,D112E,0.4,Gain of ubiquitination at K114 (P = 0.0505); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1443); Gain of glycosylation at P111 (P = 0.2072); Gain of methylation at K114 (P = 0.2561)
7:117171015:T:G,P13569,D112E,0.4,Gain of ubiquitination at K114 (P = 0.0505); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1443); Gain of glycosylation at P111 (P = 0.2072); Gain of methylation at K114 (P = 0.2561)
7:117171016:A:C,P13569,N113H,0.523,Gain of ubiquitination at K114 (P = 0.0671); Gain of disorder (P = 0.1119); Loss of stability (P = 0.1187); Gain of helix (P = 0.132); Gain of glycosylation at K114 (P = 0.1507)
7:117171016:A:G,P13569,N113D,0.491,Gain of ubiquitination at K114 (P = 0.0467); Gain of disorder (P = 0.1177); Loss of methylation at K114 (P = 0.1305); Loss of glycosylation at P111 (P = 0.1483); Gain of relative solvent accessibility (P = 0.1894)
7:117171016:A:T,P13569,N113Y,0.564,Loss of methylation at K114 (P = 0.0677); Loss of disorder (P = 0.0796); Gain of phosphorylation at N113 (P = 0.0982); Gain of ubiquitination at K114 (P = 0.0985); Loss of glycosylation at S118 (P = 0.1273)
7:117171017:A:C,P13569,N113T,0.428,Gain of phosphorylation at N113 (P = 0.0524); Gain of ubiquitination at K114 (P = 0.078); Loss of stability (P = 0.1084); Gain of helix (P = 0.132); Gain of relative solvent accessibility (P = 0.1894)
7:117171017:A:G,P13569,N113S,0.463,Gain of glycosylation at N113 (P = 0.0323); Gain of ubiquitination at K114 (P = 0.0467); Gain of disorder (P = 0.0576); Gain of phosphorylation at N113 (P = 0.0964); Loss of methylation at K114 (P = 0.1531)
7:117171017:A:T,P13569,N113I,0.849,Loss of disorder (P = 0.0452); Loss of ubiquitination at K114 (P = 0.055); Loss of glycosylation at P111 (P = 0.0719); Gain of loop (P = 0.2045); Loss of helix (P = 0.2271)
7:117171018:C:A,P13569,N113K,0.489,Gain of solvent accessibility (P = 0.0086); Gain of ubiquitination at N113 (P = 0.0121); Gain of methylation at N113 (P = 0.0192); Gain of relative solvent accessibility (P = 0.0275); Loss of stability (P = 0.0855)
7:117171018:C:G,P13569,N113K,0.489,Gain of solvent accessibility (P = 0.0086); Gain of ubiquitination at N113 (P = 0.0121); Gain of methylation at N113 (P = 0.0192); Gain of relative solvent accessibility (P = 0.0275); Loss of stability (P = 0.0855)
7:117171019:A:C,P13569,K114Q,0.415,Loss of methylation at K114 (P = 0.0072); Loss of ubiquitination at K114 (P = 0.0183); Loss of glycosylation at K114 (P = 0.0756); Loss of loop (P = 0.0804); Loss of solvent accessibility (P = 0.1077)
7:117171019:A:G,P13569,K114E,0.433,Loss of methylation at K114 (P = 0.0072); Loss of ubiquitination at K114 (P = 0.0183); Loss of glycosylation at K114 (P = 0.0756); Loss of solvent accessibility (P = 0.089); Gain of disorder (P = 0.1227)
7:117171020:A:C,P13569,K114T,0.421,Loss of methylation at K114 (P = 0.0072); Loss of ubiquitination at K114 (P = 0.0183); Loss of solvent accessibility (P = 0.0249); Gain of phosphorylation at K114 (P = 0.0516); Loss of glycosylation at P111 (P = 0.091)
7:117171020:A:G,P13569,K114R,0.413,Loss of methylation at K114 (P = 0.0101); Loss of ubiquitination at K114 (P = 0.0183); Loss of glycosylation at K114 (P = 0.0756); Loss of relative solvent accessibility (P = 0.1967); Gain of catalytic residue at K114 (P = 0.2004)
7:117171020:A:T,P13569,K114M,0.529,Loss of solvent accessibility (P = 0.0045); Gain of catalytic residue at K114 (P = 0.0051); Loss of methylation at K114 (P = 0.0072); Loss of ubiquitination at K114 (P = 0.0183); Loss of relative solvent accessibility (P = 0.0404)
7:117171021:G:C,P13569,K114N,0.42,Loss of methylation at K114 (P = 0.0072); Loss of ubiquitination at K114 (P = 0.0183); Loss of glycosylation at K114 (P = 0.0756); Loss of solvent accessibility (P = 0.1177); Loss of disorder (P = 0.217)
7:117171021:G:T,P13569,K114N,0.42,Loss of methylation at K114 (P = 0.0072); Loss of ubiquitination at K114 (P = 0.0183); Loss of glycosylation at K114 (P = 0.0756); Loss of solvent accessibility (P = 0.1177); Loss of disorder (P = 0.217)
7:117171022:G:A,P13569,E115K,0.608,Gain of methylation at E115 (P = 0.01); Gain of ubiquitination at E115 (P = 0.0219); Loss of glycosylation at S118 (P = 0.0636); Gain of helix (P = 0.2059); Loss of disorder (P = 0.2326)
7:117171022:G:C,P13569,E115Q,0.525,Loss of disorder (P = 0.1115); Loss of ubiquitination at K114 (P = 0.1151); Loss of glycosylation at P111 (P = 0.185); Gain of methylation at K114 (P = 0.2624); Loss of helix (P = 0.2662)
7:117171023:A:C,P13569,E115A,0.64,Loss of disorder (P = 0.0536); Loss of ubiquitination at K114 (P = 0.0637); Loss of glycosylation at P111 (P = 0.1151); Loss of helix (P = 0.2662); Loss of solvent accessibility (P = 0.2732)
7:117171023:A:G,P13569,E115G,0.533,Loss of ubiquitination at K114 (P = 0.0777); Loss of glycosylation at P111 (P = 0.1109); Loss of disorder (P = 0.1173); Gain of catalytic residue at P111 (P = 0.1227); Loss of stability (P = 0.1385)
7:117171023:A:T,P13569,E115V,0.672,Loss of disorder (P = 0.0038); Loss of glycosylation at P111 (P = 0.0695); Loss of ubiquitination at K114 (P = 0.0709); Gain of methylation at K114 (P = 0.1817); Loss of solvent accessibility (P = 0.2106)
7:117171024:G:C,P13569,E115D,0.451,Loss of glycosylation at P111 (P = 0.1174); Loss of ubiquitination at K114 (P = 0.1322); Loss of methylation at K114 (P = 0.1707); Loss of disorder (P = 0.195); Loss of helix (P = 0.2662)
7:117171024:G:T,P13569,E115D,0.451,Loss of glycosylation at P111 (P = 0.1174); Loss of ubiquitination at K114 (P = 0.1322); Loss of methylation at K114 (P = 0.1707); Loss of disorder (P = 0.195); Loss of helix (P = 0.2662)
7:117171025:G:A,P13569,E116K,0.875,Gain of methylation at E116 (P = 0.0016); Gain of ubiquitination at E116 (P = 0.0177); Loss of glycosylation at S118 (P = 0.1152); Loss of catalytic residue at E116 (P = 0.1358); Loss of disorder (P = 0.236)
7:117171025:G:C,P13569,E116Q,0.833,Loss of ubiquitination at K114 (P = 0.0992); Loss of disorder (P = 0.1003); Loss of glycosylation at S118 (P = 0.108); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117171026:A:C,P13569,E116A,0.666,Loss of disorder (P = 0.05); Loss of glycosylation at S118 (P = 0.1065); Loss of ubiquitination at K114 (P = 0.1151); Loss of methylation at K114 (P = 0.1261); Loss of helix (P = 0.1299)
7:117171026:A:G,P13569,E116G,0.662,Loss of stability (P = 0.0866); Gain of ubiquitination at K114 (P = 0.0872); Loss of glycosylation at S118 (P = 0.0884); Loss of disorder (P = 0.1053); Loss of helix (P = 0.1299)
7:117171026:A:T,P13569,E116V,0.676,Loss of disorder (P = 0.0036); Loss of glycosylation at S118 (P = 0.0748); Loss of catalytic residue at E116 (P = 0.1067); Loss of helix (P = 0.1299); Loss of ubiquitination at K114 (P = 0.1322)
7:117171027:A:C,P13569,E116D,0.591,Loss of glycosylation at S118 (P = 0.0931); Gain of ubiquitination at K114 (P = 0.115); Loss of catalytic residue at E116 (P = 0.1654); Loss of disorder (P = 0.1865); Loss of methylation at K114 (P = 0.217)
7:117171027:A:T,P13569,E116D,0.591,Loss of glycosylation at S118 (P = 0.0931); Gain of ubiquitination at K114 (P = 0.115); Loss of catalytic residue at E116 (P = 0.1654); Loss of disorder (P = 0.1865); Loss of methylation at K114 (P = 0.217)
7:117171028:C:A,P13569,R117S,0.694,Gain of disorder (P = 0.0452); Gain of ubiquitination at K114 (P = 0.0719); Gain of glycosylation at S118 (P = 0.1064); Loss of helix (P = 0.1299); Loss of methylation at K114 (P = 0.1516)
7:117171028:C:G,P13569,R117G,0.906,Loss of ubiquitination at K114 (P = 0.0709); Gain of glycosylation at S118 (P = 0.0888); Loss of solvent accessibility (P = 0.1077); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1454)
7:117171029:G:C,P13569,R117P,0.886,Gain of glycosylation at R117 (P = 0.0484); Loss of helix (P = 0.0558); Gain of disorder (P = 0.0966); Gain of ubiquitination at K114 (P = 0.115); Gain of loop (P = 0.2045)
7:117171029:G:T,P13569,R117L,0.891,Loss of disorder (P = 0.0494); Loss of ubiquitination at K114 (P = 0.055); Loss of methylation at K114 (P = 0.0939); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1362)
7:117171031:T:A,P13569,S118T,0.619,Loss of glycosylation at S118 (P = 0.0398); Loss of disorder (P = 0.0792); Loss of ubiquitination at K114 (P = 0.0992); Gain of helix (P = 0.132); Loss of catalytic residue at S118 (P = 0.1512)
7:117171031:T:C,P13569,S118P,0.653,Loss of glycosylation at S118 (P = 0.0387); Gain of ubiquitination at K114 (P = 0.115); Loss of disorder (P = 0.195); Loss of catalytic residue at S118 (P = 0.2529); Loss of stability (P = 0.2598)
7:117171031:T:G,P13569,S118A,0.655,Loss of glycosylation at S118 (P = 0.0204); Loss of disorder (P = 0.0678); Loss of ubiquitination at K114 (P = 0.0992); Loss of methylation at K114 (P = 0.111); Gain of helix (P = 0.132)
7:117171032:C:A,P13569,S118Y,0.682,Loss of glycosylation at S118 (P = 0.0204); Loss of disorder (P = 0.0267); Loss of ubiquitination at K114 (P = 0.1151); Loss of catalytic residue at S118 (P = 0.1359); Loss of helix (P = 0.2662)
7:117171032:C:G,P13569,S118C,0.637,Loss of disorder (P = 0.0025); Loss of glycosylation at S118 (P = 0.0204); Loss of catalytic residue at S118 (P = 0.0965); Gain of ubiquitination at K114 (P = 0.0985); Gain of helix (P = 0.132)
7:117171032:C:T,P13569,S118F,0.653,Loss of disorder (P = 0.0062); Loss of glycosylation at S118 (P = 0.0204); Loss of ubiquitination at K114 (P = 0.1151); Loss of catalytic residue at S118 (P = 0.1251); Loss of methylation at K114 (P = 0.1307)
7:117171034:A:C,P13569,I119L,0.631,Loss of methylation at K114 (P = 0.0952); Gain of ubiquitination at K114 (P = 0.115); Gain of disorder (P = 0.1628); Loss of glycosylation at S118 (P = 0.1722); Loss of loop (P = 0.2237)
7:117171034:A:T,P13569,I119F,0.642,Loss of glycosylation at S118 (P = 0.0666); Gain of helix (P = 0.132); Loss of ubiquitination at K114 (P = 0.1322); Loss of methylation at K114 (P = 0.2059); Loss of disorder (P = 0.2208)
7:117171035:T:A,P13569,I119N,0.657,Gain of disorder (P = 0.0105); Gain of catalytic residue at I119 (P = 0.0303); Gain of ubiquitination at K114 (P = 0.0436); Loss of methylation at K114 (P = 0.0909); Loss of stability (P = 0.1029)
7:117171035:T:C,P13569,I119T,0.59,Gain of disorder (P = 0.0274); Loss of stability (P = 0.033); Gain of ubiquitination at K114 (P = 0.0483); Gain of catalytic residue at I119 (P = 0.0577); Gain of glycosylation at S118 (P = 0.1288)
7:117171035:T:G,P13569,I119S,0.618,Gain of disorder (P = 0.002); Gain of ubiquitination at K114 (P = 0.0483); Gain of glycosylation at I119 (P = 0.0674); Loss of stability (P = 0.0744); Gain of phosphorylation at I119 (P = 0.0747)
7:117171036:C:G,P13569,I119M,0.623,Loss of glycosylation at S118 (P = 0.0416); Gain of ubiquitination at K114 (P = 0.0483); Gain of disorder (P = 0.0674); Loss of loop (P = 0.2237); Loss of methylation at K114 (P = 0.2439)
7:117171037:G:A,P13569,A120T,0.873,Gain of disorder (P = 0.1512); Gain of glycosylation at A120 (P = 0.1783); Gain of loop (P = 0.2045); Loss of catalytic residue at A120 (P = 0.3016); Loss of stability (P = 0.3903)
7:117171037:G:C,P13569,A120P,0.865,Gain of disorder (P = 0.0585); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of glycosylation at S118 (P = 0.2137); Gain of phosphorylation at S118 (P = 0.2671)
7:117171037:G:T,P13569,A120S,0.75,Gain of disorder (P = 0.0292); Gain of phosphorylation at A120 (P = 0.0652); Loss of glycosylation at S118 (P = 0.096); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949)
7:117171038:C:A,P13569,A120E,0.845,Gain of disorder (P = 0.0284); Loss of glycosylation at S118 (P = 0.1009); Loss of helix (P = 0.1299); Loss of catalytic residue at S118 (P = 0.1393); Gain of phosphorylation at S118 (P = 0.1665)
7:117171038:C:G,P13569,A120G,0.763,Gain of disorder (P = 0.0775); Loss of stability (P = 0.1811); Loss of glycosylation at S118 (P = 0.1892); Gain of helix (P = 0.2684); Gain of catalytic residue at A120 (P = 0.3122)
7:117171038:C:T,P13569,A120V,0.719,Loss of disorder (P = 0.0972); Gain of helix (P = 0.132); Loss of glycosylation at S118 (P = 0.1956); Gain of catalytic residue at A120 (P = 0.2598); Loss of loop (P = 0.2897)
7:117171040:A:C,P13569,I121L,0.657,Loss of glycosylation at S118 (P = 0.0731); Gain of disorder (P = 0.1721); Loss of loop (P = 0.2237); Loss of catalytic residue at I121 (P = 0.3225); Loss of helix (P = 0.3949)
7:117171040:A:G,P13569,I121V,0.623,Loss of glycosylation at S118 (P = 0.1892); Loss of stability (P = 0.1998); Gain of disorder (P = 0.2149); Loss of loop (P = 0.2237); Loss of catalytic residue at L123 (P = 0.3463)
7:117171040:A:T,P13569,I121F,0.652,Loss of stability (P = 0.0781); Loss of glycosylation at S118 (P = 0.1676); Gain of catalytic residue at I121 (P = 0.2067); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2353)
7:117171041:T:A,P13569,I121N,0.76,Loss of stability (P = 0.0044); Gain of disorder (P = 0.0272); Loss of glycosylation at S118 (P = 0.1014); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2363)
7:117171041:T:C,P13569,I121T,0.676,Loss of stability (P = 0.0012); Gain of disorder (P = 0.0412); Loss of catalytic residue at I121 (P = 0.1182); Loss of glycosylation at S118 (P = 0.1234); Loss of loop (P = 0.2237)
7:117171041:T:G,P13569,I121S,0.785,Loss of stability (P = 0.0062); Gain of disorder (P = 0.0063); Loss of glycosylation at S118 (P = 0.0839); Loss of loop (P = 0.2237); Gain of phosphorylation at S118 (P = 0.2341)
7:117171042:T:G,P13569,I121M,0.681,Gain of disorder (P = 0.0812); Loss of glycosylation at S118 (P = 0.1036); Loss of stability (P = 0.1156); Loss of catalytic residue at I121 (P = 0.118); Loss of loop (P = 0.2237)
7:117171043:T:A,P13569,Y122N,0.75,Gain of disorder (P = 0.0637); Loss of stability (P = 0.0807); Loss of catalytic residue at I121 (P = 0.2132); Loss of helix (P = 0.2271); Loss of glycosylation at S118 (P = 0.2646)
7:117171043:T:C,P13569,Y122H,0.89,Gain of disorder (P = 0.034); Loss of catalytic residue at Y122 (P = 0.0537); Loss of stability (P = 0.059); Gain of helix (P = 0.132); Gain of glycosylation at S118 (P = 0.1946)
7:117171043:T:G,P13569,Y122D,0.771,Gain of disorder (P = 0.0425); Gain of helix (P = 0.132); Loss of stability (P = 0.1496); Gain of phosphorylation at S118 (P = 0.1901); Loss of catalytic residue at I121 (P = 0.216)
7:117171044:A:C,P13569,Y122S,0.701,Gain of disorder (P = 0.0197); Loss of stability (P = 0.0754); Gain of phosphorylation at S118 (P = 0.1262); Gain of helix (P = 0.132); Gain of glycosylation at Y122 (P = 0.1429)
7:117171044:A:T,P13569,Y122F,0.792,Loss of disorder (P = 0.1546); Loss of glycosylation at S118 (P = 0.1667); Loss of catalytic residue at I121 (P = 0.2146); Loss of stability (P = 0.3146); Gain of phosphorylation at S118 (P = 0.3656)
7:117171046:C:A,P13569,L123I,0.683,Gain of catalytic residue at G124 (P = 0.1856); Loss of glycosylation at S118 (P = 0.2317); Gain of disorder (P = 0.3828); Loss of helix (P = 0.3949); Gain of phosphorylation at S118 (P = 0.4722)
7:117171046:C:G,P13569,L123V,0.724,Gain of catalytic residue at G124 (P = 0.2133); Gain of glycosylation at S118 (P = 0.2275); Loss of stability (P = 0.279); Gain of disorder (P = 0.3922); Loss of helix (P = 0.3949)
7:117171047:T:A,P13569,L123Q,0.756,Gain of disorder (P = 0.0643); Loss of stability (P = 0.0654); Loss of glycosylation at S118 (P = 0.1155); Loss of catalytic residue at S118 (P = 0.1329); Loss of helix (P = 0.3949)
7:117171047:T:C,P13569,L123P,0.865,Loss of stability (P = 0.0275); Gain of disorder (P = 0.0452); Loss of catalytic residue at S118 (P = 0.1492); Loss of helix (P = 0.2271); Gain of glycosylation at S118 (P = 0.2273)
7:117171047:T:G,P13569,L123R,0.911,Gain of methylation at L123 (P = 0.0176); Gain of disorder (P = 0.0483); Loss of stability (P = 0.0567); Loss of glycosylation at S118 (P = 0.1119); Loss of catalytic residue at S118 (P = 0.1458)
7:117171049:G:A,P13569,G124S,0.676,Gain of catalytic residue at G124 (P = 0.0373); Loss of helix (P = 0.2271); Loss of stability (P = 0.4334); Gain of disorder (P = 0.4681); Gain of MoRF binding (P = 0.5646)
7:117171049:G:C,P13569,G124R,0.946,Gain of methylation at G124 (P = 0.041); Gain of MoRF binding (P = 0.082); Gain of catalytic residue at G124 (P = 0.1353); Gain of helix (P = 0.2294); Gain of disorder (P = 0.59)
7:117171049:G:T,P13569,G124C,0.717,Gain of catalytic residue at G124 (P = 0.0826); Loss of helix (P = 0.4763); Loss of disorder (P = 0.5782); Loss of MoRF binding (P = 0.6116); Loss of stability (P = 0.6361)
7:117171050:G:A,P13569,G124D,0.739,Gain of catalytic residue at G124 (P = 0.0225); Loss of helix (P = 0.4763); Gain of phosphorylation at Y122 (P = 0.5528); Gain of disorder (P = 0.5922); Loss of stability (P = 0.604)
7:117171050:G:C,P13569,G124A,0.732,Gain of catalytic residue at G124 (P = 0.0652); Loss of stability (P = 0.2368); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.6152); Loss of disorder (P = 0.6416)
7:117171050:G:T,P13569,G124V,0.722,Gain of catalytic residue at G124 (P = 0.0328); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.5919); Loss of disorder (P = 0.5986); Loss of sheet (P = 0.6423)
7:117171052:A:C,P13569,I125L,0.715,Loss of catalytic residue at L130 (P = 0.021); Loss of MoRF binding (P = 0.6105); Gain of sheet (P = 0.6509); Loss of helix (P = 0.6555); Loss of phosphorylation at Y122 (P = 0.6982)
7:117171052:A:G,P13569,I125V,0.716,Loss of catalytic residue at L130 (P = 0.021); Loss of helix (P = 0.2271); Gain of phosphorylation at Y122 (P = 0.6107); Loss of MoRF binding (P = 0.6145); Gain of sheet (P = 0.6509)
7:117171052:A:T,P13569,I125L,0.715,Loss of catalytic residue at L130 (P = 0.021); Loss of MoRF binding (P = 0.6105); Gain of sheet (P = 0.6509); Loss of helix (P = 0.6555); Loss of phosphorylation at Y122 (P = 0.6982)
7:117171053:T:A,P13569,I125K,0.816,Loss of catalytic residue at L130 (P = 0.0185); Gain of ubiquitination at I125 (P = 0.0351); Gain of glycosylation at I125 (P = 0.0415); Loss of stability (P = 0.0707); Gain of MoRF binding (P = 0.3802)
7:117171053:T:G,P13569,I125R,0.922,Gain of methylation at I125 (P = 0.0039); Loss of catalytic residue at L130 (P = 0.0194); Loss of stability (P = 0.1869); Gain of MoRF binding (P = 0.2812); Gain of disorder (P = 0.6403)
7:117171054:A:G,P13569,I125M,0.74,Loss of catalytic residue at L130 (P = 0.0209); Loss of stability (P = 0.5194); Gain of phosphorylation at Y122 (P = 0.5551); Gain of MoRF binding (P = 0.6136); Gain of sheet (P = 0.6509)
7:117171055:G:A,P13569,G126S,0.913,Loss of catalytic residue at I125 (P = 0.2968); Gain of MoRF binding (P = 0.574); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Gain of phosphorylation at Y122 (P = 0.686)
7:117171055:G:C,P13569,G126R,0.947,Gain of methylation at G126 (P = 0.0192); Gain of MoRF binding (P = 0.1318); Loss of catalytic residue at I125 (P = 0.2271); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117171055:G:T,P13569,G126C,0.814,Loss of catalytic residue at I125 (P = 0.2827); Gain of helix (P = 0.5668); Loss of MoRF binding (P = 0.61); Loss of phosphorylation at Y122 (P = 0.6965); Loss of sheet (P = 0.7751)
7:117171056:G:A,P13569,G126D,0.947,Loss of catalytic residue at I125 (P = 0.2465); Gain of phosphorylation at Y122 (P = 0.5197); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.6027); Gain of sheet (P = 0.6509)
7:117171056:G:C,P13569,G126A,0.857,Loss of catalytic residue at I125 (P = 0.3083); Gain of MoRF binding (P = 0.6147); Loss of helix (P = 0.6555); Loss of phosphorylation at Y122 (P = 0.7055); Loss of sheet (P = 0.7751)
7:117171056:G:T,P13569,G126V,0.847,Loss of catalytic residue at I125 (P = 0.2576); Gain of MoRF binding (P = 0.5752); Loss of helix (P = 0.6555); Loss of phosphorylation at Y122 (P = 0.7052); Loss of sheet (P = 0.7751)
7:117171058:T:A,P13569,L127I,0.689,Gain of MoRF binding (P = 0.5912); Gain of catalytic residue at L123 (P = 0.6452); Loss of helix (P = 0.6555); Loss of phosphorylation at Y122 (P = 0.7052); Loss of sheet (P = 0.7751)
7:117171058:T:G,P13569,L127V,0.692,Gain of MoRF binding (P = 0.587); Loss of stability (P = 0.5957); Gain of phosphorylation at Y122 (P = 0.6367); Loss of helix (P = 0.6555); Gain of catalytic residue at F131 (P = 0.7298)
7:117171059:T:C,P13569,L127S,0.721,Loss of stability (P = 0.1003); Gain of catalytic residue at L123 (P = 0.5019); Gain of MoRF binding (P = 0.5487); Gain of phosphorylation at Y122 (P = 0.6082); Loss of sheet (P = 0.6423)
7:117171060:A:C,P13569,L127F,0.741,Loss of catalytic residue at L127 (P = 0.1217); Loss of stability (P = 0.3351); Gain of MoRF binding (P = 0.5915); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555)
7:117171060:A:T,P13569,L127F,0.741,Loss of catalytic residue at L127 (P = 0.1217); Loss of stability (P = 0.3351); Gain of MoRF binding (P = 0.5915); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555)
7:117171061:T:A,P13569,C128S,0.666,Loss of stability (P = 0.0721); Loss of catalytic residue at L129 (P = 0.3882); Gain of MoRF binding (P = 0.5449); Gain of sheet (P = 0.6509); Gain of glycosylation at C128 (P = 0.7596)
7:117171061:T:C,P13569,C128R,0.94,Gain of methylation at C128 (P = 0.0145); Gain of MoRF binding (P = 0.0936); Loss of stability (P = 0.1079); Loss of catalytic residue at L129 (P = 0.1798); Gain of sheet (P = 0.6509)
7:117171061:T:G,P13569,C128G,0.7,Loss of stability (P = 0.0148); Loss of catalytic residue at C128 (P = 0.2592); Gain of MoRF binding (P = 0.5843); Gain of sheet (P = 0.6509); Loss of helix (P = 0.7926)
7:117171062:G:A,P13569,C128Y,0.77,Loss of stability (P = 0.2331); Loss of catalytic residue at L129 (P = 0.4027); Gain of MoRF binding (P = 0.5937); Loss of sheet (P = 0.7751); Loss of helix (P = 0.7926)
7:117171062:G:C,P13569,C128S,0.666,Loss of stability (P = 0.0721); Loss of catalytic residue at L129 (P = 0.3882); Gain of MoRF binding (P = 0.5449); Gain of sheet (P = 0.6509); Gain of glycosylation at C128 (P = 0.7596)
7:117171062:G:T,P13569,C128F,0.767,Loss of catalytic residue at C128 (P = 0.0571); Loss of stability (P = 0.246); Gain of MoRF binding (P = 0.5164); Gain of sheet (P = 0.6509); Loss of helix (P = 0.6835)
7:117171063:C:G,P13569,C128W,0.782,Loss of stability (P = 0.1962); Loss of catalytic residue at L129 (P = 0.2527); Gain of MoRF binding (P = 0.2922); Loss of helix (P = 0.6835); Loss of sheet (P = 0.7751)
7:117171064:C:A,P13569,L129I,0.701,Loss of catalytic residue at L129 (P = 0.122); Loss of methylation at R134 (P = 0.3685); Gain of MoRF binding (P = 0.5721); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7108)
7:117171064:C:G,P13569,L129V,0.687,Loss of catalytic residue at L129 (P = 0.2868); Gain of methylation at R134 (P = 0.3517); Loss of stability (P = 0.3991); Gain of MoRF binding (P = 0.5868); Loss of sheet (P = 0.6423)
7:117171064:C:T,P13569,L129F,0.714,Loss of catalytic residue at L129 (P = 0.0373); Loss of stability (P = 0.3231); Gain of methylation at R134 (P = 0.3521); Gain of MoRF binding (P = 0.585); Loss of sheet (P = 0.6423)
7:117171065:T:A,P13569,L129H,0.729,Loss of stability (P = 0.065); Gain of catalytic residue at F131 (P = 0.1448); Gain of methylation at R134 (P = 0.3715); Loss of MoRF binding (P = 0.6106); Loss of sheet (P = 0.6423)
7:117171065:T:C,P13569,L129P,0.788,Loss of stability (P = 0.0439); Gain of methylation at R134 (P = 0.3536); Gain of catalytic residue at F131 (P = 0.4053); Loss of MoRF binding (P = 0.5911); Loss of sheet (P = 0.6423)
7:117171065:T:G,P13569,L129R,0.832,Gain of methylation at L129 (P = 0.0192); Loss of stability (P = 0.0936); Gain of MoRF binding (P = 0.2704); Gain of catalytic residue at F131 (P = 0.398); Loss of sheet (P = 0.6423)
7:117171067:C:A,P13569,L130I,0.725,Loss of catalytic residue at L130 (P = 0.0258); Loss of methylation at R134 (P = 0.367); Loss of stability (P = 0.5056); Gain of MoRF binding (P = 0.5917); Loss of sheet (P = 0.6423)
7:117171067:C:G,P13569,L130V,0.744,Loss of stability (P = 0.2386); Gain of methylation at R134 (P = 0.3517); Gain of MoRF binding (P = 0.59); Loss of sheet (P = 0.6423); Gain of helix (P = 0.6868)
7:117171067:C:T,P13569,L130F,0.77,Loss of catalytic residue at L130 (P = 0.0383); Loss of stability (P = 0.1092); Gain of methylation at R134 (P = 0.3537); Gain of MoRF binding (P = 0.5956); Loss of sheet (P = 0.7751)
7:117171068:T:A,P13569,L130H,0.78,Loss of stability (P = 0.0119); Gain of methylation at R134 (P = 0.2997); Gain of catalytic residue at F131 (P = 0.5198); Gain of MoRF binding (P = 0.57); Loss of sheet (P = 0.6423)
7:117171068:T:C,P13569,L130P,0.866,Loss of stability (P = 0.0127); Loss of catalytic residue at L130 (P = 0.0442); Gain of methylation at R134 (P = 0.3036); Loss of MoRF binding (P = 0.5977); Loss of sheet (P = 0.6423)
7:117171068:T:G,P13569,L130R,0.954,Gain of methylation at L130 (P = 0.0166); Loss of stability (P = 0.0237); Gain of MoRF binding (P = 0.0599); Loss of catalytic residue at V133 (P = 0.306); Loss of sheet (P = 0.6423)
7:117171070:T:A,P13569,F131I,0.757,Gain of catalytic residue at L136 (P = 0.0361); Loss of methylation at R134 (P = 0.3416); Loss of MoRF binding (P = 0.6147); Loss of helix (P = 0.6835); Gain of phosphorylation at T135 (P = 0.8207)
7:117171070:T:C,P13569,F131L,0.781,Loss of methylation at R134 (P = 0.3533); Loss of stability (P = 0.383); Gain of catalytic residue at F131 (P = 0.5624); Loss of MoRF binding (P = 0.6108); Loss of helix (P = 0.6835)
7:117171070:T:G,P13569,F131V,0.767,Gain of catalytic residue at F131 (P = 0.2881); Loss of methylation at R134 (P = 0.3745); Loss of stability (P = 0.5667); Loss of MoRF binding (P = 0.6142); Loss of helix (P = 0.6835)
7:117171071:T:A,P13569,F131Y,0.764,Loss of stability (P = 0.2186); Gain of catalytic residue at F131 (P = 0.2226); Gain of methylation at R134 (P = 0.3601); Loss of MoRF binding (P = 0.6111); Loss of helix (P = 0.6835)
7:117171071:T:C,P13569,F131S,0.752,Loss of stability (P = 0.0421); Gain of catalytic residue at F131 (P = 0.077); Gain of methylation at R134 (P = 0.325); Gain of MoRF binding (P = 0.5904); Loss of helix (P = 0.6835)
7:117171071:T:G,P13569,F131C,0.788,Loss of stability (P = 0.2136); Gain of catalytic residue at F131 (P = 0.2535); Gain of methylation at R134 (P = 0.3517); Loss of MoRF binding (P = 0.6063); Loss of helix (P = 0.6835)
7:117171072:T:A,P13569,F131L,0.781,Loss of methylation at R134 (P = 0.3533); Loss of stability (P = 0.383); Gain of catalytic residue at F131 (P = 0.5624); Loss of MoRF binding (P = 0.6108); Loss of helix (P = 0.6835)
7:117171072:T:G,P13569,F131L,0.781,Loss of methylation at R134 (P = 0.3533); Loss of stability (P = 0.383); Gain of catalytic residue at F131 (P = 0.5624); Loss of MoRF binding (P = 0.6108); Loss of helix (P = 0.6835)
7:117171073:A:C,P13569,I132L,0.774,Loss of catalytic residue at L137 (P = 0.1666); Gain of methylation at R134 (P = 0.3048); Loss of stability (P = 0.5779); Loss of MoRF binding (P = 0.6096); Loss of helix (P = 0.6835)
7:117171073:A:G,P13569,I132V,0.733,Loss of catalytic residue at L137 (P = 0.1661); Gain of methylation at R134 (P = 0.2212); Loss of stability (P = 0.603); Loss of MoRF binding (P = 0.6128); Loss of helix (P = 0.6835)
7:117171073:A:T,P13569,I132F,0.791,Loss of catalytic residue at L137 (P = 0.1663); Gain of methylation at R134 (P = 0.2306); Loss of stability (P = 0.2855); Loss of MoRF binding (P = 0.6131); Loss of helix (P = 0.6835)
7:117171074:T:A,P13569,I132N,0.807,Loss of stability (P = 0.042); Gain of methylation at R134 (P = 0.0459); Gain of catalytic residue at I132 (P = 0.0669); Loss of MoRF binding (P = 0.6143); Loss of helix (P = 0.6835)
7:117171074:T:C,P13569,I132T,0.764,Loss of stability (P = 0.0132); Gain of methylation at R134 (P = 0.0835); Loss of catalytic residue at L137 (P = 0.1819); Loss of MoRF binding (P = 0.6109); Loss of helix (P = 0.6835)
7:117171074:T:G,P13569,I132S,0.704,Gain of catalytic residue at I132 (P = 0.0058); Loss of stability (P = 0.0235); Gain of methylation at R134 (P = 0.0747); Gain of glycosylation at I132 (P = 0.6054); Loss of MoRF binding (P = 0.6133)
7:117171075:T:G,P13569,I132M,0.794,Loss of catalytic residue at L137 (P = 0.1728); Gain of methylation at R134 (P = 0.1975); Loss of stability (P = 0.3489); Gain of MoRF binding (P = 0.6144); Loss of helix (P = 0.6835)
7:117171076:G:A,P13569,V133M,0.717,Loss of catalytic residue at V133 (P = 0.2373); Loss of methylation at R134 (P = 0.3652); Loss of stability (P = 0.3809); Loss of MoRF binding (P = 0.6142); Gain of helix (P = 0.6868)
7:117171076:G:C,P13569,V133L,0.728,Loss of catalytic residue at V133 (P = 0.053); Loss of methylation at R134 (P = 0.3524); Loss of MoRF binding (P = 0.6113); Loss of stability (P = 0.6502); Loss of helix (P = 0.6835)
7:117171076:G:T,P13569,V133L,0.728,Loss of catalytic residue at V133 (P = 0.053); Loss of methylation at R134 (P = 0.3524); Loss of MoRF binding (P = 0.6113); Loss of stability (P = 0.6502); Loss of helix (P = 0.6835)
7:117171077:T:A,P13569,V133E,0.81,Loss of stability (P = 0.1101); Loss of methylation at R134 (P = 0.3393); Loss of catalytic residue at R134 (P = 0.4345); Loss of MoRF binding (P = 0.5819); Gain of helix (P = 0.6868)
7:117171077:T:C,P13569,V133A,0.779,Loss of stability (P = 0.0237); Gain of methylation at R134 (P = 0.2915); Loss of catalytic residue at V133 (P = 0.5586); Loss of MoRF binding (P = 0.6082); Loss of helix (P = 0.6835)
7:117171077:T:G,P13569,V133G,0.762,Loss of stability (P = 0.0014); Gain of methylation at R134 (P = 0.1219); Loss of catalytic residue at V133 (P = 0.2937); Loss of MoRF binding (P = 0.6078); Loss of helix (P = 0.6835)
7:117171079:A:G,P13569,R134G,0.826,Loss of methylation at R134 (P = 0.1954); Gain of catalytic residue at F131 (P = 0.2318); Loss of stability (P = 0.2481); Loss of MoRF binding (P = 0.578); Loss of helix (P = 0.6835)
7:117171079:A:T,P13569,R134W,0.815,Gain of catalytic residue at R134 (P = 0.136); Loss of methylation at R134 (P = 0.1954); Loss of MoRF binding (P = 0.5958); Loss of helix (P = 0.6835); Gain of glycosylation at T135 (P = 0.788)
7:117171080:G:A,P13569,R134K,0.741,Gain of ubiquitination at R134 (P = 0.0238); Gain of catalytic residue at R134 (P = 0.1166); Gain of glycosylation at R134 (P = 0.1711); Loss of methylation at R134 (P = 0.3134); Loss of stability (P = 0.5888)
7:117171080:G:C,P13569,R134T,0.793,Gain of glycosylation at R134 (P = 0.0374); Gain of catalytic residue at R134 (P = 0.1269); Loss of methylation at R134 (P = 0.1954); Loss of stability (P = 0.5409); Loss of MoRF binding (P = 0.5778)
7:117171080:G:T,P13569,R134M,0.81,Loss of methylation at R134 (P = 0.1954); Loss of catalytic residue at R134 (P = 0.248); Gain of stability (P = 0.4742); Loss of MoRF binding (P = 0.5816); Loss of helix (P = 0.6835)
7:117171081:G:C,P13569,R134S,0.76,Gain of glycosylation at R134 (P = 0.0491); Gain of catalytic residue at R134 (P = 0.0617); Loss of methylation at R134 (P = 0.1954); Loss of MoRF binding (P = 0.5793); Loss of stability (P = 0.6661)
7:117171081:G:T,P13569,R134S,0.76,Gain of glycosylation at R134 (P = 0.0491); Gain of catalytic residue at R134 (P = 0.0617); Loss of methylation at R134 (P = 0.1954); Loss of MoRF binding (P = 0.5793); Loss of stability (P = 0.6661)
7:117171082:A:C,P13569,T135P,0.836,Loss of catalytic residue at T135 (P = 0.1121); Loss of stability (P = 0.1272); Gain of methylation at R134 (P = 0.3645); Loss of MoRF binding (P = 0.5985); Loss of helix (P = 0.6835)
7:117171082:A:G,P13569,T135A,0.794,Gain of methylation at R134 (P = 0.2209); Loss of stability (P = 0.2381); Loss of catalytic residue at T135 (P = 0.3696); Loss of MoRF binding (P = 0.6147); Gain of helix (P = 0.6868)
7:117171082:A:T,P13569,T135S,0.751,Loss of stability (P = 0.3311); Gain of methylation at R134 (P = 0.3737); Gain of MoRF binding (P = 0.6072); Gain of catalytic residue at R134 (P = 0.6948); Gain of glycosylation at T135 (P = 0.7482)
7:117171083:C:A,P13569,T135K,0.819,Gain of ubiquitination at T135 (P = 0.0185); Loss of stability (P = 0.1524); Loss of methylation at R134 (P = 0.3337); Gain of MoRF binding (P = 0.3665); Gain of glycosylation at T135 (P = 0.3958)
7:117171083:C:G,P13569,T135R,0.921,Gain of methylation at T135 (P = 0.0784); Loss of catalytic residue at T135 (P = 0.2278); Gain of MoRF binding (P = 0.2943); Loss of stability (P = 0.3962); Loss of helix (P = 0.6835)
7:117171083:C:T,P13569,T135I,0.8,Loss of catalytic residue at T135 (P = 0.0525); Loss of methylation at R134 (P = 0.327); Gain of MoRF binding (P = 0.5734); Loss of helix (P = 0.6835); Loss of glycosylation at P140 (P = 0.7922)
7:117171085:C:A,P13569,L136M,0.757,Loss of stability (P = 0.0897); Gain of methylation at R134 (P = 0.3093); Gain of catalytic residue at R134 (P = 0.5159); Gain of MoRF binding (P = 0.6018); Gain of helix (P = 0.6868)
7:117171085:C:G,P13569,L136V,0.799,Loss of stability (P = 0.1095); Gain of catalytic residue at H139 (P = 0.2642); Gain of methylation at R134 (P = 0.3395); Gain of MoRF binding (P = 0.6073); Gain of glycosylation at T135 (P = 0.7772)
7:117171086:T:A,P13569,L136Q,0.781,Loss of stability (P = 0.0115); Gain of catalytic residue at L136 (P = 0.0227); Loss of methylation at R134 (P = 0.3658); Loss of MoRF binding (P = 0.6218); Gain of helix (P = 0.6868)
7:117171086:T:C,P13569,L136P,0.901,Loss of stability (P = 0.0038); Gain of methylation at R134 (P = 0.2795); Gain of catalytic residue at R134 (P = 0.404); Loss of MoRF binding (P = 0.607); Gain of glycosylation at L136 (P = 0.6261)
7:117171086:T:G,P13569,L136R,0.917,Loss of stability (P = 0.0074); Gain of methylation at L136 (P = 0.0079); Gain of catalytic residue at L136 (P = 0.0474); Gain of MoRF binding (P = 0.3894); Gain of helix (P = 0.6868)
7:117171088:C:A,P13569,L137I,0.849,Loss of catalytic residue at L137 (P = 0.1462); Loss of methylation at R134 (P = 0.3456); Gain of MoRF binding (P = 0.6035); Loss of stability (P = 0.7442); Loss of glycosylation at P140 (P = 0.7824)
7:117171088:C:G,P13569,L137V,0.872,Loss of catalytic residue at L137 (P = 0.1991); Gain of methylation at R134 (P = 0.3459); Loss of stability (P = 0.5231); Gain of MoRF binding (P = 0.6088); Loss of helix (P = 0.6835)
7:117171088:C:T,P13569,L137F,0.852,Loss of catalytic residue at L137 (P = 0.1864); Loss of stability (P = 0.3096); Gain of methylation at R134 (P = 0.3313); Gain of MoRF binding (P = 0.6061); Loss of helix (P = 0.6835)
7:117171089:T:A,P13569,L137H,0.936,Loss of stability (P = 0.0516); Loss of catalytic residue at L137 (P = 0.0864); Gain of methylation at R134 (P = 0.1189); Gain of MoRF binding (P = 0.6116); Gain of disorder (P = 0.6264)
7:117171089:T:C,P13569,L137P,0.945,Loss of catalytic residue at L137 (P = 0.0245); Loss of stability (P = 0.0468); Gain of methylation at R134 (P = 0.3144); Gain of glycosylation at L137 (P = 0.4578); Loss of MoRF binding (P = 0.6131)
7:117171089:T:G,P13569,L137R,0.983,Gain of methylation at L137 (P = 0.0124); Loss of stability (P = 0.1303); Gain of MoRF binding (P = 0.1878); Loss of catalytic residue at L138 (P = 0.4163); Loss of helix (P = 0.6835)
7:117171091:C:A,P13569,L138I,0.74,Loss of methylation at R134 (P = 0.3538); Loss of catalytic residue at L138 (P = 0.3783); Gain of MoRF binding (P = 0.611); Loss of stability (P = 0.6634); Gain of helix (P = 0.6868)
7:117171091:C:G,P13569,L138V,0.747,Loss of methylation at R134 (P = 0.3695); Gain of catalytic residue at H139 (P = 0.3737); Loss of stability (P = 0.4751); Gain of MoRF binding (P = 0.6125); Loss of glycosylation at P140 (P = 0.7803)
7:117171092:T:A,P13569,L138Q,0.664,Loss of stability (P = 0.1334); Loss of methylation at R134 (P = 0.3377); Loss of catalytic residue at L138 (P = 0.4313); Gain of MoRF binding (P = 0.5726); Loss of helix (P = 0.6835)
7:117171092:T:G,P13569,L138R,0.811,Gain of relative solvent accessibility (P = 0.1259); Loss of stability (P = 0.126); Gain of solvent accessibility (P = 0.1319); Gain of MoRF binding (P = 0.2065); Gain of methylation at L138 (P = 0.2828)
7:117171094:C:A,P13569,H139N,0.846,Loss of catalytic residue at L138 (P = 0.1254); Loss of methylation at R134 (P = 0.3643); Loss of stability (P = 0.454); Gain of MoRF binding (P = 0.6122); Loss of helix (P = 0.6835)
7:117171094:C:G,P13569,H139D,0.792,Gain of catalytic residue at H139 (P = 0.089); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2291); Loss of methylation at R134 (P = 0.3359); Loss of stability (P = 0.6344)
7:117171094:C:T,P13569,H139Y,0.838,Gain of catalytic residue at H139 (P = 0.0764); Loss of methylation at R134 (P = 0.3673); Gain of MoRF binding (P = 0.6432); Gain of helix (P = 0.6868); Loss of disorder (P = 0.8019)
7:117171095:A:C,P13569,H139P,0.821,Gain of catalytic residue at H139 (P = 0.0361); Gain of glycosylation at P140 (P = 0.1651); Loss of methylation at R134 (P = 0.3628); Loss of stability (P = 0.408); Loss of MoRF binding (P = 0.6368)
7:117171095:A:G,P13569,H139R,0.96,Loss of catalytic residue at L138 (P = 0.1179); Gain of methylation at H139 (P = 0.1763); Gain of MoRF binding (P = 0.2696); Loss of stability (P = 0.6806); Gain of helix (P = 0.6868)
7:117171095:A:T,P13569,H139L,0.915,Loss of catalytic residue at L138 (P = 0.1049); Loss of methylation at R134 (P = 0.3549); Gain of MoRF binding (P = 0.625); Loss of helix (P = 0.6835); Gain of glycosylation at P140 (P = 0.7637)
7:117171096:C:A,P13569,H139Q,0.838,Gain of catalytic residue at H139 (P = 0.102); Loss of methylation at R134 (P = 0.3336); Gain of MoRF binding (P = 0.6183); Loss of stability (P = 0.6556); Loss of helix (P = 0.6835)
7:117171096:C:G,P13569,H139Q,0.838,Gain of catalytic residue at H139 (P = 0.102); Loss of methylation at R134 (P = 0.3336); Gain of MoRF binding (P = 0.6183); Loss of stability (P = 0.6556); Loss of helix (P = 0.6835)
7:117171097:C:A,P13569,P140T,0.836,Gain of catalytic residue at F143 (P = 0.268); Loss of stability (P = 0.3339); Gain of MoRF binding (P = 0.4928); Gain of helix (P = 0.6868); Loss of glycosylation at P140 (P = 0.7884)
7:117171097:C:G,P13569,P140A,0.793,Loss of catalytic residue at L138 (P = 0.3754); Gain of MoRF binding (P = 0.5137); Loss of stability (P = 0.5927); Loss of glycosylation at P140 (P = 0.7443); Loss of helix (P = 0.7926)
7:117171098:C:A,P13569,P140Q,0.826,Loss of catalytic residue at L138 (P = 0.456); Gain of MoRF binding (P = 0.4819); Gain of helix (P = 0.6868); Loss of stability (P = 0.7271); Loss of glycosylation at P140 (P = 0.7443)
7:117171098:C:G,P13569,P140R,0.873,Gain of methylation at P140 (P = 0.0585); Gain of MoRF binding (P = 0.0822); Loss of catalytic residue at L138 (P = 0.3746); Gain of helix (P = 0.6868); Loss of stability (P = 0.7005)
7:117171098:C:T,P13569,P140L,0.907,Loss of catalytic residue at P140 (P = 0.0639); Gain of MoRF binding (P = 0.4762); Gain of helix (P = 0.6868); Loss of glycosylation at P140 (P = 0.7443); Loss of disorder (P = 0.8058)
7:117171100:G:A,P13569,A141T,0.692,Gain of glycosylation at A141 (P = 0.1017); Gain of catalytic residue at H139 (P = 0.2631); Loss of stability (P = 0.3391); Gain of helix (P = 0.5668); Gain of MoRF binding (P = 0.6113)
7:117171100:G:C,P13569,A141P,0.893,Loss of stability (P = 0.257); Gain of catalytic residue at L138 (P = 0.3763); Gain of glycosylation at P140 (P = 0.556); Gain of helix (P = 0.5668); Loss of MoRF binding (P = 0.5971)
7:117171100:G:T,P13569,A141S,0.691,Gain of glycosylation at A141 (P = 0.0436); Loss of catalytic residue at A141 (P = 0.1461); Loss of stability (P = 0.5044); Gain of helix (P = 0.5668); Gain of MoRF binding (P = 0.6052)
7:117171101:C:A,P13569,A141D,0.894,Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2291); Loss of catalytic residue at A141 (P = 0.2539); Gain of helix (P = 0.5668); Loss of MoRF binding (P = 0.5973)
7:117171101:C:G,P13569,A141G,0.789,Loss of stability (P = 0.1092); Gain of catalytic residue at F143 (P = 0.4827); Gain of helix (P = 0.5668); Loss of MoRF binding (P = 0.6131); Gain of disorder (P = 0.7191)
7:117171101:C:T,P13569,A141V,0.829,Gain of MoRF binding (P = 0.5726); Loss of catalytic residue at I142 (P = 0.5902); Loss of helix (P = 0.6555); Loss of glycosylation at P140 (P = 0.7822); Loss of disorder (P = 0.8066)
7:117171103:A:C,P13569,I142L,0.72,Loss of catalytic residue at I142 (P = 0.2411); Gain of glycosylation at P140 (P = 0.5047); Loss of MoRF binding (P = 0.5596); Loss of stability (P = 0.5849); Gain of helix (P = 0.6868)
7:117171103:A:G,P13569,I142V,0.746,Loss of stability (P = 0.2803); Gain of catalytic residue at I142 (P = 0.4236); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.564); Gain of disorder (P = 0.7969)
7:117171103:A:T,P13569,I142F,0.78,Loss of stability (P = 0.1986); Gain of catalytic residue at H146 (P = 0.2535); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.5626); Gain of glycosylation at P140 (P = 0.5985)
7:117171104:T:A,P13569,I142N,0.783,Loss of stability (P = 0.0469); Loss of catalytic residue at L138 (P = 0.4049); Gain of disorder (P = 0.5221); Gain of MoRF binding (P = 0.5507); Gain of glycosylation at P140 (P = 0.6727)
7:117171104:T:C,P13569,I142T,0.753,Loss of stability (P = 0.0268); Gain of catalytic residue at I142 (P = 0.3054); Gain of glycosylation at I142 (P = 0.5302); Loss of MoRF binding (P = 0.5622); Gain of disorder (P = 0.5916)
7:117171104:T:G,P13569,I142S,0.727,Loss of stability (P = 0.0344); Gain of disorder (P = 0.2218); Gain of glycosylation at P140 (P = 0.4294); Loss of MoRF binding (P = 0.5639); Gain of catalytic residue at L138 (P = 0.5693)
7:117171105:T:G,P13569,I142M,0.72,Gain of catalytic residue at I142 (P = 0.1209); Loss of stability (P = 0.3479); Gain of glycosylation at P140 (P = 0.5509); Gain of MoRF binding (P = 0.558); Gain of helix (P = 0.6868)
7:117171106:T:A,P13569,F143I,0.815,Gain of catalytic residue at F143 (P = 0.3387); Loss of MoRF binding (P = 0.5117); Gain of helix (P = 0.5668); Loss of stability (P = 0.776); Gain of disorder (P = 0.7802)
7:117171106:T:C,P13569,F143L,0.769,Gain of catalytic residue at F143 (P = 0.2331); Loss of MoRF binding (P = 0.5083); Gain of helix (P = 0.5668); Loss of stability (P = 0.7107); Gain of disorder (P = 0.7462)
7:117171106:T:G,P13569,F143V,0.792,Gain of catalytic residue at F143 (P = 0.1589); Loss of stability (P = 0.3649); Gain of MoRF binding (P = 0.5066); Gain of helix (P = 0.5668); Gain of disorder (P = 0.7796)
7:117171107:T:A,P13569,F143Y,0.72,Gain of catalytic residue at F143 (P = 0.1223); Loss of stability (P = 0.3794); Gain of helix (P = 0.4875); Loss of MoRF binding (P = 0.5106); Gain of phosphorylation at F143 (P = 0.7564)
7:117171107:T:C,P13569,F143S,0.799,Gain of glycosylation at F143 (P = 0.0512); Gain of disorder (P = 0.1018); Loss of stability (P = 0.2135); Gain of catalytic residue at G144 (P = 0.4622); Gain of MoRF binding (P = 0.4863)
7:117171107:T:G,P13569,F143C,0.841,Gain of catalytic residue at F143 (P = 0.2404); Loss of stability (P = 0.3125); Loss of MoRF binding (P = 0.5046); Gain of helix (P = 0.5668); Loss of glycosylation at P140 (P = 0.7968)
7:117171108:T:A,P13569,F143L,0.769,Gain of catalytic residue at F143 (P = 0.2331); Loss of MoRF binding (P = 0.5083); Gain of helix (P = 0.5668); Loss of stability (P = 0.7107); Gain of disorder (P = 0.7462)
7:117171108:T:G,P13569,F143L,0.769,Gain of catalytic residue at F143 (P = 0.2331); Loss of MoRF binding (P = 0.5083); Gain of helix (P = 0.5668); Loss of stability (P = 0.7107); Gain of disorder (P = 0.7462)
7:117171109:G:A,P13569,G144S,0.724,Gain of catalytic residue at G144 (P = 0.2506); Gain of MoRF binding (P = 0.4187); Gain of helix (P = 0.5668); Loss of stability (P = 0.6424); Gain of disorder (P = 0.7311)
7:117171109:G:C,P13569,G144R,0.872,Gain of methylation at G144 (P = 0.0064); Gain of catalytic residue at G144 (P = 0.0547); Gain of MoRF binding (P = 0.0654); Gain of helix (P = 0.5668); Gain of disorder (P = 0.777)
7:117171109:G:T,P13569,G144C,0.765,Gain of catalytic residue at G144 (P = 0.1524); Loss of MoRF binding (P = 0.4609); Gain of helix (P = 0.5668); Gain of glycosylation at P140 (P = 0.7418); Loss of disorder (P = 0.7697)
7:117171110:G:A,P13569,G144D,0.837,Gain of catalytic residue at G144 (P = 0.0908); Loss of MoRF binding (P = 0.444); Gain of helix (P = 0.5668); Loss of stability (P = 0.7167); Loss of disorder (P = 0.7893)
7:117171110:G:C,P13569,G144A,0.754,Gain of catalytic residue at G144 (P = 0.099); Gain of MoRF binding (P = 0.461); Gain of helix (P = 0.5668); Gain of glycosylation at P140 (P = 0.7248); Loss of disorder (P = 0.7858)
7:117171110:G:T,P13569,G144V,0.77,Loss of catalytic residue at I142 (P = 0.2261); Gain of MoRF binding (P = 0.4249); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7744); Gain of glycosylation at P140 (P = 0.7945)
7:117171112:C:A,P13569,L145I,0.772,Gain of helix (P = 0.2294); Loss of stability (P = 0.2516); Loss of catalytic residue at L145 (P = 0.3387); Gain of MoRF binding (P = 0.3742); Gain of disorder (P = 0.7607)
7:117171112:C:G,P13569,L145V,0.758,Loss of stability (P = 0.177); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.3871); Gain of catalytic residue at H146 (P = 0.5296); Gain of disorder (P = 0.763)
7:117171112:C:T,P13569,L145F,0.765,Loss of stability (P = 0.0956); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.385); Loss of catalytic residue at M150 (P = 0.5654); Gain of disorder (P = 0.7591)
7:117171113:T:A,P13569,L145H,0.912,Loss of stability (P = 0.0175); Gain of helix (P = 0.1736); Gain of catalytic residue at H146 (P = 0.3325); Gain of disorder (P = 0.3711); Loss of MoRF binding (P = 0.3868)
7:117171113:T:C,P13569,L145P,0.89,Loss of stability (P = 0.0119); Gain of catalytic residue at G144 (P = 0.1354); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3666); Gain of disorder (P = 0.3713)
7:117171113:T:G,P13569,L145R,0.917,Gain of methylation at L145 (P = 0.0194); Loss of stability (P = 0.0325); Gain of MoRF binding (P = 0.1901); Gain of helix (P = 0.2294); Loss of catalytic residue at G149 (P = 0.4177)
7:117171115:C:A,P13569,H146N,0.787,Gain of catalytic residue at H146 (P = 0.0124); Gain of MoRF binding (P = 0.2934); Loss of stability (P = 0.5199); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7476)
7:117171115:C:G,P13569,H146D,0.784,Gain of catalytic residue at H146 (P = 0.0155); Loss of MoRF binding (P = 0.3298); Gain of helix (P = 0.5668); Loss of stability (P = 0.6699); Loss of disorder (P = 0.7514)
7:117171115:C:T,P13569,H146Y,0.814,Gain of catalytic residue at H146 (P = 0.0565); Gain of MoRF binding (P = 0.3538); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7353); Loss of stability (P = 0.7863)
7:117171116:A:C,P13569,H146P,0.887,Loss of stability (P = 0.3096); Loss of MoRF binding (P = 0.3246); Loss of catalytic residue at F143 (P = 0.4781); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7526)
7:117171116:A:G,P13569,H146R,0.975,Gain of MoRF binding (P = 0.0307); Gain of methylation at H146 (P = 0.036); Gain of catalytic residue at H146 (P = 0.1142); Loss of stability (P = 0.5469); Gain of helix (P = 0.5668)
7:117171116:A:T,P13569,H146L,0.782,Gain of catalytic residue at H146 (P = 0.1387); Gain of MoRF binding (P = 0.3535); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7351); Loss of loop (P = 0.8632)
7:117171117:T:A,P13569,H146Q,0.793,Gain of catalytic residue at H146 (P = 0.0342); Gain of MoRF binding (P = 0.3056); Gain of helix (P = 0.5668); Loss of stability (P = 0.6139); Loss of disorder (P = 0.7548)
7:117171117:T:G,P13569,H146Q,0.793,Gain of catalytic residue at H146 (P = 0.0342); Gain of MoRF binding (P = 0.3056); Gain of helix (P = 0.5668); Loss of stability (P = 0.6139); Loss of disorder (P = 0.7548)
7:117171118:C:A,P13569,H147N,0.528,Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2346); Gain of MoRF binding (P = 0.2486); Loss of helix (P = 0.5596); Loss of catalytic residue at F143 (P = 0.6812)
7:117171118:C:G,P13569,H147D,0.6,Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.2291); Loss of MoRF binding (P = 0.26); Loss of catalytic residue at F143 (P = 0.6574)
7:117171118:C:T,P13569,H147Y,0.589,Gain of MoRF binding (P = 0.2787); Gain of helix (P = 0.5668); Gain of catalytic residue at F143 (P = 0.6388); Loss of disorder (P = 0.7348); Gain of phosphorylation at H147 (P = 0.7945)
7:117171119:A:C,P13569,H147P,0.661,Loss of catalytic residue at H147 (P = 0.0427); Loss of MoRF binding (P = 0.2615); Gain of helix (P = 0.5668); Loss of stability (P = 0.6836); Loss of disorder (P = 0.7557)
7:117171119:A:G,P13569,H147R,0.578,Gain of MoRF binding (P = 0.0312); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2455); Gain of methylation at H147 (P = 0.3202); Loss of catalytic residue at F143 (P = 0.3817)
7:117171119:A:T,P13569,H147L,0.594,Gain of stability (P = 0.1765); Gain of MoRF binding (P = 0.2594); Gain of helix (P = 0.5668); Gain of catalytic residue at G144 (P = 0.6406); Loss of disorder (P = 0.7348)
7:117171120:C:A,P13569,H147Q,0.527,Loss of catalytic residue at H147 (P = 0.0605); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Gain of MoRF binding (P = 0.2623); Gain of helix (P = 0.5668)
7:117171120:C:G,P13569,H147Q,0.527,Loss of catalytic residue at H147 (P = 0.0605); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Gain of MoRF binding (P = 0.2623); Gain of helix (P = 0.5668)
7:117171121:A:C,P13569,I148L,0.499,Loss of MoRF binding (P = 0.2424); Loss of catalytic residue at G149 (P = 0.273); Gain of methylation at R153 (P = 0.3913); Loss of helix (P = 0.6555); Gain of disorder (P = 0.7077)
7:117171121:A:G,P13569,I148V,0.572,Loss of MoRF binding (P = 0.2528); Gain of methylation at R153 (P = 0.4004); Loss of helix (P = 0.5596); Loss of stability (P = 0.6039); Gain of catalytic residue at F143 (P = 0.616)
7:117171121:A:T,P13569,I148F,0.577,Loss of MoRF binding (P = 0.2546); Gain of methylation at R153 (P = 0.4075); Loss of catalytic residue at I148 (P = 0.4219); Loss of stability (P = 0.4701); Loss of helix (P = 0.5596)
7:117171122:T:A,P13569,I148N,0.847,Loss of stability (P = 0.092); Loss of MoRF binding (P = 0.224); Gain of disorder (P = 0.3695); Gain of methylation at R153 (P = 0.3996); Gain of catalytic residue at M150 (P = 0.4573)
7:117171122:T:G,P13569,I148S,0.668,Gain of glycosylation at I148 (P = 0.0396); Gain of disorder (P = 0.0615); Loss of stability (P = 0.1069); Loss of MoRF binding (P = 0.2245); Loss of catalytic residue at I148 (P = 0.291)
7:117171123:T:G,P13569,I148M,0.552,Loss of MoRF binding (P = 0.2396); Gain of methylation at R153 (P = 0.3909); Gain of disorder (P = 0.5501); Loss of helix (P = 0.5596); Gain of catalytic residue at M150 (P = 0.5756)
7:117171124:G:A,P13569,G149R,0.977,Gain of MoRF binding (P = 0.0153); Gain of methylation at G149 (P = 0.0242); Loss of catalytic residue at Q151 (P = 0.1125); Loss of stability (P = 0.561); Loss of helix (P = 0.6555)
7:117171124:G:C,P13569,G149R,0.977,Gain of MoRF binding (P = 0.0153); Gain of methylation at G149 (P = 0.0242); Loss of catalytic residue at Q151 (P = 0.1125); Loss of stability (P = 0.561); Loss of helix (P = 0.6555)
7:117171125:G:A,P13569,G149E,0.891,Loss of MoRF binding (P = 0.104); Loss of catalytic residue at Q151 (P = 0.1921); Loss of helix (P = 0.2271); Loss of methylation at R153 (P = 0.4517); Gain of loop (P = 0.4661)
7:117171125:G:C,P13569,G149A,0.915,Loss of MoRF binding (P = 0.2041); Loss of catalytic residue at I148 (P = 0.2646); Loss of stability (P = 0.4016); Loss of methylation at R153 (P = 0.4535); Gain of helix (P = 0.5668)
7:117171125:G:T,P13569,G149V,0.967,Gain of MoRF binding (P = 0.1777); Loss of catalytic residue at I148 (P = 0.2278); Loss of methylation at R153 (P = 0.4464); Gain of helix (P = 0.5668); Loss of stability (P = 0.6351)
7:117171127:A:C,P13569,M150L,0.724,Gain of catalytic residue at M150 (P = 0.1297); Loss of MoRF binding (P = 0.1544); Loss of methylation at R153 (P = 0.4568); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7483)
7:117171127:A:G,P13569,M150V,0.719,Gain of catalytic residue at M150 (P = 0.0783); Gain of MoRF binding (P = 0.1637); Loss of methylation at R153 (P = 0.461); Gain of helix (P = 0.5668); Loss of stability (P = 0.6052)
7:117171127:A:T,P13569,M150L,0.724,Gain of catalytic residue at M150 (P = 0.1297); Loss of MoRF binding (P = 0.1544); Loss of methylation at R153 (P = 0.4568); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7483)
7:117171128:T:A,P13569,M150K,0.912,Gain of MoRF binding (P = 0.0359); Gain of glycosylation at M150 (P = 0.0613); Gain of ubiquitination at M150 (P = 0.0797); Gain of solvent accessibility (P = 0.0837); Loss of catalytic residue at G149 (P = 0.0846)
7:117171128:T:C,P13569,M150T,0.715,Gain of catalytic residue at M150 (P = 0.0547); Gain of MoRF binding (P = 0.1651); Loss of stability (P = 0.2155); Loss of methylation at R153 (P = 0.4555); Gain of glycosylation at M150 (P = 0.496)
7:117171128:T:G,P13569,M150R,0.817,Gain of MoRF binding (P = 0.022); Gain of methylation at M150 (P = 0.055); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at Q151 (P = 0.2271)
7:117171129:G:A,P13569,M150I,0.729,Loss of MoRF binding (P = 0.1639); Gain of catalytic residue at M150 (P = 0.1752); Loss of methylation at R153 (P = 0.4479); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7444)
7:117171129:G:C,P13569,M150I,0.729,Loss of MoRF binding (P = 0.1639); Gain of catalytic residue at M150 (P = 0.1752); Loss of methylation at R153 (P = 0.4479); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7444)
7:117171129:G:T,P13569,M150I,0.729,Loss of MoRF binding (P = 0.1639); Gain of catalytic residue at M150 (P = 0.1752); Loss of methylation at R153 (P = 0.4479); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7444)
7:117171130:C:G,P13569,Q151E,0.707,Loss of MoRF binding (P = 0.0616); Gain of methylation at R153 (P = 0.3691); Loss of catalytic residue at R153 (P = 0.4294); Gain of helix (P = 0.5668); Gain of disorder (P = 0.6414)
7:117171131:A:C,P13569,Q151P,0.775,Loss of MoRF binding (P = 0.0762); Loss of catalytic residue at Q151 (P = 0.0781); Loss of stability (P = 0.3144); Loss of solvent accessibility (P = 0.3368); Gain of methylation at R153 (P = 0.3625)
7:117171131:A:G,P13569,Q151R,0.687,Gain of methylation at Q151 (P = 0.0264); Gain of MoRF binding (P = 0.0276); Gain of solvent accessibility (P = 0.4496); Loss of catalytic residue at R153 (P = 0.4779); Loss of stability (P = 0.5595)
7:117171131:A:T,P13569,Q151L,0.702,Loss of catalytic residue at Q151 (P = 0.0704); Gain of MoRF binding (P = 0.1141); Loss of solvent accessibility (P = 0.3368); Loss of relative solvent accessibility (P = 0.4508); Gain of methylation at R153 (P = 0.4546)
7:117171132:G:C,P13569,Q151H,0.706,Loss of MoRF binding (P = 0.1233); Gain of methylation at R153 (P = 0.1635); Loss of solvent accessibility (P = 0.3368); Loss of stability (P = 0.4203); Loss of relative solvent accessibility (P = 0.4508)
7:117171132:G:T,P13569,Q151H,0.706,Loss of MoRF binding (P = 0.1233); Gain of methylation at R153 (P = 0.1635); Loss of solvent accessibility (P = 0.3368); Loss of stability (P = 0.4203); Loss of relative solvent accessibility (P = 0.4508)
7:117171133:A:C,P13569,M152L,0.893,Gain of MoRF binding (P = 0.1255); Loss of methylation at R153 (P = 0.4573); Gain of helix (P = 0.5668); Gain of catalytic residue at M152 (P = 0.6672); Loss of disorder (P = 0.7483)
7:117171133:A:G,P13569,M152V,0.88,Gain of catalytic residue at M152 (P = 0.0055); Gain of MoRF binding (P = 0.1041); Gain of methylation at R153 (P = 0.438); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7445)
7:117171133:A:T,P13569,M152L,0.893,Gain of MoRF binding (P = 0.1255); Loss of methylation at R153 (P = 0.4573); Gain of helix (P = 0.5668); Gain of catalytic residue at M152 (P = 0.6672); Loss of disorder (P = 0.7483)
7:117171134:T:A,P13569,M152K,0.919,Gain of MoRF binding (P = 0.0557); Gain of ubiquitination at M152 (P = 0.068); Gain of catalytic residue at M152 (P = 0.0791); Loss of stability (P = 0.1584); Gain of glycosylation at M152 (P = 0.2676)
7:117171134:T:C,P13569,M152T,0.807,Gain of catalytic residue at M152 (P = 0.0956); Loss of MoRF binding (P = 0.1068); Loss of stability (P = 0.3114); Loss of methylation at R153 (P = 0.4504); Loss of helix (P = 0.5596)
7:117171134:T:G,P13569,M152R,0.971,Gain of MoRF binding (P = 0.05); Gain of catalytic residue at M152 (P = 0.1548); Gain of methylation at M152 (P = 0.3207); Loss of stability (P = 0.4397); Gain of helix (P = 0.5668)
7:117171135:G:A,P13569,M152I,0.825,Gain of MoRF binding (P = 0.0947); Loss of methylation at R153 (P = 0.4383); Gain of catalytic residue at M152 (P = 0.49); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7442)
7:117171135:G:C,P13569,M152I,0.825,Gain of MoRF binding (P = 0.0947); Loss of methylation at R153 (P = 0.4383); Gain of catalytic residue at M152 (P = 0.49); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7442)
7:117171135:G:T,P13569,M152I,0.825,Gain of MoRF binding (P = 0.0947); Loss of methylation at R153 (P = 0.4383); Gain of catalytic residue at M152 (P = 0.49); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7442)
7:117171136:A:G,P13569,R153G,0.772,Loss of MoRF binding (P = 0.0329); Loss of stability (P = 0.2317); Loss of catalytic residue at R153 (P = 0.2525); Loss of methylation at R153 (P = 0.3904); Gain of helix (P = 0.5668)
7:117171137:G:C,P13569,R153T,0.789,Loss of MoRF binding (P = 0.0348); Gain of catalytic residue at R153 (P = 0.2758); Loss of methylation at R153 (P = 0.3904); Loss of helix (P = 0.5596); Gain of glycosylation at R153 (P = 0.6357)
7:117171137:G:T,P13569,R153I,0.741,Loss of MoRF binding (P = 0.0447); Loss of catalytic residue at R153 (P = 0.1187); Loss of helix (P = 0.2271); Gain of stability (P = 0.3886); Loss of methylation at R153 (P = 0.3904)
7:117171138:A:C,P13569,R153S,0.784,Loss of MoRF binding (P = 0.0345); Loss of helix (P = 0.2271); Loss of methylation at R153 (P = 0.3904); Gain of catalytic residue at R153 (P = 0.3923); Gain of phosphorylation at R153 (P = 0.5781)
7:117171138:A:T,P13569,R153S,0.784,Loss of MoRF binding (P = 0.0345); Loss of helix (P = 0.2271); Loss of methylation at R153 (P = 0.3904); Gain of catalytic residue at R153 (P = 0.3923); Gain of phosphorylation at R153 (P = 0.5781)
7:117171139:A:C,P13569,I154L,0.647,Loss of catalytic residue at L159 (P = 0.039); Loss of MoRF binding (P = 0.1241); Gain of methylation at R153 (P = 0.2516); Gain of phosphorylation at S158 (P = 0.586); Gain of disorder (P = 0.7074)
7:117171139:A:G,P13569,I154V,0.638,Loss of catalytic residue at L159 (P = 0.039); Gain of relative solvent accessibility (P = 0.1259); Gain of MoRF binding (P = 0.1418); Gain of methylation at R153 (P = 0.1645); Gain of solvent accessibility (P = 0.2601)
7:117171139:A:T,P13569,I154L,0.647,Loss of catalytic residue at L159 (P = 0.039); Loss of MoRF binding (P = 0.1241); Gain of methylation at R153 (P = 0.2516); Gain of phosphorylation at S158 (P = 0.586); Gain of disorder (P = 0.7074)
7:117171140:T:A,P13569,I154K,0.684,Gain of MoRF binding (P = 0.0287); Loss of catalytic residue at L159 (P = 0.0388); Gain of ubiquitination at I154 (P = 0.0539); Loss of stability (P = 0.0594); Gain of solvent accessibility (P = 0.0837)
7:117171140:T:G,P13569,I154R,0.707,Gain of MoRF binding (P = 0.0181); Loss of catalytic residue at L159 (P = 0.0373); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of stability (P = 0.1705)
7:117171141:A:G,P13569,I154M,0.624,Loss of catalytic residue at I154 (P = 0.0098); Loss of MoRF binding (P = 0.1316); Gain of methylation at R153 (P = 0.149); Loss of stability (P = 0.5456); Gain of disorder (P = 0.5484)
7:117171142:G:A,P13569,A155T,0.744,Gain of MoRF binding (P = 0.1225); Loss of stability (P = 0.2017); Loss of catalytic residue at A155 (P = 0.2646); Loss of methylation at R153 (P = 0.4591); Gain of phosphorylation at A155 (P = 0.561)
7:117171142:G:C,P13569,A155P,0.939,Loss of MoRF binding (P = 0.0631); Loss of stability (P = 0.1524); Gain of catalytic residue at R153 (P = 0.4308); Loss of methylation at R153 (P = 0.4543); Gain of phosphorylation at S158 (P = 0.5588)
7:117171142:G:T,P13569,A155S,0.718,Gain of MoRF binding (P = 0.1252); Gain of relative solvent accessibility (P = 0.1259); Loss of stability (P = 0.2697); Gain of solvent accessibility (P = 0.28); Gain of phosphorylation at A155 (P = 0.3716)
7:117171143:C:A,P13569,A155D,0.879,Loss of MoRF binding (P = 0.0719); Gain of relative solvent accessibility (P = 0.1259); Loss of catalytic residue at S158 (P = 0.1545); Gain of solvent accessibility (P = 0.2291); Loss of stability (P = 0.424)
7:117171143:C:G,P13569,A155G,0.779,Gain of catalytic residue at M156 (P = 0.0366); Loss of stability (P = 0.0567); Gain of relative solvent accessibility (P = 0.1259); Gain of MoRF binding (P = 0.141); Gain of solvent accessibility (P = 0.367)
7:117171143:C:T,P13569,A155V,0.82,Gain of MoRF binding (P = 0.0921); Loss of methylation at R153 (P = 0.45); Loss of stability (P = 0.5607); Loss of phosphorylation at S158 (P = 0.6441); Gain of catalytic residue at R153 (P = 0.6574)
7:117171145:A:C,P13569,M156L,0.552,Gain of catalytic residue at M156 (P = 0.0186); Loss of MoRF binding (P = 0.1336); Loss of methylation at R153 (P = 0.4603); Loss of stability (P = 0.5214); Loss of phosphorylation at S158 (P = 0.6423)
7:117171145:A:T,P13569,M156L,0.552,Gain of catalytic residue at M156 (P = 0.0186); Loss of MoRF binding (P = 0.1336); Loss of methylation at R153 (P = 0.4603); Loss of stability (P = 0.5214); Loss of phosphorylation at S158 (P = 0.6423)
7:117171146:T:A,P13569,M156K,0.896,Loss of stability (P = 0.0074); Gain of MoRF binding (P = 0.0302); Gain of ubiquitination at M156 (P = 0.1767); Loss of catalytic residue at S158 (P = 0.2156); Loss of methylation at R153 (P = 0.4546)
7:117171146:T:C,P13569,M156T,0.733,Loss of stability (P = 0.0343); Loss of MoRF binding (P = 0.1281); Gain of catalytic residue at M156 (P = 0.2881); Gain of methylation at R153 (P = 0.4342); Gain of disorder (P = 0.5994)
7:117171146:T:G,P13569,M156R,0.901,Gain of MoRF binding (P = 0.0174); Loss of stability (P = 0.0605); Gain of methylation at M156 (P = 0.0775); Gain of phosphorylation at S158 (P = 0.12); Gain of catalytic residue at M156 (P = 0.2027)
7:117171147:G:A,P13569,M156I,0.614,Gain of MoRF binding (P = 0.1267); Gain of catalytic residue at M156 (P = 0.2076); Loss of stability (P = 0.2882); Loss of methylation at R153 (P = 0.4498); Loss of phosphorylation at S158 (P = 0.6488)
7:117171147:G:C,P13569,M156I,0.614,Gain of MoRF binding (P = 0.1267); Gain of catalytic residue at M156 (P = 0.2076); Loss of stability (P = 0.2882); Loss of methylation at R153 (P = 0.4498); Loss of phosphorylation at S158 (P = 0.6488)
7:117171147:G:T,P13569,M156I,0.614,Gain of MoRF binding (P = 0.1267); Gain of catalytic residue at M156 (P = 0.2076); Loss of stability (P = 0.2882); Loss of methylation at R153 (P = 0.4498); Loss of phosphorylation at S158 (P = 0.6488)
7:117171148:T:A,P13569,F157I,0.677,Gain of MoRF binding (P = 0.142); Gain of ubiquitination at K162 (P = 0.3791); Gain of methylation at K162 (P = 0.4008); Gain of phosphorylation at S158 (P = 0.504); Gain of disorder (P = 0.5523)
7:117171148:T:C,P13569,F157L,0.695,Loss of MoRF binding (P = 0.1233); Gain of ubiquitination at K162 (P = 0.3712); Gain of methylation at R153 (P = 0.4327); Gain of phosphorylation at S158 (P = 0.4431); Gain of disorder (P = 0.4566)
7:117171148:T:G,P13569,F157V,0.705,Gain of catalytic residue at F157 (P = 0.0758); Gain of MoRF binding (P = 0.1327); Gain of ubiquitination at K162 (P = 0.3791); Loss of stability (P = 0.4); Gain of methylation at R153 (P = 0.4333)
7:117171149:T:A,P13569,F157Y,0.8,Gain of catalytic residue at F157 (P = 0.0468); Loss of MoRF binding (P = 0.0946); Loss of stability (P = 0.2186); Gain of methylation at K162 (P = 0.2631); Gain of ubiquitination at K162 (P = 0.3791)
7:117171149:T:C,P13569,F157S,0.723,Gain of disorder (P = 0.0262); Loss of stability (P = 0.105); Loss of MoRF binding (P = 0.1325); Gain of phosphorylation at S158 (P = 0.1738); Gain of ubiquitination at K162 (P = 0.386)
7:117171149:T:G,P13569,F157C,0.896,Loss of MoRF binding (P = 0.09); Gain of catalytic residue at F157 (P = 0.1051); Loss of stability (P = 0.1858); Gain of ubiquitination at K162 (P = 0.3791); Gain of methylation at K162 (P = 0.4549)
7:117171150:T:A,P13569,F157L,0.695,Loss of MoRF binding (P = 0.1233); Gain of ubiquitination at K162 (P = 0.3712); Gain of methylation at R153 (P = 0.4327); Gain of phosphorylation at S158 (P = 0.4431); Gain of disorder (P = 0.4566)
7:117171150:T:G,P13569,F157L,0.695,Loss of MoRF binding (P = 0.1233); Gain of ubiquitination at K162 (P = 0.3712); Gain of methylation at R153 (P = 0.4327); Gain of phosphorylation at S158 (P = 0.4431); Gain of disorder (P = 0.4566)
7:117171151:A:C,P13569,S158R,0.863,Gain of MoRF binding (P = 0.0202); Gain of solvent accessibility (P = 0.2987); Gain of ubiquitination at K162 (P = 0.3927); Gain of methylation at K163 (P = 0.4037); Loss of catalytic residue at S158 (P = 0.4188)
7:117171151:A:G,P13569,S158G,0.648,Loss of catalytic residue at S158 (P = 0.1122); Loss of MoRF binding (P = 0.1245); Loss of stability (P = 0.1462); Loss of ubiquitination at K162 (P = 0.3929); Loss of disorder (P = 0.4317)
7:117171151:A:T,P13569,S158C,0.663,Gain of catalytic residue at M156 (P = 5e-04); Loss of MoRF binding (P = 0.0911); Loss of disorder (P = 0.2369); Gain of ubiquitination at K162 (P = 0.3791); Loss of methylation at K163 (P = 0.4453)
7:117171152:G:A,P13569,S158N,0.666,Gain of MoRF binding (P = 0.1268); Gain of relative solvent accessibility (P = 0.2629); Gain of solvent accessibility (P = 0.3194); Loss of ubiquitination at K162 (P = 0.3916); Loss of disorder (P = 0.4059)
7:117171152:G:C,P13569,S158T,0.657,Loss of MoRF binding (P = 0.1297); Loss of catalytic residue at S158 (P = 0.318); Gain of methylation at K163 (P = 0.3865); Loss of ubiquitination at K162 (P = 0.3921); Loss of disorder (P = 0.4241)
7:117171152:G:T,P13569,S158I,0.661,Loss of catalytic residue at S158 (P = 0.0535); Gain of MoRF binding (P = 0.1062); Loss of disorder (P = 0.2754); Gain of methylation at K163 (P = 0.3623); Gain of ubiquitination at K162 (P = 0.3712)
7:117171153:T:A,P13569,S158R,0.863,Gain of MoRF binding (P = 0.0202); Gain of solvent accessibility (P = 0.2987); Gain of ubiquitination at K162 (P = 0.3927); Gain of methylation at K163 (P = 0.4037); Loss of catalytic residue at S158 (P = 0.4188)
7:117171153:T:G,P13569,S158R,0.863,Gain of MoRF binding (P = 0.0202); Gain of solvent accessibility (P = 0.2987); Gain of ubiquitination at K162 (P = 0.3927); Gain of methylation at K163 (P = 0.4037); Loss of catalytic residue at S158 (P = 0.4188)
7:117171154:T:A,P13569,L159M,0.557,Gain of catalytic residue at M156 (P = 0.0455); Gain of MoRF binding (P = 0.126); Gain of phosphorylation at T164 (P = 0.1421); Gain of disorder (P = 0.2126); Gain of methylation at K163 (P = 0.3536)
7:117171154:T:G,P13569,L159V,0.624,Gain of MoRF binding (P = 0.1192); Gain of methylation at K163 (P = 0.2906); Loss of stability (P = 0.3112); Loss of ubiquitination at K162 (P = 0.3929); Loss of catalytic residue at L159 (P = 0.4067)
7:117171155:T:C,P13569,L159S,0.802,Gain of disorder (P = 0.0138); Loss of stability (P = 0.0531); Loss of catalytic residue at L159 (P = 0.0854); Gain of MoRF binding (P = 0.1321); Gain of relative solvent accessibility (P = 0.1571)
7:117171155:T:G,P13569,L159W,0.613,Gain of MoRF binding (P = 0.05); Loss of stability (P = 0.1905); Gain of relative solvent accessibility (P = 0.2751); Gain of solvent accessibility (P = 0.28); Loss of disorder (P = 0.3084)
7:117171156:G:C,P13569,L159F,0.577,Loss of catalytic residue at L159 (P = 0.0404); Gain of MoRF binding (P = 0.1304); Gain of methylation at K163 (P = 0.3083); Loss of ubiquitination at K162 (P = 0.3929); Loss of disorder (P = 0.4037)
7:117171156:G:T,P13569,L159F,0.577,Loss of catalytic residue at L159 (P = 0.0404); Gain of MoRF binding (P = 0.1304); Gain of methylation at K163 (P = 0.3083); Loss of ubiquitination at K162 (P = 0.3929); Loss of disorder (P = 0.4037)
7:117171157:A:C,P13569,I160L,0.569,Loss of catalytic residue at I160 (P = 0.0087); Loss of MoRF binding (P = 0.1079); Gain of disorder (P = 0.1545); Loss of stability (P = 0.1921); Loss of ubiquitination at K162 (P = 0.3921)
7:117171157:A:G,P13569,I160V,0.572,Loss of catalytic residue at L165 (P = 0.0269); Loss of MoRF binding (P = 0.1415); Gain of disorder (P = 0.1805); Loss of stability (P = 0.2788); Loss of ubiquitination at K162 (P = 0.3921)
7:117171157:A:T,P13569,I160F,0.594,Loss of catalytic residue at I160 (P = 0.0036); Loss of MoRF binding (P = 0.1301); Loss of stability (P = 0.1477); Gain of disorder (P = 0.2841); Gain of ubiquitination at K162 (P = 0.3927)
7:117171158:T:A,P13569,I160N,0.656,Loss of stability (P = 0.0172); Loss of catalytic residue at I160 (P = 0.023); Gain of disorder (P = 0.0269); Gain of MoRF binding (P = 0.1204); Loss of ubiquitination at K162 (P = 0.3921)
7:117171158:T:C,P13569,I160T,0.669,Loss of stability (P = 0.0046); Gain of disorder (P = 0.0204); Loss of catalytic residue at I160 (P = 0.0215); Gain of phosphorylation at I160 (P = 0.0514); Loss of MoRF binding (P = 0.1187)
7:117171158:T:G,P13569,I160S,0.703,Gain of disorder (P = 0.0025); Loss of stability (P = 0.0063); Loss of catalytic residue at L165 (P = 0.0269); Loss of MoRF binding (P = 0.1215); Gain of phosphorylation at T164 (P = 0.1441)
7:117171159:T:G,P13569,I160M,0.587,Loss of catalytic residue at L165 (P = 0.0273); Gain of disorder (P = 0.0576); Loss of stability (P = 0.0924); Loss of MoRF binding (P = 0.1384); Gain of phosphorylation at T164 (P = 0.3408)
7:117171160:T:A,P13569,Y161N,0.954,Loss of stability (P = 0.0361); Gain of catalytic residue at M156 (P = 0.0431); Gain of disorder (P = 0.0529); Gain of MoRF binding (P = 0.1227); Gain of methylation at K163 (P = 0.2483)
7:117171160:T:C,P13569,Y161H,0.924,Gain of disorder (P = 0.0251); Loss of stability (P = 0.0346); Gain of catalytic residue at M156 (P = 0.044); Loss of MoRF binding (P = 0.1303); Gain of methylation at K163 (P = 0.2634)
7:117171160:T:G,P13569,Y161D,0.971,Gain of disorder (P = 0.0266); Gain of catalytic residue at M156 (P = 0.0422); Loss of MoRF binding (P = 0.064); Loss of stability (P = 0.0866); Gain of phosphorylation at T164 (P = 0.1816)
7:117171161:A:C,P13569,Y161S,0.972,Gain of disorder (P = 0.0049); Loss of stability (P = 0.0205); Gain of MoRF binding (P = 0.1325); Gain of catalytic residue at K162 (P = 0.1854); Gain of phosphorylation at T164 (P = 0.2146)
7:117171161:A:G,P13569,Y161C,0.895,Gain of methylation at K162 (P = 0.0148); Loss of stability (P = 0.1017); Loss of MoRF binding (P = 0.1213); Loss of catalytic residue at I160 (P = 0.2524); Loss of disorder (P = 0.315)
7:117171161:A:T,P13569,Y161F,0.777,Gain of methylation at K162 (P = 0.0394); Gain of MoRF binding (P = 0.0838); Loss of catalytic residue at I160 (P = 0.234); Loss of stability (P = 0.2733); Gain of loop (P = 0.2754)
7:117171163:A:C,P13569,K162Q,0.678,Loss of MoRF binding (P = 0.0448); Loss of helix (P = 0.2271); Loss of disorder (P = 0.3251); Gain of methylation at K163 (P = 0.3679); Loss of ubiquitination at K162 (P = 0.384)
7:117171163:A:G,P13569,K162E,0.846,Loss of MoRF binding (P = 7e-04); Gain of ubiquitination at K163 (P = 0.0563); Gain of catalytic residue at K162 (P = 0.1506); Gain of helix (P = 0.2059); Loss of loop (P = 0.3664)
7:117171164:A:C,P13569,K162T,0.678,Loss of MoRF binding (P = 0.0352); Loss of helix (P = 0.2271); Loss of stability (P = 0.2401); Gain of catalytic residue at K163 (P = 0.2814); Loss of disorder (P = 0.3011)
7:117171164:A:G,P13569,K162R,0.484,Gain of MoRF binding (P = 0.0791); Gain of phosphorylation at T164 (P = 0.1736); Loss of helix (P = 0.2271); Loss of disorder (P = 0.317); Gain of catalytic residue at K163 (P = 0.3594)
7:117171164:A:T,P13569,K162M,0.715,Loss of MoRF binding (P = 0.0477); Loss of solvent accessibility (P = 0.1551); Loss of disorder (P = 0.1828); Loss of relative solvent accessibility (P = 0.3219); Gain of ubiquitination at K163 (P = 0.3295)
7:117171165:G:C,P13569,K162N,0.672,Loss of MoRF binding (P = 0.0482); Loss of disorder (P = 0.2767); Loss of loop (P = 0.3664); Loss of ubiquitination at K162 (P = 0.384); Loss of helix (P = 0.3949)
7:117171165:G:T,P13569,K162N,0.672,Loss of MoRF binding (P = 0.0482); Loss of disorder (P = 0.2767); Loss of loop (P = 0.3664); Loss of ubiquitination at K162 (P = 0.384); Loss of helix (P = 0.3949)
7:117171166:A:C,P13569,K163Q,0.473,Loss of MoRF binding (P = 0.0516); Loss of phosphorylation at S168 (P = 0.1599); Gain of helix (P = 0.2294); Loss of disorder (P = 0.3031); Loss of methylation at K163 (P = 0.3613)
7:117171166:A:G,P13569,K163E,0.478,Loss of MoRF binding (P = 0.001); Gain of ubiquitination at K162 (P = 0.187); Loss of phosphorylation at S168 (P = 0.2228); Gain of relative solvent accessibility (P = 0.2629); Gain of solvent accessibility (P = 0.3602)
7:117171167:A:C,P13569,K163T,0.513,Loss of MoRF binding (P = 0.0478); Loss of phosphorylation at S168 (P = 0.151); Gain of catalytic residue at K162 (P = 0.1935); Gain of helix (P = 0.2294); Loss of disorder (P = 0.2735)
7:117171167:A:G,P13569,K163R,0.421,Gain of MoRF binding (P = 0.0893); Gain of solvent accessibility (P = 0.2192); Gain of phosphorylation at S168 (P = 0.2272); Gain of helix (P = 0.2294); Gain of relative solvent accessibility (P = 0.2629)
7:117171167:A:T,P13569,K163M,0.517,Loss of MoRF binding (P = 0.0648); Loss of disorder (P = 0.1514); Loss of phosphorylation at S168 (P = 0.177); Gain of helix (P = 0.2294); Gain of ubiquitination at K162 (P = 0.3247)
7:117171168:G:C,P13569,K163N,0.495,Loss of MoRF binding (P = 0.0545); Loss of phosphorylation at S168 (P = 0.1319); Loss of disorder (P = 0.2606); Loss of methylation at K163 (P = 0.3613); Gain of ubiquitination at K166 (P = 0.3719)
7:117171168:G:T,P13569,K163N,0.495,Loss of MoRF binding (P = 0.0545); Loss of phosphorylation at S168 (P = 0.1319); Loss of disorder (P = 0.2606); Loss of methylation at K163 (P = 0.3613); Gain of ubiquitination at K166 (P = 0.3719)
7:117174330:A:C,P13569,T164P,0.811,Loss of MoRF binding (P = 0.0616); Gain of disorder (P = 0.1143); Gain of glycosylation at T164 (P = 0.1252); Gain of phosphorylation at S168 (P = 0.1525); Gain of methylation at K163 (P = 0.2015)
7:117174330:A:T,P13569,T164S,0.676,Gain of disorder (P = 0.0293); Gain of phosphorylation at S168 (P = 0.1095); Loss of MoRF binding (P = 0.1576); Gain of loop (P = 0.2045); Gain of methylation at K163 (P = 0.3299)
7:117174331:C:A,P13569,T164N,0.601,Loss of MoRF binding (P = 0.1609); Gain of disorder (P = 0.2053); Gain of catalytic residue at K162 (P = 0.2193); Gain of phosphorylation at S168 (P = 0.2567); Loss of ubiquitination at K162 (P = 0.3921)
7:117174331:C:G,P13569,T164S,0.676,Gain of disorder (P = 0.0293); Gain of phosphorylation at S168 (P = 0.1095); Loss of MoRF binding (P = 0.1576); Gain of loop (P = 0.2045); Gain of methylation at K163 (P = 0.3299)
7:117174331:C:T,P13569,T164I,0.519,Gain of MoRF binding (P = 0.0975); Loss of disorder (P = 0.1418); Gain of loop (P = 0.2045); Gain of helix (P = 0.2294); Loss of phosphorylation at S168 (P = 0.2588)
7:117174333:T:A,P13569,L165I,0.698,Gain of MoRF binding (P = 0.1076); Loss of stability (P = 0.1828); Loss of phosphorylation at S168 (P = 0.1856); Gain of methylation at K163 (P = 0.2543); Loss of disorder (P = 0.3002)
7:117174333:T:G,P13569,L165V,0.708,Loss of catalytic residue at L165 (P = 0.007); Loss of stability (P = 0.0777); Gain of MoRF binding (P = 0.1286); Loss of phosphorylation at S168 (P = 0.2055); Gain of helix (P = 0.2294)
7:117174334:T:C,P13569,L165S,0.935,Gain of disorder (P = 0.0017); Loss of stability (P = 0.0047); Loss of catalytic residue at L165 (P = 0.0064); Gain of methylation at K163 (P = 0.0879); Gain of phosphorylation at S168 (P = 0.1209)
7:117174335:A:C,P13569,L165F,0.688,Loss of catalytic residue at L165 (P = 0.0107); Loss of stability (P = 0.0948); Gain of MoRF binding (P = 0.12); Gain of methylation at K166 (P = 0.1257); Loss of phosphorylation at S168 (P = 0.1584)
7:117174335:A:T,P13569,L165F,0.688,Loss of catalytic residue at L165 (P = 0.0107); Loss of stability (P = 0.0948); Gain of MoRF binding (P = 0.12); Gain of methylation at K166 (P = 0.1257); Loss of phosphorylation at S168 (P = 0.1584)
7:117174336:A:C,P13569,K166Q,0.605,Loss of MoRF binding (P = 0.0378); Loss of phosphorylation at S168 (P = 0.1454); Gain of sheet (P = 0.1945); Loss of disorder (P = 0.2257); Loss of methylation at R170 (P = 0.2578)
7:117174336:A:G,P13569,K166E,0.825,Loss of MoRF binding (P = 6e-04); Gain of ubiquitination at K163 (P = 0.0716); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294); Loss of phosphorylation at S168 (P = 0.2369)
7:117174337:A:C,P13569,K166T,0.639,Loss of MoRF binding (P = 0.0203); Loss of phosphorylation at S168 (P = 0.155); Loss of disorder (P = 0.1758); Gain of catalytic residue at K162 (P = 0.2004); Loss of loop (P = 0.2237)
7:117174337:A:G,P13569,K166R,0.48,Gain of MoRF binding (P = 0.0714); Gain of phosphorylation at S168 (P = 0.0834); Gain of methylation at R170 (P = 0.1766); Loss of disorder (P = 0.1991); Gain of catalytic residue at K166 (P = 0.211)
7:117174337:A:T,P13569,K166M,0.657,Loss of MoRF binding (P = 0.0247); Loss of disorder (P = 0.086); Loss of phosphorylation at S168 (P = 0.1707); Gain of catalytic residue at K162 (P = 0.1731); Gain of helix (P = 0.2294)
7:117174338:G:C,P13569,K166N,0.611,Loss of MoRF binding (P = 0.0388); Loss of phosphorylation at S168 (P = 0.1115); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1997); Loss of loop (P = 0.2237)
7:117174338:G:T,P13569,K166N,0.611,Loss of MoRF binding (P = 0.0388); Loss of phosphorylation at S168 (P = 0.1115); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1997); Loss of loop (P = 0.2237)
7:117174339:C:A,P13569,L167M,0.559,Gain of MoRF binding (P = 0.1055); Gain of disorder (P = 0.1727); Gain of sheet (P = 0.1945); Gain of phosphorylation at S169 (P = 0.2143); Loss of helix (P = 0.2271)
7:117174339:C:G,P13569,L167V,0.568,Gain of MoRF binding (P = 0.1142); Loss of helix (P = 0.1706); Loss of phosphorylation at S168 (P = 0.2477); Gain of methylation at R170 (P = 0.257); Gain of loop (P = 0.2754)
7:117174340:T:A,P13569,L167Q,0.685,Gain of disorder (P = 0.0149); Gain of methylation at K162 (P = 0.0755); Loss of MoRF binding (P = 0.1273); Loss of loop (P = 0.2237); Loss of helix (P = 0.2271)
7:117174340:T:C,P13569,L167P,0.767,Gain of disorder (P = 0.0112); Loss of MoRF binding (P = 0.0489); Gain of methylation at K163 (P = 0.05); Gain of glycosylation at L167 (P = 0.0582); Gain of phosphorylation at S169 (P = 0.1333)
7:117174340:T:G,P13569,L167R,0.743,Gain of disorder (P = 0.0171); Gain of MoRF binding (P = 0.0384); Gain of phosphorylation at S169 (P = 0.0525); Gain of methylation at K163 (P = 0.0628); Gain of helix (P = 0.2059)
7:117174342:T:A,P13569,S168T,0.539,Loss of phosphorylation at S168 (P = 0.0773); Gain of MoRF binding (P = 0.1285); Loss of disorder (P = 0.1673); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117174342:T:C,P13569,S168P,0.698,Loss of phosphorylation at S168 (P = 0.0553); Loss of MoRF binding (P = 0.0568); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117174342:T:G,P13569,S168A,0.552,Loss of phosphorylation at S168 (P = 0.0553); Loss of disorder (P = 0.1038); Gain of MoRF binding (P = 0.1115); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117174343:C:T,P13569,S168L,0.578,Loss of phosphorylation at S168 (P = 0.0553); Loss of disorder (P = 0.0659); Gain of MoRF binding (P = 0.0972); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117174345:A:C,P13569,S169R,0.706,Gain of MoRF binding (P = 0.0275); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S168 (P = 0.1065); Loss of ubiquitination at K174 (P = 0.1278)
7:117174345:A:G,P13569,S169G,0.64,Gain of methylation at R170 (P = 0.05); Gain of glycosylation at S168 (P = 0.103); Loss of stability (P = 0.1219); Gain of MoRF binding (P = 0.1348); Loss of phosphorylation at S169 (P = 0.1704)
7:117174345:A:T,P13569,S169C,0.674,Loss of disorder (P = 0.0437); Loss of phosphorylation at S168 (P = 0.1136); Loss of MoRF binding (P = 0.1151); Gain of ubiquitination at K174 (P = 0.1696); Gain of catalytic residue at V171 (P = 0.2044)
7:117174346:G:A,P13569,S169N,0.526,Gain of MoRF binding (P = 0.1145); Loss of phosphorylation at S168 (P = 0.1227); Loss of disorder (P = 0.191); Loss of ubiquitination at K174 (P = 0.1982); Gain of loop (P = 0.2045)
7:117174346:G:C,P13569,S169T,0.657,Gain of MoRF binding (P = 0.1292); Loss of phosphorylation at S168 (P = 0.1608); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1768); Gain of loop (P = 0.2045)
7:117174346:G:T,P13569,S169I,0.661,Loss of disorder (P = 0.0557); Gain of MoRF binding (P = 0.0831); Gain of ubiquitination at K174 (P = 0.1434); Loss of phosphorylation at S169 (P = 0.1704); Gain of sheet (P = 0.1945)
7:117174347:C:A,P13569,S169R,0.706,Gain of MoRF binding (P = 0.0275); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S168 (P = 0.1065); Loss of ubiquitination at K174 (P = 0.1278)
7:117174347:C:G,P13569,S169R,0.706,Gain of MoRF binding (P = 0.0275); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S168 (P = 0.1065); Loss of ubiquitination at K174 (P = 0.1278)
7:117174348:C:A,P13569,R170S,0.652,Loss of MoRF binding (P = 0.0054); Loss of stability (P = 0.0181); Gain of disorder (P = 0.0399); Gain of ubiquitination at K174 (P = 0.0599); Loss of methylation at R170 (P = 0.0748)
7:117174348:C:G,P13569,R170G,0.826,Loss of stability (P = 0.0038); Loss of MoRF binding (P = 0.004); Loss of methylation at R170 (P = 0.0748); Gain of catalytic residue at V171 (P = 0.0876); Gain of ubiquitination at K174 (P = 0.1165)
7:117174348:C:T,P13569,R170C,0.862,Loss of MoRF binding (P = 0.0028); Loss of stability (P = 0.0383); Gain of ubiquitination at K174 (P = 0.0563); Loss of disorder (P = 0.0747); Loss of methylation at R170 (P = 0.0748)
7:117174349:G:C,P13569,R170P,0.789,Loss of MoRF binding (P = 3e-04); Loss of stability (P = 0.012); Loss of methylation at R170 (P = 0.0748); Gain of ubiquitination at K174 (P = 0.1165); Loss of phosphorylation at S168 (P = 0.1534)
7:117174349:G:T,P13569,R170L,0.738,Loss of MoRF binding (P = 0.0031); Gain of ubiquitination at K174 (P = 0.0599); Loss of methylation at R170 (P = 0.0748); Loss of solvent accessibility (P = 0.1077); Loss of phosphorylation at S168 (P = 0.124)
7:117174351:G:A,P13569,V171I,0.435,Gain of catalytic residue at V171 (P = 0.0579); Gain of MoRF binding (P = 0.1233); Gain of helix (P = 0.1736); Loss of methylation at R170 (P = 0.189); Gain of phosphorylation at S168 (P = 0.2238)
7:117174351:G:C,P13569,V171L,0.486,Loss of MoRF binding (P = 0.1045); Gain of helix (P = 0.1736); Gain of phosphorylation at S168 (P = 0.1856); Gain of disorder (P = 0.2184); Loss of ubiquitination at K174 (P = 0.2335)
7:117174351:G:T,P13569,V171F,0.459,Loss of stability (P = 0.0994); Gain of MoRF binding (P = 0.1339); Gain of helix (P = 0.1736); Gain of ubiquitination at K174 (P = 0.2244); Loss of phosphorylation at S168 (P = 0.2244)
7:117174352:T:A,P13569,V171D,0.668,Gain of disorder (P = 0.0021); Loss of MoRF binding (P = 0.027); Gain of ubiquitination at K174 (P = 0.0374); Loss of stability (P = 0.0612); Gain of relative solvent accessibility (P = 0.09)
7:117174352:T:C,P13569,V171A,0.638,Loss of stability (P = 0.0027); Gain of disorder (P = 0.0619); Loss of MoRF binding (P = 0.0925); Gain of helix (P = 0.1736); Gain of phosphorylation at S168 (P = 0.1757)
7:117174352:T:G,P13569,V171G,0.655,Loss of stability (P = 5e-04); Gain of disorder (P = 0.0063); Gain of methylation at R170 (P = 0.0539); Gain of ubiquitination at K174 (P = 0.0825); Loss of MoRF binding (P = 0.0875)
7:117174354:C:A,P13569,L172I,0.612,Gain of methylation at K174 (P = 0.0665); Gain of MoRF binding (P = 0.0996); Loss of catalytic residue at L172 (P = 0.1563); Loss of ubiquitination at K174 (P = 0.2248); Loss of phosphorylation at S168 (P = 0.2398)
7:117174354:C:G,P13569,L172V,0.687,Loss of stability (P = 0.0875); Loss of catalytic residue at L172 (P = 0.1182); Gain of MoRF binding (P = 0.1241); Gain of methylation at K174 (P = 0.135); Loss of loop (P = 0.2237)
7:117174355:T:A,P13569,L172Q,0.77,Gain of disorder (P = 0.0111); Loss of stability (P = 0.0174); Gain of methylation at K174 (P = 0.0977); Loss of MoRF binding (P = 0.1222); Loss of catalytic residue at L172 (P = 0.1452)
7:117174355:T:C,P13569,L172P,0.891,Loss of stability (P = 0.0087); Gain of disorder (P = 0.0132); Loss of MoRF binding (P = 0.0495); Gain of methylation at K174 (P = 0.0624); Loss of helix (P = 0.079)
7:117174355:T:G,P13569,L172R,0.855,Gain of disorder (P = 0.0173); Loss of stability (P = 0.0188); Gain of methylation at L172 (P = 0.0197); Gain of MoRF binding (P = 0.0254); Gain of phosphorylation at S169 (P = 0.0771)
7:117174357:G:A,P13569,D173N,0.675,Gain of MoRF binding (P = 0.0458); Loss of stability (P = 0.0828); Gain of methylation at K174 (P = 0.1131); Loss of ubiquitination at K174 (P = 0.1278); Loss of phosphorylation at S168 (P = 0.1564)
7:117174357:G:C,P13569,D173H,0.608,Loss of stability (P = 0.051); Gain of MoRF binding (P = 0.0587); Gain of methylation at R170 (P = 0.0778); Loss of ubiquitination at K174 (P = 0.1069); Gain of catalytic residue at K174 (P = 0.1294)
7:117174357:G:T,P13569,D173Y,0.685,Gain of MoRF binding (P = 0.0569); Loss of disorder (P = 0.1191); Gain of methylation at R170 (P = 0.1483); Loss of phosphorylation at S168 (P = 0.1654); Loss of helix (P = 0.1706)
7:117174358:A:C,P13569,D173A,0.685,Gain of methylation at R170 (P = 0.0505); Gain of MoRF binding (P = 0.0509); Loss of stability (P = 0.0598); Loss of ubiquitination at K174 (P = 0.1982); Gain of loop (P = 0.2045)
7:117174358:A:G,P13569,D173G,0.666,Loss of stability (P = 0.0308); Gain of methylation at R170 (P = 0.0468); Gain of MoRF binding (P = 0.0533); Loss of ubiquitination at K174 (P = 0.1441); Gain of catalytic residue at I175 (P = 0.186)
7:117174358:A:T,P13569,D173V,0.679,Gain of methylation at K174 (P = 0.0401); Gain of MoRF binding (P = 0.0407); Gain of catalytic residue at S176 (P = 0.1069); Loss of disorder (P = 0.1168); Loss of phosphorylation at S168 (P = 0.1749)
7:117174359:T:A,P13569,D173E,0.659,Loss of MoRF binding (P = 0.0797); Gain of methylation at K174 (P = 0.1467); Loss of stability (P = 0.1903); Loss of phosphorylation at S168 (P = 0.1937); Gain of loop (P = 0.2045)
7:117174359:T:G,P13569,D173E,0.659,Loss of MoRF binding (P = 0.0797); Gain of methylation at K174 (P = 0.1467); Loss of stability (P = 0.1903); Loss of phosphorylation at S168 (P = 0.1937); Gain of loop (P = 0.2045)
7:117174360:A:C,P13569,K174Q,0.321,Loss of ubiquitination at K174 (P = 0.0381); Loss of MoRF binding (P = 0.0432); Loss of methylation at K174 (P = 0.0704); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117174360:A:G,P13569,K174E,0.362,Loss of MoRF binding (P = 0.005); Loss of ubiquitination at K174 (P = 0.0381); Loss of methylation at K174 (P = 0.0704); Gain of relative solvent accessibility (P = 0.1684); Gain of loop (P = 0.2045)
7:117174361:A:C,P13569,K174T,0.385,Loss of ubiquitination at K174 (P = 0.0381); Loss of MoRF binding (P = 0.0423); Loss of methylation at K174 (P = 0.0704); Gain of catalytic residue at D173 (P = 0.1593); Loss of solvent accessibility (P = 0.1922)
7:117174361:A:G,P13569,K174R,0.265,Loss of ubiquitination at K174 (P = 0.0381); Gain of MoRF binding (P = 0.0801); Gain of phosphorylation at S176 (P = 0.0985); Loss of methylation at K174 (P = 0.1062); Gain of helix (P = 0.132)
7:117174361:A:T,P13569,K174I,0.479,Loss of ubiquitination at K174 (P = 0.0381); Loss of MoRF binding (P = 0.0527); Loss of solvent accessibility (P = 0.0703); Loss of methylation at K174 (P = 0.0704); Loss of disorder (P = 0.1004)
7:117174362:A:C,P13569,K174N,0.36,Loss of ubiquitination at K174 (P = 0.0381); Loss of MoRF binding (P = 0.0464); Loss of methylation at K174 (P = 0.0704); Gain of helix (P = 0.132); Gain of loop (P = 0.2045)
7:117174362:A:T,P13569,K174N,0.36,Loss of ubiquitination at K174 (P = 0.0381); Loss of MoRF binding (P = 0.0464); Loss of methylation at K174 (P = 0.0704); Gain of helix (P = 0.132); Gain of loop (P = 0.2045)
7:117174363:A:C,P13569,I175L,0.585,Loss of MoRF binding (P = 0.1044); Loss of catalytic residue at L180 (P = 0.1438); Gain of helix (P = 0.1736); Gain of disorder (P = 0.197); Loss of methylation at K174 (P = 0.2026)
7:117174363:A:G,P13569,I175V,0.776,Gain of methylation at K174 (P = 0.0764); Loss of MoRF binding (P = 0.1207); Loss of catalytic residue at L180 (P = 0.144); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045)
7:117174363:A:T,P13569,I175L,0.585,Loss of MoRF binding (P = 0.1044); Loss of catalytic residue at L180 (P = 0.1438); Gain of helix (P = 0.1736); Gain of disorder (P = 0.197); Loss of methylation at K174 (P = 0.2026)
7:117174364:T:A,P13569,I175K,0.53,Gain of disorder (P = 9e-04); Loss of stability (P = 0.0058); Gain of solvent accessibility (P = 0.012); Gain of relative solvent accessibility (P = 0.0249); Gain of MoRF binding (P = 0.0551)
7:117174364:T:C,P13569,I175T,0.643,Loss of stability (P = 0.0013); Gain of disorder (P = 0.0218); Loss of MoRF binding (P = 0.0929); Loss of catalytic residue at L180 (P = 0.1285); Gain of ubiquitination at K174 (P = 0.1696)
7:117174364:T:G,P13569,I175R,0.554,Gain of disorder (P = 0.0084); Loss of stability (P = 0.0151); Gain of MoRF binding (P = 0.0354); Gain of phosphorylation at S176 (P = 0.0847); Loss of catalytic residue at L180 (P = 0.0932)
7:117174365:A:G,P13569,I175M,0.542,Gain of catalytic residue at V171 (P = 0.0278); Loss of methylation at K174 (P = 0.1037); Loss of MoRF binding (P = 0.1283); Gain of disorder (P = 0.1348); Gain of helix (P = 0.1736)
7:117174366:A:C,P13569,S176R,0.532,Gain of MoRF binding (P = 0.0172); Gain of solvent accessibility (P = 0.1185); Gain of helix (P = 0.132); Loss of ubiquitination at K174 (P = 0.1441); Loss of phosphorylation at S176 (P = 0.2271)
7:117174366:A:G,P13569,S176G,0.472,Gain of catalytic residue at S176 (P = 0.0335); Loss of MoRF binding (P = 0.1303); Gain of helix (P = 0.132); Gain of methylation at K174 (P = 0.1804); Loss of phosphorylation at S176 (P = 0.2271)
7:117174366:A:T,P13569,S176C,0.55,Loss of disorder (P = 0.0804); Gain of methylation at K174 (P = 0.1004); Loss of MoRF binding (P = 0.1044); Gain of helix (P = 0.1736); Loss of catalytic residue at L172 (P = 0.2191)
7:117174367:G:A,P13569,S176N,0.431,Gain of MoRF binding (P = 0.1191); Gain of catalytic residue at S176 (P = 0.1409); Gain of helix (P = 0.1736); Loss of ubiquitination at K174 (P = 0.1982); Gain of loop (P = 0.2045)
7:117174367:G:C,P13569,S176T,0.496,Gain of MoRF binding (P = 0.1348); Gain of methylation at K174 (P = 0.1825); Gain of sheet (P = 0.1945); Loss of catalytic residue at L172 (P = 0.221); Gain of ubiquitination at K174 (P = 0.2244)
7:117174367:G:T,P13569,S176I,0.597,Gain of methylation at K174 (P = 0.0422); Gain of MoRF binding (P = 0.0955); Loss of loop (P = 0.0986); Loss of disorder (P = 0.1004); Gain of helix (P = 0.132)
7:117174368:T:A,P13569,S176R,0.532,Gain of MoRF binding (P = 0.0172); Gain of solvent accessibility (P = 0.1185); Gain of helix (P = 0.132); Loss of ubiquitination at K174 (P = 0.1441); Loss of phosphorylation at S176 (P = 0.2271)
7:117174368:T:G,P13569,S176R,0.532,Gain of MoRF binding (P = 0.0172); Gain of solvent accessibility (P = 0.1185); Gain of helix (P = 0.132); Loss of ubiquitination at K174 (P = 0.1441); Loss of phosphorylation at S176 (P = 0.2271)
7:117174369:A:C,P13569,I177L,0.745,Loss of MoRF binding (P = 0.121); Loss of catalytic residue at G178 (P = 0.1757); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of methylation at K174 (P = 0.2128)
7:117174369:A:G,P13569,I177V,0.581,Loss of MoRF binding (P = 0.1388); Gain of helix (P = 0.1736); Loss of ubiquitination at K174 (P = 0.2432); Loss of methylation at K174 (P = 0.2684); Gain of disorder (P = 0.3065)
7:117174369:A:T,P13569,I177F,0.722,Gain of MoRF binding (P = 0.1365); Gain of helix (P = 0.1736); Loss of stability (P = 0.2004); Gain of loop (P = 0.2045); Gain of ubiquitination at K174 (P = 0.2244)
7:117174370:T:A,P13569,I177N,0.793,Gain of disorder (P = 0.0268); Loss of stability (P = 0.036); Gain of relative solvent accessibility (P = 0.09); Gain of MoRF binding (P = 0.1031); Gain of solvent accessibility (P = 0.1422)
7:117174370:T:C,P13569,I177T,0.902,Loss of stability (P = 0.01); Gain of disorder (P = 0.0376); Gain of MoRF binding (P = 0.1335); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117174370:T:G,P13569,I177S,0.724,Gain of disorder (P = 0.0017); Loss of stability (P = 0.0492); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at I177 (P = 0.0921); Loss of MoRF binding (P = 0.1432)
7:117174371:T:G,P13569,I177M,0.77,Gain of MoRF binding (P = 0.1182); Gain of disorder (P = 0.202); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of ubiquitination at K174 (P = 0.2335)
7:117174372:G:A,P13569,G178R,0.975,Gain of MoRF binding (P = 0.0084); Gain of methylation at K174 (P = 0.111); Loss of ubiquitination at K174 (P = 0.118); Gain of phosphorylation at S176 (P = 0.1266); Loss of catalytic residue at I177 (P = 0.2182)
7:117174372:G:C,P13569,G178R,0.975,Gain of MoRF binding (P = 0.0084); Gain of methylation at K174 (P = 0.111); Loss of ubiquitination at K174 (P = 0.118); Gain of phosphorylation at S176 (P = 0.1266); Loss of catalytic residue at I177 (P = 0.2182)
7:117174373:G:A,P13569,G178E,0.955,Loss of MoRF binding (P = 0.0693); Gain of ubiquitination at K174 (P = 0.0825); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of helix (P = 0.132)
7:117174373:G:C,P13569,G178A,0.943,Loss of MoRF binding (P = 0.15); Loss of stability (P = 0.1931); Loss of catalytic residue at I177 (P = 0.2144); Loss of loop (P = 0.2237); Gain of ubiquitination at K174 (P = 0.2244)
7:117174373:G:T,P13569,G178V,0.95,Gain of MoRF binding (P = 0.1205); Loss of helix (P = 0.1706); Gain of ubiquitination at K174 (P = 0.1989); Loss of catalytic residue at I177 (P = 0.2017); Gain of methylation at K174 (P = 0.2204)
7:117174375:C:G,P13569,Q179E,0.652,Gain of ubiquitination at K174 (P = 0.0599); Loss of MoRF binding (P = 0.0708); Gain of phosphorylation at S176 (P = 0.132); Gain of helix (P = 0.2059); Loss of loop (P = 0.2237)
7:117174376:A:C,P13569,Q179P,0.732,Loss of MoRF binding (P = 0.0865); Loss of stability (P = 0.1123); Gain of helix (P = 0.132); Gain of phosphorylation at S176 (P = 0.1757); Gain of methylation at K174 (P = 0.2082)
7:117174376:A:G,P13569,Q179R,0.702,Gain of MoRF binding (P = 0.0207); Gain of methylation at Q179 (P = 0.0335); Gain of phosphorylation at S176 (P = 0.0882); Loss of ubiquitination at K174 (P = 0.1069); Gain of helix (P = 0.2059)
7:117174376:A:T,P13569,Q179L,0.675,Gain of catalytic residue at S182 (P = 0.0869); Gain of MoRF binding (P = 0.1264); Gain of ubiquitination at K174 (P = 0.1434); Loss of helix (P = 0.1706); Loss of methylation at K174 (P = 0.2756)
7:117174377:A:C,P13569,Q179H,0.617,Loss of MoRF binding (P = 0.1495); Loss of stability (P = 0.1543); Gain of catalytic residue at I177 (P = 0.2026); Gain of helix (P = 0.2059); Loss of ubiquitination at K174 (P = 0.2432)
7:117174377:A:T,P13569,Q179H,0.617,Loss of MoRF binding (P = 0.1495); Loss of stability (P = 0.1543); Gain of catalytic residue at I177 (P = 0.2026); Gain of helix (P = 0.2059); Loss of ubiquitination at K174 (P = 0.2432)
7:117174378:C:A,P13569,L180I,0.522,Loss of catalytic residue at L180 (P = 0.075); Gain of MoRF binding (P = 0.1474); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949); Loss of phosphorylation at S176 (P = 0.4508)
7:117174378:C:T,P13569,L180F,0.508,Loss of catalytic residue at L180 (P = 0.0094); Gain of MoRF binding (P = 0.1483); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of phosphorylation at S176 (P = 0.4484)
7:117174379:T:A,P13569,L180H,0.579,Gain of disorder (P = 0.0638); Loss of catalytic residue at L180 (P = 0.1702); Loss of MoRF binding (P = 0.1895); Gain of loop (P = 0.2045); Gain of helix (P = 0.2294)
7:117174379:T:C,P13569,L180P,0.707,Loss of catalytic residue at L180 (P = 0.0094); Loss of MoRF binding (P = 0.0994); Gain of disorder (P = 0.1638); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117174379:T:G,P13569,L180R,0.664,Gain of MoRF binding (P = 0.0156); Gain of methylation at L180 (P = 0.0217); Gain of disorder (P = 0.1314); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117174381:G:A,P13569,V181I,0.646,Gain of helix (P = 0.2059); Gain of catalytic residue at V181 (P = 0.2105); Gain of MoRF binding (P = 0.2203); Loss of loop (P = 0.2237); Gain of phosphorylation at S176 (P = 0.4401)
7:117174381:G:C,P13569,V181L,0.764,Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.2129); Loss of catalytic residue at S185 (P = 0.2306); Gain of phosphorylation at S176 (P = 0.3365); Gain of disorder (P = 0.3709)
7:117174381:G:T,P13569,V181F,0.724,Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.2212); Gain of phosphorylation at S176 (P = 0.4199); Loss of catalytic residue at S185 (P = 0.4305); Loss of stability (P = 0.4505)
7:117174382:T:A,P13569,V181D,0.901,Gain of catalytic residue at V181 (P = 0.0366); Gain of disorder (P = 0.04); Loss of MoRF binding (P = 0.1283); Gain of phosphorylation at S176 (P = 0.1606); Loss of helix (P = 0.1706)
7:117174382:T:C,P13569,V181A,0.726,Gain of catalytic residue at V181 (P = 0.0357); Loss of MoRF binding (P = 0.211); Gain of disorder (P = 0.2165); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117174382:T:G,P13569,V181G,0.909,Loss of stability (P = 0.0236); Gain of disorder (P = 0.0593); Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.2025); Gain of catalytic residue at S182 (P = 0.2508)
7:117174384:A:C,P13569,S182R,0.765,Gain of MoRF binding (P = 0.0194); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2268); Loss of catalytic residue at S185 (P = 0.3089); Gain of loop (P = 0.4661)
7:117174384:A:G,P13569,S182G,0.402,Gain of catalytic residue at L183 (P = 0.1264); Loss of helix (P = 0.1299); Loss of stability (P = 0.1632); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2597)
7:117174384:A:T,P13569,S182C,0.664,Gain of catalytic residue at L183 (P = 0.015); Loss of disorder (P = 0.0686); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2575)
7:117174385:G:A,P13569,S182N,0.611,Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2378); Loss of disorder (P = 0.2555); Gain of catalytic residue at S185 (P = 0.4778)
7:117174385:G:C,P13569,S182T,0.645,Loss of helix (P = 0.1299); Loss of disorder (P = 0.1996); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2613); Gain of catalytic residue at S185 (P = 0.4947)
7:117174385:G:T,P13569,S182I,0.704,Loss of helix (P = 0.0558); Loss of disorder (P = 0.0756); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2428); Gain of catalytic residue at N186 (P = 0.2741)
7:117174386:T:A,P13569,S182R,0.765,Gain of MoRF binding (P = 0.0194); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2268); Loss of catalytic residue at S185 (P = 0.3089); Gain of loop (P = 0.4661)
7:117174386:T:G,P13569,S182R,0.765,Gain of MoRF binding (P = 0.0194); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2268); Loss of catalytic residue at S185 (P = 0.3089); Gain of loop (P = 0.4661)
7:117174387:C:A,P13569,L183I,0.625,Gain of catalytic residue at L188 (P = 0.0985); Loss of helix (P = 0.2022); Loss of disorder (P = 0.218); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2363)
7:117174387:C:G,P13569,L183V,0.631,Gain of relative solvent accessibility (P = 0.1259); Loss of stability (P = 0.1491); Loss of loop (P = 0.2237); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.2601)
7:117174387:C:T,P13569,L183F,0.605,Loss of loop (P = 0.2237); Loss of stability (P = 0.23); Gain of relative solvent accessibility (P = 0.2363); Loss of disorder (P = 0.2608); Gain of MoRF binding (P = 0.2851)
7:117174388:T:A,P13569,L183H,0.603,Loss of stability (P = 0.0184); Gain of disorder (P = 0.0242); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.199); Gain of catalytic residue at L183 (P = 0.2006)
7:117174388:T:C,P13569,L183P,0.709,Loss of stability (P = 0.017); Gain of disorder (P = 0.0399); Gain of relative solvent accessibility (P = 0.1259); Loss of catalytic residue at S185 (P = 0.1802); Loss of helix (P = 0.2022)
7:117174388:T:G,P13569,L183R,0.632,Gain of MoRF binding (P = 0.0123); Loss of stability (P = 0.0322); Gain of methylation at L183 (P = 0.0539); Gain of disorder (P = 0.0575); Gain of catalytic residue at L183 (P = 0.1235)
7:117174390:C:A,P13569,L184I,0.611,Loss of disorder (P = 0.203); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Gain of MoRF binding (P = 0.3212); Loss of catalytic residue at S185 (P = 0.568)
7:117174390:C:G,P13569,L184V,0.596,Gain of helix (P = 0.2059); Loss of disorder (P = 0.2833); Loss of loop (P = 0.2897); Gain of MoRF binding (P = 0.3564); Loss of catalytic residue at S185 (P = 0.4732)
7:117174390:C:T,P13569,L184F,0.616,Loss of disorder (P = 0.2469); Gain of MoRF binding (P = 0.338); Loss of helix (P = 0.3949); Gain of loop (P = 0.4661); Loss of stability (P = 0.5027)
7:117174391:T:A,P13569,L184H,0.819,Gain of disorder (P = 0.023); Loss of stability (P = 0.0622); Gain of catalytic residue at L183 (P = 0.1137); Loss of helix (P = 0.2022); Loss of loop (P = 0.2897)
7:117174391:T:C,P13569,L184P,0.902,Gain of disorder (P = 0.0255); Loss of stability (P = 0.0425); Gain of glycosylation at L184 (P = 0.1075); Gain of catalytic residue at L183 (P = 0.1872); Loss of helix (P = 0.2022)
7:117174391:T:G,P13569,L184R,0.901,Gain of catalytic residue at L184 (P = 0.0273); Gain of methylation at L184 (P = 0.0385); Gain of disorder (P = 0.0416); Loss of stability (P = 0.1347); Gain of helix (P = 0.2059)
7:117174393:T:A,P13569,S185T,0.729,Loss of ubiquitination at K190 (P = 0.1079); Loss of disorder (P = 0.125); Loss of helix (P = 0.2271); Loss of stability (P = 0.3134); Loss of methylation at K190 (P = 0.3331)
7:117174393:T:C,P13569,S185P,0.861,Loss of ubiquitination at K190 (P = 0.1231); Loss of disorder (P = 0.1709); Gain of glycosylation at S185 (P = 0.1997); Loss of helix (P = 0.2022); Loss of stability (P = 0.2421)
7:117174393:T:G,P13569,S185A,0.811,Loss of disorder (P = 0.1119); Loss of ubiquitination at K190 (P = 0.1231); Loss of helix (P = 0.2022); Loss of catalytic residue at S185 (P = 0.2098); Gain of loop (P = 0.2754)
7:117174394:C:A,P13569,S185Y,0.79,Loss of disorder (P = 0.061); Loss of ubiquitination at K190 (P = 0.0702); Loss of catalytic residue at S185 (P = 0.26); Loss of methylation at K190 (P = 0.3327); Gain of MoRF binding (P = 0.4471)
7:117174394:C:G,P13569,S185C,0.794,Loss of disorder (P = 0.0345); Loss of ubiquitination at K190 (P = 0.1231); Loss of helix (P = 0.2022); Loss of catalytic residue at S185 (P = 0.3015); Loss of methylation at K190 (P = 0.3111)
7:117174394:C:T,P13569,S185F,0.823,Loss of disorder (P = 0.0466); Gain of ubiquitination at K190 (P = 0.123); Loss of catalytic residue at S185 (P = 0.1866); Loss of methylation at K190 (P = 0.3337); Gain of MoRF binding (P = 0.3886)
7:117174396:A:C,P13569,N186H,0.635,Loss of ubiquitination at K190 (P = 0.1079); Gain of disorder (P = 0.1157); Gain of catalytic residue at L188 (P = 0.1402); Loss of stability (P = 0.1709); Gain of helix (P = 0.2294)
7:117174396:A:G,P13569,N186D,0.676,Loss of ubiquitination at K190 (P = 0.0949); Gain of disorder (P = 0.1951); Gain of helix (P = 0.2294); Gain of methylation at K190 (P = 0.2968); Loss of catalytic residue at S185 (P = 0.3222)
7:117174396:A:T,P13569,N186Y,0.653,Loss of disorder (P = 0.079); Gain of catalytic residue at N186 (P = 0.0796); Loss of ubiquitination at K190 (P = 0.1079); Loss of methylation at K190 (P = 0.3297); Loss of helix (P = 0.3949)
7:117174397:A:C,P13569,N186T,0.64,Gain of catalytic residue at N186 (P = 0.0946); Gain of ubiquitination at K190 (P = 0.123); Loss of stability (P = 0.1306); Loss of disorder (P = 0.2227); Gain of glycosylation at N186 (P = 0.2597)
7:117174397:A:G,P13569,N186S,0.673,Gain of disorder (P = 0.0697); Gain of ubiquitination at K190 (P = 0.123); Loss of stability (P = 0.2262); Gain of methylation at K190 (P = 0.2543); Loss of helix (P = 0.3949)
7:117174397:A:T,P13569,N186I,0.609,Loss of disorder (P = 0.05); Loss of ubiquitination at K190 (P = 0.1435); Gain of catalytic residue at S182 (P = 0.2137); Gain of helix (P = 0.2294); Loss of methylation at K190 (P = 0.3313)
7:117174398:C:A,P13569,N186K,0.858,Gain of ubiquitination at N186 (P = 0.0185); Loss of stability (P = 0.1146); Loss of catalytic residue at S185 (P = 0.1193); Gain of disorder (P = 0.1412); Gain of methylation at K190 (P = 0.2012)
7:117174398:C:G,P13569,N186K,0.858,Gain of ubiquitination at N186 (P = 0.0185); Loss of stability (P = 0.1146); Loss of catalytic residue at S185 (P = 0.1193); Gain of disorder (P = 0.1412); Gain of methylation at K190 (P = 0.2012)
7:117174399:A:C,P13569,N187H,0.712,Loss of stability (P = 0.0868); Loss of ubiquitination at K190 (P = 0.1079); Gain of disorder (P = 0.157); Gain of methylation at K190 (P = 0.3294); Loss of helix (P = 0.4763)
7:117174399:A:G,P13569,N187D,0.617,Loss of ubiquitination at K190 (P = 0.1435); Gain of disorder (P = 0.1818); Loss of stability (P = 0.1981); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117174399:A:T,P13569,N187Y,0.683,Loss of disorder (P = 0.0683); Loss of ubiquitination at K190 (P = 0.1079); Loss of catalytic residue at N187 (P = 0.1788); Loss of methylation at K190 (P = 0.2509); Loss of stability (P = 0.3319)
7:117174400:A:C,P13569,N187T,0.731,Loss of ubiquitination at K190 (P = 0.1231); Loss of stability (P = 0.145); Loss of catalytic residue at N187 (P = 0.1656); Loss of disorder (P = 0.1977); Loss of helix (P = 0.2022)
7:117174400:A:G,P13569,N187S,0.698,Gain of disorder (P = 0.0702); Loss of ubiquitination at K190 (P = 0.0768); Loss of catalytic residue at N187 (P = 0.0784); Loss of stability (P = 0.1364); Loss of helix (P = 0.2271)
7:117174400:A:T,P13569,N187I,0.665,Loss of disorder (P = 0.0405); Loss of catalytic residue at N187 (P = 0.0976); Loss of ubiquitination at K190 (P = 0.1231); Gain of methylation at K190 (P = 0.1997); Gain of helix (P = 0.2294)
7:117174401:C:A,P13569,N187K,0.882,Gain of ubiquitination at N187 (P = 0.023); Loss of stability (P = 0.0581); Loss of helix (P = 0.079); Gain of disorder (P = 0.1208); Gain of relative solvent accessibility (P = 0.1259)
7:117174401:C:G,P13569,N187K,0.882,Gain of ubiquitination at N187 (P = 0.023); Loss of stability (P = 0.0581); Loss of helix (P = 0.079); Gain of disorder (P = 0.1208); Gain of relative solvent accessibility (P = 0.1259)
7:117174402:C:G,P13569,L188V,0.494,Loss of stability (P = 0.0563); Loss of ubiquitination at K190 (P = 0.0949); Gain of methylation at K190 (P = 0.1921); Loss of disorder (P = 0.2257); Loss of helix (P = 0.3949)
7:117174403:T:A,P13569,L188Q,0.702,Loss of stability (P = 0.0081); Gain of disorder (P = 0.0107); Gain of ubiquitination at K190 (P = 0.0619); Gain of methylation at K190 (P = 0.0727); Loss of helix (P = 0.1299)
7:117174403:T:C,P13569,L188P,0.757,Loss of stability (P = 0.0023); Gain of disorder (P = 0.0084); Gain of ubiquitination at K190 (P = 0.0548); Gain of methylation at K190 (P = 0.0637); Gain of glycosylation at L188 (P = 0.1082)
7:117174403:T:G,P13569,L188R,0.737,Loss of stability (P = 0.008); Gain of disorder (P = 0.0209); Gain of ubiquitination at K190 (P = 0.0671); Gain of methylation at L188 (P = 0.1096); Loss of catalytic residue at S185 (P = 0.1865)
7:117174405:A:C,P13569,N189H,0.72,Loss of stability (P = 0.0356); Loss of ubiquitination at K190 (P = 0.0768); Gain of helix (P = 0.2059); Loss of disorder (P = 0.2268); Loss of methylation at K190 (P = 0.3319)
7:117174405:A:G,P13569,N189D,0.789,Loss of stability (P = 0.0945); Gain of ubiquitination at K190 (P = 0.123); Gain of disorder (P = 0.1578); Gain of helix (P = 0.2059); Loss of methylation at K190 (P = 0.2873)
7:117174405:A:T,P13569,N189Y,0.717,Loss of disorder (P = 0.0458); Loss of ubiquitination at K190 (P = 0.0768); Loss of stability (P = 0.0879); Gain of catalytic residue at L184 (P = 0.1486); Gain of helix (P = 0.2059)
7:117174406:A:C,P13569,N189T,0.679,Loss of stability (P = 0.0166); Gain of helix (P = 0.0854); Loss of ubiquitination at K190 (P = 0.1435); Loss of disorder (P = 0.1531); Loss of loop (P = 0.2897)
7:117174406:A:G,P13569,N189S,0.662,Loss of stability (P = 0.0464); Gain of disorder (P = 0.0713); Gain of ubiquitination at K190 (P = 0.123); Gain of helix (P = 0.2059); Gain of catalytic residue at N186 (P = 0.2363)
7:117174406:A:T,P13569,N189I,0.738,Loss of disorder (P = 0.0266); Loss of ubiquitination at K190 (P = 0.0768); Gain of catalytic residue at D192 (P = 0.1957); Gain of helix (P = 0.2059); Gain of methylation at K190 (P = 0.2539)
7:117174407:C:A,P13569,N189K,0.904,Loss of stability (P = 0.0205); Gain of ubiquitination at N189 (P = 0.0267); Gain of disorder (P = 0.0969); Gain of helix (P = 0.2059); Gain of methylation at K190 (P = 0.2416)
7:117174407:C:G,P13569,N189K,0.904,Loss of stability (P = 0.0205); Gain of ubiquitination at N189 (P = 0.0267); Gain of disorder (P = 0.0969); Gain of helix (P = 0.2059); Gain of methylation at K190 (P = 0.2416)
7:117174408:A:C,P13569,K190Q,0.584,Loss of ubiquitination at K190 (P = 0.0218); Loss of helix (P = 0.079); Loss of methylation at K190 (P = 0.1182); Loss of disorder (P = 0.1743); Gain of loop (P = 0.2754)
7:117174408:A:G,P13569,K190E,0.601,Loss of ubiquitination at K190 (P = 0.0218); Loss of methylation at K190 (P = 0.1182); Gain of disorder (P = 0.1451); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117174409:A:C,P13569,K190T,0.637,Loss of ubiquitination at K190 (P = 0.0218); Loss of disorder (P = 0.0969); Loss of methylation at K190 (P = 0.1182); Loss of helix (P = 0.2022); Loss of solvent accessibility (P = 0.2882)
7:117174409:A:G,P13569,K190R,0.486,Loss of ubiquitination at K190 (P = 0.0218); Gain of methylation at K190 (P = 0.0912); Loss of disorder (P = 0.1258); Gain of catalytic residue at K190 (P = 0.1593); Loss of helix (P = 0.2022)
7:117174409:A:T,P13569,K190I,0.677,Loss of disorder (P = 0.0197); Loss of ubiquitination at K190 (P = 0.0218); Gain of catalytic residue at L195 (P = 0.0258); Loss of methylation at K190 (P = 0.1182); Loss of solvent accessibility (P = 0.1986)
7:117174410:A:C,P13569,K190N,0.635,Loss of ubiquitination at K190 (P = 0.0218); Loss of methylation at K190 (P = 0.1182); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2195); Gain of loop (P = 0.2754)
7:117174410:A:T,P13569,K190N,0.635,Loss of ubiquitination at K190 (P = 0.0218); Loss of methylation at K190 (P = 0.1182); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2195); Gain of loop (P = 0.2754)
7:117174411:T:A,P13569,F191I,0.767,Loss of ubiquitination at K190 (P = 0.0949); Loss of stability (P = 0.0971); Loss of methylation at K190 (P = 0.2388); Gain of disorder (P = 0.2587); Loss of helix (P = 0.3949)
7:117174411:T:C,P13569,F191L,0.781,Loss of stability (P = 0.0264); Gain of disorder (P = 0.0904); Gain of ubiquitination at K190 (P = 0.1062); Loss of helix (P = 0.1299); Loss of methylation at K190 (P = 0.1895)
7:117174412:T:A,P13569,F191Y,0.74,Loss of stability (P = 0.0215); Gain of ubiquitination at K190 (P = 0.0804); Gain of disorder (P = 0.1); Loss of methylation at K190 (P = 0.2027); Loss of helix (P = 0.3949)
7:117174412:T:C,P13569,F191S,0.751,Gain of disorder (P = 3e-04); Loss of stability (P = 0.0021); Gain of ubiquitination at K190 (P = 0.0577); Loss of helix (P = 0.1706); Loss of methylation at K190 (P = 0.2433)
7:117174412:T:G,P13569,F191C,0.712,Loss of stability (P = 0.0063); Gain of methylation at K190 (P = 0.0294); Gain of ubiquitination at K190 (P = 0.0913); Loss of disorder (P = 0.2146); Gain of catalytic residue at E193 (P = 0.3055)
7:117174413:T:A,P13569,F191L,0.781,Loss of stability (P = 0.0264); Gain of disorder (P = 0.0904); Gain of ubiquitination at K190 (P = 0.1062); Loss of helix (P = 0.1299); Loss of methylation at K190 (P = 0.1895)
7:117174413:T:G,P13569,F191L,0.781,Loss of stability (P = 0.0264); Gain of disorder (P = 0.0904); Gain of ubiquitination at K190 (P = 0.1062); Loss of helix (P = 0.1299); Loss of methylation at K190 (P = 0.1895)
7:117174414:G:A,P13569,D192N,0.903,Loss of ubiquitination at K190 (P = 0.1231); Gain of methylation at K190 (P = 0.1359); Loss of solvent accessibility (P = 0.2517); Gain of disorder (P = 0.2749); Loss of loop (P = 0.2897)
7:117174414:G:C,P13569,D192H,0.841,Loss of ubiquitination at K190 (P = 0.0702); Gain of methylation at K190 (P = 0.0747); Gain of disorder (P = 0.1817); Loss of solvent accessibility (P = 0.2517); Loss of catalytic residue at G194 (P = 0.2984)
7:117174414:G:T,P13569,D192Y,0.84,Loss of disorder (P = 0.0438); Loss of ubiquitination at K190 (P = 0.0594); Gain of methylation at K190 (P = 0.1875); Loss of solvent accessibility (P = 0.2517); Gain of catalytic residue at D192 (P = 0.2677)
7:117174415:A:C,P13569,D192A,0.831,Loss of ubiquitination at K190 (P = 0.0834); Loss of disorder (P = 0.12); Gain of methylation at K190 (P = 0.1236); Gain of helix (P = 0.2059); Loss of solvent accessibility (P = 0.2517)
7:117174415:A:G,P13569,D192G,0.918,Loss of ubiquitination at K190 (P = 0.0834); Gain of methylation at K190 (P = 0.0869); Loss of stability (P = 0.2235); Loss of solvent accessibility (P = 0.2517); Loss of disorder (P = 0.2775)
7:117174415:A:T,P13569,D192V,0.773,Loss of disorder (P = 0.0363); Gain of methylation at K190 (P = 0.0561); Loss of ubiquitination at K190 (P = 0.0702); Gain of helix (P = 0.2059); Loss of solvent accessibility (P = 0.2517)
7:117174416:T:A,P13569,D192E,0.738,Gain of disorder (P = 0.0897); Gain of ubiquitination at K190 (P = 0.1062); Gain of methylation at K190 (P = 0.1853); Loss of catalytic residue at G194 (P = 0.268); Loss of helix (P = 0.3949)
7:117174416:T:G,P13569,D192E,0.738,Gain of disorder (P = 0.0897); Gain of ubiquitination at K190 (P = 0.1062); Gain of methylation at K190 (P = 0.1853); Loss of catalytic residue at G194 (P = 0.268); Loss of helix (P = 0.3949)
7:117174417:G:A,P13569,E193K,0.857,Gain of ubiquitination at E193 (P = 0.0276); Gain of glycosylation at E193 (P = 0.14); Gain of methylation at K190 (P = 0.21); Gain of disorder (P = 0.2569); Loss of stability (P = 0.3905)
7:117174417:G:C,P13569,E193Q,0.565,Loss of ubiquitination at K190 (P = 0.1079); Loss of disorder (P = 0.171); Gain of methylation at K190 (P = 0.1921); Gain of catalytic residue at E193 (P = 0.2154); Gain of helix (P = 0.5668)
7:117174418:A:C,P13569,E193A,0.587,Gain of catalytic residue at E193 (P = 0.0436); Loss of disorder (P = 0.0942); Gain of ubiquitination at K190 (P = 0.1062); Loss of solvent accessibility (P = 0.2106); Loss of methylation at K190 (P = 0.3248)
7:117174418:A:G,P13569,E193G,0.602,Gain of catalytic residue at E193 (P = 0.0518); Gain of ubiquitination at K190 (P = 0.1062); Loss of disorder (P = 0.2002); Loss of stability (P = 0.2055); Loss of solvent accessibility (P = 0.2732)
7:117174418:A:T,P13569,E193V,0.615,Loss of disorder (P = 0.0331); Loss of solvent accessibility (P = 0.0703); Loss of ubiquitination at K190 (P = 0.1231); Loss of relative solvent accessibility (P = 0.1807); Gain of catalytic residue at D192 (P = 0.2442)
7:117174419:A:C,P13569,E193D,0.514,Loss of ubiquitination at K190 (P = 0.1435); Loss of disorder (P = 0.2692); Loss of methylation at K190 (P = 0.2957); Gain of catalytic residue at A196 (P = 0.4477); Loss of helix (P = 0.6555)
7:117174419:A:T,P13569,E193D,0.514,Loss of ubiquitination at K190 (P = 0.1435); Loss of disorder (P = 0.2692); Loss of methylation at K190 (P = 0.2957); Gain of catalytic residue at A196 (P = 0.4477); Loss of helix (P = 0.6555)
7:117175302:G:C,P13569,G194R,0.659,Gain of methylation at G194 (P = 0.0124); Loss of ubiquitination at K190 (P = 0.1435); Loss of catalytic residue at G194 (P = 0.1462); Gain of disorder (P = 0.2782); Gain of MoRF binding (P = 0.5751)
7:117175303:G:A,P13569,G194E,0.674,Gain of ubiquitination at K190 (P = 0.0671); Gain of disorder (P = 0.0763); Loss of catalytic residue at A196 (P = 0.1861); Gain of relative solvent accessibility (P = 0.2363); Gain of methylation at K190 (P = 0.2783)
7:117175303:G:C,P13569,G194A,0.674,Gain of ubiquitination at K190 (P = 0.123); Loss of disorder (P = 0.2208); Loss of catalytic residue at G194 (P = 0.2468); Loss of methylation at K190 (P = 0.3144); Loss of helix (P = 0.6835)
7:117175305:C:A,P13569,L195I,0.714,Gain of methylation at K190 (P = 0.0915); Loss of ubiquitination at K190 (P = 0.1079); Loss of disorder (P = 0.1603); Gain of catalytic residue at A196 (P = 0.4959); Gain of helix (P = 0.6868)
7:117175305:C:G,P13569,L195V,0.698,Gain of catalytic residue at L195 (P = 0.0487); Loss of ubiquitination at K190 (P = 0.1231); Gain of methylation at K190 (P = 0.1621); Loss of disorder (P = 0.2293); Loss of helix (P = 0.6835)
7:117175305:C:T,P13569,L195F,0.73,Loss of ubiquitination at K190 (P = 0.0949); Gain of methylation at K190 (P = 0.1842); Loss of disorder (P = 0.2032); Gain of catalytic residue at H199 (P = 0.2957); Loss of stability (P = 0.4829)
7:117175306:T:A,P13569,L195H,0.756,Gain of disorder (P = 0.0182); Gain of methylation at K190 (P = 0.0941); Gain of catalytic residue at L197 (P = 0.0977); Loss of ubiquitination at K190 (P = 0.1435); Loss of stability (P = 0.1846)
7:117175306:T:C,P13569,L195P,0.831,Gain of disorder (P = 0.0324); Gain of methylation at K190 (P = 0.0673); Gain of ubiquitination at K190 (P = 0.0913); Loss of stability (P = 0.1102); Gain of catalytic residue at G194 (P = 0.2549)
7:117175306:T:G,P13569,L195R,0.842,Gain of methylation at L195 (P = 0.0081); Gain of disorder (P = 0.0433); Gain of ubiquitination at K190 (P = 0.123); Loss of stability (P = 0.2142); Loss of catalytic residue at F200 (P = 0.2278)
7:117175308:G:A,P13569,A196T,0.638,Gain of disorder (P = 0.211); Loss of stability (P = 0.2825); Gain of catalytic residue at A196 (P = 0.4297); Gain of helix (P = 0.6868); Gain of phosphorylation at A196 (P = 0.7417)
7:117175308:G:C,P13569,A196P,0.688,Loss of stability (P = 0.1189); Loss of catalytic residue at A196 (P = 0.1278); Gain of disorder (P = 0.1343); Loss of helix (P = 0.6835); Gain of glycosylation at A196 (P = 0.7604)
7:117175308:G:T,P13569,A196S,0.628,Gain of disorder (P = 0.037); Loss of catalytic residue at A196 (P = 0.1224); Loss of stability (P = 0.3434); Loss of helix (P = 0.6835); Gain of phosphorylation at A196 (P = 0.6921)
7:117175309:C:A,P13569,A196E,0.663,Gain of disorder (P = 0.0637); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Loss of catalytic residue at A198 (P = 0.3168); Loss of stability (P = 0.6333)
7:117175309:C:G,P13569,A196G,0.666,Loss of stability (P = 0.0298); Gain of disorder (P = 0.1089); Loss of catalytic residue at A196 (P = 0.2352); Loss of helix (P = 0.6835); Loss of MoRF binding (P = 0.833)
7:117175309:C:T,P13569,A196V,0.699,Loss of disorder (P = 0.1218); Loss of catalytic residue at A196 (P = 0.3657); Loss of helix (P = 0.6835); Gain of MoRF binding (P = 0.8161); Loss of stability (P = 0.8599)
7:117175311:T:A,P13569,L197M,0.534,Gain of disorder (P = 0.2442); Gain of catalytic residue at A196 (P = 0.5394); Loss of helix (P = 0.6835); Loss of stability (P = 0.7453); Gain of MoRF binding (P = 0.8298)
7:117175311:T:G,P13569,L197V,0.55,Gain of catalytic residue at L197 (P = 0.1503); Loss of disorder (P = 0.3536); Loss of stability (P = 0.6354); Loss of helix (P = 0.6835); Gain of MoRF binding (P = 0.8297)
7:117175312:T:C,P13569,L197S,0.521,Gain of disorder (P = 0.0236); Loss of stability (P = 0.0695); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.28); Gain of glycosylation at L197 (P = 0.4281)
7:117175312:T:G,P13569,L197W,0.519,Gain of catalytic residue at L197 (P = 0.0015); Loss of disorder (P = 0.2373); Loss of stability (P = 0.2513); Loss of helix (P = 0.6835); Gain of MoRF binding (P = 0.7093)
7:117175313:G:C,P13569,L197F,0.567,Gain of catalytic residue at L197 (P = 0.1359); Loss of disorder (P = 0.3375); Loss of stability (P = 0.6142); Loss of helix (P = 0.7926); Gain of MoRF binding (P = 0.8312)
7:117175313:G:T,P13569,L197F,0.567,Gain of catalytic residue at L197 (P = 0.1359); Loss of disorder (P = 0.3375); Loss of stability (P = 0.6142); Loss of helix (P = 0.7926); Gain of MoRF binding (P = 0.8312)
7:117175314:G:A,P13569,A198T,0.658,Loss of stability (P = 0.1446); Loss of catalytic residue at A198 (P = 0.2381); Gain of disorder (P = 0.4597); Gain of helix (P = 0.6868); Gain of MoRF binding (P = 0.8266)
7:117175314:G:C,P13569,A198P,0.871,Loss of stability (P = 0.0798); Gain of catalytic residue at L195 (P = 0.1825); Gain of disorder (P = 0.4235); Loss of helix (P = 0.6835); Loss of MoRF binding (P = 0.8282)
7:117175314:G:T,P13569,A198S,0.603,Loss of stability (P = 0.1832); Gain of disorder (P = 0.1876); Loss of catalytic residue at A198 (P = 0.1888); Loss of helix (P = 0.6835); Gain of phosphorylation at A198 (P = 0.8065)
7:117175315:C:A,P13569,A198E,0.731,Gain of disorder (P = 0.2675); Loss of stability (P = 0.2947); Loss of catalytic residue at V201 (P = 0.4255); Loss of helix (P = 0.6835); Loss of MoRF binding (P = 0.8271)
7:117175315:C:G,P13569,A198G,0.627,Loss of stability (P = 0.0263); Loss of catalytic residue at A198 (P = 0.1004); Gain of disorder (P = 0.352); Loss of helix (P = 0.6835); Gain of MoRF binding (P = 0.832)
7:117175315:C:T,P13569,A198V,0.616,Loss of catalytic residue at A198 (P = 0.3426); Loss of disorder (P = 0.4137); Gain of helix (P = 0.6868); Gain of MoRF binding (P = 0.8082); Loss of stability (P = 0.8086)
7:117175317:C:A,P13569,H199N,0.812,Gain of catalytic residue at H199 (P = 0.0464); Loss of stability (P = 0.3016); Loss of disorder (P = 0.6216); Loss of helix (P = 0.6555); Gain of MoRF binding (P = 0.7974)
7:117175317:C:G,P13569,H199D,0.777,Gain of catalytic residue at H199 (P = 0.247); Loss of stability (P = 0.3324); Loss of disorder (P = 0.6283); Loss of helix (P = 0.6555); Loss of MoRF binding (P = 0.8289)
7:117175317:C:T,P13569,H199Y,0.915,Gain of catalytic residue at H199 (P = 0.0198); Loss of stability (P = 0.5334); Gain of helix (P = 0.5668); Loss of disorder (P = 0.5747); Gain of MoRF binding (P = 0.831)
7:117175318:A:C,P13569,H199P,0.816,Loss of stability (P = 0.1912); Loss of catalytic residue at F200 (P = 0.4648); Loss of disorder (P = 0.6214); Loss of helix (P = 0.6555); Gain of glycosylation at H199 (P = 0.8185)
7:117175318:A:G,P13569,H199R,0.951,Loss of catalytic residue at F200 (P = 0.1274); Gain of methylation at H199 (P = 0.4703); Loss of stability (P = 0.5187); Gain of MoRF binding (P = 0.5464); Loss of disorder (P = 0.6179)
7:117175318:A:T,P13569,H199L,0.829,Loss of catalytic residue at F200 (P = 0.4244); Gain of helix (P = 0.5668); Loss of disorder (P = 0.5785); Gain of MoRF binding (P = 0.8144); Loss of loop (P = 0.8632)
7:117175319:T:A,P13569,H199Q,0.926,Loss of stability (P = 0.4063); Loss of catalytic residue at F200 (P = 0.4367); Gain of helix (P = 0.5668); Loss of disorder (P = 0.6184); Gain of MoRF binding (P = 0.805)
7:117175319:T:G,P13569,H199Q,0.926,Loss of stability (P = 0.4063); Loss of catalytic residue at F200 (P = 0.4367); Gain of helix (P = 0.5668); Loss of disorder (P = 0.6184); Gain of MoRF binding (P = 0.805)
7:117175320:T:A,P13569,F200I,0.782,Loss of catalytic residue at F200 (P = 0.031); Loss of helix (P = 0.5596); Loss of stability (P = 0.5733); Loss of disorder (P = 0.7905); Gain of MoRF binding (P = 0.8205)
7:117175320:T:C,P13569,F200L,0.629,Loss of catalytic residue at A196 (P = 0.4336); Loss of stability (P = 0.5485); Loss of helix (P = 0.6555); Gain of disorder (P = 0.7546); Loss of MoRF binding (P = 0.8212)
7:117175320:T:G,P13569,F200V,0.619,Loss of stability (P = 0.2476); Loss of catalytic residue at F200 (P = 0.3019); Loss of helix (P = 0.6555); Gain of disorder (P = 0.7725); Loss of MoRF binding (P = 0.8215)
7:117175321:T:A,P13569,F200Y,0.577,Gain of catalytic residue at L195 (P = 0.0767); Loss of stability (P = 0.2427); Loss of helix (P = 0.6555); Gain of disorder (P = 0.7617); Gain of phosphorylation at F200 (P = 0.793)
7:117175321:T:C,P13569,F200S,0.535,Loss of catalytic residue at F200 (P = 0.0338); Loss of stability (P = 0.1038); Gain of disorder (P = 0.5539); Loss of helix (P = 0.6555); Gain of glycosylation at F200 (P = 0.7198)
7:117175321:T:G,P13569,F200C,0.605,Loss of stability (P = 0.1872); Gain of catalytic residue at H199 (P = 0.2867); Gain of helix (P = 0.5668); Loss of disorder (P = 0.7881); Loss of MoRF binding (P = 0.8199)
7:117175322:C:A,P13569,F200L,0.629,Loss of catalytic residue at A196 (P = 0.4336); Loss of stability (P = 0.5485); Loss of helix (P = 0.6555); Gain of disorder (P = 0.7546); Loss of MoRF binding (P = 0.8212)
7:117175322:C:G,P13569,F200L,0.629,Loss of catalytic residue at A196 (P = 0.4336); Loss of stability (P = 0.5485); Loss of helix (P = 0.6555); Gain of disorder (P = 0.7546); Loss of MoRF binding (P = 0.8212)
7:117175323:G:C,P13569,V201L,0.721,Gain of helix (P = 0.5668); Loss of catalytic residue at A198 (P = 0.6773); Loss of stability (P = 0.7932); Loss of MoRF binding (P = 0.818); Gain of disorder (P = 0.8577)
7:117175323:G:T,P13569,V201L,0.721,Gain of helix (P = 0.5668); Loss of catalytic residue at A198 (P = 0.6773); Loss of stability (P = 0.7932); Loss of MoRF binding (P = 0.818); Gain of disorder (P = 0.8577)
7:117175324:T:A,P13569,V201E,0.669,Loss of catalytic residue at W202 (P = 0.2336); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2987); Loss of stability (P = 0.4281); Gain of helix (P = 0.5668)
7:117175324:T:C,P13569,V201A,0.619,Gain of catalytic residue at V201 (P = 0.2375); Loss of stability (P = 0.522); Gain of helix (P = 0.5668); Loss of MoRF binding (P = 0.8173); Gain of disorder (P = 0.8198)
7:117175324:T:G,P13569,V201G,0.633,Loss of stability (P = 0.0381); Gain of catalytic residue at L206 (P = 0.1458); Gain of helix (P = 0.5668); Gain of disorder (P = 0.8004); Loss of MoRF binding (P = 0.8176)
7:117175326:T:A,P13569,W202R,0.815,Gain of methylation at W202 (P = 0.0173); Loss of catalytic residue at V201 (P = 0.1806); Gain of helix (P = 0.5668); Loss of stability (P = 0.6278); Gain of MoRF binding (P = 0.6919)
7:117175326:T:C,P13569,W202R,0.815,Gain of methylation at W202 (P = 0.0173); Loss of catalytic residue at V201 (P = 0.1806); Gain of helix (P = 0.5668); Loss of stability (P = 0.6278); Gain of MoRF binding (P = 0.6919)
7:117175326:T:G,P13569,W202G,0.744,Loss of stability (P = 0.0717); Gain of catalytic residue at V201 (P = 0.4431); Loss of helix (P = 0.6555); Loss of MoRF binding (P = 0.8099); Gain of disorder (P = 0.8501)
7:117175327:G:C,P13569,W202S,0.715,Loss of catalytic residue at W202 (P = 0.0699); Gain of glycosylation at W202 (P = 0.23); Loss of stability (P = 0.4411); Gain of helix (P = 0.5668); Gain of phosphorylation at W202 (P = 0.7711)
7:117175327:G:T,P13569,W202L,0.706,Loss of catalytic residue at W202 (P = 0.2192); Loss of helix (P = 0.6555); Loss of MoRF binding (P = 0.8103); Loss of loop (P = 0.8632); Loss of glycosylation at P205 (P = 0.8885)
7:117175328:G:C,P13569,W202C,0.694,Loss of helix (P = 0.6555); Gain of catalytic residue at V201 (P = 0.6988); Loss of stability (P = 0.7205); Loss of MoRF binding (P = 0.8093); Loss of glycosylation at P205 (P = 0.8874)
7:117175328:G:T,P13569,W202C,0.694,Loss of helix (P = 0.6555); Gain of catalytic residue at V201 (P = 0.6988); Loss of stability (P = 0.7205); Loss of MoRF binding (P = 0.8093); Loss of glycosylation at P205 (P = 0.8874)
7:117175329:A:C,P13569,I203L,0.73,Gain of helix (P = 0.5668); Loss of catalytic residue at A204 (P = 0.574); Gain of glycosylation at P205 (P = 0.7128); Loss of MoRF binding (P = 0.8095); Gain of disorder (P = 0.9264)
7:117175329:A:G,P13569,I203V,0.7,Gain of catalytic residue at I203 (P = 0.0515); Gain of helix (P = 0.5668); Loss of MoRF binding (P = 0.8099); Gain of glycosylation at P205 (P = 0.8466); Gain of loop (P = 0.8571)
7:117175329:A:T,P13569,I203F,0.727,Gain of catalytic residue at I203 (P = 0.0457); Gain of helix (P = 0.5668); Loss of stability (P = 0.7318); Gain of glycosylation at P205 (P = 0.7565); Loss of MoRF binding (P = 0.8101)
7:117175330:T:A,P13569,I203N,0.696,Gain of catalytic residue at I203 (P = 0.0117); Loss of stability (P = 0.3135); Gain of helix (P = 0.5668); Gain of glycosylation at P205 (P = 0.6241); Gain of MoRF binding (P = 0.7656)
7:117175330:T:C,P13569,I203T,0.636,Loss of stability (P = 0.0641); Gain of catalytic residue at I203 (P = 0.4565); Gain of helix (P = 0.5668); Gain of glycosylation at I203 (P = 0.6329); Gain of MoRF binding (P = 0.8014)
7:117175330:T:G,P13569,I203S,0.663,Loss of stability (P = 0.2351); Gain of catalytic residue at I203 (P = 0.4729); Gain of helix (P = 0.5668); Gain of glycosylation at P205 (P = 0.6039); Gain of MoRF binding (P = 0.7894)
7:117175331:C:G,P13569,I203M,0.859,Gain of catalytic residue at I203 (P = 0.3983); Gain of helix (P = 0.5668); Gain of glycosylation at P205 (P = 0.752); Gain of MoRF binding (P = 0.8052); Loss of stability (P = 0.8397)
7:117175332:G:A,P13569,A204T,0.859,Loss of catalytic residue at A204 (P = 0.3132); Loss of stability (P = 0.4776); Gain of glycosylation at A204 (P = 0.4843); Loss of helix (P = 0.6555); Loss of sheet (P = 0.7751)
7:117175332:G:C,P13569,A204P,0.756,Gain of catalytic residue at L206 (P = 0.2755); Loss of stability (P = 0.2765); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Gain of glycosylation at P205 (P = 0.7129)
7:117175332:G:T,P13569,A204S,0.726,Loss of catalytic residue at A204 (P = 0.2118); Loss of helix (P = 0.5596); Loss of stability (P = 0.5721); Gain of sheet (P = 0.6509); Gain of glycosylation at A204 (P = 0.7667)
7:117175333:C:A,P13569,A204D,0.747,Loss of catalytic residue at V201 (P = 0.5093); Loss of helix (P = 0.5596); Loss of stability (P = 0.672); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.8014)
7:117175333:C:G,P13569,A204G,0.694,Loss of stability (P = 0.17); Gain of catalytic residue at I203 (P = 0.3639); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Gain of MoRF binding (P = 0.8009)
7:117175333:C:T,P13569,A204V,0.705,Gain of catalytic residue at A204 (P = 0.5616); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7829); Loss of glycosylation at P205 (P = 0.8856)
7:117175335:C:A,P13569,P205T,0.816,Loss of catalytic residue at P205 (P = 0.1567); Loss of stability (P = 0.2123); Gain of MoRF binding (P = 0.6774); Loss of helix (P = 0.6835); Gain of glycosylation at P205 (P = 0.796)
7:117175335:C:G,P13569,P205A,0.791,Loss of stability (P = 0.1066); Loss of catalytic residue at P205 (P = 0.443); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.695)
7:117175335:C:T,P13569,P205S,0.881,Loss of stability (P = 0.2069); Loss of catalytic residue at P205 (P = 0.5181); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.6636)
7:117175336:C:A,P13569,P205H,0.733,Loss of catalytic residue at P205 (P = 0.0079); Loss of stability (P = 0.2101); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.6957)
7:117175336:C:G,P13569,P205R,0.935,Loss of catalytic residue at P205 (P = 0.0668); Gain of MoRF binding (P = 0.2522); Loss of stability (P = 0.2931); Gain of methylation at P205 (P = 0.3335); Loss of helix (P = 0.5596)
7:117175336:C:T,P13569,P205L,0.673,Loss of catalytic residue at P205 (P = 0.0013); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.6667); Loss of helix (P = 0.6835); Loss of glycosylation at P205 (P = 0.8764)
7:117175338:T:A,P13569,L206M,0.812,Gain of catalytic residue at L206 (P = 0.165); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7142); Gain of MoRF binding (P = 0.7977)
7:117175338:T:G,P13569,L206V,0.816,Gain of catalytic residue at L206 (P = 0.0711); Loss of helix (P = 0.6555); Loss of stability (P = 0.7572); Loss of sheet (P = 0.7751); Gain of MoRF binding (P = 0.7938)
7:117175339:T:C,P13569,L206S,0.757,Gain of glycosylation at L206 (P = 0.0564); Loss of stability (P = 0.1693); Gain of catalytic residue at L206 (P = 0.2395); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175340:G:C,P13569,L206F,0.888,Gain of catalytic residue at L206 (P = 0.0668); Loss of stability (P = 0.6258); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Gain of MoRF binding (P = 0.7844)
7:117175340:G:T,P13569,L206F,0.888,Gain of catalytic residue at L206 (P = 0.0668); Loss of stability (P = 0.6258); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Gain of MoRF binding (P = 0.7844)
7:117175341:C:A,P13569,Q207K,0.79,Gain of ubiquitination at Q207 (P = 0.0325); Loss of catalytic residue at Q207 (P = 0.429); Gain of glycosylation at Q207 (P = 0.5597); Gain of methylation at Q207 (P = 0.6071); Gain of MoRF binding (P = 0.6219)
7:117175341:C:G,P13569,Q207E,0.756,Loss of catalytic residue at Q207 (P = 0.1654); Gain of helix (P = 0.5668); Gain of sheet (P = 0.6509); Loss of MoRF binding (P = 0.7925); Loss of loop (P = 0.8632)
7:117175342:A:C,P13569,Q207P,0.775,Loss of catalytic residue at Q207 (P = 0.0416); Loss of stability (P = 0.4665); Gain of glycosylation at Q207 (P = 0.6093); Gain of sheet (P = 0.6509); Loss of helix (P = 0.6555)
7:117175342:A:G,P13569,Q207R,0.82,Gain of methylation at Q207 (P = 0.0548); Loss of catalytic residue at Q207 (P = 0.077); Gain of MoRF binding (P = 0.5308); Gain of helix (P = 0.5668); Loss of stability (P = 0.8504)
7:117175342:A:T,P13569,Q207L,0.652,Loss of catalytic residue at Q207 (P = 0.0077); Gain of stability (P = 0.3114); Gain of helix (P = 0.5668); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.7923)
7:117175343:A:C,P13569,Q207H,0.772,Loss of catalytic residue at Q207 (P = 0.0472); Loss of stability (P = 0.5358); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of MoRF binding (P = 0.8009)
7:117175343:A:T,P13569,Q207H,0.772,Loss of catalytic residue at Q207 (P = 0.0472); Loss of stability (P = 0.5358); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of MoRF binding (P = 0.8009)
7:117175344:G:A,P13569,V208M,0.588,Loss of catalytic residue at V208 (P = 0.0041); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of glycosylation at P205 (P = 0.7925); Loss of MoRF binding (P = 0.8017)
7:117175344:G:C,P13569,V208L,0.6,Gain of helix (P = 0.5668); Loss of catalytic residue at A209 (P = 0.638); Loss of sheet (P = 0.6423); Gain of glycosylation at P205 (P = 0.7436); Loss of MoRF binding (P = 0.8013)
7:117175344:G:T,P13569,V208L,0.6,Gain of helix (P = 0.5668); Loss of catalytic residue at A209 (P = 0.638); Loss of sheet (P = 0.6423); Gain of glycosylation at P205 (P = 0.7436); Loss of MoRF binding (P = 0.8013)
7:117175345:T:A,P13569,V208E,0.758,Loss of catalytic residue at V208 (P = 0.1012); Loss of helix (P = 0.6555); Gain of glycosylation at P205 (P = 0.7066); Loss of stability (P = 0.762); Loss of sheet (P = 0.7751)
7:117175345:T:C,P13569,V208A,0.483,Loss of catalytic residue at V208 (P = 0.4262); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of glycosylation at P205 (P = 0.6438); Loss of stability (P = 0.6674)
7:117175345:T:G,P13569,V208G,0.718,Loss of stability (P = 0.0949); Loss of catalytic residue at V208 (P = 0.317); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.7999)
7:117175347:G:A,P13569,A209T,0.711,Loss of stability (P = 0.2102); Gain of helix (P = 0.5668); Gain of catalytic residue at L206 (P = 0.6262); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7831)
7:117175347:G:C,P13569,A209P,0.801,Gain of catalytic residue at L206 (P = 0.1113); Loss of stability (P = 0.2049); Gain of sheet (P = 0.6509); Gain of glycosylation at A209 (P = 0.6553); Loss of helix (P = 0.6555)
7:117175347:G:T,P13569,A209S,0.834,Gain of glycosylation at A209 (P = 0.0849); Loss of stability (P = 0.3204); Loss of catalytic residue at A209 (P = 0.392); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175348:C:A,P13569,A209E,0.827,Loss of catalytic residue at A209 (P = 0.552); Loss of helix (P = 0.5596); Loss of stability (P = 0.6179); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.7942)
7:117175348:C:G,P13569,A209G,0.744,Loss of stability (P = 0.0394); Gain of catalytic residue at L210 (P = 0.0687); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Loss of MoRF binding (P = 0.8026)
7:117175348:C:T,P13569,A209V,0.628,Gain of catalytic residue at A209 (P = 0.3121); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7785); Loss of loop (P = 0.8632)
7:117175350:C:A,P13569,L210I,0.59,Gain of catalytic residue at L210 (P = 0.0907); Loss of stability (P = 0.3627); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7757); Loss of helix (P = 0.7926)
7:117175350:C:G,P13569,L210V,0.562,Gain of catalytic residue at L210 (P = 0.0664); Loss of stability (P = 0.0766); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7868)
7:117175350:C:T,P13569,L210F,0.732,Loss of stability (P = 0.161); Gain of catalytic residue at L210 (P = 0.2131); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.7788); Loss of helix (P = 0.7926)
7:117175351:T:A,P13569,L210H,0.744,Loss of stability (P = 0.0085); Loss of sheet (P = 0.6423); Gain of catalytic residue at M212 (P = 0.676); Loss of helix (P = 0.7926); Gain of MoRF binding (P = 0.8001)
7:117175351:T:C,P13569,L210P,0.932,Loss of stability (P = 0.0043); Gain of catalytic residue at L211 (P = 0.5627); Loss of sheet (P = 0.6423); Loss of helix (P = 0.7926); Loss of MoRF binding (P = 0.7949)
7:117175351:T:G,P13569,L210R,0.939,Loss of stability (P = 0.0158); Gain of methylation at L210 (P = 0.022); Gain of catalytic residue at L210 (P = 0.2887); Gain of MoRF binding (P = 0.4411); Loss of sheet (P = 0.6423)
7:117175353:C:A,P13569,L211I,0.667,Gain of catalytic residue at L211 (P = 0.2002); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7418); Gain of MoRF binding (P = 0.7756)
7:117175353:C:G,P13569,L211V,0.646,Gain of catalytic residue at L211 (P = 0.0484); Gain of helix (P = 0.5668); Loss of stability (P = 0.5707); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7852)
7:117175353:C:T,P13569,L211F,0.64,Loss of stability (P = 0.2962); Gain of catalytic residue at L211 (P = 0.444); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7785)
7:117175354:T:A,P13569,L211H,0.644,Loss of stability (P = 0.057); Gain of catalytic residue at L210 (P = 0.1479); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.8023)
7:117175354:T:C,P13569,L211P,0.739,Loss of stability (P = 0.0215); Gain of catalytic residue at L210 (P = 0.1992); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.7948)
7:117175354:T:G,P13569,L211R,0.894,Gain of methylation at L211 (P = 0.0298); Loss of stability (P = 0.1468); Gain of catalytic residue at L211 (P = 0.2814); Gain of MoRF binding (P = 0.4929); Gain of helix (P = 0.5668)
7:117175356:A:C,P13569,M212L,0.61,Loss of catalytic residue at M212 (P = 0.0751); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.8017); Loss of stability (P = 0.8479)
7:117175356:A:G,P13569,M212V,0.628,Loss of catalytic residue at V208 (P = 0.417); Gain of sheet (P = 0.6509); Loss of helix (P = 0.6555); Loss of stability (P = 0.789); Gain of MoRF binding (P = 0.7962)
7:117175356:A:T,P13569,M212L,0.61,Loss of catalytic residue at M212 (P = 0.0751); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.8017); Loss of stability (P = 0.8479)
7:117175357:T:A,P13569,M212K,0.724,Gain of ubiquitination at M212 (P = 0.0267); Gain of glycosylation at M212 (P = 0.1445); Loss of stability (P = 0.1761); Loss of catalytic residue at V208 (P = 0.1907); Loss of helix (P = 0.2271)
7:117175357:T:C,P13569,M212T,0.61,Loss of stability (P = 0.1043); Loss of catalytic residue at V208 (P = 0.38); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.8016)
7:117175357:T:G,P13569,M212R,0.86,Gain of methylation at M212 (P = 0.0276); Loss of catalytic residue at M212 (P = 0.0946); Loss of stability (P = 0.3888); Gain of MoRF binding (P = 0.5513); Gain of helix (P = 0.5668)
7:117175358:G:A,P13569,M212I,0.696,Loss of catalytic residue at V208 (P = 0.3883); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7815); Loss of disorder (P = 0.929)
7:117175358:G:C,P13569,M212I,0.696,Loss of catalytic residue at V208 (P = 0.3883); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7815); Loss of disorder (P = 0.929)
7:117175358:G:T,P13569,M212I,0.696,Loss of catalytic residue at V208 (P = 0.3883); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7815); Loss of disorder (P = 0.929)
7:117175359:G:A,P13569,G213R,0.876,Gain of methylation at G213 (P = 0.0483); Loss of catalytic residue at M212 (P = 0.0794); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.4414); Loss of stability (P = 0.5569)
7:117175359:G:C,P13569,G213R,0.876,Gain of methylation at G213 (P = 0.0483); Loss of catalytic residue at M212 (P = 0.0794); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.4414); Loss of stability (P = 0.5569)
7:117175359:G:T,P13569,G213W,0.804,Gain of catalytic residue at L211 (P = 0.0067); Loss of helix (P = 0.2271); Loss of stability (P = 0.5335); Gain of MoRF binding (P = 0.6311); Loss of sheet (P = 0.6423)
7:117175360:G:C,P13569,G213A,0.796,Loss of catalytic residue at M212 (P = 0.1345); Loss of helix (P = 0.2271); Loss of sheet (P = 0.6423); Loss of stability (P = 0.6808); Loss of MoRF binding (P = 0.8023)
7:117175360:G:T,P13569,G213V,0.882,Loss of catalytic residue at M212 (P = 0.1231); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Loss of stability (P = 0.7221); Gain of MoRF binding (P = 0.7875)
7:117175362:C:A,P13569,L214I,0.658,Loss of catalytic residue at L214 (P = 0.0211); Loss of helix (P = 0.4763); Loss of stability (P = 0.6759); Loss of sheet (P = 0.7751); Gain of MoRF binding (P = 0.7833)
7:117175362:C:G,P13569,L214V,0.633,Loss of helix (P = 0.2022); Loss of stability (P = 0.2402); Gain of catalytic residue at E217 (P = 0.5019); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.7854)
7:117175363:T:A,P13569,L214Q,0.721,Loss of stability (P = 0.0494); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Loss of catalytic residue at A209 (P = 0.535); Gain of MoRF binding (P = 0.7712)
7:117175363:T:C,P13569,L214P,0.775,Loss of catalytic residue at L214 (P = 0.0024); Loss of stability (P = 0.0193); Loss of helix (P = 0.2022); Gain of sheet (P = 0.6509); Gain of loop (P = 0.7958)
7:117175363:T:G,P13569,L214R,0.91,Gain of methylation at L214 (P = 0.0188); Loss of catalytic residue at L214 (P = 0.0405); Loss of stability (P = 0.0686); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117175365:A:C,P13569,I215L,0.735,Loss of catalytic residue at I215 (P = 0.1964); Loss of helix (P = 0.3949); Gain of sheet (P = 0.6509); Gain of loop (P = 0.7958); Loss of MoRF binding (P = 0.8005)
7:117175365:A:G,P13569,I215V,0.65,Gain of helix (P = 0.2059); Loss of catalytic residue at L218 (P = 0.342); Loss of loop (P = 0.4786); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.8018)
7:117175365:A:T,P13569,I215F,0.769,Gain of helix (P = 0.2059); Loss of catalytic residue at L218 (P = 0.324); Loss of stability (P = 0.3842); Loss of sheet (P = 0.6423); Gain of loop (P = 0.7958)
7:117175366:T:A,P13569,I215N,0.789,Loss of stability (P = 0.2097); Loss of helix (P = 0.2271); Loss of catalytic residue at E217 (P = 0.2325); Loss of sheet (P = 0.6423); Gain of loop (P = 0.7958)
7:117175366:T:C,P13569,I215T,0.762,Loss of stability (P = 0.0472); Gain of glycosylation at I215 (P = 0.2846); Loss of helix (P = 0.3949); Loss of catalytic residue at L218 (P = 0.4131); Loss of sheet (P = 0.6423)
7:117175366:T:G,P13569,I215S,0.783,Loss of stability (P = 0.1314); Loss of catalytic residue at I215 (P = 0.1729); Loss of helix (P = 0.3949); Loss of sheet (P = 0.6423); Gain of phosphorylation at I215 (P = 0.783)
7:117175367:C:G,P13569,I215M,0.777,Gain of helix (P = 0.2059); Gain of catalytic residue at I215 (P = 0.2659); Loss of stability (P = 0.5513); Loss of sheet (P = 0.6423); Gain of loop (P = 0.7958)
7:117175368:T:A,P13569,W216R,0.809,Gain of methylation at W216 (P = 0.0215); Loss of catalytic residue at L214 (P = 0.0357); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786); Loss of sheet (P = 0.6423)
7:117175368:T:C,P13569,W216R,0.809,Gain of methylation at W216 (P = 0.0215); Loss of catalytic residue at L214 (P = 0.0357); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786); Loss of sheet (P = 0.6423)
7:117175368:T:G,P13569,W216G,0.816,Loss of catalytic residue at L214 (P = 0.1465); Loss of stability (P = 0.1848); Gain of helix (P = 0.2059); Loss of sheet (P = 0.6423); Gain of disorder (P = 0.7792)
7:117175369:G:C,P13569,W216S,0.769,Loss of catalytic residue at L214 (P = 0.0765); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Loss of stability (P = 0.5154); Loss of sheet (P = 0.6423)
7:117175369:G:T,P13569,W216L,0.735,Loss of catalytic residue at L214 (P = 0.0856); Loss of helix (P = 0.3949); Loss of loop (P = 0.4786); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.797)
7:117175370:G:C,P13569,W216C,0.822,Loss of catalytic residue at L214 (P = 0.0847); Gain of helix (P = 0.2059); Loss of sheet (P = 0.6423); Loss of stability (P = 0.6678); Gain of loop (P = 0.7958)
7:117175370:G:T,P13569,W216C,0.822,Loss of catalytic residue at L214 (P = 0.0847); Gain of helix (P = 0.2059); Loss of sheet (P = 0.6423); Loss of stability (P = 0.6678); Gain of loop (P = 0.7958)
7:117175371:G:A,P13569,E217K,0.772,Gain of ubiquitination at E217 (P = 0.0311); Loss of stability (P = 0.077); Gain of methylation at E217 (P = 0.1424); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.3507)
7:117175371:G:C,P13569,E217Q,0.747,Gain of helix (P = 0.2059); Gain of catalytic residue at E217 (P = 0.3195); Loss of glycosylation at S222 (P = 0.3398); Loss of stability (P = 0.368); Loss of loop (P = 0.4786)
7:117175372:A:C,P13569,E217A,0.691,Gain of glycosylation at S222 (P = 0.1325); Gain of catalytic residue at W216 (P = 0.1872); Gain of helix (P = 0.2059); Loss of stability (P = 0.324); Loss of loop (P = 0.4786)
7:117175372:A:T,P13569,E217V,0.682,Gain of glycosylation at S222 (P = 0.1769); Gain of catalytic residue at W216 (P = 0.1889); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786); Loss of sheet (P = 0.6423)
7:117175373:G:C,P13569,E217D,0.646,Loss of helix (P = 0.2022); Gain of glycosylation at S222 (P = 0.2834); Loss of stability (P = 0.3725); Gain of loop (P = 0.4661); Loss of catalytic residue at E217 (P = 0.6023)
7:117175373:G:T,P13569,E217D,0.646,Loss of helix (P = 0.2022); Gain of glycosylation at S222 (P = 0.2834); Loss of stability (P = 0.3725); Gain of loop (P = 0.4661); Loss of catalytic residue at E217 (P = 0.6023)
7:117175374:T:A,P13569,L218M,0.562,Gain of catalytic residue at Q220 (P = 0.18); Loss of glycosylation at S222 (P = 0.3297); Loss of stability (P = 0.3565); Loss of helix (P = 0.3949); Loss of sheet (P = 0.6423)
7:117175374:T:G,P13569,L218V,0.581,Gain of catalytic residue at Q220 (P = 0.1794); Loss of helix (P = 0.2271); Loss of glycosylation at S222 (P = 0.3733); Loss of stability (P = 0.4712); Gain of sheet (P = 0.6509)
7:117175375:T:C,P13569,L218S,0.67,Loss of stability (P = 0.0408); Loss of helix (P = 0.1299); Loss of catalytic residue at L218 (P = 0.1319); Loss of glycosylation at S222 (P = 0.3629); Gain of sheet (P = 0.6509)
7:117175375:T:G,P13569,L218W,0.599,Loss of stability (P = 0.0895); Gain of catalytic residue at Q220 (P = 0.1704); Loss of helix (P = 0.2271); Loss of glycosylation at S222 (P = 0.3116); Loss of sheet (P = 0.6423)
7:117175376:G:C,P13569,L218F,0.554,Gain of catalytic residue at Q220 (P = 0.1782); Loss of stability (P = 0.2429); Loss of glycosylation at S222 (P = 0.33); Loss of helix (P = 0.3949); Loss of sheet (P = 0.6423)
7:117175376:G:T,P13569,L218F,0.554,Gain of catalytic residue at Q220 (P = 0.1782); Loss of stability (P = 0.2429); Loss of glycosylation at S222 (P = 0.33); Loss of helix (P = 0.3949); Loss of sheet (P = 0.6423)
7:117175377:T:A,P13569,L219I,0.549,Gain of glycosylation at S222 (P = 0.2104); Loss of helix (P = 0.4763); Gain of catalytic residue at L218 (P = 0.4822); Loss of stability (P = 0.6182); Gain of sheet (P = 0.6509)
7:117175377:T:G,P13569,L219V,0.551,Gain of catalytic residue at L219 (P = 0.0879); Loss of helix (P = 0.2022); Gain of glycosylation at S222 (P = 0.3142); Gain of loop (P = 0.4661); Loss of stability (P = 0.6276)
7:117175378:T:C,P13569,L219S,0.675,Gain of catalytic residue at L219 (P = 0.0077); Loss of stability (P = 0.1245); Loss of helix (P = 0.2022); Loss of glycosylation at S222 (P = 0.3446); Gain of loop (P = 0.4661)
7:117175379:A:C,P13569,L219F,0.515,Gain of glycosylation at S222 (P = 0.2333); Gain of catalytic residue at S222 (P = 0.2492); Loss of stability (P = 0.4406); Loss of helix (P = 0.4763); Loss of sheet (P = 0.6423)
7:117175379:A:T,P13569,L219F,0.515,Gain of glycosylation at S222 (P = 0.2333); Gain of catalytic residue at S222 (P = 0.2492); Loss of stability (P = 0.4406); Loss of helix (P = 0.4763); Loss of sheet (P = 0.6423)
7:117175380:C:A,P13569,Q220K,0.785,Gain of ubiquitination at Q220 (P = 0.0452); Gain of catalytic residue at Q220 (P = 0.205); Gain of glycosylation at Q220 (P = 0.2299); Gain of methylation at Q220 (P = 0.3788); Loss of helix (P = 0.3949)
7:117175380:C:G,P13569,Q220E,0.757,Gain of glycosylation at S222 (P = 0.1378); Loss of helix (P = 0.3949); Loss of catalytic residue at A221 (P = 0.4433); Gain of loop (P = 0.4661); Loss of sheet (P = 0.6423)
7:117175381:A:C,P13569,Q220P,0.788,Gain of glycosylation at S222 (P = 0.0774); Loss of helix (P = 0.2271); Loss of catalytic residue at Q220 (P = 0.2653); Gain of loop (P = 0.4661); Loss of stability (P = 0.4902)
7:117175381:A:G,P13569,Q220R,0.955,Gain of methylation at Q220 (P = 0.0116); Gain of helix (P = 0.2059); Loss of glycosylation at S222 (P = 0.2772); Loss of catalytic residue at Q220 (P = 0.3648); Gain of MoRF binding (P = 0.5906)
7:117175381:A:T,P13569,Q220L,0.737,Gain of helix (P = 0.2059); Gain of glycosylation at S222 (P = 0.2477); Gain of catalytic residue at W216 (P = 0.4639); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.8268)
7:117175382:G:C,P13569,Q220H,0.787,Gain of helix (P = 0.2059); Gain of glycosylation at S222 (P = 0.2383); Loss of catalytic residue at Q220 (P = 0.2846); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7255)
7:117175382:G:T,P13569,Q220H,0.787,Gain of helix (P = 0.2059); Gain of glycosylation at S222 (P = 0.2383); Loss of catalytic residue at Q220 (P = 0.2846); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7255)
7:117175383:G:A,P13569,A221T,0.557,Loss of helix (P = 0.2022); Gain of catalytic residue at F224 (P = 0.2208); Loss of glycosylation at S222 (P = 0.36); Gain of loop (P = 0.4661); Loss of stability (P = 0.5128)
7:117175383:G:C,P13569,A221P,0.693,Loss of catalytic residue at A221 (P = 0.039); Loss of helix (P = 0.2022); Loss of glycosylation at S222 (P = 0.3308); Loss of stability (P = 0.3832); Gain of loop (P = 0.4661)
7:117175383:G:T,P13569,A221S,0.539,Loss of catalytic residue at A221 (P = 0.0334); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.28); Loss of glycosylation at S222 (P = 0.3139)
7:117175384:C:A,P13569,A221E,0.621,Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1903); Loss of helix (P = 0.2022); Loss of glycosylation at S222 (P = 0.2191); Loss of catalytic residue at S222 (P = 0.2433)
7:117175384:C:G,P13569,A221G,0.552,Loss of stability (P = 0.1945); Loss of glycosylation at S222 (P = 0.3463); Loss of catalytic residue at A221 (P = 0.4178); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763)
7:117175384:C:T,P13569,A221V,0.555,Loss of helix (P = 0.2022); Loss of glycosylation at S222 (P = 0.2571); Loss of catalytic residue at S222 (P = 0.5047); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.802)
7:117175386:T:A,P13569,S222T,0.705,Loss of glycosylation at S222 (P = 0.1509); Loss of catalytic residue at L218 (P = 0.2078); Loss of helix (P = 0.3949); Loss of stability (P = 0.6121); Gain of sheet (P = 0.6509)
7:117175386:T:C,P13569,S222P,0.792,Loss of catalytic residue at L218 (P = 0.2283); Loss of glycosylation at S222 (P = 0.2396); Loss of stability (P = 0.3176); Loss of helix (P = 0.3949); Gain of sheet (P = 0.6509)
7:117175386:T:G,P13569,S222A,0.656,Loss of glycosylation at S222 (P = 0.0824); Loss of catalytic residue at L218 (P = 0.1514); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786); Loss of stability (P = 0.5889)
7:117175387:C:A,P13569,S222Y,0.714,Loss of glycosylation at S222 (P = 0.0824); Loss of catalytic residue at L218 (P = 0.2022); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786); Loss of stability (P = 0.5059)
7:117175387:C:G,P13569,S222C,0.725,Loss of glycosylation at S222 (P = 0.0824); Loss of catalytic residue at L218 (P = 0.2008); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786); Gain of sheet (P = 0.6509)
7:117175387:C:T,P13569,S222F,0.716,Loss of glycosylation at S222 (P = 0.0824); Loss of catalytic residue at L218 (P = 0.1869); Loss of helix (P = 0.3949); Loss of sheet (P = 0.6423); Gain of loop (P = 0.7958)
7:117175389:G:A,P13569,A223T,0.589,Loss of stability (P = 0.1533); Loss of helix (P = 0.2271); Gain of glycosylation at S222 (P = 0.3009); Gain of catalytic residue at S222 (P = 0.5669); Gain of phosphorylation at A223 (P = 0.7746)
7:117175389:G:C,P13569,A223P,0.786,Loss of catalytic residue at A223 (P = 0.0362); Loss of stability (P = 0.0367); Loss of glycosylation at S222 (P = 0.2759); Loss of helix (P = 0.3949); Loss of sheet (P = 0.6423)
7:117175389:G:T,P13569,A223S,0.721,Loss of catalytic residue at A223 (P = 0.0915); Loss of glycosylation at S222 (P = 0.1675); Loss of stability (P = 0.2262); Loss of helix (P = 0.2271); Loss of sheet (P = 0.6423)
7:117175390:C:A,P13569,A223D,0.789,Loss of glycosylation at S222 (P = 0.1845); Loss of catalytic residue at A223 (P = 0.2143); Loss of helix (P = 0.2271); Loss of stability (P = 0.2695); Loss of MoRF binding (P = 0.7702)
7:117175390:C:G,P13569,A223G,0.764,Gain of glycosylation at S222 (P = 0.059); Loss of stability (P = 0.1368); Gain of helix (P = 0.2059); Gain of catalytic residue at F224 (P = 0.451); Loss of sheet (P = 0.6423)
7:117175390:C:T,P13569,A223V,0.578,Loss of glycosylation at S222 (P = 0.1627); Loss of stability (P = 0.193); Loss of helix (P = 0.3949); Gain of catalytic residue at F224 (P = 0.5768); Loss of sheet (P = 0.6423)
7:117175392:T:A,P13569,F224I,0.491,Loss of glycosylation at S222 (P = 0.387); Loss of helix (P = 0.3949); Gain of catalytic residue at F224 (P = 0.416); Loss of stability (P = 0.4796); Gain of sheet (P = 0.6509)
7:117175392:T:C,P13569,F224L,0.515,Loss of catalytic residue at F224 (P = 0.2384); Loss of glycosylation at S222 (P = 0.2998); Loss of stability (P = 0.3837); Loss of helix (P = 0.3949); Gain of sheet (P = 0.6509)
7:117175392:T:G,P13569,F224V,0.514,Loss of stability (P = 0.1764); Gain of helix (P = 0.2059); Gain of catalytic residue at F224 (P = 0.28); Loss of glycosylation at S222 (P = 0.3337); Loss of sheet (P = 0.6423)
7:117175393:T:A,P13569,F224Y,0.528,Gain of catalytic residue at L219 (P = 0.1388); Loss of stability (P = 0.1729); Loss of glycosylation at S222 (P = 0.3684); Loss of helix (P = 0.3949); Gain of sheet (P = 0.6509)
7:117175393:T:C,P13569,F224S,0.546,Loss of stability (P = 0.043); Gain of helix (P = 0.2059); Loss of glycosylation at S222 (P = 0.2718); Gain of catalytic residue at F229 (P = 0.4553); Loss of loop (P = 0.4786)
7:117175393:T:G,P13569,F224C,0.501,Loss of stability (P = 0.1526); Gain of helix (P = 0.2059); Gain of catalytic residue at F224 (P = 0.2219); Loss of glycosylation at S222 (P = 0.3403); Loss of sheet (P = 0.6423)
7:117175394:C:A,P13569,F224L,0.515,Loss of catalytic residue at F224 (P = 0.2384); Loss of glycosylation at S222 (P = 0.2998); Loss of stability (P = 0.3837); Loss of helix (P = 0.3949); Gain of sheet (P = 0.6509)
7:117175394:C:G,P13569,F224L,0.515,Loss of catalytic residue at F224 (P = 0.2384); Loss of glycosylation at S222 (P = 0.2998); Loss of stability (P = 0.3837); Loss of helix (P = 0.3949); Gain of sheet (P = 0.6509)
7:117175395:T:A,P13569,C225S,0.676,Gain of glycosylation at C225 (P = 0.0136); Loss of stability (P = 0.1655); Gain of catalytic residue at S222 (P = 0.3642); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.5967)
7:117175395:T:C,P13569,C225R,0.935,Gain of methylation at C225 (P = 0.002); Loss of catalytic residue at S222 (P = 0.2013); Gain of MoRF binding (P = 0.2125); Loss of glycosylation at S222 (P = 0.2264); Loss of stability (P = 0.2473)
7:117175395:T:G,P13569,C225G,0.709,Loss of stability (P = 0.0345); Gain of glycosylation at S222 (P = 0.0881); Gain of catalytic residue at L230 (P = 0.3014); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.6261)
7:117175396:G:A,P13569,C225Y,0.558,Gain of glycosylation at S222 (P = 0.3605); Loss of stability (P = 0.3674); Loss of helix (P = 0.4763); Loss of catalytic residue at G226 (P = 0.535); Gain of MoRF binding (P = 0.6343)
7:117175396:G:C,P13569,C225S,0.676,Gain of glycosylation at C225 (P = 0.0136); Loss of stability (P = 0.1655); Gain of catalytic residue at S222 (P = 0.3642); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.5967)
7:117175396:G:T,P13569,C225F,0.539,Gain of glycosylation at S222 (P = 0.1284); Loss of catalytic residue at C225 (P = 0.1425); Loss of stability (P = 0.4577); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.6501)
7:117175397:T:G,P13569,C225W,0.716,Loss of stability (P = 0.2899); Loss of glycosylation at S222 (P = 0.3707); Gain of MoRF binding (P = 0.4242); Loss of catalytic residue at S222 (P = 0.4283); Gain of loop (P = 0.4661)
7:117175398:G:A,P13569,G226R,0.877,Gain of methylation at G226 (P = 0.0049); Loss of catalytic residue at L227 (P = 0.0828); Gain of MoRF binding (P = 0.2366); Loss of glycosylation at S222 (P = 0.3258); Loss of helix (P = 0.5596)
7:117175398:G:C,P13569,G226R,0.877,Gain of methylation at G226 (P = 0.0049); Loss of catalytic residue at L227 (P = 0.0828); Gain of MoRF binding (P = 0.2366); Loss of glycosylation at S222 (P = 0.3258); Loss of helix (P = 0.5596)
7:117175399:G:A,P13569,G226E,0.723,Loss of catalytic residue at L227 (P = 0.1015); Gain of glycosylation at S222 (P = 0.3585); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.6221); Loss of sheet (P = 0.7751)
7:117175399:G:C,P13569,G226A,0.607,Loss of catalytic residue at L227 (P = 0.0957); Gain of glycosylation at S222 (P = 0.1343); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.6246); Loss of sheet (P = 0.7751)
7:117175399:G:T,P13569,G226V,0.637,Loss of catalytic residue at L227 (P = 0.119); Gain of glycosylation at S222 (P = 0.2331); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.6136); Loss of sheet (P = 0.6423)
7:117175401:C:A,P13569,L227I,0.708,Loss of glycosylation at S222 (P = 0.3); Loss of catalytic residue at S222 (P = 0.3122); Gain of MoRF binding (P = 0.535); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423)
7:117175401:C:G,P13569,L227V,0.725,Loss of catalytic residue at S222 (P = 0.313); Gain of glycosylation at S222 (P = 0.3733); Loss of stability (P = 0.4569); Gain of MoRF binding (P = 0.5185); Loss of helix (P = 0.5596)
7:117175401:C:T,P13569,L227F,0.712,Loss of catalytic residue at L227 (P = 0.1674); Loss of glycosylation at S222 (P = 0.3381); Loss of stability (P = 0.3954); Loss of MoRF binding (P = 0.5587); Gain of helix (P = 0.5668)
7:117175402:T:A,P13569,L227H,0.756,Loss of stability (P = 0.0664); Gain of catalytic residue at G228 (P = 0.0989); Gain of glycosylation at S222 (P = 0.1); Gain of MoRF binding (P = 0.5327); Loss of helix (P = 0.5596)
7:117175402:T:C,P13569,L227P,0.857,Loss of stability (P = 0.0754); Gain of glycosylation at S222 (P = 0.1371); Loss of catalytic residue at S222 (P = 0.1996); Loss of MoRF binding (P = 0.5484); Gain of helix (P = 0.5668)
7:117175402:T:G,P13569,L227R,0.956,Gain of methylation at L227 (P = 0.001); Gain of MoRF binding (P = 0.1019); Loss of stability (P = 0.1721); Loss of glycosylation at S222 (P = 0.338); Loss of catalytic residue at S222 (P = 0.392)
7:117175404:G:A,P13569,G228S,0.556,Gain of catalytic residue at G228 (P = 0.1432); Loss of stability (P = 0.4031); Gain of MoRF binding (P = 0.4757); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175404:G:C,P13569,G228R,0.883,Gain of methylation at G228 (P = 0.0047); Gain of MoRF binding (P = 0.0895); Loss of catalytic residue at L227 (P = 0.23); Loss of stability (P = 0.5663); Gain of helix (P = 0.5668)
7:117175404:G:T,P13569,G228C,0.572,Gain of catalytic residue at G228 (P = 0.0916); Loss of MoRF binding (P = 0.4909); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of stability (P = 0.6466)
7:117175405:G:A,P13569,G228D,0.701,Loss of catalytic residue at G226 (P = 0.0809); Loss of MoRF binding (P = 0.482); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of stability (P = 0.6891)
7:117175405:G:C,P13569,G228A,0.573,Gain of catalytic residue at G228 (P = 0.1026); Gain of MoRF binding (P = 0.4906); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7275)
7:117175405:G:T,P13569,G228V,0.613,Gain of catalytic residue at G228 (P = 0.2057); Gain of MoRF binding (P = 0.4844); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7981)
7:117175407:T:A,P13569,F229I,0.555,Gain of catalytic residue at F229 (P = 0.3141); Gain of MoRF binding (P = 0.4032); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7466)
7:117175407:T:C,P13569,F229L,0.543,Gain of catalytic residue at F229 (P = 0.3365); Gain of MoRF binding (P = 0.4217); Loss of stability (P = 0.5571); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175407:T:G,P13569,F229V,0.524,Gain of catalytic residue at F229 (P = 0.0751); Gain of MoRF binding (P = 0.3698); Loss of stability (P = 0.4029); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175408:T:A,P13569,F229Y,0.679,Gain of catalytic residue at F229 (P = 0.1461); Gain of MoRF binding (P = 0.3913); Loss of stability (P = 0.4622); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423)
7:117175408:T:C,P13569,F229S,0.689,Gain of catalytic residue at F229 (P = 0.07); Loss of stability (P = 0.0898); Gain of MoRF binding (P = 0.3339); Gain of glycosylation at F229 (P = 0.4564); Loss of helix (P = 0.5596)
7:117175408:T:G,P13569,F229C,0.703,Gain of catalytic residue at L230 (P = 0.0393); Loss of stability (P = 0.1185); Loss of MoRF binding (P = 0.4452); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175409:C:A,P13569,F229L,0.543,Gain of catalytic residue at F229 (P = 0.3365); Gain of MoRF binding (P = 0.4217); Loss of stability (P = 0.5571); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175409:C:G,P13569,F229L,0.543,Gain of catalytic residue at F229 (P = 0.3365); Gain of MoRF binding (P = 0.4217); Loss of stability (P = 0.5571); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175410:C:A,P13569,L230M,0.753,Gain of MoRF binding (P = 0.2384); Loss of stability (P = 0.5235); Loss of helix (P = 0.5596); Gain of catalytic residue at L230 (P = 0.6504); Loss of sheet (P = 0.7751)
7:117175410:C:G,P13569,L230V,0.697,Gain of catalytic residue at L230 (P = 0.1065); Gain of MoRF binding (P = 0.3218); Loss of stability (P = 0.4147); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175411:T:A,P13569,L230Q,0.768,Gain of catalytic residue at L230 (P = 0.0422); Loss of stability (P = 0.0618); Gain of MoRF binding (P = 0.1955); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175411:T:C,P13569,L230P,0.823,Loss of stability (P = 0.0337); Loss of MoRF binding (P = 0.3721); Gain of catalytic residue at L233 (P = 0.4414); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555)
7:117175411:T:G,P13569,L230R,0.933,Gain of methylation at L230 (P = 0.0053); Gain of MoRF binding (P = 0.0101); Gain of catalytic residue at L230 (P = 0.0556); Loss of stability (P = 0.0602); Gain of helix (P = 0.5668)
7:117175413:A:C,P13569,I231L,0.64,Loss of MoRF binding (P = 0.3118); Loss of catalytic residue at I231 (P = 0.4022); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of stability (P = 0.7193)
7:117175413:A:G,P13569,I231V,0.608,Gain of MoRF binding (P = 0.2922); Loss of catalytic residue at L227 (P = 0.4054); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Loss of stability (P = 0.8892)
7:117175413:A:T,P13569,I231L,0.64,Loss of MoRF binding (P = 0.3118); Loss of catalytic residue at I231 (P = 0.4022); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of stability (P = 0.7193)
7:117175414:T:A,P13569,I231K,0.782,Gain of ubiquitination at I231 (P = 0.0276); Loss of stability (P = 0.0516); Gain of MoRF binding (P = 0.0522); Gain of catalytic residue at I231 (P = 0.1611); Gain of glycosylation at I231 (P = 0.1642)
7:117175414:T:C,P13569,I231T,0.563,Loss of stability (P = 0.0495); Gain of MoRF binding (P = 0.3035); Gain of catalytic residue at I231 (P = 0.3722); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175414:T:G,P13569,I231R,0.88,Gain of methylation at I231 (P = 0.003); Gain of MoRF binding (P = 0.02); Loss of stability (P = 0.1533); Loss of catalytic residue at L227 (P = 0.2972); Loss of helix (P = 0.5596)
7:117175415:A:G,P13569,I231M,0.616,Gain of MoRF binding (P = 0.2333); Loss of catalytic residue at L227 (P = 0.4153); Loss of stability (P = 0.4774); Gain of sheet (P = 0.6509); Loss of helix (P = 0.6555)
7:117175416:G:A,P13569,V232I,0.573,Loss of MoRF binding (P = 0.2668); Loss of catalytic residue at V232 (P = 0.3327); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Gain of disorder (P = 0.8923)
7:117175416:G:C,P13569,V232L,0.622,Loss of catalytic residue at V232 (P = 0.2061); Loss of MoRF binding (P = 0.2556); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Gain of disorder (P = 0.873)
7:117175416:G:T,P13569,V232F,0.755,Loss of catalytic residue at V232 (P = 0.0111); Loss of MoRF binding (P = 0.2491); Loss of stability (P = 0.5228); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423)
7:117175417:T:A,P13569,V232D,0.932,Loss of MoRF binding (P = 0.1959); Loss of stability (P = 0.3725); Loss of catalytic residue at Q237 (P = 0.5263); Loss of helix (P = 0.5596); Loss of sheet (P = 0.7751)
7:117175417:T:C,P13569,V232A,0.747,Gain of MoRF binding (P = 0.2702); Loss of catalytic residue at V232 (P = 0.4238); Loss of stability (P = 0.4311); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175417:T:G,P13569,V232G,0.727,Loss of stability (P = 0.0189); Loss of catalytic residue at V232 (P = 0.0253); Loss of MoRF binding (P = 0.2718); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175419:C:A,P13569,L233I,0.65,Gain of MoRF binding (P = 0.1934); Gain of catalytic residue at L235 (P = 0.4713); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of stability (P = 0.7175)
7:117175419:C:G,P13569,L233V,0.694,Gain of MoRF binding (P = 0.1536); Gain of catalytic residue at L233 (P = 0.1928); Loss of stability (P = 0.4797); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175419:C:T,P13569,L233F,0.644,Loss of MoRF binding (P = 0.2184); Loss of stability (P = 0.3607); Gain of catalytic residue at A234 (P = 0.4666); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175420:T:A,P13569,L233H,0.69,Gain of catalytic residue at L233 (P = 0.0537); Loss of stability (P = 0.0798); Gain of MoRF binding (P = 0.1638); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175420:T:C,P13569,L233P,0.835,Loss of stability (P = 0.0406); Gain of catalytic residue at L233 (P = 0.1031); Loss of MoRF binding (P = 0.1707); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423)
7:117175420:T:G,P13569,L233R,0.915,Gain of methylation at L233 (P = 0.0024); Gain of MoRF binding (P = 0.0068); Loss of stability (P = 0.0859); Loss of catalytic residue at Q237 (P = 0.2769); Gain of helix (P = 0.5668)
7:117175422:G:A,P13569,A234T,0.588,Gain of MoRF binding (P = 0.1727); Loss of stability (P = 0.2707); Gain of catalytic residue at A234 (P = 0.3438); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175422:G:C,P13569,A234P,0.822,Gain of catalytic residue at L233 (P = 0.0917); Loss of MoRF binding (P = 0.0958); Loss of stability (P = 0.1651); Gain of helix (P = 0.5668); Gain of glycosylation at A234 (P = 0.6058)
7:117175422:G:T,P13569,A234S,0.656,Gain of MoRF binding (P = 0.1276); Gain of catalytic residue at L230 (P = 0.2137); Loss of stability (P = 0.4601); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175423:C:A,P13569,A234D,0.822,Loss of MoRF binding (P = 0.0924); Loss of catalytic residue at Q237 (P = 0.3631); Loss of stability (P = 0.5185); Gain of helix (P = 0.5668); Loss of sheet (P = 0.7751)
7:117175423:C:G,P13569,A234G,0.715,Loss of stability (P = 0.0857); Gain of catalytic residue at L235 (P = 0.121); Loss of MoRF binding (P = 0.1822); Loss of helix (P = 0.5596); Gain of disorder (P = 0.7739)
7:117175423:C:T,P13569,A234V,0.588,Gain of MoRF binding (P = 0.1849); Gain of catalytic residue at L233 (P = 0.4967); Loss of helix (P = 0.5596); Loss of sheet (P = 0.7751); Loss of disorder (P = 0.8152)
7:117175425:C:A,P13569,L235I,0.691,Gain of catalytic residue at L240 (P = 0.0772); Gain of MoRF binding (P = 0.1189); Loss of stability (P = 0.2504); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175425:C:G,P13569,L235V,0.743,Gain of MoRF binding (P = 0.0908); Gain of catalytic residue at L235 (P = 0.1486); Loss of stability (P = 0.16); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175425:C:T,P13569,L235F,0.719,Loss of MoRF binding (P = 0.1355); Loss of stability (P = 0.2114); Gain of catalytic residue at Q237 (P = 0.2511); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175426:T:A,P13569,L235H,0.726,Loss of stability (P = 0.0097); Gain of MoRF binding (P = 0.0902); Gain of catalytic residue at L235 (P = 0.1858); Gain of disorder (P = 0.5352); Gain of helix (P = 0.5668)
7:117175426:T:C,P13569,L235P,0.805,Loss of stability (P = 0.0062); Loss of MoRF binding (P = 0.0973); Gain of catalytic residue at L235 (P = 0.1542); Gain of glycosylation at L235 (P = 0.2424); Loss of helix (P = 0.5596)
7:117175426:T:G,P13569,L235R,0.882,Gain of methylation at L235 (P = 0.0011); Gain of MoRF binding (P = 0.004); Loss of stability (P = 0.0304); Loss of catalytic residue at G239 (P = 0.3785); Gain of helix (P = 0.4875)
7:117175428:T:A,P13569,F236I,0.608,Gain of MoRF binding (P = 0.0858); Gain of catalytic residue at L233 (P = 0.3323); Gain of helix (P = 0.5668); Loss of stability (P = 0.606); Gain of sheet (P = 0.6509)
7:117175428:T:C,P13569,F236L,0.557,Gain of catalytic residue at F236 (P = 0.1078); Gain of MoRF binding (P = 0.1323); Loss of stability (P = 0.4149); Loss of helix (P = 0.5596); Gain of disorder (P = 0.6405)
7:117175428:T:G,P13569,F236V,0.609,Gain of MoRF binding (P = 0.0805); Gain of catalytic residue at F236 (P = 0.0985); Loss of stability (P = 0.1926); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117175429:T:A,P13569,F236Y,0.665,Gain of catalytic residue at F236 (P = 0.026); Loss of MoRF binding (P = 0.1401); Loss of stability (P = 0.1405); Loss of helix (P = 0.5596); Gain of disorder (P = 0.6165)
7:117175429:T:C,P13569,F236S,0.709,Gain of catalytic residue at F236 (P = 0.0415); Loss of stability (P = 0.0697); Gain of MoRF binding (P = 0.1165); Gain of disorder (P = 0.1604); Gain of helix (P = 0.5668)
7:117175429:T:G,P13569,F236C,0.803,Gain of catalytic residue at F236 (P = 0.0613); Loss of MoRF binding (P = 0.087); Loss of stability (P = 0.1846); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423)
7:117175430:T:A,P13569,F236L,0.557,Gain of catalytic residue at F236 (P = 0.1078); Gain of MoRF binding (P = 0.1323); Loss of stability (P = 0.4149); Loss of helix (P = 0.5596); Gain of disorder (P = 0.6405)
7:117175430:T:G,P13569,F236L,0.557,Gain of catalytic residue at F236 (P = 0.1078); Gain of MoRF binding (P = 0.1323); Loss of stability (P = 0.4149); Loss of helix (P = 0.5596); Gain of disorder (P = 0.6405)
7:117175431:C:A,P13569,Q237K,0.843,Gain of ubiquitination at Q237 (P = 0.0131); Gain of methylation at Q237 (P = 0.031); Gain of MoRF binding (P = 0.0361); Loss of catalytic residue at Q237 (P = 0.5096); Gain of helix (P = 0.5668)
7:117175431:C:G,P13569,Q237E,0.908,Loss of MoRF binding (P = 0.0495); Loss of catalytic residue at A234 (P = 0.4435); Gain of methylation at R242 (P = 0.54); Gain of helix (P = 0.5668); Gain of disorder (P = 0.6036)
7:117175432:A:C,P13569,Q237P,0.862,Loss of MoRF binding (P = 0.0561); Gain of glycosylation at Q237 (P = 0.249); Gain of catalytic residue at L240 (P = 0.4512); Gain of methylation at R242 (P = 0.5364); Loss of stability (P = 0.5525)
7:117175432:A:G,P13569,Q237R,0.83,Gain of methylation at Q237 (P = 0.0014); Gain of MoRF binding (P = 0.0194); Loss of catalytic residue at Q237 (P = 0.343); Loss of helix (P = 0.5596); Gain of disorder (P = 0.5999)
7:117175432:A:T,P13569,Q237L,0.824,Loss of MoRF binding (P = 0.0833); Loss of catalytic residue at Q237 (P = 0.1108); Gain of stability (P = 0.2545); Gain of methylation at R242 (P = 0.5366); Gain of helix (P = 0.5668)
7:117175433:G:C,P13569,Q237H,0.86,Loss of MoRF binding (P = 0.0954); Gain of methylation at R242 (P = 0.5363); Gain of disorder (P = 0.5408); Gain of helix (P = 0.5668); Gain of catalytic residue at L240 (P = 0.6108)
7:117175433:G:T,P13569,Q237H,0.86,Loss of MoRF binding (P = 0.0954); Gain of methylation at R242 (P = 0.5363); Gain of disorder (P = 0.5408); Gain of helix (P = 0.5668); Gain of catalytic residue at L240 (P = 0.6108)
7:117175434:G:A,P13569,A238T,0.749,Loss of stability (P = 0.0972); Gain of MoRF binding (P = 0.1391); Gain of disorder (P = 0.4791); Gain of catalytic residue at R242 (P = 0.5185); Loss of methylation at R242 (P = 0.5268)
7:117175434:G:C,P13569,A238P,0.799,Loss of catalytic residue at A238 (P = 0.0151); Loss of MoRF binding (P = 0.0618); Loss of stability (P = 0.0947); Gain of glycosylation at A238 (P = 0.1864); Gain of disorder (P = 0.3949)
7:117175434:G:T,P13569,A238S,0.69,Gain of glycosylation at A238 (P = 0.0087); Loss of catalytic residue at A238 (P = 0.0601); Gain of MoRF binding (P = 0.1053); Gain of disorder (P = 0.203); Loss of stability (P = 0.3893)
7:117175435:C:A,P13569,A238D,0.766,Loss of catalytic residue at A238 (P = 0.0353); Loss of MoRF binding (P = 0.0577); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2291); Gain of disorder (P = 0.3542)
7:117175435:C:G,P13569,A238G,0.759,Loss of stability (P = 0.0468); Loss of MoRF binding (P = 0.1218); Gain of disorder (P = 0.327); Gain of catalytic residue at L235 (P = 0.4188); Gain of methylation at R242 (P = 0.5409)
7:117175435:C:T,P13569,A238V,0.858,Gain of MoRF binding (P = 0.1285); Loss of disorder (P = 0.494); Loss of methylation at R242 (P = 0.5201); Gain of helix (P = 0.5668); Gain of catalytic residue at L240 (P = 0.5944)
7:117175437:G:A,P13569,G239R,0.912,Gain of methylation at G239 (P = 0.0014); Gain of MoRF binding (P = 0.012); Loss of catalytic residue at G239 (P = 0.1105); Gain of disorder (P = 0.3867); Loss of helix (P = 0.5596)
7:117175437:G:C,P13569,G239R,0.912,Gain of methylation at G239 (P = 0.0014); Gain of MoRF binding (P = 0.012); Loss of catalytic residue at G239 (P = 0.1105); Gain of disorder (P = 0.3867); Loss of helix (P = 0.5596)
7:117175437:G:T,P13569,G239W,0.668,Gain of MoRF binding (P = 0.0267); Loss of methylation at R242 (P = 0.068); Loss of disorder (P = 0.1562); Loss of catalytic residue at L240 (P = 0.2873); Loss of helix (P = 0.5596)
7:117175438:G:A,P13569,G239E,0.691,Loss of MoRF binding (P = 0.0547); Loss of catalytic residue at A238 (P = 0.057); Gain of disorder (P = 0.4097); Loss of methylation at R242 (P = 0.4596); Gain of helix (P = 0.5668)
7:117175438:G:C,P13569,G239A,0.59,Gain of MoRF binding (P = 0.123); Loss of catalytic residue at L240 (P = 0.281); Loss of disorder (P = 0.3865); Loss of methylation at R242 (P = 0.5356); Gain of helix (P = 0.5668)
7:117175438:G:T,P13569,G239V,0.613,Gain of MoRF binding (P = 0.0948); Loss of disorder (P = 0.2292); Loss of catalytic residue at L240 (P = 0.295); Loss of methylation at R242 (P = 0.488); Gain of helix (P = 0.5668)
7:117175440:C:A,P13569,L240I,0.704,Gain of MoRF binding (P = 0.0889); Loss of disorder (P = 0.2889); Gain of catalytic residue at L235 (P = 0.4845); Loss of methylation at R242 (P = 0.4971); Gain of helix (P = 0.5668)
7:117175440:C:G,P13569,L240V,0.707,Gain of catalytic residue at L240 (P = 0.0634); Gain of MoRF binding (P = 0.0836); Gain of disorder (P = 0.3103); Loss of stability (P = 0.4282); Gain of methylation at R242 (P = 0.5389)
7:117175441:T:A,P13569,L240Q,0.845,Gain of disorder (P = 0.0222); Loss of MoRF binding (P = 0.1187); Loss of stability (P = 0.1836); Loss of catalytic residue at Q237 (P = 0.2706); Loss of methylation at R242 (P = 0.4898)
7:117175441:T:C,P13569,L240P,0.839,Gain of glycosylation at L240 (P = 0.021); Gain of disorder (P = 0.029); Loss of MoRF binding (P = 0.053); Loss of stability (P = 0.0591); Loss of catalytic residue at L240 (P = 0.3241)
7:117175441:T:G,P13569,L240R,0.878,Gain of methylation at L240 (P = 2e-04); Gain of disorder (P = 0.0209); Gain of MoRF binding (P = 0.0364); Loss of stability (P = 0.2204); Gain of catalytic residue at G241 (P = 0.2315)
7:117175443:G:A,P13569,G241R,0.934,Gain of methylation at G241 (P = 0.0052); Gain of MoRF binding (P = 0.0119); Loss of catalytic residue at G239 (P = 0.094); Gain of disorder (P = 0.2197); Loss of helix (P = 0.2271)
7:117175443:G:C,P13569,G241R,0.934,Gain of methylation at G241 (P = 0.0052); Gain of MoRF binding (P = 0.0119); Loss of catalytic residue at G239 (P = 0.094); Gain of disorder (P = 0.2197); Loss of helix (P = 0.2271)
7:117175443:G:T,P13569,G241W,0.704,Gain of catalytic residue at M244 (P = 0.0044); Gain of MoRF binding (P = 0.0273); Loss of methylation at R242 (P = 0.0329); Loss of disorder (P = 0.0414); Gain of ubiquitination at K246 (P = 0.2898)
7:117175444:G:A,P13569,G241E,0.799,Loss of MoRF binding (P = 0.0511); Loss of catalytic residue at G239 (P = 0.1099); Gain of disorder (P = 0.2377); Loss of methylation at R242 (P = 0.2614); Gain of ubiquitination at K246 (P = 0.2898)
7:117175444:G:C,P13569,G241A,0.687,Gain of MoRF binding (P = 0.12); Loss of disorder (P = 0.189); Loss of catalytic residue at G239 (P = 0.2008); Loss of ubiquitination at K246 (P = 0.2991); Loss of methylation at R242 (P = 0.4521)
7:117175444:G:T,P13569,G241V,0.648,Gain of catalytic residue at G241 (P = 0.0134); Loss of disorder (P = 0.068); Gain of MoRF binding (P = 0.0932); Gain of ubiquitination at K246 (P = 0.2718); Loss of methylation at R242 (P = 0.3744)
7:117175446:A:G,P13569,R242G,0.641,Loss of methylation at R242 (P = 0.0014); Loss of MoRF binding (P = 0.0079); Gain of disorder (P = 0.2251); Loss of solvent accessibility (P = 0.239); Gain of ubiquitination at K246 (P = 0.2898)
7:117175447:G:A,P13569,R242K,0.568,Loss of methylation at R242 (P = 0.0056); Gain of ubiquitination at R242 (P = 0.0238); Loss of MoRF binding (P = 0.0743); Gain of disorder (P = 0.1885); Loss of catalytic residue at R242 (P = 0.3876)
7:117175447:G:C,P13569,R242T,0.671,Loss of methylation at R242 (P = 0.0014); Loss of MoRF binding (P = 0.0098); Loss of disorder (P = 0.1634); Gain of ubiquitination at K246 (P = 0.2718); Gain of catalytic residue at Q237 (P = 0.3852)
7:117175447:G:T,P13569,R242I,0.639,Loss of methylation at R242 (P = 0.0014); Loss of MoRF binding (P = 0.0121); Loss of disorder (P = 0.0424); Gain of catalytic residue at L240 (P = 0.2683); Loss of ubiquitination at K246 (P = 0.2943)
7:117175448:A:C,P13569,R242S,0.649,Loss of methylation at R242 (P = 0.0014); Loss of MoRF binding (P = 0.0139); Gain of disorder (P = 0.1322); Gain of catalytic residue at R242 (P = 0.1494); Gain of ubiquitination at K246 (P = 0.2526)
7:117175448:A:T,P13569,R242S,0.649,Loss of methylation at R242 (P = 0.0014); Loss of MoRF binding (P = 0.0139); Gain of disorder (P = 0.1322); Gain of catalytic residue at R242 (P = 0.1494); Gain of ubiquitination at K246 (P = 0.2526)
7:117175449:A:C,P13569,M243L,0.884,Loss of disorder (P = 0.0879); Loss of MoRF binding (P = 0.0898); Gain of methylation at R248 (P = 0.1958); Gain of ubiquitination at K246 (P = 0.2898); Loss of catalytic residue at K246 (P = 0.3344)
7:117175449:A:G,P13569,M243V,0.664,Loss of disorder (P = 0.0806); Loss of MoRF binding (P = 0.1424); Gain of methylation at R248 (P = 0.2037); Loss of ubiquitination at K246 (P = 0.2991); Loss of stability (P = 0.3364)
7:117175449:A:T,P13569,M243L,0.884,Loss of disorder (P = 0.0879); Loss of MoRF binding (P = 0.0898); Gain of methylation at R248 (P = 0.1958); Gain of ubiquitination at K246 (P = 0.2898); Loss of catalytic residue at K246 (P = 0.3344)
7:117175450:T:A,P13569,M243K,0.671,Gain of disorder (P = 0.0216); Loss of stability (P = 0.0241); Gain of ubiquitination at M243 (P = 0.0267); Gain of MoRF binding (P = 0.0658); Gain of solvent accessibility (P = 0.0837)
7:117175450:T:C,P13569,M243T,0.707,Loss of stability (P = 0.0542); Loss of MoRF binding (P = 0.0834); Gain of disorder (P = 0.1621); Gain of catalytic residue at M243 (P = 0.2022); Gain of methylation at R248 (P = 0.2259)
7:117175450:T:G,P13569,M243R,0.621,Gain of methylation at M243 (P = 0.0062); Gain of MoRF binding (P = 0.0526); Gain of disorder (P = 0.0574); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09)
7:117175451:G:A,P13569,M243I,0.677,Loss of disorder (P = 0.0675); Loss of MoRF binding (P = 0.132); Gain of methylation at R248 (P = 0.2123); Loss of ubiquitination at K246 (P = 0.2991); Gain of catalytic residue at L240 (P = 0.4423)
7:117175451:G:C,P13569,M243I,0.677,Loss of disorder (P = 0.0675); Loss of MoRF binding (P = 0.132); Gain of methylation at R248 (P = 0.2123); Loss of ubiquitination at K246 (P = 0.2991); Gain of catalytic residue at L240 (P = 0.4423)
7:117175451:G:T,P13569,M243I,0.677,Loss of disorder (P = 0.0675); Loss of MoRF binding (P = 0.132); Gain of methylation at R248 (P = 0.2123); Loss of ubiquitination at K246 (P = 0.2991); Gain of catalytic residue at L240 (P = 0.4423)
7:117175452:A:C,P13569,M244L,0.666,Loss of MoRF binding (P = 0.0845); Loss of disorder (P = 0.085); Gain of methylation at R248 (P = 0.2257); Loss of catalytic residue at K246 (P = 0.2496); Loss of ubiquitination at K246 (P = 0.2943)
7:117175452:A:G,P13569,M244V,0.642,Loss of disorder (P = 0.0774); Loss of MoRF binding (P = 0.1252); Gain of methylation at R248 (P = 0.2369); Loss of ubiquitination at K246 (P = 0.2943); Loss of stability (P = 0.466)
7:117175452:A:T,P13569,M244L,0.666,Loss of MoRF binding (P = 0.0845); Loss of disorder (P = 0.085); Gain of methylation at R248 (P = 0.2257); Loss of catalytic residue at K246 (P = 0.2496); Loss of ubiquitination at K246 (P = 0.2943)
7:117175453:T:A,P13569,M244K,0.927,Gain of disorder (P = 0.0144); Gain of ubiquitination at M244 (P = 0.0428); Gain of MoRF binding (P = 0.0513); Loss of stability (P = 0.0912); Gain of methylation at R248 (P = 0.1311)
7:117175453:T:C,P13569,M244T,0.761,Gain of catalytic residue at M244 (P = 0.0535); Gain of phosphorylation at M244 (P = 0.0546); Loss of MoRF binding (P = 0.094); Loss of stability (P = 0.1272); Gain of disorder (P = 0.1313)
7:117175453:T:G,P13569,M244R,0.864,Gain of methylation at M244 (P = 0.0011); Gain of MoRF binding (P = 0.0329); Gain of disorder (P = 0.0472); Loss of stability (P = 0.1633); Loss of helix (P = 0.1706)
7:117175454:G:A,P13569,M244I,0.615,Gain of catalytic residue at M244 (P = 0.0109); Loss of disorder (P = 0.0649); Loss of MoRF binding (P = 0.1069); Loss of methylation at R248 (P = 0.1838); Loss of ubiquitination at K246 (P = 0.2889)
7:117175454:G:C,P13569,M244I,0.615,Gain of catalytic residue at M244 (P = 0.0109); Loss of disorder (P = 0.0649); Loss of MoRF binding (P = 0.1069); Loss of methylation at R248 (P = 0.1838); Loss of ubiquitination at K246 (P = 0.2889)
7:117175454:G:T,P13569,M244I,0.615,Gain of catalytic residue at M244 (P = 0.0109); Loss of disorder (P = 0.0649); Loss of MoRF binding (P = 0.1069); Loss of methylation at R248 (P = 0.1838); Loss of ubiquitination at K246 (P = 0.2889)
7:117175455:A:C,P13569,M245L,0.513,Loss of disorder (P = 0.0821); Loss of MoRF binding (P = 0.0847); Gain of methylation at R248 (P = 0.2226); Loss of ubiquitination at K246 (P = 0.2991); Loss of catalytic residue at K246 (P = 0.4463)
7:117175455:A:G,P13569,M245V,0.567,Loss of disorder (P = 0.0734); Gain of methylation at K246 (P = 0.1053); Loss of MoRF binding (P = 0.1224); Loss of ubiquitination at K246 (P = 0.2943); Loss of solvent accessibility (P = 0.3646)
7:117175455:A:T,P13569,M245L,0.513,Loss of disorder (P = 0.0821); Loss of MoRF binding (P = 0.0847); Gain of methylation at R248 (P = 0.2226); Loss of ubiquitination at K246 (P = 0.2991); Loss of catalytic residue at K246 (P = 0.4463)
7:117175456:T:A,P13569,M245K,0.577,Gain of disorder (P = 0.0129); Gain of MoRF binding (P = 0.053); Gain of ubiquitination at M245 (P = 0.068); Gain of glycosylation at M245 (P = 0.0812); Loss of stability (P = 0.0924)
7:117175456:T:C,P13569,M245T,0.496,Gain of phosphorylation at M245 (P = 0.0662); Loss of MoRF binding (P = 0.0933); Gain of disorder (P = 0.1157); Loss of stability (P = 0.144); Gain of methylation at R248 (P = 0.2261)
7:117175456:T:G,P13569,M245R,0.517,Gain of methylation at M245 (P = 0.0201); Gain of MoRF binding (P = 0.0354); Gain of disorder (P = 0.0408); Loss of helix (P = 0.2271); Loss of stability (P = 0.25)
7:117175457:G:A,P13569,M245I,0.543,Loss of disorder (P = 0.0612); Loss of MoRF binding (P = 0.1059); Loss of methylation at R248 (P = 0.2157); Loss of ubiquitination at K246 (P = 0.2839); Gain of catalytic residue at L240 (P = 0.3788)
7:117175457:G:C,P13569,M245I,0.543,Loss of disorder (P = 0.0612); Loss of MoRF binding (P = 0.1059); Loss of methylation at R248 (P = 0.2157); Loss of ubiquitination at K246 (P = 0.2839); Gain of catalytic residue at L240 (P = 0.3788)
7:117175457:G:T,P13569,M245I,0.543,Loss of disorder (P = 0.0612); Loss of MoRF binding (P = 0.1059); Loss of methylation at R248 (P = 0.2157); Loss of ubiquitination at K246 (P = 0.2839); Gain of catalytic residue at L240 (P = 0.3788)
7:117175458:A:C,P13569,K246Q,0.513,Loss of MoRF binding (P = 0.0436); Loss of catalytic residue at K246 (P = 0.0508); Loss of ubiquitination at K246 (P = 0.0768); Loss of methylation at R248 (P = 0.1084); Loss of disorder (P = 0.1616)
7:117175458:A:G,P13569,K246E,0.539,Loss of MoRF binding (P = 0.0017); Loss of ubiquitination at K246 (P = 0.0768); Loss of methylation at R251 (P = 0.1236); Loss of catalytic residue at K246 (P = 0.1932); Gain of disorder (P = 0.211)
7:117175459:A:C,P13569,K246T,0.591,Loss of MoRF binding (P = 0.0324); Loss of disorder (P = 0.07); Loss of ubiquitination at K246 (P = 0.0768); Gain of methylation at R251 (P = 0.1488); Gain of phosphorylation at K246 (P = 0.2059)
7:117175459:A:G,P13569,K246R,0.456,Gain of methylation at K246 (P = 0.0158); Gain of MoRF binding (P = 0.0756); Loss of ubiquitination at K246 (P = 0.0768); Loss of disorder (P = 0.1338); Loss of catalytic residue at K246 (P = 0.1749)
7:117175459:A:T,P13569,K246M,0.574,Loss of disorder (P = 0.0477); Loss of MoRF binding (P = 0.0503); Loss of ubiquitination at K246 (P = 0.0768); Loss of catalytic residue at K246 (P = 0.0769); Loss of methylation at R251 (P = 0.1487)
7:117175460:G:C,P13569,K246N,0.524,Loss of MoRF binding (P = 0.0385); Loss of catalytic residue at K246 (P = 0.0652); Loss of ubiquitination at K246 (P = 0.0768); Loss of disorder (P = 0.1008); Gain of methylation at R251 (P = 0.1174)
7:117175460:G:T,P13569,K246N,0.524,Loss of MoRF binding (P = 0.0385); Loss of catalytic residue at K246 (P = 0.0652); Loss of ubiquitination at K246 (P = 0.0768); Loss of disorder (P = 0.1008); Gain of methylation at R251 (P = 0.1174)
7:117175461:T:A,P13569,Y247N,0.752,Gain of disorder (P = 0.0152); Loss of methylation at R251 (P = 0.1353); Gain of MoRF binding (P = 0.1395); Loss of ubiquitination at K246 (P = 0.2991); Loss of stability (P = 0.3946)
7:117175461:T:C,P13569,Y247H,0.774,Gain of disorder (P = 0.0154); Loss of methylation at R248 (P = 0.0921); Loss of MoRF binding (P = 0.132); Loss of stability (P = 0.2337); Loss of ubiquitination at K246 (P = 0.2889)
7:117175461:T:G,P13569,Y247D,0.799,Gain of disorder (P = 0.0057); Loss of MoRF binding (P = 0.0468); Loss of methylation at R251 (P = 0.0737); Gain of ubiquitination at K246 (P = 0.2898); Loss of stability (P = 0.4893)
7:117175462:A:C,P13569,Y247S,0.762,Gain of disorder (P = 0.0043); Gain of phosphorylation at Y247 (P = 0.0623); Gain of MoRF binding (P = 0.1095); Loss of methylation at R251 (P = 0.1323); Loss of stability (P = 0.2641)
7:117175462:A:G,P13569,Y247C,0.728,Gain of catalytic residue at M245 (P = 0.0205); Gain of methylation at K246 (P = 0.0402); Loss of disorder (P = 0.0829); Loss of MoRF binding (P = 0.0901); Loss of ubiquitination at K246 (P = 0.2943)
7:117175462:A:T,P13569,Y247F,0.648,Gain of methylation at R251 (P = 0.1236); Loss of disorder (P = 0.1297); Gain of MoRF binding (P = 0.1327); Loss of ubiquitination at K246 (P = 0.2943); Gain of helix (P = 0.5668)
7:117175464:A:G,P13569,R248G,0.816,Loss of methylation at R248 (P = 0.0104); Loss of MoRF binding (P = 0.0607); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1743); Loss of solvent accessibility (P = 0.239)
7:117175465:G:A,P13569,R248K,0.718,Loss of methylation at R248 (P = 0.0126); Gain of disorder (P = 0.0678); Loss of MoRF binding (P = 0.1179); Gain of ubiquitination at R248 (P = 0.1326); Loss of helix (P = 0.1706)
7:117175465:G:T,P13569,R248I,0.808,Loss of methylation at R248 (P = 0.0104); Loss of disorder (P = 0.0135); Loss of MoRF binding (P = 0.0732); Loss of catalytic residue at K246 (P = 0.2016); Loss of solvent accessibility (P = 0.239)
7:117176602:A:C,P13569,R248S,0.77,Loss of methylation at R248 (P = 0.0104); Gain of phosphorylation at R248 (P = 0.0528); Loss of MoRF binding (P = 0.0604); Gain of disorder (P = 0.0792); Gain of helix (P = 0.2294)
7:117176602:A:T,P13569,R248S,0.77,Loss of methylation at R248 (P = 0.0104); Gain of phosphorylation at R248 (P = 0.0528); Loss of MoRF binding (P = 0.0604); Gain of disorder (P = 0.0792); Gain of helix (P = 0.2294)
7:117176603:G:A,P13569,D249N,0.533,Loss of ubiquitination at K254 (P = 0.0225); Gain of MoRF binding (P = 0.0678); Gain of methylation at R251 (P = 0.068); Loss of disorder (P = 0.1609); Gain of loop (P = 0.4661)
7:117176603:G:C,P13569,D249H,0.555,Loss of ubiquitination at K254 (P = 0.0225); Gain of methylation at R251 (P = 0.047); Gain of MoRF binding (P = 0.0718); Gain of disorder (P = 0.1187); Gain of helix (P = 0.2294)
7:117176603:G:T,P13569,D249Y,0.58,Loss of ubiquitination at K254 (P = 0.02); Loss of disorder (P = 0.0229); Gain of MoRF binding (P = 0.072); Gain of methylation at R251 (P = 0.0852); Loss of helix (P = 0.4763)
7:117176604:A:C,P13569,D249A,0.558,Loss of ubiquitination at K254 (P = 0.0225); Gain of methylation at R251 (P = 0.0482); Gain of MoRF binding (P = 0.0637); Loss of disorder (P = 0.0761); Loss of stability (P = 0.3126)
7:117176604:A:G,P13569,D249G,0.589,Loss of ubiquitination at K254 (P = 0.0236); Gain of methylation at R251 (P = 0.044); Gain of catalytic residue at D249 (P = 0.0477); Gain of MoRF binding (P = 0.067); Loss of stability (P = 0.1059)
7:117176604:A:T,P13569,D249V,0.571,Loss of disorder (P = 0.0107); Loss of ubiquitination at K254 (P = 0.0225); Gain of MoRF binding (P = 0.0602); Gain of methylation at R251 (P = 0.0854); Loss of catalytic residue at A252 (P = 0.4136)
7:117176605:T:A,P13569,D249E,0.461,Gain of disorder (P = 0.1237); Gain of methylation at R251 (P = 0.1402); Loss of ubiquitination at K254 (P = 0.1672); Gain of MoRF binding (P = 0.1711); Gain of helix (P = 0.2294)
7:117176605:T:G,P13569,D249E,0.461,Gain of disorder (P = 0.1237); Gain of methylation at R251 (P = 0.1402); Loss of ubiquitination at K254 (P = 0.1672); Gain of MoRF binding (P = 0.1711); Gain of helix (P = 0.2294)
7:117176606:C:A,P13569,Q250K,0.507,Loss of ubiquitination at K254 (P = 0.0218); Gain of MoRF binding (P = 0.0858); Gain of disorder (P = 0.0873); Gain of methylation at R251 (P = 0.1086); Loss of catalytic residue at K246 (P = 0.2822)
7:117176606:C:G,P13569,Q250E,0.483,Loss of MoRF binding (P = 0.0466); Gain of disorder (P = 0.0832); Gain of methylation at R251 (P = 0.1193); Loss of ubiquitination at K254 (P = 0.1405); Gain of helix (P = 0.2294)
7:117176607:A:C,P13569,Q250P,0.65,Gain of methylation at R251 (P = 0.0459); Loss of MoRF binding (P = 0.0652); Loss of ubiquitination at K254 (P = 0.1154); Gain of disorder (P = 0.1876); Loss of solvent accessibility (P = 0.1986)
7:117176607:A:G,P13569,Q250R,0.51,Gain of methylation at Q250 (P = 0.0141); Loss of ubiquitination at K254 (P = 0.0211); Gain of MoRF binding (P = 0.0694); Gain of disorder (P = 0.1662); Loss of helix (P = 0.2271)
7:117176607:A:T,P13569,Q250L,0.548,Loss of disorder (P = 0.0204); Gain of methylation at R251 (P = 0.0508); Loss of ubiquitination at K254 (P = 0.0517); Loss of solvent accessibility (P = 0.1551); Loss of MoRF binding (P = 0.1769)
7:117176608:G:C,P13569,Q250H,0.499,Gain of catalytic residue at R248 (P = 0.0798); Gain of methylation at R251 (P = 0.0834); Loss of ubiquitination at K254 (P = 0.0937); Gain of disorder (P = 0.1144); Loss of MoRF binding (P = 0.1459)
7:117176608:G:T,P13569,Q250H,0.499,Gain of catalytic residue at R248 (P = 0.0798); Gain of methylation at R251 (P = 0.0834); Loss of ubiquitination at K254 (P = 0.0937); Gain of disorder (P = 0.1144); Loss of MoRF binding (P = 0.1459)
7:117176609:A:G,P13569,R251G,0.676,Loss of MoRF binding (P = 0.0236); Loss of methylation at R251 (P = 0.0252); Loss of solvent accessibility (P = 0.1077); Loss of stability (P = 0.1728); Gain of catalytic residue at Q250 (P = 0.1864)
7:117176610:G:A,P13569,R251K,0.574,Loss of methylation at R251 (P = 0.0273); Gain of disorder (P = 0.0841); Loss of MoRF binding (P = 0.0918); Gain of ubiquitination at R251 (P = 0.1008); Gain of helix (P = 0.2294)
7:117176610:G:C,P13569,R251T,0.64,Loss of methylation at R251 (P = 0.0252); Loss of MoRF binding (P = 0.0258); Gain of phosphorylation at R251 (P = 0.029); Loss of ubiquitination at K254 (P = 0.0937); Loss of solvent accessibility (P = 0.1077)
7:117176610:G:T,P13569,R251I,0.645,Loss of disorder (P = 0.014); Loss of methylation at R251 (P = 0.0252); Loss of MoRF binding (P = 0.03); Loss of ubiquitination at K254 (P = 0.0699); Loss of solvent accessibility (P = 0.1077)
7:117176611:A:C,P13569,R251S,0.611,Loss of methylation at R251 (P = 0.0252); Loss of MoRF binding (P = 0.0283); Gain of phosphorylation at R251 (P = 0.0502); Gain of disorder (P = 0.072); Loss of solvent accessibility (P = 0.1077)
7:117176611:A:T,P13569,R251S,0.611,Loss of methylation at R251 (P = 0.0252); Loss of MoRF binding (P = 0.0283); Gain of phosphorylation at R251 (P = 0.0502); Gain of disorder (P = 0.072); Loss of solvent accessibility (P = 0.1077)
7:117176612:G:A,P13569,A252T,0.704,Gain of phosphorylation at A252 (P = 0.0563); Loss of catalytic residue at A252 (P = 0.082); Loss of methylation at R251 (P = 0.0996); Loss of MoRF binding (P = 0.1085); Loss of ubiquitination at K254 (P = 0.1154)
7:117176612:G:C,P13569,A252P,0.783,Gain of disorder (P = 0.0472); Loss of MoRF binding (P = 0.0523); Loss of ubiquitination at K254 (P = 0.0605); Loss of methylation at R251 (P = 0.0886); Loss of catalytic residue at A252 (P = 0.1714)
7:117176612:G:T,P13569,A252S,0.69,Gain of disorder (P = 0.0205); Loss of catalytic residue at A252 (P = 0.0337); Gain of phosphorylation at A252 (P = 0.0554); Gain of glycosylation at A252 (P = 0.0798); Loss of methylation at R251 (P = 0.0876)
7:117176613:C:A,P13569,A252D,0.702,Loss of MoRF binding (P = 0.0285); Gain of disorder (P = 0.033); Loss of catalytic residue at A252 (P = 0.0331); Loss of methylation at R248 (P = 0.0563); Gain of relative solvent accessibility (P = 0.09)
7:117176613:C:G,P13569,A252G,0.756,Gain of disorder (P = 0.0512); Gain of methylation at R251 (P = 0.0533); Loss of stability (P = 0.0812); Loss of catalytic residue at A252 (P = 0.0874); Loss of MoRF binding (P = 0.1165)
7:117176613:C:T,P13569,A252V,0.73,Loss of ubiquitination at K254 (P = 0.0318); Loss of disorder (P = 0.0668); Loss of catalytic residue at A252 (P = 0.0972); Loss of methylation at R251 (P = 0.1097); Gain of MoRF binding (P = 0.1201)
7:117176615:G:A,P13569,G253R,0.328,Loss of ubiquitination at K254 (P = 0.0175); Gain of MoRF binding (P = 0.0335); Gain of solvent accessibility (P = 0.0674); Gain of phosphorylation at S256 (P = 0.0739); Loss of methylation at R251 (P = 0.0746)
7:117176615:G:C,P13569,G253R,0.328,Loss of ubiquitination at K254 (P = 0.0175); Gain of MoRF binding (P = 0.0335); Gain of solvent accessibility (P = 0.0674); Gain of phosphorylation at S256 (P = 0.0739); Loss of methylation at R251 (P = 0.0746)
7:117176615:G:T,P13569,G253W,0.454,Loss of disorder (P = 0.0063); Loss of ubiquitination at K254 (P = 0.0318); Loss of methylation at R248 (P = 0.0323); Gain of MoRF binding (P = 0.0504); Gain of solvent accessibility (P = 0.0854)
7:117176616:G:A,P13569,G253E,0.356,Loss of MoRF binding (P = 0.0422); Loss of methylation at R251 (P = 0.0496); Gain of disorder (P = 0.0516); Loss of catalytic residue at A252 (P = 0.0584); Gain of solvent accessibility (P = 0.0596)
7:117176616:G:C,P13569,G253A,0.329,Loss of ubiquitination at K254 (P = 0.0605); Loss of stability (P = 0.0625); Loss of catalytic residue at A252 (P = 0.0928); Gain of MoRF binding (P = 0.1286); Loss of disorder (P = 0.1291)
7:117176616:G:T,P13569,G253V,0.44,Loss of ubiquitination at K254 (P = 0.0261); Loss of disorder (P = 0.0293); Loss of methylation at R251 (P = 0.0939); Loss of catalytic residue at A252 (P = 0.0946); Loss of stability (P = 0.103)
7:117176618:A:C,P13569,K254Q,0.481,Loss of ubiquitination at K254 (P = 0.0081); Loss of MoRF binding (P = 0.0422); Loss of methylation at R251 (P = 0.1003); Loss of phosphorylation at S256 (P = 0.1506); Loss of disorder (P = 0.1677)
7:117176618:A:G,P13569,K254E,0.535,Loss of MoRF binding (P = 0.001); Loss of ubiquitination at K254 (P = 0.0081); Gain of disorder (P = 0.1454); Gain of methylation at R251 (P = 0.151); Gain of phosphorylation at S256 (P = 0.2014)
7:117176619:A:C,P13569,K254T,0.501,Loss of ubiquitination at K254 (P = 0.0081); Loss of MoRF binding (P = 0.0274); Loss of disorder (P = 0.0754); Gain of methylation at R251 (P = 0.0801); Gain of catalytic residue at K254 (P = 0.0914)
7:117176619:A:G,P13569,K254R,0.417,Loss of ubiquitination at K254 (P = 0.0081); Gain of catalytic residue at K254 (P = 0.0651); Gain of methylation at R251 (P = 0.0669); Gain of MoRF binding (P = 0.0753); Gain of phosphorylation at S256 (P = 0.0865)
7:117176619:A:T,P13569,K254M,0.529,Loss of ubiquitination at K254 (P = 0.0081); Loss of disorder (P = 0.0393); Loss of MoRF binding (P = 0.0481); Loss of solvent accessibility (P = 0.0595); Gain of methylation at R251 (P = 0.0943)
7:117176620:G:C,P13569,K254N,0.521,Loss of ubiquitination at K254 (P = 0.0081); Loss of MoRF binding (P = 0.0387); Gain of methylation at R251 (P = 0.0762); Loss of disorder (P = 0.1068); Loss of phosphorylation at S256 (P = 0.1068)
7:117176620:G:T,P13569,K254N,0.521,Loss of ubiquitination at K254 (P = 0.0081); Loss of MoRF binding (P = 0.0387); Gain of methylation at R251 (P = 0.0762); Loss of disorder (P = 0.1068); Loss of phosphorylation at S256 (P = 0.1068)
7:117176621:A:C,P13569,I255L,0.579,Loss of MoRF binding (P = 0.1123); Gain of methylation at R251 (P = 0.1165); Gain of disorder (P = 0.1267); Loss of catalytic residue at I255 (P = 0.1744); Gain of phosphorylation at S256 (P = 0.1875)
7:117176621:A:G,P13569,I255V,0.585,Gain of MoRF binding (P = 0.1118); Gain of methylation at R251 (P = 0.133); Gain of disorder (P = 0.141); Loss of ubiquitination at K254 (P = 0.1975); Gain of phosphorylation at S256 (P = 0.2028)
7:117176621:A:T,P13569,I255F,0.596,Loss of ubiquitination at K254 (P = 0.0796); Gain of methylation at R251 (P = 0.0999); Loss of MoRF binding (P = 0.1012); Loss of catalytic residue at I255 (P = 0.1961); Loss of phosphorylation at S256 (P = 0.2035)
7:117176622:T:A,P13569,I255N,0.648,Gain of disorder (P = 0.0098); Gain of relative solvent accessibility (P = 0.09); Gain of MoRF binding (P = 0.1046); Loss of catalytic residue at I255 (P = 0.1289); Loss of methylation at R251 (P = 0.1354)
7:117176622:T:C,P13569,I255T,0.621,Gain of disorder (P = 0.0142); Gain of phosphorylation at I255 (P = 0.0233); Gain of relative solvent accessibility (P = 0.09); Gain of MoRF binding (P = 0.1354); Gain of methylation at R251 (P = 0.1585)
7:117176622:T:G,P13569,I255S,0.594,Gain of disorder (P = 0.0019); Gain of phosphorylation at I255 (P = 0.0382); Gain of relative solvent accessibility (P = 0.09); Gain of MoRF binding (P = 0.123); Loss of methylation at R251 (P = 0.1303)
7:117176623:C:G,P13569,I255M,0.631,Gain of disorder (P = 0.0458); Gain of MoRF binding (P = 0.071); Gain of methylation at R251 (P = 0.1388); Loss of ubiquitination at K254 (P = 0.1405); Gain of phosphorylation at S256 (P = 0.1464)
7:117176624:A:C,P13569,S256R,0.794,Loss of ubiquitination at K254 (P = 0.0211); Gain of MoRF binding (P = 0.0394); Loss of phosphorylation at S256 (P = 0.0504); Gain of methylation at R251 (P = 0.0781); Loss of disorder (P = 0.1415)
7:117176624:A:G,P13569,S256G,0.812,Loss of phosphorylation at S256 (P = 0.0504); Loss of ubiquitination at K254 (P = 0.0937); Gain of methylation at R251 (P = 0.1057); Loss of MoRF binding (P = 0.1421); Loss of disorder (P = 0.1502)
7:117176624:A:T,P13569,S256C,0.807,Loss of disorder (P = 0.0095); Loss of ubiquitination at K254 (P = 0.0429); Loss of phosphorylation at S256 (P = 0.0504); Loss of MoRF binding (P = 0.0767); Loss of methylation at R251 (P = 0.1117)
7:117176625:G:A,P13569,S256N,0.81,Loss of ubiquitination at K254 (P = 0.0449); Loss of phosphorylation at S256 (P = 0.0504); Loss of disorder (P = 0.1011); Loss of MoRF binding (P = 0.1213); Gain of methylation at R251 (P = 0.1416)
7:117176625:G:C,P13569,S256T,0.82,Loss of ubiquitination at K254 (P = 0.0699); Loss of disorder (P = 0.0868); Loss of MoRF binding (P = 0.1259); Gain of phosphorylation at S256 (P = 0.1412); Gain of methylation at R251 (P = 0.1467)
7:117176625:G:T,P13569,S256I,0.783,Loss of disorder (P = 0.0179); Loss of ubiquitination at K254 (P = 0.0261); Gain of stability (P = 0.0417); Loss of phosphorylation at S256 (P = 0.0504); Gain of MoRF binding (P = 0.1103)
7:117176626:T:A,P13569,S256R,0.794,Loss of ubiquitination at K254 (P = 0.0211); Gain of MoRF binding (P = 0.0394); Loss of phosphorylation at S256 (P = 0.0504); Gain of methylation at R251 (P = 0.0781); Loss of disorder (P = 0.1415)
7:117176626:T:G,P13569,S256R,0.794,Loss of ubiquitination at K254 (P = 0.0211); Gain of MoRF binding (P = 0.0394); Loss of phosphorylation at S256 (P = 0.0504); Gain of methylation at R251 (P = 0.0781); Loss of disorder (P = 0.1415)
7:117176627:G:A,P13569,E257K,0.613,Gain of MoRF binding (P = 0.0056); Loss of ubiquitination at K254 (P = 0.0211); Loss of phosphorylation at S256 (P = 0.1677); Loss of stability (P = 0.1886); Gain of disorder (P = 0.2149)
7:117176627:G:C,P13569,E257Q,0.561,Loss of ubiquitination at K254 (P = 0.0225); Gain of MoRF binding (P = 0.0273); Loss of phosphorylation at S256 (P = 0.1435); Loss of disorder (P = 0.1902); Loss of helix (P = 0.2271)
7:117176628:A:C,P13569,E257A,0.601,Loss of ubiquitination at K254 (P = 0.022); Gain of MoRF binding (P = 0.0285); Loss of disorder (P = 0.0786); Loss of phosphorylation at S256 (P = 0.1426); Loss of stability (P = 0.1776)
7:117176628:A:G,P13569,E257G,0.575,Loss of ubiquitination at K254 (P = 0.0234); Gain of MoRF binding (P = 0.0331); Gain of glycosylation at S256 (P = 0.0381); Gain of methylation at R258 (P = 0.0579); Loss of stability (P = 0.0761)
7:117176628:A:T,P13569,E257V,0.597,Loss of ubiquitination at K254 (P = 0.0225); Gain of MoRF binding (P = 0.0251); Loss of disorder (P = 0.0303); Loss of phosphorylation at S256 (P = 0.1329); Gain of helix (P = 0.2294)
7:117176629:A:C,P13569,E257D,0.54,Gain of MoRF binding (P = 0.1165); Loss of ubiquitination at K254 (P = 0.2243); Gain of disorder (P = 0.2264); Gain of helix (P = 0.2294); Loss of phosphorylation at S256 (P = 0.2296)
7:117176629:A:T,P13569,E257D,0.54,Gain of MoRF binding (P = 0.1165); Loss of ubiquitination at K254 (P = 0.2243); Gain of disorder (P = 0.2264); Gain of helix (P = 0.2294); Loss of phosphorylation at S256 (P = 0.2296)
7:117176631:G:A,P13569,R258K,0.791,Gain of ubiquitination at R258 (P = 0.0211); Loss of catalytic residue at R258 (P = 0.0447); Loss of stability (P = 0.0485); Loss of MoRF binding (P = 0.0751); Gain of disorder (P = 0.1119)
7:117176631:G:C,P13569,R258T,0.815,Loss of MoRF binding (P = 0.0083); Loss of catalytic residue at R258 (P = 0.0255); Loss of stability (P = 0.0623); Loss of phosphorylation at S256 (P = 0.1012); Loss of ubiquitination at K254 (P = 0.1405)
7:117176632:A:C,P13569,R258S,0.758,Loss of MoRF binding (P = 0.0099); Loss of catalytic residue at R258 (P = 0.01); Loss of stability (P = 0.0582); Gain of phosphorylation at R258 (P = 0.062); Gain of disorder (P = 0.0678)
7:117176632:A:T,P13569,R258S,0.758,Loss of MoRF binding (P = 0.0099); Loss of catalytic residue at R258 (P = 0.01); Loss of stability (P = 0.0582); Gain of phosphorylation at R258 (P = 0.062); Gain of disorder (P = 0.0678)
7:117176633:C:A,P13569,L259I,0.558,Loss of catalytic residue at L259 (P = 0.0704); Gain of MoRF binding (P = 0.1074); Gain of glycosylation at S256 (P = 0.1716); Gain of phosphorylation at S256 (P = 0.1886); Loss of ubiquitination at K254 (P = 0.1975)
7:117176633:C:G,P13569,L259V,0.558,Loss of catalytic residue at L259 (P = 0.0772); Gain of MoRF binding (P = 0.0951); Loss of stability (P = 0.1675); Gain of disorder (P = 0.1805); Gain of phosphorylation at S256 (P = 0.2014)
7:117176633:C:T,P13569,L259F,0.589,Loss of catalytic residue at L259 (P = 0.0972); Loss of stability (P = 0.117); Loss of MoRF binding (P = 0.1245); Loss of ubiquitination at K254 (P = 0.1405); Loss of disorder (P = 0.2274)
7:117176634:T:A,P13569,L259H,0.727,Gain of disorder (P = 0.0128); Loss of stability (P = 0.0137); Loss of catalytic residue at L259 (P = 0.064); Loss of MoRF binding (P = 0.0877); Loss of ubiquitination at K254 (P = 0.1672)
7:117176634:T:C,P13569,L259P,0.79,Loss of stability (P = 0.0101); Gain of disorder (P = 0.0105); Loss of MoRF binding (P = 0.0499); Gain of glycosylation at S256 (P = 0.0652); Gain of phosphorylation at S256 (P = 0.1257)
7:117176634:T:G,P13569,L259R,0.764,Gain of disorder (P = 0.0134); Loss of ubiquitination at K254 (P = 0.0211); Loss of stability (P = 0.0232); Gain of MoRF binding (P = 0.0354); Gain of phosphorylation at T262 (P = 0.0612)
7:117176636:G:A,P13569,V260M,0.555,Gain of disorder (P = 0.0767); Loss of stability (P = 0.0772); Gain of MoRF binding (P = 0.0891); Gain of phosphorylation at S256 (P = 0.1626); Loss of helix (P = 0.2022)
7:117176636:G:C,P13569,V260L,0.581,Gain of catalytic residue at V260 (P = 0.0402); Loss of helix (P = 0.079); Loss of MoRF binding (P = 0.0918); Gain of disorder (P = 0.1805); Gain of phosphorylation at S256 (P = 0.1921)
7:117176636:G:T,P13569,V260L,0.581,Gain of catalytic residue at V260 (P = 0.0402); Loss of helix (P = 0.079); Loss of MoRF binding (P = 0.0918); Gain of disorder (P = 0.1805); Gain of phosphorylation at S256 (P = 0.1921)
7:117176637:T:A,P13569,V260E,0.59,Gain of disorder (P = 0.0021); Loss of MoRF binding (P = 0.0401); Loss of stability (P = 0.0519); Loss of catalytic residue at S263 (P = 0.091); Gain of phosphorylation at S256 (P = 0.111)
7:117176637:T:C,P13569,V260A,0.538,Loss of stability (P = 0.0076); Gain of disorder (P = 0.0475); Loss of MoRF binding (P = 0.1306); Gain of phosphorylation at S256 (P = 0.1668); Loss of catalytic residue at S263 (P = 0.1949)
7:117176637:T:G,P13569,V260G,0.572,Loss of stability (P = 2e-04); Gain of disorder (P = 0.0149); Loss of MoRF binding (P = 0.1121); Gain of phosphorylation at S256 (P = 0.1528); Loss of catalytic residue at S263 (P = 0.2692)
7:117176639:A:C,P13569,I261L,0.679,Loss of MoRF binding (P = 0.1266); Loss of catalytic residue at S263 (P = 0.1366); Gain of disorder (P = 0.1901); Gain of phosphorylation at S256 (P = 0.2014); Gain of helix (P = 0.2294)
7:117176639:A:G,P13569,I261V,0.655,Gain of MoRF binding (P = 0.1007); Gain of disorder (P = 0.1911); Loss of catalytic residue at S263 (P = 0.1998); Loss of helix (P = 0.2022); Gain of phosphorylation at S256 (P = 0.2231)
7:117176639:A:T,P13569,I261F,0.688,Loss of MoRF binding (P = 0.1091); Loss of catalytic residue at I261 (P = 0.1305); Loss of helix (P = 0.2022); Gain of phosphorylation at S256 (P = 0.2276); Gain of loop (P = 0.2754)
7:117176640:T:A,P13569,I261N,0.752,Gain of disorder (P = 0.0319); Gain of MoRF binding (P = 0.068); Loss of catalytic residue at I261 (P = 0.0733); Loss of stability (P = 0.1329); Loss of helix (P = 0.2022)
7:117176640:T:C,P13569,I261T,0.733,Gain of disorder (P = 0.033); Loss of stability (P = 0.0505); Gain of MoRF binding (P = 0.0916); Gain of phosphorylation at I261 (P = 0.0972); Loss of helix (P = 0.2022)
7:117176640:T:G,P13569,I261S,0.738,Gain of disorder (P = 0.0035); Gain of phosphorylation at I261 (P = 0.0346); Loss of catalytic residue at I261 (P = 0.0404); Gain of MoRF binding (P = 0.0799); Loss of stability (P = 0.1586)
7:117176641:T:G,P13569,I261M,0.717,Loss of catalytic residue at I261 (P = 0.061); Gain of MoRF binding (P = 0.0646); Gain of disorder (P = 0.0652); Gain of phosphorylation at S256 (P = 0.1609); Gain of helix (P = 0.2294)
7:117176642:A:C,P13569,T262P,0.845,Loss of MoRF binding (P = 0.0669); Gain of loop (P = 0.1069); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2393); Gain of phosphorylation at S263 (P = 0.2606)
7:117176642:A:G,P13569,T262A,0.571,Gain of MoRF binding (P = 0.1005); Gain of helix (P = 0.2294); Gain of disorder (P = 0.3603); Gain of phosphorylation at S263 (P = 0.4031); Loss of catalytic residue at L259 (P = 0.4599)
7:117176642:A:T,P13569,T262S,0.608,Gain of disorder (P = 0.06); Gain of MoRF binding (P = 0.1258); Gain of phosphorylation at T262 (P = 0.1286); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763)
7:117176643:C:A,P13569,T262N,0.702,Gain of MoRF binding (P = 0.1219); Gain of disorder (P = 0.282); Gain of catalytic residue at T262 (P = 0.3174); Gain of loop (P = 0.4661); Gain of phosphorylation at S263 (P = 0.4711)
7:117176643:C:G,P13569,T262S,0.608,Gain of disorder (P = 0.06); Gain of MoRF binding (P = 0.1258); Gain of phosphorylation at T262 (P = 0.1286); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763)
7:117176643:C:T,P13569,T262I,0.643,Gain of MoRF binding (P = 0.1166); Loss of disorder (P = 0.2032); Gain of helix (P = 0.2294); Gain of catalytic residue at T262 (P = 0.449); Gain of phosphorylation at S263 (P = 0.4818)
7:117176645:T:A,P13569,S263T,0.741,Loss of MoRF binding (P = 0.1218); Loss of helix (P = 0.1299); Loss of catalytic residue at L259 (P = 0.1435); Loss of phosphorylation at S263 (P = 0.3314); Loss of disorder (P = 0.3341)
7:117176645:T:C,P13569,S263P,0.788,Loss of MoRF binding (P = 0.0679); Loss of helix (P = 0.1299); Loss of catalytic residue at L259 (P = 0.1664); Gain of loop (P = 0.2045); Gain of phosphorylation at T262 (P = 0.2793)
7:117176645:T:G,P13569,S263A,0.723,Loss of catalytic residue at S263 (P = 0.0923); Gain of MoRF binding (P = 0.1078); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2865)
7:117176646:C:T,P13569,S263L,0.741,Loss of catalytic residue at L259 (P = 0.1298); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1341); Gain of stability (P = 0.1629); Loss of disorder (P = 0.189)
7:117176648:G:A,P13569,E264K,0.894,Gain of MoRF binding (P = 0.0011); Gain of ubiquitination at E264 (P = 0.0337); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of helix (P = 0.1299)
7:117176648:G:C,P13569,E264Q,0.907,Gain of MoRF binding (P = 0.0237); Loss of loop (P = 0.2237); Loss of catalytic residue at N268 (P = 0.3655); Loss of helix (P = 0.3949); Loss of disorder (P = 0.4191)
7:117176649:A:C,P13569,E264A,0.909,Gain of MoRF binding (P = 0.0299); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2728); Loss of catalytic residue at E264 (P = 0.3191); Loss of phosphorylation at S263 (P = 0.4221)
7:117176649:A:G,P13569,E264G,0.924,Gain of MoRF binding (P = 0.0351); Gain of glycosylation at S263 (P = 0.1228); Loss of stability (P = 0.1459); Gain of catalytic residue at I266 (P = 0.1572); Loss of disorder (P = 0.3461)
7:117176649:A:T,P13569,E264V,0.886,Gain of MoRF binding (P = 0.029); Loss of helix (P = 0.1299); Gain of catalytic residue at E267 (P = 0.1635); Loss of disorder (P = 0.1673); Loss of phosphorylation at S263 (P = 0.4248)
7:117176650:A:C,P13569,E264D,0.91,Gain of MoRF binding (P = 0.1409); Loss of disorder (P = 0.3848); Loss of helix (P = 0.3949); Loss of stability (P = 0.4158); Loss of phosphorylation at S263 (P = 0.4737)
7:117176650:A:T,P13569,E264D,0.91,Gain of MoRF binding (P = 0.1409); Loss of disorder (P = 0.3848); Loss of helix (P = 0.3949); Loss of stability (P = 0.4158); Loss of phosphorylation at S263 (P = 0.4737)
7:117176651:A:C,P13569,M265L,0.708,Loss of MoRF binding (P = 0.0894); Gain of helix (P = 0.132); Loss of catalytic residue at I269 (P = 0.289); Loss of disorder (P = 0.3602); Loss of phosphorylation at S263 (P = 0.4955)
7:117176651:A:G,P13569,M265V,0.709,Loss of MoRF binding (P = 0.1121); Gain of helix (P = 0.132); Loss of catalytic residue at I269 (P = 0.2949); Loss of disorder (P = 0.3558); Gain of phosphorylation at S263 (P = 0.4923)
7:117176651:A:T,P13569,M265L,0.708,Loss of MoRF binding (P = 0.0894); Gain of helix (P = 0.132); Loss of catalytic residue at I269 (P = 0.289); Loss of disorder (P = 0.3602); Loss of phosphorylation at S263 (P = 0.4955)
7:117176652:T:A,P13569,M265K,0.768,Gain of ubiquitination at M265 (P = 0.0289); Gain of disorder (P = 0.0505); Loss of stability (P = 0.0535); Gain of MoRF binding (P = 0.0547); Gain of helix (P = 0.132)
7:117176652:T:C,P13569,M265T,0.715,Loss of MoRF binding (P = 0.0978); Loss of stability (P = 0.1414); Gain of disorder (P = 0.266); Loss of catalytic residue at I269 (P = 0.268); Loss of helix (P = 0.3949)
7:117176652:T:G,P13569,M265R,0.914,Gain of MoRF binding (P = 0.0309); Gain of phosphorylation at S263 (P = 0.1133); Gain of helix (P = 0.132); Gain of disorder (P = 0.1506); Gain of catalytic residue at M265 (P = 0.2081)
7:117176653:G:A,P13569,M265I,0.72,Loss of MoRF binding (P = 0.0954); Loss of catalytic residue at I269 (P = 0.2909); Loss of disorder (P = 0.344); Loss of helix (P = 0.3949); Gain of phosphorylation at S263 (P = 0.4504)
7:117176653:G:C,P13569,M265I,0.72,Loss of MoRF binding (P = 0.0954); Loss of catalytic residue at I269 (P = 0.2909); Loss of disorder (P = 0.344); Loss of helix (P = 0.3949); Gain of phosphorylation at S263 (P = 0.4504)
7:117176653:G:T,P13569,M265I,0.72,Loss of MoRF binding (P = 0.0954); Loss of catalytic residue at I269 (P = 0.2909); Loss of disorder (P = 0.344); Loss of helix (P = 0.3949); Gain of phosphorylation at S263 (P = 0.4504)
7:117176654:A:C,P13569,I266L,0.609,Gain of catalytic residue at I266 (P = 0.0446); Loss of MoRF binding (P = 0.1717); Gain of loop (P = 0.2045); Gain of disorder (P = 0.3694); Loss of helix (P = 0.3949)
7:117176654:A:G,P13569,I266V,0.624,Gain of catalytic residue at I266 (P = 0.0767); Gain of MoRF binding (P = 0.1357); Gain of loop (P = 0.2045); Gain of disorder (P = 0.3751); Loss of helix (P = 0.3949)
7:117176654:A:T,P13569,I266F,0.767,Loss of MoRF binding (P = 0.1465); Gain of loop (P = 0.2045); Loss of stability (P = 0.3392); Gain of catalytic residue at I266 (P = 0.3761); Loss of helix (P = 0.3949)
7:117176655:T:A,P13569,I266N,0.857,Gain of disorder (P = 0.0226); Loss of stability (P = 0.0869); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1534); Gain of loop (P = 0.2045)
7:117176655:T:C,P13569,I266T,0.849,Loss of stability (P = 0.0272); Gain of disorder (P = 0.0394); Gain of MoRF binding (P = 0.1821); Gain of phosphorylation at T262 (P = 0.2039); Gain of loop (P = 0.2045)
7:117176655:T:G,P13569,I266S,0.853,Gain of disorder (P = 0.0055); Loss of stability (P = 0.0855); Gain of phosphorylation at I266 (P = 0.1168); Gain of MoRF binding (P = 0.1559); Gain of loop (P = 0.2045)
7:117176656:T:G,P13569,I266M,0.725,Gain of catalytic residue at I266 (P = 0.0119); Gain of disorder (P = 0.047); Gain of MoRF binding (P = 0.0852); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117176657:G:A,P13569,E267K,0.568,Gain of MoRF binding (P = 0.0035); Gain of methylation at E267 (P = 0.025); Gain of ubiquitination at E267 (P = 0.0351); Gain of relative solvent accessibility (P = 0.1894); Gain of catalytic residue at E267 (P = 0.1966)
7:117176657:G:C,P13569,E267Q,0.441,Gain of MoRF binding (P = 0.0381); Loss of helix (P = 0.2271); Loss of disorder (P = 0.4215); Loss of phosphorylation at S263 (P = 0.4408); Gain of solvent accessibility (P = 0.5843)
7:117176658:A:C,P13569,E267A,0.512,Gain of MoRF binding (P = 0.0476); Loss of helix (P = 0.2271); Loss of disorder (P = 0.2877); Loss of solvent accessibility (P = 0.3543); Gain of catalytic residue at E264 (P = 0.4095)
7:117176658:A:G,P13569,E267G,0.531,Gain of catalytic residue at E267 (P = 0.045); Gain of MoRF binding (P = 0.0523); Loss of stability (P = 0.1113); Loss of solvent accessibility (P = 0.2732); Loss of disorder (P = 0.3371)
7:117176658:A:T,P13569,E267V,0.584,Gain of catalytic residue at E267 (P = 0.0295); Gain of MoRF binding (P = 0.05); Gain of helix (P = 0.132); Loss of disorder (P = 0.1751); Loss of loop (P = 0.2237)
7:117176659:A:C,P13569,E267D,0.399,Gain of relative solvent accessibility (P = 0.1894); Loss of MoRF binding (P = 0.2149); Loss of helix (P = 0.2271); Loss of disorder (P = 0.3763); Gain of catalytic residue at E264 (P = 0.447)
7:117176659:A:T,P13569,E267D,0.399,Gain of relative solvent accessibility (P = 0.1894); Loss of MoRF binding (P = 0.2149); Loss of helix (P = 0.2271); Loss of disorder (P = 0.3763); Gain of catalytic residue at E264 (P = 0.447)
7:117176660:A:C,P13569,N268H,0.92,Gain of catalytic residue at I266 (P = 0.1113); Gain of ubiquitination at K273 (P = 0.1191); Loss of methylation at K273 (P = 0.1241); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117176660:A:G,P13569,N268D,0.896,Gain of relative solvent accessibility (P = 0.0479); Loss of catalytic residue at N268 (P = 0.0654); Gain of solvent accessibility (P = 0.0704); Loss of MoRF binding (P = 0.1298); Loss of helix (P = 0.1299)
7:117176660:A:T,P13569,N268Y,0.879,Gain of phosphorylation at N268 (P = 0.069); Loss of catalytic residue at N268 (P = 0.0749); Gain of ubiquitination at K273 (P = 0.0982); Gain of helix (P = 0.132); Loss of methylation at K273 (P = 0.1649)
7:117176661:A:C,P13569,N268T,0.91,Loss of helix (P = 0.079); Loss of catalytic residue at N268 (P = 0.1163); Gain of methylation at K273 (P = 0.1497); Gain of ubiquitination at K273 (P = 0.1679); Loss of MoRF binding (P = 0.2492)
7:117176661:A:G,P13569,N268S,0.888,Gain of disorder (P = 0.0866); Gain of phosphorylation at N268 (P = 0.0972); Gain of methylation at K273 (P = 0.1329); Loss of ubiquitination at K273 (P = 0.1923); Loss of catalytic residue at N268 (P = 0.2182)
7:117176661:A:T,P13569,N268I,0.91,Loss of catalytic residue at N268 (P = 0.1014); Gain of ubiquitination at K273 (P = 0.143); Loss of methylation at K273 (P = 0.1462); Loss of loop (P = 0.2237); Loss of helix (P = 0.2271)
7:117176662:T:A,P13569,N268K,0.883,Gain of methylation at N268 (P = 0.0225); Gain of solvent accessibility (P = 0.0354); Gain of ubiquitination at N268 (P = 0.0369); Gain of relative solvent accessibility (P = 0.0479); Gain of MoRF binding (P = 0.048)
7:117176662:T:G,P13569,N268K,0.883,Gain of methylation at N268 (P = 0.0225); Gain of solvent accessibility (P = 0.0354); Gain of ubiquitination at N268 (P = 0.0369); Gain of relative solvent accessibility (P = 0.0479); Gain of MoRF binding (P = 0.048)
7:117176663:A:C,P13569,I269L,0.699,Loss of methylation at K273 (P = 0.0666); Gain of helix (P = 0.132); Gain of ubiquitination at K273 (P = 0.143); Loss of catalytic residue at I269 (P = 0.2432); Loss of MoRF binding (P = 0.2742)
7:117176663:A:G,P13569,I269V,0.674,Loss of methylation at K273 (P = 0.1269); Gain of helix (P = 0.132); Gain of ubiquitination at K273 (P = 0.1679); Gain of MoRF binding (P = 0.2531); Gain of disorder (P = 0.3785)
7:117176663:A:T,P13569,I269F,0.784,Loss of methylation at K273 (P = 0.099); Gain of catalytic residue at I269 (P = 0.1656); Loss of ubiquitination at K273 (P = 0.1923); Loss of MoRF binding (P = 0.2632); Loss of helix (P = 0.3949)
7:117176664:T:A,P13569,I269N,0.862,Gain of disorder (P = 0.0332); Loss of stability (P = 0.0875); Gain of methylation at K273 (P = 0.1496); Loss of ubiquitination at K273 (P = 0.1923); Loss of helix (P = 0.2022)
7:117176664:T:G,P13569,I269S,0.854,Gain of disorder (P = 0.0089); Gain of methylation at K273 (P = 0.1277); Gain of ubiquitination at K273 (P = 0.143); Loss of stability (P = 0.1633); Gain of phosphorylation at I269 (P = 0.1676)
7:117176665:C:G,P13569,I269M,0.823,Gain of disorder (P = 0.0454); Gain of methylation at K273 (P = 0.1405); Gain of ubiquitination at K273 (P = 0.1679); Gain of MoRF binding (P = 0.2145); Gain of helix (P = 0.2294)
7:117176666:C:A,P13569,Q270K,0.484,Loss of catalytic residue at Q270 (P = 0.0054); Gain of methylation at Q270 (P = 0.0263); Gain of ubiquitination at Q270 (P = 0.0337); Gain of MoRF binding (P = 0.0754); Loss of stability (P = 0.1505)
7:117176666:C:G,P13569,Q270E,0.544,Loss of catalytic residue at Q270 (P = 0.001); Loss of methylation at K273 (P = 0.107); Gain of helix (P = 0.132); Loss of ubiquitination at K273 (P = 0.1778); Gain of disorder (P = 0.1998)
7:117176667:A:C,P13569,Q270P,0.57,Gain of ubiquitination at K273 (P = 0.143); Loss of stability (P = 0.167); Gain of methylation at K273 (P = 0.1826); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.259)
7:117176667:A:G,P13569,Q270R,0.466,Loss of catalytic residue at Q270 (P = 0.0331); Gain of MoRF binding (P = 0.0352); Loss of methylation at K273 (P = 0.0988); Gain of helix (P = 0.132); Loss of ubiquitination at K273 (P = 0.1923)
7:117176667:A:T,P13569,Q270L,0.557,Loss of methylation at K273 (P = 0.0616); Gain of ubiquitination at K273 (P = 0.0846); Gain of helix (P = 0.132); Gain of catalytic residue at S271 (P = 0.175); Loss of disorder (P = 0.2873)
7:117176668:A:C,P13569,Q270H,0.52,Loss of catalytic residue at Q270 (P = 0.0028); Loss of methylation at K273 (P = 0.0916); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132); Loss of stability (P = 0.1589)
7:117176668:A:T,P13569,Q270H,0.52,Loss of catalytic residue at Q270 (P = 0.0028); Loss of methylation at K273 (P = 0.0916); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132); Loss of stability (P = 0.1589)
7:117176669:T:A,P13569,S271T,0.629,Gain of catalytic residue at S271 (P = 0.0502); Gain of ubiquitination at K273 (P = 0.0751); Gain of helix (P = 0.132); Gain of phosphorylation at S271 (P = 0.1373); Gain of methylation at K273 (P = 0.15)
7:117176669:T:C,P13569,S271P,0.768,Gain of catalytic residue at S271 (P = 0.0435); Gain of methylation at K273 (P = 0.1); Gain of helix (P = 0.132); Loss of ubiquitination at K273 (P = 0.1923); Loss of MoRF binding (P = 0.2985)
7:117176669:T:G,P13569,S271A,0.676,Gain of ubiquitination at K273 (P = 0.0846); Gain of helix (P = 0.132); Gain of catalytic residue at S271 (P = 0.152); Gain of methylation at K273 (P = 0.175); Loss of MoRF binding (P = 0.3467)
7:117176670:C:A,P13569,S271Y,0.742,Loss of methylation at K273 (P = 0.0989); Gain of ubiquitination at K273 (P = 0.1191); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2152); Loss of MoRF binding (P = 0.3342)
7:117176670:C:G,P13569,S271C,0.754,Gain of methylation at K273 (P = 0.1072); Loss of helix (P = 0.1299); Gain of ubiquitination at K273 (P = 0.1679); Gain of catalytic residue at I269 (P = 0.1685); Loss of disorder (P = 0.2438)
7:117176670:C:T,P13569,S271F,0.772,Gain of ubiquitination at K273 (P = 0.0982); Gain of methylation at K273 (P = 0.1177); Gain of helix (P = 0.132); Loss of disorder (P = 0.1728); Loss of loop (P = 0.2237)
7:117176672:G:A,P13569,V272I,0.798,Loss of methylation at K273 (P = 0.064); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Gain of catalytic residue at V272 (P = 0.208)
7:117176672:G:C,P13569,V272L,0.836,Loss of methylation at K273 (P = 0.0359); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Loss of catalytic residue at V272 (P = 0.2532)
7:117176672:G:T,P13569,V272F,0.848,Gain of ubiquitination at K273 (P = 0.0751); Gain of methylation at K273 (P = 0.1197); Loss of helix (P = 0.2022); Loss of stability (P = 0.2886); Loss of catalytic residue at V272 (P = 0.3429)
7:117176673:T:A,P13569,V272D,0.898,Loss of methylation at K273 (P = 0.0386); Gain of disorder (P = 0.0546); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132); Gain of phosphorylation at Y275 (P = 0.1456)
7:117176673:T:C,P13569,V272A,0.873,Loss of methylation at K273 (P = 0.0376); Loss of stability (P = 0.0684); Gain of disorder (P = 0.1032); Gain of helix (P = 0.132); Gain of ubiquitination at K273 (P = 0.1679)
7:117176673:T:G,P13569,V272G,0.864,Loss of stability (P = 0.0063); Loss of methylation at K273 (P = 0.042); Gain of glycosylation at S271 (P = 0.0585); Gain of disorder (P = 0.0905); Gain of helix (P = 0.132)
7:117176675:A:C,P13569,K273Q,0.775,Loss of methylation at K273 (P = 0.013); Loss of ubiquitination at K273 (P = 0.0297); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.3714)
7:117176675:A:G,P13569,K273E,0.763,Loss of methylation at K273 (P = 0.013); Loss of ubiquitination at K273 (P = 0.0297); Loss of helix (P = 0.1299); Loss of loop (P = 0.2237); Gain of catalytic residue at K273 (P = 0.299)
7:117176676:A:C,P13569,K273T,0.761,Loss of methylation at K273 (P = 0.013); Loss of ubiquitination at K273 (P = 0.0297); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1551); Loss of relative solvent accessibility (P = 0.3219)
7:117176676:A:G,P13569,K273R,0.728,Loss of methylation at K273 (P = 0.0151); Loss of ubiquitination at K273 (P = 0.0297); Gain of catalytic residue at K273 (P = 0.0395); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.3297)
7:117176676:A:T,P13569,K273M,0.761,Loss of methylation at K273 (P = 0.013); Gain of catalytic residue at K273 (P = 0.0193); Loss of ubiquitination at K273 (P = 0.0297); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.1551)
7:117176677:G:C,P13569,K273N,0.78,Loss of methylation at K273 (P = 0.013); Gain of catalytic residue at K273 (P = 0.0252); Loss of ubiquitination at K273 (P = 0.0297); Loss of helix (P = 0.1299); Loss of loop (P = 0.2237)
7:117176677:G:T,P13569,K273N,0.78,Loss of methylation at K273 (P = 0.013); Gain of catalytic residue at K273 (P = 0.0252); Loss of ubiquitination at K273 (P = 0.0297); Loss of helix (P = 0.1299); Loss of loop (P = 0.2237)
7:117176678:G:A,P13569,A274T,0.803,Gain of methylation at K273 (P = 0.1598); Loss of ubiquitination at K273 (P = 0.1923); Loss of loop (P = 0.2237); Loss of catalytic residue at A274 (P = 0.234); Loss of stability (P = 0.3002)
7:117176678:G:C,P13569,A274P,0.865,Gain of methylation at K273 (P = 0.1129); Gain of helix (P = 0.132); Loss of ubiquitination at K273 (P = 0.1778); Loss of stability (P = 0.1798); Loss of loop (P = 0.2237)
7:117176678:G:T,P13569,A274S,0.783,Gain of disorder (P = 0.0775); Loss of methylation at K273 (P = 0.114); Gain of helix (P = 0.132); Gain of phosphorylation at A274 (P = 0.134); Loss of ubiquitination at K273 (P = 0.1612)
7:117176679:C:A,P13569,A274E,0.845,Gain of disorder (P = 0.0828); Gain of helix (P = 0.132); Loss of methylation at K273 (P = 0.1521); Loss of ubiquitination at K273 (P = 0.1923); Loss of loop (P = 0.2237)
7:117176679:C:G,P13569,A274G,0.801,Gain of helix (P = 0.0854); Loss of stability (P = 0.1648); Gain of methylation at K273 (P = 0.1709); Loss of ubiquitination at K273 (P = 0.1778); Loss of loop (P = 0.2237)
7:117176679:C:T,P13569,A274V,0.8,Gain of methylation at K273 (P = 0.0499); Gain of ubiquitination at K273 (P = 0.0846); Gain of helix (P = 0.0854); Gain of catalytic residue at E278 (P = 0.2093); Gain of MoRF binding (P = 0.4203)
7:117176681:T:A,P13569,Y275N,0.828,Gain of disorder (P = 0.0412); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132); Gain of methylation at K273 (P = 0.185); Loss of stability (P = 0.1858)
7:117176681:T:C,P13569,Y275H,0.819,Loss of stability (P = 0.0855); Gain of disorder (P = 0.1068); Gain of methylation at K273 (P = 0.1241); Loss of ubiquitination at K273 (P = 0.1612); Gain of loop (P = 0.2045)
7:117176681:T:G,P13569,Y275D,0.822,Gain of disorder (P = 0.0567); Loss of methylation at K273 (P = 0.0615); Gain of helix (P = 0.132); Gain of ubiquitination at K273 (P = 0.1679); Loss of stability (P = 0.2046)
7:117176682:A:C,P13569,Y275S,0.842,Gain of disorder (P = 0.0102); Loss of stability (P = 0.0838); Gain of phosphorylation at Y275 (P = 0.1132); Loss of methylation at K273 (P = 0.1175); Gain of helix (P = 0.132)
7:117176682:A:G,P13569,Y275C,0.838,Gain of methylation at K273 (P = 0.0993); Gain of ubiquitination at K273 (P = 0.143); Gain of disorder (P = 0.1891); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117176682:A:T,P13569,Y275F,0.627,Gain of ubiquitination at K273 (P = 0.0688); Gain of methylation at K273 (P = 0.095); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of glycosylation at K273 (P = 0.4382)
7:117176684:T:A,P13569,C276S,0.479,Gain of disorder (P = 0.0081); Loss of catalytic residue at W277 (P = 0.0441); Gain of phosphorylation at C276 (P = 0.0623); Loss of methylation at K273 (P = 0.0808); Loss of helix (P = 0.1299)
7:117176684:T:C,P13569,C276R,0.521,Loss of catalytic residue at W277 (P = 0.0052); Gain of disorder (P = 0.0332); Gain of MoRF binding (P = 0.0379); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09)
7:117176684:T:G,P13569,C276G,0.472,Gain of disorder (P = 0.0575); Loss of helix (P = 0.079); Loss of methylation at K273 (P = 0.1035); Loss of stability (P = 0.1377); Loss of ubiquitination at K273 (P = 0.1612)
7:117176685:G:A,P13569,C276Y,0.408,Loss of catalytic residue at W277 (P = 0.049); Loss of methylation at K273 (P = 0.0825); Loss of helix (P = 0.1299); Loss of ubiquitination at K273 (P = 0.1923); Gain of disorder (P = 0.2713)
7:117176685:G:C,P13569,C276S,0.479,Gain of disorder (P = 0.0081); Loss of catalytic residue at W277 (P = 0.0441); Gain of phosphorylation at C276 (P = 0.0623); Loss of methylation at K273 (P = 0.0808); Loss of helix (P = 0.1299)
7:117176685:G:T,P13569,C276F,0.421,Loss of catalytic residue at W277 (P = 0.0635); Loss of methylation at K273 (P = 0.0844); Gain of ubiquitination at K273 (P = 0.1191); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.4192)
7:117176686:C:G,P13569,C276W,0.479,Loss of catalytic residue at W277 (P = 0.0497); Gain of MoRF binding (P = 0.0851); Loss of methylation at K273 (P = 0.1103); Loss of helix (P = 0.1299); Gain of ubiquitination at K273 (P = 0.143)
7:117176687:T:A,P13569,W277R,0.85,Gain of disorder (P = 0.0028); Loss of catalytic residue at W277 (P = 0.0056); Gain of solvent accessibility (P = 0.0584); Loss of methylation at K273 (P = 0.0585); Gain of ubiquitination at K273 (P = 0.0751)
7:117176687:T:C,P13569,W277R,0.85,Gain of disorder (P = 0.0028); Loss of catalytic residue at W277 (P = 0.0056); Gain of solvent accessibility (P = 0.0584); Loss of methylation at K273 (P = 0.0585); Gain of ubiquitination at K273 (P = 0.0751)
7:117176687:T:G,P13569,W277G,0.714,Loss of catalytic residue at W277 (P = 0.0082); Gain of disorder (P = 0.0127); Gain of relative solvent accessibility (P = 0.09); Loss of methylation at K273 (P = 0.1138); Gain of ubiquitination at K273 (P = 0.143)
7:117176688:G:C,P13569,W277S,0.663,Loss of catalytic residue at W277 (P = 1e-04); Gain of disorder (P = 4e-04); Gain of phosphorylation at W277 (P = 0.06); Gain of ubiquitination at K273 (P = 0.0626); Loss of methylation at K273 (P = 0.0862)
7:117176688:G:T,P13569,W277L,0.666,Loss of methylation at K273 (P = 0.087); Gain of disorder (P = 0.1155); Gain of ubiquitination at K273 (P = 0.143); Gain of loop (P = 0.2045); Gain of stability (P = 0.2636)
7:117176689:G:C,P13569,W277C,0.67,Loss of catalytic residue at W277 (P = 0.0427); Gain of disorder (P = 0.0614); Gain of relative solvent accessibility (P = 0.09); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132)
7:117176689:G:T,P13569,W277C,0.67,Loss of catalytic residue at W277 (P = 0.0427); Gain of disorder (P = 0.0614); Gain of relative solvent accessibility (P = 0.09); Gain of ubiquitination at K273 (P = 0.1191); Gain of helix (P = 0.132)
7:117176690:G:A,P13569,E278K,0.752,Gain of methylation at E278 (P = 0.0231); Gain of MoRF binding (P = 0.0238); Gain of ubiquitination at E278 (P = 0.0238); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2601)
7:117176690:G:C,P13569,E278Q,0.714,Loss of ubiquitination at K283 (P = 0.1151); Gain of methylation at K273 (P = 0.1547); Gain of MoRF binding (P = 0.2154); Loss of helix (P = 0.2271); Gain of relative solvent accessibility (P = 0.2363)
7:117176691:A:C,P13569,E278A,0.772,Gain of ubiquitination at K273 (P = 0.0982); Loss of methylation at K273 (P = 0.1607); Gain of catalytic residue at Y275 (P = 0.2); Loss of helix (P = 0.2271); Loss of disorder (P = 0.249)
7:117176691:A:G,P13569,E278G,0.752,Loss of ubiquitination at K283 (P = 0.0982); Gain of methylation at K273 (P = 0.16); Gain of catalytic residue at Y275 (P = 0.1974); Loss of helix (P = 0.2271); Gain of relative solvent accessibility (P = 0.2363)
7:117176691:A:T,P13569,E278V,0.75,Gain of ubiquitination at K273 (P = 0.0846); Gain of methylation at K273 (P = 0.1246); Loss of disorder (P = 0.1308); Gain of helix (P = 0.132); Gain of catalytic residue at E278 (P = 0.1362)
7:117176692:A:C,P13569,E278D,0.714,Loss of ubiquitination at K283 (P = 0.1151); Loss of helix (P = 0.1299); Loss of methylation at K273 (P = 0.1483); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363)
7:117176692:A:T,P13569,E278D,0.714,Loss of ubiquitination at K283 (P = 0.1151); Loss of helix (P = 0.1299); Loss of methylation at K273 (P = 0.1483); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363)
7:117176693:G:A,P13569,E279K,0.472,Gain of methylation at E279 (P = 0.0199); Gain of ubiquitination at E279 (P = 0.0203); Gain of MoRF binding (P = 0.0237); Gain of glycosylation at E279 (P = 0.2233); Loss of disorder (P = 0.2768)
7:117176693:G:C,P13569,E279Q,0.344,Loss of ubiquitination at K283 (P = 0.0982); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1849); Loss of disorder (P = 0.2682); Loss of glycosylation at K283 (P = 0.3421)
7:117176694:A:C,P13569,E279A,0.448,Gain of ubiquitination at K283 (P = 0.1181); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1807); Loss of solvent accessibility (P = 0.239); Gain of MoRF binding (P = 0.2522)
7:117176694:A:G,P13569,E279G,0.495,Loss of ubiquitination at K283 (P = 0.0982); Loss of solvent accessibility (P = 0.1115); Loss of helix (P = 0.1299); Loss of stability (P = 0.1584); Gain of loop (P = 0.2045)
7:117176694:A:T,P13569,E279V,0.534,Gain of catalytic residue at E279 (P = 0.0405); Loss of disorder (P = 0.0831); Loss of ubiquitination at K283 (P = 0.1151); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1322)
7:117176695:A:C,P13569,E279D,0.387,Loss of ubiquitination at K283 (P = 0.1151); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2303); Loss of glycosylation at K283 (P = 0.3654)
7:117176695:A:T,P13569,E279D,0.387,Loss of ubiquitination at K283 (P = 0.1151); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2303); Loss of glycosylation at K283 (P = 0.3654)
7:117176696:G:A,P13569,A280T,0.361,Gain of phosphorylation at A280 (P = 0.0879); Gain of ubiquitination at K283 (P = 0.1181); Gain of helix (P = 0.132); Gain of disorder (P = 0.1414); Loss of glycosylation at K283 (P = 0.2927)
7:117176696:G:C,P13569,A280P,0.579,Gain of catalytic residue at A280 (P = 0.0135); Gain of glycosylation at A280 (P = 0.0155); Gain of disorder (P = 0.1134); Gain of ubiquitination at K283 (P = 0.1181); Gain of loop (P = 0.2045)
7:117176696:G:T,P13569,A280S,0.389,Gain of disorder (P = 0.0488); Gain of phosphorylation at A280 (P = 0.0837); Gain of ubiquitination at K283 (P = 0.1047); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2629)
7:117176697:C:A,P13569,A280E,0.484,Gain of disorder (P = 0.0284); Loss of ubiquitination at K283 (P = 0.1151); Gain of solvent accessibility (P = 0.194); Gain of loop (P = 0.2045); Gain of helix (P = 0.2294)
7:117176697:C:G,P13569,A280G,0.473,Gain of ubiquitination at K283 (P = 0.1181); Gain of disorder (P = 0.1464); Loss of stability (P = 0.1494); Gain of loop (P = 0.2045); Gain of glycosylation at K283 (P = 0.2519)
7:117176697:C:T,P13569,A280V,0.449,Gain of catalytic residue at A280 (P = 0.0041); Loss of ubiquitination at K283 (P = 0.1151); Gain of helix (P = 0.132); Loss of disorder (P = 0.1546); Loss of glycosylation at K283 (P = 0.2837)
7:117176699:A:C,P13569,M281L,0.782,Loss of ubiquitination at K283 (P = 0.1151); Gain of helix (P = 0.132); Loss of catalytic residue at M281 (P = 0.1375); Loss of disorder (P = 0.1766); Loss of glycosylation at K283 (P = 0.3355)
7:117176699:A:G,P13569,M281V,0.775,Gain of helix (P = 0.132); Loss of ubiquitination at K283 (P = 0.1343); Loss of disorder (P = 0.1345); Loss of catalytic residue at I285 (P = 0.2687); Loss of glycosylation at K283 (P = 0.2862)
7:117176699:A:T,P13569,M281L,0.782,Loss of ubiquitination at K283 (P = 0.1151); Gain of helix (P = 0.132); Loss of catalytic residue at M281 (P = 0.1375); Loss of disorder (P = 0.1766); Loss of glycosylation at K283 (P = 0.3355)
7:117176700:T:A,P13569,M281K,0.805,Gain of ubiquitination at M281 (P = 0.0192); Gain of disorder (P = 0.0303); Loss of stability (P = 0.0595); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09)
7:117176700:T:C,P13569,M281T,0.93,Gain of ubiquitination at K283 (P = 0.0743); Loss of stability (P = 0.0936); Loss of catalytic residue at M281 (P = 0.1401); Gain of disorder (P = 0.1515); Gain of phosphorylation at M281 (P = 0.1762)
7:117176700:T:G,P13569,M281R,0.84,Gain of ubiquitination at K283 (P = 0.0645); Gain of disorder (P = 0.1035); Loss of stability (P = 0.1313); Loss of catalytic residue at M281 (P = 0.1392); Loss of helix (P = 0.2271)
7:117176701:G:A,P13569,M281I,0.789,Loss of disorder (P = 0.1231); Gain of helix (P = 0.132); Loss of ubiquitination at K283 (P = 0.1343); Loss of catalytic residue at M281 (P = 0.1999); Loss of glycosylation at K283 (P = 0.3249)
7:117176701:G:C,P13569,M281I,0.789,Loss of disorder (P = 0.1231); Gain of helix (P = 0.132); Loss of ubiquitination at K283 (P = 0.1343); Loss of catalytic residue at M281 (P = 0.1999); Loss of glycosylation at K283 (P = 0.3249)
7:117176701:G:T,P13569,M281I,0.789,Loss of disorder (P = 0.1231); Gain of helix (P = 0.132); Loss of ubiquitination at K283 (P = 0.1343); Loss of catalytic residue at M281 (P = 0.1999); Loss of glycosylation at K283 (P = 0.3249)
7:117176702:G:A,P13569,E282K,0.507,Gain of MoRF binding (P = 0.0103); Gain of ubiquitination at E282 (P = 0.0276); Gain of glycosylation at E282 (P = 0.142); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363)
7:117176702:G:C,P13569,E282Q,0.427,Gain of MoRF binding (P = 0.0719); Loss of ubiquitination at K283 (P = 0.0747); Gain of catalytic residue at E282 (P = 0.117); Gain of helix (P = 0.132); Loss of disorder (P = 0.1947)
7:117176703:A:C,P13569,E282A,0.466,Loss of ubiquitination at K283 (P = 0.0853); Loss of disorder (P = 0.0983); Gain of MoRF binding (P = 0.1092); Gain of loop (P = 0.2045); Loss of glycosylation at K283 (P = 0.3348)
7:117176703:A:G,P13569,E282G,0.495,Loss of ubiquitination at K283 (P = 0.0747); Loss of stability (P = 0.1096); Gain of MoRF binding (P = 0.1286); Loss of disorder (P = 0.1429); Gain of loop (P = 0.2045)
7:117176703:A:T,P13569,E282V,0.501,Loss of disorder (P = 0.0428); Loss of ubiquitination at K283 (P = 0.0613); Gain of MoRF binding (P = 0.0958); Gain of helix (P = 0.2294); Loss of glycosylation at K283 (P = 0.2368)
7:117176704:A:C,P13569,E282D,0.45,Loss of ubiquitination at K283 (P = 0.0747); Loss of disorder (P = 0.1765); Gain of catalytic residue at N287 (P = 0.2801); Loss of glycosylation at K283 (P = 0.3227); Loss of MoRF binding (P = 0.3252)
7:117176705:A:C,P13569,K283Q,0.364,Loss of ubiquitination at K283 (P = 0.0161); Loss of glycosylation at K283 (P = 0.0713); Loss of MoRF binding (P = 0.2056); Loss of disorder (P = 0.2637); Loss of helix (P = 0.3949)
7:117176705:A:G,P13569,K283E,0.368,Loss of ubiquitination at K283 (P = 0.0161); Loss of glycosylation at K283 (P = 0.0713); Loss of MoRF binding (P = 0.1249); Gain of disorder (P = 0.1295); Loss of helix (P = 0.2022)
7:117176706:A:C,P13569,K283T,0.456,Loss of ubiquitination at K283 (P = 0.0161); Loss of glycosylation at K283 (P = 0.0897); Gain of helix (P = 0.132); Loss of disorder (P = 0.1621); Loss of MoRF binding (P = 0.1892)
7:117176706:A:G,P13569,K283R,0.357,Loss of ubiquitination at K283 (P = 0.0161); Loss of glycosylation at K283 (P = 0.0713); Gain of MoRF binding (P = 0.1818); Loss of disorder (P = 0.2141); Loss of helix (P = 0.3949)
7:117176706:A:T,P13569,K283I,0.461,Loss of ubiquitination at K283 (P = 0.0161); Gain of catalytic residue at L288 (P = 0.0345); Loss of disorder (P = 0.0406); Loss of glycosylation at K283 (P = 0.0713); Loss of MoRF binding (P = 0.1814)
7:117176707:A:C,P13569,K283N,0.43,Loss of ubiquitination at K283 (P = 0.0161); Loss of glycosylation at K283 (P = 0.0713); Gain of catalytic residue at K283 (P = 0.1502); Loss of MoRF binding (P = 0.1941); Loss of disorder (P = 0.225)
7:117176707:A:T,P13569,K283N,0.43,Loss of ubiquitination at K283 (P = 0.0161); Loss of glycosylation at K283 (P = 0.0713); Gain of catalytic residue at K283 (P = 0.1502); Loss of MoRF binding (P = 0.1941); Loss of disorder (P = 0.225)
7:117176708:A:C,P13569,M284L,0.531,Gain of ubiquitination at K283 (P = 0.1181); Gain of relative solvent accessibility (P = 0.1259); Loss of disorder (P = 0.1576); Loss of MoRF binding (P = 0.2021); Gain of solvent accessibility (P = 0.2291)
7:117176708:A:G,P13569,M284V,0.495,Loss of disorder (P = 0.1179); Gain of ubiquitination at K283 (P = 0.1181); Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at K283 (P = 0.1573); Gain of helix (P = 0.2294)
7:117176708:A:T,P13569,M284L,0.531,Gain of ubiquitination at K283 (P = 0.1181); Gain of relative solvent accessibility (P = 0.1259); Loss of disorder (P = 0.1576); Loss of MoRF binding (P = 0.2021); Gain of solvent accessibility (P = 0.2291)
7:117176709:T:A,P13569,M284K,0.534,Gain of ubiquitination at M284 (P = 0.0185); Gain of disorder (P = 0.0188); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of stability (P = 0.1367)
7:117176709:T:C,P13569,M284T,0.497,Gain of ubiquitination at K283 (P = 0.0913); Gain of disorder (P = 0.0955); Gain of relative solvent accessibility (P = 0.1259); Gain of phosphorylation at M284 (P = 0.1632); Loss of MoRF binding (P = 0.1967)
7:117176709:T:G,P13569,M284R,0.459,Gain of disorder (P = 0.0577); Gain of solvent accessibility (P = 0.0584); Gain of ubiquitination at K283 (P = 0.0605); Gain of MoRF binding (P = 0.0858); Gain of relative solvent accessibility (P = 0.09)
7:117176710:G:A,P13569,M284I,0.541,Loss of disorder (P = 0.1062); Loss of ubiquitination at K283 (P = 0.1343); Loss of MoRF binding (P = 0.2227); Loss of glycosylation at K283 (P = 0.3205); Gain of methylation at K283 (P = 0.3769)
7:117176710:G:C,P13569,M284I,0.541,Loss of disorder (P = 0.1062); Loss of ubiquitination at K283 (P = 0.1343); Loss of MoRF binding (P = 0.2227); Loss of glycosylation at K283 (P = 0.3205); Gain of methylation at K283 (P = 0.3769)
7:117176710:G:T,P13569,M284I,0.541,Loss of disorder (P = 0.1062); Loss of ubiquitination at K283 (P = 0.1343); Loss of MoRF binding (P = 0.2227); Loss of glycosylation at K283 (P = 0.3205); Gain of methylation at K283 (P = 0.3769)
7:117176711:A:C,P13569,I285L,0.687,Loss of catalytic residue at I285 (P = 0.0789); Gain of disorder (P = 0.0873); Loss of ubiquitination at K283 (P = 0.0982); Loss of MoRF binding (P = 0.1983); Loss of helix (P = 0.2271)
7:117176711:A:G,P13569,I285V,0.634,Loss of catalytic residue at I285 (P = 0.0853); Loss of ubiquitination at K283 (P = 0.0982); Gain of MoRF binding (P = 0.1648); Gain of disorder (P = 0.1659); Loss of helix (P = 0.2271)
7:117176712:T:A,P13569,I285N,0.778,Gain of disorder (P = 0.0062); Gain of ubiquitination at K283 (P = 0.0695); Loss of catalytic residue at I285 (P = 0.1049); Gain of MoRF binding (P = 0.1784); Loss of stability (P = 0.2017)
7:117176712:T:C,P13569,I285T,0.794,Gain of disorder (P = 0.011); Loss of stability (P = 0.0434); Loss of catalytic residue at I285 (P = 0.0677); Gain of ubiquitination at K283 (P = 0.0695); Gain of phosphorylation at I285 (P = 0.1215)
7:117176712:T:G,P13569,I285S,0.767,Gain of disorder (P = 0.0024); Loss of catalytic residue at I285 (P = 0.0545); Gain of ubiquitination at K283 (P = 0.0817); Loss of stability (P = 0.1026); Gain of MoRF binding (P = 0.1606)
7:117176713:T:G,P13569,I285M,0.699,Gain of disorder (P = 0.0261); Gain of ubiquitination at K283 (P = 0.0695); Loss of catalytic residue at I285 (P = 0.0779); Gain of MoRF binding (P = 0.112); Loss of helix (P = 0.2271)
7:117176714:G:A,P13569,E286K,0.505,Gain of MoRF binding (P = 0.0051); Gain of ubiquitination at E286 (P = 0.0494); Gain of glycosylation at E286 (P = 0.1335); Gain of relative solvent accessibility (P = 0.1894); Gain of solvent accessibility (P = 0.2192)
7:117176714:G:C,P13569,E286Q,0.377,Gain of MoRF binding (P = 0.0383); Loss of ubiquitination at K283 (P = 0.1151); Loss of disorder (P = 0.1412); Loss of glycosylation at K283 (P = 0.3319); Loss of phosphorylation at T291 (P = 0.3544)
7:117176715:A:C,P13569,E286A,0.491,Gain of MoRF binding (P = 0.0491); Loss of disorder (P = 0.059); Gain of ubiquitination at K283 (P = 0.0695); Loss of glycosylation at K283 (P = 0.2679); Loss of phosphorylation at T291 (P = 0.3366)
7:117176715:A:G,P13569,E286G,0.495,Gain of MoRF binding (P = 0.0539); Loss of ubiquitination at K283 (P = 0.0982); Loss of disorder (P = 0.1005); Gain of catalytic residue at N287 (P = 0.1296); Loss of stability (P = 0.1339)
7:117176715:A:T,P13569,E286V,0.538,Loss of disorder (P = 0.02); Gain of MoRF binding (P = 0.0468); Gain of ubiquitination at K283 (P = 0.0743); Gain of catalytic residue at E286 (P = 0.1191); Loss of glycosylation at K283 (P = 0.1847)
7:117176716:A:C,P13569,E286D,0.359,Loss of ubiquitination at K283 (P = 0.0982); Loss of disorder (P = 0.1483); Loss of MoRF binding (P = 0.184); Gain of phosphorylation at T291 (P = 0.3625); Loss of glycosylation at K283 (P = 0.364)
7:117176716:A:T,P13569,E286D,0.359,Loss of ubiquitination at K283 (P = 0.0982); Loss of disorder (P = 0.1483); Loss of MoRF binding (P = 0.184); Gain of phosphorylation at T291 (P = 0.3625); Loss of glycosylation at K283 (P = 0.364)
7:117176717:A:C,P13569,N287H,0.513,Gain of disorder (P = 0.0756); Gain of ubiquitination at K283 (P = 0.1047); Loss of MoRF binding (P = 0.1248); Gain of glycosylation at K283 (P = 0.173); Gain of phosphorylation at T291 (P = 0.2411)
7:117176717:A:G,P13569,N287D,0.501,Loss of MoRF binding (P = 0.0671); Loss of ubiquitination at K283 (P = 0.0853); Gain of disorder (P = 0.1387); Gain of phosphorylation at T291 (P = 0.1463); Gain of glycosylation at K283 (P = 0.2543)
7:117176717:A:T,P13569,N287Y,0.774,Loss of disorder (P = 0.0591); Loss of MoRF binding (P = 0.1185); Loss of ubiquitination at K283 (P = 0.1343); Gain of phosphorylation at T291 (P = 0.185); Loss of glycosylation at K283 (P = 0.3676)
7:117176718:A:C,P13569,N287T,0.468,Gain of phosphorylation at N287 (P = 0.1295); Loss of MoRF binding (P = 0.131); Loss of ubiquitination at K283 (P = 0.1343); Gain of disorder (P = 0.166); Gain of glycosylation at K283 (P = 0.2299)
7:117176718:A:G,P13569,N287S,0.321,Gain of phosphorylation at N287 (P = 0.0561); Gain of disorder (P = 0.0699); Loss of ubiquitination at K283 (P = 0.1343); Gain of MoRF binding (P = 0.1564); Gain of glycosylation at K283 (P = 0.2739)
7:117176718:A:T,P13569,N287I,0.566,Loss of disorder (P = 0.0461); Loss of ubiquitination at K283 (P = 0.0982); Loss of MoRF binding (P = 0.1222); Gain of phosphorylation at T291 (P = 0.266); Gain of glycosylation at K283 (P = 0.2981)
7:117176719:C:A,P13569,N287K,0.456,Gain of ubiquitination at N287 (P = 0.0276); Gain of MoRF binding (P = 0.0365); Gain of disorder (P = 0.0546); Gain of phosphorylation at T291 (P = 0.1291); Gain of methylation at N287 (P = 0.2524)
7:117176719:C:G,P13569,N287K,0.456,Gain of ubiquitination at N287 (P = 0.0276); Gain of MoRF binding (P = 0.0365); Gain of disorder (P = 0.0546); Gain of phosphorylation at T291 (P = 0.1291); Gain of methylation at N287 (P = 0.2524)
7:117176720:T:A,P13569,L288I,0.463,Gain of catalytic residue at L293 (P = 0.0505); Gain of MoRF binding (P = 0.0918); Loss of ubiquitination at K283 (P = 0.0982); Loss of stability (P = 0.1767); Loss of disorder (P = 0.1964)
7:117176720:T:G,P13569,L288V,0.44,Gain of MoRF binding (P = 0.0806); Gain of ubiquitination at K283 (P = 0.1181); Gain of phosphorylation at T291 (P = 0.1425); Loss of stability (P = 0.1969); Loss of disorder (P = 0.2314)
7:117176721:T:C,P13569,L288S,0.597,Gain of disorder (P = 0.0037); Loss of stability (P = 0.0148); Gain of ubiquitination at K283 (P = 0.0817); Gain of phosphorylation at T291 (P = 0.0936); Loss of MoRF binding (P = 0.1315)
7:117176722:A:C,P13569,L288F,0.529,Loss of stability (P = 0.1318); Loss of ubiquitination at K283 (P = 0.1343); Gain of phosphorylation at T291 (P = 0.1425); Gain of MoRF binding (P = 0.1443); Loss of disorder (P = 0.1734)
7:117176722:A:T,P13569,L288F,0.529,Loss of stability (P = 0.1318); Loss of ubiquitination at K283 (P = 0.1343); Gain of phosphorylation at T291 (P = 0.1425); Gain of MoRF binding (P = 0.1443); Loss of disorder (P = 0.1734)
7:117176723:A:G,P13569,R289G,0.722,Loss of MoRF binding (P = 0.0377); Loss of stability (P = 0.0453); Gain of ubiquitination at K294 (P = 0.095); Loss of solvent accessibility (P = 0.1744); Gain of disorder (P = 0.2126)
7:117176724:G:A,P13569,R289K,0.689,Gain of ubiquitination at R289 (P = 0.0258); Gain of disorder (P = 0.0447); Loss of MoRF binding (P = 0.0865); Loss of stability (P = 0.177); Loss of phosphorylation at T291 (P = 0.2589)
7:117176724:G:C,P13569,R289T,0.674,Loss of MoRF binding (P = 0.0337); Gain of ubiquitination at K294 (P = 0.095); Gain of phosphorylation at R289 (P = 0.1045); Loss of solvent accessibility (P = 0.1077); Loss of stability (P = 0.1096)
7:117176724:G:T,P13569,R289I,0.731,Loss of MoRF binding (P = 0.0432); Loss of disorder (P = 0.049); Loss of solvent accessibility (P = 0.1077); Loss of ubiquitination at K294 (P = 0.1664); Loss of phosphorylation at T291 (P = 0.1835)
7:117176725:A:C,P13569,R289S,0.673,Loss of MoRF binding (P = 0.0418); Gain of disorder (P = 0.0613); Gain of ubiquitination at K294 (P = 0.1317); Loss of stability (P = 0.1576); Loss of phosphorylation at T291 (P = 0.2267)
7:117176725:A:T,P13569,R289S,0.673,Loss of MoRF binding (P = 0.0418); Gain of disorder (P = 0.0613); Gain of ubiquitination at K294 (P = 0.1317); Loss of stability (P = 0.1576); Loss of phosphorylation at T291 (P = 0.2267)
7:117176726:C:A,P13569,Q290K,0.439,Gain of ubiquitination at Q290 (P = 0.0311); Gain of MoRF binding (P = 0.0346); Gain of disorder (P = 0.0665); Gain of phosphorylation at T291 (P = 0.1716); Gain of methylation at K294 (P = 0.4306)
7:117176726:C:G,P13569,Q290E,0.375,Loss of MoRF binding (P = 0.044); Gain of disorder (P = 0.0473); Loss of ubiquitination at K294 (P = 0.1664); Gain of phosphorylation at T291 (P = 0.2276); Gain of methylation at K294 (P = 0.4078)
7:117176727:A:C,P13569,Q290P,0.622,Gain of glycosylation at Q290 (P = 0.0433); Loss of MoRF binding (P = 0.0519); Gain of phosphorylation at T291 (P = 0.156); Loss of ubiquitination at K294 (P = 0.1828); Loss of solvent accessibility (P = 0.1986)
7:117176727:A:G,P13569,Q290R,0.368,Gain of MoRF binding (P = 0.016); Gain of phosphorylation at T291 (P = 0.1223); Loss of ubiquitination at K294 (P = 0.1664); Gain of disorder (P = 0.2097); Loss of methylation at K294 (P = 0.449)
7:117176727:A:T,P13569,Q290L,0.484,Gain of stability (P = 0.0364); Loss of disorder (P = 0.0613); Gain of catalytic residue at Q290 (P = 0.0648); Loss of MoRF binding (P = 0.0741); Gain of ubiquitination at K294 (P = 0.1111)
7:117180154:A:C,P13569,Q290H,0.372,Loss of MoRF binding (P = 0.0957); Gain of disorder (P = 0.1382); Loss of ubiquitination at K294 (P = 0.1828); Loss of phosphorylation at T291 (P = 0.3581); Loss of solvent accessibility (P = 0.4011)
7:117180154:A:T,P13569,Q290H,0.372,Loss of MoRF binding (P = 0.0957); Gain of disorder (P = 0.1382); Loss of ubiquitination at K294 (P = 0.1828); Loss of phosphorylation at T291 (P = 0.3581); Loss of solvent accessibility (P = 0.4011)
7:117180155:A:C,P13569,T291P,0.576,Gain of glycosylation at T291 (P = 0.0359); Loss of MoRF binding (P = 0.0657); Gain of disorder (P = 0.1173); Gain of ubiquitination at K294 (P = 0.1317); Loss of phosphorylation at T291 (P = 0.1339)
7:117180155:A:G,P13569,T291A,0.448,Gain of MoRF binding (P = 0.0937); Loss of phosphorylation at T291 (P = 0.1339); Loss of ubiquitination at K294 (P = 0.1828); Loss of disorder (P = 0.1943); Gain of helix (P = 0.2294)
7:117180155:A:T,P13569,T291S,0.435,Gain of disorder (P = 0.05); Gain of phosphorylation at T291 (P = 0.0864); Gain of MoRF binding (P = 0.1042); Loss of ubiquitination at K294 (P = 0.1828); Gain of helix (P = 0.2294)
7:117180156:C:A,P13569,T291K,0.499,Gain of ubiquitination at T291 (P = 0.0238); Gain of disorder (P = 0.0339); Gain of MoRF binding (P = 0.0377); Loss of phosphorylation at T291 (P = 0.1339); Gain of solvent accessibility (P = 0.154)
7:117180156:C:G,P13569,T291R,0.448,Gain of MoRF binding (P = 0.0236); Gain of solvent accessibility (P = 0.0808); Loss of ubiquitination at K294 (P = 0.1327); Loss of phosphorylation at T291 (P = 0.1339); Gain of disorder (P = 0.1489)
7:117180156:C:T,P13569,T291I,0.482,Loss of disorder (P = 0.0499); Gain of MoRF binding (P = 0.086); Loss of phosphorylation at T291 (P = 0.1339); Loss of ubiquitination at K294 (P = 0.1486); Gain of helix (P = 0.2294)
7:117180158:G:A,P13569,E292K,0.861,Gain of MoRF binding (P = 0.0065); Gain of ubiquitination at E292 (P = 0.0325); Gain of methylation at R297 (P = 0.1606); Loss of solvent accessibility (P = 0.1744); Loss of helix (P = 0.2271)
7:117180158:G:C,P13569,E292Q,0.714,Gain of MoRF binding (P = 0.0279); Loss of disorder (P = 0.1542); Loss of ubiquitination at K294 (P = 0.1664); Loss of solvent accessibility (P = 0.1744); Gain of methylation at R297 (P = 0.1999)
7:117180159:A:C,P13569,E292A,0.698,Gain of MoRF binding (P = 0.0182); Loss of disorder (P = 0.0617); Gain of methylation at R297 (P = 0.1207); Loss of ubiquitination at K294 (P = 0.121); Loss of solvent accessibility (P = 0.1744)
7:117180159:A:G,P13569,E292G,0.707,Gain of MoRF binding (P = 0.0218); Loss of stability (P = 0.0523); Gain of methylation at R297 (P = 0.1095); Loss of disorder (P = 0.1123); Loss of ubiquitination at K294 (P = 0.121)
7:117180159:A:T,P13569,E292V,0.682,Gain of MoRF binding (P = 0.0132); Loss of disorder (P = 0.0209); Loss of ubiquitination at K294 (P = 0.121); Gain of methylation at R297 (P = 0.1267); Loss of solvent accessibility (P = 0.1744)
7:117180160:A:C,P13569,E292D,0.651,Gain of ubiquitination at K294 (P = 0.0822); Gain of MoRF binding (P = 0.1191); Loss of disorder (P = 0.1665); Gain of methylation at R297 (P = 0.1887); Gain of phosphorylation at T291 (P = 0.3221)
7:117180160:A:T,P13569,E292D,0.651,Gain of ubiquitination at K294 (P = 0.0822); Gain of MoRF binding (P = 0.1191); Loss of disorder (P = 0.1665); Gain of methylation at R297 (P = 0.1887); Gain of phosphorylation at T291 (P = 0.3221)
7:117180161:C:A,P13569,L293M,0.842,Gain of MoRF binding (P = 0.0586); Gain of disorder (P = 0.0857); Loss of ubiquitination at K298 (P = 0.0896); Loss of methylation at R297 (P = 0.1304); Gain of catalytic residue at L293 (P = 0.1475)
7:117180161:C:G,P13569,L293V,0.658,Gain of methylation at K294 (P = 0.0575); Gain of ubiquitination at K294 (P = 0.0666); Gain of MoRF binding (P = 0.0731); Loss of stability (P = 0.1121); Gain of relative solvent accessibility (P = 0.1894)
7:117180162:T:A,P13569,L293Q,0.658,Gain of disorder (P = 0.0084); Loss of stability (P = 0.0255); Loss of methylation at R297 (P = 0.0446); Gain of MoRF binding (P = 0.07); Loss of ubiquitination at K298 (P = 0.0714)
7:117180162:T:C,P13569,L293P,0.758,Gain of glycosylation at L293 (P = 0.0066); Gain of disorder (P = 0.0101); Loss of stability (P = 0.0131); Loss of MoRF binding (P = 0.07); Gain of phosphorylation at T296 (P = 0.0863)
7:117180162:T:G,P13569,L293R,0.691,Gain of MoRF binding (P = 0.0087); Gain of disorder (P = 0.0126); Loss of stability (P = 0.0182); Gain of phosphorylation at T296 (P = 0.0517); Gain of methylation at K294 (P = 0.054)
7:117180164:A:C,P13569,K294Q,0.441,Loss of ubiquitination at K294 (P = 0.0283); Loss of MoRF binding (P = 0.04); Loss of methylation at R297 (P = 0.08); Loss of disorder (P = 0.1973); Loss of helix (P = 0.2271)
7:117180164:A:G,P13569,K294E,0.519,Loss of MoRF binding (P = 0.0044); Loss of ubiquitination at K294 (P = 0.0283); Loss of methylation at R297 (P = 0.1372); Gain of disorder (P = 0.174); Loss of phosphorylation at T291 (P = 0.3554)
7:117180165:A:C,P13569,K294T,0.485,Loss of MoRF binding (P = 0.0251); Loss of ubiquitination at K294 (P = 0.0283); Loss of disorder (P = 0.1214); Gain of phosphorylation at K294 (P = 0.1548); Gain of methylation at R297 (P = 0.1942)
7:117180165:A:G,P13569,K294R,0.393,Loss of ubiquitination at K294 (P = 0.0283); Gain of MoRF binding (P = 0.0665); Gain of methylation at R297 (P = 0.095); Loss of disorder (P = 0.1587); Gain of phosphorylation at T296 (P = 0.271)
7:117180165:A:T,P13569,K294I,0.544,Loss of disorder (P = 0.0235); Loss of MoRF binding (P = 0.0235); Gain of stability (P = 0.028); Loss of ubiquitination at K294 (P = 0.0283); Loss of methylation at R297 (P = 0.069)
7:117180166:A:C,P13569,K294N,0.496,Loss of ubiquitination at K294 (P = 0.0283); Loss of MoRF binding (P = 0.0387); Loss of disorder (P = 0.1556); Gain of methylation at R297 (P = 0.1648); Gain of helix (P = 0.2294)
7:117180166:A:T,P13569,K294N,0.496,Loss of ubiquitination at K294 (P = 0.0283); Loss of MoRF binding (P = 0.0387); Loss of disorder (P = 0.1556); Gain of methylation at R297 (P = 0.1648); Gain of helix (P = 0.2294)
7:117180167:C:A,P13569,L295M,0.442,Gain of MoRF binding (P = 0.0681); Loss of ubiquitination at K298 (P = 0.0896); Gain of disorder (P = 0.1177); Loss of methylation at R297 (P = 0.1921); Loss of helix (P = 0.2271)
7:117180167:C:G,P13569,L295V,0.438,Gain of methylation at K294 (P = 0.0538); Gain of ubiquitination at K294 (P = 0.0728); Gain of MoRF binding (P = 0.0767); Loss of disorder (P = 0.2293); Gain of helix (P = 0.2294)
7:117180168:T:A,P13569,L295Q,0.816,Gain of disorder (P = 0.0073); Loss of methylation at R297 (P = 0.037); Gain of ubiquitination at K294 (P = 0.0728); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0917)
7:117180168:T:C,P13569,L295P,0.714,Gain of disorder (P = 0.0083); Gain of glycosylation at L295 (P = 0.0219); Loss of stability (P = 0.0454); Loss of MoRF binding (P = 0.0462); Gain of relative solvent accessibility (P = 0.0479)
7:117180168:T:G,P13569,L295R,0.67,Gain of disorder (P = 0.0109); Gain of methylation at K294 (P = 0.0346); Gain of MoRF binding (P = 0.052); Gain of solvent accessibility (P = 0.0584); Gain of ubiquitination at K294 (P = 0.0822)
7:117180170:A:C,P13569,T296P,0.704,Gain of glycosylation at T296 (P = 0.0296); Loss of MoRF binding (P = 0.053); Loss of ubiquitination at K298 (P = 0.1016); Gain of disorder (P = 0.1441); Loss of methylation at R297 (P = 0.1782)
7:117180170:A:G,P13569,T296A,0.424,Loss of ubiquitination at K298 (P = 0.0896); Gain of MoRF binding (P = 0.1242); Gain of methylation at R297 (P = 0.1955); Loss of stability (P = 0.2097); Loss of disorder (P = 0.2174)
7:117180170:A:T,P13569,T296S,0.537,Gain of disorder (P = 0.0556); Loss of ubiquitination at K298 (P = 0.0896); Gain of MoRF binding (P = 0.099); Gain of phosphorylation at T296 (P = 0.1416); Gain of methylation at R297 (P = 0.2083)
7:117180171:C:A,P13569,T296N,0.531,Loss of ubiquitination at K298 (P = 0.0896); Gain of MoRF binding (P = 0.1057); Gain of methylation at R297 (P = 0.167); Gain of disorder (P = 0.208); Loss of helix (P = 0.2271)
7:117180171:C:G,P13569,T296S,0.537,Gain of disorder (P = 0.0556); Loss of ubiquitination at K298 (P = 0.0896); Gain of MoRF binding (P = 0.099); Gain of phosphorylation at T296 (P = 0.1416); Gain of methylation at R297 (P = 0.2083)
7:117180171:C:T,P13569,T296I,0.435,Loss of methylation at R297 (P = 0.035); Loss of disorder (P = 0.0572); Loss of ubiquitination at K298 (P = 0.0648); Gain of MoRF binding (P = 0.1057); Loss of helix (P = 0.2271)
7:117180173:C:G,P13569,R297G,0.829,Loss of methylation at R297 (P = 0.0114); Loss of MoRF binding (P = 0.0193); Loss of ubiquitination at K298 (P = 0.0714); Loss of stability (P = 0.111); Loss of helix (P = 0.2271)
7:117180174:G:C,P13569,R297P,0.835,Loss of MoRF binding (P = 0.0031); Loss of methylation at R297 (P = 0.0114); Gain of glycosylation at R297 (P = 0.0237); Gain of ubiquitination at K294 (P = 0.1111); Loss of helix (P = 0.2271)
7:117180174:G:T,P13569,R297L,0.833,Loss of methylation at R297 (P = 0.0114); Loss of MoRF binding (P = 0.0168); Loss of disorder (P = 0.0845); Loss of ubiquitination at K298 (P = 0.1166); Loss of helix (P = 0.2271)
7:117180176:A:C,P13569,K298Q,0.652,Loss of ubiquitination at K298 (P = 0.0192); Loss of MoRF binding (P = 0.0506); Loss of methylation at R297 (P = 0.0952); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2797)
7:117180176:A:G,P13569,K298E,0.632,Loss of MoRF binding (P = 0.0055); Loss of ubiquitination at K298 (P = 0.0192); Loss of methylation at R297 (P = 0.1265); Gain of disorder (P = 0.1914); Loss of helix (P = 0.2271)
7:117180177:A:C,P13569,K298T,0.678,Loss of ubiquitination at K298 (P = 0.0192); Loss of MoRF binding (P = 0.0473); Gain of methylation at R297 (P = 0.1562); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2288)
7:117180177:A:G,P13569,K298R,0.504,Gain of methylation at K298 (P = 0.0157); Loss of ubiquitination at K298 (P = 0.0192); Gain of MoRF binding (P = 0.0919); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2693)
7:117180177:A:T,P13569,K298M,0.67,Loss of ubiquitination at K298 (P = 0.0192); Loss of MoRF binding (P = 0.0773); Loss of disorder (P = 0.1023); Loss of solvent accessibility (P = 0.1551); Gain of methylation at R297 (P = 0.1804)
7:117180178:G:C,P13569,K298N,0.622,Loss of ubiquitination at K298 (P = 0.0192); Loss of MoRF binding (P = 0.0495); Gain of catalytic residue at K298 (P = 0.1111); Gain of methylation at R297 (P = 0.1435); Loss of disorder (P = 0.2187)
7:117180178:G:T,P13569,K298N,0.622,Loss of ubiquitination at K298 (P = 0.0192); Loss of MoRF binding (P = 0.0495); Gain of catalytic residue at K298 (P = 0.1111); Gain of methylation at R297 (P = 0.1435); Loss of disorder (P = 0.2187)
7:117180179:G:A,P13569,A299T,0.832,Gain of phosphorylation at A299 (P = 0.0576); Loss of ubiquitination at K298 (P = 0.1166); Loss of MoRF binding (P = 0.1218); Loss of methylation at R297 (P = 0.1297); Gain of disorder (P = 0.1489)
7:117180179:G:C,P13569,A299P,0.779,Loss of MoRF binding (P = 0.0526); Loss of methylation at R297 (P = 0.1052); Loss of ubiquitination at K298 (P = 0.1166); Gain of disorder (P = 0.15); Gain of glycosylation at A299 (P = 0.1874)
7:117180179:G:T,P13569,A299S,0.701,Gain of disorder (P = 0.0554); Gain of phosphorylation at A299 (P = 0.0951); Loss of ubiquitination at K298 (P = 0.1016); Gain of MoRF binding (P = 0.1061); Loss of methylation at R297 (P = 0.1624)
7:117180180:C:A,P13569,A299E,0.738,Loss of MoRF binding (P = 0.0367); Gain of disorder (P = 0.0587); Loss of methylation at R297 (P = 0.0697); Loss of ubiquitination at K298 (P = 0.0896); Gain of relative solvent accessibility (P = 0.1259)
7:117180180:C:G,P13569,A299G,0.672,Loss of ubiquitination at K298 (P = 0.1166); Gain of MoRF binding (P = 0.1346); Gain of disorder (P = 0.184); Gain of methylation at R297 (P = 0.185); Gain of helix (P = 0.2059)
7:117180180:C:T,P13569,A299V,0.66,Loss of ubiquitination at K298 (P = 0.0787); Gain of methylation at K298 (P = 0.0856); Gain of MoRF binding (P = 0.0963); Loss of disorder (P = 0.1404); Gain of helix (P = 0.2059)
7:117180182:G:A,P13569,A300T,0.57,Gain of phosphorylation at A300 (P = 0.0333); Loss of methylation at R297 (P = 0.1051); Loss of ubiquitination at K298 (P = 0.1166); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1301)
7:117180182:G:C,P13569,A300P,0.821,Loss of MoRF binding (P = 0.0574); Loss of methylation at R297 (P = 0.0891); Loss of helix (P = 0.1299); Loss of ubiquitination at K298 (P = 0.1343); Loss of stability (P = 0.1496)
7:117180182:G:T,P13569,A300S,0.718,Gain of phosphorylation at A300 (P = 0.0378); Gain of disorder (P = 0.0677); Gain of MoRF binding (P = 0.1014); Loss of stability (P = 0.1246); Loss of ubiquitination at K298 (P = 0.1343)
7:117180183:C:A,P13569,A300D,0.765,Loss of MoRF binding (P = 0.0542); Loss of methylation at R297 (P = 0.0589); Loss of ubiquitination at K298 (P = 0.1016); Loss of helix (P = 0.1299); Loss of catalytic residue at A300 (P = 0.1305)
7:117180183:C:T,P13569,A300V,0.616,Gain of MoRF binding (P = 0.1006); Loss of methylation at R297 (P = 0.1079); Loss of helix (P = 0.1299); Loss of ubiquitination at K298 (P = 0.1343); Loss of disorder (P = 0.1566)
7:117180185:T:A,P13569,Y301N,0.72,Gain of MoRF binding (P = 0.077); Loss of ubiquitination at K298 (P = 0.0896); Gain of helix (P = 0.132); Gain of disorder (P = 0.1352); Loss of stability (P = 0.1474)
7:117180185:T:C,P13569,Y301H,0.707,Gain of disorder (P = 0.0332); Gain of MoRF binding (P = 0.1105); Loss of stability (P = 0.1117); Loss of helix (P = 0.1299); Loss of ubiquitination at K298 (P = 0.1343)
7:117180185:T:G,P13569,Y301D,0.806,Loss of MoRF binding (P = 0.0679); Gain of disorder (P = 0.0865); Loss of ubiquitination at K298 (P = 0.0896); Gain of helix (P = 0.132); Gain of catalytic residue at N306 (P = 0.1379)
7:117180186:A:C,P13569,Y301S,0.717,Gain of disorder (P = 0.0293); Loss of ubiquitination at K298 (P = 0.0714); Gain of MoRF binding (P = 0.0806); Loss of stability (P = 0.0809); Gain of phosphorylation at Y301 (P = 0.1213)
7:117180186:A:T,P13569,Y301F,0.621,Loss of MoRF binding (P = 0.1134); Gain of ubiquitination at K298 (P = 0.1162); Loss of helix (P = 0.1299); Loss of methylation at R297 (P = 0.21); Gain of loop (P = 0.2754)
7:117180188:G:A,P13569,V302M,0.538,Gain of MoRF binding (P = 0.1118); Loss of ubiquitination at K298 (P = 0.1166); Loss of helix (P = 0.1299); Loss of methylation at R297 (P = 0.1689); Gain of loop (P = 0.2754)
7:117180188:G:C,P13569,V302L,0.554,Loss of MoRF binding (P = 0.1021); Loss of ubiquitination at K298 (P = 0.1166); Loss of methylation at R297 (P = 0.2029); Loss of helix (P = 0.2271); Gain of disorder (P = 0.4274)
7:117180188:G:T,P13569,V302L,0.554,Loss of MoRF binding (P = 0.1021); Loss of ubiquitination at K298 (P = 0.1166); Loss of methylation at R297 (P = 0.2029); Loss of helix (P = 0.2271); Gain of disorder (P = 0.4274)
7:117180189:T:A,P13569,V302E,0.735,Loss of MoRF binding (P = 0.0242); Gain of disorder (P = 0.0381); Gain of loop (P = 0.069); Loss of ubiquitination at K298 (P = 0.0896); Loss of helix (P = 0.1299)
7:117180189:T:C,P13569,V302A,0.659,Gain of catalytic residue at V302 (P = 0.0695); Loss of MoRF binding (P = 0.0927); Loss of ubiquitination at K298 (P = 0.1016); Loss of stability (P = 0.1052); Loss of helix (P = 0.1299)
7:117180189:T:G,P13569,V302G,0.67,Loss of stability (P = 0.0425); Loss of MoRF binding (P = 0.0929); Gain of disorder (P = 0.1097); Gain of catalytic residue at V302 (P = 0.1102); Loss of ubiquitination at K298 (P = 0.1166)
7:117180191:A:G,P13569,R303G,0.696,Loss of methylation at R303 (P = 0.0032); Loss of MoRF binding (P = 0.0253); Loss of stability (P = 0.0598); Gain of catalytic residue at N306 (P = 0.1061); Loss of helix (P = 0.1299)
7:117180192:G:C,P13569,R303T,0.65,Loss of methylation at R303 (P = 0.0032); Loss of MoRF binding (P = 0.0249); Gain of ubiquitination at K298 (P = 0.1008); Loss of solvent accessibility (P = 0.1077); Gain of glycosylation at S308 (P = 0.1438)
7:117180192:G:T,P13569,R303I,0.682,Loss of methylation at R303 (P = 0.0032); Loss of MoRF binding (P = 0.0325); Loss of ubiquitination at K298 (P = 0.1016); Loss of solvent accessibility (P = 0.1077); Gain of catalytic residue at N306 (P = 0.1188)
7:117180193:A:C,P13569,R303S,0.635,Loss of methylation at R303 (P = 0.0032); Loss of MoRF binding (P = 0.0272); Loss of helix (P = 0.0626); Gain of ubiquitination at K298 (P = 0.0872); Gain of phosphorylation at R303 (P = 0.1907)
7:117180193:A:T,P13569,R303S,0.635,Loss of methylation at R303 (P = 0.0032); Loss of MoRF binding (P = 0.0272); Loss of helix (P = 0.0626); Gain of ubiquitination at K298 (P = 0.0872); Gain of phosphorylation at R303 (P = 0.1907)
7:117180194:T:A,P13569,Y304N,0.712,Loss of helix (P = 0.0558); Loss of stability (P = 0.0779); Gain of MoRF binding (P = 0.0922); Gain of relative solvent accessibility (P = 0.1259); Gain of sheet (P = 0.1945)
7:117180194:T:C,P13569,Y304H,0.736,Loss of stability (P = 0.031); Gain of MoRF binding (P = 0.1235); Loss of helix (P = 0.1299); Gain of glycosylation at S308 (P = 0.1896); Gain of loop (P = 0.2754)
7:117180194:T:G,P13569,Y304D,0.838,Loss of stability (P = 0.0456); Loss of MoRF binding (P = 0.0694); Loss of helix (P = 0.1299); Loss of catalytic residue at S308 (P = 0.2138); Gain of loop (P = 0.2754)
7:117180195:A:G,P13569,Y304C,0.701,Loss of MoRF binding (P = 0.1009); Loss of stability (P = 0.1197); Loss of helix (P = 0.1299); Gain of catalytic residue at A299 (P = 0.2348); Gain of loop (P = 0.2754)
7:117180195:A:T,P13569,Y304F,0.651,Gain of MoRF binding (P = 0.1215); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of glycosylation at S308 (P = 0.2362); Loss of catalytic residue at Y304 (P = 0.2564)
7:117180197:T:A,P13569,F305I,0.61,Loss of sheet (P = 0.0457); Gain of helix (P = 0.0696); Gain of MoRF binding (P = 0.0945); Loss of catalytic residue at S308 (P = 0.1676); Gain of loop (P = 0.2045)
7:117180197:T:C,P13569,F305L,0.607,Gain of MoRF binding (P = 0.1285); Gain of helix (P = 0.132); Loss of catalytic residue at S308 (P = 0.1536); Loss of sheet (P = 0.1907); Loss of glycosylation at S308 (P = 0.1984)
7:117180197:T:G,P13569,F305V,0.589,Gain of MoRF binding (P = 0.0955); Loss of glycosylation at S308 (P = 0.262); Loss of helix (P = 0.2662); Loss of stability (P = 0.2688); Loss of sheet (P = 0.302)
7:117180198:T:A,P13569,F305Y,0.697,Loss of sheet (P = 0.0457); Gain of helix (P = 0.0854); Loss of MoRF binding (P = 0.1151); Loss of stability (P = 0.1638); Loss of catalytic residue at S308 (P = 0.1975)
7:117180198:T:C,P13569,F305S,0.737,Gain of disorder (P = 0.0231); Gain of phosphorylation at F305 (P = 0.068); Loss of stability (P = 0.0726); Gain of catalytic residue at F305 (P = 0.0951); Loss of MoRF binding (P = 0.1457)
7:117180198:T:G,P13569,F305C,0.669,Gain of catalytic residue at F305 (P = 0.0303); Loss of sheet (P = 0.0457); Gain of helix (P = 0.0854); Loss of MoRF binding (P = 0.088); Loss of stability (P = 0.2063)
7:117180199:C:A,P13569,F305L,0.607,Gain of MoRF binding (P = 0.1285); Gain of helix (P = 0.132); Loss of catalytic residue at S308 (P = 0.1536); Loss of sheet (P = 0.1907); Loss of glycosylation at S308 (P = 0.1984)
7:117180199:C:G,P13569,F305L,0.607,Gain of MoRF binding (P = 0.1285); Gain of helix (P = 0.132); Loss of catalytic residue at S308 (P = 0.1536); Loss of sheet (P = 0.1907); Loss of glycosylation at S308 (P = 0.1984)
7:117180200:A:C,P13569,N306H,0.736,Loss of stability (P = 0.1096); Loss of MoRF binding (P = 0.121); Gain of helix (P = 0.132); Gain of catalytic residue at N306 (P = 0.1391); Loss of loop (P = 0.2237)
7:117180200:A:G,P13569,N306D,0.736,Loss of MoRF binding (P = 0.0677); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Gain of catalytic residue at N306 (P = 0.1715); Loss of glycosylation at S308 (P = 0.268)
7:117180200:A:T,P13569,N306Y,0.756,Loss of loop (P = 0.0804); Loss of MoRF binding (P = 0.11); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of glycosylation at S308 (P = 0.2014)
7:117180201:A:C,P13569,N306T,0.678,Gain of phosphorylation at N306 (P = 0.0524); Loss of stability (P = 0.1256); Loss of MoRF binding (P = 0.1419); Loss of glycosylation at S308 (P = 0.184); Loss of loop (P = 0.2237)
7:117180201:A:G,P13569,N306S,0.693,Gain of phosphorylation at N306 (P = 0.0491); Loss of MoRF binding (P = 0.1425); Loss of stability (P = 0.1782); Gain of sheet (P = 0.1945); Gain of catalytic residue at N306 (P = 0.1975)
7:117180201:A:T,P13569,N306I,0.716,Gain of helix (P = 0.132); Loss of glycosylation at S308 (P = 0.1367); Gain of MoRF binding (P = 0.1419); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117180202:T:A,P13569,N306K,0.828,Gain of ubiquitination at N306 (P = 0.0267); Gain of MoRF binding (P = 0.0286); Loss of stability (P = 0.0419); Gain of catalytic residue at N306 (P = 0.2755); Loss of glycosylation at S308 (P = 0.3001)
7:117180202:T:G,P13569,N306K,0.828,Gain of ubiquitination at N306 (P = 0.0267); Gain of MoRF binding (P = 0.0286); Loss of stability (P = 0.0419); Gain of catalytic residue at N306 (P = 0.2755); Loss of glycosylation at S308 (P = 0.3001)
7:117180203:A:C,P13569,S307R,0.766,Gain of methylation at S307 (P = 0.0106); Gain of MoRF binding (P = 0.011); Loss of glycosylation at S308 (P = 0.1271); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117180203:A:G,P13569,S307G,0.722,Loss of stability (P = 0.1207); Loss of helix (P = 0.1299); Gain of glycosylation at S308 (P = 0.1483); Loss of MoRF binding (P = 0.1564); Loss of loop (P = 0.2897)
7:117180203:A:T,P13569,S307C,0.788,Loss of MoRF binding (P = 0.105); Loss of glycosylation at S308 (P = 0.1273); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Gain of catalytic residue at S307 (P = 0.194)
7:117180204:G:A,P13569,S307N,0.875,Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1485); Loss of glycosylation at S308 (P = 0.1882); Loss of loop (P = 0.2897); Loss of sheet (P = 0.3635)
7:117180204:G:C,P13569,S307T,0.767,Loss of helix (P = 0.1299); Gain of catalytic residue at F310 (P = 0.1502); Gain of MoRF binding (P = 0.1706); Gain of glycosylation at S308 (P = 0.2076); Loss of loop (P = 0.2897)
7:117180204:G:T,P13569,S307I,0.772,Gain of MoRF binding (P = 0.1639); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Gain of catalytic residue at N306 (P = 0.2278); Loss of loop (P = 0.2897)
7:117180205:C:A,P13569,S307R,0.766,Gain of methylation at S307 (P = 0.0106); Gain of MoRF binding (P = 0.011); Loss of glycosylation at S308 (P = 0.1271); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117180205:C:G,P13569,S307R,0.766,Gain of methylation at S307 (P = 0.0106); Gain of MoRF binding (P = 0.011); Loss of glycosylation at S308 (P = 0.1271); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117180206:T:A,P13569,S308T,0.72,Gain of glycosylation at S307 (P = 0.1009); Gain of catalytic residue at F311 (P = 0.1325); Gain of MoRF binding (P = 0.1802); Loss of loop (P = 0.2897); Loss of sheet (P = 0.3635)
7:117180206:T:C,P13569,S308P,0.801,Loss of MoRF binding (P = 0.0958); Gain of catalytic residue at N306 (P = 0.0981); Loss of helix (P = 0.1299); Loss of glycosylation at S308 (P = 0.2733); Loss of stability (P = 0.3101)
7:117180206:T:G,P13569,S308A,0.734,Loss of glycosylation at S308 (P = 0.0535); Gain of helix (P = 0.1736); Gain of MoRF binding (P = 0.1756); Loss of loop (P = 0.2897); Loss of sheet (P = 0.3635)
7:117180207:C:T,P13569,S308L,0.756,Loss of catalytic residue at S308 (P = 0.0247); Loss of glycosylation at S308 (P = 0.0535); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1328); Loss of sheet (P = 0.1907)
7:117180209:G:A,P13569,A309T,0.619,Gain of glycosylation at A309 (P = 0.0324); Loss of stability (P = 0.1346); Gain of catalytic residue at F312 (P = 0.146); Loss of MoRF binding (P = 0.2209); Gain of helix (P = 0.2684)
7:117180209:G:C,P13569,A309P,0.869,Gain of glycosylation at A309 (P = 0.0292); Loss of stability (P = 0.0449); Loss of MoRF binding (P = 0.1148); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907)
7:117180209:G:T,P13569,A309S,0.639,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Loss of stability (P = 0.1477); Gain of glycosylation at A309 (P = 0.1629); Loss of MoRF binding (P = 0.2128)
7:117180210:C:A,P13569,A309D,0.926,Loss of MoRF binding (P = 0.1027); Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Loss of glycosylation at S308 (P = 0.1918); Gain of loop (P = 0.2754)
7:117180210:C:G,P13569,A309G,0.879,Gain of glycosylation at S308 (P = 0.0411); Loss of sheet (P = 0.0457); Loss of stability (P = 0.0613); Gain of helix (P = 0.132); Gain of loop (P = 0.2045)
7:117180210:C:T,P13569,A309V,0.862,Gain of sheet (P = 0.1208); Loss of glycosylation at S308 (P = 0.1228); Loss of catalytic residue at A309 (P = 0.1349); Gain of MoRF binding (P = 0.1629); Gain of helix (P = 0.1736)
7:117180212:T:A,P13569,F310I,0.745,Loss of stability (P = 0.1044); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.2197); Loss of loop (P = 0.2237)
7:117180212:T:C,P13569,F310L,0.719,Gain of helix (P = 0.132); Loss of glycosylation at S308 (P = 0.167); Loss of stability (P = 0.1719); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117180212:T:G,P13569,F310V,0.693,Loss of stability (P = 0.0291); Gain of catalytic residue at F310 (P = 0.0613); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.1997); Loss of glycosylation at S308 (P = 0.2107)
7:117180213:T:A,P13569,F310Y,0.69,Loss of stability (P = 0.0192); Loss of glycosylation at S308 (P = 0.1522); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.2008)
7:117180213:T:C,P13569,F310S,0.721,Loss of stability (P = 0.0038); Gain of disorder (P = 0.0772); Loss of glycosylation at S308 (P = 0.1249); Gain of relative solvent accessibility (P = 0.1259); Gain of helix (P = 0.132)
7:117180213:T:G,P13569,F310C,0.71,Loss of stability (P = 0.0238); Gain of helix (P = 0.0496); Gain of catalytic residue at F310 (P = 0.078); Loss of loop (P = 0.1242); Loss of sheet (P = 0.1398)
7:117180214:C:A,P13569,F310L,0.719,Gain of helix (P = 0.132); Loss of glycosylation at S308 (P = 0.167); Loss of stability (P = 0.1719); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117180214:C:G,P13569,F310L,0.719,Gain of helix (P = 0.132); Loss of glycosylation at S308 (P = 0.167); Loss of stability (P = 0.1719); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117180215:T:A,P13569,F311I,0.754,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0804); Loss of catalytic residue at S308 (P = 0.1022); Gain of MoRF binding (P = 0.2439); Loss of helix (P = 0.2662)
7:117180215:T:C,P13569,F311L,0.879,Gain of sheet (P = 0.0477); Loss of glycosylation at S308 (P = 0.1161); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2653); Loss of helix (P = 0.2662)
7:117180215:T:G,P13569,F311V,0.727,Loss of stability (P = 0.0639); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of catalytic residue at F311 (P = 0.2047); Loss of glycosylation at S308 (P = 0.2136)
7:117180216:T:A,P13569,F311Y,0.724,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0804); Loss of stability (P = 0.092); Gain of helix (P = 0.1736); Loss of glycosylation at S308 (P = 0.1846)
7:117180216:T:C,P13569,F311S,0.742,Loss of stability (P = 0.0418); Loss of glycosylation at S308 (P = 0.1601); Gain of helix (P = 0.1736); Gain of disorder (P = 0.1811); Loss of sheet (P = 0.1907)
7:117180216:T:G,P13569,F311C,0.769,Gain of catalytic residue at F311 (P = 0.0495); Loss of stability (P = 0.0741); Loss of glycosylation at S313 (P = 0.1162); Gain of sheet (P = 0.1208); Gain of helix (P = 0.1736)
7:117180217:C:A,P13569,F311L,0.879,Gain of sheet (P = 0.0477); Loss of glycosylation at S308 (P = 0.1161); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2653); Loss of helix (P = 0.2662)
7:117180217:C:G,P13569,F311L,0.879,Gain of sheet (P = 0.0477); Loss of glycosylation at S308 (P = 0.1161); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2653); Loss of helix (P = 0.2662)
7:117180218:T:A,P13569,F312I,0.591,Gain of helix (P = 0.0022); Loss of loop (P = 0.0084); Loss of sheet (P = 0.0483); Loss of glycosylation at S308 (P = 0.2187); Gain of MoRF binding (P = 0.264)
7:117180218:T:C,P13569,F312L,0.639,Loss of glycosylation at S313 (P = 0.1379); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237); Loss of catalytic residue at F312 (P = 0.2334)
7:117180218:T:G,P13569,F312V,0.58,Gain of sheet (P = 0.1208); Gain of loop (P = 0.2754); Gain of MoRF binding (P = 0.2788); Gain of glycosylation at S308 (P = 0.3112); Gain of catalytic residue at F312 (P = 0.3171)
7:117180219:T:A,P13569,F312Y,0.649,Gain of helix (P = 0.0034); Loss of loop (P = 0.0084); Loss of sheet (P = 0.0483); Gain of catalytic residue at F312 (P = 0.1448); Gain of glycosylation at S308 (P = 0.1972)
7:117180219:T:C,P13569,F312S,0.732,Gain of glycosylation at F312 (P = 0.1145); Gain of sheet (P = 0.1208); Loss of stability (P = 0.1225); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045)
7:117180219:T:G,P13569,F312C,0.667,Gain of helix (P = 0.0034); Loss of loop (P = 0.0084); Loss of sheet (P = 0.0483); Loss of glycosylation at S313 (P = 0.1575); Gain of catalytic residue at F312 (P = 0.1874)
7:117180220:C:A,P13569,F312L,0.639,Loss of glycosylation at S313 (P = 0.1379); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237); Loss of catalytic residue at F312 (P = 0.2334)
7:117180220:C:G,P13569,F312L,0.639,Loss of glycosylation at S313 (P = 0.1379); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237); Loss of catalytic residue at F312 (P = 0.2334)
7:117180221:T:A,P13569,S313T,0.489,Loss of glycosylation at S313 (P = 0.0125); Gain of catalytic residue at F316 (P = 0.1901); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3448)
7:117180221:T:C,P13569,S313P,0.562,Loss of glycosylation at S313 (P = 0.0264); Loss of stability (P = 0.1279); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of catalytic residue at S313 (P = 0.3087)
7:117180221:T:G,P13569,S313A,0.474,Loss of glycosylation at S313 (P = 0.0046); Gain of helix (P = 0.0854); Loss of loop (P = 0.0986); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.3484)
7:117180222:C:T,P13569,S313L,0.487,Loss of glycosylation at S313 (P = 0.0046); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of sheet (P = 0.1158); Loss of catalytic residue at G314 (P = 0.2597)
7:117180224:G:A,P13569,G314R,0.948,Loss of glycosylation at S313 (P = 0.032); Gain of MoRF binding (P = 0.0379); Gain of methylation at G314 (P = 0.0388); Loss of catalytic residue at V317 (P = 0.1426); Loss of sheet (P = 0.1907)
7:117180224:G:C,P13569,G314R,0.948,Loss of glycosylation at S313 (P = 0.032); Gain of MoRF binding (P = 0.0379); Gain of methylation at G314 (P = 0.0388); Loss of catalytic residue at V317 (P = 0.1426); Loss of sheet (P = 0.1907)
7:117180224:G:T,P13569,G314W,0.82,Loss of glycosylation at S313 (P = 0.0134); Gain of MoRF binding (P = 0.1733); Loss of sheet (P = 0.1907); Gain of helix (P = 0.2684); Loss of loop (P = 0.3664)
7:117180225:G:A,P13569,G314E,0.895,Loss of glycosylation at S313 (P = 0.032); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of catalytic residue at G314 (P = 0.2556); Gain of helix (P = 0.2684)
7:117180225:G:C,P13569,G314A,0.746,Loss of glycosylation at S313 (P = 0.0564); Gain of sheet (P = 0.1208); Gain of catalytic residue at G314 (P = 0.182); Gain of loop (P = 0.2045); Loss of stability (P = 0.2587)
7:117180225:G:T,P13569,G314V,0.893,Loss of glycosylation at S313 (P = 0.032); Gain of sheet (P = 0.1945); Loss of helix (P = 0.2662); Gain of loop (P = 0.2754); Gain of MoRF binding (P = 0.3625)
7:117180227:T:A,P13569,F315I,0.575,Gain of helix (P = 0.005); Loss of loop (P = 0.0153); Loss of sheet (P = 0.0483); Loss of stability (P = 0.2463); Gain of catalytic residue at L320 (P = 0.3213)
7:117180227:T:C,P13569,F315L,0.602,Gain of sheet (P = 0.0477); Loss of helix (P = 0.079); Loss of stability (P = 0.1583); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.4544)
7:117180227:T:G,P13569,F315V,0.526,Loss of stability (P = 0.0663); Gain of catalytic residue at F315 (P = 0.0679); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045)
7:117180228:T:A,P13569,F315Y,0.603,Gain of helix (P = 0.005); Loss of loop (P = 0.0153); Loss of sheet (P = 0.0483); Loss of stability (P = 0.0504); Loss of MoRF binding (P = 0.4616)
7:117180228:T:C,P13569,F315S,0.66,Loss of stability (P = 0.0137); Gain of catalytic residue at F315 (P = 0.0545); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of sheet (P = 0.3635)
7:117180228:T:G,P13569,F315C,0.613,Gain of helix (P = 0.0117); Loss of stability (P = 0.042); Loss of sheet (P = 0.0483); Loss of loop (P = 0.0512); Gain of catalytic residue at F315 (P = 0.1457)
7:117180229:C:A,P13569,F315L,0.602,Gain of sheet (P = 0.0477); Loss of helix (P = 0.079); Loss of stability (P = 0.1583); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.4544)
7:117180229:C:G,P13569,F315L,0.602,Gain of sheet (P = 0.0477); Loss of helix (P = 0.079); Loss of stability (P = 0.1583); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.4544)
7:117180230:T:A,P13569,F316I,0.547,Gain of helix (P = 0.005); Loss of loop (P = 0.0153); Loss of sheet (P = 0.0483); Gain of catalytic residue at V317 (P = 0.469); Gain of MoRF binding (P = 0.4847)
7:117180230:T:C,P13569,F316L,0.604,Loss of helix (P = 0.079); Gain of loop (P = 0.1069); Gain of sheet (P = 0.1208); Loss of glycosylation at S313 (P = 0.1668); Loss of catalytic residue at F316 (P = 0.2603)
7:117180230:T:G,P13569,F316V,0.588,Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Loss of loop (P = 0.2897); Loss of stability (P = 0.3078); Gain of catalytic residue at F316 (P = 0.3587)
7:117180231:T:A,P13569,F316Y,0.52,Gain of helix (P = 0.0078); Loss of loop (P = 0.0153); Loss of sheet (P = 0.0483); Loss of stability (P = 0.1571); Gain of catalytic residue at F316 (P = 0.2908)
7:117180231:T:C,P13569,F316S,0.675,Loss of stability (P = 0.0547); Gain of catalytic residue at F316 (P = 0.113); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Loss of glycosylation at S313 (P = 0.1973)
7:117180231:T:G,P13569,F316C,0.611,Gain of helix (P = 0.0078); Loss of loop (P = 0.0288); Loss of sheet (P = 0.0483); Loss of stability (P = 0.1736); Gain of catalytic residue at F316 (P = 0.1827)
7:117180232:T:A,P13569,F316L,0.604,Loss of helix (P = 0.079); Gain of loop (P = 0.1069); Gain of sheet (P = 0.1208); Loss of glycosylation at S313 (P = 0.1668); Loss of catalytic residue at F316 (P = 0.2603)
7:117180233:G:A,P13569,V317M,0.602,Loss of sheet (P = 0.0457); Gain of helix (P = 0.062); Loss of catalytic residue at V317 (P = 0.0704); Loss of loop (P = 0.0804); Loss of glycosylation at S313 (P = 0.4619)
7:117180233:G:C,P13569,V317L,0.594,Loss of loop (P = 0.0804); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of catalytic residue at V317 (P = 0.2704); Loss of MoRF binding (P = 0.5564)
7:117180233:G:T,P13569,V317L,0.594,Loss of loop (P = 0.0804); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of catalytic residue at V317 (P = 0.2704); Loss of MoRF binding (P = 0.5564)
7:117180234:T:A,P13569,V317E,0.667,Loss of sheet (P = 0.0457); Gain of helix (P = 0.0496); Loss of loop (P = 0.0804); Loss of catalytic residue at V318 (P = 0.1869); Loss of glycosylation at S313 (P = 0.3297)
7:117180234:T:C,P13569,V317A,0.795,Loss of loop (P = 0.0804); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of stability (P = 0.3946); Gain of catalytic residue at V317 (P = 0.3985)
7:117180234:T:G,P13569,V317G,0.656,Loss of stability (P = 0.022); Gain of helix (P = 0.027); Loss of loop (P = 0.0374); Loss of sheet (P = 0.0457); Loss of catalytic residue at V317 (P = 0.3139)
7:117180236:G:A,P13569,V318M,0.639,Loss of sheet (P = 0.0457); Loss of catalytic residue at V318 (P = 0.059); Gain of helix (P = 0.062); Loss of loop (P = 0.0986); Loss of stability (P = 0.3917)
7:117180236:G:C,P13569,V318L,0.681,Loss of catalytic residue at V318 (P = 0.0825); Loss of loop (P = 0.0986); Gain of helix (P = 0.1736); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.5919)
7:117180236:G:T,P13569,V318L,0.681,Loss of catalytic residue at V318 (P = 0.0825); Loss of loop (P = 0.0986); Gain of helix (P = 0.1736); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.5919)
7:117180237:T:A,P13569,V318E,0.764,Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457); Loss of loop (P = 0.0986); Loss of stability (P = 0.168); Loss of catalytic residue at S321 (P = 0.1865)
7:117180237:T:C,P13569,V318A,0.674,Loss of stability (P = 0.0879); Loss of loop (P = 0.0986); Gain of sheet (P = 0.1945); Gain of helix (P = 0.2684); Gain of catalytic residue at V318 (P = 0.3782)
7:117180237:T:G,P13569,V318G,0.701,Loss of stability (P = 0.0031); Loss of loop (P = 0.0986); Loss of sheet (P = 0.1158); Gain of catalytic residue at L323 (P = 0.1505); Gain of helix (P = 0.1736)
7:117180239:T:A,P13569,F319I,0.627,Gain of helix (P = 0.0034); Loss of loop (P = 0.0153); Loss of sheet (P = 0.0228); Gain of catalytic residue at F319 (P = 0.1988); Gain of MoRF binding (P = 0.5336)
7:117180239:T:C,P13569,F319L,0.663,Gain of helix (P = 0.062); Loss of sheet (P = 0.1158); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.5498); Loss of catalytic residue at F319 (P = 0.5835)
7:117180239:T:G,P13569,F319V,0.622,Gain of sheet (P = 0.1208); Gain of catalytic residue at F319 (P = 0.3307); Loss of helix (P = 0.3949); Loss of stability (P = 0.541); Loss of MoRF binding (P = 0.5518)
7:117180240:T:A,P13569,F319Y,0.639,Gain of helix (P = 0.0034); Loss of sheet (P = 0.0142); Loss of loop (P = 0.0153); Gain of catalytic residue at F319 (P = 0.1879); Loss of stability (P = 0.5077)
7:117180240:T:C,P13569,F319S,0.649,Gain of catalytic residue at F319 (P = 0.0807); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Loss of stability (P = 0.1896); Gain of glycosylation at F319 (P = 0.2375)
7:117180240:T:G,P13569,F319C,0.631,Gain of helix (P = 0.0034); Loss of sheet (P = 0.0228); Loss of loop (P = 0.0288); Gain of catalytic residue at F319 (P = 0.165); Loss of stability (P = 0.3712)
7:117180241:T:A,P13569,F319L,0.663,Gain of helix (P = 0.062); Loss of sheet (P = 0.1158); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.5498); Loss of catalytic residue at F319 (P = 0.5835)
7:117180241:T:G,P13569,F319L,0.663,Gain of helix (P = 0.062); Loss of sheet (P = 0.1158); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.5498); Loss of catalytic residue at F319 (P = 0.5835)
7:117180242:T:A,P13569,L320I,0.783,Loss of sheet (P = 0.302); Gain of catalytic residue at L323 (P = 0.3248); Gain of glycosylation at S321 (P = 0.3752); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4563)
7:117180243:T:C,P13569,L320S,0.706,Loss of stability (P = 0.0827); Gain of sheet (P = 0.1208); Loss of loop (P = 0.2237); Gain of glycosylation at S321 (P = 0.2971); Loss of helix (P = 0.3949)
7:117180244:A:C,P13569,L320F,0.888,Gain of glycosylation at S321 (P = 0.2648); Loss of sheet (P = 0.302); Loss of catalytic residue at L320 (P = 0.3662); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4737)
7:117180244:A:T,P13569,L320F,0.888,Gain of glycosylation at S321 (P = 0.2648); Loss of sheet (P = 0.302); Loss of catalytic residue at L320 (P = 0.3662); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4737)
7:117180245:T:A,P13569,S321T,0.628,Gain of glycosylation at S321 (P = 0.1178); Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.449); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117180245:T:C,P13569,S321P,0.932,Loss of catalytic residue at S321 (P = 0.0423); Loss of sheet (P = 0.1158); Loss of stability (P = 0.1592); Loss of loop (P = 0.2897); Loss of MoRF binding (P = 0.4139)
7:117180245:T:G,P13569,S321A,0.67,Gain of helix (P = 0.0496); Loss of sheet (P = 0.1158); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.4404); Loss of stability (P = 0.5764)
7:117180246:C:A,P13569,S321Y,0.653,Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of MoRF binding (P = 0.4443); Loss of loop (P = 0.4786); Loss of stability (P = 0.5399)
7:117180246:C:G,P13569,S321C,0.645,Gain of sheet (P = 0.1208); Gain of helix (P = 0.1736); Loss of MoRF binding (P = 0.4345); Loss of loop (P = 0.4786); Gain of catalytic residue at L320 (P = 0.4853)
7:117180246:C:T,P13569,S321F,0.638,Loss of catalytic residue at S321 (P = 0.0519); Gain of helix (P = 0.1736); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.4462); Loss of loop (P = 0.4786)
7:117180248:G:A,P13569,V322M,0.829,Loss of sheet (P = 0.0457); Gain of helix (P = 0.062); Loss of catalytic residue at V322 (P = 0.1153); Gain of MoRF binding (P = 0.3921); Loss of stability (P = 0.4626)
7:117180248:G:C,P13569,V322L,0.71,Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457); Loss of catalytic residue at V322 (P = 0.1494); Gain of glycosylation at S321 (P = 0.3604); Loss of MoRF binding (P = 0.398)
7:117180248:G:T,P13569,V322L,0.71,Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457); Loss of catalytic residue at V322 (P = 0.1494); Gain of glycosylation at S321 (P = 0.3604); Loss of MoRF binding (P = 0.398)
7:117180249:T:A,P13569,V322E,0.752,Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of catalytic residue at S321 (P = 0.3174); Loss of MoRF binding (P = 0.3548); Loss of stability (P = 0.3559)
7:117180249:T:C,P13569,V322A,0.841,Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457); Loss of stability (P = 0.1496); Gain of catalytic residue at V322 (P = 0.2762); Loss of MoRF binding (P = 0.396)
7:117180249:T:G,P13569,V322G,0.679,Loss of stability (P = 0.0197); Gain of glycosylation at S321 (P = 0.0308); Gain of helix (P = 0.0854); Loss of sheet (P = 0.1158); Gain of catalytic residue at L323 (P = 0.138)
7:117180251:C:A,P13569,L323I,0.576,Gain of sheet (P = 0.0477); Gain of catalytic residue at L323 (P = 0.0658); Loss of helix (P = 0.079); Gain of MoRF binding (P = 0.2999); Gain of loop (P = 0.4661)
7:117180251:C:G,P13569,L323V,0.546,Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Gain of catalytic residue at L323 (P = 0.2905); Gain of MoRF binding (P = 0.3213); Gain of loop (P = 0.4661)
7:117180251:C:T,P13569,L323F,0.555,Loss of helix (P = 0.1299); Gain of catalytic residue at L323 (P = 0.1848); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.3106); Gain of loop (P = 0.4661)
7:117180252:T:A,P13569,L323H,0.608,Gain of sheet (P = 0.0221); Loss of helix (P = 0.0558); Gain of catalytic residue at L323 (P = 0.0707); Loss of stability (P = 0.0907); Loss of MoRF binding (P = 0.3381)
7:117180252:T:C,P13569,L323P,0.693,Gain of sheet (P = 0.0477); Gain of catalytic residue at L323 (P = 0.054); Loss of helix (P = 0.0558); Loss of stability (P = 0.0989); Gain of loop (P = 0.1069)
7:117180252:T:G,P13569,L323R,0.811,Gain of methylation at L323 (P = 0.0047); Gain of sheet (P = 0.0221); Loss of helix (P = 0.0558); Gain of MoRF binding (P = 0.0635); Gain of loop (P = 0.1069)
7:117180254:C:A,P13569,P324T,0.62,Gain of MoRF binding (P = 0.0971); Loss of stability (P = 0.1111); Loss of sheet (P = 0.1158); Loss of ubiquitination at K329 (P = 0.1306); Gain of methylation at K329 (P = 0.1666)
7:117180254:C:G,P13569,P324A,0.644,Gain of catalytic residue at P324 (P = 0.0554); Gain of MoRF binding (P = 0.1045); Loss of methylation at K329 (P = 0.1057); Loss of ubiquitination at K329 (P = 0.1306); Gain of helix (P = 0.1736)
7:117180254:C:T,P13569,P324S,0.656,Gain of MoRF binding (P = 0.0957); Gain of catalytic residue at P324 (P = 0.0966); Gain of ubiquitination at K329 (P = 0.115); Gain of helix (P = 0.1736); Gain of methylation at K329 (P = 0.1895)
7:117180255:C:A,P13569,P324H,0.642,Loss of sheet (P = 0.1158); Loss of ubiquitination at K329 (P = 0.1306); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1357); Loss of methylation at K329 (P = 0.1457)
7:117180255:C:G,P13569,P324R,0.867,Gain of MoRF binding (P = 0.0081); Gain of methylation at P324 (P = 0.0141); Loss of sheet (P = 0.0457); Gain of helix (P = 0.062); Loss of ubiquitination at K329 (P = 0.1306)
7:117180255:C:T,P13569,P324L,0.654,Gain of helix (P = 0.062); Gain of MoRF binding (P = 0.0821); Loss of methylation at K329 (P = 0.0948); Gain of ubiquitination at K329 (P = 0.1008); Loss of sheet (P = 0.1158)
7:117180257:T:A,P13569,Y325N,0.689,Loss of catalytic residue at L320 (P = 0.0763); Loss of ubiquitination at K329 (P = 0.0982); Loss of methylation at K329 (P = 0.1042); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945)
7:117180257:T:C,P13569,Y325H,0.695,Loss of helix (P = 0.0558); Loss of catalytic residue at L320 (P = 0.0769); Loss of ubiquitination at K329 (P = 0.0982); Loss of methylation at K329 (P = 0.1042); Gain of MoRF binding (P = 0.2677)
7:117180257:T:G,P13569,Y325D,0.741,Loss of catalytic residue at Y325 (P = 0.0491); Loss of ubiquitination at K329 (P = 0.063); Loss of methylation at K329 (P = 0.0967); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.2136)
7:117180258:A:C,P13569,Y325S,0.66,Gain of sheet (P = 0.0221); Loss of catalytic residue at Y325 (P = 0.0345); Loss of helix (P = 0.0376); Loss of ubiquitination at K329 (P = 0.0863); Gain of loop (P = 0.1069)
7:117180258:A:T,P13569,Y325F,0.67,Gain of sheet (P = 0.0221); Loss of helix (P = 0.0376); Loss of catalytic residue at L320 (P = 0.0752); Loss of ubiquitination at K329 (P = 0.1306); Gain of methylation at K329 (P = 0.1685)
7:117180260:G:A,P13569,A326T,0.514,Loss of loop (P = 0.0804); Gain of methylation at K329 (P = 0.0956); Loss of ubiquitination at K329 (P = 0.0982); Gain of helix (P = 0.132); Loss of stability (P = 0.1633)
7:117180260:G:C,P13569,A326P,0.729,Gain of methylation at K329 (P = 0.0517); Loss of loop (P = 0.0804); Loss of MoRF binding (P = 0.127); Loss of ubiquitination at K329 (P = 0.1306); Gain of helix (P = 0.132)
7:117180260:G:T,P13569,A326S,0.59,Loss of loop (P = 0.0804); Loss of ubiquitination at K329 (P = 0.0982); Gain of methylation at K329 (P = 0.1037); Gain of helix (P = 0.132); Loss of catalytic residue at A326 (P = 0.1447)
7:117180261:C:A,P13569,A326E,0.711,Loss of ubiquitination at K329 (P = 0.0496); Gain of methylation at K329 (P = 0.0694); Loss of MoRF binding (P = 0.106); Loss of catalytic residue at A326 (P = 0.1178); Gain of helix (P = 0.132)
7:117180261:C:G,P13569,A326G,0.603,Gain of helix (P = 0.0325); Loss of loop (P = 0.0512); Loss of stability (P = 0.0596); Loss of ubiquitination at K329 (P = 0.1139); Gain of methylation at K329 (P = 0.1267)
7:117180261:C:T,P13569,A326V,0.5,Gain of ubiquitination at K329 (P = 0.1008); Gain of methylation at K329 (P = 0.1124); Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.1884); Gain of sheet (P = 0.1945)
7:117180263:C:A,P13569,L327I,0.678,Gain of methylation at K329 (P = 0.0542); Loss of ubiquitination at K329 (P = 0.0982); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1848); Loss of stability (P = 0.2461)
7:117180263:C:G,P13569,L327V,0.697,Loss of stability (P = 0.0667); Gain of methylation at K329 (P = 0.0734); Gain of ubiquitination at K329 (P = 0.1008); Gain of MoRF binding (P = 0.1729); Loss of helix (P = 0.3949)
7:117180264:T:A,P13569,L327Q,0.745,Loss of stability (P = 0.0076); Loss of ubiquitination at K329 (P = 0.1139); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1364); Gain of methylation at K329 (P = 0.167)
7:117180264:T:C,P13569,L327P,0.843,Loss of stability (P = 0.0027); Gain of methylation at K329 (P = 0.0676); Gain of ubiquitination at K329 (P = 0.0725); Loss of MoRF binding (P = 0.105); Loss of helix (P = 0.1706)
7:117180266:A:C,P13569,I328L,0.553,Loss of methylation at K329 (P = 0.0814); Loss of ubiquitination at K329 (P = 0.0982); Loss of helix (P = 0.1299); Loss of catalytic residue at L333 (P = 0.1388); Loss of MoRF binding (P = 0.1525)
7:117180266:A:G,P13569,I328V,0.519,Loss of helix (P = 0.0558); Gain of methylation at K329 (P = 0.0561); Loss of ubiquitination at K329 (P = 0.1306); Loss of catalytic residue at L333 (P = 0.1385); Loss of MoRF binding (P = 0.1849)
7:117180266:A:T,P13569,I328F,0.577,Gain of methylation at K329 (P = 0.0384); Loss of stability (P = 0.1055); Loss of helix (P = 0.1299); Loss of ubiquitination at K329 (P = 0.1306); Loss of catalytic residue at L333 (P = 0.1375)
7:117180267:T:A,P13569,I328N,0.54,Loss of stability (P = 0.0308); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of ubiquitination at K329 (P = 0.0863); Loss of methylation at K329 (P = 0.089)
7:117180267:T:C,P13569,I328T,0.608,Loss of stability (P = 0.0077); Loss of methylation at K329 (P = 0.089); Loss of ubiquitination at K329 (P = 0.0982); Loss of MoRF binding (P = 0.1298); Loss of helix (P = 0.1299)
7:117180267:T:G,P13569,I328S,0.566,Loss of stability (P = 0.0314); Loss of catalytic residue at I328 (P = 0.0736); Loss of methylation at K329 (P = 0.0801); Loss of ubiquitination at K329 (P = 0.0863); Loss of helix (P = 0.1299)
7:117180268:C:G,P13569,I328M,0.513,Loss of methylation at K329 (P = 0.0436); Loss of catalytic residue at I328 (P = 0.0705); Loss of ubiquitination at K329 (P = 0.1139); Loss of helix (P = 0.1299); Loss of stability (P = 0.1416)
7:117180269:A:C,P13569,K329Q,0.573,Loss of ubiquitination at K329 (P = 0.0174); Loss of methylation at K329 (P = 0.0342); Gain of helix (P = 0.0696); Loss of MoRF binding (P = 0.0727); Loss of loop (P = 0.2897)
7:117180269:A:G,P13569,K329E,0.571,Loss of ubiquitination at K329 (P = 0.0174); Loss of methylation at K329 (P = 0.0342); Loss of MoRF binding (P = 0.0347); Loss of helix (P = 0.0558); Gain of loop (P = 0.1069)
7:117180270:A:C,P13569,K329T,0.584,Loss of ubiquitination at K329 (P = 0.0174); Loss of methylation at K329 (P = 0.0342); Loss of MoRF binding (P = 0.0731); Loss of helix (P = 0.1299); Loss of stability (P = 0.2848)
7:117180270:A:G,P13569,K329R,0.547,Loss of ubiquitination at K329 (P = 0.0174); Loss of methylation at K329 (P = 0.0658); Gain of MoRF binding (P = 0.104); Loss of helix (P = 0.1299); Loss of loop (P = 0.2897)
7:117180270:A:T,P13569,K329I,0.589,Loss of ubiquitination at K329 (P = 0.0174); Loss of methylation at K329 (P = 0.0342); Gain of helix (P = 0.0425); Loss of MoRF binding (P = 0.0877); Loss of loop (P = 0.2897)
7:117180271:A:C,P13569,K329N,0.554,Loss of ubiquitination at K329 (P = 0.0174); Loss of methylation at K329 (P = 0.0342); Loss of MoRF binding (P = 0.075); Loss of helix (P = 0.1299); Loss of glycosylation at K329 (P = 0.3457)
7:117180271:A:T,P13569,K329N,0.554,Loss of ubiquitination at K329 (P = 0.0174); Loss of methylation at K329 (P = 0.0342); Loss of MoRF binding (P = 0.075); Loss of helix (P = 0.1299); Loss of glycosylation at K329 (P = 0.3457)
7:117180272:G:A,P13569,G330R,0.692,Gain of MoRF binding (P = 0.0106); Gain of helix (P = 0.062); Loss of ubiquitination at K329 (P = 0.0982); Gain of methylation at K329 (P = 0.1497); Loss of catalytic residue at I328 (P = 0.1806)
7:117180272:G:C,P13569,G330R,0.692,Gain of MoRF binding (P = 0.0106); Gain of helix (P = 0.062); Loss of ubiquitination at K329 (P = 0.0982); Gain of methylation at K329 (P = 0.1497); Loss of catalytic residue at I328 (P = 0.1806)
7:117180273:G:A,P13569,G330E,0.636,Loss of MoRF binding (P = 0.0663); Loss of ubiquitination at K335 (P = 0.0694); Loss of catalytic residue at K329 (P = 0.0944); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299)
7:117180273:G:C,P13569,G330A,0.625,Gain of helix (P = 0.062); Gain of ubiquitination at K335 (P = 0.1103); Gain of MoRF binding (P = 0.1596); Loss of methylation at K329 (P = 0.1623); Loss of catalytic residue at I328 (P = 0.1977)
7:117180273:G:T,P13569,G330V,0.654,Gain of helix (P = 0.0325); Gain of methylation at K329 (P = 0.0397); Loss of loop (P = 0.0603); Gain of ubiquitination at K335 (P = 0.0828); Gain of MoRF binding (P = 0.1075)
7:117180275:A:C,P13569,I331L,0.514,Loss of methylation at K329 (P = 0.0782); Gain of ubiquitination at K335 (P = 0.1295); Loss of helix (P = 0.1299); Gain of catalytic residue at I331 (P = 0.1336); Loss of MoRF binding (P = 0.1384)
7:117180275:A:G,P13569,I331V,0.598,Gain of catalytic residue at I331 (P = 0.0576); Gain of ubiquitination at K329 (P = 0.115); Gain of MoRF binding (P = 0.1277); Gain of helix (P = 0.132); Loss of methylation at K329 (P = 0.1401)
7:117180275:A:T,P13569,I331F,0.586,Gain of helix (P = 0.0325); Loss of loop (P = 0.0512); Loss of methylation at K329 (P = 0.1266); Gain of ubiquitination at K335 (P = 0.1295); Gain of MoRF binding (P = 0.1383)
7:117180276:T:A,P13569,I331N,0.7,Loss of stability (P = 0.0441); Loss of ubiquitination at K329 (P = 0.0768); Loss of methylation at K329 (P = 0.077); Gain of MoRF binding (P = 0.0954); Gain of helix (P = 0.1736)
7:117180276:T:C,P13569,I331T,0.667,Loss of stability (P = 0.0204); Loss of ubiquitination at K329 (P = 0.0699); Loss of methylation at K329 (P = 0.0859); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1433)
7:117180276:T:G,P13569,I331S,0.638,Loss of stability (P = 0.0438); Gain of helix (P = 0.0696); Loss of methylation at K329 (P = 0.0707); Loss of ubiquitination at K329 (P = 0.0768); Gain of glycosylation at I331 (P = 0.0934)
7:117180277:C:G,P13569,I331M,0.549,Loss of ubiquitination at K329 (P = 0.0863); Loss of methylation at K329 (P = 0.1173); Gain of MoRF binding (P = 0.1316); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117180278:A:C,P13569,I332L,0.478,Loss of methylation at K329 (P = 0.0777); Loss of ubiquitination at K329 (P = 0.1139); Loss of MoRF binding (P = 0.1247); Gain of helix (P = 0.132); Loss of catalytic residue at L327 (P = 0.2889)
7:117180278:A:G,P13569,I332V,0.492,Gain of helix (P = 0.062); Gain of ubiquitination at K329 (P = 0.115); Loss of methylation at K329 (P = 0.1334); Gain of MoRF binding (P = 0.1354); Loss of catalytic residue at L327 (P = 0.2888)
7:117180278:A:T,P13569,I332F,0.481,Gain of ubiquitination at K335 (P = 0.1103); Loss of methylation at K329 (P = 0.1209); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1448); Loss of catalytic residue at K329 (P = 0.2346)
7:117180279:T:A,P13569,I332N,0.491,Loss of ubiquitination at K329 (P = 0.063); Loss of methylation at K329 (P = 0.0739); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1367); Loss of catalytic residue at K335 (P = 0.2)
7:117180279:T:C,P13569,I332T,0.504,Gain of helix (P = 0.062); Loss of ubiquitination at K329 (P = 0.0768); Loss of stability (P = 0.0799); Loss of methylation at K329 (P = 0.0822); Loss of MoRF binding (P = 0.1093)
7:117180279:T:G,P13569,I332S,0.462,Loss of ubiquitination at K329 (P = 0.054); Loss of methylation at K329 (P = 0.0696); Loss of stability (P = 0.1157); Loss of MoRF binding (P = 0.1219); Loss of helix (P = 0.1299)
7:117180280:C:G,P13569,I332M,0.461,Loss of ubiquitination at K329 (P = 0.0982); Loss of methylation at K329 (P = 0.1108); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1393); Loss of catalytic residue at I332 (P = 0.1806)
7:117180281:C:A,P13569,L333I,0.58,Gain of methylation at K329 (P = 0.0565); Gain of helix (P = 0.062); Loss of catalytic residue at L333 (P = 0.0654); Loss of loop (P = 0.0804); Gain of ubiquitination at K335 (P = 0.1103)
7:117180281:C:G,P13569,L333V,0.558,Gain of methylation at K329 (P = 0.0718); Gain of ubiquitination at K329 (P = 0.115); Gain of MoRF binding (P = 0.1152); Loss of helix (P = 0.1299); Loss of stability (P = 0.1371)
7:117180282:T:A,P13569,L333H,0.663,Loss of catalytic residue at L333 (P = 0.011); Loss of stability (P = 0.021); Gain of helix (P = 0.0325); Gain of methylation at K329 (P = 0.0414); Loss of loop (P = 0.0512)
7:117180282:T:C,P13569,L333P,0.706,Loss of stability (P = 0.0155); Gain of helix (P = 0.0199); Gain of methylation at K329 (P = 0.0375); Loss of loop (P = 0.0512); Loss of MoRF binding (P = 0.0524)
7:117180282:T:G,P13569,L333R,0.83,Gain of MoRF binding (P = 0.0285); Loss of stability (P = 0.0312); Gain of helix (P = 0.0325); Gain of methylation at K329 (P = 0.0432); Loss of loop (P = 0.0512)
7:117180284:C:G,P13569,R334G,0.799,Loss of MoRF binding (P = 0.0261); Loss of catalytic residue at R334 (P = 0.05); Gain of helix (P = 0.062); Loss of ubiquitination at K329 (P = 0.0699); Loss of stability (P = 0.0778)
7:117180285:G:C,P13569,R334P,0.799,Loss of MoRF binding (P = 0.0075); Loss of ubiquitination at K329 (P = 0.063); Gain of methylation at K329 (P = 0.0769); Loss of stability (P = 0.0895); Gain of loop (P = 0.2045)
7:117180285:G:T,P13569,R334L,0.932,Loss of MoRF binding (P = 0.0315); Gain of helix (P = 0.062); Loss of ubiquitination at K329 (P = 0.0982); Loss of methylation at K329 (P = 0.1108); Loss of glycosylation at T339 (P = 0.155)
7:117180287:A:C,P13569,K335Q,0.631,Loss of ubiquitination at K335 (P = 0.0233); Loss of MoRF binding (P = 0.0543); Loss of catalytic residue at K335 (P = 0.0572); Loss of helix (P = 0.1706); Loss of glycosylation at T339 (P = 0.2326)
7:117180287:A:G,P13569,K335E,0.644,Loss of MoRF binding (P = 0.0089); Loss of ubiquitination at K335 (P = 0.0233); Gain of glycosylation at T339 (P = 0.1589); Gain of helix (P = 0.2059); Loss of methylation at K335 (P = 0.2354)
7:117180288:A:C,P13569,K335T,0.648,Loss of ubiquitination at K335 (P = 0.0233); Loss of MoRF binding (P = 0.0537); Gain of helix (P = 0.132); Gain of glycosylation at T339 (P = 0.2288); Loss of methylation at K335 (P = 0.2354)
7:117180288:A:G,P13569,K335R,0.552,Loss of ubiquitination at K335 (P = 0.0233); Gain of MoRF binding (P = 0.1057); Loss of glycosylation at T339 (P = 0.1961); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897)
7:117180288:A:T,P13569,K335I,0.581,Loss of catalytic residue at K335 (P = 0.0152); Loss of ubiquitination at K335 (P = 0.0233); Loss of MoRF binding (P = 0.0708); Gain of glycosylation at T338 (P = 0.2258); Loss of methylation at K335 (P = 0.2354)
7:117180289:A:C,P13569,K335N,0.654,Loss of ubiquitination at K335 (P = 0.0233); Loss of MoRF binding (P = 0.0583); Gain of helix (P = 0.0854); Gain of glycosylation at T339 (P = 0.1786); Loss of methylation at K335 (P = 0.2354)
7:117180289:A:T,P13569,K335N,0.654,Loss of ubiquitination at K335 (P = 0.0233); Loss of MoRF binding (P = 0.0583); Gain of helix (P = 0.0854); Gain of glycosylation at T339 (P = 0.1786); Loss of methylation at K335 (P = 0.2354)
7:117180290:A:C,P13569,I336L,0.593,Gain of catalytic residue at I336 (P = 0.0369); Loss of ubiquitination at K335 (P = 0.0924); Loss of MoRF binding (P = 0.1185); Gain of helix (P = 0.132); Loss of glycosylation at T339 (P = 0.199)
7:117180290:A:G,P13569,I336V,0.521,Gain of helix (P = 0.0696); Loss of stability (P = 0.0707); Gain of MoRF binding (P = 0.1412); Loss of ubiquitination at K335 (P = 0.1498); Gain of methylation at K335 (P = 0.1936)
7:117180290:A:T,P13569,I336L,0.593,Gain of catalytic residue at I336 (P = 0.0369); Loss of ubiquitination at K335 (P = 0.0924); Loss of MoRF binding (P = 0.1185); Gain of helix (P = 0.132); Loss of glycosylation at T339 (P = 0.199)
7:117180291:T:A,P13569,I336K,0.938,Loss of stability (P = 0.0016); Gain of ubiquitination at I336 (P = 0.0247); Gain of MoRF binding (P = 0.0577); Loss of glycosylation at T339 (P = 0.1227); Gain of helix (P = 0.132)
7:117180291:T:C,P13569,I336T,0.748,Loss of stability (P = 0.0016); Gain of helix (P = 0.0696); Loss of MoRF binding (P = 0.0861); Loss of ubiquitination at K335 (P = 0.1498); Gain of catalytic residue at I336 (P = 0.2237)
7:117180291:T:G,P13569,I336R,0.903,Loss of stability (P = 0.0078); Gain of methylation at I336 (P = 0.0231); Gain of MoRF binding (P = 0.0423); Gain of helix (P = 0.0696); Loss of glycosylation at T339 (P = 0.0905)
7:117180292:A:G,P13569,I336M,0.673,Loss of stability (P = 0.0738); Loss of MoRF binding (P = 0.1206); Loss of helix (P = 0.1299); Loss of ubiquitination at K335 (P = 0.1498); Loss of glycosylation at T339 (P = 0.1971)
7:117180293:T:A,P13569,F337I,0.677,Gain of glycosylation at T339 (P = 0.0769); Gain of helix (P = 0.0854); Gain of ubiquitination at K335 (P = 0.0954); Gain of MoRF binding (P = 0.1417); Gain of catalytic residue at F337 (P = 0.1725)
7:117180293:T:C,P13569,F337L,0.672,Gain of catalytic residue at F337 (P = 0.0067); Loss of MoRF binding (P = 0.1255); Gain of glycosylation at T339 (P = 0.1466); Loss of ubiquitination at K335 (P = 0.1498); Gain of helix (P = 0.2059)
7:117180293:T:G,P13569,F337V,0.694,Gain of catalytic residue at F337 (P = 0.0566); Gain of ubiquitination at K335 (P = 0.0828); Loss of stability (P = 0.091); Gain of glycosylation at T339 (P = 0.1176); Gain of MoRF binding (P = 0.1336)
7:117180294:T:A,P13569,F337Y,0.759,Gain of catalytic residue at I336 (P = 0.0687); Loss of MoRF binding (P = 0.1026); Gain of ubiquitination at K335 (P = 0.1103); Loss of stability (P = 0.1861); Gain of helix (P = 0.2059)
7:117180294:T:C,P13569,F337S,0.755,Loss of stability (P = 0.0509); Gain of catalytic residue at F337 (P = 0.0617); Gain of glycosylation at F337 (P = 0.072); Gain of helix (P = 0.0854); Gain of ubiquitination at K335 (P = 0.1103)
7:117180294:T:G,P13569,F337C,0.764,Loss of MoRF binding (P = 0.082); Gain of helix (P = 0.0854); Gain of ubiquitination at K335 (P = 0.1103); Loss of stability (P = 0.1298); Gain of glycosylation at T339 (P = 0.2688)
7:117180295:C:A,P13569,F337L,0.672,Gain of catalytic residue at F337 (P = 0.0067); Loss of MoRF binding (P = 0.1255); Gain of glycosylation at T339 (P = 0.1466); Loss of ubiquitination at K335 (P = 0.1498); Gain of helix (P = 0.2059)
7:117180295:C:G,P13569,F337L,0.672,Gain of catalytic residue at F337 (P = 0.0067); Loss of MoRF binding (P = 0.1255); Gain of glycosylation at T339 (P = 0.1466); Loss of ubiquitination at K335 (P = 0.1498); Gain of helix (P = 0.2059)
7:117180296:A:C,P13569,T338P,0.795,Loss of MoRF binding (P = 0.0545); Loss of ubiquitination at K335 (P = 0.1351); Gain of glycosylation at T339 (P = 0.1437); Gain of helix (P = 0.1736); Gain of methylation at K335 (P = 0.2608)
7:117180296:A:G,P13569,T338A,0.845,Gain of ubiquitination at K335 (P = 0.0685); Loss of MoRF binding (P = 0.1363); Loss of glycosylation at T339 (P = 0.2028); Gain of helix (P = 0.2294); Loss of methylation at K335 (P = 0.3755)
7:117180296:A:T,P13569,T338S,0.665,Gain of MoRF binding (P = 0.1186); Loss of glycosylation at T339 (P = 0.1378); Loss of ubiquitination at K335 (P = 0.1498); Gain of helix (P = 0.2294); Loss of methylation at K335 (P = 0.3877)
7:117180297:C:A,P13569,T338N,0.782,Gain of MoRF binding (P = 0.0878); Loss of glycosylation at T339 (P = 0.1073); Gain of ubiquitination at K335 (P = 0.1103); Gain of helix (P = 0.2294); Gain of methylation at K335 (P = 0.3397)
7:117180297:C:G,P13569,T338S,0.665,Gain of MoRF binding (P = 0.1186); Loss of glycosylation at T339 (P = 0.1378); Loss of ubiquitination at K335 (P = 0.1498); Gain of helix (P = 0.2294); Loss of methylation at K335 (P = 0.3877)
7:117180297:C:T,P13569,T338I,0.873,Gain of ubiquitination at K335 (P = 0.0555); Gain of MoRF binding (P = 0.1325); Loss of glycosylation at T339 (P = 0.1351); Loss of catalytic residue at T338 (P = 0.2103); Gain of helix (P = 0.2294)
7:117180299:A:C,P13569,T339P,0.686,Loss of glycosylation at T339 (P = 0.0493); Loss of MoRF binding (P = 0.0547); Loss of catalytic residue at F342 (P = 0.1404); Loss of ubiquitination at K335 (P = 0.1498); Loss of stability (P = 0.3161)
7:117180299:A:G,P13569,T339A,0.615,Loss of glycosylation at T339 (P = 0.0364); Gain of ubiquitination at K335 (P = 0.0954); Loss of catalytic residue at F342 (P = 0.1341); Gain of MoRF binding (P = 0.1427); Loss of methylation at K335 (P = 0.3669)
7:117180299:A:T,P13569,T339S,0.589,Loss of glycosylation at T339 (P = 0.0692); Gain of MoRF binding (P = 0.1209); Loss of ubiquitination at K335 (P = 0.1498); Loss of catalytic residue at F342 (P = 0.1545); Loss of methylation at K335 (P = 0.3862)
7:117180300:C:A,P13569,T339N,0.622,Loss of glycosylation at T339 (P = 0.0364); Gain of MoRF binding (P = 0.0908); Gain of ubiquitination at K335 (P = 0.1295); Loss of catalytic residue at F342 (P = 0.1701); Loss of methylation at K335 (P = 0.3653)
7:117180300:C:G,P13569,T339S,0.589,Loss of glycosylation at T339 (P = 0.0692); Gain of MoRF binding (P = 0.1209); Loss of ubiquitination at K335 (P = 0.1498); Loss of catalytic residue at F342 (P = 0.1545); Loss of methylation at K335 (P = 0.3862)
7:117180300:C:T,P13569,T339I,0.608,Loss of glycosylation at T339 (P = 0.0364); Gain of ubiquitination at K335 (P = 0.0828); Gain of MoRF binding (P = 0.1019); Loss of catalytic residue at F342 (P = 0.1197); Gain of methylation at K335 (P = 0.3303)
7:117180302:A:C,P13569,I340L,0.615,Loss of glycosylation at T339 (P = 0.0914); Loss of MoRF binding (P = 0.1182); Loss of ubiquitination at K335 (P = 0.1498); Loss of methylation at K335 (P = 0.3526); Loss of catalytic residue at T339 (P = 0.6298)
7:117180302:A:T,P13569,I340F,0.68,Loss of MoRF binding (P = 0.1281); Loss of ubiquitination at K335 (P = 0.1498); Loss of glycosylation at T339 (P = 0.1686); Loss of methylation at K335 (P = 0.3764); Loss of catalytic residue at T339 (P = 0.5056)
7:117180303:T:A,P13569,I340N,0.889,Gain of ubiquitination at K335 (P = 0.0632); Loss of MoRF binding (P = 0.0911); Loss of glycosylation at T339 (P = 0.0954); Gain of catalytic residue at I340 (P = 0.3048); Loss of stability (P = 0.3319)
7:117180303:T:G,P13569,I340S,0.82,Gain of catalytic residue at I340 (P = 0.0179); Gain of ubiquitination at K335 (P = 0.0828); Loss of MoRF binding (P = 0.0876); Loss of glycosylation at T339 (P = 0.1133); Loss of stability (P = 0.223)
7:117180304:C:G,P13569,I340M,0.681,Gain of catalytic residue at I340 (P = 0.0837); Gain of ubiquitination at K335 (P = 0.0954); Loss of MoRF binding (P = 0.1161); Loss of glycosylation at T339 (P = 0.1587); Gain of methylation at K335 (P = 0.3876)
7:117180305:T:A,P13569,S341T,0.824,Loss of MoRF binding (P = 0.1205); Gain of glycosylation at T339 (P = 0.2327); Loss of stability (P = 0.4212); Loss of catalytic residue at F342 (P = 0.6399); Loss of helix (P = 0.6835)
7:117180305:T:C,P13569,S341P,0.93,Loss of MoRF binding (P = 0.0512); Gain of glycosylation at T338 (P = 0.0603); Loss of stability (P = 0.1714); Loss of catalytic residue at S341 (P = 0.2151); Loss of helix (P = 0.6835)
7:117180305:T:G,P13569,S341A,0.766,Loss of MoRF binding (P = 0.1259); Gain of glycosylation at T339 (P = 0.2696); Loss of stability (P = 0.4967); Gain of sheet (P = 0.6509); Loss of helix (P = 0.6835)
7:117180306:C:T,P13569,S341L,0.763,Loss of glycosylation at T339 (P = 0.1329); Loss of MoRF binding (P = 0.141); Loss of helix (P = 0.6835); Loss of catalytic residue at F342 (P = 0.6882); Loss of phosphorylation at T339 (P = 0.8204)
7:117180308:T:A,P13569,F342I,0.657,Loss of methylation at R347 (P = 0.1038); Gain of MoRF binding (P = 0.1367); Gain of glycosylation at T339 (P = 0.2516); Loss of catalytic residue at F342 (P = 0.5159); Loss of stability (P = 0.614)
7:117180308:T:C,P13569,F342L,0.666,Loss of methylation at R347 (P = 0.1265); Loss of MoRF binding (P = 0.1325); Loss of glycosylation at T339 (P = 0.1497); Loss of stability (P = 0.4816); Loss of helix (P = 0.5596)
7:117180308:T:G,P13569,F342V,0.642,Loss of methylation at R347 (P = 0.1333); Gain of MoRF binding (P = 0.1394); Loss of glycosylation at T339 (P = 0.2093); Loss of stability (P = 0.2805); Gain of catalytic residue at F342 (P = 0.4053)
7:117180309:T:A,P13569,F342Y,0.754,Loss of MoRF binding (P = 0.1068); Loss of methylation at R347 (P = 0.1376); Loss of glycosylation at T339 (P = 0.1888); Loss of stability (P = 0.3539); Gain of catalytic residue at F342 (P = 0.4681)
7:117180309:T:C,P13569,F342S,0.746,Loss of stability (P = 0.1034); Loss of MoRF binding (P = 0.1135); Loss of glycosylation at T339 (P = 0.1242); Loss of methylation at R347 (P = 0.1453); Gain of catalytic residue at F342 (P = 0.31)
7:117180309:T:G,P13569,F342C,0.774,Loss of MoRF binding (P = 0.0828); Loss of methylation at R347 (P = 0.0848); Gain of catalytic residue at I340 (P = 0.1066); Loss of glycosylation at T339 (P = 0.1144); Loss of stability (P = 0.1864)
7:117180310:C:A,P13569,F342L,0.666,Loss of methylation at R347 (P = 0.1265); Loss of MoRF binding (P = 0.1325); Loss of glycosylation at T339 (P = 0.1497); Loss of stability (P = 0.4816); Loss of helix (P = 0.5596)
7:117180310:C:G,P13569,F342L,0.666,Loss of methylation at R347 (P = 0.1265); Loss of MoRF binding (P = 0.1325); Loss of glycosylation at T339 (P = 0.1497); Loss of stability (P = 0.4816); Loss of helix (P = 0.5596)
7:117180311:T:A,P13569,C343S,0.649,Loss of stability (P = 0.0408); Gain of methylation at R347 (P = 0.063); Gain of MoRF binding (P = 0.0781); Loss of glycosylation at T339 (P = 0.196); Gain of catalytic residue at C343 (P = 0.3316)
7:117180311:T:C,P13569,C343R,0.83,Gain of MoRF binding (P = 0.0055); Gain of methylation at C343 (P = 0.0089); Gain of catalytic residue at C343 (P = 0.0819); Loss of glycosylation at T339 (P = 0.1228); Loss of stability (P = 0.1559)
7:117180311:T:G,P13569,C343G,0.649,Loss of stability (P = 0.0119); Gain of methylation at R347 (P = 0.0787); Gain of MoRF binding (P = 0.0948); Loss of glycosylation at T339 (P = 0.2328); Gain of catalytic residue at C343 (P = 0.2795)
7:117180312:G:A,P13569,C343Y,0.626,Gain of methylation at R347 (P = 0.0893); Gain of MoRF binding (P = 0.0912); Loss of stability (P = 0.1499); Gain of catalytic residue at C343 (P = 0.2188); Loss of glycosylation at T339 (P = 0.2337)
7:117180312:G:C,P13569,C343S,0.649,Loss of stability (P = 0.0408); Gain of methylation at R347 (P = 0.063); Gain of MoRF binding (P = 0.0781); Loss of glycosylation at T339 (P = 0.196); Gain of catalytic residue at C343 (P = 0.3316)
7:117180312:G:T,P13569,C343F,0.654,Gain of MoRF binding (P = 0.0867); Gain of methylation at R347 (P = 0.148); Gain of glycosylation at T339 (P = 0.2367); Loss of stability (P = 0.4642); Loss of catalytic residue at F342 (P = 0.4762)
7:117180313:C:G,P13569,C343W,0.668,Gain of MoRF binding (P = 0.0165); Loss of methylation at R347 (P = 0.0453); Gain of catalytic residue at C343 (P = 0.1021); Loss of stability (P = 0.1514); Loss of glycosylation at T339 (P = 0.2098)
7:117180314:A:C,P13569,I344L,0.661,Gain of catalytic residue at I344 (P = 0.0118); Loss of MoRF binding (P = 0.1229); Gain of methylation at R347 (P = 0.1243); Gain of glycosylation at T339 (P = 0.2188); Loss of helix (P = 0.4835)
7:117180314:A:G,P13569,I344V,0.641,Gain of catalytic residue at I344 (P = 0.0231); Gain of methylation at R347 (P = 0.0871); Loss of MoRF binding (P = 0.1363); Gain of glycosylation at T339 (P = 0.2152); Loss of helix (P = 0.6835)
7:117180314:A:T,P13569,I344F,0.666,Gain of methylation at R347 (P = 0.0778); Loss of MoRF binding (P = 0.1355); Gain of glycosylation at T339 (P = 0.2494); Loss of catalytic residue at A349 (P = 0.4423); Loss of stability (P = 0.4591)
7:117180315:T:A,P13569,I344N,0.67,Loss of stability (P = 0.0732); Gain of methylation at R347 (P = 0.1102); Loss of MoRF binding (P = 0.1336); Gain of glycosylation at T339 (P = 0.2182); Loss of catalytic residue at A349 (P = 0.3017)
7:117180315:T:C,P13569,I344T,0.689,Loss of stability (P = 0.0433); Loss of MoRF binding (P = 0.1054); Gain of methylation at R347 (P = 0.1262); Gain of glycosylation at T339 (P = 0.1988); Gain of catalytic residue at I344 (P = 0.3215)
7:117180315:T:G,P13569,I344S,0.679,Gain of methylation at R347 (P = 0.1025); Loss of stability (P = 0.1031); Loss of MoRF binding (P = 0.1134); Gain of glycosylation at T339 (P = 0.2688); Loss of catalytic residue at A349 (P = 0.3416)
7:117180316:T:G,P13569,I344M,0.706,Gain of methylation at R347 (P = 0.1223); Loss of MoRF binding (P = 0.127); Gain of glycosylation at T339 (P = 0.251); Loss of catalytic residue at A349 (P = 0.3275); Loss of stability (P = 0.5071)
7:117180317:G:A,P13569,V345I,0.653,Loss of methylation at R347 (P = 0.073); Gain of MoRF binding (P = 0.1433); Gain of catalytic residue at A349 (P = 0.55); Loss of helix (P = 0.6555); Loss of phosphorylation at S341 (P = 0.8305)
7:117180317:G:C,P13569,V345L,0.671,Loss of methylation at R347 (P = 0.122); Loss of MoRF binding (P = 0.1291); Loss of catalytic residue at F342 (P = 0.5328); Gain of helix (P = 0.5668); Loss of phosphorylation at S341 (P = 0.8304)
7:117180317:G:T,P13569,V345F,0.652,Loss of catalytic residue at V345 (P = 0.0362); Loss of MoRF binding (P = 0.143); Loss of methylation at R347 (P = 0.1558); Gain of helix (P = 0.5668); Loss of stability (P = 0.6325)
7:117180318:T:A,P13569,V345D,0.755,Gain of methylation at R347 (P = 0.0613); Loss of MoRF binding (P = 0.0638); Loss of catalytic residue at F342 (P = 0.5166); Loss of stability (P = 0.5347); Loss of helix (P = 0.5596)
7:117180318:T:C,P13569,V345A,0.705,Gain of methylation at R347 (P = 0.0601); Loss of MoRF binding (P = 0.1163); Loss of stability (P = 0.464); Gain of catalytic residue at C343 (P = 0.6081); Loss of helix (P = 0.6555)
7:117180318:T:G,P13569,V345G,0.704,Loss of stability (P = 0.0359); Gain of methylation at R347 (P = 0.0492); Loss of MoRF binding (P = 0.1185); Gain of catalytic residue at I344 (P = 0.1393); Loss of helix (P = 0.5596)
7:117180320:C:A,P13569,L346M,0.748,Gain of methylation at R347 (P = 0.1108); Loss of MoRF binding (P = 0.1375); Gain of helix (P = 0.2294); Loss of glycosylation at T351 (P = 0.4633); Loss of catalytic residue at S341 (P = 0.6195)
7:117180320:C:G,P13569,L346V,0.719,Gain of methylation at R347 (P = 0.0897); Gain of MoRF binding (P = 0.1398); Gain of catalytic residue at L346 (P = 0.1476); Gain of helix (P = 0.2294); Gain of glycosylation at T351 (P = 0.4474)
7:117180321:T:A,P13569,L346Q,0.839,Gain of catalytic residue at L346 (P = 0.0227); Loss of methylation at R347 (P = 0.0683); Loss of MoRF binding (P = 0.1041); Loss of stability (P = 0.14); Loss of glycosylation at T351 (P = 0.4211)
7:117180321:T:C,P13569,L346P,0.929,Gain of catalytic residue at L346 (P = 0.0237); Loss of MoRF binding (P = 0.0567); Loss of stability (P = 0.0795); Gain of methylation at R347 (P = 0.114); Gain of helix (P = 0.2294)
7:117180321:T:G,P13569,L346R,0.896,Gain of methylation at L346 (P = 0.0123); Gain of catalytic residue at L346 (P = 0.0315); Gain of MoRF binding (P = 0.0358); Loss of stability (P = 0.133); Gain of helix (P = 0.2294)
7:117180323:C:A,P13569,R347S,0.871,Loss of methylation at R347 (P = 0.0238); Loss of MoRF binding (P = 0.0424); Loss of helix (P = 0.2271); Loss of stability (P = 0.339); Gain of catalytic residue at C343 (P = 0.3734)
7:117180323:C:G,P13569,R347G,0.871,Loss of methylation at R347 (P = 0.0238); Loss of MoRF binding (P = 0.0426); Loss of catalytic residue at R347 (P = 0.06); Loss of stability (P = 0.061); Loss of glycosylation at T351 (P = 0.3702)
7:117180324:G:A,P13569,R347H,0.959,Loss of methylation at R347 (P = 0.0238); Loss of MoRF binding (P = 0.0361); Gain of catalytic residue at L346 (P = 0.1503); Loss of stability (P = 0.1963); Loss of helix (P = 0.2022)
7:117180324:G:T,P13569,R347L,0.914,Loss of catalytic residue at R347 (P = 0.0075); Loss of methylation at R347 (P = 0.0238); Loss of MoRF binding (P = 0.049); Loss of helix (P = 0.2022); Loss of glycosylation at T351 (P = 0.4028)
7:117180326:A:C,P13569,M348L,0.713,Loss of methylation at R347 (P = 0.1128); Loss of MoRF binding (P = 0.1458); Loss of helix (P = 0.3949); Gain of glycosylation at T351 (P = 0.4146); Gain of sheet (P = 0.6509)
7:117180326:A:G,P13569,M348V,0.874,Gain of methylation at R347 (P = 0.1377); Gain of MoRF binding (P = 0.1534); Gain of glycosylation at T351 (P = 0.2918); Gain of catalytic residue at M348 (P = 0.333); Loss of helix (P = 0.3949)
7:117180326:A:T,P13569,M348L,0.713,Loss of methylation at R347 (P = 0.1128); Loss of MoRF binding (P = 0.1458); Loss of helix (P = 0.3949); Gain of glycosylation at T351 (P = 0.4146); Gain of sheet (P = 0.6509)
7:117180327:T:C,P13569,M348T,0.744,Loss of stability (P = 0.0894); Gain of catalytic residue at M348 (P = 0.1175); Loss of MoRF binding (P = 0.1351); Gain of methylation at R347 (P = 0.1508); Loss of helix (P = 0.2271)
7:117180327:T:G,P13569,M348R,0.879,Gain of MoRF binding (P = 0.0136); Gain of methylation at M348 (P = 0.0449); Gain of catalytic residue at M348 (P = 0.051); Loss of stability (P = 0.2489); Loss of glycosylation at T351 (P = 0.2507)
7:117180328:G:A,P13569,M348I,0.729,Loss of methylation at R347 (P = 0.0552); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1324); Gain of glycosylation at T351 (P = 0.3487); Gain of sheet (P = 0.6509)
7:117180328:G:C,P13569,M348I,0.729,Loss of methylation at R347 (P = 0.0552); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1324); Gain of glycosylation at T351 (P = 0.3487); Gain of sheet (P = 0.6509)
7:117180328:G:T,P13569,M348I,0.729,Loss of methylation at R347 (P = 0.0552); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1324); Gain of glycosylation at T351 (P = 0.3487); Gain of sheet (P = 0.6509)
7:117180329:G:A,P13569,A349T,0.677,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of methylation at R347 (P = 0.1378); Loss of MoRF binding (P = 0.1608); Loss of stability (P = 0.3842)
7:117180329:G:C,P13569,A349P,0.763,Loss of catalytic residue at A349 (P = 0.0674); Loss of MoRF binding (P = 0.075); Loss of methylation at R347 (P = 0.1226); Loss of stability (P = 0.3543); Loss of helix (P = 0.3949)
7:117180329:G:T,P13569,A349S,0.662,Loss of helix (P = 0.0558); Loss of methylation at R347 (P = 0.1346); Loss of catalytic residue at A349 (P = 0.1547); Gain of MoRF binding (P = 0.1614); Gain of loop (P = 0.2754)
7:117180330:C:A,P13569,A349E,0.783,Loss of MoRF binding (P = 0.0617); Loss of methylation at R347 (P = 0.1091); Loss of helix (P = 0.2022); Loss of catalytic residue at Q353 (P = 0.3288); Loss of glycosylation at T351 (P = 0.4162)
7:117180330:C:G,P13569,A349G,0.774,Loss of stability (P = 0.0809); Gain of methylation at R347 (P = 0.1117); Loss of catalytic residue at A349 (P = 0.1186); Loss of MoRF binding (P = 0.1685); Loss of helix (P = 0.3949)
7:117180332:G:A,P13569,V350I,0.61,Gain of helix (P = 0.062); Loss of methylation at R347 (P = 0.0865); Gain of MoRF binding (P = 0.1455); Loss of loop (P = 0.2897); Gain of glycosylation at T351 (P = 0.4341)
7:117180332:G:C,P13569,V350L,0.627,Loss of catalytic residue at V350 (P = 0.1094); Loss of methylation at R347 (P = 0.1319); Loss of MoRF binding (P = 0.1636); Gain of loop (P = 0.2045); Loss of helix (P = 0.2271)
7:117180332:G:T,P13569,V350F,0.673,Gain of helix (P = 0.062); Loss of catalytic residue at V350 (P = 0.1159); Gain of methylation at R347 (P = 0.131); Gain of MoRF binding (P = 0.1699); Loss of loop (P = 0.2897)
7:117180333:T:A,P13569,V350D,0.803,Loss of catalytic residue at V350 (P = 0.0737); Loss of MoRF binding (P = 0.0749); Loss of helix (P = 0.079); Gain of loop (P = 0.0851); Loss of methylation at R347 (P = 0.1041)
7:117180333:T:C,P13569,V350A,0.76,Gain of helix (P = 0.062); Gain of methylation at R347 (P = 0.0774); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.1338); Loss of stability (P = 0.1976)
7:117180333:T:G,P13569,V350G,0.763,Loss of stability (P = 0.0187); Gain of helix (P = 0.062); Gain of methylation at R347 (P = 0.0691); Loss of MoRF binding (P = 0.1394); Gain of loop (P = 0.2754)
7:117180335:A:C,P13569,T351P,0.733,Loss of MoRF binding (P = 0.0819); Loss of catalytic residue at F354 (P = 0.1139); Loss of helix (P = 0.1299); Gain of methylation at R347 (P = 0.1465); Loss of stability (P = 0.3954)
7:117180335:A:G,P13569,T351A,0.741,Loss of catalytic residue at F354 (P = 0.108); Gain of methylation at R347 (P = 0.121); Loss of glycosylation at T351 (P = 0.131); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1707)
7:117180335:A:T,P13569,T351S,0.818,Gain of helix (P = 0.132); Loss of methylation at R347 (P = 0.1356); Loss of catalytic residue at F354 (P = 0.1541); Gain of MoRF binding (P = 0.171); Loss of sheet (P = 0.437)
7:117180336:C:A,P13569,T351N,0.707,Loss of methylation at R347 (P = 0.1274); Loss of helix (P = 0.1299); Loss of glycosylation at T351 (P = 0.131); Gain of MoRF binding (P = 0.1452); Loss of catalytic residue at F354 (P = 0.1873)
7:117180336:C:T,P13569,T351I,0.69,Gain of helix (P = 0.0696); Loss of catalytic residue at F354 (P = 0.0882); Gain of MoRF binding (P = 0.1296); Loss of glycosylation at T351 (P = 0.131); Loss of methylation at R347 (P = 0.1328)
7:117180338:C:G,P13569,R352G,0.893,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.0744); Loss of methylation at R347 (P = 0.1547); Loss of stability (P = 0.1562)
7:117180339:G:A,P13569,R352Q,0.887,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.0711); Loss of methylation at R347 (P = 0.0768); Gain of glycosylation at P355 (P = 0.3448)
7:117180339:G:C,P13569,R352P,0.791,Loss of MoRF binding (P = 0.0497); Loss of helix (P = 0.0558); Loss of methylation at R347 (P = 0.1393); Gain of glycosylation at P355 (P = 0.2482); Gain of loop (P = 0.2754)
7:117180339:G:T,P13569,R352L,0.698,Loss of helix (P = 0.0558); Loss of catalytic residue at R352 (P = 0.0767); Loss of MoRF binding (P = 0.0798); Loss of methylation at R347 (P = 0.1348); Gain of loop (P = 0.2754)
7:117180341:C:A,P13569,Q353K,0.643,Gain of ubiquitination at Q353 (P = 0.0203); Gain of methylation at Q353 (P = 0.0292); Gain of MoRF binding (P = 0.0456); Gain of glycosylation at T351 (P = 0.1764); Gain of helix (P = 0.2059)
7:117180341:C:G,P13569,Q353E,0.646,Loss of helix (P = 0.0558); Loss of MoRF binding (P = 0.078); Gain of loop (P = 0.1069); Gain of glycosylation at T351 (P = 0.1626); Loss of catalytic residue at R352 (P = 0.2035)
7:117180342:A:C,P13569,Q353P,0.641,Loss of catalytic residue at Q353 (P = 0.0472); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.104); Gain of glycosylation at T351 (P = 0.1437)
7:117180342:A:G,P13569,Q353R,0.617,Gain of MoRF binding (P = 0.043); Loss of helix (P = 0.0558); Gain of methylation at Q353 (P = 0.1032); Gain of loop (P = 0.1069); Gain of relative solvent accessibility (P = 0.1259)
7:117180342:A:T,P13569,Q353L,0.533,Loss of catalytic residue at Q353 (P = 0.0265); Gain of MoRF binding (P = 0.0815); Gain of loop (P = 0.1069); Loss of helix (P = 0.1299); Gain of glycosylation at T351 (P = 0.3408)
7:117180343:A:C,P13569,Q353H,0.721,Loss of helix (P = 0.0558); Gain of glycosylation at T351 (P = 0.061); Gain of loop (P = 0.1069); Loss of MoRF binding (P = 0.2039); Loss of stability (P = 0.2481)
7:117180343:A:T,P13569,Q353H,0.721,Loss of helix (P = 0.0558); Gain of glycosylation at T351 (P = 0.061); Gain of loop (P = 0.1069); Loss of MoRF binding (P = 0.2039); Loss of stability (P = 0.2481)
7:117180344:T:A,P13569,F354I,0.717,Loss of catalytic residue at F354 (P = 0.0941); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1948); Gain of loop (P = 0.2754); Loss of glycosylation at T351 (P = 0.4529)
7:117180344:T:C,P13569,F354L,0.729,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.2098); Loss of catalytic residue at R352 (P = 0.353); Loss of glycosylation at T351 (P = 0.3752)
7:117180344:T:G,P13569,F354V,0.692,Loss of helix (P = 0.0376); Gain of loop (P = 0.069); Loss of catalytic residue at F354 (P = 0.1528); Loss of MoRF binding (P = 0.2154); Gain of sheet (P = 0.4423)
7:117180345:T:A,P13569,F354Y,0.713,Loss of catalytic residue at F354 (P = 0.0503); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1864); Gain of loop (P = 0.2754); Gain of glycosylation at T351 (P = 0.469)
7:117180345:T:C,P13569,F354S,0.762,Gain of loop (P = 0.0312); Loss of helix (P = 0.0376); Loss of catalytic residue at F354 (P = 0.0866); Gain of glycosylation at P355 (P = 0.1815); Loss of MoRF binding (P = 0.1906)
7:117180345:T:G,P13569,F354C,0.72,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.1469); Loss of catalytic residue at F354 (P = 0.2975); Loss of glycosylation at T351 (P = 0.3416)
7:117180346:T:A,P13569,F354L,0.729,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.2098); Loss of catalytic residue at R352 (P = 0.353); Loss of glycosylation at T351 (P = 0.3752)
7:117180346:T:G,P13569,F354L,0.729,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.2098); Loss of catalytic residue at R352 (P = 0.353); Loss of glycosylation at T351 (P = 0.3752)
7:117180347:C:A,P13569,P355T,0.723,Gain of MoRF binding (P = 0.0522); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of catalytic residue at P355 (P = 0.2524); Loss of stability (P = 0.2852)
7:117180347:C:G,P13569,P355A,0.698,Gain of catalytic residue at P355 (P = 0.0199); Gain of MoRF binding (P = 0.0603); Gain of helix (P = 0.0854); Loss of stability (P = 0.1801); Loss of glycosylation at P355 (P = 0.4036)
7:117180347:C:T,P13569,P355S,0.867,Gain of MoRF binding (P = 0.0406); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1846)
7:117180348:C:A,P13569,P355H,0.727,Gain of MoRF binding (P = 0.0564); Loss of helix (P = 0.1299); Loss of stability (P = 0.2136); Gain of loop (P = 0.2754); Gain of catalytic residue at P355 (P = 0.3779)
7:117180348:C:G,P13569,P355R,0.757,Gain of MoRF binding (P = 4e-04); Gain of catalytic residue at P355 (P = 0.0636); Loss of helix (P = 0.1299); Loss of glycosylation at T351 (P = 0.3075); Loss of stability (P = 0.411)
7:117180350:T:A,P13569,W356R,0.642,Gain of solvent accessibility (P = 0.0584); Gain of MoRF binding (P = 0.0627); Loss of catalytic residue at Q353 (P = 0.0843); Gain of relative solvent accessibility (P = 0.09); Gain of loop (P = 0.1069)
7:117180350:T:C,P13569,W356R,0.642,Gain of solvent accessibility (P = 0.0584); Gain of MoRF binding (P = 0.0627); Loss of catalytic residue at Q353 (P = 0.0843); Gain of relative solvent accessibility (P = 0.09); Gain of loop (P = 0.1069)
7:117180350:T:G,P13569,W356G,0.673,Loss of helix (P = 0.0237); Loss of catalytic residue at W356 (P = 0.0326); Gain of loop (P = 0.0435); Gain of relative solvent accessibility (P = 0.09); Loss of MoRF binding (P = 0.119)
7:117180351:G:C,P13569,W356S,0.859,Loss of catalytic residue at W356 (P = 0.0104); Gain of helix (P = 0.0854); Loss of MoRF binding (P = 0.1366); Gain of methylation at R352 (P = 0.2361); Gain of glycosylation at T351 (P = 0.2962)
7:117180351:G:T,P13569,W356L,0.641,Loss of catalytic residue at W356 (P = 0.0025); Loss of helix (P = 0.0376); Gain of loop (P = 0.0435); Loss of MoRF binding (P = 0.1236); Gain of methylation at R352 (P = 0.2194)
7:117180352:G:C,P13569,W356C,0.666,Gain of catalytic residue at P355 (P = 0.0486); Loss of MoRF binding (P = 0.1059); Loss of helix (P = 0.1299); Gain of methylation at R352 (P = 0.2276); Gain of loop (P = 0.2754)
7:117180352:G:T,P13569,W356C,0.666,Gain of catalytic residue at P355 (P = 0.0486); Loss of MoRF binding (P = 0.1059); Loss of helix (P = 0.1299); Gain of methylation at R352 (P = 0.2276); Gain of loop (P = 0.2754)
7:117180353:G:A,P13569,A357T,0.534,Gain of helix (P = 0.0854); Loss of catalytic residue at A357 (P = 0.1866); Gain of MoRF binding (P = 0.2593); Gain of loop (P = 0.2754); Gain of sheet (P = 0.4423)
7:117180353:G:C,P13569,A357P,0.716,Loss of helix (P = 0.0558); Loss of MoRF binding (P = 0.1379); Loss of catalytic residue at A357 (P = 0.1521); Gain of glycosylation at A357 (P = 0.2076); Loss of stability (P = 0.2725)
7:117180353:G:T,P13569,A357S,0.502,Gain of helix (P = 0.0854); Gain of MoRF binding (P = 0.239); Loss of sheet (P = 0.437); Loss of stability (P = 0.4655); Gain of loop (P = 0.4661)
7:117180354:C:A,P13569,A357D,0.68,Loss of helix (P = 0.1299); Loss of catalytic residue at A357 (P = 0.1566); Loss of MoRF binding (P = 0.1578); Gain of loop (P = 0.4661); Gain of phosphorylation at Y362 (P = 0.4914)
7:117180354:C:G,P13569,A357G,0.512,Gain of helix (P = 0.0854); Loss of stability (P = 0.1461); Loss of catalytic residue at A357 (P = 0.1744); Gain of MoRF binding (P = 0.2555); Loss of sheet (P = 0.371)
7:117180354:C:T,P13569,A357V,0.478,Gain of helix (P = 0.0854); Gain of MoRF binding (P = 0.2212); Loss of catalytic residue at A357 (P = 0.2444); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117180356:G:A,P13569,V358I,0.756,Gain of MoRF binding (P = 0.2241); Loss of helix (P = 0.3949); Loss of phosphorylation at Y362 (P = 0.6097); Loss of glycosylation at P355 (P = 0.6342); Loss of sheet (P = 0.6423)
7:117180356:G:C,P13569,V358L,0.733,Loss of catalytic residue at V358 (P = 0.0132); Loss of helix (P = 0.028); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.2598); Gain of sheet (P = 0.3763)
7:117180356:G:T,P13569,V358L,0.733,Loss of catalytic residue at V358 (P = 0.0132); Loss of helix (P = 0.028); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.2598); Gain of sheet (P = 0.3763)
7:117180357:T:A,P13569,V358E,0.756,Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Loss of MoRF binding (P = 0.0866); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971)
7:117180357:T:C,P13569,V358A,0.791,Loss of helix (P = 0.1299); Loss of stability (P = 0.1769); Loss of MoRF binding (P = 0.2298); Gain of loop (P = 0.2754); Gain of glycosylation at P355 (P = 0.3427)
7:117180357:T:G,P13569,V358G,0.759,Loss of stability (P = 0.0167); Loss of helix (P = 0.028); Loss of catalytic residue at V358 (P = 0.0386); Gain of sheet (P = 0.0507); Gain of loop (P = 0.1069)
7:117180359:C:A,P13569,Q359K,0.674,Gain of ubiquitination at Q359 (P = 0.0289); Gain of MoRF binding (P = 0.034); Gain of methylation at Q359 (P = 0.0402); Gain of relative solvent accessibility (P = 0.1066); Gain of helix (P = 0.132)
7:117180359:C:G,P13569,Q359E,0.645,Gain of catalytic residue at W361 (P = 0.0988); Loss of MoRF binding (P = 0.1168); Gain of relative solvent accessibility (P = 0.2629); Gain of loop (P = 0.2754); Gain of phosphorylation at Y362 (P = 0.3136)
7:117180360:A:C,P13569,Q359P,0.667,Gain of helix (P = 0.0696); Loss of MoRF binding (P = 0.1276); Gain of catalytic residue at Y362 (P = 0.2634); Gain of glycosylation at Q359 (P = 0.3188); Loss of solvent accessibility (P = 0.3368)
7:117180360:A:G,P13569,Q359R,0.85,Gain of MoRF binding (P = 0.0137); Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Loss of catalytic residue at F354 (P = 0.3062); Gain of solvent accessibility (P = 0.4496)
7:117180360:A:T,P13569,Q359L,0.637,Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Gain of stability (P = 0.1258); Loss of MoRF binding (P = 0.2393); Gain of catalytic residue at Y362 (P = 0.3177)
7:117180361:A:C,P13569,Q359H,0.655,Gain of helix (P = 0.0696); Gain of loop (P = 0.1069); Loss of catalytic residue at Q359 (P = 0.1771); Loss of MoRF binding (P = 0.2455); Loss of solvent accessibility (P = 0.3368)
7:117180361:A:T,P13569,Q359H,0.655,Gain of helix (P = 0.0696); Gain of loop (P = 0.1069); Loss of catalytic residue at Q359 (P = 0.1771); Loss of MoRF binding (P = 0.2455); Loss of solvent accessibility (P = 0.3368)
7:117180362:A:C,P13569,T360P,0.656,Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Gain of catalytic residue at W361 (P = 0.1079); Loss of MoRF binding (P = 0.1578); Loss of stability (P = 0.3485)
7:117180362:A:G,P13569,T360A,0.56,Gain of catalytic residue at T360 (P = 0.0075); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.2632); Loss of loop (P = 0.2897); Loss of phosphorylation at T360 (P = 0.6129)
7:117180362:A:T,P13569,T360S,0.49,Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.2533); Gain of sheet (P = 0.4423); Gain of loop (P = 0.4661); Gain of phosphorylation at Y362 (P = 0.6028)
7:117180363:C:A,P13569,T360K,0.695,Gain of ubiquitination at T360 (P = 0.0289); Gain of MoRF binding (P = 0.0363); Loss of helix (P = 0.0558); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09)
7:117180363:C:G,P13569,T360R,0.847,Gain of MoRF binding (P = 0.0169); Gain of catalytic residue at T360 (P = 0.0434); Gain of loop (P = 0.1069); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299)
7:117180365:T:A,P13569,W361R,0.875,Loss of helix (P = 0.0376); Gain of loop (P = 0.1069); Gain of sheet (P = 0.1451); Gain of methylation at W361 (P = 0.2156); Gain of phosphorylation at T360 (P = 0.2186)
7:117180365:T:C,P13569,W361R,0.875,Loss of helix (P = 0.0376); Gain of loop (P = 0.1069); Gain of sheet (P = 0.1451); Gain of methylation at W361 (P = 0.2156); Gain of phosphorylation at T360 (P = 0.2186)
7:117180365:T:G,P13569,W361G,0.713,Loss of stability (P = 0.0287); Gain of loop (P = 0.0312); Loss of helix (P = 0.0376); Loss of MoRF binding (P = 0.1456); Gain of catalytic residue at T360 (P = 0.2625)
7:117180366:G:C,P13569,W361S,0.745,Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Loss of stability (P = 0.1125); Loss of MoRF binding (P = 0.1403); Gain of sheet (P = 0.1451)
7:117180366:G:T,P13569,W361L,0.567,Gain of helix (P = 0.0425); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.1699); Loss of catalytic residue at W361 (P = 0.2564); Gain of phosphorylation at Y362 (P = 0.4768)
7:117180367:G:C,P13569,W361C,0.553,Loss of MoRF binding (P = 0.1248); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of stability (P = 0.4384); Gain of sheet (P = 0.4423)
7:117180367:G:T,P13569,W361C,0.553,Loss of MoRF binding (P = 0.1248); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of stability (P = 0.4384); Gain of sheet (P = 0.4423)
7:117180368:T:A,P13569,Y362N,0.638,Loss of helix (P = 0.0626); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2346); Gain of MoRF binding (P = 0.2431); Gain of loop (P = 0.2754)
7:117180368:T:C,P13569,Y362H,0.644,Loss of helix (P = 0.1299); Loss of stability (P = 0.2495); Loss of MoRF binding (P = 0.2687); Gain of catalytic residue at D363 (P = 0.3343); Gain of loop (P = 0.4661)
7:117180368:T:G,P13569,Y362D,0.663,Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1915); Loss of catalytic residue at Q359 (P = 0.335); Loss of stability (P = 0.3922); Gain of phosphorylation at T360 (P = 0.4624)
7:117180369:A:C,P13569,Y362S,0.629,Gain of helix (P = 0.0696); Loss of loop (P = 0.1242); Loss of stability (P = 0.1776); Gain of MoRF binding (P = 0.257); Gain of disorder (P = 0.4908)
7:117180369:A:G,P13569,Y362C,0.651,Loss of loop (P = 0.1242); Gain of catalytic residue at Y362 (P = 0.1258); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.2595); Loss of phosphorylation at Y362 (P = 0.581)
7:117180369:A:T,P13569,Y362F,0.625,Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.2166); Loss of loop (P = 0.2897); Gain of catalytic residue at Y362 (P = 0.463); Loss of phosphorylation at Y362 (P = 0.581)
7:117180371:G:A,P13569,D363N,0.707,Gain of helix (P = 0.0425); Gain of MoRF binding (P = 0.0646); Loss of loop (P = 0.1242); Loss of solvent accessibility (P = 0.2517); Loss of catalytic residue at D363 (P = 0.2807)
7:117180371:G:C,P13569,D363H,0.672,Gain of helix (P = 0.0425); Gain of catalytic residue at L365 (P = 0.0573); Loss of loop (P = 0.0603); Gain of MoRF binding (P = 0.0989); Loss of solvent accessibility (P = 0.2517)
7:117180371:G:T,P13569,D363Y,0.674,Gain of helix (P = 0.0425); Loss of loop (P = 0.0603); Gain of MoRF binding (P = 0.1087); Gain of catalytic residue at T360 (P = 0.1842); Loss of solvent accessibility (P = 0.2517)
7:117180372:A:C,P13569,D363A,0.687,Gain of helix (P = 0.0425); Gain of MoRF binding (P = 0.0988); Loss of loop (P = 0.1242); Gain of catalytic residue at Y362 (P = 0.2497); Loss of solvent accessibility (P = 0.2517)
7:117180372:A:G,P13569,D363G,0.673,Gain of MoRF binding (P = 0.1167); Gain of helix (P = 0.132); Gain of catalytic residue at S364 (P = 0.1361); Loss of stability (P = 0.201); Loss of solvent accessibility (P = 0.2517)
7:117180372:A:T,P13569,D363V,0.67,Gain of helix (P = 0.0425); Loss of loop (P = 0.0603); Gain of MoRF binding (P = 0.0886); Gain of catalytic residue at Y362 (P = 0.232); Loss of solvent accessibility (P = 0.2517)
7:117180373:C:A,P13569,D363E,0.648,Gain of helix (P = 0.0425); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.28); Loss of catalytic residue at A367 (P = 0.5514); Loss of phosphorylation at Y362 (P = 0.6269)
7:117180373:C:G,P13569,D363E,0.648,Gain of helix (P = 0.0425); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.28); Loss of catalytic residue at A367 (P = 0.5514); Loss of phosphorylation at Y362 (P = 0.6269)
7:117180374:T:A,P13569,S364T,0.605,Gain of helix (P = 0.0696); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.3104); Gain of phosphorylation at T360 (P = 0.3562); Loss of stability (P = 0.4618)
7:117180374:T:C,P13569,S364P,0.839,Gain of helix (P = 0.0425); Gain of catalytic residue at S364 (P = 0.0433); Loss of loop (P = 0.1242); Loss of stability (P = 0.2315); Loss of MoRF binding (P = 0.2519)
7:117180374:T:G,P13569,S364A,0.644,Gain of helix (P = 0.0696); Gain of catalytic residue at S364 (P = 0.121); Loss of loop (P = 0.1242); Gain of MoRF binding (P = 0.2944); Loss of stability (P = 0.3295)
7:117180375:C:A,P13569,S364Y,0.589,Gain of helix (P = 0.0425); Loss of loop (P = 0.0603); Loss of MoRF binding (P = 0.3113); Loss of catalytic residue at D363 (P = 0.3313); Gain of phosphorylation at T360 (P = 0.6225)
7:117180375:C:G,P13569,S364C,0.675,Gain of catalytic residue at L365 (P = 0.0125); Gain of helix (P = 0.0425); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.294); Loss of stability (P = 0.4531)
7:117180375:C:T,P13569,S364F,0.597,Gain of helix (P = 0.027); Loss of loop (P = 0.0389); Gain of MoRF binding (P = 0.2477); Loss of catalytic residue at D363 (P = 0.321); Loss of phosphorylation at Y362 (P = 0.6177)
7:117180377:C:A,P13569,L365I,0.547,Gain of catalytic residue at L365 (P = 0.0254); Gain of methylation at K370 (P = 0.0641); Gain of helix (P = 0.0696); Loss of loop (P = 0.1242); Loss of ubiquitination at K370 (P = 0.2432)
7:117180377:C:G,P13569,L365V,0.552,Gain of helix (P = 0.0425); Loss of loop (P = 0.0603); Gain of methylation at K370 (P = 0.1096); Loss of stability (P = 0.17); Loss of ubiquitination at K370 (P = 0.2432)
7:117180377:C:T,P13569,L365F,0.605,Gain of helix (P = 0.0696); Gain of methylation at K370 (P = 0.1109); Loss of loop (P = 0.1242); Loss of stability (P = 0.1495); Loss of ubiquitination at K370 (P = 0.2248)
7:117180378:T:A,P13569,L365H,0.688,Loss of stability (P = 0.0166); Gain of catalytic residue at G366 (P = 0.0568); Gain of helix (P = 0.0696); Loss of loop (P = 0.1242); Gain of methylation at K370 (P = 0.1887)
7:117180378:T:C,P13569,L365P,0.923,Loss of stability (P = 0.0111); Gain of methylation at K370 (P = 0.1296); Gain of helix (P = 0.132); Gain of ubiquitination at K370 (P = 0.1989); Loss of MoRF binding (P = 0.2537)
7:117180378:T:G,P13569,L365R,0.785,Loss of stability (P = 0.0339); Gain of MoRF binding (P = 0.05); Gain of catalytic residue at L365 (P = 0.052); Gain of helix (P = 0.0696); Loss of loop (P = 0.1242)
7:117180380:G:A,P13569,G366R,0.629,Gain of MoRF binding (P = 0.0092); Gain of helix (P = 0.0425); Gain of catalytic residue at G366 (P = 0.0516); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09)
7:117180380:G:C,P13569,G366R,0.629,Gain of MoRF binding (P = 0.0092); Gain of helix (P = 0.0425); Gain of catalytic residue at G366 (P = 0.0516); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09)
7:117180381:G:A,P13569,G366E,0.626,Gain of helix (P = 0.0425); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at A367 (P = 0.0953); Gain of solvent accessibility (P = 0.0971); Loss of ubiquitination at K370 (P = 0.2432)
7:117180381:G:C,P13569,G366A,0.468,Gain of helix (P = 0.0425); Gain of ubiquitination at K370 (P = 0.1696); Loss of catalytic residue at A367 (P = 0.2013); Loss of methylation at K370 (P = 0.2532); Gain of MoRF binding (P = 0.3141)
7:117180381:G:T,P13569,G366V,0.488,Gain of catalytic residue at G366 (P = 0.0373); Loss of helix (P = 0.0558); Gain of ubiquitination at K370 (P = 0.1165); Gain of methylation at K370 (P = 0.1831); Gain of loop (P = 0.2754)
7:117180383:G:A,P13569,A367T,0.472,Gain of helix (P = 0.132); Loss of catalytic residue at A367 (P = 0.1804); Gain of ubiquitination at K370 (P = 0.2244); Loss of methylation at K370 (P = 0.2729); Gain of MoRF binding (P = 0.3344)
7:117180383:G:C,P13569,A367P,0.624,Loss of helix (P = 0.1299); Loss of catalytic residue at A367 (P = 0.1472); Gain of methylation at K370 (P = 0.1488); Loss of ubiquitination at K370 (P = 0.2432); Loss of MoRF binding (P = 0.2931)
7:117180383:G:T,P13569,A367S,0.511,Gain of helix (P = 0.132); Loss of catalytic residue at A367 (P = 0.1657); Gain of disorder (P = 0.1677); Loss of methylation at K370 (P = 0.2114); Gain of ubiquitination at K370 (P = 0.2244)
7:117180384:C:A,P13569,A367E,0.601,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Loss of helix (P = 0.1299); Loss of methylation at K370 (P = 0.2206); Loss of catalytic residue at A367 (P = 0.2345)
7:117180384:C:G,P13569,A367G,0.5,Gain of helix (P = 0.0696); Loss of stability (P = 0.1676); Loss of ubiquitination at K370 (P = 0.2432); Gain of methylation at K370 (P = 0.2621); Loss of MoRF binding (P = 0.3387)
7:117180384:C:T,P13569,A367V,0.524,Gain of helix (P = 0.0854); Gain of methylation at K370 (P = 0.1272); Gain of ubiquitination at K370 (P = 0.2244); Gain of MoRF binding (P = 0.3082); Loss of loop (P = 0.3664)
7:117180386:A:C,P13569,I368L,0.687,Loss of catalytic residue at I368 (P = 0.087); Loss of methylation at K370 (P = 0.164); Gain of ubiquitination at K370 (P = 0.1696); Loss of MoRF binding (P = 0.3633); Loss of helix (P = 0.3949)
7:117180386:A:G,P13569,I368V,0.672,Loss of helix (P = 0.1299); Gain of ubiquitination at K370 (P = 0.2244); Loss of methylation at K370 (P = 0.2331); Loss of catalytic residue at I368 (P = 0.2556); Loss of stability (P = 0.3196)
7:117180386:A:T,P13569,I368L,0.687,Loss of catalytic residue at I368 (P = 0.087); Loss of methylation at K370 (P = 0.164); Gain of ubiquitination at K370 (P = 0.1696); Loss of MoRF binding (P = 0.3633); Loss of helix (P = 0.3949)
7:117180387:T:A,P13569,I368K,0.799,Gain of disorder (P = 0.0151); Loss of stability (P = 0.0164); Gain of ubiquitination at I368 (P = 0.0198); Loss of catalytic residue at I368 (P = 0.0225); Loss of methylation at K370 (P = 0.1298)
7:117180387:T:C,P13569,I368T,0.8,Loss of stability (P = 0.0148); Gain of ubiquitination at K370 (P = 0.0658); Loss of catalytic residue at I368 (P = 0.1265); Gain of disorder (P = 0.1288); Loss of helix (P = 0.1299)
7:117180387:T:G,P13569,I368R,0.881,Loss of stability (P = 0.052); Gain of ubiquitination at K370 (P = 0.0599); Gain of disorder (P = 0.079); Gain of MoRF binding (P = 0.0895); Loss of methylation at K370 (P = 0.114)
7:117180388:A:G,P13569,I368M,0.654,Loss of catalytic residue at I368 (P = 0.0179); Loss of helix (P = 0.1299); Loss of methylation at K370 (P = 0.2152); Gain of ubiquitination at K370 (P = 0.2244); Gain of loop (P = 0.2754)
7:117180389:A:C,P13569,N369H,0.425,Loss of helix (P = 0.1299); Gain of ubiquitination at K370 (P = 0.1696); Gain of methylation at K370 (P = 0.1892); Gain of glycosylation at K370 (P = 0.3108); Gain of disorder (P = 0.3233)
7:117180389:A:G,P13569,N369D,0.424,Loss of helix (P = 0.1299); Gain of ubiquitination at K370 (P = 0.1696); Loss of methylation at K370 (P = 0.1923); Gain of relative solvent accessibility (P = 0.2363); Gain of loop (P = 0.2754)
7:117180389:A:T,P13569,N369Y,0.463,Gain of helix (P = 0.0696); Gain of ubiquitination at K370 (P = 0.0825); Loss of methylation at K370 (P = 0.218); Loss of solvent accessibility (P = 0.2668); Loss of relative solvent accessibility (P = 0.3219)
7:117180390:A:C,P13569,N369T,0.363,Gain of ubiquitination at K370 (P = 0.1165); Loss of helix (P = 0.1299); Loss of methylation at K370 (P = 0.2609); Gain of loop (P = 0.2754); Gain of MoRF binding (P = 0.3966)
7:117180390:A:G,P13569,N369S,0.406,Loss of helix (P = 0.1299); Gain of ubiquitination at K370 (P = 0.1696); Loss of methylation at K370 (P = 0.2145); Gain of catalytic residue at L365 (P = 0.2857); Gain of disorder (P = 0.292)
7:117180390:A:T,P13569,N369I,0.476,Gain of ubiquitination at K370 (P = 0.0726); Gain of catalytic residue at N369 (P = 0.0761); Gain of helix (P = 0.132); Gain of methylation at K370 (P = 0.2578); Loss of solvent accessibility (P = 0.2668)
7:117180391:C:A,P13569,N369K,0.44,Gain of ubiquitination at N369 (P = 0.0369); Gain of MoRF binding (P = 0.1112); Loss of helix (P = 0.1299); Gain of glycosylation at N369 (P = 0.1301); Gain of methylation at N369 (P = 0.1754)
7:117180391:C:G,P13569,N369K,0.44,Gain of ubiquitination at N369 (P = 0.0369); Gain of MoRF binding (P = 0.1112); Loss of helix (P = 0.1299); Gain of glycosylation at N369 (P = 0.1301); Gain of methylation at N369 (P = 0.1754)
7:117180392:A:C,P13569,K370Q,0.635,Loss of ubiquitination at K370 (P = 0.0381); Loss of methylation at K370 (P = 0.0603); Gain of helix (P = 0.0696); Loss of glycosylation at K370 (P = 0.272); Loss of MoRF binding (P = 0.3377)
7:117180392:A:G,P13569,K370E,0.609,Loss of ubiquitination at K370 (P = 0.0381); Loss of methylation at K370 (P = 0.0603); Gain of catalytic residue at K370 (P = 0.1037); Loss of helix (P = 0.2271); Loss of glycosylation at K370 (P = 0.272)
7:117180393:A:C,P13569,K370T,0.623,Loss of ubiquitination at K370 (P = 0.0381); Loss of methylation at K370 (P = 0.0603); Loss of helix (P = 0.1706); Gain of phosphorylation at K370 (P = 0.1781); Loss of MoRF binding (P = 0.3283)
7:117180393:A:G,P13569,K370R,0.603,Loss of ubiquitination at K370 (P = 0.0381); Loss of methylation at K370 (P = 0.07); Gain of helix (P = 0.132); Gain of catalytic residue at K370 (P = 0.1928); Loss of glycosylation at K370 (P = 0.272)
7:117180393:A:T,P13569,K370I,0.614,Loss of ubiquitination at K370 (P = 0.0381); Loss of methylation at K370 (P = 0.0603); Gain of helix (P = 0.132); Gain of catalytic residue at K370 (P = 0.258); Loss of glycosylation at K370 (P = 0.272)
7:117180394:A:C,P13569,K370N,0.599,Loss of ubiquitination at K370 (P = 0.0381); Loss of methylation at K370 (P = 0.0603); Loss of helix (P = 0.2271); Loss of glycosylation at K370 (P = 0.272); Loss of MoRF binding (P = 0.3329)
7:117180394:A:T,P13569,K370N,0.599,Loss of ubiquitination at K370 (P = 0.0381); Loss of methylation at K370 (P = 0.0603); Loss of helix (P = 0.2271); Loss of glycosylation at K370 (P = 0.272); Loss of MoRF binding (P = 0.3329)
7:117180395:A:C,P13569,I371L,0.672,Gain of helix (P = 0.132); Gain of ubiquitination at K370 (P = 0.1696); Loss of methylation at K370 (P = 0.1958); Gain of disorder (P = 0.2159); Loss of MoRF binding (P = 0.3945)
7:117180395:A:G,P13569,I371V,0.577,Gain of methylation at K370 (P = 0.0585); Gain of ubiquitination at K370 (P = 0.1434); Loss of helix (P = 0.2271); Gain of disorder (P = 0.3143); Loss of stability (P = 0.338)
7:117180395:A:T,P13569,I371L,0.672,Gain of helix (P = 0.132); Gain of ubiquitination at K370 (P = 0.1696); Loss of methylation at K370 (P = 0.1958); Gain of disorder (P = 0.2159); Loss of MoRF binding (P = 0.3945)
7:117180396:T:A,P13569,I371K,0.814,Gain of disorder (P = 0.0017); Gain of ubiquitination at I371 (P = 0.0247); Loss of stability (P = 0.0313); Gain of helix (P = 0.132); Gain of methylation at K370 (P = 0.2147)
7:117180396:T:G,P13569,I371R,0.815,Gain of disorder (P = 0.0332); Gain of ubiquitination at K370 (P = 0.047); Loss of stability (P = 0.063); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.2271)
7:117180397:A:G,P13569,I371M,0.682,Loss of methylation at K370 (P = 0.0944); Gain of disorder (P = 0.1087); Gain of helix (P = 0.132); Gain of ubiquitination at K370 (P = 0.1434); Gain of catalytic residue at I371 (P = 0.3322)
7:117180398:C:A,P13569,Q372K,0.72,Gain of ubiquitination at Q372 (P = 0.0311); Gain of methylation at Q372 (P = 0.1772); Gain of MoRF binding (P = 0.203); Gain of helix (P = 0.2059); Loss of stability (P = 0.2409)
7:117180398:C:G,P13569,Q372E,0.63,Gain of ubiquitination at K377 (P = 0.1235); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2277); Loss of methylation at K370 (P = 0.2344); Gain of glycosylation at K370 (P = 0.3204)
7:117180399:A:C,P13569,Q372P,0.673,Gain of ubiquitination at K377 (P = 0.0628); Gain of helix (P = 0.0854); Gain of catalytic residue at Q372 (P = 0.1397); Gain of methylation at K370 (P = 0.2112); Loss of stability (P = 0.2116)
7:117180399:A:G,P13569,Q372R,0.654,Gain of MoRF binding (P = 0.0835); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Loss of ubiquitination at K377 (P = 0.1388); Loss of methylation at K370 (P = 0.1696)
7:117180399:A:T,P13569,Q372L,0.645,Gain of helix (P = 0.0854); Loss of disorder (P = 0.1154); Loss of ubiquitination at K377 (P = 0.1388); Loss of methylation at K370 (P = 0.2109); Loss of MoRF binding (P = 0.4198)
7:117180400:G:C,P13569,Q372H,0.638,Gain of ubiquitination at K377 (P = 0.0843); Gain of helix (P = 0.2059); Gain of disorder (P = 0.206); Loss of methylation at K370 (P = 0.2431); Loss of stability (P = 0.2569)
7:117180400:G:T,P13569,Q372H,0.638,Gain of ubiquitination at K377 (P = 0.0843); Gain of helix (P = 0.2059); Gain of disorder (P = 0.206); Loss of methylation at K370 (P = 0.2431); Loss of stability (P = 0.2569)
7:117182070:G:A,P13569,D373N,0.491,Loss of ubiquitination at K377 (P = 0.0877); Gain of methylation at K370 (P = 0.1048); Gain of MoRF binding (P = 0.2115); Loss of disorder (P = 0.272); Loss of glycosylation at K370 (P = 0.5201)
7:117182070:G:C,P13569,D373H,0.506,Gain of disorder (P = 0.1151); Gain of ubiquitination at K377 (P = 0.1235); Gain of catalytic residue at I371 (P = 0.1472); Gain of methylation at K370 (P = 0.1618); Loss of helix (P = 0.2271)
7:117182070:G:T,P13569,D373Y,0.522,Gain of ubiquitination at K377 (P = 0.1092); Loss of disorder (P = 0.1385); Gain of methylation at K377 (P = 0.1445); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2536)
7:117182071:A:C,P13569,D373A,0.461,Gain of ubiquitination at K377 (P = 0.0764); Loss of disorder (P = 0.1847); Loss of helix (P = 0.2271); Loss of methylation at K370 (P = 0.2302); Gain of MoRF binding (P = 0.2394)
7:117182071:A:G,P13569,D373G,0.478,Gain of ubiquitination at K377 (P = 0.1092); Loss of helix (P = 0.2271); Loss of stability (P = 0.2414); Gain of methylation at K370 (P = 0.2584); Gain of MoRF binding (P = 0.2625)
7:117182071:A:T,P13569,D373V,0.529,Loss of disorder (P = 0.0821); Gain of ubiquitination at K377 (P = 0.0961); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2302); Loss of methylation at K370 (P = 0.2536)
7:117182072:T:A,P13569,D373E,0.757,Loss of ubiquitination at K377 (P = 0.069); Loss of helix (P = 0.079); Gain of methylation at K370 (P = 0.0968); Gain of disorder (P = 0.121); Gain of relative solvent accessibility (P = 0.2629)
7:117182072:T:G,P13569,D373E,0.757,Loss of ubiquitination at K377 (P = 0.069); Loss of helix (P = 0.079); Gain of methylation at K370 (P = 0.0968); Gain of disorder (P = 0.121); Gain of relative solvent accessibility (P = 0.2629)
7:117182073:T:A,P13569,F374I,0.547,Gain of ubiquitination at K377 (P = 0.1092); Gain of catalytic residue at F374 (P = 0.162); Gain of methylation at K370 (P = 0.177); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2334)
7:117182073:T:C,P13569,F374L,0.584,Gain of ubiquitination at K377 (P = 0.0961); Gain of disorder (P = 0.1062); Gain of helix (P = 0.2294); Loss of methylation at K370 (P = 0.2347); Gain of MoRF binding (P = 0.4783)
7:117182073:T:G,P13569,F374V,0.585,Gain of ubiquitination at K377 (P = 0.1092); Gain of disorder (P = 0.1868); Loss of helix (P = 0.2271); Gain of methylation at K370 (P = 0.2317); Loss of stability (P = 0.3521)
7:117182074:T:A,P13569,F374Y,0.595,Gain of disorder (P = 0.0694); Gain of ubiquitination at K377 (P = 0.071); Gain of methylation at K370 (P = 0.2068); Loss of helix (P = 0.2271); Loss of stability (P = 0.31)
7:117182074:T:C,P13569,F374S,0.747,Gain of disorder (P = 9e-04); Loss of stability (P = 0.0547); Gain of ubiquitination at K377 (P = 0.0628); Gain of methylation at K370 (P = 0.1181); Loss of helix (P = 0.1706)
7:117182074:T:G,P13569,F374C,0.614,Loss of helix (P = 0.079); Gain of ubiquitination at K377 (P = 0.0843); Loss of stability (P = 0.1225); Loss of disorder (P = 0.2263); Loss of methylation at K370 (P = 0.2424)
7:117182075:C:A,P13569,F374L,0.584,Gain of ubiquitination at K377 (P = 0.0961); Gain of disorder (P = 0.1062); Gain of helix (P = 0.2294); Loss of methylation at K370 (P = 0.2347); Gain of MoRF binding (P = 0.4783)
7:117182075:C:G,P13569,F374L,0.584,Gain of ubiquitination at K377 (P = 0.0961); Gain of disorder (P = 0.1062); Gain of helix (P = 0.2294); Loss of methylation at K370 (P = 0.2347); Gain of MoRF binding (P = 0.4783)
7:117182076:T:A,P13569,L375I,0.627,Loss of catalytic residue at L375 (P = 0.0945); Gain of methylation at K370 (P = 0.0967); Gain of ubiquitination at K377 (P = 0.1092); Loss of disorder (P = 0.184); Loss of stability (P = 0.2535)
7:117182076:T:G,P13569,L375V,0.679,Loss of catalytic residue at L375 (P = 0.0683); Gain of ubiquitination at K377 (P = 0.1092); Gain of methylation at K370 (P = 0.1378); Loss of stability (P = 0.1962); Loss of disorder (P = 0.23)
7:117182077:T:C,P13569,L375S,0.764,Gain of disorder (P = 0.003); Loss of stability (P = 0.0232); Gain of methylation at K370 (P = 0.0458); Loss of catalytic residue at L375 (P = 0.0535); Gain of ubiquitination at K377 (P = 0.0843)
7:117182078:A:T,P13569,L375F,0.732,Gain of ubiquitination at K377 (P = 0.0668); Loss of catalytic residue at L375 (P = 0.0688); Gain of methylation at K370 (P = 0.165); Gain of helix (P = 0.2059); Loss of stability (P = 0.2217)
7:117182079:C:A,P13569,Q376K,0.583,Gain of ubiquitination at Q376 (P = 0.03); Gain of solvent accessibility (P = 0.0354); Gain of relative solvent accessibility (P = 0.0479); Gain of disorder (P = 0.1223); Loss of stability (P = 0.1585)
7:117182079:C:G,P13569,Q376E,0.513,Gain of relative solvent accessibility (P = 0.09); Gain of disorder (P = 0.0952); Gain of ubiquitination at K377 (P = 0.0961); Gain of solvent accessibility (P = 0.0971); Loss of helix (P = 0.1299)
7:117182080:A:C,P13569,Q376P,0.652,Gain of ubiquitination at K377 (P = 0.0594); Loss of stability (P = 0.1029); Loss of helix (P = 0.1299); Gain of methylation at K381 (P = 0.1583); Gain of glycosylation at Q376 (P = 0.221)
7:117182080:A:G,P13569,Q376R,0.542,Gain of solvent accessibility (P = 0.0584); Gain of ubiquitination at K377 (P = 0.0764); Gain of relative solvent accessibility (P = 0.09); Loss of methylation at K381 (P = 0.1233); Loss of helix (P = 0.1299)
7:117182080:A:T,P13569,Q376L,0.488,Loss of disorder (P = 0.0513); Gain of ubiquitination at K377 (P = 0.0594); Gain of catalytic residue at Q376 (P = 0.0794); Loss of methylation at K381 (P = 0.0873); Loss of helix (P = 0.1299)
7:117182081:A:C,P13569,Q376H,0.534,Gain of ubiquitination at K377 (P = 0.0594); Gain of disorder (P = 0.1598); Gain of methylation at K381 (P = 0.1831); Loss of stability (P = 0.2252); Loss of helix (P = 0.3949)
7:117182081:A:T,P13569,Q376H,0.534,Gain of ubiquitination at K377 (P = 0.0594); Gain of disorder (P = 0.1598); Gain of methylation at K381 (P = 0.1831); Loss of stability (P = 0.2252); Loss of helix (P = 0.3949)
7:117182082:A:C,P13569,K377Q,0.557,Loss of ubiquitination at K377 (P = 0.0148); Loss of helix (P = 0.1299); Loss of methylation at K381 (P = 0.1791); Loss of disorder (P = 0.1963); Gain of loop (P = 0.2045)
7:117182082:A:G,P13569,K377E,0.559,Loss of ubiquitination at K377 (P = 0.0148); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of disorder (P = 0.1602); Loss of methylation at K381 (P = 0.1725)
7:117182083:A:C,P13569,K377T,0.555,Loss of ubiquitination at K377 (P = 0.0148); Loss of disorder (P = 0.0971); Gain of catalytic residue at K377 (P = 0.1438); Loss of methylation at K381 (P = 0.1827); Gain of helix (P = 0.2294)
7:117182083:A:G,P13569,K377R,0.559,Loss of ubiquitination at K377 (P = 0.0148); Gain of catalytic residue at K377 (P = 0.0568); Loss of disorder (P = 0.0997); Loss of helix (P = 0.1299); Loss of methylation at K381 (P = 0.1573)
7:117182083:A:T,P13569,K377M,0.565,Loss of ubiquitination at K377 (P = 0.0148); Loss of disorder (P = 0.0443); Gain of phosphorylation at T382 (P = 0.1073); Loss of helix (P = 0.1299); Loss of methylation at K381 (P = 0.1516)
7:117182084:G:C,P13569,K377N,0.568,Loss of ubiquitination at K377 (P = 0.0148); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1333); Loss of methylation at K381 (P = 0.1475); Gain of loop (P = 0.2045)
7:117182084:G:T,P13569,K377N,0.568,Loss of ubiquitination at K377 (P = 0.0148); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1333); Loss of methylation at K381 (P = 0.1475); Gain of loop (P = 0.2045)
7:117182085:C:A,P13569,Q378K,0.486,Gain of ubiquitination at Q378 (P = 0.0325); Gain of methylation at Q378 (P = 0.0458); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Gain of disorder (P = 0.0964)
7:117182085:C:G,P13569,Q378E,0.403,Gain of disorder (P = 0.0725); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Loss of ubiquitination at K377 (P = 0.1191); Loss of helix (P = 0.1299)
7:117182086:A:C,P13569,Q378P,0.46,Gain of ubiquitination at K377 (P = 0.0628); Gain of phosphorylation at T382 (P = 0.1323); Gain of methylation at K381 (P = 0.1941); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2717)
7:117182086:A:G,P13569,Q378R,0.7,Gain of ubiquitination at K377 (P = 0.0843); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Gain of phosphorylation at T382 (P = 0.1376); Loss of disorder (P = 0.1677)
7:117182086:A:T,P13569,Q378L,0.399,Loss of disorder (P = 0.0406); Loss of ubiquitination at K381 (P = 0.0471); Loss of methylation at K381 (P = 0.0601); Loss of helix (P = 0.1299); Loss of phosphorylation at T382 (P = 0.2201)
7:117182087:A:C,P13569,Q378H,0.36,Gain of ubiquitination at K377 (P = 0.0628); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1488); Loss of methylation at K381 (P = 0.159); Loss of loop (P = 0.2237)
7:117182087:A:T,P13569,Q378H,0.36,Gain of ubiquitination at K377 (P = 0.0628); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1488); Loss of methylation at K381 (P = 0.159); Loss of loop (P = 0.2237)
7:117182088:G:A,P13569,E379K,0.807,Loss of ubiquitination at K377 (P = 0.0357); Gain of MoRF binding (P = 0.0861); Gain of methylation at E379 (P = 0.128); Loss of helix (P = 0.1299); Gain of phosphorylation at T382 (P = 0.18)
7:117182088:G:C,P13569,E379Q,0.6,Gain of ubiquitination at K377 (P = 0.0961); Loss of disorder (P = 0.1526); Gain of methylation at K381 (P = 0.1554); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059)
7:117182089:A:C,P13569,E379A,0.606,Loss of disorder (P = 0.0474); Gain of ubiquitination at K377 (P = 0.0764); Gain of methylation at K381 (P = 0.1581); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059)
7:117182089:A:G,P13569,E379G,0.606,Loss of stability (P = 0.0621); Gain of ubiquitination at K377 (P = 0.0628); Loss of disorder (P = 0.0975); Gain of methylation at K381 (P = 0.115); Loss of helix (P = 0.1299)
7:117182089:A:T,P13569,E379V,0.615,Loss of disorder (P = 0.0141); Loss of ubiquitination at K381 (P = 0.0374); Gain of methylation at K381 (P = 0.0718); Loss of solvent accessibility (P = 0.1744); Loss of phosphorylation at T382 (P = 0.1989)
7:117182090:A:C,P13569,E379D,0.592,Gain of ubiquitination at K377 (P = 0.0961); Loss of methylation at K381 (P = 0.1275); Loss of helix (P = 0.1299); Gain of phosphorylation at T382 (P = 0.1775); Loss of disorder (P = 0.1798)
7:117182090:A:T,P13569,E379D,0.592,Gain of ubiquitination at K377 (P = 0.0961); Loss of methylation at K381 (P = 0.1275); Loss of helix (P = 0.1299); Gain of phosphorylation at T382 (P = 0.1775); Loss of disorder (P = 0.1798)
7:117182091:T:A,P13569,Y380N,0.513,Gain of disorder (P = 0.0157); Gain of methylation at K381 (P = 0.0432); Loss of catalytic residue at L375 (P = 0.0842); Gain of ubiquitination at K377 (P = 0.1235); Loss of phosphorylation at T382 (P = 0.1915)
7:117182091:T:C,P13569,Y380H,0.514,Gain of disorder (P = 0.0205); Gain of methylation at K381 (P = 0.0477); Gain of ubiquitination at K377 (P = 0.0668); Loss of catalytic residue at L375 (P = 0.0849); Loss of helix (P = 0.1299)
7:117182091:T:G,P13569,Y380D,0.597,Gain of disorder (P = 0.0081); Gain of relative solvent accessibility (P = 0.0479); Gain of methylation at K381 (P = 0.0598); Gain of solvent accessibility (P = 0.0704); Loss of helix (P = 0.079)
7:117182092:A:C,P13569,Y380S,0.602,Gain of disorder (P = 0.0056); Gain of ubiquitination at K377 (P = 0.0764); Gain of methylation at K381 (P = 0.0797); Loss of catalytic residue at L375 (P = 0.0852); Loss of stability (P = 0.1289)
7:117182092:A:G,P13569,Y380C,0.434,Gain of methylation at K381 (P = 0.0178); Gain of ubiquitination at K377 (P = 0.071); Loss of catalytic residue at L375 (P = 0.086); Loss of disorder (P = 0.0909); Loss of phosphorylation at T382 (P = 0.1937)
7:117182092:A:T,P13569,Y380F,0.358,Gain of methylation at K381 (P = 0.0306); Loss of catalytic residue at L375 (P = 0.0869); Gain of helix (P = 0.132); Loss of ubiquitination at K377 (P = 0.1388); Loss of disorder (P = 0.1497)
7:117182094:A:C,P13569,K381Q,0.387,Loss of ubiquitination at K381 (P = 0.0074); Loss of methylation at K381 (P = 0.035); Loss of solvent accessibility (P = 0.0595); Loss of helix (P = 0.1299); Loss of phosphorylation at T382 (P = 0.1787)
7:117182094:A:G,P13569,K381E,0.41,Loss of ubiquitination at K381 (P = 0.0074); Loss of helix (P = 0.0167); Gain of relative solvent accessibility (P = 0.0275); Gain of solvent accessibility (P = 0.0328); Loss of methylation at K381 (P = 0.035)
7:117182095:A:C,P13569,K381T,0.455,Loss of ubiquitination at K381 (P = 0.0074); Loss of helix (P = 0.0167); Loss of methylation at K381 (P = 0.035); Gain of loop (P = 0.0435); Loss of disorder (P = 0.1019)
7:117182095:A:G,P13569,K381R,0.363,Loss of ubiquitination at K381 (P = 0.0074); Loss of methylation at K381 (P = 0.0355); Loss of disorder (P = 0.098); Loss of helix (P = 0.2022); Gain of phosphorylation at T382 (P = 0.2225)
7:117182095:A:T,P13569,K381M,0.463,Loss of ubiquitination at K381 (P = 0.0074); Loss of methylation at K381 (P = 0.035); Loss of disorder (P = 0.0429); Loss of solvent accessibility (P = 0.0595); Loss of phosphorylation at T382 (P = 0.1208)
7:117182096:G:C,P13569,K381N,0.411,Loss of ubiquitination at K381 (P = 0.0074); Loss of methylation at K381 (P = 0.035); Loss of solvent accessibility (P = 0.0595); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1412)
7:117182096:G:T,P13569,K381N,0.411,Loss of ubiquitination at K381 (P = 0.0074); Loss of methylation at K381 (P = 0.035); Loss of solvent accessibility (P = 0.0595); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1412)
7:117182097:A:G,P13569,T382A,0.282,Loss of phosphorylation at T382 (P = 0.0553); Gain of ubiquitination at K377 (P = 0.0843); Loss of disorder (P = 0.1573); Loss of methylation at K381 (P = 0.1837); Loss of helix (P = 0.2022)
7:117182097:A:T,P13569,T382S,0.288,Gain of disorder (P = 0.0446); Loss of phosphorylation at T382 (P = 0.0974); Loss of helix (P = 0.1299); Loss of ubiquitination at K377 (P = 0.1388); Loss of methylation at K381 (P = 0.1634)
7:117182098:C:A,P13569,T382K,0.428,Gain of ubiquitination at T382 (P = 0.0198); Gain of disorder (P = 0.0363); Loss of phosphorylation at T382 (P = 0.0553); Loss of helix (P = 0.1299); Loss of methylation at K381 (P = 0.1853)
7:117182098:C:G,P13569,T382R,0.341,Loss of phosphorylation at T382 (P = 0.0553); Loss of ubiquitination at K377 (P = 0.0877); Gain of solvent accessibility (P = 0.1505); Loss of methylation at K381 (P = 0.1834); Gain of disorder (P = 0.1992)
7:117182098:C:T,P13569,T382I,0.409,Loss of disorder (P = 0.039); Gain of catalytic residue at L387 (P = 0.0434); Loss of phosphorylation at T382 (P = 0.0553); Gain of methylation at K381 (P = 0.0599); Gain of ubiquitination at K377 (P = 0.0843)
7:117182100:T:A,P13569,L383M,0.378,Gain of methylation at K381 (P = 0.0677); Gain of disorder (P = 0.1103); Loss of helix (P = 0.1299); Gain of ubiquitination at K381 (P = 0.2186); Gain of phosphorylation at T382 (P = 0.2379)
7:117182100:T:G,P13569,L383V,0.339,Gain of methylation at K381 (P = 0.0797); Gain of helix (P = 0.132); Gain of phosphorylation at T382 (P = 0.2069); Loss of disorder (P = 0.2263); Loss of ubiquitination at K381 (P = 0.264)
7:117182101:T:C,P13569,L383S,0.841,Gain of disorder (P = 0.0042); Gain of relative solvent accessibility (P = 0.0479); Gain of loop (P = 0.069); Gain of methylation at K381 (P = 0.0968); Gain of solvent accessibility (P = 0.11)
7:117182101:T:G,P13569,L383W,0.445,Loss of disorder (P = 0.0914); Loss of helix (P = 0.1299); Gain of methylation at K381 (P = 0.1548); Loss of phosphorylation at T382 (P = 0.1715); Gain of loop (P = 0.2045)
7:117182102:G:C,P13569,L383F,0.344,Gain of methylation at K381 (P = 0.091); Gain of helix (P = 0.132); Loss of disorder (P = 0.1735); Gain of phosphorylation at T382 (P = 0.196); Loss of ubiquitination at K381 (P = 0.225)
7:117182102:G:T,P13569,L383F,0.344,Gain of methylation at K381 (P = 0.091); Gain of helix (P = 0.132); Loss of disorder (P = 0.1735); Gain of phosphorylation at T382 (P = 0.196); Loss of ubiquitination at K381 (P = 0.225)
7:117182103:G:A,P13569,E384K,0.581,Gain of methylation at E384 (P = 0.0113); Gain of ubiquitination at E384 (P = 0.0138); Loss of helix (P = 0.1299); Loss of glycosylation at T389 (P = 0.2028); Gain of loop (P = 0.2045)
7:117182103:G:C,P13569,E384Q,0.308,Gain of methylation at K381 (P = 0.0759); Loss of helix (P = 0.1299); Loss of glycosylation at T389 (P = 0.1524); Loss of ubiquitination at K381 (P = 0.1668); Loss of disorder (P = 0.1683)
7:117182104:A:C,P13569,E384A,0.363,Loss of disorder (P = 0.0594); Gain of catalytic residue at Y385 (P = 0.1053); Loss of glycosylation at T389 (P = 0.1137); Loss of helix (P = 0.1299); Loss of ubiquitination at K381 (P = 0.1668)
7:117182104:A:G,P13569,E384G,0.354,Gain of catalytic residue at Y385 (P = 0.0915); Loss of disorder (P = 0.1161); Loss of glycosylation at T389 (P = 0.1258); Loss of helix (P = 0.1299); Loss of stability (P = 0.1799)
7:117182104:A:T,P13569,E384V,0.455,Loss of disorder (P = 0.0235); Loss of ubiquitination at K381 (P = 0.0675); Gain of methylation at K381 (P = 0.0908); Loss of glycosylation at T389 (P = 0.0924); Loss of helix (P = 0.1299)
7:117182105:A:C,P13569,E384D,0.255,Gain of helix (P = 0.132); Gain of phosphorylation at T382 (P = 0.1562); Loss of methylation at K381 (P = 0.1617); Loss of disorder (P = 0.1695); Loss of glycosylation at T389 (P = 0.2218)
7:117182105:A:T,P13569,E384D,0.255,Gain of helix (P = 0.132); Gain of phosphorylation at T382 (P = 0.1562); Loss of methylation at K381 (P = 0.1617); Loss of disorder (P = 0.1695); Loss of glycosylation at T389 (P = 0.2218)
7:117182106:T:A,P13569,Y385N,0.374,Gain of disorder (P = 0.0172); Gain of glycosylation at T389 (P = 0.1093); Gain of methylation at K381 (P = 0.1148); Loss of stability (P = 0.1416); Gain of helix (P = 0.2059)
7:117182106:T:C,P13569,Y385H,0.363,Gain of disorder (P = 0.0239); Gain of catalytic residue at L387 (P = 0.0756); Gain of glycosylation at T389 (P = 0.1158); Loss of helix (P = 0.1299); Gain of methylation at K381 (P = 0.1338)
7:117182106:T:G,P13569,Y385D,0.403,Gain of disorder (P = 0.013); Gain of methylation at K381 (P = 0.084); Gain of glycosylation at T389 (P = 0.1016); Gain of phosphorylation at T382 (P = 0.1055); Gain of helix (P = 0.132)
7:117182107:A:C,P13569,Y385S,0.415,Gain of disorder (P = 0.0063); Gain of glycosylation at T390 (P = 0.0961); Loss of stability (P = 0.0965); Gain of methylation at K381 (P = 0.1273); Gain of helix (P = 0.132)
7:117182107:A:G,P13569,Y385C,0.361,Loss of disorder (P = 0.1009); Loss of helix (P = 0.1299); Loss of methylation at K381 (P = 0.1573); Loss of phosphorylation at T382 (P = 0.208); Gain of glycosylation at T390 (P = 0.2288)
7:117182107:A:T,P13569,Y385F,0.309,Loss of methylation at K381 (P = 0.1467); Loss of disorder (P = 0.1546); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of phosphorylation at T382 (P = 0.2066)
7:117182109:A:C,P13569,N386H,0.305,Gain of disorder (P = 0.0704); Loss of stability (P = 0.0947); Gain of methylation at K381 (P = 0.1544); Gain of helix (P = 0.2059); Gain of ubiquitination at K381 (P = 0.2283)
7:117182109:A:G,P13569,N386D,0.291,Gain of loop (P = 0.069); Loss of helix (P = 0.1299); Loss of stability (P = 0.1466); Gain of disorder (P = 0.1565); Gain of methylation at K381 (P = 0.1621)
7:117182109:A:T,P13569,N386Y,0.395,Loss of helix (P = 0.0196); Gain of loop (P = 0.0312); Gain of methylation at K381 (P = 0.0458); Loss of disorder (P = 0.1228); Gain of phosphorylation at T382 (P = 0.1487)
7:117182110:A:C,P13569,N386T,0.394,Loss of helix (P = 0.0196); Gain of loop (P = 0.0312); Gain of methylation at K381 (P = 0.0517); Loss of stability (P = 0.0742); Gain of phosphorylation at T382 (P = 0.0877)
7:117182110:A:G,P13569,N386S,0.254,Gain of disorder (P = 0.0646); Gain of methylation at K381 (P = 0.0988); Loss of stability (P = 0.1377); Gain of phosphorylation at T382 (P = 0.189); Loss of glycosylation at T389 (P = 0.1944)
7:117182110:A:T,P13569,N386I,0.464,Gain of methylation at K381 (P = 0.0471); Loss of disorder (P = 0.0628); Gain of loop (P = 0.069); Loss of ubiquitination at K381 (P = 0.0779); Loss of glycosylation at T389 (P = 0.0972)
7:117182111:C:A,P13569,N386K,0.467,Gain of ubiquitination at N386 (P = 0.0094); Gain of methylation at N386 (P = 0.0362); Loss of stability (P = 0.072); Gain of disorder (P = 0.0774); Loss of helix (P = 0.1299)
7:117182111:C:G,P13569,N386K,0.467,Gain of ubiquitination at N386 (P = 0.0094); Gain of methylation at N386 (P = 0.0362); Loss of stability (P = 0.072); Gain of disorder (P = 0.0774); Loss of helix (P = 0.1299)
7:117182112:T:A,P13569,L387I,0.435,Gain of helix (P = 0.132); Loss of disorder (P = 0.1725); Gain of glycosylation at T389 (P = 0.1789); Loss of phosphorylation at T382 (P = 0.2032); Loss of stability (P = 0.223)
7:117182112:T:G,P13569,L387V,0.526,Loss of helix (P = 0.0123); Gain of loop (P = 0.0195); Loss of stability (P = 0.0686); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1683)
7:117182113:T:C,P13569,L387S,0.64,Gain of disorder (P = 0.0067); Loss of stability (P = 0.0072); Loss of helix (P = 0.1299); Gain of glycosylation at T389 (P = 0.1911); Gain of loop (P = 0.2045)
7:117182114:A:C,P13569,L387F,0.474,Loss of stability (P = 0.0863); Gain of helix (P = 0.132); Loss of glycosylation at T389 (P = 0.1336); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2078)
7:117182114:A:T,P13569,L387F,0.474,Loss of stability (P = 0.0863); Gain of helix (P = 0.132); Loss of glycosylation at T389 (P = 0.1336); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2078)
7:117182115:A:C,P13569,T388P,0.407,Loss of helix (P = 0.0626); Gain of catalytic residue at N386 (P = 0.078); Loss of stability (P = 0.0865); Gain of glycosylation at T389 (P = 0.1072); Gain of phosphorylation at Y385 (P = 0.1922)
7:117182115:A:G,P13569,T388A,0.42,Gain of helix (P = 0.132); Loss of stability (P = 0.1383); Loss of glycosylation at T389 (P = 0.1489); Loss of catalytic residue at T388 (P = 0.1691); Loss of disorder (P = 0.1851)
7:117182115:A:T,P13569,T388S,0.351,Gain of disorder (P = 0.1293); Gain of helix (P = 0.132); Loss of glycosylation at T389 (P = 0.1503); Gain of relative solvent accessibility (P = 0.2363); Loss of catalytic residue at T388 (P = 0.2649)
7:117182116:C:A,P13569,T388K,0.518,Gain of ubiquitination at T388 (P = 0.009); Gain of solvent accessibility (P = 0.0611); Loss of glycosylation at T389 (P = 0.0744); Gain of relative solvent accessibility (P = 0.0999); Gain of helix (P = 0.132)
7:117182116:C:G,P13569,T388R,0.439,Gain of solvent accessibility (P = 0.026); Loss of glycosylation at T389 (P = 0.0574); Gain of relative solvent accessibility (P = 0.0999); Gain of helix (P = 0.132); Loss of catalytic residue at T389 (P = 0.1846)
7:117182118:A:C,P13569,T389P,0.294,Loss of glycosylation at T389 (P = 0.0371); Loss of helix (P = 0.0626); Gain of phosphorylation at Y385 (P = 0.2302); Gain of relative solvent accessibility (P = 0.2363); Gain of loop (P = 0.2754)
7:117182118:A:G,P13569,T389A,0.277,Loss of glycosylation at T389 (P = 0.025); Loss of catalytic residue at T389 (P = 0.0777); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2166); Loss of stability (P = 0.4157)
7:117182118:A:T,P13569,T389S,0.27,Loss of glycosylation at T389 (P = 0.0732); Loss of helix (P = 0.1299); Loss of catalytic residue at T389 (P = 0.157); Gain of disorder (P = 0.1592); Gain of relative solvent accessibility (P = 0.2363)
7:117182119:C:A,P13569,T389N,0.252,Loss of glycosylation at T389 (P = 0.025); Loss of catalytic residue at T389 (P = 0.116); Loss of helix (P = 0.2022); Gain of relative solvent accessibility (P = 0.2363); Gain of loop (P = 0.2754)
7:117182119:C:G,P13569,T389S,0.27,Loss of glycosylation at T389 (P = 0.0732); Loss of helix (P = 0.1299); Loss of catalytic residue at T389 (P = 0.157); Gain of disorder (P = 0.1592); Gain of relative solvent accessibility (P = 0.2363)
7:117182119:C:T,P13569,T389I,0.381,Loss of glycosylation at T389 (P = 0.025); Loss of disorder (P = 0.085); Loss of catalytic residue at T389 (P = 0.0858); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.4821)
7:117182121:A:C,P13569,T390P,0.57,Loss of glycosylation at T390 (P = 0.0516); Loss of helix (P = 0.1299); Gain of phosphorylation at T389 (P = 0.1362); Loss of catalytic residue at T389 (P = 0.2248); Gain of loop (P = 0.2754)
7:117182121:A:G,P13569,T390A,0.534,Loss of glycosylation at T390 (P = 0.0424); Gain of helix (P = 0.2059); Loss of catalytic residue at T390 (P = 0.2103); Gain of loop (P = 0.2754); Loss of disorder (P = 0.3224)
7:117182121:A:T,P13569,T390S,0.558,Loss of glycosylation at T390 (P = 0.0714); Loss of catalytic residue at T389 (P = 0.2037); Gain of helix (P = 0.2059); Gain of disorder (P = 0.2399); Loss of stability (P = 0.3495)
7:117182122:C:A,P13569,T390K,0.574,Gain of ubiquitination at T390 (P = 0.0146); Gain of solvent accessibility (P = 0.0354); Gain of methylation at T390 (P = 0.0454); Gain of relative solvent accessibility (P = 0.0479); Loss of glycosylation at T390 (P = 0.0602)
7:117182122:C:G,P13569,T390R,0.589,Loss of glycosylation at T390 (P = 0.0424); Loss of catalytic residue at T389 (P = 0.1534); Gain of helix (P = 0.2059); Gain of phosphorylation at T389 (P = 0.3228); Loss of disorder (P = 0.4028)
7:117182122:C:T,P13569,T390I,0.574,Loss of glycosylation at T390 (P = 0.0424); Loss of disorder (P = 0.1644); Gain of helix (P = 0.2059); Loss of catalytic residue at T390 (P = 0.2289); Gain of loop (P = 0.4661)
7:117182124:G:A,P13569,E391K,0.468,Gain of ubiquitination at E391 (P = 0.0117); Gain of methylation at E391 (P = 0.0253); Loss of glycosylation at T389 (P = 0.1542); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754)
7:117182124:G:C,P13569,E391Q,0.354,Loss of glycosylation at T389 (P = 0.1101); Gain of catalytic residue at E391 (P = 0.1869); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of disorder (P = 0.4526)
7:117182125:A:C,P13569,E391A,0.416,Gain of glycosylation at T388 (P = 0.1126); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059); Loss of relative solvent accessibility (P = 0.3219); Gain of catalytic residue at V393 (P = 0.3448)
7:117182125:A:G,P13569,E391G,0.428,Gain of catalytic residue at V392 (P = 0.0736); Gain of glycosylation at T389 (P = 0.1344); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059); Loss of stability (P = 0.2542)
7:117182125:A:T,P13569,E391V,0.486,Gain of catalytic residue at E391 (P = 0.1408); Gain of glycosylation at T390 (P = 0.1519); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059); Loss of disorder (P = 0.2886)
7:117182126:A:C,P13569,E391D,0.335,Gain of catalytic residue at E391 (P = 0.1485); Loss of helix (P = 0.2022); Loss of glycosylation at T390 (P = 0.205); Loss of disorder (P = 0.438); Loss of stability (P = 0.6898)
7:117182126:A:T,P13569,E391D,0.335,Gain of catalytic residue at E391 (P = 0.1485); Loss of helix (P = 0.2022); Loss of glycosylation at T390 (P = 0.205); Loss of disorder (P = 0.438); Loss of stability (P = 0.6898)
7:117182127:G:A,P13569,V392I,0.464,Loss of glycosylation at T390 (P = 0.1103); Gain of catalytic residue at V393 (P = 0.1406); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Loss of disorder (P = 0.555)
7:117182127:G:C,P13569,V392L,0.527,Loss of glycosylation at T390 (P = 0.1618); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of catalytic residue at E395 (P = 0.2764); Gain of solvent accessibility (P = 0.4656)
7:117182127:G:T,P13569,V392L,0.527,Loss of glycosylation at T390 (P = 0.1618); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of catalytic residue at E395 (P = 0.2764); Gain of solvent accessibility (P = 0.4656)
7:117182128:T:A,P13569,V392E,0.567,Gain of disorder (P = 0.0099); Loss of catalytic residue at E395 (P = 0.1239); Loss of glycosylation at T389 (P = 0.1652); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117182128:T:C,P13569,V392A,0.772,Gain of glycosylation at T389 (P = 0.1368); Gain of helix (P = 0.2059); Loss of catalytic residue at E395 (P = 0.2235); Loss of stability (P = 0.3026); Gain of disorder (P = 0.305)
7:117182128:T:G,P13569,V392G,0.842,Loss of stability (P = 0.0288); Loss of helix (P = 0.079); Gain of disorder (P = 0.0889); Gain of catalytic residue at V393 (P = 0.1049); Gain of glycosylation at T390 (P = 0.1489)
7:117182130:G:A,P13569,V393M,0.382,Gain of helix (P = 0.132); Gain of glycosylation at T389 (P = 0.1915); Gain of phosphorylation at T398 (P = 0.2111); Loss of loop (P = 0.2897); Gain of disorder (P = 0.3558)
7:117182130:G:C,P13569,V393L,0.373,Gain of helix (P = 0.132); Loss of glycosylation at T390 (P = 0.1926); Loss of loop (P = 0.2897); Loss of catalytic residue at V393 (P = 0.5144); Gain of disorder (P = 0.551)
7:117182130:G:T,P13569,V393L,0.373,Gain of helix (P = 0.132); Loss of glycosylation at T390 (P = 0.1926); Loss of loop (P = 0.2897); Loss of catalytic residue at V393 (P = 0.5144); Gain of disorder (P = 0.551)
7:117182131:T:A,P13569,V393E,0.543,Gain of disorder (P = 0.0151); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of glycosylation at T389 (P = 0.0871); Gain of relative solvent accessibility (P = 0.09)
7:117182131:T:C,P13569,V393A,0.378,Gain of glycosylation at T390 (P = 0.1279); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Gain of disorder (P = 0.3459); Loss of stability (P = 0.4879)
7:117182131:T:G,P13569,V393G,0.532,Loss of stability (P = 0.0578); Gain of disorder (P = 0.1186); Gain of relative solvent accessibility (P = 0.1259); Gain of glycosylation at T389 (P = 0.1282); Gain of helix (P = 0.132)
7:117182133:A:C,P13569,M394L,0.494,Loss of helix (P = 0.0093); Gain of loop (P = 0.0195); Gain of catalytic residue at M394 (P = 0.1402); Gain of relative solvent accessibility (P = 0.2363); Gain of glycosylation at T389 (P = 0.2527)
7:117182133:A:G,P13569,M394V,0.484,Loss of helix (P = 0.0068); Gain of loop (P = 0.0166); Gain of sheet (P = 0.0507); Gain of glycosylation at T389 (P = 0.201); Gain of relative solvent accessibility (P = 0.2363)
7:117182133:A:T,P13569,M394L,0.494,Loss of helix (P = 0.0093); Gain of loop (P = 0.0195); Gain of catalytic residue at M394 (P = 0.1402); Gain of relative solvent accessibility (P = 0.2363); Gain of glycosylation at T389 (P = 0.2527)
7:117182134:T:A,P13569,M394K,0.728,Gain of ubiquitination at M394 (P = 0.0146); Gain of disorder (P = 0.1051); Loss of stability (P = 0.1255); Gain of helix (P = 0.2059); Gain of methylation at M394 (P = 0.2155)
7:117182134:T:C,P13569,M394T,0.528,Loss of helix (P = 0.0068); Gain of loop (P = 0.0166); Gain of phosphorylation at M394 (P = 0.0573); Gain of catalytic residue at M394 (P = 0.078); Gain of glycosylation at M394 (P = 0.1166)
7:117182134:T:G,P13569,M394R,0.875,Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of helix (P = 0.1299); Loss of glycosylation at T389 (P = 0.1582); Loss of stability (P = 0.2556)
7:117182135:G:A,P13569,M394I,0.408,Gain of helix (P = 0.2059); Loss of glycosylation at T389 (P = 0.223); Loss of loop (P = 0.2897); Gain of catalytic residue at A399 (P = 0.3592); Loss of disorder (P = 0.5318)
7:117182135:G:C,P13569,M394I,0.408,Gain of helix (P = 0.2059); Loss of glycosylation at T389 (P = 0.223); Loss of loop (P = 0.2897); Gain of catalytic residue at A399 (P = 0.3592); Loss of disorder (P = 0.5318)
7:117182135:G:T,P13569,M394I,0.408,Gain of helix (P = 0.2059); Loss of glycosylation at T389 (P = 0.223); Loss of loop (P = 0.2897); Gain of catalytic residue at A399 (P = 0.3592); Loss of disorder (P = 0.5318)
7:117182136:G:A,P13569,E395K,0.469,Gain of ubiquitination at E395 (P = 0.0177); Loss of stability (P = 0.1741); Gain of relative solvent accessibility (P = 0.1894); Gain of helix (P = 0.2059); Loss of glycosylation at T390 (P = 0.2063)
7:117182136:G:C,P13569,E395Q,0.336,Loss of glycosylation at T390 (P = 0.1622); Loss of helix (P = 0.2022); Loss of stability (P = 0.4317); Loss of loop (P = 0.4786); Loss of catalytic residue at E391 (P = 0.5157)
7:117182137:A:C,P13569,E395A,0.413,Loss of glycosylation at T390 (P = 0.115); Gain of helix (P = 0.2059); Loss of catalytic residue at E395 (P = 0.2192); Loss of loop (P = 0.2897); Loss of stability (P = 0.2907)
7:117182137:A:G,P13569,E395G,0.458,Loss of stability (P = 0.0464); Loss of catalytic residue at E395 (P = 0.0611); Loss of helix (P = 0.1299); Loss of glycosylation at T390 (P = 0.1417); Loss of solvent accessibility (P = 0.2732)
7:117182137:A:T,P13569,E395V,0.437,Loss of glycosylation at T390 (P = 0.1072); Loss of solvent accessibility (P = 0.1986); Loss of helix (P = 0.2271); Gain of catalytic residue at N396 (P = 0.2319); Loss of relative solvent accessibility (P = 0.3919)
7:117182138:G:C,P13569,E395D,0.299,Loss of helix (P = 0.2022); Loss of glycosylation at T390 (P = 0.2356); Loss of loop (P = 0.2897); Loss of stability (P = 0.3463); Loss of catalytic residue at E395 (P = 0.3981)
7:117182138:G:T,P13569,E395D,0.299,Loss of helix (P = 0.2022); Loss of glycosylation at T390 (P = 0.2356); Loss of loop (P = 0.2897); Loss of stability (P = 0.3463); Loss of catalytic residue at E395 (P = 0.3981)
7:117182139:A:C,P13569,N396H,0.355,Loss of helix (P = 0.2022); Loss of stability (P = 0.2426); Gain of catalytic residue at N396 (P = 0.3243); Gain of loop (P = 0.4661); Gain of disorder (P = 0.5134)
7:117182139:A:G,P13569,N396D,0.422,Loss of helix (P = 0.0626); Loss of catalytic residue at E395 (P = 0.1655); Gain of loop (P = 0.2754); Gain of phosphorylation at T398 (P = 0.3008); Loss of stability (P = 0.4906)
7:117182139:A:T,P13569,N396Y,0.446,Loss of catalytic residue at N396 (P = 0.2599); Gain of phosphorylation at T398 (P = 0.464); Loss of stability (P = 0.4683); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117182140:A:C,P13569,N396T,0.464,Loss of helix (P = 0.028); Gain of loop (P = 0.1069); Loss of solvent accessibility (P = 0.3543); Gain of sheet (P = 0.3763); Loss of relative solvent accessibility (P = 0.3919)
7:117182140:A:G,P13569,N396S,0.361,Loss of helix (P = 0.2271); Loss of stability (P = 0.3427); Loss of catalytic residue at N396 (P = 0.4313); Gain of phosphorylation at T398 (P = 0.4403); Gain of disorder (P = 0.4773)
7:117182140:A:T,P13569,N396I,0.502,Gain of catalytic residue at V397 (P = 0.1479); Loss of helix (P = 0.2022); Gain of loop (P = 0.4661); Loss of disorder (P = 0.4744); Gain of phosphorylation at T398 (P = 0.6336)
7:117182141:T:A,P13569,N396K,0.518,Gain of ubiquitination at N396 (P = 0.0155); Gain of methylation at N396 (P = 0.0191); Loss of stability (P = 0.2012); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.3194)
7:117182141:T:G,P13569,N396K,0.518,Gain of ubiquitination at N396 (P = 0.0155); Gain of methylation at N396 (P = 0.0191); Loss of stability (P = 0.2012); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.3194)
7:117182142:G:A,P13569,V397I,0.414,Gain of helix (P = 0.2059); Loss of disorder (P = 0.3581); Loss of catalytic residue at N396 (P = 0.4304); Gain of loop (P = 0.4661); Loss of phosphorylation at T398 (P = 0.6433)
7:117182142:G:C,P13569,V397L,0.407,Loss of helix (P = 0.2022); Gain of disorder (P = 0.3308); Gain of loop (P = 0.4661); Loss of catalytic residue at N396 (P = 0.6077); Loss of glycosylation at T398 (P = 0.6198)
7:117182142:G:T,P13569,V397L,0.407,Loss of helix (P = 0.2022); Gain of disorder (P = 0.3308); Gain of loop (P = 0.4661); Loss of catalytic residue at N396 (P = 0.6077); Loss of glycosylation at T398 (P = 0.6198)
7:117182143:T:A,P13569,V397E,0.659,Gain of disorder (P = 0.0133); Gain of catalytic residue at V397 (P = 0.1663); Loss of helix (P = 0.2022); Gain of phosphorylation at T398 (P = 0.4575); Gain of loop (P = 0.4661)
7:117182143:T:C,P13569,V397A,0.445,Gain of disorder (P = 0.1381); Loss of stability (P = 0.1903); Gain of helix (P = 0.2059); Loss of catalytic residue at N396 (P = 0.4463); Loss of loop (P = 0.4786)
7:117182143:T:G,P13569,V397G,0.573,Loss of stability (P = 0.0372); Gain of disorder (P = 0.0548); Gain of helix (P = 0.2059); Gain of catalytic residue at A399 (P = 0.2701); Gain of loop (P = 0.4661)
7:117182145:A:C,P13569,T398P,0.431,Gain of catalytic residue at N396 (P = 0.1705); Loss of helix (P = 0.2022); Loss of stability (P = 0.2482); Loss of solvent accessibility (P = 0.3103); Loss of relative solvent accessibility (P = 0.3219)
7:117182145:A:G,P13569,T398A,0.358,Loss of helix (P = 0.2022); Loss of solvent accessibility (P = 0.3103); Loss of relative solvent accessibility (P = 0.3219); Loss of disorder (P = 0.3834); Loss of loop (P = 0.4786)
7:117182145:A:T,P13569,T398S,0.313,Loss of helix (P = 0.2022); Gain of disorder (P = 0.2195); Gain of glycosylation at T398 (P = 0.3681); Gain of loop (P = 0.4661); Gain of phosphorylation at T398 (P = 0.5418)
7:117182146:C:A,P13569,T398K,0.506,Gain of methylation at T398 (P = 0.0124); Gain of ubiquitination at T398 (P = 0.0198); Gain of disorder (P = 0.2157); Gain of helix (P = 0.2294); Loss of catalytic residue at E395 (P = 0.2604)
7:117182146:C:G,P13569,T398R,0.393,Loss of helix (P = 0.2022); Loss of solvent accessibility (P = 0.3103); Loss of relative solvent accessibility (P = 0.3219); Loss of catalytic residue at E395 (P = 0.3397); Gain of disorder (P = 0.371)
7:117182146:C:T,P13569,T398I,0.437,Gain of catalytic residue at T398 (P = 0.078); Loss of disorder (P = 0.1576); Gain of helix (P = 0.2294); Loss of solvent accessibility (P = 0.3103); Loss of relative solvent accessibility (P = 0.3219)
7:117182148:G:A,P13569,A399T,0.505,Loss of helix (P = 0.0167); Gain of loop (P = 0.0435); Gain of phosphorylation at A399 (P = 0.0879); Gain of disorder (P = 0.12); Gain of glycosylation at T398 (P = 0.1479)
7:117182148:G:C,P13569,A399P,0.554,Loss of helix (P = 0.079); Gain of disorder (P = 0.1413); Gain of phosphorylation at T398 (P = 0.1598); Loss of stability (P = 0.1873); Gain of glycosylation at T398 (P = 0.324)
7:117182148:G:T,P13569,A399S,0.426,Gain of disorder (P = 0.0556); Gain of relative solvent accessibility (P = 0.1894); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.2601); Loss of catalytic residue at A399 (P = 0.3042)
7:117182149:C:A,P13569,A399D,0.759,Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Gain of disorder (P = 0.1379); Gain of solvent accessibility (P = 0.1422); Gain of relative solvent accessibility (P = 0.1894)
7:117182149:C:G,P13569,A399G,0.603,Loss of helix (P = 0.0093); Gain of loop (P = 0.0195); Gain of disorder (P = 0.1272); Loss of stability (P = 0.2365); Gain of catalytic residue at N396 (P = 0.3358)
7:117182151:T:A,P13569,F400I,0.427,Loss of disorder (P = 0.1724); Loss of catalytic residue at F400 (P = 0.1933); Loss of stability (P = 0.1965); Loss of helix (P = 0.2022); Gain of loop (P = 0.4661)
7:117182151:T:C,P13569,F400L,0.412,Loss of catalytic residue at F400 (P = 0.0541); Gain of helix (P = 0.0854); Gain of disorder (P = 0.2779); Loss of stability (P = 0.3457); Gain of loop (P = 0.4661)
7:117182151:T:G,P13569,F400V,0.405,Loss of stability (P = 0.1489); Gain of catalytic residue at E403 (P = 0.1824); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of disorder (P = 0.3283)
7:117182152:T:A,P13569,F400Y,0.401,Loss of catalytic residue at F400 (P = 0.111); Loss of stability (P = 0.1598); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2735); Gain of loop (P = 0.4661)
7:117182152:T:C,P13569,F400S,0.608,Gain of disorder (P = 0.0191); Loss of stability (P = 0.035); Loss of catalytic residue at F400 (P = 0.0585); Gain of helix (P = 0.0854); Gain of phosphorylation at F400 (P = 0.0958)
7:117182152:T:G,P13569,F400C,0.406,Gain of catalytic residue at W401 (P = 0.0104); Gain of helix (P = 0.0854); Loss of stability (P = 0.1382); Loss of disorder (P = 0.2875); Loss of loop (P = 0.4786)
7:117182153:C:A,P13569,F400L,0.412,Loss of catalytic residue at F400 (P = 0.0541); Gain of helix (P = 0.0854); Gain of disorder (P = 0.2779); Loss of stability (P = 0.3457); Gain of loop (P = 0.4661)
7:117182153:C:G,P13569,F400L,0.412,Loss of catalytic residue at F400 (P = 0.0541); Gain of helix (P = 0.0854); Gain of disorder (P = 0.2779); Loss of stability (P = 0.3457); Gain of loop (P = 0.4661)
7:117182154:T:A,P13569,W401R,0.659,Gain of disorder (P = 0.002); Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09)
7:117182154:T:C,P13569,W401R,0.659,Gain of disorder (P = 0.002); Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09)
7:117182154:T:G,P13569,W401G,0.741,Gain of disorder (P = 0.0017); Gain of loop (P = 0.0195); Loss of helix (P = 0.0196); Loss of stability (P = 0.1534); Gain of phosphorylation at T398 (P = 0.2872)
7:117182155:G:C,P13569,W401S,0.696,Gain of disorder (P = 4e-04); Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Gain of phosphorylation at W401 (P = 0.1094); Gain of glycosylation at T398 (P = 0.2036)
7:117182155:G:T,P13569,W401L,0.636,Loss of helix (P = 0.0196); Gain of disorder (P = 0.023); Gain of loop (P = 0.0435); Gain of phosphorylation at T398 (P = 0.4902); Gain of glycosylation at T398 (P = 0.5126)
7:117182156:G:C,P13569,W401C,0.547,Gain of disorder (P = 0.0412); Gain of helix (P = 0.2294); Gain of catalytic residue at E403 (P = 0.2845); Gain of phosphorylation at T398 (P = 0.4347); Gain of loop (P = 0.4661)
7:117182156:G:T,P13569,W401C,0.547,Gain of disorder (P = 0.0412); Gain of helix (P = 0.2294); Gain of catalytic residue at E403 (P = 0.2845); Gain of phosphorylation at T398 (P = 0.4347); Gain of loop (P = 0.4661)
7:117182157:G:A,P13569,E402K,0.525,Gain of methylation at E402 (P = 0.0073); Gain of ubiquitination at E402 (P = 0.023); Gain of relative solvent accessibility (P = 0.1894); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.2192)
7:117182157:G:C,P13569,E402Q,0.303,Loss of disorder (P = 0.1772); Loss of helix (P = 0.2022); Gain of catalytic residue at A399 (P = 0.3847); Gain of loop (P = 0.4661); Gain of solvent accessibility (P = 0.5843)
7:117182158:A:C,P13569,E402A,0.421,Loss of disorder (P = 0.0956); Loss of helix (P = 0.2022); Gain of catalytic residue at W401 (P = 0.2057); Loss of solvent accessibility (P = 0.2106); Gain of loop (P = 0.4661)
7:117182158:A:G,P13569,E402G,0.376,Gain of catalytic residue at W401 (P = 0.1132); Loss of stability (P = 0.1481); Loss of disorder (P = 0.1619); Loss of solvent accessibility (P = 0.1868); Gain of helix (P = 0.2059)
7:117182158:A:T,P13569,E402V,0.52,Loss of disorder (P = 0.0439); Loss of solvent accessibility (P = 0.0703); Loss of relative solvent accessibility (P = 0.1807); Gain of helix (P = 0.2059); Gain of catalytic residue at W401 (P = 0.2248)
7:117182159:G:C,P13569,E402D,0.373,Loss of helix (P = 0.028); Gain of catalytic residue at E402 (P = 0.0464); Gain of loop (P = 0.1069); Loss of disorder (P = 0.144); Gain of sheet (P = 0.4423)
7:117182159:G:T,P13569,E402D,0.373,Loss of helix (P = 0.028); Gain of catalytic residue at E402 (P = 0.0464); Gain of loop (P = 0.1069); Loss of disorder (P = 0.144); Gain of sheet (P = 0.4423)
7:117182160:G:A,P13569,E403K,0.575,Gain of methylation at E403 (P = 0.0124); Gain of ubiquitination at E403 (P = 0.0203); Gain of glycosylation at E403 (P = 0.0466); Gain of helix (P = 0.0854); Loss of disorder (P = 0.2221)
7:117182160:G:C,P13569,E403Q,0.49,Gain of catalytic residue at E403 (P = 0.1294); Loss of disorder (P = 0.1628); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Loss of solvent accessibility (P = 0.5485)
7:117182161:A:C,P13569,E403A,0.491,Loss of helix (P = 0.0626); Gain of catalytic residue at E403 (P = 0.0649); Loss of disorder (P = 0.0843); Loss of solvent accessibility (P = 0.2106); Gain of loop (P = 0.2754)
7:117182161:A:G,P13569,E403G,0.505,Loss of helix (P = 0.0626); Gain of catalytic residue at G404 (P = 0.098); Loss of stability (P = 0.0994); Gain of loop (P = 0.1069); Loss of disorder (P = 0.1497)
7:117182161:A:T,P13569,E403V,0.525,Loss of disorder (P = 0.0349); Loss of solvent accessibility (P = 0.1986); Loss of helix (P = 0.2022); Gain of catalytic residue at E402 (P = 0.2041); Loss of relative solvent accessibility (P = 0.3919)
7:117182162:G:C,P13569,E403D,0.755,Loss of disorder (P = 0.128); Gain of catalytic residue at E403 (P = 0.1847); Gain of helix (P = 0.2059); Gain of loop (P = 0.4661); Loss of stability (P = 0.6031)
7:117182162:G:T,P13569,E403D,0.755,Loss of disorder (P = 0.128); Gain of catalytic residue at E403 (P = 0.1847); Gain of helix (P = 0.2059); Gain of loop (P = 0.4661); Loss of stability (P = 0.6031)
7:117188695:G:A,P13569,G404R,0.494,Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Gain of disorder (P = 0.2261)
7:117188696:G:A,P13569,G404E,0.518,Loss of helix (P = 0.028); Gain of disorder (P = 0.0444); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1903)
7:117188696:G:C,P13569,G404A,0.403,Loss of helix (P = 0.1299); Loss of disorder (P = 0.1643); Gain of loop (P = 0.2754); Loss of catalytic residue at F400 (P = 0.3873); Loss of stability (P = 0.444)
7:117188696:G:T,P13569,G404V,0.464,Loss of disorder (P = 0.0597); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of catalytic residue at F400 (P = 0.5165); Loss of stability (P = 0.5253)
7:117188698:T:A,P13569,F405I,0.411,Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Loss of disorder (P = 0.1242); Gain of catalytic residue at F405 (P = 0.398); Gain of sheet (P = 0.6509)
7:117188698:T:C,P13569,F405L,0.401,Loss of helix (P = 0.0558); Gain of disorder (P = 0.1819); Gain of loop (P = 0.2754); Gain of catalytic residue at F405 (P = 0.3869); Gain of stability (P = 0.6106)
7:117188698:T:G,P13569,F405V,0.417,Loss of helix (P = 0.0196); Gain of loop (P = 0.0435); Gain of catalytic residue at F405 (P = 0.0568); Gain of disorder (P = 0.2497); Gain of sheet (P = 0.6509)
7:117188699:T:A,P13569,F405Y,0.332,Gain of phosphorylation at F405 (P = 0.1418); Loss of disorder (P = 0.2167); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.7065)
7:117188699:T:C,P13569,F405S,0.505,Gain of disorder (P = 0.0076); Loss of helix (P = 0.028); Gain of glycosylation at F405 (P = 0.0291); Gain of loop (P = 0.0435); Gain of relative solvent accessibility (P = 0.0479)
7:117188699:T:G,P13569,F405C,0.434,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of disorder (P = 0.1823); Gain of catalytic residue at E407 (P = 0.2619); Loss of stability (P = 0.5867)
7:117188700:T:A,P13569,F405L,0.401,Loss of helix (P = 0.0558); Gain of disorder (P = 0.1819); Gain of loop (P = 0.2754); Gain of catalytic residue at F405 (P = 0.3869); Gain of stability (P = 0.6106)
7:117188700:T:G,P13569,F405L,0.401,Loss of helix (P = 0.0558); Gain of disorder (P = 0.1819); Gain of loop (P = 0.2754); Gain of catalytic residue at F405 (P = 0.3869); Gain of stability (P = 0.6106)
7:117188701:G:A,P13569,G406R,0.386,Gain of solvent accessibility (P = 0.019); Loss of methylation at K411 (P = 0.1093); Loss of helix (P = 0.1299); Loss of ubiquitination at K411 (P = 0.1557); Gain of relative solvent accessibility (P = 0.1894)
7:117188701:G:C,P13569,G406R,0.386,Gain of solvent accessibility (P = 0.019); Loss of methylation at K411 (P = 0.1093); Loss of helix (P = 0.1299); Loss of ubiquitination at K411 (P = 0.1557); Gain of relative solvent accessibility (P = 0.1894)
7:117188701:G:T,P13569,G406W,0.47,Loss of disorder (P = 0.0162); Gain of catalytic residue at W401 (P = 0.0446); Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Gain of methylation at K411 (P = 0.1188)
7:117188702:G:C,P13569,G406A,0.356,Loss of disorder (P = 0.1364); Loss of methylation at K411 (P = 0.1787); Loss of ubiquitination at K411 (P = 0.2113); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897)
7:117188702:G:T,P13569,G406V,0.468,Loss of helix (P = 0.0196); Gain of loop (P = 0.0435); Loss of disorder (P = 0.0444); Loss of ubiquitination at K411 (P = 0.1278); Gain of methylation at K411 (P = 0.134)
7:117188704:G:A,P13569,E407K,0.533,Gain of ubiquitination at E407 (P = 0.017); Gain of methylation at E407 (P = 0.0215); Loss of helix (P = 0.0558); Gain of glycosylation at E407 (P = 0.0601); Gain of loop (P = 0.1069)
7:117188704:G:C,P13569,E407Q,0.423,Loss of disorder (P = 0.1119); Loss of ubiquitination at K411 (P = 0.1278); Loss of helix (P = 0.1299); Gain of methylation at K411 (P = 0.1398); Loss of stability (P = 0.325)
7:117188705:A:C,P13569,E407A,0.529,Loss of disorder (P = 0.0481); Loss of helix (P = 0.1299); Gain of methylation at K411 (P = 0.1848); Loss of ubiquitination at K411 (P = 0.1852); Gain of catalytic residue at E407 (P = 0.3217)
7:117188705:A:G,P13569,E407G,0.499,Loss of stability (P = 0.0571); Loss of disorder (P = 0.0982); Loss of helix (P = 0.1299); Loss of ubiquitination at K411 (P = 0.1557); Gain of methylation at K411 (P = 0.1792)
7:117188705:A:T,P13569,E407V,0.787,Loss of disorder (P = 0.0114); Loss of helix (P = 0.079); Loss of ubiquitination at K411 (P = 0.1069); Gain of methylation at K411 (P = 0.1179); Gain of catalytic residue at E410 (P = 0.1466)
7:117188706:A:C,P13569,E407D,0.43,Loss of ubiquitination at K411 (P = 0.1069); Loss of disorder (P = 0.1084); Gain of methylation at K411 (P = 0.1895); Loss of helix (P = 0.2271); Loss of loop (P = 0.2897)
7:117188706:A:T,P13569,E407D,0.43,Loss of ubiquitination at K411 (P = 0.1069); Loss of disorder (P = 0.1084); Gain of methylation at K411 (P = 0.1895); Loss of helix (P = 0.2271); Loss of loop (P = 0.2897)
7:117188707:T:A,P13569,L408I,0.336,Gain of catalytic residue at L408 (P = 0.0101); Gain of methylation at K413 (P = 0.0432); Loss of ubiquitination at K411 (P = 0.1069); Loss of disorder (P = 0.121); Loss of helix (P = 0.2022)
7:117188707:T:G,P13569,L408V,0.312,Loss of helix (P = 0.0626); Gain of methylation at K413 (P = 0.0657); Gain of ubiquitination at K411 (P = 0.1982); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2497)
7:117188708:T:C,P13569,L408S,0.536,Gain of disorder (P = 0.0084); Loss of helix (P = 0.0123); Gain of loop (P = 0.0195); Gain of relative solvent accessibility (P = 0.0215); Loss of stability (P = 0.0502)
7:117188709:A:C,P13569,L408F,0.345,Gain of loop (P = 0.0195); Loss of helix (P = 0.0196); Gain of methylation at K413 (P = 0.0696); Gain of disorder (P = 0.2187); Gain of ubiquitination at K411 (P = 0.2244)
7:117188709:A:T,P13569,L408F,0.345,Gain of loop (P = 0.0195); Loss of helix (P = 0.0196); Gain of methylation at K413 (P = 0.0696); Gain of disorder (P = 0.2187); Gain of ubiquitination at K411 (P = 0.2244)
7:117188710:T:A,P13569,F409I,0.344,Gain of methylation at K413 (P = 0.0786); Loss of disorder (P = 0.1297); Loss of helix (P = 0.1299); Loss of ubiquitination at K411 (P = 0.1557); Gain of relative solvent accessibility (P = 0.2363)
7:117188710:T:C,P13569,F409L,0.389,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of methylation at K411 (P = 0.0725); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1319)
7:117188710:T:G,P13569,F409V,0.338,Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299); Gain of methylation at K413 (P = 0.1687); Gain of ubiquitination at K411 (P = 0.2106); Gain of disorder (P = 0.237)
7:117188711:T:A,P13569,F409Y,0.343,Loss of methylation at K411 (P = 0.0638); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.154); Gain of ubiquitination at K411 (P = 0.2244)
7:117188711:T:C,P13569,F409S,0.51,Gain of disorder (P = 0.0098); Loss of methylation at K411 (P = 0.0422); Gain of relative solvent accessibility (P = 0.0479); Loss of helix (P = 0.0558); Gain of loop (P = 0.069)
7:117188711:T:G,P13569,F409C,0.356,Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299); Loss of methylation at K411 (P = 0.1309); Loss of disorder (P = 0.1745); Loss of ubiquitination at K411 (P = 0.2335)
7:117188712:T:A,P13569,F409L,0.389,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of methylation at K411 (P = 0.0725); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1319)
7:117188712:T:G,P13569,F409L,0.389,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of methylation at K411 (P = 0.0725); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1319)
7:117188713:G:A,P13569,E410K,0.454,Gain of methylation at E410 (P = 0.0043); Loss of ubiquitination at K413 (P = 0.0273); Gain of MoRF binding (P = 0.079); Loss of stability (P = 0.1702); Gain of glycosylation at E410 (P = 0.1805)
7:117188713:G:C,P13569,E410Q,0.327,Loss of ubiquitination at K411 (P = 0.0591); Gain of methylation at K413 (P = 0.0626); Loss of disorder (P = 0.1106); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.3546)
7:117188714:A:C,P13569,E410A,0.382,Loss of disorder (P = 0.0376); Loss of ubiquitination at K411 (P = 0.1278); Gain of methylation at K413 (P = 0.1492); Loss of helix (P = 0.2022); Loss of solvent accessibility (P = 0.3543)
7:117188714:A:G,P13569,E410G,0.396,Loss of stability (P = 0.0451); Loss of ubiquitination at K411 (P = 0.0591); Loss of disorder (P = 0.0971); Gain of methylation at K413 (P = 0.1236); Gain of relative solvent accessibility (P = 0.1894)
7:117188714:A:T,P13569,E410V,0.467,Loss of disorder (P = 0.003); Loss of ubiquitination at K411 (P = 0.0505); Gain of methylation at K411 (P = 0.0528); Loss of helix (P = 0.2022); Gain of catalytic residue at K413 (P = 0.2752)
7:117188715:G:C,P13569,E410D,0.368,Loss of ubiquitination at K411 (P = 0.0657); Gain of relative solvent accessibility (P = 0.09); Loss of disorder (P = 0.1073); Loss of methylation at K413 (P = 0.129); Gain of solvent accessibility (P = 0.199)
7:117188715:G:T,P13569,E410D,0.368,Loss of ubiquitination at K411 (P = 0.0657); Gain of relative solvent accessibility (P = 0.09); Loss of disorder (P = 0.1073); Loss of methylation at K413 (P = 0.129); Gain of solvent accessibility (P = 0.199)
7:117188716:A:C,P13569,K411Q,0.383,Loss of ubiquitination at K411 (P = 0.0087); Loss of methylation at K411 (P = 0.012); Loss of disorder (P = 0.1639); Loss of glycosylation at K411 (P = 0.1817); Loss of helix (P = 0.2022)
7:117188716:A:G,P13569,K411E,0.407,Loss of ubiquitination at K411 (P = 0.0087); Loss of methylation at K411 (P = 0.012); Loss of helix (P = 0.028); Gain of loop (P = 0.069); Gain of disorder (P = 0.1431)
7:117188717:A:C,P13569,K411T,0.402,Loss of ubiquitination at K411 (P = 0.0087); Loss of methylation at K411 (P = 0.012); Loss of disorder (P = 0.0739); Loss of solvent accessibility (P = 0.1922); Loss of helix (P = 0.2022)
7:117188717:A:G,P13569,K411R,0.305,Loss of ubiquitination at K411 (P = 0.0087); Loss of methylation at K411 (P = 0.0137); Loss of disorder (P = 0.0983); Gain of helix (P = 0.132); Loss of glycosylation at K411 (P = 0.1817)
7:117188717:A:T,P13569,K411I,0.431,Loss of disorder (P = 0.0012); Loss of ubiquitination at K411 (P = 0.0087); Loss of methylation at K411 (P = 0.012); Loss of solvent accessibility (P = 0.1434); Loss of glycosylation at K411 (P = 0.1817)
7:117188718:A:C,P13569,K411N,0.352,Loss of ubiquitination at K411 (P = 0.0087); Loss of methylation at K411 (P = 0.012); Gain of helix (P = 0.132); Loss of disorder (P = 0.177); Loss of glycosylation at K411 (P = 0.1817)
7:117188718:A:T,P13569,K411N,0.352,Loss of ubiquitination at K411 (P = 0.0087); Loss of methylation at K411 (P = 0.012); Gain of helix (P = 0.132); Loss of disorder (P = 0.177); Loss of glycosylation at K411 (P = 0.1817)
7:117188719:G:A,P13569,A412T,0.27,Gain of disorder (P = 0.0984); Gain of methylation at K413 (P = 0.1101); Gain of ubiquitination at K411 (P = 0.1832); Loss of loop (P = 0.2897); Gain of phosphorylation at A412 (P = 0.3007)
7:117188719:G:C,P13569,A412P,0.39,Gain of glycosylation at A412 (P = 0.0437); Gain of methylation at K413 (P = 0.0611); Gain of disorder (P = 0.0772); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1116)
7:117188719:G:T,P13569,A412S,0.316,Gain of disorder (P = 0.0398); Loss of methylation at K413 (P = 0.1649); Gain of phosphorylation at A412 (P = 0.1744); Gain of ubiquitination at K411 (P = 0.1832); Loss of loop (P = 0.2897)
7:117188720:C:A,P13569,A412E,0.373,Loss of helix (P = 0.028); Gain of disorder (P = 0.0283); Loss of loop (P = 0.0512); Gain of methylation at K411 (P = 0.151); Gain of ubiquitination at K411 (P = 0.1557)
7:117188720:C:G,P13569,A412G,0.319,Loss of helix (P = 0.028); Loss of loop (P = 0.0512); Gain of disorder (P = 0.072); Gain of methylation at K413 (P = 0.1342); Gain of glycosylation at K411 (P = 0.138)
7:117188720:C:T,P13569,A412V,0.255,Gain of methylation at K413 (P = 0.0354); Loss of disorder (P = 0.0871); Loss of ubiquitination at K411 (P = 0.0896); Loss of helix (P = 0.1299); Gain of loop (P = 0.3485)
7:117188722:A:C,P13569,K413Q,0.426,Loss of ubiquitination at K413 (P = 0.0056); Loss of methylation at K413 (P = 0.028); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2199); Gain of glycosylation at K411 (P = 0.354)
7:117188722:A:G,P13569,K413E,0.418,Loss of ubiquitination at K413 (P = 0.0056); Loss of methylation at K413 (P = 0.028); Loss of solvent accessibility (P = 0.1322); Gain of glycosylation at K411 (P = 0.1325); Gain of disorder (P = 0.139)
7:117188723:A:C,P13569,K413T,0.453,Loss of ubiquitination at K413 (P = 0.0056); Loss of methylation at K413 (P = 0.028); Gain of phosphorylation at K413 (P = 0.0758); Loss of disorder (P = 0.1116); Gain of glycosylation at K413 (P = 0.1124)
7:117188723:A:G,P13569,K413R,0.431,Loss of ubiquitination at K413 (P = 0.0056); Loss of methylation at K413 (P = 0.0338); Loss of disorder (P = 0.1511); Loss of catalytic residue at K413 (P = 0.3122); Loss of loop (P = 0.3664)
7:117188723:A:T,P13569,K413I,0.483,Loss of disorder (P = 0.0036); Loss of ubiquitination at K413 (P = 0.0056); Loss of solvent accessibility (P = 0.0187); Loss of methylation at K413 (P = 0.028); Loss of relative solvent accessibility (P = 0.0981)
7:117188724:A:C,P13569,K413N,0.398,Loss of ubiquitination at K413 (P = 0.0056); Loss of methylation at K413 (P = 0.028); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1579); Loss of disorder (P = 0.2213)
7:117188724:A:T,P13569,K413N,0.398,Loss of ubiquitination at K413 (P = 0.0056); Loss of methylation at K413 (P = 0.028); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1579); Loss of disorder (P = 0.2213)
7:117188725:C:A,P13569,Q414K,0.412,Gain of methylation at Q414 (P = 0.0172); Gain of ubiquitination at Q414 (P = 0.0177); Gain of solvent accessibility (P = 0.0328); Gain of relative solvent accessibility (P = 0.0479); Gain of disorder (P = 0.1081)
7:117188725:C:G,P13569,Q414E,0.354,Gain of solvent accessibility (P = 0.0421); Gain of relative solvent accessibility (P = 0.0479); Gain of disorder (P = 0.077); Loss of methylation at K413 (P = 0.0961); Gain of ubiquitination at K411 (P = 0.2106)
7:117188726:A:C,P13569,Q414P,0.341,Gain of glycosylation at Q414 (P = 0.0916); Gain of relative solvent accessibility (P = 0.0999); Gain of catalytic residue at K413 (P = 0.101); Loss of methylation at K413 (P = 0.1295); Gain of disorder (P = 0.1833)
7:117188726:A:G,P13569,Q414R,0.317,Loss of ubiquitination at K411 (P = 0.0539); Gain of methylation at K413 (P = 0.1021); Gain of glycosylation at K411 (P = 0.1265); Gain of solvent accessibility (P = 0.1505); Gain of disorder (P = 0.1929)
7:117188726:A:T,P13569,Q414L,0.348,Loss of methylation at K411 (P = 0.0402); Loss of disorder (P = 0.0756); Loss of ubiquitination at K413 (P = 0.1268); Gain of stability (P = 0.1826); Loss of helix (P = 0.2662)
7:117188727:A:C,P13569,Q414H,0.298,Loss of methylation at K411 (P = 0.0851); Gain of disorder (P = 0.2169); Loss of ubiquitination at K411 (P = 0.2335); Gain of relative solvent accessibility (P = 0.2363); Gain of catalytic residue at K413 (P = 0.2454)
7:117188727:A:T,P13569,Q414H,0.298,Loss of methylation at K411 (P = 0.0851); Gain of disorder (P = 0.2169); Loss of ubiquitination at K411 (P = 0.2335); Gain of relative solvent accessibility (P = 0.2363); Gain of catalytic residue at K413 (P = 0.2454)
7:117188728:A:C,P13569,N415H,0.349,Loss of methylation at K411 (P = 0.1113); Loss of stability (P = 0.1688); Gain of catalytic residue at N416 (P = 0.1713); Loss of ubiquitination at K411 (P = 0.1852); Gain of disorder (P = 0.2543)
7:117188728:A:G,P13569,N415D,0.353,Loss of methylation at K413 (P = 0.0921); Loss of ubiquitination at K411 (P = 0.2335); Loss of stability (P = 0.2533); Loss of disorder (P = 0.2717); Gain of glycosylation at K411 (P = 0.3839)
7:117188728:A:T,P13569,N415Y,0.389,Loss of disorder (P = 0.0444); Loss of methylation at K413 (P = 0.0728); Loss of ubiquitination at K413 (P = 0.1022); Loss of relative solvent accessibility (P = 0.1807); Gain of phosphorylation at N415 (P = 0.1826)
7:117188729:A:C,P13569,N415T,0.341,Loss of methylation at K413 (P = 0.1475); Loss of ubiquitination at K411 (P = 0.1557); Loss of disorder (P = 0.2249); Gain of phosphorylation at N415 (P = 0.2785); Loss of stability (P = 0.3164)
7:117188729:A:G,P13569,N415S,0.382,Loss of solvent accessibility (P = 0.1077); Loss of methylation at K413 (P = 0.1334); Loss of ubiquitination at K411 (P = 0.1557); Gain of phosphorylation at N415 (P = 0.1676); Gain of disorder (P = 0.1722)
7:117188729:A:T,P13569,N415I,0.41,Loss of disorder (P = 0.0244); Loss of methylation at K411 (P = 0.0561); Loss of ubiquitination at K413 (P = 0.071); Loss of solvent accessibility (P = 0.0721); Loss of relative solvent accessibility (P = 0.0981)
7:117188730:C:A,P13569,N415K,0.4,Gain of methylation at N415 (P = 0.0175); Gain of ubiquitination at N415 (P = 0.0185); Gain of disorder (P = 0.197); Gain of solvent accessibility (P = 0.2097); Loss of stability (P = 0.2208)
7:117188730:C:G,P13569,N415K,0.4,Gain of methylation at N415 (P = 0.0175); Gain of ubiquitination at N415 (P = 0.0185); Gain of disorder (P = 0.197); Gain of solvent accessibility (P = 0.2097); Loss of stability (P = 0.2208)
7:117188731:A:C,P13569,N416H,0.284,Loss of methylation at K411 (P = 0.1283); Loss of ubiquitination at K411 (P = 0.1852); Loss of phosphorylation at T421 (P = 0.2129); Loss of stability (P = 0.2186); Gain of catalytic residue at N417 (P = 0.2828)
7:117188731:A:G,P13569,N416D,0.346,Gain of relative solvent accessibility (P = 0.09); Loss of methylation at K413 (P = 0.0965); Gain of solvent accessibility (P = 0.1133); Gain of phosphorylation at T421 (P = 0.1816); Gain of ubiquitination at K411 (P = 0.2244)
7:117188731:A:T,P13569,N416Y,0.315,Loss of methylation at K413 (P = 0.0557); Loss of disorder (P = 0.0606); Gain of ubiquitination at K411 (P = 0.2244); Loss of phosphorylation at T421 (P = 0.2449); Gain of catalytic residue at K420 (P = 0.4266)
7:117188732:A:C,P13569,N416T,0.278,Gain of phosphorylation at N416 (P = 0.0794); Loss of methylation at K413 (P = 0.1166); Loss of ubiquitination at K411 (P = 0.2113); Loss of disorder (P = 0.2723); Loss of stability (P = 0.3524)
7:117188732:A:T,P13569,N416I,0.359,Loss of disorder (P = 0.0361); Loss of ubiquitination at K413 (P = 0.0509); Loss of methylation at K411 (P = 0.109); Loss of phosphorylation at T421 (P = 0.1728); Gain of catalytic residue at R419 (P = 0.3348)
7:117188733:T:A,P13569,N416K,0.448,Gain of solvent accessibility (P = 0.0086); Gain of ubiquitination at N416 (P = 0.0131); Gain of methylation at N416 (P = 0.0199); Gain of relative solvent accessibility (P = 0.0275); Loss of stability (P = 0.1818)
7:117188733:T:G,P13569,N416K,0.448,Gain of solvent accessibility (P = 0.0086); Gain of ubiquitination at N416 (P = 0.0131); Gain of methylation at N416 (P = 0.0199); Gain of relative solvent accessibility (P = 0.0275); Loss of stability (P = 0.1818)
7:117188734:A:C,P13569,N417H,0.286,Loss of stability (P = 0.0947); Loss of methylation at K413 (P = 0.1236); Loss of solvent accessibility (P = 0.1744); Loss of relative solvent accessibility (P = 0.1807); Gain of phosphorylation at T421 (P = 0.2457)
7:117188734:A:G,P13569,N417D,0.319,Gain of phosphorylation at T421 (P = 0.1234); Gain of methylation at K413 (P = 0.132); Loss of stability (P = 0.1926); Gain of ubiquitination at K413 (P = 0.2806); Loss of disorder (P = 0.3768)
7:117188734:A:T,P13569,N417Y,0.365,Loss of disorder (P = 0.075); Loss of relative solvent accessibility (P = 0.0981); Loss of solvent accessibility (P = 0.1235); Loss of methylation at K413 (P = 0.1368); Loss of ubiquitination at K413 (P = 0.1882)
7:117188735:A:C,P13569,N417T,0.334,Gain of phosphorylation at N417 (P = 0.0328); Gain of methylation at K413 (P = 0.089); Loss of solvent accessibility (P = 0.1177); Loss of relative solvent accessibility (P = 0.1807); Loss of stability (P = 0.1963)
7:117188735:A:G,P13569,N417S,0.335,Gain of phosphorylation at N417 (P = 0.0522); Gain of methylation at K413 (P = 0.0748); Loss of stability (P = 0.1069); Loss of ubiquitination at K413 (P = 0.2797); Gain of catalytic residue at R419 (P = 0.2996)
7:117188735:A:T,P13569,N417I,0.412,Gain of catalytic residue at N417 (P = 0.0344); Loss of disorder (P = 0.0474); Loss of solvent accessibility (P = 0.0721); Loss of relative solvent accessibility (P = 0.0981); Loss of ubiquitination at K413 (P = 0.1022)
7:117188736:C:G,P13569,N417K,0.434,Gain of ubiquitination at N417 (P = 0.017); Gain of methylation at N417 (P = 0.0236); Loss of stability (P = 0.0805); Gain of phosphorylation at T421 (P = 0.136); Gain of solvent accessibility (P = 0.2097)
7:117188737:A:C,P13569,N418H,0.331,Loss of stability (P = 0.0633); Loss of methylation at K413 (P = 0.1164); Loss of phosphorylation at S422 (P = 0.1583); Loss of solvent accessibility (P = 0.1744); Loss of relative solvent accessibility (P = 0.1807)
7:117188737:A:G,P13569,N418D,0.388,Loss of stability (P = 0.0717); Gain of phosphorylation at T421 (P = 0.1152); Gain of methylation at K413 (P = 0.1478); Gain of ubiquitination at K413 (P = 0.2806); Loss of disorder (P = 0.4142)
7:117188737:A:T,P13569,N418Y,0.336,Loss of disorder (P = 0.0873); Loss of ubiquitination at K413 (P = 0.1022); Loss of methylation at K413 (P = 0.1238); Loss of stability (P = 0.1375); Loss of relative solvent accessibility (P = 0.1807)
7:117188738:A:C,P13569,N418T,0.385,Loss of stability (P = 0.0565); Gain of glycosylation at N418 (P = 0.091); Loss of solvent accessibility (P = 0.1177); Gain of methylation at K413 (P = 0.1495); Loss of relative solvent accessibility (P = 0.1807)
7:117188738:A:G,P13569,N418S,0.703,Loss of stability (P = 0.0829); Gain of phosphorylation at N418 (P = 0.0939); Gain of methylation at K413 (P = 0.1372); Loss of ubiquitination at K413 (P = 0.2604); Gain of disorder (P = 0.3833)
7:117188738:A:T,P13569,N418I,0.379,Loss of ubiquitination at K413 (P = 0.0553); Loss of disorder (P = 0.0573); Loss of methylation at K413 (P = 0.0776); Loss of solvent accessibility (P = 0.1459); Loss of phosphorylation at T421 (P = 0.1728)
7:117188739:T:A,P13569,N418K,0.421,Gain of methylation at N418 (P = 0.0184); Gain of ubiquitination at N418 (P = 0.0247); Loss of stability (P = 0.0417); Gain of phosphorylation at T421 (P = 0.144); Gain of solvent accessibility (P = 0.2097)
7:117188739:T:G,P13569,N418K,0.421,Gain of methylation at N418 (P = 0.0184); Gain of ubiquitination at N418 (P = 0.0247); Loss of stability (P = 0.0417); Gain of phosphorylation at T421 (P = 0.144); Gain of solvent accessibility (P = 0.2097)
7:117188740:A:G,P13569,R419G,0.31,Loss of stability (P = 0.011); Loss of phosphorylation at S422 (P = 0.0782); Loss of methylation at K420 (P = 0.0827); Loss of solvent accessibility (P = 0.239); Loss of ubiquitination at K420 (P = 0.3515)
7:117188741:G:A,P13569,R419K,0.393,Gain of ubiquitination at R419 (P = 0.0069); Loss of stability (P = 0.0238); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0596); Loss of phosphorylation at S422 (P = 0.0892)
7:117188741:G:C,P13569,R419T,0.336,Loss of stability (P = 0.0497); Loss of phosphorylation at S422 (P = 0.0693); Loss of methylation at K420 (P = 0.086); Loss of solvent accessibility (P = 0.2732); Loss of catalytic residue at R419 (P = 0.3629)
7:117188741:G:T,P13569,R419I,0.315,Loss of phosphorylation at S422 (P = 0.0554); Loss of disorder (P = 0.0929); Loss of methylation at K420 (P = 0.1107); Loss of solvent accessibility (P = 0.1952); Loss of ubiquitination at K420 (P = 0.2344)
7:117188742:A:C,P13569,R419S,0.316,Gain of relative solvent accessibility (P = 0.0479); Loss of stability (P = 0.0591); Loss of methylation at K420 (P = 0.0772); Loss of phosphorylation at S422 (P = 0.0979); Gain of disorder (P = 0.3205)
7:117188742:A:T,P13569,R419S,0.316,Gain of relative solvent accessibility (P = 0.0479); Loss of stability (P = 0.0591); Loss of methylation at K420 (P = 0.0772); Loss of phosphorylation at S422 (P = 0.0979); Gain of disorder (P = 0.3205)
7:117188743:A:C,P13569,K420Q,0.315,Loss of ubiquitination at K420 (P = 0.0027); Loss of methylation at K420 (P = 0.0425); Loss of catalytic residue at K420 (P = 0.1035); Loss of solvent accessibility (P = 0.1434); Loss of phosphorylation at S422 (P = 0.1725)
7:117188744:A:C,P13569,K420T,0.381,Loss of ubiquitination at K420 (P = 0.0027); Loss of solvent accessibility (P = 0.0249); Loss of methylation at K420 (P = 0.0425); Gain of glycosylation at K420 (P = 0.0454); Loss of phosphorylation at T421 (P = 0.1684)
7:117188744:A:G,P13569,K420R,0.299,Loss of ubiquitination at K420 (P = 0.0027); Loss of methylation at K420 (P = 0.0499); Gain of phosphorylation at S422 (P = 0.1081); Loss of solvent accessibility (P = 0.2953); Loss of sheet (P = 0.302)
7:117188744:A:T,P13569,K420I,0.421,Loss of ubiquitination at K420 (P = 0.0027); Loss of solvent accessibility (P = 0.0187); Loss of methylation at K420 (P = 0.0425); Loss of disorder (P = 0.0541); Loss of relative solvent accessibility (P = 0.0981)
7:117188745:A:C,P13569,K420N,0.343,Loss of ubiquitination at K420 (P = 0.0027); Loss of methylation at K420 (P = 0.0425); Loss of loop (P = 0.0603); Loss of catalytic residue at K420 (P = 0.064); Loss of phosphorylation at S422 (P = 0.1426)
7:117188745:A:T,P13569,K420N,0.343,Loss of ubiquitination at K420 (P = 0.0027); Loss of methylation at K420 (P = 0.0425); Loss of loop (P = 0.0603); Loss of catalytic residue at K420 (P = 0.064); Loss of phosphorylation at S422 (P = 0.1426)
7:117188746:A:C,P13569,T421P,0.254,Gain of relative solvent accessibility (P = 0.0479); Loss of phosphorylation at T421 (P = 0.0585); Gain of sheet (P = 0.0827); Gain of solvent accessibility (P = 0.1071); Gain of methylation at K420 (P = 0.1137)
7:117188746:A:G,P13569,T421A,0.195,Loss of phosphorylation at T421 (P = 0.0585); Gain of catalytic residue at T421 (P = 0.1008); Loss of stability (P = 0.2112); Loss of methylation at K420 (P = 0.2236); Loss of disorder (P = 0.2783)
7:117188746:A:T,P13569,T421S,0.196,Gain of phosphorylation at T421 (P = 0.0721); Gain of disorder (P = 0.1275); Loss of methylation at K420 (P = 0.2034); Gain of relative solvent accessibility (P = 0.2363); Loss of sheet (P = 0.302)
7:117188747:C:A,P13569,T421N,0.269,Gain of relative solvent accessibility (P = 0.0479); Loss of phosphorylation at T421 (P = 0.0585); Loss of loop (P = 0.0603); Gain of solvent accessibility (P = 0.0638); Gain of sheet (P = 0.0827)
7:117188747:C:G,P13569,T421S,0.196,Gain of phosphorylation at T421 (P = 0.0721); Gain of disorder (P = 0.1275); Loss of methylation at K420 (P = 0.2034); Gain of relative solvent accessibility (P = 0.2363); Loss of sheet (P = 0.302)
7:117188747:C:T,P13569,T421I,0.322,Gain of sheet (P = 4e-04); Loss of loop (P = 0.0022); Gain of methylation at K420 (P = 0.0539); Loss of phosphorylation at T421 (P = 0.0585); Loss of disorder (P = 0.0651)
7:117188749:T:A,P13569,S422T,0.213,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.0897); Loss of phosphorylation at S422 (P = 0.0961); Loss of methylation at K420 (P = 0.2103); Loss of stability (P = 0.2397)
7:117188749:T:C,P13569,S422P,0.274,Loss of phosphorylation at S422 (P = 0.0354); Gain of sheet (P = 0.0827); Gain of methylation at K420 (P = 0.0909); Loss of stability (P = 0.1136); Loss of disorder (P = 0.1139)
7:117188749:T:G,P13569,S422A,0.274,Loss of phosphorylation at S422 (P = 0.0354); Gain of catalytic residue at S422 (P = 0.0459); Loss of disorder (P = 0.0554); Gain of sheet (P = 0.0827); Loss of stability (P = 0.1361)
7:117188750:C:A,P13569,S422Y,0.286,Loss of disorder (P = 0.0204); Loss of phosphorylation at S422 (P = 0.0427); Loss of methylation at K420 (P = 0.1496); Loss of ubiquitination at K420 (P = 0.2054); Loss of sheet (P = 0.302)
7:117188750:C:G,P13569,S422C,0.318,Loss of disorder (P = 0.0071); Loss of phosphorylation at S422 (P = 0.0354); Gain of methylation at K420 (P = 0.1191); Loss of ubiquitination at K420 (P = 0.1372); Loss of sheet (P = 0.1501)
7:117188752:A:C,P13569,N423H,0.32,Loss of stability (P = 0.0776); Gain of catalytic residue at N423 (P = 0.1482); Gain of disorder (P = 0.2098); Loss of methylation at K420 (P = 0.2155); Loss of phosphorylation at S427 (P = 0.242)
7:117188752:A:G,P13569,N423D,0.332,Gain of phosphorylation at T421 (P = 0.0906); Loss of sheet (P = 0.1158); Loss of methylation at K420 (P = 0.1583); Gain of disorder (P = 0.1722); Loss of stability (P = 0.1876)
7:117188752:A:T,P13569,N423Y,0.411,Gain of sheet (P = 4e-04); Loss of loop (P = 0.0022); Loss of disorder (P = 0.0426); Loss of methylation at K420 (P = 0.1358); Loss of solvent accessibility (P = 0.1362)
7:117188753:A:C,P13569,N423T,0.416,Gain of sheet (P = 0.0016); Loss of loop (P = 0.0022); Gain of phosphorylation at N423 (P = 0.0317); Gain of glycosylation at S422 (P = 0.0626); Gain of catalytic residue at N423 (P = 0.0641)
7:117188753:A:G,P13569,N423S,0.373,Gain of phosphorylation at N423 (P = 0.041); Gain of disorder (P = 0.0641); Loss of sheet (P = 0.1158); Loss of stability (P = 0.1817); Loss of methylation at K420 (P = 0.2035)
7:117188753:A:T,P13569,N423I,0.421,Gain of sheet (P = 4e-04); Loss of loop (P = 0.0022); Loss of disorder (P = 0.0231); Gain of catalytic residue at L428 (P = 0.027); Loss of ubiquitination at K420 (P = 0.0829)
7:117188754:T:A,P13569,N423K,0.417,Gain of ubiquitination at N423 (P = 0.0101); Gain of solvent accessibility (P = 0.039); Gain of catalytic residue at N423 (P = 0.0801); Loss of stability (P = 0.0897); Gain of relative solvent accessibility (P = 0.09)
7:117188754:T:G,P13569,N423K,0.417,Gain of ubiquitination at N423 (P = 0.0101); Gain of solvent accessibility (P = 0.039); Gain of catalytic residue at N423 (P = 0.0801); Loss of stability (P = 0.0897); Gain of relative solvent accessibility (P = 0.09)
7:117188755:G:C,P13569,G424R,0.431,Gain of sheet (P = 4e-04); Loss of loop (P = 0.0022); Loss of ubiquitination at K420 (P = 0.0502); Gain of phosphorylation at S427 (P = 0.074); Gain of solvent accessibility (P = 0.1319)
7:117188755:G:T,P13569,G424C,0.389,Loss of disorder (P = 0.0191); Loss of phosphorylation at S422 (P = 0.142); Loss of stability (P = 0.1529); Gain of methylation at K420 (P = 0.1835); Loss of loop (P = 0.2237)
7:117188756:G:A,P13569,G424D,0.461,Gain of sheet (P = 0.0016); Loss of loop (P = 0.0022); Gain of phosphorylation at T421 (P = 0.0966); Loss of stability (P = 0.1009); Gain of disorder (P = 0.1327)
7:117188756:G:C,P13569,G424A,0.352,Loss of stability (P = 0.0238); Loss of disorder (P = 0.1161); Gain of catalytic residue at G424 (P = 0.1874); Loss of methylation at K420 (P = 0.1977); Loss of loop (P = 0.2237)
7:117188756:G:T,P13569,G424V,0.408,Loss of disorder (P = 0.0392); Gain of sheet (P = 0.0827); Loss of ubiquitination at K420 (P = 0.1072); Gain of methylation at K420 (P = 0.1275); Loss of stability (P = 0.1744)
7:117188758:G:A,P13569,D425N,0.283,Gain of sheet (P = 0.0028); Loss of loop (P = 0.0073); Loss of ubiquitination at K420 (P = 0.0502); Loss of stability (P = 0.0568); Loss of phosphorylation at S422 (P = 0.1478)
7:117188758:G:C,P13569,D425H,0.327,Gain of catalytic residue at D425 (P = 0.0236); Loss of stability (P = 0.04); Loss of ubiquitination at K420 (P = 0.0456); Gain of sheet (P = 0.0827); Loss of phosphorylation at S422 (P = 0.1208)
7:117188758:G:T,P13569,D425Y,0.356,Loss of disorder (P = 0.0126); Loss of ubiquitination at K420 (P = 0.0537); Gain of sheet (P = 0.0827); Loss of stability (P = 0.1092); Gain of methylation at K420 (P = 0.1273)
7:117188759:A:C,P13569,D425A,0.333,Loss of stability (P = 0.0527); Loss of disorder (P = 0.0652); Loss of ubiquitination at K420 (P = 0.071); Gain of catalytic residue at D425 (P = 0.0715); Gain of sheet (P = 0.0827)
7:117188759:A:G,P13569,D425G,0.353,Loss of stability (P = 0.0155); Gain of catalytic residue at D425 (P = 0.0353); Loss of ubiquitination at K420 (P = 0.0829); Loss of sheet (P = 0.1158); Gain of glycosylation at S422 (P = 0.1338)
7:117188759:A:T,P13569,D425V,0.338,Loss of disorder (P = 0.0129); Loss of ubiquitination at K420 (P = 0.0502); Gain of sheet (P = 0.0827); Loss of phosphorylation at S422 (P = 0.1155); Gain of catalytic residue at D425 (P = 0.1742)
7:117188760:T:G,P13569,D425E,0.21,Loss of stability (P = 0.1223); Gain of methylation at K420 (P = 0.1838); Gain of disorder (P = 0.1888); Gain of phosphorylation at S422 (P = 0.2302); Loss of sheet (P = 0.302)
7:117188761:G:A,P13569,D426N,0.274,Gain of sheet (P = 0.0827); Loss of phosphorylation at S422 (P = 0.1997); Loss of disorder (P = 0.2286); Gain of MoRF binding (P = 0.4066); Loss of helix (P = 0.5596)
7:117188761:G:C,P13569,D426H,0.284,Gain of catalytic residue at L428 (P = 0.0586); Loss of disorder (P = 0.1015); Loss of phosphorylation at S422 (P = 0.1411); Gain of sheet (P = 0.1539); Gain of MoRF binding (P = 0.4328)
7:117188761:G:T,P13569,D426Y,0.324,Loss of disorder (P = 0.0113); Loss of phosphorylation at S422 (P = 0.1329); Gain of sheet (P = 0.1539); Gain of MoRF binding (P = 0.424); Gain of catalytic residue at F430 (P = 0.5333)
7:117188762:A:C,P13569,D426A,0.297,Loss of disorder (P = 0.0583); Gain of catalytic residue at D426 (P = 0.1138); Loss of sheet (P = 0.1158); Loss of phosphorylation at S422 (P = 0.1817); Gain of loop (P = 0.2045)
7:117188762:A:G,P13569,D426G,0.257,Gain of catalytic residue at S427 (P = 0.1614); Loss of disorder (P = 0.1933); Loss of phosphorylation at S422 (P = 0.2196); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.4055)
7:117188762:A:T,P13569,D426V,0.336,Loss of disorder (P = 0.0119); Loss of phosphorylation at S422 (P = 0.1402); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3354); Gain of catalytic residue at F430 (P = 0.386)
7:117188763:C:A,P13569,D426E,0.261,Gain of disorder (P = 0.1751); Loss of phosphorylation at T421 (P = 0.2286); Gain of catalytic residue at D426 (P = 0.2732); Loss of sheet (P = 0.302); Loss of helix (P = 0.5596)
7:117188763:C:G,P13569,D426E,0.261,Gain of disorder (P = 0.1751); Loss of phosphorylation at T421 (P = 0.2286); Gain of catalytic residue at D426 (P = 0.2732); Loss of sheet (P = 0.302); Loss of helix (P = 0.5596)
7:117188764:A:C,P13569,S427R,0.47,Loss of disorder (P = 0.0786); Loss of phosphorylation at S427 (P = 0.0827); Gain of sheet (P = 0.1539); Gain of solvent accessibility (P = 0.204); Gain of MoRF binding (P = 0.2315)
7:117188764:A:G,P13569,S427G,0.464,Loss of phosphorylation at S427 (P = 0.0827); Loss of disorder (P = 0.0981); Loss of sheet (P = 0.1158); Loss of stability (P = 0.1569); Gain of loop (P = 0.2045)
7:117188764:A:T,P13569,S427C,0.51,Loss of disorder (P = 8e-04); Gain of catalytic residue at L428 (P = 0.0115); Loss of phosphorylation at S427 (P = 0.0827); Gain of sheet (P = 0.0827); Loss of loop (P = 0.2897)
7:117188765:G:A,P13569,S427N,0.472,Loss of phosphorylation at S427 (P = 0.0827); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1174); Gain of loop (P = 0.2045); Gain of solvent accessibility (P = 0.4821)
7:117188765:G:C,P13569,S427T,0.465,Loss of disorder (P = 0.0621); Gain of sheet (P = 0.0827); Gain of catalytic residue at F430 (P = 0.1292); Loss of phosphorylation at S422 (P = 0.1426); Loss of loop (P = 0.2897)
7:117188765:G:T,P13569,S427I,0.502,Loss of disorder (P = 0.0014); Loss of sheet (P = 0.0126); Gain of loop (P = 0.0195); Loss of phosphorylation at S427 (P = 0.0827); Loss of relative solvent accessibility (P = 0.3219)
7:117188766:C:A,P13569,S427R,0.47,Loss of disorder (P = 0.0786); Loss of phosphorylation at S427 (P = 0.0827); Gain of sheet (P = 0.1539); Gain of solvent accessibility (P = 0.204); Gain of MoRF binding (P = 0.2315)
7:117188766:C:G,P13569,S427R,0.47,Loss of disorder (P = 0.0786); Loss of phosphorylation at S427 (P = 0.0827); Gain of sheet (P = 0.1539); Gain of solvent accessibility (P = 0.204); Gain of MoRF binding (P = 0.2315)
7:117188767:C:G,P13569,L428V,0.271,Loss of stability (P = 0.1305); Gain of sheet (P = 0.1539); Loss of disorder (P = 0.2154); Loss of phosphorylation at S427 (P = 0.2861); Loss of loop (P = 0.2897)
7:117188767:C:T,P13569,L428F,0.338,Loss of sheet (P = 0.0037); Gain of loop (P = 0.0195); Gain of catalytic residue at L428 (P = 0.0817); Loss of stability (P = 0.0822); Gain of relative solvent accessibility (P = 0.2363)
7:117188768:T:A,P13569,L428H,0.457,Loss of stability (P = 0.0068); Gain of disorder (P = 0.0328); Gain of catalytic residue at L428 (P = 0.0461); Gain of sheet (P = 0.1208); Loss of phosphorylation at S427 (P = 0.2976)
7:117188768:T:C,P13569,L428P,0.624,Loss of stability (P = 0.0035); Gain of disorder (P = 0.013); Gain of catalytic residue at L428 (P = 0.1066); Gain of sheet (P = 0.1208); Gain of phosphorylation at S427 (P = 0.1362)
7:117188768:T:G,P13569,L428R,0.55,Loss of stability (P = 0.0106); Gain of disorder (P = 0.0212); Gain of sheet (P = 0.0827); Gain of phosphorylation at S427 (P = 0.0921); Loss of loop (P = 0.1242)
7:117188770:T:A,P13569,F429I,0.521,Loss of catalytic residue at F429 (P = 0.0497); Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1764); Loss of loop (P = 0.2897); Loss of phosphorylation at S427 (P = 0.2976)
7:117188770:T:C,P13569,F429L,0.557,Loss of sheet (P = 7e-04); Gain of loop (P = 0.0111); Gain of disorder (P = 0.1566); Gain of relative solvent accessibility (P = 0.2629); Gain of phosphorylation at S427 (P = 0.2676)
7:117188770:T:G,P13569,F429V,0.542,Gain of sheet (P = 0.1208); Gain of disorder (P = 0.2552); Loss of catalytic residue at F429 (P = 0.2593); Gain of relative solvent accessibility (P = 0.2629); Loss of phosphorylation at S427 (P = 0.2937)
7:117188771:T:A,P13569,F429Y,0.521,Gain of phosphorylation at F429 (P = 0.0684); Gain of sheet (P = 0.1208); Loss of stability (P = 0.2262); Loss of catalytic residue at F429 (P = 0.2344); Gain of disorder (P = 0.2353)
7:117188771:T:C,P13569,F429S,0.589,Loss of sheet (P = 7e-04); Gain of disorder (P = 0.0018); Gain of loop (P = 0.0079); Loss of catalytic residue at F429 (P = 0.0394); Gain of phosphorylation at F429 (P = 0.0501)
7:117188771:T:G,P13569,F429C,0.527,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1481); Loss of phosphorylation at S427 (P = 0.251); Loss of stability (P = 0.2612); Loss of catalytic residue at F429 (P = 0.3136)
7:117188772:C:A,P13569,F429L,0.557,Loss of sheet (P = 7e-04); Gain of loop (P = 0.0111); Gain of disorder (P = 0.1566); Gain of relative solvent accessibility (P = 0.2629); Gain of phosphorylation at S427 (P = 0.2676)
7:117188772:C:G,P13569,F429L,0.557,Loss of sheet (P = 7e-04); Gain of loop (P = 0.0111); Gain of disorder (P = 0.1566); Gain of relative solvent accessibility (P = 0.2629); Gain of phosphorylation at S427 (P = 0.2676)
7:117188773:T:A,P13569,F430I,0.384,Gain of catalytic residue at L435 (P = 0.0252); Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1697); Loss of phosphorylation at S427 (P = 0.3008); Loss of helix (P = 0.6555)
7:117188773:T:C,P13569,F430L,0.397,Loss of sheet (P = 7e-04); Gain of loop (P = 0.0079); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Gain of disorder (P = 0.1626)
7:117188773:T:G,P13569,F430V,0.353,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1683); Loss of disorder (P = 0.2549); Loss of sheet (P = 0.302); Gain of phosphorylation at S427 (P = 0.307)
7:117188774:T:A,P13569,F430Y,0.376,Gain of solvent accessibility (P = 0.0739); Gain of relative solvent accessibility (P = 0.09); Loss of sheet (P = 0.1158); Gain of phosphorylation at F430 (P = 0.1802); Gain of catalytic residue at F430 (P = 0.1965)
7:117188774:T:C,P13569,F430S,0.552,Loss of sheet (P = 7e-04); Gain of disorder (P = 0.0016); Gain of loop (P = 0.0195); Loss of stability (P = 0.073); Gain of relative solvent accessibility (P = 0.09)
7:117188774:T:G,P13569,F430C,0.395,Gain of relative solvent accessibility (P = 0.09); Gain of catalytic residue at S434 (P = 0.114); Loss of stability (P = 0.1393); Loss of sheet (P = 0.1501); Loss of disorder (P = 0.1516)
7:117188775:C:A,P13569,F430L,0.397,Loss of sheet (P = 7e-04); Gain of loop (P = 0.0079); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Gain of disorder (P = 0.1626)
7:117188775:C:G,P13569,F430L,0.397,Loss of sheet (P = 7e-04); Gain of loop (P = 0.0079); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Gain of disorder (P = 0.1626)
7:117188776:A:C,P13569,S431R,0.637,Loss of disorder (P = 0.1005); Loss of catalytic residue at S431 (P = 0.1044); Gain of sheet (P = 0.1208); Loss of stability (P = 0.1536); Gain of phosphorylation at S434 (P = 0.1664)
7:117188776:A:G,P13569,S431G,0.607,Loss of stability (P = 0.0036); Gain of loop (P = 0.0312); Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1107); Loss of catalytic residue at S431 (P = 0.1971)
7:117188776:A:T,P13569,S431C,0.645,Loss of disorder (P = 0.0107); Gain of sheet (P = 0.1208); Loss of catalytic residue at S431 (P = 0.1506); Loss of stability (P = 0.1676); Loss of phosphorylation at S427 (P = 0.1724)
7:117188777:G:A,P13569,S431N,0.6,Loss of disorder (P = 0.1158); Loss of stability (P = 0.1536); Loss of phosphorylation at S427 (P = 0.2163); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302)
7:117188777:G:C,P13569,S431T,0.596,Loss of disorder (P = 0.0848); Loss of catalytic residue at S431 (P = 0.0867); Loss of stability (P = 0.1077); Gain of sheet (P = 0.1539); Loss of phosphorylation at S427 (P = 0.2012)
7:117188777:G:T,P13569,S431I,0.583,Loss of catalytic residue at S431 (P = 0.0015); Loss of disorder (P = 0.0113); Gain of sheet (P = 0.0827); Loss of phosphorylation at S427 (P = 0.1806); Gain of loop (P = 0.2754)
7:117188778:T:A,P13569,S431R,0.637,Loss of disorder (P = 0.1005); Loss of catalytic residue at S431 (P = 0.1044); Gain of sheet (P = 0.1208); Loss of stability (P = 0.1536); Gain of phosphorylation at S434 (P = 0.1664)
7:117188778:T:G,P13569,S431R,0.637,Loss of disorder (P = 0.1005); Loss of catalytic residue at S431 (P = 0.1044); Gain of sheet (P = 0.1208); Loss of stability (P = 0.1536); Gain of phosphorylation at S434 (P = 0.1664)
7:117188779:A:C,P13569,N432H,0.454,Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1927); Loss of stability (P = 0.2637); Gain of phosphorylation at S427 (P = 0.302); Gain of loop (P = 0.3485)
7:117188779:A:G,P13569,N432D,0.469,Loss of sheet (P = 0.0025); Gain of relative solvent accessibility (P = 0.0082); Gain of solvent accessibility (P = 0.0104); Gain of loop (P = 0.024); Gain of phosphorylation at S427 (P = 0.1084)
7:117188779:A:T,P13569,N432Y,0.52,Loss of sheet (P = 0.007); Gain of loop (P = 0.0312); Loss of disorder (P = 0.059); Gain of catalytic residue at N432 (P = 0.1832); Gain of phosphorylation at S427 (P = 0.282)
7:117188780:A:C,P13569,N432T,0.424,Loss of disorder (P = 0.2301); Gain of phosphorylation at S427 (P = 0.2481); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of catalytic residue at S434 (P = 0.325)
7:117188780:A:G,P13569,N432S,0.369,Loss of sheet (P = 0.0011); Gain of loop (P = 0.0111); Gain of relative solvent accessibility (P = 0.0215); Gain of solvent accessibility (P = 0.0611); Gain of disorder (P = 0.0645)
7:117188780:A:T,P13569,N432I,0.546,Loss of disorder (P = 0.042); Loss of sheet (P = 0.1398); Gain of catalytic residue at S434 (P = 0.1937); Gain of helix (P = 0.2684); Loss of phosphorylation at S427 (P = 0.2827)
7:117188781:T:A,P13569,N432K,0.606,Gain of methylation at N432 (P = 0.0111); Gain of ubiquitination at N432 (P = 0.0131); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at S431 (P = 0.1446)
7:117188781:T:G,P13569,N432K,0.606,Gain of methylation at N432 (P = 0.0111); Gain of ubiquitination at N432 (P = 0.0131); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at S431 (P = 0.1446)
7:117188782:T:A,P13569,F433I,0.516,Gain of sheet (P = 0.0221); Loss of catalytic residue at F433 (P = 0.0672); Loss of loop (P = 0.0986); Loss of disorder (P = 0.1665); Loss of phosphorylation at T438 (P = 0.2934)
7:117188782:T:C,P13569,F433L,0.518,Loss of sheet (P = 0.0025); Gain of loop (P = 0.024); Loss of catalytic residue at F433 (P = 0.0792); Gain of disorder (P = 0.1889); Gain of phosphorylation at T438 (P = 0.1999)
7:117188782:T:G,P13569,F433V,0.49,Gain of sheet (P = 0.0221); Loss of loop (P = 0.0512); Loss of catalytic residue at F433 (P = 0.2039); Gain of helix (P = 0.2059); Loss of disorder (P = 0.234)
7:117188783:T:A,P13569,F433Y,0.461,Gain of catalytic residue at L428 (P = 0.0645); Gain of sheet (P = 0.0827); Gain of phosphorylation at T438 (P = 0.2078); Loss of disorder (P = 0.237); Gain of relative solvent accessibility (P = 0.2629)
7:117188783:T:C,P13569,F433S,0.617,Loss of sheet (P = 0.0037); Gain of disorder (P = 0.0039); Gain of loop (P = 0.024); Gain of relative solvent accessibility (P = 0.0249); Loss of stability (P = 0.0915)
7:117188783:T:G,P13569,F433C,0.489,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1743); Loss of stability (P = 0.2301); Gain of relative solvent accessibility (P = 0.2629); Gain of phosphorylation at T438 (P = 0.2836)
7:117188784:C:A,P13569,F433L,0.518,Loss of sheet (P = 0.0025); Gain of loop (P = 0.024); Loss of catalytic residue at F433 (P = 0.0792); Gain of disorder (P = 0.1889); Gain of phosphorylation at T438 (P = 0.1999)
7:117188784:C:G,P13569,F433L,0.518,Loss of sheet (P = 0.0025); Gain of loop (P = 0.024); Loss of catalytic residue at F433 (P = 0.0792); Gain of disorder (P = 0.1889); Gain of phosphorylation at T438 (P = 0.1999)
7:117188785:T:A,P13569,S434T,0.287,Loss of sheet (P = 0.1158); Loss of stability (P = 0.1463); Loss of disorder (P = 0.1464); Loss of phosphorylation at T438 (P = 0.2564); Loss of helix (P = 0.5596)
7:117188785:T:C,P13569,S434P,0.464,Gain of loop (P = 0.0312); Loss of stability (P = 0.0672); Gain of sheet (P = 0.0827); Gain of relative solvent accessibility (P = 0.0999); Gain of catalytic residue at N432 (P = 0.1388)
7:117188785:T:G,P13569,S434A,0.329,Gain of catalytic residue at S434 (P = 0.0792); Loss of disorder (P = 0.0994); Loss of stability (P = 0.1137); Loss of phosphorylation at T438 (P = 0.2288); Loss of loop (P = 0.2897)
7:117188786:C:T,P13569,S434L,0.433,Loss of sheet (P = 0.0054); Gain of loop (P = 0.0435); Loss of disorder (P = 0.0742); Loss of phosphorylation at T438 (P = 0.2162); Gain of helix (P = 0.2684)
7:117188788:C:A,P13569,L435I,0.307,Gain of catalytic residue at L435 (P = 0.0715); Loss of sheet (P = 0.1158); Gain of phosphorylation at T438 (P = 0.141); Loss of stability (P = 0.2001); Gain of loop (P = 0.2754)
7:117188788:C:G,P13569,L435V,0.292,Loss of stability (P = 0.1096); Gain of phosphorylation at T438 (P = 0.1132); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3524)
7:117188788:C:T,P13569,L435F,0.406,Gain of solvent accessibility (P = 0.0018); Gain of relative solvent accessibility (P = 0.005); Gain of catalytic residue at L435 (P = 0.0203); Gain of loop (P = 0.0851); Gain of phosphorylation at T438 (P = 0.0921)
7:117188789:T:A,P13569,L435H,0.392,Loss of stability (P = 0.017); Gain of disorder (P = 0.0739); Gain of phosphorylation at T438 (P = 0.0962); Gain of catalytic residue at L435 (P = 0.128); Loss of sheet (P = 0.302)
7:117188789:T:C,P13569,L435P,0.526,Loss of stability (P = 0.0047); Gain of relative solvent accessibility (P = 0.0166); Gain of loop (P = 0.0312); Gain of disorder (P = 0.036); Gain of solvent accessibility (P = 0.0471)
7:117188789:T:G,P13569,L435R,0.499,Gain of solvent accessibility (P = 0.0018); Gain of relative solvent accessibility (P = 0.0166); Gain of catalytic residue at L435 (P = 0.019); Loss of stability (P = 0.0209); Gain of loop (P = 0.0312)
7:117188791:C:A,P13569,L436I,0.292,Gain of catalytic residue at L441 (P = 0.0373); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Loss of phosphorylation at T438 (P = 0.3159); Loss of disorder (P = 0.3449)
7:117188791:C:G,P13569,L436V,0.26,Loss of sheet (P = 0.1158); Gain of phosphorylation at T438 (P = 0.2477); Loss of loop (P = 0.2897); Loss of stability (P = 0.3099); Loss of disorder (P = 0.3956)
7:117188791:C:T,P13569,L436F,0.365,Gain of solvent accessibility (P = 0.0137); Gain of relative solvent accessibility (P = 0.0275); Gain of loop (P = 0.069); Gain of sheet (P = 0.0827); Gain of phosphorylation at T438 (P = 0.1739)
7:117188792:T:A,P13569,L436H,0.351,Loss of stability (P = 0.0272); Gain of catalytic residue at G437 (P = 0.0463); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1421); Gain of relative solvent accessibility (P = 0.1894)
7:117188792:T:C,P13569,L436P,0.441,Loss of stability (P = 0.025); Gain of disorder (P = 0.0426); Gain of phosphorylation at T438 (P = 0.0772); Gain of sheet (P = 0.1208); Gain of relative solvent accessibility (P = 0.1894)
7:117188792:T:G,P13569,L436R,0.416,Gain of methylation at L436 (P = 0.0404); Gain of solvent accessibility (P = 0.0648); Gain of disorder (P = 0.0702); Loss of stability (P = 0.0707); Gain of phosphorylation at T438 (P = 0.071)
7:117188794:G:A,P13569,G437S,0.455,Gain of loop (P = 0.0312); Gain of methylation at K442 (P = 0.1008); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1283); Gain of catalytic residue at G437 (P = 0.2021)
7:117188794:G:C,P13569,G437R,0.543,Gain of solvent accessibility (P = 0.0674); Gain of methylation at K442 (P = 0.1197); Gain of phosphorylation at T438 (P = 0.1204); Gain of sheet (P = 0.1208); Loss of ubiquitination at K442 (P = 0.2014)
7:117188794:G:T,P13569,G437C,0.527,Gain of catalytic residue at G437 (P = 0.1179); Loss of loop (P = 0.1242); Gain of ubiquitination at K442 (P = 0.1827); Gain of sheet (P = 0.1945); Loss of methylation at K442 (P = 0.2299)
7:117188795:G:A,P13569,G437D,0.792,Gain of solvent accessibility (P = 0.039); Gain of sheet (P = 0.0827); Gain of relative solvent accessibility (P = 0.09); Gain of methylation at K442 (P = 0.1142); Gain of phosphorylation at T438 (P = 0.1277)
7:117188795:G:C,P13569,G437A,0.452,Gain of catalytic residue at G437 (P = 0.0992); Gain of sheet (P = 0.1208); Loss of methylation at K442 (P = 0.1711); Loss of stability (P = 0.2584); Gain of ubiquitination at K442 (P = 0.2584)
7:117188795:G:T,P13569,G437V,0.534,Gain of sheet (P = 0.0827); Loss of loop (P = 0.1242); Gain of ubiquitination at K442 (P = 0.1536); Loss of methylation at K442 (P = 0.2126); Loss of catalytic residue at F433 (P = 0.2163)
7:117188797:A:C,P13569,T438P,0.485,Gain of sheet (P = 0.0344); Loss of phosphorylation at T438 (P = 0.0855); Gain of catalytic residue at G437 (P = 0.2064); Gain of methylation at K442 (P = 0.2213); Loss of ubiquitination at K442 (P = 0.2413)
7:117188797:A:T,P13569,T438S,0.496,Gain of loop (P = 0.0312); Loss of sheet (P = 0.0457); Gain of disorder (P = 0.1151); Gain of methylation at K442 (P = 0.1985); Gain of phosphorylation at S434 (P = 0.2655)
7:117188798:C:A,P13569,T438N,0.444,Loss of phosphorylation at T438 (P = 0.0855); Loss of sheet (P = 0.1158); Gain of ubiquitination at K442 (P = 0.1827); Gain of methylation at K442 (P = 0.2292); Gain of loop (P = 0.2754)
7:117188798:C:G,P13569,T438S,0.496,Gain of loop (P = 0.0312); Loss of sheet (P = 0.0457); Gain of disorder (P = 0.1151); Gain of methylation at K442 (P = 0.1985); Gain of phosphorylation at S434 (P = 0.2655)
7:117188798:C:T,P13569,T438I,0.494,Loss of phosphorylation at T438 (P = 0.0855); Gain of sheet (P = 0.1945); Loss of methylation at K442 (P = 0.2116); Gain of ubiquitination at K442 (P = 0.2584); Gain of catalytic residue at T438 (P = 0.3268)
7:117188800:C:A,P13569,P439T,0.661,Gain of catalytic residue at P439 (P = 0.113); Loss of phosphorylation at T438 (P = 0.1165); Loss of methylation at K442 (P = 0.1719); Loss of stability (P = 0.206); Gain of ubiquitination at K442 (P = 0.2382)
7:117188800:C:G,P13569,P439A,0.65,Gain of catalytic residue at P439 (P = 0.0435); Gain of sheet (P = 0.0827); Loss of phosphorylation at T438 (P = 0.1448); Loss of methylation at K442 (P = 0.1465); Gain of loop (P = 0.2045)
7:117188800:C:T,P13569,P439S,0.807,Gain of sheet (P = 0.0827); Gain of catalytic residue at K442 (P = 0.1043); Gain of phosphorylation at P439 (P = 0.1459); Gain of ubiquitination at K442 (P = 0.1536); Loss of methylation at K442 (P = 0.1725)
7:117188801:C:A,P13569,P439H,0.628,Gain of sheet (P = 0.0827); Gain of catalytic residue at L441 (P = 0.1143); Loss of phosphorylation at T438 (P = 0.1384); Loss of methylation at K442 (P = 0.1768); Gain of loop (P = 0.2045)
7:117188801:C:G,P13569,P439R,0.641,Gain of MoRF binding (P = 0.0079); Gain of sheet (P = 0.0827); Gain of catalytic residue at P439 (P = 0.12); Loss of ubiquitination at K442 (P = 0.1264); Loss of methylation at K442 (P = 0.1792)
7:117188801:C:T,P13569,P439L,0.629,Gain of ubiquitination at K442 (P = 0.0747); Gain of sheet (P = 0.0827); Gain of loop (P = 0.0851); Loss of phosphorylation at T438 (P = 0.1217); Loss of methylation at K442 (P = 0.1433)
7:117188803:G:A,P13569,V440I,0.666,Gain of sheet (P = 0.0827); Gain of methylation at K442 (P = 0.126); Gain of ubiquitination at K442 (P = 0.2122); Loss of phosphorylation at T438 (P = 0.2814); Gain of loop (P = 0.3485)
7:117188803:G:C,P13569,V440L,0.699,Gain of ubiquitination at K442 (P = 0.1536); Loss of methylation at K442 (P = 0.1592); Loss of phosphorylation at T438 (P = 0.2423); Gain of catalytic residue at V440 (P = 0.2495); Gain of disorder (P = 0.2646)
7:117188803:G:T,P13569,V440F,0.674,Gain of ubiquitination at K442 (P = 0.1827); Gain of methylation at K442 (P = 0.2117); Gain of phosphorylation at T438 (P = 0.2167); Loss of sheet (P = 0.302); Gain of disorder (P = 0.3355)
7:117188804:T:A,P13569,V440D,0.768,Gain of disorder (P = 0.0299); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Gain of phosphorylation at T438 (P = 0.0793); Gain of sheet (P = 0.0827)
7:117188804:T:C,P13569,V440A,0.706,Gain of sheet (P = 0.0827); Gain of ubiquitination at K442 (P = 0.1536); Loss of methylation at K442 (P = 0.1632); Gain of disorder (P = 0.1639); Gain of phosphorylation at T438 (P = 0.2067)
7:117188804:T:G,P13569,V440G,0.773,Loss of stability (P = 0.0237); Gain of disorder (P = 0.0441); Gain of sheet (P = 0.0827); Gain of catalytic residue at L441 (P = 0.1085); Gain of ubiquitination at K442 (P = 0.1536)
7:117188806:C:A,P13569,L441M,0.849,Gain of catalytic residue at L441 (P = 0.0668); Loss of methylation at K442 (P = 0.0718); Gain of sheet (P = 0.1451); Gain of ubiquitination at K442 (P = 0.1536); Gain of phosphorylation at T438 (P = 0.286)
7:117188806:C:G,P13569,L441V,0.836,Gain of methylation at K442 (P = 0.036); Loss of sheet (P = 0.0817); Loss of stability (P = 0.132); Gain of phosphorylation at T438 (P = 0.2477); Gain of ubiquitination at K442 (P = 0.2584)
7:117188807:T:A,P13569,L441Q,0.896,Gain of ubiquitination at K442 (P = 0.0682); Loss of stability (P = 0.0721); Loss of sheet (P = 0.0817); Gain of methylation at K442 (P = 0.0833); Gain of disorder (P = 0.179)
7:117188807:T:C,P13569,L441P,0.942,Loss of stability (P = 0.0282); Gain of methylation at K442 (P = 0.0608); Loss of sheet (P = 0.0817); Gain of glycosylation at T438 (P = 0.086); Gain of phosphorylation at T438 (P = 0.096)
7:117188807:T:G,P13569,L441R,0.911,Gain of methylation at L441 (P = 0.0559); Loss of stability (P = 0.0599); Gain of phosphorylation at T438 (P = 0.0806); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.0936)
7:117188809:A:C,P13569,K442Q,0.499,Loss of methylation at K442 (P = 0.0444); Loss of ubiquitination at K442 (P = 0.0496); Loss of sheet (P = 0.0817); Loss of phosphorylation at T438 (P = 0.2589); Gain of loop (P = 0.2754)
7:117188809:A:G,P13569,K442E,0.51,Loss of methylation at K442 (P = 0.0444); Loss of ubiquitination at K442 (P = 0.0496); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2754); Loss of phosphorylation at T438 (P = 0.3131)
7:117188810:A:C,P13569,K442T,0.501,Loss of methylation at K442 (P = 0.0444); Loss of ubiquitination at K442 (P = 0.0496); Loss of sheet (P = 0.0817); Loss of stability (P = 0.1031); Gain of phosphorylation at T438 (P = 0.1124)
7:117188810:A:G,P13569,K442R,0.432,Loss of ubiquitination at K442 (P = 0.0496); Loss of methylation at K442 (P = 0.0577); Gain of sheet (P = 0.0827); Gain of phosphorylation at T438 (P = 0.2517); Gain of loop (P = 0.2754)
7:117188810:A:T,P13569,K442I,0.584,Loss of methylation at K442 (P = 0.0444); Loss of ubiquitination at K442 (P = 0.0496); Gain of sheet (P = 0.0827); Loss of phosphorylation at T438 (P = 0.1855); Gain of catalytic residue at L441 (P = 0.2149)
7:117188811:A:C,P13569,K442N,0.525,Loss of methylation at K442 (P = 0.0444); Loss of ubiquitination at K442 (P = 0.0496); Loss of sheet (P = 0.0817); Loss of phosphorylation at T438 (P = 0.2649); Gain of loop (P = 0.2754)
7:117188811:A:T,P13569,K442N,0.525,Loss of methylation at K442 (P = 0.0444); Loss of ubiquitination at K442 (P = 0.0496); Loss of sheet (P = 0.0817); Loss of phosphorylation at T438 (P = 0.2649); Gain of loop (P = 0.2754)
7:117188812:G:A,P13569,D443N,0.657,Gain of methylation at K442 (P = 0.0728); Gain of sheet (P = 0.0827); Loss of ubiquitination at K442 (P = 0.1624); Gain of MoRF binding (P = 0.2296); Loss of phosphorylation at T438 (P = 0.2731)
7:117188812:G:C,P13569,D443H,0.749,Gain of methylation at K442 (P = 0.0505); Gain of sheet (P = 0.0827); Loss of ubiquitination at K442 (P = 0.2014); Loss of stability (P = 0.2092); Loss of phosphorylation at T438 (P = 0.2668)
7:117188813:A:C,P13569,D443A,0.744,Gain of methylation at K442 (P = 0.0746); Gain of sheet (P = 0.0827); Loss of ubiquitination at K442 (P = 0.1465); Loss of stability (P = 0.1661); Gain of phosphorylation at T438 (P = 0.2034)
7:117188813:A:G,P13569,D443G,0.701,Gain of methylation at K442 (P = 0.0671); Gain of catalytic residue at P439 (P = 0.0696); Loss of stability (P = 0.1104); Loss of ubiquitination at K442 (P = 0.1465); Gain of MoRF binding (P = 0.2723)
7:117188813:A:T,P13569,D443V,0.792,Gain of methylation at K442 (P = 0.0264); Gain of sheet (P = 0.0827); Loss of ubiquitination at K442 (P = 0.2413); Gain of MoRF binding (P = 0.2419); Loss of phosphorylation at T438 (P = 0.2776)
7:117188814:T:A,P13569,D443E,0.654,Loss of sheet (P = 0.0817); Gain of methylation at K442 (P = 0.1187); Gain of ubiquitination at K442 (P = 0.2584); Loss of phosphorylation at T438 (P = 0.3111); Loss of catalytic residue at K447 (P = 0.4055)
7:117188815:A:C,P13569,I444L,0.76,Loss of methylation at K447 (P = 0.0798); Gain of sheet (P = 0.1451); Gain of ubiquitination at K442 (P = 0.1536); Gain of disorder (P = 0.3964); Loss of catalytic residue at K447 (P = 0.4225)
7:117188815:A:G,P13569,I444V,0.774,Loss of sheet (P = 0.0817); Loss of catalytic residue at I444 (P = 0.0944); Loss of stability (P = 0.1682); Loss of methylation at K447 (P = 0.1732); Gain of ubiquitination at K442 (P = 0.2122)
7:117188815:A:T,P13569,I444F,0.79,Loss of sheet (P = 0.1158); Loss of methylation at K447 (P = 0.1171); Loss of catalytic residue at I444 (P = 0.1303); Gain of ubiquitination at K442 (P = 0.1827); Loss of stability (P = 0.1998)
7:117188816:T:A,P13569,I444N,0.868,Loss of stability (P = 0.0481); Gain of ubiquitination at K442 (P = 0.0566); Gain of disorder (P = 0.0575); Loss of sheet (P = 0.0817); Gain of methylation at K447 (P = 0.1054)
7:117188816:T:C,P13569,I444T,0.876,Loss of stability (P = 0.0063); Gain of ubiquitination at K442 (P = 0.0682); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.1278); Gain of methylation at K447 (P = 0.1677)
7:117188816:T:G,P13569,I444S,0.931,Loss of stability (P = 0.0117); Gain of disorder (P = 0.0188); Gain of ubiquitination at K442 (P = 0.0566); Loss of sheet (P = 0.0817); Loss of catalytic residue at I444 (P = 0.0904)
7:117188817:T:G,P13569,I444M,0.762,Gain of catalytic residue at V440 (P = 0.0685); Loss of sheet (P = 0.0817); Gain of methylation at K447 (P = 0.1729); Gain of ubiquitination at K442 (P = 0.1827); Gain of loop (P = 0.2754)
7:117188818:A:C,P13569,N445H,0.633,Loss of stability (P = 0.0131); Gain of sheet (P = 0.0827); Gain of methylation at K442 (P = 0.1483); Gain of ubiquitination at K442 (P = 0.2122); Loss of solvent accessibility (P = 0.2668)
7:117188818:A:G,P13569,N445D,0.549,Loss of stability (P = 0.0366); Loss of methylation at K447 (P = 0.0688); Gain of sheet (P = 0.0827); Gain of ubiquitination at K442 (P = 0.1536); Gain of relative solvent accessibility (P = 0.2363)
7:117188818:A:T,P13569,N445Y,0.649,Loss of stability (P = 0.0439); Loss of methylation at K447 (P = 0.073); Gain of sheet (P = 0.0827); Gain of phosphorylation at N445 (P = 0.138); Gain of ubiquitination at K442 (P = 0.1536)
7:117188819:A:C,P13569,N445T,0.625,Loss of stability (P = 0.0128); Gain of sheet (P = 0.0827); Gain of methylation at K442 (P = 0.1652); Gain of ubiquitination at K442 (P = 0.2382); Loss of solvent accessibility (P = 0.2668)
7:117188819:A:G,P13569,N445S,0.534,Loss of stability (P = 0.024); Gain of sheet (P = 0.0827); Gain of ubiquitination at K442 (P = 0.1278); Loss of methylation at K447 (P = 0.1325); Gain of catalytic residue at L441 (P = 0.1381)
7:117188819:A:T,P13569,N445I,0.621,Gain of methylation at K442 (P = 0.0449); Loss of sheet (P = 0.1158); Gain of ubiquitination at K442 (P = 0.1278); Loss of stability (P = 0.1512); Loss of solvent accessibility (P = 0.2668)
7:117188820:T:A,P13569,N445K,0.57,Loss of stability (P = 0.0188); Gain of methylation at N445 (P = 0.0379); Gain of sheet (P = 0.0827); Gain of catalytic residue at N445 (P = 0.1431); Gain of ubiquitination at N445 (P = 0.1767)
7:117188820:T:G,P13569,N445K,0.57,Loss of stability (P = 0.0188); Gain of methylation at N445 (P = 0.0379); Gain of sheet (P = 0.0827); Gain of catalytic residue at N445 (P = 0.1431); Gain of ubiquitination at N445 (P = 0.1767)
7:117188821:T:A,P13569,F446I,0.558,Loss of methylation at K447 (P = 0.0408); Gain of sheet (P = 0.0827); Loss of stability (P = 0.144); Loss of ubiquitination at K442 (P = 0.2744); Gain of catalytic residue at L441 (P = 0.3834)
7:117188821:T:C,P13569,F446L,0.599,Loss of methylation at K447 (P = 0.0289); Gain of sheet (P = 0.1451); Loss of stability (P = 0.167); Gain of ubiquitination at K442 (P = 0.2584); Gain of MoRF binding (P = 0.422)
7:117188821:T:G,P13569,F446V,0.612,Loss of stability (P = 0.0403); Loss of methylation at K447 (P = 0.0926); Gain of sheet (P = 0.1451); Gain of ubiquitination at K447 (P = 0.2629); Loss of catalytic residue at F446 (P = 0.3364)
7:117188822:T:A,P13569,F446Y,0.616,Loss of methylation at K447 (P = 0.0268); Gain of catalytic residue at L441 (P = 0.0585); Loss of stability (P = 0.0591); Gain of sheet (P = 0.1451); Gain of phosphorylation at F446 (P = 0.2059)
7:117188822:T:C,P13569,F446S,0.809,Gain of disorder (P = 0.0196); Loss of stability (P = 0.0264); Loss of methylation at K447 (P = 0.0329); Loss of sheet (P = 0.1158); Gain of ubiquitination at K442 (P = 0.2584)
7:117188822:T:G,P13569,F446C,0.65,Loss of stability (P = 0.0482); Gain of methylation at K447 (P = 0.049); Loss of sheet (P = 0.1158); Loss of ubiquitination at K442 (P = 0.2744); Gain of loop (P = 0.2754)
7:117188823:C:A,P13569,F446L,0.599,Loss of methylation at K447 (P = 0.0289); Gain of sheet (P = 0.1451); Loss of stability (P = 0.167); Gain of ubiquitination at K442 (P = 0.2584); Gain of MoRF binding (P = 0.422)
7:117188823:C:G,P13569,F446L,0.599,Loss of methylation at K447 (P = 0.0289); Gain of sheet (P = 0.1451); Loss of stability (P = 0.167); Gain of ubiquitination at K442 (P = 0.2584); Gain of MoRF binding (P = 0.422)
7:117188824:A:C,P13569,K447Q,0.505,Loss of methylation at K447 (P = 0.0121); Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.0916); Loss of ubiquitination at K447 (P = 0.0982); Loss of MoRF binding (P = 0.3853)
7:117188824:A:G,P13569,K447E,0.493,Loss of methylation at K447 (P = 0.0121); Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.0947); Loss of ubiquitination at K447 (P = 0.0982); Loss of MoRF binding (P = 0.3406)
7:117188825:A:C,P13569,K447T,0.541,Loss of methylation at K447 (P = 0.0121); Loss of ubiquitination at K447 (P = 0.0982); Gain of sheet (P = 0.1451); Loss of catalytic residue at Q452 (P = 0.1818); Loss of MoRF binding (P = 0.3836)
7:117188825:A:G,P13569,K447R,0.462,Loss of methylation at K447 (P = 0.0159); Loss of catalytic residue at Q452 (P = 0.0727); Loss of ubiquitination at K447 (P = 0.0982); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.3535)
7:117188825:A:T,P13569,K447M,0.539,Loss of methylation at K447 (P = 0.0121); Loss of ubiquitination at K447 (P = 0.0982); Gain of sheet (P = 0.1451); Loss of catalytic residue at Q452 (P = 0.2037); Gain of loop (P = 0.2754)
7:117188826:G:C,P13569,K447N,0.506,Loss of methylation at K447 (P = 0.0121); Loss of ubiquitination at K447 (P = 0.0982); Loss of catalytic residue at Q452 (P = 0.1291); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.3833)
7:117188826:G:T,P13569,K447N,0.506,Loss of methylation at K447 (P = 0.0121); Loss of ubiquitination at K447 (P = 0.0982); Loss of catalytic residue at Q452 (P = 0.1291); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.3833)
7:117188827:A:C,P13569,I448L,0.744,Loss of methylation at K447 (P = 0.0584); Loss of sheet (P = 0.0817); Loss of catalytic residue at L453 (P = 0.0883); Gain of loop (P = 0.2045); Gain of ubiquitination at K447 (P = 0.2835)
7:117188827:A:G,P13569,I448V,0.722,Loss of sheet (P = 0.0817); Loss of catalytic residue at L453 (P = 0.0881); Gain of methylation at K447 (P = 0.0928); Gain of loop (P = 0.2045); Gain of ubiquitination at K447 (P = 0.2629)
7:117188827:A:T,P13569,I448L,0.744,Loss of methylation at K447 (P = 0.0584); Loss of sheet (P = 0.0817); Loss of catalytic residue at L453 (P = 0.0883); Gain of loop (P = 0.2045); Gain of ubiquitination at K447 (P = 0.2835)
7:117188828:T:A,P13569,I448K,0.876,Gain of disorder (P = 0.0218); Gain of ubiquitination at I448 (P = 0.0311); Loss of stability (P = 0.0517); Loss of catalytic residue at Q452 (P = 0.0861); Loss of methylation at K447 (P = 0.1109)
7:117188828:T:C,P13569,I448T,0.837,Loss of stability (P = 0.0238); Gain of ubiquitination at K447 (P = 0.0851); Loss of catalytic residue at L453 (P = 0.0945); Gain of phosphorylation at I448 (P = 0.1039); Loss of methylation at K447 (P = 0.1179)
7:117188828:T:G,P13569,I448R,0.879,Loss of catalytic residue at Q452 (P = 0.0759); Loss of stability (P = 0.092); Gain of disorder (P = 0.0922); Loss of methylation at K447 (P = 0.0978); Gain of sheet (P = 0.1451)
7:117188829:A:G,P13569,I448M,0.735,Loss of methylation at K447 (P = 0.0244); Loss of catalytic residue at L453 (P = 0.0909); Gain of sheet (P = 0.1451); Gain of ubiquitination at K447 (P = 0.1571); Gain of MoRF binding (P = 0.3942)
7:117188830:G:A,P13569,E449K,0.478,Gain of MoRF binding (P = 0.008); Gain of methylation at E449 (P = 0.052); Loss of sheet (P = 0.0817); Loss of catalytic residue at Q452 (P = 0.094); Loss of ubiquitination at K447 (P = 0.1882)
7:117188830:G:C,P13569,E449Q,0.417,Gain of MoRF binding (P = 0.0882); Gain of methylation at K447 (P = 0.119); Loss of sheet (P = 0.1398); Loss of ubiquitination at K447 (P = 0.2377); Gain of catalytic residue at R450 (P = 0.4081)
7:117188831:A:C,P13569,E449A,0.496,Gain of catalytic residue at E449 (P = 0.0391); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.0911); Gain of methylation at K447 (P = 0.1425); Gain of loop (P = 0.2045)
7:117188831:A:G,P13569,E449G,0.485,Gain of MoRF binding (P = 0.1075); Gain of methylation at R450 (P = 0.1227); Gain of catalytic residue at I448 (P = 0.1576); Loss of stability (P = 0.1662); Loss of ubiquitination at K447 (P = 0.2516)
7:117188831:A:T,P13569,E449V,0.534,Gain of MoRF binding (P = 0.0646); Loss of sheet (P = 0.0817); Gain of methylation at K447 (P = 0.0877); Gain of loop (P = 0.2045); Loss of catalytic residue at Q452 (P = 0.2396)
7:117188832:A:C,P13569,E449D,0.446,Gain of catalytic residue at E449 (P = 0.0107); Loss of methylation at K447 (P = 0.111); Gain of loop (P = 0.2045); Loss of ubiquitination at K447 (P = 0.2976); Loss of sheet (P = 0.302)
7:117188833:A:G,P13569,R450G,0.478,Loss of solvent accessibility (P = 0.0092); Gain of catalytic residue at R450 (P = 0.121); Loss of stability (P = 0.1315); Gain of sheet (P = 0.1451); Gain of methylation at K447 (P = 0.1539)
7:117188834:G:A,P13569,R450K,0.414,Gain of ubiquitination at R450 (P = 0.0351); Loss of solvent accessibility (P = 0.1434); Loss of catalytic residue at Q452 (P = 0.1699); Gain of methylation at K447 (P = 0.1812); Loss of sheet (P = 0.302)
7:117188834:G:C,P13569,R450T,0.48,Loss of solvent accessibility (P = 0.0387); Gain of ubiquitination at K447 (P = 0.1051); Gain of methylation at K447 (P = 0.1682); Gain of catalytic residue at R450 (P = 0.2739); Loss of sheet (P = 0.302)
7:117188834:G:T,P13569,R450I,0.499,Loss of solvent accessibility (P = 0.0611); Gain of methylation at K447 (P = 0.0881); Gain of catalytic residue at A455 (P = 0.2347); Loss of sheet (P = 0.302); Loss of ubiquitination at K447 (P = 0.3029)
7:117188835:A:C,P13569,R450S,0.46,Loss of solvent accessibility (P = 0.0606); Gain of ubiquitination at K447 (P = 0.1283); Loss of sheet (P = 0.1398); Loss of methylation at K447 (P = 0.1424); Gain of catalytic residue at G451 (P = 0.2026)
7:117188835:A:T,P13569,R450S,0.46,Loss of solvent accessibility (P = 0.0606); Gain of ubiquitination at K447 (P = 0.1283); Loss of sheet (P = 0.1398); Loss of methylation at K447 (P = 0.1424); Gain of catalytic residue at G451 (P = 0.2026)
7:117188836:G:A,P13569,G451R,0.915,Gain of solvent accessibility (P = 0.0584); Loss of catalytic residue at Q452 (P = 0.0765); Gain of MoRF binding (P = 0.0802); Gain of methylation at K447 (P = 0.0872); Gain of relative solvent accessibility (P = 0.09)
7:117188836:G:C,P13569,G451R,0.915,Gain of solvent accessibility (P = 0.0584); Loss of catalytic residue at Q452 (P = 0.0765); Gain of MoRF binding (P = 0.0802); Gain of methylation at K447 (P = 0.0872); Gain of relative solvent accessibility (P = 0.09)
7:117188837:G:A,P13569,G451E,0.904,Gain of solvent accessibility (P = 0.0411); Gain of relative solvent accessibility (P = 0.0479); Loss of catalytic residue at Q452 (P = 0.0631); Gain of ubiquitination at K447 (P = 0.1051); Gain of methylation at K447 (P = 0.121)
7:117188837:G:C,P13569,G451A,0.95,Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.0957); Loss of methylation at K447 (P = 0.1324); Loss of loop (P = 0.2237); Loss of ubiquitination at K447 (P = 0.2924)
7:117188837:G:T,P13569,G451V,0.972,Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.093); Loss of methylation at K447 (P = 0.1943); Loss of loop (P = 0.2237); Loss of ubiquitination at K447 (P = 0.2719)
7:117188839:C:A,P13569,Q452K,0.645,Gain of ubiquitination at Q452 (P = 0.1008); Loss of methylation at K447 (P = 0.1356); Gain of MoRF binding (P = 0.1444); Loss of catalytic residue at Q452 (P = 0.2262); Gain of disorder (P = 0.2819)
7:117188839:C:G,P13569,Q452E,0.555,Loss of catalytic residue at Q452 (P = 0.1064); Loss of methylation at K447 (P = 0.168); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2414); Gain of ubiquitination at K447 (P = 0.2629)
7:117188840:A:C,P13569,Q452P,0.897,Loss of catalytic residue at Q452 (P = 0.0559); Gain of methylation at K447 (P = 0.1405); Loss of solvent accessibility (P = 0.1651); Gain of loop (P = 0.2045); Gain of ubiquitination at K447 (P = 0.2629)
7:117188840:A:G,P13569,Q452R,0.634,Gain of methylation at Q452 (P = 0.0333); Gain of MoRF binding (P = 0.0756); Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.1866); Loss of ubiquitination at K447 (P = 0.2593)
7:117188840:A:T,P13569,Q452L,0.606,Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.1199); Loss of methylation at K447 (P = 0.1235); Loss of solvent accessibility (P = 0.1651); Loss of disorder (P = 0.256)
7:117188841:G:C,P13569,Q452H,0.711,Loss of catalytic residue at Q452 (P = 0.0677); Loss of solvent accessibility (P = 0.1651); Gain of methylation at K447 (P = 0.1901); Gain of disorder (P = 0.2359); Loss of ubiquitination at K447 (P = 0.2976)
7:117188841:G:T,P13569,Q452H,0.711,Loss of catalytic residue at Q452 (P = 0.0677); Loss of solvent accessibility (P = 0.1651); Gain of methylation at K447 (P = 0.1901); Gain of disorder (P = 0.2359); Loss of ubiquitination at K447 (P = 0.2976)
7:117188842:T:A,P13569,L453M,0.601,Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.0912); Gain of disorder (P = 0.1454); Gain of MoRF binding (P = 0.3038); Gain of methylation at R450 (P = 0.5138)
7:117188842:T:G,P13569,L453V,0.563,Loss of catalytic residue at L453 (P = 0.1065); Gain of disorder (P = 0.2765); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3742); Gain of methylation at R450 (P = 0.5016)
7:117188843:T:C,P13569,L453S,0.774,Gain of disorder (P = 0.017); Gain of phosphorylation at L453 (P = 0.0592); Loss of catalytic residue at Q452 (P = 0.06); Loss of stability (P = 0.1503); Gain of loop (P = 0.2045)
7:117188843:T:G,P13569,L453W,0.638,Gain of MoRF binding (P = 0.096); Loss of catalytic residue at Q452 (P = 0.1224); Loss of disorder (P = 0.1423); Loss of sheet (P = 0.302); Loss of stability (P = 0.429)
7:117188844:G:C,P13569,L453F,0.653,Loss of catalytic residue at Q452 (P = 0.1116); Loss of disorder (P = 0.2143); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.4275); Gain of methylation at R450 (P = 0.4895)
7:117188844:G:T,P13569,L453F,0.653,Loss of catalytic residue at Q452 (P = 0.1116); Loss of disorder (P = 0.2143); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.4275); Gain of methylation at R450 (P = 0.4895)
7:117188845:T:A,P13569,L454M,0.7,Loss of catalytic residue at Q452 (P = 0.0961); Gain of disorder (P = 0.1398); Loss of loop (P = 0.2237); Loss of glycosylation at S459 (P = 0.2823); Gain of MoRF binding (P = 0.2963)
7:117188845:T:G,P13569,L454V,0.647,Loss of catalytic residue at Q452 (P = 0.1186); Gain of disorder (P = 0.2593); Gain of glycosylation at S459 (P = 0.2689); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3757)
7:117188846:T:C,P13569,L454S,0.803,Gain of disorder (P = 0.012); Loss of catalytic residue at Q452 (P = 0.078); Loss of stability (P = 0.0815); Gain of sheet (P = 0.0827); Gain of phosphorylation at S459 (P = 0.166)
7:117188846:T:G,P13569,L454W,0.663,Gain of MoRF binding (P = 0.1001); Loss of catalytic residue at Q452 (P = 0.1224); Loss of disorder (P = 0.1258); Loss of loop (P = 0.2237); Loss of stability (P = 0.2569)
7:117188847:G:C,P13569,L454F,0.608,Gain of catalytic residue at L454 (P = 0.0143); Loss of disorder (P = 0.1892); Loss of glycosylation at S459 (P = 0.1923); Loss of sheet (P = 0.302); Loss of phosphorylation at S459 (P = 0.349)
7:117188847:G:T,P13569,L454F,0.608,Gain of catalytic residue at L454 (P = 0.0143); Loss of disorder (P = 0.1892); Loss of glycosylation at S459 (P = 0.1923); Loss of sheet (P = 0.302); Loss of phosphorylation at S459 (P = 0.349)
7:117188848:G:A,P13569,A455T,0.867,Loss of catalytic residue at Q452 (P = 0.0859); Gain of disorder (P = 0.172); Loss of stability (P = 0.1859); Loss of sheet (P = 0.302); Loss of glycosylation at S459 (P = 0.3037)
7:117188848:G:C,P13569,A455P,0.906,Loss of catalytic residue at Q452 (P = 0.0793); Loss of stability (P = 0.0967); Gain of disorder (P = 0.1261); Gain of phosphorylation at T460 (P = 0.1991); Gain of loop (P = 0.2045)
7:117188848:G:T,P13569,A455S,0.908,Gain of disorder (P = 0.0454); Loss of catalytic residue at Q452 (P = 0.0747); Gain of phosphorylation at S459 (P = 0.1998); Loss of glycosylation at S459 (P = 0.2518); Loss of sheet (P = 0.302)
7:117188849:C:G,P13569,A455G,0.885,Loss of stability (P = 0.083); Loss of catalytic residue at Q452 (P = 0.0964); Gain of disorder (P = 0.1131); Loss of glycosylation at S459 (P = 0.2497); Gain of phosphorylation at S459 (P = 0.2961)
7:117188849:C:T,P13569,A455V,0.842,Loss of catalytic residue at Q452 (P = 0.103); Loss of disorder (P = 0.1119); Gain of loop (P = 0.2045); Loss of glycosylation at S459 (P = 0.2718); Loss of sheet (P = 0.302)
7:117188851:G:A,P13569,V456I,0.665,Loss of catalytic residue at Q452 (P = 0.118); Gain of glycosylation at S459 (P = 0.1997); Loss of disorder (P = 0.2005); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302)
7:117188851:G:C,P13569,V456L,0.719,Loss of catalytic residue at Q452 (P = 0.0867); Gain of disorder (P = 0.1523); Gain of phosphorylation at S459 (P = 0.2236); Loss of sheet (P = 0.302); Loss of glycosylation at S459 (P = 0.315)
7:117188851:G:T,P13569,V456F,0.924,Gain of catalytic residue at V456 (P = 0.0513); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2162); Loss of glycosylation at S459 (P = 0.262); Loss of stability (P = 0.2724)
7:117188852:T:A,P13569,V456D,0.938,Gain of disorder (P = 0.0127); Loss of catalytic residue at Q452 (P = 0.05); Loss of stability (P = 0.0515); Gain of sheet (P = 0.0827); Gain of phosphorylation at S459 (P = 0.1316)
7:117188852:T:C,P13569,V456A,0.949,Gain of disorder (P = 0.0299); Loss of stability (P = 0.0433); Gain of sheet (P = 0.0827); Loss of catalytic residue at Q452 (P = 0.0849); Gain of phosphorylation at S459 (P = 0.1368)
7:117188852:T:G,P13569,V456G,0.916,Loss of stability (P = 0.002); Gain of disorder (P = 0.0103); Loss of catalytic residue at Q452 (P = 0.0782); Gain of sheet (P = 0.0827); Gain of phosphorylation at S459 (P = 0.1181)
7:117188854:G:A,P13569,A457T,0.711,Loss of catalytic residue at Q452 (P = 0.0932); Gain of disorder (P = 0.1629); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Loss of glycosylation at S459 (P = 0.3027)
7:117188854:G:C,P13569,A457P,0.805,Gain of glycosylation at A457 (P = 0.0513); Gain of disorder (P = 0.0836); Loss of catalytic residue at Q452 (P = 0.089); Gain of phosphorylation at T460 (P = 0.2435); Loss of sheet (P = 0.302)
7:117188854:G:T,P13569,A457S,0.738,Gain of disorder (P = 0.0339); Gain of glycosylation at A457 (P = 0.0563); Loss of catalytic residue at Q452 (P = 0.081); Gain of phosphorylation at A457 (P = 0.1495); Loss of sheet (P = 0.302)
7:117188855:C:A,P13569,A457D,0.79,Loss of catalytic residue at A457 (P = 0.0651); Gain of disorder (P = 0.0766); Loss of sheet (P = 0.0817); Loss of glycosylation at S459 (P = 0.1662); Gain of phosphorylation at T460 (P = 0.3381)
7:117188855:C:G,P13569,A457G,0.746,Gain of sheet (P = 0.0827); Gain of disorder (P = 0.0832); Loss of catalytic residue at Q452 (P = 0.0933); Loss of stability (P = 0.2213); Gain of phosphorylation at S459 (P = 0.2877)
7:117188855:C:T,P13569,A457V,0.629,Loss of disorder (P = 0.0926); Loss of catalytic residue at Q452 (P = 0.1037); Loss of sheet (P = 0.302); Loss of glycosylation at S459 (P = 0.3329); Loss of phosphorylation at T460 (P = 0.3376)
7:117188857:G:A,P13569,G458R,0.972,Gain of methylation at G458 (P = 0.0365); Gain of MoRF binding (P = 0.0636); Gain of phosphorylation at T460 (P = 0.0834); Loss of glycosylation at S459 (P = 0.1463); Loss of disorder (P = 0.1777)
7:117188857:G:C,P13569,G458R,0.972,Gain of methylation at G458 (P = 0.0365); Gain of MoRF binding (P = 0.0636); Gain of phosphorylation at T460 (P = 0.0834); Loss of glycosylation at S459 (P = 0.1463); Loss of disorder (P = 0.1777)
7:117188858:G:A,P13569,G458E,0.975,Loss of catalytic residue at A457 (P = 0.0479); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.1334); Loss of glycosylation at S459 (P = 0.1392); Gain of phosphorylation at T460 (P = 0.2644)
7:117188858:G:C,P13569,G458A,0.982,Loss of disorder (P = 0.1361); Loss of glycosylation at S459 (P = 0.2904); Loss of sheet (P = 0.302); Loss of catalytic residue at A457 (P = 0.3188); Loss of phosphorylation at S459 (P = 0.3597)
7:117188858:G:T,P13569,G458V,0.98,Loss of disorder (P = 0.0436); Loss of catalytic residue at G458 (P = 0.1117); Loss of glycosylation at S459 (P = 0.2461); Loss of sheet (P = 0.302); Loss of phosphorylation at S459 (P = 0.3048)
7:117188860:T:A,P13569,S459T,0.588,Loss of ubiquitination at K464 (P = 0.0877); Loss of disorder (P = 0.0951); Gain of methylation at K464 (P = 0.1384); Loss of phosphorylation at S459 (P = 0.2373); Gain of glycosylation at S459 (P = 0.2672)
7:117188860:T:C,P13569,S459P,0.619,Gain of methylation at K464 (P = 0.1051); Gain of ubiquitination at K464 (P = 0.115); Loss of disorder (P = 0.1361); Loss of phosphorylation at S459 (P = 0.1538); Loss of sheet (P = 0.302)
7:117188860:T:G,P13569,S459A,0.615,Loss of glycosylation at S459 (P = 0.0668); Loss of disorder (P = 0.0714); Loss of methylation at K464 (P = 0.0907); Loss of ubiquitination at K464 (P = 0.1151); Loss of phosphorylation at S459 (P = 0.1538)
7:117188861:C:A,P13569,S459Y,0.732,Loss of disorder (P = 0.0204); Loss of ubiquitination at K464 (P = 0.0637); Loss of glycosylation at S459 (P = 0.0668); Gain of methylation at K464 (P = 0.087); Gain of catalytic residue at L454 (P = 0.1278)
7:117188861:C:G,P13569,S459C,0.74,Loss of disorder (P = 0.0067); Loss of glycosylation at S459 (P = 0.0668); Loss of methylation at K464 (P = 0.0778); Loss of ubiquitination at K464 (P = 0.1151); Loss of phosphorylation at S459 (P = 0.1538)
7:117188861:C:T,P13569,S459F,0.754,Loss of disorder (P = 0.0104); Loss of glycosylation at S459 (P = 0.0668); Loss of methylation at K464 (P = 0.0828); Loss of ubiquitination at K464 (P = 0.0877); Loss of phosphorylation at S459 (P = 0.1538)
7:117188863:A:C,P13569,T460P,0.739,Loss of catalytic residue at T460 (P = 0.0076); Gain of glycosylation at T460 (P = 0.0376); Gain of disorder (P = 0.1254); Loss of ubiquitination at K464 (P = 0.1322); Gain of methylation at K464 (P = 0.1334)
7:117188863:A:G,P13569,T460A,0.736,Loss of methylation at K464 (P = 0.0608); Gain of ubiquitination at K464 (P = 0.115); Loss of phosphorylation at T460 (P = 0.1404); Loss of glycosylation at S459 (P = 0.1793); Loss of disorder (P = 0.2244)
7:117188863:A:T,P13569,T460S,0.653,Gain of disorder (P = 0.0415); Gain of glycosylation at T460 (P = 0.0459); Gain of ubiquitination at K464 (P = 0.0985); Gain of phosphorylation at T460 (P = 0.1213); Gain of methylation at K464 (P = 0.1428)
7:117188864:C:A,P13569,T460N,0.679,Gain of ubiquitination at K464 (P = 0.078); Loss of phosphorylation at T460 (P = 0.1404); Loss of methylation at K464 (P = 0.1513); Gain of disorder (P = 0.2012); Loss of glycosylation at S459 (P = 0.2311)
7:117188864:C:G,P13569,T460S,0.653,Gain of disorder (P = 0.0415); Gain of glycosylation at T460 (P = 0.0459); Gain of ubiquitination at K464 (P = 0.0985); Gain of phosphorylation at T460 (P = 0.1213); Gain of methylation at K464 (P = 0.1428)
7:117188864:C:T,P13569,T460I,0.74,Loss of disorder (P = 0.0369); Loss of methylation at K464 (P = 0.0727); Loss of ubiquitination at K464 (P = 0.1151); Loss of glycosylation at S459 (P = 0.1175); Loss of phosphorylation at T460 (P = 0.1404)
7:117188866:G:A,P13569,G461R,0.954,Gain of MoRF binding (P = 0.05); Loss of methylation at K464 (P = 0.0693); Loss of ubiquitination at K464 (P = 0.0709); Loss of sheet (P = 0.0817); Loss of glycosylation at S459 (P = 0.1255)
7:117188866:G:C,P13569,G461R,0.954,Gain of MoRF binding (P = 0.05); Loss of methylation at K464 (P = 0.0693); Loss of ubiquitination at K464 (P = 0.0709); Loss of sheet (P = 0.0817); Loss of glycosylation at S459 (P = 0.1255)
7:117188867:G:A,P13569,G461E,0.974,Gain of ubiquitination at K464 (P = 0.0985); Loss of methylation at K464 (P = 0.1368); Gain of disorder (P = 0.1371); Loss of glycosylation at S459 (P = 0.1418); Loss of catalytic residue at G461 (P = 0.2023)
7:117188867:G:C,P13569,G461A,0.982,Gain of ubiquitination at K464 (P = 0.0872); Loss of methylation at K464 (P = 0.0992); Loss of disorder (P = 0.1225); Gain of glycosylation at S459 (P = 0.2511); Loss of sheet (P = 0.302)
7:117188867:G:T,P13569,G461V,0.98,Loss of disorder (P = 0.0354); Gain of ubiquitination at K464 (P = 0.078); Loss of sheet (P = 0.0817); Loss of methylation at K464 (P = 0.1516); Loss of catalytic residue at G458 (P = 0.2528)
7:117188869:G:A,P13569,A462T,0.931,Gain of ubiquitination at K464 (P = 0.0872); Gain of disorder (P = 0.1322); Gain of methylation at K464 (P = 0.148); Gain of glycosylation at S459 (P = 0.2618); Loss of sheet (P = 0.302)
7:117188869:G:C,P13569,A462P,0.827,Loss of catalytic residue at A462 (P = 0.005); Gain of glycosylation at A462 (P = 0.0058); Gain of methylation at K464 (P = 0.0623); Gain of disorder (P = 0.0747); Gain of ubiquitination at K464 (P = 0.0985)
7:117188869:G:T,P13569,A462S,0.871,Gain of disorder (P = 0.0304); Gain of glycosylation at A462 (P = 0.0311); Gain of phosphorylation at A462 (P = 0.111); Gain of ubiquitination at K464 (P = 0.115); Gain of methylation at K464 (P = 0.1507)
7:117188870:C:A,P13569,A462E,0.93,Gain of disorder (P = 0.0435); Gain of ubiquitination at K464 (P = 0.0719); Gain of methylation at K464 (P = 0.124); Loss of glycosylation at S459 (P = 0.1949); Gain of phosphorylation at S459 (P = 0.2018)
7:117188870:C:G,P13569,A462G,0.911,Gain of disorder (P = 0.068); Gain of ubiquitination at K464 (P = 0.0872); Gain of glycosylation at S459 (P = 0.0982); Gain of methylation at K464 (P = 0.1163); Gain of catalytic residue at L467 (P = 0.1468)
7:117188870:C:T,P13569,A462V,0.94,Loss of disorder (P = 0.0786); Gain of ubiquitination at K464 (P = 0.0872); Gain of methylation at K464 (P = 0.1171); Loss of glycosylation at S459 (P = 0.2785); Loss of sheet (P = 0.302)
7:117188872:G:A,P13569,G463S,0.965,Gain of catalytic residue at G463 (P = 0.0535); Gain of ubiquitination at K464 (P = 0.0872); Gain of disorder (P = 0.0943); Loss of methylation at K464 (P = 0.1268); Loss of helix (P = 0.1706)
7:117188872:G:C,P13569,G463R,0.985,Gain of methylation at K464 (P = 0.062); Gain of MoRF binding (P = 0.0668); Gain of phosphorylation at S466 (P = 0.0842); Loss of ubiquitination at K464 (P = 0.0877); Loss of catalytic residue at G461 (P = 0.1139)
7:117188872:G:T,P13569,G463C,0.941,Loss of disorder (P = 0.0157); Gain of methylation at K464 (P = 0.0263); Gain of catalytic residue at G463 (P = 0.0428); Loss of ubiquitination at K464 (P = 0.1151); Gain of helix (P = 0.132)
7:117188873:G:A,P13569,G463D,0.988,Loss of catalytic residue at G461 (P = 0.0492); Loss of methylation at K464 (P = 0.0911); Gain of ubiquitination at K464 (P = 0.115); Gain of phosphorylation at T460 (P = 0.126); Gain of disorder (P = 0.2353)
7:117188873:G:C,P13569,G463A,0.983,Gain of ubiquitination at K464 (P = 0.0985); Loss of methylation at K464 (P = 0.1107); Loss of disorder (P = 0.1249); Loss of catalytic residue at L468 (P = 0.1423); Gain of glycosylation at S459 (P = 0.1682)
7:117188873:G:T,P13569,G463V,0.969,Loss of disorder (P = 0.0384); Gain of methylation at K464 (P = 0.0439); Gain of catalytic residue at G463 (P = 0.0806); Gain of ubiquitination at K464 (P = 0.115); Gain of helix (P = 0.132)
7:117188875:A:C,P13569,K464Q,0.948,Loss of ubiquitination at K464 (P = 0.0183); Loss of methylation at K464 (P = 0.0194); Loss of disorder (P = 0.1776); Gain of catalytic residue at G463 (P = 0.1996); Loss of glycosylation at K464 (P = 0.2037)
7:117188875:A:G,P13569,K464E,0.923,Loss of ubiquitination at K464 (P = 0.0183); Loss of methylation at K464 (P = 0.0194); Gain of stability (P = 0.1295); Gain of disorder (P = 0.1746); Loss of glycosylation at K464 (P = 0.2037)
7:117188876:A:C,P13569,K464T,0.927,Loss of ubiquitination at K464 (P = 0.0183); Loss of methylation at K464 (P = 0.0194); Gain of phosphorylation at T460 (P = 0.1041); Gain of glycosylation at T465 (P = 0.1061); Loss of disorder (P = 0.139)
7:117188876:A:G,P13569,K464R,0.923,Loss of ubiquitination at K464 (P = 0.0183); Gain of phosphorylation at S466 (P = 0.0794); Loss of methylation at K464 (P = 0.0979); Loss of disorder (P = 0.1364); Gain of catalytic residue at G463 (P = 0.1927)
7:117188876:A:T,P13569,K464M,0.905,Loss of ubiquitination at K464 (P = 0.0183); Loss of methylation at K464 (P = 0.0194); Gain of stability (P = 0.0364); Loss of disorder (P = 0.0685); Gain of catalytic residue at G463 (P = 0.1959)
7:117188877:G:C,P13569,K464N,0.953,Loss of ubiquitination at K464 (P = 0.0183); Loss of methylation at K464 (P = 0.0194); Gain of catalytic residue at G463 (P = 0.1277); Loss of disorder (P = 0.1448); Gain of glycosylation at S459 (P = 0.1927)
7:117199518:A:C,P13569,T465P,0.922,Gain of glycosylation at T465 (P = 0.0564); Gain of methylation at K464 (P = 0.098); Gain of ubiquitination at K464 (P = 0.0985); Gain of disorder (P = 0.1237); Loss of phosphorylation at T465 (P = 0.1511)
7:117199518:A:G,P13569,T465A,0.915,Gain of ubiquitination at K464 (P = 0.0872); Loss of methylation at K464 (P = 0.1064); Loss of phosphorylation at T465 (P = 0.1511); Loss of disorder (P = 0.2281); Loss of helix (P = 0.3949)
7:117199518:A:T,P13569,T465S,0.857,Gain of disorder (P = 0.0432); Loss of methylation at K464 (P = 0.1055); Gain of ubiquitination at K464 (P = 0.115); Gain of phosphorylation at S466 (P = 0.1323); Gain of catalytic residue at T465 (P = 0.1539)
7:117199519:C:A,P13569,T465N,0.94,Loss of ubiquitination at K464 (P = 0.1151); Gain of methylation at K464 (P = 0.1167); Loss of phosphorylation at T465 (P = 0.1511); Gain of disorder (P = 0.2169); Loss of helix (P = 0.3949)
7:117199519:C:G,P13569,T465S,0.857,Gain of disorder (P = 0.0432); Loss of methylation at K464 (P = 0.1055); Gain of ubiquitination at K464 (P = 0.115); Gain of phosphorylation at S466 (P = 0.1323); Gain of catalytic residue at T465 (P = 0.1539)
7:117199519:C:T,P13569,T465I,0.927,Gain of stability (P = 0.028); Loss of disorder (P = 0.0512); Gain of methylation at K464 (P = 0.0924); Gain of ubiquitination at K464 (P = 0.115); Loss of phosphorylation at T465 (P = 0.1511)
7:117199521:T:A,P13569,S466T,0.856,Gain of methylation at K464 (P = 0.1108); Gain of ubiquitination at K464 (P = 0.115); Loss of disorder (P = 0.1161); Loss of catalytic residue at S466 (P = 0.1491); Loss of phosphorylation at S466 (P = 0.2031)
7:117199521:T:C,P13569,S466P,0.92,Loss of catalytic residue at S466 (P = 0.0278); Gain of methylation at K464 (P = 0.0494); Gain of glycosylation at S466 (P = 0.062); Gain of phosphorylation at T465 (P = 0.0864); Gain of ubiquitination at K464 (P = 0.0985)
7:117199521:T:G,P13569,S466A,0.957,Loss of disorder (P = 0.0854); Gain of methylation at K464 (P = 0.087); Gain of ubiquitination at K464 (P = 0.0872); Loss of phosphorylation at S466 (P = 0.139); Gain of glycosylation at K464 (P = 0.2956)
7:117199522:C:T,P13569,S466L,0.961,Loss of disorder (P = 0.0416); Gain of ubiquitination at K464 (P = 0.078); Gain of methylation at K464 (P = 0.1124); Loss of phosphorylation at S466 (P = 0.139); Gain of stability (P = 0.1409)
7:117199524:C:A,P13569,L467I,0.92,Gain of methylation at K464 (P = 0.0518); Loss of ubiquitination at K464 (P = 0.0992); Loss of disorder (P = 0.1659); Gain of phosphorylation at T465 (P = 0.294); Loss of helix (P = 0.3949)
7:117199524:C:G,P13569,L467V,0.921,Gain of methylation at K464 (P = 0.0657); Gain of ubiquitination at K464 (P = 0.0872); Gain of phosphorylation at T465 (P = 0.16); Gain of catalytic residue at L467 (P = 0.2181); Gain of disorder (P = 0.2359)
7:117199525:T:A,P13569,L467H,0.917,Loss of stability (P = 0.0338); Gain of disorder (P = 0.0345); Gain of catalytic residue at M469 (P = 0.0603); Gain of ubiquitination at K464 (P = 0.0671); Gain of methylation at K464 (P = 0.0694)
7:117199525:T:G,P13569,L467R,0.913,Gain of methylation at L467 (P = 0.0283); Gain of disorder (P = 0.0374); Loss of stability (P = 0.0539); Gain of ubiquitination at K464 (P = 0.0561); Gain of MoRF binding (P = 0.0587)
7:117199527:C:A,P13569,L468I,0.668,Gain of methylation at K464 (P = 0.0505); Loss of catalytic residue at L468 (P = 0.075); Gain of ubiquitination at K464 (P = 0.115); Loss of disorder (P = 0.184); Loss of phosphorylation at T465 (P = 0.2783)
7:117199527:C:G,P13569,L468V,0.676,Gain of methylation at K464 (P = 0.0665); Gain of ubiquitination at K464 (P = 0.115); Loss of helix (P = 0.1706); Loss of stability (P = 0.2174); Gain of disorder (P = 0.2393)
7:117199528:T:A,P13569,L468Q,0.812,Gain of disorder (P = 0.0396); Loss of stability (P = 0.0466); Gain of methylation at K464 (P = 0.0909); Gain of ubiquitination at K464 (P = 0.115); Loss of helix (P = 0.1706)
7:117199528:T:C,P13569,L468P,0.862,Loss of stability (P = 0.0169); Gain of disorder (P = 0.03); Gain of glycosylation at T465 (P = 0.0396); Gain of methylation at K464 (P = 0.0856); Gain of ubiquitination at K464 (P = 0.0872)
7:117199528:T:G,P13569,L468R,0.886,Gain of methylation at L468 (P = 0.0241); Loss of stability (P = 0.0433); Gain of disorder (P = 0.048); Gain of MoRF binding (P = 0.0682); Gain of ubiquitination at K464 (P = 0.078)
7:117199530:A:C,P13569,M469L,0.832,Loss of methylation at K464 (P = 0.0798); Gain of ubiquitination at K464 (P = 0.115); Loss of disorder (P = 0.1887); Loss of phosphorylation at S466 (P = 0.3548); Loss of helix (P = 0.3949)
7:117199530:A:G,P13569,M469V,0.896,Gain of ubiquitination at K464 (P = 0.115); Gain of methylation at K464 (P = 0.1309); Loss of disorder (P = 0.1601); Loss of phosphorylation at S466 (P = 0.3511); Loss of helix (P = 0.3949)
7:117199530:A:T,P13569,M469L,0.832,Loss of methylation at K464 (P = 0.0798); Gain of ubiquitination at K464 (P = 0.115); Loss of disorder (P = 0.1887); Loss of phosphorylation at S466 (P = 0.3548); Loss of helix (P = 0.3949)
7:117199531:T:A,P13569,M469K,0.685,Gain of ubiquitination at M469 (P = 0.0082); Loss of stability (P = 0.0637); Loss of methylation at K464 (P = 0.0653); Gain of disorder (P = 0.0866); Gain of relative solvent accessibility (P = 0.1259)
7:117199531:T:C,P13569,M469T,0.585,Loss of stability (P = 0.0853); Loss of ubiquitination at K464 (P = 0.0992); Gain of phosphorylation at T465 (P = 0.102); Gain of disorder (P = 0.127); Gain of helix (P = 0.132)
7:117199531:T:G,P13569,M469R,0.74,Loss of methylation at K464 (P = 0.046); Gain of ubiquitination at K464 (P = 0.0985); Gain of phosphorylation at S466 (P = 0.1258); Gain of helix (P = 0.132); Gain of disorder (P = 0.1413)
7:117199532:G:A,P13569,M469I,0.905,Gain of methylation at K464 (P = 0.0863); Gain of ubiquitination at K464 (P = 0.115); Loss of disorder (P = 0.1225); Gain of helix (P = 0.132); Gain of catalytic residue at V470 (P = 0.3066)
7:117199532:G:C,P13569,M469I,0.905,Gain of methylation at K464 (P = 0.0863); Gain of ubiquitination at K464 (P = 0.115); Loss of disorder (P = 0.1225); Gain of helix (P = 0.132); Gain of catalytic residue at V470 (P = 0.3066)
7:117199533:G:C,P13569,V470L,0.517,Gain of helix (P = 0.132); Gain of disorder (P = 0.1333); Loss of catalytic residue at V470 (P = 0.2314); Gain of phosphorylation at T465 (P = 0.2625); Loss of stability (P = 0.4395)
7:117199533:G:T,P13569,V470L,0.517,Gain of helix (P = 0.132); Gain of disorder (P = 0.1333); Loss of catalytic residue at V470 (P = 0.2314); Gain of phosphorylation at T465 (P = 0.2625); Loss of stability (P = 0.4395)
7:117199534:T:A,P13569,V470E,0.823,Gain of disorder (P = 0.0042); Loss of stability (P = 0.0703); Gain of helix (P = 0.132); Gain of phosphorylation at S466 (P = 0.1421); Loss of catalytic residue at E474 (P = 0.2005)
7:117199534:T:C,P13569,V470A,0.687,Loss of stability (P = 0.0178); Gain of disorder (P = 0.062); Gain of phosphorylation at T465 (P = 0.1254); Gain of helix (P = 0.132); Loss of catalytic residue at V470 (P = 0.2205)
7:117199534:T:G,P13569,V470G,0.735,Loss of stability (P = 0.002); Gain of catalytic residue at M469 (P = 0.0134); Gain of disorder (P = 0.0155); Gain of helix (P = 0.132); Gain of phosphorylation at S466 (P = 0.1726)
7:117199536:A:C,P13569,I471L,0.706,Gain of disorder (P = 0.1235); Loss of helix (P = 0.1299); Gain of catalytic residue at I471 (P = 0.177); Gain of phosphorylation at S466 (P = 0.218); Gain of loop (P = 0.4661)
7:117199536:A:G,P13569,I471V,0.742,Gain of disorder (P = 0.1552); Gain of phosphorylation at S466 (P = 0.2593); Loss of stability (P = 0.3176); Loss of catalytic residue at L468 (P = 0.326); Loss of helix (P = 0.3949)
7:117199536:A:T,P13569,I471F,0.778,Loss of stability (P = 0.2185); Gain of disorder (P = 0.2378); Gain of catalytic residue at I471 (P = 0.3); Gain of phosphorylation at S466 (P = 0.3443); Loss of loop (P = 0.3664)
7:117199537:T:A,P13569,I471N,0.878,Gain of disorder (P = 0.0185); Loss of stability (P = 0.0494); Loss of helix (P = 0.1299); Gain of catalytic residue at I471 (P = 0.1708); Gain of phosphorylation at S466 (P = 0.332)
7:117199537:T:C,P13569,I471T,0.896,Loss of stability (P = 0.0112); Gain of disorder (P = 0.022); Gain of glycosylation at I471 (P = 0.1); Loss of helix (P = 0.1299); Gain of phosphorylation at S466 (P = 0.1898)
7:117199537:T:G,P13569,I471S,0.861,Gain of disorder (P = 0.0014); Loss of stability (P = 0.0346); Gain of phosphorylation at I471 (P = 0.0501); Loss of helix (P = 0.1299); Gain of glycosylation at S466 (P = 0.1801)
7:117199538:T:G,P13569,I471M,0.8,Gain of disorder (P = 0.0316); Gain of phosphorylation at S466 (P = 0.1543); Loss of stability (P = 0.2845); Loss of catalytic residue at L468 (P = 0.3157); Loss of helix (P = 0.3949)
7:117199539:A:C,P13569,M472L,0.84,Gain of helix (P = 0.132); Loss of disorder (P = 0.1511); Loss of loop (P = 0.3664); Loss of catalytic residue at M472 (P = 0.4214); Loss of glycosylation at P477 (P = 0.4347)
7:117199539:A:G,P13569,M472V,0.815,Loss of disorder (P = 0.1295); Gain of helix (P = 0.132); Gain of catalytic residue at M472 (P = 0.2982); Loss of stability (P = 0.3921); Loss of glycosylation at P477 (P = 0.3942)
7:117199539:A:T,P13569,M472L,0.84,Gain of helix (P = 0.132); Loss of disorder (P = 0.1511); Loss of loop (P = 0.3664); Loss of catalytic residue at M472 (P = 0.4214); Loss of glycosylation at P477 (P = 0.4347)
7:117199540:T:A,P13569,M472K,0.809,Gain of ubiquitination at M472 (P = 0.0121); Gain of disorder (P = 0.03); Loss of stability (P = 0.0618); Gain of glycosylation at M472 (P = 0.0857); Loss of catalytic residue at M472 (P = 0.1414)
7:117199540:T:C,P13569,M472T,0.805,Loss of stability (P = 0.0643); Gain of disorder (P = 0.1637); Loss of helix (P = 0.2022); Loss of catalytic residue at V470 (P = 0.3926); Loss of glycosylation at P477 (P = 0.4373)
7:117199540:T:G,P13569,M472R,0.864,Gain of methylation at M472 (P = 0.0229); Gain of disorder (P = 0.1208); Loss of catalytic residue at V470 (P = 0.1399); Loss of helix (P = 0.2022); Loss of stability (P = 0.2497)
7:117199541:G:A,P13569,M472I,0.844,Loss of disorder (P = 0.0967); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of glycosylation at P477 (P = 0.3986); Loss of catalytic residue at M472 (P = 0.4543)
7:117199541:G:C,P13569,M472I,0.844,Loss of disorder (P = 0.0967); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of glycosylation at P477 (P = 0.3986); Loss of catalytic residue at M472 (P = 0.4543)
7:117199541:G:T,P13569,M472I,0.844,Loss of disorder (P = 0.0967); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of glycosylation at P477 (P = 0.3986); Loss of catalytic residue at M472 (P = 0.4543)
7:117199542:G:A,P13569,G473R,0.917,Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at M472 (P = 0.1421); Gain of phosphorylation at S478 (P = 0.1809); Loss of disorder (P = 0.2166)
7:117199542:G:C,P13569,G473R,0.917,Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at M472 (P = 0.1421); Gain of phosphorylation at S478 (P = 0.1809); Loss of disorder (P = 0.2166)
7:117199543:G:A,P13569,G473E,0.879,Gain of catalytic residue at G473 (P = 0.0463); Gain of disorder (P = 0.0686); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Loss of helix (P = 0.1299)
7:117199543:G:C,P13569,G473A,0.938,Loss of disorder (P = 0.109); Loss of catalytic residue at M472 (P = 0.1845); Loss of phosphorylation at S478 (P = 0.2083); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897)
7:117199543:G:T,P13569,G473V,0.929,Loss of disorder (P = 0.0508); Loss of catalytic residue at M472 (P = 0.1662); Loss of phosphorylation at S478 (P = 0.1764); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897)
7:117199545:G:A,P13569,E474K,0.902,Gain of methylation at E474 (P = 0.0148); Gain of ubiquitination at E474 (P = 0.0592); Loss of helix (P = 0.2022); Loss of catalytic residue at E474 (P = 0.2104); Loss of disorder (P = 0.2381)
7:117199545:G:C,P13569,E474Q,0.79,Loss of phosphorylation at S478 (P = 0.1136); Loss of disorder (P = 0.1141); Gain of helix (P = 0.132); Loss of catalytic residue at E474 (P = 0.2407); Loss of glycosylation at P477 (P = 0.3654)
7:117199546:A:C,P13569,E474A,0.779,Loss of disorder (P = 0.052); Loss of phosphorylation at S478 (P = 0.1167); Gain of helix (P = 0.132); Loss of catalytic residue at E474 (P = 0.1957); Loss of glycosylation at P477 (P = 0.3103)
7:117199546:A:G,P13569,E474G,0.829,Loss of catalytic residue at E474 (P = 0.1286); Loss of stability (P = 0.1361); Loss of disorder (P = 0.1374); Loss of phosphorylation at S478 (P = 0.1522); Loss of glycosylation at P477 (P = 0.2834)
7:117199546:A:T,P13569,E474V,0.782,Loss of disorder (P = 0.0219); Loss of phosphorylation at S478 (P = 0.1069); Gain of helix (P = 0.132); Loss of glycosylation at P477 (P = 0.2265); Loss of catalytic residue at M472 (P = 0.2586)
7:117199547:A:C,P13569,E474D,0.813,Loss of disorder (P = 0.1261); Gain of helix (P = 0.132); Loss of phosphorylation at S478 (P = 0.1874); Loss of glycosylation at P477 (P = 0.2947); Gain of catalytic residue at G473 (P = 0.3525)
7:117199547:A:T,P13569,E474D,0.813,Loss of disorder (P = 0.1261); Gain of helix (P = 0.132); Loss of phosphorylation at S478 (P = 0.1874); Loss of glycosylation at P477 (P = 0.2947); Gain of catalytic residue at G473 (P = 0.3525)
7:117199548:C:A,P13569,L475M,0.752,Gain of disorder (P = 0.059); Gain of phosphorylation at S478 (P = 0.1651); Loss of catalytic residue at L475 (P = 0.2587); Gain of glycosylation at P477 (P = 0.3671); Loss of helix (P = 0.3949)
7:117199548:C:G,P13569,L475V,0.743,Loss of phosphorylation at S478 (P = 0.2145); Gain of disorder (P = 0.2427); Loss of glycosylation at P477 (P = 0.3557); Loss of helix (P = 0.3949); Loss of catalytic residue at L475 (P = 0.49)
7:117199549:T:A,P13569,L475Q,0.795,Gain of disorder (P = 0.0209); Loss of phosphorylation at S478 (P = 0.2229); Loss of stability (P = 0.3348); Gain of glycosylation at P477 (P = 0.3676); Loss of helix (P = 0.3949)
7:117199549:T:C,P13569,L475P,0.829,Gain of disorder (P = 0.011); Gain of glycosylation at L475 (P = 0.028); Gain of phosphorylation at S478 (P = 0.1254); Loss of stability (P = 0.1828); Loss of helix (P = 0.2022)
7:117199549:T:G,P13569,L475R,0.858,Gain of disorder (P = 0.0266); Gain of phosphorylation at S478 (P = 0.0771); Gain of solvent accessibility (P = 0.1071); Gain of relative solvent accessibility (P = 0.1571); Gain of glycosylation at P477 (P = 0.2705)
7:117199551:G:A,P13569,E476K,0.67,Gain of ubiquitination at E476 (P = 0.0192); Gain of methylation at E476 (P = 0.0259); Loss of helix (P = 0.1299); Loss of phosphorylation at S478 (P = 0.1483); Loss of glycosylation at P477 (P = 0.2094)
7:117199551:G:C,P13569,E476Q,0.652,Loss of ubiquitination at K481 (P = 0.057); Loss of phosphorylation at S478 (P = 0.0961); Loss of disorder (P = 0.1132); Gain of catalytic residue at E476 (P = 0.2057); Loss of glycosylation at P477 (P = 0.2366)
7:117199552:A:C,P13569,E476A,0.665,Loss of ubiquitination at K481 (P = 0.0451); Loss of disorder (P = 0.0463); Loss of phosphorylation at S478 (P = 0.1069); Loss of glycosylation at P477 (P = 0.254); Gain of catalytic residue at K481 (P = 0.3166)
7:117199552:A:G,P13569,E476G,0.665,Loss of ubiquitination at K481 (P = 0.069); Loss of disorder (P = 0.1368); Loss of phosphorylation at S478 (P = 0.1399); Gain of catalytic residue at E476 (P = 0.1452); Loss of glycosylation at P477 (P = 0.2678)
7:117199552:A:T,P13569,E476V,0.704,Loss of disorder (P = 0.0137); Loss of ubiquitination at K481 (P = 0.0432); Loss of phosphorylation at S478 (P = 0.0856); Loss of glycosylation at P477 (P = 0.1768); Gain of helix (P = 0.2684)
7:117199553:G:C,P13569,E476D,0.633,Loss of ubiquitination at K481 (P = 0.1191); Loss of disorder (P = 0.126); Loss of phosphorylation at S478 (P = 0.1774); Gain of relative solvent accessibility (P = 0.2363); Loss of glycosylation at P477 (P = 0.2993)
7:117199553:G:T,P13569,E476D,0.633,Loss of ubiquitination at K481 (P = 0.1191); Loss of disorder (P = 0.126); Loss of phosphorylation at S478 (P = 0.1774); Gain of relative solvent accessibility (P = 0.2363); Loss of glycosylation at P477 (P = 0.2993)
7:117199554:C:A,P13569,P477T,0.628,Gain of phosphorylation at P477 (P = 0.0502); Loss of ubiquitination at K481 (P = 0.069); Gain of helix (P = 0.132); Loss of disorder (P = 0.159); Loss of glycosylation at P477 (P = 0.1606)
7:117199554:C:G,P13569,P477A,0.648,Loss of ubiquitination at K481 (P = 0.0613); Loss of disorder (P = 0.0988); Loss of glycosylation at P477 (P = 0.112); Gain of helix (P = 0.132); Loss of phosphorylation at S478 (P = 0.1743)
7:117199555:C:A,P13569,P477H,0.653,Loss of ubiquitination at K481 (P = 0.0768); Loss of glycosylation at P477 (P = 0.112); Gain of helix (P = 0.132); Loss of phosphorylation at S478 (P = 0.1483); Loss of disorder (P = 0.2264)
7:117199555:C:G,P13569,P477R,0.695,Loss of ubiquitination at K481 (P = 0.0504); Gain of MoRF binding (P = 0.0599); Loss of glycosylation at P477 (P = 0.112); Gain of phosphorylation at S478 (P = 0.1252); Gain of helix (P = 0.132)
7:117199555:C:T,P13569,P477L,0.68,Loss of disorder (P = 0.0466); Loss of ubiquitination at K481 (P = 0.0474); Loss of glycosylation at P477 (P = 0.112); Loss of phosphorylation at S478 (P = 0.1595); Gain of catalytic residue at P477 (P = 0.258)
7:117199557:T:A,P13569,S478T,0.342,Loss of ubiquitination at K483 (P = 0.0589); Loss of phosphorylation at S478 (P = 0.0847); Loss of disorder (P = 0.0893); Loss of methylation at K483 (P = 0.3386); Loss of sheet (P = 0.3635)
7:117199557:T:C,P13569,S478P,0.47,Gain of catalytic residue at P477 (P = 0.0255); Loss of phosphorylation at S478 (P = 0.0422); Gain of glycosylation at S478 (P = 0.0479); Gain of ubiquitination at K481 (P = 0.0668); Loss of helix (P = 0.1299)
7:117199557:T:G,P13569,S478A,0.401,Loss of phosphorylation at S478 (P = 0.0422); Loss of ubiquitination at K481 (P = 0.0528); Loss of disorder (P = 0.0635); Loss of solvent accessibility (P = 0.239); Loss of methylation at K483 (P = 0.2962)
7:117199558:C:T,P13569,S478L,0.453,Gain of catalytic residue at S478 (P = 0.0116); Loss of disorder (P = 0.0297); Loss of ubiquitination at K481 (P = 0.0349); Loss of phosphorylation at S478 (P = 0.0422); Gain of solvent accessibility (P = 0.11)
7:117199560:G:A,P13569,E479K,0.463,Loss of ubiquitination at K481 (P = 0.0248); Gain of catalytic residue at E479 (P = 0.0265); Gain of MoRF binding (P = 0.0526); Loss of phosphorylation at S478 (P = 0.105); Loss of disorder (P = 0.2288)
7:117199560:G:C,P13569,E479Q,0.358,Loss of ubiquitination at K483 (P = 0.0589); Loss of phosphorylation at S478 (P = 0.0954); Loss of disorder (P = 0.147); Gain of MoRF binding (P = 0.2108); Loss of glycosylation at P477 (P = 0.3155)
7:117199561:A:C,P13569,E479A,0.443,Gain of catalytic residue at E479 (P = 0.051); Loss of ubiquitination at K483 (P = 0.0511); Loss of disorder (P = 0.0691); Loss of phosphorylation at S478 (P = 0.0918); Loss of solvent accessibility (P = 0.1459)
7:117199561:A:G,P13569,E479G,0.4,Gain of ubiquitination at K481 (P = 0.0628); Loss of stability (P = 0.063); Loss of solvent accessibility (P = 0.0769); Gain of glycosylation at S478 (P = 0.0923); Loss of phosphorylation at S478 (P = 0.1384)
7:117199561:A:T,P13569,E479V,0.479,Loss of disorder (P = 0.0321); Loss of ubiquitination at K483 (P = 0.0376); Loss of solvent accessibility (P = 0.0721); Loss of phosphorylation at S478 (P = 0.0899); Gain of MoRF binding (P = 0.1603)
7:117199562:G:C,P13569,E479D,0.332,Gain of helix (P = 0.132); Loss of ubiquitination at K481 (P = 0.1388); Loss of disorder (P = 0.1465); Loss of phosphorylation at S478 (P = 0.1764); Loss of solvent accessibility (P = 0.2517)
7:117199562:G:T,P13569,E479D,0.332,Gain of helix (P = 0.132); Loss of ubiquitination at K481 (P = 0.1388); Loss of disorder (P = 0.1465); Loss of phosphorylation at S478 (P = 0.1764); Loss of solvent accessibility (P = 0.2517)
7:117199563:G:A,P13569,G480S,0.967,Gain of phosphorylation at G480 (P = 0.0524); Gain of ubiquitination at K481 (P = 0.0843); Gain of disorder (P = 0.0954); Gain of glycosylation at P477 (P = 0.1035); Loss of stability (P = 0.262)
7:117199563:G:C,P13569,G480R,0.971,Gain of MoRF binding (P = 0.0365); Loss of ubiquitination at K483 (P = 0.0391); Gain of methylation at K483 (P = 0.0686); Gain of glycosylation at P477 (P = 0.1109); Gain of phosphorylation at S478 (P = 0.1165)
7:117199563:G:T,P13569,G480C,0.976,Gain of methylation at K481 (P = 0.0197); Loss of disorder (P = 0.0404); Loss of ubiquitination at K483 (P = 0.0455); Loss of phosphorylation at S478 (P = 0.1182); Gain of sheet (P = 0.1539)
7:117199564:G:A,P13569,G480D,0.987,Gain of ubiquitination at K481 (P = 0.0628); Gain of phosphorylation at S478 (P = 0.1968); Gain of glycosylation at S485 (P = 0.1999); Loss of disorder (P = 0.2256); Loss of MoRF binding (P = 0.3086)
7:117199564:G:C,P13569,G480A,0.972,Loss of ubiquitination at K483 (P = 0.0432); Loss of disorder (P = 0.13); Gain of glycosylation at P477 (P = 0.1811); Loss of phosphorylation at S478 (P = 0.2013); Loss of methylation at K483 (P = 0.3223)
7:117199564:G:T,P13569,G480V,0.956,Loss of ubiquitination at K483 (P = 0.0391); Gain of sheet (P = 0.0477); Loss of disorder (P = 0.056); Loss of phosphorylation at S478 (P = 0.1604); Loss of glycosylation at S485 (P = 0.1783)
7:117199566:A:C,P13569,K481Q,0.298,Loss of ubiquitination at K481 (P = 0.0148); Loss of phosphorylation at S485 (P = 0.1313); Loss of glycosylation at S485 (P = 0.184); Loss of disorder (P = 0.2461); Loss of MoRF binding (P = 0.26)
7:117199566:A:G,P13569,K481E,0.331,Loss of ubiquitination at K481 (P = 0.0148); Gain of phosphorylation at S478 (P = 0.1351); Gain of disorder (P = 0.1671); Gain of catalytic residue at K481 (P = 0.1693); Gain of glycosylation at S485 (P = 0.1918)
7:117199567:A:C,P13569,K481T,0.356,Loss of ubiquitination at K481 (P = 0.0148); Gain of phosphorylation at K481 (P = 0.08); Gain of glycosylation at K481 (P = 0.1278); Loss of disorder (P = 0.1503); Loss of MoRF binding (P = 0.2531)
7:117199567:A:G,P13569,K481R,0.282,Loss of ubiquitination at K481 (P = 0.0148); Loss of glycosylation at S485 (P = 0.1185); Gain of phosphorylation at S478 (P = 0.131); Loss of sheet (P = 0.1398); Gain of MoRF binding (P = 0.236)
7:117199567:A:T,P13569,K481I,0.33,Loss of ubiquitination at K481 (P = 0.0148); Loss of disorder (P = 0.0267); Gain of methylation at K483 (P = 0.0686); Loss of phosphorylation at S485 (P = 0.1186); Loss of glycosylation at S485 (P = 0.1235)
7:117199568:A:C,P13569,K481N,0.287,Loss of ubiquitination at K481 (P = 0.0148); Loss of phosphorylation at S485 (P = 0.1157); Loss of disorder (P = 0.1601); Loss of MoRF binding (P = 0.253); Gain of glycosylation at S485 (P = 0.2585)
7:117199568:A:T,P13569,K481N,0.287,Loss of ubiquitination at K481 (P = 0.0148); Loss of phosphorylation at S485 (P = 0.1157); Loss of disorder (P = 0.1601); Loss of MoRF binding (P = 0.253); Gain of glycosylation at S485 (P = 0.2585)
7:117199569:A:C,P13569,I482L,0.727,Gain of ubiquitination at K481 (P = 0.071); Loss of catalytic residue at I482 (P = 0.0881); Loss of glycosylation at S485 (P = 0.1545); Gain of phosphorylation at S485 (P = 0.1853); Gain of disorder (P = 0.2003)
7:117199569:A:G,P13569,I482V,0.692,Loss of catalytic residue at I482 (P = 0.075); Gain of ubiquitination at K481 (P = 0.0843); Gain of methylation at K483 (P = 0.1389); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2111)
7:117199569:A:T,P13569,I482F,0.749,Gain of methylation at K483 (P = 0.0652); Loss of ubiquitination at K483 (P = 0.0816); Gain of disorder (P = 0.1862); Gain of loop (P = 0.2045); Gain of phosphorylation at S478 (P = 0.2156)
7:117199570:T:A,P13569,I482N,0.782,Loss of catalytic residue at I482 (P = 0.029); Gain of disorder (P = 0.0391); Gain of ubiquitination at K483 (P = 0.0594); Loss of stability (P = 0.1052); Loss of glycosylation at S485 (P = 0.1999)
7:117199570:T:C,P13569,I482T,0.735,Loss of stability (P = 0.038); Gain of phosphorylation at I482 (P = 0.0388); Gain of disorder (P = 0.0407); Gain of ubiquitination at K483 (P = 0.0566); Loss of catalytic residue at I482 (P = 0.0825)
7:117199570:T:G,P13569,I482S,0.726,Gain of disorder (P = 0.0085); Loss of catalytic residue at I482 (P = 0.0145); Gain of phosphorylation at I482 (P = 0.041); Gain of ubiquitination at K481 (P = 0.0513); Loss of stability (P = 0.0567)
7:117199571:T:G,P13569,I482M,0.76,Loss of catalytic residue at I482 (P = 0.0318); Gain of ubiquitination at K481 (P = 0.0668); Gain of disorder (P = 0.07); Gain of phosphorylation at S485 (P = 0.1438); Loss of glycosylation at S485 (P = 0.1581)
7:117199572:A:C,P13569,K483Q,0.415,Loss of ubiquitination at K483 (P = 0.0127); Gain of sheet (P = 0.0827); Loss of MoRF binding (P = 0.1542); Loss of phosphorylation at S485 (P = 0.164); Loss of disorder (P = 0.1672)
7:117199572:A:G,P13569,K483E,0.481,Loss of ubiquitination at K483 (P = 0.0127); Loss of MoRF binding (P = 0.087); Gain of glycosylation at S485 (P = 0.0877); Loss of methylation at K483 (P = 0.1787); Gain of phosphorylation at S485 (P = 0.1813)
7:117199573:A:C,P13569,K483T,0.424,Loss of ubiquitination at K483 (P = 0.0127); Loss of disorder (P = 0.0812); Loss of MoRF binding (P = 0.1275); Loss of phosphorylation at S485 (P = 0.1589); Loss of methylation at K483 (P = 0.1787)
7:117199573:A:G,P13569,K483R,0.371,Loss of ubiquitination at K483 (P = 0.0127); Gain of phosphorylation at S485 (P = 0.0942); Loss of glycosylation at S485 (P = 0.1264); Gain of MoRF binding (P = 0.1322); Loss of disorder (P = 0.1438)
7:117199573:A:T,P13569,K483M,0.401,Loss of ubiquitination at K483 (P = 0.0127); Loss of disorder (P = 0.039); Loss of glycosylation at S485 (P = 0.1242); Loss of MoRF binding (P = 0.165); Loss of methylation at K483 (P = 0.1787)
7:117199574:G:C,P13569,K483N,0.438,Loss of ubiquitination at K483 (P = 0.0127); Gain of catalytic residue at K483 (P = 0.0586); Loss of phosphorylation at S485 (P = 0.1088); Loss of disorder (P = 0.1144); Loss of MoRF binding (P = 0.1407)
7:117199574:G:T,P13569,K483N,0.438,Loss of ubiquitination at K483 (P = 0.0127); Gain of catalytic residue at K483 (P = 0.0586); Loss of phosphorylation at S485 (P = 0.1088); Loss of disorder (P = 0.1144); Loss of MoRF binding (P = 0.1407)
7:117199575:C:A,P13569,H484N,0.734,Gain of ubiquitination at K481 (P = 0.0564); Loss of glycosylation at S485 (P = 0.1458); Gain of MoRF binding (P = 0.2105); Loss of phosphorylation at S489 (P = 0.2437); Gain of disorder (P = 0.2475)
7:117199575:C:G,P13569,H484D,0.772,Gain of ubiquitination at K481 (P = 0.0564); Gain of phosphorylation at S485 (P = 0.1333); Loss of MoRF binding (P = 0.1438); Gain of glycosylation at S485 (P = 0.1476); Loss of sheet (P = 0.1501)
7:117199575:C:T,P13569,H484Y,0.826,Loss of disorder (P = 0.0429); Gain of catalytic residue at H484 (P = 0.0512); Loss of ubiquitination at K481 (P = 0.0768); Loss of sheet (P = 0.1501); Loss of glycosylation at S485 (P = 0.1793)
7:117199576:A:C,P13569,H484P,0.778,Gain of catalytic residue at H484 (P = 0.0204); Gain of ubiquitination at K481 (P = 0.0668); Gain of glycosylation at S485 (P = 0.1017); Gain of phosphorylation at S485 (P = 0.1298); Gain of disorder (P = 0.1438)
7:117199576:A:G,P13569,H484R,0.886,Gain of MoRF binding (P = 0.0199); Loss of ubiquitination at K483 (P = 0.0391); Gain of phosphorylation at S485 (P = 0.0939); Loss of glycosylation at S485 (P = 0.1646); Gain of disorder (P = 0.1873)
7:117199576:A:T,P13569,H484L,0.719,Loss of disorder (P = 0.0375); Loss of ubiquitination at K481 (P = 0.0528); Loss of glycosylation at S485 (P = 0.0925); Loss of catalytic residue at I482 (P = 0.1984); Loss of loop (P = 0.2237)
7:117199577:C:A,P13569,H484Q,0.75,Gain of ubiquitination at K481 (P = 0.0594); Gain of disorder (P = 0.165); Gain of MoRF binding (P = 0.1803); Gain of phosphorylation at S489 (P = 0.1868); Gain of glycosylation at S485 (P = 0.2101)
7:117199577:C:G,P13569,H484Q,0.75,Gain of ubiquitination at K481 (P = 0.0594); Gain of disorder (P = 0.165); Gain of MoRF binding (P = 0.1803); Gain of phosphorylation at S489 (P = 0.1868); Gain of glycosylation at S485 (P = 0.2101)
7:117199578:A:C,P13569,S485R,0.611,Loss of glycosylation at S485 (P = 0.029); Gain of MoRF binding (P = 0.0312); Loss of phosphorylation at S485 (P = 0.0427); Gain of ubiquitination at K481 (P = 0.071); Gain of sheet (P = 0.0827)
7:117199578:A:G,P13569,S485G,0.575,Loss of glycosylation at S485 (P = 0.029); Loss of phosphorylation at S485 (P = 0.0427); Gain of ubiquitination at K481 (P = 0.1092); Loss of disorder (P = 0.1168); Gain of sheet (P = 0.1539)
7:117199579:G:A,P13569,S485N,0.484,Loss of glycosylation at S485 (P = 0.029); Loss of phosphorylation at S485 (P = 0.0427); Gain of catalytic residue at S485 (P = 0.0748); Loss of disorder (P = 0.0808); Gain of ubiquitination at K481 (P = 0.0843)
7:117199579:G:T,P13569,S485I,0.636,Loss of disorder (P = 0.0039); Loss of glycosylation at S485 (P = 0.029); Loss of phosphorylation at S485 (P = 0.0427); Loss of ubiquitination at K483 (P = 0.0432); Gain of methylation at K483 (P = 0.0706)
7:117199580:T:A,P13569,S485R,0.611,Loss of glycosylation at S485 (P = 0.029); Gain of MoRF binding (P = 0.0312); Loss of phosphorylation at S485 (P = 0.0427); Gain of ubiquitination at K481 (P = 0.071); Gain of sheet (P = 0.0827)
7:117199580:T:G,P13569,S485R,0.611,Loss of glycosylation at S485 (P = 0.029); Gain of MoRF binding (P = 0.0312); Loss of phosphorylation at S485 (P = 0.0427); Gain of ubiquitination at K481 (P = 0.071); Gain of sheet (P = 0.0827)
7:117199581:G:A,P13569,G486R,0.868,Gain of MoRF binding (P = 0.0274); Loss of glycosylation at S485 (P = 0.0542); Loss of ubiquitination at K483 (P = 0.0589); Gain of phosphorylation at S489 (P = 0.0764); Gain of sheet (P = 0.0827)
7:117199581:G:C,P13569,G486R,0.868,Gain of MoRF binding (P = 0.0274); Loss of glycosylation at S485 (P = 0.0542); Loss of ubiquitination at K483 (P = 0.0589); Gain of phosphorylation at S489 (P = 0.0764); Gain of sheet (P = 0.0827)
7:117199582:G:A,P13569,G486E,0.892,Loss of glycosylation at S485 (P = 0.0503); Gain of ubiquitination at K481 (P = 0.0668); Gain of disorder (P = 0.0795); Gain of catalytic residue at G486 (P = 0.0903); Loss of MoRF binding (P = 0.1026)
7:117199582:G:C,P13569,G486A,0.861,Loss of glycosylation at S485 (P = 0.0506); Loss of ubiquitination at K483 (P = 0.0511); Gain of sheet (P = 0.0827); Loss of disorder (P = 0.084); Gain of catalytic residue at G486 (P = 0.0911)
7:117199582:G:T,P13569,G486V,0.858,Loss of disorder (P = 0.0226); Loss of glycosylation at S485 (P = 0.0389); Loss of ubiquitination at K483 (P = 0.0455); Loss of loop (P = 0.0804); Gain of sheet (P = 0.0827)
7:117199584:A:G,P13569,R487G,0.695,Loss of MoRF binding (P = 0.0746); Gain of ubiquitination at K483 (P = 0.0817); Loss of stability (P = 0.0853); Loss of phosphorylation at S489 (P = 0.1065); Gain of disorder (P = 0.1173)
7:117199585:G:A,P13569,R487K,0.499,Gain of methylation at R487 (P = 0.0137); Gain of ubiquitination at R487 (P = 0.03); Gain of disorder (P = 0.0457); Loss of stability (P = 0.1076); Loss of phosphorylation at S489 (P = 0.112)
7:117199585:G:C,P13569,R487T,0.664,Gain of catalytic residue at F490 (P = 0.0761); Loss of MoRF binding (P = 0.0763); Gain of ubiquitination at K483 (P = 0.0817); Loss of phosphorylation at S489 (P = 0.0884); Gain of methylation at K483 (P = 0.1277)
7:117199585:G:T,P13569,R487I,0.699,Loss of disorder (P = 0.0416); Loss of catalytic residue at R487 (P = 0.0423); Gain of methylation at K483 (P = 0.0493); Loss of ubiquitination at K483 (P = 0.0589); Loss of MoRF binding (P = 0.0757)
7:117199586:A:C,P13569,R487S,0.539,Gain of disorder (P = 0.0324); Gain of phosphorylation at R487 (P = 0.0424); Gain of ubiquitination at K483 (P = 0.0545); Loss of MoRF binding (P = 0.0763); Loss of glycosylation at S485 (P = 0.151)
7:117199586:A:T,P13569,R487S,0.539,Gain of disorder (P = 0.0324); Gain of phosphorylation at R487 (P = 0.0424); Gain of ubiquitination at K483 (P = 0.0545); Loss of MoRF binding (P = 0.0763); Loss of glycosylation at S485 (P = 0.151)
7:117199587:A:C,P13569,I488L,0.764,Gain of ubiquitination at K483 (P = 0.0745); Loss of glycosylation at S485 (P = 0.0862); Gain of disorder (P = 0.1913); Gain of phosphorylation at S489 (P = 0.2143); Loss of MoRF binding (P = 0.2215)
7:117199587:A:G,P13569,I488V,0.693,Gain of ubiquitination at K483 (P = 0.1108); Loss of catalytic residue at I488 (P = 0.155); Loss of glycosylation at S485 (P = 0.1929); Gain of MoRF binding (P = 0.196); Gain of disorder (P = 0.2064)
7:117199587:A:T,P13569,I488F,0.785,Loss of catalytic residue at I488 (P = 0.0664); Loss of sheet (P = 0.0817); Loss of ubiquitination at K483 (P = 0.1601); Loss of MoRF binding (P = 0.1972); Gain of disorder (P = 0.2004)
7:117199588:T:A,P13569,I488N,0.903,Gain of disorder (P = 0.0128); Loss of sheet (P = 0.0457); Gain of ubiquitination at K483 (P = 0.0898); Loss of stability (P = 0.1265); Loss of glycosylation at S485 (P = 0.1385)
7:117199588:T:C,P13569,I488T,0.874,Gain of disorder (P = 0.0218); Loss of stability (P = 0.0465); Gain of ubiquitination at K483 (P = 0.0745); Loss of glycosylation at S485 (P = 0.1392); Loss of sheet (P = 0.1501)
7:117199588:T:G,P13569,I488S,0.861,Gain of disorder (P = 0.0016); Gain of ubiquitination at K483 (P = 0.0594); Loss of stability (P = 0.065); Gain of phosphorylation at S489 (P = 0.0947); Loss of glycosylation at S485 (P = 0.129)
7:117199589:T:G,P13569,I488M,0.94,Gain of disorder (P = 0.0587); Gain of ubiquitination at K483 (P = 0.0898); Loss of catalytic residue at I488 (P = 0.1029); Gain of MoRF binding (P = 0.1096); Loss of glycosylation at S485 (P = 0.1351)
7:117199590:T:A,P13569,S489T,0.894,Loss of disorder (P = 0.0716); Gain of sheet (P = 0.0827); Loss of phosphorylation at S485 (P = 0.1273); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2329)
7:117199590:T:C,P13569,S489P,0.918,Loss of phosphorylation at S489 (P = 0.0554); Loss of catalytic residue at S489 (P = 0.0858); Loss of MoRF binding (P = 0.1113); Loss of disorder (P = 0.1213); Loss of sheet (P = 0.1398)
7:117199590:T:G,P13569,S489A,0.809,Loss of disorder (P = 0.0534); Loss of phosphorylation at S489 (P = 0.0554); Gain of sheet (P = 0.1451); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2109)
7:117199591:C:T,P13569,S489L,0.898,Loss of disorder (P = 0.021); Loss of phosphorylation at S489 (P = 0.0554); Loss of catalytic residue at S489 (P = 0.087); Gain of sheet (P = 0.1451); Loss of glycosylation at S485 (P = 0.1781)
7:117199593:T:A,P13569,F490I,0.807,Loss of sheet (P = 0.0817); Gain of phosphorylation at S489 (P = 0.1583); Gain of MoRF binding (P = 0.1595); Gain of glycosylation at S485 (P = 0.1828); Gain of disorder (P = 0.1946)
7:117199593:T:C,P13569,F490L,0.823,Loss of sheet (P = 0.0817); Gain of glycosylation at S485 (P = 0.1635); Gain of disorder (P = 0.1867); Gain of MoRF binding (P = 0.1977); Loss of phosphorylation at S485 (P = 0.2516)
7:117199593:T:G,P13569,F490V,0.821,Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.1043); Gain of disorder (P = 0.1975); Gain of loop (P = 0.2045); Loss of phosphorylation at S485 (P = 0.2095)
7:117199594:T:A,P13569,F490Y,0.697,Gain of catalytic residue at F490 (P = 0.0497); Loss of sheet (P = 0.1501); Gain of disorder (P = 0.1519); Gain of glycosylation at S485 (P = 0.1948); Gain of MoRF binding (P = 0.2114)
7:117199594:T:C,P13569,F490S,0.836,Gain of disorder (P = 0.002); Gain of phosphorylation at F490 (P = 0.045); Gain of catalytic residue at F490 (P = 0.0581); Loss of sheet (P = 0.0817); Gain of glycosylation at S485 (P = 0.1183)
7:117199594:T:G,P13569,F490C,0.867,Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.1886); Loss of phosphorylation at S485 (P = 0.2143); Loss of disorder (P = 0.2506); Gain of glycosylation at S485 (P = 0.2554)
7:117199595:C:A,P13569,F490L,0.823,Loss of sheet (P = 0.0817); Gain of glycosylation at S485 (P = 0.1635); Gain of disorder (P = 0.1867); Gain of MoRF binding (P = 0.1977); Loss of phosphorylation at S485 (P = 0.2516)
7:117199595:C:G,P13569,F490L,0.823,Loss of sheet (P = 0.0817); Gain of glycosylation at S485 (P = 0.1635); Gain of disorder (P = 0.1867); Gain of MoRF binding (P = 0.1977); Loss of phosphorylation at S485 (P = 0.2516)
7:117199596:T:A,P13569,C491S,0.837,Gain of disorder (P = 0.0012); Loss of catalytic residue at S495 (P = 0.0365); Gain of MoRF binding (P = 0.0696); Gain of phosphorylation at S489 (P = 0.085); Loss of sheet (P = 0.1398)
7:117199596:T:C,P13569,C491R,0.943,Gain of MoRF binding (P = 6e-04); Gain of disorder (P = 0.012); Gain of phosphorylation at S489 (P = 0.0758); Loss of catalytic residue at S495 (P = 0.0849); Loss of sheet (P = 0.1398)
7:117199596:T:G,P13569,C491G,0.878,Gain of disorder (P = 0.0091); Loss of stability (P = 0.0496); Gain of MoRF binding (P = 0.0864); Loss of catalytic residue at S495 (P = 0.0916); Gain of phosphorylation at S489 (P = 0.1112)
7:117199597:G:A,P13569,C491Y,0.729,Gain of sheet (P = 0.0827); Gain of disorder (P = 0.0911); Gain of MoRF binding (P = 0.1089); Loss of catalytic residue at S495 (P = 0.1568); Gain of phosphorylation at S489 (P = 0.1674)
7:117199597:G:C,P13569,C491S,0.837,Gain of disorder (P = 0.0012); Loss of catalytic residue at S495 (P = 0.0365); Gain of MoRF binding (P = 0.0696); Gain of phosphorylation at S489 (P = 0.085); Loss of sheet (P = 0.1398)
7:117199597:G:T,P13569,C491F,0.66,Loss of catalytic residue at C491 (P = 0.0765); Gain of sheet (P = 0.0827); Gain of disorder (P = 0.1149); Gain of phosphorylation at S489 (P = 0.152); Gain of MoRF binding (P = 0.1811)
7:117199598:T:G,P13569,C491W,0.761,Gain of MoRF binding (P = 0.0134); Loss of catalytic residue at S495 (P = 0.1141); Loss of sheet (P = 0.1501); Loss of loop (P = 0.2237); Gain of phosphorylation at S489 (P = 0.2322)
7:117199599:T:A,P13569,S492T,0.84,Loss of catalytic residue at S492 (P = 0.0526); Loss of disorder (P = 0.1225); Gain of sheet (P = 0.1451); Loss of phosphorylation at S489 (P = 0.1546); Gain of MoRF binding (P = 0.2371)
7:117199599:T:C,P13569,S492P,0.881,Loss of MoRF binding (P = 0.1064); Gain of sheet (P = 0.1539); Loss of stability (P = 0.1571); Loss of catalytic residue at S489 (P = 0.1623); Loss of disorder (P = 0.1632)
7:117199599:T:G,P13569,S492A,0.805,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.09); Loss of phosphorylation at S489 (P = 0.1792); Gain of MoRF binding (P = 0.219); Loss of stability (P = 0.3063)
7:117199600:C:A,P13569,S492Y,0.854,Loss of disorder (P = 0.0652); Gain of sheet (P = 0.0827); Loss of phosphorylation at S489 (P = 0.1764); Loss of MoRF binding (P = 0.2146); Loss of loop (P = 0.2237)
7:117199600:C:G,P13569,S492C,0.861,Loss of disorder (P = 0.0509); Gain of sheet (P = 0.0827); Loss of phosphorylation at S489 (P = 0.1129); Loss of MoRF binding (P = 0.1442); Loss of loop (P = 0.2237)
7:117199600:C:T,P13569,S492F,0.904,Loss of catalytic residue at S492 (P = 0.0028); Loss of disorder (P = 0.0605); Gain of sheet (P = 0.0827); Loss of phosphorylation at S489 (P = 0.159); Loss of MoRF binding (P = 0.2127)
7:117199602:C:A,P13569,Q493K,0.943,Gain of methylation at Q493 (P = 0.0013); Gain of MoRF binding (P = 0.0367); Gain of ubiquitination at Q493 (P = 0.0452); Gain of loop (P = 0.0851); Gain of phosphorylation at S489 (P = 0.1442)
7:117199602:C:G,P13569,Q493E,0.957,Gain of sheet (P = 0.0827); Loss of MoRF binding (P = 0.0918); Gain of phosphorylation at S489 (P = 0.1245); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117199603:A:C,P13569,Q493P,0.978,Loss of catalytic residue at Q493 (P = 0.0355); Loss of MoRF binding (P = 0.114); Gain of phosphorylation at S489 (P = 0.1525); Gain of sheet (P = 0.1539); Gain of loop (P = 0.2045)
7:117199603:A:G,P13569,Q493R,0.981,Gain of MoRF binding (P = 0.0177); Gain of sheet (P = 0.0827); Gain of loop (P = 0.0851); Gain of phosphorylation at S495 (P = 0.094); Loss of helix (P = 0.2662)
7:117199603:A:T,P13569,Q493L,0.963,Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.2215); Loss of loop (P = 0.2237); Gain of phosphorylation at S489 (P = 0.257); Loss of helix (P = 0.2662)
7:117199604:G:C,P13569,Q493H,0.955,Gain of sheet (P = 0.0827); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2025); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2193)
7:117199604:G:T,P13569,Q493H,0.955,Gain of sheet (P = 0.0827); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2025); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2193)
7:117199605:T:A,P13569,F494I,0.679,Gain of MoRF binding (P = 0.16); Gain of loop (P = 0.2045); Loss of phosphorylation at S489 (P = 0.2268); Loss of sheet (P = 0.302); Gain of catalytic residue at F494 (P = 0.3216)
7:117199605:T:C,P13569,F494L,0.679,Gain of catalytic residue at F494 (P = 0.0099); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.198); Loss of phosphorylation at S489 (P = 0.2268); Gain of helix (P = 0.2684)
7:117199605:T:G,P13569,F494V,0.68,Gain of catalytic residue at F494 (P = 0.0182); Gain of MoRF binding (P = 0.107); Gain of sheet (P = 0.1451); Gain of loop (P = 0.2045); Loss of phosphorylation at S489 (P = 0.207)
7:117199606:T:A,P13569,F494Y,0.648,Gain of catalytic residue at F494 (P = 0.0735); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.1976); Gain of loop (P = 0.2045); Loss of phosphorylation at S489 (P = 0.2371)
7:117199606:T:C,P13569,F494S,0.646,Gain of disorder (P = 0.0211); Loss of stability (P = 0.0924); Gain of phosphorylation at S489 (P = 0.1161); Gain of MoRF binding (P = 0.1415); Gain of sheet (P = 0.1451)
7:117199606:T:G,P13569,F494C,0.68,Gain of catalytic residue at F494 (P = 0.0522); Gain of sheet (P = 0.1451); Loss of MoRF binding (P = 0.1996); Gain of loop (P = 0.2045); Loss of phosphorylation at S489 (P = 0.2258)
7:117199607:T:A,P13569,F494L,0.679,Gain of catalytic residue at F494 (P = 0.0099); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.198); Loss of phosphorylation at S489 (P = 0.2268); Gain of helix (P = 0.2684)
7:117199607:T:G,P13569,F494L,0.679,Gain of catalytic residue at F494 (P = 0.0099); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.198); Loss of phosphorylation at S489 (P = 0.2268); Gain of helix (P = 0.2684)
7:117199608:T:A,P13569,S495T,0.788,Loss of catalytic residue at S495 (P = 0.0362); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.2307); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117199608:T:C,P13569,S495P,0.761,Loss of catalytic residue at S495 (P = 0.0344); Loss of MoRF binding (P = 0.1167); Loss of loop (P = 0.2237); Loss of stability (P = 0.2385); Loss of helix (P = 0.2662)
7:117199608:T:G,P13569,S495A,0.78,Gain of sheet (P = 0.1451); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.237); Loss of stability (P = 0.5519)
7:117199609:C:A,P13569,S495Y,0.806,Gain of sheet (P = 0.1451); Gain of phosphorylation at S495 (P = 0.199); Loss of MoRF binding (P = 0.2127); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662)
7:117199609:C:G,P13569,S495C,0.822,Loss of MoRF binding (P = 0.143); Loss of sheet (P = 0.1501); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662); Gain of catalytic residue at G500 (P = 0.4279)
7:117199609:C:T,P13569,S495F,0.825,Loss of catalytic residue at S495 (P = 0.0651); Loss of MoRF binding (P = 0.2031); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117199611:T:A,P13569,W496R,0.767,Gain of MoRF binding (P = 0.0343); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.1037); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319)
7:117199611:T:C,P13569,W496R,0.767,Gain of MoRF binding (P = 0.0343); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.1037); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319)
7:117199611:T:G,P13569,W496G,0.754,Gain of glycosylation at S495 (P = 0.0564); Loss of stability (P = 0.0662); Gain of relative solvent accessibility (P = 0.09); Loss of MoRF binding (P = 0.1171); Gain of disorder (P = 0.1243)
7:117199612:G:C,P13569,W496S,0.758,Gain of disorder (P = 0.0198); Loss of catalytic residue at W496 (P = 0.031); Gain of relative solvent accessibility (P = 0.1259); Loss of MoRF binding (P = 0.1316); Gain of helix (P = 0.132)
7:117199612:G:T,P13569,W496L,0.752,Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.1001); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of catalytic residue at W496 (P = 0.2748)
7:117199613:G:T,P13569,W496C,0.737,Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.0852); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of catalytic residue at W496 (P = 0.4207)
7:117199614:A:C,P13569,I497L,0.624,Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.2292); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of stability (P = 0.4689)
7:117199614:A:G,P13569,I497V,0.878,Gain of MoRF binding (P = 0.2056); Loss of loop (P = 0.2237); Loss of stability (P = 0.2569); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117199614:A:T,P13569,I497F,0.83,Loss of helix (P = 0.0558); Gain of sheet (P = 0.1451); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2129); Loss of stability (P = 0.2351)
7:117199615:T:A,P13569,I497N,0.862,Loss of stability (P = 0.0461); Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.1819); Loss of helix (P = 0.3949); Gain of catalytic residue at I497 (P = 0.5321)
7:117199615:T:C,P13569,I497T,0.846,Loss of stability (P = 0.0157); Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.2265); Loss of catalytic residue at I497 (P = 0.2392); Loss of helix (P = 0.2662)
7:117199615:T:G,P13569,I497S,0.868,Loss of stability (P = 0.036); Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.2055); Gain of disorder (P = 0.27); Gain of catalytic residue at I497 (P = 0.3363)
7:117199616:T:G,P13569,I497M,0.729,Loss of catalytic residue at I497 (P = 0.0785); Gain of MoRF binding (P = 0.136); Loss of loop (P = 0.2237); Loss of stability (P = 0.2407); Loss of sheet (P = 0.302)
7:117199617:A:C,P13569,M498L,0.829,Gain of catalytic residue at M498 (P = 0.0229); Loss of methylation at K503 (P = 0.0737); Gain of ubiquitination at K503 (P = 0.1679); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2149)
7:117199617:A:G,P13569,M498V,0.81,Gain of catalytic residue at M498 (P = 0.0031); Loss of methylation at K503 (P = 0.16); Loss of ubiquitination at K503 (P = 0.1778); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2429)
7:117199617:A:T,P13569,M498L,0.829,Gain of catalytic residue at M498 (P = 0.0229); Loss of methylation at K503 (P = 0.0737); Gain of ubiquitination at K503 (P = 0.1679); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2149)
7:117199618:T:A,P13569,M498K,0.831,Gain of methylation at M498 (P = 0.0144); Loss of stability (P = 0.0335); Gain of catalytic residue at M498 (P = 0.0394); Loss of helix (P = 0.0558); Gain of MoRF binding (P = 0.0775)
7:117199618:T:C,P13569,M498T,0.862,Loss of helix (P = 0.0558); Loss of stability (P = 0.0663); Gain of loop (P = 0.0851); Gain of sheet (P = 0.1451); Loss of methylation at K503 (P = 0.1473)
7:117199618:T:G,P13569,M498R,0.833,Gain of catalytic residue at M498 (P = 0.0095); Loss of methylation at K503 (P = 0.0433); Gain of MoRF binding (P = 0.0452); Gain of phosphorylation at T501 (P = 0.0946); Loss of stability (P = 0.1207)
7:117199619:G:A,P13569,M498I,0.902,Gain of catalytic residue at M498 (P = 0.0019); Gain of methylation at K503 (P = 0.1424); Gain of ubiquitination at K503 (P = 0.143); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117199619:G:C,P13569,M498I,0.902,Gain of catalytic residue at M498 (P = 0.0019); Gain of methylation at K503 (P = 0.1424); Gain of ubiquitination at K503 (P = 0.143); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117199619:G:T,P13569,M498I,0.902,Gain of catalytic residue at M498 (P = 0.0019); Gain of methylation at K503 (P = 0.1424); Gain of ubiquitination at K503 (P = 0.143); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117199620:C:A,P13569,P499T,0.683,Loss of helix (P = 0.0558); Gain of MoRF binding (P = 0.0985); Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at K503 (P = 0.1707); Loss of ubiquitination at K503 (P = 0.1778)
7:117199620:C:G,P13569,P499A,0.857,Loss of helix (P = 0.0558); Loss of methylation at K503 (P = 0.0628); Gain of MoRF binding (P = 0.0946); Loss of ubiquitination at K503 (P = 0.1612); Gain of sheet (P = 0.1945)
7:117199621:C:A,P13569,P499H,0.783,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of MoRF binding (P = 0.0963); Loss of methylation at K503 (P = 0.1333); Gain of catalytic residue at G500 (P = 0.1576)
7:117199621:C:G,P13569,P499R,0.679,Gain of MoRF binding (P = 0.0012); Loss of helix (P = 0.028); Loss of methylation at K503 (P = 0.1042); Loss of ubiquitination at K503 (P = 0.1154); Gain of relative solvent accessibility (P = 0.1259)
7:117199621:C:T,P13569,P499L,0.733,Loss of helix (P = 0.0558); Loss of methylation at K503 (P = 0.0559); Loss of catalytic residue at P499 (P = 0.094); Loss of ubiquitination at K503 (P = 0.1446); Gain of MoRF binding (P = 0.1564)
7:117199623:G:A,P13569,G500S,0.886,Loss of methylation at K503 (P = 0.1458); Loss of ubiquitination at K503 (P = 0.1778); Gain of helix (P = 0.2684); Gain of MoRF binding (P = 0.276); Gain of phosphorylation at S495 (P = 0.4376)
7:117199623:G:C,P13569,G500R,0.851,Gain of MoRF binding (P = 0.0161); Gain of catalytic residue at G500 (P = 0.0884); Loss of ubiquitination at K503 (P = 0.0931); Loss of helix (P = 0.1299); Loss of methylation at K503 (P = 0.135)
7:117199623:G:T,P13569,G500C,0.843,Gain of catalytic residue at M498 (P = 2e-04); Loss of helix (P = 0.1299); Gain of methylation at K503 (P = 0.1405); Loss of ubiquitination at K503 (P = 0.1778); Loss of loop (P = 0.2237)
7:117199624:G:A,P13569,G500D,0.901,Loss of methylation at K503 (P = 0.0708); Gain of relative solvent accessibility (P = 0.1259); Loss of ubiquitination at K503 (P = 0.1778); Gain of loop (P = 0.2045); Gain of catalytic residue at G500 (P = 0.2076)
7:117199624:G:C,P13569,G500A,0.864,Loss of methylation at K503 (P = 0.11); Loss of helix (P = 0.1299); Loss of ubiquitination at K503 (P = 0.1923); Gain of loop (P = 0.2045); Gain of catalytic residue at G500 (P = 0.2728)
7:117199624:G:T,P13569,G500V,0.854,Loss of helix (P = 0.1299); Loss of ubiquitination at K503 (P = 0.1446); Gain of methylation at K503 (P = 0.1586); Gain of loop (P = 0.2045); Loss of catalytic residue at T501 (P = 0.2977)
7:117199626:A:C,P13569,T501P,0.945,Gain of methylation at K503 (P = 0.0978); Gain of catalytic residue at G500 (P = 0.1251); Loss of ubiquitination at K503 (P = 0.1923); Loss of helix (P = 0.2271); Loss of stability (P = 0.2526)
7:117199626:A:G,P13569,T501A,0.968,Gain of ubiquitination at K503 (P = 0.143); Loss of methylation at K503 (P = 0.1655); Loss of helix (P = 0.2022); Loss of loop (P = 0.2897); Loss of stability (P = 0.2985)
7:117199626:A:T,P13569,T501S,0.934,Loss of methylation at K503 (P = 0.1578); Gain of ubiquitination at K503 (P = 0.1679); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.3021); Gain of phosphorylation at T501 (P = 0.3552)
7:117199627:C:A,P13569,T501N,0.933,Loss of methylation at K503 (P = 0.1441); Loss of ubiquitination at K503 (P = 0.1923); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.3139)
7:117199627:C:G,P13569,T501S,0.934,Loss of methylation at K503 (P = 0.1578); Gain of ubiquitination at K503 (P = 0.1679); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.3021); Gain of phosphorylation at T501 (P = 0.3552)
7:117199627:C:T,P13569,T501I,0.933,Gain of methylation at K503 (P = 0.0853); Loss of catalytic residue at T501 (P = 0.1001); Gain of helix (P = 0.132); Loss of ubiquitination at K503 (P = 0.1612); Loss of loop (P = 0.2237)
7:117199629:A:C,P13569,I502L,0.801,Loss of methylation at K503 (P = 0.0553); Gain of helix (P = 0.132); Gain of ubiquitination at K503 (P = 0.143); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.3928)
7:117199629:A:G,P13569,I502V,0.613,Gain of methylation at K503 (P = 0.0783); Gain of ubiquitination at K503 (P = 0.1679); Gain of helix (P = 0.1736); Loss of catalytic residue at I502 (P = 0.1859); Loss of loop (P = 0.2237)
7:117199629:A:T,P13569,I502F,0.807,Gain of methylation at K503 (P = 0.0559); Loss of catalytic residue at I502 (P = 0.0581); Gain of ubiquitination at K503 (P = 0.0982); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117199630:T:A,P13569,I502N,0.939,Loss of catalytic residue at I502 (P = 0.0077); Loss of methylation at K503 (P = 0.1131); Loss of ubiquitination at K503 (P = 0.1154); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117199630:T:C,P13569,I502T,0.953,Gain of phosphorylation at I502 (P = 0.0612); Loss of stability (P = 0.0773); Loss of methylation at K503 (P = 0.0851); Gain of helix (P = 0.132); Loss of ubiquitination at K503 (P = 0.1612)
7:117199630:T:G,P13569,I502S,0.909,Loss of methylation at K503 (P = 0.0895); Loss of ubiquitination at K503 (P = 0.1154); Gain of helix (P = 0.132); Loss of stability (P = 0.146); Gain of disorder (P = 0.1785)
7:117199631:T:G,P13569,I502M,0.79,Loss of catalytic residue at I502 (P = 9e-04); Loss of methylation at K503 (P = 0.0258); Gain of helix (P = 0.1736); Loss of ubiquitination at K503 (P = 0.1778); Gain of loop (P = 0.2045)
7:117199632:A:C,P13569,K503Q,0.809,Loss of methylation at K503 (P = 0.0137); Loss of ubiquitination at K503 (P = 0.0297); Loss of helix (P = 0.2271); Gain of loop (P = 0.2754); Loss of MoRF binding (P = 0.4335)
7:117199632:A:G,P13569,K503E,0.802,Loss of methylation at K503 (P = 0.0137); Loss of ubiquitination at K503 (P = 0.0297); Loss of helix (P = 0.1706); Gain of relative solvent accessibility (P = 0.2363); Loss of catalytic residue at K503 (P = 0.2433)
7:117199633:A:C,P13569,K503T,0.795,Loss of methylation at K503 (P = 0.0137); Loss of ubiquitination at K503 (P = 0.0297); Loss of helix (P = 0.1299); Gain of phosphorylation at K503 (P = 0.1599); Gain of loop (P = 0.2045)
7:117199633:A:G,P13569,K503R,0.747,Loss of methylation at K503 (P = 0.0179); Loss of ubiquitination at K503 (P = 0.0297); Loss of catalytic residue at K503 (P = 0.1858); Loss of helix (P = 0.2271); Gain of relative solvent accessibility (P = 0.2363)
7:117199633:A:T,P13569,K503I,0.804,Loss of methylation at K503 (P = 0.0137); Loss of ubiquitination at K503 (P = 0.0297); Gain of loop (P = 0.2045); Gain of helix (P = 0.2294); Loss of catalytic residue at K503 (P = 0.3242)
7:117199634:A:C,P13569,K503N,0.789,Loss of methylation at K503 (P = 0.0137); Loss of ubiquitination at K503 (P = 0.0297); Loss of catalytic residue at K503 (P = 0.061); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117199634:A:T,P13569,K503N,0.789,Loss of methylation at K503 (P = 0.0137); Loss of ubiquitination at K503 (P = 0.0297); Loss of catalytic residue at K503 (P = 0.061); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117199635:G:A,P13569,E504K,0.723,Gain of methylation at E504 (P = 0.0087); Gain of ubiquitination at E504 (P = 0.0276); Gain of MoRF binding (P = 0.0754); Loss of catalytic residue at E504 (P = 0.1237); Gain of helix (P = 0.2059)
7:117199635:G:C,P13569,E504Q,0.856,Gain of methylation at K503 (P = 0.108); Loss of ubiquitination at K503 (P = 0.1923); Loss of helix (P = 0.2662); Gain of MoRF binding (P = 0.3065); Gain of sheet (P = 0.4423)
7:117199636:A:C,P13569,E504A,0.772,Loss of methylation at K503 (P = 0.1086); Loss of ubiquitination at K503 (P = 0.1446); Gain of catalytic residue at N505 (P = 0.2133); Loss of helix (P = 0.2662); Gain of glycosylation at T501 (P = 0.3061)
7:117199636:A:G,P13569,E504G,0.75,Gain of catalytic residue at N505 (P = 0.1173); Loss of stability (P = 0.132); Loss of methylation at K503 (P = 0.1525); Loss of helix (P = 0.1706); Loss of ubiquitination at K503 (P = 0.1923)
7:117199636:A:T,P13569,E504V,0.738,Gain of methylation at K503 (P = 0.0626); Loss of catalytic residue at E504 (P = 0.1199); Loss of helix (P = 0.1299); Loss of ubiquitination at K503 (P = 0.1446); Gain of MoRF binding (P = 0.2796)
7:117199637:A:C,P13569,E504D,0.647,Loss of methylation at K503 (P = 0.0794); Gain of relative solvent accessibility (P = 0.1259); Gain of ubiquitination at K503 (P = 0.1679); Gain of solvent accessibility (P = 0.2291); Gain of helix (P = 0.2294)
7:117199637:A:T,P13569,E504D,0.647,Loss of methylation at K503 (P = 0.0794); Gain of relative solvent accessibility (P = 0.1259); Gain of ubiquitination at K503 (P = 0.1679); Gain of solvent accessibility (P = 0.2291); Gain of helix (P = 0.2294)
7:117199638:A:C,P13569,N505H,0.901,Gain of methylation at K503 (P = 0.1387); Loss of stability (P = 0.1436); Loss of ubiquitination at K503 (P = 0.1778); Gain of helix (P = 0.2294); Gain of loop (P = 0.2754)
7:117199638:A:G,P13569,N505D,0.912,Loss of methylation at K503 (P = 0.0705); Gain of catalytic residue at N505 (P = 0.1459); Gain of ubiquitination at K503 (P = 0.1679); Loss of helix (P = 0.1706); Loss of stability (P = 0.3059)
7:117199638:A:T,P13569,N505Y,0.879,Loss of methylation at K503 (P = 0.1136); Gain of ubiquitination at K503 (P = 0.143); Loss of catalytic residue at K503 (P = 0.1582); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754)
7:117199639:A:C,P13569,N505T,0.886,Loss of methylation at K503 (P = 0.1673); Gain of phosphorylation at T501 (P = 0.1677); Gain of ubiquitination at K503 (P = 0.1679); Loss of helix (P = 0.1706); Gain of catalytic residue at F508 (P = 0.2266)
7:117199639:A:G,P13569,N505S,0.911,Loss of methylation at K503 (P = 0.1074); Gain of ubiquitination at K503 (P = 0.143); Loss of stability (P = 0.165); Loss of catalytic residue at K503 (P = 0.2256); Gain of loop (P = 0.2754)
7:117199639:A:T,P13569,N505I,0.856,Gain of methylation at K503 (P = 0.1005); Loss of ubiquitination at K503 (P = 0.1923); Gain of helix (P = 0.2294); Gain of loop (P = 0.2754); Loss of catalytic residue at K503 (P = 0.3044)
7:117199640:T:A,P13569,N505K,0.866,Gain of methylation at N505 (P = 0.0054); Gain of ubiquitination at N505 (P = 0.0337); Loss of stability (P = 0.1361); Loss of helix (P = 0.1706); Gain of catalytic residue at N505 (P = 0.2067)
7:117199640:T:G,P13569,N505K,0.866,Gain of methylation at N505 (P = 0.0054); Gain of ubiquitination at N505 (P = 0.0337); Loss of stability (P = 0.1361); Loss of helix (P = 0.1706); Gain of catalytic residue at N505 (P = 0.2067)
7:117199641:A:C,P13569,I506L,0.847,Loss of methylation at K503 (P = 0.0521); Gain of catalytic residue at I506 (P = 0.0887); Loss of helix (P = 0.1299); Loss of ubiquitination at K503 (P = 0.1923); Gain of loop (P = 0.2754)
7:117199641:A:T,P13569,I506F,0.653,Loss of methylation at K503 (P = 0.0921); Loss of ubiquitination at K503 (P = 0.1612); Gain of catalytic residue at I506 (P = 0.1979); Loss of helix (P = 0.2022); Loss of loop (P = 0.2237)
7:117199642:T:A,P13569,I506N,0.788,Gain of catalytic residue at I506 (P = 0.0222); Loss of stability (P = 0.0316); Loss of methylation at K503 (P = 0.0793); Loss of ubiquitination at K503 (P = 0.1154); Loss of helix (P = 0.2022)
7:117199642:T:C,P13569,I506T,0.919,Loss of stability (P = 0.009); Gain of phosphorylation at I506 (P = 0.0658); Loss of methylation at K503 (P = 0.0899); Loss of ubiquitination at K503 (P = 0.0931); Loss of helix (P = 0.2022)
7:117199642:T:G,P13569,I506S,0.915,Loss of stability (P = 0.0356); Loss of methylation at K503 (P = 0.065); Loss of ubiquitination at K503 (P = 0.0931); Gain of disorder (P = 0.1829); Gain of catalytic residue at I506 (P = 0.1928)
7:117199643:C:G,P13569,I506M,0.833,Loss of methylation at K503 (P = 0.1145); Gain of ubiquitination at K503 (P = 0.1679); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Loss of stability (P = 0.2803)
7:117199644:A:C,P13569,I507L,0.552,Loss of methylation at K503 (P = 0.0493); Loss of stability (P = 0.0908); Gain of ubiquitination at K503 (P = 0.1679); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754)
7:117199644:A:T,P13569,I507F,0.682,Loss of stability (P = 0.0521); Loss of methylation at K503 (P = 0.0994); Loss of ubiquitination at K503 (P = 0.1612); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117199645:T:A,P13569,I507N,0.759,Loss of stability (P = 0.0112); Loss of methylation at K503 (P = 0.0788); Loss of ubiquitination at K503 (P = 0.1446); Loss of helix (P = 0.1706); Gain of phosphorylation at Y512 (P = 0.2465)
7:117199645:T:C,P13569,I507T,0.598,Loss of stability (P = 0.0055); Gain of ubiquitination at K503 (P = 0.0751); Loss of helix (P = 0.1299); Loss of methylation at K503 (P = 0.1645); Gain of phosphorylation at Y512 (P = 0.1879)
7:117199645:T:G,P13569,I507S,0.592,Loss of stability (P = 0.0081); Gain of ubiquitination at K503 (P = 0.0751); Loss of methylation at K503 (P = 0.1138); Gain of disorder (P = 0.136); Gain of phosphorylation at Y512 (P = 0.1842)
7:117199646:C:G,P13569,I507M,0.583,Loss of stability (P = 0.0688); Loss of methylation at K503 (P = 0.1087); Gain of ubiquitination at K503 (P = 0.1191); Gain of phosphorylation at Y512 (P = 0.1715); Gain of loop (P = 0.2045)
7:117199647:T:A,P13569,F508I,0.634,Gain of methylation at K503 (P = 0.1235); Gain of helix (P = 0.1736); Gain of catalytic residue at F508 (P = 0.1901); Loss of ubiquitination at K503 (P = 0.1923); Gain of loop (P = 0.3485)
7:117199647:T:C,P13569,F508L,0.665,Loss of methylation at K503 (P = 0.0779); Gain of helix (P = 0.1736); Loss of ubiquitination at K503 (P = 0.1778); Gain of catalytic residue at F508 (P = 0.2564); Gain of loop (P = 0.2754)
7:117199647:T:G,P13569,F508V,0.649,Gain of catalytic residue at F508 (P = 0.1135); Loss of ubiquitination at K503 (P = 0.1446); Gain of methylation at K503 (P = 0.1651); Loss of stability (P = 0.1691); Gain of helix (P = 0.1736)
7:117199648:T:A,P13569,F508Y,0.723,Gain of methylation at K503 (P = 0.075); Gain of phosphorylation at F508 (P = 0.1303); Loss of ubiquitination at K503 (P = 0.1446); Loss of stability (P = 0.1633); Gain of helix (P = 0.1736)
7:117199648:T:C,P13569,F508S,0.921,Gain of glycosylation at F508 (P = 0.029); Gain of disorder (P = 0.0551); Loss of stability (P = 0.0695); Gain of methylation at K503 (P = 0.1177); Gain of phosphorylation at Y512 (P = 0.1194)
7:117199649:T:A,P13569,F508L,0.665,Loss of methylation at K503 (P = 0.0779); Gain of helix (P = 0.1736); Loss of ubiquitination at K503 (P = 0.1778); Gain of catalytic residue at F508 (P = 0.2564); Gain of loop (P = 0.2754)
7:117199649:T:G,P13569,F508L,0.665,Loss of methylation at K503 (P = 0.0779); Gain of helix (P = 0.1736); Loss of ubiquitination at K503 (P = 0.1778); Gain of catalytic residue at F508 (P = 0.2564); Gain of loop (P = 0.2754)
7:117199650:G:A,P13569,G509S,0.815,Loss of catalytic residue at V510 (P = 0.0752); Gain of helix (P = 0.2059); Gain of disorder (P = 0.4085); Gain of phosphorylation at G509 (P = 0.4255); Loss of sheet (P = 0.437)
7:117199650:G:C,P13569,G509R,0.866,Loss of catalytic residue at V510 (P = 0.0488); Gain of phosphorylation at S511 (P = 0.1322); Gain of MoRF binding (P = 0.1778); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437)
7:117199650:G:T,P13569,G509C,0.847,Loss of catalytic residue at V510 (P = 0.0952); Gain of helix (P = 0.2059); Loss of phosphorylation at Y512 (P = 0.3407); Loss of sheet (P = 0.5184); Loss of disorder (P = 0.5866)
7:117199651:G:A,P13569,G509D,0.87,Loss of catalytic residue at V510 (P = 0.0572); Gain of phosphorylation at Y512 (P = 0.1066); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117199651:G:C,P13569,G509A,0.839,Loss of catalytic residue at V510 (P = 0.0992); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Loss of phosphorylation at Y512 (P = 0.4502); Loss of stability (P = 0.6344)
7:117199651:G:T,P13569,G509V,0.836,Loss of catalytic residue at I507 (P = 0.088); Gain of helix (P = 0.2059); Loss of loop (P = 0.2237); Loss of phosphorylation at Y512 (P = 0.3697); Loss of sheet (P = 0.437)
7:117199653:G:C,P13569,V510L,0.349,Loss of helix (P = 0.1706); Loss of catalytic residue at D513 (P = 0.2845); Loss of phosphorylation at Y512 (P = 0.4321); Loss of sheet (P = 0.437); Loss of MoRF binding (P = 0.6546)
7:117199653:G:T,P13569,V510F,0.398,Loss of helix (P = 0.2022); Loss of stability (P = 0.3045); Loss of phosphorylation at Y512 (P = 0.4025); Loss of catalytic residue at V510 (P = 0.4171); Loss of sheet (P = 0.437)
7:117199654:T:A,P13569,V510D,0.517,Gain of phosphorylation at Y512 (P = 0.0742); Gain of disorder (P = 0.1074); Loss of helix (P = 0.2022); Loss of catalytic residue at D513 (P = 0.213); Loss of stability (P = 0.2502)
7:117199654:T:C,P13569,V510A,0.392,Loss of stability (P = 0.1691); Loss of helix (P = 0.2022); Loss of catalytic residue at D513 (P = 0.273); Gain of phosphorylation at Y512 (P = 0.3629); Loss of sheet (P = 0.437)
7:117199654:T:G,P13569,V510G,0.479,Loss of stability (P = 0.0162); Gain of disorder (P = 0.1972); Gain of phosphorylation at Y512 (P = 0.3429); Gain of catalytic residue at G509 (P = 0.3931); Loss of helix (P = 0.3949)
7:117199656:T:A,P13569,S511T,0.306,Gain of phosphorylation at S511 (P = 0.1633); Loss of helix (P = 0.2022); Loss of loop (P = 0.2237); Loss of catalytic residue at G509 (P = 0.2736); Gain of methylation at R516 (P = 0.4388)
7:117199656:T:C,P13569,S511P,0.377,Loss of catalytic residue at S511 (P = 0.0204); Gain of helix (P = 0.1736); Gain of phosphorylation at Y512 (P = 0.3459); Gain of sheet (P = 0.4423); Loss of methylation at R516 (P = 0.4438)
7:117199656:T:G,P13569,S511A,0.405,Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of catalytic residue at G509 (P = 0.277); Loss of relative solvent accessibility (P = 0.3919); Loss of solvent accessibility (P = 0.4011)
7:117199657:C:A,P13569,S511Y,0.489,Loss of catalytic residue at S511 (P = 0.0752); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of relative solvent accessibility (P = 0.3219); Loss of phosphorylation at Y512 (P = 0.4036)
7:117199657:C:G,P13569,S511C,0.514,Loss of catalytic residue at S511 (P = 0.081); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of phosphorylation at Y512 (P = 0.3422); Loss of relative solvent accessibility (P = 0.3919)
7:117199657:C:T,P13569,S511F,0.519,Loss of catalytic residue at S511 (P = 0.0929); Gain of helix (P = 0.1736); Loss of relative solvent accessibility (P = 0.1807); Loss of solvent accessibility (P = 0.1952); Loss of loop (P = 0.2237)
7:117199659:T:A,P13569,Y512N,0.782,Gain of relative solvent accessibility (P = 0.1259); Loss of stability (P = 0.1293); Loss of helix (P = 0.1706); Loss of phosphorylation at Y512 (P = 0.2246); Gain of solvent accessibility (P = 0.2346)
7:117199659:T:C,P13569,Y512H,0.748,Loss of stability (P = 0.1152); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237); Loss of phosphorylation at Y512 (P = 0.2246); Gain of disorder (P = 0.2373)
7:117199659:T:G,P13569,Y512D,0.802,Gain of disorder (P = 0.0888); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at Y515 (P = 0.0998); Loss of catalytic residue at Y512 (P = 0.1374); Gain of solvent accessibility (P = 0.1376)
7:117199660:A:C,P13569,Y512S,0.791,Gain of disorder (P = 0.0319); Loss of stability (P = 0.1169); Gain of relative solvent accessibility (P = 0.1259); Loss of catalytic residue at Y512 (P = 0.1276); Loss of helix (P = 0.1299)
7:117199660:A:G,P13569,Y512C,0.756,Loss of catalytic residue at Y512 (P = 0.1049); Loss of loop (P = 0.2237); Loss of phosphorylation at Y512 (P = 0.2246); Loss of stability (P = 0.2475); Gain of helix (P = 0.2684)
7:117199660:A:T,P13569,Y512F,0.755,Loss of phosphorylation at Y512 (P = 0.2246); Gain of helix (P = 0.2684); Loss of catalytic residue at Y512 (P = 0.4034); Gain of methylation at R516 (P = 0.4187); Loss of sheet (P = 0.5184)
7:117199662:G:A,P13569,D513N,0.706,Loss of loop (P = 0.2237); Gain of methylation at R516 (P = 0.2684); Gain of helix (P = 0.2684); Loss of phosphorylation at Y512 (P = 0.3657); Gain of MoRF binding (P = 0.4051)
7:117199662:G:C,P13569,D513H,0.708,Gain of methylation at R516 (P = 0.1424); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Loss of phosphorylation at Y512 (P = 0.3884); Gain of catalytic residue at E514 (P = 0.4266)
7:117199662:G:T,P13569,D513Y,0.685,Loss of helix (P = 0.1706); Loss of loop (P = 0.2237); Gain of methylation at R516 (P = 0.2834); Loss of phosphorylation at Y512 (P = 0.3383); Gain of MoRF binding (P = 0.4224)
7:117199663:A:C,P13569,D513A,0.747,Gain of methylation at R516 (P = 0.1629); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.3314); Loss of solvent accessibility (P = 0.3543); Loss of helix (P = 0.3949)
7:117199663:A:G,P13569,D513G,0.847,Gain of methylation at R516 (P = 0.1308); Loss of loop (P = 0.2237); Gain of catalytic residue at R516 (P = 0.3526); Gain of MoRF binding (P = 0.359); Loss of phosphorylation at Y512 (P = 0.3779)
7:117199663:A:T,P13569,D513V,0.731,Loss of catalytic residue at D513 (P = 0.1236); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Gain of MoRF binding (P = 0.2962); Gain of methylation at R516 (P = 0.3107)
7:117199664:T:A,P13569,D513E,0.631,Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Gain of methylation at R516 (P = 0.383); Loss of phosphorylation at Y512 (P = 0.4001); Loss of sheet (P = 0.437)
7:117199664:T:G,P13569,D513E,0.631,Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Gain of methylation at R516 (P = 0.383); Loss of phosphorylation at Y512 (P = 0.4001); Loss of sheet (P = 0.437)
7:117199665:G:A,P13569,E514K,0.68,Gain of ubiquitination at E514 (P = 0.0351); Gain of MoRF binding (P = 0.0695); Loss of stability (P = 0.0926); Loss of catalytic residue at D513 (P = 0.2528); Loss of phosphorylation at S519 (P = 0.261)
7:117199665:G:C,P13569,E514Q,0.642,Loss of phosphorylation at S519 (P = 0.1606); Loss of stability (P = 0.2752); Gain of MoRF binding (P = 0.3673); Gain of catalytic residue at R518 (P = 0.3791); Loss of solvent accessibility (P = 0.4141)
7:117199666:A:C,P13569,E514A,0.645,Loss of solvent accessibility (P = 0.0404); Loss of stability (P = 0.117); Loss of phosphorylation at S519 (P = 0.1807); Loss of helix (P = 0.2271); Gain of methylation at R516 (P = 0.2714)
7:117199666:A:G,P13569,E514G,0.639,Loss of solvent accessibility (P = 0.0187); Loss of stability (P = 0.0452); Loss of phosphorylation at S519 (P = 0.1868); Gain of methylation at R516 (P = 0.2183); Gain of catalytic residue at R516 (P = 0.2564)
7:117199666:A:T,P13569,E514V,0.657,Loss of catalytic residue at E514 (P = 0.1089); Loss of solvent accessibility (P = 0.1144); Loss of phosphorylation at S519 (P = 0.1542); Loss of loop (P = 0.2237); Loss of helix (P = 0.2271)
7:117199667:A:C,P13569,E514D,0.559,Loss of solvent accessibility (P = 0.1813); Loss of phosphorylation at S519 (P = 0.2496); Loss of stability (P = 0.2837); Loss of catalytic residue at E514 (P = 0.3518); Loss of sheet (P = 0.437)
7:117199667:A:T,P13569,E514D,0.559,Loss of solvent accessibility (P = 0.1813); Loss of phosphorylation at S519 (P = 0.2496); Loss of stability (P = 0.2837); Loss of catalytic residue at E514 (P = 0.3518); Loss of sheet (P = 0.437)
7:117199668:T:A,P13569,Y515N,0.686,Gain of relative solvent accessibility (P = 0.1571); Gain of disorder (P = 0.189); Gain of phosphorylation at S519 (P = 0.2457); Loss of stability (P = 0.2743); Gain of solvent accessibility (P = 0.3194)
7:117199668:T:C,P13569,Y515H,0.811,Gain of relative solvent accessibility (P = 0.1571); Loss of phosphorylation at S519 (P = 0.1961); Loss of stability (P = 0.2235); Gain of disorder (P = 0.2249); Gain of solvent accessibility (P = 0.2455)
7:117199668:T:G,P13569,Y515D,0.633,Gain of disorder (P = 0.0555); Gain of relative solvent accessibility (P = 0.1571); Gain of phosphorylation at S519 (P = 0.1584); Gain of catalytic residue at Y515 (P = 0.1895); Loss of loop (P = 0.2237)
7:117199669:A:C,P13569,Y515S,0.537,Gain of disorder (P = 0.023); Gain of phosphorylation at Y515 (P = 0.0648); Gain of relative solvent accessibility (P = 0.1571); Loss of stability (P = 0.1667); Loss of catalytic residue at E514 (P = 0.4)
7:117199669:A:G,P13569,Y515C,0.617,Gain of catalytic residue at S519 (P = 0.2196); Loss of phosphorylation at S519 (P = 0.2414); Gain of relative solvent accessibility (P = 0.2751); Gain of methylation at R516 (P = 0.4372); Loss of sheet (P = 0.5184)
7:117199669:A:T,P13569,Y515F,0.587,Loss of phosphorylation at S519 (P = 0.2641); Gain of catalytic residue at R516 (P = 0.3388); Gain of methylation at R516 (P = 0.4199); Loss of sheet (P = 0.5184); Gain of MoRF binding (P = 0.5962)
7:117199671:A:G,P13569,R516G,0.888,Loss of phosphorylation at S519 (P = 0.0739); Loss of solvent accessibility (P = 0.1235); Gain of loop (P = 0.2045); Gain of catalytic residue at R516 (P = 0.2176); Loss of methylation at R516 (P = 0.3584)
7:117199672:G:A,P13569,R516K,0.724,Gain of ubiquitination at R516 (P = 0.0539); Loss of phosphorylation at S519 (P = 0.0848); Gain of loop (P = 0.2045); Loss of catalytic residue at Y517 (P = 0.2435); Gain of methylation at R516 (P = 0.3937)
7:117199672:G:C,P13569,R516T,0.74,Gain of phosphorylation at R516 (P = 0.0305); Loss of solvent accessibility (P = 0.1473); Gain of loop (P = 0.2045); Loss of methylation at R516 (P = 0.3584); Loss of catalytic residue at R516 (P = 0.3812)
7:117199672:G:T,P13569,R516I,0.78,Loss of phosphorylation at S519 (P = 0.0594); Gain of catalytic residue at R516 (P = 0.1777); Loss of solvent accessibility (P = 0.1952); Gain of loop (P = 0.2045); Loss of helix (P = 0.2271)
7:117199673:A:C,P13569,R516S,0.809,Loss of phosphorylation at S519 (P = 0.0893); Loss of solvent accessibility (P = 0.1362); Gain of loop (P = 0.2045); Gain of catalytic residue at R516 (P = 0.3174); Loss of methylation at R516 (P = 0.3584)
7:117199673:A:T,P13569,R516S,0.809,Loss of phosphorylation at S519 (P = 0.0893); Loss of solvent accessibility (P = 0.1362); Gain of loop (P = 0.2045); Gain of catalytic residue at R516 (P = 0.3174); Loss of methylation at R516 (P = 0.3584)
7:117199674:T:A,P13569,Y517N,0.768,Loss of stability (P = 0.0524); Loss of catalytic residue at Y517 (P = 0.1325); Loss of phosphorylation at S519 (P = 0.1797); Loss of ubiquitination at K522 (P = 0.1808); Loss of methylation at K522 (P = 0.187)
7:117199674:T:C,P13569,Y517H,0.772,Loss of stability (P = 0.0423); Loss of catalytic residue at Y517 (P = 0.074); Gain of ubiquitination at K522 (P = 0.1575); Loss of methylation at K522 (P = 0.1957); Gain of disorder (P = 0.2456)
7:117199674:T:G,P13569,Y517D,0.807,Loss of catalytic residue at Y517 (P = 0.0614); Gain of disorder (P = 0.0635); Loss of stability (P = 0.1207); Gain of phosphorylation at S519 (P = 0.1441); Loss of ubiquitination at K522 (P = 0.1962)
7:117199675:A:C,P13569,Y517S,0.768,Gain of disorder (P = 0.0249); Loss of stability (P = 0.0318); Gain of phosphorylation at Y517 (P = 0.0509); Loss of methylation at K522 (P = 0.1715); Loss of catalytic residue at Y517 (P = 0.2022)
7:117199675:A:G,P13569,Y517C,0.88,Loss of catalytic residue at Y517 (P = 0.0481); Loss of stability (P = 0.1157); Loss of methylation at K522 (P = 0.1739); Loss of ubiquitination at K522 (P = 0.1962); Loss of phosphorylation at S519 (P = 0.2117)
7:117199675:A:T,P13569,Y517F,0.73,Loss of methylation at K522 (P = 0.137); Loss of ubiquitination at K522 (P = 0.152); Loss of stability (P = 0.2188); Loss of phosphorylation at S519 (P = 0.2303); Gain of catalytic residue at R518 (P = 0.2938)
7:117199677:A:G,P13569,R518G,0.61,Loss of solvent accessibility (P = 0.0509); Loss of phosphorylation at S519 (P = 0.1391); Loss of ubiquitination at K522 (P = 0.152); Loss of stability (P = 0.1779); Gain of methylation at K522 (P = 0.2047)
7:117199678:G:A,P13569,R518K,0.566,Gain of ubiquitination at R518 (P = 0.0494); Loss of phosphorylation at S519 (P = 0.1561); Loss of catalytic residue at S519 (P = 0.1691); Gain of methylation at K522 (P = 0.2306); Loss of stability (P = 0.3359)
7:117199678:G:C,P13569,R518T,0.629,Loss of phosphorylation at S519 (P = 0.0885); Gain of methylation at K522 (P = 0.1073); Loss of solvent accessibility (P = 0.1651); Loss of ubiquitination at K522 (P = 0.1668); Loss of catalytic residue at R518 (P = 0.2069)
7:117199678:G:T,P13569,R518I,0.611,Loss of solvent accessibility (P = 0.0561); Gain of methylation at K522 (P = 0.0615); Loss of phosphorylation at S519 (P = 0.0818); Loss of catalytic residue at R518 (P = 0.1667); Gain of ubiquitination at K522 (P = 0.1884)
7:117199679:A:C,P13569,R518S,0.588,Gain of phosphorylation at R518 (P = 0.0502); Loss of solvent accessibility (P = 0.1322); Loss of ubiquitination at K522 (P = 0.152); Loss of catalytic residue at R518 (P = 0.2216); Loss of helix (P = 0.2271)
7:117199679:A:T,P13569,R518S,0.588,Gain of phosphorylation at R518 (P = 0.0502); Loss of solvent accessibility (P = 0.1322); Loss of ubiquitination at K522 (P = 0.152); Loss of catalytic residue at R518 (P = 0.2216); Loss of helix (P = 0.2271)
7:117199680:A:C,P13569,S519R,0.456,Loss of phosphorylation at S519 (P = 0.0387); Gain of solvent accessibility (P = 0.1185); Gain of ubiquitination at K522 (P = 0.1306); Loss of stability (P = 0.16); Gain of methylation at K522 (P = 0.161)
7:117199680:A:G,P13569,S519G,0.45,Loss of stability (P = 0.0164); Loss of phosphorylation at S519 (P = 0.0387); Gain of ubiquitination at K522 (P = 0.1575); Gain of methylation at K522 (P = 0.1645); Gain of catalytic residue at I521 (P = 0.1675)
7:117199680:A:T,P13569,S519C,0.506,Loss of phosphorylation at S519 (P = 0.0387); Gain of methylation at K522 (P = 0.0968); Loss of stability (P = 0.1466); Loss of catalytic residue at S519 (P = 0.1645); Gain of ubiquitination at K522 (P = 0.2129)
7:117199681:G:A,P13569,S519N,0.43,Loss of phosphorylation at S519 (P = 0.0387); Loss of stability (P = 0.1366); Gain of methylation at K522 (P = 0.1505); Loss of ubiquitination at K522 (P = 0.152); Loss of catalytic residue at S519 (P = 0.3581)
7:117199681:G:C,P13569,S519T,0.432,Loss of phosphorylation at S519 (P = 0.1015); Loss of stability (P = 0.1359); Gain of methylation at K522 (P = 0.1564); Loss of catalytic residue at S519 (P = 0.1881); Gain of ubiquitination at K522 (P = 0.1884)
7:117199681:G:T,P13569,S519I,0.479,Loss of phosphorylation at S519 (P = 0.0387); Gain of methylation at K522 (P = 0.0706); Gain of ubiquitination at K522 (P = 0.1306); Gain of catalytic residue at V520 (P = 0.1899); Loss of relative solvent accessibility (P = 0.3919)
7:117199682:C:A,P13569,S519R,0.456,Loss of phosphorylation at S519 (P = 0.0387); Gain of solvent accessibility (P = 0.1185); Gain of ubiquitination at K522 (P = 0.1306); Loss of stability (P = 0.16); Gain of methylation at K522 (P = 0.161)
7:117199682:C:G,P13569,S519R,0.456,Loss of phosphorylation at S519 (P = 0.0387); Gain of solvent accessibility (P = 0.1185); Gain of ubiquitination at K522 (P = 0.1306); Loss of stability (P = 0.16); Gain of methylation at K522 (P = 0.161)
7:117199683:G:C,P13569,V520L,0.894,Loss of methylation at K522 (P = 0.191); Loss of ubiquitination at K522 (P = 0.1962); Gain of phosphorylation at S519 (P = 0.2286); Loss of catalytic residue at R518 (P = 0.4226); Gain of disorder (P = 0.6113)
7:117199683:G:T,P13569,V520F,0.933,Gain of ubiquitination at K522 (P = 0.1096); Loss of methylation at K522 (P = 0.2525); Gain of phosphorylation at S519 (P = 0.2563); Loss of stability (P = 0.4524); Loss of MoRF binding (P = 0.6379)
7:117199684:T:A,P13569,V520D,0.9,Gain of disorder (P = 0.0759); Loss of methylation at K522 (P = 0.1107); Gain of relative solvent accessibility (P = 0.1259); Loss of stability (P = 0.1267); Gain of phosphorylation at S519 (P = 0.138)
7:117199684:T:C,P13569,V520A,0.726,Loss of stability (P = 0.0311); Loss of methylation at K522 (P = 0.1849); Loss of ubiquitination at K522 (P = 0.2094); Gain of phosphorylation at S519 (P = 0.2224); Loss of helix (P = 0.2271)
7:117199684:T:G,P13569,V520G,0.773,Loss of stability (P = 0.0055); Gain of phosphorylation at S519 (P = 0.1747); Loss of methylation at K522 (P = 0.188); Loss of ubiquitination at K522 (P = 0.2094); Gain of disorder (P = 0.2418)
7:117199686:A:C,P13569,I521L,0.713,Loss of catalytic residue at L526 (P = 0.0502); Loss of methylation at K522 (P = 0.1457); Loss of ubiquitination at K522 (P = 0.1962); Gain of phosphorylation at S519 (P = 0.2482); Gain of relative solvent accessibility (P = 0.2751)
7:117199686:A:G,P13569,I521V,0.823,Loss of catalytic residue at L526 (P = 0.0503); Gain of methylation at K522 (P = 0.1081); Loss of ubiquitination at K522 (P = 0.2094); Gain of phosphorylation at S519 (P = 0.2263); Loss of stability (P = 0.282)
7:117199686:A:T,P13569,I521F,0.914,Gain of methylation at K522 (P = 0.0444); Loss of catalytic residue at L526 (P = 0.0509); Gain of ubiquitination at K522 (P = 0.2129); Loss of phosphorylation at S519 (P = 0.2641); Loss of stability (P = 0.476)
7:117199687:T:A,P13569,I521N,0.864,Loss of catalytic residue at L526 (P = 0.0419); Loss of stability (P = 0.0593); Loss of methylation at K522 (P = 0.1441); Gain of disorder (P = 0.1537); Loss of phosphorylation at S519 (P = 0.2071)
7:117199687:T:C,P13569,I521T,0.846,Loss of catalytic residue at L526 (P = 0.0447); Loss of stability (P = 0.0552); Gain of phosphorylation at I521 (P = 0.0649); Loss of methylation at K522 (P = 0.151); Gain of disorder (P = 0.1703)
7:117199687:T:G,P13569,I521S,0.855,Gain of disorder (P = 0.0152); Loss of catalytic residue at L526 (P = 0.0442); Loss of stability (P = 0.085); Gain of phosphorylation at I521 (P = 0.0895); Loss of methylation at K522 (P = 0.1171)
7:117199689:A:C,P13569,K522Q,0.613,Loss of ubiquitination at K522 (P = 0.0362); Loss of methylation at K522 (P = 0.0554); Loss of phosphorylation at S519 (P = 0.1498); Loss of catalytic residue at K522 (P = 0.3348); Gain of disorder (P = 0.4446)
7:117199690:A:C,P13569,K522T,0.692,Loss of ubiquitination at K522 (P = 0.0362); Loss of methylation at K522 (P = 0.0554); Loss of phosphorylation at S519 (P = 0.1506); Loss of catalytic residue at K522 (P = 0.2535); Loss of solvent accessibility (P = 0.3744)
7:117199690:A:G,P13569,K522R,0.669,Loss of ubiquitination at K522 (P = 0.0362); Loss of methylation at K522 (P = 0.0705); Gain of phosphorylation at S519 (P = 0.1275); Gain of solvent accessibility (P = 0.2902); Gain of catalytic residue at K522 (P = 0.3024)
7:117199690:A:T,P13569,K522I,0.705,Loss of ubiquitination at K522 (P = 0.0362); Loss of methylation at K522 (P = 0.0554); Loss of phosphorylation at S519 (P = 0.1616); Gain of stability (P = 0.1689); Loss of disorder (P = 0.269)
7:117199691:A:C,P13569,K522N,0.694,Loss of ubiquitination at K522 (P = 0.0362); Loss of methylation at K522 (P = 0.0554); Loss of phosphorylation at S519 (P = 0.1427); Loss of disorder (P = 0.4183); Loss of solvent accessibility (P = 0.4838)
7:117199691:A:T,P13569,K522N,0.694,Loss of ubiquitination at K522 (P = 0.0362); Loss of methylation at K522 (P = 0.0554); Loss of phosphorylation at S519 (P = 0.1427); Loss of disorder (P = 0.4183); Loss of solvent accessibility (P = 0.4838)
7:117199692:G:A,P13569,A523T,0.509,Gain of methylation at K522 (P = 0.2033); Loss of ubiquitination at K522 (P = 0.2094); Gain of catalytic residue at K522 (P = 0.2536); Gain of phosphorylation at A523 (P = 0.259); Gain of disorder (P = 0.3623)
7:117199692:G:C,P13569,A523P,0.689,Gain of catalytic residue at A523 (P = 0.0062); Gain of methylation at K522 (P = 0.1122); Loss of ubiquitination at K522 (P = 0.1392); Gain of phosphorylation at S519 (P = 0.1914); Gain of disorder (P = 0.3036)
7:117199692:G:T,P13569,A523S,0.51,Gain of disorder (P = 0.0762); Gain of phosphorylation at S519 (P = 0.1389); Loss of ubiquitination at K522 (P = 0.1808); Gain of methylation at K522 (P = 0.258); Gain of relative solvent accessibility (P = 0.2629)
7:117199693:C:A,P13569,A523E,0.64,Gain of catalytic residue at A523 (P = 0.096); Gain of disorder (P = 0.1102); Loss of ubiquitination at K522 (P = 0.1392); Gain of phosphorylation at S519 (P = 0.1429); Gain of solvent accessibility (P = 0.194)
7:117199693:C:G,P13569,A523G,0.558,Gain of catalytic residue at I521 (P = 0.1699); Loss of ubiquitination at K522 (P = 0.1962); Gain of phosphorylation at S519 (P = 0.2155); Gain of methylation at K522 (P = 0.2201); Gain of disorder (P = 0.299)
7:117199693:C:T,P13569,A523V,0.556,Gain of methylation at K522 (P = 0.038); Loss of ubiquitination at K522 (P = 0.1962); Gain of phosphorylation at S519 (P = 0.2606); Loss of disorder (P = 0.2829); Gain of stability (P = 0.3326)
7:117199695:T:A,P13569,C524S,0.768,Gain of disorder (P = 0.0011); Gain of phosphorylation at C524 (P = 0.0895); Loss of stability (P = 0.0945); Gain of ubiquitination at K522 (P = 0.1575); Loss of methylation at K522 (P = 0.2587)
7:117199695:T:G,P13569,C524G,0.832,Gain of disorder (P = 0.0099); Loss of stability (P = 0.0238); Gain of catalytic residue at A523 (P = 0.1477); Gain of phosphorylation at S519 (P = 0.1646); Loss of ubiquitination at K522 (P = 0.2243)
7:117199696:G:A,P13569,C524Y,0.723,Gain of phosphorylation at C524 (P = 0.0655); Gain of disorder (P = 0.1154); Loss of methylation at K522 (P = 0.1674); Loss of stability (P = 0.1936); Gain of ubiquitination at K522 (P = 0.2129)
7:117199696:G:C,P13569,C524S,0.768,Gain of disorder (P = 0.0011); Gain of phosphorylation at C524 (P = 0.0895); Loss of stability (P = 0.0945); Gain of ubiquitination at K522 (P = 0.1575); Loss of methylation at K522 (P = 0.2587)
7:117199696:G:T,P13569,C524F,0.753,Gain of ubiquitination at K522 (P = 0.1575); Gain of disorder (P = 0.1678); Gain of phosphorylation at S519 (P = 0.2006); Gain of methylation at K522 (P = 0.2479); Gain of MoRF binding (P = 0.549)
7:117199697:C:G,P13569,C524W,0.786,Gain of catalytic residue at A523 (P = 0.0617); Gain of ubiquitination at K522 (P = 0.077); Loss of stability (P = 0.2139); Loss of methylation at K522 (P = 0.2255); Loss of phosphorylation at S519 (P = 0.2478)
7:117199698:C:A,P13569,Q525K,0.623,Gain of methylation at Q525 (P = 0.0202); Gain of ubiquitination at Q525 (P = 0.0797); Gain of disorder (P = 0.1767); Gain of MoRF binding (P = 0.4052); Loss of stability (P = 0.4889)
7:117199698:C:G,P13569,Q525E,0.572,Gain of disorder (P = 0.1165); Gain of ubiquitination at K522 (P = 0.2129); Loss of methylation at K522 (P = 0.2358); Loss of catalytic residue at K522 (P = 0.5174); Loss of MoRF binding (P = 0.6172)
7:117199699:A:C,P13569,Q525P,0.669,Gain of catalytic residue at K522 (P = 0.1673); Loss of ubiquitination at K522 (P = 0.1808); Gain of disorder (P = 0.2298); Gain of methylation at K522 (P = 0.248); Loss of stability (P = 0.2535)
7:117199699:A:G,P13569,Q525R,0.596,Gain of ubiquitination at K522 (P = 0.1306); Loss of methylation at K522 (P = 0.1969); Gain of MoRF binding (P = 0.2555); Gain of disorder (P = 0.284); Gain of solvent accessibility (P = 0.3194)
7:117199699:A:T,P13569,Q525L,0.621,Gain of catalytic residue at Q525 (P = 0.0065); Loss of disorder (P = 0.119); Loss of methylation at K522 (P = 0.1529); Gain of ubiquitination at K522 (P = 0.2129); Gain of stability (P = 0.6038)
7:117199700:A:C,P13569,Q525H,0.607,Gain of disorder (P = 0.1185); Gain of ubiquitination at K522 (P = 0.1306); Gain of catalytic residue at Q525 (P = 0.1755); Loss of methylation at K522 (P = 0.2114); Loss of stability (P = 0.3973)
7:117199700:A:T,P13569,Q525H,0.607,Gain of disorder (P = 0.1185); Gain of ubiquitination at K522 (P = 0.1306); Gain of catalytic residue at Q525 (P = 0.1755); Loss of methylation at K522 (P = 0.2114); Loss of stability (P = 0.3973)
7:117199701:C:A,P13569,L526I,0.877,Loss of catalytic residue at L526 (P = 0.0064); Gain of methylation at K522 (P = 0.0769); Gain of ubiquitination at K522 (P = 0.1884); Gain of loop (P = 0.2754); Gain of disorder (P = 0.284)
7:117199701:C:G,P13569,L526V,0.922,Gain of methylation at K522 (P = 0.1125); Gain of ubiquitination at K522 (P = 0.1884); Loss of catalytic residue at L526 (P = 0.2013); Gain of disorder (P = 0.2506); Loss of helix (P = 0.3949)
7:117199702:T:A,P13569,L526Q,0.878,Loss of catalytic residue at L526 (P = 0.0095); Gain of disorder (P = 0.0151); Gain of methylation at K522 (P = 0.0379); Loss of ubiquitination at K522 (P = 0.1392); Gain of loop (P = 0.2754)
7:117199702:T:C,P13569,L526P,0.901,Gain of disorder (P = 0.0172); Loss of catalytic residue at L526 (P = 0.0237); Gain of methylation at K522 (P = 0.0402); Loss of stability (P = 0.0691); Loss of ubiquitination at K522 (P = 0.1268)
7:117199702:T:G,P13569,L526R,0.895,Loss of catalytic residue at L526 (P = 0.0191); Gain of disorder (P = 0.0331); Gain of methylation at K522 (P = 0.0465); Loss of helix (P = 0.1299); Loss of ubiquitination at K522 (P = 0.2243)
7:117199704:G:A,P13569,E527K,0.81,Gain of MoRF binding (P = 0.2027); Gain of ubiquitination at K522 (P = 0.2129); Loss of methylation at K522 (P = 0.2353); Loss of disorder (P = 0.2641); Loss of stability (P = 0.358)
7:117199704:G:C,P13569,E527Q,0.892,Gain of ubiquitination at K522 (P = 0.1306); Loss of disorder (P = 0.2005); Loss of methylation at K522 (P = 0.2329); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.44)
7:117199705:A:C,P13569,E527A,0.792,Gain of ubiquitination at K522 (P = 0.0918); Loss of disorder (P = 0.1077); Loss of helix (P = 0.1706); Loss of methylation at K522 (P = 0.1867); Gain of loop (P = 0.2754)
7:117199705:A:T,P13569,E527V,0.797,Loss of disorder (P = 0.0434); Gain of ubiquitination at K522 (P = 0.1575); Loss of helix (P = 0.1706); Loss of methylation at K522 (P = 0.2439); Gain of loop (P = 0.2754)
7:117199706:A:C,P13569,E527D,0.748,Loss of helix (P = 0.1706); Loss of methylation at K522 (P = 0.2295); Loss of ubiquitination at K522 (P = 0.2335); Loss of disorder (P = 0.236); Gain of catalytic residue at K522 (P = 0.4191)
7:117199706:A:T,P13569,E527D,0.748,Loss of helix (P = 0.1706); Loss of methylation at K522 (P = 0.2295); Loss of ubiquitination at K522 (P = 0.2335); Loss of disorder (P = 0.236); Gain of catalytic residue at K522 (P = 0.4191)
7:117199707:G:A,P13569,E528K,0.576,Loss of stability (P = 0.0949); Loss of helix (P = 0.1706); Gain of ubiquitination at E528 (P = 0.2167); Gain of MoRF binding (P = 0.2208); Loss of disorder (P = 0.2659)
7:117199707:G:C,P13569,E528Q,0.562,Loss of helix (P = 0.1706); Loss of disorder (P = 0.173); Loss of stability (P = 0.2361); Loss of loop (P = 0.2897); Loss of ubiquitination at K532 (P = 0.3029)
7:117199708:A:C,P13569,E528A,0.586,Loss of disorder (P = 0.0845); Loss of helix (P = 0.1706); Loss of ubiquitination at K532 (P = 0.2884); Loss of loop (P = 0.2897); Loss of stability (P = 0.3059)
7:117199708:A:G,P13569,E528G,0.576,Loss of stability (P = 0.0409); Loss of disorder (P = 0.129); Gain of catalytic residue at E528 (P = 0.1428); Loss of helix (P = 0.1706); Loss of ubiquitination at K532 (P = 0.2884)
7:117199708:A:T,P13569,E528V,0.65,Loss of disorder (P = 0.0317); Loss of helix (P = 0.1706); Loss of loop (P = 0.2897); Gain of ubiquitination at K532 (P = 0.2995); Gain of catalytic residue at F533 (P = 0.319)
7:117199709:G:C,P13569,E528D,0.465,Loss of helix (P = 0.1706); Loss of disorder (P = 0.2212); Loss of stability (P = 0.2544); Loss of loop (P = 0.2897); Loss of ubiquitination at K532 (P = 0.3072)
7:117199709:G:T,P13569,E528D,0.465,Loss of helix (P = 0.1706); Loss of disorder (P = 0.2212); Loss of stability (P = 0.2544); Loss of loop (P = 0.2897); Loss of ubiquitination at K532 (P = 0.3072)
7:117227793:G:A,P13569,D529N,0.652,Loss of helix (P = 0.1706); Loss of stability (P = 0.1882); Loss of disorder (P = 0.214); Gain of methylation at K532 (P = 0.2657); Gain of loop (P = 0.2754)
7:117227793:G:C,P13569,D529H,0.891,Loss of solvent accessibility (P = 0.1279); Gain of methylation at K532 (P = 0.1418); Loss of stability (P = 0.1605); Loss of relative solvent accessibility (P = 0.1807); Gain of disorder (P = 0.1895)
7:117227793:G:T,P13569,D529Y,0.735,Loss of disorder (P = 0.0467); Gain of helix (P = 0.2059); Gain of catalytic residue at E528 (P = 0.214); Loss of loop (P = 0.2237); Loss of ubiquitination at K532 (P = 0.2976)
7:117227794:A:C,P13569,D529A,0.794,Loss of disorder (P = 0.121); Loss of stability (P = 0.1324); Gain of glycosylation at S531 (P = 0.161); Loss of solvent accessibility (P = 0.1868); Loss of loop (P = 0.2237)
7:117227794:A:G,P13569,D529G,0.902,Loss of stability (P = 0.04); Gain of catalytic residue at D529 (P = 0.0763); Loss of solvent accessibility (P = 0.1744); Loss of disorder (P = 0.21); Gain of glycosylation at S531 (P = 0.2744)
7:117227794:A:T,P13569,D529V,0.744,Loss of disorder (P = 0.0397); Loss of loop (P = 0.0512); Gain of helix (P = 0.0696); Loss of solvent accessibility (P = 0.1279); Gain of glycosylation at S531 (P = 0.1551)
7:117227795:C:A,P13569,D529E,0.567,Gain of disorder (P = 0.1109); Loss of helix (P = 0.1706); Gain of glycosylation at S531 (P = 0.1755); Gain of ubiquitination at K532 (P = 0.2995); Gain of methylation at K532 (P = 0.3262)
7:117227795:C:G,P13569,D529E,0.567,Gain of disorder (P = 0.1109); Loss of helix (P = 0.1706); Gain of glycosylation at S531 (P = 0.1755); Gain of ubiquitination at K532 (P = 0.2995); Gain of methylation at K532 (P = 0.3262)
7:117227796:A:C,P13569,I530L,0.843,Gain of disorder (P = 0.129); Gain of ubiquitination at K532 (P = 0.2629); Gain of helix (P = 0.2684); Gain of phosphorylation at S531 (P = 0.3958); Loss of methylation at K532 (P = 0.4009)
7:117227796:A:G,P13569,I530V,0.63,Gain of helix (P = 0.1736); Gain of disorder (P = 0.1773); Loss of loop (P = 0.2897); Gain of ubiquitination at K532 (P = 0.2995); Loss of methylation at K532 (P = 0.4215)
7:117227796:A:T,P13569,I530F,0.762,Gain of disorder (P = 0.2177); Gain of ubiquitination at K532 (P = 0.2423); Loss of loop (P = 0.3664); Loss of helix (P = 0.3949); Loss of methylation at K532 (P = 0.4135)
7:117227797:T:A,P13569,I530N,0.878,Gain of disorder (P = 0.0125); Gain of ubiquitination at K532 (P = 0.0292); Loss of helix (P = 0.1299); Loss of stability (P = 0.1478); Loss of methylation at K532 (P = 0.4182)
7:117227797:T:C,P13569,I530T,0.809,Gain of disorder (P = 0.0218); Gain of ubiquitination at K532 (P = 0.0461); Loss of stability (P = 0.0485); Gain of catalytic residue at F533 (P = 0.2152); Gain of helix (P = 0.2684)
7:117227797:T:G,P13569,I530S,0.747,Gain of disorder (P = 0.0039); Gain of ubiquitination at K532 (P = 0.0267); Gain of phosphorylation at I530 (P = 0.0707); Loss of stability (P = 0.1037); Loss of helix (P = 0.1299)
7:117227798:C:G,P13569,I530M,0.751,Gain of disorder (P = 0.0513); Gain of ubiquitination at K532 (P = 0.0737); Gain of helix (P = 0.2684); Gain of phosphorylation at S531 (P = 0.3337); Loss of loop (P = 0.3664)
7:117227799:T:A,P13569,S531T,0.57,Loss of disorder (P = 0.1017); Gain of ubiquitination at K536 (P = 0.1103); Loss of stability (P = 0.2271); Gain of phosphorylation at S531 (P = 0.2377); Gain of methylation at K536 (P = 0.307)
7:117227799:T:C,P13569,S531P,0.833,Gain of catalytic residue at S531 (P = 0.0742); Gain of ubiquitination at K536 (P = 0.0954); Loss of stability (P = 0.12); Gain of glycosylation at K532 (P = 0.1427); Loss of disorder (P = 0.2093)
7:117227799:T:G,P13569,S531A,0.581,Loss of disorder (P = 0.0904); Loss of ubiquitination at K536 (P = 0.1351); Loss of stability (P = 0.2037); Loss of glycosylation at S531 (P = 0.2528); Gain of loop (P = 0.2754)
7:117227800:C:A,P13569,S531Y,0.592,Loss of disorder (P = 0.0362); Gain of catalytic residue at I530 (P = 0.0623); Gain of ubiquitination at K536 (P = 0.0685); Gain of phosphorylation at S531 (P = 0.0933); Loss of helix (P = 0.1299)
7:117227800:C:G,P13569,S531C,0.65,Gain of methylation at K532 (P = 0.0145); Loss of disorder (P = 0.0202); Loss of ubiquitination at K536 (P = 0.1351); Loss of glycosylation at S531 (P = 0.2528); Gain of catalytic residue at K536 (P = 0.2869)
7:117227800:C:T,P13569,S531F,0.645,Loss of disorder (P = 0.0281); Gain of methylation at K532 (P = 0.039); Gain of ubiquitination at K536 (P = 0.0632); Loss of glycosylation at S531 (P = 0.2528); Loss of phosphorylation at S531 (P = 0.3452)
7:117227802:A:C,P13569,K532Q,0.295,Loss of ubiquitination at K532 (P = 0.0982); Loss of disorder (P = 0.1767); Loss of glycosylation at K532 (P = 0.2836); Gain of methylation at K536 (P = 0.2961); Loss of helix (P = 0.3949)
7:117227802:A:G,P13569,K532E,0.177,Gain of ubiquitination at K536 (P = 0.0954); Gain of phosphorylation at S531 (P = 0.1606); Gain of disorder (P = 0.178); Gain of helix (P = 0.2684); Loss of glycosylation at K532 (P = 0.2836)
7:117227803:A:C,P13569,K532T,0.396,Gain of glycosylation at S531 (P = 0.0849); Loss of disorder (P = 0.0955); Loss of ubiquitination at K532 (P = 0.0982); Gain of phosphorylation at K532 (P = 0.0996); Gain of helix (P = 0.2684)
7:117227803:A:G,P13569,K532R,0.283,Gain of ubiquitination at K536 (P = 0.0685); Gain of phosphorylation at S531 (P = 0.1127); Loss of disorder (P = 0.1199); Loss of methylation at K536 (P = 0.2765); Loss of glycosylation at K532 (P = 0.2836)
7:117227803:A:T,P13569,K532M,0.472,Loss of solvent accessibility (P = 0.0187); Gain of helix (P = 0.0325); Loss of loop (P = 0.0512); Loss of disorder (P = 0.054); Loss of relative solvent accessibility (P = 0.0793)
7:117227804:G:C,P13569,K532N,0.312,Gain of ubiquitination at K536 (P = 0.0828); Loss of disorder (P = 0.1566); Gain of helix (P = 0.2684); Loss of glycosylation at K532 (P = 0.2836); Loss of methylation at K536 (P = 0.3314)
7:117227804:G:T,P13569,K532N,0.312,Gain of ubiquitination at K536 (P = 0.0828); Loss of disorder (P = 0.1566); Gain of helix (P = 0.2684); Loss of glycosylation at K532 (P = 0.2836); Loss of methylation at K536 (P = 0.3314)
7:117227805:T:A,P13569,F533I,0.762,Loss of ubiquitination at K536 (P = 0.1498); Loss of helix (P = 0.1706); Gain of methylation at K536 (P = 0.1743); Gain of disorder (P = 0.1788); Gain of loop (P = 0.2754)
7:117227805:T:C,P13569,F533L,0.835,Gain of ubiquitination at K536 (P = 0.0582); Gain of disorder (P = 0.1064); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Gain of relative solvent accessibility (P = 0.284)
7:117227805:T:G,P13569,F533V,0.766,Gain of disorder (P = 0.1339); Loss of ubiquitination at K536 (P = 0.1498); Gain of helix (P = 0.1736); Gain of methylation at K536 (P = 0.2454); Loss of loop (P = 0.3664)
7:117227806:T:A,P13569,F533Y,0.751,Gain of ubiquitination at K536 (P = 0.052); Gain of disorder (P = 0.1169); Loss of helix (P = 0.1706); Gain of phosphorylation at F533 (P = 0.2652); Gain of methylation at K536 (P = 0.3351)
7:117227806:T:C,P13569,F533S,0.727,Gain of disorder (P = 0.0019); Gain of ubiquitination at K532 (P = 0.0401); Loss of loop (P = 0.0512); Gain of helix (P = 0.0696); Gain of phosphorylation at F533 (P = 0.0783)
7:117227806:T:G,P13569,F533C,0.751,Gain of methylation at K532 (P = 0.0382); Gain of ubiquitination at K536 (P = 0.0685); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2534)
7:117227807:T:A,P13569,F533L,0.835,Gain of ubiquitination at K536 (P = 0.0582); Gain of disorder (P = 0.1064); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Gain of relative solvent accessibility (P = 0.284)
7:117227807:T:G,P13569,F533L,0.835,Gain of ubiquitination at K536 (P = 0.0582); Gain of disorder (P = 0.1064); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Gain of relative solvent accessibility (P = 0.284)
7:117227808:G:A,P13569,A534T,0.595,Gain of phosphorylation at A534 (P = 0.053); Gain of ubiquitination at K536 (P = 0.0741); Gain of disorder (P = 0.1516); Loss of stability (P = 0.1745); Gain of helix (P = 0.2684)
7:117227808:G:C,P13569,A534P,0.657,Gain of disorder (P = 0.0461); Gain of ubiquitination at K536 (P = 0.0474); Loss of stability (P = 0.0942); Gain of methylation at K536 (P = 0.1117); Gain of glycosylation at S531 (P = 0.2695)
7:117227808:G:T,P13569,A534S,0.642,Gain of disorder (P = 0.0183); Gain of ubiquitination at K536 (P = 0.0421); Gain of phosphorylation at A534 (P = 0.0783); Gain of helix (P = 0.1736); Loss of stability (P = 0.1797)
7:117227809:C:A,P13569,A534E,0.783,Gain of disorder (P = 0.0149); Gain of ubiquitination at K536 (P = 0.052); Gain of solvent accessibility (P = 0.1185); Gain of phosphorylation at S531 (P = 0.1831); Gain of relative solvent accessibility (P = 0.2363)
7:117227809:C:G,P13569,A534G,0.717,Loss of stability (P = 0.0313); Gain of ubiquitination at K536 (P = 0.0439); Gain of disorder (P = 0.0611); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117227809:C:T,P13569,A534V,0.729,Loss of ubiquitination at K536 (P = 0.0924); Loss of disorder (P = 0.112); Gain of methylation at K536 (P = 0.2489); Loss of catalytic residue at A534 (P = 0.3086); Loss of helix (P = 0.3949)
7:117227811:G:A,P13569,E535K,0.457,Loss of ubiquitination at K536 (P = 0.0462); Loss of stability (P = 0.0511); Gain of solvent accessibility (P = 0.1505); Gain of relative solvent accessibility (P = 0.1571); Loss of helix (P = 0.1706)
7:117227811:G:C,P13569,E535Q,0.364,Loss of ubiquitination at K536 (P = 0.1202); Loss of disorder (P = 0.1457); Loss of stability (P = 0.198); Gain of methylation at K536 (P = 0.2142); Loss of helix (P = 0.2662)
7:117227812:A:C,P13569,E535A,0.513,Loss of solvent accessibility (P = 0.0224); Loss of disorder (P = 0.0768); Gain of catalytic residue at E535 (P = 0.106); Loss of ubiquitination at K536 (P = 0.1498); Loss of stability (P = 0.1536)
7:117227812:A:G,P13569,E535G,0.534,Loss of solvent accessibility (P = 0.0187); Loss of stability (P = 0.0269); Gain of catalytic residue at A534 (P = 0.0661); Gain of ubiquitination at K536 (P = 0.1295); Loss of disorder (P = 0.1338)
7:117227812:A:T,P13569,E535V,0.623,Loss of solvent accessibility (P = 0.0092); Loss of disorder (P = 0.0321); Gain of methylation at K536 (P = 0.0385); Loss of relative solvent accessibility (P = 0.0414); Loss of helix (P = 0.079)
7:117227813:G:C,P13569,E535D,0.397,Gain of ubiquitination at K536 (P = 0.0685); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of stability (P = 0.2094); Loss of disorder (P = 0.2311)
7:117227813:G:T,P13569,E535D,0.397,Gain of ubiquitination at K536 (P = 0.0685); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of stability (P = 0.2094); Loss of disorder (P = 0.2311)
7:117227814:A:C,P13569,K536Q,0.59,Loss of ubiquitination at K536 (P = 0.0233); Loss of methylation at K536 (P = 0.122); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1923); Loss of loop (P = 0.2237)
7:117227814:A:G,P13569,K536E,0.591,Loss of ubiquitination at K536 (P = 0.0233); Loss of methylation at K536 (P = 0.122); Gain of disorder (P = 0.1656); Gain of helix (P = 0.1736); Gain of relative solvent accessibility (P = 0.1894)
7:117227815:A:C,P13569,K536T,0.607,Loss of ubiquitination at K536 (P = 0.0233); Loss of disorder (P = 0.1151); Loss of methylation at K536 (P = 0.122); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045)
7:117227815:A:G,P13569,K536R,0.581,Loss of ubiquitination at K536 (P = 0.0233); Loss of disorder (P = 0.146); Loss of methylation at K536 (P = 0.1729); Gain of loop (P = 0.2045); Gain of glycosylation at S531 (P = 0.3084)
7:117227815:A:T,P13569,K536I,0.669,Loss of ubiquitination at K536 (P = 0.0233); Loss of disorder (P = 0.0383); Loss of methylation at K536 (P = 0.122); Loss of solvent accessibility (P = 0.1322); Gain of catalytic residue at D537 (P = 0.1435)
7:117227816:A:C,P13569,K536N,0.563,Loss of ubiquitination at K536 (P = 0.0233); Loss of methylation at K536 (P = 0.122); Gain of catalytic residue at D537 (P = 0.1719); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1978)
7:117227816:A:T,P13569,K536N,0.563,Loss of ubiquitination at K536 (P = 0.0233); Loss of methylation at K536 (P = 0.122); Gain of catalytic residue at D537 (P = 0.1719); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1978)
7:117227817:G:A,P13569,D537N,0.656,Gain of ubiquitination at K536 (P = 0.0828); Gain of catalytic residue at D537 (P = 0.1448); Loss of helix (P = 0.1706); Gain of methylation at K536 (P = 0.2123); Loss of loop (P = 0.2237)
7:117227817:G:C,P13569,D537H,0.653,Loss of ubiquitination at K536 (P = 0.1351); Gain of methylation at K536 (P = 0.1491); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1815); Gain of loop (P = 0.2045)
7:117227817:G:T,P13569,D537Y,0.64,Loss of disorder (P = 0.0586); Gain of ubiquitination at K536 (P = 0.1103); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of phosphorylation at D537 (P = 0.2059)
7:117227818:A:C,P13569,D537A,0.65,Loss of ubiquitination at K536 (P = 0.1351); Loss of disorder (P = 0.1417); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of methylation at K536 (P = 0.3095)
7:117227818:A:G,P13569,D537G,0.68,Loss of stability (P = 0.1027); Loss of ubiquitination at K536 (P = 0.1055); Loss of helix (P = 0.1706); Gain of catalytic residue at I539 (P = 0.2094); Loss of loop (P = 0.2237)
7:117227818:A:T,P13569,D537V,0.661,Gain of methylation at K536 (P = 0.0373); Loss of disorder (P = 0.0581); Loss of ubiquitination at K536 (P = 0.0924); Loss of helix (P = 0.1706); Loss of solvent accessibility (P = 0.4218)
7:117227819:C:A,P13569,D537E,0.645,Gain of ubiquitination at K536 (P = 0.0741); Gain of disorder (P = 0.1212); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of methylation at K536 (P = 0.2541)
7:117227819:C:G,P13569,D537E,0.645,Gain of ubiquitination at K536 (P = 0.0741); Gain of disorder (P = 0.1212); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of methylation at K536 (P = 0.2541)
7:117227820:A:C,P13569,N538H,0.417,Gain of disorder (P = 0.0797); Loss of catalytic residue at N538 (P = 0.1271); Loss of stability (P = 0.1461); Loss of ubiquitination at K536 (P = 0.1498); Gain of helix (P = 0.1736)
7:117227820:A:G,P13569,N538D,0.369,Gain of ubiquitination at K536 (P = 0.0582); Loss of catalytic residue at N538 (P = 0.1049); Gain of disorder (P = 0.1117); Gain of helix (P = 0.2684); Loss of stability (P = 0.2795)
7:117227820:A:T,P13569,N538Y,0.435,Gain of phosphorylation at N538 (P = 0.0615); Loss of catalytic residue at N538 (P = 0.0648); Loss of disorder (P = 0.092); Gain of ubiquitination at K536 (P = 0.0954); Loss of loop (P = 0.2237)
7:117227821:A:C,P13569,N538T,0.432,Loss of catalytic residue at N538 (P = 0.0552); Loss of stability (P = 0.1489); Loss of ubiquitination at K536 (P = 0.1498); Loss of loop (P = 0.2237); Gain of methylation at K536 (P = 0.2398)
7:117227821:A:G,P13569,N538S,0.392,Gain of disorder (P = 0.0504); Gain of phosphorylation at N538 (P = 0.0641); Loss of catalytic residue at N538 (P = 0.0806); Gain of ubiquitination at K536 (P = 0.1103); Loss of stability (P = 0.1488)
7:117227821:A:T,P13569,N538I,0.505,Gain of methylation at K536 (P = 0.0416); Loss of disorder (P = 0.0729); Loss of catalytic residue at N538 (P = 0.0739); Loss of relative solvent accessibility (P = 0.114); Loss of solvent accessibility (P = 0.1301)
7:117227822:T:A,P13569,N538K,0.462,Gain of ubiquitination at N538 (P = 0.0198); Gain of disorder (P = 0.078); Loss of stability (P = 0.1491); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117227822:T:G,P13569,N538K,0.462,Gain of ubiquitination at N538 (P = 0.0198); Gain of disorder (P = 0.078); Loss of stability (P = 0.1491); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117227823:A:C,P13569,I539L,0.634,Gain of ubiquitination at K536 (P = 0.0685); Loss of catalytic residue at V540 (P = 0.1551); Gain of disorder (P = 0.1751); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117227823:A:G,P13569,I539V,0.631,Gain of ubiquitination at K536 (P = 0.0741); Loss of catalytic residue at V540 (P = 0.1633); Gain of disorder (P = 0.1882); Gain of loop (P = 0.2045); Loss of methylation at K536 (P = 0.3117)
7:117227823:A:T,P13569,I539L,0.634,Gain of ubiquitination at K536 (P = 0.0685); Loss of catalytic residue at V540 (P = 0.1551); Gain of disorder (P = 0.1751); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117227824:T:A,P13569,I539K,0.689,Gain of disorder (P = 0.0051); Loss of stability (P = 0.009); Gain of ubiquitination at I539 (P = 0.0155); Gain of methylation at I539 (P = 0.0367); Loss of catalytic residue at V540 (P = 0.096)
7:117227824:T:G,P13569,I539R,0.712,Loss of stability (P = 0.0182); Gain of disorder (P = 0.0227); Gain of ubiquitination at K536 (P = 0.0582); Loss of catalytic residue at V540 (P = 0.0817); Gain of solvent accessibility (P = 0.1708)
7:117227825:A:G,P13569,I539M,0.681,Gain of ubiquitination at K536 (P = 0.052); Gain of disorder (P = 0.0703); Loss of stability (P = 0.1693); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117227826:G:C,P13569,V540L,0.713,Gain of ubiquitination at K536 (P = 0.0685); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2149); Loss of catalytic residue at V540 (P = 0.2578); Loss of methylation at K536 (P = 0.2965)
7:117227826:G:T,P13569,V540F,0.693,Gain of ubiquitination at K536 (P = 0.1295); Loss of stability (P = 0.1651); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2965); Gain of methylation at K536 (P = 0.3376)
7:117227827:T:A,P13569,V540D,0.738,Gain of disorder (P = 0.0126); Gain of ubiquitination at K536 (P = 0.0497); Gain of relative solvent accessibility (P = 0.0507); Gain of solvent accessibility (P = 0.08); Loss of stability (P = 0.1077)
7:117227827:T:C,P13569,V540A,0.696,Loss of stability (P = 0.0378); Gain of disorder (P = 0.0517); Gain of ubiquitination at K536 (P = 0.0685); Loss of catalytic residue at V540 (P = 0.1152); Gain of loop (P = 0.2045)
7:117227827:T:G,P13569,V540G,0.688,Loss of stability (P = 0.0061); Gain of disorder (P = 0.0187); Gain of ubiquitination at K536 (P = 0.0497); Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.1066)
7:117227829:C:A,P13569,L541I,0.535,Gain of methylation at K536 (P = 0.1023); Loss of ubiquitination at K536 (P = 0.1351); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Gain of disorder (P = 0.3119)
7:117227829:C:G,P13569,L541V,0.554,Loss of ubiquitination at K536 (P = 0.1498); Loss of stability (P = 0.1785); Gain of methylation at K536 (P = 0.1902); Loss of loop (P = 0.2237); Gain of disorder (P = 0.2378)
7:117227829:C:T,P13569,L541F,0.57,Loss of stability (P = 0.133); Loss of ubiquitination at K536 (P = 0.1498); Gain of methylation at K536 (P = 0.1943); Loss of loop (P = 0.2237); Gain of disorder (P = 0.3006)
7:117227830:T:A,P13569,L541H,0.632,Gain of disorder (P = 0.0178); Loss of stability (P = 0.0234); Gain of ubiquitination at K536 (P = 0.0582); Gain of catalytic residue at G542 (P = 0.1063); Gain of relative solvent accessibility (P = 0.1571)
7:117227830:T:C,P13569,L541P,0.681,Loss of stability (P = 0.0129); Gain of disorder (P = 0.032); Gain of ubiquitination at K536 (P = 0.0632); Gain of methylation at K536 (P = 0.1557); Loss of helix (P = 0.2662)
7:117227830:T:G,P13569,L541R,0.661,Loss of stability (P = 0.0279); Gain of methylation at L541 (P = 0.0391); Gain of disorder (P = 0.0428); Gain of ubiquitination at K536 (P = 0.0685); Gain of solvent accessibility (P = 0.1071)
7:117227832:G:A,P13569,G542R,0.87,Gain of catalytic residue at G542 (P = 0.0621); Gain of MoRF binding (P = 0.1438); Gain of solvent accessibility (P = 0.154); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117227832:G:C,P13569,G542R,0.87,Gain of catalytic residue at G542 (P = 0.0621); Gain of MoRF binding (P = 0.1438); Gain of solvent accessibility (P = 0.154); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117227833:G:A,P13569,G542E,0.849,Gain of solvent accessibility (P = 0.0456); Gain of catalytic residue at G542 (P = 0.1703); Loss of loop (P = 0.2237); Gain of disorder (P = 0.231); Gain of helix (P = 0.2684)
7:117227833:G:C,P13569,G542A,0.826,Loss of disorder (P = 0.1763); Gain of loop (P = 0.2045); Loss of catalytic residue at L541 (P = 0.2876); Gain of solvent accessibility (P = 0.367); Loss of helix (P = 0.3949)
7:117227833:G:T,P13569,G542V,0.861,Loss of disorder (P = 0.0846); Loss of relative solvent accessibility (P = 0.0981); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Loss of catalytic residue at G544 (P = 0.3308)
7:117227835:G:A,P13569,E543K,0.755,Gain of ubiquitination at E543 (P = 0.0211); Gain of MoRF binding (P = 0.0504); Gain of methylation at E543 (P = 0.1204); Gain of glycosylation at E543 (P = 0.1633); Loss of loop (P = 0.2237)
7:117227835:G:C,P13569,E543Q,0.782,Loss of catalytic residue at E543 (P = 0.1111); Gain of loop (P = 0.2045); Gain of disorder (P = 0.246); Gain of MoRF binding (P = 0.2508); Loss of helix (P = 0.2662)
7:117227836:A:C,P13569,E543A,0.866,Loss of disorder (P = 0.1482); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2682); Loss of helix (P = 0.4763); Loss of solvent accessibility (P = 0.4838)
7:117227836:A:G,P13569,E543G,0.773,Gain of loop (P = 0.0851); Gain of disorder (P = 0.2005); Loss of helix (P = 0.2022); Loss of stability (P = 0.2041); Gain of relative solvent accessibility (P = 0.2363)
7:117227836:A:T,P13569,E543V,0.839,Loss of disorder (P = 0.071); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.26); Loss of solvent accessibility (P = 0.4274); Loss of helix (P = 0.4763)
7:117227837:A:C,P13569,E543D,0.771,Gain of loop (P = 0.2045); Loss of disorder (P = 0.2348); Gain of catalytic residue at G542 (P = 0.2651); Loss of helix (P = 0.2662); Loss of MoRF binding (P = 0.4653)
7:117227837:A:T,P13569,E543D,0.771,Gain of loop (P = 0.2045); Loss of disorder (P = 0.2348); Gain of catalytic residue at G542 (P = 0.2651); Loss of helix (P = 0.2662); Loss of MoRF binding (P = 0.4653)
7:117227838:G:A,P13569,G544S,0.929,Gain of glycosylation at G544 (P = 0.043); Gain of disorder (P = 0.1228); Gain of phosphorylation at G544 (P = 0.1459); Loss of catalytic residue at I546 (P = 0.1911); Loss of helix (P = 0.2662)
7:117227838:G:C,P13569,G544R,0.874,Gain of MoRF binding (P = 0.0649); Gain of solvent accessibility (P = 0.1319); Loss of catalytic residue at G545 (P = 0.1428); Loss of disorder (P = 0.2452); Gain of phosphorylation at T547 (P = 0.2566)
7:117227838:G:T,P13569,G544C,0.919,Loss of disorder (P = 0.0337); Loss of catalytic residue at I546 (P = 0.1661); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.3739); Loss of glycosylation at S549 (P = 0.4338)
7:117227839:G:A,P13569,G544D,0.914,Loss of catalytic residue at G545 (P = 0.1582); Loss of disorder (P = 0.1683); Gain of sheet (P = 0.1945); Loss of helix (P = 0.2662); Gain of solvent accessibility (P = 0.2987)
7:117227839:G:C,P13569,G544A,0.882,Loss of disorder (P = 0.1364); Loss of catalytic residue at I546 (P = 0.1819); Gain of loop (P = 0.2045); Gain of glycosylation at S549 (P = 0.2066); Gain of MoRF binding (P = 0.348)
7:117227839:G:T,P13569,G544V,0.954,Loss of disorder (P = 0.0531); Loss of catalytic residue at I546 (P = 0.1625); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.3337); Loss of glycosylation at S549 (P = 0.4632)
7:117227841:G:A,P13569,G545R,0.828,Gain of MoRF binding (P = 0.0214); Gain of methylation at G545 (P = 0.0418); Loss of disorder (P = 0.2226); Gain of phosphorylation at T547 (P = 0.242); Loss of catalytic residue at G544 (P = 0.2809)
7:117227841:G:C,P13569,G545R,0.828,Gain of MoRF binding (P = 0.0214); Gain of methylation at G545 (P = 0.0418); Loss of disorder (P = 0.2226); Gain of phosphorylation at T547 (P = 0.242); Loss of catalytic residue at G544 (P = 0.2809)
7:117227842:G:A,P13569,G545E,0.757,Gain of disorder (P = 0.1592); Gain of glycosylation at S549 (P = 0.1804); Gain of sheet (P = 0.1945); Gain of stability (P = 0.2159); Gain of relative solvent accessibility (P = 0.2363)
7:117227842:G:C,P13569,G545A,0.744,Loss of disorder (P = 0.1223); Gain of glycosylation at S549 (P = 0.2252); Gain of MoRF binding (P = 0.2885); Gain of catalytic residue at G545 (P = 0.3202); Loss of helix (P = 0.4763)
7:117227842:G:T,P13569,G545V,0.773,Loss of disorder (P = 0.0435); Gain of stability (P = 0.1439); Gain of catalytic residue at G545 (P = 0.2029); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2863)
7:117227844:A:C,P13569,I546L,0.51,Gain of disorder (P = 0.1234); Gain of sheet (P = 0.1945); Loss of MoRF binding (P = 0.2778); Loss of catalytic residue at L541 (P = 0.3868); Loss of glycosylation at S549 (P = 0.3954)
7:117227844:A:G,P13569,I546V,0.439,Gain of disorder (P = 0.1679); Gain of MoRF binding (P = 0.2509); Gain of catalytic residue at I546 (P = 0.3789); Loss of glycosylation at S549 (P = 0.4389); Loss of helix (P = 0.4763)
7:117227844:A:T,P13569,I546F,0.499,Gain of catalytic residue at I546 (P = 0.1873); Gain of disorder (P = 0.2128); Loss of helix (P = 0.2662); Loss of MoRF binding (P = 0.2727); Loss of stability (P = 0.3352)
7:117227845:T:A,P13569,I546N,0.651,Gain of disorder (P = 0.0084); Loss of stability (P = 0.0688); Gain of relative solvent accessibility (P = 0.1259); Gain of MoRF binding (P = 0.2303); Gain of solvent accessibility (P = 0.2346)
7:117227845:T:C,P13569,I546T,0.615,Gain of disorder (P = 0.012); Loss of stability (P = 0.0153); Gain of catalytic residue at I546 (P = 0.1701); Gain of MoRF binding (P = 0.2674); Gain of loop (P = 0.3485)
7:117227845:T:G,P13569,I546S,0.594,Gain of disorder (P = 0.0017); Loss of stability (P = 0.0567); Gain of phosphorylation at I546 (P = 0.0598); Gain of catalytic residue at I546 (P = 0.2333); Gain of relative solvent accessibility (P = 0.2363)
7:117227846:C:G,P13569,I546M,0.502,Gain of disorder (P = 0.051); Gain of catalytic residue at I546 (P = 0.1853); Gain of MoRF binding (P = 0.2001); Loss of glycosylation at S549 (P = 0.3794); Gain of loop (P = 0.4248)
7:117227847:A:C,P13569,T547P,0.896,Gain of glycosylation at S549 (P = 0.0888); Gain of disorder (P = 0.0985); Loss of MoRF binding (P = 0.201); Gain of catalytic residue at L548 (P = 0.3367); Gain of phosphorylation at S549 (P = 0.4564)
7:117227847:A:G,P13569,T547A,0.875,Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.224); Gain of disorder (P = 0.2247); Gain of glycosylation at S549 (P = 0.2773); Loss of helix (P = 0.4763)
7:117227847:A:T,P13569,T547S,0.843,Gain of disorder (P = 0.0306); Gain of relative solvent accessibility (P = 0.1259); Gain of phosphorylation at T547 (P = 0.1291); Gain of MoRF binding (P = 0.2341); Gain of solvent accessibility (P = 0.28)
7:117227848:C:A,P13569,T547K,0.85,Gain of ubiquitination at T547 (P = 0.0146); Gain of MoRF binding (P = 0.0471); Gain of disorder (P = 0.0599); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09)
7:117227848:C:G,P13569,T547R,0.878,Gain of MoRF binding (P = 0.0229); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S549 (P = 0.0946); Gain of disorder (P = 0.1005)
7:117227848:C:T,P13569,T547I,0.886,Loss of disorder (P = 0.0488); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.2309); Loss of glycosylation at S549 (P = 0.4067); Gain of catalytic residue at L548 (P = 0.4621)
7:117227850:C:A,P13569,L548M,0.924,Gain of disorder (P = 0.0816); Gain of MoRF binding (P = 0.1092); Gain of methylation at R553 (P = 0.1238); Gain of glycosylation at S549 (P = 0.1947); Loss of stability (P = 0.342)
7:117227850:C:G,P13569,L548V,0.933,Gain of glycosylation at S549 (P = 0.1208); Gain of methylation at R553 (P = 0.149); Gain of MoRF binding (P = 0.1643); Gain of catalytic residue at L548 (P = 0.2057); Loss of disorder (P = 0.2317)
7:117227851:T:A,P13569,L548Q,0.959,Gain of disorder (P = 0.0106); Loss of stability (P = 0.0395); Gain of glycosylation at S549 (P = 0.0591); Loss of methylation at R553 (P = 0.0942); Gain of catalytic residue at L548 (P = 0.1135)
7:117227851:T:C,P13569,L548P,0.965,Gain of disorder (P = 0.0126); Loss of stability (P = 0.0189); Gain of glycosylation at S549 (P = 0.0526); Gain of phosphorylation at T547 (P = 0.0754); Gain of methylation at R553 (P = 0.1243)
7:117227851:T:G,P13569,L548R,0.927,Gain of methylation at L548 (P = 0.0092); Gain of MoRF binding (P = 0.0104); Gain of disorder (P = 0.0169); Loss of stability (P = 0.0461); Gain of phosphorylation at T547 (P = 0.1461)
7:117227853:A:C,P13569,S549R,0.97,Gain of MoRF binding (P = 0.0137); Gain of methylation at S549 (P = 0.0143); Loss of disorder (P = 0.1041); Loss of glycosylation at S549 (P = 0.1235); Loss of catalytic residue at G550 (P = 0.2255)
7:117227853:A:G,P13569,S549G,0.963,Gain of methylation at R553 (P = 0.0774); Loss of glycosylation at S549 (P = 0.1235); Loss of disorder (P = 0.1542); Loss of MoRF binding (P = 0.171); Loss of stability (P = 0.2191)
7:117227853:A:T,P13569,S549C,0.932,Loss of disorder (P = 0.0012); Loss of glycosylation at S549 (P = 0.1235); Loss of MoRF binding (P = 0.1312); Gain of methylation at R553 (P = 0.1374); Gain of catalytic residue at L548 (P = 0.3037)
7:117227854:G:C,P13569,S549T,0.981,Loss of disorder (P = 0.074); Gain of methylation at R553 (P = 0.1073); Loss of glycosylation at S549 (P = 0.1817); Loss of MoRF binding (P = 0.1917); Loss of helix (P = 0.4763)
7:117227854:G:T,P13569,S549I,0.979,Loss of disorder (P = 0.0048); Loss of glycosylation at S549 (P = 0.1235); Gain of methylation at R553 (P = 0.1244); Loss of MoRF binding (P = 0.1888); Gain of catalytic residue at A554 (P = 0.3216)
7:117227855:T:A,P13569,S549R,0.97,Gain of MoRF binding (P = 0.0137); Gain of methylation at S549 (P = 0.0143); Loss of disorder (P = 0.1041); Loss of glycosylation at S549 (P = 0.1235); Loss of catalytic residue at G550 (P = 0.2255)
7:117227856:G:A,P13569,G550R,0.952,Gain of MoRF binding (P = 0.0128); Gain of methylation at G550 (P = 0.0301); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of disorder (P = 0.1756)
7:117227856:G:C,P13569,G550R,0.952,Gain of MoRF binding (P = 0.0128); Gain of methylation at G550 (P = 0.0301); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of disorder (P = 0.1756)
7:117227857:G:A,P13569,G550E,0.892,Gain of solvent accessibility (P = 0.0411); Gain of relative solvent accessibility (P = 0.0479); Loss of methylation at R553 (P = 0.0562); Loss of MoRF binding (P = 0.0815); Gain of disorder (P = 0.0953)
7:117227857:G:C,P13569,G550A,0.9,Loss of disorder (P = 0.0825); Loss of methylation at R553 (P = 0.1231); Gain of MoRF binding (P = 0.1582); Loss of catalytic residue at G551 (P = 0.1798); Loss of glycosylation at S549 (P = 0.1956)
7:117227857:G:T,P13569,G550V,0.913,Loss of disorder (P = 0.0141); Loss of methylation at R553 (P = 0.0726); Gain of MoRF binding (P = 0.1053); Loss of catalytic residue at G551 (P = 0.1384); Loss of glycosylation at S549 (P = 0.152)
7:117227859:G:A,P13569,G551S,0.989,Gain of disorder (P = 0.0665); Loss of methylation at R553 (P = 0.0725); Gain of phosphorylation at G551 (P = 0.075); Gain of MoRF binding (P = 0.1735); Gain of helix (P = 0.2294)
7:117227859:G:C,P13569,G551R,0.97,Gain of methylation at G551 (P = 0.0171); Gain of MoRF binding (P = 0.0176); Loss of catalytic residue at G550 (P = 0.1778); Loss of disorder (P = 0.178); Gain of sheet (P = 0.1945)
7:117227859:G:T,P13569,G551C,0.968,Loss of disorder (P = 0.0048); Loss of methylation at R553 (P = 0.0837); Loss of MoRF binding (P = 0.1334); Loss of glycosylation at S549 (P = 0.2929); Loss of loop (P = 0.3664)
7:117227860:G:C,P13569,G551A,0.988,Loss of disorder (P = 0.0842); Loss of methylation at R553 (P = 0.1281); Gain of MoRF binding (P = 0.159); Loss of catalytic residue at R553 (P = 0.3131); Loss of stability (P = 0.3893)
7:117227860:G:T,P13569,G551V,0.974,Loss of disorder (P = 0.0157); Loss of methylation at R553 (P = 0.071); Gain of MoRF binding (P = 0.0977); Gain of helix (P = 0.1736); Loss of catalytic residue at G550 (P = 0.3372)
7:117227862:C:A,P13569,Q552K,0.971,Gain of MoRF binding (P = 0.0306); Gain of ubiquitination at Q552 (P = 0.0369); Gain of catalytic residue at Q552 (P = 0.0848); Gain of disorder (P = 0.0932); Gain of glycosylation at Q552 (P = 0.0936)
7:117227862:C:G,P13569,Q552E,0.944,Loss of MoRF binding (P = 0.0672); Gain of methylation at R555 (P = 0.075); Gain of disorder (P = 0.0765); Gain of phosphorylation at S557 (P = 0.1491); Gain of helix (P = 0.2294)
7:117227863:A:C,P13569,Q552P,0.936,Gain of methylation at R555 (P = 0.0404); Gain of glycosylation at Q552 (P = 0.0605); Loss of MoRF binding (P = 0.0777); Gain of phosphorylation at S557 (P = 0.1526); Gain of disorder (P = 0.1632)
7:117227863:A:G,P13569,Q552R,0.946,Gain of methylation at Q552 (P = 0.0116); Gain of MoRF binding (P = 0.0196); Gain of phosphorylation at S557 (P = 0.1095); Gain of helix (P = 0.1736); Gain of disorder (P = 0.1918)
7:117227863:A:T,P13569,Q552L,0.923,Gain of methylation at R555 (P = 0.0392); Loss of disorder (P = 0.0402); Gain of stability (P = 0.0856); Gain of helix (P = 0.1736); Loss of MoRF binding (P = 0.1767)
7:117227864:A:C,P13569,Q552H,0.958,Gain of methylation at R555 (P = 0.0343); Gain of disorder (P = 0.1309); Loss of MoRF binding (P = 0.1434); Loss of phosphorylation at S557 (P = 0.2193); Gain of glycosylation at S549 (P = 0.3661)
7:117227864:A:T,P13569,Q552H,0.958,Gain of methylation at R555 (P = 0.0343); Gain of disorder (P = 0.1309); Loss of MoRF binding (P = 0.1434); Loss of phosphorylation at S557 (P = 0.2193); Gain of glycosylation at S549 (P = 0.3661)
7:117227865:C:G,P13569,R553G,0.964,Loss of methylation at R553 (P = 0.0206); Loss of MoRF binding (P = 0.0466); Gain of disorder (P = 0.1282); Gain of glycosylation at S549 (P = 0.1379); Gain of catalytic residue at A554 (P = 0.221)
7:117227866:G:A,P13569,R553Q,0.976,Loss of methylation at R553 (P = 0.0206); Loss of MoRF binding (P = 0.0527); Gain of disorder (P = 0.1419); Loss of phosphorylation at S557 (P = 0.208); Gain of relative solvent accessibility (P = 0.2751)
7:117227866:G:C,P13569,R553P,0.922,Loss of methylation at R553 (P = 0.0206); Loss of MoRF binding (P = 0.0259); Gain of glycosylation at S549 (P = 0.0759); Gain of disorder (P = 0.1378); Loss of catalytic residue at R553 (P = 0.212)
7:117227866:G:T,P13569,R553L,0.911,Loss of methylation at R553 (P = 0.0206); Loss of MoRF binding (P = 0.0492); Loss of disorder (P = 0.0497); Gain of stability (P = 0.0826); Loss of phosphorylation at S557 (P = 0.1885)
7:117227868:G:A,P13569,A554T,0.834,Loss of methylation at R553 (P = 0.0668); Gain of disorder (P = 0.097); Gain of phosphorylation at A554 (P = 0.0982); Loss of MoRF binding (P = 0.1544); Gain of catalytic residue at A554 (P = 0.227)
7:117227868:G:C,P13569,A554P,0.859,Gain of glycosylation at A554 (P = 0.0266); Gain of disorder (P = 0.0573); Loss of methylation at R553 (P = 0.0674); Loss of MoRF binding (P = 0.0718); Gain of phosphorylation at S557 (P = 0.1819)
7:117227868:G:T,P13569,A554S,0.81,Gain of disorder (P = 0.0187); Gain of phosphorylation at A554 (P = 0.0545); Loss of methylation at R553 (P = 0.0597); Gain of catalytic residue at A554 (P = 0.1326); Loss of MoRF binding (P = 0.1441)
7:117227869:C:A,P13569,A554E,0.909,Gain of disorder (P = 0.0282); Loss of methylation at R553 (P = 0.0401); Loss of MoRF binding (P = 0.0532); Gain of phosphorylation at S557 (P = 0.1841); Loss of catalytic residue at R555 (P = 0.2892)
7:117227869:C:G,P13569,A554G,0.885,Gain of disorder (P = 0.0436); Gain of methylation at R555 (P = 0.0666); Loss of stability (P = 0.0918); Loss of MoRF binding (P = 0.1648); Gain of phosphorylation at S557 (P = 0.2356)
7:117227869:C:T,P13569,A554V,0.856,Loss of disorder (P = 0.0795); Gain of MoRF binding (P = 0.0889); Loss of methylation at R553 (P = 0.1101); Loss of phosphorylation at S557 (P = 0.1457); Gain of helix (P = 0.1736)
7:117227871:A:G,P13569,R555G,0.971,Loss of methylation at R555 (P = 0.0311); Loss of stability (P = 0.0429); Loss of MoRF binding (P = 0.0693); Loss of phosphorylation at S557 (P = 0.0768); Gain of catalytic residue at A554 (P = 0.1296)
7:117227872:G:A,P13569,R555K,0.921,Loss of methylation at R555 (P = 0.0669); Loss of phosphorylation at S557 (P = 0.0819); Loss of stability (P = 0.0926); Gain of disorder (P = 0.1236); Loss of MoRF binding (P = 0.1711)
7:117227872:G:C,P13569,R555T,0.92,Loss of methylation at R555 (P = 0.0311); Loss of phosphorylation at S557 (P = 0.0681); Loss of MoRF binding (P = 0.0705); Loss of stability (P = 0.2031); Gain of glycosylation at R555 (P = 0.2276)
7:117227872:G:T,P13569,R555I,0.929,Loss of methylation at R555 (P = 0.0311); Loss of disorder (P = 0.0495); Loss of phosphorylation at S557 (P = 0.0651); Loss of MoRF binding (P = 0.081); Gain of catalytic residue at S557 (P = 0.121)
7:117227873:A:C,P13569,R555S,0.911,Loss of methylation at R555 (P = 0.0311); Gain of phosphorylation at R555 (P = 0.0505); Gain of disorder (P = 0.0505); Loss of MoRF binding (P = 0.0691); Loss of stability (P = 0.1405)
7:117227873:A:T,P13569,R555S,0.911,Loss of methylation at R555 (P = 0.0311); Gain of phosphorylation at R555 (P = 0.0505); Gain of disorder (P = 0.0505); Loss of MoRF binding (P = 0.0691); Loss of stability (P = 0.1405)
7:117227874:A:C,P13569,I556L,0.774,Gain of methylation at R555 (P = 0.0625); Gain of disorder (P = 0.1055); Loss of MoRF binding (P = 0.1468); Gain of phosphorylation at S557 (P = 0.1593); Loss of catalytic residue at A561 (P = 0.2797)
7:117227874:A:T,P13569,I556F,0.764,Gain of methylation at R555 (P = 0.0439); Loss of MoRF binding (P = 0.1542); Loss of phosphorylation at S557 (P = 0.2064); Gain of disorder (P = 0.2126); Loss of stability (P = 0.3318)
7:117227875:T:A,P13569,I556N,0.878,Gain of disorder (P = 0.0115); Loss of stability (P = 0.0667); Gain of methylation at R555 (P = 0.0751); Gain of MoRF binding (P = 0.0951); Gain of phosphorylation at S557 (P = 0.1865)
7:117227875:T:C,P13569,I556T,0.811,Gain of disorder (P = 0.0152); Loss of stability (P = 0.0291); Gain of phosphorylation at I556 (P = 0.0412); Gain of methylation at R555 (P = 0.052); Gain of MoRF binding (P = 0.1318)
7:117227875:T:G,P13569,I556S,0.813,Gain of disorder (P = 0.0016); Gain of phosphorylation at I556 (P = 0.0319); Gain of methylation at R555 (P = 0.0531); Gain of catalytic residue at I556 (P = 0.055); Loss of stability (P = 0.0661)
7:117227876:T:G,P13569,I556M,0.799,Gain of disorder (P = 0.0468); Gain of methylation at R555 (P = 0.0487); Gain of catalytic residue at I556 (P = 0.05); Gain of MoRF binding (P = 0.0819); Gain of phosphorylation at S557 (P = 0.1374)
7:117227877:T:A,P13569,S557T,0.812,Gain of phosphorylation at S557 (P = 0.0959); Loss of disorder (P = 0.1258); Loss of methylation at R553 (P = 0.1323); Loss of MoRF binding (P = 0.1701); Loss of helix (P = 0.4763)
7:117227877:T:C,P13569,S557P,0.841,Loss of phosphorylation at S557 (P = 0.0442); Loss of MoRF binding (P = 0.0697); Loss of methylation at R553 (P = 0.1354); Loss of disorder (P = 0.1364); Gain of catalytic residue at L558 (P = 0.312)
7:117227877:T:G,P13569,S557A,0.706,Loss of phosphorylation at S557 (P = 0.0442); Loss of disorder (P = 0.0887); Gain of methylation at R560 (P = 0.1218); Loss of MoRF binding (P = 0.1321); Loss of catalytic residue at R555 (P = 0.3498)
7:117227878:C:A,P13569,S557Y,0.823,Loss of disorder (P = 0.0483); Loss of phosphorylation at S557 (P = 0.0521); Loss of methylation at R553 (P = 0.1116); Loss of MoRF binding (P = 0.1247); Gain of catalytic residue at I556 (P = 0.1479)
7:117227878:C:G,P13569,S557C,0.801,Loss of disorder (P = 0.0235); Loss of phosphorylation at S557 (P = 0.0442); Loss of methylation at R553 (P = 0.079); Loss of MoRF binding (P = 0.101); Gain of catalytic residue at L558 (P = 0.1162)
7:117227878:C:T,P13569,S557F,0.804,Loss of disorder (P = 0.0321); Loss of phosphorylation at S557 (P = 0.0442); Loss of methylation at R553 (P = 0.0818); Loss of MoRF binding (P = 0.1598); Gain of catalytic residue at A554 (P = 0.3888)
7:117227880:T:A,P13569,L558I,0.766,Loss of methylation at R560 (P = 0.1235); Gain of MoRF binding (P = 0.1352); Gain of phosphorylation at S557 (P = 0.1841); Loss of catalytic residue at L558 (P = 0.2525); Loss of disorder (P = 0.2706)
7:117227880:T:G,P13569,L558V,0.769,Gain of methylation at R555 (P = 0.1176); Gain of MoRF binding (P = 0.1222); Gain of phosphorylation at Y563 (P = 0.1768); Gain of disorder (P = 0.2705); Loss of catalytic residue at L558 (P = 0.2707)
7:117227881:T:C,P13569,L558S,0.916,Gain of disorder (P = 0.0054); Gain of phosphorylation at L558 (P = 0.0225); Gain of catalytic residue at L558 (P = 0.0716); Gain of methylation at R555 (P = 0.0976); Loss of stability (P = 0.108)
7:117227882:A:C,P13569,L558F,0.834,Gain of methylation at R560 (P = 0.1272); Gain of MoRF binding (P = 0.1784); Loss of phosphorylation at S557 (P = 0.183); Loss of disorder (P = 0.2302); Loss of catalytic residue at L558 (P = 0.4258)
7:117227882:A:T,P13569,L558F,0.834,Gain of methylation at R560 (P = 0.1272); Gain of MoRF binding (P = 0.1784); Loss of phosphorylation at S557 (P = 0.183); Loss of disorder (P = 0.2302); Loss of catalytic residue at L558 (P = 0.4258)
7:117227883:G:C,P13569,A559P,0.961,Loss of MoRF binding (P = 0.0795); Loss of methylation at R560 (P = 0.1178); Gain of phosphorylation at Y563 (P = 0.144); Loss of stability (P = 0.1595); Gain of disorder (P = 0.1807)
7:117227883:G:T,P13569,A559S,0.906,Gain of disorder (P = 0.0428); Loss of methylation at R560 (P = 0.113); Gain of phosphorylation at Y563 (P = 0.1202); Gain of MoRF binding (P = 0.1582); Loss of ubiquitination at K564 (P = 0.1962)
7:117227884:C:A,P13569,A559E,0.976,Loss of MoRF binding (P = 0.0671); Loss of methylation at R560 (P = 0.0739); Gain of phosphorylation at Y563 (P = 0.1153); Gain of disorder (P = 0.1361); Loss of ubiquitination at K564 (P = 0.1808)
7:117227884:C:G,P13569,A559G,0.943,Loss of stability (P = 0.0613); Gain of methylation at R560 (P = 0.0642); Gain of ubiquitination at K564 (P = 0.1306); Gain of disorder (P = 0.1492); Gain of MoRF binding (P = 0.1609)
7:117227884:C:T,P13569,A559V,0.96,Gain of MoRF binding (P = 0.1052); Loss of methylation at R560 (P = 0.1081); Loss of phosphorylation at S557 (P = 0.1757); Loss of disorder (P = 0.1805); Loss of ubiquitination at K564 (P = 0.2094)
7:117227886:A:G,P13569,R560G,0.993,Loss of methylation at R560 (P = 0.0289); Loss of MoRF binding (P = 0.0369); Gain of catalytic residue at A559 (P = 0.0418); Loss of stability (P = 0.0466); Loss of phosphorylation at S557 (P = 0.112)
7:117227887:G:A,P13569,R560K,0.987,Loss of methylation at R560 (P = 0.0407); Gain of ubiquitination at R560 (P = 0.0539); Loss of MoRF binding (P = 0.1012); Loss of stability (P = 0.1027); Loss of phosphorylation at S557 (P = 0.131)
7:117227887:G:T,P13569,R560I,0.952,Loss of methylation at R560 (P = 0.0289); Loss of MoRF binding (P = 0.0362); Loss of phosphorylation at S557 (P = 0.0835); Gain of catalytic residue at A559 (P = 0.1966); Loss of disorder (P = 0.1987)
7:117230407:A:C,P13569,R560S,0.991,Loss of methylation at R560 (P = 0.0289); Loss of MoRF binding (P = 0.0422); Gain of catalytic residue at R560 (P = 0.0727); Gain of phosphorylation at Y563 (P = 0.1274); Gain of ubiquitination at K564 (P = 0.1306)
7:117230407:A:T,P13569,R560S,0.991,Loss of methylation at R560 (P = 0.0289); Loss of MoRF binding (P = 0.0422); Gain of catalytic residue at R560 (P = 0.0727); Gain of phosphorylation at Y563 (P = 0.1274); Gain of ubiquitination at K564 (P = 0.1306)
7:117230408:G:A,P13569,A561T,0.889,Gain of phosphorylation at A561 (P = 0.0837); Loss of methylation at R560 (P = 0.0978); Gain of ubiquitination at K564 (P = 0.1306); Gain of MoRF binding (P = 0.1637); Loss of catalytic residue at A561 (P = 0.2702)
7:117230408:G:C,P13569,A561P,0.926,Loss of catalytic residue at A561 (P = 0.0749); Loss of MoRF binding (P = 0.0843); Loss of methylation at R560 (P = 0.1055); Gain of phosphorylation at Y563 (P = 0.1355); Loss of ubiquitination at K564 (P = 0.2094)
7:117230408:G:T,P13569,A561S,0.89,Gain of phosphorylation at A561 (P = 0.0617); Loss of methylation at R560 (P = 0.1018); Gain of disorder (P = 0.1162); Loss of catalytic residue at A561 (P = 0.1168); Gain of MoRF binding (P = 0.1628)
7:117230409:C:A,P13569,A561E,0.953,Loss of methylation at R560 (P = 0.0652); Loss of MoRF binding (P = 0.0701); Loss of catalytic residue at A561 (P = 0.0703); Gain of phosphorylation at Y563 (P = 0.1396); Loss of ubiquitination at K564 (P = 0.1808)
7:117230409:C:G,P13569,A561G,0.896,Gain of methylation at R560 (P = 0.0652); Loss of stability (P = 0.0906); Gain of ubiquitination at K564 (P = 0.1575); Gain of MoRF binding (P = 0.1594); Gain of phosphorylation at Y563 (P = 0.1853)
7:117230409:C:T,P13569,A561V,0.879,Loss of catalytic residue at A561 (P = 0.0652); Loss of methylation at R560 (P = 0.1154); Gain of MoRF binding (P = 0.1162); Loss of phosphorylation at S557 (P = 0.1897); Loss of ubiquitination at K564 (P = 0.2243)
7:117230411:G:T,P13569,V562L,0.913,Loss of phosphorylation at Y563 (P = 0.1225); Loss of MoRF binding (P = 0.1477); Loss of methylation at R560 (P = 0.1493); Loss of ubiquitination at K564 (P = 0.2335); Gain of catalytic residue at S557 (P = 0.3221)
7:117230412:T:A,P13569,V562E,0.943,Gain of disorder (P = 0.023); Loss of stability (P = 0.0549); Loss of MoRF binding (P = 0.0653); Gain of methylation at R560 (P = 0.0883); Gain of phosphorylation at S557 (P = 0.1432)
7:117230412:T:C,P13569,V562A,0.869,Loss of stability (P = 0.0506); Gain of methylation at R560 (P = 0.0536); Gain of phosphorylation at S557 (P = 0.1387); Loss of MoRF binding (P = 0.1424); Gain of ubiquitination at K564 (P = 0.2129)
7:117230412:T:G,P13569,V562G,0.841,Loss of stability (P = 4e-04); Gain of methylation at R560 (P = 0.0517); Gain of disorder (P = 0.0966); Gain of phosphorylation at S557 (P = 0.1425); Loss of MoRF binding (P = 0.1516)
7:117230414:T:A,P13569,Y563N,0.951,Loss of phosphorylation at Y563 (P = 0.0471); Loss of methylation at R560 (P = 0.1364); Gain of MoRF binding (P = 0.1542); Loss of stability (P = 0.2037); Loss of catalytic residue at L558 (P = 0.2259)
7:117230414:T:C,P13569,Y563H,0.921,Loss of phosphorylation at Y563 (P = 0.0471); Gain of methylation at R560 (P = 0.0936); Gain of disorder (P = 0.1326); Loss of stability (P = 0.1856); Loss of ubiquitination at K564 (P = 0.1962)
7:117230414:T:G,P13569,Y563D,0.955,Loss of phosphorylation at Y563 (P = 0.0471); Gain of disorder (P = 0.0788); Loss of MoRF binding (P = 0.0914); Loss of methylation at R560 (P = 0.0916); Gain of ubiquitination at K564 (P = 0.1306)
7:117230415:A:C,P13569,Y563S,0.902,Gain of disorder (P = 0.0382); Gain of phosphorylation at Y563 (P = 0.136); Loss of methylation at R560 (P = 0.1524); Gain of MoRF binding (P = 0.1529); Loss of stability (P = 0.1877)
7:117230415:A:G,P13569,Y563C,0.939,Gain of methylation at K564 (P = 0.0182); Loss of phosphorylation at Y563 (P = 0.0471); Gain of ubiquitination at K564 (P = 0.1575); Loss of MoRF binding (P = 0.1608); Loss of catalytic residue at L558 (P = 0.2267)
7:117230415:A:T,P13569,Y563F,0.815,Loss of phosphorylation at Y563 (P = 0.0471); Gain of methylation at K564 (P = 0.1111); Gain of MoRF binding (P = 0.1378); Gain of ubiquitination at K564 (P = 0.2129); Loss of catalytic residue at L558 (P = 0.2272)
7:117230417:A:C,P13569,K564Q,0.588,Loss of ubiquitination at K564 (P = 0.0362); Loss of MoRF binding (P = 0.0869); Loss of methylation at R560 (P = 0.1285); Gain of phosphorylation at Y563 (P = 0.1915); Loss of sheet (P = 0.3635)
7:117230418:A:C,P13569,K564T,0.599,Loss of ubiquitination at K564 (P = 0.0362); Loss of MoRF binding (P = 0.0793); Loss of stability (P = 0.0848); Gain of phosphorylation at K564 (P = 0.1248); Gain of methylation at R560 (P = 0.1311)
7:117230418:A:G,P13569,K564R,0.545,Gain of methylation at K564 (P = 0.0235); Loss of ubiquitination at K564 (P = 0.0362); Gain of MoRF binding (P = 0.1012); Loss of phosphorylation at Y563 (P = 0.1703); Loss of sheet (P = 0.3635)
7:117230418:A:T,P13569,K564I,0.652,Loss of ubiquitination at K564 (P = 0.0362); Gain of catalytic residue at D565 (P = 0.0456); Loss of MoRF binding (P = 0.0787); Loss of methylation at R560 (P = 0.1323); Loss of phosphorylation at Y563 (P = 0.1923)
7:117230419:A:C,P13569,K564N,0.601,Loss of ubiquitination at K564 (P = 0.0362); Loss of MoRF binding (P = 0.0847); Gain of catalytic residue at D565 (P = 0.122); Gain of methylation at R560 (P = 0.1239); Gain of phosphorylation at Y563 (P = 0.2358)
7:117230419:A:T,P13569,K564N,0.601,Loss of ubiquitination at K564 (P = 0.0362); Loss of MoRF binding (P = 0.0847); Gain of catalytic residue at D565 (P = 0.122); Gain of methylation at R560 (P = 0.1239); Gain of phosphorylation at Y563 (P = 0.2358)
7:117230420:G:A,P13569,D565N,0.575,Gain of MoRF binding (P = 0.057); Gain of methylation at R560 (P = 0.0963); Loss of ubiquitination at K564 (P = 0.1808); Loss of phosphorylation at Y563 (P = 0.1837); Loss of sheet (P = 0.3635)
7:117230420:G:C,P13569,D565H,0.651,Gain of MoRF binding (P = 0.0662); Gain of methylation at R560 (P = 0.0728); Loss of phosphorylation at Y563 (P = 0.1481); Loss of ubiquitination at K564 (P = 0.2243); Loss of solvent accessibility (P = 0.2732)
7:117230420:G:T,P13569,D565Y,0.68,Gain of MoRF binding (P = 0.0654); Gain of methylation at R560 (P = 0.0726); Loss of phosphorylation at Y563 (P = 0.108); Gain of ubiquitination at K564 (P = 0.1575); Loss of solvent accessibility (P = 0.3103)
7:117230421:A:C,P13569,D565A,0.655,Gain of methylation at R560 (P = 0.0517); Gain of MoRF binding (P = 0.055); Gain of ubiquitination at K564 (P = 0.064); Loss of phosphorylation at Y563 (P = 0.1277); Loss of stability (P = 0.1663)
7:117230421:A:G,P13569,D565G,0.855,Gain of MoRF binding (P = 0.0533); Gain of methylation at R560 (P = 0.0561); Gain of ubiquitination at K564 (P = 0.1096); Loss of phosphorylation at Y563 (P = 0.1554); Gain of catalytic residue at L570 (P = 0.175)
7:117230421:A:T,P13569,D565V,0.723,Gain of MoRF binding (P = 0.0465); Gain of ubiquitination at K564 (P = 0.064); Gain of methylation at R560 (P = 0.0643); Loss of phosphorylation at Y563 (P = 0.1292); Loss of solvent accessibility (P = 0.322)
7:117230422:T:A,P13569,D565E,0.482,Gain of methylation at R560 (P = 0.1584); Gain of phosphorylation at Y569 (P = 0.174); Gain of ubiquitination at K564 (P = 0.1884); Gain of MoRF binding (P = 0.2319); Loss of catalytic residue at K564 (P = 0.3227)
7:117230422:T:G,P13569,D565E,0.482,Gain of methylation at R560 (P = 0.1584); Gain of phosphorylation at Y569 (P = 0.174); Gain of ubiquitination at K564 (P = 0.1884); Gain of MoRF binding (P = 0.2319); Loss of catalytic residue at K564 (P = 0.3227)
7:117230423:G:A,P13569,A566T,0.903,Gain of phosphorylation at A566 (P = 0.0728); Loss of stability (P = 0.1038); Gain of sheet (P = 0.1539); Gain of ubiquitination at K564 (P = 0.1575); Gain of catalytic residue at A566 (P = 0.1698)
7:117230423:G:C,P13569,A566P,0.852,Gain of phosphorylation at Y563 (P = 0.1068); Gain of glycosylation at A566 (P = 0.1662); Loss of stability (P = 0.1692); Loss of MoRF binding (P = 0.2209); Loss of ubiquitination at K564 (P = 0.2335)
7:117230423:G:T,P13569,A566S,0.826,Gain of phosphorylation at A566 (P = 0.0857); Loss of ubiquitination at K564 (P = 0.1962); Loss of stability (P = 0.2172); Gain of disorder (P = 0.2504); Loss of MoRF binding (P = 0.2763)
7:117230424:C:A,P13569,A566D,0.923,Gain of phosphorylation at Y569 (P = 0.0847); Loss of MoRF binding (P = 0.1811); Gain of ubiquitination at K564 (P = 0.1884); Loss of catalytic residue at A566 (P = 0.2373); Gain of disorder (P = 0.3229)
7:117230424:C:G,P13569,A566G,0.825,Loss of stability (P = 0.0776); Gain of catalytic residue at L571 (P = 0.1705); Gain of phosphorylation at Y563 (P = 0.1846); Gain of ubiquitination at K564 (P = 0.1884); Gain of MoRF binding (P = 0.2639)
7:117230424:C:T,P13569,A566V,0.788,Gain of phosphorylation at Y563 (P = 0.1286); Gain of MoRF binding (P = 0.2186); Loss of ubiquitination at K564 (P = 0.2243); Loss of catalytic residue at A566 (P = 0.2499); Gain of relative solvent accessibility (P = 0.2816)
7:117230426:G:A,P13569,D567N,0.502,Gain of MoRF binding (P = 0.1057); Loss of phosphorylation at Y563 (P = 0.1263); Loss of ubiquitination at K564 (P = 0.1808); Loss of sheet (P = 0.302); Loss of stability (P = 0.3377)
7:117230426:G:C,P13569,D567H,0.508,Loss of phosphorylation at Y563 (P = 0.1423); Gain of MoRF binding (P = 0.1646); Loss of stability (P = 0.1919); Loss of ubiquitination at K564 (P = 0.2094); Gain of helix (P = 0.2294)
7:117230426:G:T,P13569,D567Y,0.664,Loss of phosphorylation at Y563 (P = 0.1082); Loss of solvent accessibility (P = 0.1279); Loss of relative solvent accessibility (P = 0.1807); Gain of MoRF binding (P = 0.2046); Loss of ubiquitination at K564 (P = 0.2335)
7:117230427:A:C,P13569,D567A,0.558,Loss of phosphorylation at Y563 (P = 0.1174); Gain of ubiquitination at K564 (P = 0.1306); Gain of MoRF binding (P = 0.1864); Loss of sheet (P = 0.302); Loss of stability (P = 0.3413)
7:117230427:A:G,P13569,D567G,0.605,Gain of catalytic residue at D567 (P = 0.0349); Loss of stability (P = 0.0762); Gain of ubiquitination at K564 (P = 0.0918); Loss of phosphorylation at Y563 (P = 0.1423); Gain of MoRF binding (P = 0.1694)
7:117230427:A:T,P13569,D567V,0.654,Gain of ubiquitination at K564 (P = 0.077); Loss of phosphorylation at Y563 (P = 0.1174); Loss of solvent accessibility (P = 0.1279); Gain of MoRF binding (P = 0.169); Loss of relative solvent accessibility (P = 0.1807)
7:117230428:T:A,P13569,D567E,0.459,Loss of phosphorylation at Y563 (P = 0.181); Loss of ubiquitination at K564 (P = 0.2094); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3193); Loss of catalytic residue at K564 (P = 0.3551)
7:117230428:T:G,P13569,D567E,0.459,Loss of phosphorylation at Y563 (P = 0.181); Loss of ubiquitination at K564 (P = 0.2094); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3193); Loss of catalytic residue at K564 (P = 0.3551)
7:117230429:T:A,P13569,L568M,0.855,Gain of phosphorylation at Y563 (P = 0.1384); Gain of ubiquitination at K564 (P = 0.1884); Gain of catalytic residue at L568 (P = 0.2899); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3152)
7:117230429:T:G,P13569,L568V,0.84,Gain of phosphorylation at Y569 (P = 0.1316); Loss of ubiquitination at K564 (P = 0.2243); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3493); Gain of methylation at K564 (P = 0.4674)
7:117230430:T:C,P13569,L568S,0.901,Gain of disorder (P = 0.0348); Gain of phosphorylation at L568 (P = 0.0559); Loss of stability (P = 0.0798); Loss of ubiquitination at K564 (P = 0.2335); Loss of sheet (P = 0.302)
7:117230430:T:G,P13569,L568W,0.872,Gain of MoRF binding (P = 0.2031); Loss of ubiquitination at K564 (P = 0.2335); Loss of stability (P = 0.2383); Loss of phosphorylation at Y563 (P = 0.2454); Loss of sheet (P = 0.302)
7:117230431:G:C,P13569,L568F,0.916,Gain of ubiquitination at K564 (P = 0.1575); Gain of phosphorylation at Y563 (P = 0.2215); Loss of sheet (P = 0.302); Gain of catalytic residue at L568 (P = 0.312); Gain of MoRF binding (P = 0.3559)
7:117230431:G:T,P13569,L568F,0.916,Gain of ubiquitination at K564 (P = 0.1575); Gain of phosphorylation at Y563 (P = 0.2215); Loss of sheet (P = 0.302); Gain of catalytic residue at L568 (P = 0.312); Gain of MoRF binding (P = 0.3559)
7:117230432:T:A,P13569,Y569N,0.932,Loss of stability (P = 0.0507); Gain of catalytic residue at Y569 (P = 0.1219); Loss of phosphorylation at Y569 (P = 0.1538); Loss of ubiquitination at K564 (P = 0.1668); Loss of sheet (P = 0.302)
7:117230432:T:C,P13569,Y569H,0.96,Loss of stability (P = 0.0657); Gain of catalytic residue at L571 (P = 0.1123); Loss of sheet (P = 0.1158); Loss of ubiquitination at K564 (P = 0.1392); Loss of phosphorylation at Y569 (P = 0.1538)
7:117230432:T:G,P13569,Y569D,0.967,Loss of stability (P = 0.0707); Gain of disorder (P = 0.1469); Loss of phosphorylation at Y569 (P = 0.1538); Loss of catalytic residue at S573 (P = 0.228); Loss of ubiquitination at K564 (P = 0.2335)
7:117230433:A:C,P13569,Y569S,0.899,Loss of stability (P = 0.0299); Gain of disorder (P = 0.0825); Gain of phosphorylation at Y569 (P = 0.1385); Loss of ubiquitination at K564 (P = 0.1808); Loss of sheet (P = 0.302)
7:117230433:A:G,P13569,Y569C,0.902,Gain of catalytic residue at L570 (P = 0.0359); Loss of stability (P = 0.1202); Loss of phosphorylation at Y569 (P = 0.1538); Loss of ubiquitination at K564 (P = 0.2335); Loss of sheet (P = 0.302)
7:117230433:A:T,P13569,Y569F,0.728,Loss of sheet (P = 0.1158); Loss of phosphorylation at Y569 (P = 0.1538); Loss of ubiquitination at K564 (P = 0.2335); Gain of catalytic residue at Y569 (P = 0.241); Loss of stability (P = 0.3681)
7:117230435:T:A,P13569,L570I,0.75,Gain of sheet (P = 0.1539); Gain of catalytic residue at D572 (P = 0.3736); Gain of phosphorylation at Y569 (P = 0.378); Gain of MoRF binding (P = 0.4763); Gain of glycosylation at S573 (P = 0.5097)
7:117230435:T:G,P13569,L570V,0.731,Gain of catalytic residue at L570 (P = 0.0958); Gain of sheet (P = 0.1539); Gain of phosphorylation at Y569 (P = 0.2452); Gain of MoRF binding (P = 0.4831); Gain of glycosylation at S573 (P = 0.5482)
7:117230436:T:C,P13569,L570S,0.907,Gain of disorder (P = 0.089); Gain of phosphorylation at L570 (P = 0.0895); Loss of stability (P = 0.1217); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302)
7:117230437:A:C,P13569,L570F,0.777,Loss of sheet (P = 0.302); Loss of phosphorylation at Y569 (P = 0.3903); Gain of catalytic residue at D572 (P = 0.393); Loss of stability (P = 0.4712); Gain of MoRF binding (P = 0.487)
7:117230437:A:T,P13569,L570F,0.777,Loss of sheet (P = 0.302); Loss of phosphorylation at Y569 (P = 0.3903); Gain of catalytic residue at D572 (P = 0.393); Loss of stability (P = 0.4712); Gain of MoRF binding (P = 0.487)
7:117230438:T:A,P13569,L571I,0.917,Loss of sheet (P = 0.302); Gain of phosphorylation at Y569 (P = 0.3318); Gain of catalytic residue at S573 (P = 0.3649); Loss of stability (P = 0.5112); Loss of glycosylation at S573 (P = 0.5249)
7:117230438:T:G,P13569,L571V,0.932,Gain of phosphorylation at Y569 (P = 0.2204); Loss of stability (P = 0.2383); Loss of sheet (P = 0.302); Gain of catalytic residue at D572 (P = 0.4639); Gain of MoRF binding (P = 0.5608)
7:117230439:T:C,P13569,L571S,0.967,Loss of stability (P = 0.0233); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1304); Gain of phosphorylation at L571 (P = 0.1445); Gain of glycosylation at S573 (P = 0.3049)
7:117230440:A:C,P13569,L571F,0.92,Loss of stability (P = 0.098); Loss of sheet (P = 0.302); Gain of catalytic residue at L571 (P = 0.3897); Gain of phosphorylation at Y569 (P = 0.4008); Gain of glycosylation at S573 (P = 0.512)
7:117230440:A:T,P13569,L571F,0.92,Loss of stability (P = 0.098); Loss of sheet (P = 0.302); Gain of catalytic residue at L571 (P = 0.3897); Gain of phosphorylation at Y569 (P = 0.4008); Gain of glycosylation at S573 (P = 0.512)
7:117230441:G:A,P13569,D572N,0.984,Gain of phosphorylation at Y569 (P = 0.1019); Gain of catalytic residue at D572 (P = 0.247); Loss of sheet (P = 0.302); Loss of glycosylation at S573 (P = 0.507); Gain of MoRF binding (P = 0.56)
7:117230441:G:C,P13569,D572H,0.971,Gain of phosphorylation at Y569 (P = 0.0877); Gain of catalytic residue at L571 (P = 0.178); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Loss of loop (P = 0.3664)
7:117230441:G:T,P13569,D572Y,0.942,Gain of phosphorylation at Y569 (P = 0.1306); Gain of sheet (P = 0.1539); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Loss of glycosylation at S573 (P = 0.552)
7:117230442:A:C,P13569,D572A,0.975,Gain of phosphorylation at Y569 (P = 0.101); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Gain of catalytic residue at Y569 (P = 0.3511); Loss of loop (P = 0.3664)
7:117230442:A:G,P13569,D572G,0.972,Gain of phosphorylation at Y569 (P = 0.087); Gain of helix (P = 0.2684); Gain of catalytic residue at S573 (P = 0.2861); Loss of sheet (P = 0.302); Loss of stability (P = 0.3109)
7:117230442:A:T,P13569,D572V,0.936,Gain of phosphorylation at Y569 (P = 0.066); Gain of sheet (P = 0.1539); Loss of loop (P = 0.2237); Loss of catalytic residue at D572 (P = 0.3137); Loss of glycosylation at S573 (P = 0.5424)
7:117230443:C:A,P13569,D572E,0.975,Gain of phosphorylation at Y569 (P = 0.0707); Loss of sheet (P = 0.302); Loss of catalytic residue at S573 (P = 0.5408); Loss of glycosylation at S573 (P = 0.5457); Loss of helix (P = 0.6555)
7:117230443:C:G,P13569,D572E,0.975,Gain of phosphorylation at Y569 (P = 0.0707); Loss of sheet (P = 0.302); Loss of catalytic residue at S573 (P = 0.5408); Loss of glycosylation at S573 (P = 0.5457); Loss of helix (P = 0.6555)
7:117230444:T:A,P13569,S573T,0.752,Loss of stability (P = 0.0991); Gain of phosphorylation at S573 (P = 0.117); Loss of sheet (P = 0.302); Loss of glycosylation at S573 (P = 0.4356); Loss of catalytic residue at D572 (P = 0.5643)
7:117230444:T:C,P13569,S573P,0.784,Loss of stability (P = 0.0873); Gain of catalytic residue at S573 (P = 0.1221); Loss of phosphorylation at Y577 (P = 0.1684); Loss of sheet (P = 0.302); Loss of glycosylation at S573 (P = 0.5113)
7:117230444:T:G,P13569,S573A,0.783,Loss of phosphorylation at Y577 (P = 0.1279); Loss of stability (P = 0.1688); Loss of sheet (P = 0.302); Loss of catalytic residue at D572 (P = 0.3219); Loss of glycosylation at S573 (P = 0.326)
7:117230445:C:A,P13569,S573Y,0.782,Loss of phosphorylation at Y577 (P = 0.1071); Gain of catalytic residue at L568 (P = 0.1662); Loss of stability (P = 0.301); Loss of sheet (P = 0.302); Loss of glycosylation at S573 (P = 0.326)
7:117230445:C:G,P13569,S573C,0.764,Loss of phosphorylation at Y577 (P = 0.083); Loss of stability (P = 0.2177); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Loss of glycosylation at S573 (P = 0.326)
7:117230445:C:T,P13569,S573F,0.783,Loss of phosphorylation at Y577 (P = 0.0932); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Loss of glycosylation at S573 (P = 0.326); Loss of catalytic residue at D572 (P = 0.3757)
7:117230447:C:A,P13569,P574T,0.922,Gain of catalytic residue at P574 (P = 0.0187); Loss of stability (P = 0.0581); Loss of sheet (P = 0.1501); Loss of phosphorylation at Y577 (P = 0.1849); Gain of glycosylation at S573 (P = 0.322)
7:117230447:C:G,P13569,P574A,0.926,Gain of catalytic residue at P574 (P = 0.0107); Loss of stability (P = 0.0361); Loss of sheet (P = 0.1501); Loss of phosphorylation at Y577 (P = 0.1877); Loss of glycosylation at S573 (P = 0.546)
7:117230447:C:T,P13569,P574S,0.972,Gain of phosphorylation at P574 (P = 0.0737); Loss of stability (P = 0.0866); Loss of sheet (P = 0.1501); Gain of catalytic residue at L570 (P = 0.2081); Loss of glycosylation at S573 (P = 0.4965)
7:117230448:C:A,P13569,P574H,0.972,Loss of stability (P = 0.0652); Loss of sheet (P = 0.1501); Gain of catalytic residue at P574 (P = 0.209); Loss of phosphorylation at Y577 (P = 0.2145); Gain of helix (P = 0.2684)
7:117230448:C:G,P13569,P574R,0.92,Gain of catalytic residue at P574 (P = 0.0243); Loss of stability (P = 0.1414); Loss of phosphorylation at Y577 (P = 0.1426); Loss of sheet (P = 0.1501); Gain of methylation at P574 (P = 0.1649)
7:117230448:C:T,P13569,P574L,0.921,Loss of phosphorylation at Y577 (P = 0.0963); Loss of sheet (P = 0.1501); Gain of helix (P = 0.2684); Loss of loop (P = 0.3664); Loss of catalytic residue at L571 (P = 0.4954)
7:117230450:T:A,P13569,F575I,0.764,Loss of phosphorylation at Y577 (P = 0.1895); Loss of sheet (P = 0.302); Gain of catalytic residue at D579 (P = 0.3584); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.5813)
7:117230450:T:C,P13569,F575L,0.786,Loss of catalytic residue at F575 (P = 0.1715); Gain of phosphorylation at Y577 (P = 0.2318); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.5603)
7:117230450:T:G,P13569,F575V,0.771,Gain of phosphorylation at Y577 (P = 0.1495); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.5638); Gain of catalytic residue at F575 (P = 0.6423)
7:117230451:T:A,P13569,F575Y,0.795,Gain of phosphorylation at F575 (P = 0.0561); Gain of catalytic residue at L570 (P = 0.0613); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.5386)
7:117230451:T:C,P13569,F575S,0.768,Gain of disorder (P = 0.039); Loss of catalytic residue at F575 (P = 0.0772); Gain of phosphorylation at F575 (P = 0.1088); Gain of glycosylation at F575 (P = 0.1211); Gain of helix (P = 0.132)
7:117230451:T:G,P13569,F575C,0.765,Gain of catalytic residue at P574 (P = 0.0135); Loss of phosphorylation at Y577 (P = 0.1704); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117230452:T:A,P13569,F575L,0.786,Loss of catalytic residue at F575 (P = 0.1715); Gain of phosphorylation at Y577 (P = 0.2318); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.5603)
7:117230452:T:G,P13569,F575L,0.786,Loss of catalytic residue at F575 (P = 0.1715); Gain of phosphorylation at Y577 (P = 0.2318); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.5603)
7:117230453:G:A,P13569,G576R,0.87,Gain of catalytic residue at G576 (P = 0.0394); Loss of phosphorylation at Y577 (P = 0.1039); Gain of helix (P = 0.2684); Loss of stability (P = 0.269); Loss of sheet (P = 0.302)
7:117230453:G:C,P13569,G576R,0.87,Gain of catalytic residue at G576 (P = 0.0394); Loss of phosphorylation at Y577 (P = 0.1039); Gain of helix (P = 0.2684); Loss of stability (P = 0.269); Loss of sheet (P = 0.302)
7:117230454:G:A,P13569,G576E,0.825,Loss of catalytic residue at Y577 (P = 0.0932); Gain of phosphorylation at Y577 (P = 0.1257); Loss of helix (P = 0.2022); Loss of stability (P = 0.2852); Loss of sheet (P = 0.302)
7:117230454:G:T,P13569,G576V,0.861,Gain of sheet (P = 0.1539); Gain of phosphorylation at Y577 (P = 0.2074); Loss of catalytic residue at L581 (P = 0.22); Gain of helix (P = 0.2684); Loss of loop (P = 0.3664)
7:117230456:T:A,P13569,Y577N,0.748,Loss of phosphorylation at Y577 (P = 0.0462); Loss of stability (P = 0.108); Loss of sheet (P = 0.1158); Gain of catalytic residue at Y577 (P = 0.3403); Loss of helix (P = 0.3949)
7:117230456:T:C,P13569,Y577H,0.759,Loss of phosphorylation at Y577 (P = 0.0462); Loss of stability (P = 0.0942); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Gain of catalytic residue at D579 (P = 0.2666)
7:117230456:T:G,P13569,Y577D,0.764,Loss of phosphorylation at Y577 (P = 0.0462); Gain of loop (P = 0.2045); Loss of stability (P = 0.2329); Loss of sheet (P = 0.302); Loss of catalytic residue at Y577 (P = 0.3252)
7:117230457:A:C,P13569,Y577S,0.781,Loss of stability (P = 0.1207); Loss of phosphorylation at Y577 (P = 0.1248); Loss of catalytic residue at Y577 (P = 0.1415); Gain of loop (P = 0.2045); Loss of helix (P = 0.2271)
7:117230457:A:G,P13569,Y577C,0.815,Gain of catalytic residue at L578 (P = 0.0169); Loss of phosphorylation at Y577 (P = 0.0462); Gain of loop (P = 0.2045); Loss of stability (P = 0.2256); Loss of helix (P = 0.2271)
7:117230457:A:T,P13569,Y577F,0.89,Loss of phosphorylation at Y577 (P = 0.0462); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Loss of stability (P = 0.4271)
7:117230459:C:A,P13569,L578I,0.656,Gain of catalytic residue at L578 (P = 0.0311); Gain of phosphorylation at Y577 (P = 0.2385); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.5665); Gain of loop (P = 0.6993)
7:117230459:C:G,P13569,L578V,0.697,Gain of phosphorylation at Y577 (P = 0.1682); Gain of catalytic residue at T582 (P = 0.2139); Loss of helix (P = 0.3949); Loss of glycosylation at S573 (P = 0.597); Loss of stability (P = 0.6007)
7:117230460:T:A,P13569,L578Q,0.783,Gain of catalytic residue at L578 (P = 0.0401); Gain of phosphorylation at Y577 (P = 0.1275); Loss of stability (P = 0.1303); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117230460:T:C,P13569,L578P,0.809,Loss of stability (P = 0.0755); Gain of phosphorylation at T582 (P = 0.1227); Loss of catalytic residue at S573 (P = 0.2732); Gain of disorder (P = 0.3728); Loss of helix (P = 0.3949)
7:117230460:T:G,P13569,L578R,0.828,Loss of stability (P = 0.108); Gain of phosphorylation at T582 (P = 0.1714); Loss of loop (P = 0.2237); Gain of catalytic residue at L578 (P = 0.3323); Loss of helix (P = 0.3949)
7:117230462:G:A,P13569,D579N,0.975,Gain of catalytic residue at D579 (P = 0.0837); Gain of ubiquitination at K584 (P = 0.0898); Loss of phosphorylation at Y577 (P = 0.1762); Gain of methylation at K584 (P = 0.2198); Gain of helix (P = 0.2294)
7:117230462:G:C,P13569,D579H,0.969,Gain of catalytic residue at D579 (P = 0.0527); Gain of ubiquitination at K584 (P = 0.102); Gain of methylation at K584 (P = 0.1055); Loss of phosphorylation at Y577 (P = 0.1401); Loss of helix (P = 0.2022)
7:117230462:G:T,P13569,D579Y,0.978,Gain of methylation at K584 (P = 0.0421); Loss of phosphorylation at Y577 (P = 0.0976); Gain of ubiquitination at K584 (P = 0.102); Loss of helix (P = 0.2022); Loss of loop (P = 0.3664)
7:117230463:A:C,P13569,D579A,0.986,Gain of ubiquitination at K584 (P = 0.102); Loss of phosphorylation at Y577 (P = 0.123); Gain of catalytic residue at D579 (P = 0.1451); Gain of methylation at K584 (P = 0.1625); Gain of helix (P = 0.2294)
7:117230463:A:G,P13569,D579G,0.984,Gain of catalytic residue at V580 (P = 0.0645); Loss of ubiquitination at K584 (P = 0.0962); Loss of stability (P = 0.1037); Gain of methylation at K584 (P = 0.1073); Loss of phosphorylation at Y577 (P = 0.13)
7:117230463:A:T,P13569,D579V,0.958,Gain of methylation at K584 (P = 0.0854); Loss of phosphorylation at Y577 (P = 0.1086); Loss of ubiquitination at K584 (P = 0.1322); Loss of helix (P = 0.2022); Loss of loop (P = 0.3664)
7:117230464:T:A,P13569,D579E,0.963,Gain of ubiquitination at K584 (P = 0.0737); Gain of methylation at K584 (P = 0.1665); Loss of phosphorylation at Y577 (P = 0.1895); Gain of catalytic residue at D579 (P = 0.221); Gain of helix (P = 0.2294)
7:117230464:T:G,P13569,D579E,0.963,Gain of ubiquitination at K584 (P = 0.0737); Gain of methylation at K584 (P = 0.1665); Loss of phosphorylation at Y577 (P = 0.1895); Gain of catalytic residue at D579 (P = 0.221); Gain of helix (P = 0.2294)
7:117230465:G:A,P13569,V580I,0.477,Loss of ubiquitination at K584 (P = 0.0962); Loss of phosphorylation at Y577 (P = 0.1823); Gain of methylation at K584 (P = 0.1862); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949)
7:117230465:G:C,P13569,V580L,0.494,Loss of phosphorylation at Y577 (P = 0.1017); Gain of ubiquitination at K584 (P = 0.102); Gain of helix (P = 0.132); Loss of methylation at K584 (P = 0.1674); Gain of relative solvent accessibility (P = 0.2363)
7:117230465:G:T,P13569,V580F,0.511,Loss of phosphorylation at Y577 (P = 0.0932); Loss of ubiquitination at K584 (P = 0.1139); Loss of stability (P = 0.1723); Gain of loop (P = 0.2045); Loss of methylation at K584 (P = 0.2465)
7:117230466:T:A,P13569,V580D,0.514,Loss of phosphorylation at Y577 (P = 0.0734); Gain of ubiquitination at K584 (P = 0.0737); Loss of stability (P = 0.0738); Gain of disorder (P = 0.0983); Gain of relative solvent accessibility (P = 0.0999)
7:117230466:T:C,P13569,V580A,0.472,Loss of stability (P = 0.0378); Gain of ubiquitination at K584 (P = 0.0898); Loss of phosphorylation at Y577 (P = 0.1437); Gain of relative solvent accessibility (P = 0.2363); Loss of methylation at K584 (P = 0.2392)
7:117230466:T:G,P13569,V580G,0.504,Loss of stability (P = 0.0037); Gain of ubiquitination at K584 (P = 0.0737); Loss of phosphorylation at Y577 (P = 0.1504); Gain of methylation at K584 (P = 0.1685); Gain of disorder (P = 0.2016)
7:117230468:T:A,P13569,L581I,0.484,Gain of methylation at K584 (P = 0.0496); Loss of ubiquitination at K584 (P = 0.0853); Loss of phosphorylation at Y577 (P = 0.1312); Loss of loop (P = 0.2237); Loss of solvent accessibility (P = 0.3136)
7:117230468:T:G,P13569,L581V,0.47,Gain of methylation at K584 (P = 0.0922); Loss of ubiquitination at K584 (P = 0.0962); Gain of phosphorylation at Y577 (P = 0.1738); Loss of solvent accessibility (P = 0.239); Loss of catalytic residue at L581 (P = 0.2896)
7:117230469:T:C,P13569,L581S,0.44,Loss of stability (P = 0.0295); Gain of disorder (P = 0.0699); Gain of ubiquitination at K584 (P = 0.102); Loss of catalytic residue at L581 (P = 0.1353); Gain of phosphorylation at Y577 (P = 0.1404)
7:117230470:A:C,P13569,L581F,0.499,Gain of methylation at K584 (P = 0.1121); Gain of ubiquitination at K584 (P = 0.1162); Gain of catalytic residue at D579 (P = 0.2208); Loss of loop (P = 0.2237); Gain of phosphorylation at Y577 (P = 0.2424)
7:117230470:A:T,P13569,L581F,0.499,Gain of methylation at K584 (P = 0.1121); Gain of ubiquitination at K584 (P = 0.1162); Gain of catalytic residue at D579 (P = 0.2208); Loss of loop (P = 0.2237); Gain of phosphorylation at Y577 (P = 0.2424)
7:117230471:A:C,P13569,T582P,0.909,Gain of ubiquitination at K584 (P = 0.0638); Gain of methylation at K584 (P = 0.1108); Gain of phosphorylation at Y577 (P = 0.1291); Loss of helix (P = 0.2022); Gain of catalytic residue at L581 (P = 0.2549)
7:117230471:A:G,P13569,T582A,0.899,Loss of ubiquitination at K584 (P = 0.1139); Loss of phosphorylation at T582 (P = 0.1874); Loss of methylation at K584 (P = 0.2255); Gain of helix (P = 0.2294); Loss of stability (P = 0.3978)
7:117230471:A:T,P13569,T582S,0.947,Gain of ubiquitination at K584 (P = 0.0898); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Gain of phosphorylation at Y577 (P = 0.2274); Loss of methylation at K584 (P = 0.236)
7:117230472:C:A,P13569,T582K,0.946,Gain of ubiquitination at T582 (P = 0.023); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Gain of methylation at K584 (P = 0.1781); Loss of phosphorylation at T582 (P = 0.1874)
7:117230472:C:G,P13569,T582R,0.966,Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Gain of helix (P = 0.132); Loss of ubiquitination at K584 (P = 0.1322); Loss of phosphorylation at T582 (P = 0.1874)
7:117230472:C:T,P13569,T582I,0.955,Gain of ubiquitination at K584 (P = 0.0898); Gain of methylation at K584 (P = 0.1125); Gain of helix (P = 0.132); Loss of phosphorylation at Y577 (P = 0.1458); Loss of loop (P = 0.2237)
7:117230474:G:A,P13569,E583K,0.721,Gain of ubiquitination at E583 (P = 0.0276); Loss of stability (P = 0.1419); Gain of methylation at K584 (P = 0.1671); Gain of loop (P = 0.2045); Gain of phosphorylation at T582 (P = 0.3231)
7:117230474:G:C,P13569,E583Q,0.731,Gain of ubiquitination at K584 (P = 0.0898); Gain of methylation at K584 (P = 0.1316); Loss of catalytic residue at E583 (P = 0.2158); Loss of solvent accessibility (P = 0.3473); Loss of stability (P = 0.3494)
7:117230475:A:C,P13569,E583A,0.782,Gain of ubiquitination at K584 (P = 0.0598); Gain of helix (P = 0.132); Loss of methylation at K584 (P = 0.2308); Loss of stability (P = 0.2923); Loss of solvent accessibility (P = 0.3473)
7:117230475:A:G,P13569,E583G,0.759,Gain of ubiquitination at K584 (P = 0.0737); Loss of stability (P = 0.0895); Gain of catalytic residue at T582 (P = 0.0971); Gain of helix (P = 0.132); Loss of methylation at K584 (P = 0.2552)
7:117230475:A:T,P13569,E583V,0.78,Gain of methylation at K584 (P = 0.0413); Gain of ubiquitination at K584 (P = 0.0598); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.3473); Loss of phosphorylation at T582 (P = 0.3559)
7:117230476:A:C,P13569,E583D,0.775,Loss of ubiquitination at K584 (P = 0.0853); Loss of methylation at K584 (P = 0.1977); Gain of loop (P = 0.2045); Gain of phosphorylation at T582 (P = 0.3122); Loss of catalytic residue at E583 (P = 0.3407)
7:117230476:A:T,P13569,E583D,0.775,Loss of ubiquitination at K584 (P = 0.0853); Loss of methylation at K584 (P = 0.1977); Gain of loop (P = 0.2045); Gain of phosphorylation at T582 (P = 0.3122); Loss of catalytic residue at E583 (P = 0.3407)
7:117230477:A:C,P13569,K584Q,0.413,Gain of catalytic residue at K584 (P = 0.0021); Loss of ubiquitination at K584 (P = 0.0167); Loss of methylation at K584 (P = 0.052); Loss of phosphorylation at T582 (P = 0.364); Loss of helix (P = 0.3949)
7:117230477:A:G,P13569,K584E,0.425,Loss of ubiquitination at K584 (P = 0.0167); Loss of methylation at K584 (P = 0.052); Gain of helix (P = 0.132); Gain of catalytic residue at K584 (P = 0.1832); Loss of loop (P = 0.2237)
7:117230478:A:C,P13569,K584T,0.465,Gain of catalytic residue at K584 (P = 0.003); Loss of ubiquitination at K584 (P = 0.0167); Loss of methylation at K584 (P = 0.052); Loss of solvent accessibility (P = 0.1922); Loss of loop (P = 0.2237)
7:117230478:A:G,P13569,K584R,0.422,Loss of ubiquitination at K584 (P = 0.0167); Loss of methylation at K584 (P = 0.0557); Gain of helix (P = 0.132); Gain of phosphorylation at T582 (P = 0.1751); Loss of loop (P = 0.2237)
7:117230478:A:T,P13569,K584I,0.444,Loss of ubiquitination at K584 (P = 0.0167); Loss of methylation at K584 (P = 0.052); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.1434); Loss of loop (P = 0.2237)
7:117230479:A:C,P13569,K584N,0.472,Gain of catalytic residue at K584 (P = 0); Loss of ubiquitination at K584 (P = 0.0167); Loss of methylation at K584 (P = 0.052); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117230479:A:T,P13569,K584N,0.472,Gain of catalytic residue at K584 (P = 0); Loss of ubiquitination at K584 (P = 0.0167); Loss of methylation at K584 (P = 0.052); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117230480:G:A,P13569,E585K,0.685,Gain of ubiquitination at E585 (P = 0.03); Gain of methylation at K584 (P = 0.1665); Gain of MoRF binding (P = 0.2389); Loss of stability (P = 0.2564); Gain of phosphorylation at T582 (P = 0.274)
7:117230480:G:C,P13569,E585Q,0.588,Gain of catalytic residue at E585 (P = 0.089); Gain of methylation at K584 (P = 0.124); Loss of ubiquitination at K584 (P = 0.1322); Gain of helix (P = 0.2294); Loss of phosphorylation at T582 (P = 0.3779)
7:117230481:A:C,P13569,E585A,0.652,Gain of catalytic residue at E585 (P = 0.0761); Gain of ubiquitination at K584 (P = 0.0804); Loss of stability (P = 0.2129); Loss of methylation at K584 (P = 0.217); Gain of helix (P = 0.2294)
7:117230481:A:G,P13569,E585G,0.653,Loss of ubiquitination at K584 (P = 0.0618); Loss of stability (P = 0.1457); Gain of helix (P = 0.2294); Loss of methylation at K584 (P = 0.245); Gain of catalytic residue at T582 (P = 0.2518)
7:117230481:A:T,P13569,E585V,0.674,Gain of methylation at K584 (P = 0.0442); Gain of ubiquitination at K584 (P = 0.0512); Gain of catalytic residue at E588 (P = 0.1982); Gain of helix (P = 0.2294); Loss of phosphorylation at T582 (P = 0.3407)
7:117230482:A:C,P13569,E585D,0.615,Loss of ubiquitination at K584 (P = 0.069); Loss of methylation at K584 (P = 0.2039); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294); Gain of phosphorylation at T582 (P = 0.2369)
7:117230482:A:T,P13569,E585D,0.615,Loss of ubiquitination at K584 (P = 0.069); Loss of methylation at K584 (P = 0.2039); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294); Gain of phosphorylation at T582 (P = 0.2369)
7:117230483:A:C,P13569,I586L,0.775,Gain of ubiquitination at K584 (P = 0.0686); Loss of methylation at K584 (P = 0.1487); Gain of phosphorylation at T582 (P = 0.1877); Loss of helix (P = 0.2271); Loss of catalytic residue at I586 (P = 0.3238)
7:117230483:A:G,P13569,I586V,0.831,Gain of ubiquitination at K584 (P = 0.102); Loss of methylation at K584 (P = 0.2162); Gain of phosphorylation at T582 (P = 0.2311); Loss of catalytic residue at L581 (P = 0.3276); Loss of stability (P = 0.4366)
7:117230483:A:T,P13569,I586L,0.775,Gain of ubiquitination at K584 (P = 0.0686); Loss of methylation at K584 (P = 0.1487); Gain of phosphorylation at T582 (P = 0.1877); Loss of helix (P = 0.2271); Loss of catalytic residue at I586 (P = 0.3238)
7:117230484:T:A,P13569,I586K,0.89,Loss of stability (P = 0.0259); Gain of ubiquitination at I586 (P = 0.0267); Gain of disorder (P = 0.0288); Gain of phosphorylation at T582 (P = 0.1516); Loss of helix (P = 0.2022)
7:117230484:T:C,P13569,I586T,0.896,Loss of stability (P = 0.0188); Gain of ubiquitination at K584 (P = 0.0686); Gain of phosphorylation at T582 (P = 0.0755); Gain of disorder (P = 0.1891); Loss of methylation at K584 (P = 0.1949)
7:117230484:T:G,P13569,I586R,0.9,Loss of stability (P = 0.0557); Gain of ubiquitination at K584 (P = 0.0686); Loss of methylation at K584 (P = 0.1624); Gain of phosphorylation at T582 (P = 0.1751); Gain of disorder (P = 0.1859)
7:117230485:A:G,P13569,I586M,0.808,Gain of ubiquitination at K584 (P = 0.0737); Gain of phosphorylation at T582 (P = 0.1924); Loss of methylation at K584 (P = 0.2196); Loss of helix (P = 0.2271); Loss of stability (P = 0.3002)
7:117230486:T:A,P13569,F587I,0.908,Loss of ubiquitination at K584 (P = 0.1139); Gain of methylation at K584 (P = 0.1444); Gain of catalytic residue at S589 (P = 0.1816); Gain of phosphorylation at T582 (P = 0.4117); Gain of MoRF binding (P = 0.4536)
7:117230486:T:C,P13569,F587L,0.842,Gain of ubiquitination at K584 (P = 0.1162); Loss of methylation at K584 (P = 0.2301); Gain of phosphorylation at T582 (P = 0.3101); Loss of catalytic residue at E583 (P = 0.4175); Loss of MoRF binding (P = 0.4658)
7:117230486:T:G,P13569,F587V,0.843,Gain of ubiquitination at K584 (P = 0.102); Gain of methylation at K584 (P = 0.1603); Gain of catalytic residue at F587 (P = 0.2269); Gain of phosphorylation at T582 (P = 0.3631); Loss of MoRF binding (P = 0.4681)
7:117230487:T:A,P13569,F587Y,0.867,Gain of ubiquitination at K584 (P = 0.0512); Gain of catalytic residue at I586 (P = 0.1058); Loss of methylation at K584 (P = 0.1953); Gain of phosphorylation at T582 (P = 0.2508); Loss of MoRF binding (P = 0.4568)
7:117230487:T:C,P13569,F587S,0.893,Gain of disorder (P = 0.0355); Gain of ubiquitination at K584 (P = 0.0737); Gain of methylation at K584 (P = 0.115); Gain of phosphorylation at T582 (P = 0.2902); Loss of catalytic residue at F587 (P = 0.373)
7:117230487:T:G,P13569,F587C,0.883,Gain of ubiquitination at K584 (P = 0.0898); Gain of catalytic residue at S589 (P = 0.1325); Gain of methylation at K584 (P = 0.1422); Gain of phosphorylation at T582 (P = 0.3833); Loss of MoRF binding (P = 0.4482)
7:117230488:T:A,P13569,F587L,0.842,Gain of ubiquitination at K584 (P = 0.1162); Loss of methylation at K584 (P = 0.2301); Gain of phosphorylation at T582 (P = 0.3101); Loss of catalytic residue at E583 (P = 0.4175); Loss of MoRF binding (P = 0.4658)
7:117230488:T:G,P13569,F587L,0.842,Gain of ubiquitination at K584 (P = 0.1162); Loss of methylation at K584 (P = 0.2301); Gain of phosphorylation at T582 (P = 0.3101); Loss of catalytic residue at E583 (P = 0.4175); Loss of MoRF binding (P = 0.4658)
7:117230489:G:A,P13569,E588K,0.697,Gain of methylation at E588 (P = 0.0135); Gain of MoRF binding (P = 0.0288); Loss of ubiquitination at K593 (P = 0.0402); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2601)
7:117230489:G:C,P13569,E588Q,0.735,Loss of ubiquitination at K593 (P = 0.0435); Gain of MoRF binding (P = 0.1668); Gain of catalytic residue at E588 (P = 0.2441); Gain of methylation at K584 (P = 0.249); Gain of glycosylation at S589 (P = 0.5706)
7:117230490:A:C,P13569,E588A,0.767,Loss of ubiquitination at K593 (P = 0.0561); Loss of methylation at K584 (P = 0.2132); Gain of catalytic residue at E588 (P = 0.2165); Gain of MoRF binding (P = 0.2253); Loss of solvent accessibility (P = 0.4838)
7:117230490:A:G,P13569,E588G,0.712,Loss of ubiquitination at K593 (P = 0.0467); Loss of stability (P = 0.1453); Gain of MoRF binding (P = 0.2153); Gain of catalytic residue at S589 (P = 0.221); Loss of methylation at K584 (P = 0.2462)
7:117230490:A:T,P13569,E588V,0.871,Loss of ubiquitination at K593 (P = 0.059); Gain of catalytic residue at E588 (P = 0.1179); Gain of MoRF binding (P = 0.1877); Gain of methylation at K584 (P = 0.2025); Loss of glycosylation at K584 (P = 0.629)
7:117230491:A:C,P13569,E588D,0.693,Loss of ubiquitination at K593 (P = 0.0901); Loss of methylation at K584 (P = 0.2325); Gain of MoRF binding (P = 0.3317); Gain of catalytic residue at S589 (P = 0.4249); Gain of glycosylation at S589 (P = 0.547)
7:117230491:A:T,P13569,E588D,0.693,Loss of ubiquitination at K593 (P = 0.0901); Loss of methylation at K584 (P = 0.2325); Gain of MoRF binding (P = 0.3317); Gain of catalytic residue at S589 (P = 0.4249); Gain of glycosylation at S589 (P = 0.547)
7:117230492:A:C,P13569,S589R,0.712,Loss of ubiquitination at K593 (P = 0.0489); Gain of MoRF binding (P = 0.051); Gain of methylation at K584 (P = 0.1585); Loss of catalytic residue at F587 (P = 0.5721); Gain of glycosylation at K584 (P = 0.5827)
7:117230492:A:G,P13569,S589G,0.706,Loss of stability (P = 0.07); Loss of ubiquitination at K593 (P = 0.1099); Gain of catalytic residue at S589 (P = 0.2022); Loss of methylation at K584 (P = 0.205); Loss of MoRF binding (P = 0.349)
7:117230492:A:T,P13569,S589C,0.737,Loss of ubiquitination at K584 (P = 0.1139); Loss of catalytic residue at S589 (P = 0.2003); Loss of methylation at K584 (P = 0.2237); Loss of MoRF binding (P = 0.3294); Gain of glycosylation at K584 (P = 0.6052)
7:117230493:G:A,P13569,S589N,0.869,Loss of ubiquitination at K584 (P = 0.1322); Loss of methylation at K584 (P = 0.2421); Loss of catalytic residue at S589 (P = 0.3017); Gain of MoRF binding (P = 0.333); Loss of stability (P = 0.5872)
7:117230493:G:C,P13569,S589T,0.834,Gain of ubiquitination at K584 (P = 0.1162); Loss of catalytic residue at S589 (P = 0.1862); Gain of methylation at K584 (P = 0.2332); Gain of MoRF binding (P = 0.3487); Gain of glycosylation at K584 (P = 0.5942)
7:117230493:G:T,P13569,S589I,0.724,Gain of catalytic residue at L594 (P = 0.0857); Gain of ubiquitination at K584 (P = 0.1162); Loss of methylation at K584 (P = 0.2244); Gain of MoRF binding (P = 0.3163); Loss of glycosylation at S589 (P = 0.6206)
7:117231988:C:A,P13569,S589R,0.712,Loss of ubiquitination at K593 (P = 0.0489); Gain of MoRF binding (P = 0.051); Gain of methylation at K584 (P = 0.1585); Loss of catalytic residue at F587 (P = 0.5721); Gain of glycosylation at K584 (P = 0.5827)
7:117231988:C:G,P13569,S589R,0.712,Loss of ubiquitination at K593 (P = 0.0489); Gain of MoRF binding (P = 0.051); Gain of methylation at K584 (P = 0.1585); Loss of catalytic residue at F587 (P = 0.5721); Gain of glycosylation at K584 (P = 0.5827)
7:117231989:T:A,P13569,C590S,0.805,Gain of catalytic residue at C590 (P = 0.0596); Loss of ubiquitination at K593 (P = 0.1099); Gain of disorder (P = 0.1385); Loss of stability (P = 0.1753); Gain of MoRF binding (P = 0.2249)
7:117231989:T:C,P13569,C590R,0.855,Gain of MoRF binding (P = 0.0229); Gain of catalytic residue at C590 (P = 0.0359); Loss of ubiquitination at K593 (P = 0.0402); Gain of helix (P = 0.2294); Loss of methylation at K593 (P = 0.2741)
7:117231989:T:G,P13569,C590G,0.821,Gain of glycosylation at S589 (P = 0.0582); Loss of stability (P = 0.0658); Loss of ubiquitination at K593 (P = 0.1099); Gain of MoRF binding (P = 0.2309); Loss of catalytic residue at K593 (P = 0.2325)
7:117231990:G:A,P13569,C590Y,0.772,Gain of catalytic residue at C590 (P = 0.0502); Loss of ubiquitination at K593 (P = 0.1403); Gain of MoRF binding (P = 0.2413); Loss of methylation at K593 (P = 0.2977); Loss of helix (P = 0.4763)
7:117231990:G:C,P13569,C590S,0.805,Gain of catalytic residue at C590 (P = 0.0596); Loss of ubiquitination at K593 (P = 0.1099); Gain of disorder (P = 0.1385); Loss of stability (P = 0.1753); Gain of MoRF binding (P = 0.2249)
7:117231990:G:T,P13569,C590F,0.782,Gain of ubiquitination at K593 (P = 0.1079); Loss of catalytic residue at K593 (P = 0.1121); Gain of MoRF binding (P = 0.1905); Gain of methylation at K593 (P = 0.3683); Loss of helix (P = 0.4763)
7:117231991:T:G,P13569,C590W,0.763,Gain of catalytic residue at C590 (P = 0.0034); Gain of MoRF binding (P = 0.0599); Loss of ubiquitination at K593 (P = 0.1576); Gain of methylation at K593 (P = 0.368); Loss of stability (P = 0.3693)
7:117231992:G:A,P13569,V591I,0.508,Loss of catalytic residue at V591 (P = 0.0215); Gain of ubiquitination at K593 (P = 0.1278); Gain of MoRF binding (P = 0.2125); Gain of helix (P = 0.2294); Gain of methylation at K593 (P = 0.3539)
7:117231992:G:C,P13569,V591L,0.487,Loss of ubiquitination at K593 (P = 0.1264); Loss of methylation at K593 (P = 0.1972); Loss of MoRF binding (P = 0.2235); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117231992:G:T,P13569,V591F,0.499,Loss of catalytic residue at V591 (P = 0.0357); Loss of ubiquitination at K593 (P = 0.1576); Gain of MoRF binding (P = 0.2256); Loss of methylation at K593 (P = 0.353); Loss of helix (P = 0.4763)
7:117231993:T:A,P13569,V591D,0.632,Loss of catalytic residue at V591 (P = 0.0064); Loss of methylation at K593 (P = 0.0459); Gain of relative solvent accessibility (P = 0.09); Loss of MoRF binding (P = 0.117); Gain of solvent accessibility (P = 0.1376)
7:117231993:T:C,P13569,V591A,0.547,Loss of ubiquitination at K593 (P = 0.1576); Loss of stability (P = 0.1926); Loss of MoRF binding (P = 0.2047); Loss of methylation at K593 (P = 0.2351); Loss of helix (P = 0.4763)
7:117231993:T:G,P13569,V591G,0.59,Loss of stability (P = 0.0137); Loss of catalytic residue at V591 (P = 0.0334); Gain of relative solvent accessibility (P = 0.09); Loss of ubiquitination at K593 (P = 0.1403); Loss of MoRF binding (P = 0.2123)
7:117231995:T:A,P13569,C592S,0.434,Loss of methylation at K593 (P = 0.0127); Gain of MoRF binding (P = 0.1104); Loss of stability (P = 0.132); Loss of ubiquitination at K593 (P = 0.1741); Loss of helix (P = 0.2271)
7:117231995:T:C,P13569,C592R,0.485,Gain of MoRF binding (P = 0.0134); Loss of methylation at K593 (P = 0.0176); Loss of ubiquitination at K593 (P = 0.0384); Gain of solvent accessibility (P = 0.2097); Loss of helix (P = 0.2271)
7:117231995:T:G,P13569,C592G,0.51,Loss of methylation at K593 (P = 0.0143); Loss of stability (P = 0.0304); Gain of MoRF binding (P = 0.1199); Loss of ubiquitination at K593 (P = 0.1403); Loss of helix (P = 0.2271)
7:117231996:G:A,P13569,C592Y,0.477,Loss of methylation at K593 (P = 0.0138); Gain of phosphorylation at C592 (P = 0.1088); Gain of MoRF binding (P = 0.1374); Loss of ubiquitination at K593 (P = 0.1403); Gain of catalytic residue at C592 (P = 0.1433)
7:117231996:G:C,P13569,C592S,0.434,Loss of methylation at K593 (P = 0.0127); Gain of MoRF binding (P = 0.1104); Loss of stability (P = 0.132); Loss of ubiquitination at K593 (P = 0.1741); Loss of helix (P = 0.2271)
7:117231996:G:T,P13569,C592F,0.533,Loss of methylation at K593 (P = 0.035); Gain of MoRF binding (P = 0.0838); Gain of ubiquitination at K593 (P = 0.1497); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.3418)
7:117231997:T:G,P13569,C592W,0.572,Loss of methylation at K593 (P = 0.0194); Gain of MoRF binding (P = 0.0351); Gain of catalytic residue at M595 (P = 0.0379); Loss of ubiquitination at K593 (P = 0.1576); Loss of helix (P = 0.2271)
7:117231998:A:C,P13569,K593Q,0.636,Loss of methylation at K593 (P = 0.0054); Loss of ubiquitination at K593 (P = 0.027); Loss of MoRF binding (P = 0.0708); Loss of helix (P = 0.2271); Loss of catalytic residue at N597 (P = 0.2582)
7:117231998:A:G,P13569,K593E,0.675,Loss of methylation at K593 (P = 0.0054); Loss of ubiquitination at K593 (P = 0.027); Loss of MoRF binding (P = 0.0375); Loss of helix (P = 0.2271); Loss of catalytic residue at S589 (P = 0.39)
7:117231999:A:C,P13569,K593T,0.661,Loss of methylation at K593 (P = 0.0054); Loss of ubiquitination at K593 (P = 0.027); Loss of MoRF binding (P = 0.0631); Loss of catalytic residue at K593 (P = 0.195); Loss of helix (P = 0.2271)
7:117231999:A:G,P13569,K593R,0.582,Loss of methylation at K593 (P = 0.0125); Loss of ubiquitination at K593 (P = 0.027); Gain of MoRF binding (P = 0.0723); Loss of helix (P = 0.4763); Loss of catalytic residue at N597 (P = 0.6202)
7:117231999:A:T,P13569,K593I,0.638,Loss of methylation at K593 (P = 0.0054); Loss of ubiquitination at K593 (P = 0.027); Loss of MoRF binding (P = 0.0626); Gain of stability (P = 0.1144); Loss of catalytic residue at K593 (P = 0.1925)
7:117232000:A:C,P13569,K593N,0.671,Loss of methylation at K593 (P = 0.0054); Loss of ubiquitination at K593 (P = 0.027); Loss of MoRF binding (P = 0.0694); Loss of catalytic residue at N597 (P = 0.3229); Loss of helix (P = 0.4763)
7:117232000:A:T,P13569,K593N,0.671,Loss of methylation at K593 (P = 0.0054); Loss of ubiquitination at K593 (P = 0.027); Loss of MoRF binding (P = 0.0694); Loss of catalytic residue at N597 (P = 0.3229); Loss of helix (P = 0.4763)
7:117232001:C:A,P13569,L594M,0.491,Loss of methylation at K593 (P = 0.0396); Gain of phosphorylation at T599 (P = 0.1306); Gain of MoRF binding (P = 0.1374); Loss of ubiquitination at K593 (P = 0.1403); Loss of helix (P = 0.2271)
7:117232001:C:G,P13569,L594V,0.564,Gain of catalytic residue at L594 (P = 0.0639); Gain of MoRF binding (P = 0.1442); Loss of ubiquitination at K593 (P = 0.1576); Loss of helix (P = 0.2271); Gain of methylation at K593 (P = 0.289)
7:117232002:T:A,P13569,L594Q,0.631,Loss of ubiquitination at K593 (P = 0.059); Gain of catalytic residue at L594 (P = 0.121); Loss of MoRF binding (P = 0.1224); Loss of sheet (P = 0.1398); Loss of stability (P = 0.1619)
7:117232002:T:C,P13569,L594P,0.9,Loss of stability (P = 0.0416); Loss of MoRF binding (P = 0.0717); Loss of ubiquitination at K593 (P = 0.0797); Loss of catalytic residue at S589 (P = 0.2079); Loss of helix (P = 0.2271)
7:117232002:T:G,P13569,L594R,0.678,Gain of MoRF binding (P = 0.0378); Loss of ubiquitination at K593 (P = 0.0426); Gain of catalytic residue at L594 (P = 0.0858); Loss of stability (P = 0.1315); Loss of sheet (P = 0.1398)
7:117232004:A:C,P13569,M595L,0.714,Loss of catalytic residue at V591 (P = 0.0258); Loss of MoRF binding (P = 0.1288); Loss of sheet (P = 0.1398); Loss of ubiquitination at K593 (P = 0.1741); Gain of helix (P = 0.2294)
7:117232004:A:G,P13569,M595V,0.659,Loss of catalytic residue at V591 (P = 0.0259); Gain of ubiquitination at K593 (P = 0.1079); Loss of MoRF binding (P = 0.151); Gain of helix (P = 0.2294); Loss of sheet (P = 0.3635)
7:117232004:A:T,P13569,M595L,0.714,Loss of catalytic residue at V591 (P = 0.0258); Loss of MoRF binding (P = 0.1288); Loss of sheet (P = 0.1398); Loss of ubiquitination at K593 (P = 0.1741); Gain of helix (P = 0.2294)
7:117232005:T:A,P13569,M595K,0.624,Loss of catalytic residue at V591 (P = 0.0222); Loss of ubiquitination at K593 (P = 0.0467); Gain of MoRF binding (P = 0.0608); Loss of methylation at K593 (P = 0.1461); Loss of stability (P = 0.1483)
7:117232005:T:C,P13569,M595T,0.584,Loss of catalytic residue at V591 (P = 0.0244); Gain of phosphorylation at M595 (P = 0.0972); Loss of MoRF binding (P = 0.1053); Loss of ubiquitination at K593 (P = 0.1264); Loss of stability (P = 0.1466)
7:117232005:T:G,P13569,M595R,0.639,Loss of catalytic residue at V591 (P = 0.0213); Gain of methylation at M595 (P = 0.0237); Gain of MoRF binding (P = 0.0432); Loss of ubiquitination at K593 (P = 0.0489); Gain of solvent accessibility (P = 0.1583)
7:117232006:G:A,P13569,M595I,0.838,Loss of catalytic residue at V591 (P = 0.0258); Gain of MoRF binding (P = 0.1289); Loss of ubiquitination at K593 (P = 0.1741); Gain of helix (P = 0.2294); Gain of methylation at K593 (P = 0.3375)
7:117232006:G:C,P13569,M595I,0.838,Loss of catalytic residue at V591 (P = 0.0258); Gain of MoRF binding (P = 0.1289); Loss of ubiquitination at K593 (P = 0.1741); Gain of helix (P = 0.2294); Gain of methylation at K593 (P = 0.3375)
7:117232006:G:T,P13569,M595I,0.838,Loss of catalytic residue at V591 (P = 0.0258); Gain of MoRF binding (P = 0.1289); Loss of ubiquitination at K593 (P = 0.1741); Gain of helix (P = 0.2294); Gain of methylation at K593 (P = 0.3375)
7:117232007:G:A,P13569,A596T,0.437,Loss of ubiquitination at K593 (P = 0.0982); Gain of MoRF binding (P = 0.1247); Gain of catalytic residue at A596 (P = 0.1726); Gain of methylation at K593 (P = 0.3462); Loss of stability (P = 0.3612)
7:117232007:G:C,P13569,A596P,0.639,Loss of MoRF binding (P = 0.0738); Loss of ubiquitination at K593 (P = 0.0797); Gain of glycosylation at A596 (P = 0.1459); Loss of helix (P = 0.2662); Loss of stability (P = 0.2783)
7:117232007:G:T,P13569,A596S,0.421,Loss of ubiquitination at K593 (P = 0.0901); Gain of MoRF binding (P = 0.1003); Gain of catalytic residue at A596 (P = 0.1481); Loss of helix (P = 0.2662); Gain of disorder (P = 0.3082)
7:117232008:C:A,P13569,A596D,0.491,Loss of ubiquitination at K593 (P = 0.0797); Loss of MoRF binding (P = 0.082); Gain of solvent accessibility (P = 0.194); Gain of relative solvent accessibility (P = 0.2363); Loss of helix (P = 0.2662)
7:117232008:C:G,P13569,A596G,0.484,Loss of stability (P = 0.061); Loss of ubiquitination at K593 (P = 0.0982); Gain of MoRF binding (P = 0.1354); Gain of methylation at K593 (P = 0.357); Loss of sheet (P = 0.3635)
7:117232008:C:T,P13569,A596V,0.447,Gain of MoRF binding (P = 0.1148); Loss of sheet (P = 0.1398); Gain of ubiquitination at K593 (P = 0.1497); Gain of helix (P = 0.2294); Gain of loop (P = 0.2754)
7:117232010:A:C,P13569,N597H,0.5,Loss of stability (P = 0.0505); Gain of catalytic residue at K598 (P = 0.0573); Loss of MoRF binding (P = 0.1081); Loss of ubiquitination at K593 (P = 0.1576); Loss of helix (P = 0.2271)
7:117232010:A:G,P13569,N597D,0.542,Loss of MoRF binding (P = 0.0661); Loss of stability (P = 0.1361); Loss of ubiquitination at K593 (P = 0.1403); Loss of catalytic residue at N597 (P = 0.1591); Gain of phosphorylation at T599 (P = 0.1913)
7:117232010:A:T,P13569,N597Y,0.638,Loss of solvent accessibility (P = 0.0576); Loss of relative solvent accessibility (P = 0.0793); Loss of MoRF binding (P = 0.1029); Loss of ubiquitination at K593 (P = 0.1403); Loss of stability (P = 0.1646)
7:117232011:A:C,P13569,N597T,0.509,Gain of catalytic residue at K598 (P = 0.0858); Loss of stability (P = 0.1059); Loss of MoRF binding (P = 0.1123); Gain of ubiquitination at K593 (P = 0.1497); Loss of helix (P = 0.2271)
7:117232011:A:G,P13569,N597S,0.464,Gain of catalytic residue at K598 (P = 0.0466); Loss of stability (P = 0.111); Loss of MoRF binding (P = 0.1304); Loss of ubiquitination at K593 (P = 0.1403); Gain of disorder (P = 0.305)
7:117232011:A:T,P13569,N597I,0.641,Gain of catalytic residue at L602 (P = 0.0204); Loss of solvent accessibility (P = 0.0576); Loss of relative solvent accessibility (P = 0.0793); Gain of ubiquitination at K593 (P = 0.1278); Gain of MoRF binding (P = 0.1295)
7:117232012:C:A,P13569,N597K,0.533,Loss of stability (P = 0.0256); Gain of MoRF binding (P = 0.0329); Loss of ubiquitination at K593 (P = 0.045); Gain of phosphorylation at T599 (P = 0.196); Loss of helix (P = 0.2271)
7:117232012:C:G,P13569,N597K,0.533,Loss of stability (P = 0.0256); Gain of MoRF binding (P = 0.0329); Loss of ubiquitination at K593 (P = 0.045); Gain of phosphorylation at T599 (P = 0.196); Loss of helix (P = 0.2271)
7:117232013:A:C,P13569,K598Q,0.722,Gain of catalytic residue at K598 (P = 0.0372); Loss of MoRF binding (P = 0.0577); Gain of ubiquitination at K593 (P = 0.1497); Loss of sheet (P = 0.3635); Loss of methylation at K593 (P = 0.3684)
7:117232013:A:G,P13569,K598E,0.699,Loss of MoRF binding (P = 0.0115); Gain of ubiquitination at K593 (P = 0.1497); Gain of relative solvent accessibility (P = 0.1894); Gain of solvent accessibility (P = 0.28); Loss of methylation at K593 (P = 0.3635)
7:117232014:A:C,P13569,K598T,0.702,Loss of MoRF binding (P = 0.0612); Gain of catalytic residue at K598 (P = 0.0897); Loss of ubiquitination at K593 (P = 0.1099); Gain of glycosylation at K598 (P = 0.1127); Loss of methylation at K593 (P = 0.3353)
7:117232014:A:G,P13569,K598R,0.704,Gain of ubiquitination at K593 (P = 0.0913); Gain of MoRF binding (P = 0.1104); Gain of catalytic residue at K598 (P = 0.1418); Gain of helix (P = 0.2294); Loss of methylation at K593 (P = 0.3234)
7:117232014:A:T,P13569,K598I,0.674,Gain of ubiquitination at K593 (P = 0.0913); Loss of MoRF binding (P = 0.0919); Loss of methylation at K593 (P = 0.2572); Loss of helix (P = 0.2662); Gain of catalytic residue at R600 (P = 0.2755)
7:117232015:A:C,P13569,K598N,0.749,Loss of MoRF binding (P = 0.0573); Gain of catalytic residue at K598 (P = 0.1496); Loss of ubiquitination at K593 (P = 0.1741); Loss of methylation at K593 (P = 0.3091); Loss of sheet (P = 0.3635)
7:117232015:A:T,P13569,K598N,0.749,Loss of MoRF binding (P = 0.0573); Gain of catalytic residue at K598 (P = 0.1496); Loss of ubiquitination at K593 (P = 0.1741); Loss of methylation at K593 (P = 0.3091); Loss of sheet (P = 0.3635)
7:117232016:A:C,P13569,T599P,0.828,Loss of MoRF binding (P = 0.0649); Loss of sheet (P = 0.1398); Loss of stability (P = 0.1855); Loss of helix (P = 0.2271); Gain of catalytic residue at N597 (P = 0.2285)
7:117232016:A:G,P13569,T599A,0.765,Gain of MoRF binding (P = 0.1208); Loss of helix (P = 0.2271); Gain of ubiquitination at K598 (P = 0.3437); Loss of sheet (P = 0.3635); Loss of stability (P = 0.3764)
7:117232016:A:T,P13569,T599S,0.77,Gain of MoRF binding (P = 0.1348); Gain of disorder (P = 0.1506); Loss of helix (P = 0.2271); Gain of ubiquitination at K598 (P = 0.3531); Loss of sheet (P = 0.3635)
7:117232017:C:A,P13569,T599N,0.79,Loss of MoRF binding (P = 0.1308); Loss of helix (P = 0.2271); Gain of ubiquitination at K598 (P = 0.3531); Loss of sheet (P = 0.3635); Loss of disorder (P = 0.4472)
7:117232017:C:G,P13569,T599S,0.77,Gain of MoRF binding (P = 0.1348); Gain of disorder (P = 0.1506); Loss of helix (P = 0.2271); Gain of ubiquitination at K598 (P = 0.3531); Loss of sheet (P = 0.3635)
7:117232017:C:T,P13569,T599I,0.788,Gain of MoRF binding (P = 0.0648); Gain of catalytic residue at T599 (P = 0.1861); Loss of helix (P = 0.2271); Loss of disorder (P = 0.2315); Gain of ubiquitination at K598 (P = 0.3617)
7:117232019:A:G,P13569,R600G,0.905,Loss of MoRF binding (P = 0.0235); Loss of stability (P = 0.1027); Gain of catalytic residue at R600 (P = 0.1715); Gain of ubiquitination at K598 (P = 0.245); Gain of disorder (P = 0.343)
7:117232019:A:T,P13569,R600W,0.737,Loss of MoRF binding (P = 0.075); Loss of disorder (P = 0.1112); Loss of helix (P = 0.2662); Gain of catalytic residue at A596 (P = 0.3063); Gain of ubiquitination at K598 (P = 0.3214)
7:117232020:G:A,P13569,R600K,0.758,Loss of MoRF binding (P = 0.0756); Loss of sheet (P = 0.1398); Gain of catalytic residue at R600 (P = 0.1769); Gain of disorder (P = 0.2108); Gain of ubiquitination at R600 (P = 0.3547)
7:117232020:G:C,P13569,R600T,0.742,Loss of MoRF binding (P = 0.0211); Gain of ubiquitination at K598 (P = 0.2182); Gain of phosphorylation at R600 (P = 0.2244); Gain of helix (P = 0.2294); Gain of disorder (P = 0.2971)
7:117232020:G:T,P13569,R600M,0.743,Loss of MoRF binding (P = 0.0304); Gain of ubiquitination at K598 (P = 0.2702); Loss of disorder (P = 0.3327); Gain of catalytic residue at A596 (P = 0.3513); Loss of sheet (P = 0.3635)
7:117232021:G:C,P13569,R600S,0.761,Loss of MoRF binding (P = 0.0248); Gain of disorder (P = 0.0892); Gain of ubiquitination at K598 (P = 0.1472); Gain of catalytic residue at N597 (P = 0.2386); Loss of helix (P = 0.2662)
7:117232021:G:T,P13569,R600S,0.761,Loss of MoRF binding (P = 0.0248); Gain of disorder (P = 0.0892); Gain of ubiquitination at K598 (P = 0.1472); Gain of catalytic residue at N597 (P = 0.2386); Loss of helix (P = 0.2662)
7:117232022:A:C,P13569,I601L,0.647,Loss of MoRF binding (P = 0.1004); Gain of disorder (P = 0.1104); Loss of sheet (P = 0.1398); Loss of catalytic residue at I601 (P = 0.3472); Gain of ubiquitination at K598 (P = 0.3757)
7:117232022:A:G,P13569,I601V,0.838,Loss of MoRF binding (P = 0.1211); Gain of disorder (P = 0.129); Gain of methylation at R600 (P = 0.3284); Loss of sheet (P = 0.3635); Gain of ubiquitination at K598 (P = 0.3757)
7:117232022:A:T,P13569,I601F,0.911,Loss of MoRF binding (P = 0.1281); Loss of stability (P = 0.1453); Gain of disorder (P = 0.2427); Loss of catalytic residue at I601 (P = 0.2546); Gain of methylation at R600 (P = 0.313)
7:117232023:T:A,P13569,I601N,0.928,Gain of disorder (P = 0.017); Loss of stability (P = 0.0375); Loss of MoRF binding (P = 0.1239); Loss of catalytic residue at I601 (P = 0.2202); Gain of ubiquitination at K598 (P = 0.245)
7:117232023:T:C,P13569,I601T,0.969,Loss of stability (P = 0.0088); Gain of disorder (P = 0.018); Loss of MoRF binding (P = 0.1006); Gain of ubiquitination at K598 (P = 0.1825); Loss of catalytic residue at I601 (P = 0.2535)
7:117232023:T:G,P13569,I601S,0.906,Gain of disorder (P = 0.0025); Loss of stability (P = 0.0137); Gain of ubiquitination at K598 (P = 0.0546); Gain of phosphorylation at I601 (P = 0.0951); Loss of MoRF binding (P = 0.1216)
7:117232024:T:G,P13569,I601M,0.769,Gain of disorder (P = 0.0389); Gain of MoRF binding (P = 0.1111); Loss of stability (P = 0.1522); Loss of catalytic residue at I601 (P = 0.2123); Gain of ubiquitination at K598 (P = 0.2702)
7:117232025:T:A,P13569,L602M,0.827,Gain of disorder (P = 0.0877); Gain of MoRF binding (P = 0.0918); Loss of helix (P = 0.1299); Loss of stability (P = 0.3274); Gain of ubiquitination at K598 (P = 0.3531)
7:117232025:T:G,P13569,L602V,0.734,Gain of catalytic residue at L602 (P = 0.0231); Gain of MoRF binding (P = 0.1281); Loss of stability (P = 0.207); Gain of disorder (P = 0.2485); Loss of sheet (P = 0.3635)
7:117232026:T:C,P13569,L602S,0.861,Gain of disorder (P = 0.0048); Loss of stability (P = 0.0323); Gain of phosphorylation at L602 (P = 0.0698); Gain of catalytic residue at L602 (P = 0.1219); Loss of MoRF binding (P = 0.1357)
7:117232026:T:G,P13569,L602W,0.765,Gain of MoRF binding (P = 0.0345); Loss of stability (P = 0.0672); Loss of disorder (P = 0.1249); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1398)
7:117232027:G:C,P13569,L602F,0.747,Gain of catalytic residue at L602 (P = 0.0825); Gain of MoRF binding (P = 0.113); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1966); Loss of stability (P = 0.2035)
7:117232027:G:T,P13569,L602F,0.747,Gain of catalytic residue at L602 (P = 0.0825); Gain of MoRF binding (P = 0.113); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1966); Loss of stability (P = 0.2035)
7:117232028:G:A,P13569,V603I,0.736,Loss of catalytic residue at V603 (P = 0.0781); Gain of MoRF binding (P = 0.1287); Gain of disorder (P = 0.2651); Loss of sheet (P = 0.3635); Loss of ubiquitination at K598 (P = 0.3776)
7:117232028:G:C,P13569,V603L,0.883,Loss of catalytic residue at V603 (P = 0.0242); Loss of MoRF binding (P = 0.1103); Gain of helix (P = 0.132); Gain of disorder (P = 0.1587); Loss of loop (P = 0.2897)
7:117232028:G:T,P13569,V603F,0.932,Loss of catalytic residue at V603 (P = 0.0338); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1395); Loss of disorder (P = 0.2446); Loss of loop (P = 0.2897)
7:117232029:T:A,P13569,V603D,0.868,Loss of catalytic residue at V603 (P = 0.0039); Gain of disorder (P = 0.0071); Loss of MoRF binding (P = 0.0505); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398)
7:117232029:T:C,P13569,V603A,0.935,Gain of disorder (P = 0.0417); Loss of MoRF binding (P = 0.0971); Loss of stability (P = 0.1201); Loss of catalytic residue at V603 (P = 0.1218); Gain of helix (P = 0.132)
7:117232029:T:G,P13569,V603G,0.918,Loss of stability (P = 0.0133); Gain of disorder (P = 0.015); Loss of catalytic residue at V603 (P = 0.0258); Loss of MoRF binding (P = 0.0976); Gain of helix (P = 0.132)
7:117232031:A:C,P13569,T604P,0.962,Loss of MoRF binding (P = 0.0564); Gain of disorder (P = 0.1253); Loss of stability (P = 0.2779); Loss of sheet (P = 0.3635); Gain of phosphorylation at T599 (P = 0.3636)
7:117232031:A:G,P13569,T604A,0.943,Loss of MoRF binding (P = 0.1075); Gain of catalytic residue at T604 (P = 0.1197); Loss of disorder (P = 0.2407); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635)
7:117232031:A:T,P13569,T604S,0.973,Gain of disorder (P = 0.038); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1317); Gain of loop (P = 0.2754); Gain of phosphorylation at T604 (P = 0.3367)
7:117232032:C:A,P13569,T604N,0.939,Gain of MoRF binding (P = 0.085); Loss of sheet (P = 0.1398); Gain of disorder (P = 0.2026); Gain of helix (P = 0.2059); Gain of loop (P = 0.3485)
7:117232032:C:G,P13569,T604S,0.973,Gain of disorder (P = 0.038); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1317); Gain of loop (P = 0.2754); Gain of phosphorylation at T604 (P = 0.3367)
7:117232032:C:T,P13569,T604I,0.974,Loss of disorder (P = 0.0634); Loss of sheet (P = 0.1398); Loss of MoRF binding (P = 0.1408); Gain of ubiquitination at K606 (P = 0.3907); Loss of helix (P = 0.3949)
7:117232034:T:A,P13569,S605T,0.751,Loss of stability (P = 0.0618); Loss of disorder (P = 0.1208); Loss of MoRF binding (P = 0.1231); Gain of helix (P = 0.2059); Gain of glycosylation at T604 (P = 0.3418)
7:117232034:T:C,P13569,S605P,0.749,Loss of MoRF binding (P = 0.0578); Loss of stability (P = 0.0872); Loss of disorder (P = 0.1519); Gain of catalytic residue at L602 (P = 0.2287); Gain of loop (P = 0.2754)
7:117232034:T:G,P13569,S605A,0.705,Loss of stability (P = 0.0455); Loss of disorder (P = 0.0807); Loss of MoRF binding (P = 0.1424); Gain of helix (P = 0.2059); Loss of catalytic residue at K606 (P = 0.27)
7:117232035:C:A,P13569,S605Y,0.51,Loss of disorder (P = 0.0337); Loss of MoRF binding (P = 0.1162); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299); Loss of stability (P = 0.2145)
7:117232035:C:G,P13569,S605C,0.665,Loss of disorder (P = 0.0152); Gain of methylation at K606 (P = 0.04); Loss of MoRF binding (P = 0.1031); Loss of helix (P = 0.1299); Loss of stability (P = 0.2053)
7:117232035:C:T,P13569,S605F,0.387,Loss of disorder (P = 0.0208); Gain of MoRF binding (P = 0.0824); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of catalytic residue at K606 (P = 0.3204)
7:117232037:A:C,P13569,K606Q,0.782,Loss of MoRF binding (P = 0.0585); Loss of disorder (P = 0.1195); Gain of helix (P = 0.132); Gain of catalytic residue at S605 (P = 0.1846); Loss of loop (P = 0.2897)
7:117232037:A:G,P13569,K606E,0.731,Loss of MoRF binding (P = 0.0104); Gain of relative solvent accessibility (P = 0.1259); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.1903); Gain of disorder (P = 0.2071)
7:117232038:A:C,P13569,K606T,0.799,Loss of MoRF binding (P = 0.0629); Gain of catalytic residue at S605 (P = 0.0836); Loss of disorder (P = 0.0919); Loss of helix (P = 0.2022); Gain of methylation at K611 (P = 0.3349)
7:117232038:A:G,P13569,K606R,0.82,Gain of MoRF binding (P = 0.0989); Loss of disorder (P = 0.105); Gain of helix (P = 0.132); Gain of catalytic residue at S605 (P = 0.1501); Gain of phosphorylation at S605 (P = 0.2788)
7:117232038:A:T,P13569,K606I,0.81,Loss of disorder (P = 0.0168); Loss of catalytic residue at K606 (P = 0.0849); Loss of MoRF binding (P = 0.1015); Loss of loop (P = 0.1242); Gain of helix (P = 0.132)
7:117232039:A:C,P13569,K606N,0.778,Loss of MoRF binding (P = 0.061); Loss of disorder (P = 0.105); Gain of helix (P = 0.132); Loss of catalytic residue at K606 (P = 0.1503); Loss of loop (P = 0.2897)
7:117232039:A:T,P13569,K606N,0.778,Loss of MoRF binding (P = 0.061); Loss of disorder (P = 0.105); Gain of helix (P = 0.132); Loss of catalytic residue at K606 (P = 0.1503); Loss of loop (P = 0.2897)
7:117232040:A:C,P13569,M607L,0.775,Loss of catalytic residue at M607 (P = 0.0228); Loss of MoRF binding (P = 0.1137); Loss of disorder (P = 0.1766); Gain of helix (P = 0.2059); Gain of ubiquitination at K612 (P = 0.3406)
7:117232040:A:G,P13569,M607V,0.804,Loss of catalytic residue at M607 (P = 0.0265); Gain of methylation at K606 (P = 0.1045); Loss of MoRF binding (P = 0.1325); Loss of disorder (P = 0.1387); Gain of ubiquitination at K612 (P = 0.3499)
7:117232040:A:T,P13569,M607L,0.775,Loss of catalytic residue at M607 (P = 0.0228); Loss of MoRF binding (P = 0.1137); Loss of disorder (P = 0.1766); Gain of helix (P = 0.2059); Gain of ubiquitination at K612 (P = 0.3406)
7:117232041:T:A,P13569,M607K,0.872,Loss of catalytic residue at M607 (P = 0.0081); Gain of disorder (P = 0.0098); Gain of MoRF binding (P = 0.0359); Loss of sheet (P = 0.1398); Loss of stability (P = 0.1468)
7:117232041:T:C,P13569,M607T,0.897,Loss of catalytic residue at M607 (P = 0.0222); Gain of disorder (P = 0.0502); Loss of MoRF binding (P = 0.1075); Gain of helix (P = 0.2059); Loss of stability (P = 0.2139)
7:117232041:T:G,P13569,M607R,0.909,Gain of MoRF binding (P = 0.0147); Loss of catalytic residue at V603 (P = 0.0177); Gain of disorder (P = 0.0397); Loss of sheet (P = 0.1398); Gain of phosphorylation at S605 (P = 0.1917)
7:117232042:G:A,P13569,M607I,0.801,Loss of catalytic residue at V603 (P = 0.0353); Loss of disorder (P = 0.0974); Gain of MoRF binding (P = 0.1301); Gain of loop (P = 0.2754); Gain of methylation at K606 (P = 0.3242)
7:117232042:G:C,P13569,M607I,0.801,Loss of catalytic residue at V603 (P = 0.0353); Loss of disorder (P = 0.0974); Gain of MoRF binding (P = 0.1301); Gain of loop (P = 0.2754); Gain of methylation at K606 (P = 0.3242)
7:117232042:G:T,P13569,M607I,0.801,Loss of catalytic residue at V603 (P = 0.0353); Loss of disorder (P = 0.0974); Gain of MoRF binding (P = 0.1301); Gain of loop (P = 0.2754); Gain of methylation at K606 (P = 0.3242)
7:117232043:G:A,P13569,E608K,0.654,Gain of MoRF binding (P = 0.0025); Gain of disorder (P = 0.1758); Gain of methylation at K611 (P = 0.3022); Loss of stability (P = 0.3277); Loss of ubiquitination at K612 (P = 0.3343)
7:117232043:G:C,P13569,E608Q,0.652,Gain of MoRF binding (P = 0.0227); Gain of helix (P = 0.132); Loss of disorder (P = 0.1381); Gain of methylation at K611 (P = 0.2834); Loss of loop (P = 0.2897)
7:117232044:A:C,P13569,E608A,0.765,Gain of MoRF binding (P = 0.0365); Loss of disorder (P = 0.0699); Loss of solvent accessibility (P = 0.0703); Loss of relative solvent accessibility (P = 0.1807); Loss of stability (P = 0.2495)
7:117232044:A:G,P13569,E608G,0.861,Gain of MoRF binding (P = 0.0341); Gain of catalytic residue at E608 (P = 0.0546); Loss of stability (P = 0.0663); Loss of disorder (P = 0.1291); Loss of helix (P = 0.1706)
7:117232044:A:T,P13569,E608V,0.735,Loss of disorder (P = 0.0222); Gain of MoRF binding (P = 0.0251); Loss of solvent accessibility (P = 0.0703); Gain of helix (P = 0.132); Loss of relative solvent accessibility (P = 0.1807)
7:117232045:A:C,P13569,E608D,0.509,Gain of MoRF binding (P = 0.0705); Gain of helix (P = 0.132); Loss of disorder (P = 0.2255); Gain of ubiquitination at K612 (P = 0.3499); Loss of methylation at K611 (P = 0.3615)
7:117232045:A:T,P13569,E608D,0.509,Gain of MoRF binding (P = 0.0705); Gain of helix (P = 0.132); Loss of disorder (P = 0.2255); Gain of ubiquitination at K612 (P = 0.3499); Loss of methylation at K611 (P = 0.3615)
7:117232046:C:A,P13569,H609N,0.794,Gain of MoRF binding (P = 0.1095); Loss of disorder (P = 0.1819); Gain of helix (P = 0.2059); Gain of ubiquitination at K612 (P = 0.3297); Gain of methylation at K612 (P = 0.3428)
7:117232046:C:G,P13569,H609D,0.788,Loss of MoRF binding (P = 0.0733); Gain of relative solvent accessibility (P = 0.09); Gain of disorder (P = 0.0978); Gain of solvent accessibility (P = 0.1376); Gain of ubiquitination at K611 (P = 0.1966)
7:117232046:C:T,P13569,H609Y,0.783,Loss of disorder (P = 0.0479); Gain of MoRF binding (P = 0.1259); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of methylation at K612 (P = 0.3434)
7:117232047:A:C,P13569,H609P,0.745,Gain of glycosylation at H609 (P = 0.0335); Loss of MoRF binding (P = 0.0777); Gain of disorder (P = 0.1584); Gain of helix (P = 0.2059); Gain of methylation at K612 (P = 0.2362)
7:117232047:A:G,P13569,H609R,0.916,Gain of MoRF binding (P = 0.017); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of helix (P = 0.132); Loss of disorder (P = 0.2104)
7:117232047:A:T,P13569,H609L,0.905,Loss of disorder (P = 0.052); Gain of MoRF binding (P = 0.0832); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Gain of stability (P = 0.2235)
7:117232048:T:A,P13569,H609Q,0.783,Gain of MoRF binding (P = 0.1176); Gain of helix (P = 0.132); Gain of disorder (P = 0.1975); Gain of methylation at K611 (P = 0.2839); Gain of ubiquitination at K612 (P = 0.3406)
7:117232048:T:G,P13569,H609Q,0.783,Gain of MoRF binding (P = 0.1176); Gain of helix (P = 0.132); Gain of disorder (P = 0.1975); Gain of methylation at K611 (P = 0.2839); Gain of ubiquitination at K612 (P = 0.3406)
7:117232049:T:A,P13569,L610I,0.834,Gain of MoRF binding (P = 0.0988); Loss of catalytic residue at L610 (P = 0.1019); Gain of methylation at K611 (P = 0.1101); Gain of helix (P = 0.132); Loss of disorder (P = 0.1922)
7:117232049:T:G,P13569,L610V,0.821,Gain of methylation at K611 (P = 0.0393); Loss of catalytic residue at L610 (P = 0.0612); Gain of MoRF binding (P = 0.1214); Loss of stability (P = 0.1698); Loss of helix (P = 0.2022)
7:117232050:T:C,P13569,L610S,0.952,Gain of disorder (P = 0.0082); Loss of catalytic residue at L610 (P = 0.0267); Loss of stability (P = 0.042); Gain of ubiquitination at K612 (P = 0.0768); Gain of sheet (P = 0.0827)
7:117232051:A:C,P13569,L610F,0.819,Gain of methylation at K611 (P = 0.0317); Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.1211); Loss of disorder (P = 0.1389); Loss of catalytic residue at L610 (P = 0.1691)
7:117232051:A:T,P13569,L610F,0.819,Gain of methylation at K611 (P = 0.0317); Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.1211); Loss of disorder (P = 0.1389); Loss of catalytic residue at L610 (P = 0.1691)
7:117232052:A:C,P13569,K611Q,0.511,Loss of MoRF binding (P = 0.0723); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.1005); Gain of helix (P = 0.2059); Loss of methylation at K611 (P = 0.2239)
7:117232052:A:G,P13569,K611E,0.466,Loss of MoRF binding (P = 0.0348); Gain of ubiquitination at K615 (P = 0.1537); Gain of helix (P = 0.2059); Gain of disorder (P = 0.2168); Loss of methylation at K611 (P = 0.2239)
7:117232053:A:C,P13569,K611T,0.537,Loss of MoRF binding (P = 0.0712); Loss of disorder (P = 0.0727); Loss of stability (P = 0.1019); Gain of phosphorylation at K611 (P = 0.1826); Gain of ubiquitination at K615 (P = 0.1884)
7:117232053:A:G,P13569,K611R,0.433,Gain of MoRF binding (P = 0.0709); Loss of disorder (P = 0.0791); Loss of sheet (P = 0.0817); Gain of helix (P = 0.132); Gain of ubiquitination at K615 (P = 0.2199)
7:117232053:A:T,P13569,K611M,0.606,Loss of disorder (P = 0.0379); Loss of MoRF binding (P = 0.078); Loss of sheet (P = 0.0817); Gain of catalytic residue at K611 (P = 0.0858); Gain of ubiquitination at K615 (P = 0.1235)
7:117232054:G:C,P13569,K611N,0.477,Loss of MoRF binding (P = 0.0731); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.0885); Gain of helix (P = 0.2059); Loss of methylation at K611 (P = 0.2239)
7:117232054:G:T,P13569,K611N,0.477,Loss of MoRF binding (P = 0.0731); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.0885); Gain of helix (P = 0.2059); Loss of methylation at K611 (P = 0.2239)
7:117232055:A:C,P13569,K612Q,0.608,Loss of MoRF binding (P = 0.0812); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.1128); Loss of glycosylation at K612 (P = 0.1319); Loss of solvent accessibility (P = 0.1551)
7:117232055:A:G,P13569,K612E,0.556,Loss of MoRF binding (P = 0.0488); Loss of glycosylation at K612 (P = 0.1319); Gain of ubiquitination at K615 (P = 0.1537); Gain of disorder (P = 0.2135); Loss of methylation at K612 (P = 0.2241)
7:117232056:A:C,P13569,K612T,0.64,Loss of MoRF binding (P = 0.0802); Loss of disorder (P = 0.0839); Gain of phosphorylation at K612 (P = 0.1023); Loss of solvent accessibility (P = 0.1551); Loss of helix (P = 0.1706)
7:117232056:A:G,P13569,K612R,0.424,Gain of MoRF binding (P = 0.0831); Loss of disorder (P = 0.0892); Loss of glycosylation at K612 (P = 0.1319); Gain of ubiquitination at K615 (P = 0.1537); Gain of helix (P = 0.2059)
7:117232056:A:T,P13569,K612I,0.641,Loss of disorder (P = 0.0133); Gain of ubiquitination at K615 (P = 0.0529); Loss of MoRF binding (P = 0.0923); Gain of catalytic residue at L617 (P = 0.094); Loss of glycosylation at K612 (P = 0.1319)
7:117232057:A:C,P13569,K612N,0.578,Loss of MoRF binding (P = 0.082); Loss of disorder (P = 0.0963); Loss of glycosylation at K612 (P = 0.1319); Loss of methylation at K612 (P = 0.2241); Gain of ubiquitination at K615 (P = 0.2682)
7:117232057:A:T,P13569,K612N,0.578,Loss of MoRF binding (P = 0.082); Loss of disorder (P = 0.0963); Loss of glycosylation at K612 (P = 0.1319); Loss of methylation at K612 (P = 0.2241); Gain of ubiquitination at K615 (P = 0.2682)
7:117232058:G:C,P13569,A613P,0.917,Gain of disorder (P = 0.0699); Loss of MoRF binding (P = 0.1163); Loss of stability (P = 0.1342); Gain of methylation at K611 (P = 0.1655); Gain of ubiquitination at K612 (P = 0.1858)
7:117232058:G:T,P13569,A613S,0.858,Gain of disorder (P = 0.0307); Gain of phosphorylation at A613 (P = 0.0972); Gain of ubiquitination at K612 (P = 0.1858); Loss of stability (P = 0.2069); Gain of MoRF binding (P = 0.2144)
7:117232059:C:A,P13569,A613D,0.9,Gain of disorder (P = 0.0446); Gain of ubiquitination at K612 (P = 0.0768); Gain of sheet (P = 0.0827); Loss of MoRF binding (P = 0.1008); Loss of stability (P = 0.3333)
7:117232059:C:G,P13569,A613G,0.888,Loss of stability (P = 0.04); Gain of disorder (P = 0.082); Gain of glycosylation at K612 (P = 0.1365); Gain of ubiquitination at K612 (P = 0.1489); Gain of MoRF binding (P = 0.2128)
7:117232059:C:T,P13569,A613V,0.874,Gain of methylation at K612 (P = 0.0463); Loss of disorder (P = 0.0914); Gain of MoRF binding (P = 0.1396); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754)
7:117232061:G:A,P13569,D614N,0.908,Gain of MoRF binding (P = 0.0619); Gain of methylation at K611 (P = 0.2023); Gain of helix (P = 0.2059); Loss of disorder (P = 0.2093); Loss of stability (P = 0.2958)
7:117232061:G:C,P13569,D614H,0.916,Gain of MoRF binding (P = 0.0696); Gain of disorder (P = 0.0815); Gain of methylation at K611 (P = 0.1188); Loss of stability (P = 0.1463); Gain of helix (P = 0.2059)
7:117232061:G:T,P13569,D614Y,0.971,Gain of MoRF binding (P = 0.0625); Loss of disorder (P = 0.0636); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of methylation at K611 (P = 0.3141)
7:117232062:A:C,P13569,D614A,0.934,Gain of MoRF binding (P = 0.052); Loss of disorder (P = 0.156); Loss of sheet (P = 0.302); Gain of methylation at K611 (P = 0.3302); Loss of ubiquitination at K615 (P = 0.3349)
7:117232062:A:T,P13569,D614V,0.935,Gain of MoRF binding (P = 0.0355); Loss of disorder (P = 0.0556); Gain of methylation at K615 (P = 0.1326); Loss of sheet (P = 0.302); Loss of glycosylation at K612 (P = 0.3237)
7:117232063:C:A,P13569,D614E,0.91,Gain of disorder (P = 0.1119); Loss of MoRF binding (P = 0.2494); Gain of methylation at K611 (P = 0.2531); Loss of sheet (P = 0.302); Gain of ubiquitination at K615 (P = 0.3027)
7:117232063:C:G,P13569,D614E,0.91,Gain of disorder (P = 0.1119); Loss of MoRF binding (P = 0.2494); Gain of methylation at K611 (P = 0.2531); Loss of sheet (P = 0.302); Gain of ubiquitination at K615 (P = 0.3027)
7:117232064:A:C,P13569,K615Q,0.716,Loss of sheet (P = 0.0817); Loss of disorder (P = 0.176); Loss of glycosylation at K615 (P = 0.2153); Loss of MoRF binding (P = 0.2178); Gain of helix (P = 0.2684)
7:117232064:A:G,P13569,K615E,0.679,Gain of ubiquitination at K612 (P = 0.1184); Gain of relative solvent accessibility (P = 0.1259); Loss of MoRF binding (P = 0.1302); Gain of solvent accessibility (P = 0.1903); Gain of disorder (P = 0.2039)
7:117232065:A:C,P13569,K615T,0.705,Loss of disorder (P = 0.1163); Gain of ubiquitination at K612 (P = 0.1489); Gain of methylation at K611 (P = 0.1992); Loss of MoRF binding (P = 0.2072); Gain of helix (P = 0.2684)
7:117232065:A:G,P13569,K615R,0.561,Loss of sheet (P = 0.0817); Loss of disorder (P = 0.1432); Gain of MoRF binding (P = 0.1531); Gain of glycosylation at K612 (P = 0.1935); Gain of helix (P = 0.2059)
7:117232065:A:T,P13569,K615I,0.689,Loss of disorder (P = 0.0406); Gain of methylation at K611 (P = 0.0807); Gain of sheet (P = 0.0827); Loss of MoRF binding (P = 0.2097); Loss of glycosylation at K615 (P = 0.2153)
7:117232066:A:C,P13569,K615N,0.708,Loss of disorder (P = 0.1433); Loss of glycosylation at K615 (P = 0.2153); Loss of MoRF binding (P = 0.2187); Gain of ubiquitination at K612 (P = 0.2427); Gain of helix (P = 0.2684)
7:117232066:A:T,P13569,K615N,0.708,Loss of disorder (P = 0.1433); Loss of glycosylation at K615 (P = 0.2153); Loss of MoRF binding (P = 0.2187); Gain of ubiquitination at K612 (P = 0.2427); Gain of helix (P = 0.2684)
7:117232067:A:C,P13569,I616L,0.826,Gain of disorder (P = 0.1263); Gain of ubiquitination at K612 (P = 0.2876); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.315); Loss of methylation at K612 (P = 0.3472)
7:117232067:A:G,P13569,I616V,0.758,Gain of disorder (P = 0.1756); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3173); Gain of methylation at K615 (P = 0.3367); Loss of ubiquitination at K615 (P = 0.3396)
7:117232067:A:T,P13569,I616L,0.826,Gain of disorder (P = 0.1263); Gain of ubiquitination at K612 (P = 0.2876); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.315); Loss of methylation at K612 (P = 0.3472)
7:117232068:T:A,P13569,I616K,0.866,Gain of disorder (P = 0.0024); Loss of stability (P = 0.06); Gain of MoRF binding (P = 0.0864); Gain of glycosylation at I616 (P = 0.193); Gain of ubiquitination at I616 (P = 0.278)
7:117232068:T:C,P13569,I616T,0.892,Loss of stability (P = 0.0159); Gain of disorder (P = 0.0304); Gain of ubiquitination at K612 (P = 0.1858); Loss of sheet (P = 0.302); Gain of methylation at K611 (P = 0.3054)
7:117232068:T:G,P13569,I616R,0.879,Gain of disorder (P = 0.021); Gain of MoRF binding (P = 0.0406); Loss of stability (P = 0.0973); Loss of sheet (P = 0.1158); Loss of loop (P = 0.2897)
7:117232069:A:G,P13569,I616M,0.868,Gain of disorder (P = 0.0573); Gain of ubiquitination at K612 (P = 0.2427); Gain of catalytic residue at I616 (P = 0.2531); Loss of helix (P = 0.2662); Gain of MoRF binding (P = 0.2739)
7:117232070:T:A,P13569,L617I,0.697,Gain of sheet (P = 0.0827); Gain of methylation at K612 (P = 0.1125); Loss of disorder (P = 0.2384); Gain of helix (P = 0.2684); Loss of catalytic residue at L617 (P = 0.313)
7:117232070:T:G,P13569,L617V,0.705,Gain of sheet (P = 0.0827); Gain of methylation at K612 (P = 0.2031); Gain of catalytic residue at L617 (P = 0.2219); Loss of disorder (P = 0.2477); Gain of helix (P = 0.2684)
7:117232071:T:C,P13569,L617S,0.898,Gain of disorder (P = 0.0068); Loss of stability (P = 0.0274); Gain of phosphorylation at L617 (P = 0.0649); Gain of sheet (P = 0.0827); Gain of ubiquitination at K612 (P = 0.2173)
7:117232072:A:C,P13569,L617F,0.725,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1985); Gain of methylation at K612 (P = 0.2257); Gain of helix (P = 0.2684); Loss of stability (P = 0.3142)
7:117232072:A:T,P13569,L617F,0.725,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1985); Gain of methylation at K612 (P = 0.2257); Gain of helix (P = 0.2684); Loss of stability (P = 0.3142)
7:117232073:A:C,P13569,I618L,0.871,Gain of sheet (P = 0.0827); Gain of disorder (P = 0.1529); Gain of phosphorylation at S623 (P = 0.2418); Loss of helix (P = 0.2662); Loss of ubiquitination at K615 (P = 0.3374)
7:117232073:A:G,P13569,I618V,0.721,Loss of sheet (P = 0.0817); Gain of disorder (P = 0.2431); Loss of helix (P = 0.2662); Gain of phosphorylation at S623 (P = 0.3384); Loss of ubiquitination at K615 (P = 0.3396)
7:117232073:A:T,P13569,I618F,0.859,Loss of stability (P = 0.1266); Gain of phosphorylation at S623 (P = 0.2435); Gain of loop (P = 0.2754); Loss of disorder (P = 0.2902); Loss of sheet (P = 0.302)
7:117232074:T:A,P13569,I618N,0.918,Gain of disorder (P = 0.023); Loss of stability (P = 0.0375); Loss of sheet (P = 0.0817); Loss of helix (P = 0.2662); Gain of ubiquitination at K615 (P = 0.3166)
7:117232074:T:G,P13569,I618S,0.893,Gain of disorder (P = 0.0037); Loss of stability (P = 0.0295); Gain of phosphorylation at I618 (P = 0.0551); Loss of sheet (P = 0.0817); Loss of helix (P = 0.2662)
7:117232075:T:G,P13569,I618M,0.89,Gain of disorder (P = 0.0735); Loss of stability (P = 0.1318); Gain of phosphorylation at S623 (P = 0.2435); Loss of helix (P = 0.2662); Loss of catalytic residue at I618 (P = 0.2761)
7:117232076:T:A,P13569,L619M,0.857,Loss of catalytic residue at L619 (P = 0.0067); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.1511); Gain of phosphorylation at S623 (P = 0.302); Loss of stability (P = 0.3338)
7:117232076:T:G,P13569,L619V,0.841,Loss of sheet (P = 0.0817); Loss of disorder (P = 0.2685); Gain of loop (P = 0.2754); Loss of stability (P = 0.3073); Loss of phosphorylation at S623 (P = 0.3283)
7:117232077:T:C,P13569,L619S,0.944,Loss of catalytic residue at L619 (P = 0.0043); Gain of disorder (P = 0.0151); Loss of stability (P = 0.0371); Loss of sheet (P = 0.0817); Gain of phosphorylation at S623 (P = 0.1396)
7:117232077:T:G,P13569,L619W,0.835,Loss of stability (P = 0.0585); Gain of catalytic residue at L617 (P = 0.0632); Loss of disorder (P = 0.1632); Gain of MoRF binding (P = 0.2674); Loss of phosphorylation at S623 (P = 0.2833)
7:117232078:G:C,P13569,L619F,0.851,Loss of stability (P = 0.1504); Loss of disorder (P = 0.2335); Gain of loop (P = 0.2754); Loss of catalytic residue at L619 (P = 0.2778); Gain of phosphorylation at S623 (P = 0.302)
7:117232078:G:T,P13569,L619F,0.851,Loss of stability (P = 0.1504); Loss of disorder (P = 0.2335); Gain of loop (P = 0.2754); Loss of catalytic residue at L619 (P = 0.2778); Gain of phosphorylation at S623 (P = 0.302)
7:117232079:C:A,P13569,H620N,0.769,Gain of catalytic residue at H620 (P = 0.0523); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2346); Loss of disorder (P = 0.2361); Loss of loop (P = 0.2897)
7:117232079:C:G,P13569,H620D,0.751,Gain of catalytic residue at H620 (P = 0.0465); Gain of relative solvent accessibility (P = 0.1259); Gain of phosphorylation at S623 (P = 0.1441); Gain of solvent accessibility (P = 0.2291); Loss of loop (P = 0.2897)
7:117232079:C:T,P13569,H620Y,0.779,Gain of sheet (P = 0.0827); Gain of catalytic residue at H620 (P = 0.122); Loss of disorder (P = 0.1234); Gain of phosphorylation at S623 (P = 0.2328); Loss of ubiquitination at K615 (P = 0.3426)
7:117232080:A:C,P13569,H620P,0.902,Gain of catalytic residue at H620 (P = 0.0953); Gain of phosphorylation at S623 (P = 0.1587); Loss of disorder (P = 0.2764); Loss of sheet (P = 0.302); Loss of stability (P = 0.3135)
7:117232080:A:G,P13569,H620R,0.657,Gain of phosphorylation at S623 (P = 0.0666); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Gain of MoRF binding (P = 0.2001); Loss of catalytic residue at E621 (P = 0.2509)
7:117232080:A:T,P13569,H620L,0.725,Gain of catalytic residue at H620 (P = 0.0394); Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1456); Gain of phosphorylation at S624 (P = 0.24); Loss of loop (P = 0.2897)
7:117232081:T:A,P13569,H620Q,0.86,Gain of catalytic residue at H620 (P = 0.0721); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Loss of disorder (P = 0.274); Gain of phosphorylation at S624 (P = 0.277)
7:117232081:T:G,P13569,H620Q,0.86,Gain of catalytic residue at H620 (P = 0.0721); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Loss of disorder (P = 0.274); Gain of phosphorylation at S624 (P = 0.277)
7:117232082:G:A,P13569,E621K,0.641,Gain of ubiquitination at E621 (P = 0.0325); Gain of MoRF binding (P = 0.0681); Gain of glycosylation at E621 (P = 0.0952); Gain of methylation at E621 (P = 0.111); Loss of sheet (P = 0.302)
7:117232082:G:C,P13569,E621Q,0.461,Loss of catalytic residue at E621 (P = 0.1132); Loss of phosphorylation at S623 (P = 0.2457); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3431); Loss of disorder (P = 0.4107)
7:117232083:A:C,P13569,E621A,0.672,Loss of solvent accessibility (P = 0.1744); Loss of phosphorylation at S623 (P = 0.2733); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3031); Loss of relative solvent accessibility (P = 0.3219)
7:117232083:A:G,P13569,E621G,0.641,Gain of catalytic residue at H620 (P = 0.2373); Loss of stability (P = 0.2613); Loss of sheet (P = 0.302); Loss of solvent accessibility (P = 0.3103); Loss of phosphorylation at S623 (P = 0.311)
7:117232083:A:T,P13569,E621V,0.694,Loss of sheet (P = 0.1398); Loss of solvent accessibility (P = 0.1744); Loss of disorder (P = 0.1862); Loss of phosphorylation at S623 (P = 0.2193); Gain of loop (P = 0.2754)
7:117232084:A:C,P13569,E621D,0.469,Loss of sheet (P = 0.302); Loss of phosphorylation at S623 (P = 0.3428); Loss of disorder (P = 0.4028); Gain of MoRF binding (P = 0.5198); Gain of catalytic residue at H620 (P = 0.5216)
7:117232084:A:T,P13569,E621D,0.469,Loss of sheet (P = 0.302); Loss of phosphorylation at S623 (P = 0.3428); Loss of disorder (P = 0.4028); Gain of MoRF binding (P = 0.5198); Gain of catalytic residue at H620 (P = 0.5216)
7:117232085:G:A,P13569,G622S,0.88,Gain of phosphorylation at G622 (P = 0.0767); Gain of disorder (P = 0.128); Loss of sheet (P = 0.302); Loss of catalytic residue at S623 (P = 0.4366); Gain of MoRF binding (P = 0.6399)
7:117232085:G:C,P13569,G622R,0.979,Gain of phosphorylation at S624 (P = 0.0882); Loss of catalytic residue at S624 (P = 0.2818); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3042); Loss of disorder (P = 0.4311)
7:117232085:G:T,P13569,G622C,0.956,Gain of sheet (P = 0.0827); Loss of catalytic residue at G622 (P = 0.0879); Loss of disorder (P = 0.1761); Loss of phosphorylation at S623 (P = 0.178); Gain of loop (P = 0.4661)
7:117232086:G:C,P13569,G622A,0.985,Loss of catalytic residue at S624 (P = 0.1763); Loss of phosphorylation at S623 (P = 0.2887); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3417); Gain of MoRF binding (P = 0.6378)
7:117232086:G:T,P13569,G622V,0.961,Gain of sheet (P = 0.0827); Loss of catalytic residue at S624 (P = 0.1956); Loss of disorder (P = 0.2039); Loss of phosphorylation at S623 (P = 0.2437); Loss of loop (P = 0.2897)
7:117232088:A:C,P13569,S623R,0.389,Gain of sheet (P = 0.0827); Loss of phosphorylation at S623 (P = 0.1075); Gain of solvent accessibility (P = 0.204); Loss of disorder (P = 0.2849); Loss of loop (P = 0.2897)
7:117232088:A:G,P13569,S623G,0.386,Loss of phosphorylation at S623 (P = 0.1075); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3381); Gain of catalytic residue at S623 (P = 0.4234); Loss of loop (P = 0.4786)
7:117232088:A:T,P13569,S623C,0.509,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.0987); Loss of phosphorylation at S623 (P = 0.1075); Loss of loop (P = 0.2897); Gain of catalytic residue at G628 (P = 0.4)
7:117232089:G:A,P13569,S623N,0.356,Loss of phosphorylation at S623 (P = 0.1075); Loss of disorder (P = 0.2856); Loss of sheet (P = 0.302); Gain of catalytic residue at S623 (P = 0.4454); Loss of loop (P = 0.4786)
7:117232089:G:C,P13569,S623T,0.372,Gain of catalytic residue at F626 (P = 0.2269); Loss of phosphorylation at S623 (P = 0.2544); Loss of disorder (P = 0.2808); Loss of sheet (P = 0.302); Loss of loop (P = 0.4786)
7:117232089:G:T,P13569,S623I,0.509,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.104); Loss of phosphorylation at S623 (P = 0.1075); Loss of catalytic residue at S623 (P = 0.1082); Loss of loop (P = 0.2897)
7:117232090:C:A,P13569,S623R,0.389,Gain of sheet (P = 0.0827); Loss of phosphorylation at S623 (P = 0.1075); Gain of solvent accessibility (P = 0.204); Loss of disorder (P = 0.2849); Loss of loop (P = 0.2897)
7:117232090:C:G,P13569,S623R,0.389,Gain of sheet (P = 0.0827); Loss of phosphorylation at S623 (P = 0.1075); Gain of solvent accessibility (P = 0.204); Loss of disorder (P = 0.2849); Loss of loop (P = 0.2897)
7:117232091:A:C,P13569,S624R,0.74,Loss of catalytic residue at G622 (P = 0.1183); Gain of phosphorylation at S623 (P = 0.1964); Loss of disorder (P = 0.272); Loss of sheet (P = 0.302); Gain of methylation at S624 (P = 0.3091)
7:117232091:A:G,P13569,S624G,0.59,Gain of glycosylation at S623 (P = 0.0412); Loss of stability (P = 0.099); Loss of catalytic residue at S624 (P = 0.2399); Loss of phosphorylation at S624 (P = 0.2454); Loss of sheet (P = 0.302)
7:117232091:A:T,P13569,S624C,0.557,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.0866); Loss of catalytic residue at S624 (P = 0.1128); Loss of phosphorylation at S623 (P = 0.2035); Loss of loop (P = 0.2897)
7:117232092:G:A,P13569,S624N,0.545,Loss of catalytic residue at S624 (P = 0.078); Loss of phosphorylation at S623 (P = 0.209); Loss of disorder (P = 0.2861); Loss of sheet (P = 0.302); Loss of stability (P = 0.469)
7:117232092:G:C,P13569,S624T,0.543,Loss of catalytic residue at G622 (P = 0.2013); Loss of phosphorylation at S623 (P = 0.2562); Loss of disorder (P = 0.2653); Loss of sheet (P = 0.302); Loss of stability (P = 0.4326)
7:117232092:G:T,P13569,S624I,0.532,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.0914); Loss of phosphorylation at S624 (P = 0.2454); Loss of catalytic residue at G622 (P = 0.2507); Loss of loop (P = 0.2897)
7:117232093:C:A,P13569,S624R,0.74,Loss of catalytic residue at G622 (P = 0.1183); Gain of phosphorylation at S623 (P = 0.1964); Loss of disorder (P = 0.272); Loss of sheet (P = 0.302); Gain of methylation at S624 (P = 0.3091)
7:117232093:C:G,P13569,S624R,0.74,Loss of catalytic residue at G622 (P = 0.1183); Gain of phosphorylation at S623 (P = 0.1964); Loss of disorder (P = 0.272); Loss of sheet (P = 0.302); Gain of methylation at S624 (P = 0.3091)
7:117232094:T:A,P13569,Y625N,0.606,Loss of stability (P = 0.0325); Gain of disorder (P = 0.0327); Gain of sheet (P = 0.0827); Loss of catalytic residue at S624 (P = 0.1817); Loss of phosphorylation at S623 (P = 0.2876)
7:117232094:T:C,P13569,Y625H,0.601,Gain of disorder (P = 0.0315); Loss of stability (P = 0.0379); Loss of sheet (P = 0.302); Gain of phosphorylation at S623 (P = 0.3159); Gain of catalytic residue at F626 (P = 0.3403)
7:117232094:T:G,P13569,Y625D,0.652,Gain of disorder (P = 0.0173); Gain of phosphorylation at Y627 (P = 0.0749); Loss of catalytic residue at S624 (P = 0.1098); Loss of stability (P = 0.1246); Loss of sheet (P = 0.1398)
7:117232095:A:C,P13569,Y625S,0.647,Gain of disorder (P = 0.0047); Loss of stability (P = 0.0272); Gain of phosphorylation at Y625 (P = 0.0896); Loss of sheet (P = 0.1398); Loss of catalytic residue at Y625 (P = 0.2558)
7:117232095:A:G,P13569,Y625C,0.395,Loss of stability (P = 0.105); Loss of phosphorylation at S623 (P = 0.2809); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3579); Loss of helix (P = 0.4763)
7:117232095:A:T,P13569,Y625F,0.378,Loss of sheet (P = 0.302); Loss of stability (P = 0.3028); Gain of phosphorylation at S623 (P = 0.3429); Loss of catalytic residue at Y625 (P = 0.3798); Gain of disorder (P = 0.4046)
7:117232097:T:A,P13569,F626I,0.644,Gain of sheet (P = 0.0827); Gain of catalytic residue at F626 (P = 0.1879); Gain of phosphorylation at S623 (P = 0.2656); Loss of stability (P = 0.3938); Loss of helix (P = 0.3949)
7:117232097:T:C,P13569,F626L,0.671,Loss of catalytic residue at F626 (P = 0.1713); Gain of phosphorylation at S623 (P = 0.2494); Loss of stability (P = 0.2553); Gain of disorder (P = 0.2719); Loss of sheet (P = 0.302)
7:117232097:T:G,P13569,F626V,0.643,Loss of stability (P = 0.1405); Gain of phosphorylation at Y627 (P = 0.1435); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4183)
7:117232098:T:A,P13569,F626Y,0.66,Loss of stability (P = 0.0932); Loss of helix (P = 0.1299); Gain of phosphorylation at S623 (P = 0.1687); Gain of disorder (P = 0.2362); Gain of catalytic residue at F626 (P = 0.2912)
7:117232098:T:C,P13569,F626S,0.698,Gain of disorder (P = 0.0021); Loss of stability (P = 0.0183); Gain of phosphorylation at F626 (P = 0.0731); Gain of sheet (P = 0.0827); Gain of loop (P = 0.2754)
7:117232098:T:G,P13569,F626C,0.676,Loss of stability (P = 0.0808); Loss of phosphorylation at S623 (P = 0.2639); Loss of sheet (P = 0.302); Gain of catalytic residue at F626 (P = 0.3052); Loss of disorder (P = 0.3938)
7:117232099:T:A,P13569,F626L,0.671,Loss of catalytic residue at F626 (P = 0.1713); Gain of phosphorylation at S623 (P = 0.2494); Loss of stability (P = 0.2553); Gain of disorder (P = 0.2719); Loss of sheet (P = 0.302)
7:117232099:T:G,P13569,F626L,0.671,Loss of catalytic residue at F626 (P = 0.1713); Gain of phosphorylation at S623 (P = 0.2494); Loss of stability (P = 0.2553); Gain of disorder (P = 0.2719); Loss of sheet (P = 0.302)
7:117232100:T:A,P13569,Y627N,0.519,Loss of stability (P = 0.0288); Gain of disorder (P = 0.03); Gain of sheet (P = 0.0827); Loss of catalytic residue at S624 (P = 0.1955); Gain of relative solvent accessibility (P = 0.2629)
7:117232100:T:C,P13569,Y627H,0.484,Loss of stability (P = 0.0189); Gain of disorder (P = 0.0315); Gain of sheet (P = 0.0827); Gain of catalytic residue at G628 (P = 0.2533); Gain of phosphorylation at S623 (P = 0.2915)
7:117232100:T:G,P13569,Y627D,0.509,Gain of disorder (P = 0.0165); Loss of stability (P = 0.0481); Loss of catalytic residue at S624 (P = 0.0779); Gain of sheet (P = 0.0827); Gain of relative solvent accessibility (P = 0.1066)
7:117232101:A:C,P13569,Y627S,0.521,Gain of disorder (P = 0.0043); Loss of stability (P = 0.0222); Gain of sheet (P = 0.0827); Gain of phosphorylation at S623 (P = 0.1102); Gain of glycosylation at Y627 (P = 0.1247)
7:117232101:A:G,P13569,Y627C,0.443,Loss of stability (P = 0.0594); Gain of catalytic residue at T629 (P = 0.0637); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302)
7:117232101:A:T,P13569,Y627F,0.429,Loss of stability (P = 0.1167); Gain of phosphorylation at S623 (P = 0.218); Loss of catalytic residue at Y627 (P = 0.2266); Loss of sheet (P = 0.302); Gain of disorder (P = 0.351)
7:117232103:G:A,P13569,G628R,0.947,Gain of phosphorylation at S631 (P = 0.1011); Loss of helix (P = 0.1299); Gain of catalytic residue at G628 (P = 0.1468); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2455)
7:117232103:G:C,P13569,G628R,0.947,Gain of phosphorylation at S631 (P = 0.1011); Loss of helix (P = 0.1299); Gain of catalytic residue at G628 (P = 0.1468); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2455)
7:117232103:G:T,P13569,G628W,0.889,Loss of disorder (P = 0.0758); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of catalytic residue at Y627 (P = 0.2092); Loss of phosphorylation at S623 (P = 0.2626)
7:117232104:G:A,P13569,G628E,0.845,Gain of disorder (P = 0.1197); Loss of catalytic residue at Y627 (P = 0.1274); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363)
7:117232104:G:C,P13569,G628A,0.867,Gain of catalytic residue at G628 (P = 0.0315); Loss of helix (P = 0.1299); Loss of disorder (P = 0.2566); Loss of sheet (P = 0.302); Loss of phosphorylation at S623 (P = 0.3387)
7:117232104:G:T,P13569,G628V,0.879,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1203); Loss of phosphorylation at S623 (P = 0.2833); Gain of catalytic residue at E632 (P = 0.29); Loss of helix (P = 0.3949)
7:117232106:A:C,P13569,T629P,0.444,Gain of disorder (P = 0.0819); Loss of stability (P = 0.1004); Gain of catalytic residue at T629 (P = 0.1667); Gain of phosphorylation at S624 (P = 0.2668); Loss of loop (P = 0.2897)
7:117232106:A:G,P13569,T629A,0.404,Gain of catalytic residue at T629 (P = 0.0409); Loss of stability (P = 0.171); Loss of disorder (P = 0.2734); Loss of sheet (P = 0.302); Loss of phosphorylation at T629 (P = 0.3741)
7:117232106:A:T,P13569,T629S,0.431,Gain of disorder (P = 0.0312); Gain of catalytic residue at T629 (P = 0.1055); Gain of phosphorylation at S624 (P = 0.1517); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117232107:C:A,P13569,T629K,0.511,Gain of ubiquitination at T629 (P = 0.0138); Gain of methylation at T629 (P = 0.0186); Gain of disorder (P = 0.0653); Loss of stability (P = 0.1192); Loss of helix (P = 0.1299)
7:117232107:C:G,P13569,T629R,0.468,Gain of phosphorylation at S631 (P = 0.0787); Gain of solvent accessibility (P = 0.0808); Loss of helix (P = 0.1299); Gain of disorder (P = 0.161); Gain of sheet (P = 0.1945)
7:117232107:C:T,P13569,T629I,0.528,Loss of disorder (P = 0.1132); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Gain of catalytic residue at T629 (P = 0.3082); Loss of solvent accessibility (P = 0.3103)
7:117232109:T:A,P13569,F630I,0.706,Loss of disorder (P = 0.1925); Gain of phosphorylation at Y627 (P = 0.1974); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of catalytic residue at L633 (P = 0.3665)
7:117232109:T:C,P13569,F630L,0.694,Gain of disorder (P = 0.1772); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of stability (P = 0.3545); Loss of helix (P = 0.3949)
7:117232109:T:G,P13569,F630V,0.689,Gain of phosphorylation at Y627 (P = 0.1094); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2119); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117232110:T:A,P13569,F630Y,0.686,Gain of phosphorylation at F630 (P = 0.0673); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2343); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117232110:T:C,P13569,F630S,0.757,Gain of disorder (P = 0.0024); Gain of sheet (P = 0.1451); Gain of relative solvent accessibility (P = 0.1571); Gain of phosphorylation at S631 (P = 0.1577); Loss of helix (P = 0.1706)
7:117232110:T:G,P13569,F630C,0.706,Gain of relative solvent accessibility (P = 0.1571); Loss of disorder (P = 0.2608); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of catalytic residue at F630 (P = 0.3357)
7:117232111:T:A,P13569,F630L,0.694,Gain of disorder (P = 0.1772); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of stability (P = 0.3545); Loss of helix (P = 0.3949)
7:117232111:T:G,P13569,F630L,0.694,Gain of disorder (P = 0.1772); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of stability (P = 0.3545); Loss of helix (P = 0.3949)
7:117232112:T:A,P13569,S631T,0.308,Loss of disorder (P = 0.0877); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302); Gain of phosphorylation at S631 (P = 0.3468)
7:117232112:T:C,P13569,S631P,0.373,Loss of disorder (P = 0.152); Gain of helix (P = 0.1736); Gain of phosphorylation at Y627 (P = 0.2782); Loss of sheet (P = 0.302); Gain of catalytic residue at S631 (P = 0.3055)
7:117232112:T:G,P13569,S631A,0.391,Loss of disorder (P = 0.0599); Gain of helix (P = 0.1736); Gain of catalytic residue at S631 (P = 0.178); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302)
7:117232113:C:T,P13569,S631L,0.383,Gain of stability (P = 0.0386); Loss of disorder (P = 0.0425); Gain of helix (P = 0.1736); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117232115:G:A,P13569,E632K,0.498,Gain of ubiquitination at E632 (P = 0.0155); Gain of methylation at E632 (P = 0.0289); Loss of stability (P = 0.1169); Loss of loop (P = 0.2237); Gain of disorder (P = 0.2381)
7:117232115:G:C,P13569,E632Q,0.463,Gain of catalytic residue at S631 (P = 0.1677); Loss of helix (P = 0.1706); Gain of disorder (P = 0.2192); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302)
7:117232116:A:C,P13569,E632A,0.51,Loss of disorder (P = 0.0938); Gain of catalytic residue at S631 (P = 0.1022); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1579); Gain of loop (P = 0.2045)
7:117232116:A:G,P13569,E632G,0.557,Loss of stability (P = 0.0254); Gain of catalytic residue at S631 (P = 0.0898); Loss of solvent accessibility (P = 0.1177); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1956)
7:117232116:A:T,P13569,E632V,0.565,Loss of disorder (P = 0.04); Gain of catalytic residue at S631 (P = 0.0798); Gain of sheet (P = 0.0827); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1434)
7:117232117:A:C,P13569,E632D,0.44,Gain of sheet (P = 0.1945); Loss of catalytic residue at E632 (P = 0.2118); Gain of disorder (P = 0.2344); Gain of phosphorylation at T629 (P = 0.3542); Loss of helix (P = 0.3949)
7:117232117:A:T,P13569,E632D,0.44,Gain of sheet (P = 0.1945); Loss of catalytic residue at E632 (P = 0.2118); Gain of disorder (P = 0.2344); Gain of phosphorylation at T629 (P = 0.3542); Loss of helix (P = 0.3949)
7:117232118:C:A,P13569,L633I,0.925,Loss of disorder (P = 0.1297); Loss of helix (P = 0.1299); Gain of loop (P = 0.4248); Loss of phosphorylation at T629 (P = 0.5027); Loss of sheet (P = 0.5184)
7:117232118:C:G,P13569,L633V,0.889,Loss of disorder (P = 0.1573); Gain of loop (P = 0.2754); Gain of catalytic residue at L633 (P = 0.2881); Loss of stability (P = 0.3855); Loss of helix (P = 0.3949)
7:117232118:C:T,P13569,L633F,0.904,Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2311); Loss of stability (P = 0.4214); Gain of phosphorylation at T629 (P = 0.4251)
7:117232119:T:A,P13569,L633H,0.885,Gain of disorder (P = 0.0394); Loss of stability (P = 0.0501); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of catalytic residue at S631 (P = 0.3689)
7:117232119:T:C,P13569,L633P,0.939,Gain of disorder (P = 0.0146); Loss of stability (P = 0.0506); Loss of helix (P = 0.0558); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045)
7:117232119:T:G,P13569,L633R,0.922,Gain of disorder (P = 0.0369); Loss of stability (P = 0.1016); Gain of phosphorylation at S631 (P = 0.1552); Gain of catalytic residue at S631 (P = 0.1803); Gain of loop (P = 0.2045)
7:117232121:C:A,P13569,Q634K,0.633,Gain of ubiquitination at Q634 (P = 0.0219); Gain of disorder (P = 0.1723); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897); Gain of phosphorylation at S631 (P = 0.293)
7:117232121:C:G,P13569,Q634E,0.515,Loss of helix (P = 0.1299); Gain of disorder (P = 0.1315); Gain of phosphorylation at S631 (P = 0.1468); Loss of loop (P = 0.2897); Loss of catalytic residue at E632 (P = 0.4858)
7:117232122:A:C,P13569,Q634P,0.526,Gain of catalytic residue at L633 (P = 0.1776); Gain of disorder (P = 0.1906); Gain of phosphorylation at T629 (P = 0.1975); Loss of stability (P = 0.3468); Loss of helix (P = 0.3949)
7:117232122:A:G,P13569,Q634R,0.588,Gain of helix (P = 0.132); Gain of phosphorylation at S631 (P = 0.1342); Loss of disorder (P = 0.1749); Loss of loop (P = 0.2897); Loss of sheet (P = 0.5184)
7:117232122:A:T,P13569,Q634L,0.497,Loss of disorder (P = 0.049); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of stability (P = 0.3742); Gain of catalytic residue at Q637 (P = 0.4187)
7:117232123:A:C,P13569,Q634H,0.436,Gain of catalytic residue at L636 (P = 0.0553); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1756); Loss of loop (P = 0.2897); Loss of stability (P = 0.4443)
7:117232123:A:T,P13569,Q634H,0.436,Gain of catalytic residue at L636 (P = 0.0553); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1756); Loss of loop (P = 0.2897); Loss of stability (P = 0.4443)
7:117232124:A:C,P13569,N635H,0.261,Gain of disorder (P = 0.1222); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of relative solvent accessibility (P = 0.3219); Loss of solvent accessibility (P = 0.3646)
7:117232124:A:G,P13569,N635D,0.285,Gain of disorder (P = 0.087); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Gain of phosphorylation at S631 (P = 0.3147); Gain of solvent accessibility (P = 0.5485)
7:117232124:A:T,P13569,N635Y,0.299,Gain of phosphorylation at N635 (P = 0.0309); Loss of disorder (P = 0.0513); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.1456); Loss of loop (P = 0.2237)
7:117232125:A:C,P13569,N635T,0.246,Gain of loop (P = 0.2045); Gain of disorder (P = 0.2306); Gain of phosphorylation at N635 (P = 0.2524); Loss of helix (P = 0.2662); Gain of catalytic residue at N635 (P = 0.442)
7:117232125:A:G,P13569,N635S,0.273,Gain of disorder (P = 0.0398); Gain of phosphorylation at N635 (P = 0.0714); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949); Loss of solvent accessibility (P = 0.5904)
7:117232125:A:T,P13569,N635I,0.335,Loss of disorder (P = 0.031); Loss of helix (P = 0.1299); Gain of stability (P = 0.2053); Loss of loop (P = 0.2237); Gain of catalytic residue at L633 (P = 0.2484)
7:117232126:T:A,P13569,N635K,0.401,Gain of methylation at N635 (P = 0.0121); Gain of ubiquitination at N635 (P = 0.0177); Gain of disorder (P = 0.0721); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.2097)
7:117232126:T:G,P13569,N635K,0.401,Gain of methylation at N635 (P = 0.0121); Gain of ubiquitination at N635 (P = 0.0177); Gain of disorder (P = 0.0721); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.2097)
7:117232127:C:A,P13569,L636I,0.282,Loss of disorder (P = 0.1242); Gain of helix (P = 0.132); Gain of catalytic residue at P638 (P = 0.1631); Loss of stability (P = 0.2179); Loss of loop (P = 0.2237)
7:117232127:C:G,P13569,L636V,0.306,Loss of stability (P = 0.1485); Loss of disorder (P = 0.152); Gain of helix (P = 0.2059); Loss of loop (P = 0.2237); Loss of phosphorylation at S641 (P = 0.2393)
7:117232128:T:A,P13569,L636Q,0.482,Loss of stability (P = 0.0215); Gain of disorder (P = 0.0267); Gain of helix (P = 0.2059); Loss of loop (P = 0.2237); Gain of phosphorylation at S641 (P = 0.2301)
7:117232128:T:G,P13569,L636R,0.338,Loss of stability (P = 0.0184); Gain of disorder (P = 0.0483); Gain of helix (P = 0.132); Gain of phosphorylation at S641 (P = 0.1727); Loss of loop (P = 0.2237)
7:117232130:C:A,P13569,Q637K,0.434,Gain of ubiquitination at Q637 (P = 0.0114); Gain of methylation at Q637 (P = 0.0301); Gain of relative solvent accessibility (P = 0.0999); Gain of solvent accessibility (P = 0.1071); Gain of phosphorylation at S641 (P = 0.1146)
7:117232130:C:G,P13569,Q637E,0.332,Gain of relative solvent accessibility (P = 0.0999); Gain of disorder (P = 0.1226); Gain of phosphorylation at S641 (P = 0.1269); Gain of solvent accessibility (P = 0.1319); Loss of helix (P = 0.3949)
7:117232131:A:C,P13569,Q637P,0.421,Gain of catalytic residue at Q637 (P = 0.0502); Loss of helix (P = 0.0558); Loss of stability (P = 0.0964); Gain of phosphorylation at S641 (P = 0.157); Gain of disorder (P = 0.1764)
7:117232131:A:G,P13569,Q637R,0.336,Gain of solvent accessibility (P = 0.1505); Loss of disorder (P = 0.167); Gain of helix (P = 0.2294); Gain of relative solvent accessibility (P = 0.2363); Gain of phosphorylation at S641 (P = 0.2379)
7:117232131:A:T,P13569,Q637L,0.456,Loss of disorder (P = 0.0349); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1651); Gain of catalytic residue at Q637 (P = 0.2208); Gain of phosphorylation at S641 (P = 0.2319)
7:117232132:G:C,P13569,Q637H,0.337,Loss of helix (P = 0.0626); Loss of disorder (P = 0.1475); Gain of catalytic residue at L636 (P = 0.1685); Loss of phosphorylation at S641 (P = 0.1988); Gain of loop (P = 0.2045)
7:117232132:G:T,P13569,Q637H,0.337,Loss of helix (P = 0.0626); Loss of disorder (P = 0.1475); Gain of catalytic residue at L636 (P = 0.1685); Loss of phosphorylation at S641 (P = 0.1988); Gain of loop (P = 0.2045)
7:117232133:C:A,P13569,P638T,0.324,Loss of helix (P = 0.079); Loss of ubiquitination at K643 (P = 0.1087); Gain of phosphorylation at P638 (P = 0.1365); Loss of disorder (P = 0.137); Loss of stability (P = 0.1585)
7:117232133:C:G,P13569,P638A,0.329,Loss of helix (P = 0.079); Loss of disorder (P = 0.0829); Loss of ubiquitination at K643 (P = 0.092); Gain of loop (P = 0.2045); Loss of phosphorylation at S641 (P = 0.2145)
7:117232133:C:T,P13569,P638S,0.293,Gain of disorder (P = 0.0551); Loss of ubiquitination at K643 (P = 0.1087); Gain of helix (P = 0.1736); Gain of phosphorylation at S641 (P = 0.1839); Loss of catalytic residue at P638 (P = 0.2182)
7:117232134:C:A,P13569,P638Q,0.315,Loss of ubiquitination at K643 (P = 0.1296); Gain of disorder (P = 0.1537); Gain of helix (P = 0.1736); Loss of phosphorylation at S641 (P = 0.1748); Loss of catalytic residue at P638 (P = 0.205)
7:117232134:C:G,P13569,P638R,0.325,Loss of helix (P = 0.079); Gain of phosphorylation at S641 (P = 0.0828); Loss of ubiquitination at K643 (P = 0.1087); Gain of solvent accessibility (P = 0.1708); Loss of disorder (P = 0.1991)
7:117232134:C:T,P13569,P638L,0.311,Loss of disorder (P = 0.0427); Loss of ubiquitination at K643 (P = 0.1087); Gain of helix (P = 0.1736); Loss of phosphorylation at S641 (P = 0.2095); Loss of loop (P = 0.2897)
7:117232136:G:A,P13569,D639N,0.534,Gain of catalytic residue at D639 (P = 0.0362); Loss of ubiquitination at K643 (P = 0.1087); Loss of phosphorylation at S641 (P = 0.1336); Loss of disorder (P = 0.1697); Gain of helix (P = 0.2059)
7:117232136:G:C,P13569,D639H,0.538,Loss of ubiquitination at K643 (P = 0.1087); Loss of disorder (P = 0.128); Loss of phosphorylation at S641 (P = 0.1637); Loss of stability (P = 0.2187); Loss of helix (P = 0.3949)
7:117232136:G:T,P13569,D639Y,0.824,Loss of disorder (P = 0.0217); Loss of ubiquitination at K643 (P = 0.0705); Loss of phosphorylation at S641 (P = 0.1693); Loss of helix (P = 0.1706); Gain of catalytic residue at S641 (P = 0.3366)
7:117232137:A:C,P13569,D639A,0.55,Gain of catalytic residue at D639 (P = 0.0204); Loss of disorder (P = 0.0667); Loss of ubiquitination at K643 (P = 0.1087); Loss of helix (P = 0.1706); Loss of phosphorylation at S641 (P = 0.1878)
7:117232137:A:G,P13569,D639G,0.536,Gain of catalytic residue at D639 (P = 0.0243); Loss of stability (P = 0.0474); Gain of ubiquitination at K643 (P = 0.1504); Loss of solvent accessibility (P = 0.1868); Loss of disorder (P = 0.1926)
7:117232137:A:T,P13569,D639V,0.666,Loss of disorder (P = 0.0151); Loss of ubiquitination at K643 (P = 0.1296); Loss of phosphorylation at S641 (P = 0.1457); Gain of catalytic residue at D639 (P = 0.1593); Loss of helix (P = 0.1706)
7:117232138:C:A,P13569,D639E,0.502,Gain of disorder (P = 0.1219); Loss of ubiquitination at K643 (P = 0.1576); Loss of helix (P = 0.1706); Gain of phosphorylation at S641 (P = 0.1907); Gain of loop (P = 0.2045)
7:117232138:C:G,P13569,D639E,0.502,Gain of disorder (P = 0.1219); Loss of ubiquitination at K643 (P = 0.1576); Loss of helix (P = 0.1706); Gain of phosphorylation at S641 (P = 0.1907); Gain of loop (P = 0.2045)
7:117232139:T:A,P13569,F640I,0.579,Loss of catalytic residue at F640 (P = 0.0498); Loss of ubiquitination at K643 (P = 0.0705); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1792); Gain of loop (P = 0.2045)
7:117232139:T:C,P13569,F640L,0.59,Loss of catalytic residue at F640 (P = 0.0293); Gain of disorder (P = 0.1109); Gain of ubiquitination at K643 (P = 0.1222); Loss of helix (P = 0.1299); Gain of phosphorylation at S641 (P = 0.1437)
7:117232139:T:G,P13569,F640V,0.589,Loss of catalytic residue at F640 (P = 0.0922); Loss of ubiquitination at K643 (P = 0.1296); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1967); Gain of phosphorylation at S641 (P = 0.2023)
7:117232140:T:A,P13569,F640Y,0.59,Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Gain of phosphorylation at F640 (P = 0.118); Gain of ubiquitination at K643 (P = 0.1504); Gain of disorder (P = 0.1722)
7:117232140:T:C,P13569,F640S,0.65,Gain of disorder (P = 0.0052); Loss of catalytic residue at F640 (P = 0.0084); Gain of loop (P = 0.0435); Gain of phosphorylation at F640 (P = 0.0528); Loss of helix (P = 0.0558)
7:117232140:T:G,P13569,F640C,0.599,Loss of catalytic residue at F640 (P = 0.0174); Loss of helix (P = 0.1299); Gain of ubiquitination at K643 (P = 0.1504); Loss of phosphorylation at S641 (P = 0.1908); Loss of disorder (P = 0.2202)
7:117232141:T:A,P13569,F640L,0.59,Loss of catalytic residue at F640 (P = 0.0293); Gain of disorder (P = 0.1109); Gain of ubiquitination at K643 (P = 0.1222); Loss of helix (P = 0.1299); Gain of phosphorylation at S641 (P = 0.1437)
7:117232141:T:G,P13569,F640L,0.59,Loss of catalytic residue at F640 (P = 0.0293); Gain of disorder (P = 0.1109); Gain of ubiquitination at K643 (P = 0.1222); Loss of helix (P = 0.1299); Gain of phosphorylation at S641 (P = 0.1437)
7:117232142:A:C,P13569,S641R,0.61,Loss of phosphorylation at S641 (P = 0.0641); Loss of disorder (P = 0.0801); Loss of ubiquitination at K643 (P = 0.092); Gain of catalytic residue at S641 (P = 0.1196); Gain of methylation at S641 (P = 0.1681)
7:117232142:A:G,P13569,S641G,0.517,Loss of ubiquitination at K643 (P = 0.0524); Loss of phosphorylation at S641 (P = 0.0641); Loss of disorder (P = 0.0932); Loss of stability (P = 0.0975); Loss of helix (P = 0.1299)
7:117232142:A:T,P13569,S641C,0.558,Loss of disorder (P = 0.0071); Loss of ubiquitination at K643 (P = 0.0502); Loss of phosphorylation at S641 (P = 0.0641); Gain of helix (P = 0.0854); Loss of loop (P = 0.2897)
7:117232143:G:A,P13569,S641N,0.496,Loss of phosphorylation at S641 (P = 0.0641); Loss of disorder (P = 0.0849); Loss of ubiquitination at K643 (P = 0.092); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117232143:G:C,P13569,S641T,0.529,Loss of disorder (P = 0.0591); Loss of ubiquitination at K643 (P = 0.092); Gain of helix (P = 0.1736); Loss of phosphorylation at S641 (P = 0.1817); Loss of stability (P = 0.4401)
7:117232143:G:T,P13569,S641I,0.558,Loss of disorder (P = 0.0052); Loss of ubiquitination at K643 (P = 0.0615); Loss of phosphorylation at S641 (P = 0.0641); Gain of helix (P = 0.1736); Loss of loop (P = 0.4412)
7:117232144:C:A,P13569,S641R,0.61,Loss of phosphorylation at S641 (P = 0.0641); Loss of disorder (P = 0.0801); Loss of ubiquitination at K643 (P = 0.092); Gain of catalytic residue at S641 (P = 0.1196); Gain of methylation at S641 (P = 0.1681)
7:117232144:C:G,P13569,S641R,0.61,Loss of phosphorylation at S641 (P = 0.0641); Loss of disorder (P = 0.0801); Loss of ubiquitination at K643 (P = 0.092); Gain of catalytic residue at S641 (P = 0.1196); Gain of methylation at S641 (P = 0.1681)
7:117232145:T:A,P13569,S642T,0.563,Loss of disorder (P = 0.0572); Loss of ubiquitination at K643 (P = 0.0705); Loss of helix (P = 0.1299); Loss of phosphorylation at S641 (P = 0.1626); Gain of loop (P = 0.2045)
7:117232145:T:C,P13569,S642P,0.559,Gain of catalytic residue at S642 (P = 0.071); Loss of ubiquitination at K643 (P = 0.1087); Loss of stability (P = 0.1277); Loss of phosphorylation at S642 (P = 0.1379); Loss of disorder (P = 0.1457)
7:117232145:T:G,P13569,S642A,0.54,Gain of catalytic residue at S642 (P = 0.0211); Loss of disorder (P = 0.0373); Loss of ubiquitination at K643 (P = 0.0615); Loss of phosphorylation at S642 (P = 0.1379); Gain of helix (P = 0.1736)
7:117232146:C:T,P13569,S642L,0.541,Loss of disorder (P = 0.0155); Loss of helix (P = 0.0558); Loss of ubiquitination at K643 (P = 0.0795); Loss of loop (P = 0.0804); Loss of phosphorylation at S642 (P = 0.1379)
7:117232148:A:C,P13569,K643Q,0.456,Loss of ubiquitination at K643 (P = 0.011); Gain of disorder (P = 0.1258); Loss of helix (P = 0.1299); Loss of catalytic residue at K643 (P = 0.1722); Loss of phosphorylation at S641 (P = 0.184)
7:117232148:A:G,P13569,K643E,0.471,Loss of ubiquitination at K643 (P = 0.011); Gain of disorder (P = 0.0996); Gain of phosphorylation at S642 (P = 0.1156); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117232149:A:C,P13569,K643T,0.497,Loss of ubiquitination at K643 (P = 0.011); Loss of helix (P = 0.0558); Gain of loop (P = 0.0851); Loss of disorder (P = 0.0947); Gain of sheet (P = 0.1451)
7:117232149:A:G,P13569,K643R,0.437,Loss of ubiquitination at K643 (P = 0.011); Gain of phosphorylation at S642 (P = 0.1); Loss of disorder (P = 0.146); Loss of helix (P = 0.2022); Loss of loop (P = 0.2237)
7:117232149:A:T,P13569,K643I,0.489,Loss of disorder (P = 0.0095); Loss of ubiquitination at K643 (P = 0.011); Loss of catalytic residue at K643 (P = 0.0935); Loss of solvent accessibility (P = 0.1551); Gain of helix (P = 0.1736)
7:117232150:A:C,P13569,K643N,0.482,Loss of ubiquitination at K643 (P = 0.011); Loss of helix (P = 0.0558); Loss of phosphorylation at S641 (P = 0.1594); Loss of disorder (P = 0.1612); Gain of loop (P = 0.2045)
7:117232150:A:T,P13569,K643N,0.482,Loss of ubiquitination at K643 (P = 0.011); Loss of helix (P = 0.0558); Loss of phosphorylation at S641 (P = 0.1594); Loss of disorder (P = 0.1612); Gain of loop (P = 0.2045)
7:117232151:C:A,P13569,L644I,0.353,Gain of catalytic residue at L644 (P = 0.0213); Loss of ubiquitination at K643 (P = 0.0615); Loss of disorder (P = 0.1277); Gain of helix (P = 0.2059); Loss of phosphorylation at S641 (P = 0.2602)
7:117232151:C:G,P13569,L644V,0.317,Loss of ubiquitination at K643 (P = 0.1087); Loss of disorder (P = 0.1505); Gain of helix (P = 0.2059); Loss of stability (P = 0.2142); Gain of catalytic residue at L644 (P = 0.2189)
7:117232151:C:T,P13569,L644F,0.298,Loss of ubiquitination at K643 (P = 0.1296); Gain of phosphorylation at S649 (P = 0.1994); Gain of catalytic residue at L644 (P = 0.1994); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2207)
7:117232152:T:A,P13569,L644H,0.681,Gain of catalytic residue at L644 (P = 0.0174); Gain of disorder (P = 0.0226); Loss of stability (P = 0.0254); Loss of helix (P = 0.0626); Gain of ubiquitination at K643 (P = 0.0707)
7:117232152:T:C,P13569,L644P,0.795,Gain of disorder (P = 0.0081); Loss of stability (P = 0.0132); Gain of ubiquitination at K643 (P = 0.0556); Gain of phosphorylation at S641 (P = 0.1169); Loss of helix (P = 0.1299)
7:117232152:T:G,P13569,L644R,0.753,Gain of disorder (P = 0.0169); Gain of solvent accessibility (P = 0.0584); Loss of stability (P = 0.0595); Gain of catalytic residue at L644 (P = 0.0722); Gain of ubiquitination at K643 (P = 0.0805)
7:117232154:A:C,P13569,M645L,0.364,Loss of helix (P = 0.079); Loss of catalytic residue at M645 (P = 0.0902); Loss of ubiquitination at K643 (P = 0.1576); Loss of disorder (P = 0.1741); Gain of loop (P = 0.2045)
7:117232154:A:G,P13569,M645V,0.394,Loss of catalytic residue at M645 (P = 0.0488); Loss of ubiquitination at K643 (P = 0.0705); Loss of disorder (P = 0.0868); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117232154:A:T,P13569,M645L,0.364,Loss of helix (P = 0.079); Loss of catalytic residue at M645 (P = 0.0902); Loss of ubiquitination at K643 (P = 0.1576); Loss of disorder (P = 0.1741); Gain of loop (P = 0.2045)
7:117232155:T:A,P13569,M645K,0.59,Gain of ubiquitination at M645 (P = 0.0109); Gain of disorder (P = 0.0126); Loss of stability (P = 0.0184); Gain of relative solvent accessibility (P = 0.0905); Gain of solvent accessibility (P = 0.0971)
7:117232155:T:G,P13569,M645R,0.542,Gain of disorder (P = 0.0378); Loss of stability (P = 0.0851); Gain of methylation at M645 (P = 0.1046); Loss of catalytic residue at M645 (P = 0.109); Gain of phosphorylation at S642 (P = 0.1171)
7:117232156:G:A,P13569,M645I,0.363,Loss of ubiquitination at K643 (P = 0.0705); Loss of disorder (P = 0.0769); Loss of helix (P = 0.1706); Gain of catalytic residue at D648 (P = 0.1815); Loss of phosphorylation at S649 (P = 0.2132)
7:117232156:G:C,P13569,M645I,0.363,Loss of ubiquitination at K643 (P = 0.0705); Loss of disorder (P = 0.0769); Loss of helix (P = 0.1706); Gain of catalytic residue at D648 (P = 0.1815); Loss of phosphorylation at S649 (P = 0.2132)
7:117232156:G:T,P13569,M645I,0.363,Loss of ubiquitination at K643 (P = 0.0705); Loss of disorder (P = 0.0769); Loss of helix (P = 0.1706); Gain of catalytic residue at D648 (P = 0.1815); Loss of phosphorylation at S649 (P = 0.2132)
7:117232157:G:A,P13569,G646R,0.33,Gain of solvent accessibility (P = 0.0306); Gain of phosphorylation at S649 (P = 0.0725); Gain of disorder (P = 0.1045); Gain of catalytic residue at G646 (P = 0.1068); Loss of ubiquitination at K643 (P = 0.1296)
7:117232157:G:C,P13569,G646R,0.33,Gain of solvent accessibility (P = 0.0306); Gain of phosphorylation at S649 (P = 0.0725); Gain of disorder (P = 0.1045); Gain of catalytic residue at G646 (P = 0.1068); Loss of ubiquitination at K643 (P = 0.1296)
7:117232158:G:A,P13569,G646E,0.342,Gain of disorder (P = 0.0522); Loss of helix (P = 0.0626); Gain of loop (P = 0.0851); Gain of phosphorylation at S649 (P = 0.1325); Loss of ubiquitination at K643 (P = 0.1576)
7:117232158:G:C,P13569,G646A,0.35,Loss of helix (P = 0.028); Gain of catalytic residue at G646 (P = 0.0455); Gain of loop (P = 0.0851); Loss of ubiquitination at K643 (P = 0.092); Loss of disorder (P = 0.1309)
7:117232158:G:T,P13569,G646V,0.471,Loss of disorder (P = 0.0375); Loss of helix (P = 0.079); Loss of relative solvent accessibility (P = 0.0793); Loss of ubiquitination at K643 (P = 0.0795); Gain of loop (P = 0.0851)
7:117232160:T:A,P13569,C647S,0.534,Gain of disorder (P = 5e-04); Gain of phosphorylation at C647 (P = 0.0313); Loss of stability (P = 0.0567); Gain of ubiquitination at K643 (P = 0.0571); Loss of catalytic residue at S649 (P = 0.0688)
7:117232160:T:C,P13569,C647R,0.566,Gain of disorder (P = 0.0054); Gain of phosphorylation at S649 (P = 0.0615); Loss of catalytic residue at S649 (P = 0.0696); Gain of ubiquitination at K643 (P = 0.0805); Gain of solvent accessibility (P = 0.0971)
7:117232160:T:G,P13569,C647G,0.626,Gain of disorder (P = 0.0043); Loss of stability (P = 0.0187); Gain of ubiquitination at K643 (P = 0.0707); Gain of phosphorylation at S649 (P = 0.1123); Loss of catalytic residue at M645 (P = 0.1246)
7:117232161:G:A,P13569,C647Y,0.39,Loss of catalytic residue at S649 (P = 0.0781); Loss of stability (P = 0.1119); Gain of disorder (P = 0.1161); Loss of helix (P = 0.1299); Gain of ubiquitination at K643 (P = 0.1679)
7:117232161:G:C,P13569,C647S,0.534,Gain of disorder (P = 5e-04); Gain of phosphorylation at C647 (P = 0.0313); Loss of stability (P = 0.0567); Gain of ubiquitination at K643 (P = 0.0571); Loss of catalytic residue at S649 (P = 0.0688)
7:117232161:G:T,P13569,C647F,0.385,Loss of catalytic residue at M645 (P = 0.0836); Gain of disorder (P = 0.1025); Loss of ubiquitination at K643 (P = 0.1087); Gain of phosphorylation at S649 (P = 0.1427); Loss of helix (P = 0.2022)
7:117232162:T:G,P13569,C647W,0.455,Loss of ubiquitination at K643 (P = 0.0566); Loss of catalytic residue at S649 (P = 0.0763); Loss of stability (P = 0.0959); Loss of disorder (P = 0.1188); Gain of loop (P = 0.2045)
7:117232163:G:A,P13569,D648N,0.367,Loss of ubiquitination at K643 (P = 0.1087); Loss of helix (P = 0.1299); Loss of phosphorylation at S649 (P = 0.1513); Loss of disorder (P = 0.1573); Loss of solvent accessibility (P = 0.4274)
7:117232163:G:C,P13569,D648H,0.499,Loss of ubiquitination at K643 (P = 0.0705); Loss of disorder (P = 0.1146); Loss of solvent accessibility (P = 0.1473); Loss of phosphorylation at S649 (P = 0.1545); Loss of relative solvent accessibility (P = 0.1807)
7:117232163:G:T,P13569,D648Y,0.604,Loss of disorder (P = 0.0272); Loss of ubiquitination at K643 (P = 0.1087); Loss of phosphorylation at S649 (P = 0.1559); Loss of relative solvent accessibility (P = 0.1807); Loss of helix (P = 0.2022)
7:117232164:A:C,P13569,D648A,0.515,Loss of solvent accessibility (P = 0.0595); Loss of ubiquitination at K643 (P = 0.0705); Loss of disorder (P = 0.0766); Gain of catalytic residue at D648 (P = 0.109); Loss of relative solvent accessibility (P = 0.1807)
7:117232164:A:G,P13569,D648G,0.455,Loss of helix (P = 0.0626); Loss of solvent accessibility (P = 0.0674); Loss of stability (P = 0.1481); Gain of ubiquitination at K643 (P = 0.1504); Gain of catalytic residue at D651 (P = 0.1631)
7:117232164:A:T,P13569,D648V,0.825,Loss of disorder (P = 0.0244); Loss of solvent accessibility (P = 0.0371); Loss of relative solvent accessibility (P = 0.0676); Loss of ubiquitination at K643 (P = 0.0795); Gain of catalytic residue at D648 (P = 0.0983)
7:117232165:T:A,P13569,D648E,0.294,Loss of ubiquitination at K643 (P = 0.1296); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1398); Gain of phosphorylation at S649 (P = 0.2143); Gain of solvent accessibility (P = 0.3089)
7:117232165:T:G,P13569,D648E,0.294,Loss of ubiquitination at K643 (P = 0.1296); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1398); Gain of phosphorylation at S649 (P = 0.2143); Gain of solvent accessibility (P = 0.3089)
7:117232166:T:A,P13569,S649T,0.291,Loss of disorder (P = 0.066); Loss of loop (P = 0.0986); Gain of helix (P = 0.132); Loss of phosphorylation at S649 (P = 0.2655); Loss of catalytic residue at S649 (P = 0.6409)
7:117232166:T:C,P13569,S649P,0.401,Loss of phosphorylation at S649 (P = 0.0612); Loss of loop (P = 0.0986); Loss of catalytic residue at S649 (P = 0.1015); Loss of disorder (P = 0.1236); Gain of helix (P = 0.132)
7:117232166:T:G,P13569,S649A,0.367,Loss of disorder (P = 0.0492); Loss of phosphorylation at S649 (P = 0.0612); Loss of loop (P = 0.3664); Gain of catalytic residue at S649 (P = 0.3894); Loss of helix (P = 0.3949)
7:117232167:C:A,P13569,S649Y,0.456,Loss of disorder (P = 0.012); Gain of catalytic residue at L644 (P = 0.0761); Gain of phosphorylation at S649 (P = 0.1459); Loss of loop (P = 0.2237); Loss of helix (P = 0.3949)
7:117232167:C:G,P13569,S649C,0.436,Loss of disorder (P = 0.0149); Loss of phosphorylation at S649 (P = 0.0612); Gain of helix (P = 0.132); Loss of catalytic residue at S649 (P = 0.1985); Loss of loop (P = 0.2237)
7:117232167:C:T,P13569,S649F,0.476,Loss of disorder (P = 0.0163); Loss of phosphorylation at S649 (P = 0.0612); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of relative solvent accessibility (P = 0.3219)
7:117232169:T:A,P13569,F650I,0.328,Loss of stability (P = 0.1498); Loss of disorder (P = 0.1665); Gain of helix (P = 0.1736); Gain of phosphorylation at S649 (P = 0.2038); Gain of loop (P = 0.2045)
7:117232169:T:C,P13569,F650L,0.332,Gain of disorder (P = 0.1572); Loss of stability (P = 0.1605); Gain of helix (P = 0.1736); Gain of phosphorylation at S649 (P = 0.2205); Loss of loop (P = 0.2237)
7:117232169:T:G,P13569,F650V,0.348,Loss of stability (P = 0.0819); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1933); Gain of loop (P = 0.2045); Loss of phosphorylation at S649 (P = 0.2557)
7:117232170:T:A,P13569,F650Y,0.383,Gain of phosphorylation at F650 (P = 0.0399); Loss of stability (P = 0.0495); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2186); Loss of helix (P = 0.2662)
7:117232170:T:C,P13569,F650S,0.497,Gain of disorder (P = 0.0019); Loss of stability (P = 0.0137); Gain of relative solvent accessibility (P = 0.0507); Gain of phosphorylation at F650 (P = 0.0542); Gain of solvent accessibility (P = 0.1583)
7:117232170:T:G,P13569,F650C,0.387,Loss of stability (P = 0.0271); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2191); Loss of phosphorylation at S649 (P = 0.2193)
7:117232171:C:G,P13569,F650L,0.332,Gain of disorder (P = 0.1572); Loss of stability (P = 0.1605); Gain of helix (P = 0.1736); Gain of phosphorylation at S649 (P = 0.2205); Loss of loop (P = 0.2237)
7:117232172:G:C,P13569,D651H,0.806,Loss of disorder (P = 0.098); Loss of phosphorylation at S649 (P = 0.1559); Gain of catalytic residue at D651 (P = 0.2113); Loss of loop (P = 0.2237); Loss of stability (P = 0.2576)
7:117232172:G:T,P13569,D651Y,0.626,Loss of disorder (P = 0.0171); Gain of phosphorylation at D651 (P = 0.0709); Gain of helix (P = 0.132); Gain of catalytic residue at D651 (P = 0.1947); Loss of loop (P = 0.2237)
7:117232173:A:C,P13569,D651A,0.625,Loss of disorder (P = 0.0708); Gain of catalytic residue at D651 (P = 0.1536); Loss of phosphorylation at S649 (P = 0.1836); Loss of loop (P = 0.2237); Loss of stability (P = 0.2337)
7:117232173:A:G,P13569,D651G,0.489,Loss of stability (P = 0.0979); Loss of disorder (P = 0.1593); Loss of solvent accessibility (P = 0.2034); Loss of phosphorylation at S649 (P = 0.212); Loss of loop (P = 0.2237)
7:117232173:A:T,P13569,D651V,0.634,Loss of disorder (P = 0.0152); Loss of phosphorylation at S649 (P = 0.1464); Loss of solvent accessibility (P = 0.2073); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117232174:C:A,P13569,D651E,0.311,Gain of disorder (P = 0.1269); Loss of helix (P = 0.1706); Gain of phosphorylation at S649 (P = 0.194); Loss of catalytic residue at S649 (P = 0.2939); Gain of loop (P = 0.4248)
7:117232174:C:G,P13569,D651E,0.311,Gain of disorder (P = 0.1269); Loss of helix (P = 0.1706); Gain of phosphorylation at S649 (P = 0.194); Loss of catalytic residue at S649 (P = 0.2939); Gain of loop (P = 0.4248)
7:117232175:C:A,P13569,Q652K,0.414,Gain of ubiquitination at Q652 (P = 0.0066); Gain of methylation at Q652 (P = 0.0386); Loss of stability (P = 0.0707); Loss of loop (P = 0.0986); Gain of phosphorylation at S649 (P = 0.1168)
7:117232175:C:G,P13569,Q652E,0.234,Gain of disorder (P = 0.0727); Gain of phosphorylation at S649 (P = 0.0912); Gain of helix (P = 0.2684); Loss of catalytic residue at A655 (P = 0.3429); Loss of loop (P = 0.3664)
7:117232176:A:C,P13569,Q652P,0.321,Gain of phosphorylation at S649 (P = 0.121); Loss of stability (P = 0.1231); Gain of disorder (P = 0.1576); Gain of loop (P = 0.2045); Gain of catalytic residue at D648 (P = 0.3651)
7:117232176:A:G,P13569,Q652R,0.224,Gain of phosphorylation at S654 (P = 0.062); Gain of helix (P = 0.0854); Loss of loop (P = 0.0986); Gain of disorder (P = 0.1758); Gain of solvent accessibility (P = 0.3194)
7:117232176:A:T,P13569,Q652L,0.341,Loss of disorder (P = 0.0368); Loss of loop (P = 0.0986); Gain of phosphorylation at S649 (P = 0.2156); Gain of helix (P = 0.2684); Gain of catalytic residue at D651 (P = 0.3409)
7:117232177:A:C,P13569,Q652H,0.316,Gain of catalytic residue at Q652 (P = 0.1014); Loss of disorder (P = 0.1536); Loss of stability (P = 0.2072); Gain of phosphorylation at S649 (P = 0.2205); Gain of helix (P = 0.2684)
7:117232177:A:T,P13569,Q652H,0.316,Gain of catalytic residue at Q652 (P = 0.1014); Loss of disorder (P = 0.1536); Loss of stability (P = 0.2072); Gain of phosphorylation at S649 (P = 0.2205); Gain of helix (P = 0.2684)
7:117232178:T:A,P13569,F653I,0.29,Gain of helix (P = 0.0854); Loss of disorder (P = 0.1635); Loss of phosphorylation at S649 (P = 0.2097); Loss of loop (P = 0.2237); Loss of catalytic residue at A655 (P = 0.4217)
7:117232178:T:C,P13569,F653L,0.294,Gain of helix (P = 0.0854); Gain of disorder (P = 0.1703); Loss of loop (P = 0.2237); Gain of phosphorylation at S654 (P = 0.2507); Loss of catalytic residue at A655 (P = 0.293)
7:117232178:T:G,P13569,F653V,0.297,Loss of disorder (P = 0.1891); Loss of phosphorylation at S649 (P = 0.2097); Gain of helix (P = 0.2684); Gain of loop (P = 0.3485); Loss of catalytic residue at A655 (P = 0.3782)
7:117232179:T:A,P13569,F653Y,0.321,Gain of phosphorylation at F653 (P = 0.0351); Loss of disorder (P = 0.1499); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of stability (P = 0.5405)
7:117232179:T:C,P13569,F653S,0.518,Gain of disorder (P = 0.0054); Gain of phosphorylation at F653 (P = 0.0563); Loss of stability (P = 0.1726); Gain of loop (P = 0.3485); Loss of catalytic residue at A655 (P = 0.4319)
7:117232179:T:G,P13569,F653C,0.338,Gain of helix (P = 0.1736); Loss of phosphorylation at S649 (P = 0.2097); Gain of disorder (P = 0.2106); Loss of stability (P = 0.3218); Gain of loop (P = 0.3485)
7:117232180:T:A,P13569,F653L,0.294,Gain of helix (P = 0.0854); Gain of disorder (P = 0.1703); Loss of loop (P = 0.2237); Gain of phosphorylation at S654 (P = 0.2507); Loss of catalytic residue at A655 (P = 0.293)
7:117232180:T:G,P13569,F653L,0.294,Gain of helix (P = 0.0854); Gain of disorder (P = 0.1703); Loss of loop (P = 0.2237); Gain of phosphorylation at S654 (P = 0.2507); Loss of catalytic residue at A655 (P = 0.293)
7:117232181:A:C,P13569,S654R,0.247,Loss of disorder (P = 0.1054); Loss of phosphorylation at S654 (P = 0.142); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of solvent accessibility (P = 0.3304)
7:117232181:A:G,P13569,S654G,0.183,Loss of disorder (P = 0.076); Loss of phosphorylation at S654 (P = 0.142); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of catalytic residue at F650 (P = 0.3335)
7:117232181:A:T,P13569,S654C,0.363,Loss of disorder (P = 0.003); Loss of phosphorylation at S654 (P = 0.142); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of catalytic residue at E656 (P = 0.2823)
7:117232182:G:A,P13569,S654N,0.2,Loss of disorder (P = 0.0853); Loss of phosphorylation at S649 (P = 0.1358); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of sheet (P = 0.4423)
7:117232182:G:C,P13569,S654T,0.286,Loss of disorder (P = 0.056); Gain of loop (P = 0.0851); Gain of phosphorylation at S654 (P = 0.0946); Loss of helix (P = 0.1706); Gain of catalytic residue at S649 (P = 0.6124)
7:117232182:G:T,P13569,S654I,0.431,Loss of disorder (P = 0.0016); Gain of stability (P = 0.0553); Gain of helix (P = 0.0854); Loss of loop (P = 0.0986); Loss of phosphorylation at S649 (P = 0.1296)
7:117232183:T:A,P13569,S654R,0.247,Loss of disorder (P = 0.1054); Loss of phosphorylation at S654 (P = 0.142); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of solvent accessibility (P = 0.3304)
7:117232183:T:G,P13569,S654R,0.247,Loss of disorder (P = 0.1054); Loss of phosphorylation at S654 (P = 0.142); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of solvent accessibility (P = 0.3304)
7:117232184:G:A,P13569,A655T,0.205,Gain of phosphorylation at A655 (P = 0.0327); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0638); Gain of disorder (P = 0.0898); Loss of loop (P = 0.2237)
7:117232184:G:C,P13569,A655P,0.351,Gain of disorder (P = 0.0378); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0739); Gain of glycosylation at A655 (P = 0.1021); Loss of catalytic residue at A655 (P = 0.1123)
7:117232184:G:T,P13569,A655S,0.305,Gain of disorder (P = 0.0161); Gain of phosphorylation at A655 (P = 0.0335); Gain of relative solvent accessibility (P = 0.0479); Loss of catalytic residue at A655 (P = 0.0631); Gain of solvent accessibility (P = 0.0808)
7:117232185:C:A,P13569,A655E,0.343,Gain of disorder (P = 0.0255); Gain of solvent accessibility (P = 0.0488); Loss of catalytic residue at A655 (P = 0.0951); Gain of relative solvent accessibility (P = 0.0999); Gain of phosphorylation at S654 (P = 0.1077)
7:117232185:C:G,P13569,A655G,0.2,Gain of disorder (P = 0.0632); Gain of relative solvent accessibility (P = 0.0999); Loss of catalytic residue at A655 (P = 0.1202); Gain of phosphorylation at S654 (P = 0.2179); Loss of loop (P = 0.2237)
7:117232185:C:T,P13569,A655V,0.297,Loss of disorder (P = 0.0694); Gain of loop (P = 0.2045); Loss of catalytic residue at A655 (P = 0.2736); Gain of phosphorylation at S654 (P = 0.3851); Loss of helix (P = 0.3949)
7:117232187:G:A,P13569,E656K,0.388,Gain of ubiquitination at E656 (P = 0.006); Gain of catalytic residue at E656 (P = 0.0694); Loss of stability (P = 0.1427); Gain of helix (P = 0.1736); Gain of MoRF binding (P = 0.18)
7:117232187:G:C,P13569,E656Q,0.242,Loss of disorder (P = 0.183); Loss of solvent accessibility (P = 0.239); Gain of helix (P = 0.2684); Loss of phosphorylation at S654 (P = 0.2722); Loss of stability (P = 0.345)
7:117232188:A:C,P13569,E656A,0.338,Gain of catalytic residue at E656 (P = 0.0454); Loss of disorder (P = 0.0521); Loss of solvent accessibility (P = 0.086); Loss of phosphorylation at S654 (P = 0.3124); Loss of stability (P = 0.3465)
7:117232188:A:G,P13569,E656G,0.274,Loss of stability (P = 0.0543); Loss of solvent accessibility (P = 0.0635); Loss of disorder (P = 0.099); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117232188:A:T,P13569,E656V,0.394,Loss of disorder (P = 0.0055); Loss of solvent accessibility (P = 0.1322); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of phosphorylation at S654 (P = 0.2645)
7:117232189:A:C,P13569,E656D,0.227,Gain of helix (P = 0.1736); Loss of disorder (P = 0.218); Loss of loop (P = 0.2237); Loss of solvent accessibility (P = 0.322); Loss of phosphorylation at S654 (P = 0.3848)
7:117232189:A:T,P13569,E656D,0.227,Gain of helix (P = 0.1736); Loss of disorder (P = 0.218); Loss of loop (P = 0.2237); Loss of solvent accessibility (P = 0.322); Loss of phosphorylation at S654 (P = 0.3848)
7:117232190:A:G,P13569,R657G,0.424,Loss of stability (P = 0.0388); Loss of phosphorylation at S660 (P = 0.1232); Loss of disorder (P = 0.1512); Loss of solvent accessibility (P = 0.1744); Loss of catalytic residue at R657 (P = 0.1912)
7:117232191:G:A,P13569,R657K,0.341,Gain of ubiquitination at R657 (P = 0.0045); Loss of stability (P = 0.1353); Loss of phosphorylation at S660 (P = 0.1679); Gain of helix (P = 0.1736); Gain of disorder (P = 0.1803)
7:117232191:G:C,P13569,R657T,0.41,Gain of glycosylation at R657 (P = 0.0888); Gain of phosphorylation at R657 (P = 0.1045); Loss of disorder (P = 0.1654); Loss of solvent accessibility (P = 0.1813); Loss of catalytic residue at R657 (P = 0.1937)
7:117232191:G:T,P13569,R657I,0.434,Loss of disorder (P = 0.0185); Gain of catalytic residue at L662 (P = 0.023); Loss of loop (P = 0.0512); Loss of phosphorylation at S660 (P = 0.0679); Gain of helix (P = 0.0854)
7:117232192:A:C,P13569,R657S,0.395,Gain of phosphorylation at R657 (P = 0.0673); Gain of disorder (P = 0.0759); Loss of stability (P = 0.1769); Loss of solvent accessibility (P = 0.2517); Gain of helix (P = 0.2684)
7:117232192:A:T,P13569,R657S,0.395,Gain of phosphorylation at R657 (P = 0.0673); Gain of disorder (P = 0.0759); Loss of stability (P = 0.1769); Loss of solvent accessibility (P = 0.2517); Gain of helix (P = 0.2684)
7:117232193:A:G,P13569,R658G,0.423,Loss of stability (P = 0.0144); Loss of solvent accessibility (P = 0.0769); Loss of phosphorylation at S660 (P = 0.1242); Loss of disorder (P = 0.1477); Loss of helix (P = 0.1706)
7:117232194:G:A,P13569,R658K,0.43,Gain of ubiquitination at R658 (P = 0.0045); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at R658 (P = 0.0931); Loss of stability (P = 0.1455); Gain of solvent accessibility (P = 0.1583)
7:117232194:G:C,P13569,R658T,0.365,Gain of phosphorylation at R658 (P = 0.0909); Loss of solvent accessibility (P = 0.1473); Loss of disorder (P = 0.1683); Loss of stability (P = 0.1843); Loss of sheet (P = 0.1907)
7:117232194:G:T,P13569,R658I,0.447,Loss of disorder (P = 0.0204); Loss of solvent accessibility (P = 0.045); Loss of phosphorylation at S660 (P = 0.0831); Loss of loop (P = 0.1242); Loss of relative solvent accessibility (P = 0.1903)
7:117232195:A:C,P13569,R658S,0.357,Gain of phosphorylation at R658 (P = 0.053); Gain of disorder (P = 0.0905); Loss of catalytic residue at R658 (P = 0.1088); Loss of solvent accessibility (P = 0.1362); Loss of helix (P = 0.1706)
7:117232195:A:T,P13569,R658S,0.357,Gain of phosphorylation at R658 (P = 0.053); Gain of disorder (P = 0.0905); Loss of catalytic residue at R658 (P = 0.1088); Loss of solvent accessibility (P = 0.1362); Loss of helix (P = 0.1706)
7:117232196:A:C,P13569,N659H,0.192,Gain of disorder (P = 0.137); Loss of sheet (P = 0.1398); Loss of stability (P = 0.1589); Gain of loop (P = 0.2045); Gain of phosphorylation at T663 (P = 0.2523)
7:117232196:A:G,P13569,N659D,0.205,Gain of disorder (P = 0.0906); Gain of phosphorylation at S654 (P = 0.105); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of stability (P = 0.312)
7:117232196:A:T,P13569,N659Y,0.386,Loss of disorder (P = 0.0354); Loss of loop (P = 0.0986); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of phosphorylation at T663 (P = 0.2504)
7:117232197:A:C,P13569,N659T,0.195,Gain of phosphorylation at N659 (P = 0.0502); Gain of relative solvent accessibility (P = 0.09); Gain of disorder (P = 0.124); Loss of stability (P = 0.1272); Loss of helix (P = 0.1706)
7:117232197:A:G,P13569,N659S,0.241,Gain of phosphorylation at N659 (P = 0.0163); Gain of disorder (P = 0.0357); Loss of helix (P = 0.1706); Loss of stability (P = 0.1887); Loss of sheet (P = 0.1907)
7:117232197:A:T,P13569,N659I,0.365,Loss of disorder (P = 0.0404); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of phosphorylation at S654 (P = 0.35); Loss of sheet (P = 0.3635)
7:117232198:T:A,P13569,N659K,0.349,Gain of ubiquitination at N659 (P = 0.0085); Gain of disorder (P = 0.0756); Gain of solvent accessibility (P = 0.1319); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398)
7:117232198:T:G,P13569,N659K,0.349,Gain of ubiquitination at N659 (P = 0.0085); Gain of disorder (P = 0.0756); Gain of solvent accessibility (P = 0.1319); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398)
7:117232199:T:A,P13569,S660T,0.291,Loss of sheet (P = 0.0457); Loss of phosphorylation at S660 (P = 0.0562); Loss of disorder (P = 0.0808); Gain of helix (P = 0.0854); Loss of loop (P = 0.0986)
7:117232199:T:C,P13569,S660P,0.419,Loss of phosphorylation at S660 (P = 0.0124); Loss of sheet (P = 0.0457); Gain of loop (P = 0.069); Loss of disorder (P = 0.1236); Gain of helix (P = 0.1736)
7:117232199:T:G,P13569,S660A,0.33,Loss of phosphorylation at S660 (P = 0.0124); Loss of sheet (P = 0.0457); Loss of disorder (P = 0.0485); Gain of loop (P = 0.069); Loss of stability (P = 0.1309)
7:117232200:C:T,P13569,S660L,0.404,Loss of phosphorylation at S660 (P = 0.0124); Loss of disorder (P = 0.0237); Loss of sheet (P = 0.0457); Gain of helix (P = 0.062); Gain of loop (P = 0.069)
7:117232202:A:C,P13569,I661L,0.352,Loss of catalytic residue at I661 (P = 0.0287); Gain of disorder (P = 0.0401); Gain of loop (P = 0.0435); Loss of helix (P = 0.0444); Gain of relative solvent accessibility (P = 0.09)
7:117232202:A:G,P13569,I661V,0.303,Gain of sheet (P = 0.0477); Loss of catalytic residue at I661 (P = 0.0479); Loss of stability (P = 0.062); Loss of helix (P = 0.079); Gain of disorder (P = 0.0941)
7:117232202:A:T,P13569,I661F,0.311,Gain of disorder (P = 0.0466); Loss of stability (P = 0.0556); Gain of loop (P = 0.069); Loss of helix (P = 0.1706); Loss of catalytic residue at I661 (P = 0.2127)
7:117232203:T:A,P13569,I661N,0.456,Loss of stability (P = 0.0056); Gain of disorder (P = 0.0135); Gain of relative solvent accessibility (P = 0.0289); Gain of solvent accessibility (P = 0.0713); Loss of catalytic residue at I661 (P = 0.1014)
7:117232203:T:C,P13569,I661T,0.442,Loss of stability (P = 0.0031); Gain of relative solvent accessibility (P = 0.005); Gain of disorder (P = 0.012); Gain of solvent accessibility (P = 0.0149); Gain of phosphorylation at I661 (P = 0.0194)
7:117232203:T:G,P13569,I661S,0.45,Gain of disorder (P = 0.0039); Loss of stability (P = 0.0086); Gain of relative solvent accessibility (P = 0.0166); Gain of phosphorylation at I661 (P = 0.029); Loss of catalytic residue at I661 (P = 0.0553)
7:117232204:C:G,P13569,I661M,0.413,Loss of catalytic residue at I661 (P = 0.0219); Gain of disorder (P = 0.0223); Loss of helix (P = 0.0444); Loss of stability (P = 0.0639); Gain of relative solvent accessibility (P = 0.09)
7:117232205:C:A,P13569,L662I,0.194,Loss of disorder (P = 0.1267); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2751); Gain of phosphorylation at T665 (P = 0.2834)
7:117232205:C:G,P13569,L662V,0.263,Gain of loop (P = 0.069); Loss of stability (P = 0.1034); Gain of catalytic residue at L662 (P = 0.1168); Loss of disorder (P = 0.148); Loss of sheet (P = 0.1907)
7:117232206:T:A,P13569,L662Q,0.398,Gain of disorder (P = 0.0301); Loss of stability (P = 0.0349); Gain of solvent accessibility (P = 0.0789); Gain of relative solvent accessibility (P = 0.09); Gain of helix (P = 0.1736)
7:117232206:T:C,P13569,L662P,0.505,Loss of stability (P = 0.0154); Gain of disorder (P = 0.0252); Gain of glycosylation at T663 (P = 0.0348); Gain of phosphorylation at T665 (P = 0.0843); Gain of relative solvent accessibility (P = 0.09)
7:117232206:T:G,P13569,L662R,0.421,Gain of disorder (P = 0.0257); Loss of stability (P = 0.0315); Gain of solvent accessibility (P = 0.0365); Gain of phosphorylation at T665 (P = 0.0597); Gain of loop (P = 0.069)
7:117232208:A:C,P13569,T663P,0.304,Gain of catalytic residue at T663 (P = 0.0523); Gain of disorder (P = 0.0995); Gain of phosphorylation at T665 (P = 0.1689); Gain of sheet (P = 0.1945); Loss of stability (P = 0.2115)
7:117232208:A:G,P13569,T663A,0.237,Loss of disorder (P = 0.1368); Gain of sheet (P = 0.1945); Loss of phosphorylation at T663 (P = 0.2026); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117232208:A:T,P13569,T663S,0.228,Gain of disorder (P = 0.0486); Gain of phosphorylation at T663 (P = 0.0905); Gain of catalytic residue at T663 (P = 0.1428); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117232209:C:A,P13569,T663N,0.24,Gain of disorder (P = 0.1891); Gain of sheet (P = 0.1945); Loss of phosphorylation at T663 (P = 0.2026); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2629)
7:117232209:C:G,P13569,T663S,0.228,Gain of disorder (P = 0.0486); Gain of phosphorylation at T663 (P = 0.0905); Gain of catalytic residue at T663 (P = 0.1428); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117232209:C:T,P13569,T663I,0.426,Loss of disorder (P = 0.0321); Loss of loop (P = 0.0374); Gain of sheet (P = 0.0477); Loss of helix (P = 0.2022); Loss of phosphorylation at T663 (P = 0.2026)
7:117232211:G:A,P13569,E664K,0.42,Gain of ubiquitination at E664 (P = 0.0138); Gain of MoRF binding (P = 0.059); Gain of sheet (P = 0.1451); Loss of stability (P = 0.2073); Loss of loop (P = 0.2237)
7:117232211:G:C,P13569,E664Q,0.35,Loss of catalytic residue at E664 (P = 0.0297); Gain of sheet (P = 0.0477); Loss of disorder (P = 0.1594); Loss of helix (P = 0.2022); Loss of loop (P = 0.2237)
7:117232212:A:C,P13569,E664A,0.372,Loss of disorder (P = 0.0495); Loss of catalytic residue at E664 (P = 0.1897); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Loss of stability (P = 0.3235)
7:117232212:A:G,P13569,E664G,0.412,Loss of stability (P = 0.0464); Gain of sheet (P = 0.0477); Loss of catalytic residue at E664 (P = 0.0666); Loss of disorder (P = 0.0905); Loss of solvent accessibility (P = 0.1813)
7:117232212:A:T,P13569,E664V,0.546,Loss of disorder (P = 0.0102); Gain of sheet (P = 0.0477); Loss of catalytic residue at E664 (P = 0.0823); Loss of solvent accessibility (P = 0.1868); Loss of helix (P = 0.2022)
7:117232213:G:C,P13569,E664D,0.24,Loss of catalytic residue at E664 (P = 0.1311); Loss of disorder (P = 0.1742); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662); Loss of stability (P = 0.3141)
7:117232213:G:T,P13569,E664D,0.24,Loss of catalytic residue at E664 (P = 0.1311); Loss of disorder (P = 0.1742); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662); Loss of stability (P = 0.3141)
7:117232214:A:C,P13569,T665P,0.451,Gain of loop (P = 0.0851); Gain of disorder (P = 0.0949); Loss of sheet (P = 0.1398); Gain of phosphorylation at S670 (P = 0.1527); Gain of helix (P = 0.2684)
7:117232214:A:G,P13569,T665A,0.36,Loss of disorder (P = 0.1342); Loss of sheet (P = 0.1907); Gain of phosphorylation at S670 (P = 0.1921); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897)
7:117232214:A:T,P13569,T665S,0.712,Gain of disorder (P = 0.0452); Gain of phosphorylation at T665 (P = 0.0574); Gain of loop (P = 0.0851); Loss of sheet (P = 0.1398); Gain of glycosylation at T663 (P = 0.3777)
7:117232215:C:A,P13569,T665N,0.262,Gain of relative solvent accessibility (P = 0.09); Gain of sheet (P = 0.1208); Gain of solvent accessibility (P = 0.1376); Gain of catalytic residue at T665 (P = 0.1651); Gain of disorder (P = 0.1903)
7:117232215:C:G,P13569,T665S,0.712,Gain of disorder (P = 0.0452); Gain of phosphorylation at T665 (P = 0.0574); Gain of loop (P = 0.0851); Loss of sheet (P = 0.1398); Gain of glycosylation at T663 (P = 0.3777)
7:117232215:C:T,P13569,T665I,0.42,Loss of disorder (P = 0.0332); Gain of catalytic residue at T665 (P = 0.1629); Loss of sheet (P = 0.1907); Gain of phosphorylation at S670 (P = 0.2546); Gain of helix (P = 0.2684)
7:117232217:T:A,P13569,L666I,0.365,Loss of catalytic residue at L666 (P = 0.0024); Loss of disorder (P = 0.1248); Loss of phosphorylation at S670 (P = 0.1964); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363)
7:117232217:T:G,P13569,L666V,0.391,Loss of catalytic residue at L666 (P = 0.0024); Loss of disorder (P = 0.1456); Loss of stability (P = 0.1894); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045)
7:117232218:T:C,P13569,L666S,0.449,Gain of disorder (P = 0.0113); Loss of stability (P = 0.0154); Gain of phosphorylation at L666 (P = 0.043); Gain of helix (P = 0.0496); Gain of glycosylation at L666 (P = 0.0735)
7:117232219:A:C,P13569,L666F,0.288,Loss of stability (P = 0.1522); Loss of loop (P = 0.2237); Gain of disorder (P = 0.2346); Gain of relative solvent accessibility (P = 0.2363); Loss of phosphorylation at S670 (P = 0.242)
7:117232219:A:T,P13569,L666F,0.288,Loss of stability (P = 0.1522); Loss of loop (P = 0.2237); Gain of disorder (P = 0.2346); Gain of relative solvent accessibility (P = 0.2363); Loss of phosphorylation at S670 (P = 0.242)
7:117232220:C:A,P13569,H667N,0.202,Gain of disorder (P = 0.0733); Gain of relative solvent accessibility (P = 0.1571); Loss of catalytic residue at E664 (P = 0.192); Loss of phosphorylation at S670 (P = 0.2072); Loss of loop (P = 0.2237)
7:117232220:C:G,P13569,H667D,0.297,Gain of disorder (P = 0.0391); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S670 (P = 0.1289); Gain of solvent accessibility (P = 0.1456); Loss of catalytic residue at E664 (P = 0.1779)
7:117232220:C:T,P13569,H667Y,0.377,Gain of phosphorylation at H667 (P = 0.04); Loss of disorder (P = 0.0499); Gain of catalytic residue at L662 (P = 0.0589); Loss of loop (P = 0.0804); Gain of sheet (P = 0.1945)
7:117232221:A:C,P13569,H667P,0.371,Gain of disorder (P = 0.0335); Gain of loop (P = 0.0851); Gain of phosphorylation at S670 (P = 0.13); Gain of glycosylation at H667 (P = 0.1707); Gain of catalytic residue at H667 (P = 0.2325)
7:117232221:A:G,P13569,H667R,0.281,Gain of disorder (P = 0.0359); Gain of solvent accessibility (P = 0.039); Gain of phosphorylation at S670 (P = 0.0802); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at E664 (P = 0.1044)
7:117232221:A:T,P13569,H667L,0.275,Loss of disorder (P = 0.1616); Gain of sheet (P = 0.1945); Gain of phosphorylation at S670 (P = 0.2029); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662)
7:117232222:C:A,P13569,H667Q,0.264,Gain of disorder (P = 0.0411); Loss of catalytic residue at E664 (P = 0.1201); Gain of relative solvent accessibility (P = 0.1571); Gain of solvent accessibility (P = 0.194); Gain of loop (P = 0.2045)
7:117232222:C:G,P13569,H667Q,0.264,Gain of disorder (P = 0.0411); Loss of catalytic residue at E664 (P = 0.1201); Gain of relative solvent accessibility (P = 0.1571); Gain of solvent accessibility (P = 0.194); Gain of loop (P = 0.2045)
7:117232223:C:A,P13569,R668S,0.374,Gain of disorder (P = 0.086); Gain of glycosylation at S670 (P = 0.095); Loss of loop (P = 0.0986); Loss of phosphorylation at S670 (P = 0.1112); Gain of sheet (P = 0.1451)
7:117232223:C:G,P13569,R668G,0.414,Loss of phosphorylation at S670 (P = 0.0862); Gain of glycosylation at S670 (P = 0.091); Gain of catalytic residue at R668 (P = 0.0974); Gain of sheet (P = 0.1451); Loss of disorder (P = 0.1475)
7:117232224:G:C,P13569,R668P,0.468,Gain of glycosylation at S670 (P = 0.0441); Loss of phosphorylation at S670 (P = 0.101); Gain of sheet (P = 0.1451); Gain of disorder (P = 0.1847); Gain of catalytic residue at F669 (P = 0.3286)
7:117232224:G:T,P13569,R668L,0.384,Loss of disorder (P = 0.0521); Loss of phosphorylation at S670 (P = 0.0662); Loss of loop (P = 0.0986); Loss of solvent accessibility (P = 0.1077); Gain of glycosylation at S670 (P = 0.12)
7:117232226:T:A,P13569,F669I,0.278,Loss of catalytic residue at F669 (P = 0.0952); Loss of loop (P = 0.0986); Loss of disorder (P = 0.1599); Gain of phosphorylation at S670 (P = 0.1993); Gain of helix (P = 0.2684)
7:117232226:T:C,P13569,F669L,0.266,Loss of loop (P = 0.0986); Gain of phosphorylation at S670 (P = 0.1404); Gain of disorder (P = 0.1552); Loss of stability (P = 0.2555); Gain of helix (P = 0.2684)
7:117232226:T:G,P13569,F669V,0.288,Loss of loop (P = 0.0804); Loss of catalytic residue at F669 (P = 0.0931); Loss of stability (P = 0.1272); Gain of phosphorylation at S670 (P = 0.166); Loss of disorder (P = 0.1964)
7:117232227:T:A,P13569,F669Y,0.317,Loss of stability (P = 0.0946); Loss of disorder (P = 0.098); Loss of loop (P = 0.0986); Gain of phosphorylation at F669 (P = 0.1355); Gain of sheet (P = 0.1945)
7:117232227:T:C,P13569,F669S,0.4,Gain of disorder (P = 0.0109); Loss of stability (P = 0.0194); Gain of phosphorylation at F669 (P = 0.0336); Gain of loop (P = 0.0851); Loss of catalytic residue at F669 (P = 0.1013)
7:117232227:T:G,P13569,F669C,0.413,Loss of stability (P = 0.0445); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of catalytic residue at F669 (P = 0.1194); Loss of phosphorylation at S670 (P = 0.1673)
7:117232228:C:A,P13569,F669L,0.266,Loss of loop (P = 0.0986); Gain of phosphorylation at S670 (P = 0.1404); Gain of disorder (P = 0.1552); Loss of stability (P = 0.2555); Gain of helix (P = 0.2684)
7:117232228:C:G,P13569,F669L,0.266,Loss of loop (P = 0.0986); Gain of phosphorylation at S670 (P = 0.1404); Gain of disorder (P = 0.1552); Loss of stability (P = 0.2555); Gain of helix (P = 0.2684)
7:117232229:T:A,P13569,S670T,0.246,Loss of disorder (P = 0.0967); Gain of phosphorylation at S670 (P = 0.1442); Gain of catalytic residue at S670 (P = 0.1539); Loss of glycosylation at S670 (P = 0.1603); Loss of sheet (P = 0.1907)
7:117232229:T:C,P13569,S670P,0.292,Loss of phosphorylation at S670 (P = 0.0413); Loss of stability (P = 0.1468); Loss of disorder (P = 0.1601); Loss of sheet (P = 0.1907); Loss of glycosylation at S670 (P = 0.1994)
7:117232229:T:G,P13569,S670A,0.33,Loss of phosphorylation at S670 (P = 0.0413); Loss of disorder (P = 0.0499); Loss of glycosylation at S670 (P = 0.1055); Loss of relative solvent accessibility (P = 0.1807); Loss of sheet (P = 0.1907)
7:117232230:C:T,P13569,S670L,0.372,Loss of disorder (P = 0.0253); Loss of phosphorylation at S670 (P = 0.0413); Loss of glycosylation at S670 (P = 0.1055); Loss of sheet (P = 0.1398); Loss of relative solvent accessibility (P = 0.1807)
7:117232232:T:A,P13569,L671I,0.259,Loss of disorder (P = 0.1285); Gain of catalytic residue at D674 (P = 0.1557); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of phosphorylation at S670 (P = 0.2185)
7:117232232:T:G,P13569,L671V,0.302,Loss of stability (P = 0.1205); Loss of disorder (P = 0.1489); Loss of catalytic residue at L671 (P = 0.1865); Loss of phosphorylation at S670 (P = 0.2293); Gain of relative solvent accessibility (P = 0.2751)
7:117232233:T:C,P13569,L671S,0.452,Gain of disorder (P = 0.0169); Loss of stability (P = 0.0276); Gain of phosphorylation at L671 (P = 0.029); Gain of glycosylation at L671 (P = 0.0493); Loss of catalytic residue at L671 (P = 0.1159)
7:117232234:A:C,P13569,L671F,0.288,Loss of stability (P = 0.1853); Loss of sheet (P = 0.1907); Loss of phosphorylation at S670 (P = 0.2251); Gain of disorder (P = 0.2285); Gain of helix (P = 0.2684)
7:117232234:A:T,P13569,L671F,0.288,Loss of stability (P = 0.1853); Loss of sheet (P = 0.1907); Loss of phosphorylation at S670 (P = 0.2251); Gain of disorder (P = 0.2285); Gain of helix (P = 0.2684)
7:117232235:G:A,P13569,E672K,0.404,Gain of ubiquitination at E672 (P = 0.0109); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1551); Gain of relative solvent accessibility (P = 0.1684); Loss of phosphorylation at S670 (P = 0.1722)
7:117232235:G:C,P13569,E672Q,0.269,Loss of phosphorylation at S670 (P = 0.0932); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1598); Gain of catalytic residue at E672 (P = 0.237); Loss of glycosylation at S670 (P = 0.262)
7:117232236:A:C,P13569,E672A,0.396,Loss of disorder (P = 0.0531); Loss of solvent accessibility (P = 0.0576); Loss of phosphorylation at S670 (P = 0.131); Gain of sheet (P = 0.1451); Loss of relative solvent accessibility (P = 0.1903)
7:117232236:A:G,P13569,E672G,0.304,Loss of disorder (P = 0.1071); Loss of sheet (P = 0.1158); Loss of catalytic residue at E672 (P = 0.1274); Loss of phosphorylation at S670 (P = 0.1457); Loss of solvent accessibility (P = 0.1551)
7:117232236:A:T,P13569,E672V,0.458,Loss of disorder (P = 0.0124); Loss of phosphorylation at S670 (P = 0.1018); Loss of solvent accessibility (P = 0.1322); Gain of catalytic residue at D674 (P = 0.1361); Loss of loop (P = 0.2237)
7:117232237:A:C,P13569,E672D,0.226,Gain of sheet (P = 0.1451); Gain of relative solvent accessibility (P = 0.1684); Loss of disorder (P = 0.178); Loss of phosphorylation at S670 (P = 0.1944); Loss of loop (P = 0.2237)
7:117232237:A:T,P13569,E672D,0.226,Gain of sheet (P = 0.1451); Gain of relative solvent accessibility (P = 0.1684); Loss of disorder (P = 0.178); Loss of phosphorylation at S670 (P = 0.1944); Loss of loop (P = 0.2237)
7:117232238:G:A,P13569,G673R,0.24,Gain of solvent accessibility (P = 0.0456); Gain of disorder (P = 0.0789); Gain of sheet (P = 0.0827); Gain of phosphorylation at S670 (P = 0.1151); Loss of glycosylation at S670 (P = 0.1963)
7:117232238:G:C,P13569,G673R,0.24,Gain of solvent accessibility (P = 0.0456); Gain of disorder (P = 0.0789); Gain of sheet (P = 0.0827); Gain of phosphorylation at S670 (P = 0.1151); Loss of glycosylation at S670 (P = 0.1963)
7:117232239:G:A,P13569,G673E,0.272,Gain of disorder (P = 0.0606); Gain of solvent accessibility (P = 0.1045); Gain of phosphorylation at S670 (P = 0.1137); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2363)
7:117232239:G:C,P13569,G673A,0.203,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1728); Gain of loop (P = 0.2045); Gain of phosphorylation at S678 (P = 0.2373); Loss of catalytic residue at E672 (P = 0.2785)
7:117232239:G:T,P13569,G673V,0.323,Loss of disorder (P = 0.0494); Loss of loop (P = 0.0986); Gain of sheet (P = 0.1945); Loss of phosphorylation at S670 (P = 0.1954); Loss of glycosylation at S670 (P = 0.2236)
7:117232241:G:A,P13569,D674N,0.3,Gain of catalytic residue at D674 (P = 0.0645); Gain of sheet (P = 0.0827); Loss of phosphorylation at S670 (P = 0.1638); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2454)
7:117232241:G:C,P13569,D674H,0.359,Gain of sheet (P = 0.0266); Loss of loop (P = 0.0374); Loss of solvent accessibility (P = 0.1279); Loss of phosphorylation at S678 (P = 0.1428); Loss of disorder (P = 0.1777)
7:117232241:G:T,P13569,D674Y,0.431,Loss of disorder (P = 0.0153); Gain of phosphorylation at D674 (P = 0.0349); Loss of sheet (P = 0.0817); Loss of solvent accessibility (P = 0.1434); Loss of relative solvent accessibility (P = 0.1808)
7:117232242:A:C,P13569,D674A,0.298,Loss of sheet (P = 0.0817); Loss of disorder (P = 0.1132); Loss of solvent accessibility (P = 0.1868); Loss of phosphorylation at S670 (P = 0.2149); Loss of loop (P = 0.2237)
7:117232242:A:G,P13569,D674G,0.295,Loss of sheet (P = 0.0817); Loss of solvent accessibility (P = 0.1744); Gain of catalytic residue at A675 (P = 0.1792); Gain of loop (P = 0.2045); Loss of phosphorylation at S670 (P = 0.2386)
7:117232242:A:T,P13569,D674V,0.424,Loss of disorder (P = 0.0306); Loss of sheet (P = 0.0817); Loss of loop (P = 0.0986); Loss of solvent accessibility (P = 0.1279); Loss of phosphorylation at S670 (P = 0.16)
7:117232243:T:G,P13569,D674E,0.212,Gain of solvent accessibility (P = 0.0638); Gain of disorder (P = 0.0854); Gain of relative solvent accessibility (P = 0.09); Gain of sheet (P = 0.1208); Gain of phosphorylation at S670 (P = 0.1514)
7:117232244:G:A,P13569,A675T,0.184,Gain of disorder (P = 0.0746); Loss of sheet (P = 0.0817); Gain of phosphorylation at A675 (P = 0.0869); Loss of stability (P = 0.1744); Gain of glycosylation at S670 (P = 0.2312)
7:117232244:G:C,P13569,A675P,0.43,Gain of disorder (P = 0.0379); Gain of phosphorylation at T680 (P = 0.1042); Loss of stability (P = 0.1301); Gain of glycosylation at S670 (P = 0.1318); Loss of sheet (P = 0.1398)
7:117232244:G:T,P13569,A675S,0.295,Gain of disorder (P = 0.0256); Loss of sheet (P = 0.0357); Gain of phosphorylation at A675 (P = 0.0506); Gain of glycosylation at S670 (P = 0.1574); Loss of stability (P = 0.1595)
7:117232245:C:A,P13569,A675D,0.335,Loss of sheet (P = 0.0126); Gain of disorder (P = 0.0483); Gain of loop (P = 0.1069); Gain of phosphorylation at S678 (P = 0.1329); Loss of catalytic residue at A675 (P = 0.159)
7:117232245:C:G,P13569,A675G,0.235,Loss of stability (P = 0.0393); Gain of disorder (P = 0.0741); Loss of sheet (P = 0.0817); Gain of phosphorylation at S678 (P = 0.1839); Loss of loop (P = 0.2237)
7:117232245:C:T,P13569,A675V,0.278,Loss of sheet (P = 0.0357); Loss of disorder (P = 0.1071); Loss of phosphorylation at S678 (P = 0.1961); Loss of glycosylation at S670 (P = 0.3575); Loss of relative solvent accessibility (P = 0.365)
7:117232247:C:A,P13569,P676T,0.246,Gain of phosphorylation at P676 (P = 0.0632); Gain of sheet (P = 0.0827); Gain of disorder (P = 0.2314); Gain of MoRF binding (P = 0.2887); Loss of loop (P = 0.2897)
7:117232247:C:G,P13569,P676A,0.248,Loss of sheet (P = 0.0817); Loss of disorder (P = 0.0913); Gain of catalytic residue at D674 (P = 0.1641); Loss of phosphorylation at T680 (P = 0.1899); Gain of MoRF binding (P = 0.2713)
7:117232247:C:T,P13569,P676S,0.223,Gain of phosphorylation at P676 (P = 0.0596); Gain of sheet (P = 0.0827); Gain of disorder (P = 0.0857); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2363)
7:117232248:C:A,P13569,P676H,0.264,Loss of sheet (P = 0.0817); Gain of catalytic residue at P676 (P = 0.0884); Loss of disorder (P = 0.14); Loss of phosphorylation at T680 (P = 0.1454); Gain of MoRF binding (P = 0.2955)
7:117232248:C:G,P13569,P676R,0.322,Gain of MoRF binding (P = 0.0092); Loss of sheet (P = 0.0315); Gain of solvent accessibility (P = 0.0789); Gain of phosphorylation at S678 (P = 0.082); Gain of disorder (P = 0.1483)
7:117232248:C:T,P13569,P676L,0.362,Loss of disorder (P = 0.0402); Loss of sheet (P = 0.0817); Loss of phosphorylation at S678 (P = 0.1283); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.3002)
7:117232250:G:A,P13569,V677I,0.315,Gain of catalytic residue at V677 (P = 0.0851); Loss of sheet (P = 0.1907); Gain of disorder (P = 0.1999); Loss of phosphorylation at T680 (P = 0.2132); Gain of stability (P = 0.328)
7:117232250:G:C,P13569,V677L,0.299,Gain of catalytic residue at V677 (P = 0.0457); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.0842); Loss of phosphorylation at T680 (P = 0.1433); Loss of loop (P = 0.3664)
7:117232250:G:T,P13569,V677F,0.245,Loss of sheet (P = 0.0315); Gain of disorder (P = 0.0991); Gain of loop (P = 0.1069); Gain of phosphorylation at T680 (P = 0.2281); Gain of relative solvent accessibility (P = 0.281)
7:117232251:T:A,P13569,V677D,0.467,Gain of disorder (P = 0.0171); Loss of sheet (P = 0.0315); Gain of relative solvent accessibility (P = 0.1012); Gain of phosphorylation at T680 (P = 0.1021); Gain of loop (P = 0.1069)
7:117232251:T:C,P13569,V677A,0.366,Gain of disorder (P = 0.0418); Loss of sheet (P = 0.0817); Gain of phosphorylation at T680 (P = 0.1194); Loss of loop (P = 0.2237); Gain of glycosylation at P676 (P = 0.3806)
7:117232251:T:G,P13569,V677G,0.449,Gain of disorder (P = 0.0238); Loss of sheet (P = 0.0315); Gain of loop (P = 0.1069); Gain of phosphorylation at S678 (P = 0.1124); Loss of stability (P = 0.1442)
7:117232253:T:A,P13569,S678T,0.364,Loss of sheet (P = 0.0817); Loss of disorder (P = 0.0965); Loss of ubiquitination at K683 (P = 0.1083); Gain of phosphorylation at S678 (P = 0.1977); Loss of loop (P = 0.2237)
7:117232253:T:C,P13569,S678P,0.5,Gain of catalytic residue at W679 (P = 0.0464); Loss of phosphorylation at S678 (P = 0.0516); Gain of sheet (P = 0.0827); Loss of ubiquitination at K683 (P = 0.1498); Loss of disorder (P = 0.1916)
7:117232253:T:G,P13569,S678A,0.442,Gain of catalytic residue at S678 (P = 0.0135); Loss of disorder (P = 0.0443); Loss of phosphorylation at S678 (P = 0.0516); Loss of ubiquitination at K683 (P = 0.0806); Loss of sheet (P = 0.0817)
7:117232254:C:A,P13569,S678Y,0.494,Loss of disorder (P = 0.0017); Loss of ubiquitination at K683 (P = 0.0537); Loss of loop (P = 0.0804); Loss of sheet (P = 0.0817); Gain of phosphorylation at S678 (P = 0.1257)
7:117232254:C:G,P13569,S678C,0.507,Gain of catalytic residue at W679 (P = 0.0055); Loss of disorder (P = 0.0068); Gain of sheet (P = 0.0344); Loss of phosphorylation at S678 (P = 0.0516); Loss of ubiquitination at K683 (P = 0.0584)
7:117232254:C:T,P13569,S678F,0.469,Loss of disorder (P = 0.0104); Loss of ubiquitination at K683 (P = 0.0508); Loss of phosphorylation at S678 (P = 0.0516); Gain of sheet (P = 0.0827); Gain of catalytic residue at S678 (P = 0.2008)
7:117232256:T:A,P13569,W679R,0.5,Gain of disorder (P = 0.0081); Loss of sheet (P = 0.0357); Gain of glycosylation at S678 (P = 0.0596); Gain of ubiquitination at K683 (P = 0.0599); Gain of phosphorylation at S678 (P = 0.0684)
7:117232256:T:C,P13569,W679R,0.5,Gain of disorder (P = 0.0081); Loss of sheet (P = 0.0357); Gain of glycosylation at S678 (P = 0.0596); Gain of ubiquitination at K683 (P = 0.0599); Gain of phosphorylation at S678 (P = 0.0684)
7:117232256:T:G,P13569,W679G,0.5,Gain of glycosylation at S678 (P = 0.0127); Gain of disorder (P = 0.013); Loss of sheet (P = 0.0315); Gain of ubiquitination at K683 (P = 0.0494); Gain of phosphorylation at T680 (P = 0.0858)
7:117232257:G:C,P13569,W679S,0.451,Gain of disorder (P = 0.0051); Gain of phosphorylation at W679 (P = 0.0273); Loss of sheet (P = 0.0315); Gain of ubiquitination at K683 (P = 0.0506); Gain of glycosylation at W679 (P = 0.0722)
7:117232257:G:T,P13569,W679L,0.477,Gain of disorder (P = 0.034); Gain of ubiquitination at K683 (P = 0.0719); Loss of sheet (P = 0.0817); Gain of phosphorylation at T680 (P = 0.1213); Gain of glycosylation at S678 (P = 0.235)
7:117232258:G:C,P13569,W679C,0.481,Gain of disorder (P = 0.0407); Gain of ubiquitination at K683 (P = 0.0599); Loss of sheet (P = 0.0817); Gain of phosphorylation at T680 (P = 0.1147); Loss of MoRF binding (P = 0.2406)
7:117232258:G:T,P13569,W679C,0.481,Gain of disorder (P = 0.0407); Gain of ubiquitination at K683 (P = 0.0599); Loss of sheet (P = 0.0817); Gain of phosphorylation at T680 (P = 0.1147); Loss of MoRF binding (P = 0.2406)
7:117232259:A:C,P13569,T680P,0.414,Loss of phosphorylation at T680 (P = 0.0546); Gain of ubiquitination at K683 (P = 0.0766); Loss of sheet (P = 0.0817); Gain of relative solvent accessibility (P = 0.1259); Gain of disorder (P = 0.1374)
7:117232259:A:G,P13569,T680A,0.382,Loss of phosphorylation at T680 (P = 0.0546); Gain of sheet (P = 0.0827); Loss of ubiquitination at K684 (P = 0.0915); Loss of disorder (P = 0.152); Gain of loop (P = 0.2045)
7:117232259:A:T,P13569,T680S,0.351,Gain of ubiquitination at K683 (P = 0.0766); Gain of disorder (P = 0.0773); Loss of sheet (P = 0.0817); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S678 (P = 0.1197)
7:117232260:C:A,P13569,T680K,0.456,Gain of ubiquitination at T680 (P = 0.0155); Loss of phosphorylation at T680 (P = 0.0546); Gain of MoRF binding (P = 0.0635); Loss of sheet (P = 0.0817); Gain of solvent accessibility (P = 0.0837)
7:117232260:C:G,P13569,T680R,0.413,Gain of MoRF binding (P = 0.024); Loss of phosphorylation at T680 (P = 0.0546); Loss of ubiquitination at K683 (P = 0.1083); Loss of sheet (P = 0.1158); Gain of relative solvent accessibility (P = 0.1259)
7:117232260:C:T,P13569,T680I,0.424,Loss of disorder (P = 0.0331); Loss of phosphorylation at T680 (P = 0.0546); Loss of ubiquitination at K684 (P = 0.0787); Loss of sheet (P = 0.0817); Gain of loop (P = 0.0851)
7:117232262:G:A,P13569,E681K,0.441,Gain of MoRF binding (P = 0.0045); Gain of ubiquitination at E681 (P = 0.0325); Loss of sheet (P = 0.0817); Gain of phosphorylation at T680 (P = 0.1836); Gain of loop (P = 0.2045)
7:117232262:G:C,P13569,E681Q,0.383,Loss of ubiquitination at K683 (P = 0.0537); Gain of MoRF binding (P = 0.0599); Loss of sheet (P = 0.0817); Loss of phosphorylation at S678 (P = 0.1174); Loss of disorder (P = 0.2054)
7:117232263:A:C,P13569,E681A,0.381,Loss of sheet (P = 0.0315); Loss of ubiquitination at K684 (P = 0.0561); Loss of disorder (P = 0.0595); Gain of MoRF binding (P = 0.1007); Loss of stability (P = 0.1291)
7:117232263:A:G,P13569,E681G,0.364,Loss of stability (P = 0.032); Loss of ubiquitination at K684 (P = 0.0518); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.1081); Loss of disorder (P = 0.1264)
7:117232264:A:C,P13569,E681D,0.324,Loss of sheet (P = 0.0315); Loss of ubiquitination at K684 (P = 0.0604); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Gain of phosphorylation at T680 (P = 0.1847)
7:117232264:A:T,P13569,E681D,0.324,Loss of sheet (P = 0.0315); Loss of ubiquitination at K684 (P = 0.0604); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Gain of phosphorylation at T680 (P = 0.1847)
7:117232265:A:C,P13569,T682P,0.354,Gain of catalytic residue at T682 (P = 0.0124); Loss of sheet (P = 0.0315); Gain of glycosylation at T682 (P = 0.0505); Gain of ubiquitination at K683 (P = 0.0846); Gain of relative solvent accessibility (P = 0.09)
7:117232265:A:G,P13569,T682A,0.262,Loss of sheet (P = 0.0817); Loss of ubiquitination at K684 (P = 0.0915); Loss of disorder (P = 0.1572); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2121)
7:117232265:A:T,P13569,T682S,0.309,Gain of phosphorylation at T682 (P = 0.0705); Gain of sheet (P = 0.0827); Gain of ubiquitination at K683 (P = 0.0945); Gain of disorder (P = 0.0966); Gain of loop (P = 0.2045)
7:117232266:C:A,P13569,T682K,0.399,Gain of ubiquitination at T682 (P = 0.0155); Gain of MoRF binding (P = 0.0606); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S686 (P = 0.1024)
7:117232266:C:G,P13569,T682R,0.334,Gain of MoRF binding (P = 0.0251); Gain of solvent accessibility (P = 0.0584); Loss of ubiquitination at K683 (P = 0.0806); Loss of sheet (P = 0.0817); Gain of phosphorylation at T680 (P = 0.0834)
7:117232266:C:T,P13569,T682I,0.352,Loss of disorder (P = 0.0398); Loss of ubiquitination at K684 (P = 0.0561); Gain of sheet (P = 0.0827); Loss of loop (P = 0.1242); Loss of phosphorylation at T680 (P = 0.153)
7:117232268:A:C,P13569,K683Q,0.435,Loss of ubiquitination at K683 (P = 0.013); Loss of sheet (P = 0.0817); Gain of methylation at K688 (P = 0.1254); Loss of phosphorylation at T680 (P = 0.1372); Loss of MoRF binding (P = 0.1542)
7:117232268:A:G,P13569,K683E,0.405,Gain of ubiquitination at K688 (P = 0.0121); Loss of MoRF binding (P = 0.0849); Gain of methylation at K688 (P = 0.1494); Gain of phosphorylation at S678 (P = 0.1738); Gain of disorder (P = 0.2215)
7:117232269:A:C,P13569,K683T,0.447,Loss of ubiquitination at K683 (P = 0.013); Gain of phosphorylation at K683 (P = 0.0728); Gain of sheet (P = 0.0827); Gain of methylation at K688 (P = 0.099); Loss of MoRF binding (P = 0.1558)
7:117232269:A:T,P13569,K683I,0.506,Loss of ubiquitination at K683 (P = 0.013); Loss of disorder (P = 0.0139); Gain of methylation at K688 (P = 0.048); Loss of solvent accessibility (P = 0.0595); Loss of phosphorylation at T680 (P = 0.0749)
7:117232270:A:C,P13569,K683N,0.471,Loss of ubiquitination at K683 (P = 0.013); Loss of sheet (P = 0.0817); Loss of phosphorylation at T680 (P = 0.1218); Loss of MoRF binding (P = 0.1548); Loss of disorder (P = 0.1555)
7:117232270:A:T,P13569,K683N,0.471,Loss of ubiquitination at K683 (P = 0.013); Loss of sheet (P = 0.0817); Loss of phosphorylation at T680 (P = 0.1218); Loss of MoRF binding (P = 0.1548); Loss of disorder (P = 0.1555)
7:117232271:A:C,P13569,K684Q,0.371,Loss of ubiquitination at K684 (P = 0.0098); Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.1208); Gain of methylation at K688 (P = 0.1218); Loss of phosphorylation at T680 (P = 0.1982)
7:117232271:A:G,P13569,K684E,0.348,Loss of ubiquitination at K684 (P = 0.0098); Loss of MoRF binding (P = 0.0749); Loss of sheet (P = 0.0817); Gain of methylation at K688 (P = 0.1467); Gain of phosphorylation at S686 (P = 0.2101)
7:117232272:A:C,P13569,K684T,0.434,Loss of ubiquitination at K684 (P = 0.0098); Loss of sheet (P = 0.0315); Gain of phosphorylation at K684 (P = 0.0374); Gain of methylation at K688 (P = 0.0951); Loss of MoRF binding (P = 0.1135)
7:117232272:A:G,P13569,K684R,0.347,Loss of ubiquitination at K684 (P = 0.0098); Gain of phosphorylation at S686 (P = 0.0806); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.0957); Gain of methylation at K688 (P = 0.1387)
7:117232272:A:T,P13569,K684I,0.484,Loss of ubiquitination at K684 (P = 0.0098); Loss of disorder (P = 0.0207); Loss of sheet (P = 0.0817); Gain of methylation at K688 (P = 0.1013); Loss of phosphorylation at T680 (P = 0.1174)
7:117232273:A:C,P13569,K684N,0.376,Loss of ubiquitination at K684 (P = 0.0098); Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.1215); Gain of methylation at K688 (P = 0.1545); Loss of phosphorylation at S686 (P = 0.1573)
7:117232273:A:T,P13569,K684N,0.376,Loss of ubiquitination at K684 (P = 0.0098); Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.1215); Gain of methylation at K688 (P = 0.1545); Loss of phosphorylation at S686 (P = 0.1573)
7:117232274:C:A,P13569,Q685K,0.338,Gain of ubiquitination at Q685 (P = 0.0198); Loss of sheet (P = 0.0315); Gain of MoRF binding (P = 0.043); Gain of phosphorylation at S686 (P = 0.1136); Loss of methylation at K688 (P = 0.1542)
7:117232274:C:G,P13569,Q685E,0.29,Gain of ubiquitination at K688 (P = 0.0374); Loss of sheet (P = 0.0817); Loss of methylation at K688 (P = 0.0888); Loss of MoRF binding (P = 0.1013); Gain of phosphorylation at S686 (P = 0.1213)
7:117232275:A:C,P13569,Q685P,0.284,Loss of sheet (P = 0.0315); Gain of glycosylation at Q685 (P = 0.0591); Gain of loop (P = 0.069); Gain of phosphorylation at T680 (P = 0.1011); Gain of methylation at K688 (P = 0.1034)
7:117232275:A:G,P13569,Q685R,0.265,Gain of MoRF binding (P = 0.0111); Loss of ubiquitination at K684 (P = 0.0692); Gain of phosphorylation at S686 (P = 0.083); Gain of methylation at K688 (P = 0.1266); Gain of solvent accessibility (P = 0.1505)
7:117232275:A:T,P13569,Q685L,0.333,Loss of sheet (P = 0.0315); Loss of ubiquitination at K684 (P = 0.0387); Gain of loop (P = 0.069); Loss of disorder (P = 0.0755); Loss of methylation at K688 (P = 0.1172)
7:117232276:A:C,P13569,Q685H,0.271,Gain of sheet (P = 0.1208); Gain of catalytic residue at K683 (P = 0.1306); Loss of ubiquitination at K683 (P = 0.1498); Gain of methylation at K688 (P = 0.1503); Gain of loop (P = 0.2045)
7:117232276:A:T,P13569,Q685H,0.271,Gain of sheet (P = 0.1208); Gain of catalytic residue at K683 (P = 0.1306); Loss of ubiquitination at K683 (P = 0.1498); Gain of methylation at K688 (P = 0.1503); Gain of loop (P = 0.2045)
7:117232277:T:A,P13569,S686T,0.407,Gain of phosphorylation at S686 (P = 0.0617); Gain of sheet (P = 0.0827); Gain of methylation at K688 (P = 0.0982); Loss of ubiquitination at K683 (P = 0.1083); Gain of loop (P = 0.2045)
7:117232277:T:C,P13569,S686P,0.405,Gain of methylation at K688 (P = 0.0649); Loss of phosphorylation at S686 (P = 0.0766); Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.1229); Gain of ubiquitination at K683 (P = 0.1378)
7:117232277:T:G,P13569,S686A,0.414,Loss of ubiquitination at K684 (P = 0.0692); Loss of phosphorylation at S686 (P = 0.0766); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.0835); Loss of methylation at K688 (P = 0.1467)
7:117232278:C:G,P13569,S686C,0.581,Loss of disorder (P = 0.0319); Loss of ubiquitination at K684 (P = 0.0518); Loss of phosphorylation at S686 (P = 0.0766); Loss of sheet (P = 0.0817); Gain of methylation at K688 (P = 0.0989)
7:117232278:C:T,P13569,S686F,0.496,Loss of disorder (P = 0.0427); Loss of ubiquitination at K684 (P = 0.0431); Loss of phosphorylation at S686 (P = 0.0766); Loss of sheet (P = 0.0817); Gain of methylation at K688 (P = 0.0936)
7:117232280:T:A,P13569,F687I,0.316,Loss of methylation at K688 (P = 0.0469); Loss of ubiquitination at K684 (P = 0.0692); Gain of MoRF binding (P = 0.112); Loss of sheet (P = 0.1907); Gain of phosphorylation at S686 (P = 0.1992)
7:117232280:T:C,P13569,F687L,0.322,Loss of methylation at K688 (P = 0.0294); Gain of sheet (P = 0.0827); Loss of phosphorylation at T690 (P = 0.1261); Gain of ubiquitination at K683 (P = 0.1378); Gain of MoRF binding (P = 0.1773)
7:117232280:T:G,P13569,F687V,0.315,Loss of methylation at K688 (P = 0.0778); Gain of sheet (P = 0.0827); Loss of ubiquitination at K683 (P = 0.0935); Gain of MoRF binding (P = 0.0974); Loss of stability (P = 0.1437)
7:117232281:T:A,P13569,F687Y,0.338,Loss of methylation at K688 (P = 0.0329); Gain of phosphorylation at F687 (P = 0.0566); Loss of ubiquitination at K683 (P = 0.1083); Gain of sheet (P = 0.1208); Loss of stability (P = 0.1758)
7:117232281:T:C,P13569,F687S,0.44,Loss of methylation at K688 (P = 0.0332); Loss of stability (P = 0.0419); Gain of ubiquitination at K683 (P = 0.0571); Gain of phosphorylation at F687 (P = 0.0685); Loss of sheet (P = 0.1158)
7:117232281:T:G,P13569,F687C,0.427,Gain of methylation at K688 (P = 0.036); Gain of sheet (P = 0.0827); Loss of ubiquitination at K683 (P = 0.1083); Loss of MoRF binding (P = 0.145); Loss of stability (P = 0.1513)
7:117232282:T:A,P13569,F687L,0.322,Loss of methylation at K688 (P = 0.0294); Gain of sheet (P = 0.0827); Loss of phosphorylation at T690 (P = 0.1261); Gain of ubiquitination at K683 (P = 0.1378); Gain of MoRF binding (P = 0.1773)
7:117232282:T:G,P13569,F687L,0.322,Loss of methylation at K688 (P = 0.0294); Gain of sheet (P = 0.0827); Loss of phosphorylation at T690 (P = 0.1261); Gain of ubiquitination at K683 (P = 0.1378); Gain of MoRF binding (P = 0.1773)
7:117232283:A:C,P13569,K688Q,0.356,Loss of methylation at K688 (P = 0.0179); Gain of ubiquitination at K683 (P = 0.0397); Loss of MoRF binding (P = 0.078); Loss of sheet (P = 0.0817); Loss of phosphorylation at T690 (P = 0.1603)
7:117232283:A:G,P13569,K688E,0.313,Loss of methylation at K688 (P = 0.0179); Loss of sheet (P = 0.0315); Gain of ubiquitination at K683 (P = 0.0378); Loss of MoRF binding (P = 0.0472); Gain of loop (P = 0.069)
7:117232284:A:C,P13569,K688T,0.47,Loss of methylation at K688 (P = 0.0179); Gain of ubiquitination at K683 (P = 0.0415); Loss of MoRF binding (P = 0.0704); Loss of sheet (P = 0.0817); Gain of phosphorylation at K688 (P = 0.1076)
7:117232284:A:G,P13569,K688R,0.313,Loss of methylation at K688 (P = 0.0196); Gain of ubiquitination at K683 (P = 0.046); Gain of MoRF binding (P = 0.0637); Loss of sheet (P = 0.0817); Gain of phosphorylation at S686 (P = 0.128)
7:117232284:A:T,P13569,K688I,0.503,Loss of methylation at K688 (P = 0.0179); Loss of disorder (P = 0.0273); Gain of ubiquitination at K683 (P = 0.042); Loss of MoRF binding (P = 0.0695); Gain of sheet (P = 0.0827)
7:117232285:A:C,P13569,K688N,0.498,Loss of methylation at K688 (P = 0.0179); Gain of ubiquitination at K683 (P = 0.0397); Loss of MoRF binding (P = 0.0778); Loss of phosphorylation at T690 (P = 0.1031); Gain of loop (P = 0.2045)
7:117232285:A:T,P13569,K688N,0.498,Loss of methylation at K688 (P = 0.0179); Gain of ubiquitination at K683 (P = 0.0397); Loss of MoRF binding (P = 0.0778); Loss of phosphorylation at T690 (P = 0.1031); Gain of loop (P = 0.2045)
7:117232286:C:A,P13569,Q689K,0.416,Gain of MoRF binding (P = 0.0427); Gain of sheet (P = 0.0827); Gain of phosphorylation at S686 (P = 0.105); Loss of methylation at K688 (P = 0.1284); Loss of ubiquitination at K684 (P = 0.1612)
7:117232286:C:G,P13569,Q689E,0.459,Gain of ubiquitination at K688 (P = 0.0357); Loss of MoRF binding (P = 0.0738); Loss of methylation at K688 (P = 0.0767); Gain of sheet (P = 0.0827); Gain of phosphorylation at S686 (P = 0.0991)
7:117232287:A:C,P13569,Q689P,0.419,Gain of glycosylation at T690 (P = 0.0766); Loss of sheet (P = 0.0817); Loss of stability (P = 0.0819); Loss of MoRF binding (P = 0.0897); Loss of methylation at K688 (P = 0.1353)
7:117232287:A:G,P13569,Q689R,0.388,Gain of MoRF binding (P = 0.0181); Gain of phosphorylation at S686 (P = 0.0781); Loss of ubiquitination at K684 (P = 0.0787); Gain of sheet (P = 0.0827); Gain of methylation at K688 (P = 0.1018)
7:117232287:A:T,P13569,Q689L,0.408,Loss of ubiquitination at K684 (P = 0.0455); Loss of methylation at K688 (P = 0.0457); Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1166); Loss of phosphorylation at T690 (P = 0.1275)
7:117232288:G:C,P13569,Q689H,0.377,Gain of sheet (P = 0.0827); Loss of methylation at K688 (P = 0.1322); Loss of ubiquitination at K684 (P = 0.1612); Loss of MoRF binding (P = 0.166); Loss of phosphorylation at T690 (P = 0.1879)
7:117232288:G:T,P13569,Q689H,0.377,Gain of sheet (P = 0.0827); Loss of methylation at K688 (P = 0.1322); Loss of ubiquitination at K684 (P = 0.1612); Loss of MoRF binding (P = 0.166); Loss of phosphorylation at T690 (P = 0.1879)
7:117232289:A:C,P13569,T690P,0.394,Loss of phosphorylation at T690 (P = 0.0354); Gain of catalytic residue at T690 (P = 0.0715); Loss of sheet (P = 0.0817); Loss of MoRF binding (P = 0.0907); Gain of methylation at K688 (P = 0.1179)
7:117232289:A:T,P13569,T690S,0.289,Loss of sheet (P = 0.0817); Gain of glycosylation at T690 (P = 0.095); Loss of methylation at K688 (P = 0.1227); Gain of phosphorylation at S686 (P = 0.1381); Gain of MoRF binding (P = 0.1721)
7:117232290:C:A,P13569,T690N,0.287,Loss of phosphorylation at T690 (P = 0.0354); Loss of sheet (P = 0.0817); Loss of methylation at K688 (P = 0.1297); Gain of MoRF binding (P = 0.1942); Loss of ubiquitination at K688 (P = 0.3426)
7:117232290:C:G,P13569,T690S,0.289,Loss of sheet (P = 0.0817); Gain of glycosylation at T690 (P = 0.095); Loss of methylation at K688 (P = 0.1227); Gain of phosphorylation at S686 (P = 0.1381); Gain of MoRF binding (P = 0.1721)
7:117232290:C:T,P13569,T690I,0.361,Loss of phosphorylation at T690 (P = 0.0354); Loss of sheet (P = 0.0817); Gain of methylation at K688 (P = 0.0963); Loss of disorder (P = 0.1364); Gain of MoRF binding (P = 0.1368)
7:117232292:G:A,P13569,G691R,0.378,Gain of MoRF binding (P = 0.0115); Loss of ubiquitination at K696 (P = 0.0193); Loss of sheet (P = 0.0315); Gain of glycosylation at K688 (P = 0.1055); Gain of methylation at K688 (P = 0.1096)
7:117232292:G:C,P13569,G691R,0.378,Gain of MoRF binding (P = 0.0115); Loss of ubiquitination at K696 (P = 0.0193); Loss of sheet (P = 0.0315); Gain of glycosylation at K688 (P = 0.1055); Gain of methylation at K688 (P = 0.1096)
7:117232293:G:A,P13569,G691E,0.366,Gain of ubiquitination at K696 (P = 0.0412); Loss of MoRF binding (P = 0.072); Loss of sheet (P = 0.0817); Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at K688 (P = 0.1467)
7:117232293:G:C,P13569,G691A,0.273,Loss of sheet (P = 0.0817); Loss of methylation at K688 (P = 0.109); Gain of MoRF binding (P = 0.1419); Loss of ubiquitination at K696 (P = 0.1423); Loss of phosphorylation at T690 (P = 0.2098)
7:117232293:G:T,P13569,G691V,0.374,Loss of sheet (P = 0.0315); Gain of MoRF binding (P = 0.0935); Loss of disorder (P = 0.1169); Loss of ubiquitination at K696 (P = 0.1202); Loss of methylation at K688 (P = 0.1368)
7:117232295:G:A,P13569,E692K,0.373,Gain of MoRF binding (P = 7e-04); Loss of ubiquitination at K696 (P = 0.0167); Gain of methylation at E692 (P = 0.0263); Gain of sheet (P = 0.0827); Loss of stability (P = 0.2054)
7:117232295:G:C,P13569,E692Q,0.336,Gain of MoRF binding (P = 0.0199); Loss of ubiquitination at K696 (P = 0.02); Loss of sheet (P = 0.0817); Loss of methylation at K688 (P = 0.1124); Loss of phosphorylation at T690 (P = 0.132)
7:117232296:A:C,P13569,E692A,0.351,Loss of ubiquitination at K696 (P = 0.0225); Gain of MoRF binding (P = 0.0435); Loss of loop (P = 0.0804); Gain of sheet (P = 0.0827); Gain of catalytic residue at E692 (P = 0.0845)
7:117232296:A:G,P13569,E692G,0.322,Loss of ubiquitination at K696 (P = 0.0219); Gain of MoRF binding (P = 0.0534); Gain of sheet (P = 0.0827); Gain of catalytic residue at E692 (P = 0.1023); Loss of methylation at K688 (P = 0.1236)
7:117232296:A:T,P13569,E692V,0.421,Loss of ubiquitination at K696 (P = 0.022); Loss of disorder (P = 0.0338); Gain of MoRF binding (P = 0.0381); Gain of catalytic residue at E692 (P = 0.0629); Gain of sheet (P = 0.0827)
7:117232297:G:C,P13569,E692D,0.237,Loss of sheet (P = 0.0817); Loss of methylation at K688 (P = 0.1064); Gain of ubiquitination at K696 (P = 0.1184); Gain of MoRF binding (P = 0.1303); Gain of phosphorylation at T690 (P = 0.2131)
7:117232297:G:T,P13569,E692D,0.237,Loss of sheet (P = 0.0817); Loss of methylation at K688 (P = 0.1064); Gain of ubiquitination at K696 (P = 0.1184); Gain of MoRF binding (P = 0.1303); Gain of phosphorylation at T690 (P = 0.2131)
7:117232298:T:A,P13569,F693I,0.366,Loss of ubiquitination at K698 (P = 0.0853); Loss of phosphorylation at T690 (P = 0.0857); Gain of MoRF binding (P = 0.0895); Gain of catalytic residue at F693 (P = 0.092); Gain of sheet (P = 0.1208)
7:117232298:T:C,P13569,F693L,0.635,Loss of methylation at K688 (P = 0.0951); Gain of ubiquitination at K698 (P = 0.1047); Gain of MoRF binding (P = 0.1201); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117232298:T:G,P13569,F693V,0.384,Loss of ubiquitination at K698 (P = 0.0747); Gain of MoRF binding (P = 0.0761); Gain of methylation at K688 (P = 0.1348); Gain of loop (P = 0.2045); Gain of phosphorylation at T690 (P = 0.2584)
7:117232299:T:A,P13569,F693Y,0.337,Gain of methylation at K688 (P = 0.0514); Gain of phosphorylation at F693 (P = 0.0618); Loss of ubiquitination at K698 (P = 0.0747); Gain of MoRF binding (P = 0.123); Gain of helix (P = 0.1736)
7:117232299:T:C,P13569,F693S,0.382,Gain of phosphorylation at F693 (P = 0.0317); Gain of methylation at K688 (P = 0.0441); Gain of ubiquitination at K698 (P = 0.052); Gain of MoRF binding (P = 0.0761); Gain of sheet (P = 0.0827)
7:117232299:T:G,P13569,F693C,0.401,Loss of ubiquitination at K696 (P = 0.0656); Loss of MoRF binding (P = 0.1044); Gain of methylation at K688 (P = 0.1093); Gain of sheet (P = 0.1208); Gain of catalytic residue at K696 (P = 0.1413)
7:117232300:T:A,P13569,F693L,0.635,Loss of methylation at K688 (P = 0.0951); Gain of ubiquitination at K698 (P = 0.1047); Gain of MoRF binding (P = 0.1201); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117232301:G:A,P13569,G694R,0.285,Loss of ubiquitination at K696 (P = 0.0193); Gain of MoRF binding (P = 0.0202); Loss of loop (P = 0.0235); Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457)
7:117232301:G:C,P13569,G694R,0.285,Loss of ubiquitination at K696 (P = 0.0193); Gain of MoRF binding (P = 0.0202); Loss of loop (P = 0.0235); Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457)
7:117232301:G:T,P13569,G694W,0.444,Gain of MoRF binding (P = 0.0194); Loss of disorder (P = 0.0242); Loss of ubiquitination at K698 (P = 0.0573); Gain of catalytic residue at G694 (P = 0.0862); Loss of loop (P = 0.0986)
7:117232302:G:A,P13569,G694E,0.313,Gain of ubiquitination at K698 (P = 0.0303); Loss of MoRF binding (P = 0.0531); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Gain of methylation at K698 (P = 0.1634)
7:117232302:G:C,P13569,G694A,0.23,Loss of ubiquitination at K698 (P = 0.0573); Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.1137); Loss of methylation at K698 (P = 0.1376); Gain of helix (P = 0.1736)
7:117232302:G:T,P13569,G694V,0.352,Loss of loop (P = 0.0374); Loss of ubiquitination at K698 (P = 0.0613); Gain of MoRF binding (P = 0.0793); Loss of disorder (P = 0.1059); Loss of sheet (P = 0.1158)
7:117232304:G:A,P13569,E695K,0.314,Gain of MoRF binding (P = 0.0014); Loss of ubiquitination at K696 (P = 0.0142); Loss of solvent accessibility (P = 0.0807); Gain of methylation at K698 (P = 0.0999); Gain of sheet (P = 0.1208)
7:117232304:G:C,P13569,E695Q,0.273,Loss of ubiquitination at K696 (P = 0.0167); Gain of MoRF binding (P = 0.0191); Loss of solvent accessibility (P = 0.0721); Loss of helix (P = 0.079); Gain of methylation at K698 (P = 0.1176)
7:117232305:A:C,P13569,E695A,0.349,Loss of solvent accessibility (P = 0.0111); Loss of ubiquitination at K696 (P = 0.0184); Gain of MoRF binding (P = 0.0194); Gain of catalytic residue at E695 (P = 0.0573); Loss of relative solvent accessibility (P = 0.0676)
7:117232305:A:G,P13569,E695G,0.353,Loss of solvent accessibility (P = 0.0128); Loss of ubiquitination at K696 (P = 0.0176); Gain of MoRF binding (P = 0.0261); Loss of stability (P = 0.0622); Loss of relative solvent accessibility (P = 0.0981)
7:117232305:A:T,P13569,E695V,0.416,Loss of solvent accessibility (P = 0.0062); Gain of MoRF binding (P = 0.013); Loss of ubiquitination at K696 (P = 0.0184); Loss of disorder (P = 0.0275); Loss of relative solvent accessibility (P = 0.0306)
7:117232306:A:C,P13569,E695D,0.274,Loss of solvent accessibility (P = 0.0509); Loss of ubiquitination at K698 (P = 0.0853); Gain of sheet (P = 0.1208); Gain of MoRF binding (P = 0.1213); Loss of methylation at K698 (P = 0.1213)
7:117232306:A:T,P13569,E695D,0.274,Loss of solvent accessibility (P = 0.0509); Loss of ubiquitination at K698 (P = 0.0853); Gain of sheet (P = 0.1208); Gain of MoRF binding (P = 0.1213); Loss of methylation at K698 (P = 0.1213)
7:117232307:A:C,P13569,K696Q,0.41,Loss of solvent accessibility (P = 0.0045); Loss of ubiquitination at K696 (P = 0.0118); Loss of relative solvent accessibility (P = 0.0306); Loss of methylation at K696 (P = 0.0574); Loss of MoRF binding (P = 0.0575)
7:117232307:A:G,P13569,K696E,0.316,Loss of ubiquitination at K696 (P = 0.0118); Loss of MoRF binding (P = 0.0133); Loss of methylation at K696 (P = 0.0574); Gain of helix (P = 0.062); Loss of glycosylation at K696 (P = 0.0867)
7:117232308:A:C,P13569,K696T,0.422,Loss of solvent accessibility (P = 0.0045); Loss of ubiquitination at K696 (P = 0.0118); Loss of relative solvent accessibility (P = 0.0306); Loss of MoRF binding (P = 0.0492); Loss of methylation at K696 (P = 0.0574)
7:117232308:A:G,P13569,K696R,0.276,Loss of ubiquitination at K696 (P = 0.0118); Loss of solvent accessibility (P = 0.0404); Gain of MoRF binding (P = 0.0651); Loss of methylation at K696 (P = 0.075); Loss of glycosylation at K696 (P = 0.0867)
7:117232308:A:T,P13569,K696I,0.451,Loss of solvent accessibility (P = 0.0111); Loss of ubiquitination at K696 (P = 0.0118); Loss of disorder (P = 0.0216); Loss of MoRF binding (P = 0.0521); Loss of methylation at K696 (P = 0.0574)
7:117232309:A:C,P13569,K696N,0.311,Loss of ubiquitination at K696 (P = 0.0118); Loss of MoRF binding (P = 0.0497); Loss of methylation at K696 (P = 0.0574); Gain of helix (P = 0.062); Loss of glycosylation at K696 (P = 0.0867)
7:117232309:A:T,P13569,K696N,0.311,Loss of ubiquitination at K696 (P = 0.0118); Loss of MoRF binding (P = 0.0497); Loss of methylation at K696 (P = 0.0574); Gain of helix (P = 0.062); Loss of glycosylation at K696 (P = 0.0867)
7:117232310:A:G,P13569,R697G,0.428,Gain of ubiquitination at K698 (P = 0.0396); Loss of MoRF binding (P = 0.0622); Loss of phosphorylation at S700 (P = 0.0689); Loss of methylation at K698 (P = 0.1037); Gain of sheet (P = 0.1451)
7:117232310:A:T,P13569,R697W,0.488,Loss of disorder (P = 0.0114); Gain of ubiquitination at K698 (P = 0.0436); Loss of phosphorylation at S700 (P = 0.0497); Gain of MoRF binding (P = 0.0675); Gain of catalytic residue at R697 (P = 0.07)
7:117232311:G:A,P13569,R697K,0.323,Gain of ubiquitination at R697 (P = 0.0276); Loss of phosphorylation at S700 (P = 0.0884); Loss of MoRF binding (P = 0.1001); Gain of glycosylation at R697 (P = 0.1448); Loss of helix (P = 0.1706)
7:117232311:G:C,P13569,R697T,0.47,Gain of ubiquitination at K698 (P = 0.0325); Gain of phosphorylation at R697 (P = 0.0514); Loss of MoRF binding (P = 0.0572); Loss of helix (P = 0.079); Loss of methylation at K698 (P = 0.1302)
7:117232311:G:T,P13569,R697M,0.414,Gain of ubiquitination at K698 (P = 0.0414); Loss of methylation at K698 (P = 0.0446); Loss of phosphorylation at S700 (P = 0.0635); Loss of MoRF binding (P = 0.0881); Gain of helix (P = 0.132)
7:117232312:G:C,P13569,R697S,0.388,Gain of ubiquitination at K698 (P = 0.0315); Loss of MoRF binding (P = 0.0573); Gain of phosphorylation at R697 (P = 0.0789); Loss of methylation at K698 (P = 0.0947); Gain of sheet (P = 0.1208)
7:117232312:G:T,P13569,R697S,0.388,Gain of ubiquitination at K698 (P = 0.0315); Loss of MoRF binding (P = 0.0573); Gain of phosphorylation at R697 (P = 0.0789); Loss of methylation at K698 (P = 0.0947); Gain of sheet (P = 0.1208)
7:117232313:A:C,P13569,K698Q,0.484,Loss of ubiquitination at K698 (P = 0.0161); Loss of methylation at K698 (P = 0.0364); Loss of MoRF binding (P = 0.0655); Loss of solvent accessibility (P = 0.1551); Loss of catalytic residue at K698 (P = 0.1663)
7:117232313:A:G,P13569,K698E,0.365,Loss of MoRF binding (P = 0.0115); Loss of ubiquitination at K698 (P = 0.0161); Loss of methylation at K698 (P = 0.0364); Gain of helix (P = 0.062); Gain of glycosylation at K696 (P = 0.1844)
7:117232314:A:C,P13569,K698T,0.477,Loss of ubiquitination at K698 (P = 0.0161); Gain of helix (P = 0.0325); Loss of methylation at K698 (P = 0.0364); Loss of MoRF binding (P = 0.0707); Loss of solvent accessibility (P = 0.1551)
7:117232314:A:G,P13569,K698R,0.748,Loss of ubiquitination at K698 (P = 0.0161); Loss of methylation at K698 (P = 0.0431); Gain of helix (P = 0.062); Loss of loop (P = 0.1242); Gain of MoRF binding (P = 0.1269)
7:117232314:A:T,P13569,K698M,0.485,Loss of ubiquitination at K698 (P = 0.0161); Loss of methylation at K698 (P = 0.0364); Gain of helix (P = 0.062); Loss of disorder (P = 0.083); Gain of loop (P = 0.1069)
7:117232315:G:C,P13569,K698N,0.505,Loss of ubiquitination at K698 (P = 0.0161); Loss of methylation at K698 (P = 0.0364); Loss of MoRF binding (P = 0.0561); Loss of phosphorylation at S700 (P = 0.1324); Loss of catalytic residue at K698 (P = 0.1421)
7:117232315:G:T,P13569,K698N,0.505,Loss of ubiquitination at K698 (P = 0.0161); Loss of methylation at K698 (P = 0.0364); Loss of MoRF binding (P = 0.0561); Loss of phosphorylation at S700 (P = 0.1324); Loss of catalytic residue at K698 (P = 0.1421)
7:117232316:A:C,P13569,N699H,0.273,Loss of ubiquitination at K698 (P = 0.0456); Loss of MoRF binding (P = 0.1028); Loss of loop (P = 0.1242); Gain of helix (P = 0.132); Gain of glycosylation at K696 (P = 0.1426)
7:117232316:A:G,P13569,N699D,0.349,Gain of helix (P = 0.0325); Gain of ubiquitination at K698 (P = 0.0328); Loss of MoRF binding (P = 0.0505); Loss of methylation at K698 (P = 0.111); Loss of loop (P = 0.1242)
7:117232316:A:T,P13569,N699Y,0.381,Loss of disorder (P = 0.0185); Loss of ubiquitination at K698 (P = 0.0506); Gain of helix (P = 0.0696); Loss of MoRF binding (P = 0.089); Gain of phosphorylation at N699 (P = 0.1227)
7:117232317:A:C,P13569,N699T,0.319,Gain of phosphorylation at N699 (P = 0.0391); Loss of ubiquitination at K698 (P = 0.0747); Loss of MoRF binding (P = 0.1241); Gain of methylation at K696 (P = 0.1492); Gain of sheet (P = 0.1945)
7:117232317:A:G,P13569,N699S,0.266,Gain of phosphorylation at N699 (P = 0.0286); Loss of MoRF binding (P = 0.1287); Loss of ubiquitination at K698 (P = 0.1343); Gain of helix (P = 0.1736); Loss of methylation at K698 (P = 0.1829)
7:117232317:A:T,P13569,N699I,0.388,Loss of ubiquitination at K698 (P = 0.0573); Loss of disorder (P = 0.0617); Gain of methylation at K698 (P = 0.0969); Loss of MoRF binding (P = 0.1067); Loss of solvent accessibility (P = 0.2668)
7:117232318:T:A,P13569,N699K,0.348,Loss of ubiquitination at K696 (P = 0.0176); Gain of MoRF binding (P = 0.0226); Gain of helix (P = 0.0325); Gain of methylation at N699 (P = 0.0439); Gain of solvent accessibility (P = 0.0713)
7:117232318:T:G,P13569,N699K,0.348,Loss of ubiquitination at K696 (P = 0.0176); Gain of MoRF binding (P = 0.0226); Gain of helix (P = 0.0325); Gain of methylation at N699 (P = 0.0439); Gain of solvent accessibility (P = 0.0713)
7:117232319:T:A,P13569,S700T,0.329,Loss of ubiquitination at K698 (P = 0.0683); Loss of MoRF binding (P = 0.1294); Gain of methylation at K698 (P = 0.1505); Loss of disorder (P = 0.1734); Gain of helix (P = 0.1736)
7:117232319:T:C,P13569,S700P,0.429,Loss of phosphorylation at S700 (P = 0.0247); Gain of helix (P = 0.0325); Loss of MoRF binding (P = 0.0471); Loss of ubiquitination at K698 (P = 0.0853); Gain of methylation at K698 (P = 0.1338)
7:117232319:T:G,P13569,S700A,0.364,Loss of phosphorylation at S700 (P = 0.0247); Loss of disorder (P = 0.0487); Loss of ubiquitination at K698 (P = 0.0573); Loss of MoRF binding (P = 0.1259); Loss of methylation at K698 (P = 0.1624)
7:117232320:C:A,P13569,S700Y,0.447,Loss of disorder (P = 0.0024); Loss of phosphorylation at S700 (P = 0.0316); Loss of ubiquitination at K698 (P = 0.0506); Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.0927)
7:117232320:C:G,P13569,S700C,0.476,Loss of disorder (P = 0.0217); Loss of phosphorylation at S700 (P = 0.0247); Loss of ubiquitination at K698 (P = 0.0683); Loss of MoRF binding (P = 0.0689); Gain of methylation at K698 (P = 0.136)
7:117232320:C:T,P13569,S700F,0.463,Loss of phosphorylation at S700 (P = 0.0247); Loss of disorder (P = 0.0255); Loss of ubiquitination at K698 (P = 0.0506); Loss of MoRF binding (P = 0.0919); Gain of methylation at K698 (P = 0.1275)
7:117232322:A:C,P13569,I701L,0.343,Gain of ubiquitination at K698 (P = 0.0743); Loss of methylation at K698 (P = 0.0934); Loss of MoRF binding (P = 0.1002); Gain of helix (P = 0.132); Loss of loop (P = 0.2897)
7:117232322:A:G,P13569,I701V,0.28,Gain of ubiquitination at K698 (P = 0.0913); Gain of MoRF binding (P = 0.1094); Loss of catalytic residue at I701 (P = 0.1203); Gain of helix (P = 0.132); Loss of methylation at K698 (P = 0.1388)
7:117232322:A:T,P13569,I701F,0.33,Gain of ubiquitination at K698 (P = 0.0913); Loss of MoRF binding (P = 0.1017); Loss of catalytic residue at I701 (P = 0.1163); Loss of methylation at K698 (P = 0.1354); Gain of loop (P = 0.2045)
7:117232323:T:A,P13569,I701N,0.425,Loss of stability (P = 0.0435); Gain of ubiquitination at K698 (P = 0.0605); Loss of MoRF binding (P = 0.0879); Loss of methylation at K698 (P = 0.1025); Gain of helix (P = 0.132)
7:117232323:T:C,P13569,I701T,0.4,Loss of stability (P = 0.026); Gain of glycosylation at I701 (P = 0.0341); Gain of helix (P = 0.062); Gain of ubiquitination at K698 (P = 0.0817); Gain of phosphorylation at I701 (P = 0.1001)
7:117232323:T:G,P13569,I701S,0.429,Loss of stability (P = 0.039); Gain of ubiquitination at K698 (P = 0.052); Gain of phosphorylation at I701 (P = 0.0673); Loss of methylation at K698 (P = 0.0882); Loss of catalytic residue at I701 (P = 0.0898)
7:117232324:T:G,P13569,I701M,0.333,Loss of catalytic residue at I701 (P = 0.0724); Gain of ubiquitination at K698 (P = 0.0817); Gain of MoRF binding (P = 0.0866); Loss of methylation at K698 (P = 0.1527); Gain of sheet (P = 0.1945)
7:117232325:C:A,P13569,L702I,0.295,Gain of methylation at K698 (P = 0.0653); Gain of MoRF binding (P = 0.1226); Loss of ubiquitination at K698 (P = 0.1343); Gain of helix (P = 0.1736); Loss of stability (P = 0.1781)
7:117232325:C:G,P13569,L702V,0.319,Loss of stability (P = 0.0426); Gain of MoRF binding (P = 0.0829); Gain of methylation at K698 (P = 0.1); Loss of ubiquitination at K698 (P = 0.1343); Gain of helix (P = 0.1736)
7:117232325:C:T,P13569,L702F,0.305,Gain of helix (P = 0.0325); Gain of methylation at K698 (P = 0.0935); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.1299); Loss of ubiquitination at K698 (P = 0.1343)
7:117232326:T:A,P13569,L702H,0.331,Loss of stability (P = 0.014); Gain of ubiquitination at K698 (P = 0.1047); Gain of MoRF binding (P = 0.1197); Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at K698 (P = 0.1339)
7:117232326:T:C,P13569,L702P,0.487,Loss of stability (P = 0.0119); Gain of helix (P = 0.0325); Gain of ubiquitination at K698 (P = 0.052); Gain of methylation at K698 (P = 0.0575); Loss of MoRF binding (P = 0.0607)
7:117232326:T:G,P13569,L702R,0.405,Gain of MoRF binding (P = 0.0076); Loss of stability (P = 0.0257); Loss of ubiquitination at K698 (P = 0.0258); Gain of helix (P = 0.0325); Gain of solvent accessibility (P = 0.0584)
7:117232328:A:C,P13569,N703H,0.392,Loss of ubiquitination at K698 (P = 0.0481); Loss of MoRF binding (P = 0.1118); Loss of disorder (P = 0.1301); Loss of stability (P = 0.1303); Loss of helix (P = 0.1706)
7:117232328:A:G,P13569,N703D,0.312,Gain of ubiquitination at K698 (P = 0.0325); Loss of MoRF binding (P = 0.0494); Gain of helix (P = 0.062); Gain of phosphorylation at S707 (P = 0.1602); Loss of sheet (P = 0.1907)
7:117232328:A:T,P13569,N703Y,0.483,Loss of disorder (P = 0.011); Loss of ubiquitination at K698 (P = 0.0533); Gain of methylation at K698 (P = 0.0923); Loss of MoRF binding (P = 0.0939); Gain of helix (P = 0.1736)
7:117232329:A:C,P13569,N703T,0.307,Loss of ubiquitination at K698 (P = 0.0533); Gain of phosphorylation at N703 (P = 0.1094); Loss of stability (P = 0.11); Gain of methylation at K698 (P = 0.1187); Gain of helix (P = 0.132)
7:117232329:A:G,P13569,N703S,0.193,Gain of phosphorylation at N703 (P = 0.0516); Gain of helix (P = 0.062); Gain of methylation at K698 (P = 0.0768); Gain of ubiquitination at K698 (P = 0.1181); Loss of MoRF binding (P = 0.1389)
7:117232329:A:T,P13569,N703I,0.471,Loss of disorder (P = 0.0536); Loss of ubiquitination at K698 (P = 0.0613); Loss of MoRF binding (P = 0.095); Gain of methylation at K698 (P = 0.1152); Gain of sheet (P = 0.1208)
7:117232330:T:A,P13569,N703K,0.333,Gain of methylation at N703 (P = 0.02); Loss of ubiquitination at K698 (P = 0.0235); Gain of MoRF binding (P = 0.0249); Gain of phosphorylation at S707 (P = 0.0941); Loss of stability (P = 0.0983)
7:117232330:T:G,P13569,N703K,0.333,Gain of methylation at N703 (P = 0.02); Loss of ubiquitination at K698 (P = 0.0235); Gain of MoRF binding (P = 0.0249); Gain of phosphorylation at S707 (P = 0.0941); Loss of stability (P = 0.0983)
7:117232331:C:A,P13569,P704T,0.366,Gain of MoRF binding (P = 0.0536); Gain of helix (P = 0.132); Loss of phosphorylation at S707 (P = 0.1663); Loss of sheet (P = 0.1907); Loss of disorder (P = 0.2018)
7:117232331:C:G,P13569,P704A,0.402,Loss of disorder (P = 0.045); Gain of MoRF binding (P = 0.0513); Loss of stability (P = 0.0582); Gain of helix (P = 0.062); Loss of sheet (P = 0.1398)
7:117232331:C:T,P13569,P704S,0.323,Gain of MoRF binding (P = 0.0533); Gain of phosphorylation at P704 (P = 0.1215); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Loss of stability (P = 0.152)
7:117232332:C:A,P13569,P704Q,0.359,Gain of MoRF binding (P = 0.0479); Loss of catalytic residue at P704 (P = 0.0972); Loss of loop (P = 0.0986); Gain of helix (P = 0.132); Loss of phosphorylation at S707 (P = 0.1361)
7:117232332:C:G,P13569,P704R,0.358,Gain of MoRF binding (P = 0.0081); Loss of loop (P = 0.0374); Gain of helix (P = 0.0425); Loss of sheet (P = 0.0483); Gain of phosphorylation at S707 (P = 0.0801)
7:117232332:C:T,P13569,P704L,0.457,Loss of disorder (P = 0.0398); Gain of MoRF binding (P = 0.0601); Gain of helix (P = 0.062); Loss of sheet (P = 0.1398); Loss of phosphorylation at S707 (P = 0.1592)
7:117232334:A:C,P13569,I705L,0.26,Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.1141); Loss of sheet (P = 0.1907); Loss of phosphorylation at S707 (P = 0.192); Loss of loop (P = 0.2897)
7:117232334:A:G,P13569,I705V,0.243,Gain of MoRF binding (P = 0.0999); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of phosphorylation at S707 (P = 0.2329); Loss of loop (P = 0.2897)
7:117232334:A:T,P13569,I705F,0.281,Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.1094); Loss of sheet (P = 0.1398); Loss of phosphorylation at S707 (P = 0.2488); Loss of stability (P = 0.25)
7:117232335:T:A,P13569,I705N,0.352,Loss of stability (P = 0.0378); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of MoRF binding (P = 0.1197); Gain of disorder (P = 0.1265)
7:117232335:T:C,P13569,I705T,0.38,Loss of stability (P = 0.0164); Gain of glycosylation at I705 (P = 0.0635); Loss of MoRF binding (P = 0.1409); Gain of disorder (P = 0.1729); Gain of helix (P = 0.1736)
7:117232335:T:G,P13569,I705S,0.385,Loss of stability (P = 0.05); Gain of disorder (P = 0.0751); Gain of phosphorylation at S707 (P = 0.1147); Loss of MoRF binding (P = 0.1399); Loss of helix (P = 0.1706)
7:117232336:C:G,P13569,I705M,0.3,Gain of helix (P = 0.062); Gain of MoRF binding (P = 0.0785); Loss of loop (P = 0.1242); Loss of sheet (P = 0.1398); Gain of phosphorylation at S707 (P = 0.1848)
7:117232337:A:C,P13569,N706H,0.236,Loss of MoRF binding (P = 0.1169); Loss of disorder (P = 0.1193); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Gain of catalytic residue at N706 (P = 0.1942)
7:117232337:A:G,P13569,N706D,0.296,Gain of ubiquitination at K710 (P = 0.0397); Loss of MoRF binding (P = 0.0475); Gain of phosphorylation at S707 (P = 0.1319); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945)
7:117232337:A:T,P13569,N706Y,0.462,Loss of disorder (P = 0.0127); Gain of catalytic residue at N706 (P = 0.0191); Loss of MoRF binding (P = 0.1011); Loss of loop (P = 0.1242); Gain of sheet (P = 0.1451)
7:117232338:A:C,P13569,N706T,0.26,Loss of MoRF binding (P = 0.1398); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of phosphorylation at N706 (P = 0.2163); Loss of loop (P = 0.2237)
7:117232338:A:G,P13569,N706S,0.156,Gain of phosphorylation at N706 (P = 0.0458); Gain of helix (P = 0.132); Gain of catalytic residue at L702 (P = 0.1364); Gain of MoRF binding (P = 0.1452); Loss of sheet (P = 0.1907)
7:117232338:A:T,P13569,N706I,0.405,Loss of disorder (P = 0.0639); Loss of MoRF binding (P = 0.0969); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117232339:C:A,P13569,N706K,0.291,Gain of methylation at N706 (P = 0.0236); Gain of MoRF binding (P = 0.0416); Gain of glycosylation at N706 (P = 0.0564); Gain of phosphorylation at S707 (P = 0.1012); Gain of helix (P = 0.1736)
7:117232339:C:G,P13569,N706K,0.291,Gain of methylation at N706 (P = 0.0236); Gain of MoRF binding (P = 0.0416); Gain of glycosylation at N706 (P = 0.0564); Gain of phosphorylation at S707 (P = 0.1012); Gain of helix (P = 0.1736)
7:117232340:T:A,P13569,S707T,0.295,Gain of helix (P = 0.0425); Gain of loop (P = 0.0851); Loss of disorder (P = 0.1239); Loss of MoRF binding (P = 0.1412); Loss of phosphorylation at S712 (P = 0.1533)
7:117232340:T:C,P13569,S707P,0.298,Loss of phosphorylation at S707 (P = 0.0468); Loss of MoRF binding (P = 0.048); Gain of helix (P = 0.062); Gain of loop (P = 0.0851); Gain of catalytic residue at S707 (P = 0.0905)
7:117232340:T:G,P13569,S707A,0.378,Loss of disorder (P = 0.027); Gain of loop (P = 0.0435); Loss of phosphorylation at S707 (P = 0.0468); Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.1322)
7:117232341:C:A,P13569,S707Y,0.467,Loss of disorder (P = 0.0015); Gain of helix (P = 0.0325); Loss of phosphorylation at S707 (P = 0.0587); Gain of catalytic residue at L702 (P = 0.076); Gain of loop (P = 0.0851)
7:117232341:C:G,P13569,S707C,0.43,Loss of disorder (P = 0.0236); Gain of helix (P = 0.0325); Loss of phosphorylation at S707 (P = 0.0468); Loss of MoRF binding (P = 0.0703); Loss of loop (P = 0.1242)
7:117232341:C:T,P13569,S707F,0.384,Loss of disorder (P = 0.023); Loss of phosphorylation at S707 (P = 0.0468); Loss of MoRF binding (P = 0.086); Gain of stability (P = 0.1712); Gain of helix (P = 0.1736)
7:117232343:A:C,P13569,I708L,0.241,Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.1197); Gain of sheet (P = 0.1208); Gain of catalytic residue at I708 (P = 0.1298); Gain of phosphorylation at S712 (P = 0.2004)
7:117232343:A:G,P13569,I708V,0.231,Gain of MoRF binding (P = 0.1156); Loss of stability (P = 0.1368); Loss of helix (P = 0.1706); Loss of phosphorylation at S707 (P = 0.1755); Loss of sheet (P = 0.1907)
7:117232343:A:T,P13569,I708L,0.241,Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.1197); Gain of sheet (P = 0.1208); Gain of catalytic residue at I708 (P = 0.1298); Gain of phosphorylation at S712 (P = 0.2004)
7:117232344:T:A,P13569,I708K,0.459,Gain of solvent accessibility (P = 0.0038); Loss of stability (P = 0.0055); Gain of relative solvent accessibility (P = 0.0082); Gain of sheet (P = 0.0344); Gain of methylation at I708 (P = 0.0518)
7:117232344:T:C,P13569,I708T,0.309,Loss of stability (P = 0.0044); Gain of phosphorylation at I708 (P = 0.0632); Gain of loop (P = 0.1069); Loss of MoRF binding (P = 0.1115); Gain of sheet (P = 0.1208)
7:117232344:T:G,P13569,I708R,0.427,Loss of stability (P = 0.0132); Gain of solvent accessibility (P = 0.0171); Gain of MoRF binding (P = 0.0468); Gain of relative solvent accessibility (P = 0.0479); Gain of catalytic residue at I708 (P = 0.0787)
7:117232345:A:G,P13569,I708M,0.247,Gain of loop (P = 0.0851); Gain of MoRF binding (P = 0.086); Loss of stability (P = 0.1296); Gain of helix (P = 0.132); Gain of phosphorylation at S712 (P = 0.1723)
7:117232346:C:G,P13569,R709G,0.535,Loss of MoRF binding (P = 0.0155); Loss of stability (P = 0.0257); Gain of ubiquitination at K710 (P = 0.0289); Loss of sheet (P = 0.0457); Gain of loop (P = 0.069)
7:117232347:G:A,P13569,R709Q,0.757,Loss of MoRF binding (P = 0.0198); Gain of ubiquitination at K710 (P = 0.0338); Loss of phosphorylation at S712 (P = 0.0793); Loss of stability (P = 0.0938); Loss of sheet (P = 0.1158)
7:117232347:G:C,P13569,R709P,0.537,Loss of MoRF binding (P = 6e-04); Gain of ubiquitination at K710 (P = 0.0293); Loss of stability (P = 0.0484); Loss of phosphorylation at S712 (P = 0.1145); Loss of sheet (P = 0.1158)
7:117232347:G:T,P13569,R709L,0.487,Loss of MoRF binding (P = 0.0116); Gain of ubiquitination at K710 (P = 0.0303); Loss of sheet (P = 0.0457); Loss of disorder (P = 0.0536); Loss of solvent accessibility (P = 0.0606)
7:117232349:A:C,P13569,K710Q,0.327,Loss of methylation at K710 (P = 0.0011); Loss of MoRF binding (P = 0.0443); Gain of sheet (P = 0.1208); Loss of phosphorylation at S707 (P = 0.128); Loss of helix (P = 0.1706)
7:117232349:A:G,P13569,K710E,0.33,Loss of methylation at K710 (P = 0.0011); Loss of MoRF binding (P = 0.0016); Gain of relative solvent accessibility (P = 0.1894); Loss of sheet (P = 0.1907); Gain of phosphorylation at S707 (P = 0.1932)
7:117232350:A:C,P13569,K710T,0.36,Loss of methylation at K710 (P = 0.0011); Loss of MoRF binding (P = 0.0372); Gain of catalytic residue at Q715 (P = 0.0995); Loss of disorder (P = 0.1128); Loss of phosphorylation at S707 (P = 0.1342)
7:117232350:A:G,P13569,K710R,0.292,Loss of methylation at K710 (P = 0.0018); Gain of MoRF binding (P = 0.0853); Gain of phosphorylation at S712 (P = 0.0869); Gain of sheet (P = 0.1208); Gain of catalytic residue at K710 (P = 0.15)
7:117232350:A:T,P13569,K710I,0.462,Loss of methylation at K710 (P = 0.0011); Loss of disorder (P = 0.0176); Loss of MoRF binding (P = 0.0375); Gain of sheet (P = 0.0477); Loss of helix (P = 0.079)
7:117232351:A:C,P13569,K710N,0.34,Loss of methylation at K710 (P = 0.0011); Loss of MoRF binding (P = 0.0387); Gain of sheet (P = 0.1208); Loss of phosphorylation at S712 (P = 0.124); Loss of loop (P = 0.2237)
7:117232351:A:T,P13569,K710N,0.34,Loss of methylation at K710 (P = 0.0011); Loss of MoRF binding (P = 0.0387); Gain of sheet (P = 0.1208); Loss of phosphorylation at S712 (P = 0.124); Loss of loop (P = 0.2237)
7:117232352:T:A,P13569,F711I,0.328,Loss of helix (P = 0.079); Gain of MoRF binding (P = 0.0889); Gain of phosphorylation at S712 (P = 0.1161); Gain of sheet (P = 0.1208); Gain of methylation at K716 (P = 0.1495)
7:117232352:T:C,P13569,F711L,0.334,Gain of MoRF binding (P = 0.105); Gain of phosphorylation at S712 (P = 0.1081); Gain of sheet (P = 0.1208); Loss of methylation at K710 (P = 0.1695); Gain of ubiquitination at K716 (P = 0.1898)
7:117232352:T:G,P13569,F711V,0.333,Gain of MoRF binding (P = 0.0786); Loss of helix (P = 0.079); Gain of phosphorylation at S712 (P = 0.1085); Gain of sheet (P = 0.1208); Loss of stability (P = 0.1858)
7:117232353:T:A,P13569,F711Y,0.327,Loss of methylation at K710 (P = 0.0604); Gain of phosphorylation at F711 (P = 0.0762); Loss of MoRF binding (P = 0.1374); Loss of stability (P = 0.1595); Loss of helix (P = 0.1706)
7:117232353:T:C,P13569,F711S,0.441,Gain of phosphorylation at F711 (P = 0.028); Gain of sheet (P = 0.0344); Loss of stability (P = 0.0494); Gain of disorder (P = 0.0562); Gain of ubiquitination at K716 (P = 0.0818)
7:117232353:T:G,P13569,F711C,0.438,Gain of sheet (P = 0.0344); Loss of MoRF binding (P = 0.0843); Loss of stability (P = 0.0956); Gain of ubiquitination at K716 (P = 0.1484); Loss of helix (P = 0.1706)
7:117232354:T:A,P13569,F711L,0.334,Gain of MoRF binding (P = 0.105); Gain of phosphorylation at S712 (P = 0.1081); Gain of sheet (P = 0.1208); Loss of methylation at K710 (P = 0.1695); Gain of ubiquitination at K716 (P = 0.1898)
7:117232354:T:G,P13569,F711L,0.334,Gain of MoRF binding (P = 0.105); Gain of phosphorylation at S712 (P = 0.1081); Gain of sheet (P = 0.1208); Loss of methylation at K710 (P = 0.1695); Gain of ubiquitination at K716 (P = 0.1898)
7:117232355:T:A,P13569,S712T,0.348,Gain of loop (P = 0.0851); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.1185); Loss of phosphorylation at S712 (P = 0.1217); Loss of disorder (P = 0.13)
7:117232355:T:C,P13569,S712P,0.35,Loss of MoRF binding (P = 0.0471); Loss of phosphorylation at S712 (P = 0.0517); Gain of loop (P = 0.069); Loss of sheet (P = 0.1158); Gain of methylation at K716 (P = 0.163)
7:117232355:T:G,P13569,S712A,0.447,Loss of disorder (P = 0.0289); Loss of phosphorylation at S712 (P = 0.0517); Gain of catalytic residue at S712 (P = 0.0678); Gain of sheet (P = 0.0827); Loss of MoRF binding (P = 0.1236)
7:117232356:C:A,P13569,S712Y,0.546,Loss of disorder (P = 0.0022); Loss of phosphorylation at S712 (P = 0.0587); Gain of methylation at K716 (P = 0.0655); Loss of MoRF binding (P = 0.0906); Loss of sheet (P = 0.1158)
7:117232356:C:G,P13569,S712C,0.779,Loss of disorder (P = 0.0272); Loss of phosphorylation at S712 (P = 0.0517); Gain of catalytic residue at Q715 (P = 0.0569); Loss of MoRF binding (P = 0.0677); Gain of loop (P = 0.069)
7:117232356:C:T,P13569,S712F,0.586,Loss of disorder (P = 0.0267); Loss of sheet (P = 0.0457); Gain of catalytic residue at Q715 (P = 0.0489); Loss of phosphorylation at S712 (P = 0.0517); Gain of loop (P = 0.069)
7:117232358:A:C,P13569,I713L,0.284,Gain of catalytic residue at I713 (P = 0.1043); Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.1278); Loss of methylation at K716 (P = 0.1413); Gain of loop (P = 0.2045)
7:117232358:A:G,P13569,I713V,0.249,Gain of MoRF binding (P = 0.1104); Gain of sheet (P = 0.1208); Loss of catalytic residue at V714 (P = 0.1448); Loss of methylation at K716 (P = 0.1973); Loss of phosphorylation at S712 (P = 0.2009)
7:117232358:A:T,P13569,I713F,0.329,Loss of MoRF binding (P = 0.0994); Loss of sheet (P = 0.1158); Loss of catalytic residue at V714 (P = 0.1453); Loss of methylation at K716 (P = 0.1906); Loss of phosphorylation at S712 (P = 0.1908)
7:117232359:T:A,P13569,I713N,0.342,Gain of MoRF binding (P = 0.0693); Loss of stability (P = 0.073); Gain of sheet (P = 0.0827); Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.09)
7:117232359:T:C,P13569,I713T,0.291,Gain of phosphorylation at I713 (P = 0.0319); Loss of stability (P = 0.0339); Gain of MoRF binding (P = 0.0941); Loss of sheet (P = 0.1158); Loss of catalytic residue at V714 (P = 0.1357)
7:117232359:T:G,P13569,I713S,0.333,Loss of stability (P = 0.0611); Gain of disorder (P = 0.0751); Gain of MoRF binding (P = 0.0824); Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.09)
7:117232360:T:G,P13569,I713M,0.306,Gain of MoRF binding (P = 0.0686); Gain of loop (P = 0.0851); Gain of sheet (P = 0.1208); Gain of phosphorylation at T717 (P = 0.1566); Gain of relative solvent accessibility (P = 0.1571)
7:117232361:G:A,P13569,V714M,0.287,Gain of MoRF binding (P = 0.0964); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1503); Gain of phosphorylation at S712 (P = 0.1778); Gain of ubiquitination at K716 (P = 0.2046)
7:117232361:G:C,P13569,V714L,0.29,Loss of MoRF binding (P = 0.0984); Loss of catalytic residue at V714 (P = 0.1263); Loss of methylation at K716 (P = 0.1852); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232361:G:T,P13569,V714L,0.29,Loss of MoRF binding (P = 0.0984); Loss of catalytic residue at V714 (P = 0.1263); Loss of methylation at K716 (P = 0.1852); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232362:T:A,P13569,V714E,0.43,Gain of solvent accessibility (P = 0.005); Gain of relative solvent accessibility (P = 0.0082); Loss of sheet (P = 0.0228); Gain of ubiquitination at K710 (P = 0.026); Loss of MoRF binding (P = 0.0345)
7:117232362:T:C,P13569,V714A,0.253,Gain of sheet (P = 0.0344); Loss of stability (P = 0.0619); Loss of loop (P = 0.0804); Loss of MoRF binding (P = 0.1162); Gain of ubiquitination at K716 (P = 0.1621)
7:117232362:T:G,P13569,V714G,0.342,Loss of stability (P = 0.0069); Loss of sheet (P = 0.0457); Gain of loop (P = 0.0851); Loss of MoRF binding (P = 0.1112); Gain of ubiquitination at K716 (P = 0.1367)
7:117232364:C:A,P13569,Q715K,0.323,Loss of ubiquitination at K716 (P = 0.0331); Loss of sheet (P = 0.0457); Gain of MoRF binding (P = 0.0476); Gain of loop (P = 0.069); Gain of phosphorylation at S712 (P = 0.1044)
7:117232364:C:G,P13569,Q715E,0.304,Gain of sheet (P = 0.0221); Loss of loop (P = 0.0374); Gain of ubiquitination at K710 (P = 0.0397); Loss of MoRF binding (P = 0.0432); Gain of phosphorylation at S712 (P = 0.1011)
7:117232365:A:C,P13569,Q715P,0.352,Gain of catalytic residue at Q715 (P = 0.0213); Gain of sheet (P = 0.0221); Gain of loop (P = 0.0312); Loss of MoRF binding (P = 0.0632); Gain of phosphorylation at T717 (P = 0.099)
7:117232365:A:G,P13569,Q715R,0.309,Gain of loop (P = 0.0166); Loss of sheet (P = 0.0228); Gain of MoRF binding (P = 0.0314); Loss of ubiquitination at K716 (P = 0.0331); Gain of phosphorylation at T717 (P = 0.0738)
7:117232365:A:T,P13569,Q715L,0.332,Loss of sheet (P = 0.0457); Gain of loop (P = 0.069); Loss of disorder (P = 0.0988); Gain of MoRF binding (P = 0.1161); Loss of methylation at K716 (P = 0.2113)
7:117232366:A:T,P13569,Q715H,0.265,Loss of sheet (P = 0.0457); Gain of loop (P = 0.069); Loss of ubiquitination at K716 (P = 0.0839); Loss of MoRF binding (P = 0.1086); Gain of catalytic residue at I713 (P = 0.1319)
7:117232367:A:C,P13569,K716Q,0.406,Loss of ubiquitination at K716 (P = 0.0077); Loss of MoRF binding (P = 0.0422); Loss of methylation at K716 (P = 0.0537); Gain of sheet (P = 0.1208); Loss of phosphorylation at S712 (P = 0.1964)
7:117232367:A:G,P13569,K716E,0.414,Loss of MoRF binding (P = 0.0064); Loss of ubiquitination at K716 (P = 0.0077); Loss of methylation at K716 (P = 0.0537); Gain of sheet (P = 0.1208); Loss of glycosylation at K716 (P = 0.2104)
7:117232368:A:C,P13569,K716T,0.423,Loss of ubiquitination at K716 (P = 0.0077); Loss of MoRF binding (P = 0.0279); Gain of catalytic residue at Q715 (P = 0.0486); Loss of methylation at K716 (P = 0.0537); Gain of sheet (P = 0.1208)
7:117232368:A:G,P13569,K716R,0.327,Loss of ubiquitination at K716 (P = 0.0077); Gain of sheet (P = 0.0477); Gain of MoRF binding (P = 0.0668); Loss of methylation at K716 (P = 0.0669); Loss of phosphorylation at S712 (P = 0.1556)
7:117232368:A:T,P13569,K716M,0.437,Loss of ubiquitination at K716 (P = 0.0077); Loss of MoRF binding (P = 0.0454); Loss of methylation at K716 (P = 0.0537); Gain of stability (P = 0.0795); Gain of sheet (P = 0.1208)
7:117232369:G:C,P13569,K716N,0.422,Loss of ubiquitination at K716 (P = 0.0077); Loss of MoRF binding (P = 0.0409); Loss of methylation at K716 (P = 0.0537); Gain of sheet (P = 0.1208); Loss of phosphorylation at S712 (P = 0.1757)
7:117232369:G:T,P13569,K716N,0.422,Loss of ubiquitination at K716 (P = 0.0077); Loss of MoRF binding (P = 0.0409); Loss of methylation at K716 (P = 0.0537); Gain of sheet (P = 0.1208); Loss of phosphorylation at S712 (P = 0.1757)
7:117232370:A:C,P13569,T717P,0.448,Gain of catalytic residue at T717 (P = 0.0014); Loss of MoRF binding (P = 0.0682); Gain of glycosylation at P718 (P = 0.0963); Loss of phosphorylation at T717 (P = 0.105); Loss of sheet (P = 0.1158)
7:117232370:A:G,P13569,T717A,0.266,Loss of sheet (P = 0.0457); Gain of loop (P = 0.069); Loss of phosphorylation at T717 (P = 0.105); Gain of MoRF binding (P = 0.1052); Gain of catalytic residue at T717 (P = 0.1173)
7:117232370:A:T,P13569,T717S,0.266,Gain of phosphorylation at S712 (P = 0.1085); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1195); Gain of ubiquitination at K716 (P = 0.1367); Gain of loop (P = 0.2045)
7:117232371:C:A,P13569,T717N,0.249,Gain of sheet (P = 0.0344); Gain of loop (P = 0.069); Loss of phosphorylation at T717 (P = 0.105); Gain of MoRF binding (P = 0.1398); Gain of ubiquitination at K716 (P = 0.1484)
7:117232371:C:G,P13569,T717S,0.266,Gain of phosphorylation at S712 (P = 0.1085); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1195); Gain of ubiquitination at K716 (P = 0.1367); Gain of loop (P = 0.2045)
7:117232371:C:T,P13569,T717I,0.35,Loss of ubiquitination at K716 (P = 0.0578); Gain of methylation at K716 (P = 0.0895); Gain of MoRF binding (P = 0.0951); Loss of phosphorylation at T717 (P = 0.105); Loss of sheet (P = 0.1158)
7:117232373:C:A,P13569,P718T,0.295,Gain of MoRF binding (P = 0.0609); Loss of sheet (P = 0.1158); Loss of phosphorylation at T717 (P = 0.1401); Loss of ubiquitination at K716 (P = 0.152); Loss of disorder (P = 0.1699)
7:117232373:C:G,P13569,P718A,0.367,Gain of MoRF binding (P = 0.0534); Loss of disorder (P = 0.054); Gain of catalytic residue at Q715 (P = 0.0723); Loss of ubiquitination at K716 (P = 0.0839); Loss of sheet (P = 0.1158)
7:117232373:C:T,P13569,P718S,0.282,Gain of sheet (P = 0.0477); Gain of MoRF binding (P = 0.0528); Gain of loop (P = 0.069); Gain of phosphorylation at P718 (P = 0.1514); Loss of methylation at K716 (P = 0.1796)
7:117232374:C:A,P13569,P718H,0.361,Gain of sheet (P = 0.0477); Gain of MoRF binding (P = 0.0651); Loss of disorder (P = 0.0687); Loss of ubiquitination at K716 (P = 0.0731); Loss of phosphorylation at T717 (P = 0.1615)
7:117232374:C:T,P13569,P718L,0.402,Loss of disorder (P = 0.0457); Loss of ubiquitination at K716 (P = 0.0525); Gain of MoRF binding (P = 0.0624); Gain of catalytic residue at P718 (P = 0.0791); Loss of phosphorylation at T717 (P = 0.1504)
7:117232376:T:A,P13569,L719I,0.158,Gain of methylation at K716 (P = 0.072); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1336); Gain of loop (P = 0.2045); Loss of ubiquitination at K716 (P = 0.2094)
7:117232376:T:G,P13569,L719V,0.288,Gain of sheet (P = 0.0221); Loss of loop (P = 0.0374); Loss of catalytic residue at L719 (P = 0.0685); Gain of MoRF binding (P = 0.1003); Gain of methylation at K716 (P = 0.1123)
7:117232377:T:C,P13569,L719S,0.312,Loss of catalytic residue at L719 (P = 0.0077); Gain of methylation at K716 (P = 0.0632); Gain of phosphorylation at L719 (P = 0.0783); Gain of MoRF binding (P = 0.0825); Gain of sheet (P = 0.1208)
7:117232378:A:C,P13569,L719F,0.179,Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.1302); Gain of methylation at K716 (P = 0.1703); Gain of phosphorylation at T717 (P = 0.1715); Gain of loop (P = 0.2045)
7:117232378:A:T,P13569,L719F,0.179,Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.1302); Gain of methylation at K716 (P = 0.1703); Gain of phosphorylation at T717 (P = 0.1715); Gain of loop (P = 0.2045)
7:117232379:C:A,P13569,Q720K,0.393,Gain of ubiquitination at Q720 (P = 0.0029); Gain of solvent accessibility (P = 0.0354); Gain of relative solvent accessibility (P = 0.0479); Gain of MoRF binding (P = 0.0528); Gain of phosphorylation at T717 (P = 0.12)
7:117232379:C:G,P13569,Q720E,0.329,Gain of solvent accessibility (P = 0.0411); Gain of relative solvent accessibility (P = 0.0479); Loss of MoRF binding (P = 0.0831); Gain of sheet (P = 0.1208); Loss of loop (P = 0.1242)
7:117232380:A:C,P13569,Q720P,0.393,Loss of MoRF binding (P = 0.0895); Gain of phosphorylation at T717 (P = 0.1245); Gain of methylation at K716 (P = 0.1259); Gain of glycosylation at T717 (P = 0.1887); Loss of sheet (P = 0.1907)
7:117232380:A:G,P13569,Q720R,0.309,Gain of MoRF binding (P = 0.0274); Loss of ubiquitination at K716 (P = 0.0362); Gain of solvent accessibility (P = 0.0584); Gain of catalytic residue at Q720 (P = 0.071); Gain of relative solvent accessibility (P = 0.09)
7:117232380:A:T,P13569,Q720L,0.45,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0512); Loss of disorder (P = 0.0709); Loss of ubiquitination at K716 (P = 0.1039); Loss of MoRF binding (P = 0.1233)
7:117232381:A:C,P13569,Q720H,0.393,Loss of disorder (P = 0.1054); Loss of loop (P = 0.1242); Gain of phosphorylation at T717 (P = 0.134); Gain of sheet (P = 0.1451); Loss of MoRF binding (P = 0.1459)
7:117232381:A:T,P13569,Q720H,0.393,Loss of disorder (P = 0.1054); Loss of loop (P = 0.1242); Gain of phosphorylation at T717 (P = 0.134); Gain of sheet (P = 0.1451); Loss of MoRF binding (P = 0.1459)
7:117232382:A:C,P13569,M721L,0.299,Gain of sheet (P = 0.0344); Loss of loop (P = 0.0374); Loss of methylation at K716 (P = 0.1674); Loss of MoRF binding (P = 0.177); Loss of solvent accessibility (P = 0.1868)
7:117232382:A:G,P13569,M721V,0.181,Loss of sheet (P = 0.0457); Gain of loop (P = 0.2045); Loss of ubiquitination at K716 (P = 0.2094); Loss of MoRF binding (P = 0.2154); Loss of methylation at K716 (P = 0.2236)
7:117232382:A:T,P13569,M721L,0.299,Gain of sheet (P = 0.0344); Loss of loop (P = 0.0374); Loss of methylation at K716 (P = 0.1674); Loss of MoRF binding (P = 0.177); Loss of solvent accessibility (P = 0.1868)
7:117232383:T:A,P13569,M721K,0.374,Gain of ubiquitination at M721 (P = 0.0029); Gain of methylation at M721 (P = 0.0643); Gain of solvent accessibility (P = 0.0971); Gain of relative solvent accessibility (P = 0.0999); Gain of glycosylation at P718 (P = 0.1549)
7:117232383:T:C,P13569,M721T,0.215,Gain of glycosylation at M721 (P = 0.0484); Gain of phosphorylation at T717 (P = 0.1005); Gain of methylation at K716 (P = 0.1085); Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.1541)
7:117232383:T:G,P13569,M721R,0.219,Loss of ubiquitination at K716 (P = 0.0362); Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.093); Gain of methylation at K716 (P = 0.1098); Gain of solvent accessibility (P = 0.1376)
7:117232384:G:A,P13569,M721I,0.189,Gain of sheet (P = 0.1208); Loss of ubiquitination at K716 (P = 0.1808); Loss of MoRF binding (P = 0.2088); Loss of methylation at K716 (P = 0.2538); Loss of phosphorylation at T717 (P = 0.2672)
7:117232384:G:C,P13569,M721I,0.189,Gain of sheet (P = 0.1208); Loss of ubiquitination at K716 (P = 0.1808); Loss of MoRF binding (P = 0.2088); Loss of methylation at K716 (P = 0.2538); Loss of phosphorylation at T717 (P = 0.2672)
7:117232384:G:T,P13569,M721I,0.189,Gain of sheet (P = 0.1208); Loss of ubiquitination at K716 (P = 0.1808); Loss of MoRF binding (P = 0.2088); Loss of methylation at K716 (P = 0.2538); Loss of phosphorylation at T717 (P = 0.2672)
7:117232385:A:C,P13569,N722H,0.147,Gain of sheet (P = 0.0827); Loss of stability (P = 0.1966); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2337); Loss of MoRF binding (P = 0.2614)
7:117232385:A:G,P13569,N722D,0.145,Loss of sheet (P = 0.0457); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.2002); Gain of phosphorylation at T717 (P = 0.2039); Loss of catalytic residue at N722 (P = 0.2655)
7:117232385:A:T,P13569,N722Y,0.338,Loss of disorder (P = 0.0264); Gain of phosphorylation at N722 (P = 0.0335); Gain of sheet (P = 0.0827); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2522)
7:117232386:A:C,P13569,N722T,0.141,Gain of phosphorylation at N722 (P = 0.0879); Loss of sheet (P = 0.1158); Loss of stability (P = 0.139); Loss of catalytic residue at N722 (P = 0.1413); Gain of loop (P = 0.2045)
7:117232386:A:G,P13569,N722S,0.155,Gain of phosphorylation at N722 (P = 0.0222); Gain of glycosylation at N722 (P = 0.0281); Loss of sheet (P = 0.1158); Loss of catalytic residue at N722 (P = 0.1466); Gain of MoRF binding (P = 0.2683)
7:117232386:A:T,P13569,N722I,0.275,Gain of sheet (P = 0.0827); Loss of disorder (P = 0.0932); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.258); Loss of catalytic residue at N722 (P = 0.2869)
7:117232387:T:A,P13569,N722K,0.281,Gain of ubiquitination at N722 (P = 0.0025); Loss of sheet (P = 0.0457); Gain of glycosylation at N722 (P = 0.0471); Gain of loop (P = 0.069); Gain of MoRF binding (P = 0.0739)
7:117232387:T:G,P13569,N722K,0.281,Gain of ubiquitination at N722 (P = 0.0025); Loss of sheet (P = 0.0457); Gain of glycosylation at N722 (P = 0.0471); Gain of loop (P = 0.069); Gain of MoRF binding (P = 0.0739)
7:117232388:G:A,P13569,G723S,0.316,Gain of phosphorylation at G723 (P = 0.0236); Loss of sheet (P = 0.1158); Gain of relative solvent accessibility (P = 0.2363); Loss of stability (P = 0.268); Gain of disorder (P = 0.2723)
7:117232388:G:C,P13569,G723R,0.337,Gain of MoRF binding (P = 0.0542); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2754)
7:117232388:G:T,P13569,G723C,0.432,Gain of catalytic residue at M721 (P = 5e-04); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1839); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.311)
7:117232389:G:A,P13569,G723D,0.295,Loss of sheet (P = 0.0457); Gain of relative solvent accessibility (P = 0.1259); Gain of loop (P = 0.2045); Gain of solvent accessibility (P = 0.2291); Loss of MoRF binding (P = 0.2998)
7:117232389:G:C,P13569,G723A,0.324,Loss of stability (P = 0.1489); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Loss of disorder (P = 0.2795); Gain of MoRF binding (P = 0.3243)
7:117232391:A:C,P13569,I724L,0.338,Gain of catalytic residue at I724 (P = 0.0327); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of disorder (P = 0.3942)
7:117232391:A:G,P13569,I724V,0.321,Gain of catalytic residue at I724 (P = 0.029); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2751); Loss of helix (P = 0.3949)
7:117232391:A:T,P13569,I724F,0.304,Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2751); Gain of solvent accessibility (P = 0.3418); Loss of stability (P = 0.3526)
7:117232392:T:A,P13569,I724N,0.338,Loss of stability (P = 0.1136); Gain of sheet (P = 0.1208); Gain of relative solvent accessibility (P = 0.1571); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117232392:T:C,P13569,I724T,0.368,Loss of stability (P = 0.0245); Gain of phosphorylation at I724 (P = 0.0555); Gain of glycosylation at I724 (P = 0.1166); Gain of helix (P = 0.132); Gain of relative solvent accessibility (P = 0.1571)
7:117232392:T:G,P13569,I724S,0.408,Gain of phosphorylation at I724 (P = 0.0127); Gain of sheet (P = 0.0221); Loss of loop (P = 0.0374); Loss of stability (P = 0.0621); Gain of relative solvent accessibility (P = 0.09)
7:117232393:C:G,P13569,I724M,0.327,Gain of catalytic residue at I724 (P = 0.073); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2785); Loss of stability (P = 0.3425)
7:117232394:G:C,P13569,E725Q,0.32,Gain of sheet (P = 0.1208); Loss of phosphorylation at S728 (P = 0.1488); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.3859)
7:117232395:A:C,P13569,E725A,0.429,Loss of disorder (P = 0.0802); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Loss of solvent accessibility (P = 0.1744); Gain of loop (P = 0.2045)
7:117232395:A:G,P13569,E725G,0.301,Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Loss of stability (P = 0.1909); Gain of loop (P = 0.2045); Gain of catalytic residue at I724 (P = 0.2076)
7:117232395:A:T,P13569,E725V,0.449,Gain of catalytic residue at E725 (P = 0.0236); Loss of disorder (P = 0.0514); Loss of phosphorylation at S728 (P = 0.1262); Loss of helix (P = 0.1706); Loss of solvent accessibility (P = 0.1744)
7:117232396:A:C,P13569,E725D,0.26,Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of disorder (P = 0.4209); Loss of phosphorylation at S728 (P = 0.4641)
7:117232396:A:T,P13569,E725D,0.26,Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of disorder (P = 0.4209); Loss of phosphorylation at S728 (P = 0.4641)
7:117232397:G:A,P13569,E726K,0.378,Gain of ubiquitination at E726 (P = 0.0042); Gain of methylation at E726 (P = 0.0283); Gain of solvent accessibility (P = 0.0314); Gain of relative solvent accessibility (P = 0.0479); Gain of glycosylation at E726 (P = 0.0606)
7:117232397:G:C,P13569,E726Q,0.153,Gain of sheet (P = 0.1945); Loss of phosphorylation at S728 (P = 0.2031); Gain of loop (P = 0.2045); Loss of stability (P = 0.2152); Loss of helix (P = 0.3949)
7:117232398:A:C,P13569,E726A,0.215,Loss of disorder (P = 0.1092); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045); Loss of phosphorylation at S728 (P = 0.2278); Loss of stability (P = 0.2491)
7:117232398:A:G,P13569,E726G,0.216,Loss of stability (P = 0.0351); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299); Gain of catalytic residue at E726 (P = 0.1308); Gain of loop (P = 0.2045)
7:117232398:A:T,P13569,E726V,0.244,Loss of disorder (P = 0.065); Loss of phosphorylation at S728 (P = 0.1413); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of glycosylation at P731 (P = 0.3002)
7:117232399:G:C,P13569,E726D,0.122,Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363); Loss of stability (P = 0.3563)
7:117232399:G:T,P13569,E726D,0.122,Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363); Loss of stability (P = 0.3563)
7:117232400:G:A,P13569,D727N,0.237,Loss of catalytic residue at D727 (P = 0.0865); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Loss of phosphorylation at S728 (P = 0.2427)
7:117232400:G:C,P13569,D727H,0.249,Gain of loop (P = 0.069); Loss of helix (P = 0.079); Loss of sheet (P = 0.1158); Loss of catalytic residue at D727 (P = 0.1873); Loss of phosphorylation at S728 (P = 0.2445)
7:117232400:G:T,P13569,D727Y,0.334,Gain of phosphorylation at D727 (P = 0.0073); Loss of sheet (P = 0.0457); Loss of disorder (P = 0.0575); Gain of catalytic residue at P731 (P = 0.0905); Gain of helix (P = 0.132)
7:117232401:A:C,P13569,D727A,0.256,Loss of catalytic residue at D727 (P = 0.1138); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2969); Loss of phosphorylation at S728 (P = 0.3261)
7:117232401:A:G,P13569,D727G,0.257,Loss of catalytic residue at D727 (P = 0.1038); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Loss of stability (P = 0.2944)
7:117232401:A:T,P13569,D727V,0.314,Loss of sheet (P = 0.0457); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Loss of catalytic residue at D727 (P = 0.1461); Loss of disorder (P = 0.1781)
7:117232402:T:A,P13569,D727E,0.239,Loss of catalytic residue at D727 (P = 0.1132); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of solvent accessibility (P = 0.2192)
7:117232402:T:G,P13569,D727E,0.239,Loss of catalytic residue at D727 (P = 0.1132); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of solvent accessibility (P = 0.2192)
7:117232403:T:A,P13569,S728T,0.19,Loss of loop (P = 0.0804); Gain of helix (P = 0.132); Gain of sheet (P = 0.1945); Gain of glycosylation at S728 (P = 0.3048); Loss of stability (P = 0.3201)
7:117232403:T:C,P13569,S728P,0.223,Loss of phosphorylation at S728 (P = 0.0173); Gain of sheet (P = 0.0477); Gain of glycosylation at S728 (P = 0.07); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237)
7:117232403:T:G,P13569,S728A,0.227,Loss of phosphorylation at S728 (P = 0.0173); Gain of helix (P = 0.132); Loss of disorder (P = 0.176); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117232404:C:A,P13569,S728Y,0.31,Loss of disorder (P = 0.0353); Loss of loop (P = 0.0986); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of relative solvent accessibility (P = 0.3219)
7:117232404:C:G,P13569,S728C,0.285,Loss of phosphorylation at S728 (P = 0.0173); Loss of disorder (P = 0.0993); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045)
7:117232404:C:T,P13569,S728F,0.293,Loss of phosphorylation at S728 (P = 0.0173); Loss of disorder (P = 0.0758); Gain of loop (P = 0.0851); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907)
7:117232406:G:A,P13569,D729N,0.218,Loss of helix (P = 0.0558); Gain of glycosylation at P731 (P = 0.168); Gain of catalytic residue at D729 (P = 0.1683); Loss of phosphorylation at S728 (P = 0.1792); Gain of sheet (P = 0.1945)
7:117232406:G:C,P13569,D729H,0.206,Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of phosphorylation at S728 (P = 0.2473); Gain of glycosylation at P731 (P = 0.2705)
7:117232406:G:T,P13569,D729Y,0.323,Gain of phosphorylation at D729 (P = 0.0175); Loss of helix (P = 0.0558); Loss of disorder (P = 0.1067); Gain of catalytic residue at D729 (P = 0.1279); Gain of sheet (P = 0.1945)
7:117232407:A:C,P13569,D729A,0.222,Loss of helix (P = 0.0558); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of glycosylation at P731 (P = 0.216); Loss of phosphorylation at S728 (P = 0.2496)
7:117232407:A:G,P13569,D729G,0.235,Gain of glycosylation at S728 (P = 0.0807); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of stability (P = 0.2355)
7:117232407:A:T,P13569,D729V,0.259,Loss of helix (P = 0.0558); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045); Loss of phosphorylation at S728 (P = 0.2327); Loss of disorder (P = 0.3242)
7:117232408:T:A,P13569,D729E,0.224,Gain of glycosylation at P731 (P = 0.08); Gain of loop (P = 0.0851); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Gain of solvent accessibility (P = 0.4067)
7:117232408:T:G,P13569,D729E,0.224,Gain of glycosylation at P731 (P = 0.08); Gain of loop (P = 0.0851); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Gain of solvent accessibility (P = 0.4067)
7:117232409:G:A,P13569,E730K,0.308,Gain of ubiquitination at E730 (P = 0.0075); Loss of sheet (P = 0.0457); Gain of glycosylation at E730 (P = 0.0505); Gain of helix (P = 0.062); Gain of relative solvent accessibility (P = 0.1894)
7:117232409:G:C,P13569,E730Q,0.183,Loss of sheet (P = 0.0457); Loss of phosphorylation at S728 (P = 0.1373); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Loss of glycosylation at P731 (P = 0.3056)
7:117232410:A:C,P13569,E730A,0.246,Loss of sheet (P = 0.0228); Gain of loop (P = 0.0851); Gain of helix (P = 0.1736); Loss of phosphorylation at S728 (P = 0.201); Loss of solvent accessibility (P = 0.2106)
7:117232410:A:G,P13569,E730G,0.223,Loss of stability (P = 0.0982); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of solvent accessibility (P = 0.1868); Gain of catalytic residue at E730 (P = 0.2585)
7:117232410:A:T,P13569,E730V,0.283,Loss of sheet (P = 0.0228); Gain of loop (P = 0.0851); Loss of phosphorylation at S728 (P = 0.1458); Loss of disorder (P = 0.1703); Loss of solvent accessibility (P = 0.1986)
7:117232411:G:C,P13569,E730D,0.214,Gain of helix (P = 0.0325); Loss of sheet (P = 0.0457); Loss of loop (P = 0.1242); Loss of glycosylation at P731 (P = 0.4001); Loss of stability (P = 0.4039)
7:117232411:G:T,P13569,E730D,0.214,Gain of helix (P = 0.0325); Loss of sheet (P = 0.0457); Loss of loop (P = 0.1242); Loss of glycosylation at P731 (P = 0.4001); Loss of stability (P = 0.4039)
7:117232412:C:A,P13569,P731T,0.245,Gain of phosphorylation at P731 (P = 0.0229); Gain of sheet (P = 0.0344); Gain of relative solvent accessibility (P = 0.09); Loss of glycosylation at P731 (P = 0.1514); Gain of solvent accessibility (P = 0.1683)
7:117232412:C:G,P13569,P731A,0.279,Loss of glycosylation at P731 (P = 0.1129); Gain of helix (P = 0.132); Loss of stability (P = 0.1524); Loss of loop (P = 0.2237); Loss of disorder (P = 0.3384)
7:117232412:C:T,P13569,P731S,0.265,Gain of phosphorylation at P731 (P = 0.013); Gain of relative solvent accessibility (P = 0.1259); Gain of helix (P = 0.1736); Loss of glycosylation at P731 (P = 0.2233); Loss of loop (P = 0.2237)
7:117232413:C:A,P13569,P731H,0.275,Loss of glycosylation at P731 (P = 0.1129); Gain of helix (P = 0.132); Loss of stability (P = 0.277); Loss of phosphorylation at S728 (P = 0.2843); Loss of loop (P = 0.2897)
7:117232413:C:G,P13569,P731R,0.257,Gain of helix (P = 0.062); Loss of glycosylation at P731 (P = 0.1129); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Loss of sheet (P = 0.1398)
7:117232413:C:T,P13569,P731L,0.304,Gain of helix (P = 0.062); Loss of glycosylation at P731 (P = 0.1129); Loss of sheet (P = 0.1398); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2481)
7:117232415:T:A,P13569,L732I,0.234,Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of glycosylation at P731 (P = 0.2901); Gain of loop (P = 0.4248); Loss of phosphorylation at S728 (P = 0.4962)
7:117232415:T:G,P13569,L732V,0.217,Gain of helix (P = 0.2684); Loss of glycosylation at P731 (P = 0.2876); Loss of sheet (P = 0.302); Gain of loop (P = 0.4248); Loss of phosphorylation at S728 (P = 0.4641)
7:117232416:T:C,P13569,L732S,0.288,Gain of phosphorylation at L732 (P = 0.0021); Gain of loop (P = 0.069); Loss of helix (P = 0.1706); Loss of sheet (P = 0.302); Gain of glycosylation at P731 (P = 0.3449)
7:117232417:A:C,P13569,L732F,0.223,Gain of sheet (P = 0.0827); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Loss of glycosylation at S737 (P = 0.3772); Gain of phosphorylation at S728 (P = 0.4883)
7:117232417:A:T,P13569,L732F,0.223,Gain of sheet (P = 0.0827); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Loss of glycosylation at S737 (P = 0.3772); Gain of phosphorylation at S728 (P = 0.4883)
7:117232418:G:A,P13569,E733K,0.262,Gain of ubiquitination at E733 (P = 0.0051); Loss of sheet (P = 0.0817); Gain of helix (P = 0.1736); Gain of relative solvent accessibility (P = 0.1894); Gain of solvent accessibility (P = 0.2192)
7:117232418:G:C,P13569,E733Q,0.157,Loss of sheet (P = 0.0817); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237); Loss of phosphorylation at S728 (P = 0.2921); Loss of solvent accessibility (P = 0.3103)
7:117232419:A:C,P13569,E733A,0.239,Loss of loop (P = 0.0804); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Loss of solvent accessibility (P = 0.2106); Loss of disorder (P = 0.2355)
7:117232419:A:G,P13569,E733G,0.223,Loss of stability (P = 0.0728); Gain of sheet (P = 0.0827); Loss of helix (P = 0.1706); Loss of solvent accessibility (P = 0.1868); Gain of catalytic residue at L738 (P = 0.1951)
7:117232419:A:T,P13569,E733V,0.281,Gain of helix (P = 0.0696); Loss of disorder (P = 0.0706); Gain of sheet (P = 0.0827); Loss of solvent accessibility (P = 0.1986); Loss of loop (P = 0.2237)
7:117232420:G:C,P13569,E733D,0.15,Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of sheet (P = 0.0817); Loss of glycosylation at P731 (P = 0.3178); Loss of stability (P = 0.469)
7:117232420:G:T,P13569,E733D,0.15,Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of sheet (P = 0.0817); Loss of glycosylation at P731 (P = 0.3178); Loss of stability (P = 0.469)
7:117232421:A:G,P13569,R734G,0.233,Loss of stability (P = 0.0631); Gain of sheet (P = 0.0827); Loss of helix (P = 0.1299); Gain of glycosylation at S737 (P = 0.1673); Loss of loop (P = 0.2237)
7:117232422:G:A,P13569,R734K,0.352,Gain of ubiquitination at R734 (P = 0.001); Gain of sheet (P = 0.0827); Loss of helix (P = 0.1299); Loss of loop (P = 0.2237); Loss of stability (P = 0.2327)
7:117232422:G:C,P13569,R734T,0.291,Gain of glycosylation at R734 (P = 0.0199); Gain of sheet (P = 0.0344); Gain of phosphorylation at R734 (P = 0.0465); Loss of helix (P = 0.0558); Loss of loop (P = 0.0804)
7:117232422:G:T,P13569,R734I,0.357,Loss of helix (P = 0.0558); Gain of sheet (P = 0.0827); Loss of disorder (P = 0.1009); Loss of solvent accessibility (P = 0.1077); Gain of catalytic residue at L738 (P = 0.1989)
7:117232423:A:C,P13569,R734S,0.247,Gain of phosphorylation at R734 (P = 0.0102); Gain of glycosylation at R734 (P = 0.0322); Gain of sheet (P = 0.0827); Loss of helix (P = 0.1299); Loss of stability (P = 0.2191)
7:117232423:A:T,P13569,R734S,0.247,Gain of phosphorylation at R734 (P = 0.0102); Gain of glycosylation at R734 (P = 0.0322); Gain of sheet (P = 0.0827); Loss of helix (P = 0.1299); Loss of stability (P = 0.2191)
7:117232424:A:G,P13569,R735G,0.334,Loss of stability (P = 0.0262); Gain of catalytic residue at P731 (P = 0.0813); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1706); Gain of glycosylation at S737 (P = 0.2305)
7:117232424:A:T,P13569,R735W,0.418,Loss of disorder (P = 0.007); Gain of catalytic residue at R735 (P = 0.0118); Gain of helix (P = 0.0854); Loss of sheet (P = 0.1158); Gain of glycosylation at P740 (P = 0.1411)
7:117232425:G:A,P13569,R735K,0.739,Gain of ubiquitination at R735 (P = 0.0018); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Gain of glycosylation at R735 (P = 0.0921); Loss of stability (P = 0.1035)
7:117232425:G:C,P13569,R735T,0.312,Gain of phosphorylation at R735 (P = 0.033); Loss of sheet (P = 0.1158); Loss of stability (P = 0.1431); Loss of helix (P = 0.1706); Gain of glycosylation at S737 (P = 0.2034)
7:117232425:G:T,P13569,R735M,0.307,Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Loss of glycosylation at S737 (P = 0.3264); Loss of disorder (P = 0.4798)
7:117232426:G:C,P13569,R735S,0.327,Gain of phosphorylation at R735 (P = 0.0078); Gain of glycosylation at R735 (P = 0.103); Gain of sheet (P = 0.1208); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117232426:G:T,P13569,R735S,0.327,Gain of phosphorylation at R735 (P = 0.0078); Gain of glycosylation at R735 (P = 0.103); Gain of sheet (P = 0.1208); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117232427:C:A,P13569,L736M,0.314,Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of stability (P = 0.1915); Gain of loop (P = 0.2045); Loss of glycosylation at S737 (P = 0.3661)
7:117232427:C:G,P13569,L736V,0.298,Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of glycosylation at S737 (P = 0.195); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.281)
7:117232428:T:A,P13569,L736Q,0.306,Loss of stability (P = 0.0369); Loss of sheet (P = 0.0457); Gain of helix (P = 0.062); Gain of glycosylation at S737 (P = 0.1028); Gain of loop (P = 0.2045)
7:117232428:T:C,P13569,L736P,0.372,Loss of stability (P = 0.0166); Gain of sheet (P = 0.039); Gain of glycosylation at S737 (P = 0.0785); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117232428:T:G,P13569,L736R,0.345,Loss of stability (P = 0.025); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Gain of glycosylation at S737 (P = 0.2561); Gain of loop (P = 0.2754)
7:117232430:T:A,P13569,S737T,0.334,Loss of phosphorylation at S737 (P = 0.0681); Gain of relative solvent accessibility (P = 0.09); Gain of glycosylation at S737 (P = 0.1216); Gain of solvent accessibility (P = 0.1683); Loss of stability (P = 0.2083)
7:117232430:T:C,P13569,S737P,0.368,Loss of phosphorylation at S737 (P = 0.0017); Gain of sheet (P = 0.0827); Gain of glycosylation at S742 (P = 0.105); Loss of stability (P = 0.1385); Loss of loop (P = 0.2237)
7:117232430:T:G,P13569,S737A,0.422,Loss of phosphorylation at S737 (P = 0.0017); Gain of sheet (P = 0.0344); Loss of loop (P = 0.0804); Loss of glycosylation at S737 (P = 0.0947); Loss of helix (P = 0.1706)
7:117232431:C:A,P13569,S737Y,0.61,Loss of disorder (P = 0.0185); Gain of catalytic residue at L732 (P = 0.0528); Gain of sheet (P = 0.0827); Loss of glycosylation at S737 (P = 0.0947); Loss of phosphorylation at S737 (P = 0.1056)
7:117232431:C:G,P13569,S737C,0.62,Loss of phosphorylation at S737 (P = 0.0017); Loss of disorder (P = 0.05); Gain of sheet (P = 0.0827); Gain of catalytic residue at L738 (P = 0.0882); Loss of glycosylation at S737 (P = 0.0947)
7:117232433:T:A,P13569,L738I,0.275,Gain of catalytic residue at P740 (P = 0.03); Gain of sheet (P = 0.1208); Loss of phosphorylation at S742 (P = 0.2203); Loss of loop (P = 0.2237); Loss of glycosylation at S742 (P = 0.2334)
7:117232433:T:G,P13569,L738V,0.214,Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Loss of stability (P = 0.223); Loss of loop (P = 0.2237); Loss of glycosylation at S737 (P = 0.2632)
7:117232434:T:C,P13569,L738S,0.283,Gain of phosphorylation at L738 (P = 0.0068); Loss of stability (P = 0.0382); Loss of sheet (P = 0.0817); Loss of loop (P = 0.0986); Gain of glycosylation at L738 (P = 0.2003)
7:117232435:A:C,P13569,L738F,0.237,Loss of sheet (P = 0.0817); Loss of glycosylation at S737 (P = 0.196); Gain of loop (P = 0.2045); Loss of phosphorylation at S742 (P = 0.2162); Gain of helix (P = 0.2684)
7:117232435:A:T,P13569,L738F,0.237,Loss of sheet (P = 0.0817); Loss of glycosylation at S737 (P = 0.196); Gain of loop (P = 0.2045); Loss of phosphorylation at S742 (P = 0.2162); Gain of helix (P = 0.2684)
7:117232436:G:C,P13569,V739L,0.237,Loss of stability (P = 0.0786); Loss of sheet (P = 0.0817); Gain of phosphorylation at S742 (P = 0.1747); Gain of loop (P = 0.2045); Gain of glycosylation at P740 (P = 0.2295)
7:117232436:G:T,P13569,V739L,0.237,Loss of stability (P = 0.0786); Loss of sheet (P = 0.0817); Gain of phosphorylation at S742 (P = 0.1747); Gain of loop (P = 0.2045); Gain of glycosylation at P740 (P = 0.2295)
7:117232437:T:A,P13569,V739E,0.304,Loss of stability (P = 0.0387); Loss of sheet (P = 0.0817); Gain of phosphorylation at S742 (P = 0.1081); Gain of glycosylation at P740 (P = 0.1249); Gain of loop (P = 0.2045)
7:117232437:T:C,P13569,V739A,0.262,Loss of stability (P = 0.0072); Loss of sheet (P = 0.0817); Gain of phosphorylation at S742 (P = 0.1537); Gain of loop (P = 0.2045); Gain of glycosylation at P740 (P = 0.2182)
7:117232437:T:G,P13569,V739G,0.299,Loss of stability (P = 5e-04); Gain of phosphorylation at S742 (P = 0.1395); Loss of glycosylation at S742 (P = 0.1929); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662)
7:117232439:C:A,P13569,P740T,0.187,Loss of loop (P = 0.0804); Gain of sheet (P = 0.1208); Loss of glycosylation at S742 (P = 0.1282); Loss of stability (P = 0.1306); Loss of phosphorylation at S742 (P = 0.1464)
7:117232439:C:G,P13569,P740A,0.199,Loss of loop (P = 0.0804); Gain of sheet (P = 0.1208); Loss of glycosylation at S742 (P = 0.1753); Loss of phosphorylation at S742 (P = 0.1864); Gain of helix (P = 0.2684)
7:117232439:C:T,P13569,P740S,0.164,Gain of phosphorylation at P740 (P = 0.0247); Loss of loop (P = 0.0986); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of glycosylation at S742 (P = 0.1816)
7:117232440:C:A,P13569,P740Q,0.162,Loss of loop (P = 0.0986); Loss of sheet (P = 0.1158); Loss of glycosylation at S742 (P = 0.1264); Loss of phosphorylation at S742 (P = 0.164); Gain of helix (P = 0.2684)
7:117232440:C:G,P13569,P740R,0.204,Loss of sheet (P = 0.0457); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of glycosylation at S742 (P = 0.1051); Gain of phosphorylation at S742 (P = 0.1125)
7:117232440:C:T,P13569,P740L,0.235,Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457); Loss of loop (P = 0.0804); Loss of phosphorylation at S742 (P = 0.1154); Loss of glycosylation at S742 (P = 0.1271)
7:117232442:G:A,P13569,D741N,0.225,Gain of sheet (P = 0.0827); Loss of phosphorylation at S742 (P = 0.141); Loss of glycosylation at S742 (P = 0.1604); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117232442:G:C,P13569,D741H,0.213,Gain of loop (P = 0.0851); Gain of sheet (P = 0.1208); Loss of phosphorylation at S742 (P = 0.1483); Gain of catalytic residue at D741 (P = 0.1873); Loss of glycosylation at S742 (P = 0.2362)
7:117232442:G:T,P13569,D741Y,0.308,Gain of phosphorylation at D741 (P = 0.0245); Gain of sheet (P = 0.0344); Loss of disorder (P = 0.0621); Gain of catalytic residue at L736 (P = 0.0735); Loss of loop (P = 0.0986)
7:117232443:A:C,P13569,D741A,0.214,Gain of sheet (P = 0.0827); Gain of loop (P = 0.2045); Loss of phosphorylation at S742 (P = 0.2114); Loss of helix (P = 0.2662); Loss of solvent accessibility (P = 0.2668)
7:117232443:A:G,P13569,D741G,0.212,Gain of loop (P = 0.0851); Gain of catalytic residue at Q744 (P = 0.0939); Gain of sheet (P = 0.1208); Gain of glycosylation at S742 (P = 0.1823); Loss of helix (P = 0.2022)
7:117232443:A:T,P13569,D741V,0.277,Gain of sheet (P = 0.0827); Loss of loop (P = 0.0986); Loss of solvent accessibility (P = 0.1279); Loss of phosphorylation at S742 (P = 0.1615); Loss of relative solvent accessibility (P = 0.1807)
7:117232444:T:A,P13569,D741E,0.17,Gain of sheet (P = 0.0827); Gain of phosphorylation at S742 (P = 0.1795); Gain of loop (P = 0.2045); Gain of glycosylation at P740 (P = 0.2449); Loss of helix (P = 0.2662)
7:117232444:T:G,P13569,D741E,0.17,Gain of sheet (P = 0.0827); Gain of phosphorylation at S742 (P = 0.1795); Gain of loop (P = 0.2045); Gain of glycosylation at P740 (P = 0.2449); Loss of helix (P = 0.2662)
7:117232445:T:A,P13569,S742T,0.187,Loss of sheet (P = 0.0457); Loss of glycosylation at S742 (P = 0.1065); Gain of phosphorylation at S742 (P = 0.1827); Gain of loop (P = 0.2045); Gain of catalytic residue at S742 (P = 0.238)
7:117232445:T:C,P13569,S742P,0.197,Loss of phosphorylation at S742 (P = 0.0376); Loss of sheet (P = 0.1158); Loss of glycosylation at S742 (P = 0.1766); Loss of stability (P = 0.2031); Gain of loop (P = 0.2045)
7:117232445:T:G,P13569,S742A,0.216,Loss of phosphorylation at S742 (P = 0.0376); Loss of sheet (P = 0.0457); Loss of glycosylation at S742 (P = 0.0587); Loss of disorder (P = 0.1557); Gain of loop (P = 0.2045)
7:117232446:C:A,P13569,S742Y,0.286,Loss of disorder (P = 0.0135); Loss of glycosylation at S742 (P = 0.0587); Loss of loop (P = 0.0986); Loss of sheet (P = 0.1158); Gain of phosphorylation at S742 (P = 0.127)
7:117232446:C:G,P13569,S742C,0.279,Loss of phosphorylation at S742 (P = 0.0376); Loss of sheet (P = 0.0457); Loss of glycosylation at S742 (P = 0.0587); Loss of disorder (P = 0.059); Gain of loop (P = 0.0851)
7:117232446:C:T,P13569,S742F,0.297,Loss of disorder (P = 0.0204); Loss of phosphorylation at S742 (P = 0.0376); Loss of sheet (P = 0.0457); Loss of glycosylation at S742 (P = 0.0587); Loss of loop (P = 0.0804)
7:117232448:G:A,P13569,E743K,0.352,Gain of ubiquitination at E743 (P = 0.0054); Loss of phosphorylation at S742 (P = 0.1218); Gain of glycosylation at S742 (P = 0.1665); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117232448:G:C,P13569,E743Q,0.157,Gain of sheet (P = 0.0827); Loss of phosphorylation at S742 (P = 0.1295); Loss of glycosylation at S742 (P = 0.1816); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117232449:A:C,P13569,E743A,0.217,Loss of sheet (P = 0.0817); Gain of loop (P = 0.0851); Loss of phosphorylation at S742 (P = 0.119); Loss of disorder (P = 0.1924); Loss of glycosylation at S742 (P = 0.2404)
7:117232449:A:G,P13569,E743G,0.248,Loss of sheet (P = 0.0315); Gain of glycosylation at S742 (P = 0.0484); Gain of catalytic residue at Q744 (P = 0.0649); Gain of loop (P = 0.0851); Loss of phosphorylation at S742 (P = 0.1659)
7:117232449:A:T,P13569,E743V,0.281,Loss of disorder (P = 0.079); Loss of phosphorylation at S742 (P = 0.1131); Loss of sheet (P = 0.1158); Loss of glycosylation at S742 (P = 0.127); Loss of solvent accessibility (P = 0.1744)
7:117232450:G:C,P13569,E743D,0.174,Loss of sheet (P = 0.0315); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0917); Gain of catalytic residue at G745 (P = 0.1965); Gain of glycosylation at S742 (P = 0.2024)
7:117232450:G:T,P13569,E743D,0.174,Loss of sheet (P = 0.0315); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0917); Gain of catalytic residue at G745 (P = 0.1965); Gain of glycosylation at S742 (P = 0.2024)
7:117232451:C:A,P13569,Q744K,0.311,Gain of ubiquitination at Q744 (P = 0.0077); Gain of glycosylation at Q744 (P = 0.0436); Gain of loop (P = 0.0851); Loss of sheet (P = 0.1158); Gain of phosphorylation at S742 (P = 0.1354)
7:117232451:C:G,P13569,Q744E,0.18,Gain of sheet (P = 0.0827); Gain of phosphorylation at S742 (P = 0.1078); Loss of solvent accessibility (P = 0.1551); Gain of glycosylation at S742 (P = 0.1916); Gain of loop (P = 0.2045)
7:117232452:A:C,P13569,Q744P,0.229,Loss of solvent accessibility (P = 0.0352); Gain of glycosylation at S742 (P = 0.0635); Gain of sheet (P = 0.0827); Gain of loop (P = 0.0851); Gain of phosphorylation at S742 (P = 0.1236)
7:117232452:A:G,P13569,Q744R,0.171,Gain of phosphorylation at S742 (P = 0.1048); Loss of sheet (P = 0.1158); Loss of solvent accessibility (P = 0.1279); Loss of relative solvent accessibility (P = 0.1807); Gain of loop (P = 0.2045)
7:117232452:A:T,P13569,Q744L,0.246,Loss of solvent accessibility (P = 0.1077); Gain of catalytic residue at Q744 (P = 0.114); Loss of disorder (P = 0.1151); Gain of glycosylation at S742 (P = 0.1877); Gain of phosphorylation at S742 (P = 0.1935)
7:117232453:G:C,P13569,Q744H,0.168,Gain of catalytic residue at Q744 (P = 0.1185); Loss of solvent accessibility (P = 0.1362); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2218)
7:117232453:G:T,P13569,Q744H,0.168,Gain of catalytic residue at Q744 (P = 0.1185); Loss of solvent accessibility (P = 0.1362); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2218)
7:117232454:G:A,P13569,G745R,0.227,Loss of loop (P = 0.0986); Loss of sheet (P = 0.1158); Gain of phosphorylation at S742 (P = 0.1305); Gain of glycosylation at P740 (P = 0.1845); Gain of relative solvent accessibility (P = 0.2363)
7:117232454:G:C,P13569,G745R,0.227,Loss of loop (P = 0.0986); Loss of sheet (P = 0.1158); Gain of phosphorylation at S742 (P = 0.1305); Gain of glycosylation at P740 (P = 0.1845); Gain of relative solvent accessibility (P = 0.2363)
7:117232455:G:A,P13569,G745E,0.224,Gain of sheet (P = 0.0827); Gain of relative solvent accessibility (P = 0.1259); Gain of phosphorylation at S742 (P = 0.1314); Loss of glycosylation at S742 (P = 0.1525); Gain of solvent accessibility (P = 0.1903)
7:117232455:G:C,P13569,G745A,0.191,Loss of sheet (P = 0.1907); Loss of glycosylation at S742 (P = 0.2256); Gain of relative solvent accessibility (P = 0.2363); Gain of phosphorylation at S742 (P = 0.2538); Gain of helix (P = 0.2684)
7:117232455:G:T,P13569,G745V,0.201,Loss of loop (P = 0.0986); Loss of disorder (P = 0.1707); Loss of sheet (P = 0.1907); Loss of glycosylation at S742 (P = 0.2132); Loss of phosphorylation at S742 (P = 0.219)
7:117232457:G:A,P13569,E746K,0.339,Gain of ubiquitination at E746 (P = 0.0039); Gain of MoRF binding (P = 0.062); Gain of sheet (P = 0.0827); Loss of loop (P = 0.0986); Gain of relative solvent accessibility (P = 0.1571)
7:117232457:G:C,P13569,E746Q,0.134,Loss of sheet (P = 0.1158); Loss of phosphorylation at S742 (P = 0.1488); Loss of glycosylation at S742 (P = 0.1831); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2636)
7:117232458:A:C,P13569,E746A,0.199,Gain of sheet (P = 0.0827); Loss of loop (P = 0.0986); Loss of disorder (P = 0.1123); Loss of phosphorylation at S742 (P = 0.1515); Loss of glycosylation at S742 (P = 0.2874)
7:117232458:A:G,P13569,E746G,0.156,Gain of catalytic residue at Q744 (P = 0.0778); Loss of phosphorylation at S742 (P = 0.1698); Loss of glycosylation at S742 (P = 0.1879); Gain of sheet (P = 0.1945); Loss of stability (P = 0.212)
7:117232458:A:T,P13569,E746V,0.279,Loss of sheet (P = 0.0457); Loss of disorder (P = 0.0488); Gain of helix (P = 0.0854); Loss of phosphorylation at S742 (P = 0.1248); Gain of loop (P = 0.2045)
7:117232459:G:C,P13569,E746D,0.168,Gain of sheet (P = 0.0827); Loss of phosphorylation at S742 (P = 0.1997); Loss of loop (P = 0.2237); Gain of catalytic residue at G745 (P = 0.2862); Loss of glycosylation at S742 (P = 0.3085)
7:117232459:G:T,P13569,E746D,0.168,Gain of sheet (P = 0.0827); Loss of phosphorylation at S742 (P = 0.1997); Loss of loop (P = 0.2237); Gain of catalytic residue at G745 (P = 0.2862); Loss of glycosylation at S742 (P = 0.3085)
7:117232460:G:A,P13569,A747T,0.175,Gain of glycosylation at A747 (P = 0.0129); Gain of sheet (P = 0.0827); Gain of phosphorylation at A747 (P = 0.1744); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2168)
7:117232460:G:C,P13569,A747P,0.32,Gain of sheet (P = 0.0827); Gain of disorder (P = 0.1115); Gain of phosphorylation at S742 (P = 0.1567); Gain of loop (P = 0.2045); Gain of glycosylation at S742 (P = 0.3282)
7:117232460:G:T,P13569,A747S,0.294,Gain of phosphorylation at A747 (P = 0.0431); Gain of sheet (P = 0.0827); Gain of disorder (P = 0.102); Gain of loop (P = 0.2045); Gain of glycosylation at A747 (P = 0.2561)
7:117232461:C:A,P13569,A747E,0.275,Gain of disorder (P = 0.1427); Gain of phosphorylation at S742 (P = 0.161); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of glycosylation at S742 (P = 0.2328)
7:117232461:C:G,P13569,A747G,0.19,Loss of sheet (P = 0.1158); Gain of catalytic residue at A747 (P = 0.1364); Gain of loop (P = 0.2045); Gain of phosphorylation at S742 (P = 0.2076); Loss of stability (P = 0.2092)
7:117232461:C:T,P13569,A747V,0.27,Gain of catalytic residue at A747 (P = 0.0363); Loss of phosphorylation at S742 (P = 0.2515); Loss of glycosylation at S742 (P = 0.2888); Loss of loop (P = 0.2897); Loss of disorder (P = 0.2982)
7:117232463:A:C,P13569,I748L,0.289,Loss of catalytic residue at P750 (P = 0.0427); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1929); Gain of phosphorylation at S753 (P = 0.2443); Gain of loop (P = 0.2754)
7:117232463:A:G,P13569,I748V,0.267,Loss of catalytic residue at P750 (P = 0.0334); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.2393); Gain of phosphorylation at S753 (P = 0.2682); Gain of MoRF binding (P = 0.2749)
7:117232463:A:T,P13569,I748L,0.289,Loss of catalytic residue at P750 (P = 0.0427); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1929); Gain of phosphorylation at S753 (P = 0.2443); Gain of loop (P = 0.2754)
7:117232464:T:A,P13569,I748K,0.481,Gain of ubiquitination at I748 (P = 0.0039); Loss of catalytic residue at P750 (P = 0.0334); Gain of methylation at I748 (P = 0.0411); Loss of stability (P = 0.061); Gain of MoRF binding (P = 0.0781)
7:117232464:T:C,P13569,I748T,0.288,Loss of catalytic residue at P750 (P = 0.0334); Gain of phosphorylation at I748 (P = 0.035); Gain of disorder (P = 0.0844); Loss of stability (P = 0.0855); Gain of sheet (P = 0.1208)
7:117232464:T:G,P13569,I748R,0.451,Loss of catalytic residue at P750 (P = 0.0427); Gain of disorder (P = 0.0445); Gain of MoRF binding (P = 0.0497); Gain of methylation at I748 (P = 0.0647); Gain of sheet (P = 0.1208)
7:117232465:A:G,P13569,I748M,0.299,Loss of catalytic residue at P750 (P = 0.0334); Gain of sheet (P = 0.0344); Gain of loop (P = 0.1069); Gain of disorder (P = 0.1109); Gain of MoRF binding (P = 0.2337)
7:117232466:C:A,P13569,L749M,0.331,Gain of sheet (P = 0.1208); Gain of MoRF binding (P = 0.1538); Gain of disorder (P = 0.1619); Gain of phosphorylation at S753 (P = 0.2407); Gain of loop (P = 0.2754)
7:117232466:C:G,P13569,L749V,0.311,Loss of catalytic residue at L749 (P = 0.1145); Gain of sheet (P = 0.1208); Gain of MoRF binding (P = 0.2128); Loss of stability (P = 0.2578); Gain of phosphorylation at S753 (P = 0.267)
7:117232467:T:A,P13569,L749Q,0.369,Loss of catalytic residue at L749 (P = 0.0055); Gain of loop (P = 0.069); Gain of disorder (P = 0.0701); Loss of stability (P = 0.089); Gain of sheet (P = 0.1208)
7:117232467:T:C,P13569,L749P,0.473,Loss of stability (P = 0.0295); Gain of disorder (P = 0.0534); Gain of loop (P = 0.069); Gain of sheet (P = 0.1208); Gain of glycosylation at L749 (P = 0.1303)
7:117232467:T:G,P13569,L749R,0.474,Gain of MoRF binding (P = 0.032); Loss of catalytic residue at L749 (P = 0.0448); Gain of disorder (P = 0.0589); Gain of loop (P = 0.069); Gain of methylation at L749 (P = 0.1083)
7:117232469:C:A,P13569,P750T,0.448,Loss of catalytic residue at P750 (P = 0.0373); Gain of MoRF binding (P = 0.0769); Gain of glycosylation at P750 (P = 0.1016); Gain of phosphorylation at P750 (P = 0.1039); Gain of sheet (P = 0.1208)
7:117232469:C:G,P13569,P750A,0.54,Loss of catalytic residue at P750 (P = 0.0205); Loss of disorder (P = 0.0701); Gain of MoRF binding (P = 0.0771); Loss of sheet (P = 0.1158); Loss of phosphorylation at S753 (P = 0.1819)
7:117232469:C:T,P13569,P750S,0.4,Gain of phosphorylation at P750 (P = 0.0398); Gain of MoRF binding (P = 0.0692); Loss of sheet (P = 0.1158); Loss of stability (P = 0.2164); Gain of disorder (P = 0.2352)
7:117232470:C:A,P13569,P750H,0.534,Loss of catalytic residue at P750 (P = 0.0209); Loss of disorder (P = 0.0766); Gain of MoRF binding (P = 0.0818); Gain of sheet (P = 0.1208); Loss of phosphorylation at S753 (P = 0.1261)
7:117232470:C:G,P13569,P750R,0.483,Gain of MoRF binding (P = 0.0068); Gain of phosphorylation at S753 (P = 0.1162); Loss of catalytic residue at L749 (P = 0.1817); Loss of loop (P = 0.2237); Gain of disorder (P = 0.2896)
7:117232472:C:A,P13569,R751S,0.56,Loss of catalytic residue at R751 (P = 0.0308); Gain of phosphorylation at R751 (P = 0.0475); Loss of MoRF binding (P = 0.0659); Gain of loop (P = 0.1069); Gain of glycosylation at R751 (P = 0.1098)
7:117232472:C:G,P13569,R751G,0.525,Loss of MoRF binding (P = 0.0652); Loss of phosphorylation at S753 (P = 0.0815); Loss of catalytic residue at R751 (P = 0.094); Gain of loop (P = 0.1069); Loss of sheet (P = 0.1158)
7:117232472:C:T,P13569,R751C,0.547,Loss of disorder (P = 0.031); Gain of sheet (P = 0.0344); Loss of MoRF binding (P = 0.0463); Loss of phosphorylation at S753 (P = 0.0539); Gain of loop (P = 0.1069)
7:117232473:G:A,P13569,R751H,0.525,Loss of catalytic residue at R751 (P = 0.0436); Loss of MoRF binding (P = 0.0611); Loss of phosphorylation at S753 (P = 0.0632); Loss of disorder (P = 0.0895); Gain of loop (P = 0.1069)
7:117232473:G:C,P13569,R751P,0.774,Loss of MoRF binding (P = 0.0468); Gain of glycosylation at S756 (P = 0.0727); Loss of catalytic residue at R751 (P = 0.0808); Loss of phosphorylation at S753 (P = 0.1054); Gain of loop (P = 0.1069)
7:117232475:A:C,P13569,I752L,0.338,Gain of catalytic residue at I752 (P = 0.0255); Loss of MoRF binding (P = 0.1261); Gain of glycosylation at S756 (P = 0.1505); Gain of disorder (P = 0.178); Loss of sheet (P = 0.1907)
7:117232475:A:G,P13569,I752V,0.303,Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1225); Gain of glycosylation at S756 (P = 0.1273); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2262)
7:117232475:A:T,P13569,I752F,0.371,Loss of MoRF binding (P = 0.1027); Loss of stability (P = 0.1078); Loss of sheet (P = 0.1158); Loss of phosphorylation at S753 (P = 0.1584); Loss of disorder (P = 0.1636)
7:117232476:T:A,P13569,I752N,0.432,Loss of stability (P = 0.0131); Gain of catalytic residue at I752 (P = 0.0207); Gain of glycosylation at S756 (P = 0.0581); Gain of disorder (P = 0.0587); Gain of loop (P = 0.1069)
7:117232476:T:C,P13569,I752T,0.405,Loss of stability (P = 0.002); Gain of disorder (P = 0.0618); Gain of glycosylation at S756 (P = 0.0637); Gain of loop (P = 0.1069); Loss of MoRF binding (P = 0.1115)
7:117232476:T:G,P13569,I752S,0.417,Loss of stability (P = 0.0075); Gain of disorder (P = 0.026); Gain of phosphorylation at I752 (P = 0.0273); Loss of sheet (P = 0.0457); Gain of glycosylation at S756 (P = 0.051)
7:117232477:C:G,P13569,I752M,0.366,Gain of MoRF binding (P = 0.0898); Gain of disorder (P = 0.0941); Gain of phosphorylation at T757 (P = 0.1106); Gain of sheet (P = 0.1208); Loss of stability (P = 0.1209)
7:117232478:A:C,P13569,S753R,0.811,Gain of MoRF binding (P = 0.0162); Loss of phosphorylation at S753 (P = 0.0353); Gain of glycosylation at S756 (P = 0.0977); Gain of sheet (P = 0.1208); Loss of catalytic residue at V754 (P = 0.1502)
7:117232478:A:G,P13569,S753G,0.462,Loss of phosphorylation at S753 (P = 0.0353); Loss of catalytic residue at S753 (P = 0.0623); Loss of stability (P = 0.0741); Gain of glycosylation at S756 (P = 0.0853); Loss of disorder (P = 0.0983)
7:117232478:A:T,P13569,S753C,0.587,Loss of disorder (P = 0.0159); Loss of phosphorylation at S753 (P = 0.0353); Loss of MoRF binding (P = 0.0713); Gain of sheet (P = 0.1208); Gain of glycosylation at S756 (P = 0.2064)
7:117232479:G:A,P13569,S753N,0.479,Loss of phosphorylation at S753 (P = 0.0353); Gain of glycosylation at S756 (P = 0.0933); Loss of disorder (P = 0.1128); Gain of MoRF binding (P = 0.1204); Gain of sheet (P = 0.1208)
7:117232479:G:C,P13569,S753T,0.448,Loss of disorder (P = 0.0956); Gain of glycosylation at S756 (P = 0.1133); Loss of MoRF binding (P = 0.1204); Gain of sheet (P = 0.1208); Gain of loop (P = 0.2045)
7:117232479:G:T,P13569,S753I,0.528,Loss of disorder (P = 0.0144); Gain of sheet (P = 0.0344); Loss of phosphorylation at S753 (P = 0.0353); Loss of catalytic residue at S753 (P = 0.0414); Gain of glycosylation at S756 (P = 0.0645)
7:117232480:C:A,P13569,S753R,0.811,Gain of MoRF binding (P = 0.0162); Loss of phosphorylation at S753 (P = 0.0353); Gain of glycosylation at S756 (P = 0.0977); Gain of sheet (P = 0.1208); Loss of catalytic residue at V754 (P = 0.1502)
7:117232480:C:G,P13569,S753R,0.811,Gain of MoRF binding (P = 0.0162); Loss of phosphorylation at S753 (P = 0.0353); Gain of glycosylation at S756 (P = 0.0977); Gain of sheet (P = 0.1208); Loss of catalytic residue at V754 (P = 0.1502)
7:117232481:G:C,P13569,V754L,0.47,Loss of MoRF binding (P = 0.0968); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.2017); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117232481:G:T,P13569,V754L,0.47,Loss of MoRF binding (P = 0.0968); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.2017); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117232482:T:A,P13569,V754E,0.574,Gain of disorder (P = 0.034); Loss of MoRF binding (P = 0.056); Gain of glycosylation at S756 (P = 0.069); Loss of catalytic residue at S753 (P = 0.0781); Gain of phosphorylation at S756 (P = 0.1111)
7:117232482:T:C,P13569,V754A,0.428,Loss of stability (P = 0.0563); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1203); Loss of MoRF binding (P = 0.1366); Gain of phosphorylation at S756 (P = 0.152)
7:117232482:T:G,P13569,V754G,0.498,Loss of stability (P = 0.0108); Loss of sheet (P = 0.0457); Gain of glycosylation at S753 (P = 0.0481); Gain of disorder (P = 0.0629); Gain of loop (P = 0.069)
7:117232484:A:C,P13569,I755L,0.291,Gain of loop (P = 0.069); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.1197); Loss of glycosylation at S756 (P = 0.1311); Gain of catalytic residue at I755 (P = 0.1531)
7:117232484:A:G,P13569,I755V,0.298,Gain of catalytic residue at I755 (P = 0.0194); Gain of MoRF binding (P = 0.1106); Gain of sheet (P = 0.1208); Gain of helix (P = 0.1736); Gain of glycosylation at T760 (P = 0.2076)
7:117232484:A:T,P13569,I755F,0.388,Loss of MoRF binding (P = 0.0958); Gain of sheet (P = 0.1208); Loss of phosphorylation at S753 (P = 0.1567); Loss of disorder (P = 0.1613); Loss of glycosylation at T760 (P = 0.1716)
7:117232485:T:A,P13569,I755N,0.421,Gain of catalytic residue at I755 (P = 0.0394); Loss of stability (P = 0.0506); Gain of disorder (P = 0.0544); Gain of MoRF binding (P = 0.0915); Loss of sheet (P = 0.1158)
7:117232485:T:C,P13569,I755T,0.404,Loss of stability (P = 0.0241); Gain of disorder (P = 0.0585); Gain of loop (P = 0.069); Gain of glycosylation at I755 (P = 0.0697); Loss of sheet (P = 0.1158)
7:117232485:T:G,P13569,I755S,0.46,Gain of disorder (P = 0.024); Gain of glycosylation at I755 (P = 0.0466); Loss of stability (P = 0.0481); Gain of phosphorylation at I755 (P = 0.0612); Gain of loop (P = 0.069)
7:117232486:C:G,P13569,I755M,0.374,Gain of catalytic residue at I755 (P = 0.0385); Gain of MoRF binding (P = 0.0747); Gain of disorder (P = 0.0921); Gain of sheet (P = 0.1208); Loss of glycosylation at S756 (P = 0.1524)
7:117232487:A:C,P13569,S756R,0.444,Gain of MoRF binding (P = 0.0266); Loss of glycosylation at S756 (P = 0.0527); Loss of phosphorylation at S756 (P = 0.0787); Loss of helix (P = 0.079); Gain of sheet (P = 0.1208)
7:117232487:A:G,P13569,S756G,0.312,Loss of glycosylation at S756 (P = 0.0527); Loss of phosphorylation at S756 (P = 0.0787); Loss of helix (P = 0.079); Loss of stability (P = 0.0957); Loss of disorder (P = 0.0991)
7:117232487:A:T,P13569,S756C,0.452,Loss of disorder (P = 0.0163); Gain of sheet (P = 0.0344); Loss of glycosylation at S756 (P = 0.0527); Loss of MoRF binding (P = 0.0718); Loss of phosphorylation at S753 (P = 0.0739)
7:117232488:G:A,P13569,S756N,0.328,Loss of glycosylation at S756 (P = 0.0527); Loss of phosphorylation at S756 (P = 0.0787); Loss of disorder (P = 0.1126); Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.1343)
7:117232488:G:C,P13569,S756T,0.363,Gain of glycosylation at S756 (P = 0.0404); Loss of disorder (P = 0.0988); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.1168); Loss of phosphorylation at S753 (P = 0.1616)
7:117232488:G:T,P13569,S756I,0.445,Loss of disorder (P = 0.0161); Gain of sheet (P = 0.0477); Loss of glycosylation at S756 (P = 0.0527); Loss of phosphorylation at S756 (P = 0.0787); Loss of helix (P = 0.079)
7:117232489:C:A,P13569,S756R,0.444,Gain of MoRF binding (P = 0.0266); Loss of glycosylation at S756 (P = 0.0527); Loss of phosphorylation at S756 (P = 0.0787); Loss of helix (P = 0.079); Gain of sheet (P = 0.1208)
7:117232489:C:G,P13569,S756R,0.444,Gain of MoRF binding (P = 0.0266); Loss of glycosylation at S756 (P = 0.0527); Loss of phosphorylation at S756 (P = 0.0787); Loss of helix (P = 0.079); Gain of sheet (P = 0.1208)
7:117232490:A:C,P13569,T757P,0.4,Loss of MoRF binding (P = 0.0581); Gain of loop (P = 0.069); Gain of glycosylation at T760 (P = 0.0928); Gain of disorder (P = 0.1073); Gain of phosphorylation at S756 (P = 0.1088)
7:117232490:A:G,P13569,T757A,0.355,Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1225); Loss of glycosylation at S756 (P = 0.1414); Loss of helix (P = 0.1706); Loss of disorder (P = 0.2226)
7:117232490:A:T,P13569,T757S,0.324,Gain of glycosylation at T757 (P = 0.0523); Gain of loop (P = 0.069); Gain of disorder (P = 0.0952); Gain of phosphorylation at T757 (P = 0.107); Loss of sheet (P = 0.1158)
7:117232491:C:A,P13569,T757N,0.385,Gain of MoRF binding (P = 0.0971); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1706); Loss of glycosylation at T757 (P = 0.1802); Loss of phosphorylation at S756 (P = 0.2339)
7:117232491:C:G,P13569,T757S,0.324,Gain of glycosylation at T757 (P = 0.0523); Gain of loop (P = 0.069); Gain of disorder (P = 0.0952); Gain of phosphorylation at T757 (P = 0.107); Loss of sheet (P = 0.1158)
7:117232491:C:T,P13569,T757I,0.45,Gain of catalytic residue at P759 (P = 0.0379); Loss of disorder (P = 0.0638); Loss of sheet (P = 0.1158); Loss of loop (P = 0.1242); Loss of glycosylation at P759 (P = 0.1245)
7:117232493:G:A,P13569,G758S,0.344,Gain of phosphorylation at G758 (P = 0.0629); Gain of disorder (P = 0.0905); Gain of glycosylation at G758 (P = 0.091); Gain of MoRF binding (P = 0.1086); Gain of sheet (P = 0.1208)
7:117232493:G:C,P13569,G758R,0.355,Gain of MoRF binding (P = 0.012); Loss of helix (P = 0.0558); Gain of glycosylation at T757 (P = 0.0591); Gain of phosphorylation at S756 (P = 0.0941); Gain of disorder (P = 0.1207)
7:117232493:G:T,P13569,G758C,0.463,Loss of helix (P = 0.0558); Loss of disorder (P = 0.0675); Loss of MoRF binding (P = 0.0746); Loss of sheet (P = 0.1158); Loss of glycosylation at T760 (P = 0.1201)
7:117232494:G:A,P13569,G758D,0.384,Loss of helix (P = 0.0558); Loss of MoRF binding (P = 0.056); Loss of catalytic residue at G758 (P = 0.074); Loss of glycosylation at T760 (P = 0.1668); Gain of sheet (P = 0.1945)
7:117232494:G:C,P13569,G758A,0.297,Loss of helix (P = 0.0376); Gain of loop (P = 0.1069); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1351); Gain of glycosylation at T757 (P = 0.2317)
7:117232494:G:T,P13569,G758V,0.352,Loss of helix (P = 0.0558); Loss of disorder (P = 0.0926); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1198); Gain of glycosylation at T757 (P = 0.1453)
7:117232496:C:A,P13569,P759T,0.321,Gain of catalytic residue at P759 (P = 0.0402); Gain of MoRF binding (P = 0.0546); Gain of loop (P = 0.069); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1447)
7:117232496:C:G,P13569,P759A,0.354,Gain of MoRF binding (P = 0.0452); Loss of helix (P = 0.0558); Loss of glycosylation at P759 (P = 0.0607); Gain of catalytic residue at P759 (P = 0.0641); Loss of disorder (P = 0.0766)
7:117232496:C:T,P13569,P759S,0.337,Gain of catalytic residue at P759 (P = 0.0213); Gain of MoRF binding (P = 0.0494); Loss of helix (P = 0.0558); Gain of phosphorylation at P759 (P = 0.0879); Loss of glycosylation at T760 (P = 0.1101)
7:117232497:C:A,P13569,P759H,0.345,Gain of MoRF binding (P = 0.0589); Loss of glycosylation at P759 (P = 0.0607); Loss of disorder (P = 0.0992); Gain of catalytic residue at P759 (P = 0.1142); Gain of sheet (P = 0.1208)
7:117232497:C:G,P13569,P759R,0.396,Gain of MoRF binding (P = 0.0079); Loss of glycosylation at P759 (P = 0.0607); Loss of loop (P = 0.0804); Gain of methylation at P759 (P = 0.1062); Gain of sheet (P = 0.1208)
7:117232497:C:T,P13569,P759L,0.405,Gain of stability (P = 0.0212); Loss of disorder (P = 0.0407); Gain of MoRF binding (P = 0.0499); Loss of helix (P = 0.0558); Loss of glycosylation at P759 (P = 0.0607)
7:117232499:A:C,P13569,T760P,0.431,Gain of catalytic residue at P759 (P = 0.0152); Loss of MoRF binding (P = 0.0514); Gain of glycosylation at T757 (P = 0.0577); Gain of phosphorylation at T757 (P = 0.0844); Loss of helix (P = 0.1299)
7:117232499:A:G,P13569,T760A,0.396,Loss of glycosylation at T760 (P = 0.0523); Gain of MoRF binding (P = 0.1286); Gain of helix (P = 0.132); Gain of phosphorylation at T757 (P = 0.1578); Gain of sheet (P = 0.1945)
7:117232499:A:T,P13569,T760S,0.346,Loss of helix (P = 0.0558); Loss of glycosylation at T760 (P = 0.0754); Loss of catalytic residue at T760 (P = 0.0867); Gain of MoRF binding (P = 0.1128); Gain of phosphorylation at S756 (P = 0.1202)
7:117232500:C:A,P13569,T760K,0.362,Gain of MoRF binding (P = 0.0286); Gain of ubiquitination at T760 (P = 0.0592); Gain of glycosylation at P759 (P = 0.0735); Gain of phosphorylation at T757 (P = 0.0822); Loss of helix (P = 0.1299)
7:117232500:C:G,P13569,T760R,0.41,Gain of MoRF binding (P = 0.0141); Gain of sheet (P = 0.0477); Loss of glycosylation at T760 (P = 0.0523); Gain of phosphorylation at T757 (P = 0.0718); Gain of methylation at T760 (P = 0.1018)
7:117232502:C:A,P13569,L761I,0.305,Gain of glycosylation at T760 (P = 0.0824); Gain of loop (P = 0.1069); Gain of MoRF binding (P = 0.1141); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1842)
7:117232502:C:G,P13569,L761V,0.267,Gain of helix (P = 0.062); Gain of glycosylation at T760 (P = 0.0738); Gain of MoRF binding (P = 0.0916); Gain of loop (P = 0.1069); Loss of sheet (P = 0.1907)
7:117232502:C:T,P13569,L761F,0.364,Loss of disorder (P = 0.1004); Loss of MoRF binding (P = 0.104); Gain of loop (P = 0.1069); Gain of catalytic residue at Q762 (P = 0.114); Loss of glycosylation at S756 (P = 0.1374)
7:117232503:T:A,P13569,L761H,0.292,Gain of loop (P = 0.0435); Gain of glycosylation at S756 (P = 0.1023); Gain of disorder (P = 0.1203); Gain of MoRF binding (P = 0.1215); Loss of sheet (P = 0.1398)
7:117232503:T:C,P13569,L761P,0.503,Gain of glycosylation at L761 (P = 0.0271); Gain of loop (P = 0.0435); Gain of disorder (P = 0.0585); Loss of MoRF binding (P = 0.0588); Gain of phosphorylation at T760 (P = 0.1107)
7:117232503:T:G,P13569,L761R,0.452,Gain of MoRF binding (P = 0.0165); Gain of loop (P = 0.0435); Gain of disorder (P = 0.0558); Gain of helix (P = 0.062); Gain of glycosylation at S756 (P = 0.0746)
7:117232505:C:A,P13569,Q762K,0.312,Gain of methylation at Q762 (P = 0.0317); Gain of MoRF binding (P = 0.0473); Gain of helix (P = 0.062); Gain of glycosylation at P759 (P = 0.1141); Gain of ubiquitination at Q762 (P = 0.1326)
7:117232505:C:G,P13569,Q762E,0.243,Loss of MoRF binding (P = 0.0268); Loss of helix (P = 0.1706); Gain of glycosylation at T760 (P = 0.1763); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232506:A:C,P13569,Q762P,0.409,Gain of glycosylation at Q762 (P = 0.0101); Loss of MoRF binding (P = 0.0446); Gain of helix (P = 0.1736); Gain of phosphorylation at T757 (P = 0.1885); Loss of sheet (P = 0.1907)
7:117232506:A:G,P13569,Q762R,0.235,Gain of MoRF binding (P = 0.0287); Gain of glycosylation at T760 (P = 0.1224); Gain of catalytic residue at Q762 (P = 0.1497); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117232506:A:T,P13569,Q762L,0.383,Loss of disorder (P = 0.0534); Loss of MoRF binding (P = 0.102); Gain of helix (P = 0.132); Gain of stability (P = 0.1735); Loss of sheet (P = 0.1907)
7:117232507:G:C,P13569,Q762H,0.344,Gain of glycosylation at T760 (P = 0.0645); Loss of MoRF binding (P = 0.1017); Loss of disorder (P = 0.1578); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117232507:G:T,P13569,Q762H,0.344,Gain of glycosylation at T760 (P = 0.0645); Loss of MoRF binding (P = 0.1017); Loss of disorder (P = 0.1578); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117232508:G:A,P13569,A763T,0.334,Gain of phosphorylation at A763 (P = 0.055); Loss of MoRF binding (P = 0.1048); Gain of disorder (P = 0.1425); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945)
7:117232508:G:C,P13569,A763P,0.467,Gain of glycosylation at A763 (P = 0.0192); Loss of MoRF binding (P = 0.0444); Gain of loop (P = 0.069); Gain of disorder (P = 0.0725); Gain of phosphorylation at S768 (P = 0.1603)
7:117232508:G:T,P13569,A763S,0.388,Gain of phosphorylation at A763 (P = 0.0296); Gain of disorder (P = 0.0549); Loss of MoRF binding (P = 0.1243); Loss of helix (P = 0.1706); Gain of glycosylation at P759 (P = 0.1918)
7:117232509:C:A,P13569,A763E,0.315,Loss of MoRF binding (P = 0.0235); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Loss of glycosylation at T760 (P = 0.1119); Gain of disorder (P = 0.1126)
7:117232509:C:G,P13569,A763G,0.259,Gain of catalytic residue at P759 (P = 0.0696); Gain of relative solvent accessibility (P = 0.09); Loss of MoRF binding (P = 0.1187); Gain of disorder (P = 0.1649); Loss of helix (P = 0.1706)
7:117232509:C:T,P13569,A763V,0.329,Gain of helix (P = 0.062); Gain of loop (P = 0.069); Gain of MoRF binding (P = 0.1042); Loss of disorder (P = 0.1732); Loss of glycosylation at T760 (P = 0.2022)
7:117232511:C:G,P13569,R764G,0.44,Loss of MoRF binding (P = 0.0232); Loss of stability (P = 0.0367); Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Gain of catalytic residue at A763 (P = 0.1259)
7:117232512:G:A,P13569,R764Q,0.332,Loss of MoRF binding (P = 0.025); Gain of loop (P = 0.0435); Loss of helix (P = 0.0558); Gain of sheet (P = 0.1451); Loss of catalytic residue at R764 (P = 0.1544)
7:117232512:G:C,P13569,R764P,0.45,Loss of MoRF binding (P = 9e-04); Gain of glycosylation at R764 (P = 0.0271); Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Loss of stability (P = 0.1511)
7:117232512:G:T,P13569,R764L,0.42,Loss of MoRF binding (P = 0.018); Loss of disorder (P = 0.0392); Loss of helix (P = 0.0558); Loss of glycosylation at P759 (P = 0.1587); Gain of sheet (P = 0.1945)
7:117232514:A:G,P13569,R765G,0.489,Loss of stability (P = 0.0393); Gain of methylation at R764 (P = 0.0494); Loss of MoRF binding (P = 0.0721); Loss of phosphorylation at S768 (P = 0.074); Loss of catalytic residue at R765 (P = 0.0889)
7:117232514:A:T,P13569,R765W,0.5,Loss of disorder (P = 4e-04); Loss of phosphorylation at S768 (P = 0.0523); Loss of catalytic residue at R765 (P = 0.0765); Gain of helix (P = 0.0854); Loss of glycosylation at T760 (P = 0.1011)
7:117232515:G:A,P13569,R765K,0.418,Gain of helix (P = 0.062); Loss of phosphorylation at S768 (P = 0.074); Loss of stability (P = 0.114); Loss of MoRF binding (P = 0.1375); Loss of sheet (P = 0.1398)
7:117232515:G:C,P13569,R765T,0.495,Loss of MoRF binding (P = 0.0617); Loss of phosphorylation at S768 (P = 0.0666); Loss of stability (P = 0.094); Loss of disorder (P = 0.1822); Loss of sheet (P = 0.1907)
7:117232515:G:T,P13569,R765M,0.457,Loss of phosphorylation at S768 (P = 0.0736); Loss of disorder (P = 0.0849); Gain of helix (P = 0.0854); Loss of MoRF binding (P = 0.1179); Loss of glycosylation at T760 (P = 0.1901)
7:117232516:G:C,P13569,R765S,0.42,Loss of MoRF binding (P = 0.0664); Gain of phosphorylation at R765 (P = 0.0665); Gain of loop (P = 0.069); Loss of stability (P = 0.1033); Loss of sheet (P = 0.1398)
7:117232516:G:T,P13569,R765S,0.42,Loss of MoRF binding (P = 0.0664); Gain of phosphorylation at R765 (P = 0.0665); Gain of loop (P = 0.069); Loss of stability (P = 0.1033); Loss of sheet (P = 0.1398)
7:117232517:A:G,P13569,R766G,0.632,Loss of stability (P = 0.0372); Loss of MoRF binding (P = 0.0718); Loss of phosphorylation at S768 (P = 0.0744); Loss of disorder (P = 0.1359); Loss of helix (P = 0.1706)
7:117232517:A:T,P13569,R766W,0.649,Loss of disorder (P = 4e-04); Loss of phosphorylation at S768 (P = 0.0531); Gain of MoRF binding (P = 0.1407); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945)
7:117232518:G:A,P13569,R766K,0.491,Gain of methylation at R766 (P = 0.0391); Loss of phosphorylation at S768 (P = 0.0752); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1683); Gain of ubiquitination at R766 (P = 0.1767)
7:117232518:G:C,P13569,R766T,0.604,Loss of MoRF binding (P = 0.0625); Gain of phosphorylation at R766 (P = 0.0654); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1807); Gain of sheet (P = 0.1945)
7:117232518:G:T,P13569,R766M,0.842,Loss of phosphorylation at S768 (P = 0.0736); Loss of disorder (P = 0.0832); Loss of MoRF binding (P = 0.1207); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117232519:G:C,P13569,R766S,0.569,Gain of phosphorylation at R766 (P = 0.033); Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.0662); Loss of loop (P = 0.1242); Gain of disorder (P = 0.1918)
7:117232519:G:T,P13569,R766S,0.569,Gain of phosphorylation at R766 (P = 0.033); Gain of helix (P = 0.062); Loss of MoRF binding (P = 0.0662); Loss of loop (P = 0.1242); Gain of disorder (P = 0.1918)
7:117232520:C:A,P13569,Q767K,0.497,Gain of sheet (P = 0.0477); Loss of helix (P = 0.0558); Gain of catalytic residue at Q767 (P = 0.0608); Gain of MoRF binding (P = 0.0892); Gain of ubiquitination at Q767 (P = 0.1008)
7:117232520:C:G,P13569,Q767E,0.421,Loss of MoRF binding (P = 0.0369); Loss of helix (P = 0.0376); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971)
7:117232521:A:C,P13569,Q767P,0.476,Loss of helix (P = 0.0558); Loss of MoRF binding (P = 0.0693); Gain of glycosylation at Q767 (P = 0.0704); Loss of loop (P = 0.0804); Gain of phosphorylation at S768 (P = 0.1398)
7:117232521:A:G,P13569,Q767R,0.422,Loss of helix (P = 0.0558); Gain of MoRF binding (P = 0.0698); Loss of loop (P = 0.0804); Gain of phosphorylation at S768 (P = 0.1019); Gain of relative solvent accessibility (P = 0.1259)
7:117232521:A:T,P13569,Q767L,0.424,Loss of disorder (P = 0.0367); Loss of helix (P = 0.0558); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.2201); Loss of loop (P = 0.2237)
7:117232522:G:C,P13569,Q767H,0.407,Loss of helix (P = 0.0376); Gain of loop (P = 0.069); Loss of disorder (P = 0.1202); Gain of sheet (P = 0.1451); Loss of MoRF binding (P = 0.1862)
7:117232522:G:T,P13569,Q767H,0.407,Loss of helix (P = 0.0376); Gain of loop (P = 0.069); Loss of disorder (P = 0.1202); Gain of sheet (P = 0.1451); Loss of MoRF binding (P = 0.1862)
7:117232523:T:A,P13569,S768T,0.352,Loss of phosphorylation at S768 (P = 0.0679); Loss of disorder (P = 0.1038); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.2085); Gain of loop (P = 0.2754)
7:117232523:T:C,P13569,S768P,0.464,Loss of phosphorylation at S768 (P = 0.0377); Loss of MoRF binding (P = 0.0598); Loss of disorder (P = 0.2319); Loss of loop (P = 0.2897); Loss of stability (P = 0.3794)
7:117232523:T:G,P13569,S768A,0.372,Loss of phosphorylation at S768 (P = 0.0377); Loss of disorder (P = 0.0532); Gain of helix (P = 0.1736); Loss of MoRF binding (P = 0.2089); Loss of loop (P = 0.2897)
7:117232524:C:A,P13569,S768Y,0.475,Loss of disorder (P = 0.0011); Gain of catalytic residue at S768 (P = 0.0546); Loss of phosphorylation at S768 (P = 0.0553); Loss of MoRF binding (P = 0.1486); Loss of helix (P = 0.1706)
7:117232524:C:G,P13569,S768C,0.498,Loss of disorder (P = 0.0072); Loss of phosphorylation at S768 (P = 0.0377); Loss of MoRF binding (P = 0.0754); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945)
7:117232524:C:T,P13569,S768F,0.496,Loss of disorder (P = 0.0012); Loss of phosphorylation at S768 (P = 0.0377); Loss of MoRF binding (P = 0.0996); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754)
7:117232526:G:A,P13569,V769I,0.311,Loss of catalytic residue at V769 (P = 0.0111); Loss of helix (P = 0.0558); Gain of sheet (P = 0.1451); Gain of phosphorylation at S768 (P = 0.2111); Loss of disorder (P = 0.2121)
7:117232526:G:C,P13569,V769L,0.356,Loss of catalytic residue at V769 (P = 0.0073); Loss of helix (P = 0.079); Loss of MoRF binding (P = 0.1495); Gain of disorder (P = 0.189); Gain of sheet (P = 0.1945)
7:117232526:G:T,P13569,V769F,0.393,Loss of catalytic residue at V769 (P = 0.0266); Loss of MoRF binding (P = 0.1099); Loss of disorder (P = 0.1179); Gain of helix (P = 0.132); Loss of phosphorylation at S768 (P = 0.1565)
7:117232527:T:A,P13569,V769D,0.452,Loss of catalytic residue at V769 (P = 0.0021); Gain of relative solvent accessibility (P = 0.0479); Loss of MoRF binding (P = 0.051); Gain of disorder (P = 0.0671); Gain of solvent accessibility (P = 0.0704)
7:117232527:T:C,P13569,V769A,0.329,Loss of catalytic residue at V769 (P = 0.0074); Loss of helix (P = 0.079); Loss of stability (P = 0.0969); Gain of disorder (P = 0.1072); Gain of sheet (P = 0.1451)
7:117232527:T:G,P13569,V769G,0.426,Loss of stability (P = 0.0145); Loss of catalytic residue at V769 (P = 0.0175); Gain of glycosylation at S768 (P = 0.03); Gain of sheet (P = 0.0477); Gain of disorder (P = 0.0675)
7:117232529:C:A,P13569,L770M,0.315,Loss of loop (P = 0.0804); Gain of disorder (P = 0.0893); Gain of MoRF binding (P = 0.1798); Gain of sheet (P = 0.1945); Gain of phosphorylation at S768 (P = 0.1946)
7:117232529:C:G,P13569,L770V,0.275,Gain of helix (P = 0.0854); Gain of MoRF binding (P = 0.208); Gain of phosphorylation at S768 (P = 0.2362); Gain of disorder (P = 0.2596); Gain of loop (P = 0.2754)
7:117232530:T:A,P13569,L770Q,0.372,Gain of disorder (P = 0.0348); Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.0905); Gain of solvent accessibility (P = 0.1045); Gain of helix (P = 0.132)
7:117232530:T:C,P13569,L770P,0.476,Gain of disorder (P = 0.0364); Loss of stability (P = 0.0685); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.0779); Gain of relative solvent accessibility (P = 0.0905)
7:117232530:T:G,P13569,L770R,0.44,Gain of disorder (P = 0.0359); Gain of solvent accessibility (P = 0.0638); Gain of loop (P = 0.069); Gain of MoRF binding (P = 0.0748); Gain of relative solvent accessibility (P = 0.0905)
7:117232532:A:C,P13569,N771H,0.34,Loss of stability (P = 0.1405); Loss of MoRF binding (P = 0.1636); Gain of sheet (P = 0.1945); Loss of disorder (P = 0.2177); Loss of loop (P = 0.2237)
7:117232532:A:G,P13569,N771D,0.341,Loss of MoRF binding (P = 0.0531); Gain of helix (P = 0.062); Loss of sheet (P = 0.1398); Gain of phosphorylation at S768 (P = 0.1527); Loss of disorder (P = 0.1783)
7:117232532:A:T,P13569,N771Y,0.47,Loss of disorder (P = 0.0104); Gain of phosphorylation at N771 (P = 0.0915); Loss of MoRF binding (P = 0.1123); Gain of catalytic residue at N771 (P = 0.1395); Loss of sheet (P = 0.1907)
7:117232533:A:C,P13569,N771T,0.392,Loss of stability (P = 0.0956); Gain of helix (P = 0.1736); Loss of MoRF binding (P = 0.1747); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117232533:A:G,P13569,N771S,0.323,Gain of loop (P = 0.069); Gain of disorder (P = 0.0915); Gain of phosphorylation at S768 (P = 0.1331); Loss of sheet (P = 0.1398); Gain of helix (P = 0.1736)
7:117232533:A:T,P13569,N771I,0.464,Loss of disorder (P = 0.0289); Loss of MoRF binding (P = 0.0973); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of phosphorylation at S768 (P = 0.2311)
7:117232534:C:A,P13569,N771K,0.384,Gain of helix (P = 0.0225); Loss of loop (P = 0.0512); Gain of MoRF binding (P = 0.0847); Loss of stability (P = 0.1265); Loss of sheet (P = 0.1398)
7:117232534:C:G,P13569,N771K,0.384,Gain of helix (P = 0.0225); Loss of loop (P = 0.0512); Gain of MoRF binding (P = 0.0847); Loss of stability (P = 0.1265); Loss of sheet (P = 0.1398)
7:117232535:C:A,P13569,L772M,0.359,Gain of disorder (P = 0.0855); Gain of MoRF binding (P = 0.1741); Gain of glycosylation at T774 (P = 0.1811); Loss of stability (P = 0.1872); Gain of phosphorylation at S768 (P = 0.1922)
7:117232535:C:G,P13569,L772V,0.363,Gain of sheet (P = 0.0266); Loss of helix (P = 0.0376); Gain of loop (P = 0.0435); Loss of stability (P = 0.1576); Gain of MoRF binding (P = 0.2076)
7:117232536:T:A,P13569,L772Q,0.465,Loss of stability (P = 0.0213); Gain of disorder (P = 0.0293); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299); Gain of glycosylation at T774 (P = 0.1474)
7:117232536:T:C,P13569,L772P,0.556,Loss of stability (P = 0.0077); Gain of disorder (P = 0.0305); Gain of loop (P = 0.069); Gain of glycosylation at T774 (P = 0.0696); Loss of MoRF binding (P = 0.0874)
7:117232536:T:G,P13569,L772R,0.523,Loss of stability (P = 0.0264); Gain of disorder (P = 0.0318); Gain of methylation at L772 (P = 0.0617); Gain of MoRF binding (P = 0.0637); Gain of glycosylation at T774 (P = 0.1087)
7:117232538:A:C,P13569,M773L,0.403,Loss of catalytic residue at M773 (P = 0.0034); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.1072); Gain of sheet (P = 0.1945); Loss of helix (P = 0.2022)
7:117232538:A:G,P13569,M773V,0.363,Loss of catalytic residue at M773 (P = 0.016); Loss of disorder (P = 0.1648); Loss of sheet (P = 0.1907); Loss of MoRF binding (P = 0.1968); Gain of loop (P = 0.2045)
7:117232538:A:T,P13569,M773L,0.403,Loss of catalytic residue at M773 (P = 0.0034); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.1072); Gain of sheet (P = 0.1945); Loss of helix (P = 0.2022)
7:117232539:T:A,P13569,M773K,0.475,Loss of stability (P = 0.0047); Loss of catalytic residue at V769 (P = 0.0295); Gain of solvent accessibility (P = 0.0354); Gain of disorder (P = 0.0452); Gain of relative solvent accessibility (P = 0.0479)
7:117232539:T:C,P13569,M773T,0.473,Loss of stability (P = 0.01); Loss of catalytic residue at V769 (P = 0.0274); Gain of glycosylation at M773 (P = 0.0324); Gain of disorder (P = 0.0713); Gain of helix (P = 0.0854)
7:117232539:T:G,P13569,M773R,0.496,Loss of catalytic residue at V769 (P = 0.0258); Loss of stability (P = 0.032); Gain of disorder (P = 0.0421); Gain of solvent accessibility (P = 0.0584); Loss of loop (P = 0.0804)
7:117232540:G:A,P13569,M773I,0.409,Loss of catalytic residue at V769 (P = 0.0205); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of disorder (P = 0.0963); Loss of phosphorylation at S768 (P = 0.1573)
7:117232540:G:C,P13569,M773I,0.409,Loss of catalytic residue at V769 (P = 0.0205); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of disorder (P = 0.0963); Loss of phosphorylation at S768 (P = 0.1573)
7:117232540:G:T,P13569,M773I,0.409,Loss of catalytic residue at V769 (P = 0.0205); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of disorder (P = 0.0963); Loss of phosphorylation at S768 (P = 0.1573)
7:117232541:A:C,P13569,T774P,0.459,Loss of MoRF binding (P = 0.064); Gain of disorder (P = 0.1047); Loss of helix (P = 0.1706); Loss of catalytic residue at T774 (P = 0.184); Gain of sheet (P = 0.1945)
7:117232541:A:G,P13569,T774A,0.321,Loss of disorder (P = 0.1551); Loss of helix (P = 0.1706); Loss of catalytic residue at T774 (P = 0.1856); Loss of sheet (P = 0.1907); Loss of glycosylation at T774 (P = 0.2088)
7:117232541:A:T,P13569,T774S,0.273,Gain of disorder (P = 0.0624); Gain of loop (P = 0.069); Loss of sheet (P = 0.1398); Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.2368)
7:117232542:C:A,P13569,T774K,0.363,Gain of ubiquitination at T774 (P = 0.0539); Gain of helix (P = 0.062); Gain of MoRF binding (P = 0.0794); Gain of disorder (P = 0.1177); Loss of sheet (P = 0.1398)
7:117232542:C:G,P13569,T774R,0.35,Gain of helix (P = 0.062); Gain of MoRF binding (P = 0.0628); Gain of disorder (P = 0.1228); Loss of sheet (P = 0.1398); Loss of glycosylation at T774 (P = 0.2088)
7:117232542:C:T,P13569,T774I,0.416,Loss of disorder (P = 0.0354); Gain of loop (P = 0.069); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Loss of glycosylation at T774 (P = 0.2088)
7:117232544:C:A,P13569,H775N,0.324,Loss of catalytic residue at H775 (P = 0.0396); Gain of disorder (P = 0.0951); Gain of relative solvent accessibility (P = 0.1259); Gain of MoRF binding (P = 0.2175); Loss of loop (P = 0.2237)
7:117232544:C:G,P13569,H775D,0.37,Loss of MoRF binding (P = 0.0671); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Gain of disorder (P = 0.1733); Gain of helix (P = 0.1736)
7:117232544:C:T,P13569,H775Y,0.445,Loss of disorder (P = 0.0294); Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of catalytic residue at L770 (P = 0.1021); Gain of sheet (P = 0.1945)
7:117232545:A:C,P13569,H775P,0.466,Gain of disorder (P = 0.0626); Loss of catalytic residue at H775 (P = 0.0636); Loss of MoRF binding (P = 0.0718); Gain of glycosylation at H775 (P = 0.0946); Gain of loop (P = 0.1069)
7:117232545:A:G,P13569,H775R,0.418,Gain of MoRF binding (P = 0.0569); Gain of disorder (P = 0.0727); Loss of loop (P = 0.0804); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945)
7:117232545:A:T,P13569,H775L,0.373,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Loss of disorder (P = 0.0738); Gain of sheet (P = 0.1945); Loss of MoRF binding (P = 0.2019)
7:117232546:C:A,P13569,H775Q,0.347,Gain of disorder (P = 0.0621); Loss of catalytic residue at H775 (P = 0.1114); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.1992)
7:117232546:C:G,P13569,H775Q,0.347,Gain of disorder (P = 0.0621); Loss of catalytic residue at H775 (P = 0.1114); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.1992)
7:117232547:T:A,P13569,S776T,0.362,Gain of helix (P = 0.062); Loss of disorder (P = 0.0988); Loss of loop (P = 0.1242); Loss of MoRF binding (P = 0.2129); Loss of catalytic residue at L772 (P = 0.3429)
7:117232547:T:C,P13569,S776P,0.464,Loss of helix (P = 0.028); Loss of MoRF binding (P = 0.0599); Gain of loop (P = 0.1069); Gain of catalytic residue at S776 (P = 0.1101); Gain of sheet (P = 0.1945)
7:117232547:T:G,P13569,S776A,0.34,Loss of disorder (P = 0.0524); Loss of helix (P = 0.0626); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.2297)
7:117232548:C:T,P13569,S776L,0.428,Loss of disorder (P = 0.0218); Loss of helix (P = 0.0626); Gain of sheet (P = 0.1945); Gain of stability (P = 0.1992); Loss of loop (P = 0.2237)
7:117232550:G:A,P13569,V777I,0.255,Gain of helix (P = 0.132); Loss of disorder (P = 0.203); Loss of MoRF binding (P = 0.2253); Loss of catalytic residue at V777 (P = 0.2889); Loss of loop (P = 0.2897)
7:117232550:G:C,P13569,V777L,0.348,Gain of loop (P = 0.0312); Loss of helix (P = 0.0376); Loss of MoRF binding (P = 0.1519); Gain of disorder (P = 0.1681); Gain of relative solvent accessibility (P = 0.2363)
7:117232550:G:T,P13569,V777F,0.352,Loss of MoRF binding (P = 0.1124); Loss of disorder (P = 0.1137); Gain of helix (P = 0.132); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117232551:T:A,P13569,V777D,0.43,Loss of MoRF binding (P = 0.0237); Gain of disorder (P = 0.0459); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Loss of helix (P = 0.1706)
7:117232551:T:C,P13569,V777A,0.366,Gain of loop (P = 0.0166); Loss of helix (P = 0.0376); Loss of catalytic residue at V777 (P = 0.0652); Gain of disorder (P = 0.0747); Loss of stability (P = 0.092)
7:117232551:T:G,P13569,V777G,0.481,Loss of stability (P = 0.0176); Gain of disorder (P = 0.0421); Gain of glycosylation at S776 (P = 0.1214); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1468)
7:117232553:A:C,P13569,N778H,0.269,Gain of helix (P = 0.0325); Loss of loop (P = 0.0804); Loss of sheet (P = 0.1398); Loss of MoRF binding (P = 0.1604); Loss of disorder (P = 0.2061)
7:117232553:A:G,P13569,N778D,0.281,Loss of MoRF binding (P = 0.053); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1807); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117232553:A:T,P13569,N778Y,0.368,Loss of disorder (P = 0.0132); Gain of phosphorylation at N778 (P = 0.0409); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Gain of sheet (P = 0.1208)
7:117232554:A:C,P13569,N778T,0.268,Gain of helix (P = 0.062); Gain of glycosylation at N778 (P = 0.1075); Gain of phosphorylation at N778 (P = 0.1431); Loss of sheet (P = 0.1907); Loss of MoRF binding (P = 0.2044)
7:117232554:A:G,P13569,N778S,0.221,Gain of loop (P = 0.069); Loss of helix (P = 0.079); Gain of disorder (P = 0.0918); Gain of sheet (P = 0.1945); Loss of MoRF binding (P = 0.2343)
7:117232554:A:T,P13569,N778I,0.441,Loss of disorder (P = 0.0204); Gain of sheet (P = 0.0477); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.118); Loss of helix (P = 0.1706)
7:117232555:C:A,P13569,N778K,0.322,Gain of methylation at N778 (P = 0.0141); Gain of ubiquitination at N778 (P = 0.0311); Gain of MoRF binding (P = 0.0776); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1823)
7:117232555:C:G,P13569,N778K,0.322,Gain of methylation at N778 (P = 0.0141); Gain of ubiquitination at N778 (P = 0.0311); Gain of MoRF binding (P = 0.0776); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1823)
7:117232556:C:A,P13569,Q779K,0.386,Gain of ubiquitination at Q779 (P = 0.0276); Gain of methylation at Q779 (P = 0.0431); Loss of helix (P = 0.0558); Gain of glycosylation at Q779 (P = 0.0694); Gain of MoRF binding (P = 0.0951)
7:117232556:C:G,P13569,Q779E,0.309,Loss of MoRF binding (P = 0.0376); Gain of relative solvent accessibility (P = 0.1259); Gain of helix (P = 0.132); Loss of disorder (P = 0.1831); Gain of solvent accessibility (P = 0.1903)
7:117232557:A:C,P13569,Q779P,0.369,Gain of loop (P = 0.0195); Loss of helix (P = 0.0237); Loss of MoRF binding (P = 0.068); Gain of relative solvent accessibility (P = 0.09); Loss of stability (P = 0.1171)
7:117232557:A:G,P13569,Q779R,0.335,Gain of MoRF binding (P = 0.073); Gain of relative solvent accessibility (P = 0.1259); Gain of catalytic residue at Q779 (P = 0.1283); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.1319)
7:117232557:A:T,P13569,Q779L,0.353,Loss of disorder (P = 0.0301); Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Gain of sheet (P = 0.1945); Loss of MoRF binding (P = 0.2244)
7:117232558:A:C,P13569,Q779H,0.354,Loss of helix (P = 0.1299); Gain of catalytic residue at Q779 (P = 0.1305); Loss of disorder (P = 0.1591); Loss of MoRF binding (P = 0.1688); Loss of stability (P = 0.2045)
7:117232558:A:T,P13569,Q779H,0.354,Loss of helix (P = 0.1299); Gain of catalytic residue at Q779 (P = 0.1305); Loss of disorder (P = 0.1591); Loss of MoRF binding (P = 0.1688); Loss of stability (P = 0.2045)
7:117232559:G:A,P13569,G780S,0.39,Gain of disorder (P = 0.0501); Gain of glycosylation at G780 (P = 0.0779); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.2428); Gain of loop (P = 0.2754)
7:117232559:G:C,P13569,G780R,0.372,Loss of helix (P = 0.0376); Gain of solvent accessibility (P = 0.0584); Gain of loop (P = 0.069); Gain of disorder (P = 0.0752); Gain of relative solvent accessibility (P = 0.09)
7:117232559:G:T,P13569,G780C,0.435,Loss of disorder (P = 0.0419); Loss of MoRF binding (P = 0.0919); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of catalytic residue at I783 (P = 0.3552)
7:117232560:G:A,P13569,G780D,0.385,Loss of MoRF binding (P = 0.0359); Gain of loop (P = 0.0435); Loss of helix (P = 0.0558); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376)
7:117232560:G:C,P13569,G780A,0.318,Gain of loop (P = 0.0195); Loss of helix (P = 0.0376); Gain of relative solvent accessibility (P = 0.09); Gain of MoRF binding (P = 0.2215); Loss of disorder (P = 0.2256)
7:117232560:G:T,P13569,G780V,0.344,Gain of helix (P = 0.062); Loss of disorder (P = 0.0699); Loss of loop (P = 0.1242); Gain of MoRF binding (P = 0.207); Loss of catalytic residue at I783 (P = 0.3429)
7:117232562:C:A,P13569,Q781K,0.369,Gain of methylation at Q781 (P = 0.0123); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of MoRF binding (P = 0.0982); Gain of ubiquitination at Q781 (P = 0.1326)
7:117232562:C:G,P13569,Q781E,0.338,Loss of helix (P = 0.0376); Loss of MoRF binding (P = 0.0422); Gain of loop (P = 0.069); Gain of ubiquitination at K786 (P = 0.1184); Gain of relative solvent accessibility (P = 0.1259)
7:117232563:A:C,P13569,Q781P,0.417,Loss of MoRF binding (P = 0.0677); Gain of loop (P = 0.1069); Loss of helix (P = 0.1299); Gain of methylation at K786 (P = 0.1593); Gain of disorder (P = 0.2462)
7:117232563:A:G,P13569,Q781R,0.385,Gain of catalytic residue at Q781 (P = 0.0607); Gain of MoRF binding (P = 0.0731); Loss of helix (P = 0.079); Loss of methylation at K786 (P = 0.1048); Gain of sheet (P = 0.1945)
7:117232563:A:T,P13569,Q781L,0.388,Loss of disorder (P = 0.0422); Loss of helix (P = 0.0558); Loss of methylation at K786 (P = 0.0736); Gain of sheet (P = 0.1451); Gain of catalytic residue at Q781 (P = 0.1799)
7:117232564:G:C,P13569,Q781H,0.357,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of catalytic residue at N782 (P = 0.0778); Loss of methylation at K786 (P = 0.1626); Loss of MoRF binding (P = 0.1762)
7:117232564:G:T,P13569,Q781H,0.357,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of catalytic residue at N782 (P = 0.0778); Loss of methylation at K786 (P = 0.1626); Loss of MoRF binding (P = 0.1762)
7:117232565:A:C,P13569,N782H,0.343,Gain of sheet (P = 0.0266); Loss of helix (P = 0.0376); Gain of loop (P = 0.069); Gain of methylation at K786 (P = 0.1214); Loss of MoRF binding (P = 0.1978)
7:117232565:A:G,P13569,N782D,0.347,Loss of helix (P = 0.0558); Loss of MoRF binding (P = 0.0559); Gain of ubiquitination at K786 (P = 0.0938); Gain of loop (P = 0.1069); Loss of glycosylation at T787 (P = 0.1637)
7:117232565:A:T,P13569,N782Y,0.395,Loss of disorder (P = 0.0289); Gain of methylation at K786 (P = 0.0424); Gain of helix (P = 0.0696); Gain of phosphorylation at N782 (P = 0.1009); Loss of loop (P = 0.1242)
7:117232566:A:C,P13569,N782T,0.378,Gain of loop (P = 0.0166); Loss of helix (P = 0.0376); Gain of methylation at K786 (P = 0.0905); Gain of glycosylation at N782 (P = 0.1187); Gain of sheet (P = 0.1451)
7:117232566:A:G,P13569,N782S,0.345,Gain of loop (P = 0.0195); Loss of helix (P = 0.0376); Gain of glycosylation at N782 (P = 0.0925); Gain of phosphorylation at N782 (P = 0.0951); Gain of disorder (P = 0.1128)
7:117232566:A:T,P13569,N782I,0.469,Gain of catalytic residue at N782 (P = 0.0247); Loss of disorder (P = 0.0334); Loss of helix (P = 0.0376); Gain of loop (P = 0.0435); Gain of methylation at K786 (P = 0.0626)
7:117232567:C:A,P13569,N782K,0.743,Gain of glycosylation at N782 (P = 0.0172); Gain of methylation at N782 (P = 0.0253); Loss of helix (P = 0.0376); Gain of loop (P = 0.0435); Gain of MoRF binding (P = 0.0938)
7:117232567:C:G,P13569,N782K,0.743,Gain of glycosylation at N782 (P = 0.0172); Gain of methylation at N782 (P = 0.0253); Loss of helix (P = 0.0376); Gain of loop (P = 0.0435); Gain of MoRF binding (P = 0.0938)
7:117232568:A:C,P13569,I783L,0.272,Loss of methylation at K786 (P = 0.072); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1355); Gain of glycosylation at T787 (P = 0.2035); Gain of loop (P = 0.2045)
7:117232568:A:G,P13569,I783V,0.251,Loss of helix (P = 0.0558); Loss of methylation at K786 (P = 0.1312); Gain of disorder (P = 0.1561); Gain of glycosylation at T787 (P = 0.1643); Gain of loop (P = 0.2045)
7:117232568:A:T,P13569,I783F,0.347,Loss of helix (P = 0.1299); Loss of glycosylation at T787 (P = 0.1555); Loss of methylation at K786 (P = 0.1594); Loss of MoRF binding (P = 0.1636); Gain of catalytic residue at I783 (P = 0.1789)
7:117232569:T:A,P13569,I783N,0.422,Gain of disorder (P = 0.0394); Loss of stability (P = 0.0719); Gain of loop (P = 0.0851); Gain of glycosylation at T787 (P = 0.0954); Loss of helix (P = 0.1299)
7:117232569:T:C,P13569,I783T,0.411,Gain of disorder (P = 0.0421); Gain of phosphorylation at I783 (P = 0.048); Loss of stability (P = 0.0545); Loss of helix (P = 0.0558); Gain of glycosylation at T787 (P = 0.1082)
7:117232569:T:G,P13569,I783S,0.447,Gain of disorder (P = 0.023); Loss of stability (P = 0.0506); Loss of helix (P = 0.0558); Gain of phosphorylation at I783 (P = 0.0905); Gain of glycosylation at T787 (P = 0.0908)
7:117232570:T:G,P13569,I783M,0.365,Gain of disorder (P = 0.0597); Gain of phosphorylation at T788 (P = 0.0765); Gain of methylation at K786 (P = 0.0894); Gain of glycosylation at T787 (P = 0.1144); Loss of helix (P = 0.1299)
7:117232571:C:A,P13569,H784N,0.279,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.09); Loss of stability (P = 0.106); Loss of methylation at K786 (P = 0.1373)
7:117232571:C:G,P13569,H784D,0.412,Loss of MoRF binding (P = 0.0633); Loss of methylation at K786 (P = 0.0759); Gain of ubiquitination at K786 (P = 0.1184); Loss of loop (P = 0.1242); Loss of helix (P = 0.1299)
7:117232571:C:T,P13569,H784Y,0.369,Loss of disorder (P = 0.0439); Loss of helix (P = 0.0558); Gain of catalytic residue at I783 (P = 0.1225); Loss of loop (P = 0.1242); Loss of methylation at K786 (P = 0.1259)
7:117232572:A:C,P13569,H784P,0.423,Loss of helix (P = 0.0558); Loss of stability (P = 0.0932); Gain of methylation at K786 (P = 0.1027); Gain of glycosylation at T787 (P = 0.1064); Loss of MoRF binding (P = 0.1185)
7:117232572:A:G,P13569,H784R,0.3,Gain of loop (P = 0.0312); Loss of helix (P = 0.0376); Gain of phosphorylation at T787 (P = 0.0991); Gain of MoRF binding (P = 0.1058); Loss of methylation at K786 (P = 0.1214)
7:117232572:A:T,P13569,H784L,0.33,Gain of sheet (P = 0.0266); Loss of helix (P = 0.0558); Loss of loop (P = 0.0804); Loss of methylation at K786 (P = 0.0963); Loss of disorder (P = 0.1005)
7:117232573:C:A,P13569,H784Q,0.3,Loss of stability (P = 0.1081); Gain of methylation at K786 (P = 0.1496); Gain of disorder (P = 0.2133); Gain of phosphorylation at T787 (P = 0.2302); Gain of MoRF binding (P = 0.2431)
7:117232573:C:G,P13569,H784Q,0.3,Loss of stability (P = 0.1081); Gain of methylation at K786 (P = 0.1496); Gain of disorder (P = 0.2133); Gain of phosphorylation at T787 (P = 0.2302); Gain of MoRF binding (P = 0.2431)
7:117232574:C:G,P13569,R785G,0.479,Loss of MoRF binding (P = 0.0179); Gain of ubiquitination at K786 (P = 0.0378); Loss of stability (P = 0.0403); Loss of helix (P = 0.0558); Loss of phosphorylation at T787 (P = 0.0728)
7:117232575:G:C,P13569,R785P,0.531,Loss of MoRF binding (P = 7e-04); Gain of glycosylation at T788 (P = 0.0559); Gain of catalytic residue at R785 (P = 0.0611); Gain of ubiquitination at K786 (P = 0.0768); Loss of helix (P = 0.079)
7:117232575:G:T,P13569,R785L,0.509,Loss of MoRF binding (P = 0.0143); Gain of ubiquitination at K786 (P = 0.0514); Loss of helix (P = 0.0558); Loss of phosphorylation at T787 (P = 0.0574); Loss of methylation at K786 (P = 0.0584)
7:117232577:A:C,P13569,K786Q,0.414,Loss of catalytic residue at K786 (P = 0.0215); Loss of methylation at K786 (P = 0.0301); Loss of MoRF binding (P = 0.0746); Loss of phosphorylation at S790 (P = 0.124); Gain of helix (P = 0.1736)
7:117232577:A:G,P13569,K786E,0.409,Loss of MoRF binding (P = 0.0052); Loss of methylation at K786 (P = 0.0301); Gain of helix (P = 0.062); Loss of loop (P = 0.0986); Loss of catalytic residue at K786 (P = 0.1094)
7:117232578:A:C,P13569,K786T,0.449,Loss of methylation at K786 (P = 0.0301); Gain of glycosylation at T787 (P = 0.0564); Gain of catalytic residue at T787 (P = 0.0649); Loss of MoRF binding (P = 0.0659); Gain of loop (P = 0.069)
7:117232578:A:G,P13569,K786R,0.342,Loss of methylation at K786 (P = 0.0388); Gain of phosphorylation at T788 (P = 0.1239); Loss of loop (P = 0.1242); Gain of catalytic residue at T788 (P = 0.1315); Loss of glycosylation at T787 (P = 0.1631)
7:117232578:A:T,P13569,K786M,0.45,Loss of methylation at K786 (P = 0.0301); Gain of sheet (P = 0.0477); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Gain of glycosylation at T787 (P = 0.0846)
7:117232579:G:C,P13569,K786N,0.433,Loss of catalytic residue at K786 (P = 0.0287); Loss of methylation at K786 (P = 0.0301); Loss of MoRF binding (P = 0.0683); Loss of phosphorylation at S790 (P = 0.1104); Gain of glycosylation at T787 (P = 0.1256)
7:117232579:G:T,P13569,K786N,0.433,Loss of catalytic residue at K786 (P = 0.0287); Loss of methylation at K786 (P = 0.0301); Loss of MoRF binding (P = 0.0683); Loss of phosphorylation at S790 (P = 0.1104); Gain of glycosylation at T787 (P = 0.1256)
7:117232580:A:C,P13569,T787P,0.277,Loss of phosphorylation at T787 (P = 0.0367); Loss of MoRF binding (P = 0.093); Gain of methylation at K786 (P = 0.1167); Loss of stability (P = 0.1333); Gain of glycosylation at T791 (P = 0.1488)
7:117232580:A:G,P13569,T787A,0.225,Loss of phosphorylation at T787 (P = 0.0367); Loss of glycosylation at T787 (P = 0.0497); Gain of helix (P = 0.0854); Loss of methylation at K786 (P = 0.1127); Loss of loop (P = 0.1242)
7:117232580:A:T,P13569,T787S,0.299,Loss of glycosylation at T787 (P = 0.0884); Loss of loop (P = 0.0986); Gain of methylation at K786 (P = 0.118); Gain of phosphorylation at T791 (P = 0.1358); Gain of sheet (P = 0.1451)
7:117232581:C:A,P13569,T787K,0.274,Loss of phosphorylation at T787 (P = 0.0367); Gain of helix (P = 0.0425); Gain of MoRF binding (P = 0.106); Loss of glycosylation at T787 (P = 0.1175); Gain of methylation at K786 (P = 0.1199)
7:117232581:C:G,P13569,T787R,0.251,Loss of phosphorylation at T787 (P = 0.0367); Loss of glycosylation at T787 (P = 0.0497); Gain of methylation at K786 (P = 0.0602); Gain of helix (P = 0.0854); Gain of MoRF binding (P = 0.0929)
7:117232581:C:T,P13569,T787I,0.351,Loss of phosphorylation at T787 (P = 0.0367); Gain of helix (P = 0.0425); Loss of glycosylation at T787 (P = 0.0497); Loss of disorder (P = 0.0531); Gain of methylation at K786 (P = 0.0774)
7:117232583:A:C,P13569,T788P,0.324,Gain of glycosylation at T788 (P = 0.0429); Gain of methylation at K786 (P = 0.0457); Loss of MoRF binding (P = 0.0766); Gain of phosphorylation at T787 (P = 0.0835); Gain of loop (P = 0.0851)
7:117232583:A:G,P13569,T788A,0.255,Loss of helix (P = 0.079); Loss of loop (P = 0.0804); Loss of phosphorylation at T788 (P = 0.0903); Loss of glycosylation at T788 (P = 0.1089); Gain of sheet (P = 0.1451)
7:117232583:A:T,P13569,T788S,0.31,Gain of helix (P = 0.0854); Loss of loop (P = 0.0986); Gain of phosphorylation at T787 (P = 0.1292); Gain of MoRF binding (P = 0.1354); Loss of glycosylation at T787 (P = 0.1593)
7:117232584:C:G,P13569,T788R,0.373,Gain of MoRF binding (P = 0.0378); Gain of solvent accessibility (P = 0.0584); Gain of phosphorylation at S790 (P = 0.0806); Gain of relative solvent accessibility (P = 0.09); Loss of glycosylation at T788 (P = 0.1089)
7:117232584:C:T,P13569,T788I,0.39,Gain of methylation at K786 (P = 0.0404); Loss of disorder (P = 0.0523); Loss of phosphorylation at T788 (P = 0.0903); Loss of glycosylation at T788 (P = 0.1089); Loss of MoRF binding (P = 0.1267)
7:117232586:G:A,P13569,A789T,0.24,Loss of loop (P = 0.0374); Gain of phosphorylation at A789 (P = 0.0576); Gain of helix (P = 0.0854); Gain of methylation at K786 (P = 0.0865); Gain of relative solvent accessibility (P = 0.1012)
7:117232586:G:C,P13569,A789P,0.418,Gain of glycosylation at A789 (P = 0.0097); Gain of methylation at K786 (P = 0.0336); Loss of MoRF binding (P = 0.0688); Gain of phosphorylation at T788 (P = 0.0721); Gain of disorder (P = 0.1464)
7:117232586:G:T,P13569,A789S,0.229,Gain of phosphorylation at A789 (P = 0.0571); Gain of methylation at K786 (P = 0.0798); Gain of loop (P = 0.0851); Gain of disorder (P = 0.0966); Gain of relative solvent accessibility (P = 0.1012)
7:117232587:C:A,P13569,A789E,0.313,Gain of methylation at K786 (P = 0.0544); Loss of MoRF binding (P = 0.057); Gain of relative solvent accessibility (P = 0.1012); Loss of glycosylation at T787 (P = 0.1107); Gain of solvent accessibility (P = 0.1133)
7:117232587:C:G,P13569,A789G,0.229,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0512); Gain of methylation at K786 (P = 0.1022); Loss of MoRF binding (P = 0.1385); Loss of helix (P = 0.1706)
7:117232587:C:T,P13569,A789V,0.205,Loss of loop (P = 0.0804); Gain of methylation at K786 (P = 0.0968); Loss of disorder (P = 0.1337); Gain of MoRF binding (P = 0.1401); Loss of helix (P = 0.1706)
7:117232589:T:A,P13569,S790T,0.35,Gain of glycosylation at S790 (P = 0.064); Loss of phosphorylation at S790 (P = 0.0759); Loss of methylation at K786 (P = 0.1139); Loss of MoRF binding (P = 0.1218); Loss of disorder (P = 0.1457)
7:117232589:T:C,P13569,S790P,0.406,Gain of glycosylation at S790 (P = 0.0263); Loss of phosphorylation at S790 (P = 0.0418); Loss of catalytic residue at S790 (P = 0.0537); Loss of MoRF binding (P = 0.0648); Loss of loop (P = 0.0804)
7:117232589:T:G,P13569,S790A,0.3,Loss of phosphorylation at S790 (P = 0.0418); Loss of catalytic residue at S790 (P = 0.044); Loss of disorder (P = 0.0837); Loss of methylation at K786 (P = 0.1009); Gain of MoRF binding (P = 0.137)
7:117232590:C:A,P13569,S790Y,0.376,Loss of disorder (P = 0.011); Loss of loop (P = 0.0374); Loss of phosphorylation at S790 (P = 0.0554); Loss of glycosylation at T791 (P = 0.084); Gain of helix (P = 0.0854)
7:117232590:C:G,P13569,S790C,0.435,Loss of disorder (P = 0.0114); Loss of catalytic residue at S790 (P = 0.0266); Loss of phosphorylation at S790 (P = 0.0418); Loss of MoRF binding (P = 0.078); Loss of glycosylation at T791 (P = 0.0915)
7:117232590:C:T,P13569,S790F,0.392,Loss of disorder (P = 0.0054); Loss of loop (P = 0.0203); Loss of phosphorylation at S790 (P = 0.0418); Gain of helix (P = 0.0425); Loss of glycosylation at T791 (P = 0.0658)
7:117232592:A:C,P13569,T791P,0.396,Gain of glycosylation at T788 (P = 0.0452); Loss of phosphorylation at T791 (P = 0.0654); Loss of MoRF binding (P = 0.0673); Loss of stability (P = 0.0946); Gain of methylation at K786 (P = 0.1576)
7:117232592:A:G,P13569,T791A,0.271,Loss of stability (P = 0.0301); Loss of glycosylation at T791 (P = 0.0407); Loss of phosphorylation at T791 (P = 0.0654); Loss of methylation at K786 (P = 0.0865); Gain of MoRF binding (P = 0.1128)
7:117232592:A:T,P13569,T791S,0.273,Gain of phosphorylation at T788 (P = 0.0851); Gain of methylation at K786 (P = 0.0874); Gain of glycosylation at T791 (P = 0.0985); Gain of disorder (P = 0.1014); Gain of MoRF binding (P = 0.1324)
7:117232593:C:A,P13569,T791K,0.299,Gain of MoRF binding (P = 0.052); Gain of phosphorylation at T788 (P = 0.0612); Loss of catalytic residue at S790 (P = 0.0663); Loss of glycosylation at T791 (P = 0.073); Gain of solvent accessibility (P = 0.0837)
7:117232593:C:G,P13569,T791R,0.302,Gain of MoRF binding (P = 0.0359); Loss of glycosylation at T791 (P = 0.0407); Gain of phosphorylation at T788 (P = 0.057); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09)
7:117232593:C:T,P13569,T791I,0.324,Gain of helix (P = 0.0143); Loss of loop (P = 0.0235); Loss of glycosylation at T791 (P = 0.0407); Loss of disorder (P = 0.044); Gain of catalytic residue at L796 (P = 0.0478)
7:117232596:G:C,P13569,R792P,0.574,Loss of MoRF binding (P = 7e-04); Gain of glycosylation at R792 (P = 0.0232); Loss of stability (P = 0.0664); Loss of catalytic residue at R792 (P = 0.0923); Gain of ubiquitination at K793 (P = 0.0975)
7:117232596:G:T,P13569,R792L,0.524,Loss of MoRF binding (P = 0.0113); Loss of disorder (P = 0.0599); Loss of phosphorylation at S795 (P = 0.0608); Loss of catalytic residue at R792 (P = 0.0699); Loss of glycosylation at T791 (P = 0.1075)
7:117232598:A:C,P13569,K793Q,0.436,Loss of catalytic residue at K793 (P = 0.0296); Loss of MoRF binding (P = 0.0611); Loss of loop (P = 0.0986); Loss of glycosylation at T791 (P = 0.1323); Loss of phosphorylation at S790 (P = 0.1329)
7:117232598:A:G,P13569,K793E,0.394,Loss of MoRF binding (P = 0.0068); Loss of catalytic residue at K793 (P = 0.038); Gain of disorder (P = 0.1448); Gain of glycosylation at S795 (P = 0.151); Loss of loop (P = 0.2237)
7:117232599:A:C,P13569,K793T,0.45,Loss of MoRF binding (P = 0.0549); Loss of catalytic residue at K793 (P = 0.0634); Gain of phosphorylation at K793 (P = 0.0909); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117232599:A:G,P13569,K793R,0.227,Gain of MoRF binding (P = 0.0908); Gain of phosphorylation at S790 (P = 0.1458); Gain of disorder (P = 0.1551); Gain of glycosylation at T791 (P = 0.1718); Gain of sheet (P = 0.1945)
7:117232599:A:T,P13569,K793I,0.51,Loss of disorder (P = 0.0175); Loss of catalytic residue at K793 (P = 0.0563); Loss of MoRF binding (P = 0.0718); Loss of glycosylation at T791 (P = 0.0809); Loss of loop (P = 0.0986)
7:117232600:A:C,P13569,K793N,0.385,Loss of catalytic residue at K793 (P = 0.0455); Loss of MoRF binding (P = 0.0584); Loss of phosphorylation at S795 (P = 0.1218); Gain of glycosylation at T791 (P = 0.1635); Gain of sheet (P = 0.1945)
7:117232600:A:T,P13569,K793N,0.385,Loss of catalytic residue at K793 (P = 0.0455); Loss of MoRF binding (P = 0.0584); Loss of phosphorylation at S795 (P = 0.1218); Gain of glycosylation at T791 (P = 0.1635); Gain of sheet (P = 0.1945)
7:117232601:G:A,P13569,V794M,0.264,Gain of disorder (P = 0.0453); Gain of catalytic residue at V794 (P = 0.0581); Gain of MoRF binding (P = 0.1099); Gain of phosphorylation at S790 (P = 0.1781); Loss of glycosylation at S795 (P = 0.2111)
7:117232601:G:C,P13569,V794L,0.299,Gain of disorder (P = 0.0819); Loss of MoRF binding (P = 0.0966); Loss of sheet (P = 0.1907); Loss of glycosylation at T791 (P = 0.2004); Gain of loop (P = 0.2045)
7:117232601:G:T,P13569,V794L,0.299,Gain of disorder (P = 0.0819); Loss of MoRF binding (P = 0.0966); Loss of sheet (P = 0.1907); Loss of glycosylation at T791 (P = 0.2004); Gain of loop (P = 0.2045)
7:117232602:T:A,P13569,V794E,0.448,Gain of disorder (P = 0.0105); Loss of MoRF binding (P = 0.0279); Gain of ubiquitination at K793 (P = 0.0635); Gain of loop (P = 0.0851); Loss of catalytic residue at K793 (P = 0.0867)
7:117232602:T:C,P13569,V794A,0.323,Gain of disorder (P = 0.036); Gain of glycosylation at T791 (P = 0.0982); Loss of MoRF binding (P = 0.1012); Gain of phosphorylation at S790 (P = 0.1603); Loss of sheet (P = 0.1907)
7:117232602:T:G,P13569,V794G,0.369,Gain of disorder (P = 0.0324); Loss of stability (P = 0.05); Gain of glycosylation at S795 (P = 0.0961); Loss of MoRF binding (P = 0.1015); Gain of relative solvent accessibility (P = 0.1259)
7:117232604:T:A,P13569,S795T,0.362,Loss of loop (P = 0.0374); Gain of sheet (P = 0.0477); Gain of phosphorylation at T791 (P = 0.0979); Loss of disorder (P = 0.103); Loss of glycosylation at S795 (P = 0.1196)
7:117232604:T:C,P13569,S795P,0.396,Loss of phosphorylation at S795 (P = 0.0283); Loss of MoRF binding (P = 0.0578); Gain of glycosylation at T791 (P = 0.1614); Loss of sheet (P = 0.1907); Loss of disorder (P = 0.1908)
7:117232604:T:G,P13569,S795A,0.379,Loss of phosphorylation at S795 (P = 0.0283); Loss of loop (P = 0.0374); Gain of sheet (P = 0.0477); Loss of glycosylation at S795 (P = 0.0501); Loss of disorder (P = 0.0592)
7:117232605:C:T,P13569,S795L,0.454,Loss of disorder (P = 0.0215); Gain of sheet (P = 0.0266); Loss of phosphorylation at S795 (P = 0.0283); Loss of glycosylation at S795 (P = 0.0501); Loss of loop (P = 0.0512)
7:117232607:C:A,P13569,L796M,0.332,Gain of MoRF binding (P = 0.0676); Loss of glycosylation at S795 (P = 0.0836); Gain of disorder (P = 0.1177); Gain of phosphorylation at T791 (P = 0.1837); Loss of sheet (P = 0.1907)
7:117232607:C:G,P13569,L796V,0.226,Gain of MoRF binding (P = 0.0976); Loss of disorder (P = 0.1646); Gain of glycosylation at T791 (P = 0.2182); Gain of phosphorylation at T791 (P = 0.2285); Gain of methylation at K793 (P = 0.3291)
7:117232608:T:A,P13569,L796Q,0.397,Gain of disorder (P = 0.023); Gain of MoRF binding (P = 0.0709); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Loss of sheet (P = 0.1907)
7:117232608:T:C,P13569,L796P,0.473,Gain of disorder (P = 0.023); Loss of loop (P = 0.0374); Gain of helix (P = 0.0425); Gain of glycosylation at L796 (P = 0.0523); Loss of MoRF binding (P = 0.0733)
7:117232608:T:G,P13569,L796R,0.453,Gain of MoRF binding (P = 0.0064); Gain of disorder (P = 0.0239); Gain of solvent accessibility (P = 0.0584); Gain of glycosylation at S795 (P = 0.074); Gain of relative solvent accessibility (P = 0.09)
7:117232610:G:A,P13569,A797T,0.248,Gain of phosphorylation at A797 (P = 0.0543); Gain of disorder (P = 0.0887); Gain of MoRF binding (P = 0.1395); Gain of glycosylation at A797 (P = 0.1516); Gain of sheet (P = 0.1945)
7:117232610:G:C,P13569,A797P,0.573,Gain of catalytic residue at A797 (P = 0.0099); Gain of glycosylation at A797 (P = 0.0411); Gain of disorder (P = 0.0412); Loss of MoRF binding (P = 0.0669); Loss of sheet (P = 0.1907)
7:117232610:G:T,P13569,A797S,0.425,Gain of disorder (P = 0.0251); Gain of phosphorylation at A797 (P = 0.0739); Gain of MoRF binding (P = 0.122); Gain of catalytic residue at A797 (P = 0.1388); Gain of sheet (P = 0.1945)
7:117232611:C:A,P13569,A797D,0.402,Gain of relative solvent accessibility (P = 0.0479); Loss of MoRF binding (P = 0.0645); Gain of disorder (P = 0.0652); Gain of solvent accessibility (P = 0.0704); Loss of loop (P = 0.0804)
7:117232611:C:G,P13569,A797G,0.319,Gain of sheet (P = 0.0266); Loss of loop (P = 0.0374); Loss of stability (P = 0.1094); Gain of disorder (P = 0.1343); Gain of MoRF binding (P = 0.1416)
7:117232611:C:T,P13569,A797V,0.301,Loss of disorder (P = 0.0818); Gain of MoRF binding (P = 0.1171); Gain of sheet (P = 0.1945); Loss of glycosylation at S795 (P = 0.2106); Loss of loop (P = 0.2237)
7:117232613:C:A,P13569,P798T,0.364,Gain of MoRF binding (P = 0.0526); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Gain of phosphorylation at P798 (P = 0.1094); Loss of glycosylation at S795 (P = 0.1402)
7:117232613:C:G,P13569,P798A,0.402,Gain of MoRF binding (P = 0.0434); Gain of catalytic residue at Q799 (P = 0.0769); Loss of disorder (P = 0.1291); Loss of glycosylation at S795 (P = 0.1659); Loss of phosphorylation at T803 (P = 0.1735)
7:117232614:C:A,P13569,P798H,0.344,Gain of MoRF binding (P = 0.0609); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of glycosylation at S795 (P = 0.1114); Loss of phosphorylation at S795 (P = 0.1386)
7:117232614:C:G,P13569,P798R,0.433,Gain of MoRF binding (P = 0.0049); Gain of catalytic residue at P798 (P = 0.0306); Loss of loop (P = 0.0374); Gain of sheet (P = 0.0477); Gain of disorder (P = 0.1069)
7:117232614:C:T,P13569,P798L,0.427,Gain of stability (P = 0.0212); Gain of MoRF binding (P = 0.0454); Loss of disorder (P = 0.0589); Loss of glycosylation at S795 (P = 0.0825); Loss of phosphorylation at S795 (P = 0.1509)
7:117232616:C:A,P13569,Q799K,0.408,Gain of ubiquitination at Q799 (P = 0.0066); Gain of MoRF binding (P = 0.0371); Gain of glycosylation at P798 (P = 0.0571); Gain of catalytic residue at Q799 (P = 0.0641); Gain of disorder (P = 0.1228)
7:117232616:C:G,P13569,Q799E,0.333,Loss of MoRF binding (P = 0.0585); Gain of disorder (P = 0.0953); Gain of phosphorylation at T803 (P = 0.1587); Gain of glycosylation at S795 (P = 0.1632); Gain of relative solvent accessibility (P = 0.1894)
7:117232617:A:C,P13569,Q799P,0.457,Gain of catalytic residue at P798 (P = 0.0113); Gain of relative solvent accessibility (P = 0.0275); Gain of glycosylation at Q799 (P = 0.0275); Loss of MoRF binding (P = 0.0624); Gain of loop (P = 0.0851)
7:117232617:A:G,P13569,Q799R,0.281,Gain of MoRF binding (P = 0.0122); Gain of disorder (P = 0.1642); Gain of glycosylation at P798 (P = 0.1703); Gain of phosphorylation at T803 (P = 0.1768); Loss of sheet (P = 0.1907)
7:117232617:A:T,P13569,Q799L,0.457,Loss of disorder (P = 0.0492); Loss of solvent accessibility (P = 0.0635); Loss of MoRF binding (P = 0.0818); Loss of sheet (P = 0.1158); Gain of stability (P = 0.1417)
7:117232618:G:C,P13569,Q799H,0.375,Gain of sheet (P = 0.0221); Loss of loop (P = 0.0512); Loss of MoRF binding (P = 0.0998); Loss of disorder (P = 0.1188); Loss of solvent accessibility (P = 0.1551)
7:117232618:G:T,P13569,Q799H,0.375,Gain of sheet (P = 0.0221); Loss of loop (P = 0.0512); Loss of MoRF binding (P = 0.0998); Loss of disorder (P = 0.1188); Loss of solvent accessibility (P = 0.1551)
7:117232619:G:A,P13569,A800T,0.261,Gain of disorder (P = 0.0851); Gain of catalytic residue at A800 (P = 0.104); Gain of sheet (P = 0.1208); Gain of MoRF binding (P = 0.142); Gain of loop (P = 0.2045)
7:117232619:G:C,P13569,A800P,0.522,Loss of relative solvent accessibility (P = 0.0071); Gain of disorder (P = 0.0388); Loss of solvent accessibility (P = 0.0442); Gain of sheet (P = 0.0477); Gain of glycosylation at A800 (P = 0.0555)
7:117232619:G:T,P13569,A800S,0.309,Gain of disorder (P = 0.0235); Gain of glycosylation at A800 (P = 0.0513); Gain of phosphorylation at A800 (P = 0.1045); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1213)
7:117232620:C:A,P13569,A800E,0.384,Gain of disorder (P = 0.0282); Gain of solvent accessibility (P = 0.0456); Loss of MoRF binding (P = 0.0713); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045)
7:117232620:C:G,P13569,A800G,0.736,Loss of stability (P = 0.0578); Loss of loop (P = 0.0804); Loss of relative solvent accessibility (P = 0.107); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1282)
7:117232620:C:T,P13569,A800V,0.385,Loss of relative solvent accessibility (P = 0.0186); Gain of catalytic residue at A800 (P = 0.0431); Loss of solvent accessibility (P = 0.0807); Loss of disorder (P = 0.0836); Gain of loop (P = 0.0851)
7:117232622:A:C,P13569,N801H,0.311,Gain of loop (P = 0.0851); Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.1482); Loss of disorder (P = 0.1528); Gain of phosphorylation at T803 (P = 0.1713)
7:117232622:A:G,P13569,N801D,0.329,Loss of MoRF binding (P = 0.0711); Gain of phosphorylation at T803 (P = 0.1058); Loss of catalytic residue at N801 (P = 0.1154); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1329)
7:117232622:A:T,P13569,N801Y,0.426,Loss of disorder (P = 0.0338); Gain of phosphorylation at N801 (P = 0.0519); Gain of catalytic residue at L796 (P = 0.0587); Gain of solvent accessibility (P = 0.1456); Loss of MoRF binding (P = 0.1603)
7:117232623:A:C,P13569,N801T,0.25,Loss of sheet (P = 0.0457); Gain of phosphorylation at N801 (P = 0.0609); Gain of loop (P = 0.0851); Loss of solvent accessibility (P = 0.1177); Gain of MoRF binding (P = 0.1537)
7:117232623:A:G,P13569,N801S,0.221,Gain of glycosylation at N801 (P = 0.0304); Gain of disorder (P = 0.0463); Gain of phosphorylation at N801 (P = 0.0517); Loss of catalytic residue at N801 (P = 0.1075); Gain of sheet (P = 0.1208)
7:117232623:A:T,P13569,N801I,0.411,Loss of disorder (P = 0.0396); Gain of MoRF binding (P = 0.1005); Gain of sheet (P = 0.1208); Loss of catalytic residue at N801 (P = 0.1881); Gain of phosphorylation at T803 (P = 0.2063)
7:117232624:C:A,P13569,N801K,0.387,Gain of ubiquitination at N801 (P = 0.0369); Gain of MoRF binding (P = 0.0474); Gain of solvent accessibility (P = 0.0638); Gain of loop (P = 0.0851); Gain of disorder (P = 0.0912)
7:117232624:C:G,P13569,N801K,0.387,Gain of ubiquitination at N801 (P = 0.0369); Gain of MoRF binding (P = 0.0474); Gain of solvent accessibility (P = 0.0638); Gain of loop (P = 0.0851); Gain of disorder (P = 0.0912)
7:117232625:T:A,P13569,L802M,0.246,Loss of sheet (P = 0.0315); Gain of MoRF binding (P = 0.077); Gain of disorder (P = 0.1129); Gain of catalytic residue at L802 (P = 0.2153); Loss of loop (P = 0.2237)
7:117232625:T:G,P13569,L802V,0.264,Gain of sheet (P = 0.0827); Gain of MoRF binding (P = 0.1136); Loss of disorder (P = 0.1505); Gain of catalytic residue at L802 (P = 0.1593); Gain of phosphorylation at T803 (P = 0.2063)
7:117232626:T:C,P13569,L802S,0.44,Gain of disorder (P = 0.0081); Loss of stability (P = 0.0451); Loss of sheet (P = 0.0817); Gain of phosphorylation at L802 (P = 0.0823); Gain of relative solvent accessibility (P = 0.09)
7:117232626:T:G,P13569,L802W,0.392,Loss of sheet (P = 0.0315); Loss of disorder (P = 0.038); Gain of MoRF binding (P = 0.0441); Loss of stability (P = 0.0822); Loss of phosphorylation at T803 (P = 0.1674)
7:117232627:G:C,P13569,L802F,0.309,Loss of disorder (P = 0.0849); Loss of MoRF binding (P = 0.1846); Gain of sheet (P = 0.1945); Gain of phosphorylation at T803 (P = 0.2205); Loss of loop (P = 0.2237)
7:117232627:G:T,P13569,L802F,0.309,Loss of disorder (P = 0.0849); Loss of MoRF binding (P = 0.1846); Gain of sheet (P = 0.1945); Gain of phosphorylation at T803 (P = 0.2205); Loss of loop (P = 0.2237)
7:117232628:A:C,P13569,T803P,0.435,Loss of sheet (P = 0.0315); Gain of helix (P = 0.0496); Loss of phosphorylation at T803 (P = 0.0522); Gain of disorder (P = 0.0748); Loss of loop (P = 0.0986)
7:117232628:A:G,P13569,T803A,0.211,Loss of phosphorylation at T803 (P = 0.0522); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.171); Gain of MoRF binding (P = 0.2411); Loss of loop (P = 0.3664)
7:117232628:A:T,P13569,T803S,0.261,Gain of disorder (P = 0.0362); Loss of sheet (P = 0.0817); Gain of phosphorylation at T803 (P = 0.2036); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2198)
7:117232629:C:A,P13569,T803N,0.255,Loss of sheet (P = 0.0315); Loss of phosphorylation at T803 (P = 0.0522); Gain of disorder (P = 0.1327); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117232629:C:G,P13569,T803S,0.261,Gain of disorder (P = 0.0362); Loss of sheet (P = 0.0817); Gain of phosphorylation at T803 (P = 0.2036); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2198)
7:117232629:C:T,P13569,T803I,0.338,Loss of disorder (P = 0.0493); Loss of phosphorylation at T803 (P = 0.0522); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.2367); Gain of catalytic residue at L805 (P = 0.3058)
7:117232631:G:A,P13569,E804K,0.413,Gain of MoRF binding (P = 0.0086); Gain of ubiquitination at E804 (P = 0.0138); Loss of sheet (P = 0.1158); Loss of phosphorylation at Y808 (P = 0.1783); Loss of disorder (P = 0.1879)
7:117232631:G:C,P13569,E804Q,0.426,Gain of MoRF binding (P = 0.0657); Loss of sheet (P = 0.1158); Loss of phosphorylation at Y808 (P = 0.157); Loss of solvent accessibility (P = 0.1744); Loss of catalytic residue at E804 (P = 0.1916)
7:117232632:A:C,P13569,E804A,0.45,Loss of disorder (P = 0.0627); Gain of MoRF binding (P = 0.0643); Loss of sheet (P = 0.1158); Loss of phosphorylation at Y808 (P = 0.1413); Loss of catalytic residue at E804 (P = 0.2151)
7:117232632:A:G,P13569,E804G,0.464,Gain of MoRF binding (P = 0.0661); Loss of disorder (P = 0.0849); Loss of sheet (P = 0.1158); Loss of stability (P = 0.1422); Loss of phosphorylation at Y808 (P = 0.1549)
7:117232632:A:T,P13569,E804V,0.795,Loss of disorder (P = 0.0168); Gain of MoRF binding (P = 0.0538); Loss of sheet (P = 0.1158); Loss of phosphorylation at S809 (P = 0.1238); Gain of helix (P = 0.2059)
7:117232633:A:C,P13569,E804D,0.313,Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1791); Loss of phosphorylation at Y808 (P = 0.182); Loss of catalytic residue at E804 (P = 0.2373); Gain of helix (P = 0.2684)
7:117232633:A:T,P13569,E804D,0.313,Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1791); Loss of phosphorylation at Y808 (P = 0.182); Loss of catalytic residue at E804 (P = 0.2373); Gain of helix (P = 0.2684)
7:117232634:C:A,P13569,L805M,0.29,Gain of phosphorylation at Y808 (P = 0.0965); Gain of disorder (P = 0.1068); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.2368); Loss of helix (P = 0.2662)
7:117232634:C:G,P13569,L805V,0.358,Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1333); Loss of stability (P = 0.1392); Gain of phosphorylation at T803 (P = 0.1479); Loss of loop (P = 0.2237)
7:117232635:T:A,P13569,L805Q,0.435,Gain of disorder (P = 0.0134); Loss of stability (P = 0.04); Gain of phosphorylation at Y808 (P = 0.1018); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045)
7:117232635:T:C,P13569,L805P,0.585,Gain of disorder (P = 0.0128); Loss of stability (P = 0.0181); Gain of phosphorylation at T803 (P = 0.0864); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045)
7:117232635:T:G,P13569,L805R,0.435,Gain of disorder (P = 0.0141); Loss of stability (P = 0.0241); Gain of MoRF binding (P = 0.0517); Gain of phosphorylation at T803 (P = 0.0705); Loss of sheet (P = 0.1158)
7:117232637:G:A,P13569,D806N,0.425,Gain of loop (P = 0.0195); Loss of sheet (P = 0.0228); Loss of phosphorylation at Y808 (P = 0.0952); Gain of disorder (P = 0.1379); Gain of MoRF binding (P = 0.1395)
7:117232637:G:C,P13569,D806H,0.64,Gain of sheet (P = 0.0827); Loss of phosphorylation at Y808 (P = 0.107); Loss of disorder (P = 0.1118); Gain of catalytic residue at L805 (P = 0.1839); Gain of MoRF binding (P = 0.208)
7:117232637:G:T,P13569,D806Y,0.536,Loss of disorder (P = 0.0272); Loss of phosphorylation at Y808 (P = 0.0906); Loss of sheet (P = 0.1158); Gain of catalytic residue at D806 (P = 0.1342); Loss of loop (P = 0.2237)
7:117232638:A:C,P13569,D806A,0.574,Loss of phosphorylation at Y808 (P = 0.1024); Loss of disorder (P = 0.1041); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1724); Loss of stability (P = 0.1912)
7:117232638:A:G,P13569,D806G,0.783,Gain of sheet (P = 0.0827); Loss of phosphorylation at Y808 (P = 0.1086); Loss of stability (P = 0.1293); Loss of disorder (P = 0.1705); Gain of MoRF binding (P = 0.1845)
7:117232638:A:T,P13569,D806V,0.578,Loss of disorder (P = 0.0281); Loss of phosphorylation at Y808 (P = 0.1017); Loss of sheet (P = 0.1158); Gain of catalytic residue at S809 (P = 0.1452); Gain of MoRF binding (P = 0.1497)
7:117232639:T:A,P13569,D806E,0.327,Gain of disorder (P = 0.0585); Loss of sheet (P = 0.1158); Loss of phosphorylation at Y808 (P = 0.1168); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2629)
7:117232639:T:G,P13569,D806E,0.327,Gain of disorder (P = 0.0585); Loss of sheet (P = 0.1158); Loss of phosphorylation at Y808 (P = 0.1168); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2629)
7:117232640:A:C,P13569,I807L,0.463,Loss of catalytic residue at I807 (P = 0.0265); Gain of disorder (P = 0.069); Gain of sheet (P = 0.0827); Gain of phosphorylation at T803 (P = 0.1346); Loss of helix (P = 0.2662)
7:117232640:A:G,P13569,I807V,0.403,Loss of catalytic residue at I807 (P = 0.0288); Gain of phosphorylation at Y808 (P = 0.1069); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1826); Loss of helix (P = 0.2662)
7:117232640:A:T,P13569,I807L,0.463,Loss of catalytic residue at I807 (P = 0.0265); Gain of disorder (P = 0.069); Gain of sheet (P = 0.0827); Gain of phosphorylation at T803 (P = 0.1346); Loss of helix (P = 0.2662)
7:117232641:T:A,P13569,I807K,0.534,Gain of disorder (P = 0.003); Gain of ubiquitination at I807 (P = 0.0054); Loss of stability (P = 0.0443); Loss of catalytic residue at I807 (P = 0.0509); Gain of glycosylation at I807 (P = 0.0718)
7:117232641:T:C,P13569,I807T,0.46,Gain of disorder (P = 0.0098); Gain of loop (P = 0.0195); Loss of catalytic residue at I807 (P = 0.0222); Loss of sheet (P = 0.0228); Gain of phosphorylation at I807 (P = 0.0274)
7:117232641:T:G,P13569,I807R,0.55,Gain of disorder (P = 0.0047); Loss of catalytic residue at I807 (P = 0.0441); Gain of MoRF binding (P = 0.0539); Gain of phosphorylation at T803 (P = 0.1003); Loss of sheet (P = 0.1158)
7:117232643:T:A,P13569,Y808N,0.535,Gain of disorder (P = 0.0043); Loss of sheet (P = 0.0315); Loss of phosphorylation at Y808 (P = 0.0562); Loss of catalytic residue at I807 (P = 0.0769); Loss of stability (P = 0.1433)
7:117232643:T:C,P13569,Y808H,0.537,Gain of disorder (P = 0.013); Loss of sheet (P = 0.0315); Loss of phosphorylation at Y808 (P = 0.0562); Loss of catalytic residue at I807 (P = 0.0604); Loss of stability (P = 0.1089)
7:117232643:T:G,P13569,Y808D,0.588,Gain of disorder (P = 0.0024); Loss of sheet (P = 0.0315); Loss of phosphorylation at Y808 (P = 0.0562); Loss of catalytic residue at I807 (P = 0.0867); Gain of helix (P = 0.2059)
7:117232644:A:C,P13569,Y808S,0.567,Gain of disorder (P = 9e-04); Loss of catalytic residue at Y808 (P = 0.0588); Gain of phosphorylation at Y808 (P = 0.0652); Loss of sheet (P = 0.0817); Loss of stability (P = 0.1086)
7:117232644:A:G,P13569,Y808C,0.477,Loss of catalytic residue at I807 (P = 0.0452); Gain of disorder (P = 0.0515); Loss of phosphorylation at Y808 (P = 0.0562); Loss of sheet (P = 0.0817); Gain of loop (P = 0.2754)
7:117232644:A:T,P13569,Y808F,0.369,Loss of catalytic residue at I807 (P = 0.0407); Loss of phosphorylation at Y808 (P = 0.0562); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.1382); Gain of helix (P = 0.2059)
7:117232646:T:A,P13569,S809T,0.404,Loss of disorder (P = 0.0814); Loss of phosphorylation at S809 (P = 0.0974); Loss of sheet (P = 0.1158); Loss of catalytic residue at Y808 (P = 0.2418); Gain of helix (P = 0.2684)
7:117232646:T:C,P13569,S809P,0.538,Gain of loop (P = 0.0312); Loss of phosphorylation at S809 (P = 0.0319); Loss of sheet (P = 0.0457); Gain of catalytic residue at S809 (P = 0.0808); Loss of disorder (P = 0.1529)
7:117232646:T:G,P13569,S809A,0.441,Loss of phosphorylation at S809 (P = 0.0319); Loss of disorder (P = 0.0407); Gain of sheet (P = 0.0827); Loss of catalytic residue at R811 (P = 0.2604); Loss of helix (P = 0.2662)
7:117232647:C:T,P13569,S809L,0.499,Loss of disorder (P = 0.0181); Loss of phosphorylation at S809 (P = 0.0319); Gain of catalytic residue at S809 (P = 0.0498); Gain of sheet (P = 0.1208); Gain of stability (P = 0.1621)
7:117232650:G:A,P13569,R810K,0.482,Gain of ubiquitination at R810 (P = 0.0048); Loss of stability (P = 0.045); Loss of phosphorylation at S809 (P = 0.0929); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1529)
7:117232650:G:C,P13569,R810T,0.529,Loss of stability (P = 0.031); Gain of glycosylation at R810 (P = 0.0746); Loss of phosphorylation at S809 (P = 0.1009); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.181)
7:117232650:G:T,P13569,R810I,0.569,Loss of disorder (P = 0.0199); Gain of sheet (P = 0.0344); Loss of phosphorylation at S809 (P = 0.117); Loss of catalytic residue at R810 (P = 0.12); Loss of loop (P = 0.2237)
7:117232651:A:C,P13569,R810S,0.514,Gain of glycosylation at R810 (P = 0.0251); Gain of phosphorylation at R810 (P = 0.0407); Loss of stability (P = 0.063); Gain of disorder (P = 0.0882); Loss of sheet (P = 0.1158)
7:117232651:A:T,P13569,R810S,0.514,Gain of glycosylation at R810 (P = 0.0251); Gain of phosphorylation at R810 (P = 0.0407); Loss of stability (P = 0.063); Gain of disorder (P = 0.0882); Loss of sheet (P = 0.1158)
7:117232652:A:G,P13569,R811G,0.5,Gain of relative solvent accessibility (P = 0.0166); Gain of loop (P = 0.0312); Loss of stability (P = 0.0607); Loss of catalytic residue at R811 (P = 0.1092); Loss of sheet (P = 0.1158)
7:117232652:A:T,P13569,R811W,0.532,Loss of disorder (P = 0.001); Gain of helix (P = 0.0225); Loss of sheet (P = 0.0228); Loss of catalytic residue at R811 (P = 0.0575); Loss of phosphorylation at S809 (P = 0.0648)
7:117232653:G:A,P13569,R811K,0.392,Gain of ubiquitination at R811 (P = 0.0075); Loss of catalytic residue at R811 (P = 0.0655); Gain of sheet (P = 0.0827); Loss of phosphorylation at S809 (P = 0.1457); Gain of disorder (P = 0.1597)
7:117232653:G:C,P13569,R811T,0.495,Gain of phosphorylation at R811 (P = 0.0737); Loss of catalytic residue at R811 (P = 0.0739); Gain of sheet (P = 0.0827); Loss of solvent accessibility (P = 0.1077); Loss of disorder (P = 0.1854)
7:117232653:G:T,P13569,R811M,0.495,Loss of catalytic residue at R811 (P = 0.0562); Loss of disorder (P = 0.0676); Gain of phosphorylation at Y808 (P = 0.0783); Gain of sheet (P = 0.0827); Loss of solvent accessibility (P = 0.1077)
7:117232654:G:C,P13569,R811S,0.461,Gain of phosphorylation at R811 (P = 0.0302); Gain of sheet (P = 0.0827); Gain of disorder (P = 0.0904); Loss of catalytic residue at R811 (P = 0.1457); Loss of solvent accessibility (P = 0.1651)
7:117232654:G:T,P13569,R811S,0.461,Gain of phosphorylation at R811 (P = 0.0302); Gain of sheet (P = 0.0827); Gain of disorder (P = 0.0904); Loss of catalytic residue at R811 (P = 0.1457); Loss of solvent accessibility (P = 0.1651)
7:117232655:T:A,P13569,L812I,0.274,Gain of loop (P = 0.069); Loss of sheet (P = 0.1158); Loss of phosphorylation at Y808 (P = 0.1433); Loss of disorder (P = 0.1559); Gain of helix (P = 0.2684)
7:117232655:T:G,P13569,L812V,0.289,Loss of catalytic residue at L812 (P = 0.0664); Gain of loop (P = 0.069); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1336); Gain of phosphorylation at Y808 (P = 0.1612)
7:117232656:T:C,P13569,L812S,0.434,Gain of phosphorylation at L812 (P = 0.007); Gain of disorder (P = 0.0128); Loss of stability (P = 0.0184); Loss of catalytic residue at L812 (P = 0.0983); Gain of glycosylation at S809 (P = 0.1416)
7:117232657:A:C,P13569,L812F,0.279,Gain of loop (P = 0.0435); Gain of sheet (P = 0.0507); Loss of disorder (P = 0.1123); Loss of stability (P = 0.1373); Loss of phosphorylation at S809 (P = 0.1955)
7:117232657:A:T,P13569,L812F,0.279,Gain of loop (P = 0.0435); Gain of sheet (P = 0.0507); Loss of disorder (P = 0.1123); Loss of stability (P = 0.1373); Loss of phosphorylation at S809 (P = 0.1955)
7:117232658:T:A,P13569,S813T,0.356,Gain of loop (P = 0.0195); Loss of sheet (P = 0.0228); Loss of disorder (P = 0.0846); Loss of phosphorylation at S809 (P = 0.1512); Loss of helix (P = 0.2022)
7:117232658:T:C,P13569,S813P,0.771,Loss of phosphorylation at S813 (P = 0.0058); Gain of catalytic residue at S813 (P = 0.0458); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1518); Gain of loop (P = 0.2045)
7:117232658:T:G,P13569,S813A,0.445,Loss of phosphorylation at S813 (P = 0.0058); Loss of disorder (P = 0.0425); Loss of sheet (P = 0.0457); Gain of loop (P = 0.069); Loss of helix (P = 0.2662)
7:117232659:C:A,P13569,S813Y,0.476,Loss of disorder (P = 0.0066); Loss of phosphorylation at S813 (P = 0.0221); Gain of sheet (P = 0.1208); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117232659:C:G,P13569,S813C,0.462,Loss of disorder (P = 0.0056); Loss of phosphorylation at S813 (P = 0.0058); Gain of loop (P = 0.1069); Loss of sheet (P = 0.1158); Loss of helix (P = 0.2662)
7:117232659:C:T,P13569,S813F,0.488,Loss of disorder (P = 0.003); Loss of phosphorylation at S813 (P = 0.0058); Loss of sheet (P = 0.1158); Gain of catalytic residue at S813 (P = 0.1339); Gain of loop (P = 0.2045)
7:117232661:C:A,P13569,Q814K,0.346,Gain of ubiquitination at Q814 (P = 0.0039); Gain of sheet (P = 0.1208); Gain of glycosylation at Q814 (P = 0.1295); Gain of phosphorylation at T816 (P = 0.1383); Gain of disorder (P = 0.1722)
7:117232661:C:G,P13569,Q814E,0.291,Gain of sheet (P = 0.0477); Gain of loop (P = 0.069); Gain of disorder (P = 0.0941); Gain of phosphorylation at S809 (P = 0.1821); Loss of helix (P = 0.2662)
7:117232662:A:C,P13569,Q814P,0.326,Gain of loop (P = 0.0195); Gain of sheet (P = 0.0344); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at T816 (P = 0.0968); Gain of glycosylation at Q814 (P = 0.1345)
7:117232662:A:G,P13569,Q814R,0.198,Gain of phosphorylation at T816 (P = 0.0701); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1564); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662)
7:117232662:A:T,P13569,Q814L,0.315,Gain of loop (P = 0.0435); Gain of sheet (P = 0.0477); Loss of disorder (P = 0.0555); Gain of relative solvent accessibility (P = 0.09); Loss of helix (P = 0.2022)
7:117232663:A:C,P13569,Q814H,0.222,Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1521); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662); Loss of solvent accessibility (P = 0.2668)
7:117232663:A:T,P13569,Q814H,0.222,Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1521); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662); Loss of solvent accessibility (P = 0.2668)
7:117232664:G:A,P13569,E815K,0.432,Gain of ubiquitination at E815 (P = 0.0075); Gain of loop (P = 0.0195); Loss of sheet (P = 0.0228); Loss of disorder (P = 0.1716); Loss of helix (P = 0.2022)
7:117232664:G:C,P13569,E815Q,0.345,Gain of sheet (P = 0.0221); Gain of loop (P = 0.0435); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of disorder (P = 0.1589)
7:117232665:A:C,P13569,E815A,0.352,Gain of loop (P = 0.0195); Gain of sheet (P = 0.0221); Loss of disorder (P = 0.0447); Loss of helix (P = 0.2022); Loss of solvent accessibility (P = 0.2106)
7:117232665:A:G,P13569,E815G,0.362,Gain of loop (P = 0.0195); Loss of sheet (P = 0.0228); Loss of stability (P = 0.075); Loss of disorder (P = 0.0894); Gain of catalytic residue at T816 (P = 0.1854)
7:117232665:A:T,P13569,E815V,0.43,Loss of disorder (P = 0.0053); Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Gain of catalytic residue at E819 (P = 0.1696); Loss of helix (P = 0.2022)
7:117232666:A:C,P13569,E815D,0.323,Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Loss of disorder (P = 0.1725); Loss of helix (P = 0.2022); Gain of phosphorylation at T816 (P = 0.2238)
7:117232666:A:T,P13569,E815D,0.323,Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Loss of disorder (P = 0.1725); Loss of helix (P = 0.2022); Gain of phosphorylation at T816 (P = 0.2238)
7:117232667:A:C,P13569,T816P,0.304,Gain of loop (P = 0.069); Gain of glycosylation at T816 (P = 0.086); Loss of phosphorylation at T816 (P = 0.1); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.147)
7:117232667:A:G,P13569,T816A,0.299,Gain of loop (P = 0.0195); Loss of sheet (P = 0.0228); Loss of phosphorylation at T816 (P = 0.1); Loss of disorder (P = 0.1792); Loss of stability (P = 0.3927)
7:117232667:A:T,P13569,T816S,0.239,Gain of phosphorylation at T816 (P = 0.0532); Gain of glycosylation at T816 (P = 0.0732); Gain of disorder (P = 0.0739); Gain of relative solvent accessibility (P = 0.09); Loss of loop (P = 0.0986)
7:117232668:C:A,P13569,T816N,0.275,Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Loss of phosphorylation at T816 (P = 0.1); Gain of disorder (P = 0.2312); Loss of catalytic residue at T816 (P = 0.3156)
7:117232668:C:G,P13569,T816S,0.239,Gain of phosphorylation at T816 (P = 0.0532); Gain of glycosylation at T816 (P = 0.0732); Gain of disorder (P = 0.0739); Gain of relative solvent accessibility (P = 0.09); Loss of loop (P = 0.0986)
7:117232668:C:T,P13569,T816I,0.305,Loss of disorder (P = 0.0605); Gain of loop (P = 0.069); Loss of phosphorylation at T816 (P = 0.1); Loss of sheet (P = 0.1158); Gain of catalytic residue at T816 (P = 0.1716)
7:117232670:G:A,P13569,G817S,0.28,Gain of phosphorylation at G817 (P = 0.0238); Gain of disorder (P = 0.0452); Gain of glycosylation at G817 (P = 0.0481); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232670:G:C,P13569,G817R,0.252,Gain of solvent accessibility (P = 0.0456); Gain of disorder (P = 0.0727); Gain of phosphorylation at T816 (P = 0.1367); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232670:G:T,P13569,G817C,0.306,Loss of loop (P = 0.0374); Gain of helix (P = 0.0496); Loss of disorder (P = 0.0521); Gain of catalytic residue at L818 (P = 0.1564); Loss of sheet (P = 0.1907)
7:117232671:G:A,P13569,G817D,0.26,Gain of disorder (P = 0.095); Gain of solvent accessibility (P = 0.1583); Gain of phosphorylation at T816 (P = 0.1904); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232671:G:C,P13569,G817A,0.266,Gain of loop (P = 0.0312); Gain of sheet (P = 0.1208); Loss of catalytic residue at L818 (P = 0.2016); Gain of helix (P = 0.2059); Gain of disorder (P = 0.2364)
7:117232673:T:A,P13569,L818M,0.314,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0986); Gain of disorder (P = 0.1901); Gain of phosphorylation at T816 (P = 0.2475); Loss of catalytic residue at L818 (P = 0.4842)
7:117232673:T:G,P13569,L818V,0.273,Loss of loop (P = 0.0986); Loss of disorder (P = 0.1792); Gain of sheet (P = 0.1945); Gain of helix (P = 0.2059); Gain of phosphorylation at T816 (P = 0.2172)
7:117232674:T:C,P13569,L818S,0.401,Gain of phosphorylation at L818 (P = 0.0169); Gain of disorder (P = 0.0433); Gain of sheet (P = 0.0477); Loss of loop (P = 0.0986); Gain of glycosylation at L818 (P = 0.1004)
7:117232674:T:G,P13569,L818W,0.395,Loss of loop (P = 0.0374); Gain of sheet (P = 0.0477); Loss of disorder (P = 0.059); Loss of phosphorylation at S821 (P = 0.223); Gain of helix (P = 0.2684)
7:117232675:G:C,P13569,L818F,0.329,Gain of sheet (P = 0.0266); Loss of loop (P = 0.0374); Loss of disorder (P = 0.1595); Gain of phosphorylation at T816 (P = 0.2052); Loss of catalytic residue at L818 (P = 0.3535)
7:117232675:G:T,P13569,L818F,0.329,Gain of sheet (P = 0.0266); Loss of loop (P = 0.0374); Loss of disorder (P = 0.1595); Gain of phosphorylation at T816 (P = 0.2052); Loss of catalytic residue at L818 (P = 0.3535)
7:117232676:G:A,P13569,E819K,0.325,Gain of ubiquitination at E819 (P = 0.0025); Gain of sheet (P = 0.1208); Gain of glycosylation at E819 (P = 0.1226); Loss of phosphorylation at S821 (P = 0.1873); Loss of disorder (P = 0.2213)
7:117232676:G:C,P13569,E819Q,0.262,Gain of sheet (P = 0.1208); Loss of phosphorylation at S821 (P = 0.126); Loss of disorder (P = 0.1718); Loss of solvent accessibility (P = 0.3473); Gain of loop (P = 0.4248)
7:117232677:A:C,P13569,E819A,0.3,Loss of disorder (P = 0.041); Loss of phosphorylation at S821 (P = 0.1383); Gain of loop (P = 0.2045); Loss of solvent accessibility (P = 0.3473); Loss of sheet (P = 0.3635)
7:117232677:A:G,P13569,E819G,0.253,Loss of loop (P = 0.0203); Loss of disorder (P = 0.13); Gain of sheet (P = 0.1451); Loss of phosphorylation at S821 (P = 0.181); Gain of helix (P = 0.2059)
7:117232677:A:T,P13569,E819V,0.45,Loss of disorder (P = 0.0036); Gain of sheet (P = 0.0344); Loss of phosphorylation at S821 (P = 0.0929); Gain of catalytic residue at E822 (P = 0.1639); Loss of loop (P = 0.2897)
7:117232678:A:C,P13569,E819D,0.223,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0512); Gain of phosphorylation at T816 (P = 0.1703); Loss of disorder (P = 0.1936); Gain of relative solvent accessibility (P = 0.2629)
7:117232678:A:T,P13569,E819D,0.223,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0512); Gain of phosphorylation at T816 (P = 0.1703); Loss of disorder (P = 0.1936); Gain of relative solvent accessibility (P = 0.2629)
7:117232679:A:C,P13569,I820L,0.283,Gain of phosphorylation at T816 (P = 0.1407); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2161); Loss of catalytic residue at E822 (P = 0.3886)
7:117232679:A:G,P13569,I820V,0.27,Loss of catalytic residue at I820 (P = 0.0596); Gain of sheet (P = 0.1208); Gain of loop (P = 0.2045); Gain of phosphorylation at T816 (P = 0.2101); Gain of disorder (P = 0.3301)
7:117232679:A:T,P13569,I820L,0.283,Gain of phosphorylation at T816 (P = 0.1407); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2161); Loss of catalytic residue at E822 (P = 0.3886)
7:117232680:T:A,P13569,I820K,0.474,Gain of ubiquitination at I820 (P = 0.0016); Gain of glycosylation at I820 (P = 0.0393); Loss of catalytic residue at I820 (P = 0.0546); Loss of stability (P = 0.0811); Gain of disorder (P = 0.0896)
7:117232680:T:C,P13569,I820T,0.353,Loss of catalytic residue at I820 (P = 0.0423); Loss of loop (P = 0.0512); Gain of phosphorylation at I820 (P = 0.0528); Loss of stability (P = 0.0731); Gain of disorder (P = 0.1146)
7:117232680:T:G,P13569,I820R,0.337,Gain of disorder (P = 0.0759); Gain of phosphorylation at T816 (P = 0.0952); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of stability (P = 0.22)
7:117232681:A:G,P13569,I820M,0.293,Loss of catalytic residue at I820 (P = 0.1221); Gain of phosphorylation at T816 (P = 0.1374); Gain of disorder (P = 0.1677); Loss of sheet (P = 0.3635); Loss of loop (P = 0.4412)
7:117232682:A:C,P13569,S821R,0.369,Loss of loop (P = 0.0203); Loss of phosphorylation at S821 (P = 0.0245); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1791); Gain of helix (P = 0.2059)
7:117232682:A:G,P13569,S821G,0.336,Loss of phosphorylation at S821 (P = 0.0245); Loss of stability (P = 0.1089); Loss of disorder (P = 0.1651); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232682:A:T,P13569,S821C,0.491,Loss of disorder (P = 0.0036); Loss of phosphorylation at S821 (P = 0.0245); Loss of loop (P = 0.0512); Gain of sheet (P = 0.1208); Gain of helix (P = 0.2059)
7:117232683:G:A,P13569,S821N,0.379,Loss of loop (P = 0.0203); Loss of phosphorylation at S821 (P = 0.0245); Gain of helix (P = 0.0496); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1494)
7:117232683:G:C,P13569,S821T,0.391,Loss of phosphorylation at S821 (P = 0.0402); Gain of glycosylation at S821 (P = 0.0547); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.131); Loss of stability (P = 0.302)
7:117232683:G:T,P13569,S821I,0.451,Loss of disorder (P = 0.0108); Loss of loop (P = 0.0203); Loss of phosphorylation at S821 (P = 0.0245); Gain of helix (P = 0.0496); Gain of sheet (P = 0.1208)
7:117232684:T:A,P13569,S821R,0.369,Loss of loop (P = 0.0203); Loss of phosphorylation at S821 (P = 0.0245); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1791); Gain of helix (P = 0.2059)
7:117232684:T:G,P13569,S821R,0.369,Loss of loop (P = 0.0203); Loss of phosphorylation at S821 (P = 0.0245); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1791); Gain of helix (P = 0.2059)
7:117232685:G:A,P13569,E822K,0.793,Gain of ubiquitination at E822 (P = 0.0048); Loss of loop (P = 0.0512); Gain of methylation at E822 (P = 0.0989); Loss of phosphorylation at S821 (P = 0.1125); Loss of sheet (P = 0.1158)
7:117232685:G:C,P13569,E822Q,0.289,Loss of loop (P = 0.0512); Loss of sheet (P = 0.1158); Loss of phosphorylation at S821 (P = 0.1241); Loss of disorder (P = 0.1403); Gain of helix (P = 0.2059)
7:117232686:A:C,P13569,E822A,0.343,Loss of disorder (P = 0.0491); Loss of phosphorylation at S821 (P = 0.1099); Loss of solvent accessibility (P = 0.1579); Gain of loop (P = 0.2045); Loss of catalytic residue at E822 (P = 0.2315)
7:117232686:A:G,P13569,E822G,0.379,Loss of loop (P = 0.0203); Gain of glycosylation at S821 (P = 0.0348); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1337); Gain of catalytic residue at I824 (P = 0.1781)
7:117232686:A:T,P13569,E822V,0.416,Loss of disorder (P = 0.0039); Loss of loop (P = 0.0112); Gain of sheet (P = 0.0266); Loss of phosphorylation at S821 (P = 0.1003); Gain of catalytic residue at E823 (P = 0.1903)
7:117232687:A:C,P13569,E822D,0.275,Loss of sheet (P = 0.1158); Loss of catalytic residue at E822 (P = 0.1982); Loss of disorder (P = 0.2023); Loss of phosphorylation at S821 (P = 0.2685); Loss of loop (P = 0.2897)
7:117232687:A:T,P13569,E822D,0.275,Loss of sheet (P = 0.1158); Loss of catalytic residue at E822 (P = 0.1982); Loss of disorder (P = 0.2023); Loss of phosphorylation at S821 (P = 0.2685); Loss of loop (P = 0.2897)
7:117232688:G:A,P13569,E823K,0.459,Gain of ubiquitination at E823 (P = 0.0051); Loss of loop (P = 0.0374); Loss of stability (P = 0.1168); Gain of sheet (P = 0.1208); Gain of methylation at E823 (P = 0.1394)
7:117232688:G:C,P13569,E823Q,0.333,Loss of loop (P = 0.0512); Loss of phosphorylation at S821 (P = 0.0916); Loss of disorder (P = 0.1238); Gain of helix (P = 0.2059); Loss of stability (P = 0.2661)
7:117232689:A:C,P13569,E823A,0.41,Loss of loop (P = 0.0374); Loss of disorder (P = 0.0433); Loss of solvent accessibility (P = 0.0703); Loss of phosphorylation at S821 (P = 0.125); Loss of stability (P = 0.1353)
7:117232689:A:G,P13569,E823G,0.356,Loss of stability (P = 0.0382); Loss of loop (P = 0.0512); Loss of disorder (P = 0.1173); Gain of sheet (P = 0.1208); Loss of phosphorylation at S821 (P = 0.1609)
7:117232689:A:T,P13569,E823V,0.416,Loss of disorder (P = 0.0028); Loss of loop (P = 0.0512); Loss of phosphorylation at S821 (P = 0.0939); Gain of catalytic residue at E826 (P = 0.2084); Loss of solvent accessibility (P = 0.3368)
7:117232690:A:C,P13569,E823D,0.367,Loss of loop (P = 0.0203); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1935); Gain of helix (P = 0.2059); Loss of phosphorylation at S821 (P = 0.2403)
7:117232690:A:T,P13569,E823D,0.367,Loss of loop (P = 0.0203); Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1935); Gain of helix (P = 0.2059); Loss of phosphorylation at S821 (P = 0.2403)
7:117232691:A:C,P13569,I824L,0.35,Gain of relative solvent accessibility (P = 0.0166); Gain of solvent accessibility (P = 0.0246); Loss of catalytic residue at L829 (P = 0.0436); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1288)
7:117232691:A:G,P13569,I824V,0.316,Loss of catalytic residue at L829 (P = 0.0437); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1901); Gain of relative solvent accessibility (P = 0.2751); Gain of loop (P = 0.3485)
7:117232691:A:T,P13569,I824F,0.3,Gain of sheet (P = 0.0344); Loss of catalytic residue at L829 (P = 0.0433); Gain of disorder (P = 0.1569); Loss of loop (P = 0.2237); Loss of stability (P = 0.294)
7:117232692:T:A,P13569,I824N,0.396,Gain of relative solvent accessibility (P = 0.005); Gain of solvent accessibility (P = 0.008); Gain of disorder (P = 0.0292); Loss of catalytic residue at L829 (P = 0.0429); Loss of stability (P = 0.1017)
7:117232692:T:C,P13569,I824T,0.454,Loss of stability (P = 0.0339); Gain of disorder (P = 0.0365); Loss of catalytic residue at L829 (P = 0.0437); Loss of loop (P = 0.0512); Gain of phosphorylation at I824 (P = 0.0714)
7:117232692:T:G,P13569,I824S,0.425,Gain of disorder (P = 0.0126); Gain of phosphorylation at I824 (P = 0.0167); Loss of catalytic residue at L829 (P = 0.0432); Loss of stability (P = 0.0683); Gain of loop (P = 0.1069)
7:117232693:T:G,P13569,I824M,0.311,Loss of catalytic residue at L829 (P = 0.0439); Gain of disorder (P = 0.0544); Gain of sheet (P = 0.1208); Gain of relative solvent accessibility (P = 0.1571); Gain of solvent accessibility (P = 0.199)
7:117232694:A:C,P13569,N825H,0.321,Gain of disorder (P = 0.1048); Gain of sheet (P = 0.1208); Loss of solvent accessibility (P = 0.1744); Loss of relative solvent accessibility (P = 0.1807); Loss of stability (P = 0.2012)
7:117232694:A:G,P13569,N825D,0.398,Loss of loop (P = 0.0203); Gain of disorder (P = 0.1039); Loss of solvent accessibility (P = 0.1362); Loss of sheet (P = 0.1398); Loss of relative solvent accessibility (P = 0.1807)
7:117232694:A:T,P13569,N825Y,0.382,Loss of disorder (P = 0.0438); Gain of catalytic residue at I824 (P = 0.0852); Loss of ubiquitination at K830 (P = 0.0913); Gain of phosphorylation at N825 (P = 0.1475); Loss of relative solvent accessibility (P = 0.1807)
7:117232695:A:C,P13569,N825T,0.357,Gain of glycosylation at N825 (P = 0.0294); Gain of phosphorylation at N825 (P = 0.0528); Loss of solvent accessibility (P = 0.1177); Loss of stability (P = 0.1662); Loss of relative solvent accessibility (P = 0.1807)
7:117232695:A:G,P13569,N825S,0.419,Gain of phosphorylation at N825 (P = 0.0137); Loss of solvent accessibility (P = 0.0193); Loss of loop (P = 0.0203); Loss of relative solvent accessibility (P = 0.0306); Gain of glycosylation at N825 (P = 0.045)
7:117232695:A:T,P13569,N825I,0.443,Loss of solvent accessibility (P = 0.0193); Loss of loop (P = 0.0203); Loss of disorder (P = 0.0306); Loss of relative solvent accessibility (P = 0.0306); Loss of ubiquitination at K830 (P = 0.0525)
7:117232696:C:A,P13569,N825K,0.419,Gain of ubiquitination at N825 (P = 0.0077); Gain of solvent accessibility (P = 0.0638); Gain of disorder (P = 0.1053); Gain of relative solvent accessibility (P = 0.1571); Gain of glycosylation at N825 (P = 0.1607)
7:117232696:C:G,P13569,N825K,0.419,Gain of ubiquitination at N825 (P = 0.0077); Gain of solvent accessibility (P = 0.0638); Gain of disorder (P = 0.1053); Gain of relative solvent accessibility (P = 0.1571); Gain of glycosylation at N825 (P = 0.1607)
7:117232697:G:A,P13569,E826K,0.798,Gain of ubiquitination at E826 (P = 0.0094); Gain of methylation at E826 (P = 0.0301); Loss of disorder (P = 0.1854); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117232697:G:C,P13569,E826Q,0.41,Gain of catalytic residue at E826 (P = 0.0718); Loss of solvent accessibility (P = 0.0721); Loss of disorder (P = 0.0829); Loss of phosphorylation at S821 (P = 0.1655); Loss of relative solvent accessibility (P = 0.1807)
7:117232698:A:C,P13569,E826A,0.455,Loss of solvent accessibility (P = 0.0224); Loss of disorder (P = 0.0284); Loss of loop (P = 0.0512); Gain of sheet (P = 0.1208); Loss of relative solvent accessibility (P = 0.1807)
7:117232698:A:G,P13569,E826G,0.402,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0512); Loss of disorder (P = 0.075); Loss of solvent accessibility (P = 0.0769); Loss of stability (P = 0.1593)
7:117232698:A:T,P13569,E826V,0.532,Loss of disorder (P = 0.0011); Loss of solvent accessibility (P = 0.0062); Loss of relative solvent accessibility (P = 0.0306); Loss of loop (P = 0.0512); Loss of ubiquitination at K830 (P = 0.1139)
7:117232699:A:C,P13569,E826D,0.386,Loss of disorder (P = 0.157); Loss of sheet (P = 0.1907); Loss of ubiquitination at K830 (P = 0.3029); Gain of loop (P = 0.3485); Gain of phosphorylation at S821 (P = 0.3542)
7:117232699:A:T,P13569,E826D,0.386,Loss of disorder (P = 0.157); Loss of sheet (P = 0.1907); Loss of ubiquitination at K830 (P = 0.3029); Gain of loop (P = 0.3485); Gain of phosphorylation at S821 (P = 0.3542)
7:117232700:G:A,P13569,E827K,0.59,Gain of ubiquitination at E827 (P = 0.0101); Gain of methylation at E827 (P = 0.0158); Loss of stability (P = 0.0652); Loss of disorder (P = 0.1877); Loss of sheet (P = 0.1907)
7:117232700:G:C,P13569,E827Q,0.402,Loss of disorder (P = 0.081); Loss of stability (P = 0.177); Loss of sheet (P = 0.1907); Loss of ubiquitination at K830 (P = 0.2729); Gain of methylation at K830 (P = 0.3126)
7:117232701:A:C,P13569,E827A,0.473,Loss of solvent accessibility (P = 0.0053); Loss of disorder (P = 0.0273); Loss of relative solvent accessibility (P = 0.0676); Loss of stability (P = 0.0904); Loss of ubiquitination at K830 (P = 0.2547)
7:117232701:A:G,P13569,E827G,0.48,Loss of solvent accessibility (P = 0.0062); Loss of stability (P = 0.013); Loss of loop (P = 0.0512); Loss of disorder (P = 0.0727); Loss of relative solvent accessibility (P = 0.107)
7:117232701:A:T,P13569,E827V,0.503,Loss of disorder (P = 0.0018); Loss of solvent accessibility (P = 0.0052); Loss of relative solvent accessibility (P = 0.0404); Loss of ubiquitination at K830 (P = 0.0913); Loss of methylation at K830 (P = 0.3144)
7:117232702:A:C,P13569,E827D,0.417,Loss of disorder (P = 0.1539); Loss of stability (P = 0.1571); Loss of loop (P = 0.2897); Gain of ubiquitination at K830 (P = 0.3156); Loss of methylation at K830 (P = 0.3487)
7:117232702:A:T,P13569,E827D,0.417,Loss of disorder (P = 0.1539); Loss of stability (P = 0.1571); Loss of loop (P = 0.2897); Gain of ubiquitination at K830 (P = 0.3156); Loss of methylation at K830 (P = 0.3487)
7:117232703:G:A,P13569,D828N,0.444,Loss of loop (P = 0.0112); Gain of helix (P = 0.027); Gain of sheet (P = 0.0344); Gain of catalytic residue at D828 (P = 0.1375); Gain of methylation at K830 (P = 0.1853)
7:117232703:G:C,P13569,D828H,0.533,Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1224); Loss of ubiquitination at K830 (P = 0.2053); Gain of methylation at K830 (P = 0.2188); Loss of solvent accessibility (P = 0.2732)
7:117232703:G:T,P13569,D828Y,0.5,Loss of disorder (P = 0.0204); Gain of sheet (P = 0.1208); Loss of loop (P = 0.1242); Loss of solvent accessibility (P = 0.1279); Loss of ubiquitination at K830 (P = 0.1741)
7:117232704:A:C,P13569,D828A,0.538,Loss of loop (P = 0.0512); Loss of disorder (P = 0.0662); Loss of solvent accessibility (P = 0.1868); Gain of helix (P = 0.2059); Loss of ubiquitination at K830 (P = 0.2305)
7:117232704:A:G,P13569,D828G,0.797,Gain of glycosylation at K830 (P = 0.1247); Loss of disorder (P = 0.1569); Loss of stability (P = 0.1658); Loss of solvent accessibility (P = 0.1744); Gain of methylation at K830 (P = 0.2037)
7:117232704:A:T,P13569,D828V,0.592,Loss of disorder (P = 0.0136); Loss of ubiquitination at K830 (P = 0.0913); Loss of solvent accessibility (P = 0.1579); Loss of relative solvent accessibility (P = 0.1903); Gain of sheet (P = 0.1945)
7:117232705:C:A,P13569,D828E,0.455,Gain of sheet (P = 0.0085); Loss of loop (P = 0.0203); Gain of helix (P = 0.0496); Gain of disorder (P = 0.0998); Gain of methylation at K830 (P = 0.2198)
7:117232705:C:G,P13569,D828E,0.455,Gain of sheet (P = 0.0085); Loss of loop (P = 0.0203); Gain of helix (P = 0.0496); Gain of disorder (P = 0.0998); Gain of methylation at K830 (P = 0.2198)
7:117232706:T:A,P13569,L829I,0.441,Loss of catalytic residue at L829 (P = 0.053); Gain of methylation at K830 (P = 0.1253); Loss of disorder (P = 0.2415); Loss of helix (P = 0.2662); Loss of ubiquitination at K830 (P = 0.2729)
7:117232706:T:G,P13569,L829V,0.465,Gain of methylation at K830 (P = 0.0425); Loss of catalytic residue at L829 (P = 0.0531); Gain of sheet (P = 0.1208); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117232707:T:C,P13569,L829S,0.612,Gain of disorder (P = 0.0042); Loss of catalytic residue at L829 (P = 0.021); Gain of phosphorylation at L829 (P = 0.0336); Gain of glycosylation at L829 (P = 0.0494); Loss of stability (P = 0.0511)
7:117232708:A:C,P13569,L829F,0.48,Gain of methylation at K830 (P = 0.0335); Loss of catalytic residue at L829 (P = 0.0464); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.2455); Loss of helix (P = 0.2662)
7:117232708:A:T,P13569,L829F,0.48,Gain of methylation at K830 (P = 0.0335); Loss of catalytic residue at L829 (P = 0.0464); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.2455); Loss of helix (P = 0.2662)
7:117232709:A:C,P13569,K830Q,0.476,Loss of ubiquitination at K830 (P = 0.0051); Loss of solvent accessibility (P = 0.0595); Loss of glycosylation at K830 (P = 0.1695); Loss of relative solvent accessibility (P = 0.1807); Loss of disorder (P = 0.197)
7:117232709:A:G,P13569,K830E,0.475,Loss of ubiquitination at K830 (P = 0.0051); Gain of sheet (P = 0.0085); Gain of loop (P = 0.0502); Gain of disorder (P = 0.0975); Loss of solvent accessibility (P = 0.1459)
7:117232710:A:C,P13569,K830T,0.469,Loss of ubiquitination at K830 (P = 0.0051); Gain of sheet (P = 0.0344); Loss of solvent accessibility (P = 0.0595); Gain of loop (P = 0.069); Loss of disorder (P = 0.1169)
7:117232710:A:G,P13569,K830R,0.471,Loss of ubiquitination at K830 (P = 0.0051); Loss of solvent accessibility (P = 0.0595); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1541); Loss of glycosylation at K830 (P = 0.1695)
7:117232710:A:T,P13569,K830M,0.495,Gain of catalytic residue at K830 (P = 0); Loss of ubiquitination at K830 (P = 0.0051); Gain of sheet (P = 0.0344); Loss of solvent accessibility (P = 0.0595); Loss of disorder (P = 0.0663)
7:117232711:G:C,P13569,K830N,0.472,Loss of ubiquitination at K830 (P = 0.0051); Loss of solvent accessibility (P = 0.0595); Gain of loop (P = 0.069); Loss of sheet (P = 0.1158); Loss of glycosylation at K830 (P = 0.1695)
7:117232711:G:T,P13569,K830N,0.472,Loss of ubiquitination at K830 (P = 0.0051); Loss of solvent accessibility (P = 0.0595); Gain of loop (P = 0.069); Loss of sheet (P = 0.1158); Loss of glycosylation at K830 (P = 0.1695)
7:117234984:G:A,P13569,E831K,0.531,Gain of methylation at E831 (P = 0.002); Gain of ubiquitination at E831 (P = 0.0085); Gain of sheet (P = 0.1208); Gain of glycosylation at E831 (P = 0.1654); Loss of disorder (P = 0.1803)
7:117234984:G:C,P13569,E831Q,0.459,Loss of disorder (P = 0.1101); Gain of sheet (P = 0.1208); Gain of methylation at K830 (P = 0.207); Loss of ubiquitination at K830 (P = 0.2305); Loss of loop (P = 0.4412)
7:117234985:A:C,P13569,E831A,0.511,Loss of disorder (P = 0.0576); Loss of ubiquitination at K830 (P = 0.1441); Loss of sheet (P = 0.1907); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897)
7:117234985:A:G,P13569,E831G,0.47,Loss of disorder (P = 0.1004); Loss of sheet (P = 0.1158); Loss of ubiquitination at K830 (P = 0.2053); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897)
7:117234985:A:T,P13569,E831V,0.553,Loss of disorder (P = 0.0215); Loss of ubiquitination at K830 (P = 0.0583); Gain of sheet (P = 0.1208); Gain of methylation at K830 (P = 0.2109); Gain of helix (P = 0.2684)
7:117234986:G:C,P13569,E831D,0.469,Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1757); Gain of loop (P = 0.2045); Loss of ubiquitination at K830 (P = 0.3152); Loss of methylation at K830 (P = 0.3526)
7:117234987:T:A,P13569,C832S,0.55,Gain of disorder (P = 3e-04); Loss of stability (P = 0.0246); Gain of phosphorylation at C832 (P = 0.0348); Gain of glycosylation at C832 (P = 0.0611); Loss of helix (P = 0.1706)
7:117234987:T:C,P13569,C832R,0.587,Gain of disorder (P = 0.0058); Gain of loop (P = 0.069); Loss of stability (P = 0.0723); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319)
7:117234987:T:G,P13569,C832G,0.619,Loss of stability (P = 0.0038); Gain of disorder (P = 0.0039); Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of sheet (P = 0.1208)
7:117234988:G:A,P13569,C832Y,0.408,Gain of disorder (P = 0.0777); Loss of stability (P = 0.1032); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754)
7:117234988:G:C,P13569,C832S,0.55,Gain of disorder (P = 3e-04); Loss of stability (P = 0.0246); Gain of phosphorylation at C832 (P = 0.0348); Gain of glycosylation at C832 (P = 0.0611); Loss of helix (P = 0.1706)
7:117234988:G:T,P13569,C832F,0.393,Loss of helix (P = 0.079); Gain of disorder (P = 0.1102); Gain of sheet (P = 0.1208); Gain of loop (P = 0.2754); Gain of relative solvent accessibility (P = 0.281)
7:117234989:C:G,P13569,C832W,0.404,Loss of stability (P = 0.0662); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Loss of disorder (P = 0.2174); Gain of loop (P = 0.2754)
7:117234990:T:A,P13569,F833I,0.379,Gain of helix (P = 0.0425); Loss of sheet (P = 0.0457); Loss of ubiquitination at K830 (P = 0.1741); Loss of stability (P = 0.2083); Gain of methylation at K830 (P = 0.2246)
7:117234990:T:C,P13569,F833L,0.482,Gain of catalytic residue at F833 (P = 0.0178); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1708)
7:117234990:T:G,P13569,F833V,0.47,Gain of catalytic residue at F833 (P = 0.0281); Loss of stability (P = 0.0641); Gain of relative solvent accessibility (P = 0.1259); Gain of helix (P = 0.1736); Gain of disorder (P = 0.2354)
7:117234991:T:A,P13569,F833Y,0.432,Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Loss of stability (P = 0.0966); Gain of disorder (P = 0.1841); Loss of helix (P = 0.2022)
7:117234991:T:C,P13569,F833S,0.675,Gain of disorder (P = 0.0019); Loss of stability (P = 0.0475); Gain of relative solvent accessibility (P = 0.0479); Gain of phosphorylation at F833 (P = 0.0643); Gain of solvent accessibility (P = 0.11)
7:117234991:T:G,P13569,F833C,0.451,Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Loss of stability (P = 0.0679); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2422)
7:117234992:T:A,P13569,F833L,0.482,Gain of catalytic residue at F833 (P = 0.0178); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1708)
7:117234992:T:G,P13569,F833L,0.482,Gain of catalytic residue at F833 (P = 0.0178); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1708)
7:117234993:T:A,P13569,F834I,0.39,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of sheet (P = 0.1208); Loss of ubiquitination at K830 (P = 0.1741); Gain of disorder (P = 0.2672)
7:117234993:T:C,P13569,F834L,0.395,Loss of helix (P = 0.1706); Gain of disorder (P = 0.1871); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of stability (P = 0.2414)
7:117234993:T:G,P13569,F834V,0.449,Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Loss of helix (P = 0.0444); Gain of catalytic residue at F834 (P = 0.0803); Loss of stability (P = 0.1201)
7:117234994:T:A,P13569,F834Y,0.413,Gain of phosphorylation at F834 (P = 0.0483); Gain of methylation at K830 (P = 0.0849); Loss of stability (P = 0.1417); Loss of sheet (P = 0.1907); Gain of disorder (P = 0.1983)
7:117234994:T:C,P13569,F834S,0.657,Gain of disorder (P = 0.0026); Gain of loop (P = 0.0312); Loss of stability (P = 0.0439); Loss of helix (P = 0.0444); Gain of phosphorylation at F834 (P = 0.0711)
7:117234994:T:G,P13569,F834C,0.464,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Loss of stability (P = 0.0924); Gain of sheet (P = 0.1208); Gain of catalytic residue at E831 (P = 0.1979)
7:117234995:T:A,P13569,F834L,0.395,Loss of helix (P = 0.1706); Gain of disorder (P = 0.1871); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Loss of stability (P = 0.2414)
7:117234996:G:A,P13569,D835N,0.372,Loss of helix (P = 0.079); Gain of sheet (P = 0.1208); Gain of catalytic residue at D835 (P = 0.1564); Loss of stability (P = 0.1873); Gain of loop (P = 0.2045)
7:117234996:G:C,P13569,D835H,0.383,Loss of stability (P = 0.1063); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Gain of catalytic residue at M837 (P = 0.1901); Gain of disorder (P = 0.2354)
7:117234996:G:T,P13569,D835Y,0.491,Gain of methylation at K830 (P = 0.0479); Loss of disorder (P = 0.0978); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of ubiquitination at K830 (P = 0.2053)
7:117234997:A:C,P13569,D835A,0.409,Gain of sheet (P = 0.1208); Loss of disorder (P = 0.1632); Loss of stability (P = 0.1645); Loss of helix (P = 0.1706); Loss of ubiquitination at K830 (P = 0.2547)
7:117234997:A:G,P13569,D835G,0.415,Loss of stability (P = 0.0436); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Loss of ubiquitination at K830 (P = 0.2305); Gain of methylation at K830 (P = 0.2422)
7:117234997:A:T,P13569,D835V,0.488,Gain of catalytic residue at D835 (P = 0.0441); Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of disorder (P = 0.0822); Loss of sheet (P = 0.1158)
7:117234998:T:A,P13569,D835E,0.317,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of disorder (P = 0.1706); Gain of solvent accessibility (P = 0.2192); Gain of relative solvent accessibility (P = 0.2363)
7:117234998:T:G,P13569,D835E,0.317,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of disorder (P = 0.1706); Gain of solvent accessibility (P = 0.2192); Gain of relative solvent accessibility (P = 0.2363)
7:117234999:G:A,P13569,D836N,0.527,Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Gain of catalytic residue at D836 (P = 0.309); Loss of disorder (P = 0.3766)
7:117234999:G:C,P13569,D836H,0.519,Gain of catalytic residue at D835 (P = 0.1128); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Loss of stability (P = 0.2137); Gain of loop (P = 0.2754)
7:117235000:A:C,P13569,D836A,0.538,Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Loss of disorder (P = 0.2995); Loss of stability (P = 0.3274)
7:117235000:A:G,P13569,D836G,0.525,Loss of stability (P = 0.0677); Loss of catalytic residue at D836 (P = 0.1327); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897)
7:117235000:A:T,P13569,D836V,0.578,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of sheet (P = 0.1208); Loss of catalytic residue at D836 (P = 0.1528); Loss of disorder (P = 0.1829)
7:117235001:T:A,P13569,D836E,0.451,Loss of catalytic residue at D836 (P = 0.1216); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Gain of disorder (P = 0.276)
7:117235001:T:G,P13569,D836E,0.451,Loss of catalytic residue at D836 (P = 0.1216); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Gain of disorder (P = 0.276)
7:117235002:A:C,P13569,M837L,0.573,Gain of relative solvent accessibility (P = 0.005); Gain of solvent accessibility (P = 0.007); Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of sheet (P = 0.1158)
7:117235002:A:G,P13569,M837V,0.627,Gain of helix (P = 0.0854); Loss of sheet (P = 0.1158); Loss of loop (P = 0.2897); Gain of glycosylation at S839 (P = 0.4788); Loss of disorder (P = 0.4824)
7:117235002:A:T,P13569,M837L,0.573,Gain of relative solvent accessibility (P = 0.005); Gain of solvent accessibility (P = 0.007); Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of sheet (P = 0.1158)
7:117235003:T:A,P13569,M837K,0.69,Gain of ubiquitination at M837 (P = 0.0101); Gain of disorder (P = 0.0469); Loss of stability (P = 0.0819); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706)
7:117235003:T:C,P13569,M837T,0.586,Gain of relative solvent accessibility (P = 0.0166); Gain of loop (P = 0.0312); Gain of sheet (P = 0.0344); Gain of solvent accessibility (P = 0.0421); Loss of helix (P = 0.0444)
7:117235003:T:G,P13569,M837R,0.597,Gain of phosphorylation at S839 (P = 0.1069); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Loss of stability (P = 0.2535); Gain of loop (P = 0.2754)
7:117235004:G:A,P13569,M837I,0.624,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.4712); Loss of glycosylation at S839 (P = 0.5737)
7:117235004:G:C,P13569,M837I,0.624,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.4712); Loss of glycosylation at S839 (P = 0.5737)
7:117235004:G:T,P13569,M837I,0.624,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.4712); Loss of glycosylation at S839 (P = 0.5737)
7:117235005:G:A,P13569,E838K,0.476,Gain of ubiquitination at E838 (P = 0.0101); Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of sheet (P = 0.1945); Gain of glycosylation at E838 (P = 0.2161)
7:117235005:G:C,P13569,E838Q,0.445,Gain of sheet (P = 0.0221); Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of catalytic residue at E838 (P = 0.1238); Gain of glycosylation at S839 (P = 0.3968)
7:117235006:A:C,P13569,E838A,0.486,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Loss of solvent accessibility (P = 0.1235); Gain of catalytic residue at E838 (P = 0.1604); Gain of sheet (P = 0.1945)
7:117235006:A:G,P13569,E838G,0.473,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of sheet (P = 0.0477); Gain of catalytic residue at I840 (P = 0.1353); Loss of solvent accessibility (P = 0.1868)
7:117235006:A:T,P13569,E838V,0.506,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Loss of solvent accessibility (P = 0.1434); Gain of sheet (P = 0.1945); Loss of relative solvent accessibility (P = 0.3219)
7:117235007:G:C,P13569,E838D,0.448,Gain of sheet (P = 0.0221); Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of catalytic residue at E838 (P = 0.2867); Gain of glycosylation at S839 (P = 0.3086)
7:117235007:G:T,P13569,E838D,0.448,Gain of sheet (P = 0.0221); Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of catalytic residue at E838 (P = 0.2867); Gain of glycosylation at S839 (P = 0.3086)
7:117235008:A:C,P13569,S839R,0.456,Gain of loop (P = 0.0312); Gain of solvent accessibility (P = 0.0314); Loss of helix (P = 0.0444); Gain of relative solvent accessibility (P = 0.09); Gain of sheet (P = 0.1208)
7:117235008:A:G,P13569,S839G,0.417,Gain of loop (P = 0.0312); Loss of helix (P = 0.0444); Gain of relative solvent accessibility (P = 0.09); Gain of sheet (P = 0.1208); Loss of stability (P = 0.2852)
7:117235008:A:T,P13569,S839C,0.493,Gain of catalytic residue at M837 (P = 2e-04); Gain of relative solvent accessibility (P = 0.0166); Gain of loop (P = 0.0312); Gain of solvent accessibility (P = 0.039); Loss of helix (P = 0.0444)
7:117235009:G:A,P13569,S839N,0.474,Gain of catalytic residue at S839 (P = 0.0766); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2754); Loss of glycosylation at S839 (P = 0.3172)
7:117235009:G:C,P13569,S839T,0.449,Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2754); Gain of glycosylation at S839 (P = 0.4266); Loss of phosphorylation at S839 (P = 0.5531)
7:117235009:G:T,P13569,S839I,0.479,Gain of solvent accessibility (P = 0.0155); Gain of relative solvent accessibility (P = 0.0166); Gain of catalytic residue at P841 (P = 0.0262); Gain of loop (P = 0.0312); Loss of helix (P = 0.0444)
7:117235010:C:A,P13569,S839R,0.456,Gain of loop (P = 0.0312); Gain of solvent accessibility (P = 0.0314); Loss of helix (P = 0.0444); Gain of relative solvent accessibility (P = 0.09); Gain of sheet (P = 0.1208)
7:117235010:C:G,P13569,S839R,0.456,Gain of loop (P = 0.0312); Gain of solvent accessibility (P = 0.0314); Loss of helix (P = 0.0444); Gain of relative solvent accessibility (P = 0.09); Gain of sheet (P = 0.1208)
7:117235011:A:C,P13569,I840L,0.448,Gain of helix (P = 0.062); Loss of loop (P = 0.1242); Loss of sheet (P = 0.1907); Gain of glycosylation at T845 (P = 0.2879); Loss of catalytic residue at T845 (P = 0.4405)
7:117235011:A:G,P13569,I840V,0.425,Loss of loop (P = 0.1242); Gain of helix (P = 0.1736); Gain of catalytic residue at I840 (P = 0.2511); Gain of glycosylation at T845 (P = 0.2552); Loss of sheet (P = 0.3635)
7:117235011:A:T,P13569,I840L,0.448,Gain of helix (P = 0.062); Loss of loop (P = 0.1242); Loss of sheet (P = 0.1907); Gain of glycosylation at T845 (P = 0.2879); Loss of catalytic residue at T845 (P = 0.4405)
7:117235012:T:A,P13569,I840K,0.624,Gain of disorder (P = 0.0057); Gain of ubiquitination at I840 (P = 0.0146); Gain of catalytic residue at I840 (P = 0.0219); Gain of methylation at I840 (P = 0.0391); Gain of loop (P = 0.0435)
7:117235012:T:C,P13569,I840T,0.52,Gain of glycosylation at I840 (P = 0.0295); Gain of phosphorylation at I840 (P = 0.0443); Gain of disorder (P = 0.0453); Gain of catalytic residue at I840 (P = 0.0513); Loss of helix (P = 0.079)
7:117235012:T:G,P13569,I840R,0.631,Gain of loop (P = 0.0312); Gain of disorder (P = 0.0424); Loss of helix (P = 0.0444); Gain of catalytic residue at I840 (P = 0.0519); Gain of glycosylation at S839 (P = 0.1766)
7:117235013:A:G,P13569,I840M,0.462,Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237); Gain of glycosylation at T845 (P = 0.2535); Gain of disorder (P = 0.2912)
7:117235014:C:A,P13569,P841T,0.439,Gain of glycosylation at P841 (P = 0.0685); Loss of stability (P = 0.0883); Gain of helix (P = 0.132); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117235014:C:G,P13569,P841A,0.433,Gain of helix (P = 0.062); Gain of catalytic residue at P841 (P = 0.0704); Loss of glycosylation at T844 (P = 0.1206); Loss of stability (P = 0.1512); Loss of loop (P = 0.2237)
7:117235014:C:T,P13569,P841S,0.389,Loss of stability (P = 0.1121); Gain of helix (P = 0.132); Loss of glycosylation at T844 (P = 0.1484); Gain of MoRF binding (P = 0.4289); Loss of sheet (P = 0.437)
7:117235015:C:A,P13569,P841Q,0.415,Loss of glycosylation at T845 (P = 0.1258); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.1583); Gain of loop (P = 0.2045); Loss of stability (P = 0.2132)
7:117235015:C:G,P13569,P841R,0.8,Gain of loop (P = 0.0312); Loss of helix (P = 0.0376); Loss of glycosylation at T844 (P = 0.0557); Gain of MoRF binding (P = 0.0673); Gain of catalytic residue at P841 (P = 0.1768)
7:117235015:C:T,P13569,P841L,0.445,Loss of helix (P = 0.0558); Loss of glycosylation at T844 (P = 0.0801); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2754); Loss of relative solvent accessibility (P = 0.3219)
7:117235017:G:A,P13569,A842T,0.556,Gain of glycosylation at A842 (P = 0.0062); Loss of catalytic residue at A842 (P = 0.0421); Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.1066); Loss of sheet (P = 0.1398)
7:117235017:G:C,P13569,A842P,0.729,Gain of catalytic residue at P841 (P = 0.0107); Gain of loop (P = 0.0851); Gain of glycosylation at T845 (P = 0.1087); Loss of stability (P = 0.1635); Loss of sheet (P = 0.1907)
7:117235017:G:T,P13569,A842S,0.644,Gain of loop (P = 0.069); Loss of sheet (P = 0.1398); Gain of disorder (P = 0.2069); Gain of glycosylation at T845 (P = 0.2345); Gain of relative solvent accessibility (P = 0.2629)
7:117235018:C:A,P13569,A842E,0.659,Gain of helix (P = 0.027); Gain of loop (P = 0.0312); Loss of sheet (P = 0.1398); Gain of disorder (P = 0.1968); Gain of glycosylation at T845 (P = 0.257)
7:117235018:C:G,P13569,A842G,0.6,Loss of stability (P = 0.0766); Gain of helix (P = 0.0854); Gain of relative solvent accessibility (P = 0.1066); Loss of glycosylation at T845 (P = 0.1258); Loss of catalytic residue at A842 (P = 0.1278)
7:117235018:C:T,P13569,A842V,0.75,Gain of loop (P = 0.0851); Gain of helix (P = 0.0854); Loss of sheet (P = 0.1398); Gain of glycosylation at T845 (P = 0.2163); Loss of catalytic residue at A842 (P = 0.3777)
7:117235020:G:A,P13569,V843M,0.444,Gain of sheet (P = 0.0477); Loss of loop (P = 0.0804); Loss of catalytic residue at V843 (P = 0.2095); Loss of helix (P = 0.2662); Gain of glycosylation at T845 (P = 0.275)
7:117235020:G:C,P13569,V843L,0.459,Loss of glycosylation at T844 (P = 0.1638); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of catalytic residue at V843 (P = 0.2797)
7:117235020:G:T,P13569,V843L,0.459,Loss of glycosylation at T844 (P = 0.1638); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of catalytic residue at V843 (P = 0.2797)
7:117235021:T:A,P13569,V843E,0.553,Gain of solvent accessibility (P = 9e-04); Gain of relative solvent accessibility (P = 0.0023); Loss of loop (P = 0.0203); Gain of disorder (P = 0.0254); Loss of helix (P = 0.0444)
7:117235021:T:C,P13569,V843A,0.505,Gain of relative solvent accessibility (P = 0.0082); Gain of helix (P = 0.027); Gain of loop (P = 0.0312); Gain of solvent accessibility (P = 0.0503); Loss of stability (P = 0.1009)
7:117235021:T:G,P13569,V843G,0.538,Loss of stability (P = 0.0034); Gain of glycosylation at T845 (P = 0.1658); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1758); Gain of catalytic residue at T844 (P = 0.1859)
7:117235023:A:C,P13569,T844P,0.563,Loss of glycosylation at T844 (P = 0.0123); Gain of helix (P = 0.0143); Loss of loop (P = 0.0145); Loss of sheet (P = 0.0228); Loss of MoRF binding (P = 0.3648)
7:117235023:A:G,P13569,T844A,0.479,Loss of glycosylation at T844 (P = 0.0077); Loss of loop (P = 0.0235); Gain of helix (P = 0.027); Loss of sheet (P = 0.0457); Gain of catalytic residue at T844 (P = 0.0916)
7:117235023:A:T,P13569,T844S,0.487,Gain of helix (P = 0.0143); Loss of loop (P = 0.0145); Loss of glycosylation at T844 (P = 0.0211); Loss of sheet (P = 0.0228); Gain of relative solvent accessibility (P = 0.09)
7:117235024:C:A,P13569,T844N,0.499,Loss of glycosylation at T844 (P = 0.0077); Gain of helix (P = 0.0143); Loss of sheet (P = 0.0228); Loss of loop (P = 0.0235); Gain of relative solvent accessibility (P = 0.1259)
7:117235024:C:G,P13569,T844S,0.487,Gain of helix (P = 0.0143); Loss of loop (P = 0.0145); Loss of glycosylation at T844 (P = 0.0211); Loss of sheet (P = 0.0228); Gain of relative solvent accessibility (P = 0.09)
7:117235024:C:T,P13569,T844I,0.484,Loss of glycosylation at T844 (P = 0.0077); Loss of loop (P = 0.0986); Gain of helix (P = 0.1736); Gain of sheet (P = 0.1945); Gain of stability (P = 0.2189)
7:117235026:A:C,P13569,T845P,0.487,Loss of glycosylation at T845 (P = 0.0236); Loss of catalytic residue at T845 (P = 0.0521); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of sheet (P = 0.1945)
7:117235026:A:G,P13569,T845A,0.481,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Loss of loop (P = 0.0112); Loss of glycosylation at T845 (P = 0.0192); Gain of MoRF binding (P = 0.3439)
7:117235026:A:T,P13569,T845S,0.419,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Gain of loop (P = 0.0195); Loss of glycosylation at T845 (P = 0.0217); Gain of MoRF binding (P = 0.317)
7:117235027:C:A,P13569,T845K,0.538,Gain of methylation at T845 (P = 0.0053); Gain of helix (P = 0.0078); Loss of sheet (P = 0.0104); Loss of loop (P = 0.0112); Loss of glycosylation at T845 (P = 0.0272)
7:117235027:C:G,P13569,T845R,0.571,Gain of helix (P = 0.0034); Loss of sheet (P = 0.0063); Loss of loop (P = 0.0112); Gain of methylation at T845 (P = 0.014); Loss of glycosylation at T845 (P = 0.0192)
7:117235027:C:T,P13569,T845I,0.52,Loss of sheet (P = 0.0104); Loss of loop (P = 0.0112); Gain of helix (P = 0.0143); Loss of glycosylation at T845 (P = 0.0192); Loss of catalytic residue at T845 (P = 0.1955)
7:117235029:T:A,P13569,W846R,0.623,Gain of methylation at W846 (P = 0.0051); Gain of catalytic residue at W846 (P = 0.0364); Gain of sheet (P = 0.1208); Gain of solvent accessibility (P = 0.1422); Gain of relative solvent accessibility (P = 0.1571)
7:117235029:T:C,P13569,W846R,0.623,Gain of methylation at W846 (P = 0.0051); Gain of catalytic residue at W846 (P = 0.0364); Gain of sheet (P = 0.1208); Gain of solvent accessibility (P = 0.1422); Gain of relative solvent accessibility (P = 0.1571)
7:117235029:T:G,P13569,W846G,0.708,Gain of methylation at R851 (P = 0.0317); Loss of stability (P = 0.0687); Loss of sheet (P = 0.0817); Gain of loop (P = 0.2045); Loss of glycosylation at T845 (P = 0.2185)
7:117235030:G:C,P13569,W846S,0.732,Gain of disorder (P = 0.03); Gain of glycosylation at W846 (P = 0.032); Loss of sheet (P = 0.0357); Gain of methylation at R851 (P = 0.0367); Gain of catalytic residue at W846 (P = 0.0983)
7:117235030:G:T,P13569,W846L,0.594,Loss of sheet (P = 0.0054); Gain of helix (P = 0.0078); Loss of loop (P = 0.0145); Gain of methylation at R851 (P = 0.0317); Loss of glycosylation at T845 (P = 0.1595)
7:117235031:G:C,P13569,W846C,0.614,Loss of sheet (P = 0.0084); Loss of loop (P = 0.0235); Gain of helix (P = 0.027); Gain of methylation at R851 (P = 0.0351); Loss of glycosylation at T844 (P = 0.0495)
7:117235031:G:T,P13569,W846C,0.614,Loss of sheet (P = 0.0084); Loss of loop (P = 0.0235); Gain of helix (P = 0.027); Gain of methylation at R851 (P = 0.0351); Loss of glycosylation at T844 (P = 0.0495)
7:117235032:A:C,P13569,N847H,0.481,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Loss of loop (P = 0.0235); Loss of methylation at R851 (P = 0.1342); Loss of catalytic residue at N847 (P = 0.1369)
7:117235032:A:G,P13569,N847D,0.517,Gain of sheet (P = 0.0827); Loss of methylation at R851 (P = 0.0891); Loss of loop (P = 0.0986); Loss of glycosylation at T844 (P = 0.1293); Loss of catalytic residue at N847 (P = 0.1656)
7:117235032:A:T,P13569,N847Y,0.517,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Loss of loop (P = 0.0235); Loss of methylation at R851 (P = 0.087); Gain of catalytic residue at T844 (P = 0.1835)
7:117235033:A:C,P13569,N847T,0.511,Gain of glycosylation at N847 (P = 0.0205); Gain of sheet (P = 0.0827); Loss of loop (P = 0.0986); Loss of methylation at R851 (P = 0.1169); Loss of helix (P = 0.1706)
7:117235033:A:G,P13569,N847S,0.467,Loss of sheet (P = 0.0315); Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of methylation at R851 (P = 0.1205); Loss of glycosylation at T845 (P = 0.1763)
7:117235033:A:T,P13569,N847I,0.534,Gain of helix (P = 0.0034); Loss of sheet (P = 0.0063); Loss of loop (P = 0.0145); Loss of methylation at R851 (P = 0.059); Loss of glycosylation at T845 (P = 0.0854)
7:117235034:C:A,P13569,N847K,0.573,Gain of methylation at N847 (P = 0.0116); Gain of ubiquitination at N847 (P = 0.0351); Gain of MoRF binding (P = 0.0609); Gain of loop (P = 0.069); Loss of glycosylation at T844 (P = 0.0769)
7:117235034:C:G,P13569,N847K,0.573,Gain of methylation at N847 (P = 0.0116); Gain of ubiquitination at N847 (P = 0.0351); Gain of MoRF binding (P = 0.0609); Gain of loop (P = 0.069); Loss of glycosylation at T844 (P = 0.0769)
7:117235035:A:C,P13569,T848P,0.545,Loss of sheet (P = 0.0126); Loss of loop (P = 0.0374); Gain of helix (P = 0.0425); Gain of glycosylation at T845 (P = 0.0817); Gain of methylation at R851 (P = 0.1506)
7:117235035:A:G,P13569,T848A,0.502,Loss of sheet (P = 0.0054); Gain of helix (P = 0.0117); Loss of loop (P = 0.0374); Gain of methylation at R851 (P = 0.0669); Gain of glycosylation at T845 (P = 0.1541)
7:117235035:A:T,P13569,T848S,0.505,Loss of sheet (P = 0.003); Gain of helix (P = 0.0034); Loss of loop (P = 0.0235); Gain of relative solvent accessibility (P = 0.1259); Loss of methylation at R851 (P = 0.1509)
7:117235036:C:A,P13569,T848K,0.678,Loss of sheet (P = 0.0126); Gain of ubiquitination at T848 (P = 0.0267); Loss of loop (P = 0.0374); Gain of MoRF binding (P = 0.0449); Gain of methylation at T848 (P = 0.0517)
7:117235036:C:G,P13569,T848R,0.718,Loss of sheet (P = 0.0054); Gain of helix (P = 0.0117); Loss of loop (P = 0.0235); Gain of MoRF binding (P = 0.0265); Gain of methylation at T848 (P = 0.0601)
7:117235036:C:T,P13569,T848I,0.504,Gain of sheet (P = 0.0827); Loss of methylation at R851 (P = 0.1363); Gain of catalytic residue at T848 (P = 0.1937); Gain of MoRF binding (P = 0.2173); Loss of loop (P = 0.2237)
7:117235038:T:A,P13569,Y849N,0.778,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0117); Loss of loop (P = 0.0288); Gain of methylation at R851 (P = 0.0585); Gain of catalytic residue at T848 (P = 0.1133)
7:117235038:T:C,P13569,Y849H,0.821,Loss of sheet (P = 0.0181); Gain of methylation at R851 (P = 0.0498); Loss of loop (P = 0.0512); Gain of helix (P = 0.062); Loss of stability (P = 0.1323)
7:117235038:T:G,P13569,Y849D,0.757,Gain of sheet (P = 0.0061); Loss of loop (P = 0.0512); Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at R851 (P = 0.1357); Loss of MoRF binding (P = 0.1587)
7:117235039:A:C,P13569,Y849S,0.782,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0117); Loss of loop (P = 0.0512); Loss of stability (P = 0.0673); Gain of methylation at R851 (P = 0.0985)
7:117235039:A:G,P13569,Y849C,0.824,Loss of sheet (P = 0.0181); Gain of helix (P = 0.0425); Loss of loop (P = 0.0512); Loss of methylation at R851 (P = 0.1554); Gain of catalytic residue at L850 (P = 0.2186)
7:117235039:A:T,P13569,Y849F,0.808,Loss of sheet (P = 0.0181); Gain of helix (P = 0.0425); Loss of loop (P = 0.0512); Loss of methylation at R851 (P = 0.0917); Gain of MoRF binding (P = 0.1609)
7:117235041:C:A,P13569,L850I,0.437,Gain of sheet (P = 0.0344); Loss of methylation at R851 (P = 0.0716); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2101); Loss of glycosylation at T845 (P = 0.2623)
7:117235041:C:G,P13569,L850V,0.463,Gain of sheet (P = 0.0149); Gain of methylation at R851 (P = 0.1048); Loss of catalytic residue at L850 (P = 0.1351); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2296)
7:117235041:C:T,P13569,L850F,0.465,Gain of sheet (P = 0.0344); Gain of methylation at R851 (P = 0.0927); Loss of catalytic residue at L850 (P = 0.1179); Loss of loop (P = 0.1242); Gain of MoRF binding (P = 0.2157)
7:117235042:T:A,P13569,L850H,0.61,Gain of helix (P = 0.0225); Loss of sheet (P = 0.0457); Loss of stability (P = 0.0506); Loss of loop (P = 0.0512); Loss of methylation at R851 (P = 0.0696)
7:117235042:T:C,P13569,L850P,0.704,Loss of stability (P = 0.0532); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.1173)
7:117235042:T:G,P13569,L850R,0.7,Gain of helix (P = 0.0034); Loss of sheet (P = 0.0142); Gain of methylation at L850 (P = 0.0249); Loss of loop (P = 0.0288); Gain of MoRF binding (P = 0.0504)
7:117235044:C:G,P13569,R851G,0.663,Loss of methylation at R851 (P = 0.0243); Loss of stability (P = 0.0467); Loss of catalytic residue at R851 (P = 0.0471); Loss of MoRF binding (P = 0.0751); Gain of sheet (P = 0.1451)
7:117235045:G:C,P13569,R851P,0.694,Loss of sheet (P = 0.0104); Gain of helix (P = 0.0225); Loss of methylation at R851 (P = 0.0243); Gain of glycosylation at T848 (P = 0.0296); Loss of loop (P = 0.0374)
7:117235045:G:T,P13569,R851L,0.849,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Loss of methylation at R851 (P = 0.0243); Loss of loop (P = 0.0374); Loss of MoRF binding (P = 0.0763)
7:117235047:T:A,P13569,Y852N,0.783,Loss of sheet (P = 0.003); Gain of helix (P = 0.0078); Loss of loop (P = 0.0235); Loss of stability (P = 0.0656); Loss of methylation at R851 (P = 0.1559)
7:117235047:T:C,P13569,Y852H,0.818,Loss of sheet (P = 0.0054); Gain of helix (P = 0.0117); Loss of loop (P = 0.0235); Loss of stability (P = 0.0523); Loss of methylation at R851 (P = 0.0757)
7:117235047:T:G,P13569,Y852D,0.784,Loss of sheet (P = 0.0054); Gain of helix (P = 0.0143); Loss of loop (P = 0.0235); Loss of methylation at R851 (P = 0.0747); Gain of relative solvent accessibility (P = 0.09)
7:117235048:A:C,P13569,Y852S,0.801,Loss of sheet (P = 0.0084); Loss of stability (P = 0.0166); Loss of loop (P = 0.0374); Gain of helix (P = 0.0425); Loss of ubiquitination at K857 (P = 0.1154)
7:117235048:A:G,P13569,Y852C,0.851,Loss of sheet (P = 0.0315); Loss of loop (P = 0.0804); Gain of catalytic residue at T854 (P = 0.1284); Loss of methylation at K857 (P = 0.1424); Gain of ubiquitination at K857 (P = 0.1679)
7:117235048:A:T,P13569,Y852F,0.899,Loss of sheet (P = 0.0084); Gain of helix (P = 0.0225); Loss of loop (P = 0.0235); Loss of methylation at K857 (P = 0.1091); Gain of MoRF binding (P = 0.1158)
7:117235050:A:C,P13569,I853L,0.647,Loss of methylation at K857 (P = 0.0716); Loss of sheet (P = 0.0817); Loss of ubiquitination at K857 (P = 0.1446); Gain of glycosylation at S858 (P = 0.1863); Loss of MoRF binding (P = 0.2184)
7:117235050:A:T,P13569,I853F,0.808,Loss of sheet (P = 0.0315); Gain of helix (P = 0.0425); Loss of loop (P = 0.0512); Gain of methylation at R851 (P = 0.0766); Loss of stability (P = 0.0853)
7:117235051:T:A,P13569,I853N,0.679,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Loss of stability (P = 0.0097); Loss of loop (P = 0.0288); Gain of methylation at R851 (P = 0.0532)
7:117235051:T:C,P13569,I853T,0.661,Loss of stability (P = 0.0012); Loss of sheet (P = 0.0063); Gain of helix (P = 0.0117); Loss of loop (P = 0.0512); Gain of methylation at R851 (P = 0.0636)
7:117235051:T:G,P13569,I853S,0.739,Loss of stability (P = 0.0055); Loss of sheet (P = 0.0104); Gain of helix (P = 0.0117); Loss of loop (P = 0.0512); Gain of methylation at R851 (P = 0.0628)
7:117235052:T:G,P13569,I853M,0.64,Loss of sheet (P = 0.0817); Loss of ubiquitination at K857 (P = 0.0828); Gain of methylation at R851 (P = 0.087); Loss of stability (P = 0.1005); Gain of loop (P = 0.2045)
7:117235053:A:C,P13569,T854P,0.602,Loss of sheet (P = 0.0357); Loss of stability (P = 0.0684); Loss of MoRF binding (P = 0.1068); Gain of methylation at K857 (P = 0.1165); Loss of ubiquitination at K857 (P = 0.1446)
7:117235053:A:G,P13569,T854A,0.532,Loss of sheet (P = 0.0315); Loss of stability (P = 0.0443); Gain of helix (P = 0.0854); Gain of methylation at R851 (P = 0.0861); Gain of ubiquitination at K857 (P = 0.1679)
7:117235053:A:T,P13569,T854S,0.503,Loss of sheet (P = 0.1398); Gain of methylation at R851 (P = 0.1475); Loss of ubiquitination at K857 (P = 0.1612); Loss of helix (P = 0.1706); Loss of stability (P = 0.1707)
7:117235054:C:A,P13569,T854N,0.55,Loss of sheet (P = 0.0357); Loss of stability (P = 0.1307); Gain of methylation at R851 (P = 0.1308); Gain of helix (P = 0.132); Loss of ubiquitination at K857 (P = 0.1612)
7:117235054:C:G,P13569,T854S,0.503,Loss of sheet (P = 0.1398); Gain of methylation at R851 (P = 0.1475); Loss of ubiquitination at K857 (P = 0.1612); Loss of helix (P = 0.1706); Loss of stability (P = 0.1707)
7:117235056:G:C,P13569,V855L,0.606,Gain of helix (P = 0.062); Loss of methylation at K857 (P = 0.0827); Gain of sheet (P = 0.0827); Loss of ubiquitination at K857 (P = 0.1041); Loss of glycosylation at S858 (P = 0.196)
7:117235056:G:T,P13569,V855F,0.686,Gain of sheet (P = 0.039); Loss of catalytic residue at V855 (P = 0.067); Loss of stability (P = 0.1336); Loss of methylation at K857 (P = 0.1508); Gain of helix (P = 0.1736)
7:117235057:T:A,P13569,V855D,0.654,Loss of stability (P = 0.0198); Loss of methylation at R851 (P = 0.0582); Gain of helix (P = 0.062); Loss of sheet (P = 0.0817); Loss of ubiquitination at K857 (P = 0.1041)
7:117235057:T:C,P13569,V855A,0.572,Loss of stability (P = 0.0062); Loss of sheet (P = 0.0817); Gain of helix (P = 0.0854); Loss of methylation at K857 (P = 0.1265); Loss of ubiquitination at K857 (P = 0.1612)
7:117235057:T:G,P13569,V855G,0.613,Loss of stability (P = 4e-04); Loss of sheet (P = 0.0315); Gain of loop (P = 0.069); Gain of helix (P = 0.0854); Loss of ubiquitination at K857 (P = 0.1287)
7:117235059:C:A,P13569,H856N,0.533,Gain of sheet (P = 0.0149); Loss of helix (P = 0.0444); Loss of catalytic residue at K857 (P = 0.0665); Loss of ubiquitination at K857 (P = 0.1154); Loss of methylation at R851 (P = 0.1271)
7:117235059:C:G,P13569,H856D,0.646,Loss of methylation at R851 (P = 0.0673); Loss of ubiquitination at K857 (P = 0.1041); Gain of sheet (P = 0.1208); Gain of catalytic residue at H856 (P = 0.1365); Loss of MoRF binding (P = 0.1418)
7:117235059:C:T,P13569,H856Y,0.507,Gain of helix (P = 0.0325); Gain of loop (P = 0.069); Gain of ubiquitination at K857 (P = 0.0751); Loss of methylation at K857 (P = 0.083); Loss of sheet (P = 0.1398)
7:117235060:A:C,P13569,H856P,0.655,Gain of sheet (P = 0.0344); Gain of catalytic residue at H856 (P = 0.0439); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of methylation at R851 (P = 0.0955)
7:117235060:A:G,P13569,H856R,0.774,Gain of sheet (P = 0.0149); Gain of MoRF binding (P = 0.0241); Gain of methylation at H856 (P = 0.026); Gain of ubiquitination at K857 (P = 0.0579); Gain of catalytic residue at H856 (P = 0.0654)
7:117235060:A:T,P13569,H856L,0.54,Gain of sheet (P = 0.0344); Gain of ubiquitination at K857 (P = 0.0546); Loss of helix (P = 0.079); Gain of MoRF binding (P = 0.1011); Loss of methylation at K857 (P = 0.102)
7:117235061:C:A,P13569,H856Q,0.527,Gain of sheet (P = 0.0149); Gain of catalytic residue at H856 (P = 0.0372); Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of methylation at R851 (P = 0.0783)
7:117235061:C:G,P13569,H856Q,0.527,Gain of sheet (P = 0.0149); Gain of catalytic residue at H856 (P = 0.0372); Loss of helix (P = 0.0444); Gain of loop (P = 0.069); Loss of methylation at R851 (P = 0.0783)
7:117235062:A:C,P13569,K857Q,0.566,Loss of sheet (P = 0.003); Gain of helix (P = 0.0078); Loss of methylation at K857 (P = 0.0121); Loss of ubiquitination at K857 (P = 0.0297); Gain of loop (P = 0.069)
7:117235063:A:C,P13569,K857T,0.6,Loss of methylation at K857 (P = 0.0121); Loss of sheet (P = 0.0126); Loss of ubiquitination at K857 (P = 0.0297); Gain of glycosylation at S858 (P = 0.0807); Loss of MoRF binding (P = 0.1055)
7:117235063:A:G,P13569,K857R,0.626,Loss of ubiquitination at K857 (P = 0.0297); Loss of methylation at K857 (P = 0.0496); Loss of sheet (P = 0.0817); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1958)
7:117235063:A:T,P13569,K857M,0.545,Loss of sheet (P = 0.0054); Loss of catalytic residue at K857 (P = 0.0066); Gain of helix (P = 0.0117); Loss of methylation at K857 (P = 0.0121); Loss of ubiquitination at K857 (P = 0.0297)
7:117235064:G:C,P13569,K857N,0.577,Loss of sheet (P = 0.003); Gain of helix (P = 0.0078); Loss of methylation at K857 (P = 0.0121); Loss of ubiquitination at K857 (P = 0.0297); Gain of loop (P = 0.1069)
7:117235064:G:T,P13569,K857N,0.577,Loss of sheet (P = 0.003); Gain of helix (P = 0.0078); Loss of methylation at K857 (P = 0.0121); Loss of ubiquitination at K857 (P = 0.0297); Gain of loop (P = 0.1069)
7:117235065:A:C,P13569,S858R,0.654,Gain of MoRF binding (P = 0.0091); Loss of sheet (P = 0.0104); Gain of helix (P = 0.0117); Gain of methylation at S858 (P = 0.0139); Loss of glycosylation at S858 (P = 0.0283)
7:117235065:A:G,P13569,S858G,0.481,Loss of glycosylation at S858 (P = 0.0283); Loss of helix (P = 0.0558); Loss of sheet (P = 0.0817); Gain of ubiquitination at K857 (P = 0.1191); Gain of methylation at K857 (P = 0.1402)
7:117235065:A:T,P13569,S858C,0.563,Loss of glycosylation at S858 (P = 0.0283); Gain of methylation at K857 (P = 0.0373); Gain of ubiquitination at K857 (P = 0.0688); Gain of catalytic residue at L859 (P = 0.0707); Loss of sheet (P = 0.0817)
7:117235066:G:A,P13569,S858N,0.502,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Loss of glycosylation at S858 (P = 0.0283); Gain of loop (P = 0.069); Loss of ubiquitination at K857 (P = 0.1446)
7:117235066:G:C,P13569,S858T,0.52,Loss of sheet (P = 0.0063); Gain of helix (P = 0.0078); Loss of glycosylation at S858 (P = 0.0394); Gain of loop (P = 0.069); Gain of ubiquitination at K857 (P = 0.1191)
7:117235066:G:T,P13569,S858I,0.528,Loss of sheet (P = 0.0104); Gain of helix (P = 0.0225); Loss of glycosylation at S858 (P = 0.0283); Gain of ubiquitination at K857 (P = 0.0546); Gain of methylation at K857 (P = 0.071)
7:117235067:C:A,P13569,S858R,0.654,Gain of MoRF binding (P = 0.0091); Loss of sheet (P = 0.0104); Gain of helix (P = 0.0117); Gain of methylation at S858 (P = 0.0139); Loss of glycosylation at S858 (P = 0.0283)
7:117235067:C:G,P13569,S858R,0.654,Gain of MoRF binding (P = 0.0091); Loss of sheet (P = 0.0104); Gain of helix (P = 0.0117); Gain of methylation at S858 (P = 0.0139); Loss of glycosylation at S858 (P = 0.0283)
7:117235068:T:A,P13569,L859I,0.473,Gain of helix (P = 0.0325); Gain of methylation at K857 (P = 0.0811); Gain of glycosylation at S858 (P = 0.14); Gain of ubiquitination at K857 (P = 0.143); Loss of sheet (P = 0.1907)
7:117235068:T:G,P13569,L859V,0.447,Gain of methylation at K857 (P = 0.112); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736); Loss of glycosylation at S858 (P = 0.1747); Loss of ubiquitination at K857 (P = 0.1778)
7:117235069:T:C,P13569,L859S,0.573,Loss of stability (P = 0.0143); Gain of glycosylation at L859 (P = 0.0173); Gain of helix (P = 0.062); Loss of ubiquitination at K857 (P = 0.0714); Loss of sheet (P = 0.1398)
7:117235070:A:C,P13569,L859F,0.512,Gain of helix (P = 0.0117); Loss of sheet (P = 0.0142); Gain of loop (P = 0.069); Gain of catalytic residue at L859 (P = 0.098); Loss of glycosylation at S858 (P = 0.1133)
7:117235070:A:T,P13569,L859F,0.512,Gain of helix (P = 0.0117); Loss of sheet (P = 0.0142); Gain of loop (P = 0.069); Gain of catalytic residue at L859 (P = 0.098); Loss of glycosylation at S858 (P = 0.1133)
7:117235071:A:C,P13569,I860L,0.444,Loss of methylation at K857 (P = 0.0526); Gain of catalytic residue at I860 (P = 0.0634); Loss of ubiquitination at K857 (P = 0.1446); Loss of glycosylation at S858 (P = 0.1486); Gain of helix (P = 0.1736)
7:117235071:A:G,P13569,I860V,0.414,Gain of helix (P = 0.062); Loss of ubiquitination at K857 (P = 0.1154); Loss of methylation at K857 (P = 0.1298); Gain of catalytic residue at I860 (P = 0.1642); Loss of sheet (P = 0.1907)
7:117235071:A:T,P13569,I860F,0.448,Loss of stability (P = 0.0684); Loss of methylation at K857 (P = 0.0934); Loss of ubiquitination at K857 (P = 0.1446); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117235072:T:A,P13569,I860N,0.492,Loss of stability (P = 0.0148); Gain of helix (P = 0.062); Loss of glycosylation at S858 (P = 0.0665); Loss of ubiquitination at K857 (P = 0.0714); Gain of catalytic residue at I860 (P = 0.1463)
7:117235072:T:C,P13569,I860T,0.507,Loss of stability (P = 0.0019); Gain of helix (P = 0.062); Loss of ubiquitination at K857 (P = 0.0771); Loss of sheet (P = 0.1398); Loss of methylation at K857 (P = 0.1426)
7:117235072:T:G,P13569,I860S,0.506,Loss of stability (P = 0.0064); Gain of helix (P = 0.062); Gain of catalytic residue at I860 (P = 0.0735); Loss of glycosylation at S858 (P = 0.0853); Loss of methylation at K857 (P = 0.0876)
7:117235073:T:G,P13569,I860M,0.45,Loss of stability (P = 0.0635); Loss of ubiquitination at K857 (P = 0.0931); Loss of glycosylation at S858 (P = 0.104); Loss of methylation at K857 (P = 0.1541); Gain of helix (P = 0.1736)
7:117235074:T:A,P13569,F861I,0.404,Gain of helix (P = 0.132); Gain of methylation at K857 (P = 0.1333); Loss of catalytic residue at F861 (P = 0.1537); Loss of ubiquitination at K857 (P = 0.1923); Gain of sheet (P = 0.1945)
7:117235074:T:C,P13569,F861L,0.405,Gain of helix (P = 0.0425); Loss of methylation at K857 (P = 0.0715); Loss of loop (P = 0.0804); Loss of glycosylation at S858 (P = 0.1005); Loss of sheet (P = 0.1398)
7:117235074:T:G,P13569,F861V,0.399,Gain of helix (P = 0.0696); Loss of ubiquitination at K857 (P = 0.1612); Loss of sheet (P = 0.1907); Loss of methylation at K857 (P = 0.1967); Gain of loop (P = 0.2045)
7:117235075:T:A,P13569,F861Y,0.421,Gain of catalytic residue at I860 (P = 0.077); Gain of methylation at K857 (P = 0.1275); Gain of helix (P = 0.132); Loss of ubiquitination at K857 (P = 0.1446); Loss of stability (P = 0.1609)
7:117235075:T:C,P13569,F861S,0.524,Loss of stability (P = 0.0451); Gain of sheet (P = 0.0477); Loss of helix (P = 0.0558); Loss of methylation at K857 (P = 0.0967); Gain of loop (P = 0.1069)
7:117235075:T:G,P13569,F861C,0.501,Gain of helix (P = 0.062); Loss of stability (P = 0.0761); Loss of methylation at K857 (P = 0.1084); Loss of sheet (P = 0.1398); Loss of ubiquitination at K857 (P = 0.1778)
7:117235076:T:A,P13569,F861L,0.405,Gain of helix (P = 0.0425); Loss of methylation at K857 (P = 0.0715); Loss of loop (P = 0.0804); Loss of glycosylation at S858 (P = 0.1005); Loss of sheet (P = 0.1398)
7:117235076:T:G,P13569,F861L,0.405,Gain of helix (P = 0.0425); Loss of methylation at K857 (P = 0.0715); Loss of loop (P = 0.0804); Loss of glycosylation at S858 (P = 0.1005); Loss of sheet (P = 0.1398)
7:117235077:G:A,P13569,V862M,0.558,Gain of helix (P = 0.0696); Loss of ubiquitination at K857 (P = 0.1041); Loss of sheet (P = 0.1398); Loss of glycosylation at S858 (P = 0.174); Loss of catalytic residue at V862 (P = 0.1845)
7:117235077:G:C,P13569,V862L,0.538,Gain of helix (P = 0.0696); Loss of methylation at K857 (P = 0.0781); Loss of ubiquitination at K857 (P = 0.1778); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117235077:G:T,P13569,V862L,0.538,Gain of helix (P = 0.0696); Loss of methylation at K857 (P = 0.0781); Loss of ubiquitination at K857 (P = 0.1778); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117235078:T:A,P13569,V862E,0.736,Loss of ubiquitination at K857 (P = 0.1154); Loss of MoRF binding (P = 0.127); Loss of helix (P = 0.1299); Loss of glycosylation at S858 (P = 0.1604); Gain of methylation at K857 (P = 0.1672)
7:117235078:T:C,P13569,V862A,0.626,Loss of stability (P = 0.1069); Loss of ubiquitination at K857 (P = 0.1154); Loss of methylation at K857 (P = 0.1206); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299)
7:117235078:T:G,P13569,V862G,0.58,Loss of stability (P = 0.0049); Gain of sheet (P = 0.0477); Gain of loop (P = 0.1069); Loss of ubiquitination at K857 (P = 0.1287); Loss of helix (P = 0.1299)
7:117235080:C:A,P13569,L863I,0.525,Loss of catalytic residue at L863 (P = 0.0039); Gain of helix (P = 0.1736); Gain of MoRF binding (P = 0.2337); Loss of glycosylation at S858 (P = 0.247); Loss of sheet (P = 0.302)
7:117235080:C:G,P13569,L863V,0.526,Loss of sheet (P = 0.0457); Gain of helix (P = 0.062); Gain of loop (P = 0.2045); Gain of glycosylation at S858 (P = 0.2289); Gain of MoRF binding (P = 0.2464)
7:117235081:T:A,P13569,L863Q,0.556,Loss of sheet (P = 0.0142); Gain of helix (P = 0.0199); Loss of glycosylation at S858 (P = 0.0708); Gain of MoRF binding (P = 0.2247); Loss of stability (P = 0.2288)
7:117235081:T:C,P13569,L863P,0.677,Loss of sheet (P = 0.0228); Loss of catalytic residue at L863 (P = 0.0235); Gain of helix (P = 0.0325); Loss of stability (P = 0.0984); Loss of glycosylation at S858 (P = 0.1556)
7:117235081:T:G,P13569,L863R,0.833,Gain of MoRF binding (P = 0.0134); Gain of methylation at L863 (P = 0.0354); Loss of glycosylation at S858 (P = 0.0575); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736)
7:117235083:A:C,P13569,I864L,0.609,Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of catalytic residue at I864 (P = 0.2703); Loss of MoRF binding (P = 0.2762); Loss of stability (P = 0.5023)
7:117235083:A:G,P13569,I864V,0.597,Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.2828); Loss of helix (P = 0.3949); Loss of catalytic residue at L859 (P = 0.4354); Gain of loop (P = 0.4661)
7:117235083:A:T,P13569,I864F,0.616,Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Loss of stability (P = 0.1932); Gain of MoRF binding (P = 0.2827); Loss of loop (P = 0.2897)
7:117235084:T:A,P13569,I864N,0.652,Loss of stability (P = 0.0496); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.2137); Loss of loop (P = 0.2897)
7:117235084:T:C,P13569,I864T,0.664,Loss of stability (P = 0.0063); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.2697); Loss of loop (P = 0.2897)
7:117235084:T:G,P13569,I864S,0.654,Loss of stability (P = 0.0427); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.2603); Loss of loop (P = 0.2897)
7:117235085:T:G,P13569,I864M,0.627,Loss of helix (P = 0.1706); Gain of catalytic residue at I864 (P = 0.1869); Gain of sheet (P = 0.1945); Loss of stability (P = 0.2596); Gain of MoRF binding (P = 0.2773)
7:117235086:T:A,P13569,W865R,0.837,Gain of sheet (P = 0.0125); Loss of catalytic residue at L863 (P = 0.0168); Gain of methylation at W865 (P = 0.034); Loss of helix (P = 0.0376); Gain of MoRF binding (P = 0.08)
7:117235086:T:C,P13569,W865R,0.837,Gain of sheet (P = 0.0125); Loss of catalytic residue at L863 (P = 0.0168); Gain of methylation at W865 (P = 0.034); Loss of helix (P = 0.0376); Gain of MoRF binding (P = 0.08)
7:117235086:T:G,P13569,W865G,0.699,Loss of stability (P = 0.0428); Loss of catalytic residue at L863 (P = 0.0735); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of MoRF binding (P = 0.2224)
7:117235087:G:C,P13569,W865S,0.72,Gain of sheet (P = 0.0125); Loss of catalytic residue at L863 (P = 0.0308); Loss of helix (P = 0.0376); Loss of stability (P = 0.1823); Loss of MoRF binding (P = 0.2353)
7:117235087:G:T,P13569,W865L,0.673,Loss of catalytic residue at L863 (P = 0.0402); Gain of helix (P = 0.0854); Loss of MoRF binding (P = 0.2214); Loss of sheet (P = 0.437); Gain of loop (P = 0.4661)
7:117235088:G:C,P13569,W865C,0.706,Loss of catalytic residue at L863 (P = 0.0365); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.2038); Loss of stability (P = 0.3578); Gain of sheet (P = 0.4423)
7:117235088:G:T,P13569,W865C,0.706,Loss of catalytic residue at L863 (P = 0.0365); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.2038); Loss of stability (P = 0.3578); Gain of sheet (P = 0.4423)
7:117235089:T:A,P13569,C866S,0.726,Loss of catalytic residue at L867 (P = 0.0244); Loss of stability (P = 0.0489); Loss of helix (P = 0.0558); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.2294)
7:117235089:T:C,P13569,C866R,0.864,Gain of MoRF binding (P = 0.0096); Loss of catalytic residue at L867 (P = 0.0213); Gain of sheet (P = 0.0221); Loss of helix (P = 0.0376); Loss of stability (P = 0.1102)
7:117235089:T:G,P13569,C866G,0.652,Loss of stability (P = 0.0111); Loss of catalytic residue at C866 (P = 0.1395); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.2634); Loss of sheet (P = 0.437)
7:117235090:G:C,P13569,C866S,0.726,Loss of catalytic residue at L867 (P = 0.0244); Loss of stability (P = 0.0489); Loss of helix (P = 0.0558); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.2294)
7:117235090:G:T,P13569,C866F,0.712,Gain of sheet (P = 0.0221); Loss of catalytic residue at L867 (P = 0.0352); Loss of helix (P = 0.0376); Gain of MoRF binding (P = 0.2572); Loss of stability (P = 0.4204)
7:117235091:C:G,P13569,C866W,0.738,Gain of sheet (P = 0.0221); Loss of helix (P = 0.0376); Loss of catalytic residue at L867 (P = 0.0423); Gain of MoRF binding (P = 0.06); Loss of stability (P = 0.1262)
7:117235092:T:A,P13569,L867I,0.554,Loss of catalytic residue at L867 (P = 0.0077); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.3137); Loss of stability (P = 0.4477)
7:117235092:T:G,P13569,L867V,0.583,Gain of sheet (P = 0.0221); Loss of helix (P = 0.0558); Loss of stability (P = 0.2812); Gain of MoRF binding (P = 0.3333); Loss of catalytic residue at L867 (P = 0.3787)
7:117235093:T:C,P13569,L867S,0.643,Gain of sheet (P = 0.0221); Loss of helix (P = 0.0558); Loss of catalytic residue at L867 (P = 0.0631); Loss of stability (P = 0.0643); Gain of MoRF binding (P = 0.3541)
7:117235094:A:C,P13569,L867F,0.581,Gain of sheet (P = 0.0221); Loss of helix (P = 0.0558); Loss of catalytic residue at L867 (P = 0.2121); Loss of stability (P = 0.2807); Gain of MoRF binding (P = 0.3282)
7:117235094:A:T,P13569,L867F,0.581,Gain of sheet (P = 0.0221); Loss of helix (P = 0.0558); Loss of catalytic residue at L867 (P = 0.2121); Loss of stability (P = 0.2807); Gain of MoRF binding (P = 0.3282)
7:117235095:G:A,P13569,V868I,0.542,Loss of catalytic residue at V868 (P = 0.0215); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Gain of MoRF binding (P = 0.3863)
7:117235095:G:C,P13569,V868L,0.568,Loss of catalytic residue at V868 (P = 0.0486); Gain of helix (P = 0.0696); Loss of sheet (P = 0.1907); Loss of MoRF binding (P = 0.4035); Loss of loop (P = 0.4786)
7:117235095:G:T,P13569,V868L,0.568,Loss of catalytic residue at V868 (P = 0.0486); Gain of helix (P = 0.0696); Loss of sheet (P = 0.1907); Loss of MoRF binding (P = 0.4035); Loss of loop (P = 0.4786)
7:117235096:T:A,P13569,V868E,0.734,Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of stability (P = 0.3351); Loss of MoRF binding (P = 0.3547); Loss of catalytic residue at W865 (P = 0.359)
7:117235096:T:C,P13569,V868A,0.629,Loss of stability (P = 0.0721); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Loss of MoRF binding (P = 0.4004)
7:117235096:T:G,P13569,V868G,0.651,Loss of stability (P = 0.0122); Gain of helix (P = 0.0696); Gain of sheet (P = 0.1208); Loss of catalytic residue at V868 (P = 0.3191); Loss of MoRF binding (P = 0.4018)
7:117235098:A:C,P13569,I869L,0.633,Loss of helix (P = 0.028); Gain of sheet (P = 0.0477); Gain of loop (P = 0.2754); Loss of MoRF binding (P = 0.4389); Loss of catalytic residue at I869 (P = 0.4421)
7:117235098:A:G,P13569,I869V,0.69,Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.436); Gain of catalytic residue at E873 (P = 0.6495)
7:117235098:A:T,P13569,I869F,0.714,Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.4372); Gain of sheet (P = 0.4423); Gain of loop (P = 0.4661); Loss of stability (P = 0.4749)
7:117235099:T:A,P13569,I869N,0.732,Loss of helix (P = 0.0626); Loss of stability (P = 0.1194); Gain of sheet (P = 0.1451); Gain of loop (P = 0.2754); Gain of MoRF binding (P = 0.3399)
7:117235099:T:C,P13569,I869T,0.655,Loss of stability (P = 0.0504); Gain of glycosylation at I869 (P = 0.0523); Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Gain of sheet (P = 0.1451)
7:117235099:T:G,P13569,I869S,0.75,Loss of stability (P = 0.0821); Loss of helix (P = 0.2022); Loss of catalytic residue at I869 (P = 0.2291); Gain of MoRF binding (P = 0.3863); Gain of sheet (P = 0.4423)
7:117235100:T:G,P13569,I869M,0.708,Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.4197); Gain of loop (P = 0.4661); Loss of catalytic residue at E873 (P = 0.4892); Loss of sheet (P = 0.5184)
7:117235101:T:A,P13569,F870I,0.572,Gain of helix (P = 0.132); Loss of catalytic residue at F870 (P = 0.1688); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2897); Loss of stability (P = 0.3079)
7:117235101:T:C,P13569,F870L,0.582,Loss of helix (P = 0.028); Gain of sheet (P = 0.0477); Loss of catalytic residue at F870 (P = 0.0553); Loss of stability (P = 0.1975); Gain of loop (P = 0.2754)
7:117235101:T:G,P13569,F870V,0.63,Loss of helix (P = 0.028); Gain of sheet (P = 0.0477); Loss of stability (P = 0.0539); Gain of loop (P = 0.2754); Gain of catalytic residue at F870 (P = 0.4734)
7:117235102:T:A,P13569,F870Y,0.671,Gain of helix (P = 0.0696); Loss of stability (P = 0.1575); Loss of loop (P = 0.2897); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.4615)
7:117235102:T:C,P13569,F870S,0.674,Loss of stability (P = 0.0299); Gain of glycosylation at F870 (P = 0.1258); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of catalytic residue at A875 (P = 0.4315)
7:117235102:T:G,P13569,F870C,0.669,Gain of catalytic residue at L871 (P = 0.0203); Loss of stability (P = 0.0298); Loss of helix (P = 0.0626); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2897)
7:117235103:T:A,P13569,F870L,0.582,Loss of helix (P = 0.028); Gain of sheet (P = 0.0477); Loss of catalytic residue at F870 (P = 0.0553); Loss of stability (P = 0.1975); Gain of loop (P = 0.2754)
7:117235103:T:G,P13569,F870L,0.582,Loss of helix (P = 0.028); Gain of sheet (P = 0.0477); Loss of catalytic residue at F870 (P = 0.0553); Loss of stability (P = 0.1975); Gain of loop (P = 0.2754)
7:117235104:C:A,P13569,L871M,0.589,Gain of catalytic residue at L871 (P = 0.0011); Gain of helix (P = 0.0854); Loss of sheet (P = 0.437); Gain of loop (P = 0.4661); Loss of stability (P = 0.4717)
7:117235104:C:G,P13569,L871V,0.625,Gain of catalytic residue at L871 (P = 0.0095); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.5155)
7:117235105:T:A,P13569,L871Q,0.679,Gain of catalytic residue at L871 (P = 0.0038); Gain of sheet (P = 0.0477); Loss of helix (P = 0.0558); Loss of stability (P = 0.0911); Gain of loop (P = 0.4661)
7:117235105:T:C,P13569,L871P,0.773,Gain of catalytic residue at L871 (P = 0.0244); Loss of stability (P = 0.0346); Gain of helix (P = 0.2059); Loss of sheet (P = 0.371); Gain of loop (P = 0.4661)
7:117235105:T:G,P13569,L871R,0.89,Gain of methylation at L871 (P = 0.0211); Loss of stability (P = 0.0772); Gain of catalytic residue at L871 (P = 0.1247); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.2496)
7:117235107:G:A,P13569,A872T,0.686,Loss of sheet (P = 0.0457); Gain of helix (P = 0.062); Gain of catalytic residue at A872 (P = 0.1698); Loss of stability (P = 0.1866); Loss of loop (P = 0.2897)
7:117235107:G:C,P13569,A872P,0.779,Loss of stability (P = 0.0985); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1299); Loss of catalytic residue at A872 (P = 0.2529); Gain of loop (P = 0.2754)
7:117235107:G:T,P13569,A872S,0.676,Gain of glycosylation at A872 (P = 0.0461); Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Loss of stability (P = 0.1955); Loss of loop (P = 0.2897)
7:117235108:C:G,P13569,A872G,0.675,Loss of stability (P = 0.0349); Loss of sheet (P = 0.0457); Gain of helix (P = 0.0696); Loss of catalytic residue at A872 (P = 0.2558); Loss of glycosylation at S877 (P = 0.273)
7:117235108:C:T,P13569,A872V,0.744,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.3628); Gain of catalytic residue at A872 (P = 0.3737)
7:117235110:G:A,P13569,E873K,0.752,Gain of ubiquitination at E873 (P = 0.0185); Loss of sheet (P = 0.0457); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1585); Loss of stability (P = 0.2037)
7:117235110:G:C,P13569,E873Q,0.692,Loss of sheet (P = 0.1158); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of glycosylation at S877 (P = 0.326); Gain of catalytic residue at E873 (P = 0.4184)
7:117235111:A:C,P13569,E873A,0.617,Loss of sheet (P = 0.0228); Loss of helix (P = 0.0626); Gain of loop (P = 0.069); Gain of glycosylation at S877 (P = 0.1445); Gain of catalytic residue at A872 (P = 0.2344)
7:117235111:A:G,P13569,E873G,0.662,Loss of sheet (P = 0.0228); Gain of helix (P = 0.0696); Loss of stability (P = 0.0779); Gain of catalytic residue at A872 (P = 0.1402); Loss of loop (P = 0.2897)
7:117235111:A:T,P13569,E873V,0.723,Loss of sheet (P = 0.0228); Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Gain of catalytic residue at A872 (P = 0.2236); Gain of glycosylation at S877 (P = 0.2276)
7:117235112:G:C,P13569,E873D,0.666,Loss of sheet (P = 0.0457); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Gain of glycosylation at S877 (P = 0.3164); Gain of catalytic residue at E873 (P = 0.383)
7:117235112:G:T,P13569,E873D,0.666,Loss of sheet (P = 0.0457); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Gain of glycosylation at S877 (P = 0.3164); Gain of catalytic residue at E873 (P = 0.383)
7:117242880:G:A,P13569,V874M,0.631,Loss of catalytic residue at V874 (P = 0.0344); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of glycosylation at S877 (P = 0.3135); Gain of loop (P = 0.4661)
7:117242880:G:C,P13569,V874L,0.632,Gain of helix (P = 0.0696); Loss of catalytic residue at V874 (P = 0.2509); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.3505); Loss of sheet (P = 0.437)
7:117242880:G:T,P13569,V874L,0.632,Gain of helix (P = 0.0696); Loss of catalytic residue at V874 (P = 0.2509); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.3505); Loss of sheet (P = 0.437)
7:117242881:T:A,P13569,V874E,0.774,Loss of catalytic residue at S877 (P = 0.0727); Gain of helix (P = 0.132); Loss of stability (P = 0.2219); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.3765)
7:117242881:T:G,P13569,V874G,0.605,Loss of stability (P = 0.0037); Gain of helix (P = 0.132); Gain of loop (P = 0.2754); Gain of glycosylation at S877 (P = 0.395); Loss of catalytic residue at V874 (P = 0.4253)
7:117242883:G:A,P13569,A875T,0.61,Loss of helix (P = 0.079); Gain of sheet (P = 0.1208); Gain of loop (P = 0.2754); Loss of glycosylation at S877 (P = 0.3659); Gain of catalytic residue at E873 (P = 0.6385)
7:117242883:G:C,P13569,A875P,0.732,Loss of helix (P = 0.0376); Loss of catalytic residue at A875 (P = 0.0682); Gain of loop (P = 0.069); Gain of sheet (P = 0.1208); Gain of glycosylation at S877 (P = 0.1263)
7:117242883:G:T,P13569,A875S,0.578,Gain of glycosylation at A875 (P = 0.0826); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Gain of catalytic residue at L871 (P = 0.3827)
7:117242884:C:A,P13569,A875D,0.756,Gain of helix (P = 0.132); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635); Loss of glycosylation at S877 (P = 0.3862); Gain of catalytic residue at A875 (P = 0.6013)
7:117242884:C:G,P13569,A875G,0.701,Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.3673); Loss of stability (P = 0.3735)
7:117242884:C:T,P13569,A875V,0.595,Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.388); Gain of MoRF binding (P = 0.7073)
7:117242886:G:A,P13569,A876T,0.733,Loss of helix (P = 0.1299); Gain of catalytic residue at A876 (P = 0.2034); Loss of stability (P = 0.2231); Gain of loop (P = 0.2754); Gain of glycosylation at S877 (P = 0.3162)
7:117242886:G:C,P13569,A876P,0.797,Loss of helix (P = 0.079); Loss of stability (P = 0.1548); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045); Loss of catalytic residue at A876 (P = 0.2396)
7:117242886:G:T,P13569,A876S,0.715,Gain of glycosylation at A876 (P = 0.0745); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of stability (P = 0.3415); Gain of sheet (P = 0.4423)
7:117242887:C:A,P13569,A876D,0.808,Loss of helix (P = 0.0626); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2754); Loss of catalytic residue at V879 (P = 0.3134); Loss of stability (P = 0.3356)
7:117242887:C:G,P13569,A876G,0.778,Loss of stability (P = 0.0607); Gain of helix (P = 0.132); Gain of glycosylation at S877 (P = 0.2624); Loss of loop (P = 0.2897); Gain of sheet (P = 0.4423)
7:117242887:C:T,P13569,A876V,0.788,Loss of helix (P = 0.0626); Gain of catalytic residue at A876 (P = 0.1194); Gain of loop (P = 0.2754); Gain of glycosylation at S877 (P = 0.3902); Loss of sheet (P = 0.5184)
7:117242889:T:A,P13569,S877T,0.554,Gain of helix (P = 0.2059); Loss of stability (P = 0.2784); Loss of catalytic residue at S877 (P = 0.3097); Loss of glycosylation at S877 (P = 0.3957); Loss of loop (P = 0.4786)
7:117242889:T:C,P13569,S877P,0.715,Loss of catalytic residue at S877 (P = 0.0224); Loss of stability (P = 0.0374); Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Loss of glycosylation at S877 (P = 0.1329)
7:117242889:T:G,P13569,S877A,0.554,Loss of helix (P = 0.0558); Loss of stability (P = 0.0578); Gain of loop (P = 0.069); Loss of glycosylation at S877 (P = 0.0853); Loss of catalytic residue at S877 (P = 0.3048)
7:117242890:C:A,P13569,S877Y,0.53,Loss of glycosylation at S877 (P = 0.0853); Loss of stability (P = 0.1797); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786); Loss of sheet (P = 0.6423)
7:117242890:C:G,P13569,S877C,0.55,Gain of catalytic residue at L878 (P = 0.0211); Loss of helix (P = 0.0626); Loss of glycosylation at S877 (P = 0.0853); Gain of loop (P = 0.1069); Loss of stability (P = 0.2661)
7:117242890:C:T,P13569,S877F,0.535,Loss of glycosylation at S877 (P = 0.0853); Loss of catalytic residue at S877 (P = 0.2022); Loss of helix (P = 0.2022); Gain of loop (P = 0.4661); Loss of stability (P = 0.506)
7:117242892:T:A,P13569,L878M,0.603,Gain of helix (P = 0.132); Loss of glycosylation at S877 (P = 0.1378); Loss of loop (P = 0.2897); Loss of stability (P = 0.5393); Gain of catalytic residue at V880 (P = 0.5651)
7:117242892:T:G,P13569,L878V,0.6,Gain of catalytic residue at L878 (P = 0.0273); Loss of helix (P = 0.2271); Gain of loop (P = 0.2754); Loss of glycosylation at S877 (P = 0.3097); Loss of stability (P = 0.4604)
7:117242893:T:C,P13569,L878S,0.695,Gain of catalytic residue at L878 (P = 0.0062); Loss of stability (P = 0.0582); Gain of helix (P = 0.132); Gain of glycosylation at L878 (P = 0.2257); Loss of loop (P = 0.2897)
7:117242893:T:G,P13569,L878W,0.739,Gain of catalytic residue at L878 (P = 0.0176); Gain of helix (P = 0.132); Loss of glycosylation at S877 (P = 0.1428); Loss of stability (P = 0.1702); Loss of loop (P = 0.2897)
7:117242894:G:C,P13569,L878F,0.74,Loss of helix (P = 0.1299); Gain of catalytic residue at L878 (P = 0.1451); Loss of glycosylation at S877 (P = 0.2527); Gain of loop (P = 0.2754); Loss of stability (P = 0.4403)
7:117242894:G:T,P13569,L878F,0.74,Loss of helix (P = 0.1299); Gain of catalytic residue at L878 (P = 0.1451); Loss of glycosylation at S877 (P = 0.2527); Gain of loop (P = 0.2754); Loss of stability (P = 0.4403)
7:117242895:G:A,P13569,V879I,0.651,Gain of catalytic residue at L884 (P = 0.0399); Loss of helix (P = 0.1299); Gain of glycosylation at S877 (P = 0.2542); Gain of loop (P = 0.2754); Loss of sheet (P = 0.6423)
7:117242895:G:C,P13569,V879L,0.59,Loss of catalytic residue at V879 (P = 0.0603); Loss of helix (P = 0.2022); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.3343); Loss of stability (P = 0.6191)
7:117242895:G:T,P13569,V879F,0.653,Loss of helix (P = 0.2271); Gain of glycosylation at S877 (P = 0.321); Loss of catalytic residue at V879 (P = 0.4467); Loss of stability (P = 0.4522); Gain of sheet (P = 0.6509)
7:117242896:T:A,P13569,V879D,0.806,Loss of helix (P = 0.1299); Loss of stability (P = 0.1479); Loss of catalytic residue at S877 (P = 0.1859); Loss of glycosylation at S877 (P = 0.2656); Gain of loop (P = 0.2754)
7:117242896:T:C,P13569,V879A,0.72,Gain of helix (P = 0.132); Loss of stability (P = 0.2799); Loss of loop (P = 0.2897); Gain of glycosylation at S877 (P = 0.3774); Loss of sheet (P = 0.6423)
7:117242896:T:G,P13569,V879G,0.689,Loss of stability (P = 0.0086); Loss of catalytic residue at V879 (P = 0.1145); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of glycosylation at S877 (P = 0.3297)
7:117242898:G:A,P13569,V880M,0.581,Loss of catalytic residue at V880 (P = 0.111); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of glycosylation at S877 (P = 0.3128); Loss of stability (P = 0.6077)
7:117242898:G:C,P13569,V880L,0.688,Loss of helix (P = 0.1299); Loss of glycosylation at S877 (P = 0.2325); Gain of catalytic residue at V880 (P = 0.2418); Gain of loop (P = 0.2754); Gain of sheet (P = 0.6509)
7:117242898:G:T,P13569,V880L,0.688,Loss of helix (P = 0.1299); Loss of glycosylation at S877 (P = 0.2325); Gain of catalytic residue at V880 (P = 0.2418); Gain of loop (P = 0.2754); Gain of sheet (P = 0.6509)
7:117242899:T:A,P13569,V880E,0.692,Loss of catalytic residue at S877 (P = 0.0882); Loss of helix (P = 0.1299); Loss of glycosylation at S877 (P = 0.2669); Gain of loop (P = 0.2754); Loss of stability (P = 0.6284)
7:117242899:T:C,P13569,V880A,0.619,Loss of helix (P = 0.1299); Loss of stability (P = 0.2627); Gain of loop (P = 0.2754); Gain of glycosylation at S877 (P = 0.3024); Loss of catalytic residue at V880 (P = 0.4081)
7:117242899:T:G,P13569,V880G,0.611,Loss of stability (P = 0.0189); Gain of glycosylation at S877 (P = 0.1288); Loss of catalytic residue at V880 (P = 0.1604); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786)
7:117242901:C:A,P13569,L881M,0.73,Loss of helix (P = 0.2022); Loss of glycosylation at S877 (P = 0.376); Loss of stability (P = 0.4374); Gain of catalytic residue at V880 (P = 0.5624); Gain of sheet (P = 0.6509)
7:117242901:C:G,P13569,L881V,0.756,Gain of catalytic residue at L881 (P = 0.1179); Loss of stability (P = 0.1807); Loss of helix (P = 0.2271); Gain of glycosylation at S877 (P = 0.3306); Gain of sheet (P = 0.6509)
7:117242902:T:A,P13569,L881Q,0.734,Gain of catalytic residue at L881 (P = 0.0074); Loss of stability (P = 0.038); Loss of helix (P = 0.079); Loss of glycosylation at S877 (P = 0.3009); Gain of disorder (P = 0.6187)
7:117242902:T:C,P13569,L881P,0.807,Loss of stability (P = 0.0153); Gain of catalytic residue at L881 (P = 0.0363); Gain of glycosylation at S877 (P = 0.1847); Loss of helix (P = 0.2022); Gain of disorder (P = 0.6068)
7:117242902:T:G,P13569,L881R,0.918,Loss of stability (P = 0.0309); Loss of catalytic residue at V879 (P = 0.1362); Gain of methylation at L881 (P = 0.1885); Loss of helix (P = 0.2271); Loss of glycosylation at S877 (P = 0.2435)
7:117242904:T:A,P13569,W882R,0.806,Gain of methylation at W882 (P = 0.0075); Gain of disorder (P = 0.0904); Loss of stability (P = 0.1736); Loss of catalytic residue at V880 (P = 0.1819); Loss of helix (P = 0.2022)
7:117242904:T:C,P13569,W882R,0.806,Gain of methylation at W882 (P = 0.0075); Gain of disorder (P = 0.0904); Loss of stability (P = 0.1736); Loss of catalytic residue at V880 (P = 0.1819); Loss of helix (P = 0.2022)
7:117242904:T:G,P13569,W882G,0.783,Loss of stability (P = 0.0203); Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Gain of disorder (P = 0.0503); Gain of glycosylation at T887 (P = 0.0856)
7:117242905:G:C,P13569,W882S,0.712,Gain of disorder (P = 0.0227); Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Gain of glycosylation at W882 (P = 0.0624); Loss of stability (P = 0.1682)
7:117242905:G:T,P13569,W882L,0.667,Gain of loop (P = 0.0195); Loss of helix (P = 0.028); Loss of catalytic residue at W882 (P = 0.0922); Gain of glycosylation at T887 (P = 0.1032); Gain of disorder (P = 0.351)
7:117242906:G:C,P13569,W882C,0.724,Gain of catalytic residue at L883 (P = 0.0135); Gain of glycosylation at T887 (P = 0.1378); Loss of helix (P = 0.2022); Loss of stability (P = 0.3496); Gain of loop (P = 0.4661)
7:117242906:G:T,P13569,W882C,0.724,Gain of catalytic residue at L883 (P = 0.0135); Gain of glycosylation at T887 (P = 0.1378); Loss of helix (P = 0.2022); Loss of stability (P = 0.3496); Gain of loop (P = 0.4661)
7:117242907:C:A,P13569,L883I,0.651,Gain of helix (P = 0.2059); Loss of disorder (P = 0.2672); Loss of glycosylation at T887 (P = 0.2764); Gain of catalytic residue at L884 (P = 0.4861); Loss of stability (P = 0.6216)
7:117242907:C:G,P13569,L883V,0.668,Gain of helix (P = 0.2059); Gain of catalytic residue at L883 (P = 0.2082); Gain of glycosylation at T887 (P = 0.2716); Loss of disorder (P = 0.3291); Loss of stability (P = 0.4861)
7:117242907:C:T,P13569,L883F,0.655,Gain of catalytic residue at L883 (P = 0.0981); Gain of helix (P = 0.2059); Loss of glycosylation at T887 (P = 0.2409); Loss of disorder (P = 0.283); Loss of stability (P = 0.4718)
7:117242908:T:A,P13569,L883H,0.72,Gain of disorder (P = 0.036); Loss of stability (P = 0.0707); Gain of helix (P = 0.2059); Gain of glycosylation at T887 (P = 0.2274); Gain of catalytic residue at L883 (P = 0.4249)
7:117242908:T:C,P13569,L883P,0.774,Loss of stability (P = 0.0358); Loss of helix (P = 0.0444); Gain of disorder (P = 0.0537); Gain of glycosylation at T887 (P = 0.145); Gain of sheet (P = 0.3763)
7:117242908:T:G,P13569,L883R,0.855,Gain of methylation at L883 (P = 0.0289); Loss of helix (P = 0.0558); Gain of disorder (P = 0.0948); Loss of catalytic residue at W882 (P = 0.1178); Loss of stability (P = 0.1229)
7:117242910:C:A,P13569,L884I,0.604,Loss of helix (P = 0.1299); Loss of disorder (P = 0.1452); Gain of catalytic residue at L889 (P = 0.2396); Gain of glycosylation at T887 (P = 0.2762); Loss of stability (P = 0.5667)
7:117242910:C:G,P13569,L884V,0.581,Gain of catalytic residue at L884 (P = 0.1775); Loss of stability (P = 0.1973); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2106); Loss of glycosylation at T887 (P = 0.2716)
7:117242910:C:T,P13569,L884F,0.56,Loss of helix (P = 0.0626); Loss of stability (P = 0.126); Loss of disorder (P = 0.1618); Gain of catalytic residue at L884 (P = 0.2159); Loss of glycosylation at T887 (P = 0.2688)
7:117242911:T:A,P13569,L884H,0.545,Loss of stability (P = 0.011); Gain of disorder (P = 0.0348); Gain of catalytic residue at L884 (P = 0.1422); Loss of helix (P = 0.2022); Loss of glycosylation at T887 (P = 0.2695)
7:117242911:T:C,P13569,L884P,0.619,Loss of stability (P = 0.0088); Gain of disorder (P = 0.0379); Gain of glycosylation at L884 (P = 0.0509); Loss of helix (P = 0.1299); Gain of catalytic residue at L883 (P = 0.3776)
7:117242911:T:G,P13569,L884R,0.793,Gain of methylation at L884 (P = 0.0249); Loss of stability (P = 0.0255); Gain of disorder (P = 0.0731); Loss of helix (P = 0.079); Loss of glycosylation at T887 (P = 0.0925)
7:117242913:G:A,P13569,G885R,0.759,Loss of glycosylation at T887 (P = 0.1484); Loss of catalytic residue at W882 (P = 0.2093); Loss of disorder (P = 0.2145); Loss of helix (P = 0.3949); Gain of methylation at G885 (P = 0.4266)
7:117242913:G:C,P13569,G885R,0.759,Loss of glycosylation at T887 (P = 0.1484); Loss of catalytic residue at W882 (P = 0.2093); Loss of disorder (P = 0.2145); Loss of helix (P = 0.3949); Gain of methylation at G885 (P = 0.4266)
7:117242914:G:A,P13569,G885E,0.62,Gain of catalytic residue at G885 (P = 0.025); Loss of helix (P = 0.028); Gain of loop (P = 0.1069); Gain of relative solvent accessibility (P = 0.1259); Loss of glycosylation at T887 (P = 0.1292)
7:117242914:G:C,P13569,G885A,0.607,Gain of helix (P = 0.0425); Loss of disorder (P = 0.1227); Loss of loop (P = 0.1242); Loss of glycosylation at T887 (P = 0.2073); Gain of catalytic residue at G885 (P = 0.376)
7:117242914:G:T,P13569,G885V,0.641,Gain of helix (P = 0.0425); Loss of disorder (P = 0.0562); Loss of loop (P = 0.1242); Loss of glycosylation at T887 (P = 0.1944); Gain of catalytic residue at G885 (P = 0.4139)
7:117242916:A:C,P13569,N886H,0.655,Gain of helix (P = 0.062); Loss of loop (P = 0.0804); Loss of glycosylation at T887 (P = 0.1786); Gain of disorder (P = 0.2009); Loss of catalytic residue at N886 (P = 0.2492)
7:117242916:A:G,P13569,N886D,0.709,Loss of catalytic residue at N886 (P = 0.0929); Gain of helix (P = 0.132); Gain of disorder (P = 0.1611); Loss of glycosylation at T887 (P = 0.2121); Loss of loop (P = 0.2237)
7:117242916:A:T,P13569,N886Y,0.652,Loss of disorder (P = 0.0627); Gain of catalytic residue at L881 (P = 0.0998); Gain of helix (P = 0.132); Loss of glycosylation at T887 (P = 0.1815); Loss of loop (P = 0.2897)
7:117242917:A:C,P13569,N886T,0.636,Gain of glycosylation at N886 (P = 0.0192); Gain of helix (P = 0.132); Loss of stability (P = 0.2223); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2448)
7:117242917:A:G,P13569,N886S,0.617,Gain of glycosylation at N886 (P = 0.0242); Gain of disorder (P = 0.0936); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Gain of catalytic residue at T887 (P = 0.357)
7:117242917:A:T,P13569,N886I,0.615,Loss of catalytic residue at N886 (P = 0.0012); Loss of disorder (P = 0.0392); Gain of helix (P = 0.132); Gain of glycosylation at T887 (P = 0.1943); Loss of loop (P = 0.2237)
7:117243586:C:A,P13569,N886K,0.753,Gain of methylation at N886 (P = 0.0126); Gain of ubiquitination at N886 (P = 0.0219); Loss of catalytic residue at N886 (P = 0.0336); Gain of helix (P = 0.062); Loss of loop (P = 0.1242)
7:117243586:C:G,P13569,N886K,0.753,Gain of methylation at N886 (P = 0.0126); Gain of ubiquitination at N886 (P = 0.0219); Loss of catalytic residue at N886 (P = 0.0336); Gain of helix (P = 0.062); Loss of loop (P = 0.1242)
7:117243587:A:C,P13569,T887P,0.746,Gain of catalytic residue at T887 (P = 0.0377); Gain of glycosylation at P888 (P = 0.0639); Gain of helix (P = 0.0854); Gain of disorder (P = 0.0955); Loss of ubiquitination at K892 (P = 0.225)
7:117243587:A:G,P13569,T887A,0.581,Loss of glycosylation at T887 (P = 0.0437); Loss of disorder (P = 0.1473); Loss of methylation at K892 (P = 0.1662); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059)
7:117243587:A:T,P13569,T887S,0.691,Gain of disorder (P = 0.0522); Loss of glycosylation at T887 (P = 0.1144); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059); Loss of methylation at K892 (P = 0.2156)
7:117243588:C:A,P13569,T887N,0.698,Loss of glycosylation at T887 (P = 0.0437); Gain of disorder (P = 0.1314); Gain of helix (P = 0.1736); Loss of methylation at K892 (P = 0.2006); Loss of ubiquitination at K892 (P = 0.264)
7:117243588:C:G,P13569,T887S,0.691,Gain of disorder (P = 0.0522); Loss of glycosylation at T887 (P = 0.1144); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059); Loss of methylation at K892 (P = 0.2156)
7:117243588:C:T,P13569,T887I,0.659,Loss of disorder (P = 0.0393); Loss of glycosylation at T887 (P = 0.0437); Gain of helix (P = 0.0854); Loss of methylation at K892 (P = 0.2414); Loss of ubiquitination at K892 (P = 0.264)
7:117243590:C:A,P13569,P888T,0.534,Loss of glycosylation at P888 (P = 0.1296); Loss of stability (P = 0.1604); Loss of ubiquitination at K892 (P = 0.1668); Loss of disorder (P = 0.1697); Gain of catalytic residue at P888 (P = 0.1974)
7:117243590:C:G,P13569,P888A,0.626,Loss of disorder (P = 0.0837); Loss of glycosylation at P888 (P = 0.087); Loss of stability (P = 0.1455); Loss of ubiquitination at K892 (P = 0.197); Gain of helix (P = 0.2059)
7:117243590:C:T,P13569,P888S,0.535,Gain of disorder (P = 0.1096); Loss of stability (P = 0.1638); Loss of glycosylation at T887 (P = 0.1825); Gain of helix (P = 0.2059); Loss of methylation at K892 (P = 0.2297)
7:117243591:C:A,P13569,P888H,0.523,Loss of glycosylation at P888 (P = 0.087); Gain of helix (P = 0.132); Loss of disorder (P = 0.1902); Loss of methylation at K892 (P = 0.2144); Loss of loop (P = 0.2237)
7:117243591:C:G,P13569,P888R,0.734,Gain of helix (P = 0.0854); Loss of glycosylation at P888 (P = 0.087); Loss of methylation at K892 (P = 0.1416); Loss of disorder (P = 0.1683); Loss of catalytic residue at L889 (P = 0.2199)
7:117243591:C:T,P13569,P888L,0.688,Loss of disorder (P = 0.04); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Loss of glycosylation at P888 (P = 0.087); Loss of ubiquitination at K892 (P = 0.197)
7:117243593:C:A,P13569,L889I,0.559,Gain of methylation at K892 (P = 0.0738); Loss of catalytic residue at L889 (P = 0.0911); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1331); Loss of glycosylation at P888 (P = 0.2008)
7:117243593:C:G,P13569,L889V,0.544,Gain of methylation at K892 (P = 0.0944); Gain of glycosylation at T887 (P = 0.1345); Loss of ubiquitination at K892 (P = 0.197); Loss of disorder (P = 0.2013); Gain of helix (P = 0.2059)
7:117243594:T:A,P13569,L889H,0.586,Gain of disorder (P = 0.0301); Gain of glycosylation at T887 (P = 0.0954); Gain of methylation at K892 (P = 0.154); Gain of ubiquitination at K892 (P = 0.2066); Loss of loop (P = 0.2237)
7:117243594:T:C,P13569,L889P,0.634,Gain of disorder (P = 0.012); Gain of catalytic residue at P888 (P = 0.0164); Gain of glycosylation at L889 (P = 0.0376); Gain of methylation at K892 (P = 0.0845); Loss of stability (P = 0.1736)
7:117243594:T:G,P13569,L889R,0.617,Gain of disorder (P = 0.0331); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of helix (P = 0.1299); Loss of glycosylation at T887 (P = 0.1867)
7:117243596:C:A,P13569,Q890K,0.651,Gain of ubiquitination at Q890 (P = 0.0155); Gain of methylation at Q890 (P = 0.0203); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Gain of disorder (P = 0.0975)
7:117243596:C:G,P13569,Q890E,0.588,Loss of helix (P = 0.0558); Gain of disorder (P = 0.1042); Gain of loop (P = 0.1069); Gain of relative solvent accessibility (P = 0.1259); Loss of glycosylation at T887 (P = 0.1634)
7:117243597:A:C,P13569,Q890P,0.671,Gain of glycosylation at T887 (P = 0.0557); Gain of helix (P = 0.132); Loss of stability (P = 0.1354); Gain of disorder (P = 0.1536); Gain of ubiquitination at K892 (P = 0.1663)
7:117243597:A:G,P13569,Q890R,0.827,Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of glycosylation at T887 (P = 0.1153); Gain of helix (P = 0.132); Loss of methylation at K892 (P = 0.1433)
7:117243597:A:T,P13569,Q890L,0.504,Loss of disorder (P = 0.0436); Gain of helix (P = 0.062); Loss of glycosylation at T887 (P = 0.123); Loss of ubiquitination at K892 (P = 0.1392); Loss of methylation at K892 (P = 0.1659)
7:117243598:A:C,P13569,Q890H,0.597,Gain of helix (P = 0.1736); Loss of ubiquitination at K892 (P = 0.197); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2361); Loss of methylation at K892 (P = 0.2399)
7:117243598:A:T,P13569,Q890H,0.597,Gain of helix (P = 0.1736); Loss of ubiquitination at K892 (P = 0.197); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2361); Loss of methylation at K892 (P = 0.2399)
7:117243599:G:A,P13569,D891N,0.588,Loss of helix (P = 0.0626); Gain of glycosylation at P888 (P = 0.0685); Gain of methylation at K892 (P = 0.0869); Loss of catalytic residue at G893 (P = 0.1747); Loss of ubiquitination at K892 (P = 0.197)
7:117243599:G:C,P13569,D891H,0.648,Gain of helix (P = 0.062); Gain of loop (P = 0.0851); Gain of methylation at K892 (P = 0.0885); Loss of ubiquitination at K892 (P = 0.1106); Gain of glycosylation at T887 (P = 0.1996)
7:117243599:G:T,P13569,D891Y,0.653,Loss of disorder (P = 0.0347); Loss of ubiquitination at K892 (P = 0.0506); Gain of catalytic residue at D891 (P = 0.0511); Gain of helix (P = 0.062); Loss of methylation at K892 (P = 0.2026)
7:117243600:A:C,P13569,D891A,0.617,Gain of helix (P = 0.062); Loss of disorder (P = 0.0849); Gain of glycosylation at P888 (P = 0.1376); Gain of loop (P = 0.2045); Loss of methylation at K892 (P = 0.2184)
7:117243600:A:T,P13569,D891V,0.683,Loss of disorder (P = 0.0253); Gain of methylation at K892 (P = 0.0416); Gain of helix (P = 0.062); Loss of ubiquitination at K892 (P = 0.0779); Gain of loop (P = 0.2045)
7:117243601:C:A,P13569,D891E,0.506,Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of methylation at K892 (P = 0.121); Loss of catalytic residue at G893 (P = 0.1534)
7:117243601:C:G,P13569,D891E,0.506,Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of methylation at K892 (P = 0.121); Loss of catalytic residue at G893 (P = 0.1534)
7:117243602:A:C,P13569,K892Q,0.491,Loss of ubiquitination at K892 (P = 0.0074); Loss of methylation at K892 (P = 0.0496); Gain of glycosylation at S895 (P = 0.0635); Loss of loop (P = 0.0986); Gain of helix (P = 0.132)
7:117243602:A:G,P13569,K892E,0.504,Loss of ubiquitination at K892 (P = 0.0074); Loss of methylation at K892 (P = 0.0496); Gain of glycosylation at S895 (P = 0.0824); Loss of loop (P = 0.0986); Loss of helix (P = 0.1706)
7:117243603:A:C,P13569,K892T,0.496,Loss of ubiquitination at K892 (P = 0.0074); Loss of methylation at K892 (P = 0.0496); Gain of glycosylation at S895 (P = 0.0651); Gain of helix (P = 0.132); Loss of disorder (P = 0.193)
7:117243603:A:G,P13569,K892R,0.446,Loss of ubiquitination at K892 (P = 0.0074); Gain of glycosylation at S895 (P = 0.0941); Gain of helix (P = 0.132); Gain of catalytic residue at T896 (P = 0.1468); Loss of disorder (P = 0.1788)
7:117243603:A:T,P13569,K892I,0.572,Loss of ubiquitination at K892 (P = 0.0074); Loss of disorder (P = 0.0139); Loss of methylation at K892 (P = 0.0496); Gain of glycosylation at S895 (P = 0.0682); Loss of loop (P = 0.0986)
7:117243604:A:C,P13569,K892N,0.486,Loss of ubiquitination at K892 (P = 0.0074); Loss of methylation at K892 (P = 0.0496); Gain of glycosylation at S895 (P = 0.0595); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.1551)
7:117243604:A:T,P13569,K892N,0.486,Loss of ubiquitination at K892 (P = 0.0074); Loss of methylation at K892 (P = 0.0496); Gain of glycosylation at S895 (P = 0.0595); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.1551)
7:117243605:G:A,P13569,G893R,0.687,Gain of solvent accessibility (P = 0.0971); Loss of catalytic residue at G893 (P = 0.1231); Gain of methylation at K892 (P = 0.1461); Gain of phosphorylation at T896 (P = 0.1551); Loss of disorder (P = 0.2162)
7:117243605:G:C,P13569,G893R,0.687,Gain of solvent accessibility (P = 0.0971); Loss of catalytic residue at G893 (P = 0.1231); Gain of methylation at K892 (P = 0.1461); Gain of phosphorylation at T896 (P = 0.1551); Loss of disorder (P = 0.2162)
7:117243605:G:T,P13569,G893W,0.669,Loss of disorder (P = 0.0228); Loss of ubiquitination at K892 (P = 0.0598); Loss of catalytic residue at G893 (P = 0.1377); Gain of methylation at K892 (P = 0.1717); Loss of glycosylation at S898 (P = 0.199)
7:117243606:G:A,P13569,G893E,0.624,Gain of glycosylation at T896 (P = 0.0846); Gain of loop (P = 0.1069); Gain of solvent accessibility (P = 0.1683); Loss of catalytic residue at K892 (P = 0.1764); Gain of disorder (P = 0.2006)
7:117243606:G:C,P13569,G893A,0.589,Gain of glycosylation at T896 (P = 0.0846); Loss of disorder (P = 0.1215); Loss of helix (P = 0.1299); Loss of catalytic residue at G893 (P = 0.2031); Loss of ubiquitination at K892 (P = 0.225)
7:117243606:G:T,P13569,G893V,0.58,Gain of methylation at K892 (P = 0.0448); Loss of disorder (P = 0.052); Loss of ubiquitination at K892 (P = 0.0931); Gain of glycosylation at T896 (P = 0.0954); Loss of loop (P = 0.0986)
7:117243608:A:C,P13569,N894H,0.566,Gain of catalytic residue at N894 (P = 0.0111); Gain of disorder (P = 0.1143); Gain of helix (P = 0.132); Loss of stability (P = 0.1753); Gain of glycosylation at T896 (P = 0.1926)
7:117243608:A:G,P13569,N894D,0.556,Loss of loop (P = 0.0804); Gain of helix (P = 0.132); Loss of methylation at K892 (P = 0.1553); Gain of disorder (P = 0.1799); Gain of phosphorylation at T896 (P = 0.2062)
7:117243608:A:T,P13569,N894Y,0.537,Loss of ubiquitination at K892 (P = 0.0675); Loss of disorder (P = 0.0907); Gain of catalytic residue at N894 (P = 0.0946); Gain of helix (P = 0.132); Gain of phosphorylation at N894 (P = 0.153)
7:117243609:A:C,P13569,N894T,0.491,Gain of glycosylation at N894 (P = 0.0235); Gain of helix (P = 0.062); Loss of loop (P = 0.0804); Loss of stability (P = 0.1931); Gain of disorder (P = 0.2109)
7:117243609:A:G,P13569,N894S,0.589,Gain of glycosylation at N894 (P = 0.0453); Gain of disorder (P = 0.0926); Gain of phosphorylation at N894 (P = 0.1459); Loss of methylation at K892 (P = 0.1963); Loss of loop (P = 0.2237)
7:117243609:A:T,P13569,N894I,0.63,Loss of disorder (P = 0.0555); Loss of glycosylation at S898 (P = 0.0754); Loss of ubiquitination at K892 (P = 0.0779); Loss of loop (P = 0.0986); Gain of catalytic residue at S898 (P = 0.149)
7:117243610:T:A,P13569,N894K,0.597,Gain of ubiquitination at N894 (P = 0.0069); Loss of loop (P = 0.0804); Gain of catalytic residue at N894 (P = 0.1236); Gain of helix (P = 0.132); Loss of stability (P = 0.1792)
7:117243610:T:G,P13569,N894K,0.597,Gain of ubiquitination at N894 (P = 0.0069); Loss of loop (P = 0.0804); Gain of catalytic residue at N894 (P = 0.1236); Gain of helix (P = 0.132); Loss of stability (P = 0.1792)
7:117243611:A:C,P13569,S895R,0.604,Loss of glycosylation at T896 (P = 0.0888); Gain of catalytic residue at S895 (P = 0.1331); Loss of disorder (P = 0.164); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907)
7:117243611:A:G,P13569,S895G,0.394,Gain of loop (P = 0.069); Loss of stability (P = 0.0917); Gain of relative solvent accessibility (P = 0.1259); Loss of disorder (P = 0.1423); Gain of glycosylation at S898 (P = 0.1545)
7:117243611:A:T,P13569,S895C,0.635,Loss of disorder (P = 0.0036); Gain of loop (P = 0.069); Loss of ubiquitination at K892 (P = 0.0779); Loss of glycosylation at S898 (P = 0.12); Loss of sheet (P = 0.1398)
7:117243612:G:C,P13569,S895T,0.515,Gain of glycosylation at S895 (P = 0.0162); Loss of disorder (P = 0.1315); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of methylation at K892 (P = 0.2152)
7:117243612:G:T,P13569,S895I,0.609,Loss of disorder (P = 0.0122); Loss of ubiquitination at K892 (P = 0.0675); Loss of loop (P = 0.0804); Gain of sheet (P = 0.1945); Loss of glycosylation at S895 (P = 0.2006)
7:117243613:T:A,P13569,S895R,0.604,Loss of glycosylation at T896 (P = 0.0888); Gain of catalytic residue at S895 (P = 0.1331); Loss of disorder (P = 0.164); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907)
7:117243613:T:G,P13569,S895R,0.604,Loss of glycosylation at T896 (P = 0.0888); Gain of catalytic residue at S895 (P = 0.1331); Loss of disorder (P = 0.164); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907)
7:117243614:A:C,P13569,T896P,0.524,Gain of loop (P = 0.0435); Gain of glycosylation at S898 (P = 0.0747); Gain of methylation at K892 (P = 0.1993); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2214)
7:117243614:A:G,P13569,T896A,0.634,Loss of glycosylation at T896 (P = 0.0575); Loss of methylation at K892 (P = 0.1654); Loss of stability (P = 0.2043); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2298)
7:117243614:A:T,P13569,T896S,0.436,Gain of disorder (P = 0.0732); Gain of glycosylation at T896 (P = 0.077); Gain of loop (P = 0.0851); Loss of methylation at K892 (P = 0.2154); Gain of relative solvent accessibility (P = 0.2363)
7:117243615:C:A,P13569,T896N,0.449,Loss of glycosylation at T896 (P = 0.0575); Gain of helix (P = 0.1736); Loss of methylation at K892 (P = 0.1945); Gain of loop (P = 0.2045); Gain of disorder (P = 0.2177)
7:117243615:C:G,P13569,T896S,0.436,Gain of disorder (P = 0.0732); Gain of glycosylation at T896 (P = 0.077); Gain of loop (P = 0.0851); Loss of methylation at K892 (P = 0.2154); Gain of relative solvent accessibility (P = 0.2363)
7:117243615:C:T,P13569,T896I,0.86,Loss of glycosylation at T896 (P = 0.0575); Loss of disorder (P = 0.0577); Loss of ubiquitination at K892 (P = 0.1106); Gain of helix (P = 0.1736); Loss of methylation at K892 (P = 0.1896)
7:117243617:C:A,P13569,H897N,0.374,Loss of catalytic residue at H897 (P = 0.1433); Loss of disorder (P = 0.1631); Gain of loop (P = 0.2045); Loss of methylation at K892 (P = 0.2121); Loss of glycosylation at T896 (P = 0.2349)
7:117243617:C:G,P13569,H897D,0.435,Gain of loop (P = 0.0851); Gain of relative solvent accessibility (P = 0.1259); Loss of disorder (P = 0.1502); Loss of glycosylation at T896 (P = 0.1565); Loss of methylation at K892 (P = 0.2041)
7:117243617:C:T,P13569,H897Y,0.526,Loss of disorder (P = 0.0505); Loss of ubiquitination at K892 (P = 0.0931); Gain of methylation at K892 (P = 0.1273); Gain of glycosylation at S895 (P = 0.1703); Gain of loop (P = 0.2045)
7:117243618:A:C,P13569,H897P,0.452,Gain of glycosylation at H897 (P = 0.0163); Gain of phosphorylation at T896 (P = 0.0857); Loss of catalytic residue at S902 (P = 0.1416); Gain of methylation at K892 (P = 0.1474); Loss of disorder (P = 0.1619)
7:117243618:A:G,P13569,H897R,0.623,Loss of methylation at K892 (P = 0.1241); Gain of helix (P = 0.1736); Loss of glycosylation at S898 (P = 0.1819); Loss of disorder (P = 0.184); Gain of phosphorylation at S902 (P = 0.1892)
7:117243618:A:T,P13569,H897L,0.535,Loss of disorder (P = 0.0278); Loss of ubiquitination at K892 (P = 0.0931); Loss of glycosylation at T896 (P = 0.1238); Loss of methylation at K892 (P = 0.1337); Loss of catalytic residue at H897 (P = 0.1654)
7:117243619:T:A,P13569,H897Q,0.388,Loss of disorder (P = 0.1467); Gain of glycosylation at S898 (P = 0.1575); Gain of loop (P = 0.2045); Loss of methylation at R899 (P = 0.2352); Gain of ubiquitination at K892 (P = 0.2575)
7:117243619:T:G,P13569,H897Q,0.388,Loss of disorder (P = 0.1467); Gain of glycosylation at S898 (P = 0.1575); Gain of loop (P = 0.2045); Loss of methylation at R899 (P = 0.2352); Gain of ubiquitination at K892 (P = 0.2575)
7:117243620:A:C,P13569,S898R,0.6,Loss of glycosylation at S898 (P = 0.0392); Loss of disorder (P = 0.0888); Gain of catalytic residue at S898 (P = 0.1354); Gain of phosphorylation at T896 (P = 0.1565); Gain of loop (P = 0.2045)
7:117243620:A:G,P13569,S898G,0.525,Loss of glycosylation at S898 (P = 0.0392); Gain of methylation at R899 (P = 0.0586); Loss of disorder (P = 0.085); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684)
7:117243620:A:T,P13569,S898C,0.618,Loss of disorder (P = 0); Loss of glycosylation at S898 (P = 0.0392); Gain of sheet (P = 0.0477); Loss of loop (P = 0.1242); Gain of catalytic residue at S902 (P = 0.2352)
7:117243621:G:A,P13569,S898N,0.485,Loss of glycosylation at S898 (P = 0.0392); Loss of disorder (P = 0.096); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363); Loss of helix (P = 0.2662)
7:117243621:G:C,P13569,S898T,0.527,Loss of disorder (P = 0.0745); Gain of loop (P = 0.2045); Gain of glycosylation at S898 (P = 0.2059); Loss of helix (P = 0.2662); Loss of methylation at R899 (P = 0.3313)
7:117243621:G:T,P13569,S898I,0.564,Loss of disorder (P = 8e-04); Loss of glycosylation at S898 (P = 0.0392); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of methylation at R899 (P = 0.2507)
7:117243622:T:A,P13569,S898R,0.6,Loss of glycosylation at S898 (P = 0.0392); Loss of disorder (P = 0.0888); Gain of catalytic residue at S898 (P = 0.1354); Gain of phosphorylation at T896 (P = 0.1565); Gain of loop (P = 0.2045)
7:117243622:T:G,P13569,S898R,0.6,Loss of glycosylation at S898 (P = 0.0392); Loss of disorder (P = 0.0888); Gain of catalytic residue at S898 (P = 0.1354); Gain of phosphorylation at T896 (P = 0.1565); Gain of loop (P = 0.2045)
7:117243623:A:G,P13569,R899G,0.716,Gain of glycosylation at S898 (P = 0.0387); Loss of catalytic residue at R899 (P = 0.0649); Loss of stability (P = 0.1023); Loss of methylation at R899 (P = 0.1164); Gain of disorder (P = 0.1909)
7:117243624:G:A,P13569,R899K,0.709,Gain of ubiquitination at R899 (P = 0.0117); Gain of methylation at R899 (P = 0.0878); Gain of disorder (P = 0.1112); Gain of loop (P = 0.2045); Loss of glycosylation at S898 (P = 0.232)
7:117243624:G:C,P13569,R899T,0.694,Gain of glycosylation at R899 (P = 0.0159); Loss of methylation at R899 (P = 0.1164); Gain of sheet (P = 0.1945); Gain of disorder (P = 0.2002); Loss of loop (P = 0.2237)
7:117243624:G:T,P13569,R899I,0.698,Loss of catalytic residue at R899 (P = 0.0046); Loss of disorder (P = 0.0244); Gain of glycosylation at T896 (P = 0.0933); Loss of methylation at R899 (P = 0.1164); Gain of sheet (P = 0.1451)
7:117243625:A:C,P13569,R899S,0.701,Gain of glycosylation at R899 (P = 0.0338); Gain of disorder (P = 0.0399); Loss of catalytic residue at R899 (P = 0.0932); Loss of loop (P = 0.0986); Loss of methylation at R899 (P = 0.1164)
7:117243625:A:T,P13569,R899S,0.701,Gain of glycosylation at R899 (P = 0.0338); Gain of disorder (P = 0.0399); Loss of catalytic residue at R899 (P = 0.0932); Loss of loop (P = 0.0986); Loss of methylation at R899 (P = 0.1164)
7:117243626:A:C,P13569,N900H,0.661,Gain of catalytic residue at N901 (P = 0.0432); Loss of stability (P = 0.0742); Gain of disorder (P = 0.1565); Loss of glycosylation at S898 (P = 0.1706); Loss of loop (P = 0.2237)
7:117243626:A:G,P13569,N900D,0.736,Gain of phosphorylation at Y903 (P = 0.1311); Gain of disorder (P = 0.1891); Loss of sheet (P = 0.1907); Gain of catalytic residue at N900 (P = 0.2109); Loss of loop (P = 0.2237)
7:117243626:A:T,P13569,N900Y,0.688,Loss of disorder (P = 0.0266); Gain of sheet (P = 0.1208); Loss of stability (P = 0.2083); Loss of glycosylation at T896 (P = 0.2201); Loss of loop (P = 0.2237)
7:117243627:A:C,P13569,N900T,0.569,Gain of catalytic residue at N900 (P = 0.086); Gain of glycosylation at S898 (P = 0.0933); Loss of stability (P = 0.1075); Loss of disorder (P = 0.1819); Gain of phosphorylation at T896 (P = 0.2208)
7:117243627:A:G,P13569,N900S,0.559,Gain of disorder (P = 0.0477); Gain of glycosylation at N900 (P = 0.0598); Loss of stability (P = 0.1035); Gain of phosphorylation at S902 (P = 0.1071); Loss of sheet (P = 0.1907)
7:117243627:A:T,P13569,N900I,0.628,Loss of disorder (P = 0.0064); Loss of loop (P = 0.0374); Gain of helix (P = 0.0854); Loss of glycosylation at T896 (P = 0.1689); Loss of methylation at R899 (P = 0.2505)
7:117243628:T:A,P13569,N900K,0.717,Gain of ubiquitination at N900 (P = 0.0066); Gain of methylation at N900 (P = 0.0522); Loss of stability (P = 0.0547); Gain of disorder (P = 0.1368); Loss of sheet (P = 0.1907)
7:117243628:T:G,P13569,N900K,0.717,Gain of ubiquitination at N900 (P = 0.0066); Gain of methylation at N900 (P = 0.0522); Loss of stability (P = 0.0547); Gain of disorder (P = 0.1368); Loss of sheet (P = 0.1907)
7:117243629:A:C,P13569,N901H,0.68,Gain of catalytic residue at N901 (P = 0.0361); Gain of sheet (P = 0.1945); Loss of glycosylation at S898 (P = 0.2012); Loss of stability (P = 0.2012); Loss of loop (P = 0.2237)
7:117243629:A:G,P13569,N901D,0.682,Gain of catalytic residue at N901 (P = 0.0082); Gain of loop (P = 0.0851); Gain of phosphorylation at Y903 (P = 0.1192); Loss of glycosylation at S898 (P = 0.1694); Gain of disorder (P = 0.1809)
7:117243629:A:T,P13569,N901Y,0.681,Loss of disorder (P = 0.0245); Gain of catalytic residue at N901 (P = 0.0566); Loss of glycosylation at T896 (P = 0.1722); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117243630:A:C,P13569,N901T,0.543,Gain of glycosylation at N901 (P = 0.0366); Gain of loop (P = 0.0851); Loss of disorder (P = 0.1743); Loss of helix (P = 0.2662); Gain of phosphorylation at N901 (P = 0.2816)
7:117243630:A:G,P13569,N901S,0.569,Gain of disorder (P = 0.0483); Gain of phosphorylation at S902 (P = 0.1421); Gain of loop (P = 0.2045); Gain of glycosylation at S902 (P = 0.2067); Loss of stability (P = 0.2163)
7:117243630:A:T,P13569,N901I,0.654,Loss of disorder (P = 0.0078); Loss of glycosylation at T896 (P = 0.123); Gain of loop (P = 0.2045); Loss of methylation at R899 (P = 0.2482); Loss of helix (P = 0.2662)
7:117243631:C:A,P13569,N901K,0.776,Gain of ubiquitination at N901 (P = 0.0094); Gain of methylation at N901 (P = 0.029); Loss of glycosylation at S898 (P = 0.0891); Gain of disorder (P = 0.12); Loss of stability (P = 0.1309)
7:117243631:C:G,P13569,N901K,0.776,Gain of ubiquitination at N901 (P = 0.0094); Gain of methylation at N901 (P = 0.029); Loss of glycosylation at S898 (P = 0.0891); Gain of disorder (P = 0.12); Loss of stability (P = 0.1309)
7:117243632:A:C,P13569,S902R,0.866,Loss of disorder (P = 0.0731); Loss of loop (P = 0.0804); Gain of methylation at S902 (P = 0.0981); Loss of stability (P = 0.1707); Loss of glycosylation at S898 (P = 0.1895)
7:117243632:A:G,P13569,S902G,0.598,Loss of stability (P = 0.0236); Loss of disorder (P = 0.0764); Loss of catalytic residue at S902 (P = 0.1487); Loss of glycosylation at S902 (P = 0.1964); Gain of loop (P = 0.2045)
7:117243632:A:T,P13569,S902C,0.588,Loss of disorder (P = 1e-04); Loss of loop (P = 0.0986); Loss of glycosylation at S898 (P = 0.1001); Gain of sheet (P = 0.1451); Gain of catalytic residue at S898 (P = 0.1575)
7:117243633:G:A,P13569,S902N,0.601,Gain of helix (P = 0.0854); Loss of stability (P = 0.0965); Loss of disorder (P = 0.0973); Loss of loop (P = 0.1242); Loss of sheet (P = 0.1907)
7:117243633:G:C,P13569,S902T,0.523,Loss of disorder (P = 0.0592); Gain of glycosylation at S898 (P = 0.1892); Gain of loop (P = 0.2045); Loss of catalytic residue at S902 (P = 0.2231); Loss of stability (P = 0.2675)
7:117243633:G:T,P13569,S902I,0.561,Loss of disorder (P = 0.0012); Loss of glycosylation at S898 (P = 0.0719); Loss of loop (P = 0.0804); Gain of catalytic residue at S898 (P = 0.1493); Loss of sheet (P = 0.1907)
7:117243634:C:A,P13569,S902R,0.866,Loss of disorder (P = 0.0731); Loss of loop (P = 0.0804); Gain of methylation at S902 (P = 0.0981); Loss of stability (P = 0.1707); Loss of glycosylation at S898 (P = 0.1895)
7:117243634:C:G,P13569,S902R,0.866,Loss of disorder (P = 0.0731); Loss of loop (P = 0.0804); Gain of methylation at S902 (P = 0.0981); Loss of stability (P = 0.1707); Loss of glycosylation at S898 (P = 0.1895)
7:117243635:T:A,P13569,Y903N,0.544,Gain of disorder (P = 0.0073); Loss of catalytic residue at Y903 (P = 0.0094); Gain of glycosylation at S902 (P = 0.0635); Loss of stability (P = 0.1149); Loss of sheet (P = 0.1907)
7:117243635:T:C,P13569,Y903H,0.408,Gain of disorder (P = 0.0113); Loss of stability (P = 0.1332); Loss of catalytic residue at Y903 (P = 0.1378); Gain of loop (P = 0.2045); Gain of glycosylation at S902 (P = 0.2229)
7:117243635:T:G,P13569,Y903D,0.632,Gain of disorder (P = 0.006); Loss of catalytic residue at Y903 (P = 0.1025); Loss of stability (P = 0.1779); Loss of glycosylation at S898 (P = 0.1876); Loss of sheet (P = 0.1907)
7:117243636:A:C,P13569,Y903S,0.569,Gain of disorder (P = 0.0013); Gain of glycosylation at Y903 (P = 0.0103); Loss of catalytic residue at Y903 (P = 0.0528); Loss of stability (P = 0.1104); Gain of phosphorylation at S902 (P = 0.1526)
7:117243636:A:T,P13569,Y903F,0.605,Loss of glycosylation at S898 (P = 0.0661); Loss of disorder (P = 0.1303); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684)
7:117243638:G:A,P13569,A904T,0.573,Gain of disorder (P = 0.0735); Gain of glycosylation at A904 (P = 0.0851); Loss of stability (P = 0.1096); Gain of loop (P = 0.2045); Loss of catalytic residue at A904 (P = 0.244)
7:117243638:G:C,P13569,A904P,0.807,Gain of disorder (P = 0.0371); Gain of loop (P = 0.0851); Loss of stability (P = 0.0859); Loss of sheet (P = 0.1907); Loss of catalytic residue at A904 (P = 0.2384)
7:117243638:G:T,P13569,A904S,0.554,Gain of disorder (P = 0.0089); Gain of glycosylation at A904 (P = 0.0157); Gain of phosphorylation at S902 (P = 0.1541); Gain of loop (P = 0.2045); Loss of stability (P = 0.2336)
7:117243639:C:A,P13569,A904E,0.779,Gain of disorder (P = 0.0155); Gain of loop (P = 0.0851); Loss of catalytic residue at S902 (P = 0.144); Gain of phosphorylation at S902 (P = 0.2256); Gain of relative solvent accessibility (P = 0.2363)
7:117243639:C:G,P13569,A904G,0.664,Gain of disorder (P = 0.0566); Loss of stability (P = 0.0988); Loss of glycosylation at S909 (P = 0.1522); Loss of catalytic residue at A904 (P = 0.1782); Loss of sheet (P = 0.1907)
7:117243639:C:T,P13569,A904V,0.647,Loss of disorder (P = 0.0837); Loss of glycosylation at S909 (P = 0.1796); Loss of methylation at R899 (P = 0.3068); Loss of stability (P = 0.3453); Loss of sheet (P = 0.3635)
7:117243641:G:A,P13569,V905M,0.598,Gain of disorder (P = 0.059); Loss of catalytic residue at V905 (P = 0.1271); Loss of stability (P = 0.1391); Loss of glycosylation at S909 (P = 0.2107); Loss of loop (P = 0.2897)
7:117243641:G:C,P13569,V905L,0.511,Loss of sheet (P = 0.1907); Gain of disorder (P = 0.2203); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2363); Loss of glycosylation at S909 (P = 0.264)
7:117243641:G:T,P13569,V905L,0.511,Loss of sheet (P = 0.1907); Gain of disorder (P = 0.2203); Loss of loop (P = 0.2237); Gain of relative solvent accessibility (P = 0.2363); Loss of glycosylation at S909 (P = 0.264)
7:117243642:T:A,P13569,V905E,0.747,Gain of disorder (P = 0.0011); Loss of stability (P = 0.0514); Gain of relative solvent accessibility (P = 0.1259); Loss of sheet (P = 0.1398); Gain of phosphorylation at S902 (P = 0.1421)
7:117243642:T:C,P13569,V905A,0.721,Loss of stability (P = 0.0075); Gain of disorder (P = 0.0245); Loss of sheet (P = 0.1907); Gain of glycosylation at S909 (P = 0.2018); Gain of helix (P = 0.2059)
7:117243642:T:G,P13569,V905G,0.701,Loss of stability (P = 9e-04); Gain of disorder (P = 0.0076); Loss of catalytic residue at V905 (P = 0.1236); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117243644:A:C,P13569,I906L,0.505,Loss of glycosylation at S909 (P = 0.1152); Gain of sheet (P = 0.1945); Gain of disorder (P = 0.2016); Loss of loop (P = 0.2237); Loss of solvent accessibility (P = 0.4011)
7:117243644:A:G,P13569,I906V,0.493,Gain of catalytic residue at I906 (P = 0.05); Gain of disorder (P = 0.152); Loss of sheet (P = 0.1907); Loss of glycosylation at S909 (P = 0.2015); Loss of loop (P = 0.2237)
7:117243644:A:T,P13569,I906F,0.597,Gain of catalytic residue at I906 (P = 0.051); Loss of glycosylation at S909 (P = 0.1282); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2318)
7:117243645:T:A,P13569,I906N,0.613,Gain of disorder (P = 0.0051); Loss of stability (P = 0.0451); Gain of catalytic residue at I906 (P = 0.0485); Loss of glycosylation at S909 (P = 0.1234); Loss of sheet (P = 0.1907)
7:117243645:T:C,P13569,I906T,0.448,Gain of disorder (P = 0.0101); Loss of stability (P = 0.0287); Gain of glycosylation at I906 (P = 0.0318); Gain of phosphorylation at I906 (P = 0.1459); Loss of sheet (P = 0.1907)
7:117243645:T:G,P13569,I906S,0.531,Gain of disorder (P = 3e-04); Gain of glycosylation at I906 (P = 0.0202); Loss of stability (P = 0.0357); Gain of catalytic residue at I906 (P = 0.0851); Gain of phosphorylation at S902 (P = 0.1278)
7:117243646:T:G,P13569,I906M,0.545,Gain of disorder (P = 0.0562); Loss of glycosylation at S909 (P = 0.1062); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117243647:A:C,P13569,I907L,0.595,Gain of catalytic residue at I907 (P = 0.0458); Gain of sheet (P = 0.1945); Gain of disorder (P = 0.2056); Loss of helix (P = 0.2662); Gain of glycosylation at S909 (P = 0.2776)
7:117243647:A:G,P13569,I907V,0.568,Gain of catalytic residue at I907 (P = 0.0062); Gain of sheet (P = 0.1208); Gain of disorder (P = 0.1537); Gain of helix (P = 0.1736); Gain of glycosylation at S909 (P = 0.1999)
7:117243647:A:T,P13569,I907F,0.606,Gain of catalytic residue at I907 (P = 0.057); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2378); Gain of helix (P = 0.2684); Gain of glycosylation at S909 (P = 0.2788)
7:117243648:T:A,P13569,I907N,0.653,Gain of disorder (P = 0.0068); Gain of relative solvent accessibility (P = 0.0479); Loss of stability (P = 0.0702); Gain of solvent accessibility (P = 0.0766); Gain of glycosylation at S909 (P = 0.1749)
7:117243648:T:C,P13569,I907T,0.654,Gain of disorder (P = 0.0148); Loss of stability (P = 0.017); Gain of glycosylation at I907 (P = 0.0503); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.09)
7:117243648:T:G,P13569,I907S,0.631,Gain of disorder (P = 3e-04); Gain of glycosylation at I907 (P = 0.0136); Gain of catalytic residue at I907 (P = 0.0608); Loss of stability (P = 0.065); Gain of relative solvent accessibility (P = 0.09)
7:117243649:C:G,P13569,I907M,0.646,Gain of disorder (P = 0.0619); Gain of catalytic residue at I907 (P = 0.1209); Gain of phosphorylation at Y903 (P = 0.1662); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117243650:A:C,P13569,T908P,0.691,Loss of glycosylation at S909 (P = 0.1494); Gain of catalytic residue at T908 (P = 0.1782); Loss of sheet (P = 0.1907); Loss of stability (P = 0.213); Gain of disorder (P = 0.2222)
7:117243650:A:G,P13569,T908A,0.491,Loss of glycosylation at S909 (P = 0.1159); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2062); Gain of catalytic residue at T908 (P = 0.2135)
7:117243650:A:T,P13569,T908S,0.539,Gain of disorder (P = 0.0497); Gain of catalytic residue at T908 (P = 0.0634); Loss of glycosylation at S909 (P = 0.1317); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117243651:C:G,P13569,T908S,0.539,Gain of disorder (P = 0.0497); Gain of catalytic residue at T908 (P = 0.0634); Loss of glycosylation at S909 (P = 0.1317); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117243651:C:T,P13569,T908I,0.506,Loss of disorder (P = 0.0691); Loss of glycosylation at S909 (P = 0.1426); Gain of loop (P = 0.2045); Loss of catalytic residue at T908 (P = 0.2076); Loss of helix (P = 0.2662)
7:117243653:A:C,P13569,S909R,0.629,Loss of glycosylation at S909 (P = 0.0159); Loss of sheet (P = 0.1907); Loss of disorder (P = 0.1976); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117243653:A:G,P13569,S909G,0.517,Loss of glycosylation at S909 (P = 0.0159); Loss of stability (P = 0.0613); Loss of disorder (P = 0.1615); Gain of loop (P = 0.2754); Gain of catalytic residue at T908 (P = 0.3152)
7:117243653:A:T,P13569,S909C,0.601,Loss of glycosylation at S909 (P = 0.0159); Loss of disorder (P = 0.0475); Loss of loop (P = 0.0986); Loss of catalytic residue at S909 (P = 0.1809); Loss of sheet (P = 0.1907)
7:117243654:G:A,P13569,S909N,0.573,Loss of glycosylation at S909 (P = 0.0159); Gain of helix (P = 0.132); Loss of disorder (P = 0.1766); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117243654:G:C,P13569,S909T,0.503,Loss of glycosylation at S909 (P = 0.0615); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1868); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754)
7:117243654:G:T,P13569,S909I,0.49,Loss of catalytic residue at S909 (P = 1e-04); Loss of glycosylation at S909 (P = 0.0159); Loss of disorder (P = 0.0657); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237)
7:117243655:C:A,P13569,S909R,0.629,Loss of glycosylation at S909 (P = 0.0159); Loss of sheet (P = 0.1907); Loss of disorder (P = 0.1976); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117243655:C:G,P13569,S909R,0.629,Loss of glycosylation at S909 (P = 0.0159); Loss of sheet (P = 0.1907); Loss of disorder (P = 0.1976); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117243656:A:C,P13569,T910P,0.607,Loss of catalytic residue at T910 (P = 0.03); Gain of glycosylation at T910 (P = 0.0505); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117243656:A:G,P13569,T910A,0.502,Loss of glycosylation at S909 (P = 0.0607); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of catalytic residue at Y914 (P = 0.3118)
7:117243656:A:T,P13569,T910S,0.541,Loss of loop (P = 0.0235); Loss of glycosylation at S909 (P = 0.0465); Gain of helix (P = 0.0854); Gain of disorder (P = 0.1174); Gain of sheet (P = 0.1208)
7:117243657:C:A,P13569,T910N,0.451,Loss of glycosylation at S909 (P = 0.0857); Gain of helix (P = 0.132); Gain of relative solvent accessibility (P = 0.1571); Loss of sheet (P = 0.1907); Gain of solvent accessibility (P = 0.2384)
7:117243657:C:G,P13569,T910S,0.541,Loss of loop (P = 0.0235); Loss of glycosylation at S909 (P = 0.0465); Gain of helix (P = 0.0854); Gain of disorder (P = 0.1174); Gain of sheet (P = 0.1208)
7:117243657:C:T,P13569,T910I,0.543,Loss of catalytic residue at T910 (P = 0.0047); Loss of loop (P = 0.0235); Gain of helix (P = 0.0425); Loss of glycosylation at S909 (P = 0.0532); Loss of sheet (P = 0.1398)
7:117243659:A:C,P13569,S911R,0.569,Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of glycosylation at S909 (P = 0.2506); Gain of solvent accessibility (P = 0.2987)
7:117243659:A:G,P13569,S911G,0.525,Loss of loop (P = 0.0804); Gain of sheet (P = 0.1945); Gain of helix (P = 0.2059); Gain of glycosylation at S909 (P = 0.2129); Loss of catalytic residue at S911 (P = 0.3374)
7:117243659:A:T,P13569,S911C,0.601,Gain of helix (P = 0.132); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of disorder (P = 0.234); Loss of glycosylation at S909 (P = 0.3003)
7:117243660:G:A,P13569,S911N,0.499,Loss of loop (P = 0.0804); Gain of helix (P = 0.1736); Loss of glycosylation at S909 (P = 0.2206); Loss of catalytic residue at S911 (P = 0.3062); Loss of sheet (P = 0.3635)
7:117243660:G:C,P13569,S911T,0.577,Gain of glycosylation at S911 (P = 0.1438); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662); Loss of sheet (P = 0.3635); Loss of disorder (P = 0.4502)
7:117243660:G:T,P13569,S911I,0.591,Loss of catalytic residue at S911 (P = 4e-04); Gain of stability (P = 0.1424); Gain of glycosylation at S909 (P = 0.1733); Gain of helix (P = 0.1736); Gain of sheet (P = 0.1945)
7:117243661:T:A,P13569,S911R,0.569,Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of glycosylation at S909 (P = 0.2506); Gain of solvent accessibility (P = 0.2987)
7:117243661:T:G,P13569,S911R,0.569,Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of glycosylation at S909 (P = 0.2506); Gain of solvent accessibility (P = 0.2987)
7:117243662:T:A,P13569,S912T,0.63,Gain of sheet (P = 0.1945); Loss of helix (P = 0.2022); Gain of glycosylation at S911 (P = 0.2033); Loss of disorder (P = 0.546); Gain of phosphorylation at T908 (P = 0.6109)
7:117243662:T:C,P13569,S912P,0.656,Loss of catalytic residue at S912 (P = 0.0153); Gain of glycosylation at S909 (P = 0.1365); Loss of stability (P = 0.3768); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437)
7:117243662:T:G,P13569,S912A,0.625,Loss of helix (P = 0.1299); Gain of sheet (P = 0.1945); Gain of glycosylation at S909 (P = 0.2392); Loss of loop (P = 0.3664); Loss of stability (P = 0.428)
7:117243663:C:G,P13569,S912W,0.708,Loss of catalytic residue at S912 (P = 0.126); Gain of helix (P = 0.1736); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Loss of glycosylation at S909 (P = 0.2866)
7:117243665:T:A,P13569,Y913N,0.65,Loss of stability (P = 0.0506); Loss of loop (P = 0.0986); Gain of helix (P = 0.132); Loss of catalytic residue at Y913 (P = 0.1681); Gain of glycosylation at S909 (P = 0.2579)
7:117243665:T:C,P13569,Y913H,0.711,Loss of stability (P = 0.0425); Gain of helix (P = 0.062); Loss of loop (P = 0.0804); Gain of glycosylation at S909 (P = 0.2235); Gain of disorder (P = 0.2824)
7:117243665:T:G,P13569,Y913D,0.692,Loss of stability (P = 0.092); Gain of loop (P = 0.2045); Gain of glycosylation at S909 (P = 0.233); Gain of relative solvent accessibility (P = 0.2363); Gain of helix (P = 0.2684)
7:117243666:A:C,P13569,Y913S,0.686,Loss of stability (P = 0.0202); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1431); Gain of loop (P = 0.2045); Loss of glycosylation at S909 (P = 0.3072)
7:117243666:A:G,P13569,Y913C,0.882,Loss of loop (P = 0.0986); Loss of stability (P = 0.1422); Gain of helix (P = 0.1736); Loss of glycosylation at S909 (P = 0.3087); Gain of catalytic residue at Y917 (P = 0.3721)
7:117243666:A:T,P13569,Y913F,0.695,Loss of glycosylation at S909 (P = 0.125); Loss of helix (P = 0.3949); Loss of stability (P = 0.4178); Loss of sheet (P = 0.5184); Gain of catalytic residue at Y914 (P = 0.6428)
7:117243668:T:A,P13569,Y914N,0.573,Loss of stability (P = 0.1257); Loss of helix (P = 0.1299); Loss of glycosylation at S909 (P = 0.2142); Gain of loop (P = 0.2754); Gain of catalytic residue at Y914 (P = 0.4305)
7:117243668:T:C,P13569,Y914H,0.614,Loss of stability (P = 0.0949); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Gain of glycosylation at S909 (P = 0.3154); Gain of disorder (P = 0.389)
7:117243668:T:G,P13569,Y914D,0.616,Loss of helix (P = 0.1299); Gain of phosphorylation at Y917 (P = 0.2127); Loss of loop (P = 0.2237); Loss of stability (P = 0.2411); Loss of glycosylation at S909 (P = 0.2621)
7:117243669:A:C,P13569,Y914S,0.603,Loss of stability (P = 0.077); Loss of helix (P = 0.1299); Loss of glycosylation at S909 (P = 0.1936); Gain of catalytic residue at Y914 (P = 0.235); Gain of disorder (P = 0.2445)
7:117243669:A:G,P13569,Y914C,0.57,Gain of helix (P = 0.2684); Loss of stability (P = 0.2776); Gain of glycosylation at S909 (P = 0.3065); Gain of loop (P = 0.3485); Gain of sheet (P = 0.4423)
7:117243669:A:T,P13569,Y914F,0.536,Loss of glycosylation at S909 (P = 0.2213); Gain of helix (P = 0.2294); Loss of loop (P = 0.3664); Gain of catalytic residue at Y914 (P = 0.4701); Loss of sheet (P = 0.5184)
7:117243671:G:A,P13569,V915M,0.614,Gain of helix (P = 0.0854); Loss of loop (P = 0.0986); Loss of stability (P = 0.2362); Loss of sheet (P = 0.437); Loss of catalytic residue at F916 (P = 0.5913)
7:117243671:G:T,P13569,V915L,0.555,Gain of helix (P = 0.132); Loss of catalytic residue at V915 (P = 0.1438); Loss of loop (P = 0.3664); Loss of sheet (P = 0.437); Gain of phosphorylation at S911 (P = 0.6926)
7:117243672:T:A,P13569,V915E,0.702,Gain of helix (P = 0.132); Loss of stability (P = 0.1331); Gain of loop (P = 0.2754); Gain of catalytic residue at V915 (P = 0.3392); Gain of glycosylation at T910 (P = 0.4274)
7:117243672:T:C,P13569,V915A,0.631,Loss of stability (P = 0.0213); Gain of helix (P = 0.132); Loss of loop (P = 0.3664); Gain of catalytic residue at V915 (P = 0.3758); Loss of sheet (P = 0.437)
7:117243672:T:G,P13569,V915G,0.609,Loss of stability (P = 0.0118); Loss of helix (P = 0.079); Loss of loop (P = 0.0986); Loss of catalytic residue at V915 (P = 0.1888); Gain of sheet (P = 0.1945)
7:117243674:T:A,P13569,F916I,0.468,Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of catalytic residue at F916 (P = 0.3149); Loss of stability (P = 0.4334); Loss of sheet (P = 0.437)
7:117243674:T:C,P13569,F916L,0.44,Loss of loop (P = 0.2237); Loss of stability (P = 0.3275); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Gain of catalytic residue at F916 (P = 0.5942)
7:117243674:T:G,P13569,F916V,0.5,Gain of helix (P = 0.1736); Loss of stability (P = 0.1766); Loss of loop (P = 0.2237); Loss of sheet (P = 0.437); Loss of catalytic residue at F916 (P = 0.4479)
7:117243675:T:A,P13569,F916Y,0.492,Loss of stability (P = 0.145); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Loss of catalytic residue at F916 (P = 0.2998); Loss of sheet (P = 0.437)
7:117243675:T:C,P13569,F916S,0.58,Loss of stability (P = 0.0352); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Gain of disorder (P = 0.3021); Gain of catalytic residue at F916 (P = 0.357)
7:117243675:T:G,P13569,F916C,0.556,Loss of stability (P = 0.1127); Loss of loop (P = 0.2237); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Loss of catalytic residue at F916 (P = 0.6211)
7:117243676:T:A,P13569,F916L,0.44,Loss of loop (P = 0.2237); Loss of stability (P = 0.3275); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Gain of catalytic residue at F916 (P = 0.5942)
7:117243676:T:G,P13569,F916L,0.44,Loss of loop (P = 0.2237); Loss of stability (P = 0.3275); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Gain of catalytic residue at F916 (P = 0.5942)
7:117243677:T:A,P13569,Y917N,0.793,Loss of helix (P = 0.079); Loss of stability (P = 0.201); Loss of loop (P = 0.2897); Gain of catalytic residue at Y917 (P = 0.3141); Gain of sheet (P = 0.3763)
7:117243677:T:C,P13569,Y917H,0.835,Loss of stability (P = 0.1322); Loss of helix (P = 0.2271); Gain of catalytic residue at Y917 (P = 0.3727); Loss of sheet (P = 0.437); Gain of phosphorylation at Y919 (P = 0.6089)
7:117243677:T:G,P13569,Y917D,0.946,Gain of phosphorylation at Y919 (P = 0.1604); Gain of helix (P = 0.1736); Loss of catalytic residue at Y914 (P = 0.2878); Loss of stability (P = 0.3281); Loss of sheet (P = 0.5184)
7:117243678:A:C,P13569,Y917S,0.771,Loss of stability (P = 0.1035); Gain of glycosylation at Y917 (P = 0.1225); Gain of helix (P = 0.1736); Gain of catalytic residue at Y917 (P = 0.3395); Gain of sheet (P = 0.4423)
7:117243678:A:G,P13569,Y917C,0.929,Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of sheet (P = 0.437); Loss of stability (P = 0.5472); Gain of catalytic residue at Y914 (P = 0.5855)
7:117243678:A:T,P13569,Y917F,0.797,Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Gain of catalytic residue at Y917 (P = 0.387); Loss of sheet (P = 0.437); Loss of phosphorylation at Y917 (P = 0.7001)
7:117243680:A:C,P13569,I918L,0.5,Loss of catalytic residue at I918 (P = 0.01); Gain of helix (P = 0.2294); Loss of stability (P = 0.2393); Loss of sheet (P = 0.437); Gain of phosphorylation at Y919 (P = 0.6887)
7:117243680:A:G,P13569,I918V,0.587,Loss of helix (P = 0.028); Gain of sheet (P = 0.1451); Loss of stability (P = 0.2106); Loss of catalytic residue at I918 (P = 0.3028); Gain of loop (P = 0.3485)
7:117243680:A:T,P13569,I918F,0.671,Loss of stability (P = 0.0615); Gain of helix (P = 0.132); Loss of catalytic residue at I918 (P = 0.3465); Loss of sheet (P = 0.437); Loss of phosphorylation at Y919 (P = 0.7013)
7:117243681:T:A,P13569,I918N,0.62,Loss of stability (P = 0.012); Loss of helix (P = 0.0626); Gain of sheet (P = 0.1451); Loss of loop (P = 0.4786); Loss of catalytic residue at Y914 (P = 0.5132)
7:117243681:T:C,P13569,I918T,0.639,Loss of stability (P = 0.0013); Gain of helix (P = 0.132); Gain of phosphorylation at I918 (P = 0.305); Loss of catalytic residue at I918 (P = 0.3118); Loss of sheet (P = 0.437)
7:117243681:T:G,P13569,I918S,0.635,Loss of stability (P = 0.0074); Gain of glycosylation at I918 (P = 0.0316); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of catalytic residue at Y914 (P = 0.485)
7:117243682:T:G,P13569,I918M,0.584,Loss of catalytic residue at I918 (P = 0.0102); Loss of stability (P = 0.07); Gain of helix (P = 0.2294); Gain of loop (P = 0.2754); Gain of phosphorylation at Y917 (P = 0.3516)
7:117243683:T:A,P13569,Y919N,0.774,Loss of stability (P = 0.1315); Loss of catalytic residue at I918 (P = 0.1447); Loss of helix (P = 0.2271); Gain of sheet (P = 0.4423); Gain of loop (P = 0.4661)
7:117243683:T:C,P13569,Y919H,0.778,Loss of stability (P = 0.068); Loss of helix (P = 0.079); Loss of catalytic residue at I918 (P = 0.1286); Gain of sheet (P = 0.1451); Gain of phosphorylation at Y917 (P = 0.6314)
7:117243683:T:G,P13569,Y919D,0.776,Loss of helix (P = 0.079); Loss of catalytic residue at I918 (P = 0.1538); Gain of sheet (P = 0.1945); Loss of stability (P = 0.1972); Gain of phosphorylation at Y917 (P = 0.3942)
7:117243684:A:C,P13569,Y919S,0.691,Loss of stability (P = 0.0862); Gain of glycosylation at Y919 (P = 0.1261); Loss of helix (P = 0.1299); Loss of catalytic residue at I918 (P = 0.1802); Gain of sheet (P = 0.4423)
7:117243684:A:G,P13569,Y919C,0.904,Loss of catalytic residue at I918 (P = 0.1498); Loss of stability (P = 0.1709); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Loss of phosphorylation at Y919 (P = 0.6776)
7:117243684:A:T,P13569,Y919F,0.811,Loss of catalytic residue at I918 (P = 0.1359); Loss of helix (P = 0.3949); Loss of stability (P = 0.4175); Loss of sheet (P = 0.437); Loss of phosphorylation at Y919 (P = 0.6776)
7:117243686:G:C,P13569,V920L,0.897,Loss of catalytic residue at V920 (P = 0.0236); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Loss of phosphorylation at Y919 (P = 0.7006); Loss of MoRF binding (P = 0.7844)
7:117243686:G:T,P13569,V920L,0.897,Loss of catalytic residue at V920 (P = 0.0236); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Loss of phosphorylation at Y919 (P = 0.7006); Loss of MoRF binding (P = 0.7844)
7:117243687:T:A,P13569,V920E,0.843,Gain of helix (P = 0.2059); Loss of stability (P = 0.2135); Loss of catalytic residue at G921 (P = 0.2214); Loss of sheet (P = 0.5184); Gain of glycosylation at T925 (P = 0.5748)
7:117243687:T:C,P13569,V920A,0.802,Loss of helix (P = 0.079); Loss of stability (P = 0.1278); Gain of sheet (P = 0.1945); Loss of catalytic residue at F916 (P = 0.5403); Gain of phosphorylation at Y919 (P = 0.6016)
7:117243687:T:G,P13569,V920G,0.83,Loss of stability (P = 0.027); Loss of catalytic residue at V920 (P = 0.1002); Loss of helix (P = 0.2271); Gain of sheet (P = 0.4423); Gain of phosphorylation at Y919 (P = 0.6542)
7:117243689:G:A,P13569,G921R,0.937,Gain of methylation at G921 (P = 0.0124); Loss of catalytic residue at V922 (P = 0.0318); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.3957); Loss of sheet (P = 0.437)
7:117243689:G:C,P13569,G921R,0.937,Gain of methylation at G921 (P = 0.0124); Loss of catalytic residue at V922 (P = 0.0318); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.3957); Loss of sheet (P = 0.437)
7:117243690:G:A,P13569,G921E,0.844,Loss of catalytic residue at D924 (P = 0.0704); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Gain of phosphorylation at Y919 (P = 0.6246); Loss of stability (P = 0.6632)
7:117243690:G:C,P13569,G921A,0.74,Gain of helix (P = 0.2059); Loss of catalytic residue at Y919 (P = 0.382); Loss of stability (P = 0.403); Loss of sheet (P = 0.5184); Loss of phosphorylation at Y919 (P = 0.7006)
7:117243690:G:T,P13569,G921V,0.748,Loss of helix (P = 0.2271); Loss of catalytic residue at Y919 (P = 0.4147); Loss of sheet (P = 0.437); Loss of phosphorylation at Y919 (P = 0.6988); Loss of stability (P = 0.7158)
7:117243692:G:A,P13569,V922I,0.604,Loss of catalytic residue at V922 (P = 0.0069); Loss of helix (P = 0.2271); Loss of sheet (P = 0.5184); Loss of phosphorylation at Y919 (P = 0.6985); Gain of MoRF binding (P = 0.7499)
7:117243692:G:C,P13569,V922L,0.666,Loss of catalytic residue at V922 (P = 0.1508); Gain of helix (P = 0.2294); Loss of sheet (P = 0.437); Loss of phosphorylation at Y919 (P = 0.6911); Loss of MoRF binding (P = 0.7693)
7:117243692:G:T,P13569,V922L,0.666,Loss of catalytic residue at V922 (P = 0.1508); Gain of helix (P = 0.2294); Loss of sheet (P = 0.437); Loss of phosphorylation at Y919 (P = 0.6911); Loss of MoRF binding (P = 0.7693)
7:117243693:T:A,P13569,V922E,0.836,Loss of helix (P = 0.2271); Loss of catalytic residue at G921 (P = 0.2459); Loss of stability (P = 0.3808); Gain of sheet (P = 0.4423); Gain of phosphorylation at Y917 (P = 0.6054)
7:117243693:T:C,P13569,V922A,0.746,Loss of stability (P = 0.0735); Loss of helix (P = 0.079); Gain of sheet (P = 0.4423); Gain of catalytic residue at Y917 (P = 0.6029); Gain of phosphorylation at Y917 (P = 0.6931)
7:117243693:T:G,P13569,V922G,0.79,Loss of stability (P = 0.0435); Loss of catalytic residue at V922 (P = 0.1131); Loss of sheet (P = 0.437); Loss of helix (P = 0.4763); Gain of phosphorylation at Y917 (P = 0.6811)
7:117243695:G:A,P13569,A923T,0.69,Loss of helix (P = 0.5596); Loss of stability (P = 0.5983); Gain of sheet (P = 0.6509); Gain of phosphorylation at A923 (P = 0.6517); Gain of catalytic residue at A928 (P = 0.7128)
7:117243695:G:C,P13569,A923P,0.884,Gain of catalytic residue at L926 (P = 0.4449); Loss of stability (P = 0.4782); Gain of phosphorylation at Y919 (P = 0.5514); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509)
7:117243695:G:T,P13569,A923S,0.709,Loss of helix (P = 0.079); Gain of glycosylation at A923 (P = 0.3633); Gain of sheet (P = 0.4423); Gain of phosphorylation at Y919 (P = 0.674); Loss of stability (P = 0.7038)
7:117243696:C:A,P13569,A923D,0.858,Loss of catalytic residue at G921 (P = 0.1157); Loss of helix (P = 0.2271); Gain of phosphorylation at Y919 (P = 0.4707); Gain of sheet (P = 0.6509); Loss of MoRF binding (P = 0.757)
7:117243696:C:G,P13569,A923G,0.752,Loss of helix (P = 0.2271); Loss of stability (P = 0.2782); Gain of sheet (P = 0.6509); Gain of catalytic residue at L926 (P = 0.6677); Gain of phosphorylation at Y919 (P = 0.6817)
7:117243696:C:T,P13569,A923V,0.69,Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of phosphorylation at Y919 (P = 0.701); Gain of MoRF binding (P = 0.7331); Gain of catalytic residue at A928 (P = 0.7608)
7:117243698:G:C,P13569,D924H,0.784,Gain of catalytic residue at L926 (P = 0.0468); Loss of stability (P = 0.5404); Loss of sheet (P = 0.6423); Loss of helix (P = 0.6555); Gain of MoRF binding (P = 0.6614)
7:117243698:G:T,P13569,D924Y,0.753,Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.6549); Loss of phosphorylation at Y919 (P = 0.6933); Loss of catalytic residue at A928 (P = 0.7363)
7:117243699:A:C,P13569,D924A,0.74,Gain of glycosylation at T925 (P = 0.26); Loss of helix (P = 0.5596); Gain of catalytic residue at Y919 (P = 0.5624); Loss of stability (P = 0.6322); Loss of sheet (P = 0.6423)
7:117243699:A:G,P13569,D924G,0.768,Loss of stability (P = 0.1936); Loss of catalytic residue at D924 (P = 0.2964); Gain of glycosylation at T925 (P = 0.6242); Loss of helix (P = 0.6555); Gain of MoRF binding (P = 0.665)
7:117243699:A:T,P13569,D924V,0.72,Gain of glycosylation at T925 (P = 0.3999); Gain of helix (P = 0.5668); Gain of MoRF binding (P = 0.6217); Loss of sheet (P = 0.6423); Loss of phosphorylation at Y919 (P = 0.695)
7:117243700:C:A,P13569,D924E,0.75,Loss of catalytic residue at A928 (P = 0.5048); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of phosphorylation at Y919 (P = 0.7031); Loss of MoRF binding (P = 0.7464)
7:117243700:C:G,P13569,D924E,0.75,Loss of catalytic residue at A928 (P = 0.5048); Loss of helix (P = 0.5596); Gain of sheet (P = 0.6509); Loss of phosphorylation at Y919 (P = 0.7031); Loss of MoRF binding (P = 0.7464)
7:117243701:A:C,P13569,T925P,0.793,Loss of catalytic residue at T925 (P = 0.016); Loss of stability (P = 0.1727); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.7288); Loss of sheet (P = 0.7751)
7:117243701:A:G,P13569,T925A,0.683,Loss of catalytic residue at T925 (P = 0.2665); Loss of stability (P = 0.2852); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Loss of MoRF binding (P = 0.7368)
7:117243701:A:T,P13569,T925S,0.66,Gain of glycosylation at T925 (P = 0.3162); Loss of catalytic residue at T925 (P = 0.5108); Loss of stability (P = 0.5399); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.7338)
7:117243702:C:A,P13569,T925N,0.704,Loss of helix (P = 0.2271); Loss of stability (P = 0.4976); Loss of catalytic residue at A928 (P = 0.6572); Gain of MoRF binding (P = 0.7282); Loss of sheet (P = 0.7751)
7:117243702:C:G,P13569,T925S,0.66,Gain of glycosylation at T925 (P = 0.3162); Loss of catalytic residue at T925 (P = 0.5108); Loss of stability (P = 0.5399); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.7338)
7:117243704:T:A,P13569,L926M,0.687,Loss of stability (P = 0.5211); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Gain of glycosylation at T925 (P = 0.6487); Gain of MoRF binding (P = 0.6923)
7:117243704:T:G,P13569,L926V,0.774,Gain of catalytic residue at L926 (P = 0.0668); Loss of stability (P = 0.4132); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7015)
7:117243705:T:C,P13569,L926S,0.766,Loss of stability (P = 0.0294); Gain of catalytic residue at L926 (P = 0.2145); Gain of glycosylation at L926 (P = 0.3345); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423)
7:117243705:T:G,P13569,L926W,0.789,Loss of stability (P = 0.0893); Gain of catalytic residue at L926 (P = 0.1237); Gain of MoRF binding (P = 0.5457); Loss of helix (P = 0.5596); Loss of sheet (P = 0.6423)
7:117243706:G:C,P13569,L926F,0.743,Gain of catalytic residue at L926 (P = 0.0603); Loss of stability (P = 0.3786); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7025)
7:117243706:G:T,P13569,L926F,0.743,Gain of catalytic residue at L926 (P = 0.0603); Loss of stability (P = 0.3786); Gain of helix (P = 0.5668); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7025)
7:117243707:C:A,P13569,L927I,0.767,Gain of catalytic residue at A928 (P = 0.5231); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.6596); Gain of phosphorylation at T925 (P = 0.8059); Loss of glycosylation at T925 (P = 0.8525)
7:117243707:C:G,P13569,L927V,0.737,Gain of catalytic residue at L927 (P = 0.0507); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.6767); Gain of glycosylation at T925 (P = 0.7624); Loss of stability (P = 0.7802)
7:117243707:C:T,P13569,L927F,0.754,Gain of catalytic residue at L927 (P = 0.0643); Loss of stability (P = 0.5203); Loss of helix (P = 0.6555); Gain of MoRF binding (P = 0.6773); Gain of phosphorylation at T925 (P = 0.7818)
7:117243708:T:A,P13569,L927H,0.819,Loss of stability (P = 0.14); Gain of catalytic residue at L926 (P = 0.1729); Gain of glycosylation at T925 (P = 0.6357); Loss of helix (P = 0.6555); Loss of MoRF binding (P = 0.6937)
7:117243708:T:C,P13569,L927P,0.956,Loss of stability (P = 0.0736); Gain of catalytic residue at L926 (P = 0.3017); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.6845); Gain of phosphorylation at T925 (P = 0.7228)
7:117243708:T:G,P13569,L927R,0.963,Gain of methylation at L927 (P = 0.0122); Gain of catalytic residue at L927 (P = 0.0986); Loss of stability (P = 0.2169); Gain of MoRF binding (P = 0.436); Loss of helix (P = 0.5596)
7:117243710:G:A,P13569,A928T,0.668,Loss of methylation at R933 (P = 0.1207); Gain of catalytic residue at F931 (P = 0.1314); Gain of glycosylation at A928 (P = 0.1524); Loss of stability (P = 0.1896); Loss of helix (P = 0.4763)
7:117243710:G:C,P13569,A928P,0.883,Loss of methylation at R933 (P = 0.0874); Loss of catalytic residue at A928 (P = 0.1174); Loss of stability (P = 0.1196); Loss of helix (P = 0.2022); Gain of loop (P = 0.4661)
7:117243710:G:T,P13569,A928S,0.728,Loss of methylation at R933 (P = 0.1056); Loss of stability (P = 0.2717); Gain of catalytic residue at A928 (P = 0.3771); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.6584)
7:117243711:C:A,P13569,A928D,0.832,Loss of methylation at R933 (P = 0.065); Loss of stability (P = 0.4751); Loss of helix (P = 0.4763); Gain of catalytic residue at F931 (P = 0.4976); Loss of MoRF binding (P = 0.6674)
7:117243711:C:G,P13569,A928G,0.747,Loss of stability (P = 0.0811); Loss of methylation at R933 (P = 0.128); Loss of helix (P = 0.1706); Gain of catalytic residue at F931 (P = 0.4669); Gain of sheet (P = 0.6509)
7:117243711:C:T,P13569,A928V,0.65,Loss of methylation at R933 (P = 0.1226); Gain of catalytic residue at A928 (P = 0.2636); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.6502); Loss of stability (P = 0.7504)
7:117243713:A:C,P13569,M929L,0.754,Loss of catalytic residue at M929 (P = 0.051); Gain of methylation at R933 (P = 0.1548); Loss of stability (P = 0.4382); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.658)
7:117243713:A:G,P13569,M929V,0.8,Loss of stability (P = 0.1307); Gain of methylation at R933 (P = 0.148); Loss of helix (P = 0.4763); Gain of catalytic residue at F931 (P = 0.5926); Loss of MoRF binding (P = 0.6611)
7:117243713:A:T,P13569,M929L,0.754,Loss of catalytic residue at M929 (P = 0.051); Gain of methylation at R933 (P = 0.1548); Loss of stability (P = 0.4382); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.658)
7:117243714:T:A,P13569,M929K,0.821,Loss of stability (P = 0.002); Gain of ubiquitination at M929 (P = 0.0276); Loss of catalytic residue at M929 (P = 0.0631); Loss of methylation at R933 (P = 0.1367); Gain of glycosylation at M929 (P = 0.1548)
7:117243714:T:C,P13569,M929T,0.754,Loss of stability (P = 0.014); Gain of glycosylation at M929 (P = 0.0505); Gain of methylation at R933 (P = 0.1096); Gain of catalytic residue at F932 (P = 0.1382); Loss of helix (P = 0.4763)
7:117243714:T:G,P13569,M929R,0.928,Gain of methylation at M929 (P = 0.0124); Loss of stability (P = 0.0326); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.308); Loss of catalytic residue at G930 (P = 0.3081)
7:117243715:G:A,P13569,M929I,0.805,Loss of methylation at R933 (P = 0.1266); Loss of stability (P = 0.2916); Loss of catalytic residue at M929 (P = 0.3463); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.6618)
7:117243715:G:C,P13569,M929I,0.805,Loss of methylation at R933 (P = 0.1266); Loss of stability (P = 0.2916); Loss of catalytic residue at M929 (P = 0.3463); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.6618)
7:117243715:G:T,P13569,M929I,0.805,Loss of methylation at R933 (P = 0.1266); Loss of stability (P = 0.2916); Loss of catalytic residue at M929 (P = 0.3463); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.6618)
7:117243716:G:A,P13569,G930R,0.919,Gain of methylation at G930 (P = 0.0335); Loss of catalytic residue at G930 (P = 0.1692); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2783); Loss of stability (P = 0.4952)
7:117243716:G:C,P13569,G930R,0.919,Gain of methylation at G930 (P = 0.0335); Loss of catalytic residue at G930 (P = 0.1692); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2783); Loss of stability (P = 0.4952)
7:117243717:G:A,P13569,G930E,0.887,Loss of methylation at R933 (P = 0.0499); Loss of catalytic residue at M929 (P = 0.1977); Loss of helix (P = 0.4763); Loss of stability (P = 0.507); Loss of MoRF binding (P = 0.6038)
7:117243717:G:C,P13569,G930A,0.829,Loss of methylation at R933 (P = 0.1508); Loss of catalytic residue at L935 (P = 0.1865); Gain of helix (P = 0.2294); Loss of stability (P = 0.2658); Loss of MoRF binding (P = 0.6205)
7:117243717:G:T,P13569,G930V,0.85,Loss of methylation at R933 (P = 0.1033); Gain of helix (P = 0.2294); Loss of catalytic residue at M929 (P = 0.2591); Loss of stability (P = 0.5172); Gain of MoRF binding (P = 0.5909)
7:117243719:T:A,P13569,F931I,0.859,Loss of methylation at R933 (P = 0.0722); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of catalytic residue at A928 (P = 0.5435); Gain of MoRF binding (P = 0.5573)
7:117243719:T:C,P13569,F931L,0.82,Loss of methylation at R933 (P = 0.1169); Gain of catalytic residue at F931 (P = 0.1191); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of MoRF binding (P = 0.5757)
7:117243719:T:G,P13569,F931V,0.793,Gain of catalytic residue at F931 (P = 0.0736); Loss of methylation at R933 (P = 0.1546); Loss of stability (P = 0.1792); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786)
7:117243720:T:A,P13569,F931Y,0.776,Gain of catalytic residue at L926 (P = 0.0791); Gain of methylation at R933 (P = 0.1015); Loss of stability (P = 0.1147); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117243720:T:C,P13569,F931S,0.738,Loss of stability (P = 0.0576); Gain of methylation at R933 (P = 0.1046); Loss of helix (P = 0.2271); Loss of loop (P = 0.4786); Gain of catalytic residue at F931 (P = 0.5125)
7:117243720:T:G,P13569,F931C,0.813,Gain of methylation at R933 (P = 0.1027); Loss of stability (P = 0.1355); Gain of catalytic residue at F931 (P = 0.1648); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117243721:C:A,P13569,F931L,0.82,Loss of methylation at R933 (P = 0.1169); Gain of catalytic residue at F931 (P = 0.1191); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of MoRF binding (P = 0.5757)
7:117243721:C:G,P13569,F931L,0.82,Loss of methylation at R933 (P = 0.1169); Gain of catalytic residue at F931 (P = 0.1191); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of MoRF binding (P = 0.5757)
7:117243722:T:A,P13569,F932I,0.714,Gain of catalytic residue at F932 (P = 0.0363); Loss of methylation at R933 (P = 0.0479); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.5208); Loss of stability (P = 0.7563)
7:117243722:T:C,P13569,F932L,0.769,Loss of methylation at R933 (P = 0.0955); Loss of helix (P = 0.2271); Loss of catalytic residue at A928 (P = 0.5396); Loss of MoRF binding (P = 0.5409); Loss of stability (P = 0.841)
7:117243722:T:G,P13569,F932V,0.733,Loss of methylation at R933 (P = 0.1351); Loss of helix (P = 0.2271); Gain of catalytic residue at F932 (P = 0.4575); Gain of loop (P = 0.4661); Gain of MoRF binding (P = 0.5273)
7:117243723:T:A,P13569,F932Y,0.743,Loss of methylation at R933 (P = 0.1084); Gain of catalytic residue at P936 (P = 0.1427); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Loss of stability (P = 0.487)
7:117243723:T:C,P13569,F932S,0.933,Gain of catalytic residue at F932 (P = 0.0466); Loss of methylation at R933 (P = 0.0823); Gain of glycosylation at F932 (P = 0.0879); Loss of stability (P = 0.2086); Gain of MoRF binding (P = 0.5405)
7:117243723:T:G,P13569,F932C,0.822,Loss of methylation at R933 (P = 0.1126); Gain of catalytic residue at F932 (P = 0.1353); Loss of helix (P = 0.2271); Loss of stability (P = 0.3803); Loss of MoRF binding (P = 0.5332)
7:117243724:C:A,P13569,F932L,0.769,Loss of methylation at R933 (P = 0.0955); Loss of helix (P = 0.2271); Loss of catalytic residue at A928 (P = 0.5396); Loss of MoRF binding (P = 0.5409); Loss of stability (P = 0.841)
7:117243724:C:G,P13569,F932L,0.769,Loss of methylation at R933 (P = 0.0955); Loss of helix (P = 0.2271); Loss of catalytic residue at A928 (P = 0.5396); Loss of MoRF binding (P = 0.5409); Loss of stability (P = 0.841)
7:117243725:A:G,P13569,R933G,0.939,Loss of methylation at R933 (P = 0.0172); Gain of catalytic residue at G934 (P = 0.1387); Loss of stability (P = 0.1649); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4639)
7:117243726:G:A,P13569,R933K,0.773,Gain of ubiquitination at R933 (P = 0.0247); Gain of glycosylation at R933 (P = 0.0437); Loss of methylation at R933 (P = 0.0755); Gain of helix (P = 0.2294); Loss of stability (P = 0.36)
7:117243726:G:C,P13569,R933T,0.854,Loss of methylation at R933 (P = 0.0172); Gain of helix (P = 0.2294); Gain of catalytic residue at F932 (P = 0.3924); Loss of MoRF binding (P = 0.4672); Loss of stability (P = 0.5323)
7:117243726:G:T,P13569,R933I,0.801,Loss of methylation at R933 (P = 0.0172); Gain of catalytic residue at L937 (P = 0.1989); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.4684); Gain of stability (P = 0.8402)
7:117243727:A:C,P13569,R933S,0.903,Gain of glycosylation at R933 (P = 0.0021); Loss of methylation at R933 (P = 0.0172); Gain of helix (P = 0.2294); Gain of catalytic residue at G934 (P = 0.3592); Loss of MoRF binding (P = 0.4686)
7:117243727:A:T,P13569,R933S,0.903,Gain of glycosylation at R933 (P = 0.0021); Loss of methylation at R933 (P = 0.0172); Gain of helix (P = 0.2294); Gain of catalytic residue at G934 (P = 0.3592); Loss of MoRF binding (P = 0.4686)
7:117243728:G:A,P13569,G934S,0.746,Loss of methylation at R933 (P = 0.0472); Loss of catalytic residue at L935 (P = 0.1919); Gain of MoRF binding (P = 0.5003); Loss of stability (P = 0.6097); Loss of helix (P = 0.6555)
7:117243728:G:C,P13569,G934R,0.886,Loss of methylation at R933 (P = 0.0482); Loss of helix (P = 0.2271); Loss of catalytic residue at L935 (P = 0.2389); Gain of MoRF binding (P = 0.2805); Loss of stability (P = 0.855)
7:117243728:G:T,P13569,G934C,0.793,Loss of methylation at R933 (P = 0.0467); Loss of catalytic residue at M929 (P = 0.136); Loss of MoRF binding (P = 0.4926); Loss of helix (P = 0.6555); Loss of stability (P = 0.7546)
7:117243729:G:A,P13569,G934D,0.859,Loss of methylation at R933 (P = 0.0406); Gain of catalytic residue at G934 (P = 0.1871); Loss of MoRF binding (P = 0.4675); Loss of helix (P = 0.6555); Loss of stability (P = 0.801)
7:117243729:G:C,P13569,G934A,0.807,Loss of methylation at R933 (P = 0.0634); Loss of catalytic residue at L935 (P = 0.1095); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.49); Loss of stability (P = 0.7541)
7:117243729:G:T,P13569,G934V,0.783,Loss of methylation at R933 (P = 0.0499); Loss of catalytic residue at L935 (P = 0.1956); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.4435); Gain of loop (P = 0.8571)
7:117243731:C:A,P13569,L935I,0.793,Loss of catalytic residue at L935 (P = 0.0844); Loss of methylation at R933 (P = 0.0889); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.422); Loss of stability (P = 0.5109)
7:117243731:C:G,P13569,L935V,0.763,Gain of methylation at R933 (P = 0.1435); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.4478); Loss of stability (P = 0.4893); Gain of catalytic residue at F931 (P = 0.6542)
7:117243732:T:A,P13569,L935Q,0.854,Loss of stability (P = 0.0856); Loss of methylation at R933 (P = 0.0988); Loss of helix (P = 0.2271); Gain of catalytic residue at F931 (P = 0.3195); Gain of loop (P = 0.4661)
7:117243732:T:C,P13569,L935P,0.937,Loss of stability (P = 0.0469); Gain of methylation at R933 (P = 0.1087); Gain of catalytic residue at G934 (P = 0.2265); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4399)
7:117243732:T:G,P13569,L935R,0.953,Gain of methylation at L935 (P = 0.004); Loss of stability (P = 0.0572); Gain of MoRF binding (P = 0.1926); Loss of helix (P = 0.2271); Gain of catalytic residue at F931 (P = 0.2893)
7:117243734:C:A,P13569,P936T,0.686,Gain of catalytic residue at P936 (P = 0.0159); Gain of methylation at R933 (P = 0.1502); Loss of stability (P = 0.1605); Gain of phosphorylation at P936 (P = 0.1653); Gain of helix (P = 0.2294)
7:117243734:C:G,P13569,P936A,0.742,Gain of methylation at R933 (P = 0.1138); Loss of catalytic residue at L935 (P = 0.2008); Loss of helix (P = 0.2271); Loss of stability (P = 0.2654); Gain of MoRF binding (P = 0.2879)
7:117243734:C:T,P13569,P936S,0.733,Gain of catalytic residue at P936 (P = 0.0598); Loss of methylation at R933 (P = 0.1588); Loss of stability (P = 0.1858); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2361)
7:117243735:C:A,P13569,P936Q,0.781,Gain of catalytic residue at P936 (P = 0.0466); Loss of methylation at R933 (P = 0.0584); Gain of MoRF binding (P = 0.2076); Loss of helix (P = 0.2271); Loss of stability (P = 0.3776)
7:117243735:C:G,P13569,P936R,0.88,Gain of methylation at P936 (P = 0.0071); Gain of MoRF binding (P = 0.0073); Gain of catalytic residue at P936 (P = 0.0918); Gain of helix (P = 0.2294); Loss of stability (P = 0.4124)
7:117243735:C:T,P13569,P936L,0.734,Loss of methylation at R933 (P = 0.1048); Gain of helix (P = 0.1736); Gain of MoRF binding (P = 0.298); Loss of catalytic residue at L935 (P = 0.3288); Loss of phosphorylation at T940 (P = 0.813)
7:117243737:C:A,P13569,L937M,0.695,Loss of methylation at R933 (P = 0.1416); Loss of catalytic residue at L937 (P = 0.2061); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.3361); Loss of loop (P = 0.4786)
7:117243737:C:G,P13569,L937V,0.707,Loss of methylation at R933 (P = 0.1351); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.3927); Gain of loop (P = 0.4661); Gain of catalytic residue at H939 (P = 0.6241)
7:117243738:T:A,P13569,L937Q,0.706,Loss of methylation at R933 (P = 0.08); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.375); Loss of catalytic residue at L937 (P = 0.4185); Loss of stability (P = 0.4468)
7:117243738:T:C,P13569,L937P,0.841,Gain of catalytic residue at P936 (P = 0.0145); Gain of methylation at R933 (P = 0.1441); Gain of helix (P = 0.2294); Loss of stability (P = 0.2986); Loss of MoRF binding (P = 0.3776)
7:117243738:T:G,P13569,L937R,0.899,Gain of methylation at L937 (P = 0.0062); Gain of MoRF binding (P = 0.0535); Gain of catalytic residue at L937 (P = 0.0877); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786)
7:117243740:G:A,P13569,V938M,0.754,Loss of stability (P = 0.0779); Gain of catalytic residue at V938 (P = 0.1575); Gain of methylation at R933 (P = 0.1578); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.3918)
7:117243740:G:C,P13569,V938L,0.773,Gain of methylation at R933 (P = 0.143); Loss of stability (P = 0.2766); Gain of catalytic residue at V938 (P = 0.3063); Loss of MoRF binding (P = 0.4022); Loss of helix (P = 0.4763)
7:117243740:G:T,P13569,V938L,0.773,Gain of methylation at R933 (P = 0.143); Loss of stability (P = 0.2766); Gain of catalytic residue at V938 (P = 0.3063); Loss of MoRF binding (P = 0.4022); Loss of helix (P = 0.4763)
7:117243741:T:A,P13569,V938E,0.831,Loss of stability (P = 0.0394); Loss of methylation at R933 (P = 0.1254); Gain of helix (P = 0.2294); Loss of catalytic residue at H939 (P = 0.3188); Loss of MoRF binding (P = 0.3313)
7:117243741:T:C,P13569,V938A,0.775,Loss of stability (P = 0.0124); Gain of methylation at R933 (P = 0.1279); Loss of helix (P = 0.2271); Gain of catalytic residue at V938 (P = 0.3347); Loss of MoRF binding (P = 0.3968)
7:117243741:T:G,P13569,V938G,0.876,Loss of stability (P = 2e-04); Gain of methylation at R933 (P = 0.1173); Loss of helix (P = 0.2271); Gain of catalytic residue at H939 (P = 0.3502); Loss of MoRF binding (P = 0.3949)
7:117243743:C:A,P13569,H939N,0.786,Loss of catalytic residue at L941 (P = 0.1515); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.338); Gain of loop (P = 0.4661); Loss of stability (P = 0.5766)
7:117243743:C:G,P13569,H939D,0.927,Gain of relative solvent accessibility (P = 0.1259); Loss of catalytic residue at L941 (P = 0.1422); Gain of solvent accessibility (P = 0.2291); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3696)
7:117243743:C:T,P13569,H939Y,0.736,Loss of catalytic residue at L941 (P = 0.1539); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.4028); Gain of loop (P = 0.4661); Loss of disorder (P = 0.6296)
7:117243744:A:C,P13569,H939P,0.862,Gain of glycosylation at T940 (P = 0.1508); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3583); Loss of catalytic residue at H939 (P = 0.4116); Loss of stability (P = 0.6445)
7:117243744:A:G,P13569,H939R,0.934,Gain of MoRF binding (P = 0.0311); Gain of methylation at H939 (P = 0.0417); Loss of catalytic residue at L941 (P = 0.0874); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661)
7:117243744:A:T,P13569,H939L,0.745,Loss of catalytic residue at L941 (P = 0.1769); Gain of helix (P = 0.2294); Gain of stability (P = 0.2614); Loss of MoRF binding (P = 0.4019); Gain of loop (P = 0.4661)
7:117243745:T:A,P13569,H939Q,0.752,Loss of catalytic residue at L941 (P = 0.1494); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.3454); Loss of disorder (P = 0.6648); Loss of glycosylation at T943 (P = 0.7265)
7:117243745:T:G,P13569,H939Q,0.752,Loss of catalytic residue at L941 (P = 0.1494); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.3454); Loss of disorder (P = 0.6648); Loss of glycosylation at T943 (P = 0.7265)
7:117243746:A:C,P13569,T940P,0.813,Loss of catalytic residue at T940 (P = 0.0867); Loss of helix (P = 0.2271); Loss of stability (P = 0.248); Loss of MoRF binding (P = 0.3544); Gain of loop (P = 0.4661)
7:117243746:A:G,P13569,T940A,0.708,Loss of helix (P = 0.2271); Loss of catalytic residue at T940 (P = 0.2511); Gain of MoRF binding (P = 0.3949); Gain of loop (P = 0.4661); Loss of stability (P = 0.4882)
7:117243746:A:T,P13569,T940S,0.705,Gain of helix (P = 0.2294); Loss of catalytic residue at T940 (P = 0.2978); Gain of disorder (P = 0.3742); Gain of MoRF binding (P = 0.3794); Loss of stability (P = 0.5259)
7:117243747:C:A,P13569,T940N,0.752,Gain of helix (P = 0.2294); Loss of catalytic residue at H939 (P = 0.2699); Gain of MoRF binding (P = 0.363); Loss of stability (P = 0.4512); Loss of disorder (P = 0.6194)
7:117243747:C:G,P13569,T940S,0.705,Gain of helix (P = 0.2294); Loss of catalytic residue at T940 (P = 0.2978); Gain of disorder (P = 0.3742); Gain of MoRF binding (P = 0.3794); Loss of stability (P = 0.5259)
7:117243747:C:T,P13569,T940I,0.683,Gain of helix (P = 0.2294); Gain of catalytic residue at L937 (P = 0.3262); Gain of MoRF binding (P = 0.3446); Loss of disorder (P = 0.5535); Gain of glycosylation at T943 (P = 0.5865)
7:117243749:C:A,P13569,L941I,0.717,Loss of catalytic residue at L941 (P = 0.0109); Gain of methylation at K946 (P = 0.0781); Gain of helix (P = 0.2294); Loss of ubiquitination at K946 (P = 0.2828); Gain of MoRF binding (P = 0.3513)
7:117243749:C:G,P13569,L941V,0.701,Loss of catalytic residue at L941 (P = 0.1148); Gain of methylation at K946 (P = 0.1409); Gain of helix (P = 0.2294); Loss of ubiquitination at K946 (P = 0.2684); Loss of stability (P = 0.3532)
7:117243750:T:A,P13569,L941Q,0.676,Loss of stability (P = 0.0406); Loss of helix (P = 0.2022); Gain of methylation at K946 (P = 0.2152); Gain of disorder (P = 0.2414); Loss of ubiquitination at K946 (P = 0.2608)
7:117243750:T:C,P13569,L941P,0.744,Loss of stability (P = 0.0199); Loss of catalytic residue at L941 (P = 0.0271); Gain of methylation at K946 (P = 0.1021); Gain of disorder (P = 0.1621); Loss of helix (P = 0.2271)
7:117243750:T:G,P13569,L941R,0.87,Loss of stability (P = 0.0268); Gain of methylation at L941 (P = 0.0307); Gain of MoRF binding (P = 0.0742); Gain of glycosylation at T940 (P = 0.1764); Gain of disorder (P = 0.2226)
7:117243752:A:C,P13569,I942L,0.686,Loss of methylation at K946 (P = 0.217); Gain of helix (P = 0.2294); Gain of ubiquitination at K946 (P = 0.2694); Loss of MoRF binding (P = 0.3932); Gain of disorder (P = 0.4134)
7:117243752:A:G,P13569,I942V,0.639,Gain of catalytic residue at I942 (P = 0.2101); Loss of helix (P = 0.2271); Gain of ubiquitination at K946 (P = 0.2496); Loss of methylation at K946 (P = 0.2718); Loss of MoRF binding (P = 0.401)
7:117243752:A:T,P13569,I942F,0.696,Loss of stability (P = 0.1342); Loss of helix (P = 0.2271); Loss of methylation at K946 (P = 0.2753); Loss of ubiquitination at K946 (P = 0.2828); Gain of MoRF binding (P = 0.3912)
7:117243753:T:A,P13569,I942N,0.686,Loss of stability (P = 0.0308); Gain of disorder (P = 0.0795); Gain of relative solvent accessibility (P = 0.1259); Gain of catalytic residue at I942 (P = 0.1726); Loss of methylation at K946 (P = 0.2208)
7:117243753:T:C,P13569,I942T,0.674,Loss of stability (P = 0.0075); Gain of catalytic residue at I942 (P = 0.0129); Gain of glycosylation at I942 (P = 0.0455); Gain of disorder (P = 0.0607); Gain of relative solvent accessibility (P = 0.1259)
7:117243753:T:G,P13569,I942S,0.677,Gain of disorder (P = 0.0079); Loss of stability (P = 0.0139); Gain of catalytic residue at I942 (P = 0.021); Loss of helix (P = 0.2271); Gain of relative solvent accessibility (P = 0.2363)
7:117243754:C:G,P13569,I942M,0.659,Gain of catalytic residue at V938 (P = 0.0691); Loss of stability (P = 0.1205); Gain of disorder (P = 0.1916); Gain of helix (P = 0.2294); Loss of ubiquitination at K946 (P = 0.255)
7:117243755:A:C,P13569,T943P,0.663,Loss of catalytic residue at K946 (P = 0.1566); Gain of methylation at K946 (P = 0.1612); Gain of glycosylation at T940 (P = 0.1852); Loss of helix (P = 0.2271); Loss of ubiquitination at K946 (P = 0.2684)
7:117243755:A:G,P13569,T943A,0.555,Loss of ubiquitination at K946 (P = 0.2828); Loss of methylation at K946 (P = 0.3066); Loss of MoRF binding (P = 0.3965); Gain of catalytic residue at T943 (P = 0.4111); Loss of disorder (P = 0.5366)
7:117243755:A:T,P13569,T943S,0.495,Gain of disorder (P = 0.1849); Loss of helix (P = 0.2271); Loss of ubiquitination at K946 (P = 0.2684); Gain of catalytic residue at T943 (P = 0.2709); Loss of methylation at K946 (P = 0.2788)
7:117243756:C:A,P13569,T943K,0.623,Gain of methylation at T943 (P = 0.0182); Gain of ubiquitination at T943 (P = 0.0325); Gain of MoRF binding (P = 0.0536); Gain of disorder (P = 0.2971); Loss of catalytic residue at V944 (P = 0.3379)
7:117243756:C:G,P13569,T943R,0.585,Gain of MoRF binding (P = 0.017); Loss of ubiquitination at K946 (P = 0.2073); Loss of helix (P = 0.2271); Loss of methylation at K946 (P = 0.2376); Loss of catalytic residue at V944 (P = 0.29)
7:117243756:C:T,P13569,T943I,0.609,Gain of ubiquitination at K946 (P = 0.0934); Gain of methylation at K946 (P = 0.167); Gain of catalytic residue at V944 (P = 0.1782); Gain of MoRF binding (P = 0.3987); Loss of disorder (P = 0.4431)
7:117243758:G:A,P13569,V944M,0.655,Gain of disorder (P = 0.2204); Loss of helix (P = 0.2271); Loss of ubiquitination at K946 (P = 0.2287); Gain of methylation at K946 (P = 0.3132); Gain of MoRF binding (P = 0.3913)
7:117243758:G:C,P13569,V944L,0.727,Gain of helix (P = 0.2294); Loss of methylation at K946 (P = 0.2515); Loss of ubiquitination at K946 (P = 0.2828); Loss of catalytic residue at K946 (P = 0.3597); Loss of MoRF binding (P = 0.3951)
7:117243758:G:T,P13569,V944L,0.727,Gain of helix (P = 0.2294); Loss of methylation at K946 (P = 0.2515); Loss of ubiquitination at K946 (P = 0.2828); Loss of catalytic residue at K946 (P = 0.3597); Loss of MoRF binding (P = 0.3951)
7:117243759:T:A,P13569,V944E,0.924,Gain of disorder (P = 0.0057); Loss of stability (P = 0.1241); Gain of ubiquitination at K946 (P = 0.14); Loss of helix (P = 0.2022); Loss of methylation at K946 (P = 0.2505)
7:117243759:T:G,P13569,V944G,0.841,Loss of stability (P = 0.0037); Gain of disorder (P = 0.0332); Loss of helix (P = 0.0626); Gain of catalytic residue at T943 (P = 0.1827); Loss of ubiquitination at K946 (P = 0.2608)
7:117243761:T:A,P13569,S945T,0.76,Gain of methylation at K946 (P = 0.2734); Loss of ubiquitination at K946 (P = 0.2757); Gain of catalytic residue at S945 (P = 0.3408); Loss of MoRF binding (P = 0.3993); Loss of disorder (P = 0.4339)
7:117243761:T:C,P13569,S945P,0.868,Gain of methylation at K946 (P = 0.1315); Gain of glycosylation at K946 (P = 0.2729); Loss of ubiquitination at K946 (P = 0.2757); Loss of MoRF binding (P = 0.3411); Loss of stability (P = 0.4178)
7:117243761:T:G,P13569,S945A,0.772,Gain of ubiquitination at K946 (P = 0.1688); Loss of catalytic residue at K946 (P = 0.1772); Loss of methylation at K946 (P = 0.305); Gain of MoRF binding (P = 0.3844); Loss of disorder (P = 0.3853)
7:117243762:C:G,P13569,S945W,0.857,Gain of MoRF binding (P = 0.0724); Gain of ubiquitination at K946 (P = 0.0934); Gain of catalytic residue at S945 (P = 0.1571); Gain of methylation at K946 (P = 0.16); Loss of disorder (P = 0.2267)
7:117243762:C:T,P13569,S945L,0.908,Gain of ubiquitination at K946 (P = 0.0934); Loss of catalytic residue at K946 (P = 0.2146); Loss of methylation at K946 (P = 0.2752); Loss of disorder (P = 0.3258); Gain of MoRF binding (P = 0.3468)
7:117243764:A:C,P13569,K946Q,0.732,Gain of ubiquitination at K951 (P = 0.048); Loss of methylation at K946 (P = 0.0916); Loss of MoRF binding (P = 0.3269); Gain of catalytic residue at V944 (P = 0.4073); Loss of glycosylation at K946 (P = 0.4547)
7:117243764:A:G,P13569,K946E,0.72,Gain of ubiquitination at K951 (P = 0.0511); Loss of methylation at K946 (P = 0.0916); Loss of MoRF binding (P = 0.2748); Loss of glycosylation at K946 (P = 0.4547); Loss of helix (P = 0.4763)
7:117243765:A:C,P13569,K946T,0.736,Gain of catalytic residue at S945 (P = 0.0401); Gain of ubiquitination at K951 (P = 0.0511); Loss of methylation at K946 (P = 0.0916); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.3179)
7:117243765:A:G,P13569,K946R,0.612,Loss of ubiquitination at K946 (P = 0.0546); Loss of methylation at K946 (P = 0.2028); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2647); Gain of catalytic residue at S945 (P = 0.3143)
7:117243765:A:T,P13569,K946I,0.696,Gain of catalytic residue at S945 (P = 0.0309); Gain of ubiquitination at K951 (P = 0.0434); Loss of methylation at K946 (P = 0.0916); Loss of disorder (P = 0.2892); Loss of solvent accessibility (P = 0.3136)
7:117243766:A:C,P13569,K946N,0.749,Loss of ubiquitination at K946 (P = 0.0546); Loss of methylation at K946 (P = 0.0916); Gain of catalytic residue at S945 (P = 0.259); Loss of MoRF binding (P = 0.3288); Gain of glycosylation at T943 (P = 0.3925)
7:117243766:A:T,P13569,K946N,0.749,Loss of ubiquitination at K946 (P = 0.0546); Loss of methylation at K946 (P = 0.0916); Gain of catalytic residue at S945 (P = 0.259); Loss of MoRF binding (P = 0.3288); Gain of glycosylation at T943 (P = 0.3925)
7:117243767:A:C,P13569,I947L,0.587,Loss of methylation at K946 (P = 0.2242); Loss of ubiquitination at K946 (P = 0.2757); Gain of disorder (P = 0.2873); Loss of MoRF binding (P = 0.3914); Gain of catalytic residue at I947 (P = 0.3963)
7:117243767:A:G,P13569,I947V,0.542,Gain of methylation at K946 (P = 0.1062); Gain of relative solvent accessibility (P = 0.281); Loss of ubiquitination at K946 (P = 0.2828); Gain of disorder (P = 0.3406); Loss of MoRF binding (P = 0.4026)
7:117243767:A:T,P13569,I947F,0.543,Gain of methylation at K946 (P = 0.0506); Loss of ubiquitination at K946 (P = 0.2757); Loss of catalytic residue at I947 (P = 0.3094); Loss of stability (P = 0.3677); Gain of MoRF binding (P = 0.3976)
7:117243768:T:A,P13569,I947N,0.616,Gain of disorder (P = 0.0133); Loss of stability (P = 0.0661); Gain of relative solvent accessibility (P = 0.1259); Gain of ubiquitination at K946 (P = 0.1688); Gain of solvent accessibility (P = 0.2346)
7:117243768:T:C,P13569,I947T,0.611,Gain of disorder (P = 0.0198); Loss of stability (P = 0.0344); Gain of relative solvent accessibility (P = 0.1259); Gain of ubiquitination at K946 (P = 0.2496); Gain of solvent accessibility (P = 0.2601)
7:117243768:T:G,P13569,I947S,0.584,Gain of disorder (P = 6e-04); Loss of stability (P = 0.038); Gain of relative solvent accessibility (P = 0.1259); Gain of ubiquitination at K951 (P = 0.1767); Loss of methylation at K946 (P = 0.2542)
7:117243769:T:G,P13569,I947M,0.561,Gain of disorder (P = 0.0991); Loss of methylation at K946 (P = 0.1333); Loss of ubiquitination at K946 (P = 0.2757); Loss of stability (P = 0.3152); Gain of MoRF binding (P = 0.3377)
7:117243770:T:A,P13569,L948I,0.8,Gain of methylation at K946 (P = 0.1179); Gain of catalytic residue at L953 (P = 0.1567); Loss of ubiquitination at K946 (P = 0.2608); Gain of glycosylation at S945 (P = 0.3174); Loss of stability (P = 0.3229)
7:117243770:T:G,P13569,L948V,0.808,Loss of stability (P = 0.1348); Gain of methylation at K946 (P = 0.1652); Gain of catalytic residue at L948 (P = 0.1791); Loss of ubiquitination at K946 (P = 0.2757); Gain of MoRF binding (P = 0.3706)
7:117243771:T:C,P13569,L948S,0.897,Gain of disorder (P = 0.0032); Loss of stability (P = 0.0119); Gain of methylation at K946 (P = 0.1785); Loss of ubiquitination at K946 (P = 0.2828); Gain of catalytic residue at L948 (P = 0.3433)
7:117243772:A:C,P13569,L948F,0.832,Loss of stability (P = 0.1496); Gain of methylation at K946 (P = 0.2451); Loss of ubiquitination at K946 (P = 0.255); Gain of MoRF binding (P = 0.3529); Loss of catalytic residue at L948 (P = 0.3578)
7:117243772:A:T,P13569,L948F,0.832,Loss of stability (P = 0.1496); Gain of methylation at K946 (P = 0.2451); Loss of ubiquitination at K946 (P = 0.255); Gain of MoRF binding (P = 0.3529); Loss of catalytic residue at L948 (P = 0.3578)
7:117243773:C:A,P13569,H949N,0.881,Loss of catalytic residue at I947 (P = 0.1442); Loss of disorder (P = 0.2532); Loss of ubiquitination at K946 (P = 0.255); Gain of methylation at K946 (P = 0.2848); Gain of MoRF binding (P = 0.3176)
7:117243773:C:G,P13569,H949D,0.836,Gain of catalytic residue at H949 (P = 0.0334); Gain of ubiquitination at K951 (P = 0.0605); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2291); Loss of methylation at K946 (P = 0.2713)
7:117243773:C:T,P13569,H949Y,0.914,Loss of disorder (P = 0.1467); Loss of catalytic residue at I947 (P = 0.1862); Loss of methylation at K946 (P = 0.2018); Gain of ubiquitination at K946 (P = 0.2694); Gain of MoRF binding (P = 0.3526)
7:117243774:A:C,P13569,H949P,0.879,Gain of catalytic residue at H949 (P = 0.021); Gain of methylation at K946 (P = 0.1724); Loss of stability (P = 0.2383); Gain of ubiquitination at K946 (P = 0.2694); Loss of disorder (P = 0.3372)
7:117243774:A:G,P13569,H949R,0.948,Gain of MoRF binding (P = 0.0314); Gain of ubiquitination at K946 (P = 0.14); Loss of catalytic residue at I947 (P = 0.167); Loss of methylation at K946 (P = 0.2684); Loss of disorder (P = 0.2696)
7:117243774:A:T,P13569,H949L,0.824,Gain of catalytic residue at H949 (P = 0.0077); Loss of disorder (P = 0.1546); Loss of methylation at K946 (P = 0.2273); Gain of ubiquitination at K946 (P = 0.2496); Gain of MoRF binding (P = 0.3014)
7:117243775:C:A,P13569,H949Q,0.881,Gain of catalytic residue at H949 (P = 0.0998); Gain of methylation at K946 (P = 0.203); Loss of ubiquitination at K946 (P = 0.2608); Gain of MoRF binding (P = 0.3292); Loss of disorder (P = 0.33)
7:117243775:C:G,P13569,H949Q,0.881,Gain of catalytic residue at H949 (P = 0.0998); Gain of methylation at K946 (P = 0.203); Loss of ubiquitination at K946 (P = 0.2608); Gain of MoRF binding (P = 0.3292); Loss of disorder (P = 0.33)
7:117243776:C:A,P13569,H950N,0.664,Loss of catalytic residue at K951 (P = 0.0219); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.2346); Loss of disorder (P = 0.242); Loss of ubiquitination at K946 (P = 0.2684)
7:117243776:C:G,P13569,H950D,0.665,Gain of catalytic residue at H950 (P = 0.0438); Gain of ubiquitination at K951 (P = 0.0558); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Gain of methylation at K946 (P = 0.2587)
7:117243776:C:T,P13569,H950Y,0.652,Loss of catalytic residue at K951 (P = 0.0824); Loss of disorder (P = 0.1404); Loss of ubiquitination at K946 (P = 0.2684); Loss of methylation at K946 (P = 0.2981); Gain of MoRF binding (P = 0.375)
7:117243777:A:C,P13569,H950P,0.759,Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at K946 (P = 0.2025); Loss of catalytic residue at K951 (P = 0.2203); Loss of ubiquitination at K946 (P = 0.2684); Gain of solvent accessibility (P = 0.2689)
7:117243777:A:G,P13569,H950R,0.688,Gain of MoRF binding (P = 0.0212); Loss of catalytic residue at K951 (P = 0.1114); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Gain of ubiquitination at K946 (P = 0.14)
7:117243777:A:T,P13569,H950L,0.648,Loss of disorder (P = 0.1485); Loss of catalytic residue at M952 (P = 0.2022); Loss of methylation at K946 (P = 0.2137); Loss of ubiquitination at K946 (P = 0.2684); Gain of MoRF binding (P = 0.3603)
7:117243778:C:A,P13569,H950Q,0.669,Loss of catalytic residue at K951 (P = 0.0492); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Gain of methylation at K946 (P = 0.2044); Loss of ubiquitination at K946 (P = 0.2684)
7:117243778:C:G,P13569,H950Q,0.669,Loss of catalytic residue at K951 (P = 0.0492); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Gain of methylation at K946 (P = 0.2044); Loss of ubiquitination at K946 (P = 0.2684)
7:117243779:A:C,P13569,K951Q,0.595,Gain of ubiquitination at K946 (P = 0.0507); Gain of disorder (P = 0.2667); Gain of methylation at K946 (P = 0.2915); Loss of MoRF binding (P = 0.3385); Loss of glycosylation at K951 (P = 0.4521)
7:117243780:A:C,P13569,K951T,0.63,Gain of ubiquitination at K946 (P = 0.0545); Loss of stability (P = 0.2368); Loss of methylation at K946 (P = 0.3129); Loss of disorder (P = 0.3237); Loss of MoRF binding (P = 0.3387)
7:117243780:A:G,P13569,K951R,0.563,Loss of catalytic residue at K951 (P = 0.1358); Gain of methylation at K951 (P = 0.2647); Loss of ubiquitination at K946 (P = 0.2684); Gain of MoRF binding (P = 0.3044); Loss of disorder (P = 0.3328)
7:117243780:A:T,P13569,K951I,0.601,Loss of catalytic residue at K951 (P = 0.03); Gain of ubiquitination at K946 (P = 0.0453); Loss of disorder (P = 0.121); Loss of methylation at K946 (P = 0.2778); Loss of MoRF binding (P = 0.3568)
7:117243781:A:C,P13569,K951N,0.586,Gain of ubiquitination at K946 (P = 0.0507); Loss of methylation at K946 (P = 0.2937); Loss of disorder (P = 0.3409); Loss of MoRF binding (P = 0.3412); Loss of stability (P = 0.4145)
7:117243781:A:T,P13569,K951N,0.586,Gain of ubiquitination at K946 (P = 0.0507); Loss of methylation at K946 (P = 0.2937); Loss of disorder (P = 0.3409); Loss of MoRF binding (P = 0.3412); Loss of stability (P = 0.4145)
7:117243782:A:C,P13569,M952L,0.685,Loss of disorder (P = 0.2344); Loss of ubiquitination at K951 (P = 0.3467); Gain of methylation at K951 (P = 0.3949); Loss of MoRF binding (P = 0.4001); Loss of catalytic residue at V956 (P = 0.5018)
7:117243782:A:G,P13569,M952V,0.774,Gain of methylation at K951 (P = 0.0373); Loss of disorder (P = 0.209); Gain of ubiquitination at K951 (P = 0.3359); Gain of catalytic residue at S955 (P = 0.3469); Gain of MoRF binding (P = 0.3883)
7:117243782:A:T,P13569,M952L,0.685,Loss of disorder (P = 0.2344); Loss of ubiquitination at K951 (P = 0.3467); Gain of methylation at K951 (P = 0.3949); Loss of MoRF binding (P = 0.4001); Loss of catalytic residue at V956 (P = 0.5018)
7:117243783:T:A,P13569,M952K,0.93,Gain of disorder (P = 0.0155); Loss of stability (P = 0.0639); Gain of methylation at K951 (P = 0.097); Loss of catalytic residue at M952 (P = 0.2207); Gain of MoRF binding (P = 0.2655)
7:117243783:T:G,P13569,M952R,0.935,Gain of methylation at M952 (P = 0.0112); Gain of MoRF binding (P = 0.1456); Gain of disorder (P = 0.148); Loss of stability (P = 0.1589); Loss of ubiquitination at K951 (P = 0.3488)
7:117243784:G:A,P13569,M952I,0.879,Gain of catalytic residue at L957 (P = 0.0495); Gain of methylation at K951 (P = 0.1235); Loss of disorder (P = 0.1292); Gain of ubiquitination at K951 (P = 0.3121); Gain of MoRF binding (P = 0.3567)
7:117243784:G:T,P13569,M952I,0.879,Gain of catalytic residue at L957 (P = 0.0495); Gain of methylation at K951 (P = 0.1235); Loss of disorder (P = 0.1292); Gain of ubiquitination at K951 (P = 0.3121); Gain of MoRF binding (P = 0.3567)
7:117243785:T:A,P13569,L953I,0.784,Loss of disorder (P = 0.2264); Gain of catalytic residue at S955 (P = 0.266); Loss of ubiquitination at K951 (P = 0.3488); Gain of MoRF binding (P = 0.375); Loss of stability (P = 0.3921)
7:117243785:T:G,P13569,L953V,0.766,Loss of helix (P = 0.2271); Gain of loop (P = 0.2754); Loss of stability (P = 0.3303); Gain of disorder (P = 0.3344); Loss of ubiquitination at K951 (P = 0.3488)
7:117243786:T:C,P13569,L953S,0.84,Gain of disorder (P = 0.0028); Loss of stability (P = 0.0341); Loss of helix (P = 0.2271); Loss of catalytic residue at L953 (P = 0.2566); Gain of loop (P = 0.2754)
7:117243787:A:C,P13569,L953F,0.8,Loss of stability (P = 0.1729); Loss of disorder (P = 0.218); Gain of ubiquitination at K951 (P = 0.3121); Gain of MoRF binding (P = 0.3798); Loss of helix (P = 0.3949)
7:117243787:A:T,P13569,L953F,0.8,Loss of stability (P = 0.1729); Loss of disorder (P = 0.218); Gain of ubiquitination at K951 (P = 0.3121); Gain of MoRF binding (P = 0.3798); Loss of helix (P = 0.3949)
7:117243788:C:A,P13569,H954N,0.584,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1422); Loss of catalytic residue at L953 (P = 0.2185); Loss of disorder (P = 0.2653); Gain of ubiquitination at K951 (P = 0.3452)
7:117243788:C:G,P13569,H954D,0.677,Gain of ubiquitination at K951 (P = 0.048); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Loss of catalytic residue at L953 (P = 0.2166); Loss of disorder (P = 0.3151)
7:117243788:C:T,P13569,H954Y,0.66,Gain of catalytic residue at H954 (P = 0.0468); Loss of disorder (P = 0.0821); Gain of helix (P = 0.2294); Gain of ubiquitination at K951 (P = 0.2985); Gain of MoRF binding (P = 0.4278)
7:117243789:A:C,P13569,H954P,0.912,Gain of disorder (P = 0.2662); Gain of ubiquitination at K951 (P = 0.3452); Loss of helix (P = 0.3949); Gain of glycosylation at H954 (P = 0.3963); Loss of catalytic residue at L953 (P = 0.4139)
7:117243789:A:G,P13569,H954R,0.606,Gain of MoRF binding (P = 0.0421); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of catalytic residue at H954 (P = 0.1945); Gain of methylation at H954 (P = 0.1982)
7:117243789:A:T,P13569,H954L,0.673,Gain of stability (P = 0.0667); Loss of disorder (P = 0.0877); Loss of catalytic residue at L953 (P = 0.2297); Gain of ubiquitination at K951 (P = 0.3121); Loss of helix (P = 0.3949)
7:117243790:T:A,P13569,H954Q,0.587,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0917); Loss of catalytic residue at L953 (P = 0.2189); Gain of disorder (P = 0.3202); Loss of ubiquitination at K951 (P = 0.3488)
7:117243790:T:G,P13569,H954Q,0.587,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0917); Loss of catalytic residue at L953 (P = 0.2189); Gain of disorder (P = 0.3202); Loss of ubiquitination at K951 (P = 0.3488)
7:117243791:T:A,P13569,S955T,0.531,Loss of disorder (P = 0.1344); Loss of helix (P = 0.2271); Gain of ubiquitination at K951 (P = 0.2599); Gain of glycosylation at P960 (P = 0.2667); Gain of MoRF binding (P = 0.4665)
7:117243791:T:C,P13569,S955P,0.638,Gain of glycosylation at P960 (P = 0.2194); Loss of disorder (P = 0.2463); Loss of loop (P = 0.2897); Gain of ubiquitination at K951 (P = 0.3452); Loss of helix (P = 0.3949)
7:117243791:T:G,P13569,S955A,0.548,Loss of disorder (P = 0.0988); Gain of glycosylation at P960 (P = 0.252); Loss of loop (P = 0.2897); Gain of ubiquitination at K951 (P = 0.3359); Loss of helix (P = 0.3949)
7:117243792:C:A,P13569,S955Y,0.688,Loss of disorder (P = 0.0493); Loss of glycosylation at P960 (P = 0.2196); Loss of helix (P = 0.2271); Loss of loop (P = 0.2897); Gain of ubiquitination at K951 (P = 0.2985)
7:117243792:C:G,P13569,S955C,0.663,Loss of disorder (P = 0.0294); Gain of catalytic residue at S955 (P = 0.0296); Loss of glycosylation at P960 (P = 0.1689); Gain of helix (P = 0.2059); Gain of ubiquitination at K951 (P = 0.2599)
7:117243792:C:T,P13569,S955F,0.639,Loss of disorder (P = 0.0334); Loss of glycosylation at P960 (P = 0.1054); Gain of helix (P = 0.1736); Gain of stability (P = 0.1765); Loss of loop (P = 0.2897)
7:117243794:G:A,P13569,V956I,0.43,Gain of catalytic residue at V956 (P = 0.2093); Gain of helix (P = 0.2294); Gain of glycosylation at P960 (P = 0.2398); Loss of disorder (P = 0.2815); Loss of loop (P = 0.2897)
7:117243794:G:C,P13569,V956L,0.644,Loss of catalytic residue at Q958 (P = 0.1761); Gain of disorder (P = 0.1812); Gain of helix (P = 0.2294); Gain of glycosylation at P960 (P = 0.262); Loss of loop (P = 0.2897)
7:117243794:G:T,P13569,V956F,0.6,Loss of glycosylation at P960 (P = 0.1159); Gain of helix (P = 0.2294); Loss of disorder (P = 0.28); Loss of loop (P = 0.2897); Loss of stability (P = 0.3116)
7:117243795:T:A,P13569,V956D,0.875,Gain of disorder (P = 0.0054); Gain of ubiquitination at K951 (P = 0.0605); Loss of glycosylation at P960 (P = 0.0781); Gain of catalytic residue at V956 (P = 0.1395); Loss of stability (P = 0.1446)
7:117243795:T:C,P13569,V956A,0.894,Gain of disorder (P = 0.0272); Loss of stability (P = 0.0641); Gain of helix (P = 0.2294); Gain of glycosylation at P960 (P = 0.2385); Gain of ubiquitination at K951 (P = 0.3121)
7:117243795:T:G,P13569,V956G,0.893,Loss of stability (P = 0.0051); Gain of disorder (P = 0.0092); Gain of glycosylation at S955 (P = 0.0286); Gain of catalytic residue at L957 (P = 0.1658); Loss of helix (P = 0.2662)
7:117243797:C:A,P13569,L957I,0.629,Loss of glycosylation at S962 (P = 0.174); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2159); Gain of helix (P = 0.2684); Gain of MoRF binding (P = 0.4316)
7:117243797:C:G,P13569,L957V,0.632,Gain of catalytic residue at L957 (P = 0.0258); Loss of glycosylation at P960 (P = 0.1768); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897); Loss of disorder (P = 0.3314)
7:117243797:C:T,P13569,L957F,0.655,Loss of glycosylation at S962 (P = 0.1053); Loss of disorder (P = 0.1931); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897); Gain of catalytic residue at S962 (P = 0.4207)
7:117243798:T:A,P13569,L957H,0.858,Gain of disorder (P = 0.0117); Loss of stability (P = 0.1676); Loss of glycosylation at P960 (P = 0.184); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897)
7:117243798:T:C,P13569,L957P,0.921,Gain of disorder (P = 0.0063); Gain of glycosylation at P960 (P = 0.0988); Loss of stability (P = 0.1117); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117243798:T:G,P13569,L957R,0.916,Gain of disorder (P = 0.0216); Gain of methylation at L957 (P = 0.0285); Loss of glycosylation at S962 (P = 0.115); Gain of catalytic residue at L957 (P = 0.1245); Gain of MoRF binding (P = 0.1972)
7:117243800:C:A,P13569,Q958K,0.51,Gain of methylation at Q958 (P = 0.0387); Gain of ubiquitination at Q958 (P = 0.0592); Gain of disorder (P = 0.106); Gain of relative solvent accessibility (P = 0.1894); Gain of glycosylation at S962 (P = 0.2203)
7:117243800:C:G,P13569,Q958E,0.535,Loss of catalytic residue at Q958 (P = 0.0739); Loss of glycosylation at P960 (P = 0.0933); Gain of disorder (P = 0.0995); Loss of helix (P = 0.2662); Loss of loop (P = 0.2897)
7:117243801:A:C,P13569,Q958P,0.641,Loss of catalytic residue at Q958 (P = 0.003); Gain of glycosylation at Q958 (P = 0.0622); Gain of disorder (P = 0.1833); Loss of helix (P = 0.2271); Loss of stability (P = 0.2512)
7:117243801:A:G,P13569,Q958R,0.498,Gain of methylation at Q958 (P = 0.0162); Gain of MoRF binding (P = 0.0748); Loss of glycosylation at P960 (P = 0.1484); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2659)
7:117243801:A:T,P13569,Q958L,0.641,Loss of catalytic residue at Q958 (P = 0.0594); Loss of solvent accessibility (P = 0.0635); Loss of disorder (P = 0.0827); Loss of relative solvent accessibility (P = 0.1807); Loss of glycosylation at P960 (P = 0.1882)
7:117243802:A:C,P13569,Q958H,0.523,Gain of glycosylation at S962 (P = 0.1458); Gain of disorder (P = 0.1604); Gain of catalytic residue at L957 (P = 0.1763); Loss of helix (P = 0.2271); Loss of loop (P = 0.2897)
7:117243802:A:T,P13569,Q958H,0.523,Gain of glycosylation at S962 (P = 0.1458); Gain of disorder (P = 0.1604); Gain of catalytic residue at L957 (P = 0.1763); Loss of helix (P = 0.2271); Loss of loop (P = 0.2897)
7:117243803:G:A,P13569,A959T,0.595,Gain of disorder (P = 0.1312); Gain of phosphorylation at A959 (P = 0.1717); Gain of glycosylation at P960 (P = 0.1954); Gain of loop (P = 0.2045); Loss of catalytic residue at A959 (P = 0.2398)
7:117243803:G:C,P13569,A959P,0.811,Gain of glycosylation at A959 (P = 0.0321); Gain of disorder (P = 0.0453); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of catalytic residue at A959 (P = 0.2344)
7:117243803:G:T,P13569,A959S,0.745,Gain of disorder (P = 0.0149); Gain of glycosylation at A959 (P = 0.0465); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.281); Loss of helix (P = 0.3949)
7:117243804:C:A,P13569,A959E,0.845,Gain of disorder (P = 0.022); Loss of glycosylation at P960 (P = 0.1002); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Gain of relative solvent accessibility (P = 0.281)
7:117243804:C:G,P13569,A959G,0.663,Gain of disorder (P = 0.0868); Loss of stability (P = 0.1559); Gain of loop (P = 0.2045); Loss of glycosylation at P960 (P = 0.2474); Gain of relative solvent accessibility (P = 0.281)
7:117243804:C:T,P13569,A959V,0.824,Loss of glycosylation at P960 (P = 0.1249); Loss of disorder (P = 0.1668); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Gain of catalytic residue at S962 (P = 0.3459)
7:117243806:C:A,P13569,P960T,0.66,Loss of stability (P = 0.1115); Loss of glycosylation at P960 (P = 0.1199); Gain of catalytic residue at P960 (P = 0.1468); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117243806:C:G,P13569,P960A,0.66,Loss of glycosylation at P960 (P = 0.0411); Gain of catalytic residue at P960 (P = 0.1154); Loss of stability (P = 0.1495); Gain of helix (P = 0.1736); Loss of disorder (P = 0.2028)
7:117243807:C:A,P13569,P960H,0.621,Loss of glycosylation at P960 (P = 0.0411); Gain of catalytic residue at P960 (P = 0.0474); Gain of disorder (P = 0.1299); Loss of stability (P = 0.1346); Gain of loop (P = 0.2045)
7:117243807:C:G,P13569,P960R,0.768,Gain of methylation at P960 (P = 0.0189); Loss of glycosylation at P960 (P = 0.0411); Gain of MoRF binding (P = 0.0615); Gain of catalytic residue at P960 (P = 0.1258); Gain of loop (P = 0.2045)
7:117243807:C:T,P13569,P960L,0.706,Loss of glycosylation at P960 (P = 0.0411); Loss of disorder (P = 0.1046); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2579)
7:117243809:A:C,P13569,M961L,0.673,Loss of catalytic residue at M961 (P = 0.0209); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294); Loss of disorder (P = 0.2295); Loss of glycosylation at S962 (P = 0.2404)
7:117243809:A:G,P13569,M961V,0.714,Loss of glycosylation at P960 (P = 0.1006); Loss of catalytic residue at M961 (P = 0.1492); Loss of disorder (P = 0.2034); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294)
7:117243809:A:T,P13569,M961L,0.673,Loss of catalytic residue at M961 (P = 0.0209); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294); Loss of disorder (P = 0.2295); Loss of glycosylation at S962 (P = 0.2404)
7:117243810:T:A,P13569,M961K,0.811,Gain of disorder (P = 0.0141); Gain of ubiquitination at M961 (P = 0.0351); Gain of glycosylation at P960 (P = 0.1095); Gain of MoRF binding (P = 0.1286); Loss of catalytic residue at T963 (P = 0.1936)
7:117243810:T:C,P13569,M961T,0.704,Gain of glycosylation at M961 (P = 0.0539); Gain of disorder (P = 0.0751); Loss of catalytic residue at M961 (P = 0.1936); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294)
7:117243810:T:G,P13569,M961R,0.845,Gain of methylation at M961 (P = 0.0209); Gain of MoRF binding (P = 0.0568); Gain of disorder (P = 0.0827); Loss of glycosylation at P960 (P = 0.1544); Loss of loop (P = 0.2237)
7:117243811:G:A,P13569,M961I,0.863,Loss of catalytic residue at M961 (P = 0.02); Loss of glycosylation at P960 (P = 0.0885); Loss of disorder (P = 0.1257); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117243811:G:C,P13569,M961I,0.863,Loss of catalytic residue at M961 (P = 0.02); Loss of glycosylation at P960 (P = 0.0885); Loss of disorder (P = 0.1257); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117243811:G:T,P13569,M961I,0.863,Loss of catalytic residue at M961 (P = 0.02); Loss of glycosylation at P960 (P = 0.0885); Loss of disorder (P = 0.1257); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117243812:T:A,P13569,S962T,0.737,Loss of disorder (P = 0.1841); Loss of glycosylation at S962 (P = 0.2187); Loss of helix (P = 0.2271); Gain of loop (P = 0.2754); Gain of catalytic residue at S962 (P = 0.3767)
7:117243812:T:C,P13569,S962P,0.786,Gain of glycosylation at S962 (P = 0.0782); Gain of loop (P = 0.2045); Loss of catalytic residue at S962 (P = 0.2373); Loss of disorder (P = 0.2424); Loss of MoRF binding (P = 0.3539)
7:117243812:T:G,P13569,S962A,0.746,Loss of glycosylation at S962 (P = 0.0458); Loss of disorder (P = 0.1444); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662); Loss of catalytic residue at T963 (P = 0.3561)
7:117243813:C:T,P13569,S962L,0.724,Loss of glycosylation at S962 (P = 0.0458); Loss of disorder (P = 0.0838); Gain of stability (P = 0.2083); Loss of catalytic residue at S962 (P = 0.2143); Gain of loop (P = 0.3485)
7:117243815:A:C,P13569,T963P,0.857,Gain of glycosylation at T963 (P = 0.043); Loss of catalytic residue at T963 (P = 0.1047); Gain of methylation at K968 (P = 0.1167); Gain of disorder (P = 0.157); Gain of loop (P = 0.2045)
7:117243815:A:G,P13569,T963A,0.714,Loss of methylation at K968 (P = 0.0891); Loss of glycosylation at S962 (P = 0.1438); Gain of helix (P = 0.1736); Gain of ubiquitination at K968 (P = 0.2129); Loss of loop (P = 0.2237)
7:117243815:A:T,P13569,T963S,0.72,Gain of disorder (P = 0.0527); Loss of glycosylation at S962 (P = 0.0962); Gain of methylation at K968 (P = 0.1225); Loss of catalytic residue at T963 (P = 0.141); Loss of ubiquitination at K968 (P = 0.2094)
7:117243816:C:A,P13569,T963N,0.841,Loss of methylation at K968 (P = 0.1334); Loss of glycosylation at S962 (P = 0.1503); Loss of ubiquitination at K968 (P = 0.2335); Gain of disorder (P = 0.256); Loss of helix (P = 0.2662)
7:117243816:C:G,P13569,T963S,0.72,Gain of disorder (P = 0.0527); Loss of glycosylation at S962 (P = 0.0962); Gain of methylation at K968 (P = 0.1225); Loss of catalytic residue at T963 (P = 0.141); Loss of ubiquitination at K968 (P = 0.2094)
7:117243816:C:T,P13569,T963I,0.742,Loss of glycosylation at P960 (P = 0.0897); Loss of catalytic residue at T963 (P = 0.0932); Loss of disorder (P = 0.1269); Loss of methylation at K968 (P = 0.1461); Loss of loop (P = 0.2237)
7:117243818:C:A,P13569,L964I,0.735,Gain of methylation at K968 (P = 0.0586); Gain of glycosylation at T963 (P = 0.1147); Loss of ubiquitination at K968 (P = 0.2243); Loss of helix (P = 0.2662); Gain of MoRF binding (P = 0.292)
7:117243818:C:G,P13569,L964V,0.789,Gain of catalytic residue at L964 (P = 0.0062); Gain of methylation at K968 (P = 0.0786); Gain of glycosylation at T963 (P = 0.1227); Loss of ubiquitination at K968 (P = 0.2335); Loss of helix (P = 0.2662)
7:117243818:C:T,P13569,L964F,0.739,Loss of glycosylation at P960 (P = 0.095); Gain of methylation at K968 (P = 0.102); Loss of ubiquitination at K968 (P = 0.1808); Loss of helix (P = 0.2662); Gain of MoRF binding (P = 0.3087)
7:117243819:T:A,P13569,L964H,0.895,Gain of disorder (P = 0.0211); Loss of stability (P = 0.0485); Gain of methylation at K968 (P = 0.0774); Gain of catalytic residue at L964 (P = 0.089); Loss of glycosylation at S962 (P = 0.1314)
7:117243819:T:C,P13569,L964P,0.897,Gain of disorder (P = 0.0101); Gain of glycosylation at L964 (P = 0.0182); Gain of methylation at K968 (P = 0.0422); Loss of stability (P = 0.0557); Gain of phosphorylation at T966 (P = 0.1095)
7:117243819:T:G,P13569,L964R,0.908,Gain of methylation at L964 (P = 0.0153); Gain of disorder (P = 0.0346); Gain of MoRF binding (P = 0.0381); Gain of catalytic residue at L964 (P = 0.0422); Gain of glycosylation at T963 (P = 0.0792)
7:117243821:A:C,P13569,N965H,0.68,Gain of catalytic residue at L967 (P = 0.0569); Gain of disorder (P = 0.0941); Loss of methylation at K968 (P = 0.1632); Loss of glycosylation at P960 (P = 0.1938); Loss of ubiquitination at K968 (P = 0.1962)
7:117243821:A:G,P13569,N965D,0.626,Gain of ubiquitination at K968 (P = 0.0411); Loss of methylation at K968 (P = 0.0975); Loss of glycosylation at P960 (P = 0.1183); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117243821:A:T,P13569,N965Y,0.736,Loss of methylation at K968 (P = 0.0585); Loss of ubiquitination at K968 (P = 0.1139); Gain of helix (P = 0.1736); Loss of glycosylation at P960 (P = 0.2056); Loss of disorder (P = 0.2106)
7:117243822:A:C,P13569,N965T,0.667,Gain of catalytic residue at N965 (P = 0.0848); Loss of methylation at K968 (P = 0.1211); Gain of glycosylation at P960 (P = 0.1824); Loss of loop (P = 0.2237); Loss of ubiquitination at K968 (P = 0.2243)
7:117243822:A:G,P13569,N965S,0.645,Gain of disorder (P = 0.0601); Gain of glycosylation at P960 (P = 0.1389); Loss of methylation at K968 (P = 0.1422); Gain of helix (P = 0.1736); Loss of ubiquitination at K968 (P = 0.1962)
7:117243822:A:T,P13569,N965I,0.728,Loss of methylation at K968 (P = 0.1168); Loss of disorder (P = 0.1516); Loss of glycosylation at P960 (P = 0.1682); Gain of helix (P = 0.1736); Loss of ubiquitination at K968 (P = 0.1962)
7:117243823:C:A,P13569,N965K,0.758,Gain of MoRF binding (P = 0.0698); Gain of methylation at K968 (P = 0.097); Loss of glycosylation at S962 (P = 0.1126); Loss of ubiquitination at K968 (P = 0.1392); Gain of disorder (P = 0.1451)
7:117243823:C:G,P13569,N965K,0.758,Gain of MoRF binding (P = 0.0698); Gain of methylation at K968 (P = 0.097); Loss of glycosylation at S962 (P = 0.1126); Loss of ubiquitination at K968 (P = 0.1392); Gain of disorder (P = 0.1451)
7:117243824:A:C,P13569,T966P,0.67,Gain of glycosylation at T963 (P = 0.0659); Gain of methylation at K968 (P = 0.0716); Gain of disorder (P = 0.2012); Gain of loop (P = 0.2045); Loss of stability (P = 0.2053)
7:117243824:A:G,P13569,T966A,0.487,Loss of methylation at K968 (P = 0.1241); Loss of helix (P = 0.1299); Gain of glycosylation at S962 (P = 0.2045); Gain of loop (P = 0.2045); Gain of ubiquitination at K968 (P = 0.2129)
7:117243824:A:T,P13569,T966S,0.511,Gain of disorder (P = 0.0671); Loss of catalytic residue at T966 (P = 0.1051); Loss of methylation at K968 (P = 0.1645); Gain of loop (P = 0.2045); Loss of ubiquitination at K968 (P = 0.2243)
7:117243825:C:A,P13569,T966K,0.606,Gain of MoRF binding (P = 0.0699); Gain of disorder (P = 0.0836); Loss of ubiquitination at K968 (P = 0.1039); Gain of methylation at K968 (P = 0.1287); Loss of glycosylation at S962 (P = 0.1577)
7:117243825:C:G,P13569,T966R,0.604,Gain of methylation at T966 (P = 0.0276); Gain of MoRF binding (P = 0.0395); Loss of ubiquitination at K968 (P = 0.079); Loss of glycosylation at S962 (P = 0.1104); Loss of helix (P = 0.1299)
7:117243825:C:T,P13569,T966M,0.623,Gain of methylation at K968 (P = 0.0947); Gain of loop (P = 0.2045); Loss of glycosylation at S962 (P = 0.2114); Loss of ubiquitination at K968 (P = 0.2243); Gain of MoRF binding (P = 0.2566)
7:117243827:T:A,P13569,L967M,0.447,Loss of methylation at K968 (P = 0.0475); Loss of stability (P = 0.0513); Loss of helix (P = 0.1299); Gain of disorder (P = 0.177); Loss of ubiquitination at K968 (P = 0.2243)
7:117243827:T:G,P13569,L967V,0.481,Loss of stability (P = 0.0136); Gain of methylation at K968 (P = 0.0331); Loss of ubiquitination at K968 (P = 0.1962); Gain of helix (P = 0.2294); Gain of glycosylation at S962 (P = 0.2603)
7:117243828:T:G,P13569,L967W,0.501,Loss of stability (P = 0.0038); Gain of methylation at K968 (P = 0.0578); Gain of MoRF binding (P = 0.0728); Loss of ubiquitination at K968 (P = 0.0935); Gain of glycosylation at S962 (P = 0.2037)
7:117243829:G:C,P13569,L967F,0.501,Gain of methylation at K968 (P = 0.0293); Loss of stability (P = 0.0334); Loss of glycosylation at S962 (P = 0.1292); Loss of ubiquitination at K968 (P = 0.152); Loss of helix (P = 0.1706)
7:117243829:G:T,P13569,L967F,0.501,Gain of methylation at K968 (P = 0.0293); Loss of stability (P = 0.0334); Loss of glycosylation at S962 (P = 0.1292); Loss of ubiquitination at K968 (P = 0.152); Loss of helix (P = 0.1706)
7:117243830:A:C,P13569,K968Q,0.632,Loss of methylation at K968 (P = 0.0285); Loss of ubiquitination at K968 (P = 0.0362); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.2333); Gain of disorder (P = 0.3386)
7:117243830:A:G,P13569,K968E,0.599,Loss of methylation at K968 (P = 0.0285); Loss of ubiquitination at K968 (P = 0.0362); Loss of MoRF binding (P = 0.1402); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117243831:A:C,P13569,K968T,0.579,Loss of methylation at K968 (P = 0.0285); Loss of ubiquitination at K968 (P = 0.0362); Gain of loop (P = 0.2045); Gain of glycosylation at T963 (P = 0.2185); Loss of MoRF binding (P = 0.2212)
7:117243831:A:G,P13569,K968R,0.521,Loss of ubiquitination at K968 (P = 0.0362); Loss of helix (P = 0.1299); Gain of methylation at K968 (P = 0.152); Gain of MoRF binding (P = 0.2137); Gain of loop (P = 0.2754)
7:117243831:A:T,P13569,K968I,0.709,Loss of methylation at K968 (P = 0.0285); Loss of ubiquitination at K968 (P = 0.0362); Gain of catalytic residue at L973 (P = 0.0905); Loss of disorder (P = 0.1483); Loss of solvent accessibility (P = 0.1551)
7:117243832:A:C,P13569,K968N,0.602,Loss of methylation at K968 (P = 0.0285); Loss of ubiquitination at K968 (P = 0.0362); Gain of catalytic residue at K968 (P = 0.1996); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2281)
7:117243832:A:T,P13569,K968N,0.602,Loss of methylation at K968 (P = 0.0285); Loss of ubiquitination at K968 (P = 0.0362); Gain of catalytic residue at K968 (P = 0.1996); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2281)
7:117243833:G:A,P13569,A969T,0.6,Loss of catalytic residue at A969 (P = 0.0794); Gain of helix (P = 0.0854); Gain of methylation at K968 (P = 0.1187); Loss of ubiquitination at K968 (P = 0.1392); Loss of loop (P = 0.2237)
7:117243833:G:C,P13569,A969P,0.764,Loss of catalytic residue at A969 (P = 0.0094); Gain of methylation at K968 (P = 0.0606); Loss of ubiquitination at K968 (P = 0.1139); Gain of disorder (P = 0.1231); Gain of helix (P = 0.132)
7:117243833:G:T,P13569,A969S,0.64,Loss of catalytic residue at A969 (P = 0.004); Gain of glycosylation at A969 (P = 0.0312); Gain of disorder (P = 0.0357); Gain of helix (P = 0.132); Gain of methylation at K968 (P = 0.1654)
7:117243834:C:A,P13569,A969E,0.674,Gain of solvent accessibility (P = 9e-04); Gain of relative solvent accessibility (P = 0.0023); Gain of ubiquitination at K968 (P = 0.0373); Gain of disorder (P = 0.0497); Loss of catalytic residue at A969 (P = 0.1128)
7:117243834:C:G,P13569,A969G,0.726,Loss of stability (P = 0.1061); Gain of helix (P = 0.132); Loss of methylation at K968 (P = 0.1704); Gain of disorder (P = 0.1882); Loss of ubiquitination at K968 (P = 0.1962)
7:117243834:C:T,P13569,A969V,0.647,Gain of methylation at K968 (P = 0.0354); Loss of catalytic residue at A969 (P = 0.087); Gain of helix (P = 0.132); Loss of ubiquitination at K968 (P = 0.152); Gain of MoRF binding (P = 0.2432)
7:117243836:G:A,P13569,G970S,0.959,Gain of glycosylation at G970 (P = 0.0657); Loss of methylation at K968 (P = 0.1185); Loss of catalytic residue at G970 (P = 0.1236); Loss of helix (P = 0.1299); Loss of ubiquitination at K968 (P = 0.1808)
7:117243836:G:C,P13569,G970R,0.973,Gain of MoRF binding (P = 0.0181); Gain of methylation at G970 (P = 0.032); Loss of ubiquitination at K968 (P = 0.0578); Loss of catalytic residue at G971 (P = 0.0806); Gain of helix (P = 0.1736)
7:117243836:G:T,P13569,G970C,0.951,Gain of methylation at K968 (P = 0.083); Loss of helix (P = 0.1299); Loss of catalytic residue at I972 (P = 0.1403); Loss of disorder (P = 0.1851); Loss of ubiquitination at K968 (P = 0.1962)
7:117246728:G:A,P13569,G970D,0.963,Loss of catalytic residue at G970 (P = 0.0317); Gain of ubiquitination at K968 (P = 0.0444); Loss of methylation at K968 (P = 0.0715); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117246728:G:C,P13569,G970A,0.96,Loss of catalytic residue at I972 (P = 0.1623); Loss of methylation at K968 (P = 0.1628); Gain of helix (P = 0.1736); Loss of ubiquitination at K968 (P = 0.2243); Gain of MoRF binding (P = 0.3123)
7:117246728:G:T,P13569,G970V,0.967,Gain of methylation at K968 (P = 0.0674); Loss of catalytic residue at G970 (P = 0.0991); Loss of helix (P = 0.1299); Loss of ubiquitination at K968 (P = 0.152); Gain of MoRF binding (P = 0.2303)
7:117246730:G:A,P13569,G971R,0.623,Gain of MoRF binding (P = 0.0098); Gain of methylation at G971 (P = 0.0726); Loss of ubiquitination at K968 (P = 0.1139); Loss of helix (P = 0.2022); Loss of catalytic residue at G970 (P = 0.2446)
7:117246730:G:C,P13569,G971R,0.623,Gain of MoRF binding (P = 0.0098); Gain of methylation at G971 (P = 0.0726); Loss of ubiquitination at K968 (P = 0.1139); Loss of helix (P = 0.2022); Loss of catalytic residue at G970 (P = 0.2446)
7:117246730:G:T,P13569,G971W,0.68,Gain of MoRF binding (P = 0.05); Gain of methylation at K968 (P = 0.0856); Loss of ubiquitination at K968 (P = 0.152); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1869)
7:117246731:G:A,P13569,G971E,0.609,Loss of catalytic residue at G971 (P = 0.0376); Gain of ubiquitination at K968 (P = 0.0444); Loss of methylation at K968 (P = 0.1109); Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.242)
7:117246731:G:C,P13569,G971A,0.547,Loss of methylation at K968 (P = 0.1635); Gain of helix (P = 0.2294); Loss of ubiquitination at K968 (P = 0.2335); Gain of MoRF binding (P = 0.3153); Loss of loop (P = 0.3664)
7:117246731:G:T,P13569,G971V,0.632,Gain of methylation at K968 (P = 0.0767); Loss of ubiquitination at K968 (P = 0.1808); Loss of loop (P = 0.2237); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2464)
7:117246733:A:C,P13569,I972L,0.635,Loss of methylation at K968 (P = 0.0627); Gain of helix (P = 0.132); Loss of ubiquitination at K968 (P = 0.1962); Gain of disorder (P = 0.2569); Loss of MoRF binding (P = 0.3042)
7:117246733:A:G,P13569,I972V,0.637,Loss of methylation at K968 (P = 0.109); Gain of helix (P = 0.132); Loss of ubiquitination at K968 (P = 0.2335); Loss of MoRF binding (P = 0.3247); Gain of disorder (P = 0.3921)
7:117246733:A:T,P13569,I972F,0.704,Loss of catalytic residue at I972 (P = 0.0895); Loss of methylation at K968 (P = 0.1086); Gain of helix (P = 0.132); Loss of ubiquitination at K968 (P = 0.1808); Loss of MoRF binding (P = 0.3181)
7:117246734:T:A,P13569,I972N,0.896,Gain of disorder (P = 0.0133); Loss of methylation at K968 (P = 0.0587); Gain of ubiquitination at K968 (P = 0.1575); Loss of stability (P = 0.1887); Gain of helix (P = 0.2059)
7:117246734:T:C,P13569,I972T,0.9,Gain of disorder (P = 0.0281); Loss of methylation at K968 (P = 0.0903); Loss of stability (P = 0.0932); Loss of ubiquitination at K968 (P = 0.1668); Loss of catalytic residue at I972 (P = 0.1678)
7:117246734:T:G,P13569,I972S,0.855,Gain of disorder (P = 0.002); Loss of methylation at K968 (P = 0.0704); Gain of phosphorylation at I972 (P = 0.0767); Gain of helix (P = 0.132); Loss of stability (P = 0.1678)
7:117246735:T:G,P13569,I972M,0.637,Gain of disorder (P = 0.0939); Loss of methylation at K968 (P = 0.0954); Loss of catalytic residue at I972 (P = 0.1277); Gain of helix (P = 0.132); Loss of ubiquitination at K968 (P = 0.1808)
7:117246736:C:A,P13569,L973I,0.561,Gain of methylation at K968 (P = 0.0477); Gain of ubiquitination at K978 (P = 0.1375); Loss of helix (P = 0.2022); Gain of catalytic residue at L973 (P = 0.2252); Gain of loop (P = 0.2754)
7:117246736:C:G,P13569,L973V,0.563,Gain of methylation at K968 (P = 0.0632); Gain of ubiquitination at K978 (P = 0.1375); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Gain of MoRF binding (P = 0.2833)
7:117246737:T:A,P13569,L973H,0.914,Gain of disorder (P = 0.0624); Gain of methylation at K968 (P = 0.0755); Gain of ubiquitination at K978 (P = 0.0837); Loss of helix (P = 0.1299); Loss of stability (P = 0.223)
7:117246737:T:C,P13569,L973P,0.941,Gain of methylation at K968 (P = 0.0597); Gain of ubiquitination at K978 (P = 0.0837); Gain of disorder (P = 0.0877); Loss of helix (P = 0.1299); Loss of stability (P = 0.1754)
7:117246737:T:G,P13569,L973R,0.901,Gain of methylation at L973 (P = 0.0161); Gain of MoRF binding (P = 0.0828); Loss of ubiquitination at K968 (P = 0.1039); Gain of disorder (P = 0.1114); Loss of helix (P = 0.1299)
7:117246739:A:C,P13569,N974H,0.832,Loss of helix (P = 0.1299); Loss of ubiquitination at K978 (P = 0.1601); Loss of catalytic residue at N974 (P = 0.2364); Gain of loop (P = 0.2754); Loss of MoRF binding (P = 0.3113)
7:117246739:A:G,P13569,N974D,0.812,Gain of relative solvent accessibility (P = 0.09); Gain of ubiquitination at K978 (P = 0.1128); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.1376); Loss of loop (P = 0.2237)
7:117246739:A:T,P13569,N974Y,0.822,Gain of ubiquitination at K978 (P = 0.1128); Loss of helix (P = 0.1299); Gain of catalytic residue at N974 (P = 0.3088); Loss of MoRF binding (P = 0.3182); Loss of disorder (P = 0.509)
7:117246740:A:C,P13569,N974T,0.691,Loss of helix (P = 0.1299); Gain of ubiquitination at K978 (P = 0.1375); Gain of MoRF binding (P = 0.317); Loss of stability (P = 0.3309); Gain of phosphorylation at S977 (P = 0.5191)
7:117246740:A:G,P13569,N974S,0.628,Gain of helix (P = 0.132); Loss of ubiquitination at K978 (P = 0.1423); Gain of phosphorylation at N974 (P = 0.2033); Loss of loop (P = 0.2237); Gain of catalytic residue at N974 (P = 0.2684)
7:117246740:A:T,P13569,N974I,0.811,Gain of ubiquitination at K978 (P = 0.0635); Gain of helix (P = 0.0696); Loss of loop (P = 0.0804); Gain of MoRF binding (P = 0.2554); Gain of catalytic residue at L973 (P = 0.4105)
7:117246741:T:A,P13569,N974K,0.893,Gain of ubiquitination at N974 (P = 0.0494); Gain of MoRF binding (P = 0.069); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of stability (P = 0.2602)
7:117246741:T:G,P13569,N974K,0.893,Gain of ubiquitination at N974 (P = 0.0494); Gain of MoRF binding (P = 0.069); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of stability (P = 0.2602)
7:117246742:A:G,P13569,R975G,0.92,Loss of stability (P = 0.0453); Gain of ubiquitination at K978 (P = 0.056); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Gain of catalytic residue at F976 (P = 0.14)
7:117246743:G:A,P13569,R975K,0.861,Gain of ubiquitination at R975 (P = 0.0203); Loss of catalytic residue at R975 (P = 0.0273); Loss of stability (P = 0.0889); Loss of helix (P = 0.1299); Gain of methylation at R975 (P = 0.1773)
7:117246743:G:C,P13569,R975T,0.914,Gain of ubiquitination at K978 (P = 0.0693); Loss of catalytic residue at R975 (P = 0.0767); Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.1833); Gain of loop (P = 0.2045)
7:117246743:G:T,P13569,R975I,0.914,Loss of catalytic residue at R975 (P = 0.0429); Gain of ubiquitination at K978 (P = 0.0475); Gain of loop (P = 0.069); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1815)
7:117246744:A:C,P13569,R975S,0.928,Gain of ubiquitination at K978 (P = 0.0522); Loss of catalytic residue at R975 (P = 0.0631); Loss of MoRF binding (P = 0.182); Loss of stability (P = 0.1876); Gain of loop (P = 0.2045)
7:117246744:A:T,P13569,R975S,0.928,Gain of ubiquitination at K978 (P = 0.0522); Loss of catalytic residue at R975 (P = 0.0631); Loss of MoRF binding (P = 0.182); Loss of stability (P = 0.1876); Gain of loop (P = 0.2045)
7:117246745:T:A,P13569,F976I,0.69,Loss of stability (P = 0.064); Loss of ubiquitination at K978 (P = 0.1601); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Gain of MoRF binding (P = 0.3072)
7:117246745:T:C,P13569,F976L,0.728,Loss of stability (P = 0.0517); Gain of ubiquitination at K978 (P = 0.0972); Loss of loop (P = 0.2897); Loss of MoRF binding (P = 0.3114); Loss of helix (P = 0.3949)
7:117246745:T:G,P13569,F976V,0.662,Loss of stability (P = 0.0206); Gain of ubiquitination at K978 (P = 0.1128); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.3179); Gain of methylation at R975 (P = 0.5531)
7:117246746:T:A,P13569,F976Y,0.868,Loss of stability (P = 0.0123); Gain of ubiquitination at K978 (P = 0.0972); Gain of helix (P = 0.2059); Loss of MoRF binding (P = 0.2881); Loss of loop (P = 0.2897)
7:117246746:T:C,P13569,F976S,0.885,Loss of stability (P = 0.0014); Gain of disorder (P = 0.0048); Gain of ubiquitination at K978 (P = 0.044); Loss of helix (P = 0.2022); Gain of phosphorylation at S977 (P = 0.2421)
7:117246746:T:G,P13569,F976C,0.812,Loss of stability (P = 0.0062); Loss of helix (P = 0.1299); Gain of ubiquitination at K978 (P = 0.1375); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2771)
7:117246747:C:A,P13569,F976L,0.728,Loss of stability (P = 0.0517); Gain of ubiquitination at K978 (P = 0.0972); Loss of loop (P = 0.2897); Loss of MoRF binding (P = 0.3114); Loss of helix (P = 0.3949)
7:117246747:C:G,P13569,F976L,0.728,Loss of stability (P = 0.0517); Gain of ubiquitination at K978 (P = 0.0972); Loss of loop (P = 0.2897); Loss of MoRF binding (P = 0.3114); Loss of helix (P = 0.3949)
7:117246748:T:A,P13569,S977T,0.683,Gain of ubiquitination at K978 (P = 0.0837); Loss of stability (P = 0.1254); Loss of catalytic residue at K978 (P = 0.202); Gain of phosphorylation at S977 (P = 0.2567); Gain of MoRF binding (P = 0.3206)
7:117246748:T:C,P13569,S977P,0.955,Loss of stability (P = 0.0517); Loss of ubiquitination at K978 (P = 0.1601); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.2652); Gain of loop (P = 0.2754)
7:117246749:C:A,P13569,S977Y,0.892,Gain of ubiquitination at K978 (P = 0.1128); Loss of stability (P = 0.1938); Loss of catalytic residue at K978 (P = 0.2078); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3184)
7:117246749:C:G,P13569,S977C,0.857,Gain of methylation at K978 (P = 0.0231); Loss of helix (P = 0.0626); Gain of ubiquitination at K978 (P = 0.0635); Loss of stability (P = 0.2072); Gain of loop (P = 0.2754)
7:117246751:A:C,P13569,K978Q,0.643,Loss of ubiquitination at K978 (P = 0.0244); Gain of helix (P = 0.2059); Gain of catalytic residue at D979 (P = 0.2345); Loss of MoRF binding (P = 0.2653); Loss of solvent accessibility (P = 0.2668)
7:117246751:A:G,P13569,K978E,0.599,Loss of ubiquitination at K978 (P = 0.0244); Loss of catalytic residue at K978 (P = 0.1797); Loss of MoRF binding (P = 0.2033); Loss of helix (P = 0.3949); Gain of phosphorylation at S977 (P = 0.4457)
7:117246752:A:C,P13569,K978T,0.569,Loss of ubiquitination at K978 (P = 0.0244); Gain of catalytic residue at D979 (P = 0.1925); Loss of MoRF binding (P = 0.2603); Gain of loop (P = 0.2754); Loss of solvent accessibility (P = 0.2882)
7:117246752:A:G,P13569,K978R,0.489,Loss of ubiquitination at K978 (P = 0.0244); Gain of helix (P = 0.2059); Gain of phosphorylation at S977 (P = 0.2373); Gain of MoRF binding (P = 0.2697); Loss of catalytic residue at K978 (P = 0.2852)
7:117246752:A:T,P13569,K978I,0.632,Gain of catalytic residue at L983 (P = 0.0199); Loss of ubiquitination at K978 (P = 0.0244); Loss of helix (P = 0.0558); Loss of solvent accessibility (P = 0.1986); Gain of loop (P = 0.2045)
7:117246753:A:C,P13569,K978N,0.577,Loss of ubiquitination at K978 (P = 0.0244); Loss of catalytic residue at K978 (P = 0.0654); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2636)
7:117246753:A:T,P13569,K978N,0.577,Loss of ubiquitination at K978 (P = 0.0244); Loss of catalytic residue at K978 (P = 0.0654); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2636)
7:117246754:G:A,P13569,D979N,0.945,Loss of ubiquitination at K978 (P = 0.1423); Gain of MoRF binding (P = 0.1553); Gain of helix (P = 0.2059); Loss of stability (P = 0.2148); Loss of solvent accessibility (P = 0.4141)
7:117246754:G:C,P13569,D979H,0.943,Loss of ubiquitination at K978 (P = 0.1264); Loss of catalytic residue at D979 (P = 0.1949); Gain of MoRF binding (P = 0.1982); Loss of stability (P = 0.1986); Loss of helix (P = 0.2022)
7:117246754:G:T,P13569,D979Y,0.964,Loss of ubiquitination at K978 (P = 0.1423); Gain of MoRF binding (P = 0.1873); Loss of catalytic residue at D979 (P = 0.2706); Loss of loop (P = 0.2897); Loss of helix (P = 0.3949)
7:117246755:A:C,P13569,D979A,0.98,Loss of ubiquitination at K978 (P = 0.1601); Gain of MoRF binding (P = 0.1875); Loss of helix (P = 0.2022); Loss of stability (P = 0.2455); Gain of catalytic residue at D979 (P = 0.3428)
7:117246755:A:G,P13569,D979G,0.946,Loss of stability (P = 0.1033); Gain of catalytic residue at D979 (P = 0.1569); Loss of ubiquitination at K978 (P = 0.1601); Gain of MoRF binding (P = 0.1758); Gain of glycosylation at K978 (P = 0.309)
7:117246755:A:T,P13569,D979V,0.976,Gain of MoRF binding (P = 0.1019); Gain of ubiquitination at K978 (P = 0.1128); Gain of helix (P = 0.2059); Gain of methylation at K978 (P = 0.2197); Loss of catalytic residue at D979 (P = 0.2707)
7:117246756:T:A,P13569,D979E,0.933,Loss of catalytic residue at K978 (P = 0.1254); Loss of helix (P = 0.1299); Loss of ubiquitination at K978 (P = 0.1601); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.3373)
7:117246756:T:G,P13569,D979E,0.933,Loss of catalytic residue at K978 (P = 0.1254); Loss of helix (P = 0.1299); Loss of ubiquitination at K978 (P = 0.1601); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.3373)
7:117246757:A:C,P13569,I980L,0.753,Gain of ubiquitination at K978 (P = 0.0972); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of catalytic residue at D984 (P = 0.3032); Loss of MoRF binding (P = 0.3759)
7:117246757:A:G,P13569,I980V,0.585,Gain of ubiquitination at K978 (P = 0.1128); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of catalytic residue at D984 (P = 0.3635); Loss of MoRF binding (P = 0.3847)
7:117246757:A:T,P13569,I980L,0.753,Gain of ubiquitination at K978 (P = 0.0972); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of catalytic residue at D984 (P = 0.3032); Loss of MoRF binding (P = 0.3759)
7:117246758:T:A,P13569,I980K,0.947,Gain of ubiquitination at I980 (P = 0.023); Gain of disorder (P = 0.0271); Loss of stability (P = 0.0549); Loss of helix (P = 0.1299); Loss of catalytic residue at D984 (P = 0.1713)
7:117246758:T:C,P13569,I980T,0.859,Loss of stability (P = 0.0241); Gain of ubiquitination at K978 (P = 0.0585); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of catalytic residue at D984 (P = 0.3252)
7:117246758:T:G,P13569,I980R,0.936,Gain of ubiquitination at K978 (P = 0.0693); Gain of helix (P = 0.132); Gain of disorder (P = 0.1786); Loss of stability (P = 0.1817); Gain of phosphorylation at S977 (P = 0.2011)
7:117246759:A:G,P13569,I980M,0.898,Gain of ubiquitination at K978 (P = 0.0754); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of catalytic residue at D984 (P = 0.2882); Loss of MoRF binding (P = 0.3798)
7:117246760:G:A,P13569,A981T,0.42,Loss of stability (P = 0.061); Gain of ubiquitination at K978 (P = 0.0972); Loss of helix (P = 0.1299); Loss of catalytic residue at A981 (P = 0.1702); Gain of relative solvent accessibility (P = 0.1894)
7:117246760:G:C,P13569,A981P,0.582,Loss of stability (P = 0.0526); Loss of helix (P = 0.0558); Loss of catalytic residue at A981 (P = 0.0778); Gain of ubiquitination at K978 (P = 0.0837); Gain of relative solvent accessibility (P = 0.1894)
7:117246760:G:T,P13569,A981S,0.467,Loss of catalytic residue at A981 (P = 0.0236); Gain of ubiquitination at K978 (P = 0.0837); Gain of helix (P = 0.132); Loss of stability (P = 0.1346); Loss of loop (P = 0.2237)
7:117246761:C:A,P13569,A981E,0.58,Gain of ubiquitination at K978 (P = 0.0522); Loss of catalytic residue at A981 (P = 0.0622); Gain of solvent accessibility (P = 0.0789); Gain of helix (P = 0.132); Gain of relative solvent accessibility (P = 0.1894)
7:117246761:C:G,P13569,A981G,0.548,Loss of stability (P = 0.0424); Gain of ubiquitination at K978 (P = 0.0837); Gain of catalytic residue at I980 (P = 0.0903); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117246761:C:T,P13569,A981V,0.561,Gain of ubiquitination at K978 (P = 0.1128); Loss of loop (P = 0.2237); Loss of catalytic residue at A981 (P = 0.2683); Gain of MoRF binding (P = 0.3772); Gain of solvent accessibility (P = 0.3819)
7:117246763:A:C,P13569,I982L,0.63,Loss of catalytic residue at L987 (P = 0.088); Gain of ubiquitination at K978 (P = 0.1128); Loss of helix (P = 0.1299); Loss of stability (P = 0.4289); Loss of MoRF binding (P = 0.4448)
7:117246763:A:G,P13569,I982V,0.63,Loss of catalytic residue at L987 (P = 0.088); Gain of ubiquitination at K978 (P = 0.1128); Loss of helix (P = 0.1299); Loss of stability (P = 0.2526); Gain of MoRF binding (P = 0.4312)
7:117246763:A:T,P13569,I982F,0.68,Loss of catalytic residue at L987 (P = 0.0877); Loss of stability (P = 0.0967); Gain of helix (P = 0.132); Loss of ubiquitination at K978 (P = 0.1601); Loss of loop (P = 0.2237)
7:117246764:T:A,P13569,I982N,0.634,Loss of stability (P = 0.0132); Gain of ubiquitination at K978 (P = 0.0635); Loss of catalytic residue at L987 (P = 0.0739); Gain of relative solvent accessibility (P = 0.09); Gain of helix (P = 0.132)
7:117246764:T:C,P13569,I982T,0.573,Loss of stability (P = 0.0025); Loss of catalytic residue at L987 (P = 0.0816); Gain of ubiquitination at K978 (P = 0.1128); Gain of phosphorylation at I982 (P = 0.3809); Loss of helix (P = 0.3949)
7:117246764:T:G,P13569,I982S,0.579,Loss of stability (P = 0.0137); Gain of disorder (P = 0.0562); Gain of ubiquitination at K978 (P = 0.0754); Loss of catalytic residue at L987 (P = 0.0806); Gain of relative solvent accessibility (P = 0.09)
7:117246765:T:G,P13569,I982M,0.624,Loss of catalytic residue at L987 (P = 0.0865); Gain of ubiquitination at K978 (P = 0.0972); Gain of helix (P = 0.132); Loss of stability (P = 0.1477); Loss of loop (P = 0.2237)
7:117246766:T:A,P13569,L983M,0.71,Gain of ubiquitination at K978 (P = 0.1375); Loss of stability (P = 0.3563); Loss of helix (P = 0.3949); Gain of catalytic residue at D985 (P = 0.4585); Gain of MoRF binding (P = 0.4703)
7:117246766:T:G,P13569,L983V,0.569,Gain of helix (P = 0.132); Gain of ubiquitination at K978 (P = 0.1375); Gain of catalytic residue at L983 (P = 0.1397); Loss of stability (P = 0.1667); Loss of loop (P = 0.2237)
7:117246767:T:C,P13569,L983S,0.821,Loss of stability (P = 0.0425); Gain of helix (P = 0.0696); Loss of loop (P = 0.0804); Loss of ubiquitination at K978 (P = 0.0957); Gain of glycosylation at L983 (P = 0.1758)
7:117246767:T:G,P13569,L983W,0.727,Loss of stability (P = 0.0585); Gain of catalytic residue at I980 (P = 0.1005); Loss of ubiquitination at K978 (P = 0.1264); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.3286)
7:117246768:G:C,P13569,L983F,0.712,Loss of stability (P = 0.093); Loss of ubiquitination at K978 (P = 0.1423); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.4625); Loss of loop (P = 0.4786)
7:117246768:G:T,P13569,L983F,0.712,Loss of stability (P = 0.093); Loss of ubiquitination at K978 (P = 0.1423); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.4625); Loss of loop (P = 0.4786)
7:117246769:G:A,P13569,D984N,0.742,Gain of loop (P = 0.2045); Loss of solvent accessibility (P = 0.2517); Gain of catalytic residue at D985 (P = 0.2653); Loss of stability (P = 0.3184); Loss of relative solvent accessibility (P = 0.3219)
7:117246769:G:C,P13569,D984H,0.747,Gain of catalytic residue at L986 (P = 0.0853); Gain of helix (P = 0.2294); Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Loss of stability (P = 0.3233)
7:117246769:G:T,P13569,D984Y,0.751,Loss of catalytic residue at D984 (P = 0.1155); Gain of loop (P = 0.2045); Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Gain of MoRF binding (P = 0.3898)
7:117246770:A:C,P13569,D984A,0.753,Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Gain of MoRF binding (P = 0.3925); Loss of helix (P = 0.3949); Loss of catalytic residue at D979 (P = 0.5196)
7:117246770:A:G,P13569,D984G,0.761,Loss of stability (P = 0.0948); Loss of catalytic residue at D984 (P = 0.1149); Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Gain of MoRF binding (P = 0.3827)
7:117246770:A:T,P13569,D984V,0.801,Gain of helix (P = 0.132); Loss of catalytic residue at D984 (P = 0.1337); Loss of solvent accessibility (P = 0.2517); Loss of loop (P = 0.2897); Loss of relative solvent accessibility (P = 0.3219)
7:117246771:T:A,P13569,D984E,0.665,Loss of catalytic residue at D984 (P = 0.161); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949); Loss of MoRF binding (P = 0.5438); Loss of stability (P = 0.5895)
7:117246771:T:G,P13569,D984E,0.665,Loss of catalytic residue at D984 (P = 0.161); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949); Loss of MoRF binding (P = 0.5438); Loss of stability (P = 0.5895)
7:117246772:G:A,P13569,D985N,0.887,Loss of helix (P = 0.2271); Loss of solvent accessibility (P = 0.2517); Loss of stability (P = 0.2784); Loss of relative solvent accessibility (P = 0.3219); Gain of catalytic residue at D985 (P = 0.3473)
7:117246772:G:C,P13569,D985H,0.942,Gain of helix (P = 0.2294); Loss of solvent accessibility (P = 0.2517); Loss of stability (P = 0.295); Loss of relative solvent accessibility (P = 0.3219); Gain of catalytic residue at L986 (P = 0.4581)
7:117246772:G:T,P13569,D985Y,0.942,Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Loss of catalytic residue at A981 (P = 0.4682); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117246773:A:C,P13569,D985A,0.863,Gain of catalytic residue at D985 (P = 0.1763); Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117246773:A:G,P13569,D985G,0.856,Gain of catalytic residue at L986 (P = 0.0915); Loss of stability (P = 0.0956); Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Loss of helix (P = 0.4763)
7:117246773:A:T,P13569,D985V,0.887,Loss of helix (P = 0.2271); Loss of solvent accessibility (P = 0.2517); Loss of relative solvent accessibility (P = 0.3219); Loss of catalytic residue at A981 (P = 0.3667); Gain of MoRF binding (P = 0.4765)
7:117246774:C:A,P13569,D985E,0.704,Gain of catalytic residue at D985 (P = 0.2208); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.4496); Loss of loop (P = 0.4786); Loss of MoRF binding (P = 0.6158)
7:117246774:C:G,P13569,D985E,0.704,Gain of catalytic residue at D985 (P = 0.2208); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.4496); Loss of loop (P = 0.4786); Loss of MoRF binding (P = 0.6158)
7:117246775:C:A,P13569,L986I,0.698,Gain of catalytic residue at P988 (P = 0.0537); Gain of helix (P = 0.2294); Loss of stability (P = 0.3477); Loss of loop (P = 0.4786); Gain of MoRF binding (P = 0.6638)
7:117246775:C:G,P13569,L986V,0.705,Loss of stability (P = 0.1727); Gain of helix (P = 0.2294); Gain of catalytic residue at T990 (P = 0.3961); Gain of MoRF binding (P = 0.6643); Gain of glycosylation at T990 (P = 0.7634)
7:117246775:C:T,P13569,L986F,0.683,Loss of stability (P = 0.1074); Gain of helix (P = 0.2294); Loss of catalytic residue at L986 (P = 0.4765); Loss of loop (P = 0.4786); Gain of MoRF binding (P = 0.6617)
7:117246776:T:A,P13569,L986H,0.625,Loss of stability (P = 0.0076); Gain of helix (P = 0.2294); Gain of catalytic residue at D985 (P = 0.2749); Gain of disorder (P = 0.6439); Gain of glycosylation at T990 (P = 0.6814)
7:117246776:T:C,P13569,L986P,0.682,Loss of stability (P = 0.0074); Gain of catalytic residue at L983 (P = 0.1874); Gain of helix (P = 0.2294); Gain of glycosylation at P988 (P = 0.6065); Gain of disorder (P = 0.6659)
7:117246776:T:G,P13569,L986R,0.766,Loss of stability (P = 0.022); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.4378); Gain of methylation at L986 (P = 0.5211); Gain of glycosylation at P988 (P = 0.6611)
7:117246778:C:A,P13569,L987M,0.698,Loss of catalytic residue at L987 (P = 0.1388); Loss of stability (P = 0.236); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.7224)
7:117246778:C:G,P13569,L987V,0.697,Loss of catalytic residue at L987 (P = 0.0502); Loss of helix (P = 0.4763); Loss of stability (P = 0.5265); Gain of MoRF binding (P = 0.7209); Gain of phosphorylation at T990 (P = 0.7493)
7:117246779:T:A,P13569,L987Q,0.742,Loss of stability (P = 0.0476); Loss of catalytic residue at L987 (P = 0.1591); Loss of helix (P = 0.2271); Gain of phosphorylation at T990 (P = 0.7246); Gain of disorder (P = 0.7258)
7:117246779:T:C,P13569,L987P,0.796,Loss of stability (P = 0.0125); Gain of catalytic residue at L986 (P = 0.1545); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Gain of phosphorylation at T990 (P = 0.6202)
7:117246779:T:G,P13569,L987R,0.892,Loss of stability (P = 0.0324); Loss of catalytic residue at L987 (P = 0.0823); Gain of methylation at L987 (P = 0.3752); Gain of phosphorylation at T990 (P = 0.4266); Loss of helix (P = 0.4763)
7:117246781:C:A,P13569,P988T,0.742,Loss of stability (P = 0.1278); Gain of catalytic residue at P988 (P = 0.3106); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.7281)
7:117246781:C:G,P13569,P988A,0.697,Gain of catalytic residue at P988 (P = 0.0985); Loss of stability (P = 0.2606); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.7459)
7:117246781:C:T,P13569,P988S,0.673,Loss of stability (P = 0.2577); Loss of catalytic residue at D984 (P = 0.3873); Loss of helix (P = 0.4763); Gain of phosphorylation at P988 (P = 0.5955); Gain of MoRF binding (P = 0.7156)
7:117246782:C:A,P13569,P988H,0.733,Gain of helix (P = 0.2294); Loss of stability (P = 0.2717); Gain of catalytic residue at D985 (P = 0.4586); Gain of MoRF binding (P = 0.7251); Loss of phosphorylation at T990 (P = 0.7956)
7:117246782:C:G,P13569,P988R,0.851,Loss of catalytic residue at D984 (P = 0.0905); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.4344); Loss of stability (P = 0.4457); Gain of methylation at P988 (P = 0.531)
7:117246782:C:T,P13569,P988L,0.751,Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Loss of catalytic residue at D984 (P = 0.5421); Gain of MoRF binding (P = 0.749); Loss of phosphorylation at T990 (P = 0.7956)
7:117246784:C:A,P13569,L989I,0.747,Loss of helix (P = 0.2271); Gain of catalytic residue at L986 (P = 0.3155); Gain of glycosylation at T990 (P = 0.7149); Loss of stability (P = 0.7216); Loss of phosphorylation at T990 (P = 0.7973)
7:117246784:C:G,P13569,L989V,0.759,Loss of stability (P = 0.3387); Gain of catalytic residue at F994 (P = 0.3482); Loss of helix (P = 0.5596); Gain of glycosylation at T990 (P = 0.6472); Loss of phosphorylation at T990 (P = 0.7977)
7:117246784:C:T,P13569,L989F,0.73,Loss of stability (P = 0.4964); Loss of helix (P = 0.5596); Gain of catalytic residue at F994 (P = 0.7645); Gain of glycosylation at T990 (P = 0.7667); Gain of phosphorylation at T990 (P = 0.791)
7:117246785:T:A,P13569,L989H,0.703,Loss of stability (P = 0.0572); Gain of catalytic residue at T990 (P = 0.4058); Loss of helix (P = 0.5596); Gain of disorder (P = 0.751); Gain of phosphorylation at T990 (P = 0.7938)
7:117246785:T:C,P13569,L989P,0.679,Gain of catalytic residue at P988 (P = 0.0202); Loss of stability (P = 0.0585); Loss of helix (P = 0.079); Gain of glycosylation at T990 (P = 0.2076); Gain of loop (P = 0.4661)
7:117246785:T:G,P13569,L989R,0.72,Loss of stability (P = 0.0927); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Loss of helix (P = 0.2271); Loss of catalytic residue at F994 (P = 0.369)
7:117246787:A:C,P13569,T990P,0.712,Loss of stability (P = 0.0846); Gain of catalytic residue at T990 (P = 0.1571); Loss of helix (P = 0.2022); Gain of loop (P = 0.4661); Loss of phosphorylation at T990 (P = 0.7946)
7:117246787:A:G,P13569,T990A,0.698,Loss of stability (P = 0.1322); Gain of catalytic residue at T990 (P = 0.1593); Loss of helix (P = 0.2271); Loss of loop (P = 0.4786); Loss of phosphorylation at T990 (P = 0.7946)
7:117246787:A:T,P13569,T990S,0.649,Gain of catalytic residue at L986 (P = 0.1275); Loss of stability (P = 0.1764); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Gain of phosphorylation at T990 (P = 0.6157)
7:117246788:C:A,P13569,T990N,0.676,Gain of catalytic residue at T990 (P = 0.1088); Loss of stability (P = 0.2256); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of phosphorylation at T990 (P = 0.7946)
7:117246788:C:T,P13569,T990I,0.704,Gain of helix (P = 0.2294); Gain of catalytic residue at L989 (P = 0.3443); Loss of loop (P = 0.4786); Loss of phosphorylation at T990 (P = 0.7946); Loss of glycosylation at T990 (P = 0.8135)
7:117246790:A:C,P13569,I991L,0.571,Loss of helix (P = 0.2271); Loss of catalytic residue at D993 (P = 0.3014); Gain of loop (P = 0.4661); Loss of stability (P = 0.6185); Gain of glycosylation at P988 (P = 0.711)
7:117246790:A:G,P13569,I991V,0.835,Loss of helix (P = 0.2271); Gain of catalytic residue at I991 (P = 0.2492); Loss of stability (P = 0.4361); Gain of loop (P = 0.4661); Loss of phosphorylation at T990 (P = 0.7976)
7:117246790:A:T,P13569,I991L,0.571,Loss of helix (P = 0.2271); Loss of catalytic residue at D993 (P = 0.3014); Gain of loop (P = 0.4661); Loss of stability (P = 0.6185); Gain of glycosylation at P988 (P = 0.711)
7:117246791:T:A,P13569,I991K,0.798,Gain of ubiquitination at I991 (P = 0.0452); Loss of stability (P = 0.0455); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Loss of catalytic residue at D993 (P = 0.4924)
7:117246791:T:C,P13569,I991T,0.694,Loss of stability (P = 0.0322); Gain of glycosylation at I991 (P = 0.0513); Gain of catalytic residue at F994 (P = 0.1632); Loss of helix (P = 0.2022); Gain of loop (P = 0.4661)
7:117246791:T:G,P13569,I991R,0.853,Gain of methylation at I991 (P = 0.023); Loss of stability (P = 0.1121); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Loss of catalytic residue at L986 (P = 0.535)
7:117246793:T:A,P13569,F992I,0.7,Gain of catalytic residue at L997 (P = 0.1306); Loss of stability (P = 0.1606); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of phosphorylation at T990 (P = 0.7969)
7:117246793:T:C,P13569,F992L,0.693,Loss of stability (P = 0.0978); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Gain of catalytic residue at T990 (P = 0.6439); Loss of phosphorylation at T990 (P = 0.7968)
7:117246793:T:G,P13569,F992V,0.66,Loss of stability (P = 0.0405); Gain of catalytic residue at F992 (P = 0.0486); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Loss of phosphorylation at T990 (P = 0.7971)
7:117246794:T:A,P13569,F992Y,0.658,Loss of stability (P = 0.0512); Gain of catalytic residue at I991 (P = 0.0988); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Gain of phosphorylation at T990 (P = 0.7875)
7:117246794:T:C,P13569,F992S,0.592,Loss of stability (P = 0.0128); Gain of helix (P = 0.2294); Gain of glycosylation at F992 (P = 0.2502); Loss of loop (P = 0.4786); Gain of catalytic residue at F992 (P = 0.5111)
7:117246794:T:G,P13569,F992C,0.686,Loss of stability (P = 0.0377); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Gain of catalytic residue at F994 (P = 0.6344); Loss of phosphorylation at T990 (P = 0.7972)
7:117246795:T:A,P13569,F992L,0.693,Loss of stability (P = 0.0978); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Gain of catalytic residue at T990 (P = 0.6439); Loss of phosphorylation at T990 (P = 0.7968)
7:117246795:T:G,P13569,F992L,0.693,Loss of stability (P = 0.0978); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Gain of catalytic residue at T990 (P = 0.6439); Loss of phosphorylation at T990 (P = 0.7968)
7:117246796:G:A,P13569,D993N,0.857,Gain of helix (P = 0.2294); Loss of stability (P = 0.4084); Loss of loop (P = 0.4786); Gain of glycosylation at T990 (P = 0.6072); Loss of catalytic residue at D993 (P = 0.7024)
7:117246796:G:C,P13569,D993H,0.84,Loss of stability (P = 0.2172); Loss of helix (P = 0.2271); Gain of catalytic residue at I991 (P = 0.3303); Gain of glycosylation at T990 (P = 0.5757); Gain of loop (P = 0.7958)
7:117246796:G:T,P13569,D993Y,0.927,Gain of catalytic residue at T990 (P = 0.2263); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Loss of stability (P = 0.5775); Gain of glycosylation at T990 (P = 0.643)
7:117246797:A:C,P13569,D993A,0.842,Loss of helix (P = 0.2271); Gain of catalytic residue at F994 (P = 0.4416); Gain of loop (P = 0.4661); Loss of stability (P = 0.48); Gain of glycosylation at T990 (P = 0.5473)
7:117246797:A:G,P13569,D993G,0.943,Loss of stability (P = 0.1607); Gain of catalytic residue at F994 (P = 0.2153); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Loss of phosphorylation at T990 (P = 0.7962)
7:117246797:A:T,P13569,D993V,0.881,Gain of catalytic residue at F994 (P = 0.419); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Loss of stability (P = 0.5743); Gain of glycosylation at T990 (P = 0.6583)
7:117246798:C:A,P13569,D993E,0.831,Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Gain of catalytic residue at D993 (P = 0.5717); Loss of stability (P = 0.5981); Loss of phosphorylation at T990 (P = 0.7968)
7:117246798:C:G,P13569,D993E,0.831,Loss of helix (P = 0.2271); Gain of loop (P = 0.4661); Gain of catalytic residue at D993 (P = 0.5717); Loss of stability (P = 0.5981); Loss of phosphorylation at T990 (P = 0.7968)
7:117246799:T:A,P13569,F994I,0.712,Gain of catalytic residue at L999 (P = 0.1145); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Loss of stability (P = 0.5935); Loss of phosphorylation at T990 (P = 0.7971)
7:117246799:T:C,P13569,F994L,0.756,Loss of catalytic residue at Q996 (P = 0.2003); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Loss of stability (P = 0.5961); Gain of phosphorylation at T990 (P = 0.7796)
7:117246799:T:G,P13569,F994V,0.76,Loss of stability (P = 0.36); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Loss of catalytic residue at L998 (P = 0.7668); Loss of phosphorylation at T990 (P = 0.7971)
7:117246800:T:A,P13569,F994Y,0.802,Gain of catalytic residue at L989 (P = 0.0568); Loss of stability (P = 0.1998); Gain of helix (P = 0.2294); Gain of phosphorylation at T990 (P = 0.795); Loss of MoRF binding (P = 0.8397)
7:117246800:T:C,P13569,F994S,0.75,Loss of stability (P = 0.0613); Gain of helix (P = 0.2294); Gain of glycosylation at F994 (P = 0.3148); Gain of catalytic residue at D993 (P = 0.6864); Gain of phosphorylation at T990 (P = 0.7938)
7:117246800:T:G,P13569,F994C,0.897,Loss of stability (P = 0.1471); Loss of catalytic residue at F994 (P = 0.3948); Loss of helix (P = 0.4763); Loss of phosphorylation at T990 (P = 0.7973); Loss of MoRF binding (P = 0.8386)
7:117246801:C:G,P13569,F994L,0.756,Loss of catalytic residue at Q996 (P = 0.2003); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Loss of stability (P = 0.5961); Gain of phosphorylation at T990 (P = 0.7796)
7:117246802:A:C,P13569,I995L,0.613,Loss of catalytic residue at L998 (P = 0.3812); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Gain of phosphorylation at T990 (P = 0.7749); Loss of stability (P = 0.7849)
7:117246802:A:G,P13569,I995V,0.608,Gain of helix (P = 0.2294); Loss of catalytic residue at L998 (P = 0.3742); Loss of loop (P = 0.4786); Loss of stability (P = 0.7264); Loss of phosphorylation at T990 (P = 0.7975)
7:117246802:A:T,P13569,I995F,0.607,Gain of catalytic residue at I995 (P = 0.1858); Loss of stability (P = 0.3048); Loss of helix (P = 0.4763); Gain of phosphorylation at T990 (P = 0.7813); Gain of loop (P = 0.7958)
7:117246803:T:A,P13569,I995N,0.69,Gain of catalytic residue at I995 (P = 0.0199); Loss of stability (P = 0.0521); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Gain of glycosylation at T990 (P = 0.7795)
7:117246803:T:C,P13569,I995T,0.72,Loss of stability (P = 0.0143); Gain of catalytic residue at I995 (P = 0.3545); Loss of helix (P = 0.4763); Gain of phosphorylation at T990 (P = 0.7828); Gain of loop (P = 0.7958)
7:117246803:T:G,P13569,I995S,0.697,Loss of stability (P = 0.0587); Gain of catalytic residue at I995 (P = 0.1777); Loss of helix (P = 0.4763); Gain of glycosylation at I995 (P = 0.7919); Gain of phosphorylation at T990 (P = 0.7925)
7:117246804:C:G,P13569,I995M,0.616,Gain of catalytic residue at I995 (P = 0.1812); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786); Loss of stability (P = 0.4827); Gain of phosphorylation at T990 (P = 0.791)
7:117246805:C:A,P13569,Q996K,0.79,Gain of ubiquitination at Q996 (P = 0.0247); Loss of catalytic residue at Q996 (P = 0.1351); Gain of methylation at Q996 (P = 0.2497); Loss of stability (P = 0.3324); Gain of glycosylation at Q996 (P = 0.3618)
7:117246805:C:G,P13569,Q996E,0.793,Loss of helix (P = 0.5596); Loss of catalytic residue at D993 (P = 0.6454); Loss of stability (P = 0.7939); Loss of MoRF binding (P = 0.8143); Gain of loop (P = 0.8571)
7:117246806:A:C,P13569,Q996P,0.81,Loss of catalytic residue at Q996 (P = 0.1306); Loss of stability (P = 0.263); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.8154); Gain of loop (P = 0.8571)
7:117246806:A:G,P13569,Q996R,0.833,Loss of catalytic residue at Q996 (P = 0.0933); Gain of methylation at Q996 (P = 0.5159); Loss of helix (P = 0.5596); Loss of stability (P = 0.5695); Gain of MoRF binding (P = 0.5859)
7:117246806:A:T,P13569,Q996L,0.69,Gain of stability (P = 0.4402); Loss of helix (P = 0.5596); Gain of catalytic residue at L998 (P = 0.5912); Loss of MoRF binding (P = 0.8193); Loss of disorder (P = 0.947)
7:117246807:G:C,P13569,Q996H,0.774,Gain of catalytic residue at L998 (P = 0.1929); Loss of stability (P = 0.4039); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.8199); Gain of disorder (P = 0.9357)
7:117246807:G:T,P13569,Q996H,0.774,Gain of catalytic residue at L998 (P = 0.1929); Loss of stability (P = 0.4039); Loss of helix (P = 0.5596); Loss of MoRF binding (P = 0.8199); Gain of disorder (P = 0.9357)
7:117250573:T:A,P13569,L997M,0.711,Loss of catalytic residue at L997 (P = 0.2243); Loss of stability (P = 0.3759); Gain of helix (P = 0.5668); Gain of MoRF binding (P = 0.8079); Loss of loop (P = 0.8632)
7:117250573:T:G,P13569,L997V,0.755,Loss of stability (P = 0.3761); Gain of catalytic residue at F994 (P = 0.5414); Gain of helix (P = 0.5668); Gain of MoRF binding (P = 0.8077); Loss of loop (P = 0.8632)
7:117250574:T:C,P13569,L997S,0.657,Loss of stability (P = 0.0354); Gain of glycosylation at L997 (P = 0.0635); Loss of catalytic residue at L997 (P = 0.1997); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.805)
7:117250574:T:G,P13569,L997W,0.734,Loss of stability (P = 0.1217); Loss of catalytic residue at L997 (P = 0.5038); Loss of helix (P = 0.5596); Gain of MoRF binding (P = 0.6617); Loss of loop (P = 0.8632)
7:117250575:G:T,P13569,L997F,0.73,Loss of stability (P = 0.2182); Loss of catalytic residue at L997 (P = 0.3379); Gain of helix (P = 0.5668); Gain of MoRF binding (P = 0.8065); Loss of loop (P = 0.8632)
7:117250576:T:A,P13569,L998I,0.679,Loss of catalytic residue at L998 (P = 0.2039); Loss of helix (P = 0.4763); Loss of stability (P = 0.5516); Gain of MoRF binding (P = 0.7989); Gain of loop (P = 0.8571)
7:117250576:T:G,P13569,L998V,0.685,Loss of stability (P = 0.449); Loss of helix (P = 0.4763); Gain of catalytic residue at F994 (P = 0.5775); Gain of MoRF binding (P = 0.807); Gain of loop (P = 0.8571)
7:117250577:T:C,P13569,L998S,0.709,Loss of stability (P = 0.0117); Gain of glycosylation at L998 (P = 0.0613); Loss of catalytic residue at L998 (P = 0.4007); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.8184)
7:117250578:A:C,P13569,L998F,0.695,Loss of stability (P = 0.0658); Gain of helix (P = 0.2294); Gain of catalytic residue at L998 (P = 0.6731); Gain of MoRF binding (P = 0.8028); Loss of loop (P = 0.8632)
7:117250578:A:T,P13569,L998F,0.695,Loss of stability (P = 0.0658); Gain of helix (P = 0.2294); Gain of catalytic residue at L998 (P = 0.6731); Gain of MoRF binding (P = 0.8028); Loss of loop (P = 0.8632)
7:117250579:T:A,P13569,L999I,0.596,Gain of helix (P = 0.2294); Loss of catalytic residue at L999 (P = 0.3188); Loss of sheet (P = 0.6423); Loss of stability (P = 0.7862); Gain of MoRF binding (P = 0.809)
7:117250579:T:G,P13569,L999V,0.614,Gain of helix (P = 0.2294); Gain of catalytic residue at L999 (P = 0.3782); Loss of stability (P = 0.4575); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.8088)
7:117250580:T:C,P13569,L999S,0.6,Loss of stability (P = 0.0189); Gain of glycosylation at L999 (P = 0.0704); Gain of helix (P = 0.2294); Loss of catalytic residue at L999 (P = 0.5279); Loss of sheet (P = 0.6423)
7:117250581:A:C,P13569,L999F,0.667,Gain of helix (P = 0.2294); Loss of stability (P = 0.3741); Gain of catalytic residue at L999 (P = 0.6157); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.8059)
7:117250581:A:T,P13569,L999F,0.667,Gain of helix (P = 0.2294); Loss of stability (P = 0.3741); Gain of catalytic residue at L999 (P = 0.6157); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.8059)
7:117250582:A:C,P13569,I1000L,0.638,Loss of stability (P = 0.1712); Loss of catalytic residue at L998 (P = 0.3599); Loss of helix (P = 0.4763); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.8188)
7:117250582:A:G,P13569,I1000V,0.672,Loss of stability (P = 0.2282); Loss of catalytic residue at L998 (P = 0.3549); Loss of helix (P = 0.4763); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.8171)
7:117250582:A:T,P13569,I1000F,0.746,Loss of stability (P = 0.0859); Gain of helix (P = 0.2294); Loss of catalytic residue at I1000 (P = 0.3388); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.8138)
7:117250583:T:A,P13569,I1000N,0.649,Loss of stability (P = 0.0119); Loss of catalytic residue at I1000 (P = 0.1253); Gain of helix (P = 0.2294); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.7525)
7:117250583:T:C,P13569,I1000T,0.638,Loss of stability (P = 0.001); Gain of glycosylation at I1000 (P = 0.0725); Gain of helix (P = 0.2294); Loss of catalytic residue at L998 (P = 0.307); Loss of sheet (P = 0.6423)
7:117250583:T:G,P13569,I1000S,0.634,Loss of stability (P = 0.0089); Loss of catalytic residue at I1000 (P = 0.2134); Gain of helix (P = 0.2294); Gain of glycosylation at I1000 (P = 0.3916); Loss of sheet (P = 0.6423)
7:117250584:T:G,P13569,I1000M,0.688,Loss of catalytic residue at I1000 (P = 0.0848); Loss of stability (P = 0.0953); Gain of helix (P = 0.2294); Loss of sheet (P = 0.6423); Gain of MoRF binding (P = 0.804)
7:117250585:G:A,P13569,V1001M,0.573,Loss of catalytic residue at V1001 (P = 0.0778); Loss of helix (P = 0.2271); Loss of stability (P = 0.5205); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.8187)
7:117250585:G:C,P13569,V1001L,0.557,Loss of catalytic residue at V1001 (P = 0.1096); Gain of helix (P = 0.2294); Loss of stability (P = 0.5046); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.8181)
7:117250585:G:T,P13569,V1001L,0.557,Loss of catalytic residue at V1001 (P = 0.1096); Gain of helix (P = 0.2294); Loss of stability (P = 0.5046); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.8181)
7:117250586:T:A,P13569,V1001E,0.827,Loss of stability (P = 0.1293); Loss of helix (P = 0.2271); Gain of catalytic residue at L999 (P = 0.6953); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.8098)
7:117250586:T:C,P13569,V1001A,0.731,Loss of stability (P = 0.0568); Loss of helix (P = 0.4763); Loss of catalytic residue at L998 (P = 0.4767); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.8171)
7:117250586:T:G,P13569,V1001G,0.717,Loss of stability (P = 0.0026); Loss of helix (P = 0.2271); Gain of catalytic residue at L999 (P = 0.6061); Loss of sheet (P = 0.7751); Loss of MoRF binding (P = 0.817)
7:117250588:A:C,P13569,I1002L,0.666,Loss of catalytic residue at I1002 (P = 0.1927); Loss of helix (P = 0.2271); Gain of sheet (P = 0.4423); Loss of stability (P = 0.7561); Loss of MoRF binding (P = 0.818)
7:117250588:A:G,P13569,I1002V,0.527,Loss of helix (P = 0.2271); Loss of catalytic residue at L998 (P = 0.3793); Loss of stability (P = 0.4048); Loss of sheet (P = 0.5184); Loss of MoRF binding (P = 0.8187)
7:117250588:A:T,P13569,I1002F,0.673,Loss of catalytic residue at I1002 (P = 0.0666); Gain of helix (P = 0.2294); Loss of stability (P = 0.286); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.8185)
7:117250589:T:A,P13569,I1002N,0.718,Loss of stability (P = 0.0365); Loss of catalytic residue at L998 (P = 0.3974); Loss of sheet (P = 0.437); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.8132)
7:117250589:T:C,P13569,I1002T,0.641,Loss of stability (P = 0.0148); Gain of glycosylation at I1002 (P = 0.0586); Gain of helix (P = 0.2294); Loss of catalytic residue at L999 (P = 0.3962); Loss of sheet (P = 0.437)
7:117250589:T:G,P13569,I1002S,0.65,Gain of glycosylation at I1002 (P = 0.0053); Loss of stability (P = 0.0638); Loss of catalytic residue at I1002 (P = 0.1889); Loss of sheet (P = 0.437); Loss of helix (P = 0.4763)
7:117250590:T:G,P13569,I1002M,0.652,Loss of catalytic residue at I1002 (P = 0.0102); Gain of helix (P = 0.2294); Loss of sheet (P = 0.437); Loss of stability (P = 0.5002); Loss of MoRF binding (P = 0.8189)
7:117250591:G:A,P13569,G1003R,0.927,Gain of methylation at G1003 (P = 0.0295); Loss of catalytic residue at I1005 (P = 0.1516); Gain of MoRF binding (P = 0.4459); Loss of helix (P = 0.4763); Loss of sheet (P = 0.5184)
7:117250591:G:C,P13569,G1003R,0.927,Gain of methylation at G1003 (P = 0.0295); Loss of catalytic residue at I1005 (P = 0.1516); Gain of MoRF binding (P = 0.4459); Loss of helix (P = 0.4763); Loss of sheet (P = 0.5184)
7:117250592:G:A,P13569,G1003E,0.84,Loss of catalytic residue at I1005 (P = 0.1485); Loss of helix (P = 0.2271); Gain of sheet (P = 0.4423); Loss of stability (P = 0.7761); Loss of MoRF binding (P = 0.8118)
7:117250592:G:C,P13569,G1003A,0.755,Loss of catalytic residue at I1005 (P = 0.1681); Loss of sheet (P = 0.437); Loss of helix (P = 0.4763); Loss of stability (P = 0.6485); Loss of MoRF binding (P = 0.8184)
7:117250592:G:T,P13569,G1003V,0.727,Loss of catalytic residue at I1005 (P = 0.1422); Gain of helix (P = 0.2294); Loss of sheet (P = 0.437); Loss of stability (P = 0.7585); Gain of MoRF binding (P = 0.8175)
7:117250594:G:A,P13569,A1004T,0.668,Gain of glycosylation at A1004 (P = 0.0313); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Gain of catalytic residue at L999 (P = 0.5774); Loss of stability (P = 0.6373)
7:117250594:G:C,P13569,A1004P,0.812,Gain of helix (P = 0.2059); Loss of stability (P = 0.2789); Loss of sheet (P = 0.437); Gain of catalytic residue at L999 (P = 0.4527); Loss of MoRF binding (P = 0.8133)
7:117250594:G:T,P13569,A1004S,0.58,Gain of glycosylation at A1004 (P = 0.0571); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Loss of stability (P = 0.571); Gain of catalytic residue at L999 (P = 0.5832)
7:117250595:C:A,P13569,A1004D,0.758,Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Loss of catalytic residue at I1005 (P = 0.5703); Loss of stability (P = 0.7866); Loss of MoRF binding (P = 0.8151)
7:117250595:C:G,P13569,A1004G,0.618,Loss of stability (P = 0.1681); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Gain of catalytic residue at L999 (P = 0.4821); Loss of MoRF binding (P = 0.8194)
7:117250595:C:T,P13569,A1004V,0.697,Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Gain of catalytic residue at L999 (P = 0.5603); Gain of MoRF binding (P = 0.7922); Loss of loop (P = 0.8632)
7:117250597:A:C,P13569,I1005L,0.508,Gain of helix (P = 0.2294); Loss of stability (P = 0.367); Loss of sheet (P = 0.5184); Loss of catalytic residue at I1005 (P = 0.8121); Loss of MoRF binding (P = 0.818)
7:117250597:A:G,P13569,I1005V,0.662,Loss of helix (P = 0.3949); Loss of sheet (P = 0.5184); Loss of stability (P = 0.5645); Gain of catalytic residue at I1005 (P = 0.582); Loss of MoRF binding (P = 0.8185)
7:117250597:A:T,P13569,I1005L,0.508,Gain of helix (P = 0.2294); Loss of stability (P = 0.367); Loss of sheet (P = 0.5184); Loss of catalytic residue at I1005 (P = 0.8121); Loss of MoRF binding (P = 0.818)
7:117250598:T:A,P13569,I1005K,0.894,Loss of stability (P = 0.0123); Gain of ubiquitination at I1005 (P = 0.0267); Loss of helix (P = 0.2022); Loss of catalytic residue at V1008 (P = 0.242); Gain of sheet (P = 0.4423)
7:117250598:T:C,P13569,I1005T,0.689,Loss of stability (P = 0.0236); Gain of glycosylation at I1005 (P = 0.0809); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Gain of catalytic residue at I1005 (P = 0.443)
7:117250598:T:G,P13569,I1005R,0.966,Gain of methylation at I1005 (P = 0.0061); Loss of stability (P = 0.0383); Loss of catalytic residue at V1008 (P = 0.1432); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437)
7:117250599:A:G,P13569,I1005M,0.541,Loss of catalytic residue at I1005 (P = 0.0841); Gain of helix (P = 0.2294); Loss of stability (P = 0.2594); Loss of sheet (P = 0.437); Loss of MoRF binding (P = 0.8188)
7:117250600:G:A,P13569,A1006T,0.579,Gain of helix (P = 0.2059); Gain of glycosylation at A1006 (P = 0.2275); Loss of sheet (P = 0.437); Loss of stability (P = 0.5397); Loss of catalytic residue at A1006 (P = 0.5442)
7:117250600:G:C,P13569,A1006P,0.826,Loss of catalytic residue at A1006 (P = 0.043); Gain of helix (P = 0.2059); Loss of stability (P = 0.2186); Loss of sheet (P = 0.437); Loss of MoRF binding (P = 0.8144)
7:117250600:G:T,P13569,A1006S,0.701,Gain of glycosylation at A1006 (P = 0.1235); Gain of helix (P = 0.2059); Loss of stability (P = 0.4099); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.7826)
7:117250601:C:A,P13569,A1006E,0.914,Gain of helix (P = 0.1736); Loss of sheet (P = 0.437); Gain of loop (P = 0.4661); Loss of catalytic residue at V1008 (P = 0.4805); Loss of stability (P = 0.651)
7:117250601:C:G,P13569,A1006G,0.699,Gain of catalytic residue at L1011 (P = 0.1278); Loss of stability (P = 0.1438); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Gain of MoRF binding (P = 0.8157)
7:117250601:C:T,P13569,A1006V,0.551,Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Loss of catalytic residue at I1005 (P = 0.7618); Gain of MoRF binding (P = 0.8028); Loss of stability (P = 0.8799)
7:117250603:G:A,P13569,V1007I,0.652,Loss of catalytic residue at V1007 (P = 0.0963); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Gain of sheet (P = 0.4423); Loss of stability (P = 0.7318)
7:117250603:G:C,P13569,V1007L,0.632,Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Gain of sheet (P = 0.4423); Loss of catalytic residue at V1007 (P = 0.7642); Loss of stability (P = 0.7693)
7:117250603:G:T,P13569,V1007F,0.631,Gain of helix (P = 0.132); Loss of stability (P = 0.4074); Loss of sheet (P = 0.437); Gain of loop (P = 0.7958); Gain of MoRF binding (P = 0.8098)
7:117250604:T:A,P13569,V1007D,0.762,Loss of stability (P = 0.116); Gain of helix (P = 0.1736); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437); Loss of catalytic residue at I1005 (P = 0.4482)
7:117250604:T:C,P13569,V1007A,0.702,Loss of helix (P = 0.1299); Loss of stability (P = 0.1807); Gain of loop (P = 0.2754); Gain of sheet (P = 0.4423); Loss of catalytic residue at I1005 (P = 0.6906)
7:117250604:T:G,P13569,V1007G,0.67,Loss of stability (P = 0.0026); Gain of helix (P = 0.1736); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437); Gain of catalytic residue at I1005 (P = 0.506)
7:117250606:G:A,P13569,V1008I,0.624,Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of catalytic residue at V1008 (P = 0.4129); Loss of sheet (P = 0.437); Gain of stability (P = 0.7333)
7:117250606:G:C,P13569,V1008L,0.551,Loss of catalytic residue at V1008 (P = 0.0916); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437); Loss of MoRF binding (P = 0.8217)
7:117250606:G:T,P13569,V1008F,0.71,Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437); Loss of stability (P = 0.5454); Gain of MoRF binding (P = 0.813)
7:117250607:T:A,P13569,V1008D,0.885,Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of stability (P = 0.3689); Loss of sheet (P = 0.437); Loss of catalytic residue at I1005 (P = 0.4679)
7:117250607:T:C,P13569,V1008A,0.752,Loss of helix (P = 0.1299); Loss of stability (P = 0.3213); Gain of sheet (P = 0.4423); Loss of catalytic residue at I1005 (P = 0.7614); Gain of loop (P = 0.7958)
7:117250607:T:G,P13569,V1008G,0.761,Loss of stability (P = 0.0343); Loss of helix (P = 0.2022); Loss of sheet (P = 0.437); Gain of loop (P = 0.7958); Loss of MoRF binding (P = 0.8213)
7:117250609:G:C,P13569,A1009P,0.713,Loss of catalytic residue at A1009 (P = 0.0194); Loss of helix (P = 0.2022); Loss of sheet (P = 0.437); Gain of loop (P = 0.4661); Loss of stability (P = 0.612)
7:117250609:G:T,P13569,A1009S,0.712,Gain of glycosylation at A1009 (P = 0.049); Loss of helix (P = 0.1299); Loss of catalytic residue at A1009 (P = 0.234); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117250610:C:A,P13569,A1009E,0.757,Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of catalytic residue at V1010 (P = 0.3372); Loss of sheet (P = 0.437); Loss of MoRF binding (P = 0.8206)
7:117250610:C:G,P13569,A1009G,0.691,Loss of stability (P = 0.2838); Loss of helix (P = 0.3949); Loss of catalytic residue at A1009 (P = 0.4047); Loss of sheet (P = 0.437); Gain of loop (P = 0.7958)
7:117250610:C:T,P13569,A1009V,0.615,Loss of helix (P = 0.2271); Loss of sheet (P = 0.5184); Gain of stability (P = 0.5205); Gain of loop (P = 0.7958); Gain of MoRF binding (P = 0.8106)
7:117250612:G:A,P13569,V1010I,0.675,Loss of catalytic residue at V1010 (P = 0.1244); Gain of helix (P = 0.132); Loss of sheet (P = 0.437); Loss of loop (P = 0.4786); Loss of stability (P = 0.7634)
7:117250612:G:C,P13569,V1010L,0.69,Gain of helix (P = 0.132); Loss of sheet (P = 0.437); Loss of loop (P = 0.4786); Gain of catalytic residue at V1010 (P = 0.5064); Loss of stability (P = 0.7877)
7:117250612:G:T,P13569,V1010F,0.674,Gain of helix (P = 0.132); Loss of sheet (P = 0.437); Loss of stability (P = 0.4462); Gain of catalytic residue at V1010 (P = 0.7579); Gain of loop (P = 0.7958)
7:117250613:T:A,P13569,V1010D,0.752,Loss of stability (P = 0.0894); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437); Loss of catalytic residue at V1008 (P = 0.4628)
7:117250613:T:C,P13569,V1010A,0.703,Loss of stability (P = 0.045); Gain of sheet (P = 0.1945); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of catalytic residue at Y1014 (P = 0.3966)
7:117250613:T:G,P13569,V1010G,0.688,Loss of stability (P = 0.005); Gain of catalytic residue at L1011 (P = 0.1293); Gain of helix (P = 0.132); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117250615:T:A,P13569,L1011I,0.635,Gain of catalytic residue at P1013 (P = 0.0314); Loss of helix (P = 0.2022); Loss of sheet (P = 0.437); Gain of loop (P = 0.7958); Loss of stability (P = 0.8091)
7:117250615:T:G,P13569,L1011V,0.653,Gain of catalytic residue at L1011 (P = 0.089); Loss of helix (P = 0.1299); Loss of sheet (P = 0.5184); Loss of stability (P = 0.6443); Gain of loop (P = 0.7958)
7:117250616:T:C,P13569,L1011S,0.678,Gain of glycosylation at L1011 (P = 0.0289); Gain of catalytic residue at L1011 (P = 0.0999); Loss of helix (P = 0.1299); Loss of stability (P = 0.2169); Gain of loop (P = 0.2754)
7:117250617:A:C,P13569,L1011F,0.613,Gain of catalytic residue at L1011 (P = 0.0367); Loss of helix (P = 0.2022); Loss of sheet (P = 0.5184); Loss of stability (P = 0.6752); Gain of loop (P = 0.7958)
7:117250617:A:T,P13569,L1011F,0.613,Gain of catalytic residue at L1011 (P = 0.0367); Loss of helix (P = 0.2022); Loss of sheet (P = 0.5184); Loss of stability (P = 0.6752); Gain of loop (P = 0.7958)
7:117250618:C:A,P13569,Q1012K,0.771,Gain of ubiquitination at Q1012 (P = 0.0325); Gain of methylation at Q1012 (P = 0.0362); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117250618:C:G,P13569,Q1012E,0.7,Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Gain of loop (P = 0.7958); Loss of catalytic residue at V1017 (P = 0.8003); Gain of phosphorylation at Y1014 (P = 0.8324)
7:117250619:A:C,P13569,Q1012P,0.749,Loss of helix (P = 0.2022); Gain of catalytic residue at L1011 (P = 0.2165); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437); Loss of stability (P = 0.5474)
7:117250619:A:G,P13569,Q1012R,0.858,Gain of methylation at Q1012 (P = 0.0367); Gain of helix (P = 0.132); Loss of catalytic residue at V1010 (P = 0.3041); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.6596)
7:117250619:A:T,P13569,Q1012L,0.695,Loss of catalytic residue at Q1012 (P = 0.0917); Gain of helix (P = 0.132); Gain of stability (P = 0.375); Loss of sheet (P = 0.437); Loss of loop (P = 0.4786)
7:117250620:A:C,P13569,Q1012H,0.741,Gain of catalytic residue at L1011 (P = 0.1287); Gain of helix (P = 0.132); Loss of sheet (P = 0.437); Loss of stability (P = 0.5868); Gain of loop (P = 0.7958)
7:117250620:A:T,P13569,Q1012H,0.741,Gain of catalytic residue at L1011 (P = 0.1287); Gain of helix (P = 0.132); Loss of sheet (P = 0.437); Loss of stability (P = 0.5868); Gain of loop (P = 0.7958)
7:117250621:C:A,P13569,P1013T,0.796,Gain of glycosylation at P1013 (P = 0.0977); Gain of helix (P = 0.132); Gain of catalytic residue at P1013 (P = 0.1471); Loss of sheet (P = 0.437); Loss of stability (P = 0.4751)
7:117250621:C:G,P13569,P1013A,0.835,Gain of catalytic residue at P1013 (P = 0.0376); Gain of helix (P = 0.132); Loss of sheet (P = 0.437); Loss of stability (P = 0.7489); Gain of MoRF binding (P = 0.7745)
7:117250621:C:T,P13569,P1013S,0.78,Gain of glycosylation at P1013 (P = 0.0221); Gain of helix (P = 0.132); Loss of stability (P = 0.387); Loss of sheet (P = 0.437); Gain of catalytic residue at P1013 (P = 0.5894)
7:117250622:C:G,P13569,P1013R,0.913,Gain of methylation at P1013 (P = 0.0546); Gain of helix (P = 0.132); Gain of catalytic residue at P1013 (P = 0.1876); Loss of sheet (P = 0.437); Loss of loop (P = 0.4786)
7:117250622:C:T,P13569,P1013L,0.911,Gain of helix (P = 0.132); Loss of sheet (P = 0.437); Loss of loop (P = 0.4786); Loss of catalytic residue at Y1014 (P = 0.6763); Gain of stability (P = 0.7523)
7:117250624:T:A,P13569,Y1014N,0.599,Loss of helix (P = 0.1299); Loss of stability (P = 0.2366); Gain of glycosylation at T1019 (P = 0.2531); Gain of sheet (P = 0.4423); Gain of loop (P = 0.4661)
7:117250624:T:C,P13569,Y1014H,0.618,Loss of stability (P = 0.1658); Gain of glycosylation at T1019 (P = 0.28); Loss of helix (P = 0.3949); Gain of sheet (P = 0.4423); Loss of catalytic residue at I1015 (P = 0.5763)
7:117250624:T:G,P13569,Y1014D,0.61,Loss of helix (P = 0.1299); Gain of relative solvent accessibility (P = 0.2363); Gain of loop (P = 0.2754); Gain of glycosylation at T1019 (P = 0.2827); Gain of solvent accessibility (P = 0.3418)
7:117250625:A:C,P13569,Y1014S,0.579,Gain of glycosylation at Y1014 (P = 0.0124); Loss of helix (P = 0.1299); Loss of stability (P = 0.1307); Loss of catalytic residue at Y1014 (P = 0.1736); Gain of sheet (P = 0.4423)
7:117250625:A:T,P13569,Y1014F,0.742,Loss of helix (P = 0.2022); Loss of glycosylation at T1019 (P = 0.2942); Gain of catalytic residue at Y1014 (P = 0.5751); Loss of sheet (P = 0.7751); Gain of loop (P = 0.7958)
7:117250627:A:C,P13569,I1015L,0.453,Loss of helix (P = 0.1299); Loss of glycosylation at T1019 (P = 0.3463); Loss of catalytic residue at I1015 (P = 0.3989); Loss of stability (P = 0.4075); Gain of sheet (P = 0.4423)
7:117250627:A:G,P13569,I1015V,0.606,Gain of catalytic residue at I1015 (P = 0.083); Loss of helix (P = 0.1299); Loss of stability (P = 0.2612); Loss of glycosylation at T1019 (P = 0.3627); Gain of sheet (P = 0.4423)
7:117250627:A:T,P13569,I1015F,0.625,Gain of catalytic residue at I1015 (P = 0.0739); Loss of stability (P = 0.1168); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Gain of glycosylation at T1019 (P = 0.3648)
7:117250628:T:A,P13569,I1015N,0.682,Loss of stability (P = 0.0313); Loss of helix (P = 0.1299); Loss of glycosylation at T1019 (P = 0.2634); Gain of loop (P = 0.2754); Gain of catalytic residue at I1015 (P = 0.3394)
7:117250628:T:C,P13569,I1015T,0.62,Loss of stability (P = 0.0086); Gain of glycosylation at I1015 (P = 0.0266); Gain of helix (P = 0.2059); Loss of sheet (P = 0.6423); Gain of catalytic residue at I1015 (P = 0.6477)
7:117250628:T:G,P13569,I1015S,0.642,Loss of stability (P = 0.0134); Gain of glycosylation at I1015 (P = 0.0415); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Gain of sheet (P = 0.4423)
7:117250629:C:G,P13569,I1015M,0.53,Loss of helix (P = 0.1299); Loss of stability (P = 0.1762); Loss of glycosylation at T1019 (P = 0.2386); Loss of catalytic residue at I1015 (P = 0.4034); Gain of sheet (P = 0.4423)
7:117250630:T:A,P13569,F1016I,0.615,Loss of catalytic residue at F1016 (P = 0.0455); Loss of stability (P = 0.3046); Gain of glycosylation at T1019 (P = 0.3703); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437)
7:117250630:T:C,P13569,F1016L,0.626,Loss of catalytic residue at F1016 (P = 0.0554); Loss of helix (P = 0.1299); Loss of glycosylation at T1019 (P = 0.2568); Loss of stability (P = 0.3563); Loss of sheet (P = 0.5184)
7:117250630:T:G,P13569,F1016V,0.595,Loss of stability (P = 0.1851); Gain of glycosylation at T1019 (P = 0.3585); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.7844)
7:117250631:T:A,P13569,F1016Y,0.615,Gain of catalytic residue at L1011 (P = 0.0581); Loss of stability (P = 0.1796); Loss of glycosylation at T1019 (P = 0.2517); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437)
7:117250631:T:C,P13569,F1016S,0.825,Loss of catalytic residue at F1016 (P = 0.0557); Gain of glycosylation at F1016 (P = 0.0606); Loss of stability (P = 0.0731); Loss of helix (P = 0.2022); Loss of sheet (P = 0.437)
7:117250631:T:G,P13569,F1016C,0.616,Loss of stability (P = 0.1535); Loss of glycosylation at T1019 (P = 0.1662); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Loss of catalytic residue at F1016 (P = 0.5805)
7:117250632:T:A,P13569,F1016L,0.626,Loss of catalytic residue at F1016 (P = 0.0554); Loss of helix (P = 0.1299); Loss of glycosylation at T1019 (P = 0.2568); Loss of stability (P = 0.3563); Loss of sheet (P = 0.5184)
7:117250632:T:G,P13569,F1016L,0.626,Loss of catalytic residue at F1016 (P = 0.0554); Loss of helix (P = 0.1299); Loss of glycosylation at T1019 (P = 0.2568); Loss of stability (P = 0.3563); Loss of sheet (P = 0.5184)
7:117250633:G:A,P13569,V1017I,0.495,Loss of catalytic residue at V1017 (P = 0.1729); Gain of helix (P = 0.2059); Gain of glycosylation at T1019 (P = 0.342); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.7525)
7:117250633:G:C,P13569,V1017L,0.495,Loss of catalytic residue at V1017 (P = 0.1258); Gain of helix (P = 0.132); Loss of glycosylation at T1019 (P = 0.2606); Loss of sheet (P = 0.437); Loss of stability (P = 0.7106)
7:117250633:G:T,P13569,V1017F,0.676,Gain of helix (P = 0.132); Loss of glycosylation at T1019 (P = 0.1407); Loss of stability (P = 0.1452); Loss of sheet (P = 0.437); Gain of catalytic residue at V1017 (P = 0.4691)
7:117250634:T:A,P13569,V1017D,0.755,Loss of stability (P = 0.0863); Loss of glycosylation at T1019 (P = 0.0885); Gain of helix (P = 0.132); Loss of catalytic residue at Y1014 (P = 0.2653); Loss of sheet (P = 0.437)
7:117250634:T:C,P13569,V1017A,0.684,Loss of stability (P = 0.0248); Gain of helix (P = 0.132); Loss of glycosylation at T1019 (P = 0.2747); Loss of sheet (P = 0.437); Gain of catalytic residue at V1017 (P = 0.5857)
7:117250634:T:G,P13569,V1017G,0.646,Loss of stability (P = 0.0037); Gain of catalytic residue at P1013 (P = 0.0765); Gain of helix (P = 0.132); Loss of glycosylation at T1019 (P = 0.3323); Loss of sheet (P = 0.437)
7:117250636:G:A,P13569,A1018T,0.542,Gain of glycosylation at A1018 (P = 0.0035); Loss of helix (P = 0.3949); Loss of stability (P = 0.52); Gain of catalytic residue at T1019 (P = 0.6468); Gain of sheet (P = 0.6509)
7:117250636:G:C,P13569,A1018P,0.83,Gain of glycosylation at T1019 (P = 0.2021); Loss of stability (P = 0.2878); Loss of helix (P = 0.3949); Loss of catalytic residue at V1017 (P = 0.6228); Gain of sheet (P = 0.6509)
7:117250636:G:T,P13569,A1018S,0.627,Gain of glycosylation at A1018 (P = 0.0121); Loss of catalytic residue at A1018 (P = 0.0242); Gain of helix (P = 0.2059); Loss of stability (P = 0.4818); Gain of sheet (P = 0.6509)
7:117250637:C:A,P13569,A1018E,0.791,Loss of glycosylation at T1019 (P = 0.0547); Gain of helix (P = 0.2059); Loss of catalytic residue at V1017 (P = 0.3779); Gain of sheet (P = 0.6509); Loss of stability (P = 0.7158)
7:117250637:C:G,P13569,A1018G,0.628,Loss of stability (P = 0.074); Loss of glycosylation at T1019 (P = 0.1994); Gain of helix (P = 0.2059); Gain of catalytic residue at I1015 (P = 0.4753); Gain of sheet (P = 0.6509)
7:117250637:C:T,P13569,A1018V,0.505,Loss of glycosylation at T1019 (P = 0.1664); Gain of helix (P = 0.2059); Gain of sheet (P = 0.6509); Gain of MoRF binding (P = 0.7202); Loss of catalytic residue at V1017 (P = 0.7278)
7:117250639:A:C,P13569,T1019P,0.715,Loss of glycosylation at T1019 (P = 0.0174); Loss of stability (P = 0.1466); Loss of catalytic residue at T1019 (P = 0.2978); Loss of helix (P = 0.3949); Gain of loop (P = 0.4661)
7:117250639:A:G,P13569,T1019A,0.497,Loss of glycosylation at T1019 (P = 0.012); Loss of helix (P = 0.2022); Loss of stability (P = 0.222); Gain of catalytic residue at T1019 (P = 0.422); Gain of loop (P = 0.4661)
7:117250639:A:T,P13569,T1019S,0.583,Loss of glycosylation at T1019 (P = 0.0389); Loss of stability (P = 0.3669); Loss of helix (P = 0.3949); Gain of loop (P = 0.4661); Gain of catalytic residue at T1019 (P = 0.5937)
7:117250640:C:A,P13569,T1019K,0.831,Loss of glycosylation at T1019 (P = 0.018); Gain of methylation at T1019 (P = 0.0283); Gain of ubiquitination at T1019 (P = 0.03); Loss of stability (P = 0.1334); Loss of catalytic residue at V1017 (P = 0.3551)
7:117250640:C:G,P13569,T1019R,0.838,Gain of methylation at T1019 (P = 0.0076); Loss of glycosylation at T1019 (P = 0.012); Loss of helix (P = 0.2022); Loss of catalytic residue at V1017 (P = 0.2387); Loss of stability (P = 0.394)
7:117250640:C:T,P13569,T1019I,0.54,Loss of glycosylation at T1019 (P = 0.012); Gain of catalytic residue at P1021 (P = 0.0419); Loss of helix (P = 0.3949); Gain of loop (P = 0.4661); Loss of sheet (P = 0.6423)
7:117250642:G:A,P13569,V1020M,0.529,Loss of catalytic residue at V1020 (P = 0.1189); Loss of glycosylation at T1019 (P = 0.1962); Gain of helix (P = 0.2059); Loss of stability (P = 0.381); Loss of sheet (P = 0.437)
7:117250642:G:C,P13569,V1020L,0.504,Loss of glycosylation at T1019 (P = 0.0825); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Loss of catalytic residue at T1019 (P = 0.635); Loss of MoRF binding (P = 0.6641)
7:117250642:G:T,P13569,V1020L,0.504,Loss of glycosylation at T1019 (P = 0.0825); Gain of helix (P = 0.2059); Loss of sheet (P = 0.437); Loss of catalytic residue at T1019 (P = 0.635); Loss of MoRF binding (P = 0.6641)
7:117250643:T:A,P13569,V1020E,0.921,Loss of glycosylation at T1019 (P = 0.1048); Loss of helix (P = 0.2022); Loss of stability (P = 0.2645); Loss of sheet (P = 0.437); Gain of loop (P = 0.4661)
7:117250643:T:C,P13569,V1020A,0.71,Loss of glycosylation at T1019 (P = 0.1183); Loss of stability (P = 0.1709); Loss of helix (P = 0.2022); Loss of sheet (P = 0.437); Loss of MoRF binding (P = 0.661)
7:117250643:T:G,P13569,V1020G,0.734,Loss of stability (P = 0.0123); Loss of glycosylation at T1019 (P = 0.0697); Loss of helix (P = 0.2022); Loss of sheet (P = 0.437); Gain of loop (P = 0.4661)
7:117250645:C:A,P13569,P1021T,0.833,Gain of catalytic residue at P1021 (P = 0.0293); Gain of helix (P = 0.2059); Loss of glycosylation at T1019 (P = 0.246); Gain of MoRF binding (P = 0.4746); Loss of sheet (P = 0.5184)
7:117250645:C:G,P13569,P1021A,0.884,Gain of catalytic residue at P1021 (P = 0.0295); Gain of helix (P = 0.2059); Loss of glycosylation at T1019 (P = 0.2691); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.4983)
7:117250645:C:T,P13569,P1021S,0.867,Gain of catalytic residue at P1021 (P = 0.0207); Gain of glycosylation at P1021 (P = 0.1045); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4485); Loss of sheet (P = 0.5184)
7:117250646:C:A,P13569,P1021Q,0.785,Gain of catalytic residue at P1021 (P = 0.0202); Loss of glycosylation at T1019 (P = 0.091); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.42); Loss of sheet (P = 0.437)
7:117250646:C:G,P13569,P1021R,0.888,Gain of methylation at P1021 (P = 0.0042); Gain of MoRF binding (P = 0.0523); Loss of glycosylation at T1019 (P = 0.1042); Gain of catalytic residue at P1021 (P = 0.1467); Gain of helix (P = 0.2059)
7:117250646:C:T,P13569,P1021L,0.731,Loss of glycosylation at T1019 (P = 0.1148); Gain of helix (P = 0.2059); Loss of catalytic residue at F1026 (P = 0.4198); Loss of sheet (P = 0.437); Loss of loop (P = 0.4786)
7:117250648:G:C,P13569,V1022L,0.631,Loss of catalytic residue at V1022 (P = 0.1756); Loss of glycosylation at T1019 (P = 0.1808); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.5803); Loss of sheet (P = 0.7751)
7:117250648:G:T,P13569,V1022L,0.631,Loss of catalytic residue at V1022 (P = 0.1756); Loss of glycosylation at T1019 (P = 0.1808); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.5803); Loss of sheet (P = 0.7751)
7:117250649:T:A,P13569,V1022E,0.819,Loss of glycosylation at T1019 (P = 0.0654); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of catalytic residue at A1025 (P = 0.2968); Loss of stability (P = 0.4941)
7:117250649:T:C,P13569,V1022A,0.666,Loss of helix (P = 0.2022); Gain of glycosylation at T1019 (P = 0.3073); Loss of stability (P = 0.3203); Gain of loop (P = 0.4661); Loss of catalytic residue at F1026 (P = 0.5405)
7:117250649:T:G,P13569,V1022G,0.656,Loss of stability (P = 0.0336); Loss of glycosylation at T1019 (P = 0.1293); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of MoRF binding (P = 0.5807)
7:117250651:A:C,P13569,I1023L,0.539,Loss of helix (P = 0.2271); Loss of glycosylation at T1019 (P = 0.335); Loss of MoRF binding (P = 0.5619); Loss of catalytic residue at F1026 (P = 0.7086); Loss of sheet (P = 0.7751)
7:117250651:A:G,P13569,I1023V,0.642,Gain of catalytic residue at I1023 (P = 0.1113); Loss of helix (P = 0.2022); Loss of glycosylation at T1019 (P = 0.2906); Gain of MoRF binding (P = 0.5425); Loss of sheet (P = 0.7751)
7:117250651:A:T,P13569,I1023L,0.539,Loss of helix (P = 0.2271); Loss of glycosylation at T1019 (P = 0.335); Loss of MoRF binding (P = 0.5619); Loss of catalytic residue at F1026 (P = 0.7086); Loss of sheet (P = 0.7751)
7:117250652:T:A,P13569,I1023K,0.885,Gain of methylation at I1023 (P = 0.0176); Gain of ubiquitination at I1023 (P = 0.0369); Loss of helix (P = 0.1299); Loss of glycosylation at T1019 (P = 0.1325); Loss of catalytic residue at A1025 (P = 0.1611)
7:117250652:T:C,P13569,I1023T,0.625,Gain of glycosylation at I1023 (P = 0.0208); Gain of catalytic residue at I1023 (P = 0.0733); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of stability (P = 0.3156)
7:117250652:T:G,P13569,I1023R,0.925,Gain of methylation at I1023 (P = 0.0026); Gain of MoRF binding (P = 0.0688); Loss of glycosylation at T1019 (P = 0.1177); Loss of catalytic residue at A1025 (P = 0.1328); Loss of helix (P = 0.2022)
7:117250653:A:G,P13569,I1023M,0.584,Loss of helix (P = 0.2022); Loss of glycosylation at T1019 (P = 0.241); Gain of catalytic residue at I1027 (P = 0.3778); Gain of MoRF binding (P = 0.4975); Loss of sheet (P = 0.7751)
7:117250654:G:A,P13569,V1024M,0.608,Loss of catalytic residue at V1024 (P = 9e-04); Gain of helix (P = 0.2294); Loss of glycosylation at T1019 (P = 0.3542); Gain of MoRF binding (P = 0.5256); Loss of sheet (P = 0.6423)
7:117250654:G:C,P13569,V1024L,0.73,Loss of catalytic residue at V1024 (P = 0.0528); Loss of helix (P = 0.2271); Gain of glycosylation at T1019 (P = 0.3558); Loss of MoRF binding (P = 0.5438); Loss of sheet (P = 0.7751)
7:117250654:G:T,P13569,V1024L,0.73,Loss of catalytic residue at V1024 (P = 0.0528); Loss of helix (P = 0.2271); Gain of glycosylation at T1019 (P = 0.3558); Loss of MoRF binding (P = 0.5438); Loss of sheet (P = 0.7751)
7:117250655:T:A,P13569,V1024E,0.718,Loss of helix (P = 0.2022); Loss of catalytic residue at A1025 (P = 0.2496); Gain of glycosylation at T1019 (P = 0.3101); Loss of stability (P = 0.4591); Gain of loop (P = 0.4661)
7:117250655:T:C,P13569,V1024A,0.655,Loss of stability (P = 0.1998); Loss of helix (P = 0.2022); Gain of glycosylation at T1019 (P = 0.3678); Gain of loop (P = 0.4661); Loss of MoRF binding (P = 0.5434)
7:117250655:T:G,P13569,V1024G,0.583,Loss of stability (P = 0.0457); Gain of catalytic residue at I1023 (P = 0.1578); Loss of helix (P = 0.2022); Gain of glycosylation at T1019 (P = 0.365); Gain of loop (P = 0.4661)
7:117250657:G:A,P13569,A1025T,0.538,Gain of glycosylation at A1025 (P = 0.0389); Loss of methylation at R1030 (P = 0.1322); Loss of catalytic residue at A1025 (P = 0.1802); Gain of helix (P = 0.2059); Loss of stability (P = 0.4193)
7:117250657:G:C,P13569,A1025P,0.866,Loss of stability (P = 0.1127); Loss of methylation at R1030 (P = 0.1235); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.5178); Loss of sheet (P = 0.6423)
7:117250657:G:T,P13569,A1025S,0.649,Loss of methylation at R1030 (P = 0.1448); Loss of helix (P = 0.2022); Loss of stability (P = 0.4393); Gain of MoRF binding (P = 0.5095); Loss of catalytic residue at F1026 (P = 0.5717)
7:117250658:C:A,P13569,A1025D,0.9,Loss of methylation at R1030 (P = 0.0706); Gain of helix (P = 0.2059); Loss of catalytic residue at F1026 (P = 0.5088); Loss of MoRF binding (P = 0.5182); Loss of sheet (P = 0.6423)
7:117250658:C:G,P13569,A1025G,0.692,Gain of catalytic residue at P1021 (P = 0.1094); Gain of methylation at R1030 (P = 0.1548); Loss of stability (P = 0.1826); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.5358)
7:117250658:C:T,P13569,A1025V,0.54,Loss of methylation at R1030 (P = 0.1322); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.5181); Loss of catalytic residue at F1026 (P = 0.5687); Loss of stability (P = 0.7572)
7:117250660:T:A,P13569,F1026I,0.656,Loss of methylation at R1030 (P = 0.1181); Loss of catalytic residue at F1026 (P = 0.155); Loss of helix (P = 0.2271); Loss of stability (P = 0.4295); Gain of MoRF binding (P = 0.5078)
7:117250660:T:C,P13569,F1026L,0.652,Loss of methylation at R1030 (P = 0.1542); Loss of catalytic residue at F1026 (P = 0.1663); Loss of helix (P = 0.2271); Loss of stability (P = 0.4174); Gain of sheet (P = 0.4423)
7:117250660:T:G,P13569,F1026V,0.66,Gain of methylation at R1030 (P = 0.13); Loss of stability (P = 0.1407); Loss of helix (P = 0.2271); Gain of catalytic residue at F1026 (P = 0.411); Gain of MoRF binding (P = 0.4651)
7:117250661:T:A,P13569,F1026Y,0.755,Loss of stability (P = 0.0619); Gain of methylation at R1030 (P = 0.1441); Gain of catalytic residue at F1026 (P = 0.2693); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4843)
7:117250661:T:C,P13569,F1026S,0.768,Loss of stability (P = 0.0215); Gain of methylation at R1030 (P = 0.1039); Loss of helix (P = 0.2022); Loss of catalytic residue at F1026 (P = 0.2121); Gain of glycosylation at F1026 (P = 0.3432)
7:117250661:T:G,P13569,F1026C,0.791,Loss of stability (P = 0.0889); Loss of methylation at R1030 (P = 0.1197); Gain of helix (P = 0.2294); Gain of catalytic residue at F1026 (P = 0.4136); Loss of MoRF binding (P = 0.5343)
7:117250662:T:A,P13569,F1026L,0.652,Loss of methylation at R1030 (P = 0.1542); Loss of catalytic residue at F1026 (P = 0.1663); Loss of helix (P = 0.2271); Loss of stability (P = 0.4174); Gain of sheet (P = 0.4423)
7:117250662:T:G,P13569,F1026L,0.652,Loss of methylation at R1030 (P = 0.1542); Loss of catalytic residue at F1026 (P = 0.1663); Loss of helix (P = 0.2271); Loss of stability (P = 0.4174); Gain of sheet (P = 0.4423)
7:117250663:A:C,P13569,I1027L,0.761,Gain of methylation at R1030 (P = 0.1086); Gain of helix (P = 0.2059); Loss of catalytic residue at R1030 (P = 0.2435); Loss of MoRF binding (P = 0.5234); Loss of sheet (P = 0.7751)
7:117250663:A:G,P13569,I1027V,0.756,Gain of methylation at R1030 (P = 0.0728); Loss of helix (P = 0.2022); Loss of catalytic residue at R1030 (P = 0.2549); Gain of MoRF binding (P = 0.4911); Gain of sheet (P = 0.6509)
7:117250663:A:T,P13569,I1027F,0.769,Gain of methylation at R1030 (P = 0.0798); Gain of catalytic residue at I1027 (P = 0.1281); Gain of helix (P = 0.2059); Loss of stability (P = 0.4909); Loss of MoRF binding (P = 0.5209)
7:117250664:T:A,P13569,I1027N,0.798,Gain of methylation at R1030 (P = 0.0652); Loss of stability (P = 0.1027); Gain of catalytic residue at I1027 (P = 0.1067); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.4608)
7:117250664:T:G,P13569,I1027S,0.83,Gain of methylation at R1030 (P = 0.0625); Loss of stability (P = 0.1223); Gain of catalytic residue at I1027 (P = 0.2768); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4663)
7:117250665:T:G,P13569,I1027M,0.786,Gain of methylation at R1030 (P = 0.0912); Loss of helix (P = 0.2022); Loss of catalytic residue at R1030 (P = 0.2455); Gain of MoRF binding (P = 0.4475); Loss of stability (P = 0.4955)
7:117250666:A:C,P13569,M1028L,0.743,Loss of methylation at R1030 (P = 0.1106); Gain of helix (P = 0.2059); Gain of catalytic residue at M1028 (P = 0.3687); Loss of MoRF binding (P = 0.5138); Loss of stability (P = 0.5847)
7:117250666:A:T,P13569,M1028L,0.743,Loss of methylation at R1030 (P = 0.1106); Gain of helix (P = 0.2059); Gain of catalytic residue at M1028 (P = 0.3687); Loss of MoRF binding (P = 0.5138); Loss of stability (P = 0.5847)
7:117250667:T:A,P13569,M1028K,0.95,Gain of methylation at M1028 (P = 0.0193); Gain of ubiquitination at M1028 (P = 0.0276); Loss of stability (P = 0.0457); Gain of MoRF binding (P = 0.2387); Loss of catalytic residue at A1025 (P = 0.252)
7:117250667:T:C,P13569,M1028T,0.779,Gain of methylation at R1030 (P = 0.0834); Loss of stability (P = 0.1146); Gain of catalytic residue at M1028 (P = 0.1913); Gain of helix (P = 0.2059); Loss of MoRF binding (P = 0.5169)
7:117250667:T:G,P13569,M1028R,0.98,Gain of methylation at M1028 (P = 0.0029); Gain of MoRF binding (P = 0.0925); Loss of stability (P = 0.1888); Loss of catalytic residue at A1025 (P = 0.2024); Loss of helix (P = 0.2271)
7:117250668:G:A,P13569,M1028I,0.875,Loss of methylation at R1030 (P = 0.0745); Loss of catalytic residue at M1028 (P = 0.1591); Gain of helix (P = 0.2059); Loss of MoRF binding (P = 0.5182); Loss of sheet (P = 0.6423)
7:117250668:G:C,P13569,M1028I,0.875,Loss of methylation at R1030 (P = 0.0745); Loss of catalytic residue at M1028 (P = 0.1591); Gain of helix (P = 0.2059); Loss of MoRF binding (P = 0.5182); Loss of sheet (P = 0.6423)
7:117250668:G:T,P13569,M1028I,0.875,Loss of methylation at R1030 (P = 0.0745); Loss of catalytic residue at M1028 (P = 0.1591); Gain of helix (P = 0.2059); Loss of MoRF binding (P = 0.5182); Loss of sheet (P = 0.6423)
7:117250669:T:A,P13569,L1029M,0.681,Gain of methylation at R1030 (P = 0.1132); Loss of helix (P = 0.2022); Loss of stability (P = 0.4155); Gain of MoRF binding (P = 0.4426); Loss of catalytic residue at F1026 (P = 0.6362)
7:117250669:T:G,P13569,L1029V,0.707,Gain of methylation at R1030 (P = 0.0831); Gain of catalytic residue at L1029 (P = 0.1388); Loss of helix (P = 0.2022); Loss of stability (P = 0.3217); Gain of MoRF binding (P = 0.4606)
7:117250670:T:C,P13569,L1029S,0.707,Gain of catalytic residue at L1029 (P = 0.0017); Loss of stability (P = 0.038); Gain of methylation at R1030 (P = 0.0999); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.506)
7:117250670:T:G,P13569,L1029W,0.734,Loss of methylation at R1030 (P = 0.0426); Loss of stability (P = 0.0895); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2331); Gain of catalytic residue at F1026 (P = 0.4946)
7:117250671:G:C,P13569,L1029F,0.704,Gain of methylation at R1030 (P = 0.0862); Gain of catalytic residue at L1029 (P = 0.101); Loss of helix (P = 0.2022); Loss of stability (P = 0.2398); Loss of MoRF binding (P = 0.5237)
7:117250671:G:T,P13569,L1029F,0.704,Gain of methylation at R1030 (P = 0.0862); Gain of catalytic residue at L1029 (P = 0.101); Loss of helix (P = 0.2022); Loss of stability (P = 0.2398); Loss of MoRF binding (P = 0.5237)
7:117250672:A:G,P13569,R1030G,0.695,Loss of methylation at R1030 (P = 0.0223); Loss of catalytic residue at R1030 (P = 0.0896); Gain of helix (P = 0.2294); Loss of stability (P = 0.3534); Loss of MoRF binding (P = 0.4749)
7:117250673:G:A,P13569,R1030K,0.682,Gain of ubiquitination at R1030 (P = 0.0428); Loss of methylation at R1030 (P = 0.0432); Loss of catalytic residue at R1030 (P = 0.1034); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786)
7:117250673:G:C,P13569,R1030T,0.709,Loss of methylation at R1030 (P = 0.0223); Loss of catalytic residue at R1030 (P = 0.1416); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.4729); Loss of loop (P = 0.4786)
7:117250673:G:T,P13569,R1030I,0.738,Loss of methylation at R1030 (P = 0.0223); Loss of catalytic residue at R1030 (P = 0.1181); Gain of helix (P = 0.2294); Gain of stability (P = 0.4758); Loss of loop (P = 0.4786)
7:117250674:A:C,P13569,R1030S,0.703,Loss of methylation at R1030 (P = 0.0223); Loss of catalytic residue at R1030 (P = 0.1978); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4755); Loss of loop (P = 0.4786)
7:117250674:A:T,P13569,R1030S,0.703,Loss of methylation at R1030 (P = 0.0223); Loss of catalytic residue at R1030 (P = 0.1978); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4755); Loss of loop (P = 0.4786)
7:117250675:G:A,P13569,A1031T,0.79,Loss of methylation at R1030 (P = 0.0895); Loss of stability (P = 0.0955); Loss of catalytic residue at A1031 (P = 0.1851); Gain of helix (P = 0.2294); Gain of disorder (P = 0.2898)
7:117250675:G:C,P13569,A1031P,0.876,Loss of methylation at R1030 (P = 0.0945); Loss of stability (P = 0.1199); Gain of glycosylation at A1031 (P = 0.1415); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2749)
7:117250675:G:T,P13569,A1031S,0.773,Gain of disorder (P = 0.0734); Loss of methylation at R1030 (P = 0.095); Loss of stability (P = 0.1093); Loss of helix (P = 0.2271); Gain of loop (P = 0.4661)
7:117250676:C:A,P13569,A1031E,0.838,Loss of methylation at R1030 (P = 0.0537); Loss of catalytic residue at A1031 (P = 0.1029); Gain of disorder (P = 0.1906); Gain of helix (P = 0.2294); Loss of stability (P = 0.4329)
7:117250676:C:G,P13569,A1031G,0.777,Loss of stability (P = 0.0293); Gain of methylation at R1030 (P = 0.0585); Loss of catalytic residue at A1031 (P = 0.1447); Gain of helix (P = 0.2294); Gain of disorder (P = 0.3095)
7:117250676:C:T,P13569,A1031V,0.812,Loss of methylation at R1030 (P = 0.1265); Loss of catalytic residue at A1031 (P = 0.2157); Gain of helix (P = 0.2294); Loss of disorder (P = 0.39); Gain of MoRF binding (P = 0.4886)
7:117250678:T:A,P13569,Y1032N,0.903,Loss of stability (P = 0.0549); Gain of disorder (P = 0.0747); Gain of methylation at R1030 (P = 0.0763); Loss of helix (P = 0.2271); Loss of catalytic residue at Y1032 (P = 0.3307)
7:117250678:T:C,P13569,Y1032H,0.843,Gain of disorder (P = 0.0236); Loss of stability (P = 0.0505); Gain of methylation at R1030 (P = 0.0583); Gain of catalytic residue at L1034 (P = 0.1246); Loss of helix (P = 0.2271)
7:117250678:T:G,P13569,Y1032D,0.884,Gain of disorder (P = 0.0483); Loss of stability (P = 0.0828); Loss of methylation at R1030 (P = 0.1461); Loss of helix (P = 0.2271); Loss of catalytic residue at Y1032 (P = 0.3625)
7:117250679:A:C,P13569,Y1032S,0.805,Gain of disorder (P = 0.0137); Loss of stability (P = 0.0367); Gain of methylation at R1030 (P = 0.1013); Loss of catalytic residue at Y1032 (P = 0.1405); Loss of helix (P = 0.2022)
7:117250679:A:T,P13569,Y1032F,0.773,Loss of catalytic residue at Y1032 (P = 0.0719); Loss of methylation at R1030 (P = 0.1292); Loss of disorder (P = 0.2682); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.483)
7:117250681:T:A,P13569,F1033I,0.663,Loss of methylation at R1030 (P = 0.085); Loss of disorder (P = 0.2503); Gain of MoRF binding (P = 0.4612); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117250681:T:C,P13569,F1033L,0.68,Gain of disorder (P = 0.104); Loss of methylation at R1030 (P = 0.1334); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.5216); Gain of catalytic residue at M1028 (P = 0.5502)
7:117250681:T:G,P13569,F1033V,0.702,Gain of methylation at R1030 (P = 0.1467); Gain of disorder (P = 0.1778); Gain of catalytic residue at F1033 (P = 0.2593); Loss of stability (P = 0.2989); Gain of MoRF binding (P = 0.4343)
7:117250682:T:A,P13569,F1033Y,0.778,Gain of disorder (P = 0.0904); Gain of catalytic residue at F1033 (P = 0.144); Gain of methylation at R1030 (P = 0.1532); Loss of helix (P = 0.2271); Loss of stability (P = 0.4508)
7:117250682:T:C,P13569,F1033S,0.825,Gain of disorder (P = 0.0039); Loss of stability (P = 0.1035); Gain of methylation at R1030 (P = 0.1426); Loss of helix (P = 0.2271); Gain of catalytic residue at F1033 (P = 0.3119)
7:117250682:T:G,P13569,F1033C,0.838,Gain of catalytic residue at L1034 (P = 0.0159); Gain of methylation at R1030 (P = 0.1275); Loss of stability (P = 0.1857); Loss of disorder (P = 0.2002); Loss of helix (P = 0.2271)
7:117250683:C:A,P13569,F1033L,0.68,Gain of disorder (P = 0.104); Loss of methylation at R1030 (P = 0.1334); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.5216); Gain of catalytic residue at M1028 (P = 0.5502)
7:117250683:C:G,P13569,F1033L,0.68,Gain of disorder (P = 0.104); Loss of methylation at R1030 (P = 0.1334); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.5216); Gain of catalytic residue at M1028 (P = 0.5502)
7:117250684:C:A,P13569,L1034I,0.55,Gain of catalytic residue at L1034 (P = 0.015); Loss of methylation at R1030 (P = 0.1201); Loss of disorder (P = 0.1306); Gain of helix (P = 0.2059); Loss of stability (P = 0.3055)
7:117250684:C:G,P13569,L1034V,0.576,Loss of stability (P = 0.1221); Gain of methylation at R1030 (P = 0.1456); Gain of catalytic residue at L1034 (P = 0.185); Loss of disorder (P = 0.1906); Gain of helix (P = 0.2059)
7:117250684:C:T,P13569,L1034F,0.61,Gain of methylation at R1030 (P = 0.1423); Loss of stability (P = 0.1448); Loss of disorder (P = 0.1893); Gain of helix (P = 0.2059); Loss of loop (P = 0.4786)
7:117250685:T:A,P13569,L1034H,0.685,Loss of stability (P = 0.0131); Gain of disorder (P = 0.0229); Gain of methylation at R1030 (P = 0.105); Gain of helix (P = 0.2059); Gain of catalytic residue at L1034 (P = 0.3114)
7:117250685:T:C,P13569,L1034P,0.696,Loss of stability (P = 0.0081); Gain of disorder (P = 0.0242); Gain of glycosylation at L1034 (P = 0.0824); Gain of methylation at R1030 (P = 0.1412); Gain of helix (P = 0.2059)
7:117250685:T:G,P13569,L1034R,0.742,Gain of MoRF binding (P = 0.0181); Loss of stability (P = 0.0192); Gain of methylation at L1034 (P = 0.0296); Gain of disorder (P = 0.0306); Gain of catalytic residue at L1034 (P = 0.0377)
7:117250687:C:A,P13569,Q1035K,0.572,Gain of ubiquitination at Q1035 (P = 0.0258); Gain of methylation at R1030 (P = 0.1021); Gain of disorder (P = 0.184); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2324)
7:117250687:C:G,P13569,Q1035E,0.607,Gain of disorder (P = 0.1469); Gain of methylation at R1030 (P = 0.1513); Gain of helix (P = 0.2059); Gain of relative solvent accessibility (P = 0.2629); Gain of solvent accessibility (P = 0.3418)
7:117250688:A:C,P13569,Q1035P,0.731,Gain of glycosylation at Q1035 (P = 0.0347); Gain of methylation at R1030 (P = 0.0808); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2117); Gain of loop (P = 0.2754)
7:117250688:A:G,P13569,Q1035R,0.538,Gain of methylation at R1030 (P = 0.0535); Gain of catalytic residue at Q1035 (P = 0.0763); Gain of MoRF binding (P = 0.0832); Loss of disorder (P = 0.167); Gain of solvent accessibility (P = 0.204)
7:117250688:A:T,P13569,Q1035L,0.716,Loss of disorder (P = 0.0462); Gain of stability (P = 0.0553); Gain of methylation at R1030 (P = 0.073); Gain of helix (P = 0.2059); Loss of solvent accessibility (P = 0.3368)
7:117250689:A:C,P13569,Q1035H,0.694,Gain of methylation at R1030 (P = 0.0618); Gain of helix (P = 0.2059); Loss of disorder (P = 0.2261); Loss of solvent accessibility (P = 0.3368); Gain of catalytic residue at L1034 (P = 0.3943)
7:117250689:A:T,P13569,Q1035H,0.694,Gain of methylation at R1030 (P = 0.0618); Gain of helix (P = 0.2059); Loss of disorder (P = 0.2261); Loss of solvent accessibility (P = 0.3368); Gain of catalytic residue at L1034 (P = 0.3943)
7:117250690:A:C,P13569,T1036P,0.751,Gain of glycosylation at T1036 (P = 0.0593); Gain of disorder (P = 0.0919); Gain of catalytic residue at T1036 (P = 0.0991); Loss of helix (P = 0.2022); Gain of ubiquitination at K1041 (P = 0.2392)
7:117250690:A:G,P13569,T1036A,0.644,Loss of disorder (P = 0.209); Loss of helix (P = 0.2271); Loss of ubiquitination at K1041 (P = 0.264); Loss of methylation at K1041 (P = 0.36); Gain of MoRF binding (P = 0.4672)
7:117250690:A:T,P13569,T1036S,0.63,Gain of disorder (P = 0.027); Gain of relative solvent accessibility (P = 0.09); Gain of ubiquitination at K1041 (P = 0.1419); Gain of solvent accessibility (P = 0.1846); Loss of helix (P = 0.2271)
7:117250691:C:A,P13569,T1036N,0.827,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1422); Gain of disorder (P = 0.1455); Loss of ubiquitination at K1041 (P = 0.225); Gain of helix (P = 0.2294)
7:117250691:C:G,P13569,T1036S,0.63,Gain of disorder (P = 0.027); Gain of relative solvent accessibility (P = 0.09); Gain of ubiquitination at K1041 (P = 0.1419); Gain of solvent accessibility (P = 0.1846); Loss of helix (P = 0.2271)
7:117250691:C:T,P13569,T1036I,0.88,Loss of disorder (P = 0.0387); Gain of stability (P = 0.0553); Loss of ubiquitination at K1041 (P = 0.1106); Loss of helix (P = 0.2271); Gain of methylation at K1041 (P = 0.3446)
7:117250693:T:A,P13569,S1037T,0.641,Loss of disorder (P = 0.0753); Loss of ubiquitination at K1041 (P = 0.225); Loss of helix (P = 0.2271); Gain of methylation at K1041 (P = 0.2714); Gain of catalytic residue at T1036 (P = 0.3897)
7:117250693:T:C,P13569,S1037P,0.784,Loss of helix (P = 0.079); Loss of disorder (P = 0.1281); Gain of glycosylation at S1037 (P = 0.1515); Loss of ubiquitination at K1041 (P = 0.264); Gain of methylation at K1041 (P = 0.2915)
7:117250693:T:G,P13569,S1037A,0.611,Loss of disorder (P = 0.0449); Loss of ubiquitination at K1041 (P = 0.1392); Loss of helix (P = 0.2022); Gain of methylation at K1041 (P = 0.3871); Gain of glycosylation at K1041 (P = 0.4622)
7:117250694:C:T,P13569,S1037L,0.658,Loss of disorder (P = 0.0119); Loss of ubiquitination at K1041 (P = 0.0675); Gain of stability (P = 0.1212); Loss of methylation at K1041 (P = 0.3871); Loss of helix (P = 0.4763)
7:117250696:C:A,P13569,Q1038K,0.536,Gain of ubiquitination at Q1038 (P = 0.03); Gain of methylation at Q1038 (P = 0.0896); Gain of disorder (P = 0.1239); Loss of helix (P = 0.2022); Gain of relative solvent accessibility (P = 0.2363)
7:117250696:C:G,P13569,Q1038E,0.641,Gain of disorder (P = 0.0974); Gain of ubiquitination at K1041 (P = 0.1809); Loss of helix (P = 0.2022); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.3089)
7:117250697:A:C,P13569,Q1038P,0.756,Gain of glycosylation at Q1038 (P = 0.072); Loss of helix (P = 0.2022); Loss of disorder (P = 0.2271); Loss of ubiquitination at K1041 (P = 0.264); Gain of methylation at K1041 (P = 0.3659)
7:117250697:A:G,P13569,Q1038R,0.486,Loss of ubiquitination at K1041 (P = 0.0439); Loss of disorder (P = 0.1381); Gain of MoRF binding (P = 0.1433); Gain of helix (P = 0.2059); Gain of phosphorylation at T1036 (P = 0.248)
7:117250697:A:T,P13569,Q1038L,0.7,Loss of disorder (P = 0.0205); Loss of ubiquitination at K1041 (P = 0.0931); Gain of helix (P = 0.2059); Gain of catalytic residue at Q1035 (P = 0.283); Loss of solvent accessibility (P = 0.322)
7:117250698:G:C,P13569,Q1038H,0.632,Gain of catalytic residue at L1040 (P = 0.0817); Loss of disorder (P = 0.1294); Loss of helix (P = 0.2022); Gain of ubiquitination at K1041 (P = 0.2186); Gain of methylation at K1041 (P = 0.3296)
7:117250698:G:T,P13569,Q1038H,0.632,Gain of catalytic residue at L1040 (P = 0.0817); Loss of disorder (P = 0.1294); Loss of helix (P = 0.2022); Gain of ubiquitination at K1041 (P = 0.2186); Gain of methylation at K1041 (P = 0.3296)
7:117250699:C:A,P13569,Q1039K,0.429,Gain of ubiquitination at Q1039 (P = 0.0267); Gain of disorder (P = 0.1317); Loss of helix (P = 0.2022); Gain of methylation at Q1039 (P = 0.2244); Gain of MoRF binding (P = 0.2824)
7:117250699:C:G,P13569,Q1039E,0.352,Gain of disorder (P = 0.1035); Gain of ubiquitination at K1041 (P = 0.1283); Loss of helix (P = 0.2022); Loss of methylation at K1041 (P = 0.3735); Gain of loop (P = 0.4661)
7:117250700:A:C,P13569,Q1039P,0.65,Gain of glycosylation at Q1039 (P = 0.0844); Loss of disorder (P = 0.2257); Gain of helix (P = 0.2294); Gain of ubiquitination at K1041 (P = 0.2491); Gain of methylation at K1041 (P = 0.2506)
7:117250700:A:G,P13569,Q1039R,0.443,Gain of catalytic residue at Q1039 (P = 0.0254); Loss of ubiquitination at K1041 (P = 0.1106); Loss of disorder (P = 0.1404); Gain of MoRF binding (P = 0.1469); Gain of helix (P = 0.2294)
7:117250700:A:T,P13569,Q1039L,0.546,Loss of disorder (P = 0.018); Loss of ubiquitination at K1041 (P = 0.0931); Gain of stability (P = 0.1288); Loss of helix (P = 0.2022); Loss of solvent accessibility (P = 0.3854)
7:117250701:A:C,P13569,Q1039H,0.448,Loss of disorder (P = 0.1366); Loss of helix (P = 0.2022); Gain of ubiquitination at K1041 (P = 0.2283); Gain of methylation at K1041 (P = 0.2803); Loss of solvent accessibility (P = 0.4653)
7:117250701:A:T,P13569,Q1039H,0.448,Loss of disorder (P = 0.1366); Loss of helix (P = 0.2022); Gain of ubiquitination at K1041 (P = 0.2283); Gain of methylation at K1041 (P = 0.2803); Loss of solvent accessibility (P = 0.4653)
7:117250702:C:A,P13569,L1040I,0.545,Gain of methylation at K1041 (P = 0.103); Loss of disorder (P = 0.1241); Gain of helix (P = 0.2294); Loss of ubiquitination at K1041 (P = 0.2457); Loss of phosphorylation at S1045 (P = 0.2942)
7:117250702:C:G,P13569,L1040V,0.594,Gain of methylation at K1041 (P = 0.0388); Loss of disorder (P = 0.1856); Loss of ubiquitination at K1041 (P = 0.2457); Loss of phosphorylation at S1045 (P = 0.289); Gain of MoRF binding (P = 0.4649)
7:117250702:C:T,P13569,L1040F,0.619,Gain of methylation at K1041 (P = 0.0296); Loss of disorder (P = 0.1648); Loss of helix (P = 0.2022); Loss of ubiquitination at K1041 (P = 0.225); Loss of phosphorylation at S1045 (P = 0.2929)
7:117250703:T:A,P13569,L1040H,0.852,Gain of disorder (P = 0.023); Loss of stability (P = 0.0498); Gain of ubiquitination at K1041 (P = 0.1184); Gain of methylation at K1041 (P = 0.1496); Loss of helix (P = 0.2022)
7:117250703:T:C,P13569,L1040P,0.9,Gain of disorder (P = 0.022); Gain of glycosylation at L1040 (P = 0.025); Loss of stability (P = 0.0376); Gain of ubiquitination at K1041 (P = 0.0711); Gain of methylation at K1041 (P = 0.1638)
7:117250703:T:G,P13569,L1040R,0.897,Gain of disorder (P = 0.0299); Loss of stability (P = 0.0841); Gain of methylation at K1041 (P = 0.0925); Gain of ubiquitination at K1041 (P = 0.1283); Gain of phosphorylation at S1045 (P = 0.1624)
7:117250705:A:C,P13569,K1041Q,0.486,Loss of ubiquitination at K1041 (P = 0.0074); Gain of disorder (P = 0.1965); Loss of helix (P = 0.2022); Loss of methylation at K1041 (P = 0.2384); Loss of phosphorylation at S1045 (P = 0.2499)
7:117250705:A:G,P13569,K1041E,0.492,Loss of ubiquitination at K1041 (P = 0.0074); Gain of disorder (P = 0.1316); Loss of helix (P = 0.2022); Loss of methylation at K1041 (P = 0.2384); Gain of phosphorylation at S1045 (P = 0.2455)
7:117250706:A:C,P13569,K1041T,0.519,Loss of ubiquitination at K1041 (P = 0.0074); Loss of disorder (P = 0.1446); Gain of phosphorylation at K1041 (P = 0.1495); Loss of solvent accessibility (P = 0.1744); Loss of helix (P = 0.2022)
7:117250706:A:G,P13569,K1041R,0.391,Loss of ubiquitination at K1041 (P = 0.0074); Loss of disorder (P = 0.1674); Loss of helix (P = 0.2022); Loss of phosphorylation at S1045 (P = 0.235); Loss of methylation at K1041 (P = 0.3915)
7:117250706:A:T,P13569,K1041I,0.62,Loss of disorder (P = 0.0044); Loss of ubiquitination at K1041 (P = 0.0074); Gain of catalytic residue at E1044 (P = 0.0498); Loss of solvent accessibility (P = 0.0595); Loss of relative solvent accessibility (P = 0.1807)
7:117250707:A:C,P13569,K1041N,0.482,Loss of ubiquitination at K1041 (P = 0.0074); Loss of disorder (P = 0.1606); Loss of phosphorylation at S1045 (P = 0.1986); Loss of helix (P = 0.2271); Loss of methylation at K1041 (P = 0.2384)
7:117250707:A:T,P13569,K1041N,0.482,Loss of ubiquitination at K1041 (P = 0.0074); Loss of disorder (P = 0.1606); Loss of phosphorylation at S1045 (P = 0.1986); Loss of helix (P = 0.2271); Loss of methylation at K1041 (P = 0.2384)
7:117250708:C:A,P13569,Q1042K,0.496,Gain of ubiquitination at Q1042 (P = 0.0069); Loss of helix (P = 0.1299); Gain of phosphorylation at S1045 (P = 0.155); Gain of relative solvent accessibility (P = 0.1894); Gain of disorder (P = 0.2308)
7:117250708:C:G,P13569,Q1042E,0.563,Gain of phosphorylation at S1045 (P = 0.0845); Gain of ubiquitination at K1041 (P = 0.0978); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1769); Gain of relative solvent accessibility (P = 0.1894)
7:117250709:A:C,P13569,Q1042P,0.708,Gain of phosphorylation at S1045 (P = 0.1121); Loss of disorder (P = 0.2057); Loss of helix (P = 0.2271); Gain of ubiquitination at K1041 (P = 0.2575); Gain of methylation at K1041 (P = 0.3164)
7:117250709:A:G,P13569,Q1042R,0.416,Gain of phosphorylation at S1045 (P = 0.061); Loss of ubiquitination at K1041 (P = 0.1106); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1791); Gain of loop (P = 0.2045)
7:117250709:A:T,P13569,Q1042L,0.598,Loss of disorder (P = 0.0389); Loss of ubiquitination at K1041 (P = 0.0547); Loss of helix (P = 0.1299); Gain of catalytic residue at Q1042 (P = 0.1686); Gain of phosphorylation at S1045 (P = 0.2209)
7:117250710:A:C,P13569,Q1042H,0.596,Loss of helix (P = 0.2022); Gain of disorder (P = 0.2255); Gain of ubiquitination at K1041 (P = 0.2491); Gain of phosphorylation at S1045 (P = 0.2628); Gain of loop (P = 0.2754)
7:117250710:A:T,P13569,Q1042H,0.596,Loss of helix (P = 0.2022); Gain of disorder (P = 0.2255); Gain of ubiquitination at K1041 (P = 0.2491); Gain of phosphorylation at S1045 (P = 0.2628); Gain of loop (P = 0.2754)
7:117250711:C:A,P13569,L1043M,0.528,Gain of helix (P = 0.132); Gain of disorder (P = 0.1401); Gain of ubiquitination at K1041 (P = 0.1419); Gain of phosphorylation at S1045 (P = 0.1484); Gain of methylation at K1041 (P = 0.2131)
7:117250711:C:G,P13569,L1043V,0.465,Loss of disorder (P = 0.192); Loss of helix (P = 0.2022); Gain of methylation at K1041 (P = 0.2221); Loss of loop (P = 0.2237); Loss of ubiquitination at K1041 (P = 0.225)
7:117250712:T:A,P13569,L1043Q,0.584,Gain of disorder (P = 0.0349); Gain of ubiquitination at K1041 (P = 0.0799); Gain of phosphorylation at S1045 (P = 0.1472); Loss of helix (P = 0.2022); Loss of methylation at R1048 (P = 0.2109)
7:117250712:T:C,P13569,L1043P,0.665,Gain of disorder (P = 0.0531); Gain of catalytic residue at L1043 (P = 0.0634); Gain of glycosylation at L1043 (P = 0.0792); Gain of ubiquitination at K1041 (P = 0.0843); Gain of methylation at K1041 (P = 0.0876)
7:117250712:T:G,P13569,L1043R,0.79,Gain of disorder (P = 0.0541); Gain of phosphorylation at S1045 (P = 0.058); Gain of ubiquitination at K1041 (P = 0.1096); Loss of stability (P = 0.1569); Gain of solvent accessibility (P = 0.1683)
7:117250714:G:A,P13569,E1044K,0.604,Gain of ubiquitination at E1044 (P = 0.023); Gain of helix (P = 0.132); Loss of disorder (P = 0.1809); Gain of methylation at R1048 (P = 0.1884); Loss of phosphorylation at S1045 (P = 0.244)
7:117250714:G:C,P13569,E1044Q,0.539,Loss of ubiquitination at K1041 (P = 0.0779); Gain of helix (P = 0.132); Loss of phosphorylation at S1045 (P = 0.1882); Loss of disorder (P = 0.1901); Gain of methylation at R1048 (P = 0.2639)
7:117250715:A:C,P13569,E1044A,0.59,Loss of ubiquitination at K1041 (P = 0.0471); Loss of solvent accessibility (P = 0.0703); Loss of disorder (P = 0.0713); Gain of methylation at R1048 (P = 0.127); Loss of helix (P = 0.1299)
7:117250715:A:G,P13569,E1044G,0.596,Loss of solvent accessibility (P = 0.0703); Loss of stability (P = 0.1037); Gain of methylation at R1048 (P = 0.1174); Loss of helix (P = 0.1299); Loss of relative solvent accessibility (P = 0.1807)
7:117250715:A:T,P13569,E1044V,0.585,Loss of disorder (P = 0.0126); Loss of ubiquitination at K1041 (P = 0.0547); Loss of solvent accessibility (P = 0.0703); Loss of helix (P = 0.1299); Gain of methylation at R1048 (P = 0.152)
7:117250716:A:C,P13569,E1044D,0.463,Loss of helix (P = 0.1299); Loss of disorder (P = 0.1704); Loss of ubiquitination at K1041 (P = 0.225); Loss of phosphorylation at S1045 (P = 0.2402); Loss of methylation at R1048 (P = 0.2842)
7:117250716:A:T,P13569,E1044D,0.463,Loss of helix (P = 0.1299); Loss of disorder (P = 0.1704); Loss of ubiquitination at K1041 (P = 0.225); Loss of phosphorylation at S1045 (P = 0.2402); Loss of methylation at R1048 (P = 0.2842)
7:117250717:T:A,P13569,S1045T,0.582,Loss of ubiquitination at K1041 (P = 0.0547); Loss of disorder (P = 0.0899); Gain of phosphorylation at S1045 (P = 0.1769); Gain of helix (P = 0.2059); Loss of loop (P = 0.2237)
7:117250717:T:C,P13569,S1045P,0.611,Loss of phosphorylation at S1045 (P = 0.0869); Gain of glycosylation at S1045 (P = 0.0927); Loss of disorder (P = 0.1445); Loss of helix (P = 0.2022); Loss of loop (P = 0.2237)
7:117250717:T:G,P13569,S1045A,0.593,Loss of ubiquitination at K1041 (P = 0.0471); Loss of disorder (P = 0.0478); Loss of phosphorylation at S1045 (P = 0.0869); Gain of methylation at R1048 (P = 0.1157); Gain of helix (P = 0.2059)
7:117250718:C:A,P13569,S1045Y,0.834,Loss of disorder (P = 0.0099); Loss of ubiquitination at K1041 (P = 0.0439); Gain of catalytic residue at L1040 (P = 0.0609); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117250718:C:G,P13569,S1045C,0.683,Loss of disorder (P = 2e-04); Gain of catalytic residue at S1049 (P = 0.0516); Loss of ubiquitination at K1041 (P = 0.0598); Loss of phosphorylation at S1045 (P = 0.0869); Gain of helix (P = 0.132)
7:117250718:C:T,P13569,S1045F,0.671,Loss of disorder (P = 0.0039); Loss of ubiquitination at K1041 (P = 0.0675); Loss of phosphorylation at S1045 (P = 0.0869); Gain of helix (P = 0.132); Gain of methylation at R1048 (P = 0.1543)
7:117250720:G:A,P13569,E1046K,0.483,Gain of ubiquitination at E1046 (P = 0.0211); Loss of stability (P = 0.1293); Loss of helix (P = 0.1299); Loss of phosphorylation at S1045 (P = 0.1816); Loss of disorder (P = 0.1889)
7:117250720:G:C,P13569,E1046Q,0.403,Loss of ubiquitination at K1041 (P = 0.0779); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1402); Loss of phosphorylation at S1045 (P = 0.1882); Gain of loop (P = 0.2045)
7:117250721:A:C,P13569,E1046A,0.558,Loss of disorder (P = 0.0391); Loss of ubiquitination at K1041 (P = 0.0547); Loss of helix (P = 0.1299); Loss of phosphorylation at S1045 (P = 0.1666); Loss of stability (P = 0.184)
7:117250721:A:G,P13569,E1046G,0.526,Loss of stability (P = 0.0646); Gain of glycosylation at S1045 (P = 0.0944); Gain of methylation at R1048 (P = 0.117); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1353)
7:117250721:A:T,P13569,E1046V,0.539,Loss of disorder (P = 0.0025); Loss of ubiquitination at K1041 (P = 0.0598); Loss of helix (P = 0.1299); Loss of phosphorylation at S1045 (P = 0.1615); Loss of methylation at R1048 (P = 0.2552)
7:117250722:A:C,P13569,E1046D,0.42,Loss of helix (P = 0.1299); Loss of disorder (P = 0.1494); Loss of phosphorylation at S1045 (P = 0.2402); Loss of ubiquitination at K1041 (P = 0.2457); Loss of methylation at R1048 (P = 0.2751)
7:117250722:A:T,P13569,E1046D,0.42,Loss of helix (P = 0.1299); Loss of disorder (P = 0.1494); Loss of phosphorylation at S1045 (P = 0.2402); Loss of ubiquitination at K1041 (P = 0.2457); Loss of methylation at R1048 (P = 0.2751)
7:117250723:G:A,P13569,G1047S,0.417,Gain of phosphorylation at G1047 (P = 0.0519); Gain of disorder (P = 0.0529); Loss of helix (P = 0.1299); Loss of methylation at R1048 (P = 0.1677); Gain of glycosylation at P1050 (P = 0.2025)
7:117250723:G:C,P13569,G1047R,0.831,Gain of solvent accessibility (P = 0.0584); Gain of phosphorylation at S1049 (P = 0.0684); Gain of relative solvent accessibility (P = 0.09); Loss of methylation at R1048 (P = 0.1109); Gain of helix (P = 0.132)
7:117250723:G:T,P13569,G1047C,0.531,Loss of disorder (P = 0.0055); Loss of methylation at R1048 (P = 0.1652); Loss of phosphorylation at S1045 (P = 0.2031); Gain of helix (P = 0.2059); Gain of catalytic residue at S1049 (P = 0.2069)
7:117251635:G:A,P13569,G1047D,0.607,Gain of relative solvent accessibility (P = 0.0215); Gain of solvent accessibility (P = 0.0306); Loss of methylation at R1048 (P = 0.111); Gain of helix (P = 0.132); Gain of disorder (P = 0.1614)
7:117251635:G:C,P13569,G1047A,0.398,Loss of disorder (P = 0.1055); Loss of helix (P = 0.1299); Loss of methylation at R1048 (P = 0.2103); Gain of relative solvent accessibility (P = 0.281); Loss of phosphorylation at S1045 (P = 0.3118)
7:117251635:G:T,P13569,G1047V,0.503,Loss of disorder (P = 0.027); Gain of helix (P = 0.132); Loss of methylation at R1048 (P = 0.1898); Loss of phosphorylation at S1045 (P = 0.2571); Gain of relative solvent accessibility (P = 0.281)
7:117251637:A:G,P13569,R1048G,0.687,Loss of methylation at R1048 (P = 0.0677); Gain of glycosylation at S1045 (P = 0.0865); Loss of solvent accessibility (P = 0.1235); Gain of disorder (P = 0.1336); Loss of phosphorylation at S1045 (P = 0.1908)
7:117251637:A:T,P13569,R1048W,0.594,Loss of disorder (P = 0.0071); Loss of solvent accessibility (P = 0.0299); Loss of methylation at R1048 (P = 0.0677); Gain of helix (P = 0.132); Loss of phosphorylation at S1045 (P = 0.135)
7:117251638:G:A,P13569,R1048K,0.528,Gain of ubiquitination at R1048 (P = 0.0054); Gain of disorder (P = 0.0866); Loss of methylation at R1048 (P = 0.0961); Loss of catalytic residue at R1048 (P = 0.1433); Loss of phosphorylation at S1045 (P = 0.2003)
7:117251638:G:C,P13569,R1048T,0.675,Loss of solvent accessibility (P = 0.0299); Loss of methylation at R1048 (P = 0.0677); Gain of glycosylation at R1048 (P = 0.1305); Gain of helix (P = 0.132); Loss of phosphorylation at S1045 (P = 0.1615)
7:117251638:G:T,P13569,R1048M,0.594,Loss of solvent accessibility (P = 0.0299); Loss of methylation at R1048 (P = 0.0677); Loss of disorder (P = 0.0815); Loss of catalytic residue at R1048 (P = 0.0964); Gain of phosphorylation at T1053 (P = 0.1289)
7:117251639:G:C,P13569,R1048S,0.596,Loss of solvent accessibility (P = 0.0299); Gain of disorder (P = 0.037); Loss of catalytic residue at R1048 (P = 0.0601); Loss of methylation at R1048 (P = 0.0677); Gain of glycosylation at R1048 (P = 0.1162)
7:117251639:G:T,P13569,R1048S,0.596,Loss of solvent accessibility (P = 0.0299); Gain of disorder (P = 0.037); Loss of catalytic residue at R1048 (P = 0.0601); Loss of methylation at R1048 (P = 0.0677); Gain of glycosylation at R1048 (P = 0.1162)
7:117251640:A:C,P13569,S1049R,0.819,Loss of disorder (P = 0.0839); Loss of phosphorylation at S1049 (P = 0.1068); Gain of MoRF binding (P = 0.1273); Gain of helix (P = 0.132); Loss of methylation at R1048 (P = 0.2187)
7:117251640:A:G,P13569,S1049G,0.704,Gain of methylation at R1048 (P = 0.0449); Gain of catalytic residue at S1049 (P = 0.0936); Loss of phosphorylation at S1049 (P = 0.1068); Loss of disorder (P = 0.1082); Gain of helix (P = 0.132)
7:117251640:A:T,P13569,S1049C,0.746,Loss of disorder (P = 4e-04); Loss of phosphorylation at S1049 (P = 0.1068); Gain of helix (P = 0.132); Gain of catalytic residue at E1046 (P = 0.2292); Loss of methylation at R1048 (P = 0.2649)
7:117251641:G:A,P13569,S1049N,0.766,Loss of disorder (P = 0.0824); Loss of phosphorylation at T1053 (P = 0.1048); Loss of methylation at R1048 (P = 0.2595); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949)
7:117251641:G:C,P13569,S1049T,0.742,Loss of disorder (P = 0.0674); Gain of catalytic residue at F1052 (P = 0.1207); Loss of phosphorylation at T1053 (P = 0.177); Loss of methylation at R1048 (P = 0.2716); Gain of loop (P = 0.2754)
7:117251641:G:T,P13569,S1049I,0.725,Loss of disorder (P = 0.0033); Loss of phosphorylation at S1049 (P = 0.1068); Loss of methylation at R1048 (P = 0.173); Gain of relative solvent accessibility (P = 0.284); Loss of loop (P = 0.3664)
7:117251642:T:A,P13569,S1049R,0.819,Loss of disorder (P = 0.0839); Loss of phosphorylation at S1049 (P = 0.1068); Gain of MoRF binding (P = 0.1273); Gain of helix (P = 0.132); Loss of methylation at R1048 (P = 0.2187)
7:117251642:T:G,P13569,S1049R,0.819,Loss of disorder (P = 0.0839); Loss of phosphorylation at S1049 (P = 0.1068); Gain of MoRF binding (P = 0.1273); Gain of helix (P = 0.132); Loss of methylation at R1048 (P = 0.2187)
7:117251643:C:A,P13569,P1050T,0.505,Gain of helix (P = 0.132); Loss of phosphorylation at T1053 (P = 0.1625); Loss of disorder (P = 0.1633); Gain of MoRF binding (P = 0.2213); Gain of catalytic residue at S1049 (P = 0.2262)
7:117251643:C:T,P13569,P1050S,0.412,Gain of disorder (P = 0.0682); Gain of phosphorylation at P1050 (P = 0.0737); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1993); Gain of methylation at R1048 (P = 0.2143)
7:117251644:C:A,P13569,P1050Q,0.462,Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1354); Loss of phosphorylation at T1053 (P = 0.1371); Loss of glycosylation at P1050 (P = 0.2156); Loss of methylation at R1048 (P = 0.2156)
7:117251644:C:G,P13569,P1050R,0.557,Gain of MoRF binding (P = 0.0106); Gain of methylation at P1050 (P = 0.0755); Gain of phosphorylation at T1053 (P = 0.1298); Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.2097)
7:117251644:C:T,P13569,P1050L,0.58,Loss of disorder (P = 0.0306); Gain of helix (P = 0.062); Loss of phosphorylation at T1053 (P = 0.076); Loss of loop (P = 0.0804); Loss of glycosylation at P1050 (P = 0.2156)
7:117251646:A:C,P13569,I1051L,0.581,Gain of disorder (P = 0.0921); Loss of helix (P = 0.1299); Gain of glycosylation at P1050 (P = 0.1592); Gain of methylation at R1048 (P = 0.1815); Gain of loop (P = 0.2045)
7:117251647:T:A,P13569,I1051N,0.856,Gain of disorder (P = 0.0058); Loss of stability (P = 0.0348); Gain of methylation at R1048 (P = 0.0617); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117251647:T:C,P13569,I1051T,0.672,Gain of disorder (P = 0.0084); Loss of stability (P = 0.0242); Gain of phosphorylation at I1051 (P = 0.0335); Gain of methylation at R1048 (P = 0.0818); Gain of glycosylation at I1051 (P = 0.0862)
7:117251647:T:G,P13569,I1051S,0.691,Gain of disorder (P = 3e-04); Loss of stability (P = 0.031); Gain of phosphorylation at I1051 (P = 0.0465); Gain of methylation at R1048 (P = 0.0583); Gain of glycosylation at P1050 (P = 0.0923)
7:117251648:T:G,P13569,I1051M,0.632,Gain of disorder (P = 0.0392); Gain of methylation at R1048 (P = 0.0974); Loss of phosphorylation at T1053 (P = 0.1085); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.2019)
7:117251649:T:A,P13569,F1052I,0.782,Gain of helix (P = 0.132); Gain of disorder (P = 0.1855); Loss of phosphorylation at T1053 (P = 0.2017); Gain of MoRF binding (P = 0.2235); Loss of methylation at R1048 (P = 0.2598)
7:117251649:T:C,P13569,F1052L,0.783,Gain of disorder (P = 0.0966); Gain of catalytic residue at F1052 (P = 0.1244); Gain of helix (P = 0.132); Gain of phosphorylation at S1049 (P = 0.2208); Gain of MoRF binding (P = 0.2456)
7:117251650:T:A,P13569,F1052Y,0.724,Gain of phosphorylation at F1052 (P = 0.1062); Gain of disorder (P = 0.1078); Gain of helix (P = 0.132); Gain of catalytic residue at F1052 (P = 0.1688); Gain of MoRF binding (P = 0.2355)
7:117251650:T:C,P13569,F1052S,0.729,Gain of disorder (P = 4e-04); Gain of phosphorylation at S1049 (P = 0.0994); Loss of stability (P = 0.1011); Gain of methylation at R1048 (P = 0.1199); Gain of glycosylation at P1050 (P = 0.1906)
7:117251650:T:G,P13569,F1052C,0.744,Gain of catalytic residue at H1054 (P = 0.1289); Gain of helix (P = 0.132); Loss of stability (P = 0.1927); Loss of disorder (P = 0.1941); Loss of MoRF binding (P = 0.235)
7:117251651:C:A,P13569,F1052L,0.783,Gain of disorder (P = 0.0966); Gain of catalytic residue at F1052 (P = 0.1244); Gain of helix (P = 0.132); Gain of phosphorylation at S1049 (P = 0.2208); Gain of MoRF binding (P = 0.2456)
7:117251651:C:G,P13569,F1052L,0.783,Gain of disorder (P = 0.0966); Gain of catalytic residue at F1052 (P = 0.1244); Gain of helix (P = 0.132); Gain of phosphorylation at S1049 (P = 0.2208); Gain of MoRF binding (P = 0.2456)
7:117251652:A:C,P13569,T1053P,0.792,Loss of phosphorylation at T1053 (P = 0.0398); Gain of disorder (P = 0.1092); Gain of catalytic residue at T1053 (P = 0.1242); Loss of MoRF binding (P = 0.1438); Loss of stability (P = 0.1508)
7:117251652:A:G,P13569,T1053A,0.6,Loss of phosphorylation at T1053 (P = 0.0398); Loss of disorder (P = 0.177); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2236); Loss of stability (P = 0.2268)
7:117251652:A:T,P13569,T1053S,0.535,Gain of disorder (P = 0.0389); Loss of phosphorylation at T1053 (P = 0.0559); Gain of MoRF binding (P = 0.2052); Gain of relative solvent accessibility (P = 0.2363); Gain of methylation at R1048 (P = 0.2438)
7:117251653:C:A,P13569,T1053N,0.549,Loss of phosphorylation at T1053 (P = 0.0398); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1745); Loss of stability (P = 0.1892); Gain of catalytic residue at T1053 (P = 0.2025)
7:117251653:C:G,P13569,T1053S,0.535,Gain of disorder (P = 0.0389); Loss of phosphorylation at T1053 (P = 0.0559); Gain of MoRF binding (P = 0.2052); Gain of relative solvent accessibility (P = 0.2363); Gain of methylation at R1048 (P = 0.2438)
7:117251655:C:A,P13569,H1054N,0.708,Loss of disorder (P = 0.1171); Gain of MoRF binding (P = 0.1536); Loss of phosphorylation at T1053 (P = 0.193); Loss of stability (P = 0.2397); Gain of catalytic residue at H1054 (P = 0.315)
7:117251655:C:G,P13569,H1054D,0.913,Loss of MoRF binding (P = 0.1066); Gain of phosphorylation at S1049 (P = 0.1106); Loss of disorder (P = 0.1632); Gain of catalytic residue at H1054 (P = 0.1966); Gain of relative solvent accessibility (P = 0.2363)
7:117251655:C:T,P13569,H1054Y,0.651,Loss of disorder (P = 0.0499); Loss of helix (P = 0.1706); Gain of phosphorylation at T1053 (P = 0.1896); Gain of MoRF binding (P = 0.2027); Gain of glycosylation at P1050 (P = 0.2086)
7:117251656:A:C,P13569,H1054P,0.81,Gain of phosphorylation at T1053 (P = 0.0955); Loss of MoRF binding (P = 0.111); Loss of helix (P = 0.1299); Loss of stability (P = 0.2114); Loss of disorder (P = 0.2231)
7:117251656:A:G,P13569,H1054R,0.824,Gain of MoRF binding (P = 0.0137); Gain of phosphorylation at T1053 (P = 0.1091); Loss of disorder (P = 0.1918); Gain of catalytic residue at H1054 (P = 0.1929); Loss of glycosylation at S1058 (P = 0.2203)
7:117251656:A:T,P13569,H1054L,0.656,Loss of disorder (P = 0.0513); Gain of glycosylation at P1050 (P = 0.1688); Loss of helix (P = 0.1706); Loss of phosphorylation at T1053 (P = 0.1728); Gain of MoRF binding (P = 0.1788)
7:117251657:T:G,P13569,H1054Q,0.664,Gain of MoRF binding (P = 0.1206); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1839); Gain of phosphorylation at T1053 (P = 0.2179); Gain of loop (P = 0.2754)
7:117251658:C:A,P13569,L1055I,0.834,Gain of MoRF binding (P = 0.1239); Gain of helix (P = 0.132); Loss of disorder (P = 0.2153); Gain of phosphorylation at T1053 (P = 0.2179); Gain of ubiquitination at K1060 (P = 0.2261)
7:117251658:C:G,P13569,L1055V,0.722,Gain of MoRF binding (P = 0.1168); Gain of helix (P = 0.132); Gain of phosphorylation at T1053 (P = 0.174); Gain of disorder (P = 0.255); Gain of glycosylation at S1058 (P = 0.276)
7:117251658:C:T,P13569,L1055F,0.7,Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1527); Gain of phosphorylation at T1053 (P = 0.1701); Gain of ubiquitination at K1060 (P = 0.2261); Loss of disorder (P = 0.2607)
7:117251659:T:A,P13569,L1055H,0.875,Gain of disorder (P = 0.0152); Loss of stability (P = 0.0569); Gain of catalytic residue at L1055 (P = 0.0748); Gain of glycosylation at T1053 (P = 0.1464); Gain of phosphorylation at T1053 (P = 0.1701)
7:117251659:T:C,P13569,L1055P,0.879,Gain of disorder (P = 0.0285); Loss of stability (P = 0.0555); Loss of MoRF binding (P = 0.0944); Gain of phosphorylation at T1053 (P = 0.1166); Gain of glycosylation at T1053 (P = 0.1986)
7:117251659:T:G,P13569,L1055R,0.911,Gain of MoRF binding (P = 0.0205); Gain of disorder (P = 0.0317); Gain of methylation at L1055 (P = 0.0384); Gain of phosphorylation at T1053 (P = 0.0897); Loss of stability (P = 0.102)
7:117251661:G:A,P13569,V1056I,0.62,Loss of catalytic residue at V1056 (P = 0.0436); Loss of phosphorylation at T1053 (P = 0.0991); Gain of MoRF binding (P = 0.1644); Gain of helix (P = 0.2684); Gain of ubiquitination at K1060 (P = 0.2694)
7:117251661:G:C,P13569,V1056L,0.695,Loss of MoRF binding (P = 0.1325); Gain of ubiquitination at K1060 (P = 0.2496); Loss of phosphorylation at T1053 (P = 0.2513); Gain of helix (P = 0.2684); Gain of loop (P = 0.2754)
7:117251661:G:T,P13569,V1056F,0.684,Loss of MoRF binding (P = 0.1665); Gain of phosphorylation at T1053 (P = 0.2425); Loss of ubiquitination at K1060 (P = 0.2757); Gain of glycosylation at S1058 (P = 0.361); Gain of disorder (P = 0.3787)
7:117251662:T:A,P13569,V1056D,0.718,Gain of disorder (P = 0.0458); Loss of MoRF binding (P = 0.0788); Gain of ubiquitination at K1060 (P = 0.0934); Gain of phosphorylation at T1053 (P = 0.1151); Gain of relative solvent accessibility (P = 0.1259)
7:117251662:T:C,P13569,V1056A,0.568,Gain of disorder (P = 0.1288); Gain of MoRF binding (P = 0.1684); Gain of phosphorylation at T1053 (P = 0.2004); Loss of helix (P = 0.2271); Gain of glycosylation at S1058 (P = 0.2533)
7:117251662:T:G,P13569,V1056G,0.61,Loss of stability (P = 0.0345); Gain of disorder (P = 0.0348); Loss of catalytic residue at V1056 (P = 0.0778); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1528)
7:117251664:A:C,P13569,T1057P,0.79,Loss of MoRF binding (P = 0.0775); Loss of phosphorylation at T1053 (P = 0.1414); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662); Loss of ubiquitination at K1060 (P = 0.2684)
7:117251664:A:T,P13569,T1057S,0.663,Gain of MoRF binding (P = 0.1374); Loss of phosphorylation at T1053 (P = 0.1392); Gain of disorder (P = 0.2233); Loss of ubiquitination at K1060 (P = 0.2474); Loss of helix (P = 0.2662)
7:117251665:C:A,P13569,T1057K,0.736,Gain of MoRF binding (P = 0.0189); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of phosphorylation at T1053 (P = 0.1251); Loss of catalytic residue at V1056 (P = 0.1718)
7:117251665:C:G,P13569,T1057R,0.736,Gain of MoRF binding (P = 0.006); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at V1056 (P = 0.1111); Loss of phosphorylation at T1053 (P = 0.151)
7:117251665:C:T,P13569,T1057I,0.814,Gain of catalytic residue at L1062 (P = 0.0651); Gain of ubiquitination at K1060 (P = 0.0799); Loss of phosphorylation at T1053 (P = 0.0814); Gain of MoRF binding (P = 0.1466); Loss of helix (P = 0.2662)
7:117251667:A:C,P13569,S1058R,0.901,Gain of MoRF binding (P = 0.0186); Loss of glycosylation at S1058 (P = 0.1068); Gain of catalytic residue at S1058 (P = 0.1379); Loss of sheet (P = 0.1907); Gain of phosphorylation at T1053 (P = 0.2169)
7:117251667:A:G,P13569,S1058G,0.739,Loss of stability (P = 0.018); Loss of glycosylation at S1058 (P = 0.1068); Loss of MoRF binding (P = 0.1469); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117251667:A:T,P13569,S1058C,0.78,Loss of glycosylation at S1058 (P = 0.1068); Loss of MoRF binding (P = 0.1151); Gain of catalytic residue at L1059 (P = 0.1602); Gain of helix (P = 0.1736); Loss of phosphorylation at T1053 (P = 0.1895)
7:117251668:G:A,P13569,S1058N,0.728,Loss of glycosylation at S1058 (P = 0.1068); Gain of catalytic residue at S1058 (P = 0.1519); Loss of MoRF binding (P = 0.1583); Loss of sheet (P = 0.1907); Loss of phosphorylation at T1053 (P = 0.1954)
7:117251668:G:C,P13569,S1058T,0.776,Loss of stability (P = 0.0977); Loss of MoRF binding (P = 0.1386); Loss of glycosylation at S1058 (P = 0.1881); Loss of sheet (P = 0.1907); Gain of ubiquitination at K1060 (P = 0.1993)
7:117251668:G:T,P13569,S1058I,0.776,Gain of ubiquitination at K1060 (P = 0.0638); Gain of MoRF binding (P = 0.0841); Loss of glycosylation at S1058 (P = 0.1068); Loss of phosphorylation at T1053 (P = 0.1895); Loss of loop (P = 0.2237)
7:117251669:C:A,P13569,S1058R,0.901,Gain of MoRF binding (P = 0.0186); Loss of glycosylation at S1058 (P = 0.1068); Gain of catalytic residue at S1058 (P = 0.1379); Loss of sheet (P = 0.1907); Gain of phosphorylation at T1053 (P = 0.2169)
7:117251669:C:G,P13569,S1058R,0.901,Gain of MoRF binding (P = 0.0186); Loss of glycosylation at S1058 (P = 0.1068); Gain of catalytic residue at S1058 (P = 0.1379); Loss of sheet (P = 0.1907); Gain of phosphorylation at T1053 (P = 0.2169)
7:117251670:T:A,P13569,L1059I,0.707,Gain of MoRF binding (P = 0.0913); Gain of ubiquitination at K1060 (P = 0.1993); Loss of loop (P = 0.2237); Loss of stability (P = 0.3362); Loss of sheet (P = 0.3635)
7:117251670:T:G,P13569,L1059V,0.705,Gain of MoRF binding (P = 0.0916); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684); Gain of ubiquitination at K1060 (P = 0.2694); Loss of stability (P = 0.2704)
7:117251671:T:C,P13569,L1059S,0.894,Loss of stability (P = 0.0482); Gain of catalytic residue at L1055 (P = 0.1113); Gain of MoRF binding (P = 0.1284); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1923)
7:117251672:A:C,P13569,L1059F,0.704,Gain of MoRF binding (P = 0.1103); Gain of sheet (P = 0.1945); Loss of catalytic residue at L1059 (P = 0.1978); Gain of ubiquitination at K1060 (P = 0.2261); Loss of stability (P = 0.2345)
7:117251672:A:T,P13569,L1059F,0.704,Gain of MoRF binding (P = 0.1103); Gain of sheet (P = 0.1945); Loss of catalytic residue at L1059 (P = 0.1978); Gain of ubiquitination at K1060 (P = 0.2261); Loss of stability (P = 0.2345)
7:117251673:A:C,P13569,K1060Q,0.695,Loss of ubiquitination at K1060 (P = 0.0546); Loss of MoRF binding (P = 0.0594); Gain of catalytic residue at K1060 (P = 0.1129); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117251673:A:G,P13569,K1060E,0.604,Loss of MoRF binding (P = 0.016); Loss of ubiquitination at K1060 (P = 0.0546); Gain of catalytic residue at K1060 (P = 0.165); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117251674:A:C,P13569,K1060T,0.84,Loss of MoRF binding (P = 0.0486); Loss of ubiquitination at K1060 (P = 0.0546); Gain of catalytic residue at K1060 (P = 0.1034); Gain of glycosylation at S1058 (P = 0.1792); Loss of sheet (P = 0.1907)
7:117251674:A:G,P13569,K1060R,0.627,Loss of ubiquitination at K1060 (P = 0.0546); Gain of MoRF binding (P = 0.0697); Gain of catalytic residue at K1060 (P = 0.1667); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117251674:A:T,P13569,K1060I,0.701,Loss of ubiquitination at K1060 (P = 0.0546); Loss of MoRF binding (P = 0.0658); Gain of catalytic residue at K1060 (P = 0.0842); Gain of glycosylation at S1058 (P = 0.1358); Gain of helix (P = 0.1736)
7:117251675:A:C,P13569,K1060N,0.656,Loss of ubiquitination at K1060 (P = 0.0546); Loss of MoRF binding (P = 0.0568); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117251675:A:T,P13569,K1060N,0.656,Loss of ubiquitination at K1060 (P = 0.0546); Loss of MoRF binding (P = 0.0568); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117251676:G:A,P13569,G1061R,0.973,Gain of MoRF binding (P = 0.0163); Loss of ubiquitination at K1060 (P = 0.2196); Loss of loop (P = 0.2237); Loss of catalytic residue at V1056 (P = 0.2623); Gain of helix (P = 0.2684)
7:117251677:G:A,P13569,G1061E,0.884,Loss of MoRF binding (P = 0.0528); Gain of ubiquitination at K1060 (P = 0.0707); Gain of catalytic residue at W1063 (P = 0.0891); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971)
7:117251677:G:C,P13569,G1061A,0.914,Gain of MoRF binding (P = 0.1454); Gain of sheet (P = 0.1945); Gain of ubiquitination at K1060 (P = 0.1993); Loss of loop (P = 0.2237); Loss of glycosylation at S1058 (P = 0.3299)
7:117251677:G:T,P13569,G1061V,0.916,Gain of ubiquitination at K1060 (P = 0.0934); Gain of MoRF binding (P = 0.096); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Gain of helix (P = 0.2684)
7:117251679:C:A,P13569,L1062I,0.555,Gain of MoRF binding (P = 0.0929); Gain of ubiquitination at K1060 (P = 0.2261); Loss of loop (P = 0.2897); Gain of catalytic residue at A1067 (P = 0.2979); Loss of sheet (P = 0.3635)
7:117251679:C:G,P13569,L1062V,0.575,Gain of MoRF binding (P = 0.0882); Gain of catalytic residue at L1062 (P = 0.1588); Loss of stability (P = 0.1862); Loss of sheet (P = 0.1907); Gain of ubiquitination at K1060 (P = 0.2496)
7:117251680:T:A,P13569,L1062Q,0.789,Loss of stability (P = 0.0488); Gain of MoRF binding (P = 0.0714); Gain of sheet (P = 0.1208); Gain of catalytic residue at L1062 (P = 0.1235); Loss of helix (P = 0.1706)
7:117251680:T:C,P13569,L1062P,0.879,Loss of stability (P = 0.0261); Gain of catalytic residue at W1063 (P = 0.045); Loss of MoRF binding (P = 0.0755); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117251680:T:G,P13569,L1062R,0.89,Gain of MoRF binding (P = 0.0064); Loss of stability (P = 0.0463); Gain of methylation at L1062 (P = 0.1353); Gain of catalytic residue at L1062 (P = 0.1468); Loss of helix (P = 0.1706)
7:117251682:T:A,P13569,W1063R,0.533,Gain of methylation at W1063 (P = 0.0463); Gain of ubiquitination at K1060 (P = 0.0545); Gain of MoRF binding (P = 0.0581); Gain of solvent accessibility (P = 0.0648); Gain of relative solvent accessibility (P = 0.0905)
7:117251682:T:C,P13569,W1063R,0.533,Gain of methylation at W1063 (P = 0.0463); Gain of ubiquitination at K1060 (P = 0.0545); Gain of MoRF binding (P = 0.0581); Gain of solvent accessibility (P = 0.0648); Gain of relative solvent accessibility (P = 0.0905)
7:117251682:T:G,P13569,W1063G,0.68,Loss of MoRF binding (P = 0.0547); Gain of disorder (P = 0.0953); Gain of ubiquitination at K1060 (P = 0.14); Gain of relative solvent accessibility (P = 0.1571); Loss of stability (P = 0.1876)
7:117251683:G:C,P13569,W1063S,0.64,Gain of disorder (P = 0.0189); Loss of MoRF binding (P = 0.0648); Gain of relative solvent accessibility (P = 0.0905); Gain of ubiquitination at K1060 (P = 0.14); Gain of solvent accessibility (P = 0.204)
7:117251683:G:T,P13569,W1063L,0.626,Loss of MoRF binding (P = 0.0573); Gain of ubiquitination at K1060 (P = 0.14); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2045)
7:117251684:G:C,P13569,W1063C,0.692,Gain of catalytic residue at W1063 (P = 0.0414); Loss of MoRF binding (P = 0.0514); Gain of ubiquitination at K1060 (P = 0.0707); Loss of sheet (P = 0.1907); Gain of glycosylation at S1058 (P = 0.2892)
7:117251684:G:T,P13569,W1063C,0.692,Gain of catalytic residue at W1063 (P = 0.0414); Loss of MoRF binding (P = 0.0514); Gain of ubiquitination at K1060 (P = 0.0707); Loss of sheet (P = 0.1907); Gain of glycosylation at S1058 (P = 0.2892)
7:117251685:A:C,P13569,T1064P,0.846,Loss of MoRF binding (P = 0.0684); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of ubiquitination at K1060 (P = 0.2684); Gain of catalytic residue at K1060 (P = 0.4724)
7:117251685:A:G,P13569,T1064A,0.744,Loss of MoRF binding (P = 0.1573); Gain of ubiquitination at K1060 (P = 0.1993); Loss of helix (P = 0.2662); Gain of catalytic residue at T1064 (P = 0.3343); Gain of loop (P = 0.3485)
7:117251685:A:T,P13569,T1064S,0.745,Gain of MoRF binding (P = 0.1385); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of ubiquitination at K1060 (P = 0.255); Gain of catalytic residue at T1064 (P = 0.4023)
7:117251686:C:A,P13569,T1064K,0.856,Gain of MoRF binding (P = 0.0221); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045); Loss of ubiquitination at K1060 (P = 0.2287)
7:117251686:C:G,P13569,T1064R,0.87,Gain of MoRF binding (P = 0.0105); Gain of methylation at T1064 (P = 0.1743); Loss of sheet (P = 0.1907); Gain of catalytic residue at T1064 (P = 0.2048); Loss of ubiquitination at K1060 (P = 0.2196)
7:117251686:C:T,P13569,T1064I,0.719,Gain of ubiquitination at K1060 (P = 0.0799); Gain of MoRF binding (P = 0.1094); Loss of helix (P = 0.2662); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635)
7:117251688:C:A,P13569,L1065I,0.617,Gain of MoRF binding (P = 0.0888); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662); Gain of ubiquitination at K1060 (P = 0.2694)
7:117251688:C:G,P13569,L1065V,0.631,Gain of MoRF binding (P = 0.0899); Loss of stability (P = 0.167); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117251688:C:T,P13569,L1065F,0.894,Gain of MoRF binding (P = 0.1228); Loss of stability (P = 0.1682); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237); Loss of helix (P = 0.2662)
7:117251689:T:A,P13569,L1065H,0.904,Loss of stability (P = 0.0131); Loss of MoRF binding (P = 0.1129); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2237)
7:117251689:T:C,P13569,L1065P,0.968,Loss of stability (P = 0.0143); Loss of MoRF binding (P = 0.0677); Gain of catalytic residue at L1065 (P = 0.1128); Gain of helix (P = 0.132); Gain of phosphorylation at T1064 (P = 0.148)
7:117251689:T:G,P13569,L1065R,0.972,Loss of stability (P = 0.0216); Gain of MoRF binding (P = 0.0321); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of ubiquitination at K1060 (P = 0.2196)
7:117251691:C:A,P13569,R1066S,0.963,Loss of MoRF binding (P = 0.045); Gain of helix (P = 0.132); Loss of catalytic residue at R1066 (P = 0.2173); Loss of methylation at R1070 (P = 0.3479); Loss of sheet (P = 0.3635)
7:117251691:C:G,P13569,R1066G,0.915,Loss of MoRF binding (P = 0.0387); Loss of catalytic residue at R1066 (P = 0.0568); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045)
7:117251692:G:A,P13569,R1066H,0.972,Loss of MoRF binding (P = 0.0397); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of catalytic residue at Q1071 (P = 0.3156); Loss of methylation at R1070 (P = 0.3536)
7:117251692:G:C,P13569,R1066P,0.933,Loss of MoRF binding (P = 0.0183); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2754); Gain of catalytic residue at Q1071 (P = 0.3161)
7:117251692:G:T,P13569,R1066L,0.961,Loss of MoRF binding (P = 0.0424); Loss of catalytic residue at R1066 (P = 0.0596); Gain of helix (P = 0.132); Loss of sheet (P = 0.1907); Loss of methylation at R1070 (P = 0.3436)
7:117251694:G:C,P13569,A1067P,0.974,Loss of MoRF binding (P = 0.0773); Loss of stability (P = 0.1274); Gain of loop (P = 0.2045); Loss of catalytic residue at A1067 (P = 0.2126); Loss of methylation at R1070 (P = 0.3435)
7:117251694:G:T,P13569,A1067S,0.905,Gain of MoRF binding (P = 0.122); Loss of stability (P = 0.2434); Gain of phosphorylation at A1067 (P = 0.2556); Gain of helix (P = 0.2684); Loss of methylation at R1070 (P = 0.3383)
7:117251695:C:A,P13569,A1067D,0.983,Loss of MoRF binding (P = 0.0825); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of methylation at R1070 (P = 0.3179); Loss of stability (P = 0.4066)
7:117251695:C:G,P13569,A1067G,0.901,Loss of stability (P = 0.0478); Loss of MoRF binding (P = 0.1536); Loss of sheet (P = 0.1907); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897)
7:117251697:T:A,P13569,F1068I,0.872,Gain of catalytic residue at F1068 (P = 0.0098); Gain of MoRF binding (P = 0.1159); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Loss of stability (P = 0.3401)
7:117251697:T:C,P13569,F1068L,0.887,Gain of catalytic residue at F1068 (P = 0.1572); Gain of MoRF binding (P = 0.1639); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.3485)
7:117251697:T:G,P13569,F1068V,0.9,Gain of MoRF binding (P = 0.0916); Loss of stability (P = 0.1077); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.3485)
7:117251698:T:A,P13569,F1068Y,0.897,Loss of stability (P = 0.0859); Gain of MoRF binding (P = 0.1671); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of catalytic residue at P1072 (P = 0.2236)
7:117251698:T:C,P13569,F1068S,0.934,Loss of stability (P = 0.0201); Gain of disorder (P = 0.0856); Gain of MoRF binding (P = 0.1107); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945)
7:117251698:T:G,P13569,F1068C,0.91,Loss of stability (P = 0.0692); Gain of catalytic residue at F1068 (P = 0.0848); Loss of MoRF binding (P = 0.1038); Gain of helix (P = 0.132); Gain of sheet (P = 0.1945)
7:117251699:C:A,P13569,F1068L,0.887,Gain of catalytic residue at F1068 (P = 0.1572); Gain of MoRF binding (P = 0.1639); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.3485)
7:117251699:C:G,P13569,F1068L,0.887,Gain of catalytic residue at F1068 (P = 0.1572); Gain of MoRF binding (P = 0.1639); Loss of helix (P = 0.1706); Gain of sheet (P = 0.1945); Gain of loop (P = 0.3485)
7:117251700:G:C,P13569,G1069R,0.925,Gain of MoRF binding (P = 0.025); Gain of catalytic residue at G1069 (P = 0.027); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of helix (P = 0.1736)
7:117251701:G:A,P13569,G1069E,0.81,Loss of MoRF binding (P = 0.0721); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Loss of helix (P = 0.1706); Loss of catalytic residue at Q1071 (P = 0.1888)
7:117251701:G:C,P13569,G1069A,0.795,Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1744); Loss of sheet (P = 0.1907); Loss of stability (P = 0.2667); Loss of loop (P = 0.2897)
7:117251701:G:T,P13569,G1069V,0.853,Gain of MoRF binding (P = 0.1058); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Loss of methylation at R1070 (P = 0.3337)
7:117251703:C:G,P13569,R1070G,0.868,Loss of MoRF binding (P = 0.0626); Gain of catalytic residue at G1069 (P = 0.1631); Loss of helix (P = 0.1706); Loss of stability (P = 0.1857); Gain of sheet (P = 0.1945)
7:117251704:G:C,P13569,R1070P,0.956,Loss of MoRF binding (P = 0.0465); Gain of catalytic residue at G1069 (P = 0.0834); Gain of helix (P = 0.132); Loss of methylation at R1070 (P = 0.2201); Gain of loop (P = 0.2754)
7:117251704:G:T,P13569,R1070L,0.874,Loss of MoRF binding (P = 0.0648); Loss of solvent accessibility (P = 0.1077); Gain of sheet (P = 0.1945); Loss of methylation at R1070 (P = 0.2201); Loss of helix (P = 0.2271)
7:117251706:C:A,P13569,Q1071K,0.867,Gain of ubiquitination at Q1071 (P = 0.0311); Gain of MoRF binding (P = 0.048); Gain of methylation at Q1071 (P = 0.1614); Loss of helix (P = 0.1706); Loss of catalytic residue at R1070 (P = 0.2691)
7:117251706:C:G,P13569,Q1071E,0.685,Loss of MoRF binding (P = 0.0895); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754); Loss of catalytic residue at T1076 (P = 0.2783); Gain of phosphorylation at T1076 (P = 0.3306)
7:117251707:A:C,P13569,Q1071P,0.923,Gain of methylation at R1070 (P = 0.1152); Loss of MoRF binding (P = 0.1169); Gain of glycosylation at Q1071 (P = 0.1206); Gain of phosphorylation at T1076 (P = 0.1634); Loss of helix (P = 0.1706)
7:117251707:A:G,P13569,Q1071R,0.828,Gain of MoRF binding (P = 0.0362); Gain of methylation at Q1071 (P = 0.0435); Loss of helix (P = 0.1706); Gain of phosphorylation at T1076 (P = 0.3024); Loss of sheet (P = 0.3635)
7:117251707:A:T,P13569,Q1071L,0.822,Gain of stability (P = 0.1167); Gain of MoRF binding (P = 0.1303); Gain of methylation at R1070 (P = 0.1464); Loss of catalytic residue at Q1071 (P = 0.1892); Loss of sheet (P = 0.1907)
7:117251708:G:C,P13569,Q1071H,0.921,Loss of catalytic residue at Q1071 (P = 0.1408); Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.2093); Gain of methylation at R1070 (P = 0.2621); Gain of loop (P = 0.2754)
7:117251708:G:T,P13569,Q1071H,0.921,Loss of catalytic residue at Q1071 (P = 0.1408); Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.2093); Gain of methylation at R1070 (P = 0.2621); Gain of loop (P = 0.2754)
7:117251709:C:A,P13569,P1072T,0.4,Gain of phosphorylation at P1072 (P = 0.062); Gain of MoRF binding (P = 0.0742); Gain of helix (P = 0.2294); Gain of loop (P = 0.2754); Gain of methylation at R1070 (P = 0.3145)
7:117251709:C:G,P13569,P1072A,0.485,Gain of MoRF binding (P = 0.0662); Gain of methylation at R1070 (P = 0.1683); Loss of loop (P = 0.2237); Loss of helix (P = 0.3949); Gain of catalytic residue at P1072 (P = 0.4011)
7:117251709:C:T,P13569,P1072S,0.45,Gain of MoRF binding (P = 0.0684); Gain of helix (P = 0.132); Loss of catalytic residue at P1072 (P = 0.2236); Gain of loop (P = 0.2754); Gain of phosphorylation at P1072 (P = 0.3373)
7:117251710:C:A,P13569,P1072H,0.58,Gain of MoRF binding (P = 0.0893); Gain of methylation at R1070 (P = 0.184); Loss of relative solvent accessibility (P = 0.1903); Gain of catalytic residue at R1070 (P = 0.2513); Loss of loop (P = 0.2897)
7:117251710:C:G,P13569,P1072R,0.571,Gain of MoRF binding (P = 0.0115); Gain of helix (P = 0.1736); Gain of catalytic residue at P1072 (P = 0.2093); Loss of loop (P = 0.2237); Gain of solvent accessibility (P = 0.2601)
7:117251710:C:T,P13569,P1072L,0.837,Gain of MoRF binding (P = 0.055); Loss of relative solvent accessibility (P = 0.1903); Loss of catalytic residue at P1072 (P = 0.2141); Loss of loop (P = 0.2237); Loss of helix (P = 0.2271)
7:117251712:T:A,P13569,Y1073N,0.675,Gain of helix (P = 0.132); Gain of disorder (P = 0.1654); Gain of MoRF binding (P = 0.1958); Loss of catalytic residue at E1075 (P = 0.2282); Loss of stability (P = 0.2893)
7:117251712:T:C,P13569,Y1073H,0.732,Gain of disorder (P = 0.152); Gain of helix (P = 0.1736); Loss of stability (P = 0.2311); Gain of MoRF binding (P = 0.2424); Loss of loop (P = 0.2897)
7:117251712:T:G,P13569,Y1073D,0.732,Gain of disorder (P = 0.0575); Gain of helix (P = 0.132); Gain of phosphorylation at T1076 (P = 0.1764); Loss of MoRF binding (P = 0.2391); Loss of catalytic residue at Q1071 (P = 0.2536)
7:117251713:A:C,P13569,Y1073S,0.681,Gain of disorder (P = 0.0278); Gain of helix (P = 0.1736); Loss of stability (P = 0.1831); Gain of MoRF binding (P = 0.2221); Gain of phosphorylation at T1076 (P = 0.288)
7:117251713:A:G,P13569,Y1073C,0.898,Gain of catalytic residue at Y1073 (P = 0.0217); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.2667); Loss of loop (P = 0.2897); Loss of solvent accessibility (P = 0.3368)
7:117251713:A:T,P13569,Y1073F,0.773,Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2633); Loss of loop (P = 0.2897); Loss of solvent accessibility (P = 0.2953); Loss of methylation at R1070 (P = 0.3771)
7:117251715:T:A,P13569,F1074I,0.811,Loss of catalytic residue at P1072 (P = 0.2582); Gain of helix (P = 0.2684); Gain of MoRF binding (P = 0.2729); Loss of loop (P = 0.3664); Loss of methylation at R1070 (P = 0.3804)
7:117251715:T:C,P13569,F1074L,0.899,Loss of helix (P = 0.1299); Loss of catalytic residue at P1072 (P = 0.2352); Gain of MoRF binding (P = 0.2961); Loss of methylation at R1070 (P = 0.3835); Loss of phosphorylation at T1076 (P = 0.4833)
7:117251715:T:G,P13569,F1074V,0.769,Loss of helix (P = 0.1299); Loss of catalytic residue at P1072 (P = 0.2352); Gain of MoRF binding (P = 0.2559); Loss of loop (P = 0.3664); Loss of methylation at R1070 (P = 0.3796)
7:117251716:T:A,P13569,F1074Y,0.745,Loss of helix (P = 0.1299); Gain of catalytic residue at F1074 (P = 0.2237); Gain of MoRF binding (P = 0.2975); Gain of phosphorylation at T1076 (P = 0.319); Loss of loop (P = 0.3664)
7:117251716:T:C,P13569,F1074S,0.691,Gain of disorder (P = 0.0168); Gain of relative solvent accessibility (P = 0.09); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.1846); Loss of stability (P = 0.2065)
7:117251716:T:G,P13569,F1074C,0.843,Gain of catalytic residue at T1076 (P = 0.2004); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897); Loss of MoRF binding (P = 0.2932); Loss of methylation at R1070 (P = 0.3723)
7:117251717:T:G,P13569,F1074L,0.899,Loss of helix (P = 0.1299); Loss of catalytic residue at P1072 (P = 0.2352); Gain of MoRF binding (P = 0.2961); Loss of methylation at R1070 (P = 0.3835); Loss of phosphorylation at T1076 (P = 0.4833)
7:117251718:G:A,P13569,E1075K,0.73,Gain of MoRF binding (P = 0.0155); Gain of ubiquitination at E1075 (P = 0.0276); Loss of stability (P = 0.1983); Loss of catalytic residue at E1075 (P = 0.2266); Gain of methylation at R1070 (P = 0.294)
7:117251718:G:C,P13569,E1075Q,0.656,Loss of ubiquitination at K1080 (P = 0.0705); Gain of MoRF binding (P = 0.096); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.3473); Loss of methylation at R1070 (P = 0.3849)
7:117251719:A:C,P13569,E1075A,0.689,Loss of ubiquitination at K1080 (P = 0.0566); Gain of MoRF binding (P = 0.0831); Loss of helix (P = 0.1299); Loss of stability (P = 0.1801); Gain of methylation at R1070 (P = 0.2458)
7:117251719:A:G,P13569,E1075G,0.666,Loss of ubiquitination at K1080 (P = 0.0615); Loss of stability (P = 0.0819); Gain of MoRF binding (P = 0.0865); Gain of catalytic residue at K1080 (P = 0.2547); Gain of methylation at R1070 (P = 0.2793)
7:117251719:A:T,P13569,E1075V,0.709,Loss of ubiquitination at K1080 (P = 0.0437); Gain of MoRF binding (P = 0.0578); Loss of catalytic residue at E1075 (P = 0.2521); Loss of helix (P = 0.2662); Loss of loop (P = 0.2897)
7:117251720:A:C,P13569,E1075D,0.552,Loss of ubiquitination at K1080 (P = 0.1576); Loss of catalytic residue at E1075 (P = 0.2245); Gain of MoRF binding (P = 0.2828); Loss of loop (P = 0.2897); Loss of methylation at R1070 (P = 0.3856)
7:117251720:A:T,P13569,E1075D,0.552,Loss of ubiquitination at K1080 (P = 0.1576); Loss of catalytic residue at E1075 (P = 0.2245); Gain of MoRF binding (P = 0.2828); Loss of loop (P = 0.2897); Loss of methylation at R1070 (P = 0.3856)
7:117251721:A:C,P13569,T1076P,0.616,Loss of stability (P = 0.0938); Loss of ubiquitination at K1080 (P = 0.1087); Loss of helix (P = 0.2271); Loss of phosphorylation at T1076 (P = 0.2915); Loss of MoRF binding (P = 0.3841)
7:117251721:A:G,P13569,T1076A,0.505,Gain of helix (P = 0.132); Loss of ubiquitination at K1080 (P = 0.1828); Loss of stability (P = 0.2675); Loss of phosphorylation at T1076 (P = 0.2915); Loss of catalytic residue at T1076 (P = 0.2978)
7:117251721:A:T,P13569,T1076S,0.462,Loss of ubiquitination at K1080 (P = 0.0795); Gain of helix (P = 0.132); Loss of catalytic residue at T1076 (P = 0.2061); Loss of stability (P = 0.2705); Loss of phosphorylation at T1076 (P = 0.3611)
7:117251722:C:A,P13569,T1076N,0.423,Loss of ubiquitination at K1080 (P = 0.092); Loss of catalytic residue at T1076 (P = 0.1411); Loss of helix (P = 0.2271); Loss of stability (P = 0.2907); Loss of phosphorylation at T1076 (P = 0.2915)
7:117251722:C:G,P13569,T1076S,0.462,Loss of ubiquitination at K1080 (P = 0.0795); Gain of helix (P = 0.132); Loss of catalytic residue at T1076 (P = 0.2061); Loss of stability (P = 0.2705); Loss of phosphorylation at T1076 (P = 0.3611)
7:117251722:C:T,P13569,T1076I,0.555,Gain of ubiquitination at K1080 (P = 0.1679); Gain of catalytic residue at A1081 (P = 0.2262); Loss of phosphorylation at T1076 (P = 0.2915); Gain of MoRF binding (P = 0.3574); Loss of helix (P = 0.3949)
7:117251724:C:A,P13569,L1077M,0.497,Loss of ubiquitination at K1080 (P = 0.1828); Loss of stability (P = 0.2669); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4073); Gain of phosphorylation at T1076 (P = 0.419)
7:117251724:C:G,P13569,L1077V,0.525,Gain of relative solvent accessibility (P = 0.1259); Loss of ubiquitination at K1080 (P = 0.1296); Loss of stability (P = 0.1611); Gain of solvent accessibility (P = 0.2601); Loss of loop (P = 0.2897)
7:117251725:T:A,P13569,L1077Q,0.56,Loss of stability (P = 0.055); Loss of ubiquitination at K1080 (P = 0.0705); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1846); Loss of helix (P = 0.2271)
7:117251725:T:G,P13569,L1077R,0.656,Gain of methylation at L1077 (P = 0.0169); Gain of catalytic residue at L1077 (P = 0.0235); Loss of stability (P = 0.0422); Loss of ubiquitination at K1080 (P = 0.0566); Gain of MoRF binding (P = 0.0652)
7:117251727:T:A,P13569,F1078I,0.777,Loss of ubiquitination at K1080 (P = 0.0795); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of stability (P = 0.4315); Gain of catalytic residue at L1082 (P = 0.4412)
7:117251727:T:C,P13569,F1078L,0.801,Loss of ubiquitination at K1080 (P = 0.0502); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of stability (P = 0.3321); Gain of catalytic residue at F1078 (P = 0.4412)
7:117251727:T:G,P13569,F1078V,0.779,Loss of ubiquitination at K1080 (P = 0.0705); Gain of catalytic residue at F1078 (P = 0.0857); Loss of helix (P = 0.2022); Loss of stability (P = 0.2731); Gain of loop (P = 0.2754)
7:117251728:T:A,P13569,F1078Y,0.719,Loss of ubiquitination at K1080 (P = 0.092); Loss of stability (P = 0.1475); Loss of helix (P = 0.2022); Gain of phosphorylation at F1078 (P = 0.3337); Loss of MoRF binding (P = 0.5153)
7:117251728:T:C,P13569,F1078S,0.852,Gain of disorder (P = 0.021); Loss of stability (P = 0.0328); Loss of ubiquitination at K1080 (P = 0.0795); Loss of helix (P = 0.2022); Gain of phosphorylation at T1076 (P = 0.3439)
7:117251728:T:G,P13569,F1078C,0.816,Loss of ubiquitination at K1080 (P = 0.1087); Loss of stability (P = 0.173); Loss of helix (P = 0.2022); Gain of catalytic residue at H1079 (P = 0.2831); Gain of phosphorylation at T1076 (P = 0.481)
7:117251729:C:A,P13569,F1078L,0.801,Loss of ubiquitination at K1080 (P = 0.0502); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of stability (P = 0.3321); Gain of catalytic residue at F1078 (P = 0.4412)
7:117251729:C:G,P13569,F1078L,0.801,Loss of ubiquitination at K1080 (P = 0.0502); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of stability (P = 0.3321); Gain of catalytic residue at F1078 (P = 0.4412)
7:117251730:C:A,P13569,H1079N,0.561,Loss of ubiquitination at K1080 (P = 0.092); Loss of catalytic residue at K1080 (P = 0.1843); Loss of helix (P = 0.2271); Gain of relative solvent accessibility (P = 0.2629); Gain of MoRF binding (P = 0.4284)
7:117251730:C:G,P13569,H1079D,0.595,Loss of ubiquitination at K1080 (P = 0.0705); Loss of catalytic residue at K1080 (P = 0.2163); Loss of helix (P = 0.2271); Gain of relative solvent accessibility (P = 0.2629); Loss of loop (P = 0.2897)
7:117251730:C:T,P13569,H1079Y,0.676,Loss of ubiquitination at K1080 (P = 0.1087); Gain of helix (P = 0.2059); Gain of catalytic residue at H1079 (P = 0.2074); Loss of loop (P = 0.2897); Gain of MoRF binding (P = 0.4467)
7:117251731:A:C,P13569,H1079P,0.887,Gain of glycosylation at H1079 (P = 0.0735); Loss of ubiquitination at K1080 (P = 0.1087); Gain of catalytic residue at H1079 (P = 0.1884); Gain of helix (P = 0.2059); Gain of relative solvent accessibility (P = 0.2629)
7:117251731:A:G,P13569,H1079R,0.644,Loss of ubiquitination at K1080 (P = 0.0422); Gain of MoRF binding (P = 0.0759); Gain of solvent accessibility (P = 0.1903); Gain of helix (P = 0.2059); Loss of catalytic residue at E1075 (P = 0.2127)
7:117251731:A:T,P13569,H1079L,0.637,Loss of ubiquitination at K1080 (P = 0.1296); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Loss of catalytic residue at K1080 (P = 0.3903); Loss of phosphorylation at T1076 (P = 0.417)
7:117251732:C:A,P13569,H1079Q,0.555,Loss of ubiquitination at K1080 (P = 0.0795); Loss of catalytic residue at E1075 (P = 0.2014); Gain of helix (P = 0.2059); Gain of relative solvent accessibility (P = 0.2629); Loss of loop (P = 0.2897)
7:117251732:C:G,P13569,H1079Q,0.555,Loss of ubiquitination at K1080 (P = 0.0795); Loss of catalytic residue at E1075 (P = 0.2014); Gain of helix (P = 0.2059); Gain of relative solvent accessibility (P = 0.2629); Loss of loop (P = 0.2897)
7:117251733:A:C,P13569,K1080Q,0.521,Loss of ubiquitination at K1080 (P = 0.011); Gain of catalytic residue at K1080 (P = 0.2308); Loss of glycosylation at K1080 (P = 0.3516); Loss of MoRF binding (P = 0.394); Loss of helix (P = 0.4763)
7:117251733:A:G,P13569,K1080E,0.517,Loss of ubiquitination at K1080 (P = 0.011); Loss of helix (P = 0.2022); Loss of glycosylation at K1080 (P = 0.3516); Loss of MoRF binding (P = 0.357); Gain of phosphorylation at T1076 (P = 0.4346)
7:117251734:A:C,P13569,K1080T,0.579,Loss of ubiquitination at K1080 (P = 0.011); Gain of phosphorylation at T1076 (P = 0.1702); Loss of MoRF binding (P = 0.3909); Gain of catalytic residue at H1085 (P = 0.3998); Loss of stability (P = 0.4358)
7:117251734:A:G,P13569,K1080R,0.475,Loss of ubiquitination at K1080 (P = 0.011); Gain of methylation at K1080 (P = 0.2534); Loss of glycosylation at K1080 (P = 0.3516); Gain of MoRF binding (P = 0.3564); Gain of phosphorylation at T1076 (P = 0.4369)
7:117251734:A:T,P13569,K1080I,0.636,Loss of ubiquitination at K1080 (P = 0.011); Loss of solvent accessibility (P = 0.1986); Gain of helix (P = 0.2294); Gain of catalytic residue at H1085 (P = 0.248); Loss of glycosylation at K1080 (P = 0.3516)
7:117251735:A:C,P13569,K1080N,0.517,Loss of ubiquitination at K1080 (P = 0.011); Loss of helix (P = 0.2022); Gain of catalytic residue at K1080 (P = 0.3062); Loss of glycosylation at K1080 (P = 0.3516); Loss of MoRF binding (P = 0.3938)
7:117251735:A:T,P13569,K1080N,0.517,Loss of ubiquitination at K1080 (P = 0.011); Loss of helix (P = 0.2022); Gain of catalytic residue at K1080 (P = 0.3062); Loss of glycosylation at K1080 (P = 0.3516); Loss of MoRF binding (P = 0.3938)
7:117251736:G:A,P13569,A1081T,0.706,Loss of ubiquitination at K1080 (P = 0.1087); Gain of catalytic residue at K1080 (P = 0.3242); Gain of glycosylation at T1086 (P = 0.3398); Loss of MoRF binding (P = 0.3935); Loss of phosphorylation at T1076 (P = 0.4754)
7:117251736:G:C,P13569,A1081P,0.936,Loss of ubiquitination at K1080 (P = 0.0566); Gain of catalytic residue at L1082 (P = 0.2864); Gain of phosphorylation at T1076 (P = 0.3274); Loss of MoRF binding (P = 0.3559); Loss of stability (P = 0.3684)
7:117251736:G:T,P13569,A1081S,0.724,Loss of ubiquitination at K1080 (P = 0.0705); Loss of helix (P = 0.2022); Gain of catalytic residue at L1077 (P = 0.2537); Gain of disorder (P = 0.3578); Gain of MoRF binding (P = 0.3781)
7:117251737:C:A,P13569,A1081D,0.789,Loss of ubiquitination at K1080 (P = 0.0795); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Loss of helix (P = 0.2022); Gain of glycosylation at T1086 (P = 0.2296)
7:117251737:C:G,P13569,A1081G,0.719,Loss of ubiquitination at K1080 (P = 0.0795); Gain of catalytic residue at L1082 (P = 0.1925); Gain of glycosylation at K1080 (P = 0.2258); Loss of stability (P = 0.2609); Gain of MoRF binding (P = 0.3863)
7:117251737:C:T,P13569,A1081V,0.714,Loss of ubiquitination at K1080 (P = 0.1296); Gain of MoRF binding (P = 0.3269); Loss of catalytic residue at T1076 (P = 0.407); Loss of phosphorylation at T1076 (P = 0.4407); Loss of helix (P = 0.4763)
7:117251739:C:A,P13569,L1082M,0.689,Loss of ubiquitination at K1080 (P = 0.1296); Loss of catalytic residue at L1082 (P = 0.1316); Loss of stability (P = 0.2696); Gain of MoRF binding (P = 0.3168); Gain of loop (P = 0.4661)
7:117251739:C:G,P13569,L1082V,0.731,Loss of stability (P = 0.0741); Loss of ubiquitination at K1080 (P = 0.1576); Loss of catalytic residue at L1082 (P = 0.2765); Gain of MoRF binding (P = 0.2954); Gain of glycosylation at T1086 (P = 0.438)
7:117251740:T:A,P13569,L1082Q,0.779,Loss of stability (P = 0.0213); Loss of ubiquitination at K1080 (P = 0.0705); Gain of catalytic residue at L1082 (P = 0.1492); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2201)
7:117251740:T:C,P13569,L1082P,0.856,Loss of stability (P = 0.0079); Loss of ubiquitination at K1080 (P = 0.0502); Gain of disorder (P = 0.1388); Loss of catalytic residue at L1082 (P = 0.1757); Loss of helix (P = 0.2271)
7:117251740:T:G,P13569,L1082R,0.872,Loss of stability (P = 0.017); Gain of methylation at L1082 (P = 0.0285); Loss of ubiquitination at K1080 (P = 0.0355); Gain of MoRF binding (P = 0.0608); Gain of relative solvent accessibility (P = 0.1259)
7:117251742:A:C,P13569,N1083H,0.653,Loss of ubiquitination at K1080 (P = 0.1576); Loss of catalytic residue at N1083 (P = 0.1662); Loss of stability (P = 0.2307); Loss of MoRF binding (P = 0.2823); Gain of glycosylation at K1080 (P = 0.3087)
7:117251742:A:G,P13569,N1083D,0.628,Loss of ubiquitination at K1080 (P = 0.1576); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.2397); Gain of catalytic residue at N1088 (P = 0.2955); Loss of stability (P = 0.3532)
7:117251742:A:T,P13569,N1083Y,0.695,Loss of ubiquitination at K1080 (P = 0.1576); Loss of MoRF binding (P = 0.293); Gain of catalytic residue at N1083 (P = 0.3772); Loss of helix (P = 0.4763); Gain of glycosylation at K1080 (P = 0.4918)
7:117251743:A:C,P13569,N1083T,0.69,Loss of ubiquitination at K1080 (P = 0.1828); Loss of stability (P = 0.2081); Gain of catalytic residue at N1083 (P = 0.2746); Loss of MoRF binding (P = 0.289); Gain of glycosylation at K1080 (P = 0.4365)
7:117251743:A:G,P13569,N1083S,0.642,Loss of ubiquitination at K1080 (P = 0.1828); Loss of stability (P = 0.2477); Loss of MoRF binding (P = 0.2966); Loss of catalytic residue at N1083 (P = 0.2991); Gain of loop (P = 0.4661)
7:117251743:A:T,P13569,N1083I,0.71,Loss of ubiquitination at K1080 (P = 0.1828); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.2767); Gain of catalytic residue at A1087 (P = 0.3393); Gain of glycosylation at K1080 (P = 0.3502)
7:117251744:T:A,P13569,N1083K,0.666,Gain of ubiquitination at N1083 (P = 0.0289); Gain of MoRF binding (P = 0.0714); Loss of helix (P = 0.2022); Loss of stability (P = 0.2777); Gain of solvent accessibility (P = 0.3194)
7:117251744:T:G,P13569,N1083K,0.666,Gain of ubiquitination at N1083 (P = 0.0289); Gain of MoRF binding (P = 0.0714); Loss of helix (P = 0.2022); Loss of stability (P = 0.2777); Gain of solvent accessibility (P = 0.3194)
7:117251745:T:A,P13569,L1084I,0.47,Loss of ubiquitination at K1080 (P = 0.1296); Gain of MoRF binding (P = 0.2124); Gain of glycosylation at T1086 (P = 0.2181); Loss of helix (P = 0.2271); Loss of stability (P = 0.3857)
7:117251745:T:G,P13569,L1084V,0.528,Loss of ubiquitination at K1080 (P = 0.1576); Loss of stability (P = 0.1784); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2294); Gain of catalytic residue at H1085 (P = 0.3753)
7:117251746:T:C,P13569,L1084S,0.429,Loss of stability (P = 0.0118); Gain of disorder (P = 0.155); Loss of ubiquitination at K1080 (P = 0.1576); Loss of helix (P = 0.2022); Gain of relative solvent accessibility (P = 0.2363)
7:117251747:A:C,P13569,L1084F,0.441,Loss of ubiquitination at K1080 (P = 0.1296); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.2352); Loss of stability (P = 0.262); Gain of loop (P = 0.2754)
7:117251747:A:T,P13569,L1084F,0.441,Loss of ubiquitination at K1080 (P = 0.1296); Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.2352); Loss of stability (P = 0.262); Gain of loop (P = 0.2754)
7:117251748:C:A,P13569,H1085N,0.749,Loss of ubiquitination at K1080 (P = 0.1828); Gain of MoRF binding (P = 0.1934); Loss of helix (P = 0.2022); Loss of catalytic residue at W1089 (P = 0.3828); Loss of stability (P = 0.4158)
7:117251748:C:G,P13569,H1085D,0.77,Gain of relative solvent accessibility (P = 0.09); Loss of ubiquitination at K1080 (P = 0.1296); Gain of solvent accessibility (P = 0.1376); Gain of catalytic residue at H1085 (P = 0.1457); Loss of MoRF binding (P = 0.1601)
7:117251748:C:T,P13569,H1085Y,0.756,Loss of ubiquitination at K1080 (P = 0.1828); Gain of MoRF binding (P = 0.2193); Gain of glycosylation at T1086 (P = 0.4389); Loss of catalytic residue at W1089 (P = 0.4574); Gain of loop (P = 0.4661)
7:117251749:A:C,P13569,H1085P,0.783,Gain of glycosylation at T1086 (P = 0.0471); Loss of MoRF binding (P = 0.1468); Loss of ubiquitination at K1080 (P = 0.1828); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117251749:A:G,P13569,H1085R,0.93,Gain of MoRF binding (P = 0.02); Loss of ubiquitination at K1080 (P = 0.0524); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Loss of catalytic residue at W1089 (P = 0.2031)
7:117251749:A:T,P13569,H1085L,0.696,Loss of ubiquitination at K1080 (P = 0.1296); Gain of MoRF binding (P = 0.2072); Gain of glycosylation at T1086 (P = 0.4097); Loss of catalytic residue at L1082 (P = 0.4726); Loss of helix (P = 0.4763)
7:117251750:T:A,P13569,H1085Q,0.75,Gain of catalytic residue at H1085 (P = 0.084); Loss of ubiquitination at K1080 (P = 0.1828); Gain of MoRF binding (P = 0.1845); Loss of helix (P = 0.4763); Loss of stability (P = 0.5153)
7:117251750:T:G,P13569,H1085Q,0.75,Gain of catalytic residue at H1085 (P = 0.084); Loss of ubiquitination at K1080 (P = 0.1828); Gain of MoRF binding (P = 0.1845); Loss of helix (P = 0.4763); Loss of stability (P = 0.5153)
7:117251751:A:C,P13569,T1086P,0.747,Loss of MoRF binding (P = 0.1031); Loss of helix (P = 0.2022); Loss of catalytic residue at T1086 (P = 0.2056); Gain of loop (P = 0.2754); Loss of stability (P = 0.5303)
7:117251751:A:G,P13569,T1086A,0.872,Gain of MoRF binding (P = 0.2019); Loss of helix (P = 0.2271); Loss of glycosylation at T1086 (P = 0.3805); Gain of loop (P = 0.4661); Gain of catalytic residue at T1086 (P = 0.5011)
7:117251752:C:A,P13569,T1086N,0.733,Gain of catalytic residue at T1086 (P = 0.1123); Loss of MoRF binding (P = 0.2093); Loss of helix (P = 0.2271); Loss of glycosylation at T1086 (P = 0.3805); Gain of loop (P = 0.4661)
7:117251752:C:G,P13569,T1086S,0.706,Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.2071); Gain of catalytic residue at T1086 (P = 0.2893); Gain of loop (P = 0.4661); Loss of glycosylation at T1086 (P = 0.5417)
7:117251752:C:T,P13569,T1086I,0.914,Gain of MoRF binding (P = 0.086); Gain of catalytic residue at L1091 (P = 0.148); Loss of helix (P = 0.2271); Loss of glycosylation at T1086 (P = 0.3805); Gain of loop (P = 0.4661)
7:117251754:G:A,P13569,A1087T,0.584,Gain of glycosylation at A1087 (P = 0.0418); Gain of catalytic residue at F1090 (P = 0.1383); Loss of MoRF binding (P = 0.1825); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117251754:G:C,P13569,A1087P,0.865,Loss of MoRF binding (P = 0.084); Loss of catalytic residue at A1087 (P = 0.0942); Gain of glycosylation at A1087 (P = 0.1971); Loss of helix (P = 0.2022); Loss of stability (P = 0.2767)
7:117251754:G:T,P13569,A1087S,0.503,Gain of MoRF binding (P = 0.1652); Loss of helix (P = 0.2022); Gain of glycosylation at A1087 (P = 0.2526); Loss of catalytic residue at A1087 (P = 0.3382); Loss of stability (P = 0.3612)
7:117251755:C:A,P13569,A1087D,0.58,Loss of MoRF binding (P = 0.0896); Loss of helix (P = 0.2022); Loss of catalytic residue at N1088 (P = 0.2036); Gain of loop (P = 0.2754); Gain of solvent accessibility (P = 0.3602)
7:117251755:C:G,P13569,A1087G,0.507,Loss of stability (P = 0.075); Gain of MoRF binding (P = 0.1847); Gain of helix (P = 0.2294); Gain of catalytic residue at T1086 (P = 0.244); Loss of glycosylation at T1086 (P = 0.5717)
7:117251755:C:T,P13569,A1087V,0.556,Gain of MoRF binding (P = 0.1171); Loss of helix (P = 0.2271); Gain of catalytic residue at A1087 (P = 0.3047); Gain of glycosylation at T1086 (P = 0.5832); Loss of phosphorylation at T1086 (P = 0.748)
7:117251757:A:C,P13569,N1088H,0.758,Loss of MoRF binding (P = 0.1199); Loss of stability (P = 0.1384); Loss of helix (P = 0.2022); Gain of glycosylation at T1086 (P = 0.3401); Gain of catalytic residue at F1090 (P = 0.3708)
7:117251757:A:G,P13569,N1088D,0.884,Loss of MoRF binding (P = 0.0746); Gain of relative solvent accessibility (P = 0.1571); Loss of helix (P = 0.2271); Gain of solvent accessibility (P = 0.2384); Loss of catalytic residue at W1089 (P = 0.3069)
7:117251757:A:T,P13569,N1088Y,0.745,Loss of MoRF binding (P = 0.1367); Loss of helix (P = 0.2271); Loss of stability (P = 0.3596); Gain of catalytic residue at N1088 (P = 0.5632); Gain of glycosylation at T1086 (P = 0.5718)
7:117251758:A:C,P13569,N1088T,0.664,Loss of MoRF binding (P = 0.136); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of stability (P = 0.2966); Gain of glycosylation at N1088 (P = 0.3725)
7:117251758:A:G,P13569,N1088S,0.682,Loss of MoRF binding (P = 0.1496); Loss of helix (P = 0.2022); Loss of stability (P = 0.2442); Gain of catalytic residue at L1084 (P = 0.3041); Gain of loop (P = 0.4661)
7:117251758:A:T,P13569,N1088I,0.716,Gain of catalytic residue at L1093 (P = 0.0608); Gain of MoRF binding (P = 0.1151); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of glycosylation at T1086 (P = 0.5898)
7:117251759:C:A,P13569,N1088K,0.799,Gain of ubiquitination at N1088 (P = 0.0247); Gain of MoRF binding (P = 0.0325); Loss of stability (P = 0.1348); Loss of helix (P = 0.2022); Loss of catalytic residue at W1089 (P = 0.2213)
7:117251759:C:G,P13569,N1088K,0.799,Gain of ubiquitination at N1088 (P = 0.0247); Gain of MoRF binding (P = 0.0325); Loss of stability (P = 0.1348); Loss of helix (P = 0.2022); Loss of catalytic residue at W1089 (P = 0.2213)
7:117251760:T:A,P13569,W1089R,0.935,Gain of methylation at W1089 (P = 0.0077); Gain of MoRF binding (P = 0.0851); Loss of catalytic residue at N1088 (P = 0.1974); Gain of phosphorylation at T1086 (P = 0.2625); Loss of stability (P = 0.297)
7:117251760:T:C,P13569,W1089R,0.935,Gain of methylation at W1089 (P = 0.0077); Gain of MoRF binding (P = 0.0851); Loss of catalytic residue at N1088 (P = 0.1974); Gain of phosphorylation at T1086 (P = 0.2625); Loss of stability (P = 0.297)
7:117251760:T:G,P13569,W1089G,0.835,Loss of MoRF binding (P = 0.0585); Loss of stability (P = 0.0692); Loss of helix (P = 0.2022); Gain of catalytic residue at F1090 (P = 0.3897); Gain of loop (P = 0.4661)
7:117251761:G:C,P13569,W1089S,0.829,Loss of MoRF binding (P = 0.0594); Loss of helix (P = 0.2022); Loss of stability (P = 0.2244); Loss of catalytic residue at W1089 (P = 0.2465); Gain of loop (P = 0.2754)
7:117251761:G:T,P13569,W1089L,0.796,Loss of catalytic residue at W1089 (P = 0.0528); Loss of MoRF binding (P = 0.0626); Loss of helix (P = 0.2022); Loss of glycosylation at T1086 (P = 0.6069); Gain of phosphorylation at T1086 (P = 0.6495)
7:117251762:G:T,P13569,W1089C,0.865,Loss of MoRF binding (P = 0.0511); Loss of helix (P = 0.2271); Loss of stability (P = 0.2713); Gain of catalytic residue at S1094 (P = 0.3813); Loss of glycosylation at T1086 (P = 0.5448)
7:117251763:T:A,P13569,F1090I,0.718,Gain of MoRF binding (P = 0.1446); Gain of helix (P = 0.2059); Gain of catalytic residue at S1094 (P = 0.3684); Gain of glycosylation at T1086 (P = 0.5929); Loss of phosphorylation at T1086 (P = 0.7499)
7:117251763:T:C,P13569,F1090L,0.769,Loss of MoRF binding (P = 0.1277); Gain of helix (P = 0.2059); Loss of catalytic residue at A1087 (P = 0.5224); Gain of glycosylation at T1086 (P = 0.5683); Gain of phosphorylation at T1086 (P = 0.7012)
7:117251763:T:G,P13569,F1090V,0.709,Gain of MoRF binding (P = 0.1518); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of stability (P = 0.5395); Gain of glycosylation at T1086 (P = 0.5442)
7:117251764:T:A,P13569,F1090Y,0.822,Loss of MoRF binding (P = 0.1373); Gain of helix (P = 0.2059); Gain of catalytic residue at F1090 (P = 0.3128); Gain of loop (P = 0.4661); Gain of glycosylation at T1086 (P = 0.4908)
7:117251764:T:C,P13569,F1090S,0.845,Loss of stability (P = 0.1523); Gain of MoRF binding (P = 0.1548); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Gain of glycosylation at T1086 (P = 0.4624)
7:117251764:T:G,P13569,F1090C,0.836,Gain of catalytic residue at L1091 (P = 0.0599); Loss of MoRF binding (P = 0.1084); Gain of helix (P = 0.2059); Loss of stability (P = 0.3415); Gain of glycosylation at T1086 (P = 0.4793)
7:117251765:C:A,P13569,F1090L,0.769,Loss of MoRF binding (P = 0.1277); Gain of helix (P = 0.2059); Loss of catalytic residue at A1087 (P = 0.5224); Gain of glycosylation at T1086 (P = 0.5683); Gain of phosphorylation at T1086 (P = 0.7012)
7:117251765:C:G,P13569,F1090L,0.769,Loss of MoRF binding (P = 0.1277); Gain of helix (P = 0.2059); Loss of catalytic residue at A1087 (P = 0.5224); Gain of glycosylation at T1086 (P = 0.5683); Gain of phosphorylation at T1086 (P = 0.7012)
7:117251766:T:A,P13569,L1091M,0.502,Gain of MoRF binding (P = 0.1348); Loss of stability (P = 0.2311); Loss of helix (P = 0.3949); Gain of solvent accessibility (P = 0.571); Loss of catalytic residue at N1088 (P = 0.5905)
7:117251766:T:G,P13569,L1091V,0.55,Gain of MoRF binding (P = 0.1093); Loss of stability (P = 0.2105); Gain of catalytic residue at L1091 (P = 0.3644); Loss of helix (P = 0.3949); Gain of glycosylation at T1086 (P = 0.57)
7:117251767:T:C,P13569,L1091S,0.507,Loss of stability (P = 0.0175); Gain of catalytic residue at L1091 (P = 0.0435); Loss of MoRF binding (P = 0.1534); Gain of relative solvent accessibility (P = 0.2751); Loss of loop (P = 0.2897)
7:117251767:T:G,P13569,L1091W,0.651,Gain of MoRF binding (P = 0.0269); Loss of stability (P = 0.0584); Loss of helix (P = 0.2022); Gain of catalytic residue at L1091 (P = 0.2636); Gain of solvent accessibility (P = 0.4821)
7:117251768:G:C,P13569,L1091F,0.564,Gain of MoRF binding (P = 0.1238); Loss of stability (P = 0.1479); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.5485); Gain of glycosylation at T1086 (P = 0.6121)
7:117251768:G:T,P13569,L1091F,0.564,Gain of MoRF binding (P = 0.1238); Loss of stability (P = 0.1479); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.5485); Gain of glycosylation at T1086 (P = 0.6121)
7:117251769:T:A,P13569,Y1092N,0.807,Loss of stability (P = 0.1059); Gain of MoRF binding (P = 0.12); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Gain of methylation at R1097 (P = 0.2868)
7:117251769:T:G,P13569,Y1092D,0.823,Loss of MoRF binding (P = 0.0726); Gain of relative solvent accessibility (P = 0.1259); Gain of helix (P = 0.2059); Gain of solvent accessibility (P = 0.2291); Loss of stability (P = 0.2469)
7:117251770:A:C,P13569,Y1092S,0.739,Loss of stability (P = 0.1182); Gain of MoRF binding (P = 0.1378); Gain of helix (P = 0.2059); Loss of catalytic residue at Y1092 (P = 0.2444); Gain of methylation at R1097 (P = 0.2829)
7:117251770:A:G,P13569,Y1092C,0.846,Gain of catalytic residue at L1093 (P = 0.0186); Loss of MoRF binding (P = 0.1236); Gain of helix (P = 0.2059); Loss of methylation at R1097 (P = 0.2953); Loss of stability (P = 0.419)
7:117251770:A:T,P13569,Y1092F,0.815,Loss of catalytic residue at Y1092 (P = 0.1007); Gain of MoRF binding (P = 0.1037); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.2932); Loss of stability (P = 0.4276)
7:117251772:C:A,P13569,L1093M,0.674,Gain of catalytic residue at L1093 (P = 0.0041); Gain of MoRF binding (P = 0.1234); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.3042); Gain of sheet (P = 0.6509)
7:117251772:C:G,P13569,L1093V,0.69,Gain of MoRF binding (P = 0.1074); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.305); Gain of catalytic residue at L1093 (P = 0.3558); Gain of sheet (P = 0.6509)
7:117251773:T:A,P13569,L1093Q,0.757,Gain of MoRF binding (P = 0.0999); Loss of stability (P = 0.1476); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2791); Loss of catalytic residue at N1088 (P = 0.3004)
7:117251773:T:C,P13569,L1093P,0.942,Loss of MoRF binding (P = 0.0657); Loss of stability (P = 0.0893); Loss of helix (P = 0.2022); Gain of methylation at R1097 (P = 0.2933); Gain of loop (P = 0.4661)
7:117251773:T:G,P13569,L1093R,0.931,Gain of MoRF binding (P = 0.0075); Gain of methylation at L1093 (P = 0.0668); Gain of catalytic residue at L1093 (P = 0.0669); Loss of stability (P = 0.1537); Loss of helix (P = 0.2022)
7:117251775:T:A,P13569,S1094T,0.634,Gain of catalytic residue at S1094 (P = 0.0914); Loss of stability (P = 0.1136); Loss of MoRF binding (P = 0.1355); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.3106)
7:117251775:T:C,P13569,S1094P,0.831,Loss of MoRF binding (P = 0.0585); Loss of stability (P = 0.1726); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.3012); Loss of catalytic residue at T1095 (P = 0.324)
7:117251775:T:G,P13569,S1094A,0.64,Loss of stability (P = 0.0838); Loss of MoRF binding (P = 0.136); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.2202); Gain of catalytic residue at S1094 (P = 0.3285)
7:117251776:C:T,P13569,S1094L,0.615,Loss of MoRF binding (P = 0.1449); Gain of helix (P = 0.2059); Loss of methylation at R1097 (P = 0.2899); Loss of catalytic residue at S1094 (P = 0.4672); Loss of sheet (P = 0.6423)
7:117251778:A:C,P13569,T1095P,0.87,Loss of MoRF binding (P = 0.0608); Loss of catalytic residue at T1095 (P = 0.0899); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.3103); Loss of stability (P = 0.3675)
7:117251778:A:G,P13569,T1095A,0.755,Loss of MoRF binding (P = 0.1557); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.2398); Loss of catalytic residue at R1097 (P = 0.558); Loss of sheet (P = 0.6423)
7:117251778:A:T,P13569,T1095S,0.772,Loss of catalytic residue at T1095 (P = 0.1425); Loss of MoRF binding (P = 0.1578); Loss of helix (P = 0.2022); Gain of methylation at R1097 (P = 0.2248); Loss of stability (P = 0.5808)
7:117251779:C:A,P13569,T1095K,0.845,Gain of MoRF binding (P = 0.0255); Gain of ubiquitination at T1095 (P = 0.03); Loss of helix (P = 0.2271); Loss of catalytic residue at T1095 (P = 0.2575); Loss of methylation at R1097 (P = 0.3055)
7:117251779:C:G,P13569,T1095R,0.958,Gain of MoRF binding (P = 0.0183); Gain of methylation at T1095 (P = 0.027); Gain of helix (P = 0.2059); Loss of catalytic residue at T1095 (P = 0.3968); Gain of phosphorylation at S1094 (P = 0.7064)
7:117251779:C:T,P13569,T1095I,0.771,Gain of MoRF binding (P = 0.0889); Gain of helix (P = 0.2059); Loss of methylation at R1097 (P = 0.2243); Loss of catalytic residue at F1099 (P = 0.5209); Loss of sheet (P = 0.7751)
7:117251781:C:A,P13569,L1096M,0.732,Loss of catalytic residue at L1096 (P = 0.012); Loss of MoRF binding (P = 0.1519); Loss of stability (P = 0.1982); Loss of helix (P = 0.2022); Gain of methylation at R1097 (P = 0.2576)
7:117251781:C:G,P13569,L1096V,0.723,Loss of catalytic residue at L1096 (P = 0.074); Gain of MoRF binding (P = 0.1103); Loss of stability (P = 0.1137); Loss of helix (P = 0.2022); Gain of methylation at R1097 (P = 0.2333)
7:117251782:T:A,P13569,L1096Q,0.782,Loss of stability (P = 0.0266); Loss of MoRF binding (P = 0.0978); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2349); Gain of relative solvent accessibility (P = 0.2363)
7:117251782:T:C,P13569,L1096P,0.817,Loss of stability (P = 0.013); Loss of MoRF binding (P = 0.0516); Loss of helix (P = 0.2022); Gain of methylation at R1097 (P = 0.2862); Loss of catalytic residue at L1096 (P = 0.3018)
7:117251782:T:G,P13569,L1096R,0.915,Loss of stability (P = 0.0248); Gain of MoRF binding (P = 0.0379); Loss of helix (P = 0.1299); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2455)
7:117251784:C:A,P13569,R1097S,0.797,Loss of MoRF binding (P = 0.0373); Loss of methylation at R1097 (P = 0.0905); Loss of catalytic residue at R1097 (P = 0.1393); Loss of helix (P = 0.2022); Loss of stability (P = 0.3292)
7:117251784:C:G,P13569,R1097G,0.804,Loss of MoRF binding (P = 0.0345); Gain of catalytic residue at W1098 (P = 0.0666); Loss of methylation at R1097 (P = 0.0905); Loss of stability (P = 0.1603); Loss of helix (P = 0.2022)
7:117251785:G:A,P13569,R1097H,0.811,Loss of MoRF binding (P = 0.0311); Loss of catalytic residue at R1097 (P = 0.0404); Loss of methylation at R1097 (P = 0.0905); Loss of helix (P = 0.2022); Loss of stability (P = 0.2305)
7:117251785:G:C,P13569,R1097P,0.811,Loss of MoRF binding (P = 0.0107); Gain of catalytic residue at W1098 (P = 0.0306); Loss of methylation at R1097 (P = 0.0905); Loss of helix (P = 0.2022); Loss of stability (P = 0.2279)
7:117251785:G:T,P13569,R1097L,0.846,Loss of catalytic residue at R1097 (P = 0.0288); Loss of MoRF binding (P = 0.0375); Loss of methylation at R1097 (P = 0.0905); Loss of helix (P = 0.2022); Loss of loop (P = 0.4786)
7:117251787:T:A,P13569,W1098R,0.962,Loss of catalytic residue at L1096 (P = 0.0026); Gain of methylation at W1098 (P = 0.0101); Gain of MoRF binding (P = 0.0776); Gain of helix (P = 0.2059); Loss of stability (P = 0.4165)
7:117251787:T:C,P13569,W1098R,0.962,Loss of catalytic residue at L1096 (P = 0.0026); Gain of methylation at W1098 (P = 0.0101); Gain of MoRF binding (P = 0.0776); Gain of helix (P = 0.2059); Loss of stability (P = 0.4165)
7:117251787:T:G,P13569,W1098G,0.883,Loss of catalytic residue at L1096 (P = 0.0045); Gain of methylation at R1097 (P = 0.0208); Loss of stability (P = 0.0457); Loss of MoRF binding (P = 0.0521); Loss of helix (P = 0.2022)
7:117251788:G:C,P13569,W1098S,0.881,Loss of catalytic residue at L1096 (P = 0.0028); Gain of methylation at R1097 (P = 0.0331); Loss of MoRF binding (P = 0.0561); Loss of stability (P = 0.173); Loss of helix (P = 0.2022)
7:117251788:G:T,P13569,W1098L,0.953,Loss of catalytic residue at L1096 (P = 0.0031); Gain of methylation at R1097 (P = 0.0375); Loss of MoRF binding (P = 0.0536); Loss of helix (P = 0.3949); Gain of loop (P = 0.4661)
7:117251789:G:C,P13569,W1098C,0.942,Loss of catalytic residue at L1096 (P = 0.0029); Gain of methylation at R1097 (P = 0.0313); Loss of MoRF binding (P = 0.0444); Loss of stability (P = 0.3101); Loss of helix (P = 0.3949)
7:117251789:G:T,P13569,W1098C,0.942,Loss of catalytic residue at L1096 (P = 0.0029); Gain of methylation at R1097 (P = 0.0313); Loss of MoRF binding (P = 0.0444); Loss of stability (P = 0.3101); Loss of helix (P = 0.3949)
7:117251790:T:A,P13569,F1099I,0.803,Gain of MoRF binding (P = 0.1357); Loss of helix (P = 0.2022); Loss of catalytic residue at F1099 (P = 0.2337); Loss of methylation at R1097 (P = 0.2573); Gain of loop (P = 0.4661)
7:117251790:T:C,P13569,F1099L,0.909,Loss of MoRF binding (P = 0.1263); Loss of helix (P = 0.2022); Loss of catalytic residue at F1099 (P = 0.2156); Loss of methylation at R1097 (P = 0.282); Gain of loop (P = 0.4661)
7:117251790:T:G,P13569,F1099V,0.761,Gain of MoRF binding (P = 0.1593); Loss of helix (P = 0.2022); Loss of catalytic residue at F1099 (P = 0.3041); Loss of methylation at R1097 (P = 0.3052); Loss of stability (P = 0.3336)
7:117251791:T:A,P13569,F1099Y,0.864,Loss of MoRF binding (P = 0.0962); Loss of helix (P = 0.2022); Loss of stability (P = 0.2669); Loss of methylation at R1097 (P = 0.3081); Loss of catalytic residue at F1099 (P = 0.3532)
7:117251791:T:C,P13569,F1099S,0.802,Loss of MoRF binding (P = 0.0946); Loss of stability (P = 0.1324); Loss of catalytic residue at F1099 (P = 0.1438); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117251791:T:G,P13569,F1099C,0.828,Loss of MoRF binding (P = 0.083); Gain of helix (P = 0.2059); Gain of catalytic residue at F1099 (P = 0.2476); Loss of stability (P = 0.295); Loss of methylation at R1097 (P = 0.3128)
7:117251792:C:G,P13569,F1099L,0.909,Loss of MoRF binding (P = 0.1263); Loss of helix (P = 0.2022); Loss of catalytic residue at F1099 (P = 0.2156); Loss of methylation at R1097 (P = 0.282); Gain of loop (P = 0.4661)
7:117251793:C:A,P13569,Q1100K,0.794,Gain of ubiquitination at Q1100 (P = 0.0198); Gain of MoRF binding (P = 0.0287); Loss of stability (P = 0.1886); Gain of methylation at R1097 (P = 0.1899); Loss of helix (P = 0.2022)
7:117251793:C:G,P13569,Q1100E,0.821,Loss of MoRF binding (P = 0.0513); Gain of methylation at R1097 (P = 0.1935); Loss of helix (P = 0.2022); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2987)
7:117251794:A:C,P13569,Q1100P,0.945,Loss of MoRF binding (P = 0.0692); Gain of methylation at R1097 (P = 0.1437); Loss of helix (P = 0.2022); Loss of stability (P = 0.2255); Gain of loop (P = 0.2754)
7:117251794:A:G,P13569,Q1100R,0.93,Gain of MoRF binding (P = 0.0211); Gain of methylation at Q1100 (P = 0.0321); Gain of helix (P = 0.2059); Loss of catalytic residue at F1099 (P = 0.3799); Loss of stability (P = 0.4919)
7:117251794:A:T,P13569,Q1100L,0.774,Gain of MoRF binding (P = 0.1145); Gain of methylation at R1097 (P = 0.1903); Gain of helix (P = 0.2059); Loss of catalytic residue at Q1100 (P = 0.2867); Loss of loop (P = 0.4786)
7:117251795:A:C,P13569,Q1100H,0.805,Gain of methylation at R1097 (P = 0.043); Loss of MoRF binding (P = 0.1325); Loss of helix (P = 0.2271); Loss of stability (P = 0.263); Gain of loop (P = 0.4661)
7:117251795:A:T,P13569,Q1100H,0.805,Gain of methylation at R1097 (P = 0.043); Loss of MoRF binding (P = 0.1325); Loss of helix (P = 0.2271); Loss of stability (P = 0.263); Gain of loop (P = 0.4661)
7:117251796:A:C,P13569,M1101L,0.723,Loss of MoRF binding (P = 0.1441); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.2892); Loss of loop (P = 0.4786); Gain of catalytic residue at F1099 (P = 0.5815)
7:117251796:A:G,P13569,M1101V,0.748,Gain of MoRF binding (P = 0.1486); Loss of helix (P = 0.2022); Gain of methylation at R1097 (P = 0.2733); Loss of stability (P = 0.3841); Loss of catalytic residue at M1101 (P = 0.4418)
7:117251796:A:T,P13569,M1101L,0.723,Loss of MoRF binding (P = 0.1441); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.2892); Loss of loop (P = 0.4786); Gain of catalytic residue at F1099 (P = 0.5815)
7:117251797:T:A,P13569,M1101K,0.944,Loss of catalytic residue at M1101 (P = 0.0107); Gain of MoRF binding (P = 0.0194); Gain of ubiquitination at M1101 (P = 0.0311); Loss of stability (P = 0.0543); Loss of helix (P = 0.2022)
7:117251797:T:C,P13569,M1101T,0.721,Loss of stability (P = 0.0956); Gain of MoRF binding (P = 0.1595); Loss of catalytic residue at M1101 (P = 0.199); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117251797:T:G,P13569,M1101R,0.962,Gain of MoRF binding (P = 0.0124); Loss of catalytic residue at M1101 (P = 0.0957); Loss of stability (P = 0.1935); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2366)
7:117251798:G:A,P13569,M1101I,0.745,Loss of catalytic residue at M1101 (P = 0.0381); Gain of MoRF binding (P = 0.1573); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.3031); Loss of loop (P = 0.4786)
7:117251798:G:C,P13569,M1101I,0.745,Loss of catalytic residue at M1101 (P = 0.0381); Gain of MoRF binding (P = 0.1573); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.3031); Loss of loop (P = 0.4786)
7:117251798:G:T,P13569,M1101I,0.745,Loss of catalytic residue at M1101 (P = 0.0381); Gain of MoRF binding (P = 0.1573); Gain of helix (P = 0.2059); Gain of methylation at R1097 (P = 0.3031); Loss of loop (P = 0.4786)
7:117251799:A:G,P13569,R1102G,0.894,Loss of MoRF binding (P = 0.0606); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2379); Loss of stability (P = 0.2445); Loss of catalytic residue at R1102 (P = 0.3238)
7:117251800:G:A,P13569,R1102K,0.79,Gain of ubiquitination at R1102 (P = 0.0276); Loss of MoRF binding (P = 0.136); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2363); Gain of loop (P = 0.2754)
7:117251800:G:C,P13569,R1102T,0.835,Loss of MoRF binding (P = 0.0597); Gain of glycosylation at R1102 (P = 0.074); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2379); Loss of catalytic residue at F1099 (P = 0.3822)
7:117251800:G:T,P13569,R1102I,0.821,Loss of MoRF binding (P = 0.0707); Loss of catalytic residue at R1102 (P = 0.1782); Gain of stability (P = 0.2023); Gain of helix (P = 0.2059); Loss of methylation at R1097 (P = 0.212)
7:117251801:A:C,P13569,R1102S,0.838,Loss of MoRF binding (P = 0.0614); Loss of catalytic residue at R1102 (P = 0.1259); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2253); Gain of loop (P = 0.2754)
7:117251801:A:T,P13569,R1102S,0.838,Loss of MoRF binding (P = 0.0614); Loss of catalytic residue at R1102 (P = 0.1259); Loss of helix (P = 0.2022); Loss of methylation at R1097 (P = 0.2253); Gain of loop (P = 0.2754)
7:117251802:A:C,P13569,I1103L,0.749,Loss of MoRF binding (P = 0.1281); Gain of helix (P = 0.2059); Gain of methylation at R1102 (P = 0.415); Loss of catalytic residue at R1102 (P = 0.6596); Loss of stability (P = 0.741)
7:117251802:A:G,P13569,I1103V,0.7,Loss of MoRF binding (P = 0.1453); Gain of methylation at R1102 (P = 0.3525); Loss of helix (P = 0.3949); Loss of stability (P = 0.4408); Gain of loop (P = 0.4661)
7:117251802:A:T,P13569,I1103L,0.749,Loss of MoRF binding (P = 0.1281); Gain of helix (P = 0.2059); Gain of methylation at R1102 (P = 0.415); Loss of catalytic residue at R1102 (P = 0.6596); Loss of stability (P = 0.741)
7:117251803:T:A,P13569,I1103K,0.819,Gain of ubiquitination at I1103 (P = 0.0337); Loss of stability (P = 0.04); Gain of MoRF binding (P = 0.1101); Loss of catalytic residue at R1102 (P = 0.2281); Gain of loop (P = 0.2754)
7:117251803:T:C,P13569,I1103T,0.821,Loss of stability (P = 0.019); Loss of MoRF binding (P = 0.0853); Gain of catalytic residue at I1103 (P = 0.1797); Loss of helix (P = 0.3949); Gain of glycosylation at I1103 (P = 0.421)
7:117251803:T:G,P13569,I1103R,0.862,Gain of MoRF binding (P = 0.0991); Loss of stability (P = 0.1099); Gain of helix (P = 0.2059); Loss of catalytic residue at R1102 (P = 0.3574); Gain of methylation at I1103 (P = 0.5213)
7:117251804:A:G,P13569,I1103M,0.821,Loss of MoRF binding (P = 0.106); Gain of helix (P = 0.2059); Gain of methylation at R1102 (P = 0.3517); Loss of stability (P = 0.38); Gain of catalytic residue at V1108 (P = 0.5221)
7:117251805:G:A,P13569,E1104K,0.852,Gain of MoRF binding (P = 7e-04); Gain of ubiquitination at E1104 (P = 0.0238); Loss of stability (P = 0.1643); Loss of catalytic residue at E1104 (P = 0.1971); Gain of helix (P = 0.2059)
7:117251805:G:C,P13569,E1104Q,0.816,Gain of MoRF binding (P = 0.0243); Gain of helix (P = 0.2059); Loss of stability (P = 0.3151); Loss of loop (P = 0.4786); Loss of methylation at R1102 (P = 0.5247)
7:117251806:A:C,P13569,E1104A,0.842,Gain of MoRF binding (P = 0.0381); Gain of catalytic residue at Q1100 (P = 0.3715); Loss of stability (P = 0.3839); Loss of helix (P = 0.3949); Loss of loop (P = 0.4786)
7:117251806:A:G,P13569,E1104G,0.838,Gain of MoRF binding (P = 0.0371); Loss of stability (P = 0.0798); Gain of catalytic residue at I1106 (P = 0.2287); Loss of helix (P = 0.3949); Gain of methylation at R1102 (P = 0.4641)
7:117251806:A:T,P13569,E1104V,0.845,Gain of MoRF binding (P = 0.0307); Gain of catalytic residue at Q1100 (P = 0.349); Loss of helix (P = 0.3949); Loss of stability (P = 0.407); Loss of loop (P = 0.4786)
7:117251807:A:C,P13569,E1104D,0.838,Gain of MoRF binding (P = 0.0789); Loss of stability (P = 0.3784); Loss of helix (P = 0.3949); Loss of methylation at R1102 (P = 0.5291); Gain of catalytic residue at R1102 (P = 0.5914)
7:117251807:A:T,P13569,E1104D,0.838,Gain of MoRF binding (P = 0.0789); Loss of stability (P = 0.3784); Loss of helix (P = 0.3949); Loss of methylation at R1102 (P = 0.5291); Gain of catalytic residue at R1102 (P = 0.5914)
7:117251808:A:C,P13569,M1105L,0.782,Gain of MoRF binding (P = 0.1938); Loss of catalytic residue at I1109 (P = 0.3027); Loss of helix (P = 0.3949); Loss of methylation at R1102 (P = 0.5283); Loss of stability (P = 0.6685)
7:117251808:A:G,P13569,M1105V,0.761,Gain of MoRF binding (P = 0.1789); Gain of helix (P = 0.2059); Loss of catalytic residue at M1105 (P = 0.281); Loss of stability (P = 0.3825); Loss of loop (P = 0.4786)
7:117251808:A:T,P13569,M1105L,0.782,Gain of MoRF binding (P = 0.1938); Loss of catalytic residue at I1109 (P = 0.3027); Loss of helix (P = 0.3949); Loss of methylation at R1102 (P = 0.5283); Loss of stability (P = 0.6685)
7:117251809:T:A,P13569,M1105K,0.923,Loss of stability (P = 0.0129); Gain of ubiquitination at M1105 (P = 0.0267); Gain of MoRF binding (P = 0.0273); Gain of helix (P = 0.2059); Loss of catalytic residue at I1109 (P = 0.2551)
7:117251809:T:C,P13569,M1105T,0.734,Loss of stability (P = 0.0707); Gain of MoRF binding (P = 0.1924); Gain of helix (P = 0.2059); Loss of catalytic residue at I1109 (P = 0.2844); Loss of loop (P = 0.4786)
7:117251809:T:G,P13569,M1105R,0.985,Gain of MoRF binding (P = 0.0166); Loss of stability (P = 0.0817); Gain of helix (P = 0.2059); Loss of catalytic residue at V1108 (P = 0.2665); Gain of methylation at M1105 (P = 0.4122)
7:117251810:G:A,P13569,M1105I,0.769,Gain of MoRF binding (P = 0.1805); Gain of helix (P = 0.2059); Loss of catalytic residue at I1109 (P = 0.3015); Loss of loop (P = 0.4786); Loss of methylation at R1102 (P = 0.5252)
7:117251810:G:C,P13569,M1105I,0.769,Gain of MoRF binding (P = 0.1805); Gain of helix (P = 0.2059); Loss of catalytic residue at I1109 (P = 0.3015); Loss of loop (P = 0.4786); Loss of methylation at R1102 (P = 0.5252)
7:117251810:G:T,P13569,M1105I,0.769,Gain of MoRF binding (P = 0.1805); Gain of helix (P = 0.2059); Loss of catalytic residue at I1109 (P = 0.3015); Loss of loop (P = 0.4786); Loss of methylation at R1102 (P = 0.5252)
7:117251811:A:C,P13569,I1106L,0.665,Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.2047); Gain of loop (P = 0.3485); Loss of stability (P = 0.4608); Gain of methylation at R1102 (P = 0.4904)
7:117251811:A:G,P13569,I1106V,0.696,Loss of MoRF binding (P = 0.2115); Gain of catalytic residue at I1106 (P = 0.3); Loss of stability (P = 0.3236); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117251811:A:T,P13569,I1106F,0.778,Loss of stability (P = 0.1323); Loss of MoRF binding (P = 0.2078); Loss of catalytic residue at M1105 (P = 0.3653); Loss of helix (P = 0.4763); Gain of methylation at R1102 (P = 0.4912)
7:117251812:T:A,P13569,I1106N,0.759,Loss of stability (P = 0.0279); Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.2019); Gain of catalytic residue at I1106 (P = 0.3343); Gain of methylation at R1102 (P = 0.4771)
7:117251812:T:C,P13569,I1106T,0.737,Loss of stability (P = 0.0088); Gain of glycosylation at I1106 (P = 0.1066); Loss of MoRF binding (P = 0.1927); Gain of catalytic residue at I1106 (P = 0.231); Loss of helix (P = 0.4763)
7:117251812:T:G,P13569,I1106S,0.716,Loss of helix (P = 0.0104); Gain of loop (P = 0.024); Loss of stability (P = 0.0256); Loss of MoRF binding (P = 0.2031); Gain of methylation at R1102 (P = 0.4888)
7:117251813:T:G,P13569,I1106M,0.746,Loss of helix (P = 0.0104); Gain of loop (P = 0.024); Loss of MoRF binding (P = 0.1975); Loss of stability (P = 0.1976); Gain of methylation at R1102 (P = 0.4912)
7:117251814:T:A,P13569,F1107I,0.836,Gain of MoRF binding (P = 0.2163); Gain of catalytic residue at F1107 (P = 0.2824); Loss of stability (P = 0.4035); Loss of methylation at R1102 (P = 0.5269); Gain of helix (P = 0.5668)
7:117251814:T:C,P13569,F1107L,0.773,Gain of catalytic residue at F1107 (P = 0.1486); Loss of MoRF binding (P = 0.2294); Loss of stability (P = 0.4475); Gain of methylation at R1102 (P = 0.5169); Gain of helix (P = 0.5668)
7:117251814:T:G,P13569,F1107V,0.817,Loss of stability (P = 0.2041); Gain of catalytic residue at F1107 (P = 0.2194); Gain of MoRF binding (P = 0.2238); Gain of methylation at R1102 (P = 0.5165); Gain of helix (P = 0.5668)
7:117251815:T:A,P13569,F1107Y,0.852,Gain of catalytic residue at I1106 (P = 0.0672); Loss of stability (P = 0.1457); Loss of MoRF binding (P = 0.2144); Gain of methylation at R1102 (P = 0.498); Loss of helix (P = 0.5596)
7:117251815:T:C,P13569,F1107S,0.721,Loss of helix (P = 0.0104); Gain of loop (P = 0.024); Loss of stability (P = 0.0693); Loss of MoRF binding (P = 0.2281); Gain of methylation at R1102 (P = 0.495)
7:117251815:T:G,P13569,F1107C,0.843,Loss of helix (P = 0.0444); Loss of MoRF binding (P = 0.1812); Loss of stability (P = 0.1816); Gain of catalytic residue at M1105 (P = 0.2146); Gain of loop (P = 0.3485)
7:117251816:T:A,P13569,F1107L,0.773,Gain of catalytic residue at F1107 (P = 0.1486); Loss of MoRF binding (P = 0.2294); Loss of stability (P = 0.4475); Gain of methylation at R1102 (P = 0.5169); Gain of helix (P = 0.5668)
7:117251816:T:G,P13569,F1107L,0.773,Gain of catalytic residue at F1107 (P = 0.1486); Loss of MoRF binding (P = 0.2294); Loss of stability (P = 0.4475); Gain of methylation at R1102 (P = 0.5169); Gain of helix (P = 0.5668)
7:117251817:G:A,P13569,V1108I,0.741,Loss of catalytic residue at V1108 (P = 0.1439); Loss of MoRF binding (P = 0.2502); Loss of helix (P = 0.6555); Loss of stability (P = 0.8566); Gain of disorder (P = 0.9477)
7:117251817:G:C,P13569,V1108L,0.879,Loss of helix (P = 0.0376); Gain of loop (P = 0.0502); Gain of catalytic residue at V1108 (P = 0.2497); Loss of MoRF binding (P = 0.2518); Gain of sheet (P = 0.6509)
7:117251817:G:T,P13569,V1108F,0.728,Loss of catalytic residue at V1108 (P = 0.1852); Loss of MoRF binding (P = 0.2494); Loss of stability (P = 0.5253); Loss of helix (P = 0.5596); Gain of disorder (P = 0.9461)
7:117251818:T:A,P13569,V1108D,0.834,Loss of helix (P = 0.0068); Gain of loop (P = 0.0111); Loss of MoRF binding (P = 0.1983); Loss of stability (P = 0.3106); Loss of catalytic residue at M1105 (P = 0.3687)
7:117251818:T:C,P13569,V1108A,0.726,Loss of stability (P = 0.1037); Gain of catalytic residue at V1108 (P = 0.2267); Loss of MoRF binding (P = 0.2482); Gain of helix (P = 0.5668); Gain of disorder (P = 0.9366)
7:117251818:T:G,P13569,V1108G,0.72,Loss of helix (P = 0.0104); Loss of stability (P = 0.02); Gain of loop (P = 0.024); Gain of catalytic residue at I1106 (P = 0.199); Loss of MoRF binding (P = 0.2521)
7:117251820:A:C,P13569,I1109L,0.744,Loss of catalytic residue at I1109 (P = 0.1016); Gain of MoRF binding (P = 0.2726); Loss of stability (P = 0.4735); Loss of helix (P = 0.5596); Loss of loop (P = 0.9475)
7:117251820:A:G,P13569,I1109V,0.733,Loss of stability (P = 0.257); Gain of MoRF binding (P = 0.2691); Loss of catalytic residue at I1109 (P = 0.3586); Loss of helix (P = 0.7926); Loss of loop (P = 0.9475)
7:117251820:A:T,P13569,I1109F,0.762,Loss of catalytic residue at I1109 (P = 0.1157); Loss of stability (P = 0.1467); Gain of MoRF binding (P = 0.2744); Loss of helix (P = 0.7926); Gain of disorder (P = 0.958)
7:117251821:T:A,P13569,I1109N,0.697,Loss of helix (P = 0.0104); Gain of loop (P = 0.024); Loss of stability (P = 0.0415); Gain of sheet (P = 0.0507); Gain of MoRF binding (P = 0.1816)
7:117251821:T:C,P13569,I1109T,0.717,Loss of stability (P = 0.0174); Gain of MoRF binding (P = 0.2478); Loss of catalytic residue at I1109 (P = 0.3015); Gain of glycosylation at I1109 (P = 0.4056); Loss of helix (P = 0.7926)
7:117251821:T:G,P13569,I1109S,0.724,Loss of stability (P = 0.0383); Loss of helix (P = 0.0444); Loss of catalytic residue at I1109 (P = 0.1315); Gain of MoRF binding (P = 0.2288); Gain of glycosylation at I1109 (P = 0.2937)
7:117251822:C:G,P13569,I1109M,0.673,Loss of helix (P = 0.0068); Gain of loop (P = 0.0111); Gain of sheet (P = 0.0166); Loss of catalytic residue at I1109 (P = 0.0356); Gain of MoRF binding (P = 0.2603)
7:117251823:T:A,P13569,F1110I,0.673,Gain of MoRF binding (P = 0.2943); Loss of stability (P = 0.4909); Gain of catalytic residue at T1115 (P = 0.498); Loss of helix (P = 0.6555); Loss of phosphorylation at T1115 (P = 0.6753)
7:117251823:T:C,P13569,F1110L,0.631,Loss of helix (P = 0.0068); Gain of sheet (P = 0.0073); Gain of loop (P = 0.0111); Gain of MoRF binding (P = 0.3151); Loss of stability (P = 0.4499)
7:117251823:T:G,P13569,F1110V,0.689,Gain of catalytic residue at F1110 (P = 0.0514); Loss of stability (P = 0.1373); Gain of MoRF binding (P = 0.3108); Loss of helix (P = 0.6555); Loss of phosphorylation at T1115 (P = 0.674)
7:117251824:T:A,P13569,F1110Y,0.673,Gain of sheet (P = 0.0166); Loss of helix (P = 0.0167); Gain of loop (P = 0.0321); Gain of catalytic residue at F1110 (P = 0.0681); Loss of stability (P = 0.1891)
7:117251824:T:C,P13569,F1110S,0.646,Loss of helix (P = 0.0033); Gain of sheet (P = 0.0036); Gain of loop (P = 0.0051); Loss of stability (P = 0.0765); Gain of catalytic residue at F1110 (P = 0.1031)
7:117251824:T:G,P13569,F1110C,0.705,Loss of helix (P = 0.0033); Gain of sheet (P = 0.0073); Gain of loop (P = 0.0111); Loss of catalytic residue at M1105 (P = 0.152); Loss of stability (P = 0.2055)
7:117251825:C:A,P13569,F1110L,0.631,Loss of helix (P = 0.0068); Gain of sheet (P = 0.0073); Gain of loop (P = 0.0111); Gain of MoRF binding (P = 0.3151); Loss of stability (P = 0.4499)
7:117251825:C:G,P13569,F1110L,0.631,Loss of helix (P = 0.0068); Gain of sheet (P = 0.0073); Gain of loop (P = 0.0111); Gain of MoRF binding (P = 0.3151); Loss of stability (P = 0.4499)
7:117251826:T:A,P13569,F1111I,0.702,Gain of MoRF binding (P = 0.3501); Loss of stability (P = 0.5982); Loss of helix (P = 0.6555); Loss of phosphorylation at T1115 (P = 0.6757); Gain of catalytic residue at F1111 (P = 0.7143)
7:117251826:T:C,P13569,F1111L,0.641,Gain of catalytic residue at F1111 (P = 0.0409); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.345); Gain of sheet (P = 0.6509); Loss of stability (P = 0.6606)
7:117251826:T:G,P13569,F1111V,0.655,Gain of catalytic residue at F1111 (P = 0.1116); Gain of MoRF binding (P = 0.3418); Loss of stability (P = 0.4828); Loss of helix (P = 0.6555); Loss of phosphorylation at T1115 (P = 0.674)
7:117251827:T:A,P13569,F1111Y,0.664,Loss of helix (P = 0.0444); Gain of catalytic residue at F1111 (P = 0.0573); Loss of stability (P = 0.2667); Gain of MoRF binding (P = 0.3292); Gain of sheet (P = 0.3763)
7:117251827:T:C,P13569,F1111S,0.625,Loss of helix (P = 0.0033); Gain of sheet (P = 0.0073); Gain of loop (P = 0.0111); Gain of catalytic residue at F1111 (P = 0.057); Loss of stability (P = 0.0776)
7:117251827:T:G,P13569,F1111C,0.653,Gain of catalytic residue at F1111 (P = 0.0747); Loss of stability (P = 0.3129); Loss of MoRF binding (P = 0.3553); Loss of helix (P = 0.5596); Loss of phosphorylation at T1115 (P = 0.6698)
7:117251828:C:A,P13569,F1111L,0.641,Gain of catalytic residue at F1111 (P = 0.0409); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.345); Gain of sheet (P = 0.6509); Loss of stability (P = 0.6606)
7:117251828:C:G,P13569,F1111L,0.641,Gain of catalytic residue at F1111 (P = 0.0409); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.345); Gain of sheet (P = 0.6509); Loss of stability (P = 0.6606)
7:117251829:A:C,P13569,I1112L,0.679,Loss of helix (P = 0.0093); Gain of sheet (P = 0.0166); Gain of loop (P = 0.0502); Gain of catalytic residue at I1112 (P = 0.2994); Gain of MoRF binding (P = 0.3966)
7:117251829:A:G,P13569,I1112V,0.734,Gain of catalytic residue at I1112 (P = 0.3877); Gain of MoRF binding (P = 0.3928); Gain of phosphorylation at T1115 (P = 0.6265); Loss of stability (P = 0.637); Loss of helix (P = 0.6555)
7:117251829:A:T,P13569,I1112F,0.774,Loss of stability (P = 0.2845); Gain of MoRF binding (P = 0.3971); Gain of phosphorylation at T1115 (P = 0.5816); Loss of catalytic residue at I1112 (P = 0.587); Loss of helix (P = 0.6555)
7:117251830:T:A,P13569,I1112N,0.646,Loss of helix (P = 0.0033); Gain of loop (P = 0.0045); Gain of sheet (P = 0.0073); Loss of stability (P = 0.0755); Gain of catalytic residue at I1112 (P = 0.1762)
7:117251830:T:C,P13569,I1112T,0.739,Loss of stability (P = 0.0268); Gain of catalytic residue at I1112 (P = 0.3635); Gain of MoRF binding (P = 0.3949); Gain of phosphorylation at T1115 (P = 0.5667); Gain of sheet (P = 0.6509)
7:117251830:T:G,P13569,I1112S,0.614,Loss of helix (P = 0.0033); Gain of sheet (P = 0.0036); Gain of loop (P = 0.0111); Loss of stability (P = 0.0582); Gain of glycosylation at I1112 (P = 0.0809)
7:117251831:T:G,P13569,I1112M,0.649,Gain of sheet (P = 0.0016); Loss of helix (P = 0.0033); Gain of loop (P = 0.0111); Loss of catalytic residue at I1112 (P = 0.2884); Gain of MoRF binding (P = 0.385)
7:117251832:G:A,P13569,A1113T,0.709,Gain of catalytic residue at F1116 (P = 0.1322); Loss of helix (P = 0.2022); Gain of glycosylation at S1118 (P = 0.2606); Loss of stability (P = 0.2762); Gain of MoRF binding (P = 0.4458)
7:117251832:G:C,P13569,A1113P,0.858,Loss of stability (P = 0.0879); Loss of catalytic residue at A1113 (P = 0.1274); Gain of glycosylation at S1118 (P = 0.2796); Loss of MoRF binding (P = 0.4147); Gain of phosphorylation at T1115 (P = 0.4385)
7:117251832:G:T,P13569,A1113S,0.672,Gain of glycosylation at A1113 (P = 0.1881); Loss of stability (P = 0.2852); Gain of MoRF binding (P = 0.4314); Loss of helix (P = 0.4763); Gain of sheet (P = 0.6509)
7:117251833:C:A,P13569,A1113D,0.838,Loss of helix (P = 0.2271); Gain of glycosylation at S1118 (P = 0.2536); Loss of stability (P = 0.3723); Loss of MoRF binding (P = 0.4135); Gain of catalytic residue at V1108 (P = 0.5936)
7:117251833:C:G,P13569,A1113G,0.744,Loss of stability (P = 0.0459); Loss of catalytic residue at A1113 (P = 0.1254); Loss of glycosylation at S1118 (P = 0.1639); Gain of MoRF binding (P = 0.4375); Loss of helix (P = 0.4763)
7:117251833:C:T,P13569,A1113V,0.699,Loss of glycosylation at S1118 (P = 0.2207); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.4061); Loss of stability (P = 0.5526); Loss of catalytic residue at V1114 (P = 0.6067)
7:117251835:G:A,P13569,V1114I,0.599,Loss of catalytic residue at V1114 (P = 0.0923); Loss of glycosylation at S1118 (P = 0.2157); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.4808); Loss of phosphorylation at T1115 (P = 0.6717)
7:117251835:G:C,P13569,V1114L,0.552,Loss of helix (P = 0.0068); Gain of sheet (P = 0.0166); Gain of loop (P = 0.0195); Gain of catalytic residue at V1114 (P = 0.2068); Loss of glycosylation at S1118 (P = 0.2758)
7:117251835:G:T,P13569,V1114F,0.718,Loss of glycosylation at S1118 (P = 0.1988); Loss of catalytic residue at V1114 (P = 0.2716); Loss of stability (P = 0.4492); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.4906)
7:117251836:T:A,P13569,V1114D,0.76,Loss of helix (P = 0.028); Gain of sheet (P = 0.0507); Gain of loop (P = 0.1069); Loss of catalytic residue at S1118 (P = 0.2048); Loss of stability (P = 0.2108)
7:117251836:T:C,P13569,V1114A,0.672,Gain of glycosylation at S1118 (P = 0.173); Loss of stability (P = 0.2105); Gain of catalytic residue at V1114 (P = 0.2265); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.4864)
7:117251836:T:G,P13569,V1114G,0.612,Loss of stability (P = 0.0106); Loss of helix (P = 0.0167); Gain of sheet (P = 0.0507); Gain of loop (P = 0.1069); Gain of catalytic residue at I1112 (P = 0.1979)
7:117251838:A:C,P13569,T1115P,0.858,Loss of stability (P = 0.1289); Loss of helix (P = 0.2271); Gain of glycosylation at S1118 (P = 0.2398); Loss of catalytic residue at S1118 (P = 0.3275); Loss of MoRF binding (P = 0.5183)
7:117251838:A:G,P13569,T1115A,0.731,Gain of catalytic residue at T1115 (P = 0.065); Gain of glycosylation at S1118 (P = 0.1531); Loss of helix (P = 0.2022); Loss of stability (P = 0.44); Gain of sheet (P = 0.4423)
7:117251838:A:T,P13569,T1115S,0.744,Gain of catalytic residue at T1115 (P = 0.073); Loss of glycosylation at S1118 (P = 0.2429); Loss of helix (P = 0.4763); Loss of stability (P = 0.4801); Gain of MoRF binding (P = 0.5228)
7:117251839:C:A,P13569,T1115N,0.736,Gain of catalytic residue at T1115 (P = 0.0542); Loss of glycosylation at S1118 (P = 0.2777); Loss of stability (P = 0.4406); Loss of helix (P = 0.4763); Gain of MoRF binding (P = 0.4805)
7:117251839:C:G,P13569,T1115S,0.744,Gain of catalytic residue at T1115 (P = 0.073); Loss of glycosylation at S1118 (P = 0.2429); Loss of helix (P = 0.4763); Loss of stability (P = 0.4801); Gain of MoRF binding (P = 0.5228)
7:117251839:C:T,P13569,T1115I,0.735,Gain of catalytic residue at L1120 (P = 0.095); Gain of glycosylation at S1118 (P = 0.1046); Loss of helix (P = 0.4763); Loss of MoRF binding (P = 0.5395); Loss of phosphorylation at T1115 (P = 0.6405)
7:117251841:T:A,P13569,F1116I,0.668,Loss of glycosylation at S1118 (P = 0.1868); Gain of catalytic residue at S1118 (P = 0.3128); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4931); Gain of MoRF binding (P = 0.5716)
7:117251841:T:C,P13569,F1116L,0.652,Loss of helix (P = 0.028); Gain of loop (P = 0.1069); Loss of glycosylation at S1118 (P = 0.2229); Gain of sheet (P = 0.3763); Gain of disorder (P = 0.4367)
7:117251841:T:G,P13569,F1116V,0.678,Gain of catalytic residue at F1116 (P = 0.0357); Gain of glycosylation at S1118 (P = 0.2766); Loss of stability (P = 0.2989); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4382)
7:117251842:T:A,P13569,F1116Y,0.638,Loss of helix (P = 0.0068); Gain of loop (P = 0.0079); Gain of sheet (P = 0.0166); Gain of catalytic residue at F1116 (P = 0.0521); Gain of glycosylation at S1118 (P = 0.2718)
7:117251842:T:C,P13569,F1116S,0.621,Loss of helix (P = 0.0068); Gain of sheet (P = 0.0073); Gain of loop (P = 0.0079); Gain of disorder (P = 0.0198); Gain of catalytic residue at F1116 (P = 0.053)
7:117251842:T:G,P13569,F1116C,0.633,Loss of helix (P = 0.0033); Gain of sheet (P = 0.0036); Gain of loop (P = 0.0079); Loss of glycosylation at S1118 (P = 0.1208); Gain of catalytic residue at F1116 (P = 0.15)
7:117251843:C:A,P13569,F1116L,0.652,Loss of helix (P = 0.028); Gain of loop (P = 0.1069); Loss of glycosylation at S1118 (P = 0.2229); Gain of sheet (P = 0.3763); Gain of disorder (P = 0.4367)
7:117251843:C:G,P13569,F1116L,0.652,Loss of helix (P = 0.028); Gain of loop (P = 0.1069); Loss of glycosylation at S1118 (P = 0.2229); Gain of sheet (P = 0.3763); Gain of disorder (P = 0.4367)
7:117251844:A:C,P13569,I1117L,0.515,Loss of helix (P = 0.0196); Gain of catalytic residue at I1117 (P = 0.0251); Gain of loop (P = 0.0435); Gain of sheet (P = 0.0507); Loss of glycosylation at S1118 (P = 0.0863)
7:117251844:A:G,P13569,I1117V,0.501,Loss of glycosylation at S1118 (P = 0.1467); Gain of disorder (P = 0.2479); Gain of catalytic residue at I1117 (P = 0.2503); Loss of helix (P = 0.3949); Loss of MoRF binding (P = 0.6181)
7:117251844:A:T,P13569,I1117F,0.513,Loss of glycosylation at S1118 (P = 0.1699); Gain of disorder (P = 0.3362); Loss of helix (P = 0.3949); Loss of catalytic residue at L1120 (P = 0.4188); Loss of loop (P = 0.4786)
7:117251845:T:A,P13569,I1117N,0.555,Gain of sheet (P = 0.0036); Loss of helix (P = 0.0068); Gain of loop (P = 0.0079); Gain of catalytic residue at I1117 (P = 0.051); Gain of disorder (P = 0.0552)
7:117251845:T:C,P13569,I1117T,0.589,Gain of disorder (P = 0.0299); Loss of stability (P = 0.1201); Loss of helix (P = 0.2271); Gain of catalytic residue at I1117 (P = 0.2476); Loss of glycosylation at S1118 (P = 0.2674)
7:117251845:T:G,P13569,I1117S,0.612,Gain of disorder (P = 0.0085); Gain of catalytic residue at I1117 (P = 0.0194); Loss of helix (P = 0.028); Gain of loop (P = 0.0502); Loss of glycosylation at S1118 (P = 0.2098)
7:117251846:T:G,P13569,I1117M,0.519,Loss of helix (P = 0.028); Loss of glycosylation at S1118 (P = 0.0926); Gain of loop (P = 0.1069); Gain of disorder (P = 0.1162); Gain of sheet (P = 0.3763)
7:117251847:T:A,P13569,S1118T,0.817,Loss of glycosylation at S1118 (P = 0.0559); Loss of disorder (P = 0.1819); Loss of helix (P = 0.2022); Loss of stability (P = 0.3545); Gain of loop (P = 0.4661)
7:117251847:T:C,P13569,S1118P,0.819,Loss of glycosylation at S1118 (P = 0.0653); Loss of catalytic residue at S1118 (P = 0.1719); Gain of helix (P = 0.1736); Loss of disorder (P = 0.175); Loss of stability (P = 0.1856)
7:117251847:T:G,P13569,S1118A,0.686,Loss of glycosylation at S1118 (P = 0.0424); Loss of disorder (P = 0.0947); Gain of helix (P = 0.1736); Gain of catalytic residue at S1118 (P = 0.3749); Loss of stability (P = 0.3855)
7:117251848:C:A,P13569,S1118Y,0.879,Loss of glycosylation at S1118 (P = 0.0424); Loss of disorder (P = 0.0619); Gain of helix (P = 0.1736); Gain of catalytic residue at I1117 (P = 0.2477); Loss of stability (P = 0.5739)
7:117251848:C:G,P13569,S1118C,0.94,Loss of disorder (P = 0.0339); Loss of glycosylation at S1118 (P = 0.0424); Gain of helix (P = 0.1736); Loss of stability (P = 0.598); Loss of MoRF binding (P = 0.6568)
7:117251850:A:C,P13569,I1119L,0.579,Loss of glycosylation at S1118 (P = 0.1337); Loss of catalytic residue at I1119 (P = 0.1447); Gain of disorder (P = 0.1561); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117251850:A:G,P13569,I1119V,0.587,Loss of glycosylation at S1118 (P = 0.0989); Gain of disorder (P = 0.1624); Loss of stability (P = 0.2215); Loss of catalytic residue at I1119 (P = 0.3421); Loss of helix (P = 0.3949)
7:117251850:A:T,P13569,I1119F,0.594,Loss of stability (P = 0.0633); Loss of glycosylation at S1118 (P = 0.0781); Gain of helix (P = 0.1736); Loss of disorder (P = 0.2536); Loss of catalytic residue at L1120 (P = 0.4201)
7:117251851:T:A,P13569,I1119N,0.753,Loss of stability (P = 0.0082); Gain of disorder (P = 0.0237); Gain of loop (P = 0.069); Loss of helix (P = 0.1299); Loss of glycosylation at S1118 (P = 0.2079)
7:117251851:T:C,P13569,I1119T,0.746,Loss of stability (P = 0.0057); Gain of disorder (P = 0.0184); Gain of glycosylation at S1118 (P = 0.1168); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117251851:T:G,P13569,I1119S,0.713,Gain of disorder (P = 0.003); Loss of stability (P = 0.0081); Gain of glycosylation at I1119 (P = 0.0564); Loss of helix (P = 0.0626); Gain of catalytic residue at I1119 (P = 0.1899)
7:117251852:T:G,P13569,I1119M,0.61,Loss of glycosylation at S1118 (P = 0.0577); Gain of loop (P = 0.069); Gain of disorder (P = 0.0711); Loss of helix (P = 0.079); Loss of stability (P = 0.0932)
7:117251853:T:A,P13569,L1120I,0.757,Gain of glycosylation at S1118 (P = 0.1034); Gain of helix (P = 0.1736); Gain of disorder (P = 0.2404); Loss of catalytic residue at L1120 (P = 0.2421); Loss of loop (P = 0.2897)
7:117251853:T:G,P13569,L1120V,0.785,Loss of stability (P = 0.0737); Gain of glycosylation at S1118 (P = 0.1437); Gain of helix (P = 0.1736); Gain of catalytic residue at L1120 (P = 0.1788); Gain of disorder (P = 0.1867)
7:117251854:T:C,P13569,L1120S,0.789,Gain of disorder (P = 0.0023); Gain of glycosylation at L1120 (P = 0.0053); Loss of stability (P = 0.0186); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117251855:A:C,P13569,L1120F,0.762,Loss of stability (P = 0.104); Gain of glycosylation at S1118 (P = 0.1635); Gain of helix (P = 0.1736); Loss of disorder (P = 0.2009); Loss of loop (P = 0.2897)
7:117251855:A:T,P13569,L1120F,0.762,Loss of stability (P = 0.104); Gain of glycosylation at S1118 (P = 0.1635); Gain of helix (P = 0.1736); Loss of disorder (P = 0.2009); Loss of loop (P = 0.2897)
7:117251856:A:C,P13569,T1121P,0.741,Gain of glycosylation at S1118 (P = 0.0981); Loss of stability (P = 0.127); Gain of disorder (P = 0.1361); Gain of catalytic residue at L1120 (P = 0.1883); Gain of loop (P = 0.3485)
7:117251856:A:G,P13569,T1121A,0.562,Loss of disorder (P = 0.1391); Loss of helix (P = 0.2022); Gain of glycosylation at S1118 (P = 0.265); Loss of loop (P = 0.2897); Loss of stability (P = 0.3483)
7:117251856:A:T,P13569,T1121S,0.652,Gain of disorder (P = 0.0409); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of glycosylation at S1118 (P = 0.2169); Loss of stability (P = 0.5012)
7:117251857:C:A,P13569,T1121K,0.779,Gain of methylation at T1121 (P = 0.0158); Gain of ubiquitination at T1121 (P = 0.023); Gain of disorder (P = 0.0809); Loss of catalytic residue at T1121 (P = 0.0944); Loss of glycosylation at S1118 (P = 0.1069)
7:117251857:C:G,P13569,T1121R,0.796,Gain of methylation at T1121 (P = 0.0157); Gain of helix (P = 0.132); Loss of glycosylation at S1118 (P = 0.1396); Loss of catalytic residue at S1118 (P = 0.1677); Gain of disorder (P = 0.18)
7:117251857:C:T,P13569,T1121I,0.555,Loss of catalytic residue at T1121 (P = 0.031); Loss of disorder (P = 0.0514); Loss of helix (P = 0.2022); Gain of glycosylation at S1118 (P = 0.2461); Loss of loop (P = 0.2897)
7:117251859:A:C,P13569,T1122P,0.695,Loss of catalytic residue at T1122 (P = 0.0479); Gain of disorder (P = 0.118); Loss of helix (P = 0.1706); Gain of glycosylation at S1118 (P = 0.2069); Gain of loop (P = 0.2754)
7:117251859:A:G,P13569,T1122A,0.581,Gain of loop (P = 0.069); Loss of disorder (P = 0.1331); Loss of helix (P = 0.1706); Gain of glycosylation at S1118 (P = 0.1956); Loss of catalytic residue at T1121 (P = 0.3031)
7:117251859:A:T,P13569,T1122S,0.543,Gain of glycosylation at T1122 (P = 0.0118); Gain of disorder (P = 0.0364); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Loss of catalytic residue at T1122 (P = 0.1017)
7:117251860:C:A,P13569,T1122K,0.702,Gain of ubiquitination at T1122 (P = 0.0211); Gain of methylation at T1122 (P = 0.025); Loss of catalytic residue at T1122 (P = 0.0413); Gain of disorder (P = 0.06); Gain of loop (P = 0.069)
7:117251860:C:G,P13569,T1122R,0.788,Gain of methylation at T1122 (P = 0.0296); Loss of glycosylation at S1118 (P = 0.1667); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1722); Gain of loop (P = 0.2045)
7:117251860:C:T,P13569,T1122I,0.628,Loss of disorder (P = 0.0427); Loss of catalytic residue at T1122 (P = 0.0435); Loss of helix (P = 0.079); Loss of glycosylation at S1118 (P = 0.1832); Gain of stability (P = 0.3023)
7:117251862:G:A,P13569,G1123R,0.853,Gain of methylation at G1123 (P = 0.0457); Loss of catalytic residue at G1123 (P = 0.1371); Loss of disorder (P = 0.1649); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117251862:G:C,P13569,G1123R,0.853,Gain of methylation at G1123 (P = 0.0457); Loss of catalytic residue at G1123 (P = 0.1371); Loss of disorder (P = 0.1649); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117254667:G:A,P13569,G1123E,0.635,Gain of disorder (P = 0.0666); Gain of glycosylation at S1118 (P = 0.0868); Loss of methylation at R1128 (P = 0.1188); Loss of helix (P = 0.1299); Loss of catalytic residue at G1123 (P = 0.1575)
7:117254667:G:C,P13569,G1123A,0.589,Loss of disorder (P = 0.0693); Gain of glycosylation at S1118 (P = 0.1343); Loss of helix (P = 0.1706); Gain of methylation at R1128 (P = 0.2756); Loss of loop (P = 0.3664)
7:117254667:G:T,P13569,G1123V,0.626,Loss of disorder (P = 0.0255); Loss of helix (P = 0.0558); Loss of catalytic residue at G1123 (P = 0.0794); Gain of glycosylation at S1118 (P = 0.2349); Gain of loop (P = 0.2754)
7:117254669:G:C,P13569,E1124Q,0.586,Gain of loop (P = 0.069); Loss of disorder (P = 0.0849); Loss of helix (P = 0.1706); Gain of methylation at R1128 (P = 0.2846); Gain of glycosylation at T1121 (P = 0.4443)
7:117254670:A:C,P13569,E1124A,0.576,Loss of disorder (P = 0.0324); Gain of loop (P = 0.069); Loss of helix (P = 0.1299); Gain of methylation at R1128 (P = 0.2153); Gain of catalytic residue at E1124 (P = 0.2992)
7:117254670:A:G,P13569,E1124G,0.626,Gain of loop (P = 0.069); Loss of disorder (P = 0.123); Gain of helix (P = 0.1736); Gain of methylation at R1128 (P = 0.2223); Gain of catalytic residue at E1124 (P = 0.3103)
7:117254670:A:T,P13569,E1124V,0.572,Loss of disorder (P = 0.0071); Gain of loop (P = 0.069); Loss of helix (P = 0.1299); Gain of methylation at R1128 (P = 0.2365); Gain of catalytic residue at E1124 (P = 0.3233)
7:117254671:A:C,P13569,E1124D,0.563,Loss of disorder (P = 0.1179); Loss of helix (P = 0.1299); Loss of catalytic residue at E1124 (P = 0.2332); Gain of relative solvent accessibility (P = 0.2751); Gain of loop (P = 0.2754)
7:117254671:A:T,P13569,E1124D,0.563,Loss of disorder (P = 0.1179); Loss of helix (P = 0.1299); Loss of catalytic residue at E1124 (P = 0.2332); Gain of relative solvent accessibility (P = 0.2751); Gain of loop (P = 0.2754)
7:117254672:G:A,P13569,G1125R,0.79,Loss of methylation at R1128 (P = 0.0496); Loss of catalytic residue at G1123 (P = 0.117); Loss of disorder (P = 0.1642); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117254672:G:C,P13569,G1125R,0.79,Loss of methylation at R1128 (P = 0.0496); Loss of catalytic residue at G1123 (P = 0.117); Loss of disorder (P = 0.1642); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117254673:G:A,P13569,G1125E,0.628,Loss of methylation at R1128 (P = 0.0486); Loss of catalytic residue at G1125 (P = 0.0683); Gain of disorder (P = 0.0706); Loss of helix (P = 0.079); Gain of loop (P = 0.2045)
7:117254673:G:C,P13569,G1125A,0.661,Loss of disorder (P = 0.0634); Loss of helix (P = 0.1299); Loss of catalytic residue at G1125 (P = 0.1933); Gain of loop (P = 0.2045); Gain of methylation at R1128 (P = 0.2916)
7:117254673:G:T,P13569,G1125V,0.742,Loss of disorder (P = 0.0186); Loss of helix (P = 0.0626); Loss of catalytic residue at G1125 (P = 0.0673); Gain of loop (P = 0.2045); Loss of methylation at R1128 (P = 0.2508)
7:117254675:G:A,P13569,E1126K,0.661,Gain of ubiquitination at E1126 (P = 0.0138); Gain of methylation at E1126 (P = 0.1048); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1733); Loss of catalytic residue at G1125 (P = 0.3303)
7:117254675:G:C,P13569,E1126Q,0.631,Loss of disorder (P = 0.0851); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.1744); Loss of methylation at R1128 (P = 0.198); Gain of loop (P = 0.2754)
7:117254676:A:C,P13569,E1126A,0.612,Loss of disorder (P = 0.0332); Gain of loop (P = 0.069); Gain of helix (P = 0.0696); Loss of solvent accessibility (P = 0.1744); Gain of methylation at R1128 (P = 0.2561)
7:117254676:A:G,P13569,E1126G,0.564,Gain of loop (P = 0.069); Gain of helix (P = 0.0696); Loss of disorder (P = 0.1228); Loss of solvent accessibility (P = 0.1744); Gain of methylation at R1128 (P = 0.2365)
7:117254676:A:T,P13569,E1126V,0.623,Loss of disorder (P = 0.0076); Gain of loop (P = 0.069); Gain of helix (P = 0.0696); Loss of solvent accessibility (P = 0.1744); Gain of stability (P = 0.2053)
7:117254677:A:C,P13569,E1126D,0.529,Loss of disorder (P = 0.1181); Loss of helix (P = 0.1706); Loss of methylation at R1128 (P = 0.2678); Loss of loop (P = 0.3664); Loss of solvent accessibility (P = 0.4995)
7:117254677:A:T,P13569,E1126D,0.529,Loss of disorder (P = 0.1181); Loss of helix (P = 0.1706); Loss of methylation at R1128 (P = 0.2678); Loss of loop (P = 0.3664); Loss of solvent accessibility (P = 0.4995)
7:117254678:G:A,P13569,G1127R,0.924,Loss of methylation at R1128 (P = 0.0262); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of catalytic residue at G1125 (P = 0.1135); Loss of disorder (P = 0.1844)
7:117254678:G:C,P13569,G1127R,0.924,Loss of methylation at R1128 (P = 0.0262); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of catalytic residue at G1125 (P = 0.1135); Loss of disorder (P = 0.1844)
7:117254679:G:A,P13569,G1127E,0.953,Loss of methylation at R1128 (P = 0.0276); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of disorder (P = 0.0703); Loss of catalytic residue at G1125 (P = 0.194)
7:117254679:G:C,P13569,G1127A,0.835,Loss of helix (P = 0.0376); Loss of disorder (P = 0.0689); Gain of loop (P = 0.069); Loss of methylation at R1128 (P = 0.1323); Loss of stability (P = 0.1532)
7:117254679:G:T,P13569,G1127V,0.833,Loss of disorder (P = 0.0252); Loss of helix (P = 0.0376); Gain of loop (P = 0.069); Loss of catalytic residue at G1127 (P = 0.0862); Loss of methylation at R1128 (P = 0.1004)
7:117254681:A:G,P13569,R1128G,0.607,Loss of methylation at R1128 (P = 0.0079); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of disorder (P = 0.0954); Gain of catalytic residue at V1129 (P = 0.1286)
7:117254682:G:A,P13569,R1128K,0.571,Gain of ubiquitination at R1128 (P = 0.0185); Loss of methylation at R1128 (P = 0.0205); Gain of disorder (P = 0.0681); Loss of catalytic residue at G1127 (P = 0.1972); Gain of loop (P = 0.2045)
7:117254682:G:C,P13569,R1128T,0.612,Loss of methylation at R1128 (P = 0.0079); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of disorder (P = 0.1926); Gain of catalytic residue at V1129 (P = 0.2131)
7:117254682:G:T,P13569,R1128I,0.624,Loss of methylation at R1128 (P = 0.0079); Loss of disorder (P = 0.0411); Gain of catalytic residue at L1133 (P = 0.052); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117254683:A:C,P13569,R1128S,0.549,Loss of methylation at R1128 (P = 0.0079); Gain of glycosylation at R1128 (P = 0.0264); Gain of disorder (P = 0.0486); Loss of helix (P = 0.0558); Gain of catalytic residue at V1129 (P = 0.2114)
7:117254683:A:T,P13569,R1128S,0.549,Loss of methylation at R1128 (P = 0.0079); Gain of glycosylation at R1128 (P = 0.0264); Gain of disorder (P = 0.0486); Loss of helix (P = 0.0558); Gain of catalytic residue at V1129 (P = 0.2114)
7:117254684:G:A,P13569,V1129I,0.554,Loss of methylation at R1128 (P = 0.0636); Gain of loop (P = 0.069); Loss of helix (P = 0.1706); Gain of disorder (P = 0.2206); Gain of catalytic residue at L1133 (P = 0.3926)
7:117254684:G:C,P13569,V1129L,0.599,Gain of helix (P = 0.132); Gain of disorder (P = 0.1513); Loss of methylation at R1128 (P = 0.2072); Loss of loop (P = 0.3664); Gain of catalytic residue at V1129 (P = 0.5152)
7:117254684:G:T,P13569,V1129F,0.622,Gain of helix (P = 0.132); Loss of disorder (P = 0.2036); Gain of methylation at R1128 (P = 0.2871); Loss of catalytic residue at V1129 (P = 0.3528); Loss of loop (P = 0.3664)
7:117254685:T:A,P13569,V1129D,0.776,Gain of disorder (P = 0.0064); Loss of helix (P = 0.028); Gain of loop (P = 0.0502); Loss of methylation at R1128 (P = 0.0691); Loss of catalytic residue at G1127 (P = 0.1866)
7:117254685:T:C,P13569,V1129A,0.648,Gain of disorder (P = 0.0373); Loss of helix (P = 0.0626); Gain of loop (P = 0.069); Gain of catalytic residue at V1129 (P = 0.1572); Gain of methylation at R1128 (P = 0.2615)
7:117254685:T:G,P13569,V1129G,0.768,Gain of disorder (P = 0.0057); Loss of stability (P = 0.023); Gain of loop (P = 0.069); Gain of catalytic residue at G1130 (P = 0.1457); Loss of helix (P = 0.1706)
7:117254687:G:A,P13569,G1130S,0.773,Gain of catalytic residue at G1130 (P = 0.078); Gain of helix (P = 0.132); Gain of disorder (P = 0.1322); Gain of phosphorylation at G1130 (P = 0.1431); Loss of methylation at R1128 (P = 0.2564)
7:117254687:G:C,P13569,G1130R,0.909,Gain of methylation at G1130 (P = 0.0272); Gain of helix (P = 0.0696); Loss of loop (P = 0.1242); Gain of MoRF binding (P = 0.1308); Loss of catalytic residue at L1135 (P = 0.1556)
7:117254687:G:T,P13569,G1130C,0.825,Loss of disorder (P = 0.0237); Gain of helix (P = 0.0696); Gain of catalytic residue at G1130 (P = 0.1006); Loss of methylation at R1128 (P = 0.1632); Loss of loop (P = 0.2237)
7:117254688:G:A,P13569,G1130D,0.878,Gain of helix (P = 0.0696); Gain of catalytic residue at G1130 (P = 0.1503); Loss of methylation at R1128 (P = 0.1582); Loss of disorder (P = 0.1913); Loss of loop (P = 0.2897)
7:117254688:G:T,P13569,G1130V,0.861,Loss of disorder (P = 0.05); Gain of helix (P = 0.0696); Loss of methylation at R1128 (P = 0.0967); Gain of catalytic residue at G1130 (P = 0.1511); Loss of loop (P = 0.2897)
7:117254690:A:C,P13569,I1131L,0.717,Loss of helix (P = 0.1299); Gain of catalytic residue at I1131 (P = 0.1446); Gain of disorder (P = 0.147); Gain of methylation at R1128 (P = 0.263); Gain of loop (P = 0.2754)
7:117254690:A:G,P13569,I1131V,0.822,Gain of catalytic residue at I1131 (P = 0.0024); Gain of disorder (P = 0.1618); Gain of helix (P = 0.2294); Gain of methylation at R1128 (P = 0.2416); Loss of stability (P = 0.3156)
7:117254690:A:T,P13569,I1131F,0.691,Gain of catalytic residue at I1131 (P = 0.1609); Loss of disorder (P = 0.2283); Gain of methylation at R1128 (P = 0.2402); Loss of stability (P = 0.3723); Loss of helix (P = 0.3949)
7:117254691:T:A,P13569,I1131N,0.686,Loss of stability (P = 0.0148); Gain of catalytic residue at I1131 (P = 0.0221); Gain of disorder (P = 0.037); Loss of helix (P = 0.0558); Gain of loop (P = 0.069)
7:117254691:T:C,P13569,I1131T,0.661,Loss of stability (P = 0.0047); Gain of disorder (P = 0.0211); Gain of catalytic residue at I1131 (P = 0.037); Loss of helix (P = 0.1299); Gain of methylation at R1128 (P = 0.2157)
7:117254691:T:G,P13569,I1131S,0.663,Gain of disorder (P = 0.0068); Loss of stability (P = 0.0376); Gain of catalytic residue at I1131 (P = 0.0516); Loss of helix (P = 0.0558); Gain of phosphorylation at I1131 (P = 0.0889)
7:117254692:T:G,P13569,I1131M,0.71,Gain of catalytic residue at I1131 (P = 0.0344); Gain of disorder (P = 0.0751); Loss of helix (P = 0.1299); Gain of methylation at R1128 (P = 0.2246); Gain of loop (P = 0.2754)
7:117254693:A:C,P13569,I1132L,0.706,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of disorder (P = 0.1747); Gain of methylation at R1128 (P = 0.2693); Loss of catalytic residue at A1136 (P = 0.3457)
7:117254693:A:G,P13569,I1132V,0.645,Gain of catalytic residue at I1132 (P = 0.0493); Gain of helix (P = 0.1736); Gain of disorder (P = 0.1968); Gain of methylation at R1128 (P = 0.2715); Gain of MoRF binding (P = 0.4294)
7:117254693:A:T,P13569,I1132F,0.782,Gain of helix (P = 0.1736); Gain of methylation at R1128 (P = 0.2692); Loss of disorder (P = 0.2906); Loss of catalytic residue at L1135 (P = 0.3844); Loss of stability (P = 0.4418)
7:117254694:T:A,P13569,I1132N,0.702,Gain of disorder (P = 0.0526); Gain of catalytic residue at I1132 (P = 0.1518); Gain of helix (P = 0.1736); Gain of methylation at R1128 (P = 0.2257); Loss of stability (P = 0.2913)
7:117254694:T:C,P13569,I1132T,0.672,Gain of disorder (P = 0.0252); Loss of stability (P = 0.124); Gain of helix (P = 0.1736); Gain of methylation at R1128 (P = 0.2353); Loss of catalytic residue at A1136 (P = 0.3472)
7:117254694:T:G,P13569,I1132S,0.675,Gain of disorder (P = 0.0106); Gain of catalytic residue at I1132 (P = 0.0197); Gain of helix (P = 0.1736); Loss of stability (P = 0.2123); Gain of methylation at R1128 (P = 0.225)
7:117254695:C:G,P13569,I1132M,0.709,Gain of catalytic residue at I1132 (P = 0.0396); Gain of disorder (P = 0.0898); Loss of helix (P = 0.1299); Gain of methylation at R1128 (P = 0.2496); Gain of MoRF binding (P = 0.3762)
7:117254696:C:A,P13569,L1133M,0.646,Gain of catalytic residue at V1129 (P = 0.1251); Gain of helix (P = 0.132); Gain of disorder (P = 0.2667); Gain of methylation at R1128 (P = 0.2786); Loss of loop (P = 0.2897)
7:117254696:C:G,P13569,L1133V,0.559,Gain of catalytic residue at L1133 (P = 0.0283); Loss of helix (P = 0.2022); Loss of methylation at R1128 (P = 0.2773); Gain of MoRF binding (P = 0.3746); Gain of disorder (P = 0.4341)
7:117254697:T:A,P13569,L1133Q,0.745,Loss of stability (P = 0.0765); Gain of disorder (P = 0.0991); Gain of helix (P = 0.132); Gain of catalytic residue at L1133 (P = 0.1393); Loss of methylation at R1128 (P = 0.2847)
7:117254697:T:C,P13569,L1133P,0.851,Loss of stability (P = 0.0534); Gain of catalytic residue at L1133 (P = 0.0763); Gain of disorder (P = 0.0806); Gain of helix (P = 0.132); Gain of glycosylation at T1134 (P = 0.147)
7:117254697:T:G,P13569,L1133R,0.909,Gain of methylation at L1133 (P = 0.0197); Gain of MoRF binding (P = 0.054); Gain of disorder (P = 0.069); Loss of stability (P = 0.085); Gain of helix (P = 0.132)
7:117254699:A:C,P13569,T1134P,0.909,Gain of catalytic residue at L1133 (P = 0.1614); Loss of stability (P = 0.1817); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4009); Gain of disorder (P = 0.5704)
7:117254699:A:G,P13569,T1134A,0.749,Loss of helix (P = 0.079); Gain of loop (P = 0.3485); Loss of MoRF binding (P = 0.4369); Loss of catalytic residue at T1134 (P = 0.446); Loss of disorder (P = 0.6029)
7:117254699:A:T,P13569,T1134S,0.734,Gain of MoRF binding (P = 0.3987); Gain of disorder (P = 0.4574); Loss of stability (P = 0.551); Gain of catalytic residue at T1134 (P = 0.5574); Gain of helix (P = 0.5668)
7:117254700:C:A,P13569,T1134N,0.832,Gain of MoRF binding (P = 0.3862); Loss of stability (P = 0.4442); Loss of catalytic residue at N1138 (P = 0.4615); Gain of helix (P = 0.5668); Loss of disorder (P = 0.6106)
7:117254700:C:G,P13569,T1134S,0.734,Gain of MoRF binding (P = 0.3987); Gain of disorder (P = 0.4574); Loss of stability (P = 0.551); Gain of catalytic residue at T1134 (P = 0.5574); Gain of helix (P = 0.5668)
7:117254700:C:T,P13569,T1134I,0.761,Loss of catalytic residue at T1134 (P = 0.0463); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4276); Loss of disorder (P = 0.5476); Loss of sheet (P = 0.6423)
7:117254702:T:A,P13569,L1135I,0.757,Loss of catalytic residue at L1135 (P = 0.0308); Gain of MoRF binding (P = 0.3875); Loss of helix (P = 0.4763); Loss of sheet (P = 0.6423); Gain of glycosylation at T1134 (P = 0.6492)
7:117254702:T:G,P13569,L1135V,0.81,Gain of MoRF binding (P = 0.3377); Loss of catalytic residue at L1135 (P = 0.3454); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Loss of sheet (P = 0.6423)
7:117254703:T:C,P13569,L1135S,0.775,Loss of stability (P = 0.1093); Gain of MoRF binding (P = 0.3403); Loss of catalytic residue at T1134 (P = 0.365); Loss of helix (P = 0.4763); Gain of disorder (P = 0.4804)
7:117254704:A:C,P13569,L1135F,0.808,Loss of catalytic residue at L1135 (P = 0.2024); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4276); Loss of stability (P = 0.6393); Loss of sheet (P = 0.6423)
7:117254704:A:T,P13569,L1135F,0.808,Loss of catalytic residue at L1135 (P = 0.2024); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.4276); Loss of stability (P = 0.6393); Loss of sheet (P = 0.6423)
7:117254705:G:A,P13569,A1136T,0.922,Loss of stability (P = 0.142); Loss of catalytic residue at A1136 (P = 0.387); Loss of MoRF binding (P = 0.403); Loss of helix (P = 0.4763); Gain of loop (P = 0.7958)
7:117254705:G:C,P13569,A1136P,0.894,Loss of catalytic residue at A1136 (P = 0.0427); Loss of stability (P = 0.1094); Loss of helix (P = 0.2271); Gain of glycosylation at A1136 (P = 0.3559); Loss of MoRF binding (P = 0.3622)
7:117254705:G:T,P13569,A1136S,0.803,Loss of stability (P = 0.2023); Gain of helix (P = 0.2294); Loss of catalytic residue at A1136 (P = 0.3163); Loss of MoRF binding (P = 0.4111); Gain of phosphorylation at A1136 (P = 0.7496)
7:117254706:C:A,P13569,A1136D,0.914,Gain of helix (P = 0.2294); Loss of stability (P = 0.2398); Loss of MoRF binding (P = 0.3466); Gain of catalytic residue at L1133 (P = 0.4837); Gain of loop (P = 0.7958)
7:117254706:C:G,P13569,A1136G,0.8,Loss of catalytic residue at A1136 (P = 0.0059); Loss of stability (P = 0.0646); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.4126); Gain of disorder (P = 0.7881)
7:117254706:C:T,P13569,A1136V,0.759,Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.3641); Loss of catalytic residue at M1137 (P = 0.6455); Loss of stability (P = 0.7067); Gain of loop (P = 0.7958)
7:117254708:A:C,P13569,M1137L,0.764,Gain of catalytic residue at M1137 (P = 0.1841); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3749); Loss of stability (P = 0.6955); Gain of loop (P = 0.7958)
7:117254708:A:G,P13569,M1137V,0.912,Gain of helix (P = 0.2294); Gain of catalytic residue at M1137 (P = 0.2339); Loss of stability (P = 0.3166); Loss of MoRF binding (P = 0.3928); Gain of loop (P = 0.7958)
7:117254708:A:T,P13569,M1137L,0.764,Gain of catalytic residue at M1137 (P = 0.1841); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3749); Loss of stability (P = 0.6955); Gain of loop (P = 0.7958)
7:117254709:T:A,P13569,M1137K,0.901,Gain of ubiquitination at M1137 (P = 0.0337); Loss of stability (P = 0.0413); Gain of MoRF binding (P = 0.0984); Loss of catalytic residue at M1137 (P = 0.1395); Loss of helix (P = 0.2022)
7:117254709:T:C,P13569,M1137T,0.876,Loss of stability (P = 0.1018); Loss of helix (P = 0.2022); Gain of catalytic residue at M1137 (P = 0.2325); Loss of MoRF binding (P = 0.3867); Gain of loop (P = 0.4661)
7:117254709:T:G,P13569,M1137R,0.983,Gain of methylation at M1137 (P = 0.0124); Gain of MoRF binding (P = 0.0429); Loss of stability (P = 0.1654); Loss of catalytic residue at N1138 (P = 0.428); Gain of loop (P = 0.4661)
7:117254710:G:A,P13569,M1137I,0.847,Gain of helix (P = 0.2294); Loss of catalytic residue at M1137 (P = 0.3251); Loss of MoRF binding (P = 0.3817); Loss of stability (P = 0.5281); Gain of loop (P = 0.7958)
7:117254710:G:T,P13569,M1137I,0.847,Gain of helix (P = 0.2294); Loss of catalytic residue at M1137 (P = 0.3251); Loss of MoRF binding (P = 0.3817); Loss of stability (P = 0.5281); Gain of loop (P = 0.7958)
7:117254711:A:C,P13569,N1138H,0.873,Gain of catalytic residue at M1140 (P = 0.0433); Loss of stability (P = 0.1902); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3815); Gain of disorder (P = 0.7598)
7:117254711:A:G,P13569,N1138D,0.901,Loss of catalytic residue at S1141 (P = 0.191); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3326); Loss of stability (P = 0.3645); Gain of phosphorylation at S1141 (P = 0.7665)
7:117254711:A:T,P13569,N1138Y,0.855,Gain of catalytic residue at L1133 (P = 0.066); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3732); Loss of stability (P = 0.4775); Gain of phosphorylation at N1138 (P = 0.7669)
7:117254712:A:C,P13569,N1138T,0.819,Loss of helix (P = 0.2022); Loss of stability (P = 0.2038); Loss of catalytic residue at N1138 (P = 0.231); Gain of loop (P = 0.2754); Loss of MoRF binding (P = 0.3845)
7:117254712:A:G,P13569,N1138S,0.77,Loss of stability (P = 0.2803); Loss of MoRF binding (P = 0.3942); Gain of loop (P = 0.4661); Loss of helix (P = 0.4763); Gain of glycosylation at N1138 (P = 0.7088)
7:117254712:A:T,P13569,N1138I,0.865,Loss of catalytic residue at N1138 (P = 0.1485); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3773); Gain of loop (P = 0.4661); Gain of glycosylation at S1141 (P = 0.7672)
7:117254713:T:A,P13569,N1138K,0.857,Gain of ubiquitination at N1138 (P = 0.0211); Loss of catalytic residue at N1138 (P = 0.0698); Gain of MoRF binding (P = 0.0781); Loss of stability (P = 0.1526); Gain of helix (P = 0.2294)
7:117254713:T:G,P13569,N1138K,0.857,Gain of ubiquitination at N1138 (P = 0.0211); Loss of catalytic residue at N1138 (P = 0.0698); Gain of MoRF binding (P = 0.0781); Loss of stability (P = 0.1526); Gain of helix (P = 0.2294)
7:117254714:A:C,P13569,I1139L,0.678,Loss of helix (P = 0.2022); Loss of catalytic residue at S1141 (P = 0.2313); Gain of loop (P = 0.2754); Loss of MoRF binding (P = 0.3788); Loss of stability (P = 0.7257)
7:117254714:A:T,P13569,I1139F,0.8,Loss of catalytic residue at S1141 (P = 0.2168); Gain of helix (P = 0.2294); Loss of stability (P = 0.3337); Loss of MoRF binding (P = 0.3782); Loss of loop (P = 0.4786)
7:117254715:T:A,P13569,I1139N,0.877,Loss of stability (P = 0.0451); Loss of helix (P = 0.2271); Loss of catalytic residue at S1141 (P = 0.281); Loss of MoRF binding (P = 0.3742); Gain of disorder (P = 0.5852)
7:117254715:T:C,P13569,I1139T,0.843,Loss of stability (P = 0.0278); Gain of catalytic residue at I1139 (P = 0.0468); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.3757); Gain of loop (P = 0.4661)
7:117254715:T:G,P13569,I1139S,0.857,Loss of stability (P = 0.042); Gain of catalytic residue at I1139 (P = 0.1567); Loss of helix (P = 0.2271); Gain of disorder (P = 0.3468); Loss of MoRF binding (P = 0.3825)
7:117254716:C:G,P13569,I1139M,0.684,Loss of helix (P = 0.2022); Loss of catalytic residue at S1141 (P = 0.2466); Gain of MoRF binding (P = 0.3461); Loss of stability (P = 0.3848); Gain of loop (P = 0.4661)
7:117254717:A:C,P13569,M1140L,0.86,Gain of catalytic residue at M1140 (P = 0.1965); Gain of helix (P = 0.2294); Loss of stability (P = 0.2731); Loss of MoRF binding (P = 0.3671); Loss of disorder (P = 0.7733)
7:117254717:A:G,P13569,M1140V,0.804,Gain of catalytic residue at M1140 (P = 0.0635); Loss of stability (P = 0.1786); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3867); Loss of disorder (P = 0.7736)
7:117254717:A:T,P13569,M1140L,0.86,Gain of catalytic residue at M1140 (P = 0.1965); Gain of helix (P = 0.2294); Loss of stability (P = 0.2731); Loss of MoRF binding (P = 0.3671); Loss of disorder (P = 0.7733)
7:117254718:T:A,P13569,M1140K,0.95,Gain of ubiquitination at M1140 (P = 0.0289); Loss of stability (P = 0.0296); Gain of MoRF binding (P = 0.1346); Loss of catalytic residue at S1141 (P = 0.1487); Loss of helix (P = 0.2022)
7:117254718:T:C,P13569,M1140T,0.83,Loss of stability (P = 0.0464); Loss of helix (P = 0.2271); Gain of catalytic residue at M1140 (P = 0.2474); Loss of MoRF binding (P = 0.3721); Gain of glycosylation at S1141 (P = 0.4794)
7:117254718:T:G,P13569,M1140R,0.954,Gain of MoRF binding (P = 0.0573); Loss of stability (P = 0.0892); Loss of helix (P = 0.2271); Loss of catalytic residue at Q1144 (P = 0.3181); Gain of methylation at M1140 (P = 0.413)
7:117254719:G:A,P13569,M1140I,0.848,Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3788); Loss of stability (P = 0.4474); Loss of catalytic residue at M1137 (P = 0.659); Gain of glycosylation at S1141 (P = 0.6976)
7:117254719:G:C,P13569,M1140I,0.848,Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3788); Loss of stability (P = 0.4474); Loss of catalytic residue at M1137 (P = 0.659); Gain of glycosylation at S1141 (P = 0.6976)
7:117254719:G:T,P13569,M1140I,0.848,Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3788); Loss of stability (P = 0.4474); Loss of catalytic residue at M1137 (P = 0.659); Gain of glycosylation at S1141 (P = 0.6976)
7:117254720:A:C,P13569,S1141R,0.658,Gain of solvent accessibility (P = 0.0171); Loss of helix (P = 0.0237); Gain of MoRF binding (P = 0.0238); Gain of relative solvent accessibility (P = 0.0479); Gain of loop (P = 0.0502)
7:117254720:A:G,P13569,S1141G,0.817,Gain of catalytic residue at M1140 (P = 0.0815); Gain of helix (P = 0.2294); Loss of stability (P = 0.2423); Loss of MoRF binding (P = 0.3827); Loss of disorder (P = 0.7032)
7:117254720:A:T,P13569,S1141C,0.8,Gain of catalytic residue at I1139 (P = 0.1064); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.3466); Loss of loop (P = 0.4786); Loss of disorder (P = 0.674)
7:117254721:G:A,P13569,S1141N,0.796,Loss of catalytic residue at S1141 (P = 0.0391); Gain of helix (P = 0.2294); Gain of MoRF binding (P = 0.3853); Loss of stability (P = 0.6174); Loss of disorder (P = 0.7062)
7:117254721:G:C,P13569,S1141T,0.767,Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.3842); Loss of catalytic residue at T1142 (P = 0.4522); Loss of stability (P = 0.5578); Loss of disorder (P = 0.7084)
7:117254721:G:T,P13569,S1141I,0.756,Loss of catalytic residue at S1141 (P = 0.1278); Loss of helix (P = 0.1706); Gain of loop (P = 0.3485); Loss of MoRF binding (P = 0.3688); Loss of disorder (P = 0.6801)
7:117254722:T:A,P13569,S1141R,0.658,Gain of solvent accessibility (P = 0.0171); Loss of helix (P = 0.0237); Gain of MoRF binding (P = 0.0238); Gain of relative solvent accessibility (P = 0.0479); Gain of loop (P = 0.0502)
7:117254722:T:G,P13569,S1141R,0.658,Gain of solvent accessibility (P = 0.0171); Loss of helix (P = 0.0237); Gain of MoRF binding (P = 0.0238); Gain of relative solvent accessibility (P = 0.0479); Gain of loop (P = 0.0502)
7:117254723:A:C,P13569,T1142P,0.826,Loss of catalytic residue at T1142 (P = 0.1115); Loss of stability (P = 0.1641); Gain of helix (P = 0.2059); Loss of MoRF binding (P = 0.3331); Loss of loop (P = 0.4786)
7:117254723:A:G,P13569,T1142A,0.812,Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.3663); Loss of stability (P = 0.4406); Loss of loop (P = 0.4786); Loss of catalytic residue at S1141 (P = 0.5532)
7:117254723:A:T,P13569,T1142S,0.738,Loss of catalytic residue at T1142 (P = 0.1389); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.354); Gain of disorder (P = 0.4276); Loss of stability (P = 0.5624)
7:117254724:C:A,P13569,T1142K,0.882,Gain of ubiquitination at T1142 (P = 0.0258); Loss of catalytic residue at S1141 (P = 0.061); Gain of MoRF binding (P = 0.0615); Loss of helix (P = 0.2271); Gain of methylation at T1142 (P = 0.2424)
7:117254724:C:G,P13569,T1142R,0.926,Gain of MoRF binding (P = 0.0245); Gain of helix (P = 0.2059); Loss of catalytic residue at Q1144 (P = 0.2344); Gain of methylation at T1142 (P = 0.3645); Loss of loop (P = 0.4786)
7:117254724:C:T,P13569,T1142I,0.931,Gain of helix (P = 0.0854); Gain of catalytic residue at A1146 (P = 0.3527); Gain of MoRF binding (P = 0.3783); Loss of loop (P = 0.4786); Loss of disorder (P = 0.6624)
7:117254726:T:A,P13569,L1143M,0.72,Loss of catalytic residue at L1143 (P = 0.0069); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2509); Gain of disorder (P = 0.4583); Loss of stability (P = 0.6067)
7:117254726:T:G,P13569,L1143V,0.71,Loss of catalytic residue at L1143 (P = 0.2355); Gain of MoRF binding (P = 0.2885); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786); Loss of stability (P = 0.4791)
7:117254727:T:C,P13569,L1143S,0.869,Gain of disorder (P = 0.0603); Loss of catalytic residue at L1143 (P = 0.0882); Loss of stability (P = 0.0965); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.3549)
7:117254727:T:G,P13569,L1143W,0.796,Gain of MoRF binding (P = 0.068); Loss of helix (P = 0.2271); Loss of stability (P = 0.2283); Loss of catalytic residue at T1142 (P = 0.3913); Gain of loop (P = 0.4661)
7:117254728:G:C,P13569,L1143F,0.716,Loss of catalytic residue at L1143 (P = 0.0273); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.3522); Loss of stability (P = 0.6545); Loss of disorder (P = 0.6578)
7:117254728:G:T,P13569,L1143F,0.716,Loss of catalytic residue at L1143 (P = 0.0273); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.3522); Loss of stability (P = 0.6545); Loss of disorder (P = 0.6578)
7:117254729:C:A,P13569,Q1144K,0.805,Gain of methylation at Q1144 (P = 0.0195); Gain of ubiquitination at Q1144 (P = 0.0247); Gain of MoRF binding (P = 0.066); Loss of stability (P = 0.2083); Loss of helix (P = 0.2271)
7:117254729:C:G,P13569,Q1144E,0.785,Loss of helix (P = 0.2022); Gain of phosphorylation at S1149 (P = 0.2302); Gain of relative solvent accessibility (P = 0.2363); Gain of catalytic residue at N1148 (P = 0.2385); Loss of MoRF binding (P = 0.245)
7:117254730:A:C,P13569,Q1144P,0.84,Loss of stability (P = 0.1635); Gain of catalytic residue at W1145 (P = 0.1686); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.2552); Gain of phosphorylation at S1149 (P = 0.2691)
7:117254730:A:G,P13569,Q1144R,0.806,Gain of MoRF binding (P = 0.03); Gain of methylation at Q1144 (P = 0.1348); Gain of phosphorylation at S1149 (P = 0.2278); Gain of helix (P = 0.2294); Gain of relative solvent accessibility (P = 0.2363)
7:117254730:A:T,P13569,Q1144L,0.819,Gain of catalytic residue at N1148 (P = 0.1584); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.2861); Gain of phosphorylation at S1149 (P = 0.3957); Loss of disorder (P = 0.5344)
7:117254731:G:C,P13569,Q1144H,0.795,Loss of stability (P = 0.1743); Gain of catalytic residue at N1148 (P = 0.2236); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.2966); Loss of phosphorylation at S1149 (P = 0.444)
7:117254731:G:T,P13569,Q1144H,0.795,Loss of stability (P = 0.1743); Gain of catalytic residue at N1148 (P = 0.2236); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.2966); Loss of phosphorylation at S1149 (P = 0.444)
7:117254732:T:A,P13569,W1145R,0.885,Loss of catalytic residue at L1143 (P = 0.0018); Gain of methylation at W1145 (P = 0.0203); Gain of disorder (P = 0.0226); Gain of MoRF binding (P = 0.0553); Gain of relative solvent accessibility (P = 0.1259)
7:117254732:T:C,P13569,W1145R,0.885,Loss of catalytic residue at L1143 (P = 0.0018); Gain of methylation at W1145 (P = 0.0203); Gain of disorder (P = 0.0226); Gain of MoRF binding (P = 0.0553); Gain of relative solvent accessibility (P = 0.1259)
7:117254732:T:G,P13569,W1145G,0.791,Loss of catalytic residue at L1143 (P = 0.005); Gain of disorder (P = 0.0349); Loss of helix (P = 0.0626); Gain of relative solvent accessibility (P = 0.09); Gain of loop (P = 0.1069)
7:117254733:G:C,P13569,W1145S,0.672,Loss of catalytic residue at L1143 (P = 0.0028); Gain of disorder (P = 0.003); Loss of helix (P = 0.0444); Gain of relative solvent accessibility (P = 0.0479); Gain of loop (P = 0.0502)
7:117254733:G:T,P13569,W1145L,0.787,Loss of catalytic residue at L1143 (P = 0.0028); Gain of phosphorylation at S1149 (P = 0.1704); Gain of disorder (P = 0.1758); Loss of MoRF binding (P = 0.2028); Gain of helix (P = 0.2294)
7:117254734:G:C,P13569,W1145C,0.766,Loss of catalytic residue at L1143 (P = 0.003); Gain of relative solvent accessibility (P = 0.09); Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.1734); Gain of solvent accessibility (P = 0.1751)
7:117254734:G:T,P13569,W1145C,0.766,Loss of catalytic residue at L1143 (P = 0.003); Gain of relative solvent accessibility (P = 0.09); Loss of helix (P = 0.1706); Loss of MoRF binding (P = 0.1734); Gain of solvent accessibility (P = 0.1751)
7:117254735:G:A,P13569,A1146T,0.744,Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.2446); Loss of stability (P = 0.2529); Loss of catalytic residue at A1146 (P = 0.343); Gain of disorder (P = 0.353)
7:117254735:G:C,P13569,A1146P,0.866,Loss of catalytic residue at A1146 (P = 0.1401); Loss of stability (P = 0.1608); Loss of MoRF binding (P = 0.1633); Gain of helix (P = 0.2294); Gain of disorder (P = 0.2536)
7:117254735:G:T,P13569,A1146S,0.76,Gain of disorder (P = 0.0569); Loss of catalytic residue at A1146 (P = 0.1656); Gain of phosphorylation at S1149 (P = 0.1828); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.2481)
7:117254736:C:A,P13569,A1146D,0.834,Loss of MoRF binding (P = 0.1207); Gain of disorder (P = 0.1991); Gain of phosphorylation at S1149 (P = 0.2101); Loss of helix (P = 0.2271); Loss of catalytic residue at A1146 (P = 0.2646)
7:117254736:C:G,P13569,A1146G,0.763,Loss of stability (P = 0.0332); Gain of helix (P = 0.2294); Loss of MoRF binding (P = 0.2521); Loss of catalytic residue at A1146 (P = 0.2528); Gain of disorder (P = 0.3282)
7:117254736:C:T,P13569,A1146V,0.704,Loss of helix (P = 0.2022); Gain of MoRF binding (P = 0.2306); Gain of loop (P = 0.2754); Gain of catalytic residue at S1149 (P = 0.3848); Loss of phosphorylation at S1149 (P = 0.4248)
7:117254738:G:A,P13569,V1147I,0.865,Gain of catalytic residue at S1149 (P = 0.1316); Loss of MoRF binding (P = 0.2114); Loss of disorder (P = 0.3505); Gain of phosphorylation at S1149 (P = 0.3957); Loss of stability (P = 0.4073)
7:117254738:G:C,P13569,V1147L,0.734,Loss of catalytic residue at V1147 (P = 0.0445); Loss of MoRF binding (P = 0.1884); Loss of helix (P = 0.2271); Gain of disorder (P = 0.3657); Loss of phosphorylation at S1149 (P = 0.4276)
7:117254738:G:T,P13569,V1147L,0.734,Loss of catalytic residue at V1147 (P = 0.0445); Loss of MoRF binding (P = 0.1884); Loss of helix (P = 0.2271); Gain of disorder (P = 0.3657); Loss of phosphorylation at S1149 (P = 0.4276)
7:117254739:T:A,P13569,V1147E,0.892,Gain of disorder (P = 0.0355); Loss of MoRF binding (P = 0.0954); Loss of catalytic residue at D1152 (P = 0.147); Gain of phosphorylation at S1149 (P = 0.1514); Loss of stability (P = 0.1524)
7:117254739:T:C,P13569,V1147A,0.827,Loss of stability (P = 0.0673); Loss of catalytic residue at D1152 (P = 0.1205); Gain of disorder (P = 0.165); Loss of MoRF binding (P = 0.2118); Loss of helix (P = 0.2271)
7:117254739:T:G,P13569,V1147G,0.742,Loss of stability (P = 0.0027); Gain of loop (P = 0.0111); Loss of helix (P = 0.0167); Gain of sheet (P = 0.0507); Gain of disorder (P = 0.1088)
7:117254741:A:C,P13569,N1148H,0.548,Gain of disorder (P = 0.1155); Gain of catalytic residue at N1148 (P = 0.1315); Loss of MoRF binding (P = 0.1556); Gain of helix (P = 0.2294); Gain of phosphorylation at S1149 (P = 0.4009)
7:117254741:A:G,P13569,N1148D,0.538,Loss of MoRF binding (P = 0.0797); Gain of disorder (P = 0.136); Gain of phosphorylation at S1149 (P = 0.1372); Loss of helix (P = 0.2271); Gain of catalytic residue at N1148 (P = 0.4519)
7:117254741:A:T,P13569,N1148Y,0.533,Gain of phosphorylation at N1148 (P = 0.0632); Gain of catalytic residue at N1148 (P = 0.0667); Loss of MoRF binding (P = 0.1283); Loss of disorder (P = 0.162); Gain of helix (P = 0.2294)
7:117254742:A:C,P13569,N1148T,0.522,Loss of MoRF binding (P = 0.1646); Gain of catalytic residue at S1150 (P = 0.1887); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2625); Gain of phosphorylation at S1149 (P = 0.3418)
7:117254742:A:G,P13569,N1148S,0.473,Gain of disorder (P = 0.0526); Gain of phosphorylation at S1149 (P = 0.1172); Loss of MoRF binding (P = 0.1735); Loss of helix (P = 0.2271); Loss of catalytic residue at D1152 (P = 0.2335)
7:117254742:A:T,P13569,N1148I,0.567,Gain of catalytic residue at S1150 (P = 0.0882); Loss of MoRF binding (P = 0.1218); Loss of disorder (P = 0.1288); Gain of stability (P = 0.1553); Gain of helix (P = 0.2294)
7:117254743:C:G,P13569,N1148K,0.79,Gain of MoRF binding (P = 0.0298); Gain of ubiquitination at N1148 (P = 0.0337); Loss of catalytic residue at D1152 (P = 0.152); Gain of phosphorylation at S1149 (P = 0.1808); Gain of methylation at N1148 (P = 0.1887)
7:117254744:T:A,P13569,S1149T,0.384,Loss of disorder (P = 0.0964); Gain of MoRF binding (P = 0.1705); Loss of helix (P = 0.2271); Loss of stability (P = 0.2485); Loss of phosphorylation at S1149 (P = 0.4029)
7:117254744:T:G,P13569,S1149A,0.42,Loss of disorder (P = 0.0799); Gain of MoRF binding (P = 0.1331); Loss of phosphorylation at S1149 (P = 0.2134); Loss of catalytic residue at D1152 (P = 0.2695); Loss of stability (P = 0.3507)
7:117254745:C:A,P13569,S1149Y,0.486,Loss of disorder (P = 0.0499); Loss of MoRF binding (P = 0.1533); Gain of helix (P = 0.2294); Loss of phosphorylation at S1149 (P = 0.2701); Loss of catalytic residue at D1152 (P = 0.3198)
7:117254745:C:G,P13569,S1149C,0.551,Loss of disorder (P = 0.0306); Gain of catalytic residue at S1149 (P = 0.0483); Loss of MoRF binding (P = 0.0965); Loss of phosphorylation at S1149 (P = 0.2134); Gain of helix (P = 0.2294)
7:117254745:C:T,P13569,S1149F,0.482,Loss of disorder (P = 0.0372); Gain of catalytic residue at S1149 (P = 0.1343); Loss of MoRF binding (P = 0.1641); Loss of phosphorylation at S1149 (P = 0.2134); Loss of helix (P = 0.2271)
7:117254747:A:C,P13569,S1150R,0.74,Gain of MoRF binding (P = 0.0201); Loss of disorder (P = 0.1232); Loss of catalytic residue at D1152 (P = 0.1382); Loss of helix (P = 0.2271); Loss of stability (P = 0.2382)
7:117254747:A:G,P13569,S1150G,0.47,Loss of stability (P = 0.0433); Loss of disorder (P = 0.1065); Gain of MoRF binding (P = 0.1523); Loss of phosphorylation at S1155 (P = 0.2107); Loss of helix (P = 0.2271)
7:117254747:A:T,P13569,S1150C,0.626,Loss of disorder (P = 0.026); Loss of MoRF binding (P = 0.0876); Loss of phosphorylation at S1155 (P = 0.1698); Gain of helix (P = 0.2059); Loss of stability (P = 0.3511)
7:117254748:G:A,P13569,S1150N,0.457,Loss of disorder (P = 0.0961); Loss of MoRF binding (P = 0.1554); Loss of phosphorylation at S1155 (P = 0.1691); Loss of stability (P = 0.1761); Loss of helix (P = 0.2022)
7:117254748:G:C,P13569,S1150T,0.442,Loss of disorder (P = 0.0906); Gain of MoRF binding (P = 0.1594); Loss of phosphorylation at S1155 (P = 0.1749); Gain of helix (P = 0.2059); Gain of catalytic residue at S1150 (P = 0.2333)
7:117254748:G:T,P13569,S1150I,0.474,Loss of disorder (P = 0.0347); Gain of MoRF binding (P = 0.1535); Loss of phosphorylation at S1155 (P = 0.1884); Gain of helix (P = 0.2059); Gain of catalytic residue at D1154 (P = 0.3049)
7:117254749:C:A,P13569,S1150R,0.74,Gain of MoRF binding (P = 0.0201); Loss of disorder (P = 0.1232); Loss of catalytic residue at D1152 (P = 0.1382); Loss of helix (P = 0.2271); Loss of stability (P = 0.2382)
7:117254749:C:G,P13569,S1150R,0.74,Gain of MoRF binding (P = 0.0201); Loss of disorder (P = 0.1232); Loss of catalytic residue at D1152 (P = 0.1382); Loss of helix (P = 0.2271); Loss of stability (P = 0.2382)
7:117254750:A:C,P13569,I1151L,0.454,Loss of stability (P = 0.0248); Gain of disorder (P = 0.1192); Loss of MoRF binding (P = 0.1264); Loss of catalytic residue at D1152 (P = 0.1274); Gain of phosphorylation at S1155 (P = 0.1828)
7:117254750:A:G,P13569,I1151V,0.4,Loss of stability (P = 0.017); Gain of disorder (P = 0.1038); Gain of MoRF binding (P = 0.1244); Loss of catalytic residue at L1156 (P = 0.1607); Gain of phosphorylation at S1155 (P = 0.1737)
7:117254750:A:T,P13569,I1151L,0.454,Loss of stability (P = 0.0248); Gain of disorder (P = 0.1192); Loss of MoRF binding (P = 0.1264); Loss of catalytic residue at D1152 (P = 0.1274); Gain of phosphorylation at S1155 (P = 0.1828)
7:117254751:T:A,P13569,I1151K,0.491,Loss of stability (P = 2e-04); Gain of disorder (P = 0.009); Gain of solvent accessibility (P = 0.0171); Gain of MoRF binding (P = 0.0174); Gain of ubiquitination at I1151 (P = 0.0177)
7:117254751:T:C,P13569,I1151T,0.393,Loss of stability (P = 0); Gain of disorder (P = 0.0286); Gain of catalytic residue at I1151 (P = 0.0486); Gain of phosphorylation at I1151 (P = 0.0797); Gain of relative solvent accessibility (P = 0.1012)
7:117254751:T:G,P13569,I1151R,0.52,Loss of stability (P = 0.0018); Gain of MoRF binding (P = 0.0068); Gain of disorder (P = 0.0157); Gain of solvent accessibility (P = 0.0263); Gain of relative solvent accessibility (P = 0.0507)
7:117254752:A:G,P13569,I1151M,0.465,Loss of stability (P = 0.0146); Gain of disorder (P = 0.0416); Gain of MoRF binding (P = 0.0725); Loss of catalytic residue at D1152 (P = 0.1079); Gain of phosphorylation at S1155 (P = 0.1454)
7:117254753:G:A,P13569,D1152N,0.377,Gain of MoRF binding (P = 0.0298); Loss of stability (P = 0.0707); Loss of catalytic residue at D1152 (P = 0.1014); Loss of phosphorylation at S1155 (P = 0.1654); Loss of disorder (P = 0.2005)
7:117254753:G:T,P13569,D1152Y,0.569,Gain of catalytic residue at I1151 (P = 0.0238); Loss of helix (P = 0.0376); Loss of disorder (P = 0.0455); Gain of MoRF binding (P = 0.0457); Gain of loop (P = 0.0502)
7:117254754:A:C,P13569,D1152A,0.463,Loss of stability (P = 0.0255); Gain of MoRF binding (P = 0.0336); Loss of disorder (P = 0.0964); Loss of catalytic residue at D1152 (P = 0.1432); Loss of helix (P = 0.2271)
7:117254754:A:G,P13569,D1152G,0.449,Loss of stability (P = 0.0201); Gain of MoRF binding (P = 0.0357); Loss of catalytic residue at D1152 (P = 0.0463); Loss of disorder (P = 0.1805); Loss of helix (P = 0.2022)
7:117254754:A:T,P13569,D1152V,0.542,Gain of MoRF binding (P = 0.0309); Loss of disorder (P = 0.0523); Gain of catalytic residue at S1150 (P = 0.15); Loss of phosphorylation at S1155 (P = 0.1857); Loss of stability (P = 0.1893)
7:117254755:T:A,P13569,D1152E,0.286,Gain of MoRF binding (P = 0.1249); Loss of stability (P = 0.1689); Loss of helix (P = 0.2022); Gain of disorder (P = 0.212); Gain of phosphorylation at S1155 (P = 0.271)
7:117254755:T:G,P13569,D1152E,0.286,Gain of MoRF binding (P = 0.1249); Loss of stability (P = 0.1689); Loss of helix (P = 0.2022); Gain of disorder (P = 0.212); Gain of phosphorylation at S1155 (P = 0.271)
7:117254756:G:C,P13569,V1153L,0.412,Loss of catalytic residue at V1153 (P = 0.0054); Loss of MoRF binding (P = 0.0944); Gain of disorder (P = 0.2404); Loss of phosphorylation at S1155 (P = 0.2593); Loss of helix (P = 0.3949)
7:117254756:G:T,P13569,V1153L,0.412,Loss of catalytic residue at V1153 (P = 0.0054); Loss of MoRF binding (P = 0.0944); Gain of disorder (P = 0.2404); Loss of phosphorylation at S1155 (P = 0.2593); Loss of helix (P = 0.3949)
7:117254757:T:A,P13569,V1153E,0.906,Gain of disorder (P = 0.0171); Loss of catalytic residue at V1153 (P = 0.0231); Loss of MoRF binding (P = 0.0332); Loss of stability (P = 0.0652); Gain of phosphorylation at S1155 (P = 0.1151)
7:117254757:T:C,P13569,V1153A,0.487,Loss of stability (P = 0.0259); Loss of catalytic residue at V1153 (P = 0.0276); Gain of disorder (P = 0.0714); Loss of MoRF binding (P = 0.1141); Gain of phosphorylation at S1155 (P = 0.1963)
7:117254757:T:G,P13569,V1153G,0.695,Loss of stability (P = 0.002); Gain of disorder (P = 0.0354); Loss of helix (P = 0.079); Loss of MoRF binding (P = 0.1011); Gain of phosphorylation at S1155 (P = 0.184)
7:117254759:G:A,P13569,D1154N,0.513,Gain of MoRF binding (P = 0.028); Gain of helix (P = 0.132); Loss of phosphorylation at S1159 (P = 0.1729); Loss of disorder (P = 0.1891); Loss of stability (P = 0.2792)
7:117254759:G:C,P13569,D1154H,0.707,Gain of MoRF binding (P = 0.0405); Gain of helix (P = 0.132); Loss of disorder (P = 0.1498); Loss of phosphorylation at S1155 (P = 0.1842); Gain of catalytic residue at L1156 (P = 0.1849)
7:117254759:G:T,P13569,D1154Y,0.658,Loss of disorder (P = 0.0351); Gain of phosphorylation at D1154 (P = 0.0357); Gain of MoRF binding (P = 0.043); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.2517)
7:117254760:A:C,P13569,D1154A,0.659,Gain of MoRF binding (P = 0.0298); Loss of disorder (P = 0.0822); Gain of helix (P = 0.132); Loss of phosphorylation at S1155 (P = 0.2239); Loss of solvent accessibility (P = 0.2517)
7:117254760:A:G,P13569,D1154G,0.84,Gain of MoRF binding (P = 0.0325); Loss of stability (P = 0.0791); Gain of helix (P = 0.132); Gain of catalytic residue at D1154 (P = 0.1504); Loss of disorder (P = 0.1687)
7:117254760:A:T,P13569,D1154V,0.634,Gain of MoRF binding (P = 0.0284); Loss of disorder (P = 0.0407); Gain of helix (P = 0.0696); Loss of loop (P = 0.1242); Loss of phosphorylation at S1155 (P = 0.2097)
7:117254761:T:A,P13569,D1154E,0.431,Gain of MoRF binding (P = 0.1261); Gain of helix (P = 0.132); Gain of disorder (P = 0.1978); Gain of phosphorylation at S1155 (P = 0.2672); Loss of loop (P = 0.2897)
7:117254761:T:G,P13569,D1154E,0.431,Gain of MoRF binding (P = 0.1261); Gain of helix (P = 0.132); Gain of disorder (P = 0.1978); Gain of phosphorylation at S1155 (P = 0.2672); Loss of loop (P = 0.2897)
7:117254762:A:C,P13569,S1155R,0.357,Gain of MoRF binding (P = 0.01); Loss of phosphorylation at S1155 (P = 0.0751); Gain of solvent accessibility (P = 0.0766); Loss of disorder (P = 0.0988); Loss of catalytic residue at D1152 (P = 0.167)
7:117254762:A:G,P13569,S1155G,0.288,Loss of phosphorylation at S1155 (P = 0.0751); Loss of disorder (P = 0.0963); Loss of MoRF binding (P = 0.126); Gain of catalytic residue at S1155 (P = 0.1428); Gain of helix (P = 0.2059)
7:117254762:A:T,P13569,S1155C,0.535,Loss of disorder (P = 0.0089); Loss of MoRF binding (P = 0.0708); Loss of phosphorylation at S1155 (P = 0.0751); Gain of catalytic residue at L1156 (P = 0.1164); Gain of helix (P = 0.2059)
7:117254763:G:A,P13569,S1155N,0.258,Loss of phosphorylation at S1155 (P = 0.0751); Loss of disorder (P = 0.0972); Gain of MoRF binding (P = 0.109); Gain of helix (P = 0.2059); Gain of relative solvent accessibility (P = 0.2363)
7:117254763:G:C,P13569,S1155T,0.251,Loss of disorder (P = 0.0706); Loss of phosphorylation at S1155 (P = 0.1087); Gain of MoRF binding (P = 0.1371); Gain of helix (P = 0.2059); Gain of catalytic residue at D1154 (P = 0.3708)
7:117254763:G:T,P13569,S1155I,0.473,Loss of disorder (P = 0.0153); Loss of phosphorylation at S1155 (P = 0.0751); Loss of MoRF binding (P = 0.1068); Gain of stability (P = 0.1076); Gain of helix (P = 0.2059)
7:117254764:C:A,P13569,S1155R,0.357,Gain of MoRF binding (P = 0.01); Loss of phosphorylation at S1155 (P = 0.0751); Gain of solvent accessibility (P = 0.0766); Loss of disorder (P = 0.0988); Loss of catalytic residue at D1152 (P = 0.167)
7:117254764:C:G,P13569,S1155R,0.357,Gain of MoRF binding (P = 0.01); Loss of phosphorylation at S1155 (P = 0.0751); Gain of solvent accessibility (P = 0.0766); Loss of disorder (P = 0.0988); Loss of catalytic residue at D1152 (P = 0.167)
7:117254765:T:A,P13569,L1156M,0.435,Gain of disorder (P = 0.0546); Gain of MoRF binding (P = 0.071); Loss of catalytic residue at L1156 (P = 0.1453); Gain of phosphorylation at S1155 (P = 0.1656); Loss of stability (P = 0.1667)
7:117254765:T:G,P13569,L1156V,0.379,Loss of helix (P = 0.0167); Gain of loop (P = 0.0435); Gain of MoRF binding (P = 0.0944); Loss of stability (P = 0.1594); Gain of disorder (P = 0.1663)
7:117254766:T:C,P13569,L1156S,0.465,Gain of disorder (P = 0.0037); Loss of stability (P = 0.0059); Loss of helix (P = 0.0167); Gain of phosphorylation at L1156 (P = 0.0377); Gain of loop (P = 0.0435)
7:117254766:T:G,P13569,L1156W,0.442,Gain of MoRF binding (P = 0.0236); Loss of stability (P = 0.0251); Loss of disorder (P = 0.1232); Loss of phosphorylation at S1161 (P = 0.1524); Loss of helix (P = 0.2271)
7:117254767:G:C,P13569,L1156F,0.377,Loss of stability (P = 0.0994); Loss of MoRF binding (P = 0.1267); Loss of catalytic residue at L1156 (P = 0.1764); Loss of disorder (P = 0.2268); Loss of helix (P = 0.2271)
7:117267576:A:C,P13569,M1157L,0.558,Loss of catalytic residue at V1153 (P = 0.0179); Loss of MoRF binding (P = 0.0743); Loss of disorder (P = 0.1693); Loss of helix (P = 0.2022); Loss of phosphorylation at S1159 (P = 0.2127)
7:117267576:A:G,P13569,M1157V,0.512,Loss of catalytic residue at V1153 (P = 0.018); Loss of helix (P = 0.0626); Loss of MoRF binding (P = 0.0953); Gain of loop (P = 0.1069); Loss of disorder (P = 0.1866)
7:117267576:A:T,P13569,M1157L,0.558,Loss of catalytic residue at V1153 (P = 0.0179); Loss of MoRF binding (P = 0.0743); Loss of disorder (P = 0.1693); Loss of helix (P = 0.2022); Loss of phosphorylation at S1159 (P = 0.2127)
7:117267577:T:A,P13569,M1157K,0.757,Loss of catalytic residue at V1153 (P = 0.0193); Gain of disorder (P = 0.0222); Gain of ubiquitination at M1157 (P = 0.0276); Loss of stability (P = 0.0588); Gain of MoRF binding (P = 0.0618)
7:117267577:T:C,P13569,M1157T,0.673,Loss of catalytic residue at V1153 (P = 0.022); Gain of phosphorylation at M1157 (P = 0.0602); Loss of stability (P = 0.0668); Loss of MoRF binding (P = 0.0784); Gain of disorder (P = 0.1087)
7:117267577:T:G,P13569,M1157R,0.749,Loss of catalytic residue at V1153 (P = 0.0149); Gain of methylation at M1157 (P = 0.0367); Gain of MoRF binding (P = 0.048); Gain of disorder (P = 0.0545); Gain of phosphorylation at S1155 (P = 0.0816)
7:117267578:G:A,P13569,M1157I,0.535,Loss of catalytic residue at V1153 (P = 0.0161); Loss of MoRF binding (P = 0.0934); Loss of disorder (P = 0.1169); Gain of helix (P = 0.2059); Loss of phosphorylation at S1161 (P = 0.2272)
7:117267578:G:C,P13569,M1157I,0.535,Loss of catalytic residue at V1153 (P = 0.0161); Loss of MoRF binding (P = 0.0934); Loss of disorder (P = 0.1169); Gain of helix (P = 0.2059); Loss of phosphorylation at S1161 (P = 0.2272)
7:117267578:G:T,P13569,M1157I,0.535,Loss of catalytic residue at V1153 (P = 0.0161); Loss of MoRF binding (P = 0.0934); Loss of disorder (P = 0.1169); Gain of helix (P = 0.2059); Loss of phosphorylation at S1161 (P = 0.2272)
7:117267579:C:G,P13569,R1158G,0.436,Loss of MoRF binding (P = 0.0074); Loss of solvent accessibility (P = 0.0299); Loss of phosphorylation at S1161 (P = 0.0679); Loss of stability (P = 0.0725); Gain of catalytic residue at D1154 (P = 0.0992)
7:117267580:G:A,P13569,R1158Q,0.448,Loss of MoRF binding (P = 0.0162); Loss of solvent accessibility (P = 0.0299); Loss of phosphorylation at S1161 (P = 0.0535); Loss of helix (P = 0.1299); Loss of relative solvent accessibility (P = 0.1807)
7:117267580:G:C,P13569,R1158P,0.533,Loss of MoRF binding (P = 0.0011); Loss of solvent accessibility (P = 0.0299); Loss of helix (P = 0.0626); Loss of phosphorylation at S1161 (P = 0.0847); Gain of catalytic residue at D1154 (P = 0.1487)
7:117267580:G:T,P13569,R1158L,0.482,Loss of MoRF binding (P = 0.0047); Loss of solvent accessibility (P = 0.0299); Loss of phosphorylation at S1161 (P = 0.0605); Loss of disorder (P = 0.076); Gain of catalytic residue at D1154 (P = 0.1238)
7:117267582:T:A,P13569,S1159T,0.769,Loss of phosphorylation at S1159 (P = 0.0343); Loss of disorder (P = 0.09); Gain of MoRF binding (P = 0.1353); Gain of helix (P = 0.2059); Gain of catalytic residue at S1161 (P = 0.4128)
7:117267582:T:C,P13569,S1159P,0.915,Loss of phosphorylation at S1159 (P = 0.0233); Loss of MoRF binding (P = 0.0526); Loss of disorder (P = 0.1283); Loss of helix (P = 0.2022); Gain of catalytic residue at L1156 (P = 0.2476)
7:117267582:T:G,P13569,S1159A,0.756,Loss of phosphorylation at S1159 (P = 0.0233); Loss of disorder (P = 0.0708); Gain of MoRF binding (P = 0.1201); Loss of helix (P = 0.2022); Gain of methylation at R1158 (P = 0.3134)
7:117267583:C:A,P13569,S1159Y,0.864,Loss of phosphorylation at S1159 (P = 0.0264); Loss of disorder (P = 0.0421); Loss of MoRF binding (P = 0.1059); Gain of helix (P = 0.2059); Loss of stability (P = 0.4182)
7:117267583:C:G,P13569,S1159C,0.809,Gain of catalytic residue at M1157 (P = 2e-04); Loss of phosphorylation at S1159 (P = 0.0233); Loss of disorder (P = 0.0252); Loss of MoRF binding (P = 0.0716); Gain of helix (P = 0.2059)
7:117267583:C:T,P13569,S1159F,0.917,Loss of phosphorylation at S1159 (P = 0.0233); Loss of disorder (P = 0.0318); Loss of MoRF binding (P = 0.1059); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897)
7:117267585:G:A,P13569,V1160M,0.436,Gain of disorder (P = 0.0909); Gain of MoRF binding (P = 0.0964); Gain of ubiquitination at K1165 (P = 0.1586); Gain of phosphorylation at S1155 (P = 0.1885); Loss of helix (P = 0.2022)
7:117267585:G:C,P13569,V1160L,0.414,Loss of MoRF binding (P = 0.0963); Loss of ubiquitination at K1165 (P = 0.1664); Gain of helix (P = 0.2059); Gain of disorder (P = 0.2524); Gain of phosphorylation at S1155 (P = 0.2615)
7:117267585:G:T,P13569,V1160L,0.414,Loss of MoRF binding (P = 0.0963); Loss of ubiquitination at K1165 (P = 0.1664); Gain of helix (P = 0.2059); Gain of disorder (P = 0.2524); Gain of phosphorylation at S1155 (P = 0.2615)
7:117267586:T:A,P13569,V1160E,0.741,Gain of disorder (P = 0.013); Loss of MoRF binding (P = 0.0189); Loss of helix (P = 0.1299); Gain of phosphorylation at S1155 (P = 0.1623); Loss of ubiquitination at K1165 (P = 0.1664)
7:117267586:T:C,P13569,V1160A,0.393,Gain of disorder (P = 0.1151); Loss of MoRF binding (P = 0.1171); Loss of stability (P = 0.1535); Loss of ubiquitination at K1165 (P = 0.1664); Gain of helix (P = 0.2059)
7:117267586:T:G,P13569,V1160G,0.655,Loss of stability (P = 0.0203); Loss of helix (P = 0.0376); Gain of disorder (P = 0.0423); Loss of MoRF binding (P = 0.1031); Gain of loop (P = 0.1069)
7:117267588:A:C,P13569,S1161R,0.78,Gain of MoRF binding (P = 0.0148); Loss of phosphorylation at S1161 (P = 0.0295); Loss of ubiquitination at K1165 (P = 0.0718); Loss of disorder (P = 0.1503); Gain of solvent accessibility (P = 0.204)
7:117267588:A:G,P13569,S1161G,0.516,Loss of phosphorylation at S1161 (P = 0.0295); Loss of stability (P = 0.1119); Loss of disorder (P = 0.1194); Loss of MoRF binding (P = 0.1245); Gain of ubiquitination at K1165 (P = 0.1317)
7:117267588:A:T,P13569,S1161C,0.633,Loss of phosphorylation at S1161 (P = 0.0295); Loss of disorder (P = 0.0375); Loss of MoRF binding (P = 0.0664); Gain of ubiquitination at K1165 (P = 0.1586); Loss of helix (P = 0.2022)
7:117267589:G:A,P13569,S1161N,0.538,Loss of phosphorylation at S1161 (P = 0.0295); Loss of disorder (P = 0.1037); Gain of MoRF binding (P = 0.1214); Loss of ubiquitination at K1165 (P = 0.1828); Loss of helix (P = 0.2022)
7:117267589:G:C,P13569,S1161T,0.488,Loss of phosphorylation at S1161 (P = 0.0747); Loss of disorder (P = 0.1088); Loss of MoRF binding (P = 0.1373); Loss of ubiquitination at K1165 (P = 0.1828); Gain of catalytic residue at F1164 (P = 0.2973)
7:117267589:G:T,P13569,S1161I,0.598,Loss of phosphorylation at S1161 (P = 0.0295); Loss of disorder (P = 0.0466); Gain of ubiquitination at K1165 (P = 0.095); Loss of MoRF binding (P = 0.1147); Gain of helix (P = 0.2294)
7:117267590:C:A,P13569,S1161R,0.78,Gain of MoRF binding (P = 0.0148); Loss of phosphorylation at S1161 (P = 0.0295); Loss of ubiquitination at K1165 (P = 0.0718); Loss of disorder (P = 0.1503); Gain of solvent accessibility (P = 0.204)
7:117267590:C:G,P13569,S1161R,0.78,Gain of MoRF binding (P = 0.0148); Loss of phosphorylation at S1161 (P = 0.0295); Loss of ubiquitination at K1165 (P = 0.0718); Loss of disorder (P = 0.1503); Gain of solvent accessibility (P = 0.204)
7:117267591:C:G,P13569,R1162G,0.807,Loss of MoRF binding (P = 0.0144); Loss of stability (P = 0.0596); Gain of ubiquitination at K1165 (P = 0.0822); Loss of phosphorylation at S1161 (P = 0.1101); Gain of catalytic residue at V1163 (P = 0.1309)
7:117267592:G:A,P13569,R1162Q,0.896,Loss of MoRF binding (P = 0.0224); Loss of phosphorylation at S1161 (P = 0.0877); Loss of helix (P = 0.1299); Gain of ubiquitination at K1165 (P = 0.1317); Loss of disorder (P = 0.3018)
7:117267592:G:C,P13569,R1162P,0.809,Loss of MoRF binding (P = 0.0023); Gain of ubiquitination at K1165 (P = 0.095); Gain of disorder (P = 0.1593); Loss of stability (P = 0.1688); Loss of phosphorylation at S1159 (P = 0.1887)
7:117267594:G:A,P13569,V1163I,0.504,Loss of MoRF binding (P = 0.1288); Gain of ubiquitination at K1165 (P = 0.1317); Loss of helix (P = 0.2022); Loss of disorder (P = 0.3121); Gain of phosphorylation at S1161 (P = 0.3147)
7:117267594:G:C,P13569,V1163L,0.591,Loss of MoRF binding (P = 0.098); Loss of ubiquitination at K1165 (P = 0.1664); Loss of helix (P = 0.2271); Gain of phosphorylation at S1161 (P = 0.3147); Gain of disorder (P = 0.3353)
7:117267594:G:T,P13569,V1163F,0.601,Loss of MoRF binding (P = 0.0823); Loss of stability (P = 0.1522); Loss of ubiquitination at K1165 (P = 0.1828); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897)
7:117267595:T:A,P13569,V1163D,0.869,Gain of disorder (P = 0.0134); Loss of MoRF binding (P = 0.0277); Loss of stability (P = 0.0491); Loss of helix (P = 0.0558); Gain of ubiquitination at K1165 (P = 0.0728)
7:117267595:T:C,P13569,V1163A,0.584,Loss of stability (P = 0.0148); Loss of MoRF binding (P = 0.1179); Loss of helix (P = 0.1299); Loss of ubiquitination at K1165 (P = 0.1327); Gain of disorder (P = 0.1617)
7:117267595:T:G,P13569,V1163G,0.765,Loss of stability (P = 7e-04); Gain of disorder (P = 0.0454); Loss of ubiquitination at K1165 (P = 0.0853); Loss of MoRF binding (P = 0.1068); Gain of phosphorylation at S1161 (P = 0.2636)
7:117267597:T:A,P13569,F1164I,0.413,Gain of MoRF binding (P = 0.08); Gain of ubiquitination at K1165 (P = 0.1111); Gain of helix (P = 0.132); Gain of disorder (P = 0.236); Gain of phosphorylation at S1161 (P = 0.2763)
7:117267597:T:C,P13569,F1164L,0.386,Gain of MoRF binding (P = 0.0972); Gain of ubiquitination at K1165 (P = 0.1111); Gain of helix (P = 0.132); Gain of disorder (P = 0.2008); Gain of phosphorylation at S1161 (P = 0.2724)
7:117267597:T:G,P13569,F1164V,0.438,Gain of MoRF binding (P = 0.0724); Loss of stability (P = 0.1225); Gain of ubiquitination at K1165 (P = 0.1317); Gain of disorder (P = 0.155); Gain of phosphorylation at S1161 (P = 0.2432)
7:117267598:T:A,P13569,F1164Y,0.402,Gain of phosphorylation at F1164 (P = 0.026); Gain of ubiquitination at K1165 (P = 0.095); Gain of MoRF binding (P = 0.1164); Gain of helix (P = 0.132); Loss of stability (P = 0.1602)
7:117267598:T:C,P13569,F1164S,0.6,Gain of disorder (P = 0.0017); Gain of phosphorylation at F1164 (P = 0.044); Loss of stability (P = 0.0565); Gain of MoRF binding (P = 0.0807); Gain of ubiquitination at K1165 (P = 0.095)
7:117267598:T:G,P13569,F1164C,0.483,Loss of loop (P = 0.0804); Loss of MoRF binding (P = 0.0881); Loss of stability (P = 0.16); Loss of phosphorylation at S1161 (P = 0.1647); Loss of ubiquitination at K1165 (P = 0.1664)
7:117267599:T:A,P13569,F1164L,0.386,Gain of MoRF binding (P = 0.0972); Gain of ubiquitination at K1165 (P = 0.1111); Gain of helix (P = 0.132); Gain of disorder (P = 0.2008); Gain of phosphorylation at S1161 (P = 0.2724)
7:117267599:T:G,P13569,F1164L,0.386,Gain of MoRF binding (P = 0.0972); Gain of ubiquitination at K1165 (P = 0.1111); Gain of helix (P = 0.132); Gain of disorder (P = 0.2008); Gain of phosphorylation at S1161 (P = 0.2724)
7:117267600:A:C,P13569,K1165Q,0.454,Loss of methylation at K1165 (P = 2e-04); Loss of ubiquitination at K1165 (P = 0.0283); Loss of MoRF binding (P = 0.0395); Loss of disorder (P = 0.1706); Loss of phosphorylation at S1161 (P = 0.2077)
7:117267600:A:G,P13569,K1165E,0.478,Loss of methylation at K1165 (P = 2e-04); Loss of MoRF binding (P = 0.0051); Loss of ubiquitination at K1165 (P = 0.0283); Loss of disorder (P = 0.2434); Gain of phosphorylation at S1161 (P = 0.271)
7:117267601:A:C,P13569,K1165T,0.502,Loss of methylation at K1165 (P = 2e-04); Gain of phosphorylation at K1165 (P = 0.0223); Loss of MoRF binding (P = 0.0252); Loss of ubiquitination at K1165 (P = 0.0283); Loss of stability (P = 0.0948)
7:117267601:A:G,P13569,K1165R,0.425,Loss of methylation at K1165 (P = 0.0012); Loss of ubiquitination at K1165 (P = 0.0283); Gain of MoRF binding (P = 0.0674); Loss of helix (P = 0.1299); Gain of catalytic residue at K1165 (P = 0.1467)
7:117267601:A:T,P13569,K1165M,0.462,Loss of methylation at K1165 (P = 2e-04); Loss of ubiquitination at K1165 (P = 0.0283); Loss of MoRF binding (P = 0.0352); Loss of disorder (P = 0.1295); Loss of helix (P = 0.1299)
7:117267602:G:C,P13569,K1165N,0.494,Loss of methylation at K1165 (P = 2e-04); Loss of ubiquitination at K1165 (P = 0.0283); Loss of MoRF binding (P = 0.0353); Loss of disorder (P = 0.1337); Loss of phosphorylation at S1161 (P = 0.1837)
7:117267602:G:T,P13569,K1165N,0.494,Loss of methylation at K1165 (P = 2e-04); Loss of ubiquitination at K1165 (P = 0.0283); Loss of MoRF binding (P = 0.0353); Loss of disorder (P = 0.1337); Loss of phosphorylation at S1161 (P = 0.1837)
7:117267603:T:A,P13569,F1166I,0.65,Gain of MoRF binding (P = 0.0834); Loss of helix (P = 0.1706); Loss of ubiquitination at K1165 (P = 0.1828); Gain of disorder (P = 0.2286); Loss of phosphorylation at S1161 (P = 0.2657)
7:117267603:T:C,P13569,F1166L,0.653,Gain of MoRF binding (P = 0.0955); Gain of ubiquitination at K1165 (P = 0.1317); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1887); Gain of phosphorylation at S1161 (P = 0.3089)
7:117267603:T:G,P13569,F1166V,0.679,Gain of MoRF binding (P = 0.0699); Gain of disorder (P = 0.1454); Loss of helix (P = 0.1706); Loss of ubiquitination at K1165 (P = 0.1828); Loss of stability (P = 0.251)
7:117267604:T:A,P13569,F1166Y,0.629,Gain of phosphorylation at F1166 (P = 0.0132); Gain of catalytic residue at P1170 (P = 0.089); Gain of MoRF binding (P = 0.0997); Loss of helix (P = 0.1299); Gain of ubiquitination at K1165 (P = 0.1317)
7:117267604:T:C,P13569,F1166S,0.849,Gain of disorder (P = 0.0016); Gain of phosphorylation at F1166 (P = 0.0543); Loss of stability (P = 0.0574); Gain of MoRF binding (P = 0.0721); Loss of helix (P = 0.1299)
7:117267604:T:G,P13569,F1166C,0.866,Loss of MoRF binding (P = 0.0971); Loss of ubiquitination at K1165 (P = 0.1486); Loss of stability (P = 0.164); Loss of helix (P = 0.1706); Loss of phosphorylation at S1161 (P = 0.2396)
7:117267605:C:A,P13569,F1166L,0.653,Gain of MoRF binding (P = 0.0955); Gain of ubiquitination at K1165 (P = 0.1317); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1887); Gain of phosphorylation at S1161 (P = 0.3089)
7:117267605:C:G,P13569,F1166L,0.653,Gain of MoRF binding (P = 0.0955); Gain of ubiquitination at K1165 (P = 0.1317); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1887); Gain of phosphorylation at S1161 (P = 0.3089)
7:117267606:A:C,P13569,I1167L,0.319,Loss of MoRF binding (P = 0.1128); Gain of disorder (P = 0.1462); Loss of ubiquitination at K1165 (P = 0.1664); Gain of helix (P = 0.1736); Gain of phosphorylation at T1171 (P = 0.3843)
7:117267606:A:G,P13569,I1167V,0.295,Gain of disorder (P = 0.1122); Gain of MoRF binding (P = 0.1202); Loss of ubiquitination at K1165 (P = 0.1486); Gain of helix (P = 0.1736); Gain of phosphorylation at T1171 (P = 0.3138)
7:117267606:A:T,P13569,I1167F,0.466,Loss of MoRF binding (P = 0.0908); Loss of ubiquitination at K1165 (P = 0.121); Gain of disorder (P = 0.1571); Loss of helix (P = 0.2271); Gain of phosphorylation at T1171 (P = 0.2486)
7:117267607:T:A,P13569,I1167N,0.608,Gain of disorder (P = 0.0084); Loss of stability (P = 0.092); Gain of catalytic residue at K1165 (P = 0.1045); Loss of MoRF binding (P = 0.1245); Loss of helix (P = 0.1299)
7:117267607:T:C,P13569,I1167T,0.633,Gain of disorder (P = 0.0103); Loss of stability (P = 0.0244); Gain of phosphorylation at I1167 (P = 0.0267); Loss of MoRF binding (P = 0.1174); Loss of ubiquitination at K1165 (P = 0.1828)
7:117267607:T:G,P13569,I1167S,0.616,Gain of disorder (P = 0.0011); Loss of stability (P = 0.0465); Gain of phosphorylation at I1167 (P = 0.0863); Gain of ubiquitination at K1165 (P = 0.1111); Loss of helix (P = 0.1299)
7:117267608:T:G,P13569,I1167M,0.57,Gain of disorder (P = 0.0199); Gain of catalytic residue at V1163 (P = 0.0578); Gain of MoRF binding (P = 0.0838); Gain of ubiquitination at K1165 (P = 0.1111); Loss of helix (P = 0.1299)
7:117267609:G:A,P13569,D1168N,0.532,Gain of MoRF binding (P = 0.0325); Gain of catalytic residue at D1168 (P = 0.054); Loss of ubiquitination at K1165 (P = 0.094); Gain of helix (P = 0.132); Loss of disorder (P = 0.2187)
7:117267609:G:C,P13569,D1168H,0.522,Gain of MoRF binding (P = 0.0472); Loss of ubiquitination at K1165 (P = 0.094); Loss of disorder (P = 0.1266); Gain of helix (P = 0.132); Loss of stability (P = 0.2156)
7:117267609:G:T,P13569,D1168Y,0.529,Loss of disorder (P = 0.0306); Gain of phosphorylation at D1168 (P = 0.0353); Gain of MoRF binding (P = 0.05); Loss of ubiquitination at K1165 (P = 0.0853); Gain of helix (P = 0.132)
7:117267610:A:C,P13569,D1168A,0.57,Gain of MoRF binding (P = 0.0376); Loss of ubiquitination at K1165 (P = 0.0718); Loss of disorder (P = 0.0761); Gain of helix (P = 0.132); Loss of phosphorylation at T1171 (P = 0.3559)
7:117267610:A:T,P13569,D1168V,0.565,Gain of MoRF binding (P = 0.032); Gain of catalytic residue at D1168 (P = 0.037); Loss of disorder (P = 0.0483); Gain of helix (P = 0.132); Loss of ubiquitination at K1165 (P = 0.1327)
7:117267611:C:A,P13569,D1168E,0.392,Gain of disorder (P = 0.1256); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1373); Loss of ubiquitination at K1165 (P = 0.1828); Loss of phosphorylation at T1171 (P = 0.3559)
7:117267611:C:G,P13569,D1168E,0.392,Gain of disorder (P = 0.1256); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1373); Loss of ubiquitination at K1165 (P = 0.1828); Loss of phosphorylation at T1171 (P = 0.3559)
7:117267612:A:C,P13569,M1169L,0.389,Loss of MoRF binding (P = 0.0797); Loss of disorder (P = 0.084); Gain of phosphorylation at T1171 (P = 0.0877); Gain of ubiquitination at K1174 (P = 0.1008); Gain of helix (P = 0.1736)
7:117267612:A:G,P13569,M1169V,0.318,Gain of phosphorylation at T1171 (P = 0.0806); Loss of disorder (P = 0.097); Loss of MoRF binding (P = 0.1008); Gain of ubiquitination at K1174 (P = 0.1222); Loss of stability (P = 0.3474)
7:117267612:A:T,P13569,M1169L,0.389,Loss of MoRF binding (P = 0.0797); Loss of disorder (P = 0.084); Gain of phosphorylation at T1171 (P = 0.0877); Gain of ubiquitination at K1174 (P = 0.1008); Gain of helix (P = 0.1736)
7:117267613:T:A,P13569,M1169K,0.521,Gain of disorder (P = 0.0198); Gain of methylation at M1169 (P = 0.0227); Gain of MoRF binding (P = 0.0406); Loss of stability (P = 0.0443); Loss of ubiquitination at K1165 (P = 0.0488)
7:117267613:T:C,P13569,M1169T,0.358,Gain of phosphorylation at M1169 (P = 0.0275); Loss of MoRF binding (P = 0.0918); Loss of stability (P = 0.0921); Gain of disorder (P = 0.0991); Gain of glycosylation at M1169 (P = 0.1031)
7:117267613:T:G,P13569,M1169R,0.33,Gain of MoRF binding (P = 0.0162); Gain of phosphorylation at T1171 (P = 0.0429); Gain of disorder (P = 0.066); Loss of ubiquitination at K1165 (P = 0.0666); Gain of helix (P = 0.1736)
7:117267614:G:A,P13569,M1169I,0.381,Loss of disorder (P = 0.0702); Loss of MoRF binding (P = 0.084); Gain of phosphorylation at T1171 (P = 0.0887); Gain of ubiquitination at K1174 (P = 0.1008); Loss of helix (P = 0.1299)
7:117267614:G:C,P13569,M1169I,0.381,Loss of disorder (P = 0.0702); Loss of MoRF binding (P = 0.084); Gain of phosphorylation at T1171 (P = 0.0887); Gain of ubiquitination at K1174 (P = 0.1008); Loss of helix (P = 0.1299)
7:117267614:G:T,P13569,M1169I,0.381,Loss of disorder (P = 0.0702); Loss of MoRF binding (P = 0.084); Gain of phosphorylation at T1171 (P = 0.0887); Gain of ubiquitination at K1174 (P = 0.1008); Loss of helix (P = 0.1299)
7:117267615:C:A,P13569,P1170T,0.323,Gain of MoRF binding (P = 0.0552); Gain of phosphorylation at P1170 (P = 0.118); Loss of disorder (P = 0.1232); Gain of ubiquitination at K1165 (P = 0.1317); Gain of helix (P = 0.1736)
7:117267615:C:G,P13569,P1170A,0.348,Loss of disorder (P = 0.0476); Gain of MoRF binding (P = 0.0483); Gain of ubiquitination at K1174 (P = 0.0849); Loss of stability (P = 0.2174); Loss of phosphorylation at T1171 (P = 0.2843)
7:117267615:C:T,P13569,P1170S,0.282,Gain of MoRF binding (P = 0.0449); Gain of phosphorylation at P1170 (P = 0.0532); Gain of disorder (P = 0.1429); Loss of ubiquitination at K1165 (P = 0.1828); Gain of relative solvent accessibility (P = 0.2363)
7:117267616:C:A,P13569,P1170Q,0.292,Gain of MoRF binding (P = 0.0446); Loss of ubiquitination at K1165 (P = 0.1664); Loss of disorder (P = 0.169); Gain of helix (P = 0.1736); Loss of glycosylation at T1171 (P = 0.2457)
7:117267616:C:G,P13569,P1170R,0.38,Gain of MoRF binding (P = 0.0013); Gain of catalytic residue at P1170 (P = 0.0255); Loss of ubiquitination at K1165 (P = 0.0779); Gain of solvent accessibility (P = 0.0789); Loss of helix (P = 0.1299)
7:117267616:C:T,P13569,P1170L,0.414,Loss of disorder (P = 0.0202); Gain of MoRF binding (P = 0.0553); Gain of ubiquitination at K1165 (P = 0.095); Gain of stability (P = 0.1212); Gain of helix (P = 0.1736)
7:117267618:A:C,P13569,T1171P,0.348,Gain of catalytic residue at P1170 (P = 0.0107); Gain of disorder (P = 0.0569); Loss of MoRF binding (P = 0.0861); Loss of phosphorylation at T1171 (P = 0.1366); Gain of glycosylation at T1171 (P = 0.1401)
7:117267618:A:G,P13569,T1171A,0.245,Gain of ubiquitination at K1174 (P = 0.0849); Loss of disorder (P = 0.1134); Loss of solvent accessibility (P = 0.1177); Gain of helix (P = 0.132); Loss of phosphorylation at T1171 (P = 0.1366)
7:117267618:A:T,P13569,T1171S,0.212,Gain of disorder (P = 0.0408); Gain of phosphorylation at T1171 (P = 0.0613); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1348); Loss of glycosylation at T1171 (P = 0.2201)
7:117267619:C:A,P13569,T1171K,0.4,Gain of methylation at T1171 (P = 0.0024); Gain of MoRF binding (P = 0.0365); Gain of ubiquitination at T1171 (P = 0.0388); Gain of disorder (P = 0.0426); Gain of helix (P = 0.132)
7:117267619:C:G,P13569,T1171R,0.261,Gain of MoRF binding (P = 0.018); Loss of loop (P = 0.0804); Gain of glycosylation at K1174 (P = 0.1304); Gain of helix (P = 0.132); Loss of phosphorylation at T1171 (P = 0.1366)
7:117267619:C:T,P13569,T1171I,0.294,Loss of disorder (P = 0.046); Loss of relative solvent accessibility (P = 0.0981); Loss of solvent accessibility (P = 0.1235); Loss of phosphorylation at T1171 (P = 0.1366); Gain of MoRF binding (P = 0.1395)
7:117267621:G:A,P13569,E1172K,0.419,Gain of methylation at E1172 (P = 0.0024); Gain of MoRF binding (P = 0.003); Loss of ubiquitination at K1177 (P = 0.0416); Gain of catalytic residue at E1172 (P = 0.0523); Gain of glycosylation at P1175 (P = 0.0907)
7:117267621:G:C,P13569,E1172Q,0.355,Gain of MoRF binding (P = 0.0329); Loss of ubiquitination at K1177 (P = 0.0477); Loss of helix (P = 0.1299); Loss of phosphorylation at T1176 (P = 0.2434); Loss of disorder (P = 0.2536)
7:117267622:A:C,P13569,E1172A,0.429,Gain of catalytic residue at E1172 (P = 0.0295); Gain of MoRF binding (P = 0.0485); Loss of ubiquitination at K1177 (P = 0.0503); Loss of disorder (P = 0.0676); Loss of solvent accessibility (P = 0.1459)
7:117267622:A:G,P13569,E1172G,0.377,Loss of ubiquitination at K1177 (P = 0.0477); Gain of MoRF binding (P = 0.054); Loss of solvent accessibility (P = 0.0769); Gain of glycosylation at K1174 (P = 0.1087); Loss of helix (P = 0.1299)
7:117267622:A:T,P13569,E1172V,0.413,Loss of disorder (P = 0.0383); Gain of MoRF binding (P = 0.0383); Loss of ubiquitination at K1177 (P = 0.0547); Gain of helix (P = 0.1736); Loss of phosphorylation at T1176 (P = 0.2187)
7:117267623:A:C,P13569,E1172D,0.3,Loss of ubiquitination at K1177 (P = 0.1264); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1953); Loss of MoRF binding (P = 0.204); Gain of phosphorylation at T1176 (P = 0.2314)
7:117267623:A:T,P13569,E1172D,0.3,Loss of ubiquitination at K1177 (P = 0.1264); Loss of helix (P = 0.1299); Gain of disorder (P = 0.1953); Loss of MoRF binding (P = 0.204); Gain of phosphorylation at T1176 (P = 0.2314)
7:117267624:G:C,P13569,G1173R,0.281,Gain of MoRF binding (P = 0.0211); Loss of ubiquitination at K1177 (P = 0.0477); Gain of glycosylation at S1178 (P = 0.0559); Gain of phosphorylation at T1171 (P = 0.0905); Gain of disorder (P = 0.1008)
7:117267624:G:T,P13569,G1173C,0.318,Loss of ubiquitination at K1177 (P = 0.0547); Loss of disorder (P = 0.0623); Loss of relative solvent accessibility (P = 0.0981); Loss of phosphorylation at T1176 (P = 0.1479); Loss of MoRF binding (P = 0.148)
7:117267625:G:A,P13569,G1173D,0.337,Gain of ubiquitination at K1174 (P = 0.0419); Gain of disorder (P = 0.0832); Loss of MoRF binding (P = 0.0946); Gain of solvent accessibility (P = 0.1014); Gain of glycosylation at S1178 (P = 0.1053)
7:117267625:G:C,P13569,G1173A,0.24,Loss of ubiquitination at K1177 (P = 0.079); Loss of relative solvent accessibility (P = 0.0981); Loss of disorder (P = 0.1535); Gain of MoRF binding (P = 0.2049); Loss of methylation at K1177 (P = 0.2585)
7:117267625:G:T,P13569,G1173V,0.235,Loss of relative solvent accessibility (P = 0.0676); Loss of ubiquitination at K1177 (P = 0.0716); Loss of disorder (P = 0.0932); Loss of phosphorylation at T1176 (P = 0.1397); Gain of MoRF binding (P = 0.1495)
7:117267627:A:C,P13569,K1174Q,0.335,Loss of methylation at K1174 (P = 0.0036); Gain of ubiquitination at K1177 (P = 0.0251); Loss of solvent accessibility (P = 0.0364); Loss of relative solvent accessibility (P = 0.107); Loss of phosphorylation at S1178 (P = 0.1089)
7:117267627:A:G,P13569,K1174E,0.327,Loss of methylation at K1174 (P = 0.0036); Gain of ubiquitination at K1177 (P = 0.0211); Loss of MoRF binding (P = 0.0792); Loss of glycosylation at K1174 (P = 0.1123); Loss of phosphorylation at S1178 (P = 0.157)
7:117267628:A:G,P13569,K1174R,0.338,Loss of methylation at K1174 (P = 0.008); Loss of ubiquitination at K1174 (P = 0.0341); Loss of solvent accessibility (P = 0.0721); Loss of relative solvent accessibility (P = 0.107); Loss of glycosylation at K1174 (P = 0.1123)
7:117267628:A:T,P13569,K1174I,0.426,Loss of solvent accessibility (P = 0.0036); Loss of methylation at K1174 (P = 0.0036); Loss of disorder (P = 0.0215); Gain of ubiquitination at K1177 (P = 0.0259); Loss of relative solvent accessibility (P = 0.0404)
7:117267629:A:C,P13569,K1174N,0.362,Loss of methylation at K1174 (P = 0.0036); Loss of solvent accessibility (P = 0.0155); Gain of ubiquitination at K1177 (P = 0.0251); Loss of phosphorylation at T1176 (P = 0.0983); Loss of relative solvent accessibility (P = 0.107)
7:117267629:A:T,P13569,K1174N,0.362,Loss of methylation at K1174 (P = 0.0036); Loss of solvent accessibility (P = 0.0155); Gain of ubiquitination at K1177 (P = 0.0251); Loss of phosphorylation at T1176 (P = 0.0983); Loss of relative solvent accessibility (P = 0.107)
7:117267630:C:A,P13569,P1175T,0.314,Gain of phosphorylation at P1175 (P = 0.0148); Gain of MoRF binding (P = 0.1066); Loss of ubiquitination at K1177 (P = 0.1091); Loss of disorder (P = 0.1693); Loss of methylation at K1177 (P = 0.174)
7:117267630:C:G,P13569,P1175A,0.35,Loss of methylation at K1180 (P = 0.0577); Loss of disorder (P = 0.0649); Gain of ubiquitination at K1174 (P = 0.0745); Gain of MoRF binding (P = 0.0775); Loss of phosphorylation at T1176 (P = 0.1138)
7:117267630:C:T,P13569,P1175S,0.306,Gain of phosphorylation at P1175 (P = 0.0371); Gain of MoRF binding (P = 0.0798); Gain of ubiquitination at K1177 (P = 0.1128); Gain of glycosylation at P1175 (P = 0.1202); Loss of methylation at K1177 (P = 0.1527)
7:117267631:C:A,P13569,P1175H,0.297,Loss of methylation at K1180 (P = 0.0541); Loss of ubiquitination at K1177 (P = 0.0877); Loss of phosphorylation at T1176 (P = 0.1027); Gain of MoRF binding (P = 0.1172); Loss of disorder (P = 0.1311)
7:117267631:C:G,P13569,P1175R,0.33,Gain of MoRF binding (P = 0.0055); Gain of solvent accessibility (P = 0.0216); Loss of ubiquitination at K1177 (P = 0.0428); Loss of methylation at K1180 (P = 0.1177); Gain of phosphorylation at S1178 (P = 0.1211)
7:117267631:C:T,P13569,P1175L,0.367,Loss of disorder (P = 0.0398); Loss of methylation at K1180 (P = 0.041); Loss of ubiquitination at K1177 (P = 0.052); Loss of phosphorylation at T1176 (P = 0.0818); Gain of MoRF binding (P = 0.0943)
7:117267633:A:C,P13569,T1176P,0.315,Gain of catalytic residue at P1175 (P = 0.0113); Gain of glycosylation at T1176 (P = 0.0266); Loss of phosphorylation at T1176 (P = 0.0352); Loss of ubiquitination at K1177 (P = 0.1264); Gain of disorder (P = 0.1713)
7:117267633:A:G,P13569,T1176A,0.26,Loss of phosphorylation at T1176 (P = 0.0352); Loss of methylation at K1180 (P = 0.065); Loss of ubiquitination at K1177 (P = 0.1264); Loss of disorder (P = 0.1445); Gain of MoRF binding (P = 0.268)
7:117267633:A:T,P13569,T1176S,0.294,Loss of ubiquitination at K1177 (P = 0.1264); Loss of phosphorylation at T1176 (P = 0.1314); Gain of disorder (P = 0.146); Loss of methylation at K1180 (P = 0.203); Gain of MoRF binding (P = 0.2631)
7:117267634:C:A,P13569,T1176N,0.287,Loss of phosphorylation at T1176 (P = 0.0352); Loss of ubiquitination at K1177 (P = 0.1264); Loss of methylation at K1180 (P = 0.1575); Gain of catalytic residue at K1174 (P = 0.2135); Gain of MoRF binding (P = 0.262)
7:117267634:C:G,P13569,T1176S,0.294,Loss of ubiquitination at K1177 (P = 0.1264); Loss of phosphorylation at T1176 (P = 0.1314); Gain of disorder (P = 0.146); Loss of methylation at K1180 (P = 0.203); Gain of MoRF binding (P = 0.2631)
7:117267634:C:T,P13569,T1176I,0.272,Loss of phosphorylation at T1176 (P = 0.0352); Loss of ubiquitination at K1177 (P = 0.0579); Loss of disorder (P = 0.0737); Loss of methylation at K1180 (P = 0.1347); Gain of MoRF binding (P = 0.2632)
7:117267636:A:C,P13569,K1177Q,0.421,Loss of methylation at K1177 (P = 0.0067); Loss of ubiquitination at K1177 (P = 0.0244); Loss of phosphorylation at S1178 (P = 0.1285); Loss of MoRF binding (P = 0.1932); Gain of glycosylation at T1179 (P = 0.2561)
7:117267636:A:G,P13569,K1177E,0.428,Loss of methylation at K1177 (P = 0.0067); Loss of ubiquitination at K1177 (P = 0.0244); Loss of MoRF binding (P = 0.1041); Loss of phosphorylation at T1179 (P = 0.2198); Gain of glycosylation at K1174 (P = 0.3021)
7:117267637:A:C,P13569,K1177T,0.496,Loss of methylation at K1177 (P = 0.0067); Gain of phosphorylation at K1177 (P = 0.0202); Loss of ubiquitination at K1177 (P = 0.0244); Loss of solvent accessibility (P = 0.0249); Gain of glycosylation at S1178 (P = 0.0598)
7:117267637:A:G,P13569,K1177R,0.717,Loss of methylation at K1177 (P = 0.0084); Loss of ubiquitination at K1177 (P = 0.0244); Loss of solvent accessibility (P = 0.1115); Gain of glycosylation at K1174 (P = 0.123); Gain of MoRF binding (P = 0.1303)
7:117267637:A:T,P13569,K1177M,0.484,Loss of methylation at K1177 (P = 0.0067); Loss of solvent accessibility (P = 0.0217); Loss of ubiquitination at K1177 (P = 0.0244); Loss of phosphorylation at T1179 (P = 0.0558); Loss of relative solvent accessibility (P = 0.0981)
7:117267638:G:C,P13569,K1177N,0.473,Loss of methylation at K1177 (P = 0.0067); Loss of ubiquitination at K1177 (P = 0.0244); Loss of solvent accessibility (P = 0.0371); Loss of phosphorylation at T1176 (P = 0.087); Loss of MoRF binding (P = 0.1801)
7:117267638:G:T,P13569,K1177N,0.473,Loss of methylation at K1177 (P = 0.0067); Loss of ubiquitination at K1177 (P = 0.0244); Loss of solvent accessibility (P = 0.0371); Loss of phosphorylation at T1176 (P = 0.087); Loss of MoRF binding (P = 0.1801)
7:117267639:T:A,P13569,S1178T,0.315,Gain of glycosylation at S1178 (P = 0.0308); Loss of ubiquitination at K1177 (P = 0.0877); Loss of phosphorylation at Y1182 (P = 0.1595); Loss of relative solvent accessibility (P = 0.1807); Loss of solvent accessibility (P = 0.2073)
7:117267639:T:C,P13569,S1178P,0.319,Loss of phosphorylation at S1178 (P = 0.0323); Gain of glycosylation at T1179 (P = 0.0972); Loss of ubiquitination at K1183 (P = 0.1278); Gain of methylation at K1180 (P = 0.1656); Loss of MoRF binding (P = 0.1663)
7:117267639:T:G,P13569,S1178A,0.347,Loss of phosphorylation at S1178 (P = 0.0323); Loss of methylation at K1183 (P = 0.0578); Gain of ubiquitination at K1174 (P = 0.0745); Loss of disorder (P = 0.0945); Loss of solvent accessibility (P = 0.1473)
7:117267640:C:T,P13569,S1178L,0.39,Loss of phosphorylation at S1178 (P = 0.0323); Loss of methylation at K1183 (P = 0.0401); Loss of ubiquitination at K1177 (P = 0.0547); Loss of relative solvent accessibility (P = 0.0676); Gain of catalytic residue at S1178 (P = 0.0683)
7:117267642:A:C,P13569,T1179P,0.338,Gain of relative solvent accessibility (P = 0.005); Gain of solvent accessibility (P = 0.0156); Loss of phosphorylation at T1179 (P = 0.03); Gain of glycosylation at T1179 (P = 0.0578); Loss of ubiquitination at K1177 (P = 0.0957)
7:117267642:A:G,P13569,T1179A,0.25,Loss of phosphorylation at T1179 (P = 0.03); Loss of methylation at K1183 (P = 0.0798); Gain of ubiquitination at K1183 (P = 0.1084); Loss of glycosylation at T1179 (P = 0.1762); Gain of MoRF binding (P = 0.2009)
7:117267642:A:T,P13569,T1179S,0.258,Gain of relative solvent accessibility (P = 0.0166); Gain of solvent accessibility (P = 0.0503); Gain of phosphorylation at T1176 (P = 0.1242); Loss of ubiquitination at K1183 (P = 0.1278); Loss of methylation at K1180 (P = 0.1396)
7:117267643:C:A,P13569,T1179N,0.257,Gain of relative solvent accessibility (P = 0.0166); Gain of solvent accessibility (P = 0.026); Loss of phosphorylation at T1179 (P = 0.03); Loss of ubiquitination at K1177 (P = 0.0957); Loss of methylation at K1183 (P = 0.1431)
7:117267643:C:G,P13569,T1179S,0.258,Gain of relative solvent accessibility (P = 0.0166); Gain of solvent accessibility (P = 0.0503); Gain of phosphorylation at T1176 (P = 0.1242); Loss of ubiquitination at K1183 (P = 0.1278); Loss of methylation at K1180 (P = 0.1396)
7:117267643:C:T,P13569,T1179I,0.287,Loss of phosphorylation at T1179 (P = 0.03); Gain of ubiquitination at K1183 (P = 0.0471); Loss of disorder (P = 0.1275); Gain of methylation at K1180 (P = 0.1388); Loss of glycosylation at T1179 (P = 0.1762)
7:117267645:A:C,P13569,K1180Q,0.424,Loss of methylation at K1180 (P = 0.011); Gain of ubiquitination at K1177 (P = 0.0219); Loss of MoRF binding (P = 0.0877); Loss of catalytic residue at K1180 (P = 0.0997); Loss of phosphorylation at S1178 (P = 0.1065)
7:117267645:A:G,P13569,K1180E,0.424,Loss of methylation at K1180 (P = 0.011); Gain of ubiquitination at K1177 (P = 0.0204); Loss of MoRF binding (P = 0.056); Loss of catalytic residue at K1180 (P = 0.1476); Loss of phosphorylation at T1179 (P = 0.2077)
7:117267646:A:C,P13569,K1180T,0.448,Loss of methylation at K1180 (P = 0.011); Gain of ubiquitination at K1177 (P = 0.0219); Gain of phosphorylation at K1180 (P = 0.0266); Gain of glycosylation at T1179 (P = 0.0584); Loss of MoRF binding (P = 0.0807)
7:117267646:A:G,P13569,K1180R,0.388,Loss of methylation at K1180 (P = 0.0124); Loss of ubiquitination at K1180 (P = 0.0341); Gain of MoRF binding (P = 0.0774); Gain of glycosylation at K1177 (P = 0.1433); Loss of disorder (P = 0.1686)
7:117267646:A:T,P13569,K1180I,0.452,Loss of methylation at K1180 (P = 0.011); Gain of ubiquitination at K1177 (P = 0.0251); Loss of disorder (P = 0.0281); Loss of phosphorylation at T1179 (P = 0.0802); Loss of MoRF binding (P = 0.0882)
7:117267647:A:C,P13569,K1180N,0.436,Loss of methylation at K1180 (P = 0.011); Gain of ubiquitination at K1177 (P = 0.0239); Loss of catalytic residue at K1180 (P = 0.0767); Loss of MoRF binding (P = 0.0827); Loss of phosphorylation at S1178 (P = 0.0962)
7:117267647:A:T,P13569,K1180N,0.436,Loss of methylation at K1180 (P = 0.011); Gain of ubiquitination at K1177 (P = 0.0239); Loss of catalytic residue at K1180 (P = 0.0767); Loss of MoRF binding (P = 0.0827); Loss of phosphorylation at S1178 (P = 0.0962)
7:117267648:C:A,P13569,P1181T,0.291,Gain of MoRF binding (P = 0.0581); Loss of catalytic residue at P1181 (P = 0.0687); Gain of phosphorylation at P1181 (P = 0.0716); Loss of methylation at K1180 (P = 0.1114); Gain of ubiquitination at K1183 (P = 0.1245)
7:117267648:C:G,P13569,P1181A,0.338,Gain of MoRF binding (P = 0.0511); Loss of disorder (P = 0.0515); Loss of methylation at K1183 (P = 0.0929); Loss of ubiquitination at K1177 (P = 0.0957); Loss of loop (P = 0.0986)
7:117267648:C:T,P13569,P1181S,0.291,Gain of MoRF binding (P = 0.0524); Gain of phosphorylation at P1181 (P = 0.0587); Loss of methylation at K1180 (P = 0.0593); Loss of catalytic residue at P1181 (P = 0.0675); Loss of ubiquitination at K1177 (P = 0.1091)
7:117267649:C:A,P13569,P1181Q,0.317,Gain of MoRF binding (P = 0.0476); Loss of catalytic residue at P1181 (P = 0.0781); Loss of phosphorylation at T1176 (P = 0.1072); Loss of ubiquitination at K1177 (P = 0.1091); Gain of solvent accessibility (P = 0.1505)
7:117267649:C:G,P13569,P1181R,0.38,Gain of MoRF binding (P = 6e-04); Gain of solvent accessibility (P = 0.0411); Loss of ubiquitination at K1177 (P = 0.0457); Loss of methylation at K1177 (P = 0.0931); Loss of phosphorylation at Y1182 (P = 0.0952)
7:117267649:C:T,P13569,P1181L,0.363,Loss of disorder (P = 0.0396); Loss of methylation at K1177 (P = 0.0496); Loss of ubiquitination at K1177 (P = 0.0579); Gain of MoRF binding (P = 0.0612); Loss of catalytic residue at P1181 (P = 0.0889)
7:117267651:T:A,P13569,Y1182N,0.368,Gain of disorder (P = 0.0222); Loss of phosphorylation at Y1182 (P = 0.0244); Loss of ubiquitination at K1183 (P = 0.0795); Loss of methylation at K1177 (P = 0.1012); Gain of relative solvent accessibility (P = 0.1066)
7:117267651:T:C,P13569,Y1182H,0.31,Loss of phosphorylation at Y1182 (P = 0.0244); Gain of disorder (P = 0.0281); Loss of ubiquitination at K1183 (P = 0.0661); Loss of methylation at K1177 (P = 0.1108); Gain of MoRF binding (P = 0.191)
7:117267651:T:G,P13569,Y1182D,0.466,Gain of relative solvent accessibility (P = 0.0098); Gain of disorder (P = 0.0174); Gain of solvent accessibility (P = 0.0202); Loss of phosphorylation at Y1182 (P = 0.0244); Gain of ubiquitination at K1177 (P = 0.0458)
7:117267652:A:C,P13569,Y1182S,0.394,Gain of disorder (P = 0.0093); Loss of phosphorylation at Y1182 (P = 0.0802); Loss of methylation at K1177 (P = 0.0823); Gain of ubiquitination at K1177 (P = 0.0972); Gain of MoRF binding (P = 0.138)
7:117267652:A:G,P13569,Y1182C,0.311,Loss of phosphorylation at Y1182 (P = 0.0244); Gain of methylation at K1183 (P = 0.0562); Gain of ubiquitination at K1183 (P = 0.0737); Gain of disorder (P = 0.1033); Loss of MoRF binding (P = 0.1458)
7:117267652:A:T,P13569,Y1182F,0.269,Loss of phosphorylation at Y1182 (P = 0.0244); Loss of methylation at K1177 (P = 0.0543); Loss of ubiquitination at K1177 (P = 0.1091); Gain of disorder (P = 0.1437); Gain of MoRF binding (P = 0.2048)
7:117267654:A:C,P13569,K1183Q,0.396,Loss of methylation at K1183 (P = 0.0096); Loss of ubiquitination at K1183 (P = 0.0224); Loss of MoRF binding (P = 0.083); Loss of phosphorylation at S1178 (P = 0.1415); Loss of disorder (P = 0.1489)
7:117267654:A:G,P13569,K1183E,0.427,Loss of methylation at K1183 (P = 0.0096); Loss of ubiquitination at K1183 (P = 0.0224); Gain of solvent accessibility (P = 0.0471); Gain of relative solvent accessibility (P = 0.0479); Loss of MoRF binding (P = 0.048)
7:117267655:A:C,P13569,K1183T,0.444,Loss of methylation at K1183 (P = 0.0096); Loss of ubiquitination at K1183 (P = 0.0224); Gain of phosphorylation at K1183 (P = 0.0509); Loss of MoRF binding (P = 0.0831); Loss of disorder (P = 0.0974)
7:117267655:A:G,P13569,K1183R,0.417,Loss of methylation at K1183 (P = 0.011); Loss of ubiquitination at K1183 (P = 0.0224); Gain of MoRF binding (P = 0.0829); Loss of disorder (P = 0.0995); Gain of glycosylation at K1180 (P = 0.1337)
7:117267655:A:T,P13569,K1183M,0.46,Loss of methylation at K1183 (P = 0.0096); Loss of ubiquitination at K1183 (P = 0.0224); Loss of disorder (P = 0.0849); Loss of MoRF binding (P = 0.1345); Loss of phosphorylation at T1179 (P = 0.1805)
7:117267656:G:C,P13569,K1183N,0.388,Loss of methylation at K1183 (P = 0.0096); Loss of ubiquitination at K1183 (P = 0.0224); Loss of MoRF binding (P = 0.0795); Loss of disorder (P = 0.1105); Loss of phosphorylation at S1178 (P = 0.1208)
7:117267656:G:T,P13569,K1183N,0.388,Loss of methylation at K1183 (P = 0.0096); Loss of ubiquitination at K1183 (P = 0.0224); Loss of MoRF binding (P = 0.0795); Loss of disorder (P = 0.1105); Loss of phosphorylation at S1178 (P = 0.1208)
7:117267657:A:C,P13569,N1184H,0.274,Gain of ubiquitination at K1189 (P = 0.0931); Loss of MoRF binding (P = 0.1813); Gain of disorder (P = 0.1969); Gain of methylation at K1180 (P = 0.1997); Gain of catalytic residue at G1185 (P = 0.208)
7:117267657:A:G,P13569,N1184D,0.374,Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0648); Loss of MoRF binding (P = 0.0792); Gain of ubiquitination at K1189 (P = 0.0817); Loss of methylation at K1183 (P = 0.0826)
7:117267657:A:T,P13569,N1184Y,0.358,Loss of disorder (P = 0.0432); Gain of phosphorylation at N1184 (P = 0.0695); Gain of methylation at K1180 (P = 0.1023); Gain of ubiquitination at K1183 (P = 0.1084); Loss of MoRF binding (P = 0.1608)
7:117267658:A:C,P13569,N1184T,0.247,Gain of phosphorylation at N1184 (P = 0.0652); Gain of ubiquitination at K1189 (P = 0.0931); Gain of methylation at K1180 (P = 0.1676); Gain of disorder (P = 0.1933); Loss of MoRF binding (P = 0.2024)
7:117267658:A:G,P13569,N1184S,0.312,Gain of disorder (P = 0.0453); Gain of phosphorylation at N1184 (P = 0.0472); Loss of loop (P = 0.0512); Gain of ubiquitination at K1189 (P = 0.0737); Gain of methylation at K1180 (P = 0.1812)
7:117267658:A:T,P13569,N1184I,0.307,Loss of disorder (P = 0.0483); Loss of ubiquitination at K1189 (P = 0.0896); Gain of methylation at K1183 (P = 0.1301); Loss of phosphorylation at Y1182 (P = 0.1606); Gain of MoRF binding (P = 0.1687)
7:117267659:T:A,P13569,N1184K,0.447,Gain of methylation at N1184 (P = 0.0133); Gain of MoRF binding (P = 0.0299); Gain of ubiquitination at N1184 (P = 0.0388); Gain of disorder (P = 0.0521); Gain of glycosylation at N1184 (P = 0.1045)
7:117267659:T:G,P13569,N1184K,0.447,Gain of methylation at N1184 (P = 0.0133); Gain of MoRF binding (P = 0.0299); Gain of ubiquitination at N1184 (P = 0.0388); Gain of disorder (P = 0.0521); Gain of glycosylation at N1184 (P = 0.1045)
7:117267660:G:A,P13569,G1185S,0.34,Gain of disorder (P = 0.0436); Gain of phosphorylation at G1185 (P = 0.0814); Gain of ubiquitination at K1189 (P = 0.0817); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at P1181 (P = 0.0914)
7:117267660:G:C,P13569,G1185R,0.323,Gain of MoRF binding (P = 0.0107); Loss of loop (P = 0.0512); Gain of ubiquitination at K1189 (P = 0.0624); Gain of glycosylation at P1181 (P = 0.0874); Loss of catalytic residue at P1181 (P = 0.0914)
7:117267660:G:T,P13569,G1185C,0.412,Loss of disorder (P = 0.0435); Loss of loop (P = 0.0512); Loss of catalytic residue at P1181 (P = 0.0914); Gain of ubiquitination at K1189 (P = 0.0931); Loss of phosphorylation at Y1182 (P = 0.1103)
7:117267661:G:A,P13569,G1185D,0.397,Gain of solvent accessibility (P = 0.039); Gain of ubiquitination at K1189 (P = 0.0457); Loss of MoRF binding (P = 0.0771); Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at P1181 (P = 0.0914)
7:117267661:G:C,P13569,G1185A,0.3,Loss of disorder (P = 0.0864); Loss of catalytic residue at P1181 (P = 0.0914); Gain of ubiquitination at K1183 (P = 0.1245); Loss of methylation at K1180 (P = 0.1691); Gain of MoRF binding (P = 0.1938)
7:117267661:G:T,P13569,G1185V,0.312,Loss of loop (P = 0.0512); Loss of disorder (P = 0.0615); Loss of catalytic residue at P1181 (P = 0.0914); Gain of MoRF binding (P = 0.1188); Gain of ubiquitination at K1183 (P = 0.1245)
7:117267663:C:A,P13569,Q1186K,0.419,Gain of methylation at Q1186 (P = 0.0084); Gain of MoRF binding (P = 0.0307); Gain of ubiquitination at Q1186 (P = 0.0337); Gain of disorder (P = 0.051); Gain of catalytic residue at Y1182 (P = 0.155)
7:117267663:C:G,P13569,Q1186E,0.364,Gain of ubiquitination at K1189 (P = 0.0554); Loss of MoRF binding (P = 0.0713); Gain of disorder (P = 0.1011); Loss of methylation at K1183 (P = 0.1112); Gain of relative solvent accessibility (P = 0.1684)
7:117267664:A:C,P13569,Q1186P,0.431,Gain of glycosylation at Q1186 (P = 0.0632); Gain of disorder (P = 0.0763); Loss of MoRF binding (P = 0.0796); Gain of ubiquitination at K1189 (P = 0.0817); Gain of relative solvent accessibility (P = 0.1684)
7:117267664:A:G,P13569,Q1186R,0.32,Gain of MoRF binding (P = 0.009); Gain of solvent accessibility (P = 0.0704); Gain of phosphorylation at S1188 (P = 0.0876); Loss of methylation at K1183 (P = 0.1117); Loss of ubiquitination at K1183 (P = 0.1278)
7:117267664:A:T,P13569,Q1186L,0.411,Loss of disorder (P = 0.0429); Gain of ubiquitination at K1189 (P = 0.0817); Loss of methylation at K1183 (P = 0.0926); Loss of solvent accessibility (P = 0.1551); Loss of MoRF binding (P = 0.1851)
7:117267665:A:C,P13569,Q1186H,0.294,Loss of ubiquitination at K1189 (P = 0.1113); Loss of MoRF binding (P = 0.166); Loss of disorder (P = 0.1682); Loss of solvent accessibility (P = 0.1922); Gain of methylation at K1183 (P = 0.2484)
7:117267665:A:T,P13569,Q1186H,0.294,Loss of ubiquitination at K1189 (P = 0.1113); Loss of MoRF binding (P = 0.166); Loss of disorder (P = 0.1682); Loss of solvent accessibility (P = 0.1922); Gain of methylation at K1183 (P = 0.2484)
7:117267666:C:A,P13569,L1187I,0.312,Gain of ubiquitination at K1189 (P = 0.0931); Gain of catalytic residue at L1187 (P = 0.1208); Gain of methylation at K1183 (P = 0.1442); Gain of MoRF binding (P = 0.1534); Gain of disorder (P = 0.1795)
7:117267666:C:G,P13569,L1187V,0.348,Gain of catalytic residue at L1187 (P = 0.0218); Gain of ubiquitination at K1189 (P = 0.0817); Gain of MoRF binding (P = 0.1174); Gain of disorder (P = 0.1197); Gain of methylation at K1183 (P = 0.1833)
7:117267666:C:T,P13569,L1187F,0.278,Gain of ubiquitination at K1189 (P = 0.1084); Gain of methylation at K1183 (P = 0.1721); Gain of sheet (P = 0.1945); Loss of MoRF binding (P = 0.2028); Loss of loop (P = 0.2237)
7:117267667:T:A,P13569,L1187H,0.436,Gain of disorder (P = 0.0191); Gain of ubiquitination at K1189 (P = 0.1245); Gain of MoRF binding (P = 0.1472); Loss of stability (P = 0.159); Gain of sheet (P = 0.1945)
7:117267667:T:C,P13569,L1187P,0.537,Gain of disorder (P = 0.005); Loss of ubiquitination at K1183 (P = 0.0896); Loss of MoRF binding (P = 0.0985); Loss of stability (P = 0.132); Gain of methylation at K1183 (P = 0.1875)
7:117267667:T:G,P13569,L1187R,0.472,Gain of MoRF binding (P = 0.0013); Gain of disorder (P = 0.0166); Gain of catalytic residue at L1187 (P = 0.0444); Loss of ubiquitination at K1189 (P = 0.0724); Gain of solvent accessibility (P = 0.1071)
7:117267669:T:A,P13569,S1188T,0.29,Loss of disorder (P = 0.0889); Gain of ubiquitination at K1183 (P = 0.0931); Gain of methylation at K1183 (P = 0.1975); Loss of MoRF binding (P = 0.2058); Gain of glycosylation at K1189 (P = 0.3626)
7:117267669:T:C,P13569,S1188P,0.418,Gain of ubiquitination at K1189 (P = 0.0737); Loss of MoRF binding (P = 0.0831); Gain of glycosylation at K1189 (P = 0.0939); Gain of methylation at K1183 (P = 0.1985); Gain of disorder (P = 0.2331)
7:117267669:T:G,P13569,S1188A,0.384,Loss of disorder (P = 0.0304); Gain of ubiquitination at K1183 (P = 0.0931); Gain of MoRF binding (P = 0.1985); Gain of methylation at K1183 (P = 0.2443); Gain of glycosylation at K1189 (P = 0.3395)
7:117267670:C:G,P13569,S1188W,0.516,Loss of disorder (P = 8e-04); Gain of catalytic residue at M1191 (P = 0.011); Gain of MoRF binding (P = 0.0247); Loss of loop (P = 0.0512); Gain of ubiquitination at K1183 (P = 0.1084)
7:117267670:C:T,P13569,S1188L,0.429,Loss of disorder (P = 0.0144); Gain of ubiquitination at K1189 (P = 0.0931); Gain of sheet (P = 0.1451); Loss of MoRF binding (P = 0.2006); Loss of loop (P = 0.2237)
7:117267672:A:C,P13569,K1189Q,0.459,Loss of methylation at K1189 (P = 0.0025); Loss of ubiquitination at K1189 (P = 0.0224); Loss of solvent accessibility (P = 0.0364); Loss of MoRF binding (P = 0.0787); Loss of glycosylation at K1189 (P = 0.09)
7:117267672:A:G,P13569,K1189E,0.479,Loss of methylation at K1189 (P = 0.0025); Loss of solvent accessibility (P = 0.0111); Loss of ubiquitination at K1189 (P = 0.0224); Loss of MoRF binding (P = 0.0444); Loss of relative solvent accessibility (P = 0.0676)
7:117267673:A:C,P13569,K1189T,0.455,Loss of methylation at K1189 (P = 0.0025); Loss of solvent accessibility (P = 0.0056); Loss of ubiquitination at K1189 (P = 0.0224); Loss of relative solvent accessibility (P = 0.0676); Loss of disorder (P = 0.071)
7:117267673:A:G,P13569,K1189R,0.408,Loss of methylation at K1189 (P = 0.0032); Loss of ubiquitination at K1189 (P = 0.0224); Loss of disorder (P = 0.0756); Gain of MoRF binding (P = 0.0808); Loss of glycosylation at K1189 (P = 0.09)
7:117267673:A:T,P13569,K1189I,0.529,Loss of solvent accessibility (P = 7e-04); Loss of methylation at K1189 (P = 0.0025); Loss of relative solvent accessibility (P = 0.0071); Loss of disorder (P = 0.0097); Loss of ubiquitination at K1189 (P = 0.0224)
7:117267674:A:C,P13569,K1189N,0.462,Loss of methylation at K1189 (P = 0.0025); Loss of solvent accessibility (P = 0.0155); Loss of ubiquitination at K1189 (P = 0.0224); Loss of MoRF binding (P = 0.0764); Loss of glycosylation at K1189 (P = 0.09)
7:117267674:A:T,P13569,K1189N,0.462,Loss of methylation at K1189 (P = 0.0025); Loss of solvent accessibility (P = 0.0155); Loss of ubiquitination at K1189 (P = 0.0224); Loss of MoRF binding (P = 0.0764); Loss of glycosylation at K1189 (P = 0.09)
7:117267675:G:A,P13569,V1190I,0.356,Loss of ubiquitination at K1189 (P = 0.1453); Loss of MoRF binding (P = 0.1851); Loss of catalytic residue at V1190 (P = 0.2433); Gain of disorder (P = 0.2517); Gain of glycosylation at K1189 (P = 0.3296)
7:117267675:G:C,P13569,V1190L,0.371,Loss of methylation at K1189 (P = 0.0715); Gain of ubiquitination at K1189 (P = 0.1084); Loss of MoRF binding (P = 0.1502); Gain of disorder (P = 0.2072); Gain of glycosylation at K1189 (P = 0.2906)
7:117267675:G:T,P13569,V1190F,0.361,Gain of ubiquitination at K1189 (P = 0.1245); Loss of MoRF binding (P = 0.1412); Loss of disorder (P = 0.1879); Gain of sheet (P = 0.1945); Loss of stability (P = 0.2144)
7:117267676:T:A,P13569,V1190D,0.838,Gain of disorder (P = 0.0075); Loss of methylation at K1189 (P = 0.0398); Gain of ubiquitination at K1189 (P = 0.0519); Loss of stability (P = 0.0749); Loss of MoRF binding (P = 0.0871)
7:117267676:T:C,P13569,V1190A,0.367,Loss of stability (P = 0.05); Loss of methylation at K1189 (P = 0.07); Gain of disorder (P = 0.077); Gain of ubiquitination at K1189 (P = 0.1245); Gain of glycosylation at K1189 (P = 0.195)
7:117267676:T:G,P13569,V1190G,0.553,Loss of stability (P = 0.005); Gain of disorder (P = 0.0133); Gain of glycosylation at K1189 (P = 0.0647); Loss of methylation at K1189 (P = 0.082); Gain of ubiquitination at K1189 (P = 0.1245)
7:117267678:A:C,P13569,M1191L,0.434,Loss of disorder (P = 0.0789); Gain of ubiquitination at K1189 (P = 0.1084); Loss of MoRF binding (P = 0.1202); Gain of sheet (P = 0.1451); Loss of loop (P = 0.2237)
7:117267678:A:G,P13569,M1191V,0.401,Loss of disorder (P = 0.0884); Gain of ubiquitination at K1189 (P = 0.0931); Loss of loop (P = 0.0986); Gain of sheet (P = 0.1451); Loss of MoRF binding (P = 0.1677)
7:117267678:A:T,P13569,M1191L,0.434,Loss of disorder (P = 0.0789); Gain of ubiquitination at K1189 (P = 0.1084); Loss of MoRF binding (P = 0.1202); Gain of sheet (P = 0.1451); Loss of loop (P = 0.2237)
7:117267679:T:A,P13569,M1191K,0.508,Gain of methylation at M1191 (P = 0.0079); Gain of disorder (P = 0.0158); Gain of ubiquitination at M1191 (P = 0.0289); Gain of MoRF binding (P = 0.0413); Loss of stability (P = 0.0591)
7:117267679:T:C,P13569,M1191T,0.375,Loss of stability (P = 0.0938); Gain of disorder (P = 0.1196); Gain of ubiquitination at K1189 (P = 0.1245); Loss of MoRF binding (P = 0.1495); Gain of relative solvent accessibility (P = 0.2629)
7:117267679:T:G,P13569,M1191R,0.351,Gain of MoRF binding (P = 0.0132); Gain of solvent accessibility (P = 0.0713); Gain of relative solvent accessibility (P = 0.1066); Loss of ubiquitination at K1189 (P = 0.1113); Gain of disorder (P = 0.1121)
7:117267680:G:A,P13569,M1191I,0.378,Loss of disorder (P = 0.0688); Loss of loop (P = 0.0986); Gain of sheet (P = 0.1451); Loss of ubiquitination at K1189 (P = 0.1453); Loss of MoRF binding (P = 0.1461)
7:117267680:G:C,P13569,M1191I,0.378,Loss of disorder (P = 0.0688); Loss of loop (P = 0.0986); Gain of sheet (P = 0.1451); Loss of ubiquitination at K1189 (P = 0.1453); Loss of MoRF binding (P = 0.1461)
7:117267680:G:T,P13569,M1191I,0.378,Loss of disorder (P = 0.0688); Loss of loop (P = 0.0986); Gain of sheet (P = 0.1451); Loss of ubiquitination at K1189 (P = 0.1453); Loss of MoRF binding (P = 0.1461)
7:117267681:A:C,P13569,I1192L,0.26,Gain of ubiquitination at K1189 (P = 0.0931); Gain of catalytic residue at I1192 (P = 0.0966); Loss of loop (P = 0.1242); Gain of disorder (P = 0.1568); Gain of sheet (P = 0.1945)
7:117267681:A:G,P13569,I1192V,0.278,Gain of ubiquitination at K1189 (P = 0.0931); Gain of disorder (P = 0.1313); Gain of MoRF binding (P = 0.1553); Gain of catalytic residue at I1192 (P = 0.2949); Loss of glycosylation at K1189 (P = 0.3887)
7:117267681:A:T,P13569,I1192F,0.309,Gain of ubiquitination at K1189 (P = 0.1084); Loss of MoRF binding (P = 0.1835); Loss of disorder (P = 0.2191); Loss of loop (P = 0.3664); Gain of catalytic residue at I1192 (P = 0.3955)
7:117267682:T:A,P13569,I1192N,0.461,Gain of disorder (P = 0.0096); Gain of MoRF binding (P = 0.0851); Loss of stability (P = 0.1188); Loss of ubiquitination at K1189 (P = 0.1278); Gain of relative solvent accessibility (P = 0.2363)
7:117267682:T:C,P13569,I1192T,0.473,Gain of disorder (P = 0.0159); Loss of stability (P = 0.0197); Gain of phosphorylation at I1192 (P = 0.0709); Gain of ubiquitination at K1189 (P = 0.1084); Gain of MoRF binding (P = 0.1149)
7:117267682:T:G,P13569,I1192S,0.513,Gain of disorder (P = 0.0023); Loss of stability (P = 0.0742); Loss of ubiquitination at K1189 (P = 0.0795); Gain of phosphorylation at I1192 (P = 0.0905); Gain of MoRF binding (P = 0.1043)
7:117267683:T:G,P13569,I1192M,0.358,Gain of disorder (P = 0.0216); Gain of MoRF binding (P = 0.0808); Gain of ubiquitination at K1189 (P = 0.1084); Gain of glycosylation at K1189 (P = 0.2404); Loss of loop (P = 0.3664)
7:117267684:A:C,P13569,I1193L,0.245,Gain of ubiquitination at K1189 (P = 0.0817); Gain of disorder (P = 0.1588); Loss of MoRF binding (P = 0.2163); Loss of methylation at K1189 (P = 0.2458); Loss of loop (P = 0.3664)
7:117267684:A:G,P13569,I1193V,0.324,Gain of catalytic residue at I1193 (P = 0.0048); Gain of ubiquitination at K1189 (P = 0.0931); Gain of disorder (P = 0.132); Gain of MoRF binding (P = 0.1512); Loss of glycosylation at K1189 (P = 0.3584)
7:117267684:A:T,P13569,I1193F,0.282,Gain of ubiquitination at K1189 (P = 0.1084); Loss of MoRF binding (P = 0.1951); Gain of catalytic residue at S1196 (P = 0.1966); Loss of disorder (P = 0.217); Loss of stability (P = 0.3514)
7:117267685:T:A,P13569,I1193N,0.526,Gain of disorder (P = 0.0102); Loss of loop (P = 0.0512); Gain of MoRF binding (P = 0.0679); Loss of stability (P = 0.089); Loss of ubiquitination at K1189 (P = 0.0997)
7:117267685:T:C,P13569,I1193T,0.503,Gain of disorder (P = 0.0169); Loss of stability (P = 0.0421); Gain of MoRF binding (P = 0.0901); Gain of glycosylation at I1193 (P = 0.1063); Loss of loop (P = 0.1242)
7:117267685:T:G,P13569,I1193S,0.53,Gain of disorder (P = 0.0026); Loss of loop (P = 0.0512); Loss of stability (P = 0.0611); Gain of MoRF binding (P = 0.0833); Loss of ubiquitination at K1189 (P = 0.0896)
7:117267686:T:G,P13569,I1193M,0.442,Gain of catalytic residue at I1193 (P = 0.0152); Gain of disorder (P = 0.0227); Gain of MoRF binding (P = 0.0741); Gain of ubiquitination at K1189 (P = 0.1084); Gain of phosphorylation at S1196 (P = 0.3164)
7:117267687:G:A,P13569,E1194K,0.503,Gain of MoRF binding (P = 0.0037); Gain of methylation at E1194 (P = 0.0123); Loss of ubiquitination at K1199 (P = 0.0272); Gain of disorder (P = 0.0806); Loss of stability (P = 0.1425)
7:117267687:G:C,P13569,E1194Q,0.344,Gain of MoRF binding (P = 0.034); Gain of ubiquitination at K1189 (P = 0.1084); Gain of methylation at K1199 (P = 0.1162); Loss of solvent accessibility (P = 0.1868); Gain of disorder (P = 0.192)
7:117267688:A:C,P13569,E1194A,0.49,Loss of solvent accessibility (P = 0.0111); Gain of MoRF binding (P = 0.0189); Loss of disorder (P = 0.0654); Loss of relative solvent accessibility (P = 0.0676); Loss of methylation at K1199 (P = 0.0704)
7:117267688:A:G,P13569,E1194G,0.489,Loss of solvent accessibility (P = 0.0062); Gain of MoRF binding (P = 0.0206); Loss of stability (P = 0.0295); Loss of relative solvent accessibility (P = 0.0306); Gain of catalytic residue at S1196 (P = 0.0396)
7:117267688:A:T,P13569,E1194V,0.565,Loss of solvent accessibility (P = 0.0062); Gain of MoRF binding (P = 0.0124); Loss of relative solvent accessibility (P = 0.0306); Loss of disorder (P = 0.0425); Loss of loop (P = 0.0986)
7:117267689:G:C,P13569,E1194D,0.361,Gain of ubiquitination at K1189 (P = 0.068); Loss of solvent accessibility (P = 0.1177); Loss of methylation at K1199 (P = 0.1479); Gain of disorder (P = 0.1891); Gain of sheet (P = 0.1945)
7:117267689:G:T,P13569,E1194D,0.361,Gain of ubiquitination at K1189 (P = 0.068); Loss of solvent accessibility (P = 0.1177); Loss of methylation at K1199 (P = 0.1479); Gain of disorder (P = 0.1891); Gain of sheet (P = 0.1945)
7:117267690:A:C,P13569,N1195H,0.363,Loss of ubiquitination at K1200 (P = 0.0715); Gain of methylation at K1199 (P = 0.1508); Gain of catalytic residue at I1193 (P = 0.1522); Gain of disorder (P = 0.1617); Gain of sheet (P = 0.1945)
7:117267690:A:G,P13569,N1195D,0.408,Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0648); Gain of catalytic residue at N1195 (P = 0.1039); Gain of disorder (P = 0.1081); Loss of ubiquitination at K1200 (P = 0.1083)
7:117267690:A:T,P13569,N1195Y,0.444,Gain of phosphorylation at N1195 (P = 0.0223); Loss of disorder (P = 0.0501); Gain of methylation at K1199 (P = 0.0694); Gain of ubiquitination at K1200 (P = 0.1215); Gain of sheet (P = 0.1945)
7:117267691:A:C,P13569,N1195T,0.71,Gain of methylation at K1199 (P = 0.0943); Gain of ubiquitination at K1200 (P = 0.1215); Gain of disorder (P = 0.2089); Gain of MoRF binding (P = 0.2473); Gain of loop (P = 0.3485)
7:117267691:A:G,P13569,N1195S,0.285,Gain of disorder (P = 0.0475); Gain of phosphorylation at N1195 (P = 0.0977); Gain of methylation at K1200 (P = 0.1016); Gain of ubiquitination at K1200 (P = 0.1378); Gain of catalytic residue at N1195 (P = 0.2192)
7:117267691:A:T,P13569,N1195I,0.401,Loss of disorder (P = 0.0562); Gain of methylation at K1199 (P = 0.0828); Loss of ubiquitination at K1200 (P = 0.1287); Gain of catalytic residue at N1195 (P = 0.1638); Gain of sheet (P = 0.1945)
7:117267692:T:A,P13569,N1195K,0.45,Gain of methylation at N1195 (P = 0.0193); Gain of solvent accessibility (P = 0.0221); Gain of ubiquitination at N1195 (P = 0.0351); Gain of disorder (P = 0.0424); Gain of MoRF binding (P = 0.0462)
7:117267692:T:G,P13569,N1195K,0.45,Gain of methylation at N1195 (P = 0.0193); Gain of solvent accessibility (P = 0.0221); Gain of ubiquitination at N1195 (P = 0.0351); Gain of disorder (P = 0.0424); Gain of MoRF binding (P = 0.0462)
7:117267693:T:A,P13569,S1196T,0.289,Loss of disorder (P = 0.1125); Gain of methylation at K1199 (P = 0.128); Gain of ubiquitination at K1200 (P = 0.1378); Gain of phosphorylation at S1196 (P = 0.1744); Loss of stability (P = 0.2646)
7:117267693:T:C,P13569,S1196P,0.424,Gain of methylation at K1199 (P = 0.073); Loss of stability (P = 0.112); Loss of catalytic residue at K1199 (P = 0.1253); Gain of ubiquitination at K1200 (P = 0.1378); Gain of sheet (P = 0.1945)
7:117267693:T:G,P13569,S1196A,0.351,Loss of disorder (P = 0.0535); Loss of methylation at K1200 (P = 0.0628); Loss of stability (P = 0.0922); Loss of ubiquitination at K1200 (P = 0.1498); Gain of catalytic residue at S1196 (P = 0.2527)
7:117267694:C:T,P13569,S1196L,0.379,Loss of disorder (P = 0.0332); Loss of methylation at K1200 (P = 0.0572); Loss of ubiquitination at K1199 (P = 0.0796); Gain of catalytic residue at S1196 (P = 0.1149); Gain of sheet (P = 0.1945)
7:117267696:C:A,P13569,H1197N,0.332,Gain of disorder (P = 0.0703); Gain of methylation at K1200 (P = 0.1177); Gain of ubiquitination at K1200 (P = 0.1215); Gain of relative solvent accessibility (P = 0.1571); Loss of stability (P = 0.1739)
7:117267696:C:G,P13569,H1197D,0.381,Gain of disorder (P = 0.0418); Loss of methylation at K1199 (P = 0.0737); Loss of ubiquitination at K1200 (P = 0.1498); Gain of relative solvent accessibility (P = 0.1571); Gain of sheet (P = 0.1945)
7:117267696:C:T,P13569,H1197Y,0.346,Loss of methylation at K1200 (P = 0.066); Gain of phosphorylation at H1197 (P = 0.0693); Loss of disorder (P = 0.0825); Gain of ubiquitination at K1200 (P = 0.0945); Gain of catalytic residue at H1197 (P = 0.1541)
7:117267697:A:C,P13569,H1197P,0.448,Gain of disorder (P = 0.0345); Gain of methylation at K1200 (P = 0.0584); Gain of ubiquitination at K1200 (P = 0.1079); Loss of stability (P = 0.12); Gain of catalytic residue at N1195 (P = 0.1349)
7:117267697:A:G,P13569,H1197R,0.327,Gain of MoRF binding (P = 0.0139); Loss of methylation at K1200 (P = 0.0977); Gain of phosphorylation at S1196 (P = 0.1069); Gain of ubiquitination at K1200 (P = 0.1215); Gain of disorder (P = 0.1337)
7:117267697:A:T,P13569,H1197L,0.38,Gain of catalytic residue at H1197 (P = 0.0218); Loss of disorder (P = 0.0849); Loss of methylation at K1200 (P = 0.1076); Gain of ubiquitination at K1200 (P = 0.1079); Gain of MoRF binding (P = 0.2417)
7:117267698:C:A,P13569,H1197Q,0.382,Gain of catalytic residue at H1197 (P = 0.0238); Gain of disorder (P = 0.0575); Gain of methylation at K1200 (P = 0.0843); Gain of ubiquitination at K1200 (P = 0.1215); Loss of stability (P = 0.1916)
7:117267698:C:G,P13569,H1197Q,0.382,Gain of catalytic residue at H1197 (P = 0.0238); Gain of disorder (P = 0.0575); Gain of methylation at K1200 (P = 0.0843); Gain of ubiquitination at K1200 (P = 0.1215); Loss of stability (P = 0.1916)
7:117267699:G:A,P13569,V1198M,0.453,Loss of catalytic residue at V1198 (P = 0.016); Loss of methylation at K1199 (P = 0.0258); Gain of disorder (P = 0.0399); Gain of solvent accessibility (P = 0.0713); Gain of ubiquitination at K1200 (P = 0.0766)
7:117267699:G:C,P13569,V1198L,0.428,Loss of methylation at K1199 (P = 0.0388); Gain of ubiquitination at K1200 (P = 0.1215); Loss of relative solvent accessibility (P = 0.1807); Loss of solvent accessibility (P = 0.1986); Gain of disorder (P = 0.2154)
7:117267699:G:T,P13569,V1198L,0.428,Loss of methylation at K1199 (P = 0.0388); Gain of ubiquitination at K1200 (P = 0.1215); Loss of relative solvent accessibility (P = 0.1807); Loss of solvent accessibility (P = 0.1986); Gain of disorder (P = 0.2154)
7:117267700:T:A,P13569,V1198E,0.546,Gain of disorder (P = 0.013); Loss of methylation at K1199 (P = 0.0561); Gain of solvent accessibility (P = 0.0611); Gain of ubiquitination at K1200 (P = 0.0719); Loss of stability (P = 0.0737)
7:117267700:T:C,P13569,V1198A,0.459,Loss of stability (P = 0.0131); Loss of methylation at K1199 (P = 0.041); Gain of ubiquitination at K1200 (P = 0.0638); Gain of disorder (P = 0.101); Loss of solvent accessibility (P = 0.1177)
7:117267700:T:G,P13569,V1198G,0.476,Loss of stability (P = 0.0024); Gain of disorder (P = 0.0285); Loss of methylation at K1199 (P = 0.0464); Loss of catalytic residue at V1198 (P = 0.0592); Gain of ubiquitination at K1200 (P = 0.0846)
7:117267702:A:C,P13569,K1199Q,0.45,Loss of ubiquitination at K1199 (P = 0.0081); Loss of methylation at K1199 (P = 0.0189); Loss of disorder (P = 0.1573); Loss of MoRF binding (P = 0.2614); Loss of catalytic residue at K1199 (P = 0.277)
7:117267702:A:G,P13569,K1199E,0.464,Loss of ubiquitination at K1199 (P = 0.0081); Loss of methylation at K1199 (P = 0.0189); Gain of relative solvent accessibility (P = 0.1571); Loss of MoRF binding (P = 0.198); Loss of disorder (P = 0.2135)
7:117267703:A:C,P13569,K1199T,0.396,Loss of ubiquitination at K1199 (P = 0.0081); Loss of methylation at K1199 (P = 0.0189); Gain of phosphorylation at K1199 (P = 0.0602); Gain of catalytic residue at H1197 (P = 0.1013); Loss of disorder (P = 0.1078)
7:117267703:A:G,P13569,K1199R,0.419,Loss of ubiquitination at K1199 (P = 0.0081); Loss of methylation at K1199 (P = 0.0199); Loss of disorder (P = 0.0984); Loss of solvent accessibility (P = 0.1115); Loss of relative solvent accessibility (P = 0.1807)
7:117267703:A:T,P13569,K1199M,0.426,Loss of ubiquitination at K1199 (P = 0.0081); Loss of methylation at K1199 (P = 0.0189); Loss of solvent accessibility (P = 0.0217); Loss of disorder (P = 0.0837); Loss of relative solvent accessibility (P = 0.0981)
7:117267704:G:C,P13569,K1199N,0.485,Loss of ubiquitination at K1199 (P = 0.0081); Loss of methylation at K1199 (P = 0.0189); Loss of catalytic residue at K1199 (P = 0.0478); Loss of disorder (P = 0.1413); Loss of MoRF binding (P = 0.2532)
7:117267704:G:T,P13569,K1199N,0.485,Loss of ubiquitination at K1199 (P = 0.0081); Loss of methylation at K1199 (P = 0.0189); Loss of catalytic residue at K1199 (P = 0.0478); Loss of disorder (P = 0.1413); Loss of MoRF binding (P = 0.2532)
7:117267705:A:C,P13569,K1200Q,0.582,Loss of ubiquitination at K1200 (P = 0.013); Loss of methylation at K1200 (P = 0.0219); Loss of disorder (P = 0.1693); Loss of catalytic residue at K1199 (P = 0.2437); Loss of MoRF binding (P = 0.3092)
7:117267705:A:G,P13569,K1200E,0.769,Loss of ubiquitination at K1200 (P = 0.013); Loss of methylation at K1200 (P = 0.0219); Loss of catalytic residue at K1199 (P = 0.1614); Loss of disorder (P = 0.2218); Loss of MoRF binding (P = 0.26)
7:117267706:A:C,P13569,K1200T,0.484,Loss of ubiquitination at K1200 (P = 0.013); Loss of methylation at K1200 (P = 0.0219); Loss of solvent accessibility (P = 0.0674); Loss of stability (P = 0.1035); Loss of disorder (P = 0.107)
7:117267706:A:G,P13569,K1200R,0.499,Loss of ubiquitination at K1200 (P = 0.013); Loss of methylation at K1200 (P = 0.0226); Loss of disorder (P = 0.1053); Loss of catalytic residue at K1200 (P = 0.2963); Gain of MoRF binding (P = 0.2989)
7:117267706:A:T,P13569,K1200I,0.545,Loss of solvent accessibility (P = 0.0036); Loss of ubiquitination at K1200 (P = 0.013); Loss of methylation at K1200 (P = 0.0219); Loss of disorder (P = 0.0297); Loss of relative solvent accessibility (P = 0.0404)
7:117267707:A:C,P13569,K1200N,0.559,Loss of ubiquitination at K1200 (P = 0.013); Loss of methylation at K1200 (P = 0.0219); Loss of solvent accessibility (P = 0.1177); Loss of disorder (P = 0.1512); Loss of catalytic residue at K1200 (P = 0.2268)
7:117267707:A:T,P13569,K1200N,0.559,Loss of ubiquitination at K1200 (P = 0.013); Loss of methylation at K1200 (P = 0.0219); Loss of solvent accessibility (P = 0.1177); Loss of disorder (P = 0.1512); Loss of catalytic residue at K1200 (P = 0.2268)
7:117267708:G:A,P13569,D1201N,0.459,Loss of solvent accessibility (P = 0.0387); Gain of methylation at K1200 (P = 0.0561); Loss of relative solvent accessibility (P = 0.0676); Loss of catalytic residue at D1201 (P = 0.0772); Gain of MoRF binding (P = 0.1056)
7:117267708:G:C,P13569,D1201H,0.454,Loss of solvent accessibility (P = 0.0217); Loss of relative solvent accessibility (P = 0.0404); Gain of methylation at K1200 (P = 0.05); Gain of MoRF binding (P = 0.1349); Loss of ubiquitination at K1199 (P = 0.1405)
7:117267708:G:T,P13569,D1201Y,0.507,Loss of solvent accessibility (P = 0.0352); Loss of disorder (P = 0.0393); Loss of relative solvent accessibility (P = 0.0404); Gain of MoRF binding (P = 0.09); Gain of methylation at K1200 (P = 0.1125)
7:117267709:A:C,P13569,D1201A,0.501,Loss of solvent accessibility (P = 0.0352); Loss of ubiquitination at K1199 (P = 0.0554); Gain of MoRF binding (P = 0.0646); Loss of disorder (P = 0.0827); Gain of methylation at K1200 (P = 0.0953)
7:117267709:A:G,P13569,D1201G,0.43,Loss of solvent accessibility (P = 0.0595); Loss of ubiquitination at K1199 (P = 0.0605); Gain of methylation at K1200 (P = 0.068); Gain of MoRF binding (P = 0.0697); Loss of stability (P = 0.1765)
7:117267709:A:T,P13569,D1201V,0.539,Loss of solvent accessibility (P = 0.0159); Gain of methylation at K1200 (P = 0.0351); Loss of relative solvent accessibility (P = 0.0404); Loss of disorder (P = 0.0441); Gain of MoRF binding (P = 0.0529)
7:117267710:T:A,P13569,D1201E,0.39,Gain of methylation at K1200 (P = 0.0687); Loss of ubiquitination at K1200 (P = 0.1083); Gain of disorder (P = 0.1839); Loss of glycosylation at S1206 (P = 0.2373); Loss of catalytic residue at K1200 (P = 0.2572)
7:117267710:T:G,P13569,D1201E,0.39,Gain of methylation at K1200 (P = 0.0687); Loss of ubiquitination at K1200 (P = 0.1083); Gain of disorder (P = 0.1839); Loss of glycosylation at S1206 (P = 0.2373); Loss of catalytic residue at K1200 (P = 0.2572)
7:117267711:G:A,P13569,D1202N,0.349,Gain of methylation at K1200 (P = 0.0558); Loss of ubiquitination at K1200 (P = 0.1083); Gain of MoRF binding (P = 0.1176); Loss of disorder (P = 0.1965); Gain of glycosylation at S1206 (P = 0.277)
7:117267711:G:C,P13569,D1202H,0.351,Gain of methylation at K1200 (P = 0.0463); Loss of ubiquitination at K1200 (P = 0.1083); Loss of disorder (P = 0.1919); Gain of glycosylation at S1206 (P = 0.1953); Gain of MoRF binding (P = 0.2133)
7:117267711:G:T,P13569,D1202Y,0.496,Loss of disorder (P = 0.038); Gain of phosphorylation at D1202 (P = 0.0758); Gain of methylation at K1200 (P = 0.0792); Loss of ubiquitination at K1199 (P = 0.0937); Loss of relative solvent accessibility (P = 0.0981)
7:117267712:A:G,P13569,D1202G,0.356,Gain of methylation at K1200 (P = 0.055); Loss of ubiquitination at K1199 (P = 0.0796); Loss of solvent accessibility (P = 0.1813); Gain of MoRF binding (P = 0.1981); Loss of glycosylation at S1206 (P = 0.2064)
7:117267712:A:T,P13569,D1202V,0.471,Loss of disorder (P = 0.0429); Gain of methylation at K1200 (P = 0.0482); Loss of solvent accessibility (P = 0.0907); Loss of ubiquitination at K1199 (P = 0.0937); Gain of MoRF binding (P = 0.1206)
7:117267713:C:A,P13569,D1202E,0.314,Gain of methylation at K1200 (P = 0.0692); Loss of ubiquitination at K1200 (P = 0.0935); Gain of disorder (P = 0.1863); Loss of catalytic residue at K1199 (P = 0.2137); Loss of glycosylation at S1206 (P = 0.2435)
7:117267713:C:G,P13569,D1202E,0.314,Gain of methylation at K1200 (P = 0.0692); Loss of ubiquitination at K1200 (P = 0.0935); Gain of disorder (P = 0.1863); Loss of catalytic residue at K1199 (P = 0.2137); Loss of glycosylation at S1206 (P = 0.2435)
7:117267714:A:C,P13569,I1203L,0.476,Loss of catalytic residue at P1205 (P = 0.0306); Loss of methylation at K1199 (P = 0.0568); Gain of ubiquitination at K1200 (P = 0.1079); Gain of disorder (P = 0.1657); Loss of glycosylation at S1206 (P = 0.179)
7:117267714:A:T,P13569,I1203F,0.539,Loss of catalytic residue at P1205 (P = 0.0306); Gain of ubiquitination at K1200 (P = 0.0846); Loss of methylation at K1200 (P = 0.0888); Loss of disorder (P = 0.222); Loss of glycosylation at S1206 (P = 0.235)
7:117267715:T:A,P13569,I1203N,0.522,Gain of catalytic residue at I1203 (P = 0.0077); Gain of disorder (P = 0.0239); Gain of relative solvent accessibility (P = 0.0249); Gain of solvent accessibility (P = 0.0421); Gain of ubiquitination at K1200 (P = 0.0554)
7:117267715:T:C,P13569,I1203T,0.467,Gain of relative solvent accessibility (P = 0.0098); Loss of stability (P = 0.0166); Gain of solvent accessibility (P = 0.0263); Gain of disorder (P = 0.0277); Loss of catalytic residue at P1205 (P = 0.0306)
7:117267715:T:G,P13569,I1203S,0.452,Gain of disorder (P = 0.0085); Gain of relative solvent accessibility (P = 0.0249); Loss of catalytic residue at P1205 (P = 0.0374); Loss of stability (P = 0.0455); Gain of ubiquitination at K1200 (P = 0.0525)
7:117267716:C:G,P13569,I1203M,0.469,Loss of catalytic residue at P1205 (P = 0.0306); Gain of disorder (P = 0.0418); Gain of ubiquitination at K1200 (P = 0.0719); Loss of methylation at K1199 (P = 0.1195); Loss of glycosylation at S1206 (P = 0.208)
7:117267717:T:A,P13569,W1204R,0.608,Gain of disorder (P = 0.0096); Loss of methylation at K1200 (P = 0.0545); Gain of phosphorylation at S1206 (P = 0.0554); Gain of solvent accessibility (P = 0.0917); Gain of relative solvent accessibility (P = 0.1066)
7:117267717:T:C,P13569,W1204R,0.608,Gain of disorder (P = 0.0096); Loss of methylation at K1200 (P = 0.0545); Gain of phosphorylation at S1206 (P = 0.0554); Gain of solvent accessibility (P = 0.0917); Gain of relative solvent accessibility (P = 0.1066)
7:117267717:T:G,P13569,W1204G,0.605,Gain of disorder (P = 0.0054); Gain of relative solvent accessibility (P = 0.0249); Loss of stability (P = 0.0386); Gain of ubiquitination at K1200 (P = 0.0945); Gain of glycosylation at S1206 (P = 0.1058)
7:117267718:G:C,P13569,W1204S,0.569,Gain of disorder (P = 0.0018); Loss of catalytic residue at W1204 (P = 0.0083); Gain of phosphorylation at W1204 (P = 0.0654); Loss of methylation at K1200 (P = 0.0809); Gain of ubiquitination at K1200 (P = 0.0945)
7:117267718:G:T,P13569,W1204L,0.598,Gain of disorder (P = 0.0479); Loss of methylation at K1199 (P = 0.0761); Loss of ubiquitination at K1200 (P = 0.0806); Gain of glycosylation at S1206 (P = 0.1792); Loss of MoRF binding (P = 0.3627)
7:117267719:G:C,P13569,W1204C,0.582,Gain of disorder (P = 0.0526); Loss of ubiquitination at K1199 (P = 0.0796); Gain of catalytic residue at S1206 (P = 0.0882); Loss of methylation at K1200 (P = 0.1124); Loss of glycosylation at S1206 (P = 0.1514)
7:117267719:G:T,P13569,W1204C,0.582,Gain of disorder (P = 0.0526); Loss of ubiquitination at K1199 (P = 0.0796); Gain of catalytic residue at S1206 (P = 0.0882); Loss of methylation at K1200 (P = 0.1124); Loss of glycosylation at S1206 (P = 0.1514)
7:117267720:C:A,P13569,P1205T,0.528,Loss of catalytic residue at P1205 (P = 0.0297); Loss of ubiquitination at K1200 (P = 0.1083); Loss of methylation at K1200 (P = 0.1458); Gain of glycosylation at P1205 (P = 0.176); Gain of MoRF binding (P = 0.1972)
7:117267720:C:G,P13569,P1205A,0.568,Loss of methylation at K1200 (P = 0.0691); Loss of disorder (P = 0.1157); Loss of ubiquitination at K1200 (P = 0.1287); Gain of MoRF binding (P = 0.1627); Loss of glycosylation at S1206 (P = 0.1796)
7:117267720:C:T,P13569,P1205S,0.46,Loss of ubiquitination at K1200 (P = 0.0935); Loss of catalytic residue at P1205 (P = 0.0992); Loss of methylation at K1200 (P = 0.1028); Gain of disorder (P = 0.1075); Gain of phosphorylation at P1205 (P = 0.1238)
7:117267721:C:A,P13569,P1205H,0.552,Loss of ubiquitination at K1200 (P = 0.0806); Gain of catalytic residue at I1203 (P = 0.1213); Loss of methylation at K1200 (P = 0.1541); Loss of glycosylation at S1206 (P = 0.1643); Loss of sheet (P = 0.1907)
7:117267721:C:G,P13569,P1205R,0.526,Gain of MoRF binding (P = 0.0042); Gain of solvent accessibility (P = 0.0411); Loss of ubiquitination at K1200 (P = 0.0431); Loss of catalytic residue at W1204 (P = 0.0546); Loss of methylation at K1200 (P = 0.0823)
7:117267721:C:T,P13569,P1205L,0.598,Loss of methylation at K1200 (P = 0.0526); Loss of disorder (P = 0.0563); Loss of glycosylation at S1206 (P = 0.0862); Loss of catalytic residue at P1205 (P = 0.0889); Loss of ubiquitination at K1200 (P = 0.1287)
7:117267723:T:A,P13569,S1206T,0.308,Loss of disorder (P = 0.118); Gain of glycosylation at S1206 (P = 0.2586); Gain of phosphorylation at T1211 (P = 0.3021); Gain of catalytic residue at S1206 (P = 0.3391); Loss of sheet (P = 0.3635)
7:117267723:T:C,P13569,S1206P,0.382,Loss of glycosylation at S1206 (P = 0.062); Gain of phosphorylation at T1211 (P = 0.176); Loss of sheet (P = 0.1907); Loss of disorder (P = 0.2112); Loss of MoRF binding (P = 0.3594)
7:117267723:T:G,P13569,S1206A,0.414,Gain of catalytic residue at S1206 (P = 0.0235); Loss of glycosylation at S1206 (P = 0.043); Loss of relative solvent accessibility (P = 0.0676); Loss of solvent accessibility (P = 0.0703); Loss of disorder (P = 0.0775)
7:117267724:C:T,P13569,S1206L,0.504,Loss of glycosylation at S1206 (P = 0.043); Loss of disorder (P = 0.0432); Loss of relative solvent accessibility (P = 0.0981); Gain of catalytic residue at S1206 (P = 0.1491); Loss of solvent accessibility (P = 0.1551)
7:117267726:G:A,P13569,G1207R,0.368,Gain of MoRF binding (P = 0.0529); Loss of glycosylation at S1206 (P = 0.0838); Gain of solvent accessibility (P = 0.1014); Loss of catalytic residue at Q1209 (P = 0.1226); Loss of disorder (P = 0.2349)
7:117267726:G:C,P13569,G1207R,0.368,Gain of MoRF binding (P = 0.0529); Loss of glycosylation at S1206 (P = 0.0838); Gain of solvent accessibility (P = 0.1014); Loss of catalytic residue at Q1209 (P = 0.1226); Loss of disorder (P = 0.2349)
7:117267726:G:T,P13569,G1207W,0.542,Gain of catalytic residue at M1210 (P = 0.008); Loss of glycosylation at S1206 (P = 0.0462); Loss of disorder (P = 0.0499); Gain of MoRF binding (P = 0.0803); Loss of relative solvent accessibility (P = 0.114)
7:117267727:G:A,P13569,G1207E,0.437,Loss of glycosylation at S1206 (P = 0.064); Gain of solvent accessibility (P = 0.0837); Gain of disorder (P = 0.1651); Loss of sheet (P = 0.1907); Loss of catalytic residue at Q1209 (P = 0.2061)
7:117267727:G:C,P13569,G1207A,0.385,Loss of glycosylation at S1206 (P = 0.071); Gain of catalytic residue at G1207 (P = 0.0746); Loss of disorder (P = 0.1456); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.369)
7:117267727:G:T,P13569,G1207V,0.456,Loss of glycosylation at S1206 (P = 0.057); Loss of disorder (P = 0.0857); Loss of sheet (P = 0.1907); Loss of catalytic residue at G1208 (P = 0.2224); Gain of MoRF binding (P = 0.3355)
7:117267729:G:A,P13569,G1208S,0.648,Gain of disorder (P = 0.1049); Gain of methylation at K1213 (P = 0.1308); Loss of ubiquitination at K1213 (P = 0.1322); Loss of glycosylation at S1206 (P = 0.1451); Gain of relative solvent accessibility (P = 0.1894)
7:117267729:G:C,P13569,G1208R,0.672,Loss of ubiquitination at K1213 (P = 0.0394); Gain of solvent accessibility (P = 0.0674); Gain of MoRF binding (P = 0.0803); Gain of relative solvent accessibility (P = 0.1012); Loss of methylation at K1213 (P = 0.105)
7:117267729:G:T,P13569,G1208C,0.761,Loss of ubiquitination at K1213 (P = 0.0449); Loss of disorder (P = 0.0663); Loss of methylation at K1213 (P = 0.1534); Loss of glycosylation at S1206 (P = 0.1743); Gain of catalytic residue at G1208 (P = 0.2642)
7:117267730:G:A,P13569,G1208D,0.668,Loss of ubiquitination at K1213 (P = 0.0777); Gain of relative solvent accessibility (P = 0.1012); Loss of methylation at K1213 (P = 0.1378); Gain of solvent accessibility (P = 0.1583); Loss of glycosylation at S1206 (P = 0.1612)
7:117267730:G:C,P13569,G1208A,0.753,Loss of ubiquitination at K1213 (P = 0.055); Loss of methylation at K1213 (P = 0.1326); Loss of disorder (P = 0.1538); Gain of glycosylation at S1206 (P = 0.2127); Gain of catalytic residue at G1208 (P = 0.2301)
7:117267730:G:T,P13569,G1208V,0.798,Loss of ubiquitination at K1213 (P = 0.0502); Loss of disorder (P = 0.0973); Loss of methylation at K1213 (P = 0.1221); Gain of glycosylation at S1206 (P = 0.2385); Gain of catalytic residue at G1208 (P = 0.2831)
7:117267732:C:A,P13569,Q1209K,0.394,Gain of ubiquitination at Q1209 (P = 0.0311); Gain of MoRF binding (P = 0.086); Loss of methylation at K1213 (P = 0.109); Loss of stability (P = 0.1269); Gain of disorder (P = 0.1415)
7:117267732:C:G,P13569,Q1209E,0.379,Loss of ubiquitination at K1213 (P = 0.0992); Loss of methylation at K1213 (P = 0.1216); Gain of disorder (P = 0.1717); Gain of phosphorylation at T1211 (P = 0.2387); Loss of glycosylation at S1206 (P = 0.2659)
7:117267733:A:C,P13569,Q1209P,0.588,Loss of catalytic residue at Q1209 (P = 0.0492); Gain of glycosylation at S1206 (P = 0.0715); Gain of phosphorylation at T1211 (P = 0.0974); Loss of ubiquitination at K1213 (P = 0.1151); Gain of methylation at K1213 (P = 0.1342)
7:117267733:A:G,P13569,Q1209R,0.352,Gain of MoRF binding (P = 0.0315); Loss of ubiquitination at K1213 (P = 0.0502); Loss of methylation at K1213 (P = 0.0798); Gain of phosphorylation at T1211 (P = 0.0817); Gain of glycosylation at S1206 (P = 0.1144)
7:117267733:A:T,P13569,Q1209L,0.475,Loss of ubiquitination at K1213 (P = 0.0468); Loss of methylation at K1213 (P = 0.0778); Loss of disorder (P = 0.1014); Loss of glycosylation at S1206 (P = 0.1544); Loss of catalytic residue at Q1209 (P = 0.2858)
7:117267734:A:C,P13569,Q1209H,0.427,Loss of ubiquitination at K1213 (P = 0.1151); Loss of methylation at K1213 (P = 0.1371); Gain of disorder (P = 0.1492); Loss of stability (P = 0.1871); Gain of glycosylation at S1206 (P = 0.1908)
7:117267734:A:T,P13569,Q1209H,0.427,Loss of ubiquitination at K1213 (P = 0.1151); Loss of methylation at K1213 (P = 0.1371); Gain of disorder (P = 0.1492); Loss of stability (P = 0.1871); Gain of glycosylation at S1206 (P = 0.1908)
7:117267735:A:C,P13569,M1210L,0.723,Loss of methylation at K1213 (P = 0.054); Loss of ubiquitination at K1213 (P = 0.0587); Loss of disorder (P = 0.1957); Gain of glycosylation at S1206 (P = 0.2745); Loss of sheet (P = 0.302)
7:117267735:A:G,P13569,M1210V,0.686,Loss of ubiquitination at K1213 (P = 0.0637); Loss of methylation at K1213 (P = 0.0943); Gain of glycosylation at S1206 (P = 0.2131); Loss of disorder (P = 0.2267); Loss of sheet (P = 0.302)
7:117267735:A:T,P13569,M1210L,0.723,Loss of methylation at K1213 (P = 0.054); Loss of ubiquitination at K1213 (P = 0.0587); Loss of disorder (P = 0.1957); Gain of glycosylation at S1206 (P = 0.2745); Loss of sheet (P = 0.302)
7:117267736:T:A,P13569,M1210K,0.939,Gain of disorder (P = 0.0205); Gain of ubiquitination at M1210 (P = 0.0311); Gain of glycosylation at M1210 (P = 0.0769); Gain of phosphorylation at T1211 (P = 0.0955); Gain of methylation at K1213 (P = 0.1239)
7:117267736:T:C,P13569,M1210T,0.734,Gain of disorder (P = 0.0736); Gain of ubiquitination at K1213 (P = 0.078); Loss of methylation at K1213 (P = 0.114); Gain of glycosylation at S1206 (P = 0.1242); Gain of phosphorylation at M1210 (P = 0.1256)
7:117267736:T:G,P13569,M1210R,0.744,Gain of catalytic residue at M1210 (P = 0.0302); Loss of ubiquitination at K1213 (P = 0.0709); Gain of phosphorylation at T1211 (P = 0.0744); Gain of MoRF binding (P = 0.086); Gain of disorder (P = 0.0935)
7:117267737:G:A,P13569,M1210I,0.848,Gain of catalytic residue at M1210 (P = 0.0401); Loss of ubiquitination at K1213 (P = 0.0468); Loss of disorder (P = 0.1492); Gain of methylation at K1213 (P = 0.1539); Loss of glycosylation at S1206 (P = 0.1982)
7:117267737:G:C,P13569,M1210I,0.848,Gain of catalytic residue at M1210 (P = 0.0401); Loss of ubiquitination at K1213 (P = 0.0468); Loss of disorder (P = 0.1492); Gain of methylation at K1213 (P = 0.1539); Loss of glycosylation at S1206 (P = 0.1982)
7:117267737:G:T,P13569,M1210I,0.848,Gain of catalytic residue at M1210 (P = 0.0401); Loss of ubiquitination at K1213 (P = 0.0468); Loss of disorder (P = 0.1492); Gain of methylation at K1213 (P = 0.1539); Loss of glycosylation at S1206 (P = 0.1982)
7:117267738:A:C,P13569,T1211P,0.465,Loss of sheet (P = 0.0817); Gain of ubiquitination at K1213 (P = 0.0872); Gain of methylation at K1213 (P = 0.0874); Loss of phosphorylation at T1211 (P = 0.1554); Gain of disorder (P = 0.1584)
7:117267738:A:G,P13569,T1211A,0.351,Loss of ubiquitination at K1213 (P = 0.0777); Loss of sheet (P = 0.0817); Gain of methylation at K1213 (P = 0.1287); Loss of phosphorylation at T1211 (P = 0.1554); Gain of glycosylation at S1206 (P = 0.1887)
7:117267738:A:T,P13569,T1211S,0.341,Gain of disorder (P = 0.0636); Loss of methylation at K1213 (P = 0.065); Loss of sheet (P = 0.0817); Gain of ubiquitination at K1213 (P = 0.0872); Loss of glycosylation at S1206 (P = 0.1929)
7:117267739:C:A,P13569,T1211N,0.374,Loss of methylation at K1213 (P = 0.0667); Loss of sheet (P = 0.0817); Gain of ubiquitination at K1213 (P = 0.0985); Loss of phosphorylation at T1211 (P = 0.1554); Loss of glycosylation at S1206 (P = 0.1861)
7:117267739:C:G,P13569,T1211S,0.341,Gain of disorder (P = 0.0636); Loss of methylation at K1213 (P = 0.065); Loss of sheet (P = 0.0817); Gain of ubiquitination at K1213 (P = 0.0872); Loss of glycosylation at S1206 (P = 0.1929)
7:117267739:C:T,P13569,T1211I,0.415,Loss of ubiquitination at K1213 (P = 0.0468); Gain of methylation at K1213 (P = 0.055); Loss of disorder (P = 0.0728); Loss of sheet (P = 0.0817); Loss of phosphorylation at T1211 (P = 0.1554)
7:117267741:G:A,P13569,V1212I,0.852,Loss of methylation at K1213 (P = 0.0497); Loss of ubiquitination at K1213 (P = 0.0637); Loss of sheet (P = 0.0817); Loss of phosphorylation at T1216 (P = 0.2439); Loss of disorder (P = 0.2757)
7:117267741:G:C,P13569,V1212L,0.755,Loss of methylation at K1213 (P = 0.0376); Loss of ubiquitination at K1213 (P = 0.0992); Gain of disorder (P = 0.2126); Gain of phosphorylation at T1216 (P = 0.2517); Loss of sheet (P = 0.302)
7:117267741:G:T,P13569,V1212F,0.753,Gain of catalytic residue at V1212 (P = 0.057); Loss of ubiquitination at K1213 (P = 0.0637); Gain of methylation at K1213 (P = 0.0718); Loss of sheet (P = 0.0817); Gain of phosphorylation at T1216 (P = 0.2314)
7:117267742:T:A,P13569,V1212D,0.859,Gain of disorder (P = 0.0063); Loss of methylation at K1213 (P = 0.0346); Loss of sheet (P = 0.0817); Loss of stability (P = 0.091); Loss of ubiquitination at K1213 (P = 0.1151)
7:117267742:T:C,P13569,V1212A,0.85,Gain of disorder (P = 0.0361); Loss of stability (P = 0.0429); Loss of methylation at K1213 (P = 0.0447); Loss of sheet (P = 0.0817); Gain of ubiquitination at K1213 (P = 0.0985)
7:117267742:T:G,P13569,V1212G,0.861,Gain of disorder (P = 0.0092); Loss of stability (P = 0.015); Loss of methylation at K1213 (P = 0.047); Gain of ubiquitination at K1213 (P = 0.078); Loss of sheet (P = 0.0817)
7:117267744:A:C,P13569,K1213Q,0.476,Loss of ubiquitination at K1213 (P = 0.0183); Loss of methylation at K1213 (P = 0.0189); Loss of sheet (P = 0.0817); Loss of phosphorylation at T1216 (P = 0.1662); Loss of catalytic residue at K1213 (P = 0.172)
7:117267744:A:G,P13569,K1213E,0.469,Loss of ubiquitination at K1213 (P = 0.0183); Loss of methylation at K1213 (P = 0.0189); Loss of sheet (P = 0.0817); Loss of catalytic residue at K1213 (P = 0.0873); Gain of disorder (P = 0.2283)
7:117267745:A:C,P13569,K1213T,0.516,Loss of ubiquitination at K1213 (P = 0.0183); Loss of methylation at K1213 (P = 0.0189); Loss of catalytic residue at K1213 (P = 0.0778); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.1624)
7:117267745:A:G,P13569,K1213R,0.418,Loss of ubiquitination at K1213 (P = 0.0183); Loss of methylation at K1213 (P = 0.0223); Loss of sheet (P = 0.0817); Gain of phosphorylation at T1216 (P = 0.1057); Loss of disorder (P = 0.147)
7:117267745:A:T,P13569,K1213I,0.596,Loss of catalytic residue at K1213 (P = 0.0124); Loss of ubiquitination at K1213 (P = 0.0183); Loss of methylation at K1213 (P = 0.0189); Loss of disorder (P = 0.0336); Loss of sheet (P = 0.0817)
7:117267746:A:C,P13569,K1213N,0.538,Loss of ubiquitination at K1213 (P = 0.0183); Loss of methylation at K1213 (P = 0.0189); Loss of catalytic residue at K1213 (P = 0.0255); Loss of sheet (P = 0.0817); Loss of phosphorylation at T1216 (P = 0.1588)
7:117267746:A:T,P13569,K1213N,0.538,Loss of ubiquitination at K1213 (P = 0.0183); Loss of methylation at K1213 (P = 0.0189); Loss of catalytic residue at K1213 (P = 0.0255); Loss of sheet (P = 0.0817); Loss of phosphorylation at T1216 (P = 0.1588)
7:117267747:G:A,P13569,D1214N,0.576,Loss of ubiquitination at K1213 (P = 0.052); Loss of sheet (P = 0.0817); Gain of methylation at K1213 (P = 0.0863); Loss of phosphorylation at T1216 (P = 0.1073); Gain of MoRF binding (P = 0.1207)
7:117267747:G:C,P13569,D1214H,0.613,Loss of ubiquitination at K1213 (P = 0.0431); Gain of methylation at K1213 (P = 0.0738); Loss of sheet (P = 0.0817); Loss of phosphorylation at T1216 (P = 0.1351); Gain of MoRF binding (P = 0.1969)
7:117267747:G:T,P13569,D1214Y,0.68,Loss of ubiquitination at K1213 (P = 0.0394); Loss of disorder (P = 0.0683); Loss of sheet (P = 0.0817); Gain of methylation at K1218 (P = 0.1006); Gain of phosphorylation at D1214 (P = 0.1365)
7:117267748:A:C,P13569,D1214A,0.632,Loss of ubiquitination at K1213 (P = 0.0419); Loss of sheet (P = 0.0817); Gain of methylation at K1213 (P = 0.1489); Loss of phosphorylation at T1216 (P = 0.1516); Loss of disorder (P = 0.1516)
7:117267748:A:G,P13569,D1214G,0.635,Loss of ubiquitination at K1213 (P = 0.0468); Loss of sheet (P = 0.0817); Gain of methylation at K1213 (P = 0.1035); Loss of stability (P = 0.18); Loss of phosphorylation at T1216 (P = 0.1803)
7:117267748:A:T,P13569,D1214V,0.707,Gain of methylation at K1213 (P = 0.0395); Loss of ubiquitination at K1213 (P = 0.0419); Loss of disorder (P = 0.0603); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.137)
7:117267749:T:A,P13569,D1214E,0.544,Gain of methylation at K1213 (P = 0.0694); Gain of sheet (P = 0.0827); Gain of ubiquitination at K1218 (P = 0.095); Gain of disorder (P = 0.123); Loss of phosphorylation at T1216 (P = 0.2537)
7:117267749:T:G,P13569,D1214E,0.544,Gain of methylation at K1213 (P = 0.0694); Gain of sheet (P = 0.0827); Gain of ubiquitination at K1218 (P = 0.095); Gain of disorder (P = 0.123); Loss of phosphorylation at T1216 (P = 0.2537)
7:117267750:C:A,P13569,L1215I,0.454,Loss of ubiquitination at K1213 (P = 0.0468); Gain of methylation at K1213 (P = 0.0774); Gain of sheet (P = 0.0827); Gain of loop (P = 0.2045); Loss of phosphorylation at T1216 (P = 0.231)
7:117267750:C:G,P13569,L1215V,0.435,Gain of methylation at K1213 (P = 0.0758); Loss of ubiquitination at K1213 (P = 0.0777); Loss of sheet (P = 0.1501); Gain of phosphorylation at T1216 (P = 0.1807); Gain of loop (P = 0.2045)
7:117267750:C:T,P13569,L1215F,0.444,Loss of ubiquitination at K1213 (P = 0.055); Gain of methylation at K1213 (P = 0.0932); Gain of loop (P = 0.2045); Gain of phosphorylation at T1216 (P = 0.2067); Loss of disorder (P = 0.2653)
7:117267751:T:A,P13569,L1215H,0.791,Gain of disorder (P = 0.0178); Gain of ubiquitination at K1218 (P = 0.0609); Loss of stability (P = 0.0638); Gain of catalytic residue at L1215 (P = 0.0651); Gain of methylation at K1213 (P = 0.073)
7:117267751:T:C,P13569,L1215P,0.869,Gain of disorder (P = 0.011); Gain of ubiquitination at K1218 (P = 0.0444); Gain of methylation at K1213 (P = 0.0472); Loss of stability (P = 0.0627); Gain of phosphorylation at T1216 (P = 0.0977)
7:117267751:T:G,P13569,L1215R,0.864,Gain of disorder (P = 0.0226); Gain of ubiquitination at K1218 (P = 0.0399); Gain of methylation at L1215 (P = 0.0671); Gain of phosphorylation at T1216 (P = 0.0899); Gain of MoRF binding (P = 0.0946)
7:117267753:A:C,P13569,T1216P,0.508,Loss of phosphorylation at T1216 (P = 0.0442); Gain of ubiquitination at K1218 (P = 0.0568); Loss of catalytic residue at T1216 (P = 0.0582); Loss of sheet (P = 0.1158); Gain of methylation at K1213 (P = 0.118)
7:117267753:A:G,P13569,T1216A,0.357,Loss of phosphorylation at T1216 (P = 0.0442); Loss of ubiquitination at K1213 (P = 0.0637); Loss of catalytic residue at T1216 (P = 0.0772); Loss of methylation at K1213 (P = 0.0825); Loss of sheet (P = 0.1158)
7:117267753:A:T,P13569,T1216S,0.358,Loss of phosphorylation at T1216 (P = 0.0681); Gain of disorder (P = 0.0751); Gain of ubiquitination at K1213 (P = 0.078); Gain of sheet (P = 0.0827); Loss of catalytic residue at T1216 (P = 0.0891)
7:117267754:C:A,P13569,T1216K,0.402,Gain of ubiquitination at T1216 (P = 0.0311); Loss of phosphorylation at T1216 (P = 0.0442); Gain of disorder (P = 0.0594); Gain of solvent accessibility (P = 0.0674); Loss of methylation at K1213 (P = 0.08)
7:117267754:C:G,P13569,T1216R,0.448,Loss of phosphorylation at T1216 (P = 0.0442); Loss of methylation at K1213 (P = 0.048); Loss of ubiquitination at K1213 (P = 0.0502); Gain of MoRF binding (P = 0.0584); Gain of sheet (P = 0.0827)
7:117267754:C:T,P13569,T1216I,0.487,Loss of catalytic residue at T1216 (P = 0.0432); Loss of phosphorylation at T1216 (P = 0.0442); Loss of ubiquitination at K1213 (P = 0.0468); Loss of disorder (P = 0.0611); Gain of methylation at K1213 (P = 0.0638)
7:117267756:G:A,P13569,A1217T,0.565,Gain of ubiquitination at K1218 (P = 0.0728); Gain of methylation at K1213 (P = 0.0808); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.1035); Loss of phosphorylation at T1216 (P = 0.1492)
7:117267756:G:C,P13569,A1217P,0.614,Gain of ubiquitination at K1218 (P = 0.0568); Gain of methylation at K1213 (P = 0.0579); Gain of disorder (P = 0.0607); Loss of sheet (P = 0.0817); Gain of phosphorylation at T1216 (P = 0.0851)
7:117267756:G:T,P13569,A1217S,0.625,Gain of disorder (P = 0.0305); Gain of ubiquitination at K1218 (P = 0.0483); Gain of methylation at K1213 (P = 0.0554); Loss of sheet (P = 0.0817); Gain of phosphorylation at T1216 (P = 0.1833)
7:117267757:C:A,P13569,A1217E,0.626,Gain of disorder (P = 0.0227); Gain of ubiquitination at K1218 (P = 0.0462); Gain of methylation at K1213 (P = 0.0469); Loss of sheet (P = 0.0817); Gain of phosphorylation at T1216 (P = 0.1308)
7:117267757:C:G,P13569,A1217G,0.569,Gain of ubiquitination at K1218 (P = 0.0483); Gain of disorder (P = 0.0568); Gain of methylation at K1213 (P = 0.0804); Loss of sheet (P = 0.0817); Loss of stability (P = 0.1836)
7:117267757:C:T,P13569,A1217V,0.536,Loss of ubiquitination at K1213 (P = 0.055); Gain of methylation at K1218 (P = 0.081); Loss of sheet (P = 0.0817); Loss of disorder (P = 0.1477); Loss of phosphorylation at T1220 (P = 0.184)
7:117267759:A:C,P13569,K1218Q,0.423,Loss of ubiquitination at K1218 (P = 0.0283); Loss of sheet (P = 0.0817); Loss of methylation at K1213 (P = 0.133); Gain of catalytic residue at Y1219 (P = 0.1442); Gain of phosphorylation at Y1219 (P = 0.1592)
7:117267759:A:G,P13569,K1218E,0.449,Loss of ubiquitination at K1218 (P = 0.0283); Gain of phosphorylation at Y1219 (P = 0.0811); Gain of methylation at K1213 (P = 0.1065); Loss of sheet (P = 0.1158); Gain of catalytic residue at K1218 (P = 0.1867)
7:117267760:A:C,P13569,K1218T,0.454,Loss of ubiquitination at K1218 (P = 0.0283); Gain of catalytic residue at Y1219 (P = 0.0448); Loss of methylation at K1213 (P = 0.1305); Loss of sheet (P = 0.1501); Loss of disorder (P = 0.1932)
7:117267760:A:G,P13569,K1218R,0.404,Loss of ubiquitination at K1218 (P = 0.0283); Gain of catalytic residue at Y1219 (P = 0.0815); Loss of sheet (P = 0.0817); Loss of methylation at K1213 (P = 0.0991); Gain of phosphorylation at T1220 (P = 0.1035)
7:117267760:A:T,P13569,K1218I,0.504,Loss of ubiquitination at K1218 (P = 0.0283); Loss of disorder (P = 0.0406); Gain of catalytic residue at Y1219 (P = 0.0573); Loss of sheet (P = 0.0817); Loss of methylation at K1213 (P = 0.1188)
7:117267761:A:C,P13569,K1218N,0.44,Loss of ubiquitination at K1218 (P = 0.0283); Gain of catalytic residue at Y1219 (P = 0.0596); Loss of methylation at K1213 (P = 0.0939); Loss of sheet (P = 0.1501); Loss of phosphorylation at T1216 (P = 0.1656)
7:117267761:A:T,P13569,K1218N,0.44,Loss of ubiquitination at K1218 (P = 0.0283); Gain of catalytic residue at Y1219 (P = 0.0596); Loss of methylation at K1213 (P = 0.0939); Loss of sheet (P = 0.1501); Loss of phosphorylation at T1216 (P = 0.1656)
7:117267762:T:A,P13569,Y1219N,0.806,Gain of disorder (P = 0.0191); Gain of ubiquitination at K1218 (P = 0.0399); Loss of sheet (P = 0.0817); Gain of catalytic residue at Y1219 (P = 0.1116); Gain of methylation at K1218 (P = 0.1294)
7:117267762:T:C,P13569,Y1219H,0.886,Gain of disorder (P = 0.0276); Gain of ubiquitination at K1218 (P = 0.0509); Loss of sheet (P = 0.0817); Gain of methylation at K1218 (P = 0.1155); Gain of phosphorylation at T1216 (P = 0.144)
7:117267762:T:G,P13569,Y1219D,0.842,Gain of disorder (P = 0.0118); Gain of ubiquitination at K1218 (P = 0.0399); Gain of phosphorylation at T1216 (P = 0.1121); Loss of catalytic residue at T1216 (P = 0.1124); Loss of sheet (P = 0.1158)
7:117267763:A:C,P13569,Y1219S,0.882,Gain of disorder (P = 0.0077); Gain of ubiquitination at K1218 (P = 0.0399); Gain of sheet (P = 0.0827); Loss of catalytic residue at T1216 (P = 0.1308); Gain of loop (P = 0.2045)
7:117267763:A:G,P13569,Y1219C,0.795,Gain of methylation at K1218 (P = 0.0139); Loss of sheet (P = 0.0817); Loss of phosphorylation at Y1219 (P = 0.1459); Loss of catalytic residue at T1216 (P = 0.1692); Loss of ubiquitination at K1218 (P = 0.1828)
7:117267763:A:T,P13569,Y1219F,0.762,Gain of catalytic residue at Y1219 (P = 0.0082); Gain of methylation at K1218 (P = 0.0421); Loss of sheet (P = 0.0817); Loss of ubiquitination at K1218 (P = 0.121); Loss of phosphorylation at Y1219 (P = 0.1459)
7:117267765:A:C,P13569,T1220P,0.473,Loss of phosphorylation at T1220 (P = 0.0738); Gain of sheet (P = 0.0827); Gain of ubiquitination at K1218 (P = 0.1111); Gain of disorder (P = 0.1859); Gain of methylation at K1218 (P = 0.3495)
7:117267765:A:G,P13569,T1220A,0.304,Loss of phosphorylation at T1220 (P = 0.0738); Gain of sheet (P = 0.0827); Loss of ubiquitination at K1218 (P = 0.1486); Loss of disorder (P = 0.2646); Loss of methylation at K1218 (P = 0.3971)
7:117267765:A:T,P13569,T1220S,0.292,Gain of ubiquitination at K1218 (P = 0.0822); Gain of sheet (P = 0.0827); Gain of disorder (P = 0.0855); Loss of phosphorylation at T1216 (P = 0.1038); Gain of relative solvent accessibility (P = 0.2363)
7:117267766:C:A,P13569,T1220K,0.46,Gain of ubiquitination at T1220 (P = 0.0258); Gain of methylation at T1220 (P = 0.0308); Gain of solvent accessibility (P = 0.0611); Loss of phosphorylation at T1220 (P = 0.0738); Gain of disorder (P = 0.0751)
7:117267766:C:G,P13569,T1220R,0.408,Loss of phosphorylation at T1220 (P = 0.0738); Gain of solvent accessibility (P = 0.0808); Gain of sheet (P = 0.0827); Gain of methylation at T1220 (P = 0.0976); Gain of MoRF binding (P = 0.1031)
7:117267768:G:A,P13569,E1221K,0.514,Gain of methylation at E1221 (P = 0.0267); Gain of ubiquitination at E1221 (P = 0.0311); Gain of MoRF binding (P = 0.0622); Gain of phosphorylation at T1216 (P = 0.1706); Gain of disorder (P = 0.2722)
7:117267768:G:C,P13569,E1221Q,0.431,Gain of catalytic residue at E1221 (P = 0.0721); Loss of sheet (P = 0.0817); Loss of ubiquitination at K1218 (P = 0.1486); Loss of phosphorylation at T1216 (P = 0.2251); Loss of disorder (P = 0.2471)
7:117267769:A:C,P13569,E1221A,0.482,Gain of catalytic residue at E1221 (P = 0.0031); Loss of solvent accessibility (P = 0.0769); Gain of phosphorylation at T1216 (P = 0.144); Loss of disorder (P = 0.1502); Loss of ubiquitination at K1218 (P = 0.1828)
7:117267769:A:G,P13569,E1221G,0.492,Loss of solvent accessibility (P = 0.0387); Gain of ubiquitination at K1218 (P = 0.0568); Gain of catalytic residue at Y1219 (P = 0.0687); Loss of sheet (P = 0.0817); Loss of stability (P = 0.1076)
7:117267769:A:T,P13569,E1221V,0.508,Loss of disorder (P = 0.0628); Loss of sheet (P = 0.0817); Gain of catalytic residue at K1218 (P = 0.1402); Gain of ubiquitination at K1218 (P = 0.1586); Gain of methylation at K1218 (P = 0.1656)
7:117267770:A:C,P13569,E1221D,0.405,Gain of catalytic residue at E1221 (P = 0.0464); Gain of ubiquitination at K1218 (P = 0.0822); Gain of phosphorylation at T1216 (P = 0.1819); Gain of disorder (P = 0.2984); Loss of sheet (P = 0.302)
7:117267770:A:T,P13569,E1221D,0.405,Gain of catalytic residue at E1221 (P = 0.0464); Gain of ubiquitination at K1218 (P = 0.0822); Gain of phosphorylation at T1216 (P = 0.1819); Gain of disorder (P = 0.2984); Loss of sheet (P = 0.302)
7:117267771:G:A,P13569,G1222S,0.371,Loss of sheet (P = 0.0817); Loss of ubiquitination at K1218 (P = 0.121); Gain of solvent accessibility (P = 0.1683); Gain of disorder (P = 0.1753); Gain of loop (P = 0.2045)
7:117267771:G:C,P13569,G1222R,0.483,Gain of solvent accessibility (P = 0.0037); Gain of phosphorylation at T1220 (P = 0.0947); Loss of sheet (P = 0.1158); Gain of ubiquitination at K1218 (P = 0.1317); Gain of loop (P = 0.2045)
7:117267771:G:T,P13569,G1222C,0.487,Loss of disorder (P = 0.0658); Loss of ubiquitination at K1218 (P = 0.0853); Loss of sheet (P = 0.1158); Gain of solvent accessibility (P = 0.1456); Gain of catalytic residue at A1217 (P = 0.175)
7:117267772:G:A,P13569,G1222D,0.433,Gain of solvent accessibility (P = 0.0638); Gain of phosphorylation at T1220 (P = 0.1073); Loss of sheet (P = 0.1158); Loss of ubiquitination at K1218 (P = 0.1486); Gain of loop (P = 0.2045)
7:117267772:G:C,P13569,G1222A,0.406,Loss of ubiquitination at K1218 (P = 0.121); Loss of sheet (P = 0.1398); Gain of catalytic residue at G1222 (P = 0.1597); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2563)
7:117267772:G:T,P13569,G1222V,0.481,Loss of disorder (P = 0.0932); Loss of sheet (P = 0.1158); Gain of ubiquitination at K1218 (P = 0.1586); Gain of phosphorylation at Y1219 (P = 0.1785); Gain of loop (P = 0.2045)
7:117267774:G:A,P13569,G1223R,0.503,Gain of solvent accessibility (P = 0.0306); Gain of phosphorylation at T1220 (P = 0.1073); Loss of sheet (P = 0.1158); Gain of methylation at G1223 (P = 0.1317); Loss of ubiquitination at K1218 (P = 0.1828)
7:117267774:G:C,P13569,G1223R,0.503,Gain of solvent accessibility (P = 0.0306); Gain of phosphorylation at T1220 (P = 0.1073); Loss of sheet (P = 0.1158); Gain of methylation at G1223 (P = 0.1317); Loss of ubiquitination at K1218 (P = 0.1828)
7:117267775:G:A,P13569,G1223E,0.456,Gain of solvent accessibility (P = 0.0837); Gain of ubiquitination at K1218 (P = 0.095); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1579); Gain of phosphorylation at T1220 (P = 0.1753)
7:117267775:G:C,P13569,G1223A,0.363,Loss of ubiquitination at K1218 (P = 0.1664); Gain of phosphorylation at T1220 (P = 0.2746); Loss of disorder (P = 0.2768); Loss of sheet (P = 0.302); Gain of catalytic residue at G1223 (P = 0.3118)
7:117267775:G:T,P13569,G1223V,0.459,Loss of disorder (P = 0.1112); Loss of sheet (P = 0.1158); Loss of ubiquitination at K1218 (P = 0.1486); Loss of phosphorylation at T1220 (P = 0.245); Gain of catalytic residue at G1223 (P = 0.319)
7:117267777:A:C,P13569,N1224H,0.412,Loss of sheet (P = 0.1398); Gain of disorder (P = 0.1406); Gain of phosphorylation at Y1219 (P = 0.2738); Gain of catalytic residue at G1222 (P = 0.337); Loss of MoRF binding (P = 0.6282)
7:117267777:A:G,P13569,N1224D,0.384,Gain of catalytic residue at N1229 (P = 0.165); Gain of phosphorylation at T1220 (P = 0.1763); Gain of disorder (P = 0.1936); Gain of relative solvent accessibility (P = 0.2363); Loss of sheet (P = 0.302)
7:117267777:A:T,P13569,N1224Y,0.457,Gain of phosphorylation at N1224 (P = 0.0506); Loss of sheet (P = 0.1398); Loss of disorder (P = 0.1934); Gain of catalytic residue at G1222 (P = 0.3371); Loss of MoRF binding (P = 0.6254)
7:117267778:A:C,P13569,N1224T,0.367,Gain of phosphorylation at T1220 (P = 0.0827); Gain of disorder (P = 0.2326); Loss of sheet (P = 0.302); Gain of catalytic residue at G1222 (P = 0.3182); Loss of stability (P = 0.5056)
7:117267778:A:G,P13569,N1224S,0.344,Gain of disorder (P = 0.1072); Gain of catalytic residue at G1222 (P = 0.1466); Gain of phosphorylation at T1220 (P = 0.2258); Loss of sheet (P = 0.302); Gain of glycosylation at N1224 (P = 0.4661)
7:117267778:A:T,P13569,N1224I,0.478,Loss of sheet (P = 0.1398); Loss of disorder (P = 0.143); Loss of phosphorylation at T1220 (P = 0.2034); Gain of catalytic residue at G1222 (P = 0.2618); Loss of solvent accessibility (P = 0.4838)
7:117267779:T:G,P13569,N1224K,0.517,Gain of methylation at N1224 (P = 0.0053); Gain of ubiquitination at N1224 (P = 0.0258); Gain of glycosylation at N1224 (P = 0.0793); Loss of sheet (P = 0.1158); Gain of phosphorylation at T1220 (P = 0.157)
7:117267780:G:A,P13569,A1225T,0.36,Gain of disorder (P = 0.2126); Loss of phosphorylation at T1220 (P = 0.2331); Loss of sheet (P = 0.302); Gain of catalytic residue at A1225 (P = 0.4261); Gain of solvent accessibility (P = 0.4304)
7:117267780:G:C,P13569,A1225P,0.509,Loss of sheet (P = 0.1398); Gain of disorder (P = 0.1409); Gain of phosphorylation at T1220 (P = 0.264); Gain of loop (P = 0.2754); Gain of catalytic residue at A1225 (P = 0.4144)
7:117267780:G:T,P13569,A1225S,0.39,Gain of disorder (P = 0.0362); Gain of phosphorylation at A1225 (P = 0.1032); Loss of sheet (P = 0.302); Loss of catalytic residue at N1224 (P = 0.4721); Gain of solvent accessibility (P = 0.4821)
7:117267781:C:A,P13569,A1225D,0.494,Loss of sheet (P = 0.1398); Gain of disorder (P = 0.1568); Gain of solvent accessibility (P = 0.194); Gain of catalytic residue at A1225 (P = 0.2095); Loss of phosphorylation at T1220 (P = 0.2228)
7:117267781:C:G,P13569,A1225G,0.394,Loss of sheet (P = 0.1398); Gain of disorder (P = 0.1488); Loss of phosphorylation at T1220 (P = 0.2401); Gain of catalytic residue at G1222 (P = 0.3738); Loss of stability (P = 0.4384)
7:117267783:A:C,P13569,I1226L,0.531,Gain of catalytic residue at I1226 (P = 0.0905); Gain of sheet (P = 0.1451); Gain of disorder (P = 0.2129); Gain of loop (P = 0.4661); Loss of stability (P = 0.5755)
7:117267783:A:G,P13569,I1226V,0.495,Gain of sheet (P = 0.1451); Gain of loop (P = 0.2754); Gain of disorder (P = 0.3025); Loss of stability (P = 0.3797); Gain of MoRF binding (P = 0.6009)
7:117267783:A:T,P13569,I1226L,0.531,Gain of catalytic residue at I1226 (P = 0.0905); Gain of sheet (P = 0.1451); Gain of disorder (P = 0.2129); Gain of loop (P = 0.4661); Loss of stability (P = 0.5755)
7:117267784:T:A,P13569,I1226K,0.875,Gain of disorder (P = 0.0076); Loss of stability (P = 0.0152); Gain of ubiquitination at I1226 (P = 0.017); Gain of sheet (P = 0.1451); Gain of loop (P = 0.2754)
7:117267784:T:C,P13569,I1226T,0.821,Loss of stability (P = 0.0279); Gain of disorder (P = 0.0388); Gain of sheet (P = 0.1451); Gain of loop (P = 0.2754); Loss of phosphorylation at S1231 (P = 0.6035)
7:117267784:T:G,P13569,I1226R,0.945,Gain of disorder (P = 0.0299); Gain of methylation at I1226 (P = 0.031); Loss of stability (P = 0.0524); Gain of sheet (P = 0.1451); Gain of catalytic residue at I1226 (P = 0.1935)
7:117267785:A:G,P13569,I1226M,0.598,Gain of disorder (P = 0.1095); Gain of sheet (P = 0.1451); Loss of stability (P = 0.2357); Gain of catalytic residue at I1230 (P = 0.3534); Gain of phosphorylation at S1231 (P = 0.5563)
7:117267786:T:A,P13569,L1227I,0.672,Loss of catalytic residue at L1227 (P = 0.0069); Loss of sheet (P = 0.1398); Loss of disorder (P = 0.3828); Loss of stability (P = 0.4261); Loss of loop (P = 0.4786)
7:117267786:T:G,P13569,L1227V,0.722,Loss of stability (P = 0.0983); Loss of catalytic residue at L1227 (P = 0.1539); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3918)
7:117267787:T:C,P13569,L1227S,0.955,Gain of disorder (P = 0.0051); Loss of catalytic residue at L1227 (P = 0.0056); Loss of stability (P = 0.0626); Loss of sheet (P = 0.1398); Gain of phosphorylation at L1227 (P = 0.1884)
7:117267788:A:C,P13569,L1227F,0.672,Loss of sheet (P = 0.1398); Loss of stability (P = 0.2001); Loss of catalytic residue at L1227 (P = 0.3231); Loss of disorder (P = 0.3627); Loss of loop (P = 0.4786)
7:117267788:A:T,P13569,L1227F,0.672,Loss of sheet (P = 0.1398); Loss of stability (P = 0.2001); Loss of catalytic residue at L1227 (P = 0.3231); Loss of disorder (P = 0.3627); Loss of loop (P = 0.4786)
7:117267789:G:A,P13569,E1228K,0.606,Gain of methylation at E1228 (P = 0.0098); Gain of ubiquitination at E1228 (P = 0.0408); Gain of MoRF binding (P = 0.0652); Loss of catalytic residue at E1228 (P = 0.068); Loss of sheet (P = 0.1398)
7:117267789:G:C,P13569,E1228Q,0.542,Loss of catalytic residue at E1228 (P = 0.1424); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3454); Loss of disorder (P = 0.3917); Loss of loop (P = 0.4786)
7:117267790:A:C,P13569,E1228A,0.621,Loss of catalytic residue at E1228 (P = 0.0648); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3454); Loss of solvent accessibility (P = 0.3543); Gain of MoRF binding (P = 0.4207)
7:117267790:A:G,P13569,E1228G,0.826,Loss of catalytic residue at E1228 (P = 0.0064); Loss of stability (P = 0.0521); Loss of sheet (P = 0.1398); Gain of disorder (P = 0.3872); Loss of solvent accessibility (P = 0.4011)
7:117267790:A:T,P13569,E1228V,0.662,Loss of catalytic residue at E1228 (P = 0.0423); Gain of sheet (P = 0.1451); Loss of disorder (P = 0.1959); Gain of loop (P = 0.2754); Loss of solvent accessibility (P = 0.3136)
7:117267791:G:C,P13569,E1228D,0.498,Loss of sheet (P = 0.302); Loss of disorder (P = 0.3915); Loss of loop (P = 0.4786); Loss of stability (P = 0.4786); Gain of catalytic residue at G1223 (P = 0.4868)
7:117267791:G:T,P13569,E1228D,0.498,Loss of sheet (P = 0.302); Loss of disorder (P = 0.3915); Loss of loop (P = 0.4786); Loss of stability (P = 0.4786); Gain of catalytic residue at G1223 (P = 0.4868)
7:117267792:A:C,P13569,N1229H,0.577,Gain of disorder (P = 0.1926); Gain of loop (P = 0.2754); Loss of stability (P = 0.2968); Loss of sheet (P = 0.302); Gain of phosphorylation at S1231 (P = 0.5046)
7:117267792:A:G,P13569,N1229D,0.587,Gain of catalytic residue at N1229 (P = 0.1247); Gain of phosphorylation at S1231 (P = 0.2363); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of disorder (P = 0.3631)
7:117267792:A:T,P13569,N1229Y,0.592,Gain of phosphorylation at N1229 (P = 0.1076); Gain of sheet (P = 0.1451); Loss of disorder (P = 0.2501); Gain of loop (P = 0.2754); Gain of catalytic residue at S1233 (P = 0.3238)
7:117267793:A:C,P13569,N1229T,0.576,Gain of sheet (P = 0.1451); Gain of loop (P = 0.2754); Gain of disorder (P = 0.3376); Loss of stability (P = 0.3892); Gain of catalytic residue at F1232 (P = 0.396)
7:117267793:A:G,P13569,N1229S,0.547,Gain of disorder (P = 0.0521); Loss of sheet (P = 0.1398); Gain of phosphorylation at S1231 (P = 0.1694); Gain of catalytic residue at N1229 (P = 0.3085); Loss of stability (P = 0.3233)
7:117267793:A:T,P13569,N1229I,0.621,Gain of catalytic residue at S1231 (P = 0.0921); Loss of sheet (P = 0.1398); Loss of disorder (P = 0.2434); Gain of loop (P = 0.2754); Gain of phosphorylation at S1231 (P = 0.4602)
7:117267794:C:G,P13569,N1229K,0.609,Gain of methylation at N1229 (P = 0.0179); Gain of ubiquitination at N1229 (P = 0.0369); Loss of stability (P = 0.1887); Gain of disorder (P = 0.2393); Gain of phosphorylation at S1233 (P = 0.2442)
7:117267795:A:C,P13569,I1230L,0.493,Gain of disorder (P = 0.1752); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Gain of phosphorylation at S1233 (P = 0.4109); Loss of catalytic residue at S1233 (P = 0.4569)
7:117267795:A:G,P13569,I1230V,0.463,Gain of disorder (P = 0.259); Loss of sheet (P = 0.302); Gain of catalytic residue at S1233 (P = 0.3436); Loss of stability (P = 0.3474); Gain of MoRF binding (P = 0.4661)
7:117267795:A:T,P13569,I1230F,0.516,Loss of stability (P = 0.173); Gain of catalytic residue at S1233 (P = 0.2775); Gain of disorder (P = 0.2884); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302)
7:117267796:T:A,P13569,I1230N,0.902,Gain of disorder (P = 0.0132); Loss of stability (P = 0.023); Gain of catalytic residue at I1230 (P = 0.0695); Loss of sheet (P = 0.0817); Gain of loop (P = 0.2754)
7:117267796:T:C,P13569,I1230T,0.958,Loss of stability (P = 0.0062); Gain of disorder (P = 0.0332); Loss of sheet (P = 0.0817); Gain of catalytic residue at I1230 (P = 0.2656); Loss of loop (P = 0.2897)
7:117267796:T:G,P13569,I1230S,0.935,Gain of disorder (P = 0.0018); Loss of stability (P = 0.0197); Loss of sheet (P = 0.0817); Gain of catalytic residue at I1230 (P = 0.0897); Gain of phosphorylation at S1233 (P = 0.1371)
7:117267797:T:G,P13569,I1230M,0.555,Gain of disorder (P = 0.0978); Gain of catalytic residue at I1230 (P = 0.1069); Loss of stability (P = 0.2491); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302)
7:117267798:T:A,P13569,S1231T,0.683,Loss of stability (P = 0.1063); Gain of catalytic residue at S1231 (P = 0.1362); Loss of disorder (P = 0.1752); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.4609)
7:117267798:T:C,P13569,S1231P,0.733,Loss of stability (P = 0.0385); Gain of catalytic residue at N1229 (P = 0.0696); Loss of sheet (P = 0.1398); Loss of disorder (P = 0.2903); Gain of glycosylation at S1233 (P = 0.3873)
7:117267798:T:G,P13569,S1231A,0.687,Gain of catalytic residue at S1231 (P = 0.1196); Loss of disorder (P = 0.1437); Loss of stability (P = 0.165); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.4603)
7:117267799:C:A,P13569,S1231Y,0.651,Loss of disorder (P = 0.0828); Gain of phosphorylation at S1231 (P = 0.0887); Loss of stability (P = 0.14); Gain of sheet (P = 0.1451); Gain of catalytic residue at I1230 (P = 0.1595)
7:117267799:C:G,P13569,S1231C,0.716,Loss of disorder (P = 0.0695); Gain of catalytic residue at S1233 (P = 0.074); Gain of sheet (P = 0.1451); Loss of stability (P = 0.1646); Loss of MoRF binding (P = 0.4316)
7:117267799:C:T,P13569,S1231F,0.716,Loss of disorder (P = 0.0832); Gain of catalytic residue at S1231 (P = 0.1323); Loss of sheet (P = 0.1398); Loss of stability (P = 0.3268); Loss of MoRF binding (P = 0.4367)
7:117267801:T:A,P13569,F1232I,0.63,Gain of disorder (P = 0.1927); Loss of catalytic residue at F1232 (P = 0.2382); Gain of phosphorylation at S1233 (P = 0.2682); Loss of sheet (P = 0.302); Gain of glycosylation at S1233 (P = 0.3581)
7:117267801:T:C,P13569,F1232L,0.644,Gain of disorder (P = 0.0969); Gain of phosphorylation at S1233 (P = 0.2244); Loss of catalytic residue at F1232 (P = 0.2699); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.363)
7:117267801:T:G,P13569,F1232V,0.647,Gain of disorder (P = 0.1565); Loss of catalytic residue at F1232 (P = 0.1625); Loss of stability (P = 0.1909); Gain of phosphorylation at S1233 (P = 0.253); Loss of sheet (P = 0.302)
7:117267802:T:A,P13569,F1232Y,0.672,Gain of disorder (P = 0.1885); Gain of phosphorylation at S1233 (P = 0.2222); Loss of stability (P = 0.2617); Gain of catalytic residue at F1232 (P = 0.2684); Loss of sheet (P = 0.302)
7:117267802:T:C,P13569,F1232S,0.886,Gain of disorder (P = 4e-04); Gain of phosphorylation at S1233 (P = 0.0793); Loss of stability (P = 0.0926); Loss of sheet (P = 0.1398); Gain of glycosylation at P1236 (P = 0.2112)
7:117267802:T:G,P13569,F1232C,0.651,Loss of sheet (P = 0.1398); Gain of catalytic residue at I1230 (P = 0.157); Loss of stability (P = 0.1966); Gain of disorder (P = 0.2609); Loss of MoRF binding (P = 0.4244)
7:117267803:C:A,P13569,F1232L,0.644,Gain of disorder (P = 0.0969); Gain of phosphorylation at S1233 (P = 0.2244); Loss of catalytic residue at F1232 (P = 0.2699); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.363)
7:117267803:C:G,P13569,F1232L,0.644,Gain of disorder (P = 0.0969); Gain of phosphorylation at S1233 (P = 0.2244); Loss of catalytic residue at F1232 (P = 0.2699); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.363)
7:117267804:T:A,P13569,S1233T,0.356,Gain of glycosylation at S1233 (P = 0.0995); Loss of disorder (P = 0.1436); Gain of catalytic residue at S1235 (P = 0.2783); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3843)
7:117267804:T:C,P13569,S1233P,0.5,Gain of catalytic residue at S1233 (P = 0.0999); Loss of disorder (P = 0.2209); Loss of stability (P = 0.2969); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.3517)
7:117267804:T:G,P13569,S1233A,0.327,Loss of disorder (P = 0.0982); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3578); Loss of stability (P = 0.4048); Loss of phosphorylation at S1233 (P = 0.4065)
7:117267805:C:T,P13569,S1233L,0.444,Loss of disorder (P = 0.0733); Gain of catalytic residue at S1233 (P = 0.2503); Loss of sheet (P = 0.302); Loss of relative solvent accessibility (P = 0.3219); Loss of solvent accessibility (P = 0.3368)
7:117267807:A:C,P13569,I1234L,0.678,Loss of catalytic residue at P1236 (P = 0.0309); Gain of disorder (P = 0.1065); Loss of sheet (P = 0.302); Gain of methylation at R1239 (P = 0.3072); Loss of MoRF binding (P = 0.3546)
7:117267807:A:G,P13569,I1234V,0.811,Loss of catalytic residue at P1236 (P = 0.0309); Gain of disorder (P = 0.1504); Loss of sheet (P = 0.302); Gain of methylation at R1239 (P = 0.3084); Loss of stability (P = 0.3217)
7:117267807:A:T,P13569,I1234L,0.678,Loss of catalytic residue at P1236 (P = 0.0309); Gain of disorder (P = 0.1065); Loss of sheet (P = 0.302); Gain of methylation at R1239 (P = 0.3072); Loss of MoRF binding (P = 0.3546)
7:117267808:T:A,P13569,I1234K,0.894,Gain of disorder (P = 0.0032); Loss of stability (P = 0.0132); Gain of ubiquitination at I1234 (P = 0.03); Loss of catalytic residue at P1236 (P = 0.0309); Gain of glycosylation at P1236 (P = 0.095)
7:117267808:T:C,P13569,I1234T,0.907,Loss of stability (P = 0.0103); Gain of disorder (P = 0.0214); Loss of catalytic residue at P1236 (P = 0.0309); Gain of phosphorylation at I1234 (P = 0.1365); Loss of sheet (P = 0.1907)
7:117267808:T:G,P13569,I1234R,0.925,Gain of disorder (P = 0.0089); Loss of catalytic residue at P1236 (P = 0.0408); Loss of stability (P = 0.0482); Gain of MoRF binding (P = 0.0619); Gain of glycosylation at P1236 (P = 0.0829)
7:117267809:A:G,P13569,I1234M,0.679,Loss of catalytic residue at P1236 (P = 0.0309); Gain of disorder (P = 0.0597); Loss of stability (P = 0.2178); Gain of methylation at R1239 (P = 0.2526); Gain of MoRF binding (P = 0.283)
7:117267810:A:C,P13569,S1235R,0.727,Gain of MoRF binding (P = 0.0168); Gain of solvent accessibility (P = 0.1185); Loss of disorder (P = 0.1778); Gain of catalytic residue at S1235 (P = 0.2706); Loss of sheet (P = 0.302)
7:117267810:A:G,P13569,S1235G,0.375,Loss of stability (P = 0.1834); Loss of disorder (P = 0.1918); Gain of catalytic residue at S1235 (P = 0.2153); Loss of sheet (P = 0.302); Gain of methylation at R1239 (P = 0.3059)
7:117267810:A:T,P13569,S1235C,0.502,Loss of disorder (P = 0.0311); Loss of MoRF binding (P = 0.2752); Loss of sheet (P = 0.302); Loss of methylation at R1239 (P = 0.3215); Loss of loop (P = 0.3664)
7:117267811:G:A,P13569,S1235N,0.367,Loss of disorder (P = 0.1053); Gain of MoRF binding (P = 0.2868); Loss of sheet (P = 0.302); Loss of methylation at R1239 (P = 0.3477); Gain of catalytic residue at S1235 (P = 0.3721)
7:117267811:G:C,P13569,S1235T,0.34,Loss of disorder (P = 0.1215); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.3267); Loss of methylation at R1239 (P = 0.3457); Gain of catalytic residue at S1235 (P = 0.4122)
7:117267811:G:T,P13569,S1235I,0.457,Loss of disorder (P = 0.0387); Loss of MoRF binding (P = 0.2933); Loss of sheet (P = 0.302); Loss of methylation at R1239 (P = 0.3158); Gain of catalytic residue at S1233 (P = 0.3219)
7:117267812:T:A,P13569,S1235R,0.727,Gain of MoRF binding (P = 0.0168); Gain of solvent accessibility (P = 0.1185); Loss of disorder (P = 0.1778); Gain of catalytic residue at S1235 (P = 0.2706); Loss of sheet (P = 0.302)
7:117267813:C:A,P13569,P1236T,0.415,Gain of MoRF binding (P = 0.0911); Loss of disorder (P = 0.2458); Gain of catalytic residue at S1233 (P = 0.2535); Loss of sheet (P = 0.302); Gain of methylation at R1239 (P = 0.3428)
7:117267813:C:G,P13569,P1236A,0.453,Gain of MoRF binding (P = 0.0785); Loss of disorder (P = 0.1514); Loss of stability (P = 0.2455); Gain of catalytic residue at S1233 (P = 0.2552); Gain of methylation at R1239 (P = 0.2813)
7:117267813:C:T,P13569,P1236S,0.337,Gain of disorder (P = 0.0606); Gain of phosphorylation at P1236 (P = 0.0783); Gain of MoRF binding (P = 0.0889); Gain of catalytic residue at S1233 (P = 0.1116); Loss of sheet (P = 0.302)
7:117267814:C:A,P13569,P1236H,0.442,Gain of MoRF binding (P = 0.1326); Gain of catalytic residue at I1234 (P = 0.1567); Gain of methylation at R1239 (P = 0.2014); Gain of disorder (P = 0.2166); Loss of sheet (P = 0.302)
7:117267814:C:G,P13569,P1236R,0.466,Gain of MoRF binding (P = 0.0045); Gain of solvent accessibility (P = 0.1708); Gain of disorder (P = 0.1823); Gain of phosphorylation at S1233 (P = 0.2961); Loss of sheet (P = 0.302)
7:117267814:C:T,P13569,P1236L,0.478,Loss of catalytic residue at P1236 (P = 0.0822); Loss of disorder (P = 0.0839); Gain of MoRF binding (P = 0.122); Loss of relative solvent accessibility (P = 0.1807); Loss of solvent accessibility (P = 0.2517)
7:117267816:G:A,P13569,G1237S,0.939,Gain of disorder (P = 0.0736); Gain of phosphorylation at G1237 (P = 0.0827); Gain of MoRF binding (P = 0.2762); Loss of catalytic residue at L1242 (P = 0.2801); Loss of sheet (P = 0.302)
7:117267816:G:C,P13569,G1237R,0.901,Gain of MoRF binding (P = 0.0585); Gain of solvent accessibility (P = 0.1319); Gain of disorder (P = 0.2436); Gain of catalytic residue at G1237 (P = 0.2896); Loss of sheet (P = 0.302)
7:117267816:G:T,P13569,G1237C,0.915,Loss of disorder (P = 0.0349); Gain of catalytic residue at Q1238 (P = 0.0767); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.2378); Loss of sheet (P = 0.302)
7:117267817:G:A,P13569,G1237D,0.869,Gain of catalytic residue at G1237 (P = 0.1281); Gain of solvent accessibility (P = 0.1583); Loss of MoRF binding (P = 0.1756); Loss of disorder (P = 0.1946); Gain of relative solvent accessibility (P = 0.2363)
7:117267817:G:C,P13569,G1237A,0.912,Loss of disorder (P = 0.1078); Loss of catalytic residue at L1242 (P = 0.1999); Gain of MoRF binding (P = 0.2513); Loss of sheet (P = 0.302); Loss of relative solvent accessibility (P = 0.3219)
7:117267817:G:T,P13569,G1237V,0.911,Loss of disorder (P = 0.0562); Loss of loop (P = 0.2237); Loss of catalytic residue at G1237 (P = 0.2305); Gain of MoRF binding (P = 0.2404); Loss of sheet (P = 0.302)
7:117267819:C:A,P13569,Q1238K,0.761,Gain of ubiquitination at Q1238 (P = 0.0258); Gain of MoRF binding (P = 0.0532); Gain of catalytic residue at Q1238 (P = 0.0835); Gain of disorder (P = 0.116); Loss of stability (P = 0.1256)
7:117267819:C:G,P13569,Q1238E,0.526,Gain of disorder (P = 0.0885); Loss of MoRF binding (P = 0.1392); Gain of phosphorylation at S1235 (P = 0.1917); Gain of methylation at R1239 (P = 0.2462); Loss of sheet (P = 0.302)
7:117267820:A:C,P13569,Q1238P,0.76,Gain of methylation at R1239 (P = 0.102); Gain of disorder (P = 0.1279); Loss of stability (P = 0.138); Loss of MoRF binding (P = 0.1566); Loss of solvent accessibility (P = 0.1651)
7:117267820:A:G,P13569,Q1238R,0.859,Gain of MoRF binding (P = 0.0288); Gain of methylation at Q1238 (P = 0.0357); Gain of catalytic residue at Q1238 (P = 0.0715); Gain of disorder (P = 0.1469); Gain of phosphorylation at S1235 (P = 0.1706)
7:117267820:A:T,P13569,Q1238L,0.64,Loss of disorder (P = 0.0689); Gain of sheet (P = 0.0827); Gain of catalytic residue at Q1238 (P = 0.1189); Loss of solvent accessibility (P = 0.1651); Loss of loop (P = 0.2237)
7:117267821:G:C,P13569,Q1238H,0.678,Gain of catalytic residue at Q1238 (P = 0.1245); Gain of disorder (P = 0.142); Loss of stability (P = 0.1549); Loss of solvent accessibility (P = 0.1651); Loss of MoRF binding (P = 0.2367)
7:117267821:G:T,P13569,Q1238H,0.678,Gain of catalytic residue at Q1238 (P = 0.1245); Gain of disorder (P = 0.142); Loss of stability (P = 0.1549); Loss of solvent accessibility (P = 0.1651); Loss of MoRF binding (P = 0.2367)
7:117267822:A:G,P13569,R1239G,0.662,Gain of catalytic residue at V1240 (P = 0.0807); Loss of MoRF binding (P = 0.0863); Loss of methylation at R1239 (P = 0.1403); Gain of disorder (P = 0.1656); Loss of sheet (P = 0.302)
7:117267822:A:T,P13569,R1239W,0.65,Loss of disorder (P = 0.0193); Loss of sheet (P = 0.0817); Loss of methylation at R1239 (P = 0.1403); Gain of catalytic residue at Q1238 (P = 0.1413); Loss of MoRF binding (P = 0.1871)
7:117267823:G:A,P13569,R1239K,0.616,Gain of ubiquitination at R1239 (P = 0.0267); Gain of methylation at R1239 (P = 0.0426); Loss of catalytic residue at R1239 (P = 0.0646); Gain of disorder (P = 0.1033); Loss of MoRF binding (P = 0.2008)
7:117267823:G:C,P13569,R1239T,0.627,Gain of phosphorylation at R1239 (P = 0.0607); Loss of MoRF binding (P = 0.0873); Loss of methylation at R1239 (P = 0.1403); Loss of disorder (P = 0.2224); Gain of catalytic residue at Q1238 (P = 0.2588)
7:117267823:G:T,P13569,R1239M,0.646,Loss of sheet (P = 0.0817); Loss of disorder (P = 0.0884); Loss of MoRF binding (P = 0.1087); Gain of stability (P = 0.1295); Loss of catalytic residue at R1239 (P = 0.1346)
7:117267824:G:C,P13569,R1239S,0.629,Gain of disorder (P = 0.051); Loss of MoRF binding (P = 0.0913); Loss of catalytic residue at R1239 (P = 0.1145); Loss of methylation at R1239 (P = 0.1403); Gain of phosphorylation at R1239 (P = 0.1617)
7:117267824:G:T,P13569,R1239S,0.629,Gain of disorder (P = 0.051); Loss of MoRF binding (P = 0.0913); Loss of catalytic residue at R1239 (P = 0.1145); Loss of methylation at R1239 (P = 0.1403); Gain of phosphorylation at R1239 (P = 0.1617)
7:117282492:G:A,P13569,V1240M,0.552,Gain of disorder (P = 0.0544); Gain of methylation at R1245 (P = 0.1535); Gain of MoRF binding (P = 0.1777); Loss of sheet (P = 0.302); Gain of phosphorylation at S1235 (P = 0.5341)
7:117282492:G:C,P13569,V1240L,0.572,Gain of disorder (P = 0.1089); Loss of methylation at R1245 (P = 0.1349); Loss of MoRF binding (P = 0.1772); Gain of catalytic residue at S1235 (P = 0.2734); Loss of sheet (P = 0.302)
7:117282493:T:A,P13569,V1240E,0.888,Gain of disorder (P = 0.0037); Loss of MoRF binding (P = 0.0773); Loss of methylation at R1245 (P = 0.1); Loss of stability (P = 0.2723); Loss of sheet (P = 0.302)
7:117282493:T:C,P13569,V1240A,0.815,Gain of catalytic residue at V1240 (P = 0.033); Gain of disorder (P = 0.0339); Loss of stability (P = 0.1069); Gain of methylation at R1245 (P = 0.129); Loss of MoRF binding (P = 0.2098)
7:117282493:T:G,P13569,V1240G,0.945,Loss of stability (P = 0.0049); Gain of disorder (P = 0.0062); Gain of methylation at R1239 (P = 0.0696); Loss of MoRF binding (P = 0.1756); Gain of catalytic residue at G1237 (P = 0.1848)
7:117282495:G:A,P13569,G1241S,0.604,Gain of phosphorylation at G1241 (P = 0.0524); Gain of disorder (P = 0.0806); Gain of MoRF binding (P = 0.132); Gain of methylation at R1245 (P = 0.1438); Loss of catalytic residue at L1242 (P = 0.2042)
7:117282495:G:C,P13569,G1241R,0.837,Gain of MoRF binding (P = 0.0078); Gain of methylation at G1241 (P = 0.0365); Loss of catalytic residue at L1242 (P = 0.1951); Loss of disorder (P = 0.2289); Loss of sheet (P = 0.302)
7:117282495:G:T,P13569,G1241C,0.655,Loss of disorder (P = 0.0107); Gain of catalytic residue at Q1238 (P = 0.0817); Loss of methylation at R1245 (P = 0.0888); Loss of MoRF binding (P = 0.1271); Loss of sheet (P = 0.302)
7:117282496:G:A,P13569,G1241D,0.782,Loss of MoRF binding (P = 0.0962); Loss of methylation at R1245 (P = 0.1234); Loss of disorder (P = 0.196); Loss of catalytic residue at L1242 (P = 0.2087); Loss of sheet (P = 0.302)
7:117282496:G:C,P13569,G1241A,0.629,Loss of disorder (P = 0.0753); Loss of methylation at R1245 (P = 0.1445); Loss of catalytic residue at L1242 (P = 0.1519); Gain of MoRF binding (P = 0.1637); Loss of sheet (P = 0.302)
7:117282496:G:T,P13569,G1241V,0.653,Loss of disorder (P = 0.0317); Loss of methylation at R1245 (P = 0.095); Gain of MoRF binding (P = 0.1793); Loss of catalytic residue at L1242 (P = 0.2112); Loss of sheet (P = 0.302)
7:117282498:C:A,P13569,L1242I,0.626,Loss of methylation at R1245 (P = 0.1228); Loss of disorder (P = 0.136); Gain of MoRF binding (P = 0.1422); Loss of catalytic residue at L1242 (P = 0.161); Loss of sheet (P = 0.302)
7:117282498:C:G,P13569,L1242V,0.646,Gain of MoRF binding (P = 0.1116); Gain of methylation at R1245 (P = 0.1196); Loss of disorder (P = 0.2465); Loss of stability (P = 0.2469); Loss of sheet (P = 0.302)
7:117282498:C:T,P13569,L1242F,0.634,Gain of methylation at R1245 (P = 0.0961); Loss of disorder (P = 0.13); Loss of MoRF binding (P = 0.1853); Loss of sheet (P = 0.302); Loss of stability (P = 0.4235)
7:117282499:T:A,P13569,L1242H,0.803,Gain of disorder (P = 0.0248); Loss of stability (P = 0.0482); Gain of methylation at R1245 (P = 0.0606); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.118)
7:117282499:T:C,P13569,L1242P,0.871,Gain of disorder (P = 0.0114); Loss of stability (P = 0.0407); Loss of sheet (P = 0.0817); Loss of catalytic residue at L1242 (P = 0.0852); Gain of methylation at R1245 (P = 0.1123)
7:117282499:T:G,P13569,L1242R,0.887,Gain of MoRF binding (P = 0.0046); Gain of methylation at L1242 (P = 0.0125); Gain of disorder (P = 0.0169); Loss of sheet (P = 0.0817); Loss of stability (P = 0.1231)
7:117282501:T:A,P13569,L1243M,0.619,Gain of MoRF binding (P = 0.0713); Loss of sheet (P = 0.0817); Gain of methylation at R1245 (P = 0.0906); Gain of disorder (P = 0.0933); Gain of phosphorylation at S1248 (P = 0.2722)
7:117282501:T:G,P13569,L1243V,0.547,Gain of MoRF binding (P = 0.107); Gain of methylation at R1245 (P = 0.1224); Loss of phosphorylation at S1248 (P = 0.2336); Loss of disorder (P = 0.2462); Loss of sheet (P = 0.302)
7:117282502:T:C,P13569,L1243S,0.764,Gain of disorder (P = 0.0058); Gain of catalytic residue at L1243 (P = 0.0185); Gain of phosphorylation at L1243 (P = 0.0485); Gain of methylation at R1245 (P = 0.059); Loss of sheet (P = 0.0817)
7:117282502:T:G,P13569,L1243W,0.673,Gain of MoRF binding (P = 0.023); Loss of methylation at R1245 (P = 0.0436); Loss of disorder (P = 0.0638); Loss of phosphorylation at S1248 (P = 0.1209); Loss of glycosylation at S1248 (P = 0.2103)
7:117282503:G:C,P13569,L1243F,0.637,Gain of methylation at R1245 (P = 0.1039); Loss of disorder (P = 0.1256); Gain of catalytic residue at L1243 (P = 0.1319); Loss of glycosylation at S1248 (P = 0.1673); Loss of MoRF binding (P = 0.1835)
7:117282503:G:T,P13569,L1243F,0.637,Gain of methylation at R1245 (P = 0.1039); Loss of disorder (P = 0.1256); Gain of catalytic residue at L1243 (P = 0.1319); Loss of glycosylation at S1248 (P = 0.1673); Loss of MoRF binding (P = 0.1835)
7:117282504:G:A,P13569,G1244R,0.982,Gain of MoRF binding (P = 0.0264); Loss of methylation at R1245 (P = 0.0444); Gain of phosphorylation at T1246 (P = 0.1687); Loss of disorder (P = 0.2036); Loss of loop (P = 0.2237)
7:117282504:G:C,P13569,G1244R,0.982,Gain of MoRF binding (P = 0.0264); Loss of methylation at R1245 (P = 0.0444); Gain of phosphorylation at T1246 (P = 0.1687); Loss of disorder (P = 0.2036); Loss of loop (P = 0.2237)
7:117282505:G:A,P13569,G1244E,0.979,Loss of methylation at R1245 (P = 0.0428); Loss of MoRF binding (P = 0.0718); Loss of sheet (P = 0.0817); Gain of catalytic residue at G1244 (P = 0.1038); Gain of disorder (P = 0.1451)
7:117282505:G:C,P13569,G1244A,0.966,Loss of disorder (P = 0.0607); Loss of methylation at R1245 (P = 0.0674); Gain of MoRF binding (P = 0.127); Gain of glycosylation at S1248 (P = 0.1589); Loss of phosphorylation at S1248 (P = 0.2234)
7:117282505:G:T,P13569,G1244V,0.976,Loss of disorder (P = 0.0163); Loss of methylation at R1245 (P = 0.0497); Gain of MoRF binding (P = 0.0929); Loss of phosphorylation at S1248 (P = 0.1805); Loss of sheet (P = 0.302)
7:117282507:A:G,P13569,R1245G,0.58,Loss of methylation at R1245 (P = 0.0214); Gain of ubiquitination at K1250 (P = 0.0421); Loss of stability (P = 0.0481); Loss of MoRF binding (P = 0.0481); Loss of sheet (P = 0.0817)
7:117282508:G:A,P13569,R1245K,0.521,Loss of methylation at R1245 (P = 0.0317); Gain of ubiquitination at R1245 (P = 0.0388); Loss of sheet (P = 0.0817); Loss of phosphorylation at S1248 (P = 0.0884); Loss of MoRF binding (P = 0.1026)
7:117282508:G:C,P13569,R1245T,0.588,Loss of methylation at R1245 (P = 0.0214); Gain of glycosylation at R1245 (P = 0.0289); Gain of ubiquitination at K1250 (P = 0.044); Loss of MoRF binding (P = 0.0475); Loss of phosphorylation at S1248 (P = 0.0719)
7:117282508:G:T,P13569,R1245I,0.68,Loss of disorder (P = 0.0107); Loss of methylation at R1245 (P = 0.0214); Gain of ubiquitination at K1250 (P = 0.039); Loss of phosphorylation at S1248 (P = 0.0555); Loss of MoRF binding (P = 0.0579)
7:117282509:A:C,P13569,R1245S,0.552,Loss of methylation at R1245 (P = 0.0214); Gain of ubiquitination at K1250 (P = 0.0398); Loss of MoRF binding (P = 0.0511); Gain of disorder (P = 0.0588); Gain of phosphorylation at R1245 (P = 0.0612)
7:117282509:A:T,P13569,R1245S,0.552,Loss of methylation at R1245 (P = 0.0214); Gain of ubiquitination at K1250 (P = 0.0398); Loss of MoRF binding (P = 0.0511); Gain of disorder (P = 0.0588); Gain of phosphorylation at R1245 (P = 0.0612)
7:117282510:A:C,P13569,T1246P,0.694,Loss of catalytic residue at T1246 (P = 0.0272); Gain of glycosylation at T1246 (P = 0.0655); Loss of MoRF binding (P = 0.0806); Gain of disorder (P = 0.1002); Loss of methylation at R1245 (P = 0.1278)
7:117282510:A:G,P13569,T1246A,0.668,Gain of methylation at R1245 (P = 0.0895); Gain of ubiquitination at K1250 (P = 0.1375); Gain of MoRF binding (P = 0.1433); Loss of disorder (P = 0.1433); Gain of glycosylation at S1248 (P = 0.1547)
7:117282510:A:T,P13569,T1246S,0.46,Gain of disorder (P = 0.0398); Gain of phosphorylation at T1246 (P = 0.0455); Gain of glycosylation at T1246 (P = 0.0648); Gain of methylation at R1245 (P = 0.1354); Loss of ubiquitination at K1250 (P = 0.1601)
7:117282511:C:A,P13569,T1246N,0.478,Loss of ubiquitination at K1250 (P = 0.1264); Loss of methylation at R1245 (P = 0.1427); Loss of phosphorylation at S1248 (P = 0.1563); Gain of MoRF binding (P = 0.161); Gain of disorder (P = 0.1928)
7:117282511:C:G,P13569,T1246S,0.46,Gain of disorder (P = 0.0398); Gain of phosphorylation at T1246 (P = 0.0455); Gain of glycosylation at T1246 (P = 0.0648); Gain of methylation at R1245 (P = 0.1354); Loss of ubiquitination at K1250 (P = 0.1601)
7:117282511:C:T,P13569,T1246I,0.676,Loss of disorder (P = 0.0226); Loss of methylation at R1245 (P = 0.0514); Loss of ubiquitination at K1250 (P = 0.079); Gain of MoRF binding (P = 0.1214); Loss of phosphorylation at S1248 (P = 0.2069)
7:117282513:G:A,P13569,G1247R,0.98,Gain of MoRF binding (P = 0.02); Gain of methylation at G1247 (P = 0.05); Loss of ubiquitination at K1250 (P = 0.0547); Loss of glycosylation at S1248 (P = 0.0966); Gain of phosphorylation at S1248 (P = 0.1721)
7:117282513:G:C,P13569,G1247R,0.98,Gain of MoRF binding (P = 0.02); Gain of methylation at G1247 (P = 0.05); Loss of ubiquitination at K1250 (P = 0.0547); Loss of glycosylation at S1248 (P = 0.0966); Gain of phosphorylation at S1248 (P = 0.1721)
7:117282514:G:A,P13569,G1247E,0.959,Gain of ubiquitination at K1250 (P = 0.037); Loss of methylation at R1245 (P = 0.0562); Loss of MoRF binding (P = 0.0668); Loss of glycosylation at S1248 (P = 0.1133); Gain of disorder (P = 0.1959)
7:117282514:G:C,P13569,G1247A,0.96,Loss of disorder (P = 0.0676); Loss of ubiquitination at K1250 (P = 0.0957); Gain of MoRF binding (P = 0.122); Loss of methylation at R1245 (P = 0.1305); Loss of glycosylation at S1248 (P = 0.1589)
7:117282514:G:T,P13569,G1247V,0.948,Loss of disorder (P = 0.0219); Loss of methylation at R1245 (P = 0.0808); Loss of sheet (P = 0.0817); Gain of MoRF binding (P = 0.0842); Loss of ubiquitination at K1250 (P = 0.0957)
7:117282516:T:A,P13569,S1248T,0.663,Loss of glycosylation at S1248 (P = 0.0693); Loss of disorder (P = 0.0885); Loss of ubiquitination at K1250 (P = 0.1091); Gain of methylation at R1245 (P = 0.1411); Loss of MoRF binding (P = 0.164)
7:117282516:T:C,P13569,S1248P,0.712,Loss of catalytic residue at S1248 (P = 0.0046); Loss of phosphorylation at S1248 (P = 0.0349); Gain of glycosylation at S1248 (P = 0.0718); Loss of MoRF binding (P = 0.0734); Loss of methylation at R1245 (P = 0.1086)
7:117282516:T:G,P13569,S1248A,0.513,Loss of phosphorylation at S1248 (P = 0.0349); Loss of disorder (P = 0.0446); Loss of glycosylation at S1248 (P = 0.0603); Gain of methylation at R1245 (P = 0.0933); Loss of ubiquitination at K1250 (P = 0.1091)
7:117282517:C:T,P13569,S1248L,0.686,Loss of disorder (P = 0.0133); Loss of phosphorylation at S1248 (P = 0.0349); Loss of glycosylation at S1248 (P = 0.0603); Loss of ubiquitination at K1250 (P = 0.079); Loss of MoRF binding (P = 0.1235)
7:117282519:G:A,P13569,G1249R,0.984,Gain of MoRF binding (P = 0.0075); Gain of methylation at G1249 (P = 0.0377); Loss of ubiquitination at K1250 (P = 0.0579); Gain of phosphorylation at S1251 (P = 0.0765); Loss of glycosylation at S1248 (P = 0.0947)
7:117282519:G:C,P13569,G1249R,0.984,Gain of MoRF binding (P = 0.0075); Gain of methylation at G1249 (P = 0.0377); Loss of ubiquitination at K1250 (P = 0.0579); Gain of phosphorylation at S1251 (P = 0.0765); Loss of glycosylation at S1248 (P = 0.0947)
7:117282519:G:T,P13569,G1249W,0.91,Loss of disorder (P = 0.0041); Gain of MoRF binding (P = 0.0217); Loss of methylation at R1245 (P = 0.0454); Loss of glycosylation at S1248 (P = 0.0635); Loss of ubiquitination at K1250 (P = 0.0716)
7:117282520:G:A,P13569,G1249E,0.974,Gain of ubiquitination at K1250 (P = 0.0301); Loss of methylation at R1245 (P = 0.0613); Loss of catalytic residue at G1249 (P = 0.0639); Loss of MoRF binding (P = 0.0729); Loss of glycosylation at S1248 (P = 0.0743)
7:117282520:G:C,P13569,G1249A,0.952,Loss of disorder (P = 0.085); Loss of glycosylation at S1248 (P = 0.0934); Gain of methylation at R1245 (P = 0.1267); Gain of helix (P = 0.132); Loss of ubiquitination at K1250 (P = 0.1423)
7:117282520:G:T,P13569,G1249V,0.942,Loss of disorder (P = 0.0294); Loss of glycosylation at S1248 (P = 0.0739); Loss of ubiquitination at K1250 (P = 0.0877); Gain of MoRF binding (P = 0.1014); Gain of helix (P = 0.132)
7:117282522:A:C,P13569,K1250Q,0.851,Loss of ubiquitination at K1250 (P = 0.0244); Loss of MoRF binding (P = 0.0786); Loss of methylation at R1245 (P = 0.14); Loss of phosphorylation at S1248 (P = 0.1452); Loss of catalytic residue at K1250 (P = 0.1535)
7:117282522:A:G,P13569,K1250E,0.846,Loss of ubiquitination at K1250 (P = 0.0244); Loss of MoRF binding (P = 0.0357); Loss of methylation at R1245 (P = 0.1238); Gain of disorder (P = 0.1793); Gain of phosphorylation at S1248 (P = 0.2001)
7:117282523:A:C,P13569,K1250T,0.832,Loss of ubiquitination at K1250 (P = 0.0244); Gain of phosphorylation at K1250 (P = 0.0535); Loss of MoRF binding (P = 0.0742); Gain of methylation at R1245 (P = 0.0999); Loss of disorder (P = 0.126)
7:117282523:A:G,P13569,K1250R,0.853,Gain of methylation at K1250 (P = 0.0238); Loss of ubiquitination at K1250 (P = 0.0244); Gain of MoRF binding (P = 0.1152); Gain of phosphorylation at S1251 (P = 0.1334); Loss of disorder (P = 0.1973)
7:117282523:A:T,P13569,K1250M,0.848,Loss of ubiquitination at K1250 (P = 0.0244); Gain of stability (P = 0.0386); Loss of disorder (P = 0.0484); Gain of methylation at R1245 (P = 0.1052); Loss of MoRF binding (P = 0.1092)
7:117282524:G:C,P13569,K1250N,0.829,Loss of ubiquitination at K1250 (P = 0.0244); Loss of MoRF binding (P = 0.0762); Gain of methylation at R1245 (P = 0.0975); Loss of phosphorylation at S1248 (P = 0.124); Loss of disorder (P = 0.1328)
7:117282524:G:T,P13569,K1250N,0.829,Loss of ubiquitination at K1250 (P = 0.0244); Loss of MoRF binding (P = 0.0762); Gain of methylation at R1245 (P = 0.0975); Loss of phosphorylation at S1248 (P = 0.124); Loss of disorder (P = 0.1328)
7:117282525:A:C,P13569,S1251R,0.901,Gain of MoRF binding (P = 0.0176); Gain of methylation at S1251 (P = 0.047); Loss of ubiquitination at K1250 (P = 0.0665); Loss of disorder (P = 0.0864); Loss of phosphorylation at S1251 (P = 0.1145)
7:117282525:A:G,P13569,S1251G,0.905,Gain of glycosylation at S1248 (P = 0.0763); Loss of ubiquitination at K1250 (P = 0.1091); Loss of phosphorylation at S1251 (P = 0.1145); Gain of catalytic residue at S1251 (P = 0.1149); Loss of disorder (P = 0.1175)
7:117282525:A:T,P13569,S1251C,0.855,Loss of disorder (P = 0.0019); Gain of methylation at K1250 (P = 0.016); Loss of ubiquitination at K1250 (P = 0.0547); Loss of phosphorylation at S1248 (P = 0.0758); Loss of MoRF binding (P = 0.106)
7:117282526:G:A,P13569,S1251N,0.973,Loss of disorder (P = 0.0674); Loss of ubiquitination at K1250 (P = 0.0957); Loss of phosphorylation at S1251 (P = 0.1145); Gain of MoRF binding (P = 0.1865); Loss of catalytic residue at G1249 (P = 0.2409)
7:117282526:G:C,P13569,S1251T,0.929,Loss of disorder (P = 0.075); Loss of ubiquitination at K1250 (P = 0.0957); Loss of phosphorylation at S1251 (P = 0.1575); Gain of glycosylation at S1248 (P = 0.1624); Loss of MoRF binding (P = 0.1798)
7:117282526:G:T,P13569,S1251I,0.88,Loss of disorder (P = 0.0044); Gain of stability (P = 0.0409); Loss of ubiquitination at K1250 (P = 0.0716); Gain of MoRF binding (P = 0.1061); Gain of glycosylation at S1248 (P = 0.1126)
7:117282527:T:A,P13569,S1251R,0.901,Gain of MoRF binding (P = 0.0176); Gain of methylation at S1251 (P = 0.047); Loss of ubiquitination at K1250 (P = 0.0665); Loss of disorder (P = 0.0864); Loss of phosphorylation at S1251 (P = 0.1145)
7:117282527:T:G,P13569,S1251R,0.901,Gain of MoRF binding (P = 0.0176); Gain of methylation at S1251 (P = 0.047); Loss of ubiquitination at K1250 (P = 0.0665); Loss of disorder (P = 0.0864); Loss of phosphorylation at S1251 (P = 0.1145)
7:117282528:A:C,P13569,T1252P,0.97,Gain of glycosylation at T1252 (P = 0.0275); Loss of MoRF binding (P = 0.0798); Gain of disorder (P = 0.1176); Gain of phosphorylation at S1251 (P = 0.1471); Loss of ubiquitination at K1250 (P = 0.1601)
7:117282528:A:G,P13569,T1252A,0.918,Loss of ubiquitination at K1250 (P = 0.1091); Loss of disorder (P = 0.1674); Loss of MoRF binding (P = 0.1752); Loss of loop (P = 0.2237); Gain of glycosylation at S1248 (P = 0.2275)
7:117282528:A:T,P13569,T1252S,0.906,Gain of disorder (P = 0.0382); Gain of phosphorylation at T1252 (P = 0.0992); Loss of ubiquitination at K1250 (P = 0.1264); Gain of MoRF binding (P = 0.1706); Loss of glycosylation at S1248 (P = 0.2692)
7:117282529:C:A,P13569,T1252N,0.948,Gain of MoRF binding (P = 0.1043); Loss of ubiquitination at K1250 (P = 0.1423); Gain of disorder (P = 0.1578); Loss of stability (P = 0.234); Loss of phosphorylation at S1248 (P = 0.2465)
7:117282529:C:G,P13569,T1252S,0.906,Gain of disorder (P = 0.0382); Gain of phosphorylation at T1252 (P = 0.0992); Loss of ubiquitination at K1250 (P = 0.1264); Gain of MoRF binding (P = 0.1706); Loss of glycosylation at S1248 (P = 0.2692)
7:117282529:C:T,P13569,T1252I,0.913,Loss of disorder (P = 0.0337); Gain of methylation at K1250 (P = 0.1012); Gain of catalytic residue at A1256 (P = 0.1145); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.148)
7:117282531:T:A,P13569,L1253M,0.608,Gain of MoRF binding (P = 0.0741); Loss of ubiquitination at K1250 (P = 0.1091); Gain of disorder (P = 0.1344); Gain of methylation at K1250 (P = 0.1965); Gain of catalytic residue at L1253 (P = 0.2176)
7:117282531:T:G,P13569,L1253V,0.651,Gain of MoRF binding (P = 0.0922); Loss of ubiquitination at K1250 (P = 0.1091); Loss of disorder (P = 0.1633); Gain of methylation at K1250 (P = 0.1781); Loss of phosphorylation at S1248 (P = 0.2262)
7:117282532:T:C,P13569,L1253S,0.875,Gain of disorder (P = 0.0064); Loss of stability (P = 0.0453); Gain of phosphorylation at L1253 (P = 0.0711); Loss of ubiquitination at K1250 (P = 0.079); Gain of catalytic residue at L1253 (P = 0.0995)
7:117282532:T:G,P13569,L1253W,0.654,Gain of MoRF binding (P = 0.0245); Loss of ubiquitination at K1250 (P = 0.0665); Loss of disorder (P = 0.0707); Loss of stability (P = 0.1076); Loss of phosphorylation at S1248 (P = 0.1735)
7:117282533:G:C,P13569,L1253F,0.636,Loss of ubiquitination at K1250 (P = 0.0665); Loss of disorder (P = 0.1722); Loss of glycosylation at S1248 (P = 0.1753); Loss of MoRF binding (P = 0.1815); Gain of methylation at K1250 (P = 0.2262)
7:117282533:G:T,P13569,L1253F,0.636,Loss of ubiquitination at K1250 (P = 0.0665); Loss of disorder (P = 0.1722); Loss of glycosylation at S1248 (P = 0.1753); Loss of MoRF binding (P = 0.1815); Gain of methylation at K1250 (P = 0.2262)
7:117282534:T:A,P13569,L1254I,0.66,Gain of methylation at K1250 (P = 0.09); Gain of MoRF binding (P = 0.1155); Loss of disorder (P = 0.1191); Loss of ubiquitination at K1250 (P = 0.1601); Loss of phosphorylation at S1251 (P = 0.3299)
7:117282534:T:G,P13569,L1254V,0.64,Gain of MoRF binding (P = 0.0942); Loss of ubiquitination at K1250 (P = 0.1091); Loss of disorder (P = 0.1651); Gain of methylation at K1250 (P = 0.1806); Loss of phosphorylation at S1251 (P = 0.3344)
7:117282535:T:C,P13569,L1254S,0.792,Gain of disorder (P = 0.0064); Gain of catalytic residue at L1254 (P = 0.0567); Loss of ubiquitination at K1250 (P = 0.0665); Gain of phosphorylation at L1254 (P = 0.0736); Loss of stability (P = 0.0812)
7:117282536:A:C,P13569,L1254F,0.623,Loss of ubiquitination at K1250 (P = 0.0716); Loss of disorder (P = 0.1786); Loss of MoRF binding (P = 0.1829); Gain of methylation at K1250 (P = 0.1842); Gain of phosphorylation at T1252 (P = 0.3032)
7:117282536:A:T,P13569,L1254F,0.623,Loss of ubiquitination at K1250 (P = 0.0716); Loss of disorder (P = 0.1786); Loss of MoRF binding (P = 0.1829); Gain of methylation at K1250 (P = 0.1842); Gain of phosphorylation at T1252 (P = 0.3032)
7:117282537:T:A,P13569,S1255T,0.698,Loss of disorder (P = 0.0967); Gain of helix (P = 0.132); Loss of catalytic residue at S1255 (P = 0.1406); Loss of ubiquitination at K1250 (P = 0.1423); Gain of phosphorylation at S1255 (P = 0.1514)
7:117282537:T:C,P13569,S1255P,0.932,Loss of MoRF binding (P = 0.0901); Loss of ubiquitination at K1250 (P = 0.1091); Gain of glycosylation at S1255 (P = 0.1179); Loss of disorder (P = 0.1242); Gain of helix (P = 0.132)
7:117282537:T:G,P13569,S1255A,0.754,Loss of disorder (P = 0.0686); Loss of catalytic residue at S1255 (P = 0.0779); Gain of ubiquitination at K1250 (P = 0.1128); Loss of MoRF binding (P = 0.1702); Loss of phosphorylation at S1251 (P = 0.2673)
7:117282540:G:A,P13569,A1256T,0.646,Loss of stability (P = 0.084); Gain of disorder (P = 0.1269); Gain of helix (P = 0.132); Gain of phosphorylation at T1252 (P = 0.1424); Loss of MoRF binding (P = 0.2016)
7:117282540:G:C,P13569,A1256P,0.892,Gain of disorder (P = 0.073); Gain of glycosylation at A1256 (P = 0.0954); Loss of MoRF binding (P = 0.1018); Loss of stability (P = 0.1079); Gain of helix (P = 0.132)
7:117282540:G:T,P13569,A1256S,0.806,Gain of disorder (P = 0.0245); Gain of phosphorylation at A1256 (P = 0.0693); Gain of helix (P = 0.132); Loss of stability (P = 0.1593); Loss of MoRF binding (P = 0.2143)
7:117282541:C:A,P13569,A1256D,0.865,Gain of disorder (P = 0.0865); Loss of MoRF binding (P = 0.0866); Gain of helix (P = 0.132); Gain of phosphorylation at S1251 (P = 0.1505); Loss of loop (P = 0.2237)
7:117282541:C:G,P13569,A1256G,0.799,Loss of stability (P = 0.0504); Gain of disorder (P = 0.0668); Gain of phosphorylation at S1251 (P = 0.2116); Loss of MoRF binding (P = 0.2145); Loss of loop (P = 0.2237)
7:117282541:C:T,P13569,A1256V,0.692,Loss of disorder (P = 0.1167); Gain of MoRF binding (P = 0.1765); Loss of loop (P = 0.2237); Loss of phosphorylation at S1251 (P = 0.3288); Loss of helix (P = 0.3949)
7:117282543:T:A,P13569,F1257I,0.748,Gain of MoRF binding (P = 0.1314); Gain of helix (P = 0.132); Gain of disorder (P = 0.2497); Loss of stability (P = 0.3227); Gain of catalytic residue at L1258 (P = 0.4448)
7:117282543:T:C,P13569,F1257L,0.855,Gain of disorder (P = 0.1019); Gain of helix (P = 0.132); Loss of stability (P = 0.1867); Gain of MoRF binding (P = 0.208); Gain of phosphorylation at T1252 (P = 0.413)
7:117282543:T:G,P13569,F1257V,0.778,Loss of stability (P = 0.0883); Gain of MoRF binding (P = 0.1013); Gain of helix (P = 0.132); Gain of disorder (P = 0.2069); Loss of methylation at R1259 (P = 0.4603)
7:117282544:T:A,P13569,F1257Y,0.773,Gain of catalytic residue at F1257 (P = 0.0198); Loss of stability (P = 0.0745); Gain of helix (P = 0.132); Gain of disorder (P = 0.139); Gain of MoRF binding (P = 0.1982)
7:117282544:T:C,P13569,F1257S,0.893,Gain of disorder (P = 0.004); Loss of stability (P = 0.0081); Gain of phosphorylation at F1257 (P = 0.0604); Gain of MoRF binding (P = 0.1474); Gain of catalytic residue at R1259 (P = 0.201)
7:117282544:T:G,P13569,F1257C,0.847,Loss of stability (P = 0.0427); Gain of catalytic residue at L1258 (P = 0.0492); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1778); Loss of disorder (P = 0.2311)
7:117282545:T:A,P13569,F1257L,0.855,Gain of disorder (P = 0.1019); Gain of helix (P = 0.132); Loss of stability (P = 0.1867); Gain of MoRF binding (P = 0.208); Gain of phosphorylation at T1252 (P = 0.413)
7:117282545:T:G,P13569,F1257L,0.855,Gain of disorder (P = 0.1019); Gain of helix (P = 0.132); Loss of stability (P = 0.1867); Gain of MoRF binding (P = 0.208); Gain of phosphorylation at T1252 (P = 0.413)
7:117282546:T:A,P13569,L1258M,0.748,Gain of MoRF binding (P = 0.0959); Gain of disorder (P = 0.2088); Loss of stability (P = 0.2155); Gain of methylation at R1259 (P = 0.3726); Loss of helix (P = 0.3949)
7:117282546:T:G,P13569,L1258V,0.791,Gain of MoRF binding (P = 0.1441); Gain of loop (P = 0.2045); Loss of stability (P = 0.271); Loss of disorder (P = 0.2719); Gain of methylation at R1259 (P = 0.3855)
7:117282547:T:C,P13569,L1258S,0.771,Loss of stability (P = 0.0176); Gain of disorder (P = 0.0202); Gain of phosphorylation at L1258 (P = 0.1884); Gain of MoRF binding (P = 0.1887); Gain of catalytic residue at L1254 (P = 0.2947)
7:117282547:T:G,P13569,L1258W,0.816,Gain of MoRF binding (P = 0.0441); Loss of stability (P = 0.0567); Loss of disorder (P = 0.1507); Loss of helix (P = 0.3949); Loss of methylation at R1259 (P = 0.44)
7:117282548:G:C,P13569,L1258F,0.784,Loss of stability (P = 0.0993); Gain of helix (P = 0.132); Gain of catalytic residue at R1259 (P = 0.2137); Loss of MoRF binding (P = 0.238); Loss of disorder (P = 0.2721)
7:117282548:G:T,P13569,L1258F,0.784,Loss of stability (P = 0.0993); Gain of helix (P = 0.132); Gain of catalytic residue at R1259 (P = 0.2137); Loss of MoRF binding (P = 0.238); Loss of disorder (P = 0.2721)
7:117282549:A:G,P13569,R1259G,0.765,Loss of stability (P = 0.0358); Loss of MoRF binding (P = 0.0872); Gain of catalytic residue at N1262 (P = 0.1305); Loss of solvent accessibility (P = 0.239); Loss of helix (P = 0.3949)
7:117282550:G:A,P13569,R1259K,0.698,Gain of ubiquitination at R1259 (P = 0.0247); Gain of methylation at R1259 (P = 0.0629); Loss of MoRF binding (P = 0.2117); Loss of stability (P = 0.3636); Loss of helix (P = 0.3949)
7:117282550:G:C,P13569,R1259T,0.816,Loss of MoRF binding (P = 0.0894); Loss of solvent accessibility (P = 0.1077); Gain of helix (P = 0.132); Gain of catalytic residue at N1262 (P = 0.2437); Loss of stability (P = 0.2596)
7:117282550:G:T,P13569,R1259I,0.884,Gain of catalytic residue at N1262 (P = 0.0645); Loss of MoRF binding (P = 0.0815); Loss of solvent accessibility (P = 0.1077); Loss of disorder (P = 0.2923); Loss of relative solvent accessibility (P = 0.3219)
7:117282551:A:C,P13569,R1259S,0.725,Loss of MoRF binding (P = 0.0933); Gain of helix (P = 0.132); Gain of disorder (P = 0.1852); Gain of catalytic residue at N1262 (P = 0.2862); Loss of stability (P = 0.351)
7:117282551:A:T,P13569,R1259S,0.725,Loss of MoRF binding (P = 0.0933); Gain of helix (P = 0.132); Gain of disorder (P = 0.1852); Gain of catalytic residue at N1262 (P = 0.2862); Loss of stability (P = 0.351)
7:117282552:C:A,P13569,L1260I,0.738,Gain of MoRF binding (P = 0.2464); Loss of helix (P = 0.3949); Loss of methylation at R1259 (P = 0.449); Gain of catalytic residue at L1258 (P = 0.4609); Loss of sheet (P = 0.5184)
7:117282552:C:G,P13569,L1260V,0.748,Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.2255); Loss of stability (P = 0.2886); Loss of helix (P = 0.3949); Gain of methylation at R1259 (P = 0.3995)
7:117282553:T:A,P13569,L1260Q,0.857,Loss of stability (P = 0.0341); Gain of disorder (P = 0.1181); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2547); Gain of loop (P = 0.4248)
7:117282553:T:C,P13569,L1260P,0.931,Loss of stability (P = 0.0145); Gain of disorder (P = 0.1587); Loss of helix (P = 0.2271); Gain of glycosylation at L1260 (P = 0.2533); Loss of MoRF binding (P = 0.2627)
7:117282553:T:G,P13569,L1260R,0.974,Loss of stability (P = 0.0387); Gain of MoRF binding (P = 0.0519); Gain of methylation at L1260 (P = 0.0754); Gain of phosphorylation at T1263 (P = 0.0923); Gain of disorder (P = 0.1384)
7:117282555:C:A,P13569,L1261M,0.719,Loss of stability (P = 0.1237); Gain of sheet (P = 0.1451); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2477); Gain of disorder (P = 0.3271)
7:117282555:C:G,P13569,L1261V,0.724,Loss of stability (P = 0.1237); Gain of sheet (P = 0.1451); Gain of MoRF binding (P = 0.2789); Loss of helix (P = 0.3949); Gain of catalytic residue at E1264 (P = 0.4079)
7:117282556:T:A,P13569,L1261Q,0.789,Loss of stability (P = 0.0422); Gain of disorder (P = 0.0785); Gain of relative solvent accessibility (P = 0.0905); Gain of solvent accessibility (P = 0.1045); Gain of sheet (P = 0.1451)
7:117282556:T:C,P13569,L1261P,0.821,Loss of stability (P = 0.0094); Gain of catalytic residue at L1261 (P = 0.0489); Gain of disorder (P = 0.0973); Gain of sheet (P = 0.1451); Loss of helix (P = 0.1706)
7:117282556:T:G,P13569,L1261R,0.856,Loss of stability (P = 0.0257); Gain of solvent accessibility (P = 0.0638); Gain of MoRF binding (P = 0.0774); Gain of relative solvent accessibility (P = 0.0905); Gain of disorder (P = 0.1053)
7:117282558:A:C,P13569,N1262H,0.625,Gain of catalytic residue at E1264 (P = 0.1075); Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Gain of disorder (P = 0.1985); Gain of methylation at R1259 (P = 0.3855)
7:117282558:A:G,P13569,N1262D,0.612,Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045); Loss of helix (P = 0.2271); Gain of disorder (P = 0.3093); Loss of MoRF binding (P = 0.3688)
7:117282558:A:T,P13569,N1262Y,0.638,Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Gain of catalytic residue at R1259 (P = 0.333); Loss of MoRF binding (P = 0.4008); Loss of disorder (P = 0.4173)
7:117282559:A:C,P13569,N1262T,0.528,Gain of catalytic residue at N1262 (P = 0.1283); Loss of stability (P = 0.287); Loss of sheet (P = 0.3635); Gain of disorder (P = 0.3787); Loss of helix (P = 0.3949)
7:117282559:A:G,P13569,N1262S,0.489,Gain of phosphorylation at N1262 (P = 0.0823); Gain of disorder (P = 0.1236); Gain of catalytic residue at L1258 (P = 0.1912); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949)
7:117282559:A:T,P13569,N1262I,0.72,Loss of sheet (P = 0.1398); Loss of solvent accessibility (P = 0.1473); Gain of catalytic residue at E1264 (P = 0.1516); Loss of relative solvent accessibility (P = 0.1808); Gain of loop (P = 0.2045)
7:117282560:C:A,P13569,N1262K,0.687,Gain of ubiquitination at N1262 (P = 0.0247); Gain of helix (P = 0.132); Gain of methylation at N1262 (P = 0.1537); Gain of MoRF binding (P = 0.1657); Gain of solvent accessibility (P = 0.3194)
7:117282560:C:G,P13569,N1262K,0.687,Gain of ubiquitination at N1262 (P = 0.0247); Gain of helix (P = 0.132); Gain of methylation at N1262 (P = 0.1537); Gain of MoRF binding (P = 0.1657); Gain of solvent accessibility (P = 0.3194)
7:117282561:A:C,P13569,T1263P,0.686,Gain of helix (P = 0.132); Gain of sheet (P = 0.1451); Loss of stability (P = 0.1672); Gain of disorder (P = 0.3154); Loss of MoRF binding (P = 0.4489)
7:117282561:A:G,P13569,T1263A,0.87,Gain of helix (P = 0.132); Gain of sheet (P = 0.1451); Loss of stability (P = 0.2622); Gain of methylation at R1259 (P = 0.4164); Gain of MoRF binding (P = 0.4589)
7:117282561:A:T,P13569,T1263S,0.461,Gain of relative solvent accessibility (P = 0.0249); Gain of solvent accessibility (P = 0.0766); Gain of disorder (P = 0.1278); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117282562:C:A,P13569,T1263N,0.553,Gain of relative solvent accessibility (P = 0.0249); Gain of solvent accessibility (P = 0.0365); Loss of sheet (P = 0.302); Gain of disorder (P = 0.3539); Loss of helix (P = 0.3949)
7:117282562:C:G,P13569,T1263S,0.461,Gain of relative solvent accessibility (P = 0.0249); Gain of solvent accessibility (P = 0.0766); Gain of disorder (P = 0.1278); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117282562:C:T,P13569,T1263I,0.865,Gain of helix (P = 0.132); Gain of sheet (P = 0.1451); Loss of disorder (P = 0.3626); Gain of catalytic residue at E1266 (P = 0.4167); Gain of methylation at R1259 (P = 0.4534)
7:117282564:G:A,P13569,E1264K,0.529,Gain of ubiquitination at E1264 (P = 0.0258); Loss of stability (P = 0.0991); Loss of sheet (P = 0.1398); Gain of MoRF binding (P = 0.1405); Gain of solvent accessibility (P = 0.1505)
7:117282564:G:C,P13569,E1264Q,0.428,Loss of sheet (P = 0.1398); Loss of stability (P = 0.2974); Gain of MoRF binding (P = 0.3484); Loss of helix (P = 0.3949); Gain of loop (P = 0.4248)
7:117282565:A:C,P13569,E1264A,0.445,Loss of sheet (P = 0.1398); Loss of solvent accessibility (P = 0.1459); Loss of stability (P = 0.1733); Gain of catalytic residue at E1264 (P = 0.2385); Gain of MoRF binding (P = 0.3292)
7:117282565:A:G,P13569,E1264G,0.443,Loss of stability (P = 0.0527); Loss of solvent accessibility (P = 0.0769); Loss of sheet (P = 0.1398); Gain of catalytic residue at N1262 (P = 0.162); Gain of MoRF binding (P = 0.3458)
7:117282565:A:T,P13569,E1264V,0.508,Loss of sheet (P = 0.1398); Loss of solvent accessibility (P = 0.1579); Gain of loop (P = 0.2045); Loss of helix (P = 0.2271); Loss of disorder (P = 0.2491)
7:117282566:A:C,P13569,E1264D,0.365,Gain of helix (P = 0.132); Loss of stability (P = 0.2987); Loss of sheet (P = 0.3635); Gain of methylation at R1259 (P = 0.4617); Loss of disorder (P = 0.479)
7:117282566:A:T,P13569,E1264D,0.365,Gain of helix (P = 0.132); Loss of stability (P = 0.2987); Loss of sheet (P = 0.3635); Gain of methylation at R1259 (P = 0.4617); Loss of disorder (P = 0.479)
7:117282567:G:A,P13569,G1265R,0.964,Loss of catalytic residue at G1265 (P = 0.1224); Gain of sheet (P = 0.1451); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4373); Gain of phosphorylation at T1263 (P = 0.4477)
7:117282567:G:C,P13569,G1265R,0.964,Loss of catalytic residue at G1265 (P = 0.1224); Gain of sheet (P = 0.1451); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4373); Gain of phosphorylation at T1263 (P = 0.4477)
7:117282568:G:C,P13569,G1265A,0.966,Loss of catalytic residue at G1265 (P = 0.1134); Gain of sheet (P = 0.1451); Loss of disorder (P = 0.3941); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.6085)
7:117282568:G:T,P13569,G1265V,0.973,Loss of catalytic residue at G1265 (P = 0.1373); Gain of sheet (P = 0.1451); Loss of disorder (P = 0.274); Loss of loop (P = 0.2897); Loss of helix (P = 0.3949)
7:117282570:G:A,P13569,E1266K,0.596,Gain of ubiquitination at E1266 (P = 0.03); Gain of sheet (P = 0.1451); Loss of catalytic residue at E1266 (P = 0.2475); Loss of stability (P = 0.2834); Gain of MoRF binding (P = 0.2959)
7:117282570:G:C,P13569,E1266Q,0.47,Loss of catalytic residue at E1266 (P = 0.1941); Loss of sheet (P = 0.302); Loss of loop (P = 0.3664); Loss of disorder (P = 0.4234); Gain of MoRF binding (P = 0.5366)
7:117282571:A:C,P13569,E1266A,0.621,Gain of sheet (P = 0.1451); Gain of catalytic residue at E1266 (P = 0.2686); Loss of disorder (P = 0.2826); Loss of stability (P = 0.3297); Loss of solvent accessibility (P = 0.3543)
7:117282571:A:G,P13569,E1266G,0.606,Gain of sheet (P = 0.1451); Loss of stability (P = 0.1719); Gain of catalytic residue at E1264 (P = 0.203); Loss of loop (P = 0.2897); Loss of solvent accessibility (P = 0.3103)
7:117282571:A:T,P13569,E1266V,0.587,Gain of sheet (P = 0.1451); Loss of disorder (P = 0.1806); Gain of catalytic residue at E1266 (P = 0.2043); Loss of solvent accessibility (P = 0.4274); Gain of MoRF binding (P = 0.5987)
7:117282572:A:C,P13569,E1266D,0.482,Gain of sheet (P = 0.1451); Loss of loop (P = 0.3664); Gain of catalytic residue at G1265 (P = 0.4435); Loss of disorder (P = 0.4651); Loss of stability (P = 0.6316)
7:117282572:A:T,P13569,E1266D,0.482,Gain of sheet (P = 0.1451); Loss of loop (P = 0.3664); Gain of catalytic residue at G1265 (P = 0.4435); Loss of disorder (P = 0.4651); Loss of stability (P = 0.6316)
7:117282573:A:C,P13569,I1267L,0.718,Loss of sheet (P = 0.1398); Loss of catalytic residue at D1270 (P = 0.1617); Gain of loop (P = 0.2045); Gain of disorder (P = 0.313); Gain of phosphorylation at T1263 (P = 0.654)
7:117282573:A:G,P13569,I1267V,0.673,Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045); Gain of disorder (P = 0.3475); Loss of catalytic residue at D1270 (P = 0.3613); Loss of stability (P = 0.4991)
7:117282573:A:T,P13569,I1267F,0.721,Gain of loop (P = 0.2045); Loss of stability (P = 0.2987); Loss of sheet (P = 0.302); Loss of catalytic residue at D1270 (P = 0.4951); Loss of disorder (P = 0.4973)
7:117282574:T:A,P13569,I1267N,0.882,Gain of disorder (P = 0.0098); Loss of stability (P = 0.0914); Loss of catalytic residue at D1270 (P = 0.0938); Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045)
7:117282574:T:C,P13569,I1267T,0.899,Gain of disorder (P = 0.0175); Loss of stability (P = 0.021); Loss of catalytic residue at D1270 (P = 0.1138); Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045)
7:117282574:T:G,P13569,I1267S,0.839,Gain of disorder (P = 0.0016); Loss of stability (P = 0.0527); Loss of catalytic residue at D1270 (P = 0.0976); Loss of sheet (P = 0.1398); Gain of phosphorylation at I1267 (P = 0.1698)
7:117282575:C:G,P13569,I1267M,0.826,Gain of catalytic residue at I1267 (P = 0.0786); Gain of disorder (P = 0.1261); Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045); Loss of stability (P = 0.3707)
7:117282576:C:A,P13569,Q1268K,0.621,Gain of ubiquitination at Q1268 (P = 0.0289); Gain of relative solvent accessibility (P = 0.1259); Loss of sheet (P = 0.1398); Gain of solvent accessibility (P = 0.1708); Gain of catalytic residue at Q1268 (P = 0.1713)
7:117282576:C:G,P13569,Q1268E,0.668,Gain of relative solvent accessibility (P = 0.1259); Gain of disorder (P = 0.1366); Gain of catalytic residue at Q1268 (P = 0.1422); Gain of solvent accessibility (P = 0.1903); Loss of sheet (P = 0.302)
7:117282577:A:C,P13569,Q1268P,0.676,Loss of sheet (P = 0.1398); Loss of catalytic residue at D1270 (P = 0.1634); Gain of loop (P = 0.2045); Loss of stability (P = 0.2665); Gain of disorder (P = 0.3942)
7:117282577:A:G,P13569,Q1268R,0.601,Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1319); Gain of catalytic residue at Q1268 (P = 0.2027); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302)
7:117282577:A:T,P13569,Q1268L,0.518,Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2659); Loss of catalytic residue at D1270 (P = 0.3283); Gain of MoRF binding (P = 0.5858)
7:117282578:G:C,P13569,Q1268H,0.571,Loss of sheet (P = 0.1398); Gain of catalytic residue at Q1268 (P = 0.1463); Gain of loop (P = 0.2045); Loss of stability (P = 0.4741); Gain of disorder (P = 0.4825)
7:117282578:G:T,P13569,Q1268H,0.571,Loss of sheet (P = 0.1398); Gain of catalytic residue at Q1268 (P = 0.1463); Gain of loop (P = 0.2045); Loss of stability (P = 0.4741); Gain of disorder (P = 0.4825)
7:117282579:A:C,P13569,I1269L,0.607,Gain of catalytic residue at I1269 (P = 0.039); Loss of sheet (P = 0.1398); Loss of stability (P = 0.2137); Gain of disorder (P = 0.3193); Gain of loop (P = 0.3485)
7:117282579:A:G,P13569,I1269V,0.661,Gain of sheet (P = 0.1208); Loss of loop (P = 0.2237); Loss of stability (P = 0.298); Gain of disorder (P = 0.3502); Loss of catalytic residue at S1273 (P = 0.4672)
7:117282579:A:T,P13569,I1269F,0.713,Loss of stability (P = 0.1078); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302); Loss of catalytic residue at S1273 (P = 0.4274); Gain of disorder (P = 0.4976)
7:117282580:T:A,P13569,I1269N,0.953,Gain of disorder (P = 0.012); Loss of stability (P = 0.025); Loss of sheet (P = 0.0817); Gain of catalytic residue at I1269 (P = 0.1966); Gain of loop (P = 0.3485)
7:117282580:T:C,P13569,I1269T,0.896,Loss of stability (P = 0.0055); Gain of disorder (P = 0.0194); Loss of sheet (P = 0.1501); Loss of catalytic residue at D1270 (P = 0.3549); Loss of MoRF binding (P = 0.5374)
7:117282580:T:G,P13569,I1269S,0.859,Gain of disorder (P = 0.0016); Loss of stability (P = 0.017); Loss of sheet (P = 0.1501); Loss of catalytic residue at D1270 (P = 0.266); Gain of phosphorylation at I1269 (P = 0.2758)
7:117282582:G:C,P13569,D1270H,0.9,Loss of sheet (P = 0.1158); Loss of stability (P = 0.1744); Gain of loop (P = 0.2045); Loss of catalytic residue at D1270 (P = 0.2401); Gain of MoRF binding (P = 0.3294)
7:117282582:G:T,P13569,D1270Y,0.882,Gain of catalytic residue at I1269 (P = 0.0714); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Loss of disorder (P = 0.2661); Gain of MoRF binding (P = 0.3218)
7:117282583:A:C,P13569,D1270A,0.904,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2745); Loss of stability (P = 0.3143); Loss of disorder (P = 0.375)
7:117282583:A:G,P13569,D1270G,0.895,Loss of stability (P = 0.0613); Gain of catalytic residue at I1269 (P = 0.0989); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.3007)
7:117282583:A:T,P13569,D1270V,0.899,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of MoRF binding (P = 0.2617); Loss of disorder (P = 0.263); Gain of catalytic residue at W1274 (P = 0.3779)
7:117282584:T:A,P13569,D1270E,0.919,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of disorder (P = 0.291); Loss of stability (P = 0.4329); Gain of solvent accessibility (P = 0.4496)
7:117282584:T:G,P13569,D1270E,0.919,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of disorder (P = 0.291); Loss of stability (P = 0.4329); Gain of solvent accessibility (P = 0.4496)
7:117282585:G:A,P13569,G1271S,0.795,Loss of catalytic residue at V1272 (P = 0.0966); Gain of disorder (P = 0.2092); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3899)
7:117282585:G:C,P13569,G1271R,0.849,Gain of MoRF binding (P = 0.0522); Loss of catalytic residue at V1272 (P = 0.0656); Gain of sheet (P = 0.1451); Loss of loop (P = 0.2237); Gain of phosphorylation at S1273 (P = 0.2267)
7:117282585:G:T,P13569,G1271C,0.828,Loss of catalytic residue at G1271 (P = 0.0932); Gain of sheet (P = 0.1208); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2298); Loss of MoRF binding (P = 0.4081)
7:117282586:G:A,P13569,G1271D,0.837,Loss of catalytic residue at V1272 (P = 0.079); Gain of sheet (P = 0.1451); Gain of disorder (P = 0.3706); Loss of MoRF binding (P = 0.3863); Gain of helix (P = 0.5668)
7:117282586:G:C,P13569,G1271A,0.848,Loss of catalytic residue at V1272 (P = 0.1094); Gain of sheet (P = 0.1208); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.404); Loss of disorder (P = 0.4204)
7:117282586:G:T,P13569,G1271V,0.88,Loss of catalytic residue at V1272 (P = 0.1008); Gain of sheet (P = 0.1208); Loss of loop (P = 0.2237); Loss of disorder (P = 0.3168); Gain of MoRF binding (P = 0.3796)
7:117282588:G:A,P13569,V1272M,0.561,Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1941); Gain of loop (P = 0.2045); Loss of stability (P = 0.229); Loss of catalytic residue at D1270 (P = 0.3303)
7:117282588:G:C,P13569,V1272L,0.468,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of catalytic residue at V1272 (P = 0.3476); Loss of MoRF binding (P = 0.3491); Gain of disorder (P = 0.3639)
7:117282588:G:T,P13569,V1272L,0.468,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of catalytic residue at V1272 (P = 0.3476); Loss of MoRF binding (P = 0.3491); Gain of disorder (P = 0.3639)
7:117282589:T:A,P13569,V1272E,0.663,Gain of disorder (P = 0.0034); Loss of catalytic residue at D1275 (P = 0.0346); Loss of stability (P = 0.0942); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045)
7:117282589:T:C,P13569,V1272A,0.54,Loss of stability (P = 0.0335); Loss of sheet (P = 0.1158); Gain of disorder (P = 0.1311); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.3404)
7:117282589:T:G,P13569,V1272G,0.636,Loss of stability (P = 0.0076); Gain of disorder (P = 0.0158); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.3364)
7:117282591:T:A,P13569,S1273T,0.658,Loss of catalytic residue at S1273 (P = 0.1446); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.2969); Loss of sheet (P = 0.302); Loss of disorder (P = 0.447)
7:117282591:T:C,P13569,S1273P,0.693,Gain of catalytic residue at W1274 (P = 0.0582); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2489); Loss of sheet (P = 0.302); Loss of disorder (P = 0.4524)
7:117282591:T:G,P13569,S1273A,0.654,Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.294); Loss of sheet (P = 0.302); Loss of catalytic residue at G1271 (P = 0.3379); Loss of disorder (P = 0.3741)
7:117282592:C:A,P13569,S1273Y,0.705,Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.2935); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3051); Loss of catalytic residue at G1271 (P = 0.3078)
7:117282592:C:G,P13569,S1273C,0.702,Gain of catalytic residue at W1274 (P = 0.0207); Loss of sheet (P = 0.1501); Loss of disorder (P = 0.2219); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.2817)
7:117282592:C:T,P13569,S1273F,0.7,Loss of loop (P = 0.2237); Loss of catalytic residue at G1271 (P = 0.2333); Loss of disorder (P = 0.2359); Gain of MoRF binding (P = 0.266); Loss of sheet (P = 0.302)
7:117282594:T:A,P13569,W1274R,0.859,Gain of disorder (P = 0.0274); Gain of MoRF binding (P = 0.1017); Gain of phosphorylation at S1276 (P = 0.1102); Loss of catalytic residue at D1270 (P = 0.1199); Gain of loop (P = 0.2045)
7:117282594:T:C,P13569,W1274R,0.859,Gain of disorder (P = 0.0274); Gain of MoRF binding (P = 0.1017); Gain of phosphorylation at S1276 (P = 0.1102); Loss of catalytic residue at D1270 (P = 0.1199); Gain of loop (P = 0.2045)
7:117282594:T:G,P13569,W1274G,0.894,Gain of disorder (P = 0.0115); Gain of catalytic residue at W1274 (P = 0.0371); Gain of glycosylation at S1273 (P = 0.0783); Loss of stability (P = 0.0936); Gain of sheet (P = 0.1539)
7:117282595:G:C,P13569,W1274S,0.788,Gain of disorder (P = 0.002); Gain of sheet (P = 0.1539); Loss of MoRF binding (P = 0.1888); Gain of phosphorylation at W1274 (P = 0.1982); Gain of loop (P = 0.2045)
7:117282595:G:T,P13569,W1274L,0.723,Gain of catalytic residue at W1274 (P = 0.0377); Gain of sheet (P = 0.1539); Loss of MoRF binding (P = 0.2019); Gain of disorder (P = 0.244); Loss of loop (P = 0.2897)
7:117282596:G:C,P13569,W1274C,0.741,Gain of catalytic residue at S1276 (P = 0.0417); Gain of sheet (P = 0.1539); Loss of MoRF binding (P = 0.1691); Gain of helix (P = 0.2059); Loss of stability (P = 0.4582)
7:117282596:G:T,P13569,W1274C,0.741,Gain of catalytic residue at S1276 (P = 0.0417); Gain of sheet (P = 0.1539); Loss of MoRF binding (P = 0.1691); Gain of helix (P = 0.2059); Loss of stability (P = 0.4582)
7:117282597:G:A,P13569,D1275N,0.389,Gain of MoRF binding (P = 0.0567); Loss of helix (P = 0.2022); Loss of sheet (P = 0.302); Gain of catalytic residue at W1274 (P = 0.3192); Loss of stability (P = 0.4786)
7:117282597:G:C,P13569,D1275H,0.509,Gain of MoRF binding (P = 0.0669); Gain of catalytic residue at W1274 (P = 0.1539); Loss of helix (P = 0.2022); Loss of sheet (P = 0.302); Loss of stability (P = 0.3943)
7:117282597:G:T,P13569,D1275Y,0.549,Gain of MoRF binding (P = 0.0613); Loss of helix (P = 0.2022); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302); Gain of catalytic residue at W1274 (P = 0.3932)
7:117282598:A:C,P13569,D1275A,0.467,Gain of MoRF binding (P = 0.0446); Loss of helix (P = 0.2022); Gain of catalytic residue at W1274 (P = 0.2552); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302)
7:117282598:A:G,P13569,D1275G,0.428,Gain of MoRF binding (P = 0.0513); Gain of catalytic residue at W1274 (P = 0.1444); Loss of stability (P = 0.1989); Loss of helix (P = 0.2022); Loss of sheet (P = 0.302)
7:117282598:A:T,P13569,D1275V,0.565,Gain of MoRF binding (P = 0.0363); Loss of catalytic residue at D1275 (P = 0.0881); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302)
7:117282599:T:A,P13569,D1275E,0.336,Gain of solvent accessibility (P = 0.1751); Gain of relative solvent accessibility (P = 0.1894); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.2373); Loss of catalytic residue at S1273 (P = 0.2663)
7:117282599:T:G,P13569,D1275E,0.336,Gain of solvent accessibility (P = 0.1751); Gain of relative solvent accessibility (P = 0.1894); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.2373); Loss of catalytic residue at S1273 (P = 0.2663)
7:117282600:T:A,P13569,S1276T,0.503,Gain of catalytic residue at S1276 (P = 0.0966); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.2092); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949)
7:117282600:T:C,P13569,S1276P,0.568,Loss of MoRF binding (P = 0.1031); Loss of catalytic residue at S1273 (P = 0.1665); Gain of loop (P = 0.2045); Loss of stability (P = 0.3553); Loss of sheet (P = 0.3635)
7:117282600:T:G,P13569,S1276A,0.577,Gain of catalytic residue at S1276 (P = 0.1609); Loss of MoRF binding (P = 0.1979); Loss of loop (P = 0.2237); Loss of solvent accessibility (P = 0.239); Loss of relative solvent accessibility (P = 0.3219)
7:117282601:C:T,P13569,S1276L,0.547,Loss of catalytic residue at S1273 (P = 0.1778); Loss of MoRF binding (P = 0.2075); Gain of helix (P = 0.2684); Gain of stability (P = 0.2795); Gain of loop (P = 0.3485)
7:117282603:A:C,P13569,I1277L,0.591,Loss of MoRF binding (P = 0.1621); Gain of loop (P = 0.2045); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Loss of catalytic residue at D1275 (P = 0.4992)
7:117282603:A:G,P13569,I1277V,0.552,Loss of MoRF binding (P = 0.1936); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Loss of catalytic residue at T1278 (P = 0.6161)
7:117282603:A:T,P13569,I1277L,0.591,Loss of MoRF binding (P = 0.1621); Gain of loop (P = 0.2045); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Loss of catalytic residue at D1275 (P = 0.4992)
7:117282604:T:A,P13569,I1277K,0.713,Gain of ubiquitination at I1277 (P = 0.0247); Gain of MoRF binding (P = 0.0261); Gain of solvent accessibility (P = 0.0263); Gain of relative solvent accessibility (P = 0.0289); Gain of disorder (P = 0.0407)
7:117282604:T:C,P13569,I1277T,0.629,Loss of stability (P = 0.0149); Gain of catalytic residue at I1277 (P = 0.1126); Gain of relative solvent accessibility (P = 0.1571); Loss of MoRF binding (P = 0.1702); Gain of disorder (P = 0.2861)
7:117282604:T:G,P13569,I1277R,0.752,Gain of MoRF binding (P = 0.0094); Loss of stability (P = 0.0811); Gain of solvent accessibility (P = 0.11); Gain of sheet (P = 0.1208); Gain of relative solvent accessibility (P = 0.1571)
7:117282605:A:G,P13569,I1277M,0.554,Gain of catalytic residue at I1277 (P = 0.0374); Gain of MoRF binding (P = 0.1319); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059); Loss of sheet (P = 0.3635)
7:117282606:A:C,P13569,T1278P,0.538,Loss of MoRF binding (P = 0.0819); Loss of catalytic residue at T1278 (P = 0.2892); Gain of loop (P = 0.3485); Loss of sheet (P = 0.3635); Loss of stability (P = 0.3872)
7:117282606:A:G,P13569,T1278A,0.495,Loss of MoRF binding (P = 0.1799); Loss of sheet (P = 0.3635); Loss of loop (P = 0.3664); Loss of helix (P = 0.3949); Loss of solvent accessibility (P = 0.4653)
7:117282606:A:T,P13569,T1278S,0.401,Loss of MoRF binding (P = 0.1747); Loss of helix (P = 0.2271); Loss of catalytic residue at T1278 (P = 0.2388); Loss of sheet (P = 0.3635); Gain of disorder (P = 0.4595)
7:117282607:C:A,P13569,T1278N,0.417,Gain of MoRF binding (P = 0.176); Loss of catalytic residue at T1278 (P = 0.28); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Gain of solvent accessibility (P = 0.5093)
7:117282607:C:G,P13569,T1278S,0.401,Loss of MoRF binding (P = 0.1747); Loss of helix (P = 0.2271); Loss of catalytic residue at T1278 (P = 0.2388); Loss of sheet (P = 0.3635); Gain of disorder (P = 0.4595)
7:117282607:C:T,P13569,T1278I,0.667,Gain of MoRF binding (P = 0.0946); Loss of loop (P = 0.1242); Loss of solvent accessibility (P = 0.1651); Loss of relative solvent accessibility (P = 0.1807); Gain of helix (P = 0.2059)
7:117282609:T:A,P13569,L1279M,0.631,Gain of methylation at K1284 (P = 0.0489); Gain of MoRF binding (P = 0.0972); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.2451); Loss of stability (P = 0.287)
7:117282609:T:G,P13569,L1279V,0.683,Gain of methylation at K1284 (P = 0.0766); Gain of MoRF binding (P = 0.142); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.2547); Loss of stability (P = 0.3487)
7:117282610:T:C,P13569,L1279S,0.609,Gain of methylation at K1284 (P = 0.0331); Loss of stability (P = 0.0349); Gain of disorder (P = 0.0499); Gain of relative solvent accessibility (P = 0.1571); Gain of MoRF binding (P = 0.1673)
7:117282610:T:G,P13569,L1279W,0.748,Gain of MoRF binding (P = 0.0331); Gain of catalytic residue at W1274 (P = 0.0613); Loss of stability (P = 0.0866); Gain of methylation at K1284 (P = 0.1187); Gain of ubiquitination at K1284 (P = 0.1557)
7:117282611:G:C,P13569,L1279F,0.712,Gain of methylation at K1284 (P = 0.0981); Gain of MoRF binding (P = 0.1491); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.2451); Loss of stability (P = 0.3025)
7:117282611:G:T,P13569,L1279F,0.712,Gain of methylation at K1284 (P = 0.0981); Gain of MoRF binding (P = 0.1491); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.2451); Loss of stability (P = 0.3025)
7:117282612:C:A,P13569,Q1280K,0.545,Gain of MoRF binding (P = 0.0217); Gain of ubiquitination at Q1280 (P = 0.0388); Gain of methylation at Q1280 (P = 0.045); Gain of relative solvent accessibility (P = 0.1684); Gain of solvent accessibility (P = 0.194)
7:117282612:C:G,P13569,Q1280E,0.505,Gain of ubiquitination at K1284 (P = 0.0573); Loss of MoRF binding (P = 0.064); Gain of catalytic residue at W1282 (P = 0.0748); Loss of methylation at K1284 (P = 0.1653); Gain of helix (P = 0.1736)
7:117282613:A:C,P13569,Q1280P,0.545,Loss of MoRF binding (P = 0.0715); Loss of methylation at K1284 (P = 0.1608); Gain of ubiquitination at K1284 (P = 0.2106); Loss of helix (P = 0.2271); Loss of catalytic residue at Q1280 (P = 0.2693)
7:117282613:A:G,P13569,Q1280R,0.498,Gain of MoRF binding (P = 0.0084); Loss of methylation at K1284 (P = 0.0936); Loss of ubiquitination at K1284 (P = 0.1327); Gain of helix (P = 0.1736); Gain of solvent accessibility (P = 0.2601)
7:117282613:A:T,P13569,Q1280L,0.546,Gain of ubiquitination at K1284 (P = 0.0573); Loss of methylation at K1284 (P = 0.0677); Gain of catalytic residue at Q1280 (P = 0.1147); Loss of MoRF binding (P = 0.1283); Loss of helix (P = 0.2271)
7:117282614:A:C,P13569,Q1280H,0.488,Loss of methylation at K1284 (P = 0.106); Gain of ubiquitination at K1284 (P = 0.1283); Loss of MoRF binding (P = 0.141); Gain of catalytic residue at L1279 (P = 0.2557); Loss of loop (P = 0.3664)
7:117282614:A:T,P13569,Q1280H,0.488,Loss of methylation at K1284 (P = 0.106); Gain of ubiquitination at K1284 (P = 0.1283); Loss of MoRF binding (P = 0.141); Gain of catalytic residue at L1279 (P = 0.2557); Loss of loop (P = 0.3664)
7:117282615:C:A,P13569,Q1281K,0.619,Gain of MoRF binding (P = 0.0284); Gain of ubiquitination at Q1281 (P = 0.0592); Gain of methylation at Q1281 (P = 0.0878); Loss of loop (P = 0.2897); Loss of sheet (P = 0.3635)
7:117282615:C:G,P13569,Q1281E,0.614,Loss of MoRF binding (P = 0.0616); Gain of ubiquitination at K1284 (P = 0.0758); Loss of methylation at K1284 (P = 0.1141); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897)
7:117282616:A:C,P13569,Q1281P,0.651,Gain of catalytic residue at W1282 (P = 0.0716); Loss of MoRF binding (P = 0.0788); Gain of methylation at K1284 (P = 0.1264); Loss of helix (P = 0.1706); Loss of ubiquitination at K1284 (P = 0.226)
7:117282616:A:G,P13569,Q1281R,0.586,Gain of MoRF binding (P = 0.0193); Loss of methylation at K1284 (P = 0.0778); Loss of ubiquitination at K1284 (P = 0.1741); Gain of helix (P = 0.2059); Gain of catalytic residue at K1284 (P = 0.3056)
7:117282616:A:T,P13569,Q1281L,0.638,Loss of methylation at K1284 (P = 0.0822); Gain of MoRF binding (P = 0.0854); Gain of ubiquitination at K1284 (P = 0.1283); Gain of catalytic residue at S1276 (P = 0.1314); Loss of helix (P = 0.1706)
7:117282617:G:C,P13569,Q1281H,0.601,Loss of methylation at K1284 (P = 0.119); Loss of MoRF binding (P = 0.1523); Gain of ubiquitination at K1284 (P = 0.1557); Gain of helix (P = 0.2059); Gain of catalytic residue at Q1280 (P = 0.2533)
7:117282617:G:T,P13569,Q1281H,0.601,Loss of methylation at K1284 (P = 0.119); Loss of MoRF binding (P = 0.1523); Gain of ubiquitination at K1284 (P = 0.1557); Gain of helix (P = 0.2059); Gain of catalytic residue at Q1280 (P = 0.2533)
7:117282618:T:A,P13569,W1282R,0.936,Gain of methylation at K1284 (P = 0.0391); Loss of ubiquitination at K1284 (P = 0.0829); Loss of MoRF binding (P = 0.0977); Loss of helix (P = 0.1706); Gain of disorder (P = 0.256)
7:117282618:T:C,P13569,W1282R,0.936,Gain of methylation at K1284 (P = 0.0391); Loss of ubiquitination at K1284 (P = 0.0829); Loss of MoRF binding (P = 0.0977); Loss of helix (P = 0.1706); Gain of disorder (P = 0.256)
7:117282618:T:G,P13569,W1282G,0.962,Loss of stability (P = 0.0461); Loss of MoRF binding (P = 0.0577); Gain of methylation at K1284 (P = 0.0627); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1706)
7:117282619:G:C,P13569,W1282S,0.871,Gain of disorder (P = 0.0399); Gain of methylation at K1284 (P = 0.0505); Loss of MoRF binding (P = 0.056); Loss of helix (P = 0.1706); Loss of stability (P = 0.2491)
7:117282619:G:T,P13569,W1282L,0.826,Loss of MoRF binding (P = 0.0697); Loss of sheet (P = 0.1158); Loss of methylation at K1284 (P = 0.1312); Loss of ubiquitination at K1284 (P = 0.1454); Gain of helix (P = 0.2059)
7:117282620:G:T,P13569,W1282C,0.912,Loss of MoRF binding (P = 0.0499); Gain of methylation at K1284 (P = 0.0794); Loss of sheet (P = 0.1158); Gain of helix (P = 0.2059); Loss of ubiquitination at K1284 (P = 0.226)
7:117282621:A:G,P13569,R1283G,0.94,Loss of MoRF binding (P = 0.0321); Gain of ubiquitination at K1284 (P = 0.0625); Loss of methylation at K1284 (P = 0.1104); Gain of catalytic residue at W1282 (P = 0.1184); Loss of stability (P = 0.1411)
7:117282621:A:T,P13569,R1283W,0.947,Gain of ubiquitination at K1284 (P = 0.0408); Loss of MoRF binding (P = 0.0898); Gain of sheet (P = 0.1451); Gain of methylation at K1284 (P = 0.1465); Loss of helix (P = 0.2271)
7:117282622:G:A,P13569,R1283K,0.937,Gain of methylation at R1283 (P = 0.0317); Gain of ubiquitination at R1283 (P = 0.0337); Loss of MoRF binding (P = 0.0884); Gain of sheet (P = 0.1451); Loss of helix (P = 0.1706)
7:117282622:G:C,P13569,R1283T,0.935,Loss of MoRF binding (P = 0.0345); Gain of ubiquitination at K1284 (P = 0.0542); Loss of methylation at K1284 (P = 0.1204); Gain of sheet (P = 0.1208); Gain of catalytic residue at F1286 (P = 0.1552)
7:117282622:G:T,P13569,R1283M,0.966,Loss of methylation at K1284 (P = 0.0376); Gain of ubiquitination at K1284 (P = 0.0393); Loss of MoRF binding (P = 0.044); Gain of sheet (P = 0.1451); Loss of helix (P = 0.1706)
7:117282623:G:C,P13569,R1283S,0.899,Loss of MoRF binding (P = 0.0372); Gain of ubiquitination at K1284 (P = 0.0573); Loss of methylation at K1284 (P = 0.1033); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706)
7:117282623:G:T,P13569,R1283S,0.899,Loss of MoRF binding (P = 0.0372); Gain of ubiquitination at K1284 (P = 0.0573); Loss of methylation at K1284 (P = 0.1033); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706)
7:117282624:A:C,P13569,K1284Q,0.562,Loss of methylation at K1284 (P = 0.0268); Loss of ubiquitination at K1284 (P = 0.0412); Loss of MoRF binding (P = 0.0488); Loss of sheet (P = 0.1398); Gain of catalytic residue at R1283 (P = 0.2223)
7:117282624:A:G,P13569,K1284E,0.566,Loss of MoRF binding (P = 0.011); Loss of methylation at K1284 (P = 0.0268); Loss of ubiquitination at K1284 (P = 0.0412); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736)
7:117282625:A:C,P13569,K1284T,0.604,Loss of methylation at K1284 (P = 0.0268); Loss of ubiquitination at K1284 (P = 0.0412); Loss of MoRF binding (P = 0.0502); Gain of catalytic residue at R1283 (P = 0.1127); Loss of stability (P = 0.187)
7:117282625:A:G,P13569,K1284R,0.506,Loss of methylation at K1284 (P = 0.029); Loss of ubiquitination at K1284 (P = 0.0412); Gain of MoRF binding (P = 0.0917); Loss of sheet (P = 0.1158); Gain of helix (P = 0.1736)
7:117282625:A:T,P13569,K1284I,0.695,Loss of methylation at K1284 (P = 0.0268); Loss of ubiquitination at K1284 (P = 0.0412); Loss of MoRF binding (P = 0.0573); Loss of solvent accessibility (P = 0.0703); Loss of sheet (P = 0.1398)
7:117282626:A:C,P13569,K1284N,0.568,Loss of methylation at K1284 (P = 0.0268); Loss of ubiquitination at K1284 (P = 0.0412); Loss of MoRF binding (P = 0.0556); Loss of sheet (P = 0.1398); Gain of catalytic residue at R1283 (P = 0.2004)
7:117282626:A:T,P13569,K1284N,0.568,Loss of methylation at K1284 (P = 0.0268); Loss of ubiquitination at K1284 (P = 0.0412); Loss of MoRF binding (P = 0.0556); Loss of sheet (P = 0.1398); Gain of catalytic residue at R1283 (P = 0.2004)
7:117282627:G:A,P13569,A1285T,0.474,Loss of catalytic residue at A1285 (P = 0.0691); Gain of MoRF binding (P = 0.1327); Gain of methylation at K1284 (P = 0.1617); Loss of helix (P = 0.2022); Gain of ubiquitination at K1284 (P = 0.2106)
7:117282627:G:C,P13569,A1285P,0.752,Loss of MoRF binding (P = 0.0612); Gain of methylation at K1284 (P = 0.0853); Loss of stability (P = 0.1178); Loss of helix (P = 0.1706); Gain of catalytic residue at K1284 (P = 0.1875)
7:117282627:G:T,P13569,A1285S,0.445,Loss of catalytic residue at A1285 (P = 0.0402); Loss of methylation at K1284 (P = 0.1141); Gain of MoRF binding (P = 0.1213); Gain of sheet (P = 0.1539); Loss of helix (P = 0.1706)
7:117282628:C:A,P13569,A1285D,0.664,Loss of MoRF binding (P = 0.0679); Loss of methylation at K1284 (P = 0.0711); Gain of ubiquitination at K1284 (P = 0.0758); Loss of catalytic residue at A1285 (P = 0.0841); Gain of sheet (P = 0.1539)
7:117282628:C:G,P13569,A1285G,0.647,Loss of stability (P = 0.0988); Loss of catalytic residue at A1285 (P = 0.1368); Loss of MoRF binding (P = 0.1373); Gain of methylation at K1284 (P = 0.1508); Loss of helix (P = 0.1706)
7:117282628:C:T,P13569,A1285V,0.677,Gain of methylation at K1284 (P = 0.0334); Loss of catalytic residue at A1285 (P = 0.074); Gain of MoRF binding (P = 0.0983); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1706)
7:117282630:T:A,P13569,F1286I,0.514,Gain of methylation at K1284 (P = 0.0745); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.1268); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.2451)
7:117282630:T:C,P13569,F1286L,0.493,Loss of methylation at K1284 (P = 0.1025); Loss of MoRF binding (P = 0.1286); Loss of sheet (P = 0.1398); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.226)
7:117282630:T:G,P13569,F1286V,0.566,Loss of stability (P = 0.0633); Gain of MoRF binding (P = 0.1155); Loss of sheet (P = 0.1158); Gain of methylation at K1284 (P = 0.1341); Loss of helix (P = 0.2022)
7:117282631:T:A,P13569,F1286Y,0.797,Loss of stability (P = 0.0548); Gain of catalytic residue at P1290 (P = 0.0651); Loss of MoRF binding (P = 0.0956); Loss of sheet (P = 0.1158); Loss of methylation at K1284 (P = 0.1242)
7:117282631:T:C,P13569,F1286S,0.918,Loss of stability (P = 0.0162); Gain of glycosylation at F1286 (P = 0.0315); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.1303); Loss of methylation at K1284 (P = 0.1321)
7:117282631:T:G,P13569,F1286C,0.796,Loss of stability (P = 0.0647); Loss of MoRF binding (P = 0.0767); Loss of sheet (P = 0.1158); Gain of methylation at K1284 (P = 0.1225); Gain of ubiquitination at K1284 (P = 0.1283)
7:117282632:T:A,P13569,F1286L,0.493,Loss of methylation at K1284 (P = 0.1025); Loss of MoRF binding (P = 0.1286); Loss of sheet (P = 0.1398); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.226)
7:117282632:T:G,P13569,F1286L,0.493,Loss of methylation at K1284 (P = 0.1025); Loss of MoRF binding (P = 0.1286); Loss of sheet (P = 0.1398); Loss of helix (P = 0.2022); Loss of ubiquitination at K1284 (P = 0.226)
7:117282633:G:A,P13569,G1287R,0.898,Gain of MoRF binding (P = 0.0049); Loss of catalytic residue at V1288 (P = 0.0362); Loss of ubiquitination at K1292 (P = 0.0432); Loss of methylation at K1284 (P = 0.0906); Gain of sheet (P = 0.1208)
7:117282633:G:C,P13569,G1287R,0.898,Gain of MoRF binding (P = 0.0049); Loss of catalytic residue at V1288 (P = 0.0362); Loss of ubiquitination at K1292 (P = 0.0432); Loss of methylation at K1284 (P = 0.0906); Gain of sheet (P = 0.1208)
7:117282634:G:A,P13569,G1287E,0.849,Loss of ubiquitination at K1292 (P = 0.0432); Loss of catalytic residue at V1288 (P = 0.0505); Loss of MoRF binding (P = 0.0568); Loss of methylation at K1284 (P = 0.1084); Gain of sheet (P = 0.1451)
7:117282634:G:C,P13569,G1287A,0.828,Gain of catalytic residue at G1287 (P = 0.0721); Gain of sheet (P = 0.1208); Loss of MoRF binding (P = 0.1249); Gain of ubiquitination at K1284 (P = 0.1283); Loss of methylation at K1284 (P = 0.132)
7:117282634:G:T,P13569,G1287V,0.809,Gain of ubiquitination at K1284 (P = 0.0872); Gain of methylation at K1284 (P = 0.1093); Gain of sheet (P = 0.1208); Gain of MoRF binding (P = 0.1443); Loss of catalytic residue at V1288 (P = 0.1489)
7:117282636:G:A,P13569,V1288M,0.576,Loss of catalytic residue at V1288 (P = 0.0205); Loss of ubiquitination at K1292 (P = 0.0547); Gain of MoRF binding (P = 0.1053); Loss of methylation at K1284 (P = 0.1409); Loss of loop (P = 0.2897)
7:117282636:G:C,P13569,V1288L,0.554,Loss of methylation at K1284 (P = 0.0882); Loss of ubiquitination at K1292 (P = 0.1381); Loss of MoRF binding (P = 0.1459); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302)
7:117282636:G:T,P13569,V1288L,0.554,Loss of methylation at K1284 (P = 0.0882); Loss of ubiquitination at K1292 (P = 0.1381); Loss of MoRF binding (P = 0.1459); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302)
7:117282637:T:A,P13569,V1288E,0.826,Loss of ubiquitination at K1292 (P = 0.0397); Loss of catalytic residue at V1288 (P = 0.0445); Loss of MoRF binding (P = 0.053); Loss of methylation at K1284 (P = 0.1191); Gain of helix (P = 0.2059)
7:117282637:T:C,P13569,V1288A,0.718,Loss of methylation at K1284 (P = 0.0944); Loss of ubiquitination at K1292 (P = 0.1062); Loss of MoRF binding (P = 0.1159); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302)
7:117282637:T:G,P13569,V1288G,0.812,Loss of ubiquitination at K1292 (P = 0.0499); Loss of stability (P = 0.0625); Loss of methylation at K1284 (P = 0.1172); Loss of MoRF binding (P = 0.1187); Gain of sheet (P = 0.1208)
7:117282639:A:C,P13569,I1289L,0.688,Loss of methylation at K1284 (P = 0.0654); Loss of catalytic residue at Q1291 (P = 0.098); Loss of MoRF binding (P = 0.1121); Loss of sheet (P = 0.1158); Loss of ubiquitination at K1292 (P = 0.1216)
7:117282639:A:G,P13569,I1289V,0.581,Loss of ubiquitination at K1292 (P = 0.1062); Loss of methylation at K1284 (P = 0.109); Loss of MoRF binding (P = 0.1118); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1706)
7:117282639:A:T,P13569,I1289L,0.688,Loss of methylation at K1284 (P = 0.0654); Loss of catalytic residue at Q1291 (P = 0.098); Loss of MoRF binding (P = 0.1121); Loss of sheet (P = 0.1158); Loss of ubiquitination at K1292 (P = 0.1216)
7:117282640:T:A,P13569,I1289K,0.878,Loss of ubiquitination at K1292 (P = 0.0342); Gain of MoRF binding (P = 0.0615); Loss of sheet (P = 0.1158); Gain of methylation at K1284 (P = 0.1282); Loss of catalytic residue at Q1291 (P = 0.1635)
7:117282640:T:C,P13569,I1289T,0.767,Loss of ubiquitination at K1292 (P = 0.0547); Gain of phosphorylation at I1289 (P = 0.0635); Loss of MoRF binding (P = 0.0844); Gain of methylation at K1284 (P = 0.1561); Loss of stability (P = 0.2128)
7:117282640:T:G,P13569,I1289R,0.888,Loss of ubiquitination at K1292 (P = 0.0327); Gain of MoRF binding (P = 0.0353); Loss of methylation at K1284 (P = 0.0919); Loss of catalytic residue at Q1291 (P = 0.0972); Loss of sheet (P = 0.1158)
7:117282641:A:G,P13569,I1289M,0.622,Loss of ubiquitination at K1292 (P = 0.047); Loss of methylation at K1284 (P = 0.1128); Loss of sheet (P = 0.1158); Loss of catalytic residue at I1289 (P = 0.116); Gain of MoRF binding (P = 0.1491)
7:117282642:C:A,P13569,P1290T,0.808,Gain of MoRF binding (P = 0.036); Gain of ubiquitination at K1292 (P = 0.1047); Gain of catalytic residue at P1290 (P = 0.1713); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302)
7:117282642:C:G,P13569,P1290A,0.801,Gain of MoRF binding (P = 0.0427); Gain of ubiquitination at K1292 (P = 0.0613); Gain of catalytic residue at P1290 (P = 0.0984); Loss of sheet (P = 0.1158); Loss of stability (P = 0.2141)
7:117282642:C:T,P13569,P1290S,0.88,Gain of MoRF binding (P = 0.0338); Loss of ubiquitination at K1292 (P = 0.1062); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754)
7:117282643:C:A,P13569,P1290Q,0.831,Gain of MoRF binding (P = 0.038); Loss of ubiquitination at K1292 (P = 0.0811); Gain of sheet (P = 0.1451); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117282643:C:G,P13569,P1290R,0.837,Gain of MoRF binding (P = 0.0015); Loss of ubiquitination at K1292 (P = 0.0615); Loss of catalytic residue at Q1291 (P = 0.1485); Loss of helix (P = 0.1706); Gain of loop (P = 0.2754)
7:117282643:C:T,P13569,P1290L,0.807,Gain of MoRF binding (P = 0.0302); Gain of ubiquitination at K1292 (P = 0.0575); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949)
7:117282645:C:A,P13569,Q1291K,0.925,Gain of methylation at Q1291 (P = 0.0059); Gain of ubiquitination at Q1291 (P = 0.0289); Gain of MoRF binding (P = 0.0291); Gain of sheet (P = 0.1945); Gain of helix (P = 0.2684)
7:117282645:C:G,P13569,Q1291E,0.942,Loss of MoRF binding (P = 0.0444); Loss of ubiquitination at K1292 (P = 0.0518); Gain of sheet (P = 0.1208); Gain of loop (P = 0.2754); Loss of helix (P = 0.4763)
7:117282646:A:C,P13569,Q1291P,0.947,Gain of catalytic residue at P1290 (P = 0.0179); Loss of MoRF binding (P = 0.0549); Gain of sheet (P = 0.1208); Loss of ubiquitination at K1292 (P = 0.1381); Loss of stability (P = 0.3693)
7:117282646:A:G,P13569,Q1291R,0.979,Gain of MoRF binding (P = 0.0148); Loss of ubiquitination at K1292 (P = 0.0615); Loss of catalytic residue at Q1291 (P = 0.0645); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2754)
7:117282646:A:T,P13569,Q1291L,0.953,Gain of sheet (P = 0.0827); Gain of ubiquitination at K1292 (P = 0.0898); Gain of MoRF binding (P = 0.1438); Gain of helix (P = 0.2684); Gain of loop (P = 0.2754)
7:117282647:G:C,P13569,Q1291H,0.982,Loss of MoRF binding (P = 0.1135); Loss of ubiquitination at K1292 (P = 0.1216); Gain of sheet (P = 0.1451); Loss of catalytic residue at Q1291 (P = 0.1701); Loss of helix (P = 0.2662)
7:117282647:G:T,P13569,Q1291H,0.982,Loss of MoRF binding (P = 0.1135); Loss of ubiquitination at K1292 (P = 0.1216); Gain of sheet (P = 0.1451); Loss of catalytic residue at Q1291 (P = 0.1701); Loss of helix (P = 0.2662)
7:117292896:A:C,P13569,K1292Q,0.584,Loss of methylation at K1292 (P = 0.0012); Loss of ubiquitination at K1292 (P = 0.021); Loss of MoRF binding (P = 0.0495); Gain of sheet (P = 0.1208); Loss of glycosylation at S1297 (P = 0.2057)
7:117292896:A:G,P13569,K1292E,0.625,Loss of methylation at K1292 (P = 0.0012); Loss of MoRF binding (P = 0.011); Loss of ubiquitination at K1292 (P = 0.021); Gain of sheet (P = 0.1208); Gain of glycosylation at S1297 (P = 0.2112)
7:117292897:A:C,P13569,K1292T,0.605,Loss of methylation at K1292 (P = 0.0012); Loss of ubiquitination at K1292 (P = 0.021); Loss of MoRF binding (P = 0.0522); Gain of glycosylation at S1297 (P = 0.1847); Loss of loop (P = 0.2237)
7:117292897:A:G,P13569,K1292R,0.679,Loss of methylation at K1292 (P = 0.0042); Loss of ubiquitination at K1292 (P = 0.021); Gain of MoRF binding (P = 0.0794); Loss of glycosylation at S1297 (P = 0.2084); Loss of helix (P = 0.2662)
7:117292897:A:T,P13569,K1292I,0.63,Loss of methylation at K1292 (P = 0.0012); Loss of catalytic residue at K1292 (P = 0.0025); Loss of ubiquitination at K1292 (P = 0.021); Loss of MoRF binding (P = 0.0648); Loss of glycosylation at S1297 (P = 0.2023)
7:117292898:A:C,P13569,K1292N,0.585,Loss of methylation at K1292 (P = 0.0012); Loss of ubiquitination at K1292 (P = 0.021); Loss of MoRF binding (P = 0.0555); Loss of catalytic residue at K1292 (P = 0.1499); Gain of glycosylation at S1297 (P = 0.2216)
7:117292898:A:T,P13569,K1292N,0.585,Loss of methylation at K1292 (P = 0.0012); Loss of ubiquitination at K1292 (P = 0.021); Loss of MoRF binding (P = 0.0555); Loss of catalytic residue at K1292 (P = 0.1499); Gain of glycosylation at S1297 (P = 0.2216)
7:117292899:G:A,P13569,V1293I,0.897,Gain of MoRF binding (P = 0.1165); Loss of ubiquitination at K1292 (P = 0.1381); Loss of glycosylation at S1297 (P = 0.1651); Loss of helix (P = 0.1706); Loss of sheet (P = 0.302)
7:117292899:G:C,P13569,V1293L,0.77,Gain of catalytic residue at V1293 (P = 0.0133); Loss of ubiquitination at K1292 (P = 0.093); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1485); Loss of loop (P = 0.2237)
7:117292899:G:T,P13569,V1293L,0.77,Gain of catalytic residue at V1293 (P = 0.0133); Loss of ubiquitination at K1292 (P = 0.093); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.1485); Loss of loop (P = 0.2237)
7:117292900:T:A,P13569,V1293E,0.706,Loss of MoRF binding (P = 0.0341); Loss of ubiquitination at K1292 (P = 0.0518); Loss of helix (P = 0.1706); Loss of sheet (P = 0.1907); Gain of catalytic residue at V1293 (P = 0.2144)
7:117292900:T:C,P13569,V1293A,0.684,Gain of catalytic residue at V1293 (P = 0.05); Loss of ubiquitination at K1292 (P = 0.0736); Loss of MoRF binding (P = 0.1023); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1451)
7:117292900:T:G,P13569,V1293G,0.711,Loss of stability (P = 0.0337); Loss of ubiquitination at K1292 (P = 0.0432); Loss of MoRF binding (P = 0.0958); Gain of sheet (P = 0.1451); Loss of glycosylation at S1297 (P = 0.1536)
7:117292902:T:A,P13569,F1294I,0.608,Gain of ubiquitination at K1292 (P = 0.1204); Gain of MoRF binding (P = 0.1479); Gain of glycosylation at S1297 (P = 0.2052); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117292902:T:C,P13569,F1294L,0.607,Loss of ubiquitination at K1292 (P = 0.093); Loss of helix (P = 0.1299); Loss of glycosylation at S1297 (P = 0.1336); Gain of MoRF binding (P = 0.1512); Loss of sheet (P = 0.302)
7:117292902:T:G,P13569,F1294V,0.612,Loss of ubiquitination at K1292 (P = 0.0811); Gain of MoRF binding (P = 0.105); Loss of catalytic residue at F1294 (P = 0.1193); Loss of helix (P = 0.1299); Loss of glycosylation at S1297 (P = 0.2026)
7:117292903:T:A,P13569,F1294Y,0.587,Loss of ubiquitination at K1292 (P = 0.1062); Gain of MoRF binding (P = 0.1196); Loss of glycosylation at S1297 (P = 0.1241); Loss of stability (P = 0.1712); Gain of helix (P = 0.1736)
7:117292903:T:C,P13569,F1294S,0.615,Loss of stability (P = 0.0309); Loss of ubiquitination at K1292 (P = 0.0368); Gain of MoRF binding (P = 0.0726); Loss of glycosylation at S1297 (P = 0.0943); Gain of relative solvent accessibility (P = 0.1571)
7:117292903:T:G,P13569,F1294C,0.624,Loss of ubiquitination at K1292 (P = 0.0811); Loss of MoRF binding (P = 0.1251); Loss of glycosylation at S1297 (P = 0.1284); Loss of stability (P = 0.1651); Loss of helix (P = 0.2022)
7:117292904:T:A,P13569,F1294L,0.607,Loss of ubiquitination at K1292 (P = 0.093); Loss of helix (P = 0.1299); Loss of glycosylation at S1297 (P = 0.1336); Gain of MoRF binding (P = 0.1512); Loss of sheet (P = 0.302)
7:117292904:T:G,P13569,F1294L,0.607,Loss of ubiquitination at K1292 (P = 0.093); Loss of helix (P = 0.1299); Loss of glycosylation at S1297 (P = 0.1336); Gain of MoRF binding (P = 0.1512); Loss of sheet (P = 0.302)
7:117292905:A:C,P13569,I1295L,0.594,Loss of ubiquitination at K1292 (P = 0.1216); Loss of catalytic residue at I1295 (P = 0.1327); Loss of MoRF binding (P = 0.165); Gain of glycosylation at S1297 (P = 0.1983); Loss of helix (P = 0.2662)
7:117292905:A:G,P13569,I1295V,0.694,Loss of catalytic residue at I1295 (P = 0.1162); Loss of ubiquitination at K1292 (P = 0.1216); Gain of glycosylation at S1297 (P = 0.1336); Loss of stability (P = 0.1544); Gain of MoRF binding (P = 0.166)
7:117292905:A:T,P13569,I1295F,0.707,Gain of ubiquitination at K1292 (P = 0.0797); Gain of glycosylation at S1297 (P = 0.1183); Loss of MoRF binding (P = 0.1579); Loss of stability (P = 0.1591); Loss of helix (P = 0.2022)
7:117292906:T:A,P13569,I1295N,0.764,Loss of stability (P = 0.0407); Loss of ubiquitination at K1292 (P = 0.0432); Gain of MoRF binding (P = 0.0815); Loss of catalytic residue at I1295 (P = 0.2261); Loss of glycosylation at S1297 (P = 0.2574)
7:117292906:T:C,P13569,I1295T,0.712,Loss of stability (P = 0.0062); Loss of ubiquitination at K1292 (P = 0.0499); Loss of catalytic residue at I1295 (P = 0.0706); Gain of phosphorylation at I1295 (P = 0.0767); Gain of MoRF binding (P = 0.1249)
7:117292906:T:G,P13569,I1295S,0.794,Loss of catalytic residue at I1295 (P = 0.0317); Loss of ubiquitination at K1292 (P = 0.0373); Loss of stability (P = 0.0492); Gain of MoRF binding (P = 0.1001); Gain of disorder (P = 0.1153)
7:117292907:T:G,P13569,I1295M,0.643,Loss of catalytic residue at I1295 (P = 0.0231); Loss of ubiquitination at K1292 (P = 0.047); Gain of MoRF binding (P = 0.0861); Loss of helix (P = 0.1299); Loss of glycosylation at S1297 (P = 0.1984)
7:117292908:T:A,P13569,F1296I,0.827,Loss of ubiquitination at K1292 (P = 0.1062); Gain of MoRF binding (P = 0.1508); Loss of glycosylation at S1297 (P = 0.2399); Gain of helix (P = 0.2684); Loss of loop (P = 0.2897)
7:117292908:T:C,P13569,F1296L,0.81,Loss of glycosylation at S1297 (P = 0.0794); Loss of ubiquitination at K1292 (P = 0.093); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1786); Gain of loop (P = 0.2045)
7:117292908:T:G,P13569,F1296V,0.809,Loss of ubiquitination at K1292 (P = 0.1062); Gain of MoRF binding (P = 0.1216); Gain of helix (P = 0.132); Loss of glycosylation at S1297 (P = 0.1679); Gain of catalytic residue at F1296 (P = 0.1772)
7:117292909:T:A,P13569,F1296Y,0.821,Loss of ubiquitination at K1292 (P = 0.093); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1678); Loss of glycosylation at S1297 (P = 0.1829); Loss of stability (P = 0.281)
7:117292909:T:C,P13569,F1296S,0.871,Loss of ubiquitination at K1292 (P = 0.047); Gain of disorder (P = 0.0839); Loss of stability (P = 0.0914); Gain of MoRF binding (P = 0.1403); Gain of loop (P = 0.2045)
7:117292909:T:G,P13569,F1296C,0.845,Loss of glycosylation at S1297 (P = 0.0733); Loss of ubiquitination at K1292 (P = 0.093); Loss of MoRF binding (P = 0.1157); Gain of helix (P = 0.132); Loss of stability (P = 0.2804)
7:117292910:T:A,P13569,F1296L,0.81,Loss of glycosylation at S1297 (P = 0.0794); Loss of ubiquitination at K1292 (P = 0.093); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1786); Gain of loop (P = 0.2045)
7:117292910:T:G,P13569,F1296L,0.81,Loss of glycosylation at S1297 (P = 0.0794); Loss of ubiquitination at K1292 (P = 0.093); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.1786); Gain of loop (P = 0.2045)
7:117292911:T:A,P13569,S1297T,0.534,Loss of glycosylation at S1297 (P = 0.0387); Loss of catalytic residue at S1297 (P = 0.1121); Gain of ubiquitination at K1292 (P = 0.1204); Gain of methylation at K1302 (P = 0.1677); Gain of helix (P = 0.1736)
7:117292911:T:C,P13569,S1297P,0.621,Loss of glycosylation at S1297 (P = 0.0372); Loss of MoRF binding (P = 0.0881); Loss of ubiquitination at K1302 (P = 0.0949); Gain of methylation at K1302 (P = 0.1442); Gain of phosphorylation at T1299 (P = 0.1459)
7:117292911:T:G,P13569,S1297A,0.56,Loss of glycosylation at S1297 (P = 0.0264); Loss of ubiquitination at K1302 (P = 0.0524); Gain of helix (P = 0.1736); Loss of MoRF binding (P = 0.189); Gain of sheet (P = 0.1945)
7:117292912:C:A,P13569,S1297Y,0.655,Loss of glycosylation at S1297 (P = 0.0264); Gain of methylation at K1302 (P = 0.0472); Loss of ubiquitination at K1302 (P = 0.0594); Loss of MoRF binding (P = 0.1735); Gain of helix (P = 0.1736)
7:117292912:C:G,P13569,S1297C,0.673,Loss of glycosylation at S1297 (P = 0.0264); Loss of ubiquitination at K1302 (P = 0.064); Loss of loop (P = 0.0804); Gain of catalytic residue at T1299 (P = 0.0916); Loss of MoRF binding (P = 0.1469)
7:117292912:C:T,P13569,S1297F,0.671,Loss of catalytic residue at S1297 (P = 0.0148); Loss of glycosylation at S1297 (P = 0.0264); Loss of ubiquitination at K1302 (P = 0.064); Gain of MoRF binding (P = 0.1369); Gain of methylation at K1302 (P = 0.1491)
7:117292914:G:A,P13569,G1298R,0.816,Gain of MoRF binding (P = 0.0117); Loss of glycosylation at S1297 (P = 0.0572); Loss of ubiquitination at K1302 (P = 0.064); Gain of catalytic residue at G1298 (P = 0.0902); Gain of relative solvent accessibility (P = 0.1259)
7:117292914:G:C,P13569,G1298R,0.816,Gain of MoRF binding (P = 0.0117); Loss of glycosylation at S1297 (P = 0.0572); Loss of ubiquitination at K1302 (P = 0.064); Gain of catalytic residue at G1298 (P = 0.0902); Gain of relative solvent accessibility (P = 0.1259)
7:117292915:G:A,P13569,G1298E,0.791,Loss of glycosylation at S1297 (P = 0.0494); Loss of MoRF binding (P = 0.0942); Loss of ubiquitination at K1302 (P = 0.0949); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1903)
7:117292915:G:C,P13569,G1298A,0.779,Loss of glycosylation at S1297 (P = 0.0542); Loss of ubiquitination at K1302 (P = 0.1079); Loss of helix (P = 0.1299); Loss of MoRF binding (P = 0.2066); Gain of catalytic residue at G1298 (P = 0.2261)
7:117292915:G:T,P13569,G1298V,0.775,Loss of glycosylation at S1297 (P = 0.0406); Loss of ubiquitination at K1302 (P = 0.0702); Gain of MoRF binding (P = 0.1901); Loss of helix (P = 0.2022); Gain of methylation at K1302 (P = 0.2423)
7:117292917:A:C,P13569,T1299P,0.921,Loss of ubiquitination at K1302 (P = 0.0949); Gain of glycosylation at T1299 (P = 0.1013); Loss of MoRF binding (P = 0.1258); Loss of stability (P = 0.1324); Gain of methylation at K1302 (P = 0.15)
7:117292917:A:G,P13569,T1299A,0.932,Gain of catalytic residue at T1299 (P = 0.053); Loss of ubiquitination at K1302 (P = 0.0834); Gain of helix (P = 0.1736); Gain of glycosylation at S1297 (P = 0.1994); Loss of MoRF binding (P = 0.2195)
7:117292917:A:T,P13569,T1299S,0.855,Gain of catalytic residue at T1299 (P = 0.0107); Gain of disorder (P = 0.0665); Gain of ubiquitination at K1302 (P = 0.123); Loss of glycosylation at S1297 (P = 0.1279); Loss of helix (P = 0.1299)
7:117292918:C:A,P13569,T1299K,0.917,Gain of methylation at T1299 (P = 0.0276); Gain of MoRF binding (P = 0.0383); Gain of ubiquitination at T1299 (P = 0.068); Loss of helix (P = 0.1299); Loss of stability (P = 0.1658)
7:117292918:C:G,P13569,T1299R,0.93,Gain of MoRF binding (P = 0.0174); Gain of methylation at T1299 (P = 0.029); Gain of catalytic residue at T1299 (P = 0.0727); Loss of glycosylation at S1297 (P = 0.1301); Loss of ubiquitination at K1302 (P = 0.1435)
7:117292918:C:T,P13569,T1299I,0.965,Gain of catalytic residue at L1304 (P = 0.0375); Loss of ubiquitination at K1302 (P = 0.0438); Gain of methylation at K1302 (P = 0.0857); Loss of disorder (P = 0.1429); Gain of glycosylation at S1297 (P = 0.1575)
7:117292920:T:A,P13569,F1300I,0.53,Loss of ubiquitination at K1302 (P = 0.0702); Gain of methylation at K1302 (P = 0.1499); Gain of MoRF binding (P = 0.207); Gain of glycosylation at S1297 (P = 0.2278); Loss of helix (P = 0.2662)
7:117292920:T:C,P13569,F1300L,0.832,Gain of ubiquitination at K1302 (P = 0.0913); Loss of glycosylation at S1297 (P = 0.0916); Gain of disorder (P = 0.1871); Loss of helix (P = 0.2022); Loss of methylation at K1302 (P = 0.2437)
7:117292920:T:G,P13569,F1300V,0.591,Gain of ubiquitination at K1302 (P = 0.1062); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1903); Loss of glycosylation at S1297 (P = 0.2283); Gain of methylation at K1302 (P = 0.2443)
7:117292921:T:A,P13569,F1300Y,0.675,Gain of disorder (P = 0.1088); Loss of ubiquitination at K1302 (P = 0.1435); Loss of helix (P = 0.2022); Loss of MoRF binding (P = 0.2232); Loss of stability (P = 0.2256)
7:117292921:T:C,P13569,F1300S,0.872,Gain of disorder (P = 0.0056); Loss of stability (P = 0.0543); Gain of ubiquitination at K1302 (P = 0.0913); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117292921:T:G,P13569,F1300C,0.702,Gain of ubiquitination at K1302 (P = 0.123); Loss of stability (P = 0.1697); Gain of helix (P = 0.1736); Loss of MoRF binding (P = 0.1818); Loss of glycosylation at S1297 (P = 0.2045)
7:117292922:T:A,P13569,F1300L,0.832,Gain of ubiquitination at K1302 (P = 0.0913); Loss of glycosylation at S1297 (P = 0.0916); Gain of disorder (P = 0.1871); Loss of helix (P = 0.2022); Loss of methylation at K1302 (P = 0.2437)
7:117292922:T:G,P13569,F1300L,0.832,Gain of ubiquitination at K1302 (P = 0.0913); Loss of glycosylation at S1297 (P = 0.0916); Gain of disorder (P = 0.1871); Loss of helix (P = 0.2022); Loss of methylation at K1302 (P = 0.2437)
7:117292923:A:G,P13569,R1301G,0.823,Loss of catalytic residue at R1301 (P = 0.004); Gain of glycosylation at S1297 (P = 0.0948); Loss of MoRF binding (P = 0.1212); Loss of ubiquitination at K1302 (P = 0.1435); Loss of helix (P = 0.1706)
7:117292924:G:A,P13569,R1301K,0.774,Gain of methylation at R1301 (P = 0.0168); Gain of ubiquitination at R1301 (P = 0.0276); Gain of disorder (P = 0.1272); Gain of glycosylation at S1297 (P = 0.1334); Loss of helix (P = 0.2022)
7:117292924:G:C,P13569,R1301T,0.806,Loss of catalytic residue at R1301 (P = 0.0063); Gain of phosphorylation at R1301 (P = 0.0754); Gain of glycosylation at S1297 (P = 0.0867); Gain of ubiquitination at K1302 (P = 0.123); Loss of MoRF binding (P = 0.1239)
7:117292924:G:T,P13569,R1301I,0.848,Loss of ubiquitination at K1302 (P = 0.0428); Gain of methylation at K1302 (P = 0.0709); Loss of disorder (P = 0.0837); Gain of glycosylation at S1297 (P = 0.0941); Loss of MoRF binding (P = 0.1458)
7:117292925:A:C,P13569,R1301S,0.828,Loss of catalytic residue at R1301 (P = 0.0022); Gain of disorder (P = 0.0637); Gain of glycosylation at S1297 (P = 0.1006); Loss of ubiquitination at K1302 (P = 0.1231); Loss of MoRF binding (P = 0.1265)
7:117292925:A:T,P13569,R1301S,0.828,Loss of catalytic residue at R1301 (P = 0.0022); Gain of disorder (P = 0.0637); Gain of glycosylation at S1297 (P = 0.1006); Loss of ubiquitination at K1302 (P = 0.1231); Loss of MoRF binding (P = 0.1265)
7:117292926:A:C,P13569,K1302Q,0.455,Loss of ubiquitination at K1302 (P = 0.0218); Loss of methylation at K1302 (P = 0.0725); Loss of helix (P = 0.1299); Gain of disorder (P = 0.2008); Loss of loop (P = 0.2237)
7:117292926:A:G,P13569,K1302E,0.486,Loss of ubiquitination at K1302 (P = 0.0218); Loss of methylation at K1302 (P = 0.0725); Gain of disorder (P = 0.1323); Loss of MoRF binding (P = 0.161); Gain of glycosylation at S1297 (P = 0.1689)
7:117292927:A:C,P13569,K1302T,0.492,Loss of ubiquitination at K1302 (P = 0.0218); Loss of methylation at K1302 (P = 0.0725); Loss of stability (P = 0.0956); Loss of helix (P = 0.1299); Gain of glycosylation at S1297 (P = 0.1399)
7:117292927:A:G,P13569,K1302R,0.385,Loss of ubiquitination at K1302 (P = 0.0218); Gain of catalytic residue at K1302 (P = 0.1109); Loss of methylation at K1302 (P = 0.1334); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237)
7:117292927:A:T,P13569,K1302I,0.586,Loss of ubiquitination at K1302 (P = 0.0218); Loss of solvent accessibility (P = 0.0595); Loss of disorder (P = 0.0628); Loss of methylation at K1302 (P = 0.0725); Gain of catalytic residue at K1302 (P = 0.0862)
7:117292928:A:C,P13569,K1302N,0.518,Loss of ubiquitination at K1302 (P = 0.0218); Loss of methylation at K1302 (P = 0.0725); Gain of glycosylation at S1297 (P = 0.182); Loss of MoRF binding (P = 0.2339); Loss of stability (P = 0.2586)
7:117292928:A:T,P13569,K1302N,0.518,Loss of ubiquitination at K1302 (P = 0.0218); Loss of methylation at K1302 (P = 0.0725); Gain of glycosylation at S1297 (P = 0.182); Loss of MoRF binding (P = 0.2339); Loss of stability (P = 0.2586)
7:117292929:A:C,P13569,N1303H,0.956,Loss of ubiquitination at K1302 (P = 0.0557); Gain of disorder (P = 0.1057); Loss of helix (P = 0.1299); Gain of methylation at K1302 (P = 0.202); Loss of stability (P = 0.3238)
7:117292929:A:G,P13569,N1303D,0.922,Gain of ubiquitination at K1302 (P = 0.1062); Gain of disorder (P = 0.1286); Gain of helix (P = 0.1736); Loss of methylation at K1302 (P = 0.2322); Loss of MoRF binding (P = 0.3073)
7:117292929:A:T,P13569,N1303Y,0.912,Loss of ubiquitination at K1302 (P = 0.0428); Loss of disorder (P = 0.1216); Gain of loop (P = 0.2045); Loss of methylation at K1302 (P = 0.2732); Gain of catalytic residue at T1299 (P = 0.3396)
7:117292930:A:C,P13569,N1303T,0.902,Gain of phosphorylation at N1303 (P = 0.0419); Loss of ubiquitination at K1302 (P = 0.0557); Gain of methylation at K1302 (P = 0.1743); Gain of catalytic residue at K1302 (P = 0.2013); Gain of disorder (P = 0.2937)
7:117292930:A:G,P13569,N1303S,0.914,Gain of disorder (P = 0.0565); Loss of ubiquitination at K1302 (P = 0.0949); Gain of phosphorylation at N1303 (P = 0.1068); Gain of helix (P = 0.1736); Gain of methylation at K1302 (P = 0.251)
7:117292931:C:A,P13569,N1303K,0.96,Gain of ubiquitination at N1303 (P = 0.03); Gain of methylation at N1303 (P = 0.033); Gain of disorder (P = 0.1022); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1651)
7:117292932:T:A,P13569,L1304M,0.782,Gain of methylation at K1302 (P = 0.0706); Gain of disorder (P = 0.0788); Gain of ubiquitination at K1302 (P = 0.0804); Loss of helix (P = 0.1706); Loss of stability (P = 0.2143)
7:117292932:T:G,P13569,L1304V,0.746,Loss of stability (P = 0.0629); Gain of ubiquitination at K1302 (P = 0.0725); Gain of methylation at K1302 (P = 0.1244); Loss of helix (P = 0.1706); Gain of disorder (P = 0.2866)
7:117292933:T:C,P13569,L1304S,0.893,Gain of disorder (P = 0.0025); Loss of stability (P = 0.0092); Gain of methylation at K1302 (P = 0.055); Gain of phosphorylation at L1304 (P = 0.069); Gain of ubiquitination at K1302 (P = 0.0804)
7:117292933:T:G,P13569,L1304W,0.78,Loss of stability (P = 0.0215); Loss of ubiquitination at K1302 (P = 0.0834); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1901); Gain of MoRF binding (P = 0.2252)
7:117292934:G:C,P13569,L1304F,0.767,Loss of helix (P = 0.1299); Loss of ubiquitination at K1302 (P = 0.1435); Loss of stability (P = 0.1503); Gain of methylation at K1302 (P = 0.2045); Loss of disorder (P = 0.2787)
7:117292934:G:T,P13569,L1304F,0.767,Loss of helix (P = 0.1299); Loss of ubiquitination at K1302 (P = 0.1435); Loss of stability (P = 0.1503); Gain of methylation at K1302 (P = 0.2045); Loss of disorder (P = 0.2787)
7:117292935:G:A,P13569,D1305N,0.652,Loss of solvent accessibility (P = 0.0509); Loss of relative solvent accessibility (P = 0.0793); Loss of ubiquitination at K1302 (P = 0.0949); Loss of helix (P = 0.1299); Gain of methylation at K1302 (P = 0.1743)
7:117292935:G:C,P13569,D1305H,0.626,Loss of solvent accessibility (P = 0.0509); Loss of relative solvent accessibility (P = 0.0793); Loss of ubiquitination at K1302 (P = 0.0834); Loss of helix (P = 0.1299); Gain of methylation at K1302 (P = 0.1687)
7:117292935:G:T,P13569,D1305Y,0.664,Loss of solvent accessibility (P = 0.0509); Loss of disorder (P = 0.054); Loss of ubiquitination at K1302 (P = 0.0702); Loss of relative solvent accessibility (P = 0.0793); Loss of helix (P = 0.1299)
7:117292936:A:C,P13569,D1305A,0.622,Loss of solvent accessibility (P = 0.0509); Loss of ubiquitination at K1302 (P = 0.0702); Loss of relative solvent accessibility (P = 0.0793); Loss of disorder (P = 0.0921); Loss of helix (P = 0.1299)
7:117292936:A:G,P13569,D1305G,0.627,Loss of solvent accessibility (P = 0.0509); Loss of relative solvent accessibility (P = 0.0793); Loss of ubiquitination at K1302 (P = 0.1079); Loss of helix (P = 0.1299); Gain of methylation at R1301 (P = 0.1958)
7:117292936:A:T,P13569,D1305V,0.645,Loss of disorder (P = 0.0382); Loss of solvent accessibility (P = 0.0509); Loss of relative solvent accessibility (P = 0.0793); Loss of ubiquitination at K1302 (P = 0.1079); Gain of catalytic residue at D1305 (P = 0.1688)
7:117292937:T:A,P13569,D1305E,0.815,Gain of methylation at K1302 (P = 0.1176); Gain of disorder (P = 0.1314); Loss of ubiquitination at K1302 (P = 0.1435); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.3602)
7:117292937:T:G,P13569,D1305E,0.815,Gain of methylation at K1302 (P = 0.1176); Gain of disorder (P = 0.1314); Loss of ubiquitination at K1302 (P = 0.1435); Loss of helix (P = 0.2022); Gain of solvent accessibility (P = 0.3602)
7:117292938:C:A,P13569,P1306T,0.61,Loss of ubiquitination at K1302 (P = 0.0949); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1977); Gain of relative solvent accessibility (P = 0.2363); Loss of methylation at K1302 (P = 0.273)
7:117292938:C:G,P13569,P1306A,0.626,Loss of ubiquitination at K1302 (P = 0.0594); Loss of disorder (P = 0.1166); Gain of helix (P = 0.1736); Loss of methylation at K1302 (P = 0.1982); Loss of loop (P = 0.2237)
7:117292938:C:T,P13569,P1306S,0.602,Gain of disorder (P = 0.0845); Gain of ubiquitination at K1302 (P = 0.1062); Gain of helix (P = 0.1736); Gain of relative solvent accessibility (P = 0.2363); Gain of methylation at K1302 (P = 0.2732)
7:117292939:C:A,P13569,P1306H,0.617,Loss of ubiquitination at K1302 (P = 0.0702); Gain of helix (P = 0.1736); Gain of catalytic residue at E1308 (P = 0.1953); Loss of loop (P = 0.2237); Loss of methylation at K1302 (P = 0.2337)
7:117292939:C:G,P13569,P1306R,0.713,Gain of MoRF binding (P = 0.0752); Loss of ubiquitination at K1302 (P = 0.1231); Gain of catalytic residue at P1306 (P = 0.1292); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2455)
7:117292939:C:T,P13569,P1306L,0.661,Loss of ubiquitination at K1302 (P = 0.046); Loss of disorder (P = 0.054); Loss of methylation at K1302 (P = 0.1704); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4098)
7:117292941:T:A,P13569,Y1307N,0.736,Gain of disorder (P = 0.0137); Gain of ubiquitination at K1302 (P = 0.0577); Gain of methylation at K1302 (P = 0.1042); Loss of helix (P = 0.2022); Loss of stability (P = 0.421)
7:117292941:T:C,P13569,Y1307H,0.769,Gain of disorder (P = 0.019); Gain of ubiquitination at K1302 (P = 0.0725); Gain of methylation at K1302 (P = 0.2007); Gain of catalytic residue at D1305 (P = 0.2709); Loss of stability (P = 0.3061)
7:117292941:T:G,P13569,Y1307D,0.745,Gain of disorder (P = 0.0067); Gain of ubiquitination at K1302 (P = 0.0671); Gain of methylation at K1302 (P = 0.0749); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117292942:A:C,P13569,Y1307S,0.68,Gain of disorder (P = 0.0041); Gain of methylation at K1302 (P = 0.0706); Gain of ubiquitination at K1302 (P = 0.123); Loss of helix (P = 0.1299); Gain of phosphorylation at S1311 (P = 0.1994)
7:117292942:A:G,P13569,Y1307C,0.878,Gain of catalytic residue at P1306 (P = 0.013); Loss of ubiquitination at K1302 (P = 0.0768); Loss of disorder (P = 0.1256); Gain of helix (P = 0.1736); Loss of methylation at K1302 (P = 0.2462)
7:117292942:A:T,P13569,Y1307F,0.742,Loss of ubiquitination at K1302 (P = 0.0702); Gain of helix (P = 0.1736); Loss of disorder (P = 0.2113); Loss of methylation at K1302 (P = 0.2411); Loss of loop (P = 0.3664)
7:117292944:G:A,P13569,E1308K,0.53,Gain of methylation at E1308 (P = 0.0168); Gain of ubiquitination at E1308 (P = 0.0247); Loss of catalytic residue at W1310 (P = 0.0297); Loss of helix (P = 0.1706); Gain of MoRF binding (P = 0.2048)
7:117292944:G:C,P13569,E1308Q,0.374,Loss of catalytic residue at W1310 (P = 0.0391); Loss of disorder (P = 0.214); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Gain of MoRF binding (P = 0.4507)
7:117292945:A:C,P13569,E1308A,0.556,Loss of catalytic residue at W1310 (P = 0.0645); Loss of disorder (P = 0.0761); Loss of helix (P = 0.2022); Loss of solvent accessibility (P = 0.2732); Loss of loop (P = 0.3664)
7:117292945:A:G,P13569,E1308G,0.577,Loss of catalytic residue at W1310 (P = 0.0799); Loss of disorder (P = 0.1599); Loss of solvent accessibility (P = 0.3103); Loss of stability (P = 0.3238); Loss of helix (P = 0.3949)
7:117292945:A:T,P13569,E1308V,0.668,Loss of disorder (P = 0.0347); Loss of catalytic residue at W1310 (P = 0.0643); Loss of solvent accessibility (P = 0.3136); Loss of loop (P = 0.3664); Loss of helix (P = 0.3949)
7:117292946:A:C,P13569,E1308D,0.435,Loss of catalytic residue at W1310 (P = 0.0356); Loss of disorder (P = 0.274); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Gain of phosphorylation at Y1307 (P = 0.4515)
7:117292946:A:T,P13569,E1308D,0.435,Loss of catalytic residue at W1310 (P = 0.0356); Loss of disorder (P = 0.274); Loss of helix (P = 0.3949); Loss of sheet (P = 0.437); Gain of phosphorylation at Y1307 (P = 0.4515)
7:117292947:C:A,P13569,Q1309K,0.524,Loss of catalytic residue at Q1309 (P = 0.0085); Gain of methylation at Q1309 (P = 0.0199); Gain of ubiquitination at Q1309 (P = 0.0325); Loss of stability (P = 0.1178); Gain of disorder (P = 0.1446)
7:117292947:C:G,P13569,Q1309E,0.404,Loss of catalytic residue at Q1309 (P = 0.0271); Gain of disorder (P = 0.0906); Gain of helix (P = 0.1736); Gain of phosphorylation at S1311 (P = 0.2376); Loss of loop (P = 0.3664)
7:117292948:A:C,P13569,Q1309P,0.507,Loss of catalytic residue at Q1309 (P = 0.0331); Loss of stability (P = 0.1441); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2109); Gain of phosphorylation at S1311 (P = 0.3362)
7:117292948:A:G,P13569,Q1309R,0.517,Gain of phosphorylation at S1311 (P = 0.078); Loss of catalytic residue at Q1309 (P = 0.0823); Gain of helix (P = 0.1736); Loss of disorder (P = 0.2845); Loss of loop (P = 0.3664)
7:117292948:A:T,P13569,Q1309L,0.519,Loss of catalytic residue at Q1309 (P = 0.0264); Loss of disorder (P = 0.0691); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Gain of sheet (P = 0.4423)
7:117292949:G:C,P13569,Q1309H,0.764,Loss of catalytic residue at Q1309 (P = 0.0169); Gain of disorder (P = 0.1571); Gain of helix (P = 0.1736); Loss of stability (P = 0.1949); Loss of loop (P = 0.3664)
7:117292949:G:T,P13569,Q1309H,0.764,Loss of catalytic residue at Q1309 (P = 0.0169); Gain of disorder (P = 0.1571); Gain of helix (P = 0.1736); Loss of stability (P = 0.1949); Loss of loop (P = 0.3664)
7:117292950:T:A,P13569,W1310R,0.681,Gain of disorder (P = 0.0048); Gain of phosphorylation at S1311 (P = 0.0831); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.1012); Loss of catalytic residue at W1310 (P = 0.1168)
7:117292950:T:C,P13569,W1310R,0.681,Gain of disorder (P = 0.0048); Gain of phosphorylation at S1311 (P = 0.0831); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.1012); Loss of catalytic residue at W1310 (P = 0.1168)
7:117292950:T:G,P13569,W1310G,0.742,Gain of disorder (P = 0.0031); Loss of catalytic residue at W1310 (P = 0.0297); Loss of helix (P = 0.1706); Gain of relative solvent accessibility (P = 0.1894); Gain of phosphorylation at S1311 (P = 0.1957)
7:117292951:G:C,P13569,W1310S,0.635,Gain of disorder (P = 3e-04); Loss of catalytic residue at W1310 (P = 0.0079); Gain of relative solvent accessibility (P = 0.1012); Gain of phosphorylation at S1311 (P = 0.1436); Loss of helix (P = 0.1706)
7:117292951:G:T,P13569,W1310L,0.664,Loss of catalytic residue at W1310 (P = 0.0374); Gain of disorder (P = 0.065); Gain of relative solvent accessibility (P = 0.281); Loss of helix (P = 0.3949); Gain of phosphorylation at Y1307 (P = 0.4009)
7:117292952:G:C,P13569,W1310C,0.682,Loss of catalytic residue at W1310 (P = 0.0464); Gain of disorder (P = 0.2426); Loss of loop (P = 0.3664); Loss of helix (P = 0.3949); Loss of phosphorylation at S1311 (P = 0.5127)
7:117292952:G:T,P13569,W1310C,0.682,Loss of catalytic residue at W1310 (P = 0.0464); Gain of disorder (P = 0.2426); Loss of loop (P = 0.3664); Loss of helix (P = 0.3949); Loss of phosphorylation at S1311 (P = 0.5127)
7:117292953:A:C,P13569,S1311R,0.562,Gain of solvent accessibility (P = 0.1185); Loss of catalytic residue at W1310 (P = 0.1943); Gain of loop (P = 0.2045); Loss of disorder (P = 0.214); Loss of helix (P = 0.3949)
7:117292953:A:G,P13569,S1311G,0.534,Loss of stability (P = 0.1006); Loss of disorder (P = 0.1977); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949); Loss of phosphorylation at S1311 (P = 0.4065)
7:117292953:A:T,P13569,S1311C,0.624,Loss of disorder (P = 0.0439); Gain of catalytic residue at S1311 (P = 0.2289); Gain of helix (P = 0.2684); Loss of loop (P = 0.3664); Loss of phosphorylation at S1311 (P = 0.4065)
7:117292954:G:A,P13569,S1311N,0.501,Loss of disorder (P = 0.1872); Gain of loop (P = 0.2045); Loss of helix (P = 0.3949); Loss of phosphorylation at S1311 (P = 0.4065); Gain of solvent accessibility (P = 0.4304)
7:117292954:G:C,P13569,S1311T,0.511,Loss of disorder (P = 0.1729); Gain of loop (P = 0.2045); Loss of stability (P = 0.2565); Loss of helix (P = 0.3949); Loss of phosphorylation at S1311 (P = 0.4856)
7:117292954:G:T,P13569,S1311I,0.589,Loss of disorder (P = 0.052); Gain of helix (P = 0.2684); Loss of loop (P = 0.3664); Loss of phosphorylation at S1311 (P = 0.4065); Loss of sheet (P = 0.5184)
7:117292955:T:A,P13569,S1311R,0.562,Gain of solvent accessibility (P = 0.1185); Loss of catalytic residue at W1310 (P = 0.1943); Gain of loop (P = 0.2045); Loss of disorder (P = 0.214); Loss of helix (P = 0.3949)
7:117292955:T:G,P13569,S1311R,0.562,Gain of solvent accessibility (P = 0.1185); Loss of catalytic residue at W1310 (P = 0.1943); Gain of loop (P = 0.2045); Loss of disorder (P = 0.214); Loss of helix (P = 0.3949)
7:117292956:G:A,P13569,D1312N,0.613,Gain of ubiquitination at K1317 (P = 0.1832); Loss of methylation at K1317 (P = 0.1945); Loss of stability (P = 0.2321); Loss of disorder (P = 0.2836); Loss of catalytic residue at E1314 (P = 0.2899)
7:117292956:G:C,P13569,D1312H,0.591,Gain of methylation at K1317 (P = 0.1817); Gain of disorder (P = 0.1825); Loss of stability (P = 0.2309); Gain of ubiquitination at K1317 (P = 0.2348); Loss of loop (P = 0.3664)
7:117292956:G:T,P13569,D1312Y,0.634,Gain of phosphorylation at D1312 (P = 0.0767); Gain of methylation at K1317 (P = 0.083); Loss of disorder (P = 0.1403); Gain of ubiquitination at K1317 (P = 0.1557); Loss of loop (P = 0.3664)
7:117292957:A:C,P13569,D1312A,0.618,Loss of solvent accessibility (P = 0.1202); Loss of methylation at K1317 (P = 0.1361); Gain of catalytic residue at D1312 (P = 0.1397); Loss of disorder (P = 0.1873); Gain of ubiquitination at K1317 (P = 0.2106)
7:117292957:A:G,P13569,D1312G,0.617,Loss of solvent accessibility (P = 0.0595); Loss of stability (P = 0.1518); Loss of methylation at K1317 (P = 0.1959); Gain of ubiquitination at K1317 (P = 0.2348); Gain of catalytic residue at I1315 (P = 0.2634)
7:117292957:A:T,P13569,D1312V,0.643,Loss of disorder (P = 0.0893); Loss of methylation at K1317 (P = 0.1661); Gain of ubiquitination at K1317 (P = 0.1832); Loss of solvent accessibility (P = 0.2882); Loss of sheet (P = 0.437)
7:117292958:T:A,P13569,D1312E,0.604,Gain of methylation at K1317 (P = 0.1253); Gain of disorder (P = 0.2017); Gain of ubiquitination at K1317 (P = 0.2348); Gain of solvent accessibility (P = 0.2601); Loss of loop (P = 0.3664)
7:117292958:T:G,P13569,D1312E,0.604,Gain of methylation at K1317 (P = 0.1253); Gain of disorder (P = 0.2017); Gain of ubiquitination at K1317 (P = 0.2348); Gain of solvent accessibility (P = 0.2601); Loss of loop (P = 0.3664)
7:117292959:C:G,P13569,Q1313E,0.502,Gain of relative solvent accessibility (P = 0.0999); Gain of solvent accessibility (P = 0.1319); Gain of phosphorylation at S1311 (P = 0.1468); Gain of disorder (P = 0.1744); Gain of methylation at K1317 (P = 0.1975)
7:117292960:A:C,P13569,Q1313P,0.632,Gain of catalytic residue at Q1313 (P = 0.0258); Loss of methylation at K1317 (P = 0.2005); Gain of phosphorylation at S1311 (P = 0.2483); Loss of ubiquitination at K1317 (P = 0.2547); Gain of disorder (P = 0.3041)
7:117292960:A:G,P13569,Q1313R,0.535,Gain of phosphorylation at S1311 (P = 0.1127); Loss of methylation at K1317 (P = 0.1611); Gain of ubiquitination at K1317 (P = 0.2106); Loss of catalytic residue at E1314 (P = 0.3102); Loss of disorder (P = 0.3489)
7:117292960:A:T,P13569,Q1313L,0.562,Gain of ubiquitination at K1317 (P = 0.0573); Loss of methylation at K1317 (P = 0.0679); Loss of disorder (P = 0.1472); Loss of loop (P = 0.3664); Gain of catalytic residue at K1317 (P = 0.4616)
7:117292961:A:C,P13569,Q1313H,0.511,Loss of methylation at K1317 (P = 0.1681); Gain of disorder (P = 0.2056); Loss of ubiquitination at K1317 (P = 0.2547); Loss of loop (P = 0.3664); Gain of catalytic residue at E1314 (P = 0.4342)
7:117292961:A:T,P13569,Q1313H,0.511,Loss of methylation at K1317 (P = 0.1681); Gain of disorder (P = 0.2056); Loss of ubiquitination at K1317 (P = 0.2547); Loss of loop (P = 0.3664); Gain of catalytic residue at E1314 (P = 0.4342)
7:117292962:G:A,P13569,E1314K,0.567,Gain of methylation at E1314 (P = 0.0397); Gain of ubiquitination at E1314 (P = 0.0797); Loss of catalytic residue at W1316 (P = 0.1066); Loss of stability (P = 0.327); Loss of disorder (P = 0.3741)
7:117292962:G:C,P13569,E1314Q,0.475,Loss of catalytic residue at W1316 (P = 0.112); Gain of methylation at K1317 (P = 0.1311); Loss of ubiquitination at K1317 (P = 0.2547); Loss of disorder (P = 0.3899); Gain of sheet (P = 0.4423)
7:117292963:A:C,P13569,E1314A,0.549,Loss of catalytic residue at W1316 (P = 0.1265); Loss of methylation at K1317 (P = 0.1769); Gain of ubiquitination at K1317 (P = 0.1832); Loss of stability (P = 0.187); Loss of helix (P = 0.2022)
7:117292963:A:G,P13569,E1314G,0.562,Loss of catalytic residue at W1316 (P = 0.1318); Loss of stability (P = 0.1429); Gain of methylation at K1317 (P = 0.1896); Gain of ubiquitination at K1317 (P = 0.2348); Loss of solvent accessibility (P = 0.2732)
7:117292963:A:T,P13569,E1314V,0.589,Gain of ubiquitination at K1317 (P = 0.0872); Loss of catalytic residue at W1316 (P = 0.1285); Loss of disorder (P = 0.1475); Gain of methylation at K1317 (P = 0.1776); Loss of helix (P = 0.2022)
7:117292964:A:C,P13569,E1314D,0.488,Loss of catalytic residue at W1316 (P = 0.1087); Loss of methylation at K1317 (P = 0.1242); Gain of ubiquitination at K1317 (P = 0.2106); Loss of disorder (P = 0.3942); Loss of loop (P = 0.4412)
7:117292964:A:T,P13569,E1314D,0.488,Loss of catalytic residue at W1316 (P = 0.1087); Loss of methylation at K1317 (P = 0.1242); Gain of ubiquitination at K1317 (P = 0.2106); Loss of disorder (P = 0.3942); Loss of loop (P = 0.4412)
7:117292965:A:C,P13569,I1315L,0.584,Loss of methylation at K1317 (P = 0.0929); Gain of helix (P = 0.2294); Loss of catalytic residue at A1319 (P = 0.2412); Gain of disorder (P = 0.2415); Loss of ubiquitination at K1317 (P = 0.2547)
7:117292965:A:G,P13569,I1315V,0.547,Loss of methylation at K1317 (P = 0.1516); Loss of ubiquitination at K1317 (P = 0.2368); Loss of catalytic residue at A1319 (P = 0.2438); Gain of disorder (P = 0.2801); Loss of helix (P = 0.4763)
7:117292965:A:T,P13569,I1315L,0.584,Loss of methylation at K1317 (P = 0.0929); Gain of helix (P = 0.2294); Loss of catalytic residue at A1319 (P = 0.2412); Gain of disorder (P = 0.2415); Loss of ubiquitination at K1317 (P = 0.2547)
7:117292966:T:A,P13569,I1315K,0.678,Gain of disorder (P = 0.0017); Gain of ubiquitination at I1315 (P = 0.0267); Loss of stability (P = 0.0384); Gain of relative solvent accessibility (P = 0.1066); Gain of solvent accessibility (P = 0.1116)
7:117292966:T:C,P13569,I1315T,0.633,Gain of disorder (P = 0.0266); Loss of stability (P = 0.027); Loss of methylation at K1317 (P = 0.1345); Gain of phosphorylation at I1315 (P = 0.1514); Gain of ubiquitination at K1317 (P = 0.2348)
7:117292966:T:G,P13569,I1315R,0.67,Gain of disorder (P = 0.017); Loss of stability (P = 0.0639); Gain of ubiquitination at K1317 (P = 0.0758); Loss of methylation at K1317 (P = 0.108); Gain of solvent accessibility (P = 0.1708)
7:117292967:A:G,P13569,I1315M,0.583,Gain of disorder (P = 0.0962); Loss of methylation at K1317 (P = 0.1623); Loss of ubiquitination at K1317 (P = 0.2368); Loss of catalytic residue at A1319 (P = 0.2485); Loss of stability (P = 0.279)
7:117292968:T:A,P13569,W1316R,0.562,Gain of disorder (P = 0.0134); Gain of solvent accessibility (P = 0.0648); Loss of stability (P = 0.081); Loss of catalytic residue at W1316 (P = 0.097); Gain of relative solvent accessibility (P = 0.0999)
7:117292968:T:G,P13569,W1316G,0.639,Gain of disorder (P = 0.0065); Loss of stability (P = 0.0213); Gain of catalytic residue at I1315 (P = 0.0645); Gain of relative solvent accessibility (P = 0.0999); Loss of methylation at K1317 (P = 0.1405)
7:117292969:G:C,P13569,W1316S,0.569,Gain of disorder (P = 4e-04); Loss of stability (P = 0.0433); Gain of glycosylation at W1316 (P = 0.0556); Loss of catalytic residue at W1316 (P = 0.0747); Gain of relative solvent accessibility (P = 0.0999)
7:117292969:G:T,P13569,W1316L,0.596,Loss of methylation at K1317 (P = 0.0974); Loss of catalytic residue at W1316 (P = 0.118); Gain of ubiquitination at K1317 (P = 0.2348); Gain of relative solvent accessibility (P = 0.2363); Gain of disorder (P = 0.2592)
7:117292970:G:C,P13569,W1316C,0.631,Gain of methylation at K1317 (P = 0.0202); Loss of catalytic residue at W1316 (P = 0.086); Loss of ubiquitination at K1317 (P = 0.226); Gain of helix (P = 0.2294); Loss of stability (P = 0.2337)
7:117292970:G:T,P13569,W1316C,0.631,Gain of methylation at K1317 (P = 0.0202); Loss of catalytic residue at W1316 (P = 0.086); Loss of ubiquitination at K1317 (P = 0.226); Gain of helix (P = 0.2294); Loss of stability (P = 0.2337)
7:117292971:A:C,P13569,K1317Q,0.414,Loss of methylation at K1317 (P = 0.0379); Loss of ubiquitination at K1317 (P = 0.0412); Gain of disorder (P = 0.3598); Loss of catalytic residue at K1317 (P = 0.3912); Loss of solvent accessibility (P = 0.4218)
7:117292971:A:G,P13569,K1317E,0.384,Loss of methylation at K1317 (P = 0.0379); Loss of ubiquitination at K1317 (P = 0.0412); Gain of disorder (P = 0.2597); Loss of solvent accessibility (P = 0.4011); Gain of loop (P = 0.4248)
7:117292972:A:C,P13569,K1317T,0.509,Loss of methylation at K1317 (P = 0.0379); Loss of ubiquitination at K1317 (P = 0.0412); Loss of solvent accessibility (P = 0.1922); Loss of catalytic residue at K1317 (P = 0.2895); Gain of phosphorylation at K1317 (P = 0.3337)
7:117292972:A:G,P13569,K1317R,0.412,Loss of methylation at K1317 (P = 0.0395); Loss of ubiquitination at K1317 (P = 0.0412); Gain of helix (P = 0.2294); Loss of glycosylation at K1317 (P = 0.4315); Gain of disorder (P = 0.4721)
7:117292972:A:T,P13569,K1317I,0.519,Loss of methylation at K1317 (P = 0.0379); Loss of ubiquitination at K1317 (P = 0.0412); Gain of catalytic residue at D1320 (P = 0.0513); Loss of solvent accessibility (P = 0.2882); Loss of disorder (P = 0.3024)
7:117292973:A:C,P13569,K1317N,0.475,Loss of methylation at K1317 (P = 0.0379); Loss of ubiquitination at K1317 (P = 0.0412); Loss of solvent accessibility (P = 0.239); Gain of catalytic residue at W1316 (P = 0.3715); Gain of loop (P = 0.4248)
7:117292973:A:T,P13569,K1317N,0.475,Loss of methylation at K1317 (P = 0.0379); Loss of ubiquitination at K1317 (P = 0.0412); Loss of solvent accessibility (P = 0.239); Gain of catalytic residue at W1316 (P = 0.3715); Gain of loop (P = 0.4248)
7:117292974:G:A,P13569,V1318I,0.758,Gain of ubiquitination at K1317 (P = 0.1064); Loss of methylation at K1317 (P = 0.1068); Loss of catalytic residue at E1321 (P = 0.4171); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117292974:G:C,P13569,V1318L,0.77,Loss of methylation at K1317 (P = 0.0634); Gain of ubiquitination at K1317 (P = 0.1557); Loss of catalytic residue at E1321 (P = 0.2226); Loss of helix (P = 0.4763); Gain of disorder (P = 0.4902)
7:117292974:G:T,P13569,V1318F,0.795,Gain of ubiquitination at K1317 (P = 0.0872); Gain of methylation at K1317 (P = 0.0888); Loss of catalytic residue at E1321 (P = 0.2253); Loss of stability (P = 0.3902); Loss of loop (P = 0.4412)
7:117292975:T:A,P13569,V1318D,0.867,Gain of disorder (P = 0.0251); Loss of methylation at K1317 (P = 0.0527); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1376); Loss of stability (P = 0.1428)
7:117292975:T:C,P13569,V1318A,0.873,Loss of stability (P = 0.0587); Loss of methylation at K1317 (P = 0.0623); Gain of disorder (P = 0.1694); Loss of catalytic residue at E1321 (P = 0.1963); Loss of helix (P = 0.2022)
7:117292975:T:G,P13569,V1318G,0.782,Loss of stability (P = 0.0435); Loss of helix (P = 0.0444); Gain of disorder (P = 0.062); Loss of methylation at K1317 (P = 0.0668); Gain of loop (P = 0.069)
7:117292977:G:A,P13569,A1319T,0.601,Loss of catalytic residue at A1319 (P = 0.1738); Gain of methylation at K1317 (P = 0.1813); Loss of ubiquitination at K1317 (P = 0.2547); Loss of stability (P = 0.3918); Gain of disorder (P = 0.436)
7:117292977:G:C,P13569,A1319P,0.809,Gain of methylation at K1317 (P = 0.0883); Gain of catalytic residue at A1319 (P = 0.1037); Loss of ubiquitination at K1317 (P = 0.2368); Gain of disorder (P = 0.3065); Loss of stability (P = 0.3937)
7:117292977:G:T,P13569,A1319S,0.747,Gain of disorder (P = 0.0977); Loss of methylation at K1317 (P = 0.1808); Loss of ubiquitination at K1317 (P = 0.2139); Loss of catalytic residue at A1319 (P = 0.2576); Gain of phosphorylation at A1319 (P = 0.3781)
7:117292978:C:A,P13569,A1319E,0.817,Gain of disorder (P = 0.1005); Gain of ubiquitination at K1317 (P = 0.1283); Loss of methylation at K1317 (P = 0.1735); Loss of catalytic residue at A1319 (P = 0.218); Gain of solvent accessibility (P = 0.3602)
7:117292978:C:G,P13569,A1319G,0.767,Loss of stability (P = 0.1205); Gain of catalytic residue at L1324 (P = 0.1314); Gain of methylation at K1317 (P = 0.1732); Loss of ubiquitination at K1317 (P = 0.2451); Gain of disorder (P = 0.3704)
7:117292978:C:T,P13569,A1319V,0.605,Gain of methylation at K1317 (P = 0.075); Loss of catalytic residue at A1319 (P = 0.1713); Gain of ubiquitination at K1317 (P = 0.2106); Loss of relative solvent accessibility (P = 0.4508); Loss of helix (P = 0.4763)
7:117292980:G:A,P13569,D1320N,0.487,Gain of methylation at K1317 (P = 0.0774); Gain of ubiquitination at K1317 (P = 0.2106); Loss of stability (P = 0.476); Gain of catalytic residue at E1321 (P = 0.476); Loss of helix (P = 0.4763)
7:117292980:G:C,P13569,D1320H,0.484,Gain of methylation at K1317 (P = 0.0602); Gain of ubiquitination at K1317 (P = 0.1832); Loss of stability (P = 0.2309); Gain of catalytic residue at W1316 (P = 0.4066); Loss of helix (P = 0.4763)
7:117292980:G:T,P13569,D1320Y,0.497,Gain of ubiquitination at K1317 (P = 0.1064); Loss of methylation at K1317 (P = 0.1854); Gain of catalytic residue at D1320 (P = 0.466); Loss of helix (P = 0.4763); Loss of loop (P = 0.4786)
7:117292981:A:C,P13569,D1320A,0.493,Gain of methylation at K1317 (P = 0.1806); Gain of ubiquitination at K1317 (P = 0.2348); Loss of solvent accessibility (P = 0.2668); Gain of catalytic residue at D1320 (P = 0.3387); Loss of stability (P = 0.4738)
7:117292981:A:G,P13569,D1320G,0.535,Gain of methylation at K1317 (P = 0.122); Loss of stability (P = 0.1247); Gain of catalytic residue at A1319 (P = 0.1481); Loss of helix (P = 0.1706); Loss of solvent accessibility (P = 0.1868)
7:117292981:A:T,P13569,D1320V,0.532,Gain of methylation at K1317 (P = 0.0836); Gain of ubiquitination at K1317 (P = 0.1064); Gain of catalytic residue at W1316 (P = 0.4141); Loss of solvent accessibility (P = 0.4141); Loss of helix (P = 0.4763)
7:117292982:T:A,P13569,D1320E,0.375,Gain of methylation at K1317 (P = 0.1252); Loss of helix (P = 0.1706); Gain of ubiquitination at K1317 (P = 0.2348); Gain of solvent accessibility (P = 0.3602); Loss of catalytic residue at A1319 (P = 0.4091)
7:117292982:T:G,P13569,D1320E,0.375,Gain of methylation at K1317 (P = 0.1252); Loss of helix (P = 0.1706); Gain of ubiquitination at K1317 (P = 0.2348); Gain of solvent accessibility (P = 0.3602); Loss of catalytic residue at A1319 (P = 0.4091)
7:117292983:G:A,P13569,E1321K,0.713,Gain of ubiquitination at E1321 (P = 0.0452); Gain of MoRF binding (P = 0.1491); Loss of methylation at K1317 (P = 0.1696); Loss of catalytic residue at E1321 (P = 0.2092); Loss of phosphorylation at S1326 (P = 0.4229)
7:117292983:G:C,P13569,E1321Q,0.847,Gain of methylation at K1317 (P = 0.134); Loss of catalytic residue at E1321 (P = 0.2313); Loss of ubiquitination at K1317 (P = 0.2451); Loss of phosphorylation at S1326 (P = 0.3935); Gain of MoRF binding (P = 0.4917)
7:117292984:A:C,P13569,E1321A,0.657,Loss of methylation at K1317 (P = 0.1638); Gain of catalytic residue at A1319 (P = 0.2255); Gain of ubiquitination at K1317 (P = 0.2348); Loss of solvent accessibility (P = 0.3543); Loss of phosphorylation at S1326 (P = 0.3914)
7:117292984:A:G,P13569,E1321G,0.627,Gain of catalytic residue at V1322 (P = 0.0917); Loss of methylation at K1317 (P = 0.2017); Loss of ubiquitination at K1317 (P = 0.2547); Loss of stability (P = 0.284); Loss of solvent accessibility (P = 0.3103)
7:117292984:A:T,P13569,E1321V,0.68,Gain of methylation at K1317 (P = 0.1374); Gain of ubiquitination at K1317 (P = 0.1557); Loss of catalytic residue at E1321 (P = 0.1655); Loss of phosphorylation at S1326 (P = 0.3884); Loss of solvent accessibility (P = 0.4274)
7:117292985:G:C,P13569,E1321D,0.59,Loss of methylation at K1317 (P = 0.1863); Gain of ubiquitination at K1317 (P = 0.2348); Gain of catalytic residue at A1319 (P = 0.3359); Loss of phosphorylation at S1326 (P = 0.432); Loss of glycosylation at K1317 (P = 0.6321)
7:117292985:G:T,P13569,E1321D,0.59,Loss of methylation at K1317 (P = 0.1863); Gain of ubiquitination at K1317 (P = 0.2348); Gain of catalytic residue at A1319 (P = 0.3359); Loss of phosphorylation at S1326 (P = 0.432); Loss of glycosylation at K1317 (P = 0.6321)
7:117304742:G:A,P13569,V1322I,0.717,Gain of catalytic residue at V1322 (P = 0.0137); Gain of ubiquitination at K1317 (P = 0.1283); Gain of methylation at K1317 (P = 0.1581); Loss of phosphorylation at S1326 (P = 0.4402); Gain of glycosylation at K1317 (P = 0.5654)
7:117304742:G:C,P13569,V1322L,0.802,Loss of methylation at K1317 (P = 0.1315); Gain of ubiquitination at K1317 (P = 0.1832); Gain of phosphorylation at S1326 (P = 0.415); Gain of glycosylation at K1317 (P = 0.5543); Loss of catalytic residue at E1321 (P = 0.6366)
7:117304742:G:T,P13569,V1322F,0.819,Gain of ubiquitination at K1317 (P = 0.1832); Loss of methylation at K1317 (P = 0.1977); Gain of catalytic residue at V1322 (P = 0.3143); Loss of phosphorylation at S1326 (P = 0.4492); Loss of stability (P = 0.572)
7:117304743:T:A,P13569,V1322D,0.869,Gain of disorder (P = 0.0881); Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at K1317 (P = 0.1298); Loss of stability (P = 0.1985); Loss of catalytic residue at S1326 (P = 0.2243)
7:117304743:T:C,P13569,V1322A,0.822,Gain of catalytic residue at V1322 (P = 0.0344); Loss of methylation at K1317 (P = 0.1333); Loss of stability (P = 0.2173); Gain of ubiquitination at K1317 (P = 0.2348); Gain of phosphorylation at S1326 (P = 0.4013)
7:117304743:T:G,P13569,V1322G,0.829,Loss of stability (P = 0.0115); Gain of catalytic residue at V1322 (P = 0.0774); Loss of methylation at K1317 (P = 0.1856); Gain of disorder (P = 0.1934); Gain of ubiquitination at K1317 (P = 0.2106)
7:117304745:G:A,P13569,G1323R,0.805,Gain of phosphorylation at S1326 (P = 0.0787); Gain of solvent accessibility (P = 0.1319); Gain of catalytic residue at G1323 (P = 0.2052); Gain of MoRF binding (P = 0.5254); Loss of methylation at R1325 (P = 0.5483)
7:117304745:G:C,P13569,G1323R,0.805,Gain of phosphorylation at S1326 (P = 0.0787); Gain of solvent accessibility (P = 0.1319); Gain of catalytic residue at G1323 (P = 0.2052); Gain of MoRF binding (P = 0.5254); Loss of methylation at R1325 (P = 0.5483)
7:117304745:G:T,P13569,G1323W,0.767,Gain of catalytic residue at G1323 (P = 0.0054); Gain of solvent accessibility (P = 0.3304); Loss of phosphorylation at S1326 (P = 0.3805); Loss of methylation at R1325 (P = 0.5313); Gain of MoRF binding (P = 0.5433)
7:117304746:G:A,P13569,G1323E,0.796,Gain of solvent accessibility (P = 0.1045); Gain of phosphorylation at S1326 (P = 0.1744); Gain of relative solvent accessibility (P = 0.2363); Loss of catalytic residue at S1326 (P = 0.3188); Gain of disorder (P = 0.5221)
7:117304746:G:C,P13569,G1323A,0.821,Loss of catalytic residue at L1324 (P = 0.339); Loss of phosphorylation at S1326 (P = 0.4508); Loss of methylation at R1325 (P = 0.5491); Loss of disorder (P = 0.6519); Loss of helix (P = 0.6835)
7:117304746:G:T,P13569,G1323V,0.808,Loss of catalytic residue at L1324 (P = 0.3637); Loss of phosphorylation at S1326 (P = 0.4162); Loss of methylation at R1325 (P = 0.5421); Gain of solvent accessibility (P = 0.571); Loss of disorder (P = 0.6276)
7:117304748:C:A,P13569,L1324I,0.719,Gain of catalytic residue at S1326 (P = 0.177); Gain of phosphorylation at S1326 (P = 0.3047); Loss of solvent accessibility (P = 0.3744); Loss of relative solvent accessibility (P = 0.3919); Loss of stability (P = 0.5159)
7:117304748:C:G,P13569,L1324V,0.726,Loss of solvent accessibility (P = 0.1279); Loss of relative solvent accessibility (P = 0.1807); Gain of phosphorylation at S1326 (P = 0.2682); Loss of stability (P = 0.3139); Gain of methylation at R1325 (P = 0.4984)
7:117304748:C:T,P13569,L1324F,0.683,Loss of stability (P = 0.2439); Gain of phosphorylation at S1326 (P = 0.3315); Gain of catalytic residue at L1324 (P = 0.3389); Gain of methylation at R1325 (P = 0.5112); Gain of disorder (P = 0.6661)
7:117304749:T:A,P13569,L1324H,0.751,Loss of stability (P = 0.0337); Gain of disorder (P = 0.1379); Gain of phosphorylation at S1326 (P = 0.3073); Gain of catalytic residue at E1321 (P = 0.3977); Loss of methylation at R1325 (P = 0.5491)
7:117304749:T:C,P13569,L1324P,0.91,Loss of stability (P = 0.0319); Gain of disorder (P = 0.05); Gain of phosphorylation at S1326 (P = 0.1138); Gain of catalytic residue at G1323 (P = 0.2802); Gain of methylation at R1325 (P = 0.4841)
7:117304749:T:G,P13569,L1324R,0.789,Loss of stability (P = 0.0489); Gain of methylation at L1324 (P = 0.0558); Gain of phosphorylation at S1326 (P = 0.0567); Gain of disorder (P = 0.1192); Gain of solvent accessibility (P = 0.199)
7:117304751:A:G,P13569,R1325G,0.67,Gain of catalytic residue at L1324 (P = 0.289); Loss of stability (P = 0.3157); Loss of solvent accessibility (P = 0.4011); Loss of phosphorylation at S1326 (P = 0.4162); Loss of methylation at R1325 (P = 0.5252)
7:117304752:G:A,P13569,R1325K,0.597,Gain of ubiquitination at R1325 (P = 0.0428); Loss of catalytic residue at S1326 (P = 0.182); Gain of relative solvent accessibility (P = 0.2629); Loss of phosphorylation at S1326 (P = 0.3962); Gain of solvent accessibility (P = 0.4137)
7:117304752:G:C,P13569,R1325T,0.652,Gain of catalytic residue at E1329 (P = 0.3214); Loss of phosphorylation at S1326 (P = 0.3481); Loss of stability (P = 0.5107); Loss of methylation at R1325 (P = 0.5252); Loss of solvent accessibility (P = 0.5743)
7:117304752:G:T,P13569,R1325I,0.7,Loss of solvent accessibility (P = 0.239); Gain of catalytic residue at E1329 (P = 0.2734); Loss of phosphorylation at S1326 (P = 0.3348); Gain of stability (P = 0.4356); Loss of relative solvent accessibility (P = 0.4508)
7:117304753:A:C,P13569,R1325S,0.609,Loss of catalytic residue at S1326 (P = 0.3826); Gain of disorder (P = 0.3929); Loss of phosphorylation at S1326 (P = 0.4216); Loss of methylation at R1325 (P = 0.5252); Loss of solvent accessibility (P = 0.5288)
7:117304753:A:T,P13569,R1325S,0.609,Loss of catalytic residue at S1326 (P = 0.3826); Gain of disorder (P = 0.3929); Loss of phosphorylation at S1326 (P = 0.4216); Loss of methylation at R1325 (P = 0.5252); Loss of solvent accessibility (P = 0.5288)
7:117304754:T:A,P13569,S1326T,0.663,Gain of helix (P = 0.2059); Loss of phosphorylation at S1326 (P = 0.4208); Loss of catalytic residue at S1326 (P = 0.5069); Loss of methylation at R1325 (P = 0.5501); Loss of stability (P = 0.6187)
7:117304754:T:C,P13569,S1326P,0.72,Loss of phosphorylation at S1326 (P = 0.2271); Loss of catalytic residue at S1326 (P = 0.2668); Loss of stability (P = 0.3624); Loss of helix (P = 0.3949); Gain of methylation at R1325 (P = 0.5414)
7:117304754:T:G,P13569,S1326A,0.685,Gain of helix (P = 0.2059); Loss of phosphorylation at S1326 (P = 0.2271); Gain of methylation at R1325 (P = 0.4912); Gain of catalytic residue at E1329 (P = 0.5103); Loss of disorder (P = 0.6179)
7:117304755:C:A,P13569,S1326Y,0.696,Loss of phosphorylation at S1326 (P = 0.3393); Gain of catalytic residue at E1329 (P = 0.3658); Loss of helix (P = 0.3949); Loss of methylation at R1325 (P = 0.5484); Loss of disorder (P = 0.5823)
7:117304755:C:G,P13569,S1326C,0.682,Loss of phosphorylation at S1326 (P = 0.2271); Gain of catalytic residue at E1329 (P = 0.2513); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949); Loss of stability (P = 0.5178)
7:117304755:C:T,P13569,S1326F,0.702,Loss of helix (P = 0.2271); Loss of phosphorylation at S1326 (P = 0.2271); Gain of catalytic residue at E1329 (P = 0.25); Gain of loop (P = 0.2754); Gain of methylation at R1325 (P = 0.5335)
7:117304757:G:A,P13569,V1327M,0.57,Gain of phosphorylation at S1326 (P = 0.3619); Loss of helix (P = 0.3949); Gain of catalytic residue at S1326 (P = 0.4569); Gain of disorder (P = 0.4963); Gain of methylation at R1325 (P = 0.5177)
7:117304757:G:C,P13569,V1327L,0.524,Gain of phosphorylation at S1326 (P = 0.393); Loss of helix (P = 0.3949); Loss of loop (P = 0.4786); Loss of methylation at R1325 (P = 0.5493); Loss of catalytic residue at F1331 (P = 0.5971)
7:117304757:G:T,P13569,V1327L,0.524,Gain of phosphorylation at S1326 (P = 0.393); Loss of helix (P = 0.3949); Loss of loop (P = 0.4786); Loss of methylation at R1325 (P = 0.5493); Loss of catalytic residue at F1331 (P = 0.5971)
7:117304758:T:A,P13569,V1327E,0.696,Gain of disorder (P = 0.0084); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971)
7:117304758:T:C,P13569,V1327A,0.601,Loss of stability (P = 0.0483); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Gain of disorder (P = 0.3564); Gain of phosphorylation at S1326 (P = 0.4332)
7:117304758:T:G,P13569,V1327G,0.647,Loss of stability (P = 0.0099); Gain of disorder (P = 0.0418); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.09)
7:117304760:A:C,P13569,I1328L,0.566,Gain of helix (P = 0.2059); Gain of phosphorylation at S1326 (P = 0.3649); Loss of loop (P = 0.4786); Gain of disorder (P = 0.5068); Loss of catalytic residue at Q1330 (P = 0.5275)
7:117304760:A:G,P13569,I1328V,0.529,Gain of phosphorylation at S1326 (P = 0.3338); Gain of loop (P = 0.3485); Loss of helix (P = 0.3949); Gain of methylation at R1325 (P = 0.5116); Gain of disorder (P = 0.5143)
7:117304760:A:T,P13569,I1328L,0.566,Gain of helix (P = 0.2059); Gain of phosphorylation at S1326 (P = 0.3649); Loss of loop (P = 0.4786); Gain of disorder (P = 0.5068); Loss of catalytic residue at Q1330 (P = 0.5275)
7:117304761:T:A,P13569,I1328K,0.69,Gain of disorder (P = 0.0041); Gain of solvent accessibility (P = 0.0354); Gain of ubiquitination at I1328 (P = 0.0408); Gain of relative solvent accessibility (P = 0.0479); Loss of stability (P = 0.0946)
7:117304761:T:G,P13569,I1328R,0.782,Gain of disorder (P = 0.0266); Gain of solvent accessibility (P = 0.0584); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S1326 (P = 0.0905); Gain of catalytic residue at I1328 (P = 0.1953)
7:117304762:A:G,P13569,I1328M,0.581,Gain of disorder (P = 0.324); Gain of loop (P = 0.3485); Gain of phosphorylation at S1326 (P = 0.3563); Loss of helix (P = 0.3949); Gain of methylation at R1325 (P = 0.5131)
7:117304763:G:A,P13569,E1329K,0.622,Loss of ubiquitination at K1334 (P = 0.0997); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.2445); Gain of catalytic residue at E1329 (P = 0.2561); Loss of loop (P = 0.2897)
7:117304763:G:C,P13569,E1329Q,0.856,Gain of ubiquitination at K1334 (P = 0.1245); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Gain of methylation at K1334 (P = 0.3034)
7:117304764:A:C,P13569,E1329A,0.74,Loss of ubiquitination at K1334 (P = 0.1278); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059); Loss of methylation at K1334 (P = 0.2488); Loss of loop (P = 0.2897)
7:117304764:A:G,P13569,E1329G,0.688,Loss of ubiquitination at K1334 (P = 0.1278); Loss of stability (P = 0.1703); Gain of catalytic residue at K1334 (P = 0.2055); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897)
7:117304764:A:T,P13569,E1329V,0.743,Gain of ubiquitination at K1334 (P = 0.068); Loss of solvent accessibility (P = 0.1744); Gain of helix (P = 0.2059); Gain of catalytic residue at F1331 (P = 0.2589); Loss of methylation at K1334 (P = 0.2616)
7:117304765:A:C,P13569,E1329D,0.491,Gain of ubiquitination at K1334 (P = 0.1245); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Loss of methylation at K1334 (P = 0.3011); Loss of phosphorylation at S1326 (P = 0.4229)
7:117304765:A:T,P13569,E1329D,0.491,Gain of ubiquitination at K1334 (P = 0.1245); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Loss of methylation at K1334 (P = 0.3011); Loss of phosphorylation at S1326 (P = 0.4229)
7:117304766:C:A,P13569,Q1330K,0.687,Gain of ubiquitination at Q1330 (P = 0.03); Gain of methylation at Q1330 (P = 0.0325); Loss of helix (P = 0.2022); Loss of stability (P = 0.262); Gain of loop (P = 0.2754)
7:117304767:A:C,P13569,Q1330P,0.784,Gain of catalytic residue at Q1330 (P = 0.0993); Loss of stability (P = 0.1059); Gain of ubiquitination at K1334 (P = 0.1084); Gain of phosphorylation at S1326 (P = 0.2632); Gain of methylation at K1334 (P = 0.3002)
7:117304767:A:G,P13569,Q1330R,0.701,Gain of ubiquitination at K1334 (P = 0.1245); Loss of methylation at K1334 (P = 0.2385); Gain of loop (P = 0.2754); Loss of catalytic residue at F1331 (P = 0.3482); Loss of helix (P = 0.3949)
7:117304767:A:T,P13569,Q1330L,0.728,Gain of ubiquitination at K1334 (P = 0.0931); Loss of methylation at K1334 (P = 0.1969); Gain of helix (P = 0.2059); Gain of catalytic residue at E1329 (P = 0.272); Gain of phosphorylation at S1326 (P = 0.4199)
7:117304768:G:C,P13569,Q1330H,0.7,Gain of ubiquitination at K1334 (P = 0.0817); Gain of catalytic residue at I1328 (P = 0.1412); Loss of stability (P = 0.2907); Loss of methylation at K1334 (P = 0.3067); Loss of helix (P = 0.3949)
7:117304768:G:T,P13569,Q1330H,0.7,Gain of ubiquitination at K1334 (P = 0.0817); Gain of catalytic residue at I1328 (P = 0.1412); Loss of stability (P = 0.2907); Loss of methylation at K1334 (P = 0.3067); Loss of helix (P = 0.3949)
7:117304769:T:A,P13569,F1331I,0.627,Loss of ubiquitination at K1334 (P = 0.1278); Loss of helix (P = 0.1299); Gain of methylation at K1334 (P = 0.1502); Gain of loop (P = 0.2045); Gain of phosphorylation at S1326 (P = 0.4521)
7:117304769:T:C,P13569,F1331L,0.627,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of ubiquitination at K1334 (P = 0.1245); Loss of methylation at K1334 (P = 0.2793); Gain of relative solvent accessibility (P = 0.281)
7:117304769:T:G,P13569,F1331V,0.651,Gain of ubiquitination at K1334 (P = 0.0931); Loss of helix (P = 0.1299); Gain of methylation at K1334 (P = 0.2394); Loss of catalytic residue at F1331 (P = 0.2575); Loss of stability (P = 0.3591)
7:117304770:T:A,P13569,F1331Y,0.726,Loss of ubiquitination at K1334 (P = 0.1453); Loss of methylation at K1334 (P = 0.2856); Gain of loop (P = 0.3485); Loss of stability (P = 0.3624); Loss of helix (P = 0.3949)
7:117304770:T:C,P13569,F1331S,0.705,Gain of disorder (P = 0.0078); Gain of ubiquitination at K1334 (P = 0.0817); Gain of relative solvent accessibility (P = 0.09); Loss of stability (P = 0.1274); Gain of phosphorylation at S1326 (P = 0.1357)
7:117304770:T:G,P13569,F1331C,0.722,Loss of ubiquitination at K1334 (P = 0.1278); Gain of helix (P = 0.2059); Gain of catalytic residue at K1334 (P = 0.2077); Loss of stability (P = 0.2584); Loss of loop (P = 0.2897)
7:117304771:T:A,P13569,F1331L,0.627,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of ubiquitination at K1334 (P = 0.1245); Loss of methylation at K1334 (P = 0.2793); Gain of relative solvent accessibility (P = 0.281)
7:117304771:T:G,P13569,F1331L,0.627,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of ubiquitination at K1334 (P = 0.1245); Loss of methylation at K1334 (P = 0.2793); Gain of relative solvent accessibility (P = 0.281)
7:117304772:C:A,P13569,P1332T,0.804,Gain of ubiquitination at K1334 (P = 0.1245); Gain of catalytic residue at P1332 (P = 0.1827); Gain of relative solvent accessibility (P = 0.1894); Loss of sheet (P = 0.1907); Loss of helix (P = 0.2022)
7:117304772:C:G,P13569,P1332A,0.808,Gain of catalytic residue at P1332 (P = 0.0058); Loss of ubiquitination at K1334 (P = 0.1278); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1907); Loss of methylation at K1334 (P = 0.2612)
7:117304772:C:T,P13569,P1332S,0.797,Loss of ubiquitination at K1334 (P = 0.1113); Gain of relative solvent accessibility (P = 0.1894); Loss of sheet (P = 0.1907); Loss of helix (P = 0.2022); Loss of methylation at K1334 (P = 0.2432)
7:117304773:C:A,P13569,P1332H,0.805,Gain of ubiquitination at K1334 (P = 0.1245); Gain of solvent accessibility (P = 0.1456); Gain of relative solvent accessibility (P = 0.1894); Loss of sheet (P = 0.1907); Gain of helix (P = 0.2684)
7:117304773:C:G,P13569,P1332R,0.826,Gain of solvent accessibility (P = 0.0411); Loss of ubiquitination at K1334 (P = 0.0795); Gain of methylation at P1332 (P = 0.1236); Gain of relative solvent accessibility (P = 0.1894); Loss of sheet (P = 0.1907)
7:117304773:C:T,P13569,P1332L,0.835,Gain of ubiquitination at K1334 (P = 0.0737); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1907); Loss of methylation at K1334 (P = 0.2377); Gain of loop (P = 0.2754)
7:117304775:G:A,P13569,G1333R,0.574,Gain of solvent accessibility (P = 0.0789); Loss of catalytic residue at D1336 (P = 0.0923); Gain of ubiquitination at K1334 (P = 0.1245); Gain of relative solvent accessibility (P = 0.1571); Gain of methylation at K1334 (P = 0.173)
7:117304775:G:C,P13569,G1333R,0.574,Gain of solvent accessibility (P = 0.0789); Loss of catalytic residue at D1336 (P = 0.0923); Gain of ubiquitination at K1334 (P = 0.1245); Gain of relative solvent accessibility (P = 0.1571); Gain of methylation at K1334 (P = 0.173)
7:117304775:G:T,P13569,G1333W,0.61,Gain of catalytic residue at G1333 (P = 0.0436); Gain of ubiquitination at K1334 (P = 0.068); Gain of sheet (P = 0.1945); Gain of methylation at K1334 (P = 0.2368); Loss of loop (P = 0.2897)
7:117304776:G:A,P13569,G1333E,0.57,Loss of catalytic residue at D1336 (P = 0.0706); Gain of ubiquitination at K1334 (P = 0.0817); Gain of solvent accessibility (P = 0.1376); Gain of relative solvent accessibility (P = 0.1571); Loss of helix (P = 0.2022)
7:117304776:G:C,P13569,G1333A,0.579,Gain of ubiquitination at K1334 (P = 0.0817); Gain of catalytic residue at G1333 (P = 0.0961); Loss of stability (P = 0.1522); Loss of loop (P = 0.2897); Loss of methylation at K1334 (P = 0.294)
7:117304776:G:T,P13569,G1333V,0.593,Gain of methylation at K1334 (P = 0.055); Gain of ubiquitination at K1334 (P = 0.0931); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2897); Loss of stability (P = 0.3669)
7:117304778:A:C,P13569,K1334Q,0.562,Loss of ubiquitination at K1334 (P = 0.0224); Loss of methylation at K1334 (P = 0.0941); Gain of sheet (P = 0.1945); Gain of helix (P = 0.2059); Gain of catalytic residue at K1334 (P = 0.3402)
7:117304778:A:G,P13569,K1334E,0.57,Loss of ubiquitination at K1334 (P = 0.0224); Loss of methylation at K1334 (P = 0.0941); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949); Loss of sheet (P = 0.5184)
7:117304779:A:C,P13569,K1334T,0.621,Loss of solvent accessibility (P = 0.0187); Loss of ubiquitination at K1334 (P = 0.0224); Loss of relative solvent accessibility (P = 0.0793); Loss of methylation at K1334 (P = 0.0941); Gain of helix (P = 0.2059)
7:117304779:A:G,P13569,K1334R,0.525,Loss of ubiquitination at K1334 (P = 0.0224); Gain of sheet (P = 0.1945); Gain of helix (P = 0.2059); Loss of methylation at K1334 (P = 0.2338); Loss of loop (P = 0.2897)
7:117304779:A:T,P13569,K1334M,0.69,Loss of solvent accessibility (P = 0.0187); Loss of ubiquitination at K1334 (P = 0.0224); Loss of relative solvent accessibility (P = 0.0793); Gain of catalytic residue at K1334 (P = 0.0885); Loss of methylation at K1334 (P = 0.0941)
7:117304780:G:C,P13569,K1334N,0.561,Loss of ubiquitination at K1334 (P = 0.0224); Loss of methylation at K1334 (P = 0.0941); Gain of helix (P = 0.2059); Gain of catalytic residue at K1334 (P = 0.254); Gain of loop (P = 0.2754)
7:117304780:G:T,P13569,K1334N,0.561,Loss of ubiquitination at K1334 (P = 0.0224); Loss of methylation at K1334 (P = 0.0941); Gain of helix (P = 0.2059); Gain of catalytic residue at K1334 (P = 0.254); Gain of loop (P = 0.2754)
7:117304781:C:A,P13569,L1335I,0.813,Gain of methylation at K1334 (P = 0.0778); Loss of ubiquitination at K1334 (P = 0.1453); Loss of helix (P = 0.2022); Loss of loop (P = 0.2897); Loss of sheet (P = 0.5184)
7:117304781:C:G,P13569,L1335V,0.801,Gain of methylation at K1334 (P = 0.0365); Loss of ubiquitination at K1334 (P = 0.1453); Loss of loop (P = 0.2897); Loss of stability (P = 0.3729); Loss of helix (P = 0.3949)
7:117304782:T:A,P13569,L1335H,0.823,Loss of stability (P = 0.0419); Gain of methylation at K1334 (P = 0.0624); Loss of ubiquitination at K1334 (P = 0.1453); Loss of catalytic residue at L1335 (P = 0.1704); Gain of disorder (P = 0.2578)
7:117304782:T:C,P13569,L1335P,0.968,Loss of stability (P = 0.0294); Gain of methylation at K1334 (P = 0.0694); Gain of ubiquitination at K1334 (P = 0.0817); Gain of catalytic residue at K1334 (P = 0.2076); Gain of disorder (P = 0.2333)
7:117304782:T:G,P13569,L1335R,0.923,Gain of methylation at K1334 (P = 0.0321); Loss of stability (P = 0.054); Gain of ubiquitination at K1334 (P = 0.1084); Loss of catalytic residue at L1335 (P = 0.2277); Loss of loop (P = 0.2897)
7:117304784:G:A,P13569,D1336N,0.768,Gain of ubiquitination at K1334 (P = 0.0931); Gain of methylation at K1334 (P = 0.1381); Gain of catalytic residue at K1334 (P = 0.2177); Loss of helix (P = 0.3949); Loss of sheet (P = 0.5184)
7:117304784:G:C,P13569,D1336H,0.794,Gain of methylation at K1334 (P = 0.0769); Loss of ubiquitination at K1334 (P = 0.1278); Loss of helix (P = 0.2022); Loss of loop (P = 0.2237); Gain of catalytic residue at K1334 (P = 0.3524)
7:117304784:G:T,P13569,D1336Y,0.815,Loss of ubiquitination at K1334 (P = 0.0724); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237); Gain of methylation at K1334 (P = 0.2323); Loss of solvent accessibility (P = 0.3103)
7:117304785:A:C,P13569,D1336A,0.822,Gain of methylation at K1334 (P = 0.086); Loss of ubiquitination at K1334 (P = 0.1278); Loss of loop (P = 0.2237); Loss of solvent accessibility (P = 0.3543); Loss of helix (P = 0.3949)
7:117304785:A:G,P13569,D1336G,0.769,Gain of methylation at K1334 (P = 0.071); Gain of catalytic residue at P1332 (P = 0.0838); Loss of ubiquitination at K1334 (P = 0.0997); Loss of helix (P = 0.1299); Loss of stability (P = 0.2097)
7:117304785:A:T,P13569,D1336V,0.823,Gain of methylation at K1334 (P = 0.0405); Gain of ubiquitination at K1334 (P = 0.068); Loss of catalytic residue at D1336 (P = 0.0992); Loss of solvent accessibility (P = 0.1279); Gain of helix (P = 0.1736)
7:117304786:C:A,P13569,D1336E,0.756,Loss of ubiquitination at K1334 (P = 0.1453); Gain of methylation at K1334 (P = 0.1666); Gain of solvent accessibility (P = 0.1751); Gain of relative solvent accessibility (P = 0.1894); Gain of loop (P = 0.3485)
7:117304786:C:G,P13569,D1336E,0.756,Loss of ubiquitination at K1334 (P = 0.1453); Gain of methylation at K1334 (P = 0.1666); Gain of solvent accessibility (P = 0.1751); Gain of relative solvent accessibility (P = 0.1894); Gain of loop (P = 0.3485)
7:117304787:T:A,P13569,F1337I,0.687,Loss of catalytic residue at F1337 (P = 0.0065); Loss of ubiquitination at K1334 (P = 0.1453); Gain of methylation at K1334 (P = 0.1752); Loss of helix (P = 0.3949); Loss of sheet (P = 0.5184)
7:117304787:T:C,P13569,F1337L,0.626,Loss of catalytic residue at F1337 (P = 0.0089); Gain of relative solvent accessibility (P = 0.0249); Gain of solvent accessibility (P = 0.0456); Loss of helix (P = 0.0558); Gain of loop (P = 0.0851)
7:117304787:T:G,P13569,F1337V,0.84,Loss of catalytic residue at F1337 (P = 0.007); Loss of helix (P = 0.0558); Gain of loop (P = 0.0851); Gain of ubiquitination at K1334 (P = 0.1245); Gain of methylation at K1334 (P = 0.2459)
7:117304788:T:A,P13569,F1337Y,0.583,Gain of phosphorylation at F1337 (P = 0.0736); Gain of ubiquitination at K1334 (P = 0.1084); Loss of catalytic residue at F1337 (P = 0.1126); Gain of helix (P = 0.2059); Loss of methylation at K1334 (P = 0.2624)
7:117304788:T:C,P13569,F1337S,0.543,Loss of catalytic residue at F1337 (P = 6e-04); Gain of relative solvent accessibility (P = 0.0507); Gain of ubiquitination at K1334 (P = 0.0817); Loss of stability (P = 0.0861); Gain of disorder (P = 0.1633)
7:117304788:T:G,P13569,F1337C,0.637,Loss of catalytic residue at F1337 (P = 0.0198); Loss of stability (P = 0.1197); Gain of ubiquitination at K1334 (P = 0.1245); Gain of methylation at K1334 (P = 0.1794); Gain of relative solvent accessibility (P = 0.2629)
7:117304789:T:A,P13569,F1337L,0.626,Loss of catalytic residue at F1337 (P = 0.0089); Gain of relative solvent accessibility (P = 0.0249); Gain of solvent accessibility (P = 0.0456); Loss of helix (P = 0.0558); Gain of loop (P = 0.0851)
7:117304789:T:G,P13569,F1337L,0.626,Loss of catalytic residue at F1337 (P = 0.0089); Gain of relative solvent accessibility (P = 0.0249); Gain of solvent accessibility (P = 0.0456); Loss of helix (P = 0.0558); Gain of loop (P = 0.0851)
7:117304790:G:A,P13569,V1338I,0.534,Gain of ubiquitination at K1334 (P = 0.1245); Loss of stability (P = 0.1944); Gain of methylation at K1334 (P = 0.2142); Loss of helix (P = 0.4763); Gain of catalytic residue at L1335 (P = 0.4886)
7:117304790:G:C,P13569,V1338L,0.558,Gain of ubiquitination at K1334 (P = 0.0931); Loss of stability (P = 0.0978); Loss of methylation at K1334 (P = 0.264); Gain of loop (P = 0.3485); Gain of catalytic residue at V1338 (P = 0.4019)
7:117304790:G:T,P13569,V1338F,0.539,Loss of stability (P = 0.0197); Gain of catalytic residue at V1338 (P = 0.0372); Loss of ubiquitination at K1334 (P = 0.1278); Loss of methylation at K1334 (P = 0.3115); Gain of loop (P = 0.4248)
7:117304791:T:A,P13569,V1338D,0.574,Loss of stability (P = 0.0047); Gain of ubiquitination at K1334 (P = 0.0554); Gain of relative solvent accessibility (P = 0.1066); Gain of solvent accessibility (P = 0.1751); Gain of catalytic residue at V1338 (P = 0.2135)
7:117304791:T:C,P13569,V1338A,0.564,Loss of stability (P = 0.0025); Loss of ubiquitination at K1334 (P = 0.1113); Loss of methylation at K1334 (P = 0.2598); Gain of relative solvent accessibility (P = 0.2629); Gain of catalytic residue at V1338 (P = 0.339)
7:117304791:T:G,P13569,V1338G,0.59,Loss of stability (P = 0); Gain of catalytic residue at V1338 (P = 0.0885); Gain of ubiquitination at K1334 (P = 0.1245); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2629)
7:117304793:C:A,P13569,L1339I,0.769,Gain of catalytic residue at L1339 (P = 0.046); Gain of methylation at K1334 (P = 0.1083); Loss of ubiquitination at K1334 (P = 0.1453); Loss of loop (P = 0.2897); Gain of sheet (P = 0.4423)
7:117304793:C:G,P13569,L1339V,0.779,Loss of ubiquitination at K1334 (P = 0.1453); Gain of methylation at K1334 (P = 0.1687); Loss of stability (P = 0.3426); Loss of loop (P = 0.3664); Loss of helix (P = 0.4763)
7:117304793:C:T,P13569,L1339F,0.893,Gain of catalytic residue at L1339 (P = 0.0193); Gain of ubiquitination at K1334 (P = 0.1084); Gain of methylation at K1334 (P = 0.1957); Loss of stability (P = 0.2639); Loss of loop (P = 0.2897)
7:117304794:T:A,P13569,L1339H,0.785,Loss of stability (P = 0.0509); Gain of catalytic residue at L1339 (P = 0.1245); Gain of ubiquitination at K1334 (P = 0.1245); Gain of relative solvent accessibility (P = 0.1259); Gain of methylation at K1334 (P = 0.184)
7:117304794:T:C,P13569,L1339P,0.835,Loss of stability (P = 0.0172); Gain of ubiquitination at K1334 (P = 0.1084); Gain of methylation at K1334 (P = 0.116); Gain of relative solvent accessibility (P = 0.1259); Gain of catalytic residue at L1339 (P = 0.188)
7:117304794:T:G,P13569,L1339R,0.849,Gain of solvent accessibility (P = 0.0584); Loss of stability (P = 0.0673); Gain of methylation at L1339 (P = 0.0883); Gain of relative solvent accessibility (P = 0.09); Loss of ubiquitination at K1334 (P = 0.1278)
7:117304796:G:A,P13569,V1340M,0.455,Loss of stability (P = 0.2185); Loss of loop (P = 0.2897); Gain of solvent accessibility (P = 0.3956); Loss of sheet (P = 0.437); Loss of helix (P = 0.4763)
7:117304796:G:C,P13569,V1340L,0.478,Loss of stability (P = 0.2228); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.28); Loss of loop (P = 0.2897); Loss of sheet (P = 0.437)
7:117304796:G:T,P13569,V1340L,0.478,Loss of stability (P = 0.2228); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.28); Loss of loop (P = 0.2897); Loss of sheet (P = 0.437)
7:117304797:T:A,P13569,V1340E,0.47,Gain of solvent accessibility (P = 0.0739); Loss of stability (P = 0.0846); Gain of relative solvent accessibility (P = 0.0999); Loss of loop (P = 0.2237); Loss of catalytic residue at G1342 (P = 0.3549)
7:117304797:T:C,P13569,V1340A,0.432,Loss of stability (P = 0.0244); Gain of catalytic residue at V1340 (P = 0.0847); Gain of sheet (P = 0.1945); Gain of relative solvent accessibility (P = 0.2363); Loss of loop (P = 0.2897)
7:117304797:T:G,P13569,V1340G,0.414,Loss of stability (P = 0.0029); Gain of relative solvent accessibility (P = 0.0479); Gain of catalytic residue at V1340 (P = 0.1113); Gain of sheet (P = 0.1945); Gain of solvent accessibility (P = 0.348)
7:117304799:G:A,P13569,D1341N,0.636,Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Loss of helix (P = 0.4763); Loss of solvent accessibility (P = 0.4995); Gain of MoRF binding (P = 0.5736)
7:117304799:G:C,P13569,D1341H,0.645,Loss of sheet (P = 0.1907); Loss of helix (P = 0.2662); Gain of loop (P = 0.2754); Gain of catalytic residue at G1342 (P = 0.4032); Loss of stability (P = 0.4658)
7:117304799:G:T,P13569,D1341Y,0.694,Loss of sheet (P = 0.1907); Gain of loop (P = 0.2754); Loss of relative solvent accessibility (P = 0.3589); Loss of helix (P = 0.4763); Loss of catalytic residue at G1342 (P = 0.4991)
7:117304800:A:C,P13569,D1341A,0.698,Loss of solvent accessibility (P = 0.1579); Loss of sheet (P = 0.1907); Loss of catalytic residue at D1336 (P = 0.2593); Gain of loop (P = 0.2754); Loss of relative solvent accessibility (P = 0.3589)
7:117304800:A:G,P13569,D1341G,0.645,Loss of stability (P = 0.1028); Loss of sheet (P = 0.1907); Gain of catalytic residue at V1340 (P = 0.2043); Gain of loop (P = 0.2754); Loss of solvent accessibility (P = 0.2882)
7:117304800:A:T,P13569,D1341V,0.702,Loss of sheet (P = 0.1907); Loss of solvent accessibility (P = 0.239); Gain of loop (P = 0.2754); Loss of catalytic residue at D1341 (P = 0.3528); Loss of relative solvent accessibility (P = 0.3589)
7:117304801:T:A,P13569,D1341E,0.549,Gain of solvent accessibility (P = 0.1376); Gain of relative solvent accessibility (P = 0.1684); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897)
7:117304801:T:G,P13569,D1341E,0.549,Gain of solvent accessibility (P = 0.1376); Gain of relative solvent accessibility (P = 0.1684); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897)
7:117304802:G:A,P13569,G1342R,0.556,Gain of solvent accessibility (P = 0.1846); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of catalytic residue at G1343 (P = 0.3193); Loss of stability (P = 0.3458)
7:117304802:G:C,P13569,G1342R,0.556,Gain of solvent accessibility (P = 0.1846); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of catalytic residue at G1343 (P = 0.3193); Loss of stability (P = 0.3458)
7:117304802:G:T,P13569,G1342W,0.66,Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of catalytic residue at G1343 (P = 0.2976); Loss of stability (P = 0.3746); Loss of relative solvent accessibility (P = 0.3919)
7:117304803:G:A,P13569,G1342E,0.526,Gain of solvent accessibility (P = 0.1456); Loss of sheet (P = 0.1907); Gain of catalytic residue at G1342 (P = 0.2338); Loss of stability (P = 0.2564); Loss of loop (P = 0.2897)
7:117304803:G:C,P13569,G1342A,0.534,Loss of stability (P = 0.0523); Gain of catalytic residue at G1342 (P = 0.1788); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of helix (P = 0.4763)
7:117304803:G:T,P13569,G1342V,0.563,Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907); Loss of loop (P = 0.2897); Loss of catalytic residue at G1343 (P = 0.3733); Gain of solvent accessibility (P = 0.4946)
7:117304805:G:A,P13569,G1343S,0.821,Gain of catalytic residue at L1339 (P = 0.32); Gain of loop (P = 0.3485); Loss of sheet (P = 0.437); Loss of stability (P = 0.4524); Loss of helix (P = 0.4763)
7:117304805:G:C,P13569,G1343R,0.888,Gain of methylation at G1343 (P = 0.0417); Loss of catalytic residue at G1342 (P = 0.2214); Gain of MoRF binding (P = 0.223); Gain of loop (P = 0.2754); Loss of sheet (P = 0.437)
7:117304805:G:T,P13569,G1343C,0.91,Gain of catalytic residue at S1347 (P = 0.2564); Gain of loop (P = 0.3485); Loss of sheet (P = 0.437); Loss of helix (P = 0.4763); Loss of disorder (P = 0.5746)
7:117304806:G:A,P13569,G1343D,0.794,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of sheet (P = 0.1945); Loss of catalytic residue at S1347 (P = 0.2742); Gain of loop (P = 0.2754)
7:117304806:G:C,P13569,G1343A,0.841,Loss of catalytic residue at G1342 (P = 0.321); Gain of loop (P = 0.3485); Loss of sheet (P = 0.437); Loss of helix (P = 0.4763); Loss of stability (P = 0.524)
7:117304808:T:A,P13569,C1344S,0.45,Gain of disorder (P = 0.003); Gain of relative solvent accessibility (P = 0.2629); Loss of stability (P = 0.301); Loss of loop (P = 0.3664); Gain of phosphorylation at C1344 (P = 0.3716)
7:117304808:T:C,P13569,C1344R,0.552,Gain of disorder (P = 0.0362); Gain of methylation at C1344 (P = 0.0388); Gain of MoRF binding (P = 0.0632); Gain of solvent accessibility (P = 0.1422); Loss of catalytic residue at C1344 (P = 0.2353)
7:117304808:T:G,P13569,C1344G,0.502,Gain of disorder (P = 0.0142); Loss of stability (P = 0.1146); Gain of catalytic residue at V1345 (P = 0.1794); Gain of relative solvent accessibility (P = 0.2629); Loss of sheet (P = 0.437)
7:117304809:G:A,P13569,C1344Y,0.449,Gain of catalytic residue at L1339 (P = 0.0708); Gain of phosphorylation at C1344 (P = 0.1514); Gain of MoRF binding (P = 0.4737); Loss of helix (P = 0.4763); Gain of disorder (P = 0.4767)
7:117304809:G:T,P13569,C1344F,0.5,Gain of sheet (P = 0.1945); Gain of catalytic residue at S1347 (P = 0.2586); Loss of loop (P = 0.4412); Gain of MoRF binding (P = 0.4596); Loss of helix (P = 0.4763)
7:117304810:T:G,P13569,C1344W,0.535,Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.3117); Loss of loop (P = 0.3664); Loss of catalytic residue at G1342 (P = 0.4108); Loss of helix (P = 0.4763)
7:117304811:G:A,P13569,V1345I,0.675,Gain of catalytic residue at V1345 (P = 0.1616); Gain of sheet (P = 0.1945); Loss of loop (P = 0.3664); Gain of MoRF binding (P = 0.4127); Loss of helix (P = 0.4763)
7:117304811:G:C,P13569,V1345L,0.587,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.1319); Gain of catalytic residue at V1345 (P = 0.1666); Loss of MoRF binding (P = 0.4335); Loss of sheet (P = 0.437)
7:117304811:G:T,P13569,V1345F,0.636,Gain of catalytic residue at V1345 (P = 0.1586); Gain of relative solvent accessibility (P = 0.2363); Gain of solvent accessibility (P = 0.2987); Gain of MoRF binding (P = 0.4202); Loss of loop (P = 0.4412)
7:117304812:T:A,P13569,V1345D,0.66,Gain of disorder (P = 0.0355); Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Gain of catalytic residue at V1345 (P = 0.2375); Gain of helix (P = 0.2684)
7:117304812:T:C,P13569,V1345A,0.601,Gain of relative solvent accessibility (P = 0.09); Gain of catalytic residue at V1345 (P = 0.2258); Gain of solvent accessibility (P = 0.2346); Gain of disorder (P = 0.3291); Loss of loop (P = 0.3664)
7:117304812:T:G,P13569,V1345G,0.692,Loss of stability (P = 0.0373); Gain of disorder (P = 0.055); Gain of relative solvent accessibility (P = 0.09); Gain of catalytic residue at L1346 (P = 0.1556); Gain of solvent accessibility (P = 0.2863)
7:117304814:C:A,P13569,L1346I,0.843,Gain of methylation at K1351 (P = 0.0524); Gain of catalytic residue at L1346 (P = 0.0626); Gain of sheet (P = 0.1945); Gain of ubiquitination at K1351 (P = 0.2898); Gain of MoRF binding (P = 0.3211)
7:117304814:C:G,P13569,L1346V,0.85,Gain of catalytic residue at L1346 (P = 0.0202); Gain of methylation at K1351 (P = 0.0948); Gain of sheet (P = 0.1945); Gain of ubiquitination at K1351 (P = 0.2898); Gain of MoRF binding (P = 0.3553)
7:117304815:T:A,P13569,L1346Q,0.873,Gain of catalytic residue at L1346 (P = 0.0203); Gain of methylation at K1351 (P = 0.0606); Gain of disorder (P = 0.0684); Loss of stability (P = 0.1799); Gain of helix (P = 0.2294)
7:117304815:T:C,P13569,L1346P,0.921,Gain of methylation at K1351 (P = 0.0489); Gain of disorder (P = 0.0688); Loss of stability (P = 0.0965); Gain of helix (P = 0.2294); Loss of ubiquitination at K1351 (P = 0.2943)
7:117304815:T:G,P13569,L1346R,0.897,Gain of catalytic residue at L1346 (P = 0.0137); Gain of methylation at L1346 (P = 0.0172); Gain of MoRF binding (P = 0.145); Loss of stability (P = 0.1881); Gain of disorder (P = 0.1904)
7:117304817:A:C,P13569,S1347R,0.963,Gain of MoRF binding (P = 0.0354); Gain of methylation at S1347 (P = 0.0435); Loss of ubiquitination at K1351 (P = 0.2773); Loss of catalytic residue at V1345 (P = 0.3211); Loss of stability (P = 0.3284)
7:117304817:A:G,P13569,S1347G,0.915,Loss of stability (P = 0.0288); Gain of ubiquitination at K1351 (P = 0.1697); Gain of methylation at K1351 (P = 0.2392); Gain of glycosylation at K1351 (P = 0.2618); Gain of catalytic residue at S1347 (P = 0.2842)
7:117304817:A:T,P13569,S1347C,0.933,Gain of ubiquitination at K1351 (P = 0.1697); Gain of methylation at K1351 (P = 0.1962); Loss of loop (P = 0.2237); Loss of MoRF binding (P = 0.2918); Gain of catalytic residue at L1346 (P = 0.3152)
7:117304818:G:A,P13569,S1347N,0.933,Gain of catalytic residue at S1347 (P = 0.2076); Loss of methylation at K1351 (P = 0.2242); Gain of MoRF binding (P = 0.2841); Loss of stability (P = 0.2867); Loss of ubiquitination at K1351 (P = 0.2991)
7:117304818:G:C,P13569,S1347T,0.924,Loss of stability (P = 0.1467); Gain of methylation at K1351 (P = 0.1483); Gain of ubiquitination at K1351 (P = 0.2718); Gain of MoRF binding (P = 0.3083); Gain of catalytic residue at S1347 (P = 0.3308)
7:117304818:G:T,P13569,S1347I,0.929,Gain of methylation at K1351 (P = 0.0746); Gain of ubiquitination at K1351 (P = 0.1418); Gain of MoRF binding (P = 0.2733); Loss of loop (P = 0.3664); Loss of glycosylation at K1351 (P = 0.3935)
7:117304819:C:A,P13569,S1347R,0.963,Gain of MoRF binding (P = 0.0354); Gain of methylation at S1347 (P = 0.0435); Loss of ubiquitination at K1351 (P = 0.2773); Loss of catalytic residue at V1345 (P = 0.3211); Loss of stability (P = 0.3284)
7:117304819:C:G,P13569,S1347R,0.963,Gain of MoRF binding (P = 0.0354); Gain of methylation at S1347 (P = 0.0435); Loss of ubiquitination at K1351 (P = 0.2773); Loss of catalytic residue at V1345 (P = 0.3211); Loss of stability (P = 0.3284)
7:117304820:C:A,P13569,H1348N,0.462,Loss of catalytic residue at H1348 (P = 0.0463); Loss of solvent accessibility (P = 0.1301); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.1981); Gain of methylation at K1351 (P = 0.2243)
7:117304820:C:G,P13569,H1348D,0.507,Loss of methylation at K1351 (P = 0.1724); Loss of catalytic residue at G1349 (P = 0.1797); Loss of MoRF binding (P = 0.2211); Gain of ubiquitination at K1351 (P = 0.2526); Gain of helix (P = 0.2684)
7:117304820:C:T,P13569,H1348Y,0.665,Loss of solvent accessibility (P = 0.0089); Loss of relative solvent accessibility (P = 0.0306); Loss of methylation at K1351 (P = 0.1416); Loss of catalytic residue at G1349 (P = 0.1791); Gain of ubiquitination at K1351 (P = 0.2526)
7:117304821:A:C,P13569,H1348P,0.567,Loss of catalytic residue at H1348 (P = 0.0325); Loss of solvent accessibility (P = 0.0477); Gain of methylation at K1351 (P = 0.1635); Loss of relative solvent accessibility (P = 0.1807); Gain of sheet (P = 0.1945)
7:117304821:A:G,P13569,H1348R,0.586,Gain of MoRF binding (P = 0.0151); Gain of methylation at H1348 (P = 0.1057); Loss of catalytic residue at G1349 (P = 0.1868); Loss of glycosylation at K1351 (P = 0.2704); Loss of ubiquitination at K1351 (P = 0.2943)
7:117304821:A:T,P13569,H1348L,0.668,Loss of solvent accessibility (P = 0.0089); Loss of relative solvent accessibility (P = 0.0306); Loss of methylation at K1351 (P = 0.1169); Loss of catalytic residue at G1349 (P = 0.1371); Gain of ubiquitination at K1351 (P = 0.1418)
7:117304822:T:A,P13569,H1348Q,0.479,Loss of catalytic residue at H1348 (P = 0.1304); Gain of methylation at K1351 (P = 0.1453); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.2136); Loss of solvent accessibility (P = 0.239)
7:117304822:T:G,P13569,H1348Q,0.479,Loss of catalytic residue at H1348 (P = 0.1304); Gain of methylation at K1351 (P = 0.1453); Gain of sheet (P = 0.1945); Gain of MoRF binding (P = 0.2136); Loss of solvent accessibility (P = 0.239)
7:117304823:G:C,P13569,G1349R,0.987,Gain of MoRF binding (P = 0.054); Loss of catalytic residue at H1350 (P = 0.1123); Loss of methylation at K1351 (P = 0.172); Loss of glycosylation at K1351 (P = 0.1972); Gain of ubiquitination at K1351 (P = 0.2718)
7:117304823:G:T,P13569,G1349C,0.975,Loss of sheet (P = 0.1907); Gain of methylation at K1351 (P = 0.192); Loss of MoRF binding (P = 0.2075); Gain of ubiquitination at K1351 (P = 0.2526); Loss of glycosylation at K1351 (P = 0.2931)
7:117304824:G:A,P13569,G1349D,0.98,Gain of relative solvent accessibility (P = 0.09); Loss of MoRF binding (P = 0.1182); Loss of methylation at K1351 (P = 0.1222); Gain of solvent accessibility (P = 0.1376); Loss of catalytic residue at H1350 (P = 0.1563)
7:117304824:G:C,P13569,G1349A,0.978,Loss of catalytic residue at H1350 (P = 0.1565); Loss of sheet (P = 0.1907); Loss of stability (P = 0.2052); Gain of MoRF binding (P = 0.2239); Loss of methylation at K1351 (P = 0.2342)
7:117304824:G:T,P13569,G1349V,0.974,Gain of methylation at K1351 (P = 0.1129); Gain of MoRF binding (P = 0.1459); Loss of catalytic residue at H1350 (P = 0.1634); Loss of sheet (P = 0.1907); Gain of ubiquitination at K1351 (P = 0.2285)
7:117304826:C:A,P13569,H1350N,0.687,Loss of catalytic residue at K1351 (P = 0.0591); Gain of MoRF binding (P = 0.1572); Gain of methylation at K1351 (P = 0.2379); Loss of glycosylation at K1351 (P = 0.2827); Loss of ubiquitination at K1351 (P = 0.2991)
7:117304826:C:G,P13569,H1350D,0.675,Gain of relative solvent accessibility (P = 0.09); Loss of catalytic residue at K1351 (P = 0.1106); Loss of MoRF binding (P = 0.1225); Gain of solvent accessibility (P = 0.1376); Loss of methylation at K1351 (P = 0.1624)
7:117304826:C:T,P13569,H1350Y,0.76,Loss of methylation at K1351 (P = 0.1621); Gain of ubiquitination at K1351 (P = 0.1697); Gain of MoRF binding (P = 0.1778); Gain of sheet (P = 0.1945); Loss of catalytic residue at H1350 (P = 0.1971)
7:117304827:A:C,P13569,H1350P,0.79,Gain of glycosylation at H1350 (P = 0.0696); Loss of catalytic residue at H1350 (P = 0.0926); Gain of methylation at K1351 (P = 0.115); Loss of MoRF binding (P = 0.139); Loss of ubiquitination at K1351 (P = 0.2991)
7:117304827:A:G,P13569,H1350R,0.778,Gain of MoRF binding (P = 0.0206); Gain of methylation at K1351 (P = 0.1814); Loss of glycosylation at K1351 (P = 0.2469); Loss of catalytic residue at H1350 (P = 0.2574); Loss of ubiquitination at K1351 (P = 0.2991)
7:117304827:A:T,P13569,H1350L,0.779,Loss of catalytic residue at Q1352 (P = 0.1098); Gain of MoRF binding (P = 0.1184); Loss of methylation at K1351 (P = 0.1519); Gain of sheet (P = 0.1945); Gain of ubiquitination at K1351 (P = 0.2044)
7:117304828:C:A,P13569,H1350Q,0.668,Gain of methylation at K1351 (P = 0.1631); Gain of MoRF binding (P = 0.1858); Loss of catalytic residue at K1351 (P = 0.1953); Loss of ubiquitination at K1351 (P = 0.2773); Loss of glycosylation at K1351 (P = 0.3465)
7:117304828:C:G,P13569,H1350Q,0.668,Gain of methylation at K1351 (P = 0.1631); Gain of MoRF binding (P = 0.1858); Loss of catalytic residue at K1351 (P = 0.1953); Loss of ubiquitination at K1351 (P = 0.2773); Loss of glycosylation at K1351 (P = 0.3465)
7:117304829:A:C,P13569,K1351Q,0.886,Loss of methylation at K1351 (P = 0.0464); Loss of ubiquitination at K1351 (P = 0.0768); Loss of MoRF binding (P = 0.0798); Loss of glycosylation at K1351 (P = 0.09); Gain of relative solvent accessibility (P = 0.2751)
7:117304829:A:G,P13569,K1351E,0.929,Loss of methylation at K1351 (P = 0.0464); Loss of MoRF binding (P = 0.0521); Loss of ubiquitination at K1351 (P = 0.0768); Loss of glycosylation at K1351 (P = 0.09); Gain of relative solvent accessibility (P = 0.2751)
7:117304830:A:C,P13569,K1351T,0.848,Loss of methylation at K1351 (P = 0.0464); Loss of ubiquitination at K1351 (P = 0.0768); Loss of MoRF binding (P = 0.078); Loss of glycosylation at K1351 (P = 0.1397); Gain of relative solvent accessibility (P = 0.2751)
7:117304830:A:G,P13569,K1351R,0.801,Loss of ubiquitination at K1351 (P = 0.0768); Loss of glycosylation at K1351 (P = 0.09); Gain of MoRF binding (P = 0.098); Loss of methylation at K1351 (P = 0.1115); Loss of catalytic residue at K1351 (P = 0.1532)
7:117304830:A:T,P13569,K1351M,0.859,Loss of methylation at K1351 (P = 0.0464); Loss of ubiquitination at K1351 (P = 0.0768); Loss of MoRF binding (P = 0.0792); Loss of glycosylation at K1351 (P = 0.09); Gain of stability (P = 0.1212)
7:117304831:G:C,P13569,K1351N,0.867,Loss of methylation at K1351 (P = 0.0464); Loss of ubiquitination at K1351 (P = 0.0768); Loss of MoRF binding (P = 0.0831); Loss of glycosylation at K1351 (P = 0.09); Gain of relative solvent accessibility (P = 0.2751)
7:117304831:G:T,P13569,K1351N,0.867,Loss of methylation at K1351 (P = 0.0464); Loss of ubiquitination at K1351 (P = 0.0768); Loss of MoRF binding (P = 0.0831); Loss of glycosylation at K1351 (P = 0.09); Gain of relative solvent accessibility (P = 0.2751)
7:117304832:C:A,P13569,Q1352K,0.958,Gain of MoRF binding (P = 0.0424); Loss of catalytic residue at H1350 (P = 0.1468); Gain of glycosylation at Q1352 (P = 0.1631); Loss of methylation at K1351 (P = 0.1654); Gain of ubiquitination at Q1352 (P = 0.2509)
7:117304832:C:G,P13569,Q1352E,0.973,Loss of MoRF binding (P = 0.0787); Loss of methylation at K1351 (P = 0.1949); Gain of ubiquitination at K1351 (P = 0.2285); Gain of glycosylation at K1351 (P = 0.3211); Gain of disorder (P = 0.3843)
7:117304833:A:C,P13569,Q1352P,0.962,Loss of catalytic residue at Q1352 (P = 0.0308); Gain of methylation at K1351 (P = 0.0784); Loss of MoRF binding (P = 0.103); Gain of ubiquitination at K1351 (P = 0.1697); Gain of glycosylation at K1351 (P = 0.1819)
7:117304833:A:G,P13569,Q1352R,0.974,Gain of MoRF binding (P = 0.0241); Gain of methylation at Q1352 (P = 0.0276); Loss of catalytic residue at Q1352 (P = 0.1079); Gain of ubiquitination at K1351 (P = 0.2285); Loss of glycosylation at K1351 (P = 0.3235)
7:117304833:A:T,P13569,Q1352L,0.955,Gain of ubiquitination at K1351 (P = 0.0471); Gain of stability (P = 0.0652); Gain of MoRF binding (P = 0.1359); Loss of methylation at K1351 (P = 0.2157); Gain of catalytic residue at S1347 (P = 0.2305)
7:117304834:G:T,P13569,Q1352H,0.988,Gain of catalytic residue at M1354 (P = 0.0865); Loss of MoRF binding (P = 0.1811); Gain of ubiquitination at K1351 (P = 0.2044); Gain of methylation at K1351 (P = 0.2089); Gain of glycosylation at K1351 (P = 0.2427)
7:117304835:T:A,P13569,L1353M,0.523,Gain of catalytic residue at L1353 (P = 5e-04); Gain of methylation at K1351 (P = 0.0746); Gain of MoRF binding (P = 0.1854); Gain of ubiquitination at K1351 (P = 0.2898); Gain of glycosylation at K1351 (P = 0.3058)
7:117304835:T:G,P13569,L1353V,0.695,Gain of methylation at K1351 (P = 0.0975); Gain of MoRF binding (P = 0.1645); Gain of catalytic residue at L1353 (P = 0.1755); Loss of ubiquitination at K1351 (P = 0.2943); Loss of glycosylation at K1351 (P = 0.3686)
7:117304836:T:C,P13569,L1353S,0.67,Gain of disorder (P = 0.009); Gain of methylation at K1351 (P = 0.0714); Loss of stability (P = 0.0715); Loss of MoRF binding (P = 0.1636); Gain of ubiquitination at K1351 (P = 0.1697)
7:117304836:T:G,P13569,L1353W,0.73,Gain of catalytic residue at L1353 (P = 0.0179); Gain of MoRF binding (P = 0.0488); Loss of methylation at R1358 (P = 0.0668); Loss of stability (P = 0.2367); Loss of ubiquitination at K1351 (P = 0.2943)
7:117304837:G:C,P13569,L1353F,0.704,Gain of MoRF binding (P = 0.1453); Gain of catalytic residue at L1353 (P = 0.1539); Gain of methylation at K1351 (P = 0.1553); Gain of ubiquitination at K1351 (P = 0.2526); Loss of glycosylation at K1351 (P = 0.3962)
7:117304837:G:T,P13569,L1353F,0.704,Gain of MoRF binding (P = 0.1453); Gain of catalytic residue at L1353 (P = 0.1539); Gain of methylation at K1351 (P = 0.1553); Gain of ubiquitination at K1351 (P = 0.2526); Loss of glycosylation at K1351 (P = 0.3962)
7:117304838:A:C,P13569,M1354L,0.655,Loss of methylation at K1351 (P = 0.1424); Loss of MoRF binding (P = 0.1576); Gain of ubiquitination at K1351 (P = 0.2526); Loss of glycosylation at K1351 (P = 0.4021); Gain of phosphorylation at S1359 (P = 0.463)
7:117304838:A:G,P13569,M1354V,0.565,Gain of methylation at R1358 (P = 0.1833); Loss of MoRF binding (P = 0.188); Gain of ubiquitination at K1351 (P = 0.2526); Loss of glycosylation at K1351 (P = 0.3524); Loss of helix (P = 0.4763)
7:117304838:A:T,P13569,M1354L,0.655,Loss of methylation at K1351 (P = 0.1424); Loss of MoRF binding (P = 0.1576); Gain of ubiquitination at K1351 (P = 0.2526); Loss of glycosylation at K1351 (P = 0.4021); Gain of phosphorylation at S1359 (P = 0.463)
7:117304839:T:A,P13569,M1354K,0.956,Gain of MoRF binding (P = 0.0253); Gain of disorder (P = 0.0423); Gain of methylation at M1354 (P = 0.1098); Gain of ubiquitination at K1351 (P = 0.1418); Loss of stability (P = 0.187)
7:117304839:T:C,P13569,M1354T,0.759,Gain of ubiquitination at K1351 (P = 0.1117); Loss of stability (P = 0.1486); Gain of methylation at R1358 (P = 0.1906); Loss of MoRF binding (P = 0.2016); Loss of glycosylation at K1351 (P = 0.3538)
7:117304839:T:G,P13569,M1354R,0.908,Gain of MoRF binding (P = 0.012); Gain of methylation at M1354 (P = 0.0231); Loss of catalytic residue at Q1352 (P = 0.1909); Gain of disorder (P = 0.2304); Gain of phosphorylation at S1359 (P = 0.2561)
7:117304840:G:A,P13569,M1354I,0.561,Loss of methylation at R1358 (P = 0.1823); Loss of MoRF binding (P = 0.2023); Loss of ubiquitination at K1351 (P = 0.2943); Loss of glycosylation at K1351 (P = 0.4063); Loss of helix (P = 0.4763)
7:117304840:G:C,P13569,M1354I,0.561,Loss of methylation at R1358 (P = 0.1823); Loss of MoRF binding (P = 0.2023); Loss of ubiquitination at K1351 (P = 0.2943); Loss of glycosylation at K1351 (P = 0.4063); Loss of helix (P = 0.4763)
7:117304840:G:T,P13569,M1354I,0.561,Loss of methylation at R1358 (P = 0.1823); Loss of MoRF binding (P = 0.2023); Loss of ubiquitination at K1351 (P = 0.2943); Loss of glycosylation at K1351 (P = 0.4063); Loss of helix (P = 0.4763)
7:117304841:T:A,P13569,C1355S,0.697,Gain of disorder (P = 5e-04); Loss of catalytic residue at L1356 (P = 0.0258); Gain of methylation at K1351 (P = 0.0748); Gain of MoRF binding (P = 0.1023); Gain of phosphorylation at C1355 (P = 0.118)
7:117304841:T:C,P13569,C1355R,0.878,Gain of MoRF binding (P = 0.0044); Gain of disorder (P = 0.0126); Loss of catalytic residue at L1356 (P = 0.0247); Gain of methylation at C1355 (P = 0.0346); Gain of phosphorylation at S1359 (P = 0.1735)
7:117304841:T:G,P13569,C1355G,0.751,Gain of disorder (P = 0.0076); Loss of catalytic residue at L1356 (P = 0.069); Gain of methylation at R1358 (P = 0.0858); Gain of MoRF binding (P = 0.1441); Loss of stability (P = 0.1471)
7:117304842:G:A,P13569,C1355Y,0.82,Loss of catalytic residue at L1356 (P = 0.026); Gain of methylation at K1351 (P = 0.1247); Gain of MoRF binding (P = 0.1597); Loss of ubiquitination at K1351 (P = 0.2719); Loss of glycosylation at K1351 (P = 0.3865)
7:117304842:G:C,P13569,C1355S,0.697,Gain of disorder (P = 5e-04); Loss of catalytic residue at L1356 (P = 0.0258); Gain of methylation at K1351 (P = 0.0748); Gain of MoRF binding (P = 0.1023); Gain of phosphorylation at C1355 (P = 0.118)
7:117304842:G:T,P13569,C1355F,0.853,Loss of catalytic residue at L1356 (P = 0.0267); Gain of MoRF binding (P = 0.1078); Gain of methylation at K1351 (P = 0.1804); Gain of ubiquitination at K1351 (P = 0.2044); Loss of glycosylation at K1351 (P = 0.371)
7:117304843:C:G,P13569,C1355W,0.829,Gain of catalytic residue at L1353 (P = 0.0046); Gain of MoRF binding (P = 0.0258); Loss of methylation at R1358 (P = 0.0634); Loss of ubiquitination at K1351 (P = 0.2719); Gain of glycosylation at K1351 (P = 0.4083)
7:117304844:T:A,P13569,L1356M,0.726,Gain of methylation at K1351 (P = 0.0739); Gain of MoRF binding (P = 0.1524); Loss of ubiquitination at K1351 (P = 0.2943); Gain of glycosylation at K1351 (P = 0.3592); Gain of disorder (P = 0.4105)
7:117304844:T:G,P13569,L1356V,0.616,Loss of catalytic residue at L1356 (P = 0.0628); Gain of methylation at K1351 (P = 0.11); Gain of MoRF binding (P = 0.1641); Loss of ubiquitination at K1351 (P = 0.2943); Loss of glycosylation at K1351 (P = 0.371)
7:117304845:T:C,P13569,L1356S,0.869,Gain of disorder (P = 0.018); Loss of stability (P = 0.0348); Gain of methylation at K1351 (P = 0.0508); Loss of MoRF binding (P = 0.1983); Gain of catalytic residue at R1358 (P = 0.2226)
7:117304845:T:G,P13569,L1356W,0.757,Gain of MoRF binding (P = 0.0367); Loss of stability (P = 0.0657); Loss of methylation at R1358 (P = 0.0687); Loss of ubiquitination at K1351 (P = 0.2583); Gain of catalytic residue at A1357 (P = 0.3808)
7:117304846:G:C,P13569,L1356F,0.753,Loss of catalytic residue at L1356 (P = 0.1182); Gain of methylation at R1358 (P = 0.1402); Gain of MoRF binding (P = 0.144); Gain of ubiquitination at K1351 (P = 0.2718); Loss of stability (P = 0.3643)
7:117304846:G:T,P13569,L1356F,0.753,Loss of catalytic residue at L1356 (P = 0.1182); Gain of methylation at R1358 (P = 0.1402); Gain of MoRF binding (P = 0.144); Gain of ubiquitination at K1351 (P = 0.2718); Loss of stability (P = 0.3643)
7:117304847:G:A,P13569,A1357T,0.885,Loss of methylation at R1358 (P = 0.1549); Gain of catalytic residue at A1357 (P = 0.1942); Loss of MoRF binding (P = 0.2012); Loss of helix (P = 0.2662); Loss of stability (P = 0.4327)
7:117304847:G:C,P13569,A1357P,0.919,Loss of MoRF binding (P = 0.0797); Loss of methylation at R1358 (P = 0.1626); Loss of catalytic residue at A1357 (P = 0.1768); Gain of phosphorylation at S1359 (P = 0.3733); Loss of stability (P = 0.389)
7:117304847:G:T,P13569,A1357S,0.882,Gain of phosphorylation at A1357 (P = 0.0884); Gain of disorder (P = 0.1442); Loss of MoRF binding (P = 0.1818); Loss of methylation at R1358 (P = 0.182); Gain of catalytic residue at A1357 (P = 0.2642)
7:117304848:C:A,P13569,A1357D,0.93,Loss of MoRF binding (P = 0.0772); Loss of methylation at R1358 (P = 0.114); Gain of phosphorylation at S1359 (P = 0.4064); Gain of disorder (P = 0.4428); Loss of helix (P = 0.4763)
7:117304848:C:G,P13569,A1357G,0.887,Gain of methylation at R1358 (P = 0.0599); Loss of stability (P = 0.1817); Gain of MoRF binding (P = 0.2015); Gain of disorder (P = 0.4131); Gain of catalytic residue at C1355 (P = 0.4557)
7:117304848:C:T,P13569,A1357V,0.881,Gain of MoRF binding (P = 0.1054); Loss of methylation at R1358 (P = 0.1507); Loss of helix (P = 0.4763); Loss of phosphorylation at S1359 (P = 0.501); Gain of catalytic residue at A1357 (P = 0.5707)
7:117304850:A:G,P13569,R1358G,0.939,Loss of methylation at R1358 (P = 0.0386); Loss of MoRF binding (P = 0.0498); Loss of stability (P = 0.0643); Gain of catalytic residue at C1355 (P = 0.0645); Loss of ubiquitination at K1363 (P = 0.0877)
7:117304851:G:A,P13569,R1358K,0.917,Gain of ubiquitination at R1358 (P = 0.0337); Loss of methylation at R1358 (P = 0.0486); Loss of MoRF binding (P = 0.1111); Loss of stability (P = 0.1532); Gain of catalytic residue at R1358 (P = 0.3174)
7:117304851:G:C,P13569,R1358T,0.95,Loss of methylation at R1358 (P = 0.0386); Loss of MoRF binding (P = 0.0542); Loss of ubiquitination at K1363 (P = 0.1423); Loss of stability (P = 0.2088); Gain of catalytic residue at C1355 (P = 0.2478)
7:117304851:G:T,P13569,R1358I,0.913,Loss of methylation at R1358 (P = 0.0386); Loss of MoRF binding (P = 0.0572); Loss of ubiquitination at K1363 (P = 0.0877); Gain of catalytic residue at C1355 (P = 0.1617); Loss of phosphorylation at S1359 (P = 0.437)
7:117304852:A:C,P13569,R1358S,0.97,Loss of methylation at R1358 (P = 0.0386); Loss of MoRF binding (P = 0.0519); Loss of ubiquitination at K1363 (P = 0.1091); Loss of stability (P = 0.1894); Gain of catalytic residue at C1355 (P = 0.2109)
7:117304852:A:T,P13569,R1358S,0.97,Loss of methylation at R1358 (P = 0.0386); Loss of MoRF binding (P = 0.0519); Loss of ubiquitination at K1363 (P = 0.1091); Loss of stability (P = 0.1894); Gain of catalytic residue at C1355 (P = 0.2109)
7:117304853:T:A,P13569,S1359T,0.746,Loss of catalytic residue at S1359 (P = 0.0814); Gain of ubiquitination at K1363 (P = 0.1375); Loss of stability (P = 0.1411); Loss of methylation at R1358 (P = 0.1913); Gain of MoRF binding (P = 0.1926)
7:117304853:T:C,P13569,S1359P,0.805,Loss of catalytic residue at S1359 (P = 0.0055); Loss of stability (P = 0.0695); Loss of MoRF binding (P = 0.0816); Loss of ubiquitination at K1363 (P = 0.1423); Gain of methylation at R1358 (P = 0.2078)
7:117304853:T:G,P13569,S1359A,0.67,Loss of catalytic residue at S1359 (P = 0.0993); Gain of methylation at R1358 (P = 0.1077); Loss of stability (P = 0.1219); Loss of ubiquitination at K1363 (P = 0.1601); Loss of MoRF binding (P = 0.175)
7:117304854:C:A,P13569,S1359Y,0.787,Gain of ubiquitination at K1363 (P = 0.1375); Loss of methylation at R1358 (P = 0.176); Loss of MoRF binding (P = 0.1809); Loss of stability (P = 0.2535); Loss of phosphorylation at S1359 (P = 0.3903)
7:117304854:C:G,P13569,S1359C,0.807,Loss of catalytic residue at S1359 (P = 0.0999); Gain of ubiquitination at K1363 (P = 0.1375); Loss of MoRF binding (P = 0.1474); Loss of methylation at R1358 (P = 0.1864); Loss of stability (P = 0.2555)
7:117304854:C:T,P13569,S1359F,0.745,Loss of catalytic residue at S1359 (P = 0.005); Gain of ubiquitination at K1363 (P = 0.0972); Gain of MoRF binding (P = 0.1465); Gain of methylation at R1358 (P = 0.1831); Loss of phosphorylation at S1359 (P = 0.3591)
7:117304856:G:A,P13569,V1360I,0.592,Loss of methylation at R1358 (P = 0.1235); Loss of ubiquitination at K1363 (P = 0.1601); Gain of MoRF binding (P = 0.1702); Gain of catalytic residue at S1362 (P = 0.2881); Gain of phosphorylation at S1359 (P = 0.3804)
7:117304856:G:C,P13569,V1360L,0.644,Loss of ubiquitination at K1363 (P = 0.1423); Loss of MoRF binding (P = 0.1671); Loss of methylation at K1365 (P = 0.1856); Gain of phosphorylation at S1359 (P = 0.365); Gain of disorder (P = 0.4633)
7:117304856:G:T,P13569,V1360F,0.712,Gain of catalytic residue at C1355 (P = 0.079); Loss of ubiquitination at K1363 (P = 0.1601); Gain of MoRF binding (P = 0.1932); Gain of methylation at R1358 (P = 0.2025); Loss of helix (P = 0.4763)
7:117304857:T:A,P13569,V1360D,0.924,Gain of disorder (P = 0.0637); Loss of MoRF binding (P = 0.0703); Loss of ubiquitination at K1363 (P = 0.1264); Loss of methylation at K1363 (P = 0.1359); Gain of phosphorylation at S1359 (P = 0.2514)
7:117304857:T:C,P13569,V1360A,0.869,Loss of ubiquitination at K1363 (P = 0.0716); Gain of methylation at R1358 (P = 0.0752); Loss of MoRF binding (P = 0.1291); Gain of disorder (P = 0.2184); Loss of helix (P = 0.2662)
7:117304857:T:G,P13569,V1360G,0.917,Loss of stability (P = 0.0215); Gain of methylation at R1358 (P = 0.05); Gain of catalytic residue at V1360 (P = 0.0516); Loss of ubiquitination at K1363 (P = 0.1264); Gain of disorder (P = 0.1343)
7:117304859:C:A,P13569,L1361I,0.767,Gain of methylation at K1365 (P = 0.0713); Loss of ubiquitination at K1363 (P = 0.1264); Gain of MoRF binding (P = 0.1333); Loss of sheet (P = 0.3635); Loss of helix (P = 0.4763)
7:117304859:C:G,P13569,L1361V,0.809,Gain of methylation at K1365 (P = 0.1125); Loss of ubiquitination at K1363 (P = 0.1264); Gain of MoRF binding (P = 0.1766); Loss of stability (P = 0.3634); Loss of sheet (P = 0.3635)
7:117304859:C:T,P13569,L1361F,0.762,Loss of ubiquitination at K1363 (P = 0.0957); Gain of methylation at K1365 (P = 0.1207); Gain of MoRF binding (P = 0.1474); Loss of sheet (P = 0.3635); Gain of catalytic residue at A1357 (P = 0.4618)
7:117304860:T:A,P13569,L1361H,0.866,Gain of methylation at R1358 (P = 0.0452); Loss of ubiquitination at K1363 (P = 0.0579); Loss of stability (P = 0.0974); Gain of disorder (P = 0.1237); Loss of MoRF binding (P = 0.1818)
7:117304860:T:C,P13569,L1361P,0.946,Loss of ubiquitination at K1363 (P = 0.0716); Loss of MoRF binding (P = 0.0863); Loss of stability (P = 0.0879); Gain of methylation at K1363 (P = 0.0963); Gain of disorder (P = 0.1001)
7:117304860:T:G,P13569,L1361R,0.917,Gain of methylation at L1361 (P = 0.015); Gain of MoRF binding (P = 0.0165); Loss of ubiquitination at K1363 (P = 0.0416); Gain of catalytic residue at L1361 (P = 0.0431); Gain of phosphorylation at S1359 (P = 0.0994)
7:117304862:A:C,P13569,S1362R,0.551,Gain of MoRF binding (P = 0.0126); Loss of ubiquitination at K1363 (P = 0.0457); Gain of methylation at K1365 (P = 0.125); Gain of phosphorylation at S1359 (P = 0.1848); Loss of catalytic residue at K1363 (P = 0.3035)
7:117304862:A:G,P13569,S1362G,0.55,Loss of stability (P = 0.0526); Gain of methylation at R1358 (P = 0.1085); Loss of ubiquitination at K1363 (P = 0.1423); Loss of MoRF binding (P = 0.1887); Gain of catalytic residue at L1367 (P = 0.2611)
7:117304862:A:T,P13569,S1362C,0.606,Gain of methylation at K1363 (P = 0.0143); Gain of ubiquitination at K1365 (P = 0.0918); Loss of MoRF binding (P = 0.15); Gain of catalytic residue at K1365 (P = 0.2914); Loss of disorder (P = 0.3091)
7:117304863:G:A,P13569,S1362N,0.502,Loss of catalytic residue at K1363 (P = 0.0233); Loss of ubiquitination at K1363 (P = 0.0877); Gain of MoRF binding (P = 0.1472); Gain of methylation at K1365 (P = 0.1615); Loss of sheet (P = 0.3635)
7:117304863:G:C,P13569,S1362T,0.445,Loss of ubiquitination at K1363 (P = 0.1601); Gain of MoRF binding (P = 0.1946); Gain of methylation at R1358 (P = 0.1975); Loss of stability (P = 0.2514); Gain of phosphorylation at S1362 (P = 0.3116)
7:117304863:G:T,P13569,S1362I,0.611,Gain of catalytic residue at L1367 (P = 0.0245); Gain of ubiquitination at K1365 (P = 0.0551); Gain of methylation at K1363 (P = 0.1036); Gain of MoRF binding (P = 0.2031); Loss of disorder (P = 0.3407)
7:117304864:T:A,P13569,S1362R,0.551,Gain of MoRF binding (P = 0.0126); Loss of ubiquitination at K1363 (P = 0.0457); Gain of methylation at K1365 (P = 0.125); Gain of phosphorylation at S1359 (P = 0.1848); Loss of catalytic residue at K1363 (P = 0.3035)
7:117304864:T:G,P13569,S1362R,0.551,Gain of MoRF binding (P = 0.0126); Loss of ubiquitination at K1363 (P = 0.0457); Gain of methylation at K1365 (P = 0.125); Gain of phosphorylation at S1359 (P = 0.1848); Loss of catalytic residue at K1363 (P = 0.3035)
7:117304865:A:C,P13569,K1363Q,0.627,Loss of ubiquitination at K1363 (P = 0.0244); Loss of methylation at K1363 (P = 0.0636); Loss of MoRF binding (P = 0.0828); Gain of catalytic residue at S1362 (P = 0.2351); Loss of sheet (P = 0.3635)
7:117304865:A:G,P13569,K1363E,0.63,Loss of ubiquitination at K1363 (P = 0.0244); Loss of catalytic residue at K1363 (P = 0.0422); Loss of MoRF binding (P = 0.0494); Loss of methylation at K1363 (P = 0.0636); Loss of sheet (P = 0.3635)
7:117304866:A:C,P13569,K1363T,0.647,Loss of ubiquitination at K1363 (P = 0.0244); Loss of catalytic residue at K1363 (P = 0.0631); Loss of methylation at K1363 (P = 0.0636); Loss of MoRF binding (P = 0.0827); Loss of solvent accessibility (P = 0.2882)
7:117304866:A:G,P13569,K1363R,0.562,Loss of ubiquitination at K1363 (P = 0.0244); Gain of methylation at R1358 (P = 0.0881); Gain of MoRF binding (P = 0.1159); Gain of catalytic residue at S1362 (P = 0.1162); Gain of solvent accessibility (P = 0.348)
7:117304866:A:T,P13569,K1363M,0.695,Loss of ubiquitination at K1363 (P = 0.0244); Loss of methylation at K1363 (P = 0.0636); Loss of catalytic residue at K1363 (P = 0.0654); Loss of MoRF binding (P = 0.0931); Loss of solvent accessibility (P = 0.1434)
7:117304867:G:C,P13569,K1363N,0.608,Loss of ubiquitination at K1363 (P = 0.0244); Loss of catalytic residue at K1363 (P = 0.0509); Loss of methylation at K1363 (P = 0.0636); Loss of MoRF binding (P = 0.0844); Loss of sheet (P = 0.3635)
7:117304867:G:T,P13569,K1363N,0.608,Loss of ubiquitination at K1363 (P = 0.0244); Loss of catalytic residue at K1363 (P = 0.0509); Loss of methylation at K1363 (P = 0.0636); Loss of MoRF binding (P = 0.0844); Loss of sheet (P = 0.3635)
7:117304868:G:A,P13569,A1364T,0.616,Loss of stability (P = 0.0402); Gain of methylation at K1365 (P = 0.1385); Loss of ubiquitination at K1365 (P = 0.152); Loss of MoRF binding (P = 0.2005); Gain of relative solvent accessibility (P = 0.2816)
7:117304868:G:C,P13569,A1364P,0.714,Gain of methylation at K1363 (P = 0.0595); Loss of stability (P = 0.0601); Loss of ubiquitination at K1363 (P = 0.0957); Loss of MoRF binding (P = 0.1005); Gain of disorder (P = 0.1999)
7:117304868:G:T,P13569,A1364S,0.64,Gain of disorder (P = 0.0529); Loss of ubiquitination at K1363 (P = 0.0957); Loss of stability (P = 0.0979); Gain of methylation at K1365 (P = 0.1782); Loss of MoRF binding (P = 0.1831)
7:117304869:C:A,P13569,A1364E,0.708,Gain of disorder (P = 0.0643); Loss of MoRF binding (P = 0.0746); Gain of methylation at K1363 (P = 0.0747); Loss of ubiquitination at K1363 (P = 0.1264); Loss of stability (P = 0.2189)
7:117304869:C:G,P13569,A1364G,0.762,Loss of stability (P = 0.0257); Loss of ubiquitination at K1363 (P = 0.1264); Gain of methylation at K1363 (P = 0.1946); Gain of MoRF binding (P = 0.2042); Loss of sheet (P = 0.3635)
7:117304869:C:T,P13569,A1364V,0.902,Gain of methylation at K1365 (P = 0.0377); Gain of MoRF binding (P = 0.1193); Loss of ubiquitination at K1363 (P = 0.1423); Loss of stability (P = 0.261); Gain of relative solvent accessibility (P = 0.2816)
7:117304871:A:C,P13569,K1365Q,0.612,Loss of ubiquitination at K1365 (P = 0.0362); Loss of methylation at K1365 (P = 0.0515); Loss of MoRF binding (P = 0.0962); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3498)
7:117304871:A:G,P13569,K1365E,0.647,Loss of ubiquitination at K1365 (P = 0.0362); Loss of methylation at K1365 (P = 0.0515); Loss of MoRF binding (P = 0.0651); Gain of disorder (P = 0.2198); Loss of sheet (P = 0.302)
7:117304872:A:C,P13569,K1365T,0.651,Loss of ubiquitination at K1365 (P = 0.0362); Loss of methylation at K1365 (P = 0.0515); Loss of MoRF binding (P = 0.0909); Loss of catalytic residue at K1365 (P = 0.1817); Loss of solvent accessibility (P = 0.2882)
7:117304872:A:G,P13569,K1365R,0.576,Loss of ubiquitination at K1365 (P = 0.0362); Loss of methylation at K1365 (P = 0.085); Gain of MoRF binding (P = 0.1078); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3429)
7:117304872:A:T,P13569,K1365M,0.694,Loss of ubiquitination at K1365 (P = 0.0362); Loss of methylation at K1365 (P = 0.0515); Loss of solvent accessibility (P = 0.0595); Loss of MoRF binding (P = 0.0964); Loss of relative solvent accessibility (P = 0.1807)
7:117304873:G:C,P13569,K1365N,0.642,Loss of ubiquitination at K1365 (P = 0.0362); Loss of methylation at K1365 (P = 0.0515); Loss of MoRF binding (P = 0.0974); Loss of catalytic residue at K1365 (P = 0.2842); Loss of sheet (P = 0.302)
7:117304873:G:T,P13569,K1365N,0.642,Loss of ubiquitination at K1365 (P = 0.0362); Loss of methylation at K1365 (P = 0.0515); Loss of MoRF binding (P = 0.0974); Loss of catalytic residue at K1365 (P = 0.2842); Loss of sheet (P = 0.302)
7:117304874:A:C,P13569,I1366L,0.645,Gain of disorder (P = 0.1121); Loss of methylation at K1365 (P = 0.1366); Loss of ubiquitination at K1363 (P = 0.1601); Loss of MoRF binding (P = 0.2272); Loss of sheet (P = 0.302)
7:117304874:A:G,P13569,I1366V,0.766,Gain of methylation at K1365 (P = 0.0681); Loss of ubiquitination at K1363 (P = 0.1601); Gain of disorder (P = 0.1909); Loss of MoRF binding (P = 0.2416); Loss of sheet (P = 0.302)
7:117304874:A:T,P13569,I1366F,0.907,Gain of methylation at K1365 (P = 0.0424); Loss of ubiquitination at K1363 (P = 0.1423); Loss of MoRF binding (P = 0.2461); Loss of catalytic residue at K1363 (P = 0.2869); Loss of stability (P = 0.3017)
7:117304875:T:A,P13569,I1366N,0.939,Gain of disorder (P = 0.0121); Loss of ubiquitination at K1363 (P = 0.0607); Loss of stability (P = 0.0689); Loss of methylation at K1365 (P = 0.1984); Gain of MoRF binding (P = 0.2333)
7:117304875:T:G,P13569,I1366S,0.896,Gain of disorder (P = 5e-04); Loss of stability (P = 0.059); Gain of phosphorylation at I1366 (P = 0.0792); Loss of ubiquitination at K1363 (P = 0.1264); Loss of methylation at K1365 (P = 0.1754)
7:117304876:C:G,P13569,I1366M,0.698,Gain of disorder (P = 0.0624); Loss of methylation at K1365 (P = 0.0707); Loss of ubiquitination at K1363 (P = 0.1091); Gain of MoRF binding (P = 0.2252); Gain of catalytic residue at I1366 (P = 0.2547)
7:117304877:T:A,P13569,L1367M,0.661,Gain of methylation at K1365 (P = 0.0891); Loss of ubiquitination at K1365 (P = 0.1268); Gain of disorder (P = 0.2069); Gain of MoRF binding (P = 0.2358); Loss of stability (P = 0.2777)
7:117304877:T:G,P13569,L1367V,0.679,Gain of catalytic residue at L1367 (P = 0.0799); Gain of methylation at K1365 (P = 0.0848); Loss of ubiquitination at K1363 (P = 0.1091); Loss of stability (P = 0.1571); Gain of MoRF binding (P = 0.2519)
7:117304878:T:C,P13569,L1367S,0.828,Gain of disorder (P = 0.0045); Loss of stability (P = 0.0086); Gain of phosphorylation at L1367 (P = 0.0658); Gain of methylation at K1363 (P = 0.066); Loss of ubiquitination at K1363 (P = 0.1264)
7:117304878:T:G,P13569,L1367W,0.683,Loss of stability (P = 0.0435); Gain of MoRF binding (P = 0.0837); Loss of ubiquitination at K1363 (P = 0.1091); Gain of methylation at K1365 (P = 0.1393); Loss of disorder (P = 0.1628)
7:117304879:G:C,P13569,L1367F,0.675,Loss of ubiquitination at K1363 (P = 0.0957); Gain of methylation at K1365 (P = 0.1128); Gain of catalytic residue at L1367 (P = 0.1289); Loss of stability (P = 0.1383); Loss of disorder (P = 0.2372)
7:117304879:G:T,P13569,L1367F,0.675,Loss of ubiquitination at K1363 (P = 0.0957); Gain of methylation at K1365 (P = 0.1128); Gain of catalytic residue at L1367 (P = 0.1289); Loss of stability (P = 0.1383); Loss of disorder (P = 0.2372)
7:117304880:C:A,P13569,L1368M,0.708,Gain of methylation at K1365 (P = 0.0861); Loss of ubiquitination at K1363 (P = 0.1264); Gain of disorder (P = 0.1927); Loss of stability (P = 0.2095); Gain of catalytic residue at L1368 (P = 0.2496)
7:117304880:C:G,P13569,L1368V,0.667,Gain of methylation at K1365 (P = 0.0861); Loss of ubiquitination at K1363 (P = 0.1091); Gain of catalytic residue at D1370 (P = 0.2111); Loss of disorder (P = 0.2994); Gain of MoRF binding (P = 0.3007)
7:117304881:T:A,P13569,L1368Q,0.858,Gain of disorder (P = 0.0243); Gain of methylation at K1363 (P = 0.0932); Loss of ubiquitination at K1363 (P = 0.1091); Loss of stability (P = 0.1099); Loss of catalytic residue at L1368 (P = 0.1877)
7:117304881:T:C,P13569,L1368P,0.873,Loss of stability (P = 0.011); Gain of disorder (P = 0.012); Gain of methylation at K1363 (P = 0.0427); Loss of ubiquitination at K1363 (P = 0.1264); Loss of MoRF binding (P = 0.3016)
7:117304881:T:G,P13569,L1368R,0.912,Gain of disorder (P = 0.0363); Gain of MoRF binding (P = 0.048); Loss of ubiquitination at K1363 (P = 0.0503); Gain of methylation at L1368 (P = 0.0632); Loss of stability (P = 0.0837)
7:117304883:C:A,P13569,L1369I,0.709,Loss of catalytic residue at L1369 (P = 0.0233); Gain of methylation at K1365 (P = 0.0649); Loss of ubiquitination at K1365 (P = 0.1962); Loss of disorder (P = 0.2239); Loss of sheet (P = 0.302)
7:117304883:C:G,P13569,L1369V,0.718,Loss of catalytic residue at L1369 (P = 0.0461); Gain of methylation at K1365 (P = 0.0936); Loss of ubiquitination at K1365 (P = 0.1962); Loss of disorder (P = 0.2977); Loss of sheet (P = 0.302)
7:117304883:C:T,P13569,L1369F,0.733,Gain of methylation at K1365 (P = 0.1163); Loss of ubiquitination at K1365 (P = 0.1808); Loss of stability (P = 0.2077); Loss of disorder (P = 0.2218); Loss of catalytic residue at L1369 (P = 0.2882)
7:117304884:T:A,P13569,L1369H,0.847,Gain of disorder (P = 0.0188); Loss of stability (P = 0.027); Loss of catalytic residue at L1369 (P = 0.0303); Gain of methylation at K1365 (P = 0.0494); Loss of ubiquitination at K1365 (P = 0.2335)
7:117304884:T:C,P13569,L1369P,0.906,Gain of disorder (P = 0.0099); Loss of stability (P = 0.027); Gain of methylation at K1365 (P = 0.0371); Loss of sheet (P = 0.1158); Loss of ubiquitination at K1365 (P = 0.2243)
7:117304884:T:G,P13569,L1369R,0.903,Gain of disorder (P = 0.0315); Loss of stability (P = 0.0637); Gain of MoRF binding (P = 0.0651); Gain of methylation at K1365 (P = 0.0954); Gain of ubiquitination at K1365 (P = 0.1306)
7:117304886:G:A,P13569,D1370N,0.875,Gain of catalytic residue at D1370 (P = 0.0182); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2319); Loss of ubiquitination at K1365 (P = 0.2335); Loss of methylation at K1365 (P = 0.252)
7:117304886:G:T,P13569,D1370Y,0.896,Loss of disorder (P = 0.0658); Gain of methylation at K1365 (P = 0.1263); Loss of ubiquitination at K1365 (P = 0.2094); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302)
7:117304887:A:C,P13569,D1370A,0.907,Loss of disorder (P = 0.1526); Loss of methylation at K1365 (P = 0.1924); Gain of ubiquitination at K1365 (P = 0.2129); Loss of loop (P = 0.2237); Gain of catalytic residue at D1370 (P = 0.2721)
7:117304887:A:G,P13569,D1370G,0.889,Loss of stability (P = 0.0935); Gain of ubiquitination at K1365 (P = 0.1575); Loss of loop (P = 0.2237); Loss of disorder (P = 0.2421); Loss of methylation at K1365 (P = 0.249)
7:117304887:A:T,P13569,D1370V,0.899,Loss of disorder (P = 0.061); Gain of sheet (P = 0.0827); Gain of ubiquitination at K1365 (P = 0.1884); Loss of methylation at K1365 (P = 0.2037); Loss of loop (P = 0.2237)
7:117304888:T:A,P13569,D1370E,0.894,Gain of disorder (P = 0.1545); Gain of methylation at K1365 (P = 0.1666); Gain of glycosylation at P1372 (P = 0.184); Loss of ubiquitination at K1365 (P = 0.1962); Gain of catalytic residue at D1370 (P = 0.2494)
7:117304888:T:G,P13569,D1370E,0.894,Gain of disorder (P = 0.1545); Gain of methylation at K1365 (P = 0.1666); Gain of glycosylation at P1372 (P = 0.184); Loss of ubiquitination at K1365 (P = 0.1962); Gain of catalytic residue at D1370 (P = 0.2494)
7:117304889:G:A,P13569,E1371K,0.958,Gain of ubiquitination at E1371 (P = 0.0219); Loss of stability (P = 0.0883); Gain of MoRF binding (P = 0.1981); Loss of catalytic residue at E1371 (P = 0.2643); Gain of disorder (P = 0.2953)
7:117304889:G:C,P13569,E1371Q,0.952,Loss of catalytic residue at E1371 (P = 0.0841); Loss of disorder (P = 0.2135); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.4017); Loss of stability (P = 0.4563)
7:117304890:A:C,P13569,E1371A,0.974,Loss of disorder (P = 0.1152); Loss of sheet (P = 0.302); Gain of catalytic residue at A1374 (P = 0.3874); Gain of MoRF binding (P = 0.3987); Loss of stability (P = 0.4733)
7:117304890:A:G,P13569,E1371G,0.959,Loss of stability (P = 0.0301); Loss of disorder (P = 0.1934); Gain of catalytic residue at A1374 (P = 0.2392); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3891)
7:117304890:A:T,P13569,E1371V,0.961,Loss of disorder (P = 0.0485); Loss of catalytic residue at E1371 (P = 0.1674); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.334); Loss of phosphorylation at S1373 (P = 0.4554)
7:117304891:A:C,P13569,E1371D,0.956,Loss of catalytic residue at E1371 (P = 0.0736); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3272); Loss of stability (P = 0.4604); Gain of phosphorylation at S1373 (P = 0.48)
7:117304891:A:T,P13569,E1371D,0.956,Loss of catalytic residue at E1371 (P = 0.0736); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3272); Loss of stability (P = 0.4604); Gain of phosphorylation at S1373 (P = 0.48)
7:117304892:C:A,P13569,P1372T,0.954,Gain of catalytic residue at P1372 (P = 0.0942); Loss of stability (P = 0.1376); Loss of disorder (P = 0.1876); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.4711)
7:117304892:C:G,P13569,P1372A,0.944,Loss of stability (P = 0.1317); Loss of disorder (P = 0.151); Gain of catalytic residue at D1370 (P = 0.1763); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.4917)
7:117304892:C:T,P13569,P1372S,0.908,Gain of disorder (P = 0.1275); Gain of phosphorylation at P1372 (P = 0.1698); Loss of stability (P = 0.1774); Gain of catalytic residue at L1368 (P = 0.2931); Loss of sheet (P = 0.302)
7:117304893:C:A,P13569,P1372H,0.936,Loss of stability (P = 0.1256); Gain of catalytic residue at D1370 (P = 0.1464); Loss of disorder (P = 0.225); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.4711)
7:117304893:C:G,P13569,P1372R,0.932,Loss of disorder (P = 0.2171); Loss of catalytic residue at E1371 (P = 0.2601); Loss of stability (P = 0.2681); Gain of phosphorylation at S1373 (P = 0.2888); Loss of sheet (P = 0.302)
7:117304893:C:T,P13569,P1372L,0.968,Loss of disorder (P = 0.0676); Gain of helix (P = 0.2684); Loss of catalytic residue at L1369 (P = 0.2827); Loss of sheet (P = 0.302); Loss of loop (P = 0.4412)
7:117304895:A:C,P13569,S1373R,0.775,Gain of catalytic residue at S1373 (P = 0.0032); Loss of disorder (P = 0.1685); Gain of methylation at S1373 (P = 0.2685); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.342)
7:117304895:A:G,P13569,S1373G,0.752,Gain of catalytic residue at S1373 (P = 0.1623); Loss of disorder (P = 0.1977); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.342); Loss of helix (P = 0.3949)
7:117304895:A:T,P13569,S1373C,0.744,Gain of catalytic residue at P1372 (P = 0.013); Loss of disorder (P = 0.032); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.342); Loss of helix (P = 0.3949)
7:117304896:G:A,P13569,S1373N,0.764,Loss of disorder (P = 0.1933); Loss of catalytic residue at H1375 (P = 0.3016); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.342); Loss of helix (P = 0.3949)
7:117304896:G:C,P13569,S1373T,0.62,Loss of disorder (P = 0.1436); Gain of catalytic residue at S1373 (P = 0.1869); Gain of phosphorylation at S1373 (P = 0.2426); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117304896:G:T,P13569,S1373I,0.742,Loss of disorder (P = 0.042); Gain of catalytic residue at S1373 (P = 0.0526); Gain of stability (P = 0.072); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.342)
7:117304897:T:A,P13569,S1373R,0.775,Gain of catalytic residue at S1373 (P = 0.0032); Loss of disorder (P = 0.1685); Gain of methylation at S1373 (P = 0.2685); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.342)
7:117304897:T:G,P13569,S1373R,0.775,Gain of catalytic residue at S1373 (P = 0.0032); Loss of disorder (P = 0.1685); Gain of methylation at S1373 (P = 0.2685); Loss of sheet (P = 0.302); Loss of phosphorylation at S1373 (P = 0.342)
7:117304898:G:A,P13569,A1374T,0.805,Loss of stability (P = 0.0277); Gain of phosphorylation at A1374 (P = 0.0841); Gain of catalytic residue at A1374 (P = 0.1085); Gain of disorder (P = 0.1769); Loss of sheet (P = 0.302)
7:117304898:G:C,P13569,A1374P,0.819,Loss of stability (P = 0.0205); Gain of disorder (P = 0.0385); Gain of phosphorylation at S1373 (P = 0.1599); Gain of glycosylation at A1374 (P = 0.1837); Loss of sheet (P = 0.302)
7:117304898:G:T,P13569,A1374S,0.751,Gain of disorder (P = 0.021); Loss of stability (P = 0.0573); Gain of phosphorylation at A1374 (P = 0.1295); Gain of glycosylation at A1374 (P = 0.2286); Loss of sheet (P = 0.302)
7:117304899:C:A,P13569,A1374D,0.825,Gain of disorder (P = 0.0336); Loss of stability (P = 0.1092); Gain of phosphorylation at S1373 (P = 0.207); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302)
7:117304899:C:G,P13569,A1374G,0.79,Loss of stability (P = 0.0154); Gain of disorder (P = 0.1035); Gain of glycosylation at S1373 (P = 0.1502); Loss of sheet (P = 0.302); Gain of catalytic residue at D1377 (P = 0.3387)
7:117304899:C:T,P13569,A1374V,0.866,Loss of disorder (P = 0.1444); Loss of stability (P = 0.2932); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of catalytic residue at D1377 (P = 0.4808)
7:117304901:C:G,P13569,H1375D,0.708,Gain of relative solvent accessibility (P = 0.0479); Gain of solvent accessibility (P = 0.0704); Loss of catalytic residue at H1375 (P = 0.093); Gain of disorder (P = 0.1226); Gain of phosphorylation at S1373 (P = 0.172)
7:117304901:C:T,P13569,H1375Y,0.811,Loss of disorder (P = 0.0983); Gain of phosphorylation at H1375 (P = 0.1068); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of catalytic residue at D1377 (P = 0.4467)
7:117304902:A:C,P13569,H1375P,0.898,Gain of glycosylation at H1375 (P = 0.095); Gain of disorder (P = 0.1437); Gain of phosphorylation at S1373 (P = 0.1671); Loss of catalytic residue at H1375 (P = 0.1689); Loss of stability (P = 0.2147)
7:117304902:A:G,P13569,H1375R,0.852,Gain of phosphorylation at S1373 (P = 0.1014); Loss of disorder (P = 0.2763); Loss of catalytic residue at D1377 (P = 0.2766); Gain of MoRF binding (P = 0.2797); Loss of loop (P = 0.2897)
7:117304902:A:T,P13569,H1375L,0.752,Loss of disorder (P = 0.1096); Loss of catalytic residue at D1377 (P = 0.2832); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of phosphorylation at S1373 (P = 0.4027)
7:117304903:T:A,P13569,H1375Q,0.855,Gain of disorder (P = 0.2583); Loss of catalytic residue at D1377 (P = 0.2998); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of phosphorylation at S1373 (P = 0.501)
7:117304903:T:G,P13569,H1375Q,0.855,Gain of disorder (P = 0.2583); Loss of catalytic residue at D1377 (P = 0.2998); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of phosphorylation at S1373 (P = 0.501)
7:117304904:T:A,P13569,L1376M,0.743,Loss of stability (P = 0.0831); Gain of disorder (P = 0.2025); Gain of phosphorylation at Y1381 (P = 0.2281); Loss of helix (P = 0.3949); Gain of catalytic residue at H1375 (P = 0.4535)
7:117304904:T:G,P13569,L1376V,0.722,Loss of stability (P = 0.1857); Loss of disorder (P = 0.2994); Gain of phosphorylation at Y1381 (P = 0.3464); Gain of catalytic residue at D1377 (P = 0.3513); Loss of helix (P = 0.3949)
7:117304905:T:C,P13569,L1376S,0.862,Gain of disorder (P = 0.005); Loss of stability (P = 0.0129); Loss of catalytic residue at L1376 (P = 0.0247); Gain of phosphorylation at L1376 (P = 0.1884); Gain of glycosylation at L1376 (P = 0.1938)
7:117304905:T:G,P13569,L1376W,0.764,Loss of stability (P = 0.0406); Loss of disorder (P = 0.155); Loss of catalytic residue at L1376 (P = 0.3185); Gain of MoRF binding (P = 0.3885); Loss of helix (P = 0.3949)
7:117304906:G:C,P13569,L1376F,0.756,Loss of stability (P = 0.0629); Loss of catalytic residue at L1376 (P = 0.0979); Loss of disorder (P = 0.2311); Loss of helix (P = 0.3949); Gain of phosphorylation at Y1381 (P = 0.4345)
7:117304906:G:T,P13569,L1376F,0.756,Loss of stability (P = 0.0629); Loss of catalytic residue at L1376 (P = 0.0979); Loss of disorder (P = 0.2311); Loss of helix (P = 0.3949); Gain of phosphorylation at Y1381 (P = 0.4345)
7:117304907:G:A,P13569,D1377N,0.913,Loss of catalytic residue at D1377 (P = 0.2419); Loss of disorder (P = 0.2587); Gain of MoRF binding (P = 0.2736); Loss of helix (P = 0.3949); Loss of phosphorylation at Y1381 (P = 0.4191)
7:117304907:G:C,P13569,D1377H,0.964,Gain of disorder (P = 0.161); Gain of catalytic residue at Y1381 (P = 0.2799); Loss of stability (P = 0.2964); Gain of MoRF binding (P = 0.3149); Loss of helix (P = 0.3949)
7:117304907:G:T,P13569,D1377Y,0.954,Loss of disorder (P = 0.1253); Loss of helix (P = 0.2271); Gain of catalytic residue at D1377 (P = 0.2524); Gain of MoRF binding (P = 0.3136); Loss of phosphorylation at Y1381 (P = 0.4027)
7:117304908:A:C,P13569,D1377A,0.932,Loss of disorder (P = 0.2384); Gain of MoRF binding (P = 0.2966); Loss of helix (P = 0.3949); Loss of phosphorylation at Y1381 (P = 0.4197); Gain of glycosylation at P1372 (P = 0.5034)
7:117304908:A:G,P13569,D1377G,0.937,Loss of stability (P = 0.0676); Loss of disorder (P = 0.2901); Gain of MoRF binding (P = 0.2958); Loss of helix (P = 0.3949); Gain of catalytic residue at A1374 (P = 0.4277)
7:117304908:A:T,P13569,D1377V,0.947,Loss of disorder (P = 0.1091); Gain of MoRF binding (P = 0.2728); Loss of helix (P = 0.3949); Loss of phosphorylation at Y1381 (P = 0.4115); Loss of loop (P = 0.4412)
7:117304909:T:A,P13569,D1377E,0.929,Gain of disorder (P = 0.2311); Gain of catalytic residue at D1377 (P = 0.2619); Gain of phosphorylation at Y1381 (P = 0.2646); Loss of helix (P = 0.3949); Loss of MoRF binding (P = 0.4334)
7:117304909:T:G,P13569,D1377E,0.929,Gain of disorder (P = 0.2311); Gain of catalytic residue at D1377 (P = 0.2619); Gain of phosphorylation at Y1381 (P = 0.2646); Loss of helix (P = 0.3949); Loss of MoRF binding (P = 0.4334)
7:117304910:C:A,P13569,P1378T,0.576,Gain of catalytic residue at P1378 (P = 0.0645); Gain of MoRF binding (P = 0.229); Loss of disorder (P = 0.284); Loss of stability (P = 0.346); Loss of helix (P = 0.3949)
7:117304910:C:G,P13569,P1378A,0.579,Loss of helix (P = 0.2271); Loss of disorder (P = 0.2516); Gain of MoRF binding (P = 0.2588); Loss of stability (P = 0.3225); Loss of phosphorylation at Y1381 (P = 0.4286)
7:117304910:C:T,P13569,P1378S,0.598,Gain of disorder (P = 0.1626); Gain of MoRF binding (P = 0.2052); Loss of stability (P = 0.2823); Loss of helix (P = 0.3949); Gain of phosphorylation at S1373 (P = 0.4281)
7:117304911:C:A,P13569,P1378Q,0.602,Gain of MoRF binding (P = 0.1802); Gain of solvent accessibility (P = 0.28); Loss of disorder (P = 0.3065); Loss of helix (P = 0.3949); Loss of catalytic residue at Y1381 (P = 0.4136)
7:117304911:C:G,P13569,P1378R,0.664,Gain of MoRF binding (P = 0.01); Gain of solvent accessibility (P = 0.0411); Gain of catalytic residue at P1378 (P = 0.1137); Gain of relative solvent accessibility (P = 0.1894); Loss of disorder (P = 0.2884)
7:117304911:C:T,P13569,P1378L,0.621,Loss of disorder (P = 0.1465); Gain of MoRF binding (P = 0.2544); Loss of phosphorylation at Y1381 (P = 0.3557); Loss of helix (P = 0.3949); Gain of solvent accessibility (P = 0.4304)
7:117304913:G:A,P13569,V1379I,0.496,Gain of MoRF binding (P = 0.311); Loss of phosphorylation at Y1381 (P = 0.3748); Loss of disorder (P = 0.3802); Loss of helix (P = 0.3949); Gain of solvent accessibility (P = 0.5334)
7:117304913:G:C,P13569,V1379L,0.542,Gain of relative solvent accessibility (P = 0.1066); Gain of solvent accessibility (P = 0.1751); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2345); Loss of MoRF binding (P = 0.3228)
7:117304913:G:T,P13569,V1379L,0.542,Gain of relative solvent accessibility (P = 0.1066); Gain of solvent accessibility (P = 0.1751); Loss of helix (P = 0.2271); Gain of disorder (P = 0.2345); Loss of MoRF binding (P = 0.3228)
7:117304914:T:A,P13569,V1379E,0.624,Gain of disorder (P = 0.0084); Gain of solvent accessibility (P = 0.0421); Gain of relative solvent accessibility (P = 0.0507); Gain of helix (P = 0.2059); Gain of phosphorylation at Y1381 (P = 0.2326)
7:117304914:T:C,P13569,V1379A,0.463,Gain of relative solvent accessibility (P = 0.0507); Gain of disorder (P = 0.078); Gain of solvent accessibility (P = 0.2346); Loss of MoRF binding (P = 0.3123); Loss of stability (P = 0.3503)
7:117304914:T:G,P13569,V1379G,0.504,Gain of disorder (P = 0.0442); Gain of relative solvent accessibility (P = 0.0507); Loss of stability (P = 0.0717); Gain of catalytic residue at V1379 (P = 0.1234); Loss of MoRF binding (P = 0.3139)
7:117305514:A:C,P13569,T1380P,0.865,Gain of disorder (P = 0.2048); Loss of helix (P = 0.2271); Loss of MoRF binding (P = 0.2452); Gain of phosphorylation at Y1381 (P = 0.3356); Loss of stability (P = 0.4362)
7:117305514:A:G,P13569,T1380A,0.734,Gain of catalytic residue at T1380 (P = 0.263); Gain of MoRF binding (P = 0.2851); Loss of helix (P = 0.3949); Gain of disorder (P = 0.432); Loss of phosphorylation at Y1381 (P = 0.454)
7:117305514:A:T,P13569,T1380S,0.683,Gain of disorder (P = 0.0957); Gain of MoRF binding (P = 0.2788); Gain of phosphorylation at Y1381 (P = 0.3634); Loss of helix (P = 0.3949); Gain of catalytic residue at Y1381 (P = 0.5257)
7:117305515:C:A,P13569,T1380K,0.879,Gain of ubiquitination at T1380 (P = 0.0247); Gain of methylation at T1380 (P = 0.0338); Gain of MoRF binding (P = 0.0711); Loss of helix (P = 0.2271); Loss of catalytic residue at Y1381 (P = 0.289)
7:117305515:C:G,P13569,T1380R,0.873,Gain of catalytic residue at T1380 (P = 0.0618); Gain of MoRF binding (P = 0.0643); Loss of loop (P = 0.2897); Gain of disorder (P = 0.3572); Loss of phosphorylation at Y1381 (P = 0.3724)
7:117305515:C:T,P13569,T1380I,0.822,Gain of catalytic residue at T1380 (P = 0.0961); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.2325); Loss of disorder (P = 0.2448); Loss of loop (P = 0.2897)
7:117305517:T:A,P13569,Y1381N,0.731,Loss of catalytic residue at L1376 (P = 0.156); Gain of disorder (P = 0.203); Loss of helix (P = 0.2271); Loss of phosphorylation at Y1381 (P = 0.2298); Gain of MoRF binding (P = 0.2458)
7:117305517:T:C,P13569,Y1381H,0.83,Gain of disorder (P = 0.0388); Loss of catalytic residue at L1376 (P = 0.162); Loss of phosphorylation at Y1381 (P = 0.2298); Gain of MoRF binding (P = 0.2829); Loss of helix (P = 0.3949)
7:117305517:T:G,P13569,Y1381D,0.618,Gain of disorder (P = 0.0652); Loss of catalytic residue at L1376 (P = 0.1536); Loss of MoRF binding (P = 0.2229); Loss of helix (P = 0.2271); Loss of phosphorylation at Y1381 (P = 0.2298)
7:117305518:A:C,P13569,Y1381S,0.7,Gain of disorder (P = 0.0276); Loss of catalytic residue at L1376 (P = 0.1643); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.25); Loss of stability (P = 0.3624)
7:117305518:A:T,P13569,Y1381F,0.692,Loss of catalytic residue at L1376 (P = 0.1736); Gain of helix (P = 0.2059); Gain of MoRF binding (P = 0.2225); Loss of phosphorylation at Y1381 (P = 0.2298); Loss of loop (P = 0.2897)
7:117305520:C:A,P13569,Q1382K,0.586,Gain of MoRF binding (P = 0.0421); Gain of methylation at Q1382 (P = 0.0827); Gain of catalytic residue at Q1382 (P = 0.1269); Gain of phosphorylation at T1387 (P = 0.2923); Gain of ubiquitination at Q1382 (P = 0.2985)
7:117305520:C:G,P13569,Q1382E,0.504,Loss of MoRF binding (P = 0.1357); Gain of phosphorylation at Y1381 (P = 0.3464); Loss of helix (P = 0.3949); Loss of catalytic residue at R1386 (P = 0.4342); Gain of disorder (P = 0.4379)
7:117305521:A:C,P13569,Q1382P,0.591,Loss of MoRF binding (P = 0.1486); Gain of phosphorylation at T1387 (P = 0.1682); Loss of helix (P = 0.2271); Gain of catalytic residue at Y1381 (P = 0.2482); Loss of solvent accessibility (P = 0.3854)
7:117305521:A:G,P13569,Q1382R,0.563,Gain of MoRF binding (P = 0.0185); Gain of phosphorylation at T1387 (P = 0.2311); Loss of loop (P = 0.2897); Loss of helix (P = 0.3949); Gain of catalytic residue at Q1382 (P = 0.4455)
7:117305521:A:T,P13569,Q1382L,0.558,Gain of stability (P = 0.0811); Loss of MoRF binding (P = 0.228); Gain of catalytic residue at Y1381 (P = 0.2878); Loss of solvent accessibility (P = 0.3103); Loss of helix (P = 0.3949)
7:117305522:A:C,P13569,Q1382H,0.499,Loss of MoRF binding (P = 0.2447); Gain of catalytic residue at Q1382 (P = 0.2726); Gain of disorder (P = 0.341); Loss of helix (P = 0.3949); Loss of solvent accessibility (P = 0.4011)
7:117305522:A:T,P13569,Q1382H,0.499,Loss of MoRF binding (P = 0.2447); Gain of catalytic residue at Q1382 (P = 0.2726); Gain of disorder (P = 0.341); Loss of helix (P = 0.3949); Loss of solvent accessibility (P = 0.4011)
7:117305523:A:C,P13569,I1383L,0.486,Loss of catalytic residue at L1388 (P = 0.1458); Loss of MoRF binding (P = 0.2361); Loss of helix (P = 0.3949); Gain of phosphorylation at Y1381 (P = 0.4192); Gain of disorder (P = 0.5108)
7:117305523:A:G,P13569,I1383V,0.474,Loss of catalytic residue at L1388 (P = 0.1458); Loss of MoRF binding (P = 0.2469); Gain of phosphorylation at Y1381 (P = 0.2772); Loss of helix (P = 0.3949); Gain of disorder (P = 0.5207)
7:117305523:A:T,P13569,I1383L,0.486,Loss of catalytic residue at L1388 (P = 0.1458); Loss of MoRF binding (P = 0.2361); Loss of helix (P = 0.3949); Gain of phosphorylation at Y1381 (P = 0.4192); Gain of disorder (P = 0.5108)
7:117305524:T:A,P13569,I1383K,0.566,Gain of MoRF binding (P = 0.068); Loss of stability (P = 0.0703); Gain of phosphorylation at T1380 (P = 0.1208); Loss of catalytic residue at L1388 (P = 0.1421); Gain of disorder (P = 0.157)
7:117305524:T:C,P13569,I1383T,0.582,Loss of stability (P = 0.0675); Gain of phosphorylation at I1383 (P = 0.1418); Loss of catalytic residue at L1388 (P = 0.1439); Gain of disorder (P = 0.1604); Loss of MoRF binding (P = 0.214)
7:117305524:T:G,P13569,I1383R,0.611,Gain of MoRF binding (P = 0.0502); Gain of phosphorylation at T1380 (P = 0.0854); Gain of disorder (P = 0.1284); Loss of catalytic residue at L1388 (P = 0.1415); Loss of stability (P = 0.2462)
7:117305525:A:G,P13569,I1383M,0.49,Gain of catalytic residue at V1379 (P = 0.0157); Gain of phosphorylation at Y1381 (P = 0.1683); Gain of MoRF binding (P = 0.2334); Gain of disorder (P = 0.3907); Loss of helix (P = 0.3949)
7:117305526:A:C,P13569,I1384L,0.675,Loss of MoRF binding (P = 0.2321); Loss of phosphorylation at T1387 (P = 0.3592); Gain of ubiquitination at K1389 (P = 0.3757); Loss of catalytic residue at L1388 (P = 0.4418); Loss of methylation at K1389 (P = 0.4716)
7:117305526:A:G,P13569,I1384V,0.702,Loss of MoRF binding (P = 0.2455); Gain of phosphorylation at Y1381 (P = 0.2819); Gain of ubiquitination at K1389 (P = 0.3757); Loss of catalytic residue at L1388 (P = 0.4415); Loss of methylation at K1389 (P = 0.482)
7:117305526:A:T,P13569,I1384F,0.78,Gain of MoRF binding (P = 0.2483); Gain of catalytic residue at R1385 (P = 0.2589); Loss of stability (P = 0.2612); Gain of phosphorylation at T1387 (P = 0.2668); Gain of ubiquitination at K1389 (P = 0.3617)
7:117305527:T:A,P13569,I1384N,0.918,Loss of stability (P = 0.0618); Loss of MoRF binding (P = 0.2114); Loss of helix (P = 0.2271); Gain of phosphorylation at T1387 (P = 0.3258); Loss of ubiquitination at K1389 (P = 0.3776)
7:117305527:T:C,P13569,I1384T,0.91,Loss of stability (P = 0.0226); Loss of MoRF binding (P = 0.2013); Gain of phosphorylation at T1387 (P = 0.2529); Gain of glycosylation at I1384 (P = 0.2591); Gain of disorder (P = 0.3239)
7:117305527:T:G,P13569,I1384S,0.903,Loss of stability (P = 0.032); Gain of disorder (P = 0.0881); Gain of catalytic residue at I1384 (P = 0.1187); Gain of phosphorylation at I1384 (P = 0.1617); Loss of MoRF binding (P = 0.2176)
7:117305528:T:G,P13569,I1384M,0.668,Gain of phosphorylation at Y1381 (P = 0.1879); Gain of MoRF binding (P = 0.2395); Loss of ubiquitination at K1389 (P = 0.3786); Loss of stability (P = 0.4151); Gain of methylation at K1389 (P = 0.4627)
7:117305529:A:G,P13569,R1385G,0.75,Loss of MoRF binding (P = 0.0903); Loss of stability (P = 0.0961); Loss of solvent accessibility (P = 0.239); Gain of catalytic residue at I1384 (P = 0.2434); Loss of phosphorylation at T1387 (P = 0.288)
7:117305530:G:A,P13569,R1385K,0.708,Gain of methylation at R1385 (P = 0.0261); Gain of ubiquitination at R1385 (P = 0.0797); Loss of stability (P = 0.1997); Loss of MoRF binding (P = 0.2188); Loss of solvent accessibility (P = 0.239)
7:117305530:G:C,P13569,R1385T,0.741,Loss of MoRF binding (P = 0.0883); Gain of ubiquitination at K1389 (P = 0.1825); Loss of stability (P = 0.1893); Loss of solvent accessibility (P = 0.239); Loss of phosphorylation at T1387 (P = 0.2842)
7:117305530:G:T,P13569,R1385I,0.776,Gain of ubiquitination at K1389 (P = 0.0919); Loss of MoRF binding (P = 0.1012); Loss of solvent accessibility (P = 0.239); Loss of phosphorylation at T1387 (P = 0.2508); Gain of catalytic residue at R1386 (P = 0.3343)
7:117305531:A:C,P13569,R1385S,0.741,Loss of MoRF binding (P = 0.0936); Loss of stability (P = 0.2274); Loss of solvent accessibility (P = 0.239); Gain of ubiquitination at K1389 (P = 0.245); Gain of catalytic residue at R1385 (P = 0.2661)
7:117305531:A:T,P13569,R1385S,0.741,Loss of MoRF binding (P = 0.0936); Loss of stability (P = 0.2274); Loss of solvent accessibility (P = 0.239); Gain of ubiquitination at K1389 (P = 0.245); Gain of catalytic residue at R1385 (P = 0.2661)
7:117305532:A:G,P13569,R1386G,0.578,Loss of stability (P = 0.0162); Loss of MoRF binding (P = 0.0882); Gain of ubiquitination at K1389 (P = 0.115); Loss of solvent accessibility (P = 0.1235); Gain of catalytic residue at R1386 (P = 0.1992)
7:117305533:G:A,P13569,R1386K,0.518,Gain of methylation at R1386 (P = 0.0264); Loss of stability (P = 0.1066); Gain of ubiquitination at R1386 (P = 0.1326); Loss of MoRF binding (P = 0.2202); Gain of phosphorylation at Y1381 (P = 0.355)
7:117305533:G:C,P13569,R1386T,0.61,Loss of MoRF binding (P = 0.0874); Loss of stability (P = 0.1002); Gain of ubiquitination at K1389 (P = 0.115); Gain of catalytic residue at R1386 (P = 0.232); Loss of solvent accessibility (P = 0.2814)
7:117305533:G:T,P13569,R1386I,0.622,Gain of ubiquitination at K1389 (P = 0.047); Loss of MoRF binding (P = 0.0957); Loss of solvent accessibility (P = 0.1952); Loss of phosphorylation at T1387 (P = 0.2671); Gain of catalytic residue at L1388 (P = 0.3118)
7:117305534:A:C,P13569,R1386S,0.613,Loss of MoRF binding (P = 0.0933); Loss of stability (P = 0.1254); Gain of ubiquitination at K1389 (P = 0.1825); Loss of solvent accessibility (P = 0.2106); Gain of catalytic residue at R1386 (P = 0.2427)
7:117305534:A:T,P13569,R1386S,0.613,Loss of MoRF binding (P = 0.0933); Loss of stability (P = 0.1254); Gain of ubiquitination at K1389 (P = 0.1825); Loss of solvent accessibility (P = 0.2106); Gain of catalytic residue at R1386 (P = 0.2427)
7:117305535:A:C,P13569,T1387P,0.855,Loss of stability (P = 0.104); Loss of MoRF binding (P = 0.1168); Loss of phosphorylation at T1387 (P = 0.1911); Loss of helix (P = 0.2271); Gain of catalytic residue at L1388 (P = 0.3304)
7:117305535:A:G,P13569,T1387A,0.697,Gain of catalytic residue at T1387 (P = 0.0995); Loss of stability (P = 0.1787); Loss of phosphorylation at T1387 (P = 0.1911); Loss of MoRF binding (P = 0.2401); Gain of ubiquitination at K1389 (P = 0.305)
7:117305535:A:T,P13569,T1387S,0.754,Loss of stability (P = 0.2263); Gain of MoRF binding (P = 0.2283); Gain of ubiquitination at K1389 (P = 0.3685); Loss of phosphorylation at T1387 (P = 0.409); Loss of methylation at K1389 (P = 0.4839)
7:117305536:C:A,P13569,T1387N,0.761,Loss of phosphorylation at T1387 (P = 0.1911); Gain of MoRF binding (P = 0.2308); Loss of stability (P = 0.2878); Gain of catalytic residue at T1387 (P = 0.3092); Loss of ubiquitination at K1389 (P = 0.3762)
7:117305536:C:G,P13569,T1387S,0.754,Loss of stability (P = 0.2263); Gain of MoRF binding (P = 0.2283); Gain of ubiquitination at K1389 (P = 0.3685); Loss of phosphorylation at T1387 (P = 0.409); Loss of methylation at K1389 (P = 0.4839)
7:117305536:C:T,P13569,T1387I,0.711,Gain of MoRF binding (P = 0.1723); Loss of phosphorylation at T1387 (P = 0.1911); Gain of ubiquitination at K1389 (P = 0.291); Gain of methylation at K1389 (P = 0.4239); Gain of catalytic residue at L1388 (P = 0.5446)
7:117305538:C:A,P13569,L1388I,0.813,Loss of stability (P = 0.1673); Gain of catalytic residue at Q1390 (P = 0.1974); Gain of MoRF binding (P = 0.2007); Gain of methylation at K1389 (P = 0.2594); Gain of ubiquitination at K1389 (P = 0.3437)
7:117305539:T:A,P13569,L1388Q,0.985,Loss of stability (P = 0.0233); Gain of phosphorylation at T1387 (P = 0.1524); Loss of MoRF binding (P = 0.159); Loss of catalytic residue at L1388 (P = 0.1956); Gain of ubiquitination at K1389 (P = 0.291)
7:117305539:T:C,P13569,L1388P,0.945,Loss of stability (P = 0.0145); Gain of glycosylation at L1388 (P = 0.0343); Gain of phosphorylation at T1387 (P = 0.0588); Loss of MoRF binding (P = 0.0918); Gain of methylation at K1389 (P = 0.2662)
7:117305539:T:G,P13569,L1388R,0.954,Loss of stability (P = 0.0178); Gain of phosphorylation at T1387 (P = 0.0794); Gain of MoRF binding (P = 0.0798); Loss of catalytic residue at L1388 (P = 0.2767); Loss of ubiquitination at K1389 (P = 0.3786)
7:117305541:A:C,P13569,K1389Q,0.596,Gain of catalytic residue at K1389 (P = 0.0064); Loss of MoRF binding (P = 0.09); Loss of ubiquitination at K1389 (P = 0.3599); Loss of phosphorylation at T1387 (P = 0.3813); Loss of methylation at K1389 (P = 0.4338)
7:117305541:A:G,P13569,K1389E,0.571,Loss of MoRF binding (P = 0.0599); Loss of ubiquitination at K1389 (P = 0.3599); Gain of phosphorylation at T1387 (P = 0.3634); Loss of methylation at K1389 (P = 0.4338); Loss of catalytic residue at R1385 (P = 0.4564)
7:117305542:A:C,P13569,K1389T,0.622,Gain of catalytic residue at K1389 (P = 0.0228); Loss of MoRF binding (P = 0.0847); Gain of phosphorylation at K1389 (P = 0.2033); Loss of ubiquitination at K1389 (P = 0.3599); Loss of methylation at K1389 (P = 0.4338)
7:117305542:A:G,P13569,K1389R,0.498,Gain of catalytic residue at K1389 (P = 0.0155); Gain of MoRF binding (P = 0.1342); Gain of phosphorylation at T1387 (P = 0.2037); Gain of solvent accessibility (P = 0.348); Loss of ubiquitination at K1389 (P = 0.3599)
7:117305542:A:T,P13569,K1389I,0.646,Loss of MoRF binding (P = 0.0895); Gain of catalytic residue at K1389 (P = 0.1632); Loss of phosphorylation at T1387 (P = 0.3302); Loss of ubiquitination at K1389 (P = 0.3599); Loss of solvent accessibility (P = 0.3646)
7:117305543:A:C,P13569,K1389N,0.56,Loss of MoRF binding (P = 0.0966); Loss of ubiquitination at K1389 (P = 0.3599); Loss of phosphorylation at T1387 (P = 0.3669); Loss of methylation at K1389 (P = 0.4338); Loss of helix (P = 0.4763)
7:117305543:A:T,P13569,K1389N,0.56,Loss of MoRF binding (P = 0.0966); Loss of ubiquitination at K1389 (P = 0.3599); Loss of phosphorylation at T1387 (P = 0.3669); Loss of methylation at K1389 (P = 0.4338); Loss of helix (P = 0.4763)
7:117305544:C:A,P13569,Q1390K,0.599,Gain of MoRF binding (P = 0.039); Gain of phosphorylation at T1387 (P = 0.1538); Gain of methylation at Q1390 (P = 0.157); Loss of helix (P = 0.2271); Gain of ubiquitination at Q1390 (P = 0.278)
7:117305544:C:G,P13569,Q1390E,0.484,Gain of ubiquitination at K1389 (P = 0.0599); Loss of MoRF binding (P = 0.0945); Gain of phosphorylation at T1387 (P = 0.2553); Loss of catalytic residue at A1391 (P = 0.3654); Loss of methylation at K1389 (P = 0.4748)
7:117305545:A:C,P13569,Q1390P,0.627,Loss of MoRF binding (P = 0.1147); Gain of catalytic residue at Q1390 (P = 0.1385); Gain of phosphorylation at T1387 (P = 0.2093); Loss of helix (P = 0.2271); Gain of ubiquitination at K1389 (P = 0.3437)
7:117305545:A:G,P13569,Q1390R,0.508,Gain of MoRF binding (P = 0.0185); Gain of phosphorylation at T1387 (P = 0.1176); Gain of solvent accessibility (P = 0.3194); Loss of ubiquitination at K1389 (P = 0.3728); Loss of helix (P = 0.4763)
7:117305545:A:T,P13569,Q1390L,0.506,Loss of MoRF binding (P = 0.245); Gain of ubiquitination at K1389 (P = 0.2702); Gain of stability (P = 0.3326); Loss of phosphorylation at T1387 (P = 0.3698); Gain of catalytic residue at D1394 (P = 0.3952)
7:117305546:A:C,P13569,Q1390H,0.534,Gain of catalytic residue at D1394 (P = 0.1334); Gain of phosphorylation at T1387 (P = 0.2208); Loss of MoRF binding (P = 0.231); Gain of ubiquitination at K1389 (P = 0.3685); Loss of solvent accessibility (P = 0.4653)
7:117305546:A:T,P13569,Q1390H,0.534,Gain of catalytic residue at D1394 (P = 0.1334); Gain of phosphorylation at T1387 (P = 0.2208); Loss of MoRF binding (P = 0.231); Gain of ubiquitination at K1389 (P = 0.3685); Loss of solvent accessibility (P = 0.4653)
7:117305547:G:A,P13569,A1391T,0.576,Loss of catalytic residue at A1391 (P = 0.0475); Gain of phosphorylation at T1387 (P = 0.1036); Loss of stability (P = 0.1459); Loss of MoRF binding (P = 0.2481); Loss of sheet (P = 0.3635)
7:117305547:G:C,P13569,A1391P,0.809,Loss of stability (P = 0.0732); Loss of catalytic residue at A1391 (P = 0.0751); Loss of MoRF binding (P = 0.1313); Loss of helix (P = 0.2271); Gain of phosphorylation at T1387 (P = 0.3103)
7:117305547:G:T,P13569,A1391S,0.628,Loss of catalytic residue at A1391 (P = 0.0571); Loss of stability (P = 0.1739); Gain of MoRF binding (P = 0.2274); Loss of sheet (P = 0.3635); Gain of phosphorylation at T1387 (P = 0.3744)
7:117305548:C:A,P13569,A1391E,0.761,Loss of catalytic residue at A1391 (P = 0.0472); Gain of ubiquitination at K1389 (P = 0.0599); Loss of MoRF binding (P = 0.0946); Loss of helix (P = 0.2271); Gain of phosphorylation at T1387 (P = 0.3581)
7:117305548:C:G,P13569,A1391G,0.646,Loss of stability (P = 0.043); Loss of catalytic residue at A1391 (P = 0.1514); Gain of MoRF binding (P = 0.2283); Loss of sheet (P = 0.3635); Gain of ubiquitination at K1389 (P = 0.3757)
7:117305548:C:T,P13569,A1391V,0.63,Loss of catalytic residue at A1391 (P = 0.063); Gain of MoRF binding (P = 0.1425); Gain of ubiquitination at K1389 (P = 0.3328); Loss of sheet (P = 0.3635); Gain of methylation at K1389 (P = 0.3895)
7:117305550:T:A,P13569,F1392I,0.641,Gain of MoRF binding (P = 0.2348); Gain of ubiquitination at K1389 (P = 0.3531); Loss of sheet (P = 0.3635); Gain of methylation at K1389 (P = 0.3734); Gain of phosphorylation at T1387 (P = 0.3807)
7:117305550:T:C,P13569,F1392L,0.597,Loss of MoRF binding (P = 0.2328); Loss of catalytic residue at A1393 (P = 0.295); Gain of ubiquitination at K1389 (P = 0.3437); Gain of phosphorylation at T1387 (P = 0.3468); Loss of sheet (P = 0.3635)
7:117305550:T:G,P13569,F1392V,0.626,Gain of MoRF binding (P = 0.2284); Loss of stability (P = 0.303); Gain of ubiquitination at K1389 (P = 0.3437); Loss of sheet (P = 0.3635); Loss of catalytic residue at A1393 (P = 0.3977)
7:117305551:T:A,P13569,F1392Y,0.596,Loss of MoRF binding (P = 0.2256); Loss of helix (P = 0.2271); Loss of stability (P = 0.2335); Gain of relative solvent accessibility (P = 0.2629); Gain of solvent accessibility (P = 0.2689)
7:117305551:T:C,P13569,F1392S,0.617,Loss of stability (P = 0.115); Loss of helix (P = 0.2271); Gain of catalytic residue at L1388 (P = 0.2476); Gain of MoRF binding (P = 0.2477); Gain of relative solvent accessibility (P = 0.2629)
7:117305551:T:G,P13569,F1392C,0.69,Loss of MoRF binding (P = 0.1849); Gain of relative solvent accessibility (P = 0.2629); Loss of stability (P = 0.2885); Gain of catalytic residue at C1395 (P = 0.3185); Gain of ubiquitination at K1389 (P = 0.3617)
7:117305552:T:A,P13569,F1392L,0.597,Loss of MoRF binding (P = 0.2328); Loss of catalytic residue at A1393 (P = 0.295); Gain of ubiquitination at K1389 (P = 0.3437); Gain of phosphorylation at T1387 (P = 0.3468); Loss of sheet (P = 0.3635)
7:117305552:T:G,P13569,F1392L,0.597,Loss of MoRF binding (P = 0.2328); Loss of catalytic residue at A1393 (P = 0.295); Gain of ubiquitination at K1389 (P = 0.3437); Gain of phosphorylation at T1387 (P = 0.3468); Loss of sheet (P = 0.3635)
7:117305553:G:A,P13569,A1393T,0.433,Loss of catalytic residue at A1393 (P = 0.1403); Gain of relative solvent accessibility (P = 0.1894); Loss of stability (P = 0.1911); Gain of solvent accessibility (P = 0.204); Gain of MoRF binding (P = 0.2074)
7:117305553:G:C,P13569,A1393P,0.548,Loss of stability (P = 0.1059); Loss of catalytic residue at A1393 (P = 0.1236); Loss of MoRF binding (P = 0.1721); Gain of relative solvent accessibility (P = 0.1894); Loss of helix (P = 0.2271)
7:117305553:G:T,P13569,A1393S,0.365,Gain of MoRF binding (P = 0.1688); Gain of relative solvent accessibility (P = 0.1894); Loss of stability (P = 0.2424); Gain of solvent accessibility (P = 0.2601); Gain of methylation at K1389 (P = 0.3428)
7:117305554:C:A,P13569,A1393D,0.464,Gain of ubiquitination at K1389 (P = 0.0599); Loss of catalytic residue at A1393 (P = 0.096); Gain of solvent accessibility (P = 0.1422); Gain of relative solvent accessibility (P = 0.1894); Loss of MoRF binding (P = 0.1912)
7:117305554:C:G,P13569,A1393G,0.409,Loss of stability (P = 0.1171); Gain of relative solvent accessibility (P = 0.1894); Gain of MoRF binding (P = 0.2188); Loss of sheet (P = 0.3635); Gain of catalytic residue at C1395 (P = 0.3673)
7:117305554:C:T,P13569,A1393V,0.476,Gain of MoRF binding (P = 0.1974); Gain of ubiquitination at K1389 (P = 0.3437); Loss of sheet (P = 0.3635); Gain of solvent accessibility (P = 0.3819); Gain of methylation at K1389 (P = 0.4346)
7:117305556:G:A,P13569,D1394N,0.525,Gain of MoRF binding (P = 0.0665); Loss of stability (P = 0.1758); Gain of catalytic residue at C1395 (P = 0.281); Loss of sheet (P = 0.3635); Loss of ubiquitination at K1389 (P = 0.3728)
7:117305556:G:C,P13569,D1394H,0.555,Gain of catalytic residue at D1394 (P = 0.0192); Gain of MoRF binding (P = 0.0908); Loss of stability (P = 0.0949); Loss of helix (P = 0.2271); Loss of sheet (P = 0.3635)
7:117305556:G:T,P13569,D1394Y,0.546,Gain of catalytic residue at D1394 (P = 0.0535); Gain of MoRF binding (P = 0.1001); Gain of methylation at K1389 (P = 0.1866); Gain of solvent accessibility (P = 0.2192); Loss of helix (P = 0.2271)
7:117305557:A:C,P13569,D1394A,0.506,Gain of catalytic residue at D1394 (P = 0.0544); Gain of MoRF binding (P = 0.1055); Loss of stability (P = 0.182); Loss of helix (P = 0.2271); Loss of sheet (P = 0.3635)
7:117305557:A:G,P13569,D1394G,0.515,Loss of stability (P = 0.0137); Gain of MoRF binding (P = 0.0903); Gain of catalytic residue at C1395 (P = 0.1051); Loss of helix (P = 0.2271); Loss of solvent accessibility (P = 0.2882)
7:117305557:A:T,P13569,D1394V,0.705,Loss of solvent accessibility (P = 0.0509); Gain of MoRF binding (P = 0.0767); Loss of relative solvent accessibility (P = 0.0793); Gain of catalytic residue at C1395 (P = 0.1463); Loss of helix (P = 0.2271)
7:117305558:T:A,P13569,D1394E,0.525,Gain of catalytic residue at D1394 (P = 0.2018); Loss of MoRF binding (P = 0.2239); Loss of helix (P = 0.2271); Loss of stability (P = 0.3202); Gain of solvent accessibility (P = 0.3602)
7:117305558:T:G,P13569,D1394E,0.525,Gain of catalytic residue at D1394 (P = 0.2018); Loss of MoRF binding (P = 0.2239); Loss of helix (P = 0.2271); Loss of stability (P = 0.3202); Gain of solvent accessibility (P = 0.3602)
7:117305559:T:A,P13569,C1395S,0.636,Gain of glycosylation at C1395 (P = 0.0238); Loss of stability (P = 0.1948); Gain of MoRF binding (P = 0.229); Loss of sheet (P = 0.3635); Loss of catalytic residue at V1397 (P = 0.4409)
7:117305559:T:C,P13569,C1395R,0.735,Gain of MoRF binding (P = 0.055); Gain of catalytic residue at C1395 (P = 0.139); Gain of phosphorylation at T1396 (P = 0.1876); Loss of sheet (P = 0.3635); Loss of stability (P = 0.4693)
7:117305559:T:G,P13569,C1395G,0.682,Loss of stability (P = 0.1008); Gain of MoRF binding (P = 0.2059); Loss of sheet (P = 0.3635); Loss of catalytic residue at V1397 (P = 0.4499); Loss of helix (P = 0.4763)
7:117305560:G:A,P13569,C1395Y,0.694,Gain of MoRF binding (P = 0.2332); Gain of phosphorylation at C1395 (P = 0.2944); Loss of catalytic residue at V1397 (P = 0.3607); Loss of sheet (P = 0.3635); Loss of helix (P = 0.4763)
7:117305560:G:C,P13569,C1395S,0.636,Gain of glycosylation at C1395 (P = 0.0238); Loss of stability (P = 0.1948); Gain of MoRF binding (P = 0.229); Loss of sheet (P = 0.3635); Loss of catalytic residue at V1397 (P = 0.4409)
7:117305560:G:T,P13569,C1395F,0.701,Gain of MoRF binding (P = 0.1068); Loss of helix (P = 0.2271); Loss of catalytic residue at V1397 (P = 0.2915); Loss of sheet (P = 0.3635); Gain of loop (P = 0.4661)
7:117305561:C:G,P13569,C1395W,0.757,Gain of MoRF binding (P = 0.041); Gain of catalytic residue at C1395 (P = 0.0576); Loss of helix (P = 0.2271); Loss of sheet (P = 0.3635); Loss of stability (P = 0.4472)
7:117305562:A:G,P13569,T1396A,0.829,Loss of MoRF binding (P = 0.2844); Loss of sheet (P = 0.3635); Loss of helix (P = 0.4763); Gain of catalytic residue at D1394 (P = 0.4989); Loss of phosphorylation at T1396 (P = 0.5003)
7:117305562:A:T,P13569,T1396S,0.83,Loss of catalytic residue at T1396 (P = 0.0706); Gain of MoRF binding (P = 0.2742); Loss of sheet (P = 0.3635); Loss of helix (P = 0.4763); Loss of phosphorylation at T1396 (P = 0.5296)
7:117305563:C:A,P13569,T1396K,0.878,Gain of methylation at T1396 (P = 0.0163); Gain of ubiquitination at T1396 (P = 0.0276); Gain of MoRF binding (P = 0.054); Loss of catalytic residue at T1396 (P = 0.1399); Loss of sheet (P = 0.3635)
7:117305563:C:G,P13569,T1396R,0.885,Gain of MoRF binding (P = 0.0269); Loss of sheet (P = 0.1398); Loss of catalytic residue at T1396 (P = 0.3015); Loss of helix (P = 0.4763); Gain of methylation at T1396 (P = 0.4838)
7:117305563:C:T,P13569,T1396I,0.781,Loss of catalytic residue at T1396 (P = 0.0319); Loss of helix (P = 0.2271); Gain of MoRF binding (P = 0.2715); Loss of sheet (P = 0.3635); Loss of loop (P = 0.4786)
7:117305565:G:A,P13569,V1397I,0.637,Loss of catalytic residue at V1397 (P = 0.0428); Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.316); Loss of helix (P = 0.4763); Loss of phosphorylation at T1396 (P = 0.5881)
7:117305565:G:C,P13569,V1397L,0.684,Loss of catalytic residue at V1397 (P = 0.0394); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.3202); Loss of helix (P = 0.4763); Loss of phosphorylation at T1396 (P = 0.5836)
7:117305565:G:T,P13569,V1397L,0.684,Loss of catalytic residue at V1397 (P = 0.0394); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.3202); Loss of helix (P = 0.4763); Loss of phosphorylation at T1396 (P = 0.5836)
7:117305566:T:A,P13569,V1397E,0.93,Loss of MoRF binding (P = 0.262); Gain of phosphorylation at T1396 (P = 0.2713); Loss of catalytic residue at H1402 (P = 0.2806); Loss of sheet (P = 0.302); Loss of stability (P = 0.4753)
7:117305566:T:C,P13569,V1397A,0.708,Loss of stability (P = 0.2318); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.3123); Gain of phosphorylation at T1396 (P = 0.4649); Loss of helix (P = 0.4763)
7:117305566:T:G,P13569,V1397G,0.716,Loss of stability (P = 0.0306); Loss of sheet (P = 0.302); Gain of catalytic residue at C1395 (P = 0.3185); Loss of MoRF binding (P = 0.3203); Gain of phosphorylation at T1396 (P = 0.4366)
7:117305568:A:C,P13569,I1398L,0.561,Loss of catalytic residue at I1398 (P = 0.0382); Loss of sheet (P = 0.1158); Loss of MoRF binding (P = 0.3561); Loss of helix (P = 0.4763); Loss of phosphorylation at T1396 (P = 0.5858)
7:117305568:A:G,P13569,I1398V,0.681,Loss of catalytic residue at I1398 (P = 0.2836); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.3598); Loss of helix (P = 0.4763); Gain of phosphorylation at T1396 (P = 0.5128)
7:117305568:A:T,P13569,I1398F,0.693,Loss of catalytic residue at I1398 (P = 0.1849); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3603); Loss of stability (P = 0.4193); Gain of phosphorylation at T1396 (P = 0.4474)
7:117305569:T:A,P13569,I1398N,0.747,Loss of stability (P = 0.1782); Loss of loop (P = 0.2237); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3236); Loss of catalytic residue at L1399 (P = 0.3344)
7:117305569:T:C,P13569,I1398T,0.763,Loss of stability (P = 0.0658); Loss of catalytic residue at I1398 (P = 0.1909); Loss of sheet (P = 0.302); Loss of MoRF binding (P = 0.3594); Gain of phosphorylation at T1396 (P = 0.4294)
7:117305570:T:G,P13569,I1398M,0.602,Loss of sheet (P = 0.1158); Gain of MoRF binding (P = 0.3288); Loss of catalytic residue at L1399 (P = 0.3592); Loss of helix (P = 0.4763); Gain of phosphorylation at T1396 (P = 0.5312)
7:117305571:C:A,P13569,L1399I,0.628,Loss of catalytic residue at L1399 (P = 0.0817); Loss of sheet (P = 0.3635); Gain of MoRF binding (P = 0.3889); Loss of helix (P = 0.3949); Loss of loop (P = 0.4412)
7:117305571:C:G,P13569,L1399V,0.605,Loss of stability (P = 0.2617); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.3957); Loss of loop (P = 0.4412)
7:117305571:C:T,P13569,L1399F,0.608,Gain of sheet (P = 0.1208); Loss of stability (P = 0.3474); Gain of MoRF binding (P = 0.3894); Loss of helix (P = 0.3949); Loss of loop (P = 0.4412)
7:117305572:T:A,P13569,L1399H,0.664,Loss of stability (P = 0.0231); Gain of phosphorylation at T1396 (P = 0.2847); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Loss of MoRF binding (P = 0.4088)
7:117305572:T:C,P13569,L1399P,0.816,Loss of stability (P = 0.0472); Gain of phosphorylation at T1396 (P = 0.2394); Loss of catalytic residue at E1401 (P = 0.3327); Loss of sheet (P = 0.3635); Loss of MoRF binding (P = 0.3802)
7:117305572:T:G,P13569,L1399R,0.84,Gain of MoRF binding (P = 0.0708); Loss of stability (P = 0.0809); Gain of phosphorylation at T1396 (P = 0.1541); Gain of methylation at L1399 (P = 0.2733); Loss of sheet (P = 0.3635)
7:117305574:T:A,P13569,C1400S,0.716,Loss of sheet (P = 0.1158); Gain of catalytic residue at C1400 (P = 0.1556); Loss of stability (P = 0.3479); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4061)
7:117305574:T:C,P13569,C1400R,0.812,Gain of MoRF binding (P = 0.0893); Loss of sheet (P = 0.1158); Loss of catalytic residue at I1398 (P = 0.1536); Loss of loop (P = 0.2897); Loss of helix (P = 0.3949)
7:117305574:T:G,P13569,C1400G,0.697,Loss of sheet (P = 0.1158); Loss of stability (P = 0.125); Loss of catalytic residue at H1402 (P = 0.192); Loss of loop (P = 0.2897); Loss of helix (P = 0.3949)
7:117305575:G:A,P13569,C1400Y,0.599,Gain of catalytic residue at C1400 (P = 0.1179); Loss of helix (P = 0.1299); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.4317); Gain of phosphorylation at T1396 (P = 0.5493)
7:117305575:G:C,P13569,C1400S,0.716,Loss of sheet (P = 0.1158); Gain of catalytic residue at C1400 (P = 0.1556); Loss of stability (P = 0.3479); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.4061)
7:117305575:G:T,P13569,C1400F,0.582,Gain of catalytic residue at C1400 (P = 0.0798); Loss of sheet (P = 0.1158); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.3962); Gain of phosphorylation at T1396 (P = 0.584)
7:117305576:T:G,P13569,C1400W,0.659,Loss of helix (P = 0.1299); Loss of catalytic residue at H1402 (P = 0.1818); Gain of MoRF binding (P = 0.2707); Loss of sheet (P = 0.302); Loss of phosphorylation at T1396 (P = 0.5723)
7:117305577:G:A,P13569,E1401K,0.939,Gain of methylation at E1401 (P = 0.0124); Gain of ubiquitination at E1401 (P = 0.0311); Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of MoRF binding (P = 0.166)
7:117305577:G:C,P13569,E1401Q,0.837,Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Loss of stability (P = 0.3199); Gain of MoRF binding (P = 0.3723); Loss of helix (P = 0.3949)
7:117305578:A:C,P13569,E1401A,0.914,Loss of catalytic residue at E1401 (P = 0.1301); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3726)
7:117305578:A:G,P13569,E1401G,0.928,Loss of stability (P = 0.063); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of catalytic residue at C1400 (P = 0.2349); Loss of sheet (P = 0.302)
7:117305578:A:T,P13569,E1401V,0.847,Loss of catalytic residue at E1401 (P = 0.0677); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Gain of MoRF binding (P = 0.3374)
7:117305579:A:C,P13569,E1401D,0.821,Loss of sheet (P = 0.302); Loss of stability (P = 0.3867); Loss of helix (P = 0.3949); Gain of catalytic residue at H1402 (P = 0.5006); Gain of phosphorylation at T1396 (P = 0.5103)
7:117305579:A:T,P13569,E1401D,0.821,Loss of sheet (P = 0.302); Loss of stability (P = 0.3867); Loss of helix (P = 0.3949); Gain of catalytic residue at H1402 (P = 0.5006); Gain of phosphorylation at T1396 (P = 0.5103)
7:117305580:C:A,P13569,H1402N,0.937,Loss of sheet (P = 0.1398); Gain of catalytic residue at H1402 (P = 0.28); Loss of loop (P = 0.2897); Loss of helix (P = 0.3949); Loss of stability (P = 0.4391)
7:117305580:C:G,P13569,H1402D,0.929,Gain of helix (P = 0.132); Loss of sheet (P = 0.1398); Gain of catalytic residue at H1402 (P = 0.2416); Loss of loop (P = 0.2897); Loss of stability (P = 0.5747)
7:117305580:C:T,P13569,H1402Y,0.907,Gain of sheet (P = 0.1208); Loss of catalytic residue at H1402 (P = 0.1783); Loss of helix (P = 0.2022); Gain of methylation at R1403 (P = 0.5633); Gain of MoRF binding (P = 0.6103)
7:117305581:A:C,P13569,H1402P,0.92,Loss of sheet (P = 0.1398); Loss of catalytic residue at H1402 (P = 0.1836); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Loss of stability (P = 0.3895)
7:117305581:A:G,P13569,H1402R,0.935,Loss of sheet (P = 0.1398); Gain of helix (P = 0.2059); Loss of catalytic residue at H1402 (P = 0.2069); Loss of loop (P = 0.2897); Gain of MoRF binding (P = 0.4117)
7:117305581:A:T,P13569,H1402L,0.925,Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299); Loss of loop (P = 0.2237); Gain of catalytic residue at H1402 (P = 0.3022); Gain of methylation at R1403 (P = 0.5767)
7:117305582:C:A,P13569,H1402Q,0.912,Loss of sheet (P = 0.1398); Loss of catalytic residue at H1402 (P = 0.1781); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Loss of stability (P = 0.5585)
7:117305582:C:G,P13569,H1402Q,0.912,Loss of sheet (P = 0.1398); Loss of catalytic residue at H1402 (P = 0.1781); Gain of helix (P = 0.2059); Loss of loop (P = 0.2897); Loss of stability (P = 0.5585)
7:117305583:A:G,P13569,R1403G,0.764,Gain of catalytic residue at R1403 (P = 0.1642); Gain of helix (P = 0.2059); Loss of stability (P = 0.2126); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635)
7:117305583:A:T,P13569,R1403W,0.789,Gain of catalytic residue at R1403 (P = 0.0558); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Loss of solvent accessibility (P = 0.4436)
7:117305584:G:C,P13569,R1403T,0.764,Gain of catalytic residue at R1403 (P = 0.0989); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Loss of solvent accessibility (P = 0.4436)
7:117305584:G:T,P13569,R1403M,0.822,Loss of sheet (P = 0.1398); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Gain of catalytic residue at H1402 (P = 0.3301); Loss of solvent accessibility (P = 0.4436)
7:117305585:G:C,P13569,R1403S,0.761,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Gain of catalytic residue at H1402 (P = 0.3586); Loss of sheet (P = 0.3635); Loss of stability (P = 0.4393)
7:117305585:G:T,P13569,R1403S,0.761,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Gain of catalytic residue at H1402 (P = 0.3586); Loss of sheet (P = 0.3635); Loss of stability (P = 0.4393)
7:117305586:A:C,P13569,I1404L,0.654,Loss of sheet (P = 0.1398); Gain of loop (P = 0.2754); Loss of catalytic residue at L1399 (P = 0.3647); Loss of helix (P = 0.3949); Gain of methylation at R1403 (P = 0.574)
7:117305586:A:G,P13569,I1404V,0.668,Loss of catalytic residue at I1404 (P = 0.2113); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949); Gain of methylation at R1403 (P = 0.5413); Gain of loop (P = 0.6993)
7:117305586:A:T,P13569,I1404L,0.654,Loss of sheet (P = 0.1398); Gain of loop (P = 0.2754); Loss of catalytic residue at L1399 (P = 0.3647); Loss of helix (P = 0.3949); Gain of methylation at R1403 (P = 0.574)
7:117305587:T:A,P13569,I1404K,0.858,Gain of ubiquitination at I1404 (P = 0.0289); Loss of stability (P = 0.1178); Loss of catalytic residue at I1404 (P = 0.1334); Gain of glycosylation at I1404 (P = 0.1778); Gain of disorder (P = 0.2456)
7:117305587:T:C,P13569,I1404T,0.848,Loss of stability (P = 0.0697); Loss of loop (P = 0.2897); Loss of catalytic residue at I1404 (P = 0.3263); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949)
7:117305587:T:G,P13569,I1404R,0.855,Loss of catalytic residue at I1404 (P = 0.0969); Loss of stability (P = 0.2369); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635); Loss of helix (P = 0.3949)
7:117305588:A:G,P13569,I1404M,0.68,Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Loss of sheet (P = 0.3635); Loss of catalytic residue at L1399 (P = 0.3777); Gain of methylation at R1403 (P = 0.5527)
7:117305589:G:A,P13569,E1405K,0.635,Gain of ubiquitination at E1405 (P = 0.03); Gain of methylation at E1405 (P = 0.0314); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949)
7:117305589:G:C,P13569,E1405Q,0.563,Loss of helix (P = 0.1299); Loss of sheet (P = 0.302); Gain of catalytic residue at A1406 (P = 0.4668); Loss of solvent accessibility (P = 0.5485); Loss of methylation at R1403 (P = 0.6297)
7:117305590:A:C,P13569,E1405A,0.701,Loss of solvent accessibility (P = 0.0703); Loss of sheet (P = 0.1158); Loss of relative solvent accessibility (P = 0.1807); Gain of helix (P = 0.2059); Gain of catalytic residue at A1406 (P = 0.2581)
7:117305590:A:G,P13569,E1405G,0.583,Gain of catalytic residue at A1406 (P = 0.075); Loss of sheet (P = 0.1158); Loss of stability (P = 0.1681); Loss of solvent accessibility (P = 0.1868); Loss of helix (P = 0.3949)
7:117305590:A:T,P13569,E1405V,0.708,Loss of solvent accessibility (P = 0.0703); Gain of catalytic residue at E1405 (P = 0.1146); Loss of sheet (P = 0.1158); Loss of relative solvent accessibility (P = 0.1807); Gain of loop (P = 0.2754)
7:117305591:A:C,P13569,E1405D,0.457,Loss of helix (P = 0.1299); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Loss of catalytic residue at H1402 (P = 0.4309); Gain of methylation at R1403 (P = 0.6214)
7:117305591:A:T,P13569,E1405D,0.457,Loss of helix (P = 0.1299); Loss of loop (P = 0.2897); Loss of sheet (P = 0.302); Loss of catalytic residue at H1402 (P = 0.4309); Gain of methylation at R1403 (P = 0.6214)
7:117305592:G:A,P13569,A1406T,0.652,Loss of stability (P = 0.1549); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635); Gain of phosphorylation at A1406 (P = 0.4328)
7:117305592:G:C,P13569,A1406P,0.721,Gain of catalytic residue at A1406 (P = 0.0619); Loss of stability (P = 0.1201); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117305592:G:T,P13569,A1406S,0.667,Gain of catalytic residue at A1406 (P = 0.0845); Gain of phosphorylation at A1406 (P = 0.1676); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of stability (P = 0.2844)
7:117305593:C:A,P13569,A1406E,0.678,Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.3635)
7:117305593:C:G,P13569,A1406G,0.667,Loss of stability (P = 0.0695); Loss of sheet (P = 0.1398); Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Gain of catalytic residue at E1405 (P = 0.3249)
7:117305593:C:T,P13569,A1406V,0.679,Loss of sheet (P = 0.1398); Gain of loop (P = 0.2754); Gain of catalytic residue at E1409 (P = 0.2857); Loss of helix (P = 0.3949); Loss of stability (P = 0.5603)
7:117305595:A:C,P13569,M1407L,0.538,Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Gain of catalytic residue at M1407 (P = 0.556); Gain of methylation at R1403 (P = 0.6282)
7:117305595:A:G,P13569,M1407V,0.598,Loss of sheet (P = 0.1158); Gain of catalytic residue at M1407 (P = 0.1713); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059); Loss of stability (P = 0.4797)
7:117305595:A:T,P13569,M1407L,0.538,Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Gain of catalytic residue at M1407 (P = 0.556); Gain of methylation at R1403 (P = 0.6282)
7:117305596:T:A,P13569,M1407K,0.867,Gain of ubiquitination at M1407 (P = 0.0311); Loss of stability (P = 0.0358); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117305596:T:C,P13569,M1407T,0.718,Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299); Loss of stability (P = 0.1491); Gain of loop (P = 0.2045); Gain of catalytic residue at M1407 (P = 0.4092)
7:117305596:T:G,P13569,M1407R,0.837,Loss of stability (P = 0.1099); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045); Gain of catalytic residue at M1407 (P = 0.2365)
7:117305597:G:A,P13569,M1407I,0.542,Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of catalytic residue at E1409 (P = 0.4308); Loss of stability (P = 0.5533)
7:117305597:G:C,P13569,M1407I,0.542,Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of catalytic residue at E1409 (P = 0.4308); Loss of stability (P = 0.5533)
7:117305597:G:T,P13569,M1407I,0.542,Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of catalytic residue at E1409 (P = 0.4308); Loss of stability (P = 0.5533)
7:117305598:C:A,P13569,L1408M,0.465,Gain of catalytic residue at L1408 (P = 0.0013); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Gain of methylation at R1403 (P = 0.6195)
7:117305598:C:G,P13569,L1408V,0.514,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of catalytic residue at F1413 (P = 0.3474); Loss of solvent accessibility (P = 0.5743)
7:117305599:T:A,P13569,L1408Q,0.427,Gain of solvent accessibility (P = 0.2097); Gain of relative solvent accessibility (P = 0.2363); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of stability (P = 0.3386)
7:117305599:T:C,P13569,L1408P,0.597,Gain of sheet (P = 0.0827); Loss of stability (P = 0.0978); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of catalytic residue at E1405 (P = 0.4242)
7:117305599:T:G,P13569,L1408R,0.462,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Gain of catalytic residue at L1408 (P = 0.229); Gain of solvent accessibility (P = 0.2863)
7:117305601:G:A,P13569,E1409K,0.845,Gain of methylation at E1409 (P = 0.0031); Gain of ubiquitination at E1409 (P = 0.0289); Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of loop (P = 0.2045)
7:117305601:G:C,P13569,E1409Q,0.634,Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Gain of catalytic residue at C1410 (P = 0.3889); Loss of solvent accessibility (P = 0.6134)
7:117305602:A:C,P13569,E1409A,0.82,Gain of catalytic residue at E1409 (P = 0.0863); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.1744); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302)
7:117305602:A:G,P13569,E1409G,0.791,Gain of helix (P = 0.132); Gain of catalytic residue at Q1411 (P = 0.1701); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302); Loss of solvent accessibility (P = 0.3103)
7:117305602:A:T,P13569,E1409V,0.883,Gain of stability (P = 0.0909); Gain of helix (P = 0.132); Loss of solvent accessibility (P = 0.1744); Gain of loop (P = 0.2045); Loss of sheet (P = 0.302)
7:117305603:A:C,P13569,E1409D,0.656,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of catalytic residue at E1409 (P = 0.3414); Loss of solvent accessibility (P = 0.7699)
7:117305603:A:T,P13569,E1409D,0.656,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of catalytic residue at E1409 (P = 0.3414); Loss of solvent accessibility (P = 0.7699)
7:117305604:T:A,P13569,C1410S,0.704,Loss of helix (P = 0.2022); Gain of disorder (P = 0.2146); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of stability (P = 0.36)
7:117305604:T:C,P13569,C1410R,0.842,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Gain of helix (P = 0.2684); Gain of disorder (P = 0.4251); Gain of catalytic residue at C1410 (P = 0.48)
7:117305604:T:G,P13569,C1410G,0.713,Gain of helix (P = 0.132); Loss of stability (P = 0.141); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of catalytic residue at F1413 (P = 0.4511)
7:117305605:G:A,P13569,C1410Y,0.736,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Gain of catalytic residue at E1409 (P = 0.3802); Gain of phosphorylation at C1410 (P = 0.4451)
7:117305605:G:C,P13569,C1410S,0.704,Loss of helix (P = 0.2022); Gain of disorder (P = 0.2146); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of stability (P = 0.36)
7:117305605:G:T,P13569,C1410F,0.765,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Loss of catalytic residue at F1413 (P = 0.6187); Gain of disorder (P = 0.7622)
7:117305606:C:G,P13569,C1410W,0.765,Gain of catalytic residue at L1408 (P = 0.0046); Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Loss of stability (P = 0.652)
7:117305607:C:A,P13569,Q1411K,0.821,Gain of methylation at Q1411 (P = 0.0039); Gain of ubiquitination at Q1411 (P = 0.0276); Gain of helix (P = 0.2059); Loss of sheet (P = 0.302); Loss of stability (P = 0.332)
7:117305607:C:G,P13569,Q1411E,0.776,Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of loop (P = 0.4661); Gain of disorder (P = 0.658); Loss of stability (P = 0.7829)
7:117305608:A:C,P13569,Q1411P,0.831,Gain of catalytic residue at Q1411 (P = 0.0845); Gain of loop (P = 0.2045); Gain of helix (P = 0.2059); Loss of sheet (P = 0.302); Loss of stability (P = 0.3968)
7:117305608:A:G,P13569,Q1411R,0.841,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of catalytic residue at Q1411 (P = 0.4849); Gain of MoRF binding (P = 0.6361)
7:117305608:A:T,P13569,Q1411L,0.835,Gain of catalytic residue at Q1411 (P = 0.0583); Gain of helix (P = 0.2059); Gain of stability (P = 0.2515); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302)
7:117305609:A:C,P13569,Q1411H,0.841,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of catalytic residue at Q1412 (P = 0.3708); Loss of stability (P = 0.5014)
7:117305609:A:T,P13569,Q1411H,0.841,Gain of helix (P = 0.2059); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Gain of catalytic residue at Q1412 (P = 0.3708); Loss of stability (P = 0.5014)
7:117305610:C:A,P13569,Q1412K,0.571,Gain of methylation at Q1412 (P = 0.0172); Gain of ubiquitination at Q1412 (P = 0.03); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1708); Gain of helix (P = 0.2684)
7:117305610:C:G,P13569,Q1412E,0.617,Loss of sheet (P = 0.1158); Gain of helix (P = 0.132); Gain of loop (P = 0.2045); Gain of catalytic residue at Q1412 (P = 0.2991); Gain of disorder (P = 0.5378)
7:117305611:A:C,P13569,Q1412P,0.646,Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Loss of stability (P = 0.2938); Gain of catalytic residue at Q1411 (P = 0.3317); Loss of helix (P = 0.3949)
7:117305611:A:G,P13569,Q1412R,0.598,Gain of sheet (P = 0.0827); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949); Loss of catalytic residue at F1413 (P = 0.413); Gain of methylation at Q1412 (P = 0.5479)
7:117305611:A:T,P13569,Q1412L,0.61,Loss of sheet (P = 0.0817); Gain of catalytic residue at Q1412 (P = 0.222); Gain of loop (P = 0.2754); Gain of relative solvent accessibility (P = 0.284); Loss of helix (P = 0.3949)
7:117305612:A:C,P13569,Q1412H,0.606,Gain of catalytic residue at L1414 (P = 0.065); Loss of sheet (P = 0.0817); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949); Loss of stability (P = 0.4638)
7:117305612:A:T,P13569,Q1412H,0.606,Gain of catalytic residue at L1414 (P = 0.065); Loss of sheet (P = 0.0817); Gain of loop (P = 0.2754); Loss of helix (P = 0.3949); Loss of stability (P = 0.4638)
7:117305613:T:A,P13569,F1413I,0.55,Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of catalytic residue at F1413 (P = 0.3535); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4865)
7:117305613:T:G,P13569,F1413V,0.592,Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4042); Gain of catalytic residue at E1417 (P = 0.5)
7:117305614:T:A,P13569,F1413Y,0.639,Gain of catalytic residue at L1408 (P = 0.0731); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Loss of stability (P = 0.39); Gain of phosphorylation at F1413 (P = 0.3924)
7:117305614:T:C,P13569,F1413S,0.778,Gain of disorder (P = 0.0273); Loss of stability (P = 0.0827); Loss of sheet (P = 0.1158); Gain of loop (P = 0.2045); Loss of catalytic residue at F1413 (P = 0.2516)
7:117305614:T:G,P13569,F1413C,0.659,Gain of catalytic residue at L1414 (P = 0.0214); Loss of stability (P = 0.2172); Gain of loop (P = 0.2754); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117305615:T:A,P13569,F1413L,0.574,Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Gain of catalytic residue at F1413 (P = 0.3277); Gain of disorder (P = 0.3895); Gain of loop (P = 0.6993)
7:117305615:T:G,P13569,F1413L,0.574,Gain of helix (P = 0.2684); Loss of sheet (P = 0.302); Gain of catalytic residue at F1413 (P = 0.3277); Gain of disorder (P = 0.3895); Gain of loop (P = 0.6993)
7:117305616:T:A,P13569,L1414M,0.674,Gain of disorder (P = 0.2524); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949); Loss of stability (P = 0.4096); Gain of catalytic residue at V1415 (P = 0.5162)
7:117305616:T:G,P13569,L1414V,0.64,Gain of catalytic residue at E1417 (P = 0.2387); Gain of loop (P = 0.2754); Loss of stability (P = 0.2865); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117305617:T:C,P13569,L1414S,0.938,Gain of disorder (P = 0.0313); Loss of stability (P = 0.0594); Gain of catalytic residue at L1414 (P = 0.2454); Loss of sheet (P = 0.302); Loss of helix (P = 0.3949)
7:117305617:T:G,P13569,L1414W,0.689,Loss of stability (P = 0.1281); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3885); Loss of helix (P = 0.3949); Gain of MoRF binding (P = 0.5453)
7:117305618:G:C,P13569,L1414F,0.668,Loss of sheet (P = 0.302); Loss of stability (P = 0.3684); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4856); Loss of MoRF binding (P = 0.6889)
7:117305618:G:T,P13569,L1414F,0.668,Loss of sheet (P = 0.302); Loss of stability (P = 0.3684); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4856); Loss of MoRF binding (P = 0.6889)
7:117306962:G:A,P13569,V1415I,0.644,Gain of methylation at K1420 (P = 0.085); Loss of ubiquitination at K1420 (P = 0.1435); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3859); Gain of catalytic residue at L1414 (P = 0.4454)
7:117306962:G:C,P13569,V1415L,0.701,Loss of methylation at K1420 (P = 0.0707); Loss of ubiquitination at K1420 (P = 0.1435); Loss of catalytic residue at E1418 (P = 0.2054); Loss of sheet (P = 0.302); Gain of disorder (P = 0.3572)
7:117306962:G:T,P13569,V1415F,0.728,Loss of ubiquitination at K1420 (P = 0.1435); Gain of methylation at K1420 (P = 0.1524); Loss of catalytic residue at E1418 (P = 0.2317); Loss of stability (P = 0.2717); Loss of sheet (P = 0.302)
7:117306963:T:A,P13569,V1415D,0.822,Gain of disorder (P = 0.0435); Loss of methylation at K1420 (P = 0.0548); Loss of sheet (P = 0.0817); Loss of catalytic residue at E1418 (P = 0.0954); Loss of ubiquitination at K1420 (P = 0.1231)
7:117306963:T:C,P13569,V1415A,0.746,Loss of stability (P = 0.0457); Loss of methylation at K1420 (P = 0.0779); Loss of sheet (P = 0.0817); Loss of ubiquitination at K1420 (P = 0.0949); Loss of catalytic residue at E1418 (P = 0.1429)
7:117306963:T:G,P13569,V1415G,0.779,Loss of stability (P = 0.011); Loss of sheet (P = 0.0817); Gain of disorder (P = 0.0908); Loss of ubiquitination at K1420 (P = 0.0949); Loss of methylation at K1420 (P = 0.0995)
7:117306965:A:C,P13569,I1416L,0.628,Loss of methylation at K1420 (P = 0.0525); Loss of ubiquitination at K1420 (P = 0.1231); Gain of disorder (P = 0.2353); Loss of catalytic residue at E1418 (P = 0.2948); Loss of sheet (P = 0.302)
7:117306965:A:G,P13569,I1416V,0.744,Loss of sheet (P = 0.0817); Loss of methylation at K1420 (P = 0.0934); Loss of ubiquitination at K1420 (P = 0.1435); Gain of disorder (P = 0.2259); Loss of catalytic residue at E1418 (P = 0.4633)
7:117306965:A:T,P13569,I1416L,0.628,Loss of methylation at K1420 (P = 0.0525); Loss of ubiquitination at K1420 (P = 0.1231); Gain of disorder (P = 0.2353); Loss of catalytic residue at E1418 (P = 0.2948); Loss of sheet (P = 0.302)
7:117306966:T:A,P13569,I1416K,0.853,Gain of disorder (P = 0.011); Gain of ubiquitination at I1416 (P = 0.0337); Loss of methylation at K1420 (P = 0.0737); Loss of sheet (P = 0.0817); Loss of catalytic residue at E1418 (P = 0.1139)
7:117306966:T:C,P13569,I1416T,0.797,Gain of disorder (P = 0.0548); Loss of sheet (P = 0.0817); Loss of methylation at K1420 (P = 0.0996); Loss of ubiquitination at K1420 (P = 0.1435); Loss of stability (P = 0.1806)
7:117306966:T:G,P13569,I1416R,0.895,Gain of disorder (P = 0.0209); Loss of methylation at K1420 (P = 0.0612); Loss of sheet (P = 0.0817); Gain of ubiquitination at K1420 (P = 0.1062); Loss of catalytic residue at E1418 (P = 0.1219)
7:117306967:A:G,P13569,I1416M,0.655,Loss of methylation at K1420 (P = 0.0853); Gain of disorder (P = 0.0961); Gain of ubiquitination at K1420 (P = 0.123); Loss of sheet (P = 0.1501); Gain of catalytic residue at I1416 (P = 0.2034)
7:117306968:G:A,P13569,E1417K,0.647,Gain of methylation at E1417 (P = 0.0216); Gain of ubiquitination at E1417 (P = 0.03); Gain of MoRF binding (P = 0.0973); Loss of stability (P = 0.161); Gain of relative solvent accessibility (P = 0.2629)
7:117306968:G:C,P13569,E1417Q,0.628,Gain of methylation at K1420 (P = 0.0658); Loss of ubiquitination at K1420 (P = 0.1079); Loss of sheet (P = 0.1398); Gain of MoRF binding (P = 0.3131); Loss of disorder (P = 0.366)
7:117306969:A:C,P13569,E1417A,0.718,Loss of ubiquitination at K1420 (P = 0.0505); Loss of methylation at K1420 (P = 0.1141); Loss of stability (P = 0.1343); Loss of disorder (P = 0.1931); Gain of loop (P = 0.2045)
7:117306969:A:G,P13569,E1417G,0.713,Loss of ubiquitination at K1420 (P = 0.0524); Loss of stability (P = 0.0662); Loss of methylation at K1420 (P = 0.1516); Gain of loop (P = 0.2045); Gain of catalytic residue at I1416 (P = 0.2632)
7:117306969:A:T,P13569,E1417V,0.728,Gain of catalytic residue at E1417 (P = 0.027); Loss of ubiquitination at K1420 (P = 0.0557); Loss of sheet (P = 0.1158); Loss of disorder (P = 0.1197); Gain of methylation at K1420 (P = 0.1374)
7:117306970:A:C,P13569,E1417D,0.622,Loss of methylation at K1420 (P = 0.1072); Loss of ubiquitination at K1420 (P = 0.1435); Loss of sheet (P = 0.302); Loss of stability (P = 0.3204); Loss of disorder (P = 0.3589)
7:117306970:A:T,P13569,E1417D,0.622,Loss of methylation at K1420 (P = 0.1072); Loss of ubiquitination at K1420 (P = 0.1435); Loss of sheet (P = 0.302); Loss of stability (P = 0.3204); Loss of disorder (P = 0.3589)
7:117306971:G:A,P13569,E1418K,0.546,Gain of methylation at E1418 (P = 0.0143); Gain of ubiquitination at E1418 (P = 0.023); Gain of MoRF binding (P = 0.0427); Loss of catalytic residue at E1418 (P = 0.1634); Gain of relative solvent accessibility (P = 0.2363)
7:117306971:G:C,P13569,E1418Q,0.414,Gain of methylation at K1420 (P = 0.07); Loss of catalytic residue at E1418 (P = 0.087); Loss of ubiquitination at K1420 (P = 0.1079); Gain of MoRF binding (P = 0.2277); Gain of relative solvent accessibility (P = 0.2363)
7:117306972:A:C,P13569,E1418A,0.538,Loss of ubiquitination at K1420 (P = 0.0557); Gain of methylation at K1420 (P = 0.0998); Loss of disorder (P = 0.1591); Loss of catalytic residue at E1418 (P = 0.1951); Gain of MoRF binding (P = 0.2499)
7:117306972:A:G,P13569,E1418G,0.551,Loss of stability (P = 0.0433); Loss of ubiquitination at K1420 (P = 0.064); Gain of methylation at K1420 (P = 0.0835); Loss of catalytic residue at E1418 (P = 0.1079); Loss of disorder (P = 0.2476)
7:117306972:A:T,P13569,E1418V,0.661,Loss of ubiquitination at K1420 (P = 0.0524); Gain of methylation at K1420 (P = 0.0585); Loss of disorder (P = 0.0952); Loss of catalytic residue at E1418 (P = 0.115); Loss of sheet (P = 0.1398)
7:117306973:G:C,P13569,E1418D,0.41,Loss of methylation at K1420 (P = 0.0938); Loss of ubiquitination at K1420 (P = 0.0949); Loss of catalytic residue at E1418 (P = 0.1449); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3486)
7:117306973:G:T,P13569,E1418D,0.41,Loss of methylation at K1420 (P = 0.0938); Loss of ubiquitination at K1420 (P = 0.0949); Loss of catalytic residue at E1418 (P = 0.1449); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3486)
7:117306974:A:C,P13569,N1419H,0.735,Gain of catalytic residue at K1420 (P = 0.1037); Loss of stability (P = 0.1211); Gain of methylation at K1420 (P = 0.1305); Loss of ubiquitination at K1420 (P = 0.1435); Gain of disorder (P = 0.2098)
7:117306974:A:G,P13569,N1419D,0.791,Loss of methylation at K1420 (P = 0.071); Gain of ubiquitination at K1420 (P = 0.123); Gain of disorder (P = 0.1827); Loss of catalytic residue at E1418 (P = 0.2713); Gain of phosphorylation at Y1424 (P = 0.2811)
7:117306974:A:T,P13569,N1419Y,0.74,Gain of catalytic residue at L1414 (P = 0.0623); Loss of methylation at K1420 (P = 0.0788); Loss of ubiquitination at K1420 (P = 0.0949); Loss of sheet (P = 0.1398); Loss of disorder (P = 0.1634)
7:117306975:A:C,P13569,N1419T,0.738,Loss of methylation at K1420 (P = 0.1154); Loss of ubiquitination at K1420 (P = 0.1231); Gain of phosphorylation at N1419 (P = 0.1315); Loss of stability (P = 0.2051); Gain of catalytic residue at N1419 (P = 0.2433)
7:117306975:A:G,P13569,N1419S,0.672,Loss of ubiquitination at K1420 (P = 0.0768); Gain of disorder (P = 0.0785); Loss of methylation at K1420 (P = 0.1088); Gain of phosphorylation at N1419 (P = 0.1328); Gain of catalytic residue at K1420 (P = 0.1899)
7:117306975:A:T,P13569,N1419I,0.766,Loss of ubiquitination at K1420 (P = 0.0524); Gain of methylation at K1420 (P = 0.0932); Loss of disorder (P = 0.1269); Gain of sheet (P = 0.1539); Loss of MoRF binding (P = 0.377)
7:117306976:C:A,P13569,N1419K,0.754,Gain of methylation at N1419 (P = 0.0196); Gain of ubiquitination at N1419 (P = 0.0289); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of stability (P = 0.0942)
7:117306976:C:G,P13569,N1419K,0.754,Gain of methylation at N1419 (P = 0.0196); Gain of ubiquitination at N1419 (P = 0.0289); Gain of solvent accessibility (P = 0.0837); Gain of relative solvent accessibility (P = 0.09); Loss of stability (P = 0.0942)
7:117306977:A:C,P13569,K1420Q,0.392,Loss of methylation at K1420 (P = 0.0201); Loss of ubiquitination at K1420 (P = 0.0218); Loss of MoRF binding (P = 0.2662); Gain of loop (P = 0.2754); Gain of disorder (P = 0.2964)
7:117306977:A:G,P13569,K1420E,0.405,Loss of methylation at K1420 (P = 0.0201); Loss of ubiquitination at K1420 (P = 0.0218); Loss of MoRF binding (P = 0.2128); Gain of disorder (P = 0.2354); Gain of phosphorylation at Y1424 (P = 0.2616)
7:117306978:A:C,P13569,K1420T,0.394,Loss of methylation at K1420 (P = 0.0201); Loss of ubiquitination at K1420 (P = 0.0218); Gain of phosphorylation at K1420 (P = 0.1403); Loss of disorder (P = 0.2084); Gain of catalytic residue at R1422 (P = 0.2353)
7:117306978:A:G,P13569,K1420R,0.353,Loss of methylation at K1420 (P = 0.0216); Loss of ubiquitination at K1420 (P = 0.0218); Gain of sheet (P = 0.1539); Gain of MoRF binding (P = 0.2748); Loss of disorder (P = 0.3177)
7:117306978:A:T,P13569,K1420I,0.484,Loss of methylation at K1420 (P = 0.0201); Loss of ubiquitination at K1420 (P = 0.0218); Loss of disorder (P = 0.0781); Loss of sheet (P = 0.0817); Loss of solvent accessibility (P = 0.1322)
7:117306979:A:C,P13569,K1420N,0.387,Loss of methylation at K1420 (P = 0.0201); Loss of ubiquitination at K1420 (P = 0.0218); Loss of MoRF binding (P = 0.2599); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3199)
7:117306979:A:T,P13569,K1420N,0.387,Loss of methylation at K1420 (P = 0.0201); Loss of ubiquitination at K1420 (P = 0.0218); Loss of MoRF binding (P = 0.2599); Loss of sheet (P = 0.302); Loss of disorder (P = 0.3199)
7:117306980:G:A,P13569,V1421M,0.617,Loss of methylation at K1420 (P = 0.027); Gain of disorder (P = 0.0882); Loss of ubiquitination at K1420 (P = 0.1231); Loss of sheet (P = 0.1501); Gain of phosphorylation at Y1424 (P = 0.1761)
7:117306980:G:C,P13569,V1421L,0.558,Loss of methylation at K1420 (P = 0.0407); Gain of catalytic residue at V1421 (P = 0.0934); Gain of ubiquitination at K1420 (P = 0.123); Gain of disorder (P = 0.1817); Loss of MoRF binding (P = 0.2621)
7:117306981:T:A,P13569,V1421E,0.796,Gain of disorder (P = 0.0023); Loss of ubiquitination at K1420 (P = 0.0834); Loss of methylation at K1420 (P = 0.0905); Gain of phosphorylation at Y1424 (P = 0.0909); Loss of sheet (P = 0.1398)
7:117306981:T:C,P13569,V1421A,0.641,Loss of stability (P = 0.0256); Loss of methylation at K1420 (P = 0.0459); Gain of disorder (P = 0.0746); Loss of ubiquitination at K1420 (P = 0.1079); Loss of sheet (P = 0.1501)
7:117306981:T:G,P13569,V1421G,0.791,Loss of stability (P = 0.008); Gain of disorder (P = 0.0221); Loss of methylation at K1420 (P = 0.0521); Loss of ubiquitination at K1420 (P = 0.1435); Loss of sheet (P = 0.1501)
7:117306983:C:G,P13569,R1422G,0.489,Loss of ubiquitination at K1420 (P = 0.064); Gain of methylation at K1420 (P = 0.0651); Loss of MoRF binding (P = 0.0848); Loss of solvent accessibility (P = 0.1077); Gain of sheet (P = 0.1539)
7:117306984:G:A,P13569,R1422Q,0.495,Gain of methylation at K1420 (P = 0.0579); Loss of ubiquitination at K1420 (P = 0.0768); Loss of MoRF binding (P = 0.0977); Loss of solvent accessibility (P = 0.1077); Loss of sheet (P = 0.1398)
7:117306984:G:C,P13569,R1422P,0.542,Gain of methylation at K1420 (P = 0.0433); Loss of ubiquitination at K1420 (P = 0.0702); Loss of MoRF binding (P = 0.0755); Loss of solvent accessibility (P = 0.1077); Gain of phosphorylation at Y1424 (P = 0.1511)
7:117306984:G:T,P13569,R1422L,0.576,Loss of ubiquitination at K1420 (P = 0.0702); Loss of MoRF binding (P = 0.0814); Gain of methylation at K1420 (P = 0.0907); Loss of disorder (P = 0.1); Loss of solvent accessibility (P = 0.1077)
7:117306986:C:A,P13569,Q1423K,0.636,Gain of methylation at Q1423 (P = 0.0098); Gain of ubiquitination at Q1423 (P = 0.03); Gain of solvent accessibility (P = 0.0354); Gain of relative solvent accessibility (P = 0.0479); Gain of MoRF binding (P = 0.0652)
7:117306986:C:G,P13569,Q1423E,0.572,Gain of solvent accessibility (P = 0.0411); Gain of relative solvent accessibility (P = 0.0479); Loss of ubiquitination at K1420 (P = 0.0949); Loss of methylation at K1420 (P = 0.0966); Loss of MoRF binding (P = 0.1186)
7:117306987:A:C,P13569,Q1423P,0.719,Loss of stability (P = 0.0936); Loss of ubiquitination at K1420 (P = 0.0949); Loss of methylation at K1420 (P = 0.1172); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1501)
7:117306987:A:G,P13569,Q1423R,0.623,Gain of MoRF binding (P = 0.0505); Gain of phosphorylation at S1426 (P = 0.0567); Gain of solvent accessibility (P = 0.0584); Loss of ubiquitination at K1420 (P = 0.0768); Gain of relative solvent accessibility (P = 0.09)
7:117306987:A:T,P13569,Q1423L,0.648,Loss of methylation at K1420 (P = 0.0426); Loss of ubiquitination at K1420 (P = 0.064); Loss of disorder (P = 0.0873); Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299)
7:117306988:G:C,P13569,Q1423H,0.655,Loss of methylation at K1420 (P = 0.0728); Loss of stability (P = 0.0978); Loss of ubiquitination at K1420 (P = 0.1079); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1501)
7:117306988:G:T,P13569,Q1423H,0.655,Loss of methylation at K1420 (P = 0.0728); Loss of stability (P = 0.0978); Loss of ubiquitination at K1420 (P = 0.1079); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1501)
7:117306989:T:A,P13569,Y1424N,0.463,Gain of disorder (P = 0.0082); Loss of ubiquitination at K1420 (P = 0.0594); Loss of methylation at K1429 (P = 0.0868); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.2181)
7:117306989:T:C,P13569,Y1424H,0.437,Gain of disorder (P = 0.0188); Gain of catalytic residue at R1422 (P = 0.0676); Loss of ubiquitination at K1420 (P = 0.0702); Loss of methylation at K1429 (P = 0.0927); Loss of helix (P = 0.1299)
7:117306989:T:G,P13569,Y1424D,0.531,Gain of disorder (P = 0.0051); Gain of ubiquitination at K1429 (P = 0.0498); Loss of methylation at K1429 (P = 0.072); Loss of MoRF binding (P = 0.0994); Gain of relative solvent accessibility (P = 0.1066)
7:117306990:A:C,P13569,Y1424S,0.503,Gain of disorder (P = 0.0019); Gain of methylation at K1420 (P = 0.0514); Gain of phosphorylation at Y1424 (P = 0.0526); Loss of sheet (P = 0.0817); Loss of ubiquitination at K1420 (P = 0.0834)
7:117306990:A:G,P13569,Y1424C,0.409,Gain of disorder (P = 0.0517); Loss of ubiquitination at K1420 (P = 0.0834); Loss of methylation at K1429 (P = 0.0961); Gain of catalytic residue at R1422 (P = 0.1138); Gain of sheet (P = 0.1208)
7:117306990:A:T,P13569,Y1424F,0.376,Loss of methylation at K1429 (P = 0.0679); Gain of disorder (P = 0.0941); Loss of ubiquitination at K1420 (P = 0.1079); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1501)
7:117306992:G:A,P13569,D1425N,0.574,Gain of MoRF binding (P = 0.044); Loss of helix (P = 0.1299); Loss of ubiquitination at K1420 (P = 0.1435); Gain of methylation at K1420 (P = 0.1451); Loss of solvent accessibility (P = 0.1579)
7:117306992:G:C,P13569,D1425H,0.626,Gain of MoRF binding (P = 0.0538); Loss of ubiquitination at K1420 (P = 0.0834); Loss of loop (P = 0.0986); Loss of relative solvent accessibility (P = 0.114); Gain of sheet (P = 0.1208)
7:117306992:G:T,P13569,D1425Y,0.695,Loss of ubiquitination at K1420 (P = 0.0557); Gain of MoRF binding (P = 0.0654); Loss of disorder (P = 0.0657); Gain of methylation at K1429 (P = 0.1004); Loss of relative solvent accessibility (P = 0.114)
7:117306993:A:C,P13569,D1425A,0.614,Gain of MoRF binding (P = 0.0511); Loss of solvent accessibility (P = 0.0606); Loss of methylation at K1420 (P = 0.0803); Loss of ubiquitination at K1420 (P = 0.0834); Loss of loop (P = 0.0986)
7:117306993:A:G,P13569,D1425G,0.628,Gain of MoRF binding (P = 0.0573); Loss of solvent accessibility (P = 0.0703); Loss of ubiquitination at K1420 (P = 0.0949); Loss of relative solvent accessibility (P = 0.114); Gain of catalytic residue at S1426 (P = 0.1191)
7:117306993:A:T,P13569,D1425V,0.63,Gain of MoRF binding (P = 0.0511); Loss of ubiquitination at K1420 (P = 0.0557); Loss of disorder (P = 0.0688); Loss of loop (P = 0.0986); Loss of solvent accessibility (P = 0.1077)
7:117306994:T:A,P13569,D1425E,0.531,Gain of disorder (P = 0.0867); Gain of methylation at K1420 (P = 0.099); Loss of ubiquitination at K1420 (P = 0.1231); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.1376)
7:117306994:T:G,P13569,D1425E,0.531,Gain of disorder (P = 0.0867); Gain of methylation at K1420 (P = 0.099); Loss of ubiquitination at K1420 (P = 0.1231); Loss of helix (P = 0.1299); Gain of solvent accessibility (P = 0.1376)
7:117306995:T:A,P13569,S1426T,0.456,Loss of disorder (P = 0.0587); Loss of helix (P = 0.1299); Gain of sheet (P = 0.1539); Loss of MoRF binding (P = 0.1584); Gain of methylation at K1429 (P = 0.2036)
7:117306995:T:C,P13569,S1426P,0.799,Loss of MoRF binding (P = 0.0827); Gain of methylation at K1429 (P = 0.1282); Loss of phosphorylation at S1426 (P = 0.1586); Loss of helix (P = 0.1706); Loss of disorder (P = 0.1848)
7:117306995:T:G,P13569,S1426A,0.497,Loss of disorder (P = 0.064); Loss of stability (P = 0.103); Loss of helix (P = 0.1299); Loss of phosphorylation at S1426 (P = 0.1586); Loss of MoRF binding (P = 0.1781)
7:117306996:C:A,P13569,S1426Y,0.613,Loss of disorder (P = 0.0268); Loss of MoRF binding (P = 0.1297); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1398); Gain of loop (P = 0.2045)
7:117306996:C:G,P13569,S1426C,0.654,Loss of disorder (P = 0.0359); Loss of MoRF binding (P = 0.0937); Loss of helix (P = 0.1299); Gain of methylation at K1429 (P = 0.1497); Loss of phosphorylation at S1426 (P = 0.1586)
7:117306996:C:T,P13569,S1426F,0.83,Loss of disorder (P = 0.032); Loss of MoRF binding (P = 0.1181); Loss of helix (P = 0.1299); Loss of sheet (P = 0.1398); Loss of phosphorylation at S1426 (P = 0.1586)
7:117306998:A:C,P13569,I1427L,0.619,Loss of methylation at K1429 (P = 0.0479); Gain of disorder (P = 0.0887); Loss of MoRF binding (P = 0.122); Gain of helix (P = 0.132); Gain of relative solvent accessibility (P = 0.2363)
7:117306998:A:G,P13569,I1427V,0.604,Loss of methylation at K1429 (P = 0.1105); Gain of MoRF binding (P = 0.1336); Gain of disorder (P = 0.1467); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363)
7:117306998:A:T,P13569,I1427F,0.654,Loss of methylation at K1429 (P = 0.1138); Loss of MoRF binding (P = 0.1187); Gain of disorder (P = 0.1632); Loss of stability (P = 0.2244); Gain of relative solvent accessibility (P = 0.2363)
7:117306999:T:A,P13569,I1427N,0.642,Gain of disorder (P = 0.0084); Loss of stability (P = 0.0296); Loss of methylation at K1429 (P = 0.0393); Gain of relative solvent accessibility (P = 0.09); Gain of sheet (P = 0.1208)
7:117306999:T:C,P13569,I1427T,0.68,Loss of stability (P = 0.0097); Gain of disorder (P = 0.028); Loss of methylation at K1429 (P = 0.0416); Gain of relative solvent accessibility (P = 0.09); Loss of MoRF binding (P = 0.1267)
7:117306999:T:G,P13569,I1427S,0.641,Gain of disorder (P = 0.0022); Loss of stability (P = 0.0307); Loss of methylation at K1429 (P = 0.0342); Gain of phosphorylation at I1427 (P = 0.0641); Gain of relative solvent accessibility (P = 0.09)
7:117307000:C:G,P13569,I1427M,0.64,Gain of disorder (P = 0.0426); Loss of methylation at K1429 (P = 0.0779); Gain of MoRF binding (P = 0.0948); Gain of helix (P = 0.132); Gain of relative solvent accessibility (P = 0.2363)
7:117307001:C:A,P13569,Q1428K,0.366,Gain of methylation at Q1428 (P = 0.0062); Gain of MoRF binding (P = 0.0421); Gain of relative solvent accessibility (P = 0.0999); Gain of solvent accessibility (P = 0.1071); Gain of phosphorylation at S1426 (P = 0.1249)
7:117307001:C:G,P13569,Q1428E,0.283,Loss of MoRF binding (P = 0.057); Loss of methylation at K1429 (P = 0.0826); Gain of relative solvent accessibility (P = 0.0999); Gain of phosphorylation at S1426 (P = 0.1103); Gain of disorder (P = 0.1272)
7:117307002:A:C,P13569,Q1428P,0.437,Gain of catalytic residue at Q1428 (P = 0.0468); Loss of MoRF binding (P = 0.0713); Loss of helix (P = 0.1299); Gain of phosphorylation at S1426 (P = 0.1624); Gain of loop (P = 0.2045)
7:117307002:A:G,P13569,Q1428R,0.263,Gain of MoRF binding (P = 0.0224); Gain of phosphorylation at S1426 (P = 0.0763); Loss of helix (P = 0.1299); Gain of methylation at K1429 (P = 0.2); Gain of disorder (P = 0.2003)
7:117307002:A:T,P13569,Q1428L,0.328,Loss of disorder (P = 0.0555); Loss of methylation at K1429 (P = 0.0598); Loss of MoRF binding (P = 0.1259); Loss of helix (P = 0.1706); Loss of sheet (P = 0.302)
7:117307003:G:C,P13569,Q1428H,0.286,Gain of catalytic residue at L1430 (P = 0.0969); Loss of disorder (P = 0.1142); Loss of MoRF binding (P = 0.1161); Loss of helix (P = 0.1299); Loss of methylation at K1429 (P = 0.1764)
7:117307003:G:T,P13569,Q1428H,0.286,Gain of catalytic residue at L1430 (P = 0.0969); Loss of disorder (P = 0.1142); Loss of MoRF binding (P = 0.1161); Loss of helix (P = 0.1299); Loss of methylation at K1429 (P = 0.1764)
7:117307004:A:C,P13569,K1429Q,0.346,Loss of methylation at K1429 (P = 0.0104); Loss of MoRF binding (P = 0.0541); Loss of helix (P = 0.1299); Gain of disorder (P = 0.2047); Loss of ubiquitination at K1429 (P = 0.3114)
7:117307004:A:G,P13569,K1429E,0.376,Loss of methylation at K1429 (P = 0.0104); Loss of MoRF binding (P = 0.0143); Loss of helix (P = 0.1706); Gain of disorder (P = 0.1717); Gain of phosphorylation at S1426 (P = 0.2286)
7:117307005:A:C,P13569,K1429T,0.387,Loss of methylation at K1429 (P = 0.0104); Loss of MoRF binding (P = 0.0444); Loss of disorder (P = 0.0655); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1922)
7:117307005:A:G,P13569,K1429R,0.305,Loss of methylation at K1429 (P = 0.0114); Gain of MoRF binding (P = 0.0749); Loss of helix (P = 0.1299); Gain of phosphorylation at S1426 (P = 0.1601); Gain of disorder (P = 0.1961)
7:117307005:A:T,P13569,K1429I,0.455,Loss of methylation at K1429 (P = 0.0104); Loss of disorder (P = 0.0261); Loss of MoRF binding (P = 0.0423); Gain of stability (P = 0.1076); Gain of sheet (P = 0.1208)
7:117307006:A:C,P13569,K1429N,0.358,Loss of methylation at K1429 (P = 0.0104); Loss of MoRF binding (P = 0.0495); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1707); Loss of solvent accessibility (P = 0.239)
7:117307006:A:T,P13569,K1429N,0.358,Loss of methylation at K1429 (P = 0.0104); Loss of MoRF binding (P = 0.0495); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1707); Loss of solvent accessibility (P = 0.239)
7:117307007:C:A,P13569,L1430M,0.614,Loss of methylation at K1429 (P = 0.0328); Gain of MoRF binding (P = 0.0638); Gain of disorder (P = 0.1151); Gain of helix (P = 0.132); Gain of loop (P = 0.2045)
7:117307007:C:G,P13569,L1430V,0.598,Gain of MoRF binding (P = 0.0753); Gain of methylation at K1429 (P = 0.0783); Gain of helix (P = 0.132); Loss of disorder (P = 0.1991); Loss of phosphorylation at S1435 (P = 0.2435)
7:117307008:T:A,P13569,L1430Q,0.787,Gain of disorder (P = 0.0177); Loss of stability (P = 0.0584); Gain of MoRF binding (P = 0.085); Gain of helix (P = 0.132); Gain of methylation at K1429 (P = 0.1917)
7:117307008:T:C,P13569,L1430P,0.867,Loss of stability (P = 0.0123); Gain of disorder (P = 0.023); Loss of MoRF binding (P = 0.0746); Gain of helix (P = 0.132); Gain of methylation at K1429 (P = 0.1475)
7:117307008:T:G,P13569,L1430R,0.836,Gain of MoRF binding (P = 0.0068); Gain of disorder (P = 0.0211); Loss of stability (P = 0.0389); Gain of phosphorylation at S1435 (P = 0.1725); Gain of loop (P = 0.2045)
7:117307010:C:A,P13569,L1431M,0.426,Gain of MoRF binding (P = 0.0611); Gain of disorder (P = 0.1173); Gain of methylation at K1429 (P = 0.1416); Gain of helix (P = 0.1736); Gain of phosphorylation at S1435 (P = 0.2794)
7:117307010:C:G,P13569,L1431V,0.399,Gain of MoRF binding (P = 0.0741); Gain of methylation at K1429 (P = 0.1547); Gain of helix (P = 0.1736); Loss of disorder (P = 0.1986); Gain of loop (P = 0.2045)
7:117307011:T:A,P13569,L1431Q,0.658,Gain of disorder (P = 0.0216); Gain of MoRF binding (P = 0.069); Loss of helix (P = 0.1299); Gain of methylation at K1429 (P = 0.135); Loss of stability (P = 0.1743)
7:117307011:T:C,P13569,L1431P,0.817,Gain of disorder (P = 0.0273); Loss of MoRF binding (P = 0.075); Loss of stability (P = 0.0857); Gain of methylation at K1429 (P = 0.119); Loss of helix (P = 0.1299)
7:117307011:T:G,P13569,L1431R,0.754,Gain of MoRF binding (P = 0.008); Gain of disorder (P = 0.0233); Gain of phosphorylation at S1426 (P = 0.1334); Loss of stability (P = 0.1479); Gain of methylation at K1429 (P = 0.1682)
7:117307013:A:C,P13569,N1432H,0.218,Loss of MoRF binding (P = 0.1088); Loss of disorder (P = 0.1677); Loss of methylation at K1429 (P = 0.1706); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117307013:A:G,P13569,N1432D,0.25,Loss of MoRF binding (P = 0.0504); Loss of methylation at K1429 (P = 0.098); Gain of helix (P = 0.132); Gain of disorder (P = 0.1399); Gain of phosphorylation at S1435 (P = 0.1404)
7:117307013:A:T,P13569,N1432Y,0.332,Loss of disorder (P = 0.0358); Loss of methylation at K1429 (P = 0.0438); Loss of MoRF binding (P = 0.1001); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117307014:A:C,P13569,N1432T,0.197,Loss of disorder (P = 0.1053); Gain of phosphorylation at N1432 (P = 0.1055); Loss of MoRF binding (P = 0.1172); Loss of methylation at K1429 (P = 0.1181); Gain of helix (P = 0.132)
7:117307014:A:G,P13569,N1432S,0.192,Gain of phosphorylation at N1432 (P = 0.0514); Gain of disorder (P = 0.0567); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1338); Gain of methylation at K1429 (P = 0.2262)
7:117307014:A:T,P13569,N1432I,0.301,Loss of disorder (P = 0.0441); Loss of MoRF binding (P = 0.1306); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045); Loss of methylation at K1429 (P = 0.222)
7:117307015:C:A,P13569,N1432K,0.324,Gain of methylation at N1432 (P = 0.0126); Gain of MoRF binding (P = 0.0259); Gain of ubiquitination at N1432 (P = 0.0797); Gain of disorder (P = 0.0831); Gain of solvent accessibility (P = 0.1319)
7:117307015:C:G,P13569,N1432K,0.324,Gain of methylation at N1432 (P = 0.0126); Gain of MoRF binding (P = 0.0259); Gain of ubiquitination at N1432 (P = 0.0797); Gain of disorder (P = 0.0831); Gain of solvent accessibility (P = 0.1319)
7:117307016:G:A,P13569,E1433K,0.404,Gain of MoRF binding (P = 0.0042); Gain of methylation at E1433 (P = 0.0125); Loss of stability (P = 0.0667); Gain of ubiquitination at E1433 (P = 0.1008); Loss of helix (P = 0.1299)
7:117307016:G:C,P13569,E1433Q,0.275,Gain of MoRF binding (P = 0.0245); Gain of helix (P = 0.132); Loss of phosphorylation at S1435 (P = 0.1475); Gain of disorder (P = 0.2141); Gain of methylation at K1429 (P = 0.2227)
7:117307017:A:C,P13569,E1433A,0.329,Gain of MoRF binding (P = 0.0177); Loss of disorder (P = 0.0631); Loss of methylation at K1429 (P = 0.0955); Loss of stability (P = 0.1147); Loss of helix (P = 0.1299)
7:117307017:A:G,P13569,E1433G,0.372,Gain of MoRF binding (P = 0.0218); Loss of stability (P = 0.0408); Loss of disorder (P = 0.0628); Loss of methylation at K1429 (P = 0.113); Gain of catalytic residue at E1433 (P = 0.1287)
7:117307017:A:T,P13569,E1433V,0.437,Gain of MoRF binding (P = 0.012); Loss of disorder (P = 0.0236); Loss of phosphorylation at S1435 (P = 0.1059); Loss of helix (P = 0.1299); Loss of methylation at K1429 (P = 0.1328)
7:117307018:G:C,P13569,E1433D,0.223,Gain of MoRF binding (P = 0.1163); Loss of methylation at K1429 (P = 0.1839); Loss of disorder (P = 0.2011); Loss of loop (P = 0.2237); Gain of phosphorylation at S1435 (P = 0.2794)
7:117307018:G:T,P13569,E1433D,0.223,Gain of MoRF binding (P = 0.1163); Loss of methylation at K1429 (P = 0.1839); Loss of disorder (P = 0.2011); Loss of loop (P = 0.2237); Gain of phosphorylation at S1435 (P = 0.2794)
7:117307019:A:G,P13569,R1434G,0.41,Loss of MoRF binding (P = 0.0363); Loss of stability (P = 0.0384); Loss of methylation at K1429 (P = 0.0643); Loss of disorder (P = 0.074); Loss of phosphorylation at S1435 (P = 0.1217)
7:117307019:A:T,P13569,R1434W,0.477,Loss of disorder (P = 0.0018); Loss of methylation at K1429 (P = 0.0408); Loss of phosphorylation at S1435 (P = 0.0627); Loss of MoRF binding (P = 0.0946); Gain of helix (P = 0.132)
7:117307020:G:A,P13569,R1434K,0.325,Gain of ubiquitination at R1434 (P = 0.0219); Gain of methylation at R1434 (P = 0.0378); Loss of MoRF binding (P = 0.0944); Gain of relative solvent accessibility (P = 0.0999); Loss of stability (P = 0.1004)
7:117307020:G:C,P13569,R1434T,0.4,Loss of MoRF binding (P = 0.0331); Loss of disorder (P = 0.0648); Loss of phosphorylation at S1435 (P = 0.0809); Loss of methylation at K1429 (P = 0.1186); Loss of stability (P = 0.1231)
7:117307020:G:T,P13569,R1434M,0.385,Loss of MoRF binding (P = 0.0575); Loss of disorder (P = 0.0698); Loss of phosphorylation at S1435 (P = 0.0951); Loss of methylation at K1429 (P = 0.0996); Gain of helix (P = 0.132)
7:117307021:G:C,P13569,R1434S,0.395,Loss of MoRF binding (P = 0.0371); Gain of disorder (P = 0.126); Gain of helix (P = 0.132); Loss of phosphorylation at S1435 (P = 0.1718); Loss of stability (P = 0.1981)
7:117307021:G:T,P13569,R1434S,0.395,Loss of MoRF binding (P = 0.0371); Gain of disorder (P = 0.126); Gain of helix (P = 0.132); Loss of phosphorylation at S1435 (P = 0.1718); Loss of stability (P = 0.1981)
7:117307022:A:C,P13569,S1435R,0.438,Gain of MoRF binding (P = 0.0169); Loss of phosphorylation at S1435 (P = 0.033); Gain of solvent accessibility (P = 0.0739); Loss of helix (P = 0.1299); Loss of disorder (P = 0.185)
7:117307022:A:G,P13569,S1435G,0.457,Loss of phosphorylation at S1435 (P = 0.033); Loss of disorder (P = 0.0452); Loss of stability (P = 0.0909); Loss of MoRF binding (P = 0.1115); Loss of helix (P = 0.1706)
7:117307022:A:T,P13569,S1435C,0.507,Loss of disorder (P = 0.0216); Gain of catalytic residue at L1436 (P = 0.0274); Loss of phosphorylation at S1435 (P = 0.033); Loss of MoRF binding (P = 0.0715); Gain of helix (P = 0.2059)
7:117307023:G:A,P13569,S1435N,0.394,Loss of phosphorylation at S1435 (P = 0.033); Loss of disorder (P = 0.1093); Loss of MoRF binding (P = 0.1325); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045)
7:117307023:G:C,P13569,S1435T,0.431,Loss of disorder (P = 0.0393); Loss of phosphorylation at S1435 (P = 0.088); Loss of MoRF binding (P = 0.1163); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117307023:G:T,P13569,S1435I,0.494,Loss of disorder (P = 0.0106); Loss of phosphorylation at S1435 (P = 0.033); Loss of MoRF binding (P = 0.1075); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117307024:C:A,P13569,S1435R,0.438,Gain of MoRF binding (P = 0.0169); Loss of phosphorylation at S1435 (P = 0.033); Gain of solvent accessibility (P = 0.0739); Loss of helix (P = 0.1299); Loss of disorder (P = 0.185)
7:117307024:C:G,P13569,S1435R,0.438,Gain of MoRF binding (P = 0.0169); Loss of phosphorylation at S1435 (P = 0.033); Gain of solvent accessibility (P = 0.0739); Loss of helix (P = 0.1299); Loss of disorder (P = 0.185)
7:117307025:C:A,P13569,L1436I,0.307,Gain of MoRF binding (P = 0.1005); Loss of disorder (P = 0.167); Loss of helix (P = 0.2022); Gain of phosphorylation at S1435 (P = 0.2507); Gain of catalytic residue at A1440 (P = 0.2628)
7:117307025:C:G,P13569,L1436V,0.292,Gain of MoRF binding (P = 0.0783); Loss of stability (P = 0.1744); Loss of disorder (P = 0.1957); Loss of helix (P = 0.2022); Loss of phosphorylation at S1435 (P = 0.2384)
7:117307025:C:T,P13569,L1436F,0.39,Loss of MoRF binding (P = 0.114); Gain of helix (P = 0.132); Loss of disorder (P = 0.1934); Gain of loop (P = 0.2045); Loss of stability (P = 0.2335)
7:117307026:T:A,P13569,L1436H,0.35,Loss of stability (P = 0.0269); Loss of helix (P = 0.0626); Gain of catalytic residue at R1434 (P = 0.0691); Gain of disorder (P = 0.0866); Gain of MoRF binding (P = 0.1117)
7:117307026:T:C,P13569,L1436P,0.633,Loss of stability (P = 0.0181); Gain of disorder (P = 0.0239); Gain of glycosylation at L1436 (P = 0.0625); Loss of MoRF binding (P = 0.0659); Gain of relative solvent accessibility (P = 0.1571)
7:117307026:T:G,P13569,L1436R,0.543,Gain of MoRF binding (P = 0.0084); Gain of disorder (P = 0.0261); Gain of methylation at L1436 (P = 0.028); Loss of stability (P = 0.0516); Gain of solvent accessibility (P = 0.1071)
7:117307028:T:A,P13569,F1437I,0.622,Gain of MoRF binding (P = 0.0848); Gain of helix (P = 0.132); Gain of phosphorylation at S1435 (P = 0.2118); Gain of disorder (P = 0.2154); Loss of loop (P = 0.2237)
7:117307028:T:C,P13569,F1437L,0.599,Gain of disorder (P = 0.1129); Gain of MoRF binding (P = 0.1294); Gain of helix (P = 0.132); Gain of phosphorylation at S1435 (P = 0.1919); Loss of loop (P = 0.2237)
7:117307028:T:G,P13569,F1437V,0.64,Gain of MoRF binding (P = 0.0724); Gain of helix (P = 0.132); Loss of stability (P = 0.1475); Gain of disorder (P = 0.1876); Gain of loop (P = 0.2045)
7:117307029:T:A,P13569,F1437Y,0.642,Loss of stability (P = 0.1094); Loss of MoRF binding (P = 0.1267); Loss of helix (P = 0.1706); Gain of phosphorylation at S1435 (P = 0.2129); Loss of disorder (P = 0.2315)
7:117307029:T:C,P13569,F1437S,0.719,Gain of disorder (P = 0.0099); Gain of phosphorylation at F1437 (P = 0.0145); Loss of stability (P = 0.027); Gain of MoRF binding (P = 0.1235); Loss of helix (P = 0.1706)
7:117307029:T:G,P13569,F1437C,0.732,Loss of MoRF binding (P = 0.0813); Gain of disorder (P = 0.1239); Loss of stability (P = 0.1364); Gain of helix (P = 0.2059); Loss of phosphorylation at S1435 (P = 0.2882)
7:117307030:C:A,P13569,F1437L,0.599,Gain of disorder (P = 0.1129); Gain of MoRF binding (P = 0.1294); Gain of helix (P = 0.132); Gain of phosphorylation at S1435 (P = 0.1919); Loss of loop (P = 0.2237)
7:117307030:C:G,P13569,F1437L,0.599,Gain of disorder (P = 0.1129); Gain of MoRF binding (P = 0.1294); Gain of helix (P = 0.132); Gain of phosphorylation at S1435 (P = 0.1919); Loss of loop (P = 0.2237)
7:117307031:C:G,P13569,R1438G,0.594,Loss of MoRF binding (P = 0.0084); Loss of disorder (P = 0.069); Gain of loop (P = 0.0851); Loss of catalytic residue at R1438 (P = 0.0954); Loss of phosphorylation at S1435 (P = 0.0989)
7:117307031:C:T,P13569,R1438W,0.848,Loss of disorder (P = 7e-04); Gain of catalytic residue at L1436 (P = 0.0123); Loss of MoRF binding (P = 0.0502); Loss of phosphorylation at S1435 (P = 0.0645); Gain of loop (P = 0.0851)
7:117307032:G:C,P13569,R1438P,0.53,Loss of MoRF binding (P = 0.0019); Gain of loop (P = 0.069); Loss of catalytic residue at R1438 (P = 0.1003); Gain of glycosylation at S1435 (P = 0.1252); Loss of helix (P = 0.1299)
7:117307032:G:T,P13569,R1438L,0.607,Loss of MoRF binding (P = 0.0066); Loss of disorder (P = 0.039); Gain of loop (P = 0.069); Loss of helix (P = 0.079); Loss of phosphorylation at S1435 (P = 0.0866)
7:117307034:C:A,P13569,Q1439K,0.314,Gain of methylation at Q1439 (P = 0.0157); Gain of MoRF binding (P = 0.0325); Loss of stability (P = 0.0692); Gain of phosphorylation at S1442 (P = 0.0958); Gain of disorder (P = 0.1683)
7:117307034:C:G,P13569,Q1439E,0.278,Loss of MoRF binding (P = 0.0329); Gain of phosphorylation at S1442 (P = 0.0998); Gain of disorder (P = 0.1664); Loss of catalytic residue at R1438 (P = 0.2886); Gain of glycosylation at S1444 (P = 0.3356)
7:117307035:A:C,P13569,Q1439P,0.338,Loss of MoRF binding (P = 0.0451); Gain of loop (P = 0.0851); Gain of phosphorylation at S1442 (P = 0.1041); Loss of stability (P = 0.1219); Gain of glycosylation at Q1439 (P = 0.1589)
7:117307035:A:G,P13569,Q1439R,0.247,Gain of MoRF binding (P = 0.0225); Gain of phosphorylation at S1442 (P = 0.0534); Gain of methylation at Q1439 (P = 0.0629); Gain of disorder (P = 0.203); Gain of glycosylation at S1444 (P = 0.2941)
7:117307035:A:T,P13569,Q1439L,0.377,Loss of disorder (P = 0.0432); Loss of MoRF binding (P = 0.0961); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045); Gain of phosphorylation at S1442 (P = 0.2292)
7:117307036:A:C,P13569,Q1439H,0.334,Loss of MoRF binding (P = 0.0954); Loss of disorder (P = 0.1067); Loss of stability (P = 0.1677); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117307036:A:T,P13569,Q1439H,0.334,Loss of MoRF binding (P = 0.0954); Loss of disorder (P = 0.1067); Loss of stability (P = 0.1677); Loss of helix (P = 0.1706); Gain of loop (P = 0.2045)
7:117307037:G:A,P13569,A1440T,0.445,Gain of glycosylation at A1440 (P = 0.0335); Gain of phosphorylation at A1440 (P = 0.0409); Loss of MoRF binding (P = 0.1033); Loss of helix (P = 0.2022); Gain of disorder (P = 0.2201)
7:117307037:G:C,P13569,A1440P,0.664,Loss of MoRF binding (P = 0.0419); Gain of disorder (P = 0.0419); Gain of phosphorylation at S1442 (P = 0.1445); Loss of helix (P = 0.2022); Gain of loop (P = 0.2754)
7:117307037:G:T,P13569,A1440S,0.591,Gain of phosphorylation at A1440 (P = 0.0103); Gain of disorder (P = 0.029); Loss of MoRF binding (P = 0.1049); Gain of catalytic residue at L1436 (P = 0.1474); Gain of glycosylation at A1440 (P = 0.3768)
7:117307038:C:A,P13569,A1440D,0.548,Loss of MoRF binding (P = 0.0236); Gain of disorder (P = 0.0643); Gain of relative solvent accessibility (P = 0.09); Gain of phosphorylation at S1442 (P = 0.1374); Gain of solvent accessibility (P = 0.1376)
7:117307038:C:G,P13569,A1440G,0.443,Loss of MoRF binding (P = 0.1172); Gain of disorder (P = 0.201); Loss of helix (P = 0.2022); Loss of stability (P = 0.2209); Gain of phosphorylation at S1435 (P = 0.2605)
7:117307038:C:T,P13569,A1440V,0.483,Gain of MoRF binding (P = 0.0943); Gain of helix (P = 0.132); Loss of disorder (P = 0.1324); Loss of phosphorylation at S1435 (P = 0.242); Loss of loop (P = 0.4412)
7:117307040:A:C,P13569,I1441L,0.351,Loss of catalytic residue at P1443 (P = 0.0578); Gain of disorder (P = 0.106); Loss of MoRF binding (P = 0.1068); Gain of phosphorylation at S1444 (P = 0.1913); Gain of glycosylation at P1443 (P = 0.316)
7:117307040:A:G,P13569,I1441V,0.296,Loss of catalytic residue at P1443 (P = 0.0578); Gain of MoRF binding (P = 0.1065); Gain of disorder (P = 0.1742); Gain of phosphorylation at S1442 (P = 0.2117); Gain of loop (P = 0.3485)
7:117307040:A:T,P13569,I1441F,0.365,Loss of catalytic residue at P1443 (P = 0.0578); Loss of MoRF binding (P = 0.0924); Gain of disorder (P = 0.1624); Loss of helix (P = 0.2271); Gain of phosphorylation at S1444 (P = 0.2626)
7:117307041:T:A,P13569,I1441N,0.542,Loss of helix (P = 0.0237); Gain of disorder (P = 0.0332); Loss of stability (P = 0.0482); Loss of catalytic residue at P1443 (P = 0.0578); Gain of relative solvent accessibility (P = 0.09)
7:117307041:T:C,P13569,I1441T,0.443,Gain of phosphorylation at I1441 (P = 0.0248); Loss of stability (P = 0.0368); Loss of catalytic residue at P1443 (P = 0.0578); Gain of disorder (P = 0.0805); Gain of MoRF binding (P = 0.1305)
7:117307041:T:G,P13569,I1441S,0.505,Gain of disorder (P = 0.0142); Gain of phosphorylation at I1441 (P = 0.0155); Gain of relative solvent accessibility (P = 0.0215); Loss of helix (P = 0.0444); Loss of stability (P = 0.0486)
7:117307042:C:G,P13569,I1441M,0.386,Loss of catalytic residue at P1443 (P = 0.0578); Gain of disorder (P = 0.0624); Gain of MoRF binding (P = 0.0759); Gain of phosphorylation at S1442 (P = 0.161); Loss of helix (P = 0.1706)
7:117307043:A:C,P13569,S1442R,0.29,Gain of MoRF binding (P = 0.0103); Gain of catalytic residue at S1442 (P = 0.0342); Loss of phosphorylation at S1442 (P = 0.0971); Gain of solvent accessibility (P = 0.1185); Gain of helix (P = 0.132)
7:117307043:A:G,P13569,S1442G,0.279,Gain of catalytic residue at S1442 (P = 0.0328); Loss of disorder (P = 0.049); Loss of stability (P = 0.0941); Loss of phosphorylation at S1442 (P = 0.0971); Loss of MoRF binding (P = 0.098)
7:117307043:A:T,P13569,S1442C,0.415,Loss of disorder (P = 0.0294); Loss of helix (P = 0.0444); Loss of MoRF binding (P = 0.0654); Gain of catalytic residue at S1444 (P = 0.073); Loss of phosphorylation at S1444 (P = 0.0967)
7:117307044:G:A,P13569,S1442N,0.147,Loss of phosphorylation at S1444 (P = 0.0951); Gain of MoRF binding (P = 0.0969); Loss of disorder (P = 0.1085); Gain of helix (P = 0.132); Loss of stability (P = 0.3478)
7:117307044:G:C,P13569,S1442T,0.232,Loss of disorder (P = 0.0475); Gain of phosphorylation at S1442 (P = 0.0904); Loss of MoRF binding (P = 0.1228); Loss of helix (P = 0.2022); Loss of stability (P = 0.3355)
7:117307044:G:T,P13569,S1442I,0.375,Loss of disorder (P = 0.013); Loss of MoRF binding (P = 0.0809); Loss of phosphorylation at S1442 (P = 0.0971); Gain of catalytic residue at S1444 (P = 0.1101); Loss of helix (P = 0.1706)
7:117307045:C:A,P13569,S1442R,0.29,Gain of MoRF binding (P = 0.0103); Gain of catalytic residue at S1442 (P = 0.0342); Loss of phosphorylation at S1442 (P = 0.0971); Gain of solvent accessibility (P = 0.1185); Gain of helix (P = 0.132)
7:117307045:C:G,P13569,S1442R,0.29,Gain of MoRF binding (P = 0.0103); Gain of catalytic residue at S1442 (P = 0.0342); Loss of phosphorylation at S1442 (P = 0.0971); Gain of solvent accessibility (P = 0.1185); Gain of helix (P = 0.132)
7:117307046:C:A,P13569,P1443T,0.303,Gain of MoRF binding (P = 0.0497); Gain of phosphorylation at P1443 (P = 0.0522); Loss of relative solvent accessibility (P = 0.0676); Loss of solvent accessibility (P = 0.0721); Loss of disorder (P = 0.0892)
7:117307046:C:G,P13569,P1443A,0.248,Gain of MoRF binding (P = 0.043); Loss of solvent accessibility (P = 0.0509); Loss of relative solvent accessibility (P = 0.0676); Loss of methylation at K1448 (P = 0.074); Loss of disorder (P = 0.119)
7:117307046:C:T,P13569,P1443S,0.24,Gain of phosphorylation at P1443 (P = 0.0205); Gain of MoRF binding (P = 0.0488); Loss of relative solvent accessibility (P = 0.107); Loss of methylation at K1448 (P = 0.1192); Loss of solvent accessibility (P = 0.1279)
7:117307047:C:A,P13569,P1443H,0.272,Gain of MoRF binding (P = 0.0552); Loss of relative solvent accessibility (P = 0.0676); Gain of catalytic residue at I1441 (P = 0.0761); Loss of solvent accessibility (P = 0.1301); Loss of methylation at K1448 (P = 0.1325)
7:117307047:C:G,P13569,P1443R,0.259,Gain of MoRF binding (P = 0.0079); Loss of relative solvent accessibility (P = 0.107); Loss of methylation at K1448 (P = 0.1092); Gain of phosphorylation at S1442 (P = 0.1134); Gain of helix (P = 0.132)
7:117307047:C:T,P13569,P1443L,0.359,Loss of relative solvent accessibility (P = 0.0071); Loss of solvent accessibility (P = 0.0146); Loss of loop (P = 0.0374); Gain of MoRF binding (P = 0.0474); Loss of disorder (P = 0.0624)
7:117307049:T:A,P13569,S1444T,0.316,Gain of glycosylation at S1444 (P = 0.0551); Loss of disorder (P = 0.0603); Loss of phosphorylation at S1444 (P = 0.0638); Gain of methylation at K1448 (P = 0.0861); Loss of MoRF binding (P = 0.1319)
7:117307049:T:C,P13569,S1444P,0.241,Loss of phosphorylation at S1444 (P = 0.0326); Loss of MoRF binding (P = 0.0444); Loss of loop (P = 0.0804); Gain of helix (P = 0.0854); Gain of methylation at K1448 (P = 0.0985)
7:117307049:T:G,P13569,S1444A,0.262,Loss of phosphorylation at S1444 (P = 0.0326); Loss of disorder (P = 0.0789); Gain of MoRF binding (P = 0.1142); Loss of methylation at K1448 (P = 0.1265); Gain of helix (P = 0.1736)
7:117307050:C:A,P13569,S1444Y,0.333,Loss of disorder (P = 0.0087); Gain of methylation at K1448 (P = 0.0482); Loss of phosphorylation at S1444 (P = 0.1003); Loss of MoRF binding (P = 0.113); Loss of helix (P = 0.1706)
7:117307050:C:G,P13569,S1444C,0.385,Loss of phosphorylation at S1444 (P = 0.0326); Loss of disorder (P = 0.0399); Loss of MoRF binding (P = 0.0747); Gain of methylation at K1448 (P = 0.1119); Loss of helix (P = 0.1706)
7:117307050:C:T,P13569,S1444F,0.35,Loss of disorder (P = 0.026); Loss of phosphorylation at S1444 (P = 0.0326); Gain of methylation at K1448 (P = 0.1132); Loss of MoRF binding (P = 0.1253); Loss of helix (P = 0.1706)
7:117307052:G:C,P13569,D1445H,0.415,Gain of MoRF binding (P = 0.0462); Gain of methylation at K1448 (P = 0.055); Loss of stability (P = 0.0744); Gain of helix (P = 0.132); Loss of phosphorylation at S1444 (P = 0.1444)
7:117307052:G:T,P13569,D1445Y,0.392,Gain of MoRF binding (P = 0.048); Loss of solvent accessibility (P = 0.0509); Loss of disorder (P = 0.0534); Loss of relative solvent accessibility (P = 0.0676); Gain of methylation at K1448 (P = 0.1262)
7:117307053:A:C,P13569,D1445A,0.413,Gain of MoRF binding (P = 0.0392); Loss of solvent accessibility (P = 0.0435); Loss of stability (P = 0.0623); Loss of helix (P = 0.079); Gain of catalytic residue at D1445 (P = 0.0886)
7:117307053:A:G,P13569,D1445G,0.402,Gain of glycosylation at S1444 (P = 0.032); Loss of stability (P = 0.032); Gain of MoRF binding (P = 0.044); Gain of methylation at K1448 (P = 0.0946); Loss of loop (P = 0.1242)
7:117307053:A:T,P13569,D1445V,0.383,Gain of MoRF binding (P = 0.0353); Loss of solvent accessibility (P = 0.0371); Loss of relative solvent accessibility (P = 0.0676); Loss of helix (P = 0.079); Gain of methylation at K1448 (P = 0.0835)
7:117307054:C:A,P13569,D1445E,0.312,Gain of methylation at K1448 (P = 0.0909); Gain of MoRF binding (P = 0.1262); Loss of helix (P = 0.2022); Gain of phosphorylation at S1442 (P = 0.2256); Loss of stability (P = 0.2324)
7:117307054:C:G,P13569,D1445E,0.312,Gain of methylation at K1448 (P = 0.0909); Gain of MoRF binding (P = 0.1262); Loss of helix (P = 0.2022); Gain of phosphorylation at S1442 (P = 0.2256); Loss of stability (P = 0.2324)
7:117307055:A:G,P13569,R1446G,0.391,Loss of MoRF binding (P = 0.0083); Gain of methylation at K1448 (P = 0.0638); Loss of phosphorylation at S1444 (P = 0.0912); Loss of stability (P = 0.0952); Loss of disorder (P = 0.1076)
7:117307055:A:T,P13569,R1446W,0.506,Loss of disorder (P = 0.004); Gain of methylation at K1448 (P = 0.0458); Loss of phosphorylation at S1444 (P = 0.0648); Loss of MoRF binding (P = 0.0659); Gain of ubiquitination at K1448 (P = 0.0696)
7:117307056:G:A,P13569,R1446K,0.289,Gain of methylation at R1446 (P = 0.0345); Gain of ubiquitination at R1446 (P = 0.0539); Loss of MoRF binding (P = 0.0769); Loss of phosphorylation at S1444 (P = 0.1562); Loss of helix (P = 0.1706)
7:117307056:G:C,P13569,R1446T,0.401,Loss of MoRF binding (P = 0.0094); Gain of phosphorylation at R1446 (P = 0.0605); Gain of methylation at K1448 (P = 0.0711); Loss of solvent accessibility (P = 0.1077); Loss of disorder (P = 0.1275)
7:117307056:G:T,P13569,R1446M,0.414,Loss of MoRF binding (P = 0.0217); Gain of methylation at K1448 (P = 0.0464); Loss of phosphorylation at S1444 (P = 0.0797); Loss of solvent accessibility (P = 0.1077); Loss of disorder (P = 0.1169)
7:117307057:G:C,P13569,R1446S,0.416,Loss of MoRF binding (P = 0.0104); Gain of phosphorylation at R1446 (P = 0.0378); Loss of solvent accessibility (P = 0.1077); Gain of methylation at K1448 (P = 0.1083); Loss of helix (P = 0.1706)
7:117307057:G:T,P13569,R1446S,0.416,Loss of MoRF binding (P = 0.0104); Gain of phosphorylation at R1446 (P = 0.0378); Loss of solvent accessibility (P = 0.1077); Gain of methylation at K1448 (P = 0.1083); Loss of helix (P = 0.1706)
7:117307058:G:A,P13569,V1447M,0.23,Loss of stability (P = 0.0189); Loss of methylation at K1448 (P = 0.0272); Gain of MoRF binding (P = 0.1185); Gain of glycosylation at P1451 (P = 0.1693); Gain of helix (P = 0.1736)
7:117307058:G:C,P13569,V1447L,0.308,Loss of methylation at K1448 (P = 0.0394); Loss of MoRF binding (P = 0.0924); Loss of stability (P = 0.1436); Gain of helix (P = 0.1736); Gain of glycosylation at P1451 (P = 0.2022)
7:117307058:G:T,P13569,V1447L,0.308,Loss of methylation at K1448 (P = 0.0394); Loss of MoRF binding (P = 0.0924); Loss of stability (P = 0.1436); Gain of helix (P = 0.1736); Gain of glycosylation at P1451 (P = 0.2022)
7:117307059:T:A,P13569,V1447E,0.425,Loss of stability (P = 0.0076); Loss of MoRF binding (P = 0.0091); Loss of methylation at K1448 (P = 0.0483); Gain of glycosylation at P1451 (P = 0.1273); Gain of phosphorylation at S1442 (P = 0.136)
7:117307059:T:C,P13569,V1447A,0.293,Loss of stability (P = 2e-04); Loss of methylation at K1448 (P = 0.0433); Loss of MoRF binding (P = 0.1042); Gain of helix (P = 0.1736); Gain of glycosylation at P1451 (P = 0.1761)
7:117307059:T:G,P13569,V1447G,0.383,Loss of stability (P = 0); Loss of methylation at K1448 (P = 0.044); Loss of MoRF binding (P = 0.0859); Gain of helix (P = 0.1736); Gain of phosphorylation at S1442 (P = 0.1998)
7:117307061:A:C,P13569,K1448Q,0.29,Loss of methylation at K1448 (P = 0.0216); Loss of MoRF binding (P = 0.0422); Loss of ubiquitination at K1448 (P = 0.1306); Gain of helix (P = 0.132); Loss of glycosylation at P1451 (P = 0.1654)
7:117307061:A:G,P13569,K1448E,0.27,Loss of MoRF binding (P = 0.0018); Loss of methylation at K1448 (P = 0.0216); Loss of ubiquitination at K1448 (P = 0.1306); Loss of glycosylation at P1451 (P = 0.1531); Loss of helix (P = 0.1706)
7:117307062:A:C,P13569,K1448T,0.356,Loss of methylation at K1448 (P = 0.0216); Gain of phosphorylation at K1448 (P = 0.0244); Loss of MoRF binding (P = 0.0344); Gain of glycosylation at K1448 (P = 0.0462); Loss of ubiquitination at K1448 (P = 0.1306)
7:117307062:A:G,P13569,K1448R,0.215,Loss of methylation at K1448 (P = 0.0261); Gain of MoRF binding (P = 0.0929); Loss of ubiquitination at K1448 (P = 0.1306); Loss of helix (P = 0.1706); Loss of phosphorylation at S1444 (P = 0.1986)
7:117307062:A:T,P13569,K1448M,0.355,Loss of methylation at K1448 (P = 0.0216); Loss of MoRF binding (P = 0.0618); Loss of solvent accessibility (P = 0.086); Loss of ubiquitination at K1448 (P = 0.1306); Loss of glycosylation at P1451 (P = 0.1547)
7:117307063:G:C,P13569,K1448N,0.226,Loss of methylation at K1448 (P = 0.0216); Loss of MoRF binding (P = 0.0346); Loss of ubiquitination at K1448 (P = 0.1306); Loss of glycosylation at P1451 (P = 0.1442); Loss of phosphorylation at S1444 (P = 0.1552)
7:117307063:G:T,P13569,K1448N,0.226,Loss of methylation at K1448 (P = 0.0216); Loss of MoRF binding (P = 0.0346); Loss of ubiquitination at K1448 (P = 0.1306); Loss of glycosylation at P1451 (P = 0.1442); Loss of phosphorylation at S1444 (P = 0.1552)
7:117307064:C:A,P13569,L1449I,0.233,Gain of catalytic residue at P1451 (P = 0.0282); Gain of methylation at K1448 (P = 0.0489); Gain of MoRF binding (P = 0.1329); Loss of helix (P = 0.1706); Loss of glycosylation at P1451 (P = 0.1748)
7:117307064:C:G,P13569,L1449V,0.213,Loss of stability (P = 0.0311); Gain of methylation at K1448 (P = 0.0368); Gain of MoRF binding (P = 0.1053); Gain of helix (P = 0.132); Loss of glycosylation at P1451 (P = 0.206)
7:117307064:C:T,P13569,L1449F,0.217,Gain of methylation at K1448 (P = 0.0318); Loss of MoRF binding (P = 0.1083); Loss of stability (P = 0.1267); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237)
7:117307065:T:A,P13569,L1449H,0.211,Loss of stability (P = 0.0035); Gain of methylation at K1448 (P = 0.0653); Gain of loop (P = 0.069); Gain of MoRF binding (P = 0.1019); Gain of helix (P = 0.132)
7:117307065:T:C,P13569,L1449P,0.326,Loss of stability (P = 0.0027); Gain of methylation at K1448 (P = 0.0633); Loss of MoRF binding (P = 0.0651); Gain of loop (P = 0.069); Gain of helix (P = 0.132)
7:117307065:T:G,P13569,L1449R,0.261,Gain of MoRF binding (P = 0.0162); Loss of stability (P = 0.017); Gain of methylation at K1448 (P = 0.0636); Gain of phosphorylation at S1444 (P = 0.1357); Gain of glycosylation at S1444 (P = 0.1608)
7:117307067:T:A,P13569,F1450I,0.276,Gain of methylation at K1448 (P = 0.0698); Gain of MoRF binding (P = 0.0976); Loss of helix (P = 0.1299); Loss of glycosylation at P1451 (P = 0.2012); Gain of ubiquitination at K1448 (P = 0.2763)
7:117307067:T:C,P13569,F1450L,0.214,Loss of methylation at K1448 (P = 0.0886); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1333); Gain of glycosylation at P1451 (P = 0.1952); Gain of loop (P = 0.2045)
7:117307067:T:G,P13569,F1450V,0.2,Gain of MoRF binding (P = 0.0881); Gain of methylation at K1448 (P = 0.1241); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117307068:T:A,P13569,F1450Y,0.241,Loss of methylation at K1448 (P = 0.065); Gain of MoRF binding (P = 0.1044); Gain of glycosylation at P1451 (P = 0.1242); Loss of helix (P = 0.1299); Gain of loop (P = 0.2045)
7:117307068:T:C,P13569,F1450S,0.298,Gain of phosphorylation at F1450 (P = 0.0113); Gain of MoRF binding (P = 0.0789); Loss of helix (P = 0.079); Loss of methylation at K1448 (P = 0.0929); Gain of glycosylation at P1451 (P = 0.1009)
7:117307068:T:G,P13569,F1450C,0.246,Loss of MoRF binding (P = 0.1143); Gain of relative solvent accessibility (P = 0.1259); Loss of helix (P = 0.1299); Gain of methylation at K1448 (P = 0.1507); Gain of glycosylation at P1451 (P = 0.1609)
7:117307069:T:A,P13569,F1450L,0.214,Loss of methylation at K1448 (P = 0.0886); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1333); Gain of glycosylation at P1451 (P = 0.1952); Gain of loop (P = 0.2045)
7:117307069:T:G,P13569,F1450L,0.214,Loss of methylation at K1448 (P = 0.0886); Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1333); Gain of glycosylation at P1451 (P = 0.1952); Gain of loop (P = 0.2045)
7:117307070:C:A,P13569,P1451T,0.236,Gain of phosphorylation at P1451 (P = 0.0587); Gain of MoRF binding (P = 0.0668); Loss of methylation at K1448 (P = 0.086); Loss of glycosylation at P1451 (P = 0.1622); Loss of helix (P = 0.1706)
7:117307070:C:G,P13569,P1451A,0.246,Loss of glycosylation at P1451 (P = 0.0525); Gain of MoRF binding (P = 0.0553); Loss of methylation at K1448 (P = 0.0667); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117307070:C:T,P13569,P1451S,0.198,Gain of phosphorylation at P1451 (P = 0.0207); Gain of MoRF binding (P = 0.0643); Loss of glycosylation at P1451 (P = 0.0891); Loss of methylation at K1448 (P = 0.1132); Loss of helix (P = 0.1706)
7:117307071:C:A,P13569,P1451H,0.169,Loss of glycosylation at P1451 (P = 0.0525); Gain of MoRF binding (P = 0.0781); Loss of methylation at K1448 (P = 0.0998); Gain of helix (P = 0.1736); Loss of phosphorylation at S1456 (P = 0.1999)
7:117307071:C:G,P13569,P1451R,0.241,Gain of MoRF binding (P = 0.0241); Loss of glycosylation at P1451 (P = 0.0525); Gain of helix (P = 0.062); Loss of loop (P = 0.0804); Loss of methylation at K1448 (P = 0.1188)
7:117307071:C:T,P13569,P1451L,0.338,Loss of glycosylation at P1451 (P = 0.0525); Loss of methylation at K1448 (P = 0.0585); Gain of catalytic residue at P1451 (P = 0.0596); Gain of helix (P = 0.062); Gain of MoRF binding (P = 0.0633)
7:117307073:C:A,P13569,H1452N,0.17,Gain of methylation at K1448 (P = 0.0983); Gain of MoRF binding (P = 0.1319); Gain of glycosylation at P1451 (P = 0.1435); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237)
7:117307073:C:G,P13569,H1452D,0.256,Loss of MoRF binding (P = 0.0559); Gain of methylation at K1448 (P = 0.0909); Gain of helix (P = 0.132); Gain of phosphorylation at S1456 (P = 0.1808); Gain of ubiquitination at K1448 (P = 0.2067)
7:117307073:C:T,P13569,H1452Y,0.221,Gain of phosphorylation at H1452 (P = 0.0471); Gain of methylation at K1448 (P = 0.0666); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1636); Gain of loop (P = 0.2045)
7:117307074:A:C,P13569,H1452P,0.315,Gain of catalytic residue at P1451 (P = 0.0126); Gain of glycosylation at H1452 (P = 0.0157); Loss of MoRF binding (P = 0.0618); Gain of methylation at K1448 (P = 0.103); Gain of phosphorylation at S1456 (P = 0.1725)
7:117307074:A:G,P13569,H1452R,0.255,Gain of MoRF binding (P = 0.033); Gain of methylation at K1448 (P = 0.0518); Gain of glycosylation at P1451 (P = 0.0829); Gain of solvent accessibility (P = 0.1456); Loss of helix (P = 0.1706)
7:117307074:A:T,P13569,H1452L,0.216,Loss of methylation at K1457 (P = 0.0481); Loss of solvent accessibility (P = 0.0635); Loss of MoRF binding (P = 0.1612); Gain of helix (P = 0.1736); Loss of relative solvent accessibility (P = 0.1807)
7:117307075:C:A,P13569,H1452Q,0.198,Gain of methylation at K1448 (P = 0.064); Gain of MoRF binding (P = 0.1005); Gain of helix (P = 0.132); Loss of glycosylation at P1451 (P = 0.1559); Gain of loop (P = 0.2045)
7:117307075:C:G,P13569,H1452Q,0.198,Gain of methylation at K1448 (P = 0.064); Gain of MoRF binding (P = 0.1005); Gain of helix (P = 0.132); Loss of glycosylation at P1451 (P = 0.1559); Gain of loop (P = 0.2045)
7:117307076:C:G,P13569,R1453G,0.366,Loss of MoRF binding (P = 0.0073); Loss of methylation at K1457 (P = 0.0473); Loss of phosphorylation at S1456 (P = 0.0601); Loss of stability (P = 0.0798); Loss of glycosylation at P1451 (P = 0.089)
7:117307077:G:C,P13569,R1453P,0.348,Loss of MoRF binding (P = 3e-04); Gain of glycosylation at R1453 (P = 0.035); Gain of methylation at K1448 (P = 0.052); Loss of phosphorylation at S1456 (P = 0.0778); Loss of catalytic residue at R1453 (P = 0.1311)
7:117307077:G:T,P13569,R1453L,0.37,Loss of MoRF binding (P = 0.0067); Loss of methylation at K1457 (P = 0.0391); Loss of phosphorylation at S1455 (P = 0.0472); Loss of glycosylation at P1451 (P = 0.095); Loss of catalytic residue at R1453 (P = 0.1366)
7:117307079:A:C,P13569,N1454H,0.18,Gain of methylation at K1457 (P = 0.1056); Loss of MoRF binding (P = 0.1278); Gain of helix (P = 0.132); Gain of phosphorylation at S1456 (P = 0.217); Loss of loop (P = 0.2237)
7:117307079:A:G,P13569,N1454D,0.208,Loss of MoRF binding (P = 0.0453); Gain of helix (P = 0.062); Loss of methylation at K1457 (P = 0.0666); Gain of phosphorylation at S1456 (P = 0.1598); Gain of loop (P = 0.2045)
7:117307079:A:T,P13569,N1454Y,0.299,Gain of catalytic residue at L1449 (P = 0.053); Gain of phosphorylation at N1454 (P = 0.0792); Loss of methylation at K1457 (P = 0.1289); Gain of MoRF binding (P = 0.1433); Gain of helix (P = 0.1736)
7:117307080:A:C,P13569,N1454T,0.198,Gain of phosphorylation at N1454 (P = 0.0248); Gain of methylation at K1457 (P = 0.1167); Gain of MoRF binding (P = 0.1195); Gain of helix (P = 0.1736); Gain of catalytic residue at H1452 (P = 0.2038)
7:117307080:A:G,P13569,N1454S,0.254,Gain of phosphorylation at N1454 (P = 0.0073); Loss of methylation at K1457 (P = 0.1017); Gain of MoRF binding (P = 0.118); Gain of glycosylation at P1451 (P = 0.1199); Gain of helix (P = 0.132)
7:117307080:A:T,P13569,N1454I,0.292,Gain of helix (P = 0.062); Gain of MoRF binding (P = 0.0806); Loss of loop (P = 0.0986); Gain of methylation at K1457 (P = 0.1027); Loss of glycosylation at P1451 (P = 0.1161)
7:117307081:C:A,P13569,N1454K,0.222,Gain of MoRF binding (P = 0.0512); Gain of glycosylation at P1451 (P = 0.0672); Gain of methylation at N1454 (P = 0.08); Gain of phosphorylation at S1456 (P = 0.1396); Loss of helix (P = 0.1706)
7:117307081:C:G,P13569,N1454K,0.222,Gain of MoRF binding (P = 0.0512); Gain of glycosylation at P1451 (P = 0.0672); Gain of methylation at N1454 (P = 0.08); Gain of phosphorylation at S1456 (P = 0.1396); Loss of helix (P = 0.1706)
7:117307082:T:A,P13569,S1455T,0.144,Gain of methylation at K1457 (P = 0.0803); Loss of phosphorylation at S1456 (P = 0.1321); Loss of MoRF binding (P = 0.1441); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237)
7:117307082:T:C,P13569,S1455P,0.208,Loss of phosphorylation at S1455 (P = 0.0203); Gain of glycosylation at S1455 (P = 0.0268); Loss of MoRF binding (P = 0.0533); Gain of methylation at K1457 (P = 0.0642); Loss of helix (P = 0.1706)
7:117307082:T:G,P13569,S1455A,0.16,Loss of phosphorylation at S1455 (P = 0.0203); Gain of MoRF binding (P = 0.109); Gain of methylation at K1457 (P = 0.1131); Loss of solvent accessibility (P = 0.1473); Gain of helix (P = 0.1736)
7:117307083:C:T,P13569,S1455L,0.227,Loss of phosphorylation at S1455 (P = 0.0203); Loss of relative solvent accessibility (P = 0.0981); Gain of helix (P = 0.132); Loss of MoRF binding (P = 0.1385); Gain of methylation at K1457 (P = 0.1392)
7:117307085:A:C,P13569,S1456R,0.307,Gain of catalytic residue at S1456 (P = 0.0032); Gain of MoRF binding (P = 0.023); Loss of phosphorylation at S1456 (P = 0.0295); Gain of methylation at K1457 (P = 0.055); Gain of solvent accessibility (P = 0.0837)
7:117307085:A:G,P13569,S1456G,0.233,Loss of stability (P = 0.0272); Loss of phosphorylation at S1456 (P = 0.0295); Gain of glycosylation at S1455 (P = 0.066); Loss of MoRF binding (P = 0.1308); Loss of methylation at K1457 (P = 0.1389)
7:117307085:A:T,P13569,S1456C,0.275,Gain of methylation at K1457 (P = 0.0276); Loss of phosphorylation at S1456 (P = 0.0295); Loss of MoRF binding (P = 0.0711); Gain of helix (P = 0.132); Loss of stability (P = 0.1492)
7:117307086:G:A,P13569,S1456N,0.204,Loss of phosphorylation at S1456 (P = 0.0295); Loss of stability (P = 0.0689); Loss of catalytic residue at K1457 (P = 0.0731); Gain of methylation at K1457 (P = 0.0983); Gain of MoRF binding (P = 0.1398)
7:117307086:G:C,P13569,S1456T,0.192,Gain of methylation at K1457 (P = 0.0879); Loss of stability (P = 0.1315); Gain of MoRF binding (P = 0.1439); Loss of phosphorylation at S1460 (P = 0.157); Loss of helix (P = 0.1706)
7:117307086:G:T,P13569,S1456I,0.282,Gain of catalytic residue at S1456 (P = 0.0117); Loss of phosphorylation at S1456 (P = 0.0295); Gain of methylation at K1457 (P = 0.1057); Loss of glycosylation at P1451 (P = 0.118); Loss of disorder (P = 0.1245)
7:117307087:C:A,P13569,S1456R,0.307,Gain of catalytic residue at S1456 (P = 0.0032); Gain of MoRF binding (P = 0.023); Loss of phosphorylation at S1456 (P = 0.0295); Gain of methylation at K1457 (P = 0.055); Gain of solvent accessibility (P = 0.0837)
7:117307087:C:G,P13569,S1456R,0.307,Gain of catalytic residue at S1456 (P = 0.0032); Gain of MoRF binding (P = 0.023); Loss of phosphorylation at S1456 (P = 0.0295); Gain of methylation at K1457 (P = 0.055); Gain of solvent accessibility (P = 0.0837)
7:117307088:A:C,P13569,K1457Q,0.276,Loss of methylation at K1457 (P = 0.0171); Gain of ubiquitination at K1461 (P = 0.0261); Loss of MoRF binding (P = 0.0483); Loss of phosphorylation at S1455 (P = 0.1156); Loss of catalytic residue at K1457 (P = 0.1691)
7:117307088:A:G,P13569,K1457E,0.344,Loss of MoRF binding (P = 0.0028); Gain of ubiquitination at K1461 (P = 0.0121); Loss of methylation at K1457 (P = 0.0171); Loss of catalytic residue at K1457 (P = 0.0909); Loss of helix (P = 0.1706)
7:117307089:A:C,P13569,K1457T,0.335,Loss of methylation at K1457 (P = 0.0171); Gain of ubiquitination at K1461 (P = 0.0248); Gain of phosphorylation at K1457 (P = 0.0304); Loss of MoRF binding (P = 0.038); Gain of glycosylation at K1457 (P = 0.0645)
7:117307089:A:G,P13569,K1457R,0.217,Loss of methylation at K1457 (P = 0.0203); Gain of MoRF binding (P = 0.0663); Gain of phosphorylation at S1456 (P = 0.1624); Loss of relative solvent accessibility (P = 0.1967); Gain of helix (P = 0.2684)
7:117307089:A:T,P13569,K1457M,0.268,Loss of solvent accessibility (P = 0.01); Loss of methylation at K1457 (P = 0.0171); Gain of ubiquitination at K1461 (P = 0.0252); Loss of MoRF binding (P = 0.0653); Loss of relative solvent accessibility (P = 0.0676)
7:117307090:G:C,P13569,K1457N,0.267,Loss of methylation at K1457 (P = 0.0171); Gain of ubiquitination at K1461 (P = 0.0261); Loss of MoRF binding (P = 0.0377); Loss of phosphorylation at S1460 (P = 0.1072); Loss of solvent accessibility (P = 0.1177)
7:117307090:G:T,P13569,K1457N,0.267,Loss of methylation at K1457 (P = 0.0171); Gain of ubiquitination at K1461 (P = 0.0261); Loss of MoRF binding (P = 0.0377); Loss of phosphorylation at S1460 (P = 0.1072); Loss of solvent accessibility (P = 0.1177)
7:117307091:T:A,P13569,C1458S,0.323,Loss of methylation at K1459 (P = 0.0151); Gain of relative solvent accessibility (P = 0.0166); Gain of phosphorylation at C1458 (P = 0.0184); Loss of stability (P = 0.0281); Gain of solvent accessibility (P = 0.0488)
7:117307091:T:C,P13569,C1458R,0.345,Gain of solvent accessibility (P = 4e-04); Gain of MoRF binding (P = 0.0136); Gain of relative solvent accessibility (P = 0.0166); Loss of methylation at K1459 (P = 0.0197); Loss of stability (P = 0.0718)
7:117307091:T:G,P13569,C1458G,0.285,Loss of stability (P = 0.007); Loss of methylation at K1459 (P = 0.0151); Gain of relative solvent accessibility (P = 0.0166); Gain of MoRF binding (P = 0.0652); Gain of sheet (P = 0.1451)
7:117307092:G:A,P13569,C1458Y,0.309,Gain of solvent accessibility (P = 0.0018); Loss of methylation at K1459 (P = 0.0127); Gain of relative solvent accessibility (P = 0.0166); Gain of catalytic residue at P1462 (P = 0.073); Gain of MoRF binding (P = 0.0801)
7:117307092:G:C,P13569,C1458S,0.323,Loss of methylation at K1459 (P = 0.0151); Gain of relative solvent accessibility (P = 0.0166); Gain of phosphorylation at C1458 (P = 0.0184); Loss of stability (P = 0.0281); Gain of solvent accessibility (P = 0.0488)
7:117307092:G:T,P13569,C1458F,0.158,Loss of methylation at K1459 (P = 0.0306); Gain of MoRF binding (P = 0.0696); Gain of helix (P = 0.2684); Gain of phosphorylation at S1456 (P = 0.2834); Loss of stability (P = 0.2848)
7:117307093:C:G,P13569,C1458W,0.269,Loss of methylation at K1459 (P = 0.0172); Gain of MoRF binding (P = 0.0179); Loss of stability (P = 0.0737); Loss of helix (P = 0.1706); Gain of phosphorylation at S1456 (P = 0.2927)
7:117307094:A:C,P13569,K1459Q,0.295,Loss of methylation at K1459 (P = 0.007); Loss of catalytic residue at K1459 (P = 0.0248); Gain of ubiquitination at K1461 (P = 0.0289); Loss of MoRF binding (P = 0.056); Loss of phosphorylation at S1456 (P = 0.0993)
7:117307094:A:G,P13569,K1459E,0.382,Loss of MoRF binding (P = 0.0059); Loss of methylation at K1459 (P = 0.007); Loss of catalytic residue at K1459 (P = 0.0088); Gain of ubiquitination at K1461 (P = 0.0128); Gain of relative solvent accessibility (P = 0.1684)
7:117307095:A:C,P13569,K1459T,0.351,Loss of methylation at K1459 (P = 0.007); Loss of catalytic residue at K1459 (P = 0.0101); Gain of ubiquitination at K1461 (P = 0.0219); Gain of phosphorylation at K1459 (P = 0.0262); Gain of glycosylation at K1459 (P = 0.0458)
7:117307095:A:G,P13569,K1459R,0.242,Loss of methylation at K1459 (P = 0.0099); Gain of MoRF binding (P = 0.0693); Loss of helix (P = 0.1706); Gain of phosphorylation at S1456 (P = 0.212); Loss of ubiquitination at K1459 (P = 0.2167)
7:117307095:A:T,P13569,K1459M,0.306,Loss of methylation at K1459 (P = 0.007); Gain of ubiquitination at K1461 (P = 0.0252); Loss of MoRF binding (P = 0.0809); Loss of solvent accessibility (P = 0.086); Loss of phosphorylation at S1456 (P = 0.1271)
7:117307096:G:C,P13569,K1459N,0.32,Loss of methylation at K1459 (P = 0.007); Loss of catalytic residue at K1459 (P = 0.0246); Gain of ubiquitination at K1461 (P = 0.0289); Loss of MoRF binding (P = 0.0482); Loss of phosphorylation at S1456 (P = 0.1018)
7:117307096:G:T,P13569,K1459N,0.32,Loss of methylation at K1459 (P = 0.007); Loss of catalytic residue at K1459 (P = 0.0246); Gain of ubiquitination at K1461 (P = 0.0289); Loss of MoRF binding (P = 0.0482); Loss of phosphorylation at S1456 (P = 0.1018)
7:117307097:T:A,P13569,S1460T,0.133,Gain of catalytic residue at S1460 (P = 0.1191); Loss of phosphorylation at S1456 (P = 0.1329); Loss of MoRF binding (P = 0.1417); Gain of methylation at K1457 (P = 0.1475); Gain of loop (P = 0.2045)
7:117307097:T:C,P13569,S1460P,0.167,Gain of glycosylation at S1460 (P = 0.0162); Loss of phosphorylation at S1460 (P = 0.0262); Loss of MoRF binding (P = 0.059); Gain of methylation at K1457 (P = 0.1152); Gain of loop (P = 0.2045)
7:117307097:T:G,P13569,S1460A,0.127,Loss of phosphorylation at S1460 (P = 0.0262); Loss of methylation at K1457 (P = 0.0623); Gain of MoRF binding (P = 0.1234); Loss of helix (P = 0.2662); Gain of glycosylation at S1456 (P = 0.3099)
7:117307098:C:A,P13569,S1460Y,0.212,Loss of phosphorylation at S1460 (P = 0.0424); Loss of methylation at K1457 (P = 0.0514); Loss of MoRF binding (P = 0.1061); Gain of sheet (P = 0.1451); Loss of disorder (P = 0.2606)
7:117307098:C:G,P13569,S1460C,0.211,Gain of methylation at K1461 (P = 0.0154); Loss of phosphorylation at S1460 (P = 0.0262); Loss of MoRF binding (P = 0.0725); Gain of loop (P = 0.2045); Loss of helix (P = 0.2662)
7:117307098:C:T,P13569,S1460F,0.226,Loss of phosphorylation at S1460 (P = 0.0262); Gain of methylation at K1461 (P = 0.0463); Loss of MoRF binding (P = 0.1075); Gain of sheet (P = 0.1451); Loss of helix (P = 0.2662)
7:117307100:A:C,P13569,K1461Q,0.249,Loss of catalytic residue at K1461 (P = 0.034); Loss of MoRF binding (P = 0.0537); Loss of phosphorylation at S1456 (P = 0.1211); Gain of methylation at K1457 (P = 0.139); Loss of helix (P = 0.1706)
7:117307100:A:G,P13569,K1461E,0.293,Loss of MoRF binding (P = 0.0077); Gain of ubiquitination at K1459 (P = 0.0177); Loss of catalytic residue at K1461 (P = 0.0438); Gain of methylation at K1457 (P = 0.1061); Loss of helix (P = 0.1706)
7:117307101:A:C,P13569,K1461T,0.349,Loss of catalytic residue at K1461 (P = 0.0076); Gain of phosphorylation at K1461 (P = 0.021); Loss of MoRF binding (P = 0.0473); Gain of methylation at K1457 (P = 0.0936); Gain of ubiquitination at K1459 (P = 0.1194)
7:117307101:A:G,P13569,K1461R,0.171,Gain of MoRF binding (P = 0.0638); Loss of methylation at K1457 (P = 0.0933); Gain of helix (P = 0.1736); Gain of phosphorylation at S1460 (P = 0.1976); Gain of loop (P = 0.2045)
7:117307101:A:T,P13569,K1461M,0.298,Loss of MoRF binding (P = 0.0717); Gain of methylation at K1457 (P = 0.1427); Loss of phosphorylation at S1456 (P = 0.1427); Gain of ubiquitination at K1459 (P = 0.148); Loss of helix (P = 0.1706)
7:117307102:G:C,P13569,K1461N,0.336,Loss of catalytic residue at K1461 (P = 0.0059); Loss of MoRF binding (P = 0.0478); Loss of phosphorylation at S1456 (P = 0.1075); Loss of methylation at K1457 (P = 0.1141); Gain of ubiquitination at K1459 (P = 0.148)
7:117307102:G:T,P13569,K1461N,0.336,Loss of catalytic residue at K1461 (P = 0.0059); Loss of MoRF binding (P = 0.0478); Loss of phosphorylation at S1456 (P = 0.1075); Loss of methylation at K1457 (P = 0.1141); Gain of ubiquitination at K1459 (P = 0.148)
7:117307103:C:A,P13569,P1462T,0.201,Gain of phosphorylation at P1462 (P = 0.028); Gain of MoRF binding (P = 0.0547); Gain of methylation at K1457 (P = 0.098); Gain of sheet (P = 0.1451); Loss of helix (P = 0.2022)
7:117307103:C:G,P13569,P1462A,0.186,Gain of MoRF binding (P = 0.051); Loss of methylation at K1457 (P = 0.0589); Loss of catalytic residue at K1459 (P = 0.2253); Loss of phosphorylation at S1460 (P = 0.2562); Loss of helix (P = 0.2662)
7:117307103:C:T,P13569,P1462S,0.211,Gain of phosphorylation at P1462 (P = 0.0391); Gain of MoRF binding (P = 0.0537); Gain of methylation at K1457 (P = 0.0888); Gain of sheet (P = 0.1451); Gain of catalytic residue at P1462 (P = 0.1698)
7:117307104:C:A,P13569,P1462H,0.193,Gain of MoRF binding (P = 0.0612); Loss of methylation at K1457 (P = 0.0911); Loss of loop (P = 0.0986); Gain of sheet (P = 0.1451); Loss of phosphorylation at S1460 (P = 0.1731)
7:117307104:C:G,P13569,P1462R,0.252,Gain of MoRF binding (P = 0.0066); Gain of sheet (P = 0.0477); Gain of methylation at K1457 (P = 0.1303); Loss of helix (P = 0.2022); Gain of loop (P = 0.2045)
7:117307104:C:T,P13569,P1462L,0.283,Gain of sheet (P = 0.0477); Loss of methylation at K1457 (P = 0.0495); Gain of MoRF binding (P = 0.0552); Loss of loop (P = 0.0986); Loss of phosphorylation at S1460 (P = 0.1615)
7:117307106:C:A,P13569,Q1463K,0.192,Gain of ubiquitination at Q1463 (P = 0.0311); Gain of glycosylation at P1462 (P = 0.0427); Gain of MoRF binding (P = 0.0518); Gain of catalytic residue at Q1463 (P = 0.156); Gain of helix (P = 0.1736)
7:117307106:C:G,P13569,Q1463E,0.234,Gain of ubiquitination at K1461 (P = 0.0408); Gain of sheet (P = 0.0477); Loss of MoRF binding (P = 0.0565); Loss of loop (P = 0.0986); Gain of relative solvent accessibility (P = 0.1894)
7:117307107:A:C,P13569,Q1463P,0.167,Gain of catalytic residue at P1462 (P = 0.0112); Gain of glycosylation at Q1463 (P = 0.0426); Loss of MoRF binding (P = 0.0658); Gain of loop (P = 0.2045); Gain of phosphorylation at S1460 (P = 0.217)
7:117307107:A:G,P13569,Q1463R,0.118,Gain of MoRF binding (P = 0.0245); Gain of glycosylation at P1462 (P = 0.1167); Gain of phosphorylation at S1460 (P = 0.1603); Loss of methylation at K1459 (P = 0.1707); Gain of helix (P = 0.1736)
7:117307107:A:T,P13569,Q1463L,0.209,Gain of stability (P = 0.0727); Loss of methylation at K1459 (P = 0.0763); Loss of MoRF binding (P = 0.1129); Gain of catalytic residue at Q1463 (P = 0.1452); Gain of helix (P = 0.1736)
7:117307108:G:C,P13569,Q1463H,0.089,Loss of MoRF binding (P = 0.1089); Gain of helix (P = 0.1736); Gain of glycosylation at K1468 (P = 0.1926); Gain of loop (P = 0.2045); Loss of methylation at K1459 (P = 0.2875)
7:117307108:G:T,P13569,Q1463H,0.089,Loss of MoRF binding (P = 0.1089); Gain of helix (P = 0.1736); Gain of glycosylation at K1468 (P = 0.1926); Gain of loop (P = 0.2045); Loss of methylation at K1459 (P = 0.2875)
7:117307109:A:C,P13569,I1464L,0.158,Loss of MoRF binding (P = 0.1258); Loss of methylation at K1459 (P = 0.1649); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363)
7:117307109:A:G,P13569,I1464V,0.133,Gain of MoRF binding (P = 0.0985); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363); Loss of glycosylation at K1468 (P = 0.2766)
7:117307109:A:T,P13569,I1464F,0.118,Loss of MoRF binding (P = 0.1055); Gain of loop (P = 0.2045); Gain of catalytic residue at P1462 (P = 0.2361); Gain of relative solvent accessibility (P = 0.2363); Loss of methylation at K1459 (P = 0.2506)
7:117307110:T:A,P13569,I1464N,0.137,Gain of MoRF binding (P = 0.0872); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of relative solvent accessibility (P = 0.2363); Loss of methylation at K1459 (P = 0.2781)
7:117307110:T:C,P13569,I1464T,0.149,Gain of phosphorylation at I1464 (P = 0.0321); Gain of MoRF binding (P = 0.107); Gain of helix (P = 0.1736); Loss of stability (P = 0.1755); Gain of loop (P = 0.2045)
7:117307110:T:G,P13569,I1464S,0.218,Gain of phosphorylation at I1464 (P = 0.0152); Gain of loop (P = 0.0851); Gain of MoRF binding (P = 0.0946); Gain of relative solvent accessibility (P = 0.1259); Gain of helix (P = 0.1736)
7:117307111:T:G,P13569,I1464M,0.171,Gain of MoRF binding (P = 0.0737); Gain of helix (P = 0.1736); Gain of loop (P = 0.2045); Gain of glycosylation at K1468 (P = 0.2683); Gain of phosphorylation at S1460 (P = 0.2859)
7:117307112:G:A,P13569,A1465T,0.154,Gain of phosphorylation at A1465 (P = 0.0612); Gain of glycosylation at A1465 (P = 0.0767); Gain of MoRF binding (P = 0.1381); Gain of methylation at K1461 (P = 0.1799); Gain of loop (P = 0.2045)
7:117307112:G:C,P13569,A1465P,0.21,Gain of glycosylation at A1465 (P = 0.069); Loss of MoRF binding (P = 0.0877); Gain of methylation at K1461 (P = 0.1854); Gain of loop (P = 0.2045); Gain of phosphorylation at S1460 (P = 0.2598)
7:117307112:G:T,P13569,A1465S,0.159,Gain of phosphorylation at A1465 (P = 0.0124); Gain of methylation at K1461 (P = 0.1053); Gain of MoRF binding (P = 0.1149); Loss of helix (P = 0.2022); Loss of glycosylation at K1468 (P = 0.2382)
7:117307113:C:A,P13569,A1465D,0.213,Gain of ubiquitination at K1461 (P = 0.0419); Loss of MoRF binding (P = 0.0808); Gain of helix (P = 0.1736); Loss of loop (P = 0.2237); Gain of solvent accessibility (P = 0.2291)
7:117307113:C:G,P13569,A1465G,0.117,Gain of helix (P = 0.0854); Loss of MoRF binding (P = 0.1502); Gain of glycosylation at K1468 (P = 0.22); Loss of loop (P = 0.2237); Gain of catalytic residue at I1464 (P = 0.2423)
7:117307113:C:T,P13569,A1465V,0.31,Gain of catalytic residue at A1465 (P = 0.0145); Gain of MoRF binding (P = 0.1402); Loss of relative solvent accessibility (P = 0.1903); Gain of sheet (P = 0.1945); Loss of helix (P = 0.2022)
7:117307115:G:A,P13569,A1466T,0.139,Gain of phosphorylation at A1466 (P = 0.0564); Gain of methylation at K1461 (P = 0.1489); Loss of stability (P = 0.1512); Gain of MoRF binding (P = 0.1797); Loss of helix (P = 0.2022)
7:117307115:G:C,P13569,A1466P,0.244,Gain of catalytic residue at A1466 (P = 0.0254); Loss of stability (P = 0.0543); Gain of phosphorylation at T1471 (P = 0.0985); Loss of MoRF binding (P = 0.116); Gain of methylation at K1461 (P = 0.128)
7:117307115:G:T,P13569,A1466S,0.156,Gain of phosphorylation at A1466 (P = 0.027); Gain of methylation at K1461 (P = 0.0731); Gain of MoRF binding (P = 0.1488); Loss of stability (P = 0.1592); Loss of helix (P = 0.2022)
7:117307116:C:A,P13569,A1466D,0.194,Gain of ubiquitination at K1461 (P = 0.0419); Loss of helix (P = 0.0626); Gain of loop (P = 0.069); Loss of MoRF binding (P = 0.1017); Gain of solvent accessibility (P = 0.1422)
7:117307116:C:G,P13569,A1466G,0.149,Loss of stability (P = 0.0314); Loss of helix (P = 0.0626); Gain of catalytic residue at P1462 (P = 0.0721); Gain of glycosylation at K1468 (P = 0.1357); Gain of sheet (P = 0.1451)
7:117307116:C:T,P13569,A1466V,0.195,Loss of helix (P = 0.1299); Gain of MoRF binding (P = 0.1687); Gain of sheet (P = 0.1945); Gain of methylation at K1461 (P = 0.2451); Loss of glycosylation at K1468 (P = 0.2518)
7:117307118:C:A,P13569,L1467M,0.227,Gain of phosphorylation at T1471 (P = 0.1028); Gain of MoRF binding (P = 0.1313); Loss of stability (P = 0.1515); Loss of sheet (P = 0.1907); Loss of helix (P = 0.2022)
7:117307118:C:G,P13569,L1467V,0.213,Gain of methylation at K1468 (P = 0.0475); Loss of stability (P = 0.0736); Gain of phosphorylation at T1471 (P = 0.1147); Gain of MoRF binding (P = 0.1767); Loss of sheet (P = 0.1907)
7:117307119:T:A,P13569,L1467Q,0.227,Loss of stability (P = 0.0213); Gain of phosphorylation at T1471 (P = 0.1063); Loss of sheet (P = 0.1907); Gain of MoRF binding (P = 0.2016); Gain of loop (P = 0.2045)
7:117307119:T:C,P13569,L1467P,0.303,Loss of stability (P = 0.005); Gain of glycosylation at L1467 (P = 0.0276); Gain of phosphorylation at T1471 (P = 0.0797); Gain of helix (P = 0.1736); Loss of sheet (P = 0.1907)
7:117307119:T:G,P13569,L1467R,0.269,Loss of stability (P = 0.0189); Gain of MoRF binding (P = 0.0285); Gain of solvent accessibility (P = 0.0766); Gain of phosphorylation at T1471 (P = 0.0961); Gain of relative solvent accessibility (P = 0.1012)
7:117307121:A:C,P13569,K1468Q,0.217,Loss of ubiquitination at K1468 (P = 0.002); Loss of glycosylation at K1468 (P = 0.0595); Loss of phosphorylation at T1471 (P = 0.1499); Gain of sheet (P = 0.1945); Loss of loop (P = 0.2237)
7:117307121:A:G,P13569,K1468E,0.267,Loss of ubiquitination at K1468 (P = 0.002); Loss of helix (P = 0.0068); Gain of loop (P = 0.0079); Gain of sheet (P = 0.0221); Loss of glycosylation at K1468 (P = 0.0595)
7:117307122:A:C,P13569,K1468T,0.24,Loss of ubiquitination at K1468 (P = 0.002); Gain of phosphorylation at K1468 (P = 0.0845); Loss of solvent accessibility (P = 0.1144); Loss of glycosylation at K1468 (P = 0.121); Loss of loop (P = 0.2237)
7:117307122:A:G,P13569,K1468R,0.223,Loss of ubiquitination at K1468 (P = 0.002); Loss of glycosylation at K1468 (P = 0.0595); Gain of helix (P = 0.0854); Gain of phosphorylation at T1471 (P = 0.1145); Gain of MoRF binding (P = 0.2213)
7:117307122:A:T,P13569,K1468I,0.392,Loss of ubiquitination at K1468 (P = 0.002); Loss of solvent accessibility (P = 0.0187); Loss of loop (P = 0.0374); Loss of glycosylation at K1468 (P = 0.0595); Loss of helix (P = 0.079)
7:117307123:A:C,P13569,K1468N,0.241,Loss of ubiquitination at K1468 (P = 0.002); Loss of glycosylation at K1468 (P = 0.0595); Gain of helix (P = 0.0854); Loss of phosphorylation at T1471 (P = 0.1134); Gain of loop (P = 0.2045)
7:117307123:A:T,P13569,K1468N,0.241,Loss of ubiquitination at K1468 (P = 0.002); Loss of glycosylation at K1468 (P = 0.0595); Gain of helix (P = 0.0854); Loss of phosphorylation at T1471 (P = 0.1134); Gain of loop (P = 0.2045)
7:117307124:G:A,P13569,E1469K,0.28,Gain of ubiquitination at E1469 (P = 0.0037); Gain of glycosylation at E1469 (P = 0.0585); Gain of MoRF binding (P = 0.0606); Gain of phosphorylation at T1471 (P = 0.1472); Loss of helix (P = 0.2022)
7:117307124:G:C,P13569,E1469Q,0.146,Loss of loop (P = 0.1242); Loss of sheet (P = 0.1907); Gain of helix (P = 0.2059); Loss of phosphorylation at T1471 (P = 0.2121); Gain of MoRF binding (P = 0.222)
7:117307125:A:C,P13569,E1469A,0.205,Loss of solvent accessibility (P = 0.0404); Loss of helix (P = 0.0626); Loss of phosphorylation at T1471 (P = 0.1878); Gain of sheet (P = 0.1945); Gain of loop (P = 0.2045)
7:117307125:A:G,P13569,E1469G,0.232,Loss of solvent accessibility (P = 0.0387); Loss of stability (P = 0.1623); Gain of glycosylation at K1468 (P = 0.1815); Loss of phosphorylation at T1471 (P = 0.1868); Loss of sheet (P = 0.1907)
7:117307125:A:T,P13569,E1469V,0.296,Loss of helix (P = 0.028); Gain of loop (P = 0.069); Loss of solvent accessibility (P = 0.1144); Loss of phosphorylation at T1471 (P = 0.1381); Loss of glycosylation at K1468 (P = 0.1544)
7:117307126:G:C,P13569,E1469D,0.159,Gain of phosphorylation at T1471 (P = 0.1735); Loss of sheet (P = 0.1907); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897); Loss of glycosylation at K1468 (P = 0.2991)
7:117307126:G:T,P13569,E1469D,0.159,Gain of phosphorylation at T1471 (P = 0.1735); Loss of sheet (P = 0.1907); Gain of helix (P = 0.2294); Loss of loop (P = 0.2897); Loss of glycosylation at K1468 (P = 0.2991)
7:117307127:G:A,P13569,E1470K,0.26,Gain of ubiquitination at E1470 (P = 0.0025); Gain of glycosylation at E1470 (P = 0.0806); Gain of MoRF binding (P = 0.1461); Loss of helix (P = 0.1706); Gain of phosphorylation at T1471 (P = 0.1794)
7:117307127:G:C,P13569,E1470Q,0.123,Loss of helix (P = 0.1706); Loss of glycosylation at K1468 (P = 0.2248); Gain of phosphorylation at T1471 (P = 0.2457); Gain of methylation at K1468 (P = 0.3176); Gain of MoRF binding (P = 0.3409)
7:117307128:A:C,P13569,E1470A,0.176,Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Gain of relative solvent accessibility (P = 0.1684); Gain of phosphorylation at T1471 (P = 0.2378); Gain of glycosylation at K1468 (P = 0.2777)
7:117307128:A:G,P13569,E1470G,0.215,Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Loss of stability (P = 0.0611); Loss of solvent accessibility (P = 0.1551); Gain of phosphorylation at T1471 (P = 0.2457)
7:117307128:A:T,P13569,E1470V,0.222,Loss of helix (P = 0.0167); Gain of loop (P = 0.0435); Loss of solvent accessibility (P = 0.0509); Loss of relative solvent accessibility (P = 0.114); Loss of phosphorylation at T1471 (P = 0.2093)
7:117307129:G:C,P13569,E1470D,0.1,Loss of helix (P = 0.0626); Gain of phosphorylation at T1471 (P = 0.1828); Loss of loop (P = 0.2237); Loss of glycosylation at K1468 (P = 0.2386); Loss of solvent accessibility (P = 0.322)
7:117307129:G:T,P13569,E1470D,0.1,Loss of helix (P = 0.0626); Gain of phosphorylation at T1471 (P = 0.1828); Loss of loop (P = 0.2237); Loss of glycosylation at K1468 (P = 0.2386); Loss of solvent accessibility (P = 0.322)
7:117307130:A:C,P13569,T1471P,0.263,Gain of glycosylation at T1471 (P = 0.0155); Loss of phosphorylation at T1471 (P = 0.0445); Loss of helix (P = 0.079); Gain of loop (P = 0.1069); Gain of methylation at K1468 (P = 0.385)
7:117307130:A:G,P13569,T1471A,0.239,Loss of phosphorylation at T1471 (P = 0.0445); Loss of helix (P = 0.0626); Gain of loop (P = 0.2754); Gain of glycosylation at K1468 (P = 0.324); Gain of ubiquitination at K1468 (P = 0.386)
7:117307130:A:T,P13569,T1471S,0.224,Gain of phosphorylation at T1471 (P = 0.0675); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of glycosylation at K1468 (P = 0.3111); Gain of catalytic residue at L1467 (P = 0.3342)
7:117307131:C:A,P13569,T1471K,0.339,Gain of ubiquitination at T1471 (P = 0.0037); Gain of solvent accessibility (P = 0.012); Gain of relative solvent accessibility (P = 0.0215); Loss of helix (P = 0.028); Gain of glycosylation at T1471 (P = 0.0382)
7:117307131:C:G,P13569,T1471R,0.28,Loss of phosphorylation at T1471 (P = 0.0445); Gain of glycosylation at K1468 (P = 0.0559); Gain of solvent accessibility (P = 0.0584); Loss of helix (P = 0.0626); Gain of loop (P = 0.069)
7:117307131:C:T,P13569,T1471I,0.26,Loss of phosphorylation at T1471 (P = 0.0445); Loss of helix (P = 0.1706); Loss of loop (P = 0.2237); Loss of glycosylation at K1468 (P = 0.2623); Loss of ubiquitination at K1468 (P = 0.3776)
7:117307133:G:A,P13569,E1472K,0.314,Gain of ubiquitination at E1472 (P = 0.0018); Gain of glycosylation at E1472 (P = 0.0819); Loss of helix (P = 0.1299); Gain of phosphorylation at T1471 (P = 0.1794); Loss of loop (P = 0.2897)
7:117307133:G:C,P13569,E1472Q,0.183,Loss of helix (P = 0.1706); Loss of phosphorylation at T1471 (P = 0.2013); Loss of glycosylation at K1468 (P = 0.292); Loss of ubiquitination at K1468 (P = 0.3776); Loss of methylation at K1468 (P = 0.4303)
7:117307134:A:C,P13569,E1472A,0.24,Loss of helix (P = 0.1706); Loss of solvent accessibility (P = 0.1744); Gain of glycosylation at K1468 (P = 0.2323); Gain of phosphorylation at T1471 (P = 0.2393); Gain of loop (P = 0.2754)
7:117307134:A:G,P13569,E1472G,0.259,Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1744); Gain of glycosylation at K1468 (P = 0.1854); Gain of phosphorylation at T1471 (P = 0.2471); Gain of loop (P = 0.2754)
7:117307134:A:T,P13569,E1472V,0.295,Gain of helix (P = 0.0496); Loss of solvent accessibility (P = 0.1744); Loss of phosphorylation at T1471 (P = 0.2052); Loss of loop (P = 0.2237); Gain of stability (P = 0.2992)
7:117307135:A:C,P13569,E1472D,0.182,Loss of helix (P = 0.1299); Gain of phosphorylation at T1471 (P = 0.1815); Gain of loop (P = 0.2754); Loss of glycosylation at K1468 (P = 0.316); Loss of ubiquitination at K1468 (P = 0.3833)
7:117307135:A:T,P13569,E1472D,0.182,Loss of helix (P = 0.1299); Gain of phosphorylation at T1471 (P = 0.1815); Gain of loop (P = 0.2754); Loss of glycosylation at K1468 (P = 0.316); Loss of ubiquitination at K1468 (P = 0.3833)
7:117307136:G:A,P13569,E1473K,0.29,Gain of ubiquitination at E1473 (P = 0.0042); Gain of glycosylation at E1473 (P = 0.0683); Gain of methylation at E1473 (P = 0.0857); Loss of helix (P = 0.1299); Gain of phosphorylation at T1471 (P = 0.1488)
7:117307136:G:C,P13569,E1473Q,0.182,Loss of helix (P = 0.0558); Gain of loop (P = 0.1069); Loss of phosphorylation at T1478 (P = 0.1717); Loss of glycosylation at T1478 (P = 0.1936); Gain of sheet (P = 0.3763)
7:117307137:A:C,P13569,E1473A,0.187,Loss of helix (P = 0.0558); Loss of phosphorylation at T1478 (P = 0.1311); Loss of solvent accessibility (P = 0.239); Loss of glycosylation at K1468 (P = 0.25); Gain of loop (P = 0.2754)
7:117307137:A:G,P13569,E1473G,0.219,Loss of helix (P = 0.028); Gain of loop (P = 0.1069); Loss of stability (P = 0.1338); Loss of phosphorylation at T1478 (P = 0.1468); Loss of solvent accessibility (P = 0.1551)
7:117307137:A:T,P13569,E1473V,0.269,Loss of helix (P = 0.0167); Gain of loop (P = 0.069); Loss of phosphorylation at T1478 (P = 0.1131); Loss of glycosylation at K1468 (P = 0.1699); Loss of solvent accessibility (P = 0.239)
7:117307138:A:C,P13569,E1473D,0.159,Loss of helix (P = 0.1299); Gain of phosphorylation at T1471 (P = 0.1735); Loss of loop (P = 0.2237); Loss of glycosylation at T1478 (P = 0.3042); Loss of ubiquitination at K1468 (P = 0.3833)
7:117307138:A:T,P13569,E1473D,0.159,Loss of helix (P = 0.1299); Gain of phosphorylation at T1471 (P = 0.1735); Loss of loop (P = 0.2237); Loss of glycosylation at T1478 (P = 0.3042); Loss of ubiquitination at K1468 (P = 0.3833)
7:117307139:G:A,P13569,E1474K,0.316,Gain of ubiquitination at E1474 (P = 0.0039); Gain of methylation at E1474 (P = 0.0538); Loss of stability (P = 0.1363); Gain of phosphorylation at T1471 (P = 0.1704); Gain of glycosylation at E1474 (P = 0.1748)
7:117307139:G:C,P13569,E1474Q,0.192,Loss of phosphorylation at T1478 (P = 0.1618); Loss of glycosylation at T1478 (P = 0.209); Loss of helix (P = 0.2271); Loss of stability (P = 0.4366); Gain of loop (P = 0.4661)
7:117307140:A:C,P13569,E1474A,0.2,Loss of helix (P = 0.079); Loss of glycosylation at T1478 (P = 0.1224); Loss of phosphorylation at T1478 (P = 0.1775); Loss of stability (P = 0.2486); Gain of loop (P = 0.2754)
7:117307140:A:G,P13569,E1474G,0.26,Loss of helix (P = 0.028); Gain of loop (P = 0.0312); Loss of stability (P = 0.0456); Loss of glycosylation at T1478 (P = 0.135); Loss of phosphorylation at T1478 (P = 0.1997)
7:117307140:A:T,P13569,E1474V,0.296,Loss of helix (P = 0.028); Loss of glycosylation at T1478 (P = 0.098); Gain of loop (P = 0.1069); Loss of phosphorylation at T1478 (P = 0.1587); Gain of catalytic residue at D1477 (P = 0.1791)
7:117307141:G:C,P13569,E1474D,0.191,Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Gain of phosphorylation at T1471 (P = 0.1771); Gain of relative solvent accessibility (P = 0.2363); Gain of glycosylation at T1478 (P = 0.2899)
7:117307141:G:T,P13569,E1474D,0.191,Loss of helix (P = 0.0626); Gain of loop (P = 0.1069); Gain of phosphorylation at T1471 (P = 0.1771); Gain of relative solvent accessibility (P = 0.2363); Gain of glycosylation at T1478 (P = 0.2899)
7:117307142:G:A,P13569,V1475M,0.191,Loss of helix (P = 0.1299); Gain of phosphorylation at T1471 (P = 0.1682); Gain of loop (P = 0.2045); Loss of glycosylation at T1478 (P = 0.2593); Loss of stability (P = 0.4368)
7:117307142:G:C,P13569,V1475L,0.216,Loss of phosphorylation at T1478 (P = 0.1062); Loss of glycosylation at T1478 (P = 0.2639); Gain of helix (P = 0.2684); Loss of loop (P = 0.3664); Loss of sheet (P = 0.6423)
7:117307143:T:A,P13569,V1475E,0.223,Loss of helix (P = 0.0167); Gain of loop (P = 0.0195); Gain of relative solvent accessibility (P = 0.09); Gain of solvent accessibility (P = 0.0971); Gain of phosphorylation at T1471 (P = 0.1064)
7:117307143:T:C,P13569,V1475A,0.203,Loss of helix (P = 0.028); Gain of loop (P = 0.0435); Loss of stability (P = 0.1247); Gain of phosphorylation at T1478 (P = 0.1381); Gain of glycosylation at T1478 (P = 0.2766)
7:117307143:T:G,P13569,V1475G,0.247,Loss of helix (P = 0.0093); Loss of stability (P = 0.0123); Gain of loop (P = 0.0195); Gain of relative solvent accessibility (P = 0.0479); Gain of sheet (P = 0.0507)
7:117307145:C:A,P13569,Q1476K,0.221,Gain of ubiquitination at Q1476 (P = 0.006); Gain of glycosylation at Q1476 (P = 0.0801); Gain of phosphorylation at T1478 (P = 0.129); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
7:117307145:C:G,P13569,Q1476E,0.131,Gain of loop (P = 0.069); Gain of phosphorylation at T1471 (P = 0.1151); Loss of helix (P = 0.1299); Gain of glycosylation at T1478 (P = 0.2521); Loss of sheet (P = 0.6423)
7:117307146:A:C,P13569,Q1476P,0.157,Gain of glycosylation at T1478 (P = 0.0613); Gain of phosphorylation at T1478 (P = 0.1122); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of solvent accessibility (P = 0.2953)
7:117307146:A:G,P13569,Q1476R,0.125,Gain of phosphorylation at T1478 (P = 0.1011); Gain of helix (P = 0.132); Loss of loop (P = 0.2237); Loss of glycosylation at T1478 (P = 0.2742); Gain of solvent accessibility (P = 0.3194)
7:117307146:A:T,P13569,Q1476L,0.254,Gain of sheet (P = 0.0166); Loss of helix (P = 0.0196); Loss of loop (P = 0.0288); Loss of solvent accessibility (P = 0.1434); Loss of phosphorylation at T1478 (P = 0.1493)
7:117307147:A:C,P13569,Q1476H,0.128,Gain of glycosylation at T1478 (P = 0.1124); Loss of helix (P = 0.1299); Loss of loop (P = 0.2237); Gain of phosphorylation at T1471 (P = 0.2354); Gain of catalytic residue at D1477 (P = 0.3257)
7:117307147:A:T,P13569,Q1476H,0.128,Gain of glycosylation at T1478 (P = 0.1124); Loss of helix (P = 0.1299); Loss of loop (P = 0.2237); Gain of phosphorylation at T1471 (P = 0.2354); Gain of catalytic residue at D1477 (P = 0.3257)
7:117307148:G:A,P13569,D1477N,0.326,Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of phosphorylation at T1478 (P = 0.088); Loss of glycosylation at T1478 (P = 0.2874); Loss of solvent accessibility (P = 0.4995)
7:117307148:G:C,P13569,D1477H,0.361,Loss of phosphorylation at T1478 (P = 0.0949); Loss of helix (P = 0.1299); Loss of glycosylation at T1478 (P = 0.1491); Gain of relative solvent accessibility (P = 0.1684); Gain of solvent accessibility (P = 0.1708)
7:117307148:G:T,P13569,D1477Y,0.46,Loss of helix (P = 0.0196); Gain of phosphorylation at D1477 (P = 0.0267); Gain of loop (P = 0.069); Loss of solvent accessibility (P = 0.0807); Loss of relative solvent accessibility (P = 0.0995)
7:117307149:A:C,P13569,D1477A,0.375,Loss of helix (P = 0.028); Gain of loop (P = 0.069); Loss of solvent accessibility (P = 0.0769); Loss of relative solvent accessibility (P = 0.114); Loss of phosphorylation at T1478 (P = 0.1269)
7:117307149:A:G,P13569,D1477G,0.385,Loss of helix (P = 0.0196); Gain of loop (P = 0.0435); Loss of solvent accessibility (P = 0.0703); Loss of relative solvent accessibility (P = 0.114); Loss of phosphorylation at T1478 (P = 0.1493)
7:117307149:A:T,P13569,D1477V,0.433,Loss of helix (P = 0.0196); Gain of loop (P = 0.0435); Loss of solvent accessibility (P = 0.0635); Loss of phosphorylation at T1478 (P = 0.0893); Loss of relative solvent accessibility (P = 0.0995)
7:117307150:T:A,P13569,D1477E,0.329,Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.1376); Loss of glycosylation at T1478 (P = 0.158); Gain of relative solvent accessibility (P = 0.1684); Gain of loop (P = 0.2045)
7:117307150:T:G,P13569,D1477E,0.329,Gain of helix (P = 0.132); Gain of solvent accessibility (P = 0.1376); Loss of glycosylation at T1478 (P = 0.158); Gain of relative solvent accessibility (P = 0.1684); Gain of loop (P = 0.2045)
7:117307151:A:C,P13569,T1478P,0.18,Loss of phosphorylation at T1478 (P = 0.0339); Loss of glycosylation at T1478 (P = 0.0727); Loss of helix (P = 0.079); Gain of loop (P = 0.0851); Loss of stability (P = 0.2885)
7:117307151:A:G,P13569,T1478A,0.167,Loss of phosphorylation at T1478 (P = 0.0339); Loss of glycosylation at T1478 (P = 0.057); Gain of helix (P = 0.132); Loss of loop (P = 0.2897); Loss of stability (P = 0.3521)
7:117307151:A:T,P13569,T1478S,0.157,Gain of phosphorylation at T1478 (P = 0.0839); Gain of relative solvent accessibility (P = 0.1066); Loss of helix (P = 0.1299); Loss of glycosylation at T1478 (P = 0.2026); Gain of loop (P = 0.2754)
7:117307152:C:A,P13569,T1478K,0.23,Gain of ubiquitination at T1478 (P = 0.0045); Gain of solvent accessibility (P = 0.0086); Gain of relative solvent accessibility (P = 0.0249); Loss of phosphorylation at T1478 (P = 0.0339); Gain of helix (P = 0.0854)
7:117307152:C:G,P13569,T1478R,0.184,Loss of phosphorylation at T1478 (P = 0.0339); Gain of solvent accessibility (P = 0.0503); Loss of glycosylation at T1478 (P = 0.057); Gain of relative solvent accessibility (P = 0.1066); Gain of helix (P = 0.132)
7:117307152:C:T,P13569,T1478I,0.238,Loss of phosphorylation at T1478 (P = 0.0339); Loss of glycosylation at T1478 (P = 0.057); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Gain of sheet (P = 0.6509)
7:117307154:A:G,P13569,R1479G,0.205,Loss of helix (P = 0.0093); Loss of solvent accessibility (P = 0.0329); Loss of stability (P = 0.041); Gain of loop (P = 0.069); Gain of relative solvent accessibility (P = 0.1571)
7:117307154:A:T,P13569,R1479W,0.312,Loss of solvent accessibility (P = 0.0217); Loss of helix (P = 0.0558); Loss of phosphorylation at T1478 (P = 0.0754); Loss of glycosylation at T1478 (P = 0.1396); Loss of relative solvent accessibility (P = 0.1807)
7:117307155:G:C,P13569,R1479T,0.191,Gain of glycosylation at R1479 (P = 0.0229); Loss of helix (P = 0.028); Gain of phosphorylation at R1479 (P = 0.0685); Gain of loop (P = 0.069); Loss of stability (P = 0.1478)
7:117307155:G:T,P13569,R1479M,0.284,Loss of solvent accessibility (P = 0.0022); Gain of catalytic residue at V1475 (P = 0.0139); Loss of helix (P = 0.0167); Loss of relative solvent accessibility (P = 0.0676); Loss of loop (P = 0.0804)
7:117307156:G:C,P13569,R1479S,0.195,Gain of phosphorylation at R1479 (P = 0.021); Gain of glycosylation at R1479 (P = 0.0542); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of stability (P = 0.1316)
7:117307156:G:T,P13569,R1479S,0.195,Gain of phosphorylation at R1479 (P = 0.021); Gain of glycosylation at R1479 (P = 0.0542); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Loss of stability (P = 0.1316)
7:117307157:C:A,P13569,L1480I,0.354,Loss of glycosylation at T1478 (P = 0.2242); Loss of phosphorylation at T1478 (P = 0.2283); Loss of helix (P = 0.2662); Gain of solvent accessibility (P = 0.5334); Gain of methylation at R1479 (P = 0.6834)
7:117307157:C:G,P13569,L1480V,0.41,Gain of glycosylation at T1478 (P = 0.1261); Gain of helix (P = 0.132); Gain of phosphorylation at T1478 (P = 0.2297); Loss of loop (P = 0.2897); Loss of stability (P = 0.53)
7:117307157:C:T,P13569,L1480F,0.405,Loss of helix (P = 0.1299); Loss of stability (P = 0.1998); Gain of solvent accessibility (P = 0.2384); Gain of phosphorylation at T1478 (P = 0.2521); Gain of glycosylation at T1478 (P = 0.2606)
7:117307158:T:A,P13569,L1480H,0.53,Loss of stability (P = 0.0034); Gain of glycosylation at T1478 (P = 0.0647); Gain of helix (P = 0.0696); Loss of loop (P = 0.0986); Gain of phosphorylation at T1478 (P = 0.1639)
7:117307158:T:C,P13569,L1480P,0.741,Loss of stability (P = 0.0047); Gain of glycosylation at T1478 (P = 0.069); Gain of phosphorylation at T1478 (P = 0.1007); Gain of helix (P = 0.132); Loss of loop (P = 0.2897)
7:117307158:T:G,P13569,L1480R,0.439,Loss of stability (P = 0.0191); Gain of solvent accessibility (P = 0.0503); Gain of helix (P = 0.0696); Gain of phosphorylation at T1478 (P = 0.0907); Loss of loop (P = 0.0986)
